Citrus Sinensis ID: 017262
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 374 | 2.2.26 [Sep-21-2011] | |||||||
| Q9S9M5 | 730 | Wall-associated receptor | yes | no | 0.941 | 0.482 | 0.627 | 1e-130 | |
| Q9C9L5 | 792 | Wall-associated receptor | no | no | 0.962 | 0.454 | 0.619 | 1e-130 | |
| Q8RY17 | 751 | Wall-associated receptor | no | no | 0.941 | 0.468 | 0.612 | 1e-126 | |
| Q7X8C5 | 748 | Wall-associated receptor | no | no | 0.941 | 0.470 | 0.596 | 1e-126 | |
| Q9S9M3 | 730 | Wall-associated receptor | no | no | 0.847 | 0.434 | 0.658 | 1e-126 | |
| Q8VYA3 | 769 | Wall-associated receptor | no | no | 0.933 | 0.453 | 0.625 | 1e-124 | |
| Q9LN59 | 788 | Putative wall-associated | no | no | 0.938 | 0.445 | 0.607 | 1e-124 | |
| Q9S9M2 | 761 | Wall-associated receptor | no | no | 0.946 | 0.465 | 0.584 | 1e-124 | |
| Q9S9M1 | 731 | Wall-associated receptor | no | no | 0.917 | 0.469 | 0.612 | 1e-123 | |
| Q9LMT9 | 764 | Putative wall-associated | no | no | 0.957 | 0.468 | 0.581 | 1e-121 |
| >sp|Q9S9M5|WAKLA_ARATH Wall-associated receptor kinase-like 1 OS=Arabidopsis thaliana GN=WAKL1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 464 bits (1194), Expect = e-130, Method: Compositional matrix adjust.
Identities = 222/354 (62%), Positives = 291/354 (82%), Gaps = 2/354 (0%)
Query: 2 IFAGIGTGLGGLFLSIGALWLCIIIRKR--IKQKEKNFKKNGGLLLQQQLNSIGGSIDRC 59
+ GI GL GL +G WL +I+KR I + +K FK+NGGLLL+QQL + G+++
Sbjct: 355 VLQGILIGLSGLVFFVGLFWLFKLIKKRRNINRSKKFFKRNGGLLLKQQLTTKDGNVEMS 414
Query: 60 RIFNSKELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEV 119
+IF+SKEL KATD F+++R+LGQGGQGTVYKGML DG I+AVK+SKVVDE K+EEFINE+
Sbjct: 415 KIFSSKELRKATDNFSIDRVLGQGGQGTVYKGMLVDGSIVAVKRSKVVDEDKMEEFINEI 474
Query: 120 VILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATE 179
V+LSQINHRN+VKLLGCCLE EVP+LVYE+IPNG LF+ LHD ++ ++TWE+RLRIA E
Sbjct: 475 VLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLHDESDDYTMTWEVRLRIAIE 534
Query: 180 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF 239
+A AL Y+HS+A PI+HRDIK+TNILLDEKYRAK++DFGTSRS+ +DQTH++T V GTF
Sbjct: 535 IAGALTYMHSAASFPIFHRDIKTTNILLDEKYRAKVSDFGTSRSVTLDQTHLTTLVAGTF 594
Query: 240 GYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCL 299
GY+DPEYF SSQ+T KSDVYSFGVVLVEL+TG+KP+S + + EGR L T+F+E ++EN +
Sbjct: 595 GYMDPEYFLSSQYTHKSDVYSFGVVLVELITGEKPLSRVRSEEGRGLATHFLEAMKENRV 654
Query: 300 FDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRD 353
DIID +++ + E++MAV+ +A++CLN G+NRP MKEV+ ELERIR++ D
Sbjct: 655 IDIIDIRIKDESKLEQVMAVAKLARKCLNRKGKNRPNMKEVSNELERIRSSPED 708
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9C9L5|WAKLH_ARATH Wall-associated receptor kinase-like 9 OS=Arabidopsis thaliana GN=WAKL9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 464 bits (1193), Expect = e-130, Method: Compositional matrix adjust.
Identities = 226/365 (61%), Positives = 288/365 (78%), Gaps = 5/365 (1%)
Query: 5 GIGTGLGGLFLSIGALWLCIIIRK--RIKQKEKNFKKNGGLLLQQQLNSIGGSIDRCRIF 62
G+G G L +G L I+K ++ QK+K FK+NGGLLLQQQL S G +++ +F
Sbjct: 376 GLGASFGSLIFVVGIYLLYKFIKKQRKLNQKKKFFKRNGGLLLQQQLISTVGMVEKTIVF 435
Query: 63 NSKELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVIL 122
+S+EL+KAT+ F+ NRILGQGGQGTVYKGML DGRI+AVKKSKVVDE KLEEFINEVVIL
Sbjct: 436 SSRELEKATENFSSNRILGQGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVIL 495
Query: 123 SQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEE-LSLTWEMRLRIATEVA 181
SQINHRN+VKLLGCCLE +VP+LVYEFIPNG LF++LHD ++E + TW +RLRIA ++A
Sbjct: 496 SQINHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHDEFDENIMATWNIRLRIAIDIA 555
Query: 182 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 241
AL+YLHSSA PIYHRD+KSTNI+LDEKYRAK++DFGTSR++ +D TH++T V GT GY
Sbjct: 556 GALSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGTVGY 615
Query: 242 LDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFD 301
+DPEYF+SSQFTDKSDVYSFGVVLVEL+TG+K IS + + E R L TYF+ ++EN LFD
Sbjct: 616 MDPEYFQSSQFTDKSDVYSFGVVLVELITGEKSISFLRSQENRTLATYFILAMKENKLFD 675
Query: 302 IIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDDENNIQKC 361
IID ++R ++ A + VA++CLN GR RP+M+EV+MEL+ IR D + +Q+C
Sbjct: 676 IIDARIRDGCMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDSIRMPCGDMQ--LQEC 733
Query: 362 YGKVE 366
+ E
Sbjct: 734 VSENE 738
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8RY17|WAKLI_ARATH Wall-associated receptor kinase-like 22 OS=Arabidopsis thaliana GN=WAKL22 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 452 bits (1164), Expect = e-126, Method: Compositional matrix adjust.
Identities = 217/354 (61%), Positives = 286/354 (80%), Gaps = 2/354 (0%)
Query: 2 IFAGIGTGLGGLFLSIGALWLCIIIRKRIKQKEKN--FKKNGGLLLQQQLNSIGGSIDRC 59
+F G+ G LFL +G L ++KR K K FK+NGGLLL+QQL + GG++
Sbjct: 347 LFPGLVLGFPLLFLVLGIWGLIKFVKKRRKIIRKRMFFKRNGGLLLKQQLTTRGGNVQSS 406
Query: 60 RIFNSKELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEV 119
+IF+SKEL+KATD FNMNR+LGQGGQGTVYKGML DGRI+AVK+SKV+DE K+EEFINEV
Sbjct: 407 KIFSSKELEKATDNFNMNRVLGQGGQGTVYKGMLVDGRIVAVKRSKVLDEDKVEEFINEV 466
Query: 120 VILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATE 179
+LSQINHRN+VKL+GCCLE EVP+LVYE IPNG LF+ LH ++ ++TW++RLRI+ E
Sbjct: 467 GVLSQINHRNIVKLMGCCLETEVPILVYEHIPNGDLFKRLHHDSDDYTMTWDVRLRISVE 526
Query: 180 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF 239
+A ALAYLHS+A P+YHRD+K+TNILLDEKYRAK++DFGTSRSI +DQTH++T V GTF
Sbjct: 527 IAGALAYLHSAASTPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINVDQTHLTTLVAGTF 586
Query: 240 GYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCL 299
GYLDPEYF++SQFTDKSDVYSFGVVLVEL+TG+KP S + E R L ++F E +++N +
Sbjct: 587 GYLDPEYFQTSQFTDKSDVYSFGVVLVELITGEKPFSVMRPEENRGLVSHFNEAMKQNRV 646
Query: 300 FDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRD 353
DI+D ++++ E+++AV+ +A+RCL+ G+ RP M+EV++ELERIR++ D
Sbjct: 647 LDIVDSRIKEGCTLEQVLAVAKLARRCLSLKGKKRPNMREVSVELERIRSSPED 700
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Required during plant's response to pathogen infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 451 bits (1159), Expect = e-126, Method: Compositional matrix adjust.
Identities = 211/354 (59%), Positives = 282/354 (79%), Gaps = 2/354 (0%)
Query: 2 IFAGIGTGLGGLFLSIGALWLCIIIRKRIK--QKEKNFKKNGGLLLQQQLNSIGGSIDRC 59
+ G+ G L + G L ++KR K + K F++NGG+LL+QQL G+++
Sbjct: 342 VIQGVLIGSALLLFAFGIFGLYKFVQKRRKLIRMRKFFRRNGGMLLKQQLARKEGNVEMS 401
Query: 60 RIFNSKELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEV 119
RIF+S EL+KATD FN NR+LGQGGQGTVYKGML DGRI+AVK+SK VDE ++EEFINEV
Sbjct: 402 RIFSSHELEKATDNFNKNRVLGQGGQGTVYKGMLVDGRIVAVKRSKAVDEDRVEEFINEV 461
Query: 120 VILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATE 179
V+L+QINHRN+VKLLGCCLE EVP+LVYEF+PNG L + LHD ++ ++TWE+RL IA E
Sbjct: 462 VVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLHDESDDYTMTWEVRLHIAIE 521
Query: 180 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF 239
+A AL+YLHS+A PIYHRDIK+TNILLDE+ RAK++DFGTSRS+ IDQTH++T+V GTF
Sbjct: 522 IAGALSYLHSAASFPIYHRDIKTTNILLDERNRAKVSDFGTSRSVTIDQTHLTTQVAGTF 581
Query: 240 GYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCL 299
GY+DPEYF+SS+FT+KSDVYSFGVVLVELLTG+KP S + + E R L +FVE ++EN +
Sbjct: 582 GYVDPEYFQSSKFTEKSDVYSFGVVLVELLTGEKPSSRVRSEENRGLAAHFVEAVKENRV 641
Query: 300 FDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRD 353
DI+DD+++ +++M+V+++A+RCLN G+ RP M+EV++ELE IR++ D
Sbjct: 642 LDIVDDRIKDECNMDQVMSVANLARRCLNRKGKKRPNMREVSIELEMIRSSHYD 695
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M3|WAKLC_ARATH Wall-associated receptor kinase-like 3 OS=Arabidopsis thaliana GN=WAKL3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 450 bits (1158), Expect = e-126, Method: Compositional matrix adjust.
Identities = 210/319 (65%), Positives = 271/319 (84%), Gaps = 2/319 (0%)
Query: 35 KNFKKNGGLLLQQQLNSIGGSIDRCRIFNSKELDKATDYFNMNRILGQGGQGTVYKGMLA 94
K FK+NGGLLL+QQL + GS++ +IF+S+EL+KATD F+++R+LGQGGQGTVYK ML
Sbjct: 389 KFFKRNGGLLLKQQLTTKDGSVEMSKIFSSRELEKATDNFSIDRVLGQGGQGTVYKRMLV 448
Query: 95 DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGT 154
DG I+AVK+SKVVDE K+EEFINE+V+LSQINHRN+VKLLGCCLE EVP+LVYE+IPNG
Sbjct: 449 DGSIVAVKRSKVVDEDKMEEFINEIVLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGD 508
Query: 155 LFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAK 214
LF+ LHD Y++ +TWE+RLRIA E+A AL+Y+HS+A PI+HRDIK+TNILLDEKYRAK
Sbjct: 509 LFKRLHDEYDDYMMTWEVRLRIAVEIAGALSYMHSAASFPIFHRDIKTTNILLDEKYRAK 568
Query: 215 IADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
I+DFGTSRS+A DQTH++T V GTFGY+DPEYF SSQ+T KSDVYSFGVVLVEL+TG+KP
Sbjct: 569 ISDFGTSRSVATDQTHLTTLVAGTFGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGEKP 628
Query: 275 ISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNR 334
+S + + EG L TYF+E ++EN DIID +R E++++MAV+ +A+RCLN G R
Sbjct: 629 MSRVRSEEGIGLATYFLEAMKENRAVDIID--IRIKDESKQVMAVAKLARRCLNRKGNKR 686
Query: 335 PTMKEVAMELERIRANSRD 353
P M+EV+++LERIR++ +D
Sbjct: 687 PNMREVSIKLERIRSSPKD 705
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8VYA3|WAKLJ_ARATH Wall-associated receptor kinase-like 10 OS=Arabidopsis thaliana GN=WAKL10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 446 bits (1147), Expect = e-124, Method: Compositional matrix adjust.
Identities = 220/352 (62%), Positives = 283/352 (80%), Gaps = 3/352 (0%)
Query: 5 GIGTGLGGLFLSIGALWLCIIIRK--RIKQKEKNFKKNGGLLLQQQLNSIGGSIDRCRIF 62
G+ T L G WL IR+ R+ QK+K FK+NGGLLLQQQL + G++D R+F
Sbjct: 362 GLSTSFSTLVFIGGIYWLYKFIRRQRRLNQKKKFFKRNGGLLLQQQLTTTEGNVDSTRVF 421
Query: 63 NSKELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVIL 122
NS+EL+KAT+ F++ RILG+GGQGTVYKGML DGRI+AVKKSKVVDE KLEEFINEVVIL
Sbjct: 422 NSRELEKATENFSLTRILGEGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVIL 481
Query: 123 SQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLT-WEMRLRIATEVA 181
SQINHRN+VKLLGCCLE +VP+LVYEFIPNG LF++LHD ++ ++T WE+RLRIA ++A
Sbjct: 482 SQINHRNIVKLLGCCLETDVPILVYEFIPNGNLFEHLHDDSDDYTMTTWEVRLRIAVDIA 541
Query: 182 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 241
AL+YLHS+A PIYHRDIKSTNI+LDEK+RAK++DFGTSR++ +D TH++T V GT GY
Sbjct: 542 GALSYLHSAASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVDHTHLTTVVSGTVGY 601
Query: 242 LDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFD 301
+DPEYF+SSQFTDKSDVYSFGVVL EL+TG+K +S + + E R L TYF ++EN L D
Sbjct: 602 MDPEYFQSSQFTDKSDVYSFGVVLAELITGEKSVSFLRSQEYRTLATYFTLAMKENRLSD 661
Query: 302 IIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRD 353
IID ++R + ++ A + +A++CLN GR RP+M++V+MELE+IR+ S D
Sbjct: 662 IIDARIRDGCKLNQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIRSYSED 713
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LN59|WAKLK_ARATH Putative wall-associated receptor kinase-like 11 OS=Arabidopsis thaliana GN=WAKL11 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 445 bits (1145), Expect = e-124, Method: Compositional matrix adjust.
Identities = 220/362 (60%), Positives = 285/362 (78%), Gaps = 11/362 (3%)
Query: 5 GIGTGLGGLFLSIGALWLCIIIRKRIKQKEKN------FKKNGGLLLQQQLNSIGGSIDR 58
G+G+ G L L +G WL RK +K++ + FK+NGGLLLQQQLN+ G++++
Sbjct: 380 GVGSAFGILVLVVGIWWL----RKFLKKRRMSKRKRKFFKRNGGLLLQQQLNTNKGNVEK 435
Query: 59 CRIFNSKELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINE 118
RIF+S+EL+KATD F+ +RILGQGGQGTVYKGML DGR +AVKKSKVVDE KLEEFINE
Sbjct: 436 TRIFSSRELEKATDNFSESRILGQGGQGTVYKGMLVDGRTVAVKKSKVVDEDKLEEFINE 495
Query: 119 VVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIAT 178
VVILSQINHR+VVKLLGCCLE EVP LVYEFIPNG LFQ++H+ ++ + TW MRLRIA
Sbjct: 496 VVILSQINHRHVVKLLGCCLETEVPTLVYEFIPNGNLFQHIHEESDDYTKTWGMRLRIAV 555
Query: 179 EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGT 238
++A AL+YLHS+A PIYHRDIKSTNILLDEKYR K++DFGTSRS+ ID TH +T + GT
Sbjct: 556 DIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRTKVSDFGTSRSVTIDHTHWTTVISGT 615
Query: 239 FGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIW-ANEGRNLTTYFVECIEEN 297
GY+DPEY+ SSQ+TDKSDVYSFGVVLVEL+TG+KP+ ++ + E R L +F ++EN
Sbjct: 616 VGYVDPEYYGSSQYTDKSDVYSFGVVLVELITGEKPVITVSNSQEIRGLADHFRVAMKEN 675
Query: 298 CLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDDENN 357
F+I+D ++R + E++MAV+++A+RCLNS G+ RP M++V +LE+I A+ D N
Sbjct: 676 RFFEIMDARIRDGCKPEQVMAVANLARRCLNSKGKKRPCMRKVFTDLEKILASQEDSLVN 735
Query: 358 IQ 359
I+
Sbjct: 736 IE 737
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M2|WAKLD_ARATH Wall-associated receptor kinase-like 4 OS=Arabidopsis thaliana GN=WAKL4 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 443 bits (1140), Expect = e-124, Method: Compositional matrix adjust.
Identities = 208/356 (58%), Positives = 276/356 (77%), Gaps = 2/356 (0%)
Query: 2 IFAGIGTGLGGLFLSIGALWLCIIIRKRIKQKEKN--FKKNGGLLLQQQLNSIGGSIDRC 59
+F G+ G L + G L I+K+ + F++NGG+LL+QQL G+++
Sbjct: 350 VFQGVLIGSALLLFAFGIFGLYKFIKKQRRSSRMRVFFRRNGGMLLKQQLARKEGNVEMS 409
Query: 60 RIFNSKELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEV 119
+IF+S EL+KATD FN NR+LGQGGQGTVYKGML DGRI+AVK+SK +DE K+EEFINEV
Sbjct: 410 KIFSSNELEKATDNFNTNRVLGQGGQGTVYKGMLVDGRIVAVKRSKAMDEDKVEEFINEV 469
Query: 120 VILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATE 179
V+L+QINHRN+VKLLGCCLE EVP+LVYEF+PNG L + L D ++ +TWE+RL IA E
Sbjct: 470 VVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLRDECDDYIMTWEVRLHIAIE 529
Query: 180 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF 239
+A AL+YLHS+A PIYHRDIK+TNILLDEKY+ K++DFGTSRS+ IDQTH++T+V GTF
Sbjct: 530 IAGALSYLHSAASFPIYHRDIKTTNILLDEKYQVKVSDFGTSRSVTIDQTHLTTQVAGTF 589
Query: 240 GYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCL 299
GY+DPEYF+SS+FTDKSDVYSFGVVLVEL+TG+ P S + + E R +FV ++EN
Sbjct: 590 GYVDPEYFQSSKFTDKSDVYSFGVVLVELITGKNPSSRVQSEENRGFAAHFVAAVKENRF 649
Query: 300 FDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDDE 355
DI+D++++ +++MAV+ +AKRCLN G+ RP M+EV++ELERIR++S E
Sbjct: 650 LDIVDERIKDECNLDQVMAVAKLAKRCLNRKGKKRPNMREVSVELERIRSSSYKSE 705
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Plays a role in plant mineral nutrients response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M1|WAKLE_ARATH Wall-associated receptor kinase-like 5 OS=Arabidopsis thaliana GN=WAKL5 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 441 bits (1135), Expect = e-123, Method: Compositional matrix adjust.
Identities = 212/346 (61%), Positives = 284/346 (82%), Gaps = 3/346 (0%)
Query: 17 IGALWLCIII--RKRIKQKEKNFKKNGGLLLQQQLNSIG-GSIDRCRIFNSKELDKATDY 73
+G L L I I R+RI K FK+NGGLLL+QQL + G++D R+F+S+EL KATD
Sbjct: 372 VGTLGLIIFIKKRRRIISSRKFFKRNGGLLLKQQLTTTNDGNVDMSRLFSSEELKKATDN 431
Query: 74 FNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKL 133
F++ R+LG+G QGTVYKGM+ DG+IIAVK+SKVVDE KLE+FINE+++LSQINHRN+VKL
Sbjct: 432 FSVKRVLGKGSQGTVYKGMMVDGKIIAVKRSKVVDEDKLEKFINEIILLSQINHRNIVKL 491
Query: 134 LGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYL 193
+GCCLE EVP+LVYE+IPNG +F+ LHD ++ ++TWE+RLRIA E+A AL Y+HS+A
Sbjct: 492 IGCCLETEVPILVYEYIPNGDMFKRLHDESDDYAMTWEVRLRIAIEIAGALTYMHSAASF 551
Query: 194 PIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFT 253
PIYHRDIK+TNILLDEKY AK++DFGTSRS+ IDQTH++T V GTFGY+DPEYF SSQ+T
Sbjct: 552 PIYHRDIKTTNILLDEKYGAKVSDFGTSRSVTIDQTHLTTMVAGTFGYMDPEYFLSSQYT 611
Query: 254 DKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEA 313
DKSDVYSFGVVLVEL+TG+KP+S I + EGR L T+F+E ++EN + DIID ++++ +
Sbjct: 612 DKSDVYSFGVVLVELITGEKPLSRIRSEEGRGLATHFLEAMKENRVIDIIDIRIKEESKL 671
Query: 314 EEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDDENNIQ 359
+++MAV+ +A++CL+ G RP M+E ++ELERIR++ D E +I+
Sbjct: 672 DQLMAVAKLARKCLSRKGIKRPNMREASLELERIRSSPEDLEAHIE 717
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. May be involved in plant's response to pathogen infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMT9|WAKLL_ARATH Putative wall-associated receptor kinase-like 13 OS=Arabidopsis thaliana GN=WAKL13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 436 bits (1120), Expect = e-121, Method: Compositional matrix adjust.
Identities = 210/361 (58%), Positives = 277/361 (76%), Gaps = 3/361 (0%)
Query: 2 IFAGIGTGLGGLFLSIGALWLCIIIRKR--IKQKEKNFKKNGGLLLQQQLNSIGGSIDRC 59
+ G+G G L + G W ++RKR +K K FK+NGGLLLQQQLN+ G +++
Sbjct: 380 VMLGLGAGFFVLIVGGGIWWWRKLLRKRRMTNRKRKFFKRNGGLLLQQQLNTTQGRVEKT 439
Query: 60 RIFNSKELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEV 119
++F+S+EL+KATD FN NR++GQGGQGTVYKGML DGR +AVKKS VVDE KL+EFINEV
Sbjct: 440 KLFSSRELEKATDNFNDNRVIGQGGQGTVYKGMLVDGRSVAVKKSNVVDEDKLQEFINEV 499
Query: 120 VILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATE 179
+ILSQINHR+VVKLLGCCLE EVP+LVYEFIPNG LFQ+LH+ +++ + W +R+RIA +
Sbjct: 500 IILSQINHRHVVKLLGCCLETEVPILVYEFIPNGNLFQHLHEEFDDYTALWGVRMRIAVD 559
Query: 180 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF 239
++ A +YLH++A PIYHRDIKSTNILLDEKYRAK++DFGTSRS++ID TH +T + GT
Sbjct: 560 ISGAFSYLHTAACSPIYHRDIKSTNILLDEKYRAKVSDFGTSRSVSIDHTHWTTVISGTV 619
Query: 240 GYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIW-ANEGRNLTTYFVECIEENC 298
GY+DPEY+ SS FT+KSDVYSFGVVLVEL+TG+KP+ ++ E L YF + EN
Sbjct: 620 GYVDPEYYGSSHFTEKSDVYSFGVVLVELITGEKPVITLSETQEITGLADYFRLAMRENR 679
Query: 299 LFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDDENNI 358
LF+IID ++R + E+++AV+++A RCL G+ RP M+EV+ LERI + D + I
Sbjct: 680 LFEIIDARIRNDCKLEQVIAVANLALRCLKKTGKTRPDMREVSTALERICSAPEDFQVQI 739
Query: 359 Q 359
Q
Sbjct: 740 Q 740
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 374 | ||||||
| 224118592 | 642 | predicted protein [Populus trichocarpa] | 0.917 | 0.534 | 0.686 | 1e-137 | |
| 224075820 | 626 | predicted protein [Populus trichocarpa] | 0.919 | 0.549 | 0.717 | 1e-137 | |
| 359491507 | 518 | PREDICTED: wall-associated receptor kina | 0.930 | 0.671 | 0.672 | 1e-136 | |
| 255545824 | 727 | kinase, putative [Ricinus communis] gi|2 | 0.919 | 0.473 | 0.693 | 1e-136 | |
| 147852023 | 413 | hypothetical protein VITISV_028337 [Viti | 0.906 | 0.820 | 0.686 | 1e-135 | |
| 255545828 | 694 | kinase, putative [Ricinus communis] gi|2 | 0.933 | 0.502 | 0.676 | 1e-135 | |
| 359475620 | 822 | PREDICTED: wall-associated receptor kina | 0.930 | 0.423 | 0.668 | 1e-134 | |
| 359475622 | 867 | PREDICTED: wall-associated receptor kina | 0.962 | 0.415 | 0.649 | 1e-134 | |
| 255541802 | 743 | kinase, putative [Ricinus communis] gi|2 | 0.949 | 0.477 | 0.671 | 1e-133 | |
| 115432146 | 453 | cold-induced wall associated kinase, par | 0.962 | 0.794 | 0.647 | 1e-133 |
| >gi|224118592|ref|XP_002331400.1| predicted protein [Populus trichocarpa] gi|222873614|gb|EEF10745.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 494 bits (1273), Expect = e-137, Method: Compositional matrix adjust.
Identities = 241/351 (68%), Positives = 290/351 (82%), Gaps = 8/351 (2%)
Query: 9 GLGGLFLSIGALWLCIIIRKRI--KQKEKNFKKNGGLLLQQQLNSIGGSIDRCRIFNSKE 66
G G LFL IG WL + +++ K K+K FK+NGGLLLQ+QL+S ++++ ++F SKE
Sbjct: 278 GFGALFLLIGLWWLYKVFKRKRSEKLKKKYFKRNGGLLLQEQLSSGEVNVEKIKMFPSKE 337
Query: 67 LDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQIN 126
LDKATD++N+NR LGQGGQGTVYKGMLADG+I+AVKKSK +DE L +FINEVV+LSQIN
Sbjct: 338 LDKATDHYNVNRTLGQGGQGTVYKGMLADGKIVAVKKSKEIDEGNLRQFINEVVLLSQIN 397
Query: 127 HRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAY 186
HRNVVKLLGCCLE E+PLL+YEFIPNGTLFQ+LHDP EE LTWEMRLRIA EVA AL Y
Sbjct: 398 HRNVVKLLGCCLETELPLLIYEFIPNGTLFQFLHDPNEEFPLTWEMRLRIAAEVAGALFY 457
Query: 187 LHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEY 246
LHS+A LPI+HRDIKSTNILLDE+YRAK+ADFGTSRS++IDQTHV+T+VQGTFGYLDPEY
Sbjct: 458 LHSAASLPIFHRDIKSTNILLDEEYRAKVADFGTSRSVSIDQTHVTTRVQGTFGYLDPEY 517
Query: 247 FRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANE-GRNLTTYFVECIEENCLFDIIDD 305
F+SSQFTDKSDVYSFGVVLVELLTGQKPIS + E GR+L TYF+ +E NCLFDI+D
Sbjct: 518 FQSSQFTDKSDVYSFGVVLVELLTGQKPISFTRSEEQGRSLATYFIMAMESNCLFDILDP 577
Query: 306 QVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDDEN 356
QV K GE E+++ V+ +A+ CL G+ RPTMK V M R+ ++ D N
Sbjct: 578 QVVKQGEREDVLMVASLARSCLRLNGKERPTMKGVTM-----RSGTKTDYN 623
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224075820|ref|XP_002335844.1| predicted protein [Populus trichocarpa] gi|222835559|gb|EEE73994.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 494 bits (1273), Expect = e-137, Method: Compositional matrix adjust.
Identities = 249/347 (71%), Positives = 291/347 (83%), Gaps = 3/347 (0%)
Query: 4 AGIGTGLGGLFLSIGALWLCIIIRKRI--KQKEKNFKKNGGLLLQQQLNSIGGSIDRCRI 61
AG+G G G L L IG WL + +++ K K+K FK+NGGLLLQ+QL+S ++++ ++
Sbjct: 280 AGVGVGFGALLLLIGLWWLYKVFKRKRSEKLKKKYFKRNGGLLLQEQLSSGEVNVEKIKM 339
Query: 62 FNSKELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVI 121
F SKELDKATD++N+NR LGQGGQGTVYKGMLADG+I+AVKKSKV+DE L +FINEVV+
Sbjct: 340 FPSKELDKATDHYNVNRTLGQGGQGTVYKGMLADGKIVAVKKSKVIDEGNLRQFINEVVL 399
Query: 122 LSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVA 181
LSQINHRNVVKLLGCCLE EVPLLVYEFIPNGTLFQ+LHDP EE LTWEMRLRIA EVA
Sbjct: 400 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQFLHDPNEEFPLTWEMRLRIAAEVA 459
Query: 182 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 241
AL YLHS+A LPI+HRDIKSTNILLDEKYRAK+ADFGTSRS++IDQTHV+T VQGTFGY
Sbjct: 460 GALFYLHSAASLPIFHRDIKSTNILLDEKYRAKVADFGTSRSVSIDQTHVTTLVQGTFGY 519
Query: 242 LDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANE-GRNLTTYFVECIEENCLF 300
LDPEYF+SSQFTDKSDVYSFGVVLVELLTGQK IS + E GR+L TYF+ +E NCLF
Sbjct: 520 LDPEYFQSSQFTDKSDVYSFGVVLVELLTGQKAISFTRSEEQGRSLATYFIMAMESNCLF 579
Query: 301 DIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347
DI+D QV K GE EE++ V+ +A+ CL G+ RPTMKEV M LERI
Sbjct: 580 DILDPQVVKQGEREEVLMVASLARSCLRLNGKERPTMKEVTMVLERI 626
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491507|ref|XP_003634286.1| PREDICTED: wall-associated receptor kinase-like 8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 490 bits (1261), Expect = e-136, Method: Compositional matrix adjust.
Identities = 236/351 (67%), Positives = 292/351 (83%), Gaps = 3/351 (0%)
Query: 2 IFAGIGTGLGGLFLSIGALWLCIIIRKR--IKQKEKNFKKNGGLLLQQQLNSIGGSIDRC 59
I AG+ G LFL +G+ WL +++KR IK K++ FK+NGGLLLQQQ++S +++
Sbjct: 117 ILAGLSVVGGSLFLLLGSFWLYKVLKKRREIKLKKQFFKQNGGLLLQQQISS-NKVVEKT 175
Query: 60 RIFNSKELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEV 119
+IF ++EL+KA+D FN NRILG+GGQGTVYKGML DGRI+A+KKSK+VDES+ E+FINE+
Sbjct: 176 KIFTTEELEKASDNFNENRILGRGGQGTVYKGMLTDGRIVAIKKSKIVDESQYEQFINEI 235
Query: 120 VILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATE 179
VILSQ+NHRN+VKLLGCCLE+EVPLLVYEFI +GTLFQ +HD EL +WE RL IATE
Sbjct: 236 VILSQLNHRNIVKLLGCCLEIEVPLLVYEFISHGTLFQLIHDENNELPFSWERRLEIATE 295
Query: 180 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF 239
VA ALAYLHS++ PI+HRDIKS NILLDEKYRAK+ADFGTSRS++IDQTH++T V+GTF
Sbjct: 296 VAGALAYLHSASSTPIFHRDIKSKNILLDEKYRAKVADFGTSRSVSIDQTHLTTLVRGTF 355
Query: 240 GYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCL 299
GYLDPEYFR+ QFT+KSDVYSFG+VLVELLTGQKPISS E R+L +YF+ IEE L
Sbjct: 356 GYLDPEYFRTGQFTEKSDVYSFGIVLVELLTGQKPISSTRTEEERSLASYFILSIEETNL 415
Query: 300 FDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350
FDI+D QV K G EEIMAV +VA +CLN G+ RPTMKEVA+ELER++++
Sbjct: 416 FDILDAQVVKEGGEEEIMAVVNVATQCLNLNGKKRPTMKEVALELERVKSH 466
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255545824|ref|XP_002513972.1| kinase, putative [Ricinus communis] gi|223547058|gb|EEF48555.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 489 bits (1260), Expect = e-136, Method: Compositional matrix adjust.
Identities = 240/346 (69%), Positives = 296/346 (85%), Gaps = 2/346 (0%)
Query: 24 IIIRKR-IKQKEKNFKKNGGLLLQQQLNSIGGSIDRCRIFNSKELDKATDYFNMNRILGQ 82
II R+R K K+K FK+NGGLLL+QQL+S +++ ++F SKEL+KATD ++ +RILGQ
Sbjct: 344 IIKRRRATKLKQKFFKRNGGLLLEQQLSSTESHVEQTKVFTSKELEKATDNYHTSRILGQ 403
Query: 83 GGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEV 142
GGQGTVYKGML DGR++A+KKSK+VDE KL++FINEVVILSQINHRNVVKL GCCLE EV
Sbjct: 404 GGQGTVYKGMLTDGRVVAIKKSKLVDEDKLDQFINEVVILSQINHRNVVKLTGCCLETEV 463
Query: 143 PLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKS 202
PLLVYEFIPNGTLFQY+ +P +E +TWEMRLRIATEVA ALAYLHS+A +PIYHRDIKS
Sbjct: 464 PLLVYEFIPNGTLFQYIQNPNKEFPITWEMRLRIATEVAGALAYLHSAASMPIYHRDIKS 523
Query: 203 TNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFG 262
+NILLDEKYRAK+ADFGTS+SIAI+QTHV+T VQGTFGYLDPEYF+SSQFT+KSDVYSFG
Sbjct: 524 SNILLDEKYRAKVADFGTSKSIAIEQTHVTTLVQGTFGYLDPEYFQSSQFTEKSDVYSFG 583
Query: 263 VVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDV 322
VVLVELLTGQKPISS+ + E R+L TYF+ +EEN LF+I+D +V K G EEI+A++ +
Sbjct: 584 VVLVELLTGQKPISSLRSVEERSLATYFLMTMEENRLFEILDARVLKEGGREEIIAMAKM 643
Query: 323 AKRCLNSYGRNRPTMKEVAMELERIRANSRDDENNIQKCYGKVEYI 368
A++CLN G+ RP MK VA+ELE IR+ S+ + IQ+ Y +V+Y+
Sbjct: 644 AEKCLNLNGKKRPKMKTVAIELEGIRS-SQGVSSTIQQDYEEVDYV 688
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147852023|emb|CAN82287.1| hypothetical protein VITISV_028337 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 489 bits (1258), Expect = e-135, Method: Compositional matrix adjust.
Identities = 234/341 (68%), Positives = 292/341 (85%), Gaps = 2/341 (0%)
Query: 27 RKRIKQKEKNFKKNGGLLLQQQLNSIGGSIDRCRIFNSKELDKATDYFNMNRILGQGGQG 86
R++IK KEK FK+NGGLLL+QQL+S G++D+ ++F SKEL+KATD +N NR++GQGGQG
Sbjct: 36 RRKIKHKEKCFKRNGGLLLEQQLSSSEGNVDKTKLFTSKELEKATDRYNENRVIGQGGQG 95
Query: 87 TVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146
TVYKGML DGRI+AVKK K+V + KLE+FINEVVILSQINHRNVVKLLGCCLE+EVPLLV
Sbjct: 96 TVYKGMLMDGRIVAVKKLKIVGDGKLEQFINEVVILSQINHRNVVKLLGCCLEIEVPLLV 155
Query: 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNIL 206
YE+IPNGTL +++HD EE +TW+MRL+IATEVA AL+YLHS+A +PIYHRDIKSTNIL
Sbjct: 156 YEYIPNGTLSEHIHDQNEEFPITWKMRLQIATEVAGALSYLHSAASIPIYHRDIKSTNIL 215
Query: 207 LDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLV 266
LD+KYRAK+ADFGTS+S+AIDQTH++TKVQGTFGYLDPEYF+SSQFT+KSDVYSFG+VL+
Sbjct: 216 LDDKYRAKVADFGTSKSVAIDQTHLTTKVQGTFGYLDPEYFQSSQFTEKSDVYSFGIVLI 275
Query: 267 ELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRC 326
ELLTG+KPI SI + EG++L +YF+ ++E+ L D++D +V K G EEI A++ +AKRC
Sbjct: 276 ELLTGKKPILSIGSGEGKSLASYFIMSMKEDRLSDLLDARVVKEGRKEEINAIAFLAKRC 335
Query: 327 LNSYGRNRPTMKEVAMELERIRANSRDDENNIQKCYGKVEY 367
+N G+ RPTM EVAMELERIR D N Q+ +VEY
Sbjct: 336 INLNGKKRPTMMEVAMELERIRKCEGD--FNAQENSDEVEY 374
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255545828|ref|XP_002513974.1| kinase, putative [Ricinus communis] gi|223547060|gb|EEF48557.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 488 bits (1256), Expect = e-135, Method: Compositional matrix adjust.
Identities = 236/349 (67%), Positives = 294/349 (84%)
Query: 13 LFLSIGALWLCIIIRKRIKQKEKNFKKNGGLLLQQQLNSIGGSIDRCRIFNSKELDKATD 72
L + I +L+ I R+ +K K+ FK+NGGLLL+QQL+S +++ ++F SKEL+KATD
Sbjct: 339 LLIGIWSLYKIIKRRRAMKLKQNFFKRNGGLLLEQQLSSTENYVEQTKVFTSKELEKATD 398
Query: 73 YFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVK 132
++ NRILGQGGQGTVYKGML DGR++A+KKSKVVDE KL++FINEVVILSQINHRNVVK
Sbjct: 399 DYHTNRILGQGGQGTVYKGMLIDGRVVAIKKSKVVDEDKLDQFINEVVILSQINHRNVVK 458
Query: 133 LLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAY 192
L+GCCLE EVPLLVYEFIPNGTL+QY+H+P EE +TWEMRLRIATEVA ALAYLH++A
Sbjct: 459 LIGCCLETEVPLLVYEFIPNGTLYQYIHNPNEEFPVTWEMRLRIATEVAGALAYLHAAAS 518
Query: 193 LPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQF 252
+PIYHRDIKS+NILLDEKYRAK+ADFGTS+SI+IDQTHV+T+VQGTFGYLDPEYF+SSQF
Sbjct: 519 MPIYHRDIKSSNILLDEKYRAKVADFGTSKSISIDQTHVTTRVQGTFGYLDPEYFQSSQF 578
Query: 253 TDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGE 312
T+KSDVYSFGVVLVELLTGQKPISS + E R+L TYF+ +EE+ LF+I+D +V K G
Sbjct: 579 TEKSDVYSFGVVLVELLTGQKPISSYRSVEERSLATYFLMTMEESRLFEILDARVLKEGG 638
Query: 313 AEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDDENNIQKC 361
EEI+A++ +A++CLN G+ RP MK VA+ELE IR++ + +C
Sbjct: 639 REEIIAMAKLAEKCLNLNGKKRPKMKTVAIELEGIRSSQGHNHTCPFRC 687
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475620|ref|XP_002266785.2| PREDICTED: wall-associated receptor kinase-like 1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 486 bits (1250), Expect = e-134, Method: Compositional matrix adjust.
Identities = 234/350 (66%), Positives = 293/350 (83%), Gaps = 2/350 (0%)
Query: 2 IFAGIGTGLGGLFLSIGALWLCIIIRKR--IKQKEKNFKKNGGLLLQQQLNSIGGSIDRC 59
I GI G+G L L I A WL ++++R IK KEK FK+NGGLLL+QQL+S G++D+
Sbjct: 455 ICVGILAGVGTLLLVICAWWLYKVLKRRQKIKYKEKCFKRNGGLLLEQQLSSSEGNVDKT 514
Query: 60 RIFNSKELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEV 119
++F SKEL+KATD +N NR++GQGGQGTVYKGML DGRI+AVKK K+V + K+E+FINEV
Sbjct: 515 KLFTSKELEKATDRYNENRVIGQGGQGTVYKGMLMDGRIVAVKKLKIVGDGKVEQFINEV 574
Query: 120 VILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATE 179
VILSQINHRNVVKLLGCCLE VPLLVYEFIPNGTL +++HD EE +TWEMRLRIA E
Sbjct: 575 VILSQINHRNVVKLLGCCLETAVPLLVYEFIPNGTLSEHIHDQNEEFPITWEMRLRIAIE 634
Query: 180 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF 239
VA AL+YLHS+A +PIYHRDIKSTNILLD+KYRAK+ADFGTS+S+AIDQTH++T+VQGTF
Sbjct: 635 VAGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVADFGTSKSVAIDQTHLTTQVQGTF 694
Query: 240 GYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCL 299
GYLDPEYF+SSQFT+KSDVYSFG+VL+ELLTG+KPI S + EG++L +YF+ + E+ L
Sbjct: 695 GYLDPEYFQSSQFTEKSDVYSFGIVLIELLTGKKPILSTASEEGKSLASYFILSMNEDRL 754
Query: 300 FDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRA 349
D++D QV K G+ EEI A++ +A+RC+N G+ RPTM EVAMELE ++
Sbjct: 755 SDLLDAQVVKEGKKEEINAIAFLARRCINLNGKKRPTMMEVAMELEILKT 804
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475622|ref|XP_003631717.1| PREDICTED: wall-associated receptor kinase-like 10-like, partial [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 483 bits (1243), Expect = e-134, Method: Compositional matrix adjust.
Identities = 237/365 (64%), Positives = 296/365 (81%), Gaps = 5/365 (1%)
Query: 9 GLGGLFLSIGALWLCIII--RKRIKQKEKNFKKNGGLLLQQQLNSIGGSIDRCRIFNSKE 66
LG L L + A WL I++ RK+IK KEK F +NGGLLL+QQL+S G+ID+ ++F SKE
Sbjct: 306 ALGTLLLVLCAWWLYIVLKRRKKIKYKEKCFNRNGGLLLEQQLSSTEGNIDKTKLFTSKE 365
Query: 67 LDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQIN 126
L+KATD +N NR++GQGG+GTVYKGML DGRI+AVKK K++ +SKLE+FINEVVIL QIN
Sbjct: 366 LEKATDRYNENRVIGQGGEGTVYKGMLMDGRIVAVKKLKIMSDSKLEQFINEVVILCQIN 425
Query: 127 HRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAY 186
HRNVVKLLGCCLE EVPLLVYEFIPNGTL +++H EE +TWE+RLRIATEVA AL+Y
Sbjct: 426 HRNVVKLLGCCLETEVPLLVYEFIPNGTLSEHIHGQNEEFPITWEIRLRIATEVAGALSY 485
Query: 187 LHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEY 246
LHS+A +PIYHRDIKSTNILLD+KYRAK+ADFG S+ +AIDQTH++T+VQGTFGYLDPEY
Sbjct: 486 LHSAASVPIYHRDIKSTNILLDDKYRAKVADFGISKFVAIDQTHLTTQVQGTFGYLDPEY 545
Query: 247 FRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306
F+SSQFT+KSDVYSFG+VL+ELLTG+KPI S + EG++L +YF+ + E+ L D++D Q
Sbjct: 546 FQSSQFTEKSDVYSFGIVLIELLTGKKPILSTASEEGKSLASYFILSMNEDRLSDLLDAQ 605
Query: 307 VRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRD---DENNIQKCYG 363
V K EEI A++ +A+RC+N G+ RPTM EVAMELERIR D EN+ + Y
Sbjct: 606 VVKESRKEEINAIAFLARRCINLNGKKRPTMMEVAMELERIRKCQGDFGAQENSEEIEYN 665
Query: 364 KVEYI 368
+E I
Sbjct: 666 TIELI 670
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255541802|ref|XP_002511965.1| kinase, putative [Ricinus communis] gi|223549145|gb|EEF50634.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 481 bits (1237), Expect = e-133, Method: Compositional matrix adjust.
Identities = 243/362 (67%), Positives = 299/362 (82%), Gaps = 7/362 (1%)
Query: 6 IGTGLGGLFLSIGALWLCIIIRKR--IKQKEKNFKKNGGLLLQQQLNSIGGSIDRCRIFN 63
+ GLG FL IG WL + ++R K +++ FK+NGGLLLQQQL+S SI++ +F
Sbjct: 332 LSAGLGIPFLLIGTWWLYKVQKRRKDAKLRQRFFKRNGGLLLQQQLSSSESSIEKTNMFT 391
Query: 64 SKELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILS 123
+KEL+KATD++N NRILGQGGQGTVYKGML DG+++A+KKSK+ DESK E+FINEVVILS
Sbjct: 392 AKELEKATDHYNENRILGQGGQGTVYKGMLTDGKVVAIKKSKIADESKTEQFINEVVILS 451
Query: 124 QINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEA 183
QINHRNVVKLLGCCLE EVPLLVYEFIPNGTL+Q+LHDP EE +TWEMRLRIA E A
Sbjct: 452 QINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDPSEEFPITWEMRLRIAIETGSA 511
Query: 184 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 243
L+YLHS+A +PIYHRDIKSTNILLD+KYRAK++DFGTS+SIA+DQTHV+T+VQGTFGYLD
Sbjct: 512 LSYLHSAASVPIYHRDIKSTNILLDDKYRAKVSDFGTSKSIAVDQTHVTTRVQGTFGYLD 571
Query: 244 PEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDII 303
PEYF+SSQFT+KSDVYSFGVVLVELLTGQKPISS A E R+L YF+ +E+N LF+I+
Sbjct: 572 PEYFQSSQFTEKSDVYSFGVVLVELLTGQKPISSARAVEERSLAMYFLLSMEQNRLFEIL 631
Query: 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSR-----DDENNI 358
D +V K G EEI+AV+ +A+RCLN G+ RPTM+ V E+ERIRA+ + + EN+
Sbjct: 632 DARVLKEGGKEEILAVAKLARRCLNLNGKKRPTMRTVVTEVERIRASQQGTCFTNGENDY 691
Query: 359 QK 360
Q+
Sbjct: 692 QE 693
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|115432146|gb|ABI97350.1| cold-induced wall associated kinase, partial [Ammopiptanthus mongolicus] | Back alignment and taxonomy information |
|---|
Score = 481 bits (1237), Expect = e-133, Method: Compositional matrix adjust.
Identities = 237/366 (64%), Positives = 292/366 (79%), Gaps = 6/366 (1%)
Query: 3 FAGIGTGLGGLFLSIGALWLCIIIRKRI--KQKEKNFKKNGGLLLQQQLNSIGGSIDRCR 60
G+ + LG + L G WL ++RKR+ K+KEK FK++GGLLLQQ+L+S S+DR
Sbjct: 55 LVGVLSSLGSIILLFGLWWLYKVVRKRMIKKRKEKFFKQHGGLLLQQRLSSGEVSVDRAI 114
Query: 61 IFNSKELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVV 120
+F+ K+L++ATD FN+NR+LG+GGQGTVYKGML DGR +AVKK KV + K+EEFINE V
Sbjct: 115 LFSLKDLERATDNFNINRVLGKGGQGTVYKGMLVDGRTVAVKKFKV--QGKVEEFINEFV 172
Query: 121 ILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEV 180
ILSQINHRNVVKLLGCCLE E+PLLVYEFIPNG LFQYLHD E+L +TW+MRLRIATE+
Sbjct: 173 ILSQINHRNVVKLLGCCLETEIPLLVYEFIPNGNLFQYLHDQNEDLPMTWDMRLRIATEI 232
Query: 181 AEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFG 240
A AL YLHS A PIYHRDIKSTNILLDEKYRAK+ADFGTSR ++I+ TH++T VQGTFG
Sbjct: 233 AGALFYLHSVASQPIYHRDIKSTNILLDEKYRAKVADFGTSRIVSIEATHLTTVVQGTFG 292
Query: 241 YLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLF 300
YLDPEYF +SQFT+KSDVYSFGVVL ELLTG+KPIS + + E +NL +YF +EE+ LF
Sbjct: 293 YLDPEYFHTSQFTEKSDVYSFGVVLAELLTGRKPISLVSSEEAKNLASYFALSMEEDSLF 352
Query: 301 DIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDDENNIQK 360
+IID +V K GE E IM V+++A RCL G+ RPTMKEV +ELERIR D + N Q+
Sbjct: 353 EIIDKRVAKKGEKEHIMGVANLAYRCLELNGKKRPTMKEVTLELERIRGP--DKKFNAQQ 410
Query: 361 CYGKVE 366
+ ++E
Sbjct: 411 NHEEIE 416
|
Source: Ammopiptanthus mongolicus Species: Ammopiptanthus mongolicus Genus: Ammopiptanthus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 374 | ||||||
| TAIR|locus:2200552 | 730 | WAKL1 "wall associated kinase- | 0.941 | 0.482 | 0.596 | 6.4e-115 | |
| TAIR|locus:2019893 | 751 | RFO1 "RESISTANCE TO FUSARIUM O | 0.959 | 0.478 | 0.578 | 4.6e-112 | |
| TAIR|locus:2205040 | 792 | AT1G69730 [Arabidopsis thalian | 0.962 | 0.454 | 0.586 | 2.6e-111 | |
| TAIR|locus:2019843 | 769 | WAKL10 "WALL ASSOCIATED KINASE | 0.933 | 0.453 | 0.588 | 2.3e-110 | |
| TAIR|locus:2200562 | 748 | WAKL2 "wall associated kinase- | 0.863 | 0.431 | 0.613 | 1.3e-109 | |
| TAIR|locus:2016377 | 788 | AT1G19390 [Arabidopsis thalian | 0.949 | 0.450 | 0.586 | 1.6e-109 | |
| TAIR|locus:2126316 | 786 | AT4G31100 [Arabidopsis thalian | 0.946 | 0.450 | 0.578 | 8.3e-106 | |
| TAIR|locus:2126271 | 793 | AT4G31110 [Arabidopsis thalian | 0.943 | 0.445 | 0.573 | 4.6e-105 | |
| TAIR|locus:2032875 | 720 | AT1G16260 [Arabidopsis thalian | 0.943 | 0.490 | 0.544 | 2.5e-104 | |
| TAIR|locus:2030988 | 764 | AT1G17910 [Arabidopsis thalian | 0.957 | 0.468 | 0.548 | 6.7e-104 |
| TAIR|locus:2200552 WAKL1 "wall associated kinase-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1133 (403.9 bits), Expect = 6.4e-115, P = 6.4e-115
Identities = 211/354 (59%), Positives = 275/354 (77%)
Query: 2 IFAGIGTGLGGLFLSIGALWLCXXXXXXXXXXXXN--FKKNGGXXXXXXXNSIGGSIDRC 59
+ GI GL GL +G WL FK+NGG + G+++
Sbjct: 355 VLQGILIGLSGLVFFVGLFWLFKLIKKRRNINRSKKFFKRNGGLLLKQQLTTKDGNVEMS 414
Query: 60 RIFNSKELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEV 119
+IF+SKEL KATD F+++R+LGQGGQGTVYKGML DG I+AVK+SKVVDE K+EEFINE+
Sbjct: 415 KIFSSKELRKATDNFSIDRVLGQGGQGTVYKGMLVDGSIVAVKRSKVVDEDKMEEFINEI 474
Query: 120 VILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATE 179
V+LSQINHRN+VKLLGCCLE EVP+LVYE+IPNG LF+ LHD ++ ++TWE+RLRIA E
Sbjct: 475 VLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLHDESDDYTMTWEVRLRIAIE 534
Query: 180 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF 239
+A AL Y+HS+A PI+HRDIK+TNILLDEKYRAK++DFGTSRS+ +DQTH++T V GTF
Sbjct: 535 IAGALTYMHSAASFPIFHRDIKTTNILLDEKYRAKVSDFGTSRSVTLDQTHLTTLVAGTF 594
Query: 240 GYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCL 299
GY+DPEYF SSQ+T KSDVYSFGVVLVEL+TG+KP+S + + EGR L T+F+E ++EN +
Sbjct: 595 GYMDPEYFLSSQYTHKSDVYSFGVVLVELITGEKPLSRVRSEEGRGLATHFLEAMKENRV 654
Query: 300 FDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRD 353
DIID +++ + E++MAV+ +A++CLN G+NRP MKEV+ ELERIR++ D
Sbjct: 655 IDIIDIRIKDESKLEQVMAVAKLARKCLNRKGKNRPNMKEVSNELERIRSSPED 708
|
|
| TAIR|locus:2019893 RFO1 "RESISTANCE TO FUSARIUM OXYSPORUM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1106 (394.4 bits), Expect = 4.6e-112, P = 4.6e-112
Identities = 209/361 (57%), Positives = 278/361 (77%)
Query: 2 IFAGIGTGLGGLFLSIGALWLCXXXXXXXXXXXXN--FKKNGGXXXXXXXNSIGGSIDRC 59
+F G+ G LFL +G L FK+NGG + GG++
Sbjct: 347 LFPGLVLGFPLLFLVLGIWGLIKFVKKRRKIIRKRMFFKRNGGLLLKQQLTTRGGNVQSS 406
Query: 60 RIFNSKELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEV 119
+IF+SKEL+KATD FNMNR+LGQGGQGTVYKGML DGRI+AVK+SKV+DE K+EEFINEV
Sbjct: 407 KIFSSKELEKATDNFNMNRVLGQGGQGTVYKGMLVDGRIVAVKRSKVLDEDKVEEFINEV 466
Query: 120 VILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATE 179
+LSQINHRN+VKL+GCCLE EVP+LVYE IPNG LF+ LH ++ ++TW++RLRI+ E
Sbjct: 467 GVLSQINHRNIVKLMGCCLETEVPILVYEHIPNGDLFKRLHHDSDDYTMTWDVRLRISVE 526
Query: 180 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF 239
+A ALAYLHS+A P+YHRD+K+TNILLDEKYRAK++DFGTSRSI +DQTH++T V GTF
Sbjct: 527 IAGALAYLHSAASTPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINVDQTHLTTLVAGTF 586
Query: 240 GYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCL 299
GYLDPEYF++SQFTDKSDVYSFGVVLVEL+TG+KP S + E R L ++F E +++N +
Sbjct: 587 GYLDPEYFQTSQFTDKSDVYSFGVVLVELITGEKPFSVMRPEENRGLVSHFNEAMKQNRV 646
Query: 300 FDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDDENNIQ 359
DI+D ++++ E+++AV+ +A+RCL+ G+ RP M+EV++ELERIR++ D E +I+
Sbjct: 647 LDIVDSRIKEGCTLEQVLAVAKLARRCLSLKGKKRPNMREVSVELERIRSSPEDLELHIE 706
Query: 360 K 360
+
Sbjct: 707 E 707
|
|
| TAIR|locus:2205040 AT1G69730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1099 (391.9 bits), Expect = 2.6e-111, P = 2.6e-111
Identities = 214/365 (58%), Positives = 272/365 (74%)
Query: 5 GIGTGLGGLFLSIGALWLCXXXXXXXXXXXXN--FKKNGGXXXXXXXNSIGGSIDRCRIF 62
G+G G L +G L FK+NGG S G +++ +F
Sbjct: 376 GLGASFGSLIFVVGIYLLYKFIKKQRKLNQKKKFFKRNGGLLLQQQLISTVGMVEKTIVF 435
Query: 63 NSKELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVIL 122
+S+EL+KAT+ F+ NRILGQGGQGTVYKGML DGRI+AVKKSKVVDE KLEEFINEVVIL
Sbjct: 436 SSRELEKATENFSSNRILGQGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVIL 495
Query: 123 SQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEE-LSLTWEMRLRIATEVA 181
SQINHRN+VKLLGCCLE +VP+LVYEFIPNG LF++LHD ++E + TW +RLRIA ++A
Sbjct: 496 SQINHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHDEFDENIMATWNIRLRIAIDIA 555
Query: 182 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 241
AL+YLHSSA PIYHRD+KSTNI+LDEKYRAK++DFGTSR++ +D TH++T V GT GY
Sbjct: 556 GALSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGTVGY 615
Query: 242 LDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFD 301
+DPEYF+SSQFTDKSDVYSFGVVLVEL+TG+K IS + + E R L TYF+ ++EN LFD
Sbjct: 616 MDPEYFQSSQFTDKSDVYSFGVVLVELITGEKSISFLRSQENRTLATYFILAMKENKLFD 675
Query: 302 IIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDDENNIQKC 361
IID ++R ++ A + VA++CLN GR RP+M+EV+MEL+ IR D + +Q+C
Sbjct: 676 IIDARIRDGCMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDSIRMPCGDMQ--LQEC 733
Query: 362 YGKVE 366
+ E
Sbjct: 734 VSENE 738
|
|
| TAIR|locus:2019843 WAKL10 "WALL ASSOCIATED KINASE (WAK)-LIKE 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1090 (388.8 bits), Expect = 2.3e-110, P = 2.3e-110
Identities = 207/352 (58%), Positives = 267/352 (75%)
Query: 5 GIGTGLGGLFLSIGALWLCXXXXXXXXXXXXN--FKKNGGXXXXXXXNSIGGSIDRCRIF 62
G+ T L G WL FK+NGG + G++D R+F
Sbjct: 362 GLSTSFSTLVFIGGIYWLYKFIRRQRRLNQKKKFFKRNGGLLLQQQLTTTEGNVDSTRVF 421
Query: 63 NSKELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVIL 122
NS+EL+KAT+ F++ RILG+GGQGTVYKGML DGRI+AVKKSKVVDE KLEEFINEVVIL
Sbjct: 422 NSRELEKATENFSLTRILGEGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVIL 481
Query: 123 SQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLT-WEMRLRIATEVA 181
SQINHRN+VKLLGCCLE +VP+LVYEFIPNG LF++LHD ++ ++T WE+RLRIA ++A
Sbjct: 482 SQINHRNIVKLLGCCLETDVPILVYEFIPNGNLFEHLHDDSDDYTMTTWEVRLRIAVDIA 541
Query: 182 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 241
AL+YLHS+A PIYHRDIKSTNI+LDEK+RAK++DFGTSR++ +D TH++T V GT GY
Sbjct: 542 GALSYLHSAASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVDHTHLTTVVSGTVGY 601
Query: 242 LDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFD 301
+DPEYF+SSQFTDKSDVYSFGVVL EL+TG+K +S + + E R L TYF ++EN L D
Sbjct: 602 MDPEYFQSSQFTDKSDVYSFGVVLAELITGEKSVSFLRSQEYRTLATYFTLAMKENRLSD 661
Query: 302 IIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRD 353
IID ++R + ++ A + +A++CLN GR RP+M++V+MELE+IR+ S D
Sbjct: 662 IIDARIRDGCKLNQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIRSYSED 713
|
|
| TAIR|locus:2200562 WAKL2 "wall associated kinase-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1083 (386.3 bits), Expect = 1.3e-109, P = 1.3e-109
Identities = 198/323 (61%), Positives = 263/323 (81%)
Query: 37 FKKNGGXXXXXXXNSIGGSIDRCRIFNSKELDKATDYFNMNRILGQGGQGTVYKGMLADG 96
F++NGG G+++ RIF+S EL+KATD FN NR+LGQGGQGTVYKGML DG
Sbjct: 379 FRRNGGMLLKQQLARKEGNVEMSRIFSSHELEKATDNFNKNRVLGQGGQGTVYKGMLVDG 438
Query: 97 RIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLF 156
RI+AVK+SK VDE ++EEFINEVV+L+QINHRN+VKLLGCCLE EVP+LVYEF+PNG L
Sbjct: 439 RIVAVKRSKAVDEDRVEEFINEVVVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLC 498
Query: 157 QYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIA 216
+ LHD ++ ++TWE+RL IA E+A AL+YLHS+A PIYHRDIK+TNILLDE+ RAK++
Sbjct: 499 KRLHDESDDYTMTWEVRLHIAIEIAGALSYLHSAASFPIYHRDIKTTNILLDERNRAKVS 558
Query: 217 DFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPIS 276
DFGTSRS+ IDQTH++T+V GTFGY+DPEYF+SS+FT+KSDVYSFGVVLVELLTG+KP S
Sbjct: 559 DFGTSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFTEKSDVYSFGVVLVELLTGEKPSS 618
Query: 277 SIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPT 336
+ + E R L +FVE ++EN + DI+DD+++ +++M+V+++A+RCLN G+ RP
Sbjct: 619 RVRSEENRGLAAHFVEAVKENRVLDIVDDRIKDECNMDQVMSVANLARRCLNRKGKKRPN 678
Query: 337 MKEVAMELERIRANSRDDENNIQ 359
M+EV++ELE IR++ D +I+
Sbjct: 679 MREVSIELEMIRSSHYDSGIHIE 701
|
|
| TAIR|locus:2016377 AT1G19390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1082 (385.9 bits), Expect = 1.6e-109, P = 1.6e-109
Identities = 210/358 (58%), Positives = 271/358 (75%)
Query: 5 GIGTGLGGLFLSIGALWLCXXXXXXXXXXXXN--FKKNGGXXXXXXXNSIGGSIDRCRIF 62
G+G+ G L L +G WL FK+NGG N+ G++++ RIF
Sbjct: 380 GVGSAFGILVLVVGIWWLRKFLKKRRMSKRKRKFFKRNGGLLLQQQLNTNKGNVEKTRIF 439
Query: 63 NSKELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVIL 122
+S+EL+KATD F+ +RILGQGGQGTVYKGML DGR +AVKKSKVVDE KLEEFINEVVIL
Sbjct: 440 SSRELEKATDNFSESRILGQGGQGTVYKGMLVDGRTVAVKKSKVVDEDKLEEFINEVVIL 499
Query: 123 SQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAE 182
SQINHR+VVKLLGCCLE EVP LVYEFIPNG LFQ++H+ ++ + TW MRLRIA ++A
Sbjct: 500 SQINHRHVVKLLGCCLETEVPTLVYEFIPNGNLFQHIHEESDDYTKTWGMRLRIAVDIAG 559
Query: 183 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYL 242
AL+YLHS+A PIYHRDIKSTNILLDEKYR K++DFGTSRS+ ID TH +T + GT GY+
Sbjct: 560 ALSYLHSAASSPIYHRDIKSTNILLDEKYRTKVSDFGTSRSVTIDHTHWTTVISGTVGYV 619
Query: 243 DPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIW-ANEGRNLTTYFVECIEENCLFD 301
DPEY+ SSQ+TDKSDVYSFGVVLVEL+TG+KP+ ++ + E R L +F ++EN F+
Sbjct: 620 DPEYYGSSQYTDKSDVYSFGVVLVELITGEKPVITVSNSQEIRGLADHFRVAMKENRFFE 679
Query: 302 IIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDDENNIQ 359
I+D ++R + E++MAV+++A+RCLNS G+ RP M++V +LE+I A+ D NI+
Sbjct: 680 IMDARIRDGCKPEQVMAVANLARRCLNSKGKKRPCMRKVFTDLEKILASQEDSLVNIE 737
|
|
| TAIR|locus:2126316 AT4G31100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1047 (373.6 bits), Expect = 8.3e-106, P = 8.3e-106
Identities = 207/358 (57%), Positives = 262/358 (73%)
Query: 2 IFAGIGTGLGGLFLSIGALWLCXXXXXXXXXXXXN--FKKNGGXXXXXXXNSIGGSIDRC 59
I G GTG G L L G WL FK+NGG N+ G +++
Sbjct: 370 IMIGAGTGFGVLVLVGGVWWLRKFLVKRRMAKRKKKFFKRNGGLLLQQELNTRQGVVEKA 429
Query: 60 RIFNSKELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEV 119
RIF SKEL+KAT+ F+ NR+LG GGQGTVYKGML DGR +AVKKSKV+DE KL+EFINEV
Sbjct: 430 RIFTSKELEKATENFSENRVLGHGGQGTVYKGMLVDGRTVAVKKSKVIDEDKLQEFINEV 489
Query: 120 VILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPY-EELSLTWEMRLRIAT 178
VILSQINHR+VVKLLGCCLE EVP+LVYEFI NG LF+++H+ ++ ++ W MRLRIA
Sbjct: 490 VILSQINHRHVVKLLGCCLETEVPILVYEFIINGNLFKHIHEEEADDYTMIWGMRLRIAV 549
Query: 179 EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGT 238
++A AL+YLHS+A PIYHRDIKSTNILLDEKYRAK+ADFGTSRS+ IDQTH +T + GT
Sbjct: 550 DIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGT 609
Query: 239 FGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIW-ANEGRNLTTYFVECIEEN 297
GY+DPEY+RSSQ+T+KSDVYSFGV+L EL+TG KP+ + E L +F ++E
Sbjct: 610 VGYVDPEYYRSSQYTEKSDVYSFGVILAELITGDKPVIMVQNTQEIIALAEHFRVAMKER 669
Query: 298 CLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDDE 355
L DI+D ++R + E++MAV+++A +CL+S GRNRP M+EV ELERI + D +
Sbjct: 670 RLSDIMDARIRDDSKPEQVMAVANLAMKCLSSRGRNRPNMREVFTELERICTSPEDSQ 727
|
|
| TAIR|locus:2126271 AT4G31110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1040 (371.2 bits), Expect = 4.6e-105, P = 4.6e-105
Identities = 206/359 (57%), Positives = 262/359 (72%)
Query: 2 IFAGIGTGLGGLFLSIGALWLCXXXXXXXXXXXXN---FKKNGGXXXXXXXNSIGGSIDR 58
I G GTG G L L +G LW FK+NGG N+ G +++
Sbjct: 379 IMIGAGTGFGVLVL-VGGLWWLRKFLIKRRITKRKKKFFKRNGGLLLLQELNTREGYVEK 437
Query: 59 CRIFNSKELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINE 118
R+FNS+EL+KAT+ F+ NR+LG GGQGTVYKGML DGR +AVKKSKV+DE KL+EFINE
Sbjct: 438 TRVFNSRELEKATENFSENRVLGHGGQGTVYKGMLVDGRTVAVKKSKVIDEDKLQEFINE 497
Query: 119 VVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPY-EELSLTWEMRLRIA 177
VVILSQINHR+VVKLLGCCLE EVP+LVYEFI NG LF+++H+ ++ ++ W MRLRIA
Sbjct: 498 VVILSQINHRHVVKLLGCCLETEVPMLVYEFIINGNLFKHIHEEESDDYTMLWGMRLRIA 557
Query: 178 TEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQG 237
++A AL+YLHSSA PIYHRDIKSTNILLDEKYRAK+ADFGTSRS+ IDQTH +T + G
Sbjct: 558 VDIAGALSYLHSSASSPIYHRDIKSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISG 617
Query: 238 TFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIW-ANEGRNLTTYFVECIEE 296
T GY+DPEY++SSQ+T+KSDVYSFGV+L EL+TG KP+ + E L +F ++E
Sbjct: 618 TVGYVDPEYYQSSQYTEKSDVYSFGVILAELITGDKPVIMVQNTQEIVALAEHFRVAMKE 677
Query: 297 NCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDDE 355
L DIID ++R + E++MAV+ VA +CL+S G+ RP M+EV ELERI + D +
Sbjct: 678 KRLTDIIDARIRNDCKPEQVMAVAKVAMKCLSSKGKKRPNMREVFTELERICTSPEDSQ 736
|
|
| TAIR|locus:2032875 AT1G16260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1033 (368.7 bits), Expect = 2.5e-104, P = 2.5e-104
Identities = 194/356 (54%), Positives = 266/356 (74%)
Query: 7 GTGLGGLFLSIGALWL-CXXXXXXXXXXXXN--FKKNGGXXXXXXXNSIGGSIDRCRIFN 63
GT GL L I +WL C F++NGG + + GS++R ++F+
Sbjct: 320 GTLSSGLLLLIFGMWLLCKANRKRKVAKQKRKFFQRNGGLLLQQQTSFLHGSVNRTKVFS 379
Query: 64 SKELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILS 123
S +L+ ATD FN +RILGQGGQGTVYKGML DG I+AVKKSK + E LEEFINE+++LS
Sbjct: 380 SNDLENATDRFNASRILGQGGQGTVYKGMLEDGMIVAVKKSKALKEENLEEFINEIILLS 439
Query: 124 QINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEA 183
QINHRNVVK+LGCCLE EVP+LVYEFIPN LF +LH+P E+ ++WE+RL IA EVA+A
Sbjct: 440 QINHRNVVKILGCCLETEVPILVYEFIPNRNLFDHLHNPSEDFPMSWEVRLCIACEVADA 499
Query: 184 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 243
L+YLHS+ +PIYHRD+KSTNILLDEK+RAK++DFG SRS+AID TH++T VQGT GY+D
Sbjct: 500 LSYLHSAVSIPIYHRDVKSTNILLDEKHRAKVSDFGISRSVAIDDTHLTTIVQGTIGYVD 559
Query: 244 PEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDII 303
PEY +S+ FT KSDVYSFGV+L+ELLTG+KP+S + E R L YF+E + + L +I+
Sbjct: 560 PEYLQSNHFTGKSDVYSFGVLLIELLTGEKPVSLLRRQEVRMLGAYFLEAMRNDRLHEIL 619
Query: 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDDENNIQ 359
D ++++ + EE++AV+ +A+RCL+ +RPTM++V +EL+R+++ + ++ Q
Sbjct: 620 DARIKEECDREEVLAVAKLARRCLSLNSEHRPTMRDVFIELDRMQSKRKGTQSQAQ 675
|
|
| TAIR|locus:2030988 AT1G17910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1029 (367.3 bits), Expect = 6.7e-104, P = 6.7e-104
Identities = 198/361 (54%), Positives = 262/361 (72%)
Query: 2 IFAGIGTGLGGLFLSIGALWLCXXXXXXXXXXXXN--FKKNGGXXXXXXXNSIGGSIDRC 59
+ G+G G L + G W FK+NGG N+ G +++
Sbjct: 380 VMLGLGAGFFVLIVGGGIWWWRKLLRKRRMTNRKRKFFKRNGGLLLQQQLNTTQGRVEKT 439
Query: 60 RIFNSKELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEV 119
++F+S+EL+KATD FN NR++GQGGQGTVYKGML DGR +AVKKS VVDE KL+EFINEV
Sbjct: 440 KLFSSRELEKATDNFNDNRVIGQGGQGTVYKGMLVDGRSVAVKKSNVVDEDKLQEFINEV 499
Query: 120 VILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATE 179
+ILSQINHR+VVKLLGCCLE EVP+LVYEFIPNG LFQ+LH+ +++ + W +R+RIA +
Sbjct: 500 IILSQINHRHVVKLLGCCLETEVPILVYEFIPNGNLFQHLHEEFDDYTALWGVRMRIAVD 559
Query: 180 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF 239
++ A +YLH++A PIYHRDIKSTNILLDEKYRAK++DFGTSRS++ID TH +T + GT
Sbjct: 560 ISGAFSYLHTAACSPIYHRDIKSTNILLDEKYRAKVSDFGTSRSVSIDHTHWTTVISGTV 619
Query: 240 GYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIW-ANEGRNLTTYFVECIEENC 298
GY+DPEY+ SS FT+KSDVYSFGVVLVEL+TG+KP+ ++ E L YF + EN
Sbjct: 620 GYVDPEYYGSSHFTEKSDVYSFGVVLVELITGEKPVITLSETQEITGLADYFRLAMRENR 679
Query: 299 LFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDDENNI 358
LF+IID ++R + E+++AV+++A RCL G+ RP M+EV+ LERI + D + I
Sbjct: 680 LFEIIDARIRNDCKLEQVIAVANLALRCLKKTGKTRPDMREVSTALERICSAPEDFQVQI 739
Query: 359 Q 359
Q
Sbjct: 740 Q 740
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.4190.1.1 | hypothetical protein (626 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 374 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-53 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-53 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-53 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-50 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-50 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-49 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-48 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-48 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-39 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-35 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-33 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-33 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-33 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-33 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-32 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-32 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-32 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-31 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-31 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-31 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-31 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-30 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-30 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-30 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-30 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-29 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-29 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 7e-29 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-29 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-28 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-28 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-28 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-28 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-28 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-28 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-28 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-27 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-27 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-27 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-27 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-26 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-26 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-26 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-26 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-26 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-26 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-25 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-25 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-25 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-25 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-25 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-25 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-24 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-24 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-24 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-24 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-24 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-24 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 9e-24 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-23 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-23 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-23 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-23 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-23 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-23 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-23 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-23 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-22 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-22 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-22 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-22 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-22 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-22 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-22 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-22 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-22 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-22 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-22 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-22 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-21 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-21 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-21 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-21 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-21 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-21 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-21 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-21 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-20 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-20 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-20 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-20 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-20 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-20 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-20 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-19 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-19 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-19 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-19 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-19 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-19 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-19 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-18 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-18 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-18 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-18 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-18 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 8e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-18 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-17 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-17 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-16 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-16 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 9e-16 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-15 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-15 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-15 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-15 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-15 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-15 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 6e-15 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-15 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-15 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-15 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-14 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-14 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-14 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-14 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-14 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-13 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-13 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-13 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 9e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-12 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-12 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-12 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-12 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-11 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-11 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-11 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-11 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-10 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-10 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 9e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 9e-10 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 9e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 6e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 9e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 8e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.002 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.003 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 1e-53
Identities = 74/206 (35%), Positives = 111/206 (53%), Gaps = 11/206 (5%)
Query: 76 MNRILGQGGQGTVYKGML----ADGRI-IAVKKSKV-VDESKLEEFINEVVILSQINHRN 129
+ + LG+G G VYKG L + +AVK K E ++EEF+ E I+ +++H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS 189
+VKLLG C E E ++V E++P G L YL L+ L A ++A + YL S
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKN-RPKELSLSDLLSFALQIARGMEYLES 121
Query: 190 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRS 249
HRD+ + N L+ E KI+DFG SR + D + + ++ PE +
Sbjct: 122 ---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKE 178
Query: 250 SQFTDKSDVYSFGVVLVELLT-GQKP 274
+FT KSDV+SFGV+L E+ T G++P
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 4e-53
Identities = 74/206 (35%), Positives = 108/206 (52%), Gaps = 12/206 (5%)
Query: 76 MNRILGQGGQGTVYKGML-----ADGRIIAVKKSKVV-DESKLEEFINEVVILSQINHRN 129
+ + LG+G G VYKG L +AVK K E ++EEF+ E I+ +++H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS 189
VVKLLG C E E +V E++ G L YL L+ L A ++A + YL S
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKN--RPKLSLSDLLSFALQIARGMEYLES 120
Query: 190 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRS 249
HRD+ + N L+ E KI+DFG SR + D + + ++ PE +
Sbjct: 121 ---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177
Query: 250 SQFTDKSDVYSFGVVLVELLT-GQKP 274
+FT KSDV+SFGV+L E+ T G++P
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 6e-53
Identities = 73/193 (37%), Positives = 104/193 (53%), Gaps = 10/193 (5%)
Query: 80 LGQGGQGTVYKGM-LADGRIIAVKK-SKVVDESKLEEFINEVVILSQINHRNVVKLLGCC 137
LG+GG GTVY G+ +A+K K S LEE + E+ IL ++NH N+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 138 LEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYH 197
+ LV E+ G+L L + +LS + LRI ++ E L YLHS I H
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLS--EDEILRILLQILEGLEYLHS---NGIIH 115
Query: 198 RDIKSTNILLDEK-YRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQ-FTDK 255
RD+K NILLD + K+ADFG S+ + + + GT Y+ PE +++K
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLT-SDKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174
Query: 256 SDVYSFGVVLVEL 268
SD++S GV+L EL
Sbjct: 175 SDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 169 bits (432), Expect = 1e-50
Identities = 89/289 (30%), Positives = 137/289 (47%), Gaps = 49/289 (16%)
Query: 74 FNMNRILGQGGQGTVYKGML-----ADGRIIAVKKSKV-VDESKLEEFINEVVILSQINH 127
+ + LG+G G VYKG L +AVK K E + EEF+ E I+ +++H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 128 RNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYL 187
N+V+LLG C + E +V E++P G L +L LT + L++A ++A+ + YL
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKH--GEKLTLKDLLQMALQIAKGMEYL 118
Query: 188 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFG---YLDP 244
S ++ HRD+ + N L+ E KI+DFG SR I D + G ++ P
Sbjct: 119 ESKNFV---HRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKR--GGGKLPIKWMAP 173
Query: 245 EYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIE-------- 295
E + +FT KSDV+SFGV+L E+ T G++P + E +E +E
Sbjct: 174 ESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-------VLELLEDGYRLPRP 226
Query: 296 ENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMEL 344
ENC E E+M +C +RPT E+ +L
Sbjct: 227 ENC-----------PDELYELM------LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 2e-50
Identities = 75/269 (27%), Positives = 119/269 (44%), Gaps = 23/269 (8%)
Query: 74 FNMNRILGQGGQGTVYKGM-LADGRIIAVKK-SKVVDESKLEEFINEVVILSQINHRNVV 131
+ + LG+G G VY G+++A+K K + E + E+ IL ++ H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 132 KLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSA 191
+L + + LV E+ G LF L + L+ + ++ AL YLHS
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLK---KRGRLSEDEARFYLRQILSALEYLHS-- 115
Query: 192 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQ 251
I HRD+K NILLDE K+ADFG +R +D T GT Y+ PE
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLAR--QLDPGEKLTTFVGTPEYMAPEVLLGKG 172
Query: 252 FTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSG 311
+ D++S GV+L ELLTG+ P + + + L + + S
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPP----FPGDDQLLELFKKIG---KPKPPFPPPEWDISP 225
Query: 312 EAEEIMAVSDVAKRCLNSYGRNRPTMKEV 340
EA++++ ++ L R T +E
Sbjct: 226 EAKDLI------RKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 2e-49
Identities = 86/290 (29%), Positives = 128/290 (44%), Gaps = 50/290 (17%)
Query: 78 RILGQGGQGTVYKGMLADG----RIIAVKKSK-VVDESKLEEFINEVVILSQINHRNVVK 132
+ LG+G G VYKG L +AVK K E + ++F+ E ++ ++ H NVV+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 133 LLGCCLEVEVPLLVYEFIPNGTLFQYL------HDPYEELSLTWEMRLRIATEVAEALAY 186
LLG C E E LV E++ G L YL E+ +L+ + L A ++A+ + Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 187 LHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF--GYLDP 244
L S HRD+ + N L+ E KI+DFG SR + D + G ++ P
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT-GGKLPIRWMAP 176
Query: 245 EYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIE-------- 295
E + FT KSDV+SFGV+L E+ T G P + E +E +
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-------VLEYLRKGYRLPKP 229
Query: 296 ENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345
E C ++ E+M C +RPT E+ LE
Sbjct: 230 EYCPDEL-----------YELM------LSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 1e-48
Identities = 68/213 (31%), Positives = 114/213 (53%), Gaps = 18/213 (8%)
Query: 78 RILGQGGQGTVYKGMLAD-GRIIAVKKSKV--VDESKLEEFINEVVILSQINHRNVVKLL 134
+LG+G G+VY + D G ++AVK ++ E +LE E+ ILS + H N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 135 GCCLEVEVP-LLVY-EFIPNGTLFQYLHDPYEELSLTWEMRLRI-ATEVAEALAYLHSSA 191
G + E L ++ E++ G+L L + +L E +R ++ E LAYLHS+
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKK-FGKLP---EPVIRKYTRQILEGLAYLHSNG 121
Query: 192 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA-IDQTHVSTKVQGTFGYLDPEYFRSS 250
+ HRDIK NIL+D K+ADFG ++ + I+ + V+GT ++ PE R
Sbjct: 122 IV---HRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 251 QFTDKSDVYSFGVVLVELLTGQKPISSIWANEG 283
++ +D++S G ++E+ TG+ P W+ G
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPP----WSELG 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 1e-48
Identities = 91/271 (33%), Positives = 134/271 (49%), Gaps = 21/271 (7%)
Query: 74 FNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNV 130
+ + R LG G GTVYK G+I+AVK K K + E+ IL +++H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 131 VKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSS 190
V+L+ + + LV E+ G LF YL L+ + +IA ++ L YLHS
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLS---RGGPLSEDEAKKIALQILRGLEYLHS- 116
Query: 191 AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE-YFRS 249
I HRD+K NILLDE KIADFG ++ + + ++T V GT Y+ PE
Sbjct: 117 --NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGG 173
Query: 250 SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309
+ + K DV+S GV+L ELLTG+ P S + + I + D+ +
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQL-------QLIRRILGPPLEFDEPKW 226
Query: 310 SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEV 340
S +EE D+ K+CLN RPT +E+
Sbjct: 227 SSGSEE---AKDLIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 2e-39
Identities = 68/201 (33%), Positives = 102/201 (50%), Gaps = 14/201 (6%)
Query: 80 LGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCL 138
+G+GG G VYK G+ +A+K K+ + K E+ INE+ IL + H N+VK G L
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 139 EVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIAT---EVAEALAYLHSSAYLPI 195
+ + +V EF G+L L + L+ + IA E+ + L YLHS I
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ-----IAYVCKELLKGLEYLHS---NGI 119
Query: 196 YHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDK 255
HRDIK+ NILL K+ DFG S ++ T + GT ++ PE + K
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLSAQLS--DTKARNTMVGTPYWMAPEVINGKPYDYK 177
Query: 256 SDVYSFGVVLVELLTGQKPIS 276
+D++S G+ +EL G+ P S
Sbjct: 178 ADIWSLGITAIELAEGKPPYS 198
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 132 bits (332), Expect = 3e-35
Identities = 79/279 (28%), Positives = 121/279 (43%), Gaps = 22/279 (7%)
Query: 74 FNMNRILGQGGQGTVYKGMLADGRIIAVK---KSKVVDESKLEEFINEVVILSQINH-RN 129
+ + R LG+G G VY D +++A+K K ++E F+ E+ IL+ +NH N
Sbjct: 2 YRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS 189
+VKL + LV E++ G+L L + L+ L I ++ AL YLHS
Sbjct: 60 IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119
Query: 190 SAYLPIYHRDIKSTNILLDEKY-RAKIADFGTSRSIAIDQTHVS-----TKVQGTFGYLD 243
I HRDIK NILLD K+ DFG ++ + + S + GT GY+
Sbjct: 120 K---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 244 PEYFRSSQF---TDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLF 300
PE + SD++S G+ L ELLTG P + + T +
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII----LELPT 232
Query: 301 DIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKE 339
+ + S A SD+ K+ L +NR +
Sbjct: 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSS 271
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 3e-33
Identities = 68/206 (33%), Positives = 101/206 (49%), Gaps = 18/206 (8%)
Query: 78 RILGQGGQGTVYKGM-LADGRIIAVKKSKV--VDESKLEEFINEVVILSQINHRNVVKLL 134
+ +G+G G VY +DG++ +K+ + + E + E+ +NEV IL ++NH N++K
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 135 GCCLEVEVPLLVYEFIPNGTLFQYL------HDPYEELSLTWEMRLRIATEVAEALAYLH 188
E +V E+ G L Q + P+ E E L ++ AL YLH
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPE-----EQILDWFVQLCLALKYLH 120
Query: 189 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFR 248
S I HRDIK NI L K+ DFG S+ ++ T V GT YL PE +
Sbjct: 121 SRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQ 176
Query: 249 SSQFTDKSDVYSFGVVLVELLTGQKP 274
+ + KSD++S G VL EL T + P
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 4e-33
Identities = 62/200 (31%), Positives = 103/200 (51%), Gaps = 12/200 (6%)
Query: 79 ILGQGGQGTVYKGM-LADGRIIAVKKSKV--VDESKLEEFINEVVILSQINHRNVVKLLG 135
++G+G G VYKG+ L G +A+K+ + + E L+ + E+ +L + H N+VK +G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 136 CCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRI-ATEVAEALAYLHSSAYLP 194
+ ++ E+ NG+L Q + + E + + +V + LAYLH
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIK-KFGPFP---ESLVAVYVYQVLQGLAYLHEQG--- 119
Query: 195 IYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTD 254
+ HRDIK+ NIL + K+ADFG + + D + V GT ++ PE S +
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVA-TKLNDVSKDDASVVGTPYWMAPEVIEMSGAST 178
Query: 255 KSDVYSFGVVLVELLTGQKP 274
SD++S G ++ELLTG P
Sbjct: 179 ASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 6e-33
Identities = 66/202 (32%), Positives = 108/202 (53%), Gaps = 6/202 (2%)
Query: 74 FNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKL 133
F + R LG G G V++G+ + +A+K K D K ++F EV L ++ H++++ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 134 LGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYL 193
C E ++ E + G+L +L P E L + +A +VAE +AYL +
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQNSI 126
Query: 194 PIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFT 253
HRD+ + NIL+ E K+ADFG +R I + ++S+ + + + PE F+
Sbjct: 127 ---HRDLAARNILVGEDLVCKVADFGLARLIK-EDVYLSSDKKIPYKWTAPEAASHGTFS 182
Query: 254 DKSDVYSFGVVLVELLT-GQKP 274
KSDV+SFG++L E+ T GQ P
Sbjct: 183 TKSDVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 9e-33
Identities = 79/290 (27%), Positives = 139/290 (47%), Gaps = 34/290 (11%)
Query: 78 RILGQGGQGTVYKGML-----ADGRIIAVKKSKV-VDESKLEEFINEVVILSQINHRNVV 131
+ LG+G G V G +AVK +E +F E+ IL ++H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 132 KLLGCCLEV--EVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS 189
K G C + L+ E++P+G+L YL ++++L L ++++ + + YL S
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLK--RLLLFSSQICKGMDYLGS 127
Query: 190 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQG---TFGYLDPEY 246
Y+ HRD+ + NIL++ + KI+DFG ++ + D+ + K G F Y PE
Sbjct: 128 QRYI---HRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APEC 183
Query: 247 FRSSQFTDKSDVYSFGVVLVELLT--------GQKPISSIWANEGRNLTTYFVECIEENC 298
R+S+F+ SDV+SFGV L EL T + + I +G+ + T +E ++E
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG- 242
Query: 299 LFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIR 348
R V D+ K C + ++RP+ ++ + ++R+R
Sbjct: 243 --------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 2e-32
Identities = 71/220 (32%), Positives = 108/220 (49%), Gaps = 29/220 (13%)
Query: 78 RILGQGGQGTVYKGMLA------DGRIIAVKKSK-VVDESKLEEFINEVVILSQINHRNV 130
R LG+G G V+ G D ++AVK K ++F E +L+ H N+
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 131 VKLLGCCLEVEVPLLVYEFIPNGTLFQYL--HDPY---------EELSLTWEMRLRIATE 179
VK G C E + P++V+E++ +G L ++L H P LT L+IA +
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 180 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGT- 238
+A + YL S ++ HRD+ + N L+ KI DFG SR + T +V G
Sbjct: 131 IASGMVYLASQHFV---HRDLATRNCLVGYDLVVKIGDFGMSRDV---YTTDYYRVGGHT 184
Query: 239 ---FGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKP 274
++ PE +FT +SDV+SFGVVL E+ T G++P
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 2e-32
Identities = 72/200 (36%), Positives = 104/200 (52%), Gaps = 13/200 (6%)
Query: 80 LGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQINHRNVVKLLG 135
LG+G G V G++ A+K K K++ ++E + E ILS+INH +VKL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 136 CCLEVEVPL-LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLP 194
+ E L LV E+ P G LF +L +E + E A E+ AL YLHS L
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFSEERARFYAAEIVLALEYLHS---LG 113
Query: 195 IYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTD 254
I +RD+K NILLD K+ DFG ++ ++ + + +T GT YL PE +
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGYGK 172
Query: 255 KSDVYSFGVVLVELLTGQKP 274
D +S GV+L E+LTG+ P
Sbjct: 173 AVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 9e-32
Identities = 71/206 (34%), Positives = 105/206 (50%), Gaps = 14/206 (6%)
Query: 74 FNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKL 133
+ R LG G G V+ G +AVK K S E F+ E I+ ++ H +V+L
Sbjct: 8 LKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSP-EAFLQEAQIMKKLRHDKLVQL 66
Query: 134 LGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYL 193
C E E +V E++ G+L +L E L + +A ++AE +AYL S Y+
Sbjct: 67 YAVCSEEEPIYIVTEYMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRNYI 125
Query: 194 PIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ--THVSTK--VQGTFGYLDPEYFRS 249
HRD+ + NIL+ E KIADFG +R I D+ K ++ T PE
Sbjct: 126 ---HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEAANY 178
Query: 250 SQFTDKSDVYSFGVVLVELLT-GQKP 274
+FT KSDV+SFG++L E++T G+ P
Sbjct: 179 GRFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-31
Identities = 63/208 (30%), Positives = 108/208 (51%), Gaps = 9/208 (4%)
Query: 68 DKATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQIN 126
D Y N+ +I G+G G VYK A G+ +A+KK ++ ++K E INE++I+
Sbjct: 16 DPRELYKNLEKI-GEGASGEVYKATDRATGKEVAIKKMRLRKQNK-ELIINEILIMKDCK 73
Query: 127 HRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAY 186
H N+V L + +V E++ G+L + + + + EV + L Y
Sbjct: 74 HPNIVDYYDSYLVGDELWVVMEYMDGGSL-TDIITQNF-VRMNEPQIAYVCREVLQGLEY 131
Query: 187 LHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEY 246
LHS + HRDIKS NILL + K+ADFG + + +++ ++ V GT ++ PE
Sbjct: 132 LHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEV 187
Query: 247 FRSSQFTDKSDVYSFGVVLVELLTGQKP 274
+ + K D++S G++ +E+ G+ P
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-31
Identities = 66/230 (28%), Positives = 102/230 (44%), Gaps = 40/230 (17%)
Query: 74 FNMNRILGQGGQGTVYKGML-ADGRIIAVK---KSKVVDESKLEEFINEVVILSQIN-HR 128
F +I+G+G TV + A+K K +++ E K++ E +L+++N H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 129 NVVKLLGC-----CLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEA 183
++KL L V E+ PNG L QY+ SL + A E+ A
Sbjct: 63 GIIKLYYTFQDEENL-----YFVLEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLA 114
Query: 184 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQ------- 236
L YLHS I HRD+K NILLD+ KI DFGT++ + + + S K
Sbjct: 115 LEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
Query: 237 ------------GTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
GT Y+ PE SD+++ G ++ ++LTG+ P
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 3e-31
Identities = 77/273 (28%), Positives = 131/273 (47%), Gaps = 25/273 (9%)
Query: 76 MNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLL 134
M LG G G VY+G+ +AVK K D ++EEF+ E ++ +I H N+V+LL
Sbjct: 10 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLL 68
Query: 135 GCCLEVEVPL-LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYL 193
G C E P ++ EF+ G L YL + + + + L +AT+++ A+ YL ++
Sbjct: 69 GVCTR-EPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKNFI 126
Query: 194 PIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFT 253
HRD+ + N L+ E + K+ADFG SR + D + + PE ++F+
Sbjct: 127 ---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 183
Query: 254 DKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGE 312
KSDV++FGV+L E+ T G P I +L+ ++++++ R
Sbjct: 184 IKSDVWAFGVLLWEIATYGMSPYPGI------DLSQ----------VYELLEKGYRMERP 227
Query: 313 AEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345
V ++ + C +RP+ E+ E
Sbjct: 228 EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 5e-31
Identities = 65/213 (30%), Positives = 111/213 (52%), Gaps = 21/213 (9%)
Query: 79 ILGQGGQGTVYKGMLADGRIIAVKK------SKVVDESKLEEFINEVVILSQINHRNVVK 132
+LG+G GTVY G+ G++IAVK+ + + E + E+ EV +L + H N+V+
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 133 LLGCCLEVEVPLLVYEFIPNGTLFQYLH--DPYEELSLTWEMRLRIATEVAEALAYLHSS 190
LG CL+ + EF+P G++ L+ P E + ++ + +AYLH++
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFC-----KYTKQILDGVAYLHNN 121
Query: 191 AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS-----TKVQGTFGYLDPE 245
+ HRDIK N++L K+ DFG +R +A H + + GT ++ PE
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 246 YFRSSQFTDKSDVYSFGVVLVELLTGQKPISSI 278
S + KSD++S G + E+ TG+ P++S+
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGKPPLASM 211
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-30
Identities = 63/196 (32%), Positives = 106/196 (54%), Gaps = 10/196 (5%)
Query: 80 LGQGGQGTVYKGMLADGRIIAVK--KSKVVDESKLEEFINEVVILSQINHRNVVKLLGCC 137
LG G G V+ G +A+K + + E ++FI E ++ +++H N+V+L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE---DDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 138 LEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYH 197
+ +V E++ NG L YL + +L E L + ++V EA+ YL S+ ++ H
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKGKLGT--EWLLDMCSDVCEAMEYLESNGFI---H 123
Query: 198 RDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSD 257
RD+ + N L+ E K++DFG +R + DQ S + + PE F S+F+ KSD
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSD 183
Query: 258 VYSFGVVLVELLTGQK 273
V+SFGV++ E+ + K
Sbjct: 184 VWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-30
Identities = 66/206 (32%), Positives = 108/206 (52%), Gaps = 9/206 (4%)
Query: 72 DYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLE--EFINEVVILSQINHR 128
D+ +N+I G+G G V+K + AD R+ A+K+ + ++ E E I+E +L++++
Sbjct: 1 DFEILNKI-GKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSS 59
Query: 129 NVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLH 188
+++ L+ +V E+ NG L + L L + R ++ LA+LH
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLK-MQRGRPLPEDQVWRFFIQILLGLAHLH 118
Query: 189 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFR 248
S I HRDIKS N+ LD KI D G ++ ++ D T+ + + GT YL PE
Sbjct: 119 SKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPELCE 174
Query: 249 SSQFTDKSDVYSFGVVLVELLTGQKP 274
+ +KSDV++ GVVL E TG+ P
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-30
Identities = 76/294 (25%), Positives = 136/294 (46%), Gaps = 42/294 (14%)
Query: 74 FNMNRILGQGGQGTVYKGMLA--DGRI--IAVKKSKV--VDESKLEEFINEVVILSQINH 127
+ +ILG+G G+V +G L+ DG +AVK K+ S++EEF++E + +H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 128 RNVVKLLGCCLEVE------VPLLVYEFIPNGTLFQYL-HDPYEELS--LTWEMRLRIAT 178
NV+KL+G C E P+++ F+ +G L +L + L L + L+
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 179 EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID----QTHVSTK 234
++A + YL + ++ HRD+ + N +L E +ADFG S+ I Q ++
Sbjct: 121 DIALGMEYLSNRNFI---HRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA-- 175
Query: 235 VQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVEC 293
+ ++ E +T KSDV++FGV + E+ T GQ P + +E
Sbjct: 176 -KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE----------- 223
Query: 294 IEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347
++D + R + + + D+ C + ++RPT ++ LE I
Sbjct: 224 -----IYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 4e-30
Identities = 73/272 (26%), Positives = 118/272 (43%), Gaps = 24/272 (8%)
Query: 72 DYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFI-NEVVILSQINHRN 129
++LGQG G VYK G+I A+KK V + + + + E+ L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRL-RIATEVAEALAYLH 188
VVK G + +V E++ G+L D +++ E L IA ++ + L YLH
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSL----ADLLKKVGKIPEPVLAYIARQILKGLDYLH 116
Query: 189 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFR 248
+ I HRDIK +N+L++ K KIADFG S+ + +T V GT Y+ PE +
Sbjct: 117 TK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQ 173
Query: 249 SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIID-DQV 307
++ +D++S G+ L+E G+ P F E ++ C
Sbjct: 174 GESYSYAADIWSLGLTLLECALGKFPFLP-------PGQPSFFELMQAICDGPPPSLPAE 226
Query: 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKE 339
S E + ++ CL + RP+ E
Sbjct: 227 EFSPEFRDFIS------ACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 9e-30
Identities = 73/211 (34%), Positives = 119/211 (56%), Gaps = 15/211 (7%)
Query: 78 RILGQGGQGTVYKGML--ADGRII--AVKK-SKVVDESKLEEFINEVVILSQINHRNVVK 132
R++G+G G VY G L +DG+ I AVK +++ D ++E+F+ E +I+ +H NV+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 133 LLGCCLEVE-VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSA 191
LLG CL E PL+V ++ +G L ++ E + T + + +VA+ + YL S
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRS--ETHNPTVKDLIGFGLQVAKGMEYLASKK 118
Query: 192 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI---AIDQTHVSTKVQGTFGYLDPEYFR 248
++ HRD+ + N +LDE + K+ADFG +R I H T + ++ E +
Sbjct: 119 FV---HRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 249 SSQFTDKSDVYSFGVVLVELLT-GQKPISSI 278
+ +FT KSDV+SFGV+L EL+T G P +
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 206
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-29
Identities = 61/187 (32%), Positives = 100/187 (53%), Gaps = 19/187 (10%)
Query: 97 RIIAVKKSKV-VDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTL 155
++AVK + ++ E+F+ EV ILS+++ N+ +LLG C ++ E++ NG L
Sbjct: 47 VLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106
Query: 156 FQYLH--------DPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL 207
Q+L SL++ L +AT++A + YL S ++ HRD+ + N L+
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFV---HRDLATRNCLV 163
Query: 208 DEKYRAKIADFGTSRSIAIDQTHVSTKVQGT----FGYLDPEYFRSSQFTDKSDVYSFGV 263
+ Y KIADFG SR++ + +VQG ++ E +FT KSDV++FGV
Sbjct: 164 GKNYTIKIADFGMSRNL---YSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGV 220
Query: 264 VLVELLT 270
L E+LT
Sbjct: 221 TLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 5e-29
Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 78 RILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKL-EEFINEVVILSQINHRNVVKLLGC 136
+G+G G VYKG+L +AVK + L +F+ E IL Q +H N+VKL+G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 137 CLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIY 196
C++ + +V E +P G+L +L L++ +++ + + A + YL S +
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSL--DAAAGMEYLESKNCI--- 115
Query: 197 HRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKV-QGTFGYLDPEYFRSSQFTDK 255
HRD+ + N L+ E KI+DFG SR VS + Q + PE ++T +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175
Query: 256 SDVYSFGVVLVELLTG 271
SDV+S+G++L E +
Sbjct: 176 SDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 7e-29
Identities = 66/196 (33%), Positives = 108/196 (55%), Gaps = 7/196 (3%)
Query: 80 LGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLE 139
+G G G V+ G + R +A+K + S+ E+FI E ++ +++H +V+L G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE-EDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 140 VEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRD 199
LV+EF+ +G L YL + + E L + +V E +AYL SS + HRD
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLESSNVI---HRD 125
Query: 200 IKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVY 259
+ + N L+ E K++DFG +R + DQ ST + + PE F S+++ KSDV+
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVW 185
Query: 260 SFGVVLVELLT-GQKP 274
SFGV++ E+ + G+ P
Sbjct: 186 SFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 9e-29
Identities = 69/237 (29%), Positives = 120/237 (50%), Gaps = 33/237 (13%)
Query: 60 RIFNSKELDKATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKS-KVVDESK----LE 113
RI EL+K ++LG G GTVYKG+ + +G + + + KV+ E +
Sbjct: 2 RILKETELEKI-------KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANK 54
Query: 114 EFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELS----LT 169
E ++E +++ ++H +VV+LLG CL +V L+ + +P G L Y+ + + + L
Sbjct: 55 EILDEAYVMASVDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLN 113
Query: 170 WEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229
W ++A+ ++YL + HRD+ + N+L+ KI DFG ++ + +D+
Sbjct: 114 W------CVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK 164
Query: 230 HVSTKVQG---TFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANE 282
+G ++ E +T KSDV+S+GV + EL+T G KP I A E
Sbjct: 165 EY--HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE 219
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-28
Identities = 79/280 (28%), Positives = 127/280 (45%), Gaps = 39/280 (13%)
Query: 80 LGQGGQGTVYKG--MLADGRII--AVKKSKVVDESKLE-EFINEVVILSQINHRNVVKLL 134
LG G G+V KG ++ G+ + AVK K + + EF+ E +++Q++H +V+L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 135 GCCLEVEVPLLVYEFIPNGTLFQYLHD----PYEELSLTWEMRLRIATEVAEALAYLHSS 190
G C E +LV E P G L +YL P +L +A +VA +AYL S
Sbjct: 63 GVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLKE-------LAHQVAMGMAYLESK 114
Query: 191 AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF--GYLDPEYFR 248
++ HRD+ + N+LL +++AKI+DFG SR++ + G + + PE
Sbjct: 115 HFV---HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN 171
Query: 249 SSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307
+F+ KSDV+S+GV L E + G KP + E + +E
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE-------VIAMLESG---------E 215
Query: 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347
R E + + C +RPT E+ R
Sbjct: 216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-28
Identities = 66/207 (31%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 63 NSKELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESK-LEEFINEVVI 121
NSKEL +G+G G V G G+ +AVK K D+S + F+ E +
Sbjct: 4 NSKELKLGA-------TIGKGEFGDVMLGDYR-GQKVAVKCLK--DDSTAAQAFLAEASV 53
Query: 122 LSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVA 181
++ + H N+V+LLG L+ +V E++ G+L YL +T +L A +V
Sbjct: 54 MTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRS-RGRAVITLAQQLGFALDVC 112
Query: 182 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 241
E + YL HRD+ + N+L+ E AK++DFG ++ + Q V+ T
Sbjct: 113 EGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT--- 166
Query: 242 LDPEYFRSSQFTDKSDVYSFGVVLVEL 268
PE R +F+ KSDV+SFG++L E+
Sbjct: 167 -APEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-28
Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 15/206 (7%)
Query: 80 LGQGGQGTVYKGM-LADGRIIAVKKSKVVDE--SKLEEFINEVVILSQINHRNVVKLLGC 136
+G G G VY + L G ++AVK+ ++ D ++E +E+ +L + H N+VK G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 137 CLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIY 196
+ E + E+ GTL + L L + ++ E LAYLHS I
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLE---HGRILDEHVIRVYTLQLLEGLAYLHSHG---IV 121
Query: 197 HRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFG---YLDPEYFRSSQFT 253
HRDIK NI LD K+ DFG + + + T + +VQ G Y+ PE +
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGK 181
Query: 254 DK---SDVYSFGVVLVELLTGQKPIS 276
+D++S G V++E+ TG++P S
Sbjct: 182 GHGRAADIWSLGCVVLEMATGKRPWS 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-28
Identities = 68/206 (33%), Positives = 108/206 (52%), Gaps = 14/206 (6%)
Query: 76 MNRILGQGGQGTVYKGM---LADGRI-IAVKKSKV-VDESKLEEFINEVVILSQINHRNV 130
+ R +G+G G VY+G+ + +I +AVK K S E+F+ E I+ Q +H ++
Sbjct: 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHI 69
Query: 131 VKLLGCCLEVEVPL-LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS 189
VKL+G E P+ +V E P G L YL L L + + +++ ALAYL S
Sbjct: 70 VKLIGVI--TENPVWIVMELAPLGELRSYLQVNKYSLDL--ASLILYSYQLSTALAYLES 125
Query: 190 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRS 249
++ HRDI + N+L+ K+ DFG SR + + + ++K + ++ PE
Sbjct: 126 KRFV---HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF 182
Query: 250 SQFTDKSDVYSFGVVLVELLT-GQKP 274
+FT SDV+ FGV + E+L G KP
Sbjct: 183 RRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 8e-28
Identities = 85/308 (27%), Positives = 141/308 (45%), Gaps = 53/308 (17%)
Query: 76 MNRILGQGGQGTVYKGM------LADGRIIAVKKSKV-VDESKLEEFINEVVILSQINHR 128
+ + LG+G G V K A +AVK K S+L + ++E +L Q+NH
Sbjct: 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHP 63
Query: 129 NVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLH---------------------DPYEELS 167
+V+KL G C + LL+ E+ G+L +L D +E +
Sbjct: 64 HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123
Query: 168 LTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227
LT + A +++ + YL A + + HRD+ + N+L+ E + KI+DFG SR + +
Sbjct: 124 LTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180
Query: 228 QTHVS-TKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRN 285
++V +K + ++ E +T +SDV+SFGV+L E++T G P I N
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFN 240
Query: 286 L--TTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343
L T Y +E ENC +EE + ++ C RPT +++ E
Sbjct: 241 LLKTGYRME-RPENC--------------SEE---MYNLMLTCWKQEPDKRPTFADISKE 282
Query: 344 LERIRANS 351
LE++ S
Sbjct: 283 LEKMMVKS 290
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 8e-28
Identities = 69/217 (31%), Positives = 112/217 (51%), Gaps = 25/217 (11%)
Query: 80 LGQGGQGTVYKGML------ADGRIIAVKKSKVVDESKL-EEFINEVVILSQINHRNVVK 132
LG+G G VYKG L +A+K K E K+ +EF E ++S + H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 133 LLGCCLEVEVPLLVYEFIPNGTLFQYL--HDPYEELSLTWEMR-----------LRIATE 179
LLG C + + +++E++ +G L ++L + P+ ++ L IA +
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 180 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI-AIDQTHVSTKVQGT 238
+A + YL S ++ HRD+ + N L+ E KI+DFG SR I + D V +K
Sbjct: 133 IAAGMEYLSSHHFV---HRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 239 FGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKP 274
++ PE +FT +SD++SFGVVL E+ + G +P
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 8e-28
Identities = 63/210 (30%), Positives = 109/210 (51%), Gaps = 8/210 (3%)
Query: 66 ELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQI 125
E+D+ + + R LG G G V++G+ + +AVK K ++F+ E I+ ++
Sbjct: 2 EIDRTS--IQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKP-GTMDPKDFLAEAQIMKKL 58
Query: 126 NHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALA 185
H +++L C E +V E + G+L +YL +L + +A +VA +A
Sbjct: 59 RHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGG-AGRALKLPQLIDMAAQVASGMA 117
Query: 186 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE 245
YL + Y+ HRD+ + N+L+ E K+ADFG +R I D + + PE
Sbjct: 118 YLEAQNYI---HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPE 174
Query: 246 YFRSSQFTDKSDVYSFGVVLVELLT-GQKP 274
++F+ KSDV+SFG++L E++T G+ P
Sbjct: 175 AALYNRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 9e-28
Identities = 63/207 (30%), Positives = 106/207 (51%), Gaps = 21/207 (10%)
Query: 80 LGQGGQGTVYKG--MLADGRII--AVK--KSKVVDESKLEEFINEVVILSQINHRNVVKL 133
LG G G V +G + G++I AVK KS + + +++F+ E I+ ++H N+++L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDI-MDDFLKEAAIMHSLDHENLIRL 61
Query: 134 LGCCLEVEVPLLVYEFIPNGTLFQYLHD---PYEELSLTWEMRLRIATEVAEALAYLHSS 190
G L + ++V E P G+L L + +S + A ++A + YL S
Sbjct: 62 YGVVLTHPL-MMVTELAPLGSLLDRLRKDALGHFLISTLCDY----AVQIANGMRYLESK 116
Query: 191 AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGT--FGYLDPEYFR 248
++ HRD+ + NILL + KI DFG R++ ++ H + F + PE R
Sbjct: 117 RFI---HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173
Query: 249 SSQFTDKSDVYSFGVVLVELLT-GQKP 274
+ F+ SDV+ FGV L E+ T G++P
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 9e-28
Identities = 73/209 (34%), Positives = 108/209 (51%), Gaps = 19/209 (9%)
Query: 73 YFNMNRILGQGGQGTV--YKGMLAD---GRIIAVKKSKVVDESKLEE-FINEVVILSQIN 126
Y R+LG+G G V Y A+ G ++AVK K + + E+ IL +
Sbjct: 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY 64
Query: 127 HRNVVKLLGCCLEV--EVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEAL 184
H N+VK GCC E + L+ E++P G+L YL P +L+L L A ++ E +
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNLA--QLLLFAQQICEGM 120
Query: 185 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQG---TFGY 241
AYLHS Y+ HRD+ + N+LLD KI DFG ++++ + + G F Y
Sbjct: 121 AYLHSQHYI---HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 177
Query: 242 LDPEYFRSSQFTDKSDVYSFGVVLVELLT 270
E + ++F+ SDV+SFGV L ELLT
Sbjct: 178 A-VECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 60/217 (27%), Positives = 112/217 (51%), Gaps = 26/217 (11%)
Query: 72 DYFNMNRILGQGGQGTVYKGMLA----DGRIIAVK--KSKVVDESKLEEFINEVVILSQI 125
Y + +++G G G V +G L +A+K K+ D+ +L+ F+ E I+ Q
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD-FLTEASIMGQF 62
Query: 126 NHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYL--HDPYEELSLTWEMRLRIATEVAEA 183
+H N+++L G + +++ E++ NG+L ++L +D T + + +A
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK----FTVGQLVGMLRGIASG 118
Query: 184 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTK-----VQGT 238
+ YL Y+ HRD+ + NIL++ K++DFG SR + + +TK ++ T
Sbjct: 119 MKYLSEMNYV---HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT 175
Query: 239 FGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKP 274
PE +FT SDV+SFG+V+ E+++ G++P
Sbjct: 176 ----APEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 73/237 (30%), Positives = 117/237 (49%), Gaps = 30/237 (12%)
Query: 80 LGQGGQGTVYKGMLA------DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKL 133
LG+G G V+ D ++AVK K ES ++F E +L+ + H+++V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 134 LGCCLEVEVPLLVYEFIPNGTLFQYL--HDPYEEL----------SLTWEMRLRIATEVA 181
G C E L+V+E++ +G L ++L H P ++ LT L IA+++A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 182 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI-AIDQTHVSTKVQGTFG 240
+ YL A L HRD+ + N L+ + KI DFG SR I + D V +
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 241 YLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEE 296
++ PE +FT +SD++SFGVVL E+ T G++P + E +ECI +
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA-------IECITQ 239
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-27
Identities = 70/216 (32%), Positives = 108/216 (50%), Gaps = 21/216 (9%)
Query: 76 MNRILGQGGQGTVYKGMLAD------GRIIAVKKSKVVDESKLE--EFINEVVILSQINH 127
+ R LGQG G VY+G+ +A+K + + S E EF+NE ++ + N
Sbjct: 10 LIRELGQGSFGMVYEGLAKGVVKGEPETRVAIK-TVNENASMRERIEFLNEASVMKEFNC 68
Query: 128 RNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYL--HDPYEEL-----SLTWEMRLRIATEV 180
+VV+LLG + L+V E + G L YL P E T + +++A E+
Sbjct: 69 HHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128
Query: 181 AEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI-AIDQTHVSTKVQGTF 239
A+ +AYL + ++ HRD+ + N ++ E KI DFG +R I D K
Sbjct: 129 ADGMAYLAAKKFV---HRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 240 GYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKP 274
++ PE + FT KSDV+SFGVVL E+ T ++P
Sbjct: 186 RWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 8e-27
Identities = 81/269 (30%), Positives = 130/269 (48%), Gaps = 25/269 (9%)
Query: 79 ILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLE-EFINEVVILSQINHRNVVKLLGCC 137
+LG+G G V+KG L D +AVK K +L+ +F++E IL Q +H N+VKL+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 138 LEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYH 197
+ + +V E +P G +L +EL + ++ A + A +AYL S + H
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKT--KQLVKFALDAAAGMAYLESKNCI---H 116
Query: 198 RDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKV-QGTFGYLDPEYFRSSQFTDKS 256
RD+ + N L+ E KI+DFG SR D + S+ + Q + PE +++ +S
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQ-EDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 257 DVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEE 315
DV+S+G++L E + G P + + R E +E+ R S +
Sbjct: 176 DVWSYGILLWETFSLGVCPYPGMTNQQAR-------EQVEKG---------YRMSCPQKC 219
Query: 316 IMAVSDVAKRCLNSYGRNRPTMKEVAMEL 344
V V +RC + NRP E+ EL
Sbjct: 220 PDDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-26
Identities = 84/287 (29%), Positives = 136/287 (47%), Gaps = 32/287 (11%)
Query: 80 LGQGGQGTVYK---GMLAD--GRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLL 134
LG+G G+V L D G ++AVKK + L +F E+ IL + H N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 135 GCCLEVEVP--LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAY 192
G C LV E++P G+L YL E L L A+++ + + YL S Y
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHR--KLLLYASQICKGMEYLGSKRY 129
Query: 193 LPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQG---TFGYLDPEYFRS 249
+ HRD+ + NIL++ + R KI DFG ++ + D+ + + G F Y PE
Sbjct: 130 V---HRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA-PESLTE 185
Query: 250 SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENC--------LFD 301
S+F+ SDV+SFGVVL EL T ++++ + F+ + + L +
Sbjct: 186 SKFSVASDVWSFGVVLYELFT--------YSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237
Query: 302 IIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIR 348
++ + R + + K C N+ RP+ E+A+++E IR
Sbjct: 238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-26
Identities = 68/212 (32%), Positives = 112/212 (52%), Gaps = 23/212 (10%)
Query: 79 ILGQGGQGTVYKGMLA-DGRIIAVK---------KSKVVDESKLEEFINEVVILSQINHR 128
++G G G+VY GM A G ++AVK SK S L+ E+ +L ++ H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 129 NVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLR-IATEVAEALAYL 187
N+V+ LG L+ + + E++P G++ L + Y E +R ++ + L YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSV-AALLNNYGAFE---ETLVRNFVRQILKGLNYL 122
Query: 188 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTK-----VQGTFGYL 242
H+ I HRDIK NIL+D K KI+DFG S+ + + T +QG+ ++
Sbjct: 123 HNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 243 DPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
PE + + +T K+D++S G ++VE+LTG+ P
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 1e-26
Identities = 65/203 (32%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 79 ILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEF----INEVVILSQINHRNVVKL 133
LG+G G VYK G I+A+KK ++ +E E + E+ +L ++ H N+VKL
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE--EGIPSTALREISLLKELKHPNIVKL 63
Query: 134 LGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYL 193
L LV+E+ L +YL LS + I ++ LAY HS L
Sbjct: 64 LDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSP--NLIKSIMYQLLRGLAYCHSHRIL 120
Query: 194 PIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFT 253
HRD+K NIL++ K+ADFG +R+ I + +V T Y PE S+
Sbjct: 121 ---HRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGSKHY 176
Query: 254 DKS-DVYSFGVVLVELLTGQKPI 275
+ D++S G + E++TG KP+
Sbjct: 177 STAVDIWSVGCIFAEMITG-KPL 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-26
Identities = 65/210 (30%), Positives = 106/210 (50%), Gaps = 20/210 (9%)
Query: 74 FNMNRILGQGGQGTVYK-GMLADGRIIAVKKSKVVDESKLE--EFINEVVILSQINHRNV 130
F + + LG+G G+VYK L+D + A+K+ + S+ E + +NE+ IL+ +NH N+
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 131 VK-----LLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSL-TWEMRLRIATEVAEAL 184
+ L G L +V E+ P G L + + ++ L + RI ++ L
Sbjct: 62 ISYKEAFLDGNKL-----CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGL 116
Query: 185 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDP 244
LH I HRD+KS NILL KI D G S+ + + T++ GT Y+ P
Sbjct: 117 QALHE---QKILHRDLKSANILLVANDLVKIGDLGISK--VLKKNMAKTQI-GTPHYMAP 170
Query: 245 EYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
E ++ ++ KSD++S G +L E+ T P
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-26
Identities = 74/222 (33%), Positives = 103/222 (46%), Gaps = 32/222 (14%)
Query: 72 DYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESK----LEEFINEVVILSQIN 126
DY + I G G VY + L + +A+K+ +D K ++E EV +SQ N
Sbjct: 2 DYELIEVI-GVGATAVVYAAICLPNNEKVAIKR---IDLEKCQTSVDELRKEVQAMSQCN 57
Query: 127 HRNVVKLLGCCLEVEVPLLVYEFIPNGTL-----FQYLHDPYEELSLTWEMRLRIAT--- 178
H NVVK + + LV ++ G+L Y +E IAT
Sbjct: 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAI--------IATVLK 109
Query: 179 EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA---IDQTHVSTKV 235
EV + L YLHS+ + HRDIK+ NILL E KIADFG S S+A V
Sbjct: 110 EVLKGLEYLHSNGQI---HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTF 166
Query: 236 QGTFGYLDPEYFRSSQ-FTDKSDVYSFGVVLVELLTGQKPIS 276
GT ++ PE + K+D++SFG+ +EL TG P S
Sbjct: 167 VGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYS 208
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-26
Identities = 68/276 (24%), Positives = 123/276 (44%), Gaps = 33/276 (11%)
Query: 78 RILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESK------LEEFINEVVILSQINHRNV 130
+ LG G + Y+ + G ++AVK+ V + +E E+ +++++NH ++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 131 VKLLGCCLEVEVPLLVYEFIPNGTLFQYLHD--PYEELSLTWEMRLRIATEVAEALAYLH 188
+++LG E L E++ G++ L ++E + + ++ L+YLH
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE-----AVIINYTEQLLRGLSYLH 120
Query: 189 SSAYLPIYHRDIKSTNILLDEK-YRAKIADFGTSRSIAIDQT---HVSTKVQGTFGYLDP 244
+ I HRD+K N+L+D R +IADFG + +A T ++ GT ++ P
Sbjct: 121 ENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177
Query: 245 EYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIID 304
E R Q+ DV+S G V++E+ T + P W E + + +F I
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMATAKPP----WNAE--KHSNHLA------LIFKIAS 225
Query: 305 DQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEV 340
S + DV RCL +RP +E+
Sbjct: 226 ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-26
Identities = 78/278 (28%), Positives = 125/278 (44%), Gaps = 44/278 (15%)
Query: 76 MNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESK-----LEEFINEVVILSQINHRN 129
+LG G G+VY+G+ L DG AVK+ + D+ + +++ E+ +LS++ H N
Sbjct: 4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPN 63
Query: 130 VVKLLGCCLEVEVPLLVY-EFIPNGTLFQYLHDPYEELSLTWEMRLRIATE-VAEALAYL 187
+V+ LG E E L ++ E +P G+L ++ E +R+ T + L YL
Sbjct: 64 IVQYLGTERE-EDNLYIFLELVPGGSL----AKLLKKYGSFPEPVIRLYTRQILLGLEYL 118
Query: 188 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYF 247
H HRDIK NIL+D K+ADFG ++ + S K G+ ++ PE
Sbjct: 119 HDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFK--GSPYWMAPEVI 173
Query: 248 RSS-QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306
+ +D++S G ++E+ TG+ P S + +F I
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGKPPWS---------------QLEGVAAVFKIG--- 215
Query: 307 VRKSGEAEEIM-AVSDVAK----RCLNSYGRNRPTMKE 339
+S E I +SD AK +CL RPT E
Sbjct: 216 --RSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAE 251
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 66/208 (31%), Positives = 106/208 (50%), Gaps = 10/208 (4%)
Query: 68 DKATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQIN 126
D Y +I GQG GTVY + +A G+ +A+K+ + + K E INE++++ +
Sbjct: 16 DPKKKYTRFEKI-GQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENK 74
Query: 127 HRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAY 186
H N+V L L + +V E++ G+L D E + + E +AL +
Sbjct: 75 HPNIVNYLDSYLVGDELWVVMEYLAGGSL----TDVVTETCMDEGQIAAVCRECLQALEF 130
Query: 187 LHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEY 246
LHS+ + HRDIKS NILL K+ DFG I +Q+ ST V GT ++ PE
Sbjct: 131 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEV 186
Query: 247 FRSSQFTDKSDVYSFGVVLVELLTGQKP 274
+ K D++S G++ +E++ G+ P
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-25
Identities = 73/239 (30%), Positives = 118/239 (49%), Gaps = 28/239 (11%)
Query: 76 MNRILGQGGQGTVYKGML------ADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRN 129
+ R LG+G G V+ D ++AVK K ++ ++F E +L+ + H +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYL--HDPYEEL--------SLTWEMRLRIATE 179
+VK G C+E + ++V+E++ +G L ++L H P L LT L IA +
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 180 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI-AIDQTHVSTKVQGT 238
+A + YL S ++ HRD+ + N L+ E KI DFG SR + + D V
Sbjct: 129 IAAGMVYLASQHFV---HRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185
Query: 239 FGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEE 296
++ PE +FT +SDV+S GVVL E+ T G++P + NE +ECI +
Sbjct: 186 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIECITQ 237
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 69/217 (31%), Positives = 107/217 (49%), Gaps = 31/217 (14%)
Query: 74 FNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVK 132
F++ LG+G G+VYK + G+++A+K V E L+E I E+ IL Q + +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVK 62
Query: 133 LLGCCLEVEVPLLVYEF-----------IPNGTLFQYLHDPYEELSLTWEMRLRIATEVA 181
G + +V E+ I N TL EE++ I +
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTL------TEEEIAA-------ILYQTL 109
Query: 182 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 241
+ L YLHS+ HRDIK+ NILL+E+ +AK+ADFG S D V GT +
Sbjct: 110 KGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVS-GQLTDTMAKRNTVIGTPFW 165
Query: 242 LDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSI 278
+ PE + + +K+D++S G+ +E+ G+ P S I
Sbjct: 166 MAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-25
Identities = 63/220 (28%), Positives = 115/220 (52%), Gaps = 28/220 (12%)
Query: 79 ILGQGGQGTVYKGMLAD-GRIIAVKKSKVV------DESKLEEFI----NEVVILSQINH 127
++G+G G VY + G ++AVK+ ++ +S+ ++ + +E+ L ++H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 128 RNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYL--HDPYEELSLTWEMRLRIATEVAEALA 185
N+V+ LG E + E++P G++ L + +EE ++ +V E LA
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE-----QLVRFFTEQVLEGLA 122
Query: 186 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR-SIAIDQTHVSTKVQGTFGYLDP 244
YLHS I HRD+K+ N+L+D KI+DFG S+ S I + +QG+ ++ P
Sbjct: 123 YLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 245 EYFRSSQ--FTDKSDVYSFGVVLVELLTGQKPISSIWANE 282
E S ++ K D++S G V++E+ G++P W++E
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP----WSDE 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 17/206 (8%)
Query: 78 RILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEF----INEVVILSQINHRNVVK 132
+G+G G VYK G ++A+KK ++ +E E F I E+ +L ++ H N+V+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHPNIVR 62
Query: 133 LLGCCLEVEVP--LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSS 190
L +V+E++ + L L P + + + +++ ++ E L YLHS+
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTES-QIK-CYMKQLLEGLQYLHSN 119
Query: 191 AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE-YFRS 249
L HRDIK +NIL++ K+ADFG +R + T T Y PE +
Sbjct: 120 GIL---HRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGA 176
Query: 250 SQFTDKSDVYSFGVVLVELLTGQKPI 275
+++ + D++S G +L EL G KPI
Sbjct: 177 TRYGPEVDMWSVGCILAELFLG-KPI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-25
Identities = 81/298 (27%), Positives = 147/298 (49%), Gaps = 41/298 (13%)
Query: 60 RIFNSKELDKATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKS-KVVDESKLE---- 113
RI EL + ++LG G GTVYKG+ + +G + + + K+++E+
Sbjct: 2 RILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV 54
Query: 114 EFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMR 173
EF++E +I++ ++H ++V+LLG CL + LV + +P+G L Y+H+ + + ++
Sbjct: 55 EFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGS--QLL 111
Query: 174 LRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVST 233
L ++A+ + YL + HRD+ + N+L+ KI DFG +R + D+ +
Sbjct: 112 LNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA 168
Query: 234 ---KVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTY 289
K+ + L+ ++R +FT +SDV+S+GV + EL+T G KP I E
Sbjct: 169 DGGKMPIKWMALECIHYR--KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE------- 219
Query: 290 FVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347
+ D+++ R + V V +C +RP KE+A E R+
Sbjct: 220 ---------IPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-25
Identities = 62/203 (30%), Positives = 109/203 (53%), Gaps = 11/203 (5%)
Query: 78 RILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKL--EEFINEVVILSQINHRNVVKLLG 135
+ LG G G V+ G +A+K ++E + E+FI E ++ +++H +V+L G
Sbjct: 10 KELGSGQFGVVHLGKWRAQIKVAIKA---INEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 136 CCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPI 195
C + + +V EF+ NG L YL +LS +M L + +V E + YL ++++
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSK--DMLLSMCQDVCEGMEYLERNSFI-- 122
Query: 196 YHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDK 255
HRD+ + N L+ K++DFG +R + D+ S+ + + PE F S+++ K
Sbjct: 123 -HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 256 SDVYSFGVVLVELLT-GQKPISS 277
SDV+SFGV++ E+ T G+ P
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPFEK 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-25
Identities = 78/274 (28%), Positives = 137/274 (50%), Gaps = 29/274 (10%)
Query: 76 MNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLG 135
+ + +G+G G V ML D R V + +++ + F+ E +++Q+ H N+V+LLG
Sbjct: 10 LLQTIGKGEFGDV---MLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLG 66
Query: 136 CCLEVEVPL-LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLP 194
+E + L +V E++ G+L YL + L + L+ + +V EA+ YL ++ ++
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEANNFV- 124
Query: 195 IYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTD 254
HRD+ + N+L+ E AK++DFG ++ + Q V+ T PE R +F+
Sbjct: 125 --HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFST 178
Query: 255 KSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEA 313
KSDV+SFG++L E+ + G+ P I + V +E+ D D G
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGYKMDAPD------GCP 225
Query: 314 EEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347
V DV K+C + RP+ ++ +LE I
Sbjct: 226 P---VVYDVMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 74/267 (27%), Positives = 123/267 (46%), Gaps = 26/267 (9%)
Query: 78 RILGQG--GQGTVYKGMLADGRIIAVKKSKV--VDESKLEEFINEVVILSQINHRNVVKL 133
R+LG+G G+ T+Y+ D ++ K+ + + E + + +NE+VILS + H N++
Sbjct: 6 RVLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64
Query: 134 LGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYL 193
++ L+ E+ GTL+ + +L EM L ++ A++Y+H +
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQL-FEEEMVLWYLFQIVSAVSYIHKAG-- 121
Query: 194 PIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFT 253
I HRDIK+ NI L + K+ DFG S+ + + + T V GT Y+ PE + ++
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKYN 179
Query: 254 DKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEA 313
KSD+++ G VL ELLT ++ A NL V+ + +
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFD---ATNPLNLVVKIVQGNYT-----PVVSVY----SS 227
Query: 314 EEIMAVSDVAKRCLNSYGRNRPTMKEV 340
E I V L RPT EV
Sbjct: 228 ELISLVHS----LLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 9/204 (4%)
Query: 79 ILGQGGQGTVYKGM-LADGRIIAVKKSKV--VDESKLEEFINEVVILSQINHRNVVKLLG 135
+G+G GTV K +DG+I+ K+ + E + ++ ++EV IL ++ H N+V+
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 136 CCL--EVEVPLLVYEFIPNGTLFQYLHDPYEE-LSLTWEMRLRIATEVAEALAYLHSSAY 192
+ + +V E+ G L Q + +E + E RI T++ AL H+ +
Sbjct: 67 RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSD 126
Query: 193 LP--IYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSS 250
+ HRD+K NI LD K+ DFG ++ + D + T V GT Y+ PE
Sbjct: 127 PGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQLNHM 185
Query: 251 QFTDKSDVYSFGVVLVELLTGQKP 274
+ +KSD++S G ++ EL P
Sbjct: 186 SYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 3e-24
Identities = 77/276 (27%), Positives = 128/276 (46%), Gaps = 25/276 (9%)
Query: 72 DYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVV 131
+ + + LG G G V+ G +A+K K S E F+ E ++ Q+ H +V
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP-EAFLAEANLMKQLQHPRLV 64
Query: 132 KLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSA 191
+L + E ++ E++ NG+L +L P E + LT + +A ++AE +A++
Sbjct: 65 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN 122
Query: 192 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQ 251
Y+ HRD+++ NIL+ E KIADFG +R I ++ + + PE
Sbjct: 123 YI---HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 179
Query: 252 FTDKSDVYSFGVVLVELLT-GQKPISSIWANEG-RNLTTYFVECIEENCLFDIIDDQVRK 309
FT KSDV+SFG++L E++T G+ P + E +NL + +NC
Sbjct: 180 FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNC----------- 228
Query: 310 SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345
E E+M + C RPT + + LE
Sbjct: 229 PEELYELM------RLCWKEKPEERPTFEYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 5e-24
Identities = 75/290 (25%), Positives = 140/290 (48%), Gaps = 39/290 (13%)
Query: 76 MNRILGQGGQGTVYKGML-ADGRI--IAVKKSKVV--DESKLEEFINEVVILSQINHRNV 130
+ + LG+G G+V +G L D I +AVK K+ S++E+F++E V + + +H NV
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV 62
Query: 131 VKLLGCCLE------VEVPLLVYEFIPNGTLFQYLHDPYEELS-----LTWEMRLRIATE 179
++L+G CL+ P+++ F+ +G L +L Y L L +M ++ T+
Sbjct: 63 MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLL--YSRLGDCPQYLPTQMLVKFMTD 120
Query: 180 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKV-QGT 238
+A + YL S +++ HRD+ + N +L+E +ADFG S+ I + ++ +
Sbjct: 121 IASGMEYLSSKSFI---HRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177
Query: 239 FGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEEN 297
++ E +T KSDV+SFGV + E+ T GQ P +E +
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG----------------VENS 221
Query: 298 CLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347
++D + R + + + + C ++RP+ + + ELE+
Sbjct: 222 EIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 5e-24
Identities = 79/217 (36%), Positives = 110/217 (50%), Gaps = 24/217 (11%)
Query: 78 RILGQGGQGTVYKGMLAD------GRI-IAVK--KSKVVDESKLEEFINEVVILSQINHR 128
LG G G VY+G D G I +AVK + D+ K +EF+ E ++S NH
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK-KEFLKEAHLMSNFNHP 59
Query: 129 NVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELS----LTWEMRLRIATEVAEAL 184
N+VKLLG CL E ++ E + G L YL D E LT + L I +VA+
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 185 AYLHSSAYLPIYHRDIKSTNILLDEK-YRA----KIADFGTSRSI-AIDQTHVSTKVQGT 238
YL ++ HRD+ + N L+ EK Y A KI DFG +R I D +
Sbjct: 120 VYLEQMHFI---HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 239 FGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKP 274
++ PE +FT +SDV+SFGV++ E+LT GQ+P
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 5e-24
Identities = 73/274 (26%), Positives = 136/274 (49%), Gaps = 33/274 (12%)
Query: 76 MNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLG 135
+ I+G+G G V +G G+ +AVK K + + F+ E ++++++H+N+V+LLG
Sbjct: 10 LGEIIGEGEFGAVLQGEYT-GQKVAVKNIKC--DVTAQAFLEETAVMTKLHHKNLVRLLG 66
Query: 136 CCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPI 195
L + +V E + G L +L L ++ L+ + +VAE + YL S +
Sbjct: 67 VILHNGL-YIVMELMSKGNLVNFLRTRGRALVSVIQL-LQFSLDVAEGMEYLESKKLV-- 122
Query: 196 YHRDIKSTNILLDEKYRAKIADFGTSR--SIAIDQTHVSTKVQGTFGYLDPEYFRSSQFT 253
HRD+ + NIL+ E AK++DFG +R S+ +D + + K + PE + +F+
Sbjct: 123 -HRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFS 175
Query: 254 DKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGE 312
KSDV+S+GV+L E+ + G+ P + E EC+E+ + + +
Sbjct: 176 SKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-------VKECVEKGYRMEPPEGC---PAD 225
Query: 313 AEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELER 346
+M C + + RP+ ++ +LE+
Sbjct: 226 VYVLM------TSCWETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 7e-24
Identities = 61/196 (31%), Positives = 104/196 (53%), Gaps = 7/196 (3%)
Query: 80 LGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLE 139
LG G G V G +A+K K S+ +EFI E ++ +++H +V+L G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 140 VEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRD 199
+V E++ NG L YL + + + L + +V E +AYL S ++ HRD
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPS--QLLEMCKDVCEGMAYLESKQFI---HRD 125
Query: 200 IKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVY 259
+ + N L+D++ K++DFG SR + D+ S + + PE S+F+ KSDV+
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVW 185
Query: 260 SFGVVLVELLT-GQKP 274
+FGV++ E+ + G+ P
Sbjct: 186 AFGVLMWEVYSLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 7e-24
Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 12/210 (5%)
Query: 72 DYFNMNR--ILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQINHR 128
+Y +LG+G G VY L+ IA+K+ D ++ E+ + S + HR
Sbjct: 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65
Query: 129 NVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLH 188
N+V+ LG E + E +P G+L L + L + + ++ E L YLH
Sbjct: 66 NIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH 125
Query: 189 SSAYLPIYHRDIKSTNILLDEKYRA--KIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEY 246
I HRDIK N+L++ Y KI+DFGTS+ +A T GT Y+ PE
Sbjct: 126 D---NQIVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINPCTET-FTGTLQYMAPEV 180
Query: 247 FRSSQ--FTDKSDVYSFGVVLVELLTGQKP 274
+ +D++S G +VE+ TG+ P
Sbjct: 181 IDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 9e-24
Identities = 70/208 (33%), Positives = 104/208 (50%), Gaps = 18/208 (8%)
Query: 78 RILGQGGQGTVYKGMLADGRIIAVK---KSKVVDESKLEE----FINEVVILSQINHRNV 130
R LG G G VY+G+ AV+ K + ES E+ F+ E +I+S+ NH+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 131 VKLLGCCLEVEVPLLVYEFIPNGTLFQYLHD----PYEELSLTWEMRLRIATEVAEALAY 186
V+L+G E ++ E + G L +L + P SLT + L A +VA+ Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 187 LHSSAYLPIYHRDIKSTNILLDEK---YRAKIADFGTSRSI-AIDQTHVSTKVQGTFGYL 242
L + ++ HRDI + N LL K AKIADFG +R I + ++
Sbjct: 132 LEENHFI---HRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188
Query: 243 DPEYFRSSQFTDKSDVYSFGVVLVELLT 270
PE F FT K+DV+SFGV+L E+ +
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 1e-23
Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 29/210 (13%)
Query: 80 LGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFIN-----EVVILSQINHRNVVKL 133
LG+G VYK GRI+A+KK K+ + + ++ IN E+ +L ++ H N++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 134 LGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLT------W-EMRLRIATEVAEALAY 186
L LV+EF+ L + + D + LT + M LR L Y
Sbjct: 68 LDVFGHKSNINLVFEFME-TDLEKVIKDK--SIVLTPADIKSYMLMTLR-------GLEY 117
Query: 187 LHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE- 245
LHS+ L HRD+K N+L+ K+ADFG +RS ++ +V T Y PE
Sbjct: 118 LHSNWIL---HRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPEL 173
Query: 246 YFRSSQFTDKSDVYSFGVVLVELLTGQKPI 275
F + + D++S G + ELL + P
Sbjct: 174 LFGARHYGVGVDMWSVGCIFAELLL-RVPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 1e-23
Identities = 81/305 (26%), Positives = 142/305 (46%), Gaps = 63/305 (20%)
Query: 78 RILGQGGQGTVYK----GMLA--DGRIIAVKKSKVVDESKLE---EFINEVVILSQINHR 128
R +GQG G V++ G+L ++AVK K +E+ + +F E ++++ +H
Sbjct: 11 RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK--EEASADMQADFQREAALMAEFDHP 68
Query: 129 NVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHD--PYEELS-----------------LT 169
N+VKLLG C + L++E++ G L ++L P + S L+
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 170 WEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI-AIDQ 228
+L IA +VA +AYL ++ HRD+ + N L+ E KIADFG SR+I + D
Sbjct: 129 CTEQLCIAKQVAAGMAYLSERKFV---HRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185
Query: 229 THVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLT 287
S ++ PE +++T +SDV+++GVVL E+ + G +P + A+E
Sbjct: 186 YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM-AHEE---V 241
Query: 288 TYFVE------CIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVA 341
Y+V C +NC ++ ++ + C + +RP+ +
Sbjct: 242 IYYVRDGNVLSC-PDNCPLELY-----------------NLMRLCWSKLPSDRPSFASIN 283
Query: 342 MELER 346
L+R
Sbjct: 284 RILQR 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 1e-23
Identities = 71/220 (32%), Positives = 109/220 (49%), Gaps = 19/220 (8%)
Query: 79 ILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLE-EFINEVVILSQINHRNVVKLLGC 136
ILG G GTVYK L RI+AVK + +L+ + ++E+ IL + + ++ G
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 137 CLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIY 196
+ EF+ G+L Y P L RIA V + L YL S L I
Sbjct: 68 FFVENRISICTEFMDGGSLDVYRKIPEHVLG-------RIAVAVVKGLTYLWS---LKIL 117
Query: 197 HRDIKSTNILLDEKYRAKIADFGTSRSI--AIDQTHVSTKVQGTFGYLDPEYFRSSQFTD 254
HRD+K +N+L++ + + K+ DFG S + +I +T+V GT Y+ PE Q+
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV-----GTNAYMAPERISGEQYGI 172
Query: 255 KSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECI 294
SDV+S G+ +EL G+ P I N+G + ++CI
Sbjct: 173 HSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI 212
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 2e-23
Identities = 66/211 (31%), Positives = 114/211 (54%), Gaps = 15/211 (7%)
Query: 80 LGQGGQGTVYKG---MLADGRIIAVK--KSKVVDESKLEEFINEVVILSQINHRNVVKLL 134
LG G GTV KG M + +AVK K+ D + +E + E ++ Q+++ +V+++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 135 GCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLP 194
G C E E +LV E G L ++L + +T + + +V+ + YL + ++
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQ---KNKHVTEKNITELVHQVSMGMKYLEETNFV- 117
Query: 195 IYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF--GYLDPEYFRSSQF 252
HRD+ + N+LL ++ AKI+DFG S+++ D+ + K G + + PE +F
Sbjct: 118 --HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175
Query: 253 TDKSDVYSFGVVLVELLT-GQKPISSIWANE 282
+ KSDV+SFGV++ E + GQKP + NE
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE 206
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 2e-23
Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 22/209 (10%)
Query: 80 LGQGGQGTVYKG-MLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCL 138
+G G G VYK +A G ++A+K K+ E E+ +L + H N+V G L
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 139 EVEVPLLVYEFIPNGTL---FQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPI 195
+ +V E+ G+L +Q P EL + + + E + LAYLH + +
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAY-----VCRETLKGLAYLHETGKI-- 123
Query: 196 YHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQ---GTFGYLDPEYF---RS 249
HRDIK NILL E K+ADFG S + T K + GT ++ PE R
Sbjct: 124 -HRDIKGANILLTEDGDVKLADFGVSAQL----TATIAKRKSFIGTPYWMAPEVAAVERK 178
Query: 250 SQFTDKSDVYSFGVVLVELLTGQKPISSI 278
+ K D+++ G+ +EL Q P+ +
Sbjct: 179 GGYDGKCDIWALGITAIELAELQPPMFDL 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 3e-23
Identities = 79/273 (28%), Positives = 128/273 (46%), Gaps = 33/273 (12%)
Query: 73 YFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVD----ESKLEEFINEVVILSQINHR 128
+ + RI G+G G VYKG+ D R V K++D E ++E+ E+ +LSQ +
Sbjct: 6 FTKLERI-GKGSFGEVYKGI--DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 129 NVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLH-DPYEELSLTWEMRLRIATEVAEALAYL 187
+ + G L+ ++ E++ G+ L P EE + +R E+ + L YL
Sbjct: 63 YITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR-----EILKGLDYL 117
Query: 188 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYF 247
HS + HRDIK+ N+LL E+ K+ADFG + + Q +T V GT ++ PE
Sbjct: 118 HSERKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVI 173
Query: 248 RSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307
+ S + K+D++S G+ +EL G+ P S + LF +I
Sbjct: 174 KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---------------VLF-LIPKNS 217
Query: 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEV 340
+ E + + + CLN R RPT KE+
Sbjct: 218 PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKEL 250
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 3e-23
Identities = 66/215 (30%), Positives = 103/215 (47%), Gaps = 24/215 (11%)
Query: 78 RILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESK-----LEEFINEVVILSQINHRNVV 131
++LGQG G VY D GR +AVK+ +S + E+ +L + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 132 KLLGCCLEVEVPLLVYEFIPNGTLFQYL--HDPYEELSLTWEMRLRIATEVAEALAYLHS 189
+ GC + E + E++P G++ L + LT + + ++ E + YLHS
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA-----LTETVTRKYTRQILEGVEYLHS 122
Query: 190 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR---SIAIDQTHVSTKVQGTFGYLDPEY 246
+ I HRDIK NIL D K+ DFG S+ +I T + + V GT ++ PE
Sbjct: 123 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPYWMSPEV 178
Query: 247 FRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWAN 281
+ K+DV+S G +VE+LT + P WA
Sbjct: 179 ISGEGYGRKADVWSVGCTVVEMLTEKPP----WAE 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 3e-23
Identities = 69/217 (31%), Positives = 116/217 (53%), Gaps = 20/217 (9%)
Query: 70 ATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKV----VDES----KLEEFINEVVI 121
A + M+R LGQG G VY+G +A G + +++V V+E+ + EF+NE +
Sbjct: 4 AREKITMSRELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 62
Query: 122 LSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHD--PYEELSL-----TWEMRL 174
+ + N +VV+LLG + + L++ E + G L YL P E + + + +
Sbjct: 63 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122
Query: 175 RIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI-AIDQTHVST 233
++A E+A+ +AYL+++ ++ HRD+ + N ++ E + KI DFG +R I D
Sbjct: 123 QMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 234 KVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT 270
K ++ PE + FT SDV+SFGVVL E+ T
Sbjct: 180 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 4e-23
Identities = 65/206 (31%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 74 FNMNRILGQGGQGTVYKGMLAD-GRIIAVK---KSKVVDESKLEEFINEVVILSQINHRN 129
F + R++G+G G V D ++ A+K K K V++ + +NE IL ++NH
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRI-ATEVAEALAYLH 188
+V L + E LV + + G L +L + E +++ E+ AL YLH
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHL----SQKVKFSEEQVKFWICEIVLALEYLH 117
Query: 189 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFR 248
S I HRDIK NILLDE+ I DF + + D ++T GT GY+ PE
Sbjct: 118 SKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLC 172
Query: 249 SSQFTDKSDVYSFGVVLVELLTGQKP 274
++ D +S GV E L G++P
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 4e-23
Identities = 65/210 (30%), Positives = 108/210 (51%), Gaps = 27/210 (12%)
Query: 80 LGQGGQGTVYKGML--ADGRIIAVKKSKV-VDESKLEEFINEVVILSQINHRNVVKLLGC 136
LG G G V K +L G+I+AVK ++ ++E+ ++ + E+ IL + N +V G
Sbjct: 9 LGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 137 CL-EVEVPLLVYEFIPNGTLFQYL---HDPYEELSLTWEMRLRIATEVAEALAYLHSSAY 192
++ + + E++ G+L + L E L +IA V + L YLH
Sbjct: 68 FYNNGDISICM-EYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHEK-- 119
Query: 193 LPIYHRDIKSTNILLDEKYRAKIADFGTSR----SIAIDQTHVSTKVQGTFGYLDPEYFR 248
I HRD+K +NIL++ + + K+ DFG S S+A +T V GT Y+ PE +
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA--KTFV-----GTSSYMAPERIQ 172
Query: 249 SSQFTDKSDVYSFGVVLVELLTGQKPISSI 278
+ ++ KSD++S G+ L+EL TG+ P
Sbjct: 173 GNDYSVKSDIWSLGLSLIELATGRFPYPPE 202
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 4e-23
Identities = 65/211 (30%), Positives = 110/211 (52%), Gaps = 17/211 (8%)
Query: 73 YFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVD----ESKLEEFINEVVILSQINHR 128
+ + RI G+G G V+KG+ D R V K++D E ++E+ E+ +LSQ +
Sbjct: 6 FTKLERI-GKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 129 NVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLH-DPYEELSLTWEMRLRIATEVAEALAYL 187
V K G L+ ++ E++ G+ L P++E + ++ E+ + L YL
Sbjct: 63 YVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK-----EILKGLDYL 117
Query: 188 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYF 247
HS + HRDIK+ N+LL E+ K+ADFG + + Q +T V GT ++ PE
Sbjct: 118 HSEKKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVI 173
Query: 248 RSSQFTDKSDVYSFGVVLVELLTGQKPISSI 278
+ S + K+D++S G+ +EL G+ P S +
Sbjct: 174 QQSAYDSKADIWSLGITAIELAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 6e-23
Identities = 70/244 (28%), Positives = 116/244 (47%), Gaps = 35/244 (14%)
Query: 76 MNRILGQGGQGTVYKGM------LADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRN 129
+ R LG+G G V+ D ++AVK K + ++F E +L+ + H +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYL--HDPYE-------------ELSLTWEMRL 174
+VK G C + + ++V+E++ +G L ++L H P EL L+ L
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS--QML 126
Query: 175 RIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI-AIDQTHVST 233
IA+++A + YL S ++ HRD+ + N L+ KI DFG SR + + D V
Sbjct: 127 HIASQIASGMVYLASQHFV---HRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG 183
Query: 234 KVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVE 292
++ PE +FT +SDV+SFGV+L E+ T G++P W +E
Sbjct: 184 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP----WFQLSNTEV---IE 236
Query: 293 CIEE 296
CI +
Sbjct: 237 CITQ 240
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 1e-22
Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 32/214 (14%)
Query: 73 YFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFIN--EVVILSQINHRN 129
Y + +I G+G G VYK G I+A+KK K+ ES+ E+ +L ++NH N
Sbjct: 1 YQKLGKI-GEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPN 59
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEEL------SLTWEMRLRIATEVAEA 183
++KLL LV+EF+ + L++ + D L S +++ +
Sbjct: 60 IIKLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQL--------LQG 110
Query: 184 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ---TH-VSTKVQGTF 239
LA+ HS I HRD+K N+L++ + K+ADFG +RS TH V T+
Sbjct: 111 LAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR----- 162
Query: 240 GYLDPE-YFRSSQFTDKSDVYSFGVVLVELLTGQ 272
Y PE ++ D++S G + ELL+ +
Sbjct: 163 WYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-22
Identities = 61/208 (29%), Positives = 113/208 (54%), Gaps = 19/208 (9%)
Query: 78 RILGQGGQGTVYKGML-ADGR---IIAVKKSKV-VDESKLEEFINEVVILSQINHRNVVK 132
+++G G G V++G+L GR +A+K K E + ++F++E I+ Q +H N+++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 133 LLGCCLEVEVPLLVYEFIPNGTLFQYLHD---PYEELSLTWEMRLRIATEVAEALAYLHS 189
L G + + +++ E++ NG L +YL D + L +R +A + YL
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR-----GIAAGMKYLSD 125
Query: 190 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID--QTHVSTKVQGTFGYLDPEYF 247
Y+ HRD+ + NIL++ K++DFG SR + D T+ ++ + + PE
Sbjct: 126 MNYV---HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAI 182
Query: 248 RSSQFTDKSDVYSFGVVLVELLT-GQKP 274
+FT SDV+SFG+V+ E+++ G++P
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 1e-22
Identities = 74/285 (25%), Positives = 128/285 (44%), Gaps = 42/285 (14%)
Query: 71 TDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKV---VDESKLEEFINEVVILSQIN 126
F + + +G+G VYK + L DGR++A+KK ++ +D ++ + E+ +L Q++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 127 HRNVVKLLGCCLEVEVPLLVYEFIPNGTL------FQYLHDPYEELSLTWEMRLRIATEV 180
H NV+K L +E +V E G L F+ E ++ W+ +++ +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTI-WKYFVQLCS-- 117
Query: 181 AEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFG 240
AL ++HS I HRDIK N+ + K+ D G R + T + V GT
Sbjct: 118 --ALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPY 171
Query: 241 YLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLF 300
Y+ PE + + KSD++S G +L E+ Q P + + NL + + E C +
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLYSLCKKI--EKCDY 225
Query: 301 -----DIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEV 340
D +++R D+ RC+N RP + V
Sbjct: 226 PPLPADHYSEELR------------DLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-22
Identities = 59/205 (28%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 79 ILGQGGQGTVYKGM-LADGRIIAVKKSKV-VDESKLEEFINEVVILSQINH---RNVVKL 133
++G+G G VY+G + GR++A+K + + + + EV +LSQ+ N+ K
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 134 LGCCLEVEVPLLVYEFIPNGTLFQYLH-DPYEELSLTWEMRLRIATEVAEALAYLHSSAY 192
G L+ ++ E+ G++ + P E ++ +R EV AL Y+H
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIR-----EVLVALKYIHKV-- 120
Query: 193 LPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQF 252
+ HRDIK+ NIL+ K+ DFG + + + + ST V GT ++ PE ++
Sbjct: 121 -GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKY 178
Query: 253 TD-KSDVYSFGVVLVELLTGQKPIS 276
D K+D++S G+ + E+ TG P S
Sbjct: 179 YDTKADIWSLGITIYEMATGNPPYS 203
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 2e-22
Identities = 74/304 (24%), Positives = 140/304 (46%), Gaps = 60/304 (19%)
Query: 74 FNMNRILGQGGQGTVYKGML----ADGRIIAVK--KSKVVDESKLEEFINEVVILSQINH 127
F + R+LG+G G+V + L + +AVK K+ + S +EEF+ E + + +H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 128 RNVVKLLGCCLE------VEVPLLVYEFIPNGTLFQYL------HDPYEELSLTWEMRLR 175
NV+KL+G L + +P+++ F+ +G L +L +P+ +L + +R
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPF---TLPLQTLVR 117
Query: 176 IATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI-AIDQTHVSTK 234
++A + YL S ++ HRD+ + N +L+E +ADFG S+ I + D
Sbjct: 118 FMIDIASGMEYLSSKNFI---HRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174
Query: 235 VQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFV-- 291
+ +L E + +T SDV++FGV + E++T GQ P + + E + Y +
Sbjct: 175 SKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV---ENSEIYNYLIKG 231
Query: 292 -------ECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMEL 344
+C+E+ V ++ +C + + RP+ + + +L
Sbjct: 232 NRLKQPPDCLED----------------------VYELMCQCWSPEPKCRPSFQHLRDQL 269
Query: 345 ERIR 348
E I
Sbjct: 270 ELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-22
Identities = 73/276 (26%), Positives = 126/276 (45%), Gaps = 35/276 (12%)
Query: 78 RILGQGGQGTVYK----GMLADGRII--AVKKSK-VVDESKLEEFINEVVILSQI-NHRN 129
+ LG G G V + G+ ++ AVK K S+ E ++E+ I+S + NH N
Sbjct: 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS 189
+V LLG C L++ E+ G L +L E ++ L + +VA+ +A+L S
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDL-LSFSYQVAKGMAFLAS 159
Query: 190 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGT----FGYLDPE 245
+ HRD+ + N+LL KI DFG +R I D +V V+G ++ PE
Sbjct: 160 KNCI---HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV---VKGNARLPVKWMAPE 213
Query: 246 YFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIID 304
+ +T +SDV+S+G++L E+ + G P + + + +I
Sbjct: 214 SIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK---------------FYKLIK 258
Query: 305 DQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEV 340
+ R + + D+ K C ++ RPT K++
Sbjct: 259 EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 3e-22
Identities = 64/281 (22%), Positives = 125/281 (44%), Gaps = 32/281 (11%)
Query: 79 ILGQGGQGTVYKGML------ADGRIIAVKK-SKVVDESKLEEFINEVVILSQINHRNVV 131
LG+G G V+ ++ VK K DE+ EF E+ + +++H+NVV
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 132 KLLGCCLEVEVPLLVYEFIPNGTLFQYL------HDPYEELSLTWEMRLRIATEVAEALA 185
+LLG C E E ++ E+ G L Q+L + + L+ + ++ + T++A +
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 186 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE 245
+L ++ ++ HRD+ + N L+ + K++ S+ + + + +L PE
Sbjct: 132 HLSNARFV---HRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 246 YFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIID 304
+ F+ KSDV+SFGV++ E+ T G+ P + E + ++ L +
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-------VLNRLQAGKLELPVP 241
Query: 305 DQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345
+ ++M RC ++RP+ E+ L
Sbjct: 242 EGCPSR--LYKLMT------RCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 4e-22
Identities = 73/273 (26%), Positives = 127/273 (46%), Gaps = 22/273 (8%)
Query: 77 NRILGQGGQGTVYKG-MLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLG 135
++ +G +G YKG + +G VK+ V+ S I + + ++ H N+VKL+G
Sbjct: 695 ENVISRGKKGASYKGKSIKNGMQFVVKEINDVN-SIPSSEIAD---MGKLQHPNIVKLIG 750
Query: 136 CCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPI 195
C + L++E+I L + L +L+WE R +IA +A+AL +LH +
Sbjct: 751 LCRSEKGAYLIHEYIEGKNLSEVL------RNLSWERRRKIAIGIAKALRFLHCRCSPAV 804
Query: 196 YHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDK 255
++ I++D K + + D + Y+ PE + T+K
Sbjct: 805 VVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS-----AYVAPETRETKDITEK 858
Query: 256 SDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDI-IDDQVRK--SGE 312
SD+Y FG++L+ELLTG+ P + + G ++ + C +C D+ ID +R S
Sbjct: 859 SDIYGFGLILIELLTGKSPADAEFGVHG-SIVEWARYCY-SDCHLDMWIDPSIRGDVSVN 916
Query: 313 AEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345
EI+ V ++A C + RP +V LE
Sbjct: 917 QNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 94.8 bits (235), Expect = 4e-22
Identities = 62/196 (31%), Positives = 103/196 (52%), Gaps = 9/196 (4%)
Query: 80 LGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCL 138
+GQG GTVY + +A G+ +A+K+ + + K E INE++++ + + N+V L L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 139 EVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHR 198
+ +V E++ G+L D E + + E +AL +LHS+ + HR
Sbjct: 87 VGDELWVVMEYLAGGSL----TDVVTETCMDEGQIAAVCRECLQALDFLHSNQ---VIHR 139
Query: 199 DIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDV 258
DIKS NILL K+ DFG I +Q+ ST V GT ++ PE + K D+
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 198
Query: 259 YSFGVVLVELLTGQKP 274
+S G++ +E++ G+ P
Sbjct: 199 WSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 5e-22
Identities = 82/302 (27%), Positives = 136/302 (45%), Gaps = 49/302 (16%)
Query: 60 RIFNSKELDKATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKS-KVVDESKL----E 113
RI EL K ++LG G GTVYKG+ DG + + + KV+ E+ +
Sbjct: 2 RILKETELKKV-------KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANK 54
Query: 114 EFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELS----LT 169
E ++E +++ + V +LLG CL V L V + +P G L Y+ + + + L
Sbjct: 55 EILDEAYVMAGVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLN 113
Query: 170 WEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229
W ++A+ ++YL + + HRD+ + N+L+ KI DFG +R + ID+T
Sbjct: 114 W------CVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164
Query: 230 HVST---KVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRN 285
KV ++ E +FT +SDV+S+GV + EL+T G KP I A E
Sbjct: 165 EYHADGGKV--PIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE--- 219
Query: 286 LTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345
+ D+++ R + V + +C RP +E+ E
Sbjct: 220 -------------IPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFS 266
Query: 346 RI 347
R+
Sbjct: 267 RM 268
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 6e-22
Identities = 64/216 (29%), Positives = 105/216 (48%), Gaps = 18/216 (8%)
Query: 70 ATDYFNMNRILGQGGQGTVYKGMLAD---GRIIAVKKSKVVDES----KLEEFINEVVIL 122
+ + + R LGQG G VY+G D G K V+ES + EF+NE ++
Sbjct: 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM 63
Query: 123 SQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYL-------HDPYEELSLTWEMRLR 175
+VV+LLG + + L+V E + +G L YL + T + ++
Sbjct: 64 KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123
Query: 176 IATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI-AIDQTHVSTK 234
+A E+A+ +AYL++ ++ HRD+ + N ++ + KI DFG +R I D K
Sbjct: 124 MAAEIADGMAYLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 235 VQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT 270
++ PE + FT SD++SFGVVL E+ +
Sbjct: 181 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 6e-22
Identities = 68/213 (31%), Positives = 110/213 (51%), Gaps = 16/213 (7%)
Query: 78 RILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEF--INEVVILSQINHRNVVKLL 134
R++G+G G V+ AD +++ +K+ V +K E NE +L ++H N+++
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65
Query: 135 GCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLP 194
LE + ++V E+ P GTL +Y+ L L + L ++ AL ++H+
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LDEDTILHFFVQILLALHHVHTKL--- 121
Query: 195 IYHRDIKSTNILLDE-KYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFT 253
I HRD+K+ NILLD+ K KI DFG S+ I ++ T V GT Y+ PE +
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISK-ILSSKSKAYT-VVGTPCYISPELCEGKPYN 179
Query: 254 DKSDVYSFGVVLVELLTGQKPISSIWANEGRNL 286
KSD+++ G VL EL + ++ A E NL
Sbjct: 180 QKSDIWALGCVLYELASLKR------AFEAANL 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 7e-22
Identities = 62/203 (30%), Positives = 92/203 (45%), Gaps = 22/203 (10%)
Query: 80 LGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKL--EEFINEVVILSQINHRNVVKLLGC 136
+G+G G V K A G I+A+KK K ++ + + + EV +L Q+ H N+V L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68
Query: 137 CLEVEVPLLVYEFIPNGTLFQYLH------DPYEELSLTWEMRLRIATEVAEALAYLHSS 190
LV+E++ TL + L P S W++ +A+AY HS
Sbjct: 69 FRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQL--------LQAIAYCHS- 118
Query: 191 AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSS 250
I HRDIK NIL+ E K+ DFG +R++ T T Y PE
Sbjct: 119 --HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGD 176
Query: 251 QFTDKS-DVYSFGVVLVELLTGQ 272
K DV++ G ++ ELL G+
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 7e-22
Identities = 64/202 (31%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 80 LGQGGQGTVYKGMLA----DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLG 135
+G+G G V +A GR +AVK + + + E NEVVI+ H+NVV++
Sbjct: 29 IGEGSTGIV---CIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85
Query: 136 CCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPI 195
L E ++ EF+ G L D + L E + V +AL YLHS +
Sbjct: 86 SYLVGEELWVLMEFLQGGA----LTDIVSQTRLNEEQIATVCESVLQALCYLHSQG---V 138
Query: 196 YHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDK 255
HRDIKS +ILL R K++DFG I+ D + V GT ++ PE + + +
Sbjct: 139 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTE 197
Query: 256 SDVYSFGVVLVELLTGQKPISS 277
D++S G++++E++ G+ P S
Sbjct: 198 VDIWSLGIMVIEMVDGEPPYFS 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 8e-22
Identities = 59/196 (30%), Positives = 104/196 (53%), Gaps = 9/196 (4%)
Query: 80 LGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCL 138
+GQG GTV+ + +A G+ +A+K+ + + K E INE++++ ++ + N+V L L
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 139 EVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHR 198
+ +V E++ G+L D E + + E +AL +LH++ + HR
Sbjct: 87 VGDELFVVMEYLAGGSL----TDVVTETCMDEAQIAAVCRECLQALEFLHANQ---VIHR 139
Query: 199 DIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDV 258
DIKS N+LL K+ DFG I +Q+ ST V GT ++ PE + K D+
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 198
Query: 259 YSFGVVLVELLTGQKP 274
+S G++ +E++ G+ P
Sbjct: 199 WSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 1e-21
Identities = 64/204 (31%), Positives = 105/204 (51%), Gaps = 16/204 (7%)
Query: 80 LGQGGQGTVYKGMLADGRIIAVKKSKVVD----ESKLEEFINEVVILSQINHRNVVKLLG 135
+G+G G V+KG+ D R V K++D E ++E+ E+ +LSQ + V K G
Sbjct: 12 IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 136 CCLEVEVPLLVYEFIPNGTLFQYLH-DPYEELSLTWEMRLRIATEVAEALAYLHSSAYLP 194
L+ ++ E++ G+ L P +E + +R E+ + L YLHS +
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGLDYLHSEKKI- 123
Query: 195 IYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTD 254
HRDIK+ N+LL E K+ADFG + + Q +T V GT ++ PE + S +
Sbjct: 124 --HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDS 180
Query: 255 KSDVYSFGVVLVELLTGQKPISSI 278
K+D++S G+ +EL G+ P S +
Sbjct: 181 KADIWSLGITAIELAKGEPPHSEL 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 1e-21
Identities = 59/180 (32%), Positives = 99/180 (55%), Gaps = 10/180 (5%)
Query: 96 GRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEV--EVPLLVYEFIPN 152
G +AVK K + + + E+ IL + H N+VK G C E L+ EF+P+
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 153 GTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR 212
G+L +YL P + + + +L+ A ++ + + YL S Y+ HRD+ + N+L++ +++
Sbjct: 93 GSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYLGSRQYV---HRDLAARNVLVESEHQ 147
Query: 213 AKIADFGTSRSIAIDQTHVSTK--VQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT 270
KI DFG +++I D+ + + K + + PE S+F SDV+SFGV L ELLT
Sbjct: 148 VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 1e-21
Identities = 73/253 (28%), Positives = 121/253 (47%), Gaps = 27/253 (10%)
Query: 80 LGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCL 138
+GQG GTVY M +A G+ +A+++ + + K E INE++++ + + N+V L L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 139 EVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHR 198
+ +V E++ G+L D E + + E +AL +LHS+ + HR
Sbjct: 88 VGDELWVVMEYLAGGSL----TDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHR 140
Query: 199 DIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDV 258
DIKS NILL K+ DFG I +Q+ ST V GT ++ PE + K D+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 199
Query: 259 YSFGVVLVELLTGQKPISSIWANEGRNLTTYFV--------------ECIEENCLFDIID 304
+S G++ +E++ G+ P + NE Y + I + L +D
Sbjct: 200 WSLGIMAIEMIEGEPP----YLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255
Query: 305 DQVRKSGEAEEIM 317
V K G A+E++
Sbjct: 256 MDVEKRGSAKELL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-21
Identities = 66/196 (33%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 80 LGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLE 139
LG G G V+ G +AVK K S E F+ E I+ ++ H +V+L E
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP-ESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 140 VEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRD 199
E +V E++ G+L +L D E +L + +A +VA +AY+ Y+ HRD
Sbjct: 73 -EPIYIVTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMNYI---HRD 127
Query: 200 IKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVY 259
++S NIL+ + KIADFG +R I ++ + + PE +FT KSDV+
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 260 SFGVVLVELLT-GQKP 274
SFG++L EL+T G+ P
Sbjct: 188 SFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 2e-21
Identities = 60/202 (29%), Positives = 111/202 (54%), Gaps = 13/202 (6%)
Query: 80 LGQGGQGTVYKGM--LADGRI-IAVKKSKVVDESKL-EEFINEVVILSQINHRNVVKLLG 135
LG G G V KG+ + +I +A+K K +E + +E + E I+ Q+++ +V+++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 136 CCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPI 195
C E E +LV E G L ++L +E+ T + + +V+ + YL ++
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKKDEI--TVSNVVELMHQVSMGMKYLEGKNFV-- 117
Query: 196 YHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF--GYLDPEYFRSSQFT 253
HRD+ + N+LL ++ AKI+DFG S+++ D ++ + G + + PE +F+
Sbjct: 118 -HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 254 DKSDVYSFGVVLVELLT-GQKP 274
+SDV+S+G+ + E + GQKP
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 2e-21
Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 6/204 (2%)
Query: 72 DYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVV 131
+ + + LG G G V+ G + +AVK K S ++ F+ E ++ + H +V
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLV 64
Query: 132 KLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSA 191
+L + E ++ E++ G+L +L E + + + ++AE +AY+
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN 123
Query: 192 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQ 251
Y+ HRD+++ N+L+ E KIADFG +R I ++ + + PE
Sbjct: 124 YI---HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 180
Query: 252 FTDKSDVYSFGVVLVELLT-GQKP 274
FT KSDV+SFG++L E++T G+ P
Sbjct: 181 FTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-21
Identities = 61/196 (31%), Positives = 99/196 (50%), Gaps = 7/196 (3%)
Query: 80 LGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLE 139
LGQG G V+ G +A+K K S E F+ E ++ ++ H +V+L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 140 VEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRD 199
E +V E++ G+L +L + L + +A ++A +AY+ Y+ HRD
Sbjct: 73 -EPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNYV---HRD 127
Query: 200 IKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVY 259
+++ NIL+ E K+ADFG +R I ++ + + PE +FT KSDV+
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 260 SFGVVLVELLT-GQKP 274
SFG++L EL T G+ P
Sbjct: 188 SFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 2e-21
Identities = 63/217 (29%), Positives = 112/217 (51%), Gaps = 25/217 (11%)
Query: 80 LGQGGQGTVYKGML-----ADGRIIAVKKSKVVDESK-LEEFINEVVILSQINHRNVVKL 133
LG+ G +YKG L +++A+K K ++ + EF E ++++++H N+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 134 LGCCLEVEVPLLVYEFIPNGTLFQYL--HDPYEEL------------SLTWEMRLRIATE 179
LG + + +++E++ G L ++L P+ ++ SL L IA +
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 180 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI-AIDQTHVSTKVQGT 238
+A + YL S ++ H+D+ + NIL+ E+ KI+D G SR I + D V K
Sbjct: 133 IAAGMEYLSSHFFV---HKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 239 FGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKP 274
++ PE +F+ SD++SFGVVL E+ + G +P
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 4e-21
Identities = 67/218 (30%), Positives = 106/218 (48%), Gaps = 15/218 (6%)
Query: 80 LGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLE-EFINEVVILSQINHRNVVKLLGCC 137
+G+G G V+ G L AD +AVK + L+ +F+ E IL Q +H N+V+L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 138 LEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYH 197
+ + +V E + G +L E L + +++ A + YL S + H
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKHCI---H 117
Query: 198 RDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTK--VQGTFGYLDPEYFRSSQFTDK 255
RD+ + N L+ EK KI+DFG SR D + ST Q + PE +++ +
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSREEE-DGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 256 SDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVE 292
SDV+SFG++L E + G P +AN T +E
Sbjct: 177 SDVWSFGILLWEAFSLGAVP----YANLSNQQTREAIE 210
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 4e-21
Identities = 68/208 (32%), Positives = 98/208 (47%), Gaps = 20/208 (9%)
Query: 74 FNMNRILGQGGQGTVYKGMLAD----GRIIAVK---KSKVVDESKLEEFINEVVILSQIN 126
F + LG G G V ML G+ A+K K+K+V ++E +NE IL I
Sbjct: 3 FEFIKTLGTGSFGRV---MLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR 59
Query: 127 HRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAY 186
H +V L G + LV E++P G LF +L A +V AL Y
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL-RKSGRFPEPVARFY--AAQVVLALEY 116
Query: 187 LHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEY 246
LHS L I +RD+K N+LLD KI DFG ++ + +T+ + GT YL PE
Sbjct: 117 LHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK-GRTYT---LCGTPEYLAPEI 169
Query: 247 FRSSQFTDKSDVYSFGVVLVELLTGQKP 274
S + D ++ G+++ E+L G P
Sbjct: 170 ILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 5e-21
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 10/208 (4%)
Query: 68 DKATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQIN 126
D + N +I G+G G V + GR +AVKK + + + E NEVVI+
Sbjct: 16 DPRSYLDNFVKI-GEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQ 74
Query: 127 HRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAY 186
H N+V++ L + +V EF+ G L D + E + V +AL++
Sbjct: 75 HPNIVEMYSSYLVGDELWVVMEFLEGGA----LTDIVTHTRMNEEQIATVCLAVLKALSF 130
Query: 187 LHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEY 246
LH+ + HRDIKS +ILL R K++DFG ++ + + V GT ++ PE
Sbjct: 131 LHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPEV 186
Query: 247 FRSSQFTDKSDVYSFGVVLVELLTGQKP 274
+ + D++S G++++E++ G+ P
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 1e-20
Identities = 84/313 (26%), Positives = 141/313 (45%), Gaps = 48/313 (15%)
Query: 70 ATDYFNMNRILGQG--GQGTVYKGMLAD----GRI--IAVKKSKV-VDESKLEEFINEVV 120
D + + LG+G GQ + + + D R+ +AVK K E L + I+E+
Sbjct: 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEME 75
Query: 121 ILSQI-NHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYL---------------HDPYE 164
++ I H+N++ LLG C + ++ E+ G L +YL P E
Sbjct: 76 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEE 135
Query: 165 ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 224
+LS + + A +VA + YL S + HRD+ + N+L+ E KIADFG +R I
Sbjct: 136 QLSF--KDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFGLARDI 190
Query: 225 -AIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANE 282
ID +T + ++ PE +T +SDV+SFGV+L E+ T G P + E
Sbjct: 191 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250
Query: 283 GRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342
LF ++ + R + + + + C ++ RPT K++
Sbjct: 251 ----------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294
Query: 343 ELERIRANSRDDE 355
+L+RI A + + E
Sbjct: 295 DLDRILALTSNQE 307
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 2e-20
Identities = 62/205 (30%), Positives = 104/205 (50%), Gaps = 18/205 (8%)
Query: 80 LGQGGQGTVYKGM-LADGRIIAVKKSKVVD----ESKLEEFINEVVILSQINHRNVVKLL 134
+G+G G VYK + +++A+K V+D E ++E+ E+ LSQ + K
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIK---VIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYY 65
Query: 135 GCCLEVEVPLLVYEFIPNGTLFQYLH-DPYEELSLTWEMRLRIATEVAEALAYLHSSAYL 193
G L+ ++ E+ G+ L +E + + +R EV L YLH +
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILR-----EVLLGLEYLHEEGKI 120
Query: 194 PIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFT 253
HRDIK+ NILL E+ K+ADFG S + + +T V GT ++ PE + S +
Sbjct: 121 ---HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGYD 176
Query: 254 DKSDVYSFGVVLVELLTGQKPISSI 278
+K+D++S G+ +EL G+ P+S +
Sbjct: 177 EKADIWSLGITAIELAKGEPPLSDL 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 2e-20
Identities = 63/219 (28%), Positives = 114/219 (52%), Gaps = 18/219 (8%)
Query: 74 FNMNRILGQGGQGTVYKGM-LADG---RI-IAVKKSKVVDESKL-EEFINEVVILSQINH 127
F ++LG G GTVYKG+ + +G +I +A+K+ + K +E ++E +++ +++
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 128 RNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYL 187
+V +LLG CL V L + + +P G L Y+ + + + + L ++A+ + YL
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQY--LLNWCVQIAKGMNYL 125
Query: 188 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVST---KVQGTFGYLDP 244
+ HRD+ + N+L+ KI DFG ++ + D+ KV ++
Sbjct: 126 EERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV--PIKWMAL 180
Query: 245 EYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANE 282
E +T +SDV+S+GV + EL+T G KP I A+E
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 219
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 2e-20
Identities = 65/211 (30%), Positives = 107/211 (50%), Gaps = 22/211 (10%)
Query: 74 FNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFIN--EVVILSQIN-HRN 129
+ + + LG G G+VY G ++A+KK K S EE +N EV L ++N H N
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPN 59
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLR-IATEVAEALAYLH 188
+VKL E + V+E++ G L+Q + D + E +R I ++ + LA++H
Sbjct: 60 IVKLKEVFRENDELYFVFEYM-EGNLYQLMKD--RKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 189 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH---VSTKVQGTFGYLDPE 245
+ +HRD+K N+L+ KIADFG +R I + VST+ Y PE
Sbjct: 117 KHGF---FHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-----WYRAPE 168
Query: 246 YF-RSSQFTDKSDVYSFGVVLVELLTGQKPI 275
RS+ ++ D+++ G ++ EL T +P+
Sbjct: 169 ILLRSTSYSSPVDIWALGCIMAELYTL-RPL 198
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 3e-20
Identities = 71/219 (32%), Positives = 107/219 (48%), Gaps = 45/219 (20%)
Query: 76 MNRILGQGGQGTVYKGM-LADGRIIAVKKSKVV----DESKLEEFINEVVILSQINHRNV 130
+NRI G G GTVYK + GR+ A+K V+ +++ + E+ IL +NH NV
Sbjct: 79 VNRI-GSGAGGTVYKVIHRPTGRLYALK---VIYGNHEDTVRRQICREIEILRDVNHPNV 134
Query: 131 VKLLGCCLEV-----EVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLR-IATEVAEAL 184
VK C ++ E+ +L+ EF+ G+L E + E L +A ++ +
Sbjct: 135 VK----CHDMFDHNGEIQVLL-EFMDGGSL--------EGTHIADEQFLADVARQILSGI 181
Query: 185 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDP 244
AYLH I HRDIK +N+L++ KIADFG SR +A ++ V GT Y+ P
Sbjct: 182 AYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSP 237
Query: 245 EYFRSSQFTD---------KSDVYSFGVVLVELLTGQKP 274
E TD D++S GV ++E G+ P
Sbjct: 238 ERIN----TDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 6e-20
Identities = 76/279 (27%), Positives = 121/279 (43%), Gaps = 39/279 (13%)
Query: 80 LGQGGQGTVYKGMLADG--RIIAVK----------KSKVVDESKLEEFINEVVIL-SQIN 126
LG G G VYK + ++A+K K K + + + ++EV I+ Q+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 127 HRNVVKLLGCCLEVEVPLLVYEFI---PNGTLFQYLHDPYEELSLTWEMRL-RIATEVAE 182
H N+V+ LE + +V + I P G F L + + + E R+ I ++
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFT---EERIWNIFVQMVL 124
Query: 183 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYL 242
AL YLH I HRD+ NI+L E + I DFG ++ + T V GT Y
Sbjct: 125 ALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK--LTSVVGTILYS 180
Query: 243 DPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDI 302
PE ++ + +K+DV++FG +L ++ T Q P S +L T VE + E +
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS---TNMLSLATKIVEAVYEPLPEGM 237
Query: 303 IDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVA 341
+ V DV CL RP + +V+
Sbjct: 238 YSEDVT------------DVITSCLTPDAEARPDIIQVS 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 6e-20
Identities = 69/218 (31%), Positives = 113/218 (51%), Gaps = 22/218 (10%)
Query: 74 FNMNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDES-----KLEEFINEVVILSQINH 127
+ + ++LGQG G VY AD GR +AVK+ + ES ++ E+ +L + H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 128 RNVVKLLGCCLE-VEVPLLVY-EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALA 185
+V+ GC + +E L ++ E +P G++ L Y +LT + + ++ E ++
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKS-YG--ALTENVTRKYTRQILEGVS 120
Query: 186 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR---SIAIDQTHVSTKVQGTFGYL 242
YLHS+ I HRDIK NIL D K+ DFG S+ +I + T + + V GT ++
Sbjct: 121 YLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPYWM 176
Query: 243 DPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWA 280
PE + K+D++S G +VE+LT + P WA
Sbjct: 177 SPEVISGEGYGRKADIWSVGCTVVEMLTEKPP----WA 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 6e-20
Identities = 78/292 (26%), Positives = 127/292 (43%), Gaps = 42/292 (14%)
Query: 79 ILGQGGQGTVYKGMLAD-----GRI-IAVKKSKV-VDESKLEEFINEVVILSQI-NHRNV 130
LG+G G V K +AVK K E L + ++E+ ++ I H+N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 131 VKLLGCCLEVEVPLLVYEFIPNGTLFQYL--HDPYEEL-----------SLTWEMRLRIA 177
+ LLG C + +V E+ +G L +L P E +LT + + A
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 178 TEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI-AIDQTHVSTKVQ 236
+VA + +L S HRD+ + N+L+ E + KIADFG +R I ID +T +
Sbjct: 139 YQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195
Query: 237 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIE 295
++ PE +T +SDV+SFGV+L E+ T G P I E
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE------------- 242
Query: 296 ENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347
LF ++ + R + + + C + RPT K++ +L+R+
Sbjct: 243 ---LFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 6e-20
Identities = 62/196 (31%), Positives = 100/196 (51%), Gaps = 7/196 (3%)
Query: 80 LGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLE 139
LGQG G V+ G +A+K K E F+ E I+ ++ H +V L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 140 VEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRD 199
E +V EF+ G+L +L + + L + +A ++A+ +AY+ Y+ HRD
Sbjct: 73 -EPIYIVTEFMGKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMNYI---HRD 127
Query: 200 IKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVY 259
+++ NIL+ + KIADFG +R I ++ + + PE +FT KSDV+
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 260 SFGVVLVELLT-GQKP 274
SFG++L EL+T G+ P
Sbjct: 188 SFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 6e-20
Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 28/218 (12%)
Query: 71 TDYFNMNRILGQGGQGTVYK------GMLADGRIIAVKKSKVVDESKLEEFINEVVILSQ 124
D + + LG G G VYK G+ A +II ++ E +LE+F+ E+ ILS+
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-----SEEELEDFMVEIDILSE 58
Query: 125 INHRNVVKLLGCCLEVEVPLLVYEFIPNGTL---FQYLHDPYEELSLTWEMRLRIATEVA 181
H N+V L ++ EF G L L E + + R ++
Sbjct: 59 CKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCR-----QML 113
Query: 182 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 241
EAL +LHS + HRD+K+ NILL K+ADFG S T + GT +
Sbjct: 114 EALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYW 169
Query: 242 LDPEY-----FRSSQFTDKSDVYSFGVVLVELLTGQKP 274
+ PE F+ + + K+D++S G+ L+EL + P
Sbjct: 170 MAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 1e-19
Identities = 57/196 (29%), Positives = 99/196 (50%), Gaps = 9/196 (4%)
Query: 80 LGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCL 138
+G+G G V + + G+++AVKK + + + E NEVVI+ H NVV++ L
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 139 EVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHR 198
+ +V EF+ G L D + E + V +AL+ LH+ + HR
Sbjct: 88 VGDELWVVMEFLEGGA----LTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIHR 140
Query: 199 DIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDV 258
DIKS +ILL R K++DFG ++ + + V GT ++ PE + + D+
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEVDI 199
Query: 259 YSFGVVLVELLTGQKP 274
+S G++++E++ G+ P
Sbjct: 200 WSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 1e-19
Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 10/197 (5%)
Query: 80 LGQGGQGTVYK-GMLADGRIIAVKK--SKVVDESKLEEFINEVVILSQINHRNVVKLLGC 136
+G+G G V+K G +A+KK + ++ + + E+ L H VVKLL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 137 CLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIY 196
+LV E++P L + L D EE L + + +AY+H++ I
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRD--EERPLPEAQVKSYMRMLLKGVAYMHANG---IM 121
Query: 197 HRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKS 256
HRD+K N+L+ KIADFG +R + ++ + + T Y PE ++ D
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPG 181
Query: 257 -DVYSFGVVLVELLTGQ 272
D+++ G + ELL G
Sbjct: 182 VDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 1e-19
Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 23/209 (11%)
Query: 80 LGQGGQGTVYKGMLA----DGRIIAVK---KSKVVDESKLEEFINEVVILSQINHRNVVK 132
+ +G G V+ LA G I A+K K+ ++ ++++++ + E ILSQ VVK
Sbjct: 1 ISKGAYGRVF---LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 133 LLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAY 192
L + LV E++P G L L + SL ++ E+ AL YLHS
Sbjct: 58 LYYSFQGKKNLYLVMEYLPGGDLASLLEN---VGSLDEDVARIYIAEIVLALEYLHS--- 111
Query: 193 LPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV-------STKVQGTFGYLDPE 245
I HRD+K NIL+D K+ DFG S+ + + ++ GT Y+ PE
Sbjct: 112 NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 246 YFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
+ D +S G +L E L G P
Sbjct: 172 VILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 1e-19
Identities = 80/309 (25%), Positives = 138/309 (44%), Gaps = 44/309 (14%)
Query: 72 DYFNMNRILGQGGQGTVY--------KGMLADGRIIAVKKSK-VVDESKLEEFINEVVIL 122
D + + LG+G G V K + +AVK K E L + ++E+ ++
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74
Query: 123 SQI-NHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLH---DPYEELS----------L 168
I H+N++ LLG C + ++ E+ G L +YL P E S +
Sbjct: 75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134
Query: 169 TWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI-AID 227
T++ + +VA + YL S + HRD+ + N+L+ E KIADFG +R + ID
Sbjct: 135 TFKDLVSCTYQVARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARDVNNID 191
Query: 228 QTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNL 286
+T + ++ PE +T +SDV+SFGV++ E+ T G P I E
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---- 247
Query: 287 TTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELER 346
LF ++ + R A + + + C ++ +RPT K++ +L+R
Sbjct: 248 ------------LFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDR 295
Query: 347 IRANSRDDE 355
I + ++E
Sbjct: 296 ILTLTTNEE 304
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 1e-19
Identities = 78/278 (28%), Positives = 129/278 (46%), Gaps = 44/278 (15%)
Query: 99 IAVK--KSKVVDESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVPLLVY-EFIPNGT 154
+AVK K D+ L + ++E+ ++ I H+N++ LLG C + + PL V E+ G
Sbjct: 47 VAVKMLKDDATDKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQ-DGPLYVLVEYASKGN 104
Query: 155 LFQYLHD---------------PYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRD 199
L +YL P E+L T++ + A +VA + YL S + HRD
Sbjct: 105 LREYLRARRPPGMDYSFDTCKLPEEQL--TFKDLVSCAYQVARGMEYLASQKCI---HRD 159
Query: 200 IKSTNILLDEKYRAKIADFGTSRSI-AIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDV 258
+ + N+L+ E KIADFG +R + ID +T + ++ PE +T +SDV
Sbjct: 160 LAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 219
Query: 259 YSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIM 317
+SFGV+L E+ T G P I E LF ++ + R A
Sbjct: 220 WSFGVLLWEIFTLGGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTH 263
Query: 318 AVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDDE 355
+ + + C ++ RPT K++ +L+R+ + DE
Sbjct: 264 ELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTSTDE 301
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-19
Identities = 76/208 (36%), Positives = 113/208 (54%), Gaps = 23/208 (11%)
Query: 78 RILGQGGQGTVY---KGMLAD-GRIIAVK---KS--KVVDESKLEEFINEVVILSQINHR 128
++LGQG G V+ K D G++ A+K K+ KV D + + E IL+++NH
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTK---MERDILAEVNHP 58
Query: 129 NVVKLLGCCLEVEVPL-LVYEFIPNGTLFQYLHDPYEELSLTWE-MRLRIATEVAEALAY 186
+VKL + E L L+ +F+ G LF L +E+ T E ++ +A E+A AL +
Sbjct: 59 FIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLS---KEVMFTEEDVKFYLA-ELALALDH 113
Query: 187 LHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEY 246
LHS L I +RD+K NILLDE+ K+ DFG S+ +ID + GT Y+ PE
Sbjct: 114 LHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSFCGTVEYMAPEV 169
Query: 247 FRSSQFTDKSDVYSFGVVLVELLTGQKP 274
T +D +SFGV++ E+LTG P
Sbjct: 170 VNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 2e-19
Identities = 68/214 (31%), Positives = 109/214 (50%), Gaps = 22/214 (10%)
Query: 78 RILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDES-----KLEEFINEVVILSQINHRNVV 131
++LGQG G VY D GR +A K+ + ES ++ E+ +L + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 132 KLLGCCLE-VEVPLLVY-EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS 189
+ GC + E L ++ E++P G++ L Y +LT + + ++ E ++YLHS
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQL-KAYG--ALTESVTRKYTRQILEGMSYLHS 124
Query: 190 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR---SIAIDQTHVSTKVQGTFGYLDPEY 246
+ I HRDIK NIL D K+ DFG S+ +I + T + + V GT ++ PE
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTPYWMSPEV 180
Query: 247 FRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWA 280
+ K+DV+S G +VE+LT + P WA
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPP----WA 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 2e-19
Identities = 65/237 (27%), Positives = 113/237 (47%), Gaps = 42/237 (17%)
Query: 54 GSIDRCRIFNSKELDKATDYFNMNRILGQGGQGTVYKGMLADGR--IIAVKKSKVVDESK 111
G + C + N ++L FN+ + GR ++AVK + D +K
Sbjct: 19 GEVHLCEVVNPQDLPTLQFPFNVRK-----------------GRPLLVAVKILRP-DANK 60
Query: 112 --LEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYL-HDPYEE--- 165
+F+ EV ILS++ N+++LLG C++ + ++ E++ NG L Q+L ++
Sbjct: 61 NARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEE 120
Query: 166 ------------LSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA 213
++++ L +A ++A + YL S L HRD+ + N L+ E
Sbjct: 121 NGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTI 177
Query: 214 KIADFGTSRSI-AIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELL 269
KIADFG SR++ A D + + ++ E +FT SDV++FGV L E+L
Sbjct: 178 KIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-19
Identities = 54/184 (29%), Positives = 97/184 (52%), Gaps = 14/184 (7%)
Query: 98 IIAVKKSKV-VDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLF 156
++AVK + V ++ +F+ E+ I+S++ + N+++LLG C+ + ++ E++ NG L
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 157 QYL--HDPYEEL-------SLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL 207
Q+L + S++ L +A ++A + YL S L HRD+ + N L+
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCLV 162
Query: 208 DEKYRAKIADFGTSRSI-AIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLV 266
Y KIADFG SR++ + D + + ++ E +FT SDV++FGV L
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLW 222
Query: 267 ELLT 270
E+ T
Sbjct: 223 EMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 3e-19
Identities = 71/234 (30%), Positives = 111/234 (47%), Gaps = 43/234 (18%)
Query: 58 RCRIFNSKELDKATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDE------S 110
RCR + E +K +NRI G+G G VY+ G I+A+KK ++ +E S
Sbjct: 2 RCR--SVTEFEK------LNRI-GEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPIS 52
Query: 111 KLEEFINEVVILSQINHRNVVKLLGCCLEVEVP------LLVYEFIPN--GTLFQYLHDP 162
L E + +L + H N+V+L EV V LV E+ +L + P
Sbjct: 53 SLRE----ITLLLNLRHPNIVELK----EVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP 104
Query: 163 YEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 222
+ E + + ++ L YLH + I HRD+K +N+LL +K KIADFG +R
Sbjct: 105 FSESQVKC-----LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR 156
Query: 223 SIAIDQTHVSTKVQGTFGYLDPE-YFRSSQFTDKSDVYSFGVVLVELLTGQKPI 275
+ + ++ KV T Y PE + +T D+++ G +L ELL KP+
Sbjct: 157 TYGLPAKPMTPKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH-KPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 6e-19
Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 16/202 (7%)
Query: 80 LGQGGQGTVYKGMLADGRIIAVKKSKVVD--ESKLEEFINEVVILSQINHRNVVKLLGCC 137
LG G G+V K + KK + S ++ + E+ I+ + +V G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 138 LEVEVPLLVYEFIPNGTLFQYLHDPYEELS-LTWEMRLRIATEVAEALAYLHSSAYLPIY 196
L + EF+ G+L + Y++ + E+ +IA V E L YL++ I
Sbjct: 73 LNENNICMCMEFMDCGSLDRI----YKKGGPIPVEILGKIAVAVVEGLTYLYNV--HRIM 126
Query: 197 HRDIKSTNILLDEKYRAKIADFGTSRSI--AIDQTHVSTKVQGTFGYLDPEYFRSSQFTD 254
HRDIK +NIL++ + + K+ DFG S + +I T V GT Y+ PE + ++T
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV-----GTSTYMSPERIQGGKYTV 181
Query: 255 KSDVYSFGVVLVELLTGQKPIS 276
KSDV+S G+ ++EL G+ P +
Sbjct: 182 KSDVWSLGISIIELALGKFPFA 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 1e-18
Identities = 73/302 (24%), Positives = 140/302 (46%), Gaps = 40/302 (13%)
Query: 60 RIFNSKELDKATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKS-KVVDE----SKLE 113
RI EL K ++LG G GTV+KG+ + +G I + + K + + +
Sbjct: 2 RILKETELRKL-------KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQ 54
Query: 114 EFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMR 173
E + ++ + ++H +V+LLG C + L V + P G+L ++ + SL +
Sbjct: 55 EITDHMLAMGSLDHAYIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRD--SLDPQRL 111
Query: 174 LRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI-AIDQTHVS 232
L ++A+ + YL + HR++ + NILL +IADFG + + D+ +
Sbjct: 112 LNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFY 168
Query: 233 TKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFV 291
++ + ++ E ++T +SDV+S+GV + E+++ G +P + + +E
Sbjct: 169 SEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--------- 219
Query: 292 ECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANS 351
+ D+++ R + + V V +C RPT KE+A E R+ +
Sbjct: 220 -------VPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRM---A 269
Query: 352 RD 353
RD
Sbjct: 270 RD 271
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 1e-18
Identities = 66/227 (29%), Positives = 103/227 (45%), Gaps = 25/227 (11%)
Query: 67 LDKATDYFNMNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFINEVVILSQI 125
L T F + ++G+G G VYK G+++A+K ++++ + EE E IL +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE-EEIKEEYNILRKY 59
Query: 126 -NHRNVVKLLGCCLEVEVPL-------LVYEFIPNGT---LFQYLHDPYEELSLTWEMRL 174
NH N+ G ++ + P LV E G+ L + L + L E
Sbjct: 60 SNHPNIATFYGAFIK-KNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK--RLKEEWIA 116
Query: 175 RIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTK 234
I E LAYLH + + HRDIK NILL + K+ DFG S + +T
Sbjct: 117 YILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF 173
Query: 235 VQGTFGYLDPEYFRSSQFTD-----KSDVYSFGVVLVELLTGQKPIS 276
+ GT ++ PE + D +SDV+S G+ +EL G+ P+
Sbjct: 174 I-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC 219
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-18
Identities = 66/208 (31%), Positives = 106/208 (50%), Gaps = 26/208 (12%)
Query: 80 LGQGGQGTVYK------GMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKL 133
LG G G VYK G LA ++I K E +LE+++ E+ IL+ NH +VKL
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETK-----SEEELEDYMVEIEILATCNHPYIVKL 74
Query: 134 LGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLR-IATEVAEALAYLHSSAY 192
LG ++ EF P G + + + L+ E +++ I ++ EAL YLHS
Sbjct: 75 LGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVICRQMLEALQYLHS--- 128
Query: 193 LPIYHRDIKSTNILLDEKYRAKIADFGTS-RSIAIDQTHVSTKVQGTFGYLDPEY----- 246
+ I HRD+K+ N+LL K+ADFG S +++ Q S GT ++ PE
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVVMCET 186
Query: 247 FRSSQFTDKSDVYSFGVVLVELLTGQKP 274
+ + + K+D++S G+ L+E+ + P
Sbjct: 187 MKDTPYDYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 1e-18
Identities = 71/225 (31%), Positives = 107/225 (47%), Gaps = 35/225 (15%)
Query: 72 DYFNMNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEF----INEVVILSQIN 126
D F++ +G+G G VYK D G ++A+KK ++ +E E F I E+ IL Q+N
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLN 64
Query: 127 HRNVVKLLGCCLEVEVPL----------LVYEFIPNGTLFQYLHDPYEEL-----SLTWE 171
HRN+V L + + L LV+E++ HD L + +
Sbjct: 65 HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD--------HDLMGLLESGLVHFSED 116
Query: 172 MRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV 231
++ E L Y H +L HRDIK +NILL+ K + K+ADFG +R +++
Sbjct: 117 HIKSFMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173
Query: 232 STKVQGTFGYLDPEYFRSSQ-FTDKSDVYSFGVVLVELLTGQKPI 275
T T Y PE + + DV+S G +L EL T +KPI
Sbjct: 174 YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 2e-18
Identities = 65/203 (32%), Positives = 96/203 (47%), Gaps = 14/203 (6%)
Query: 80 LGQGGQGTVYKGMLA-DGRIIAVK--KSKVVDESKLEEFI-NEVVILSQINHRNVVKLLG 135
LG GG G V + R A+K K + + E+ +E I +E IL + NH +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 136 CCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPI 195
+ + ++ E+ G L+ L D L + R IA V A YLH+ I
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRD--RGLFDEYTARFYIAC-VVLAFEYLHN---RGI 114
Query: 196 YHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ-THVSTKVQGTFGYLDPEYFRSSQFTD 254
+RD+K N+LLD K+ DFG ++ + Q T T GT Y+ PE + +
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GTPEYVAPEIILNKGYDF 171
Query: 255 KSDVYSFGVVLVELLTGQKPISS 277
D +S G++L ELLTG+ P
Sbjct: 172 SVDYWSLGILLYELLTGRPPFGE 194
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 2e-18
Identities = 66/213 (30%), Positives = 101/213 (47%), Gaps = 19/213 (8%)
Query: 74 FNMNRILGQGGQGTVY----KGMLADGRIIAVK---KSKVVDESK-LEEFINEVVILSQI 125
F + R+LG G G V+ G G++ A+K K+ +V ++K E E +L +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 126 NHRNVVKLLGCCLEVEVPL-LVYEFIPNGTLFQYL-HDPYEELSLTWEMRLRIATEVAEA 183
+ L + + L L+ +++ G LF +L + S E+R+ IA E+ A
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES---EVRVYIA-EIVLA 117
Query: 184 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 243
L +LH L I +RDIK NILLD + + DFG S+ ++ + GT Y+
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174
Query: 244 PEYFR--SSQFTDKSDVYSFGVVLVELLTGQKP 274
PE R S D +S GV+ ELLTG P
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-18
Identities = 80/291 (27%), Positives = 136/291 (46%), Gaps = 46/291 (15%)
Query: 79 ILGQGGQGTVYKGMLA-DGRII--AVKKSK-VVDESKLEEFINEVVILSQI-NHRNVVKL 133
++G+G G V + M+ DG + A+K K E+ +F E+ +L ++ +H N++ L
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 134 LGCCLEVEVPLLVYEFIPNGTLFQYLH-------DPY------EELSLTWEMRLRIATEV 180
LG C + E+ P G L +L DP +LT + L+ A++V
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128
Query: 181 AEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR--SIAIDQTHVSTKVQGT 238
A + YL ++ HRD+ + N+L+ E +KIADFG SR + + +T V+
Sbjct: 129 ATGMQYLSEKQFI---HRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVR-- 183
Query: 239 FGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANE-GRNLTTYFVECIEE 296
++ E S +T KSDV+SFGV+L E+++ G P + E L +
Sbjct: 184 --WMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKPR 241
Query: 297 NCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347
NC DD+V E+M ++C RP +++++L R+
Sbjct: 242 NC-----DDEVY------ELM------RQCWRDRPYERPPFAQISVQLSRM 275
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-18
Identities = 61/210 (29%), Positives = 108/210 (51%), Gaps = 19/210 (9%)
Query: 76 MNRILGQGGQGTVYKGMLA-DGR---IIAVKKSKV-VDESKLEEFINEVVILSQINHRNV 130
+ +++G G G V G L G+ +A+K K E + +F++E I+ Q +H N+
Sbjct: 8 IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 131 VKLLGCCLEVEVPLLVYEFIPNGTLFQYL--HD-PYEELSLTWEMRLRIATEVAEALAYL 187
+ L G + + ++V E++ NG+L +L HD + + L +R +A + YL
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR-----GIASGMKYL 122
Query: 188 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFG--YLDPE 245
Y+ HRD+ + NIL++ K++DFG SR + D T G + PE
Sbjct: 123 SDMGYV---HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE 179
Query: 246 YFRSSQFTDKSDVYSFGVVLVELLT-GQKP 274
+FT SDV+S+G+V+ E+++ G++P
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 3e-18
Identities = 64/214 (29%), Positives = 106/214 (49%), Gaps = 31/214 (14%)
Query: 79 ILGQGGQGTVYK------GMLADGRIIAVKKSKVVDESKLEEFINEVVILSQIN-HRNVV 131
++G+G G V K G+ D I +K+ D+ + +F E+ +L ++ H N++
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR--DFAGELEVLCKLGHHPNII 71
Query: 132 KLLGCCLEVEVPLLVYEFIPNGTLFQYLH-------DPYEEL------SLTWEMRLRIAT 178
LLG C L E+ P+G L +L DP + +L+ + L A
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 179 EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR--SIAIDQTHVSTKVQ 236
+VA + YL ++ HRD+ + NIL+ E Y AKIADFG SR + + +T V+
Sbjct: 132 DVARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 188
Query: 237 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT 270
++ E S +T SDV+S+GV+L E+++
Sbjct: 189 ----WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 3e-18
Identities = 58/196 (29%), Positives = 96/196 (48%), Gaps = 9/196 (4%)
Query: 80 LGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCL 138
+G+G G V G+ +AVKK + + + E NEVVI+ +H NVV + L
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 139 EVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHR 198
+ +V EF+ G L D + E + V AL+YLH+ + HR
Sbjct: 90 VGDELWVVMEFLEGGA----LTDIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHR 142
Query: 199 DIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDV 258
DIKS +ILL R K++DFG ++ + + V GT ++ PE + + D+
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEVDI 201
Query: 259 YSFGVVLVELLTGQKP 274
+S G++++E++ G+ P
Sbjct: 202 WSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 4e-18
Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 72 DYFNMNRILGQGGQGTVYKGM-LADGRIIAVKK---SKVVDESKLEEFINEVVILSQINH 127
D + +G G G V+ A+K +V+ + + NE +L +++H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 128 RNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYL 187
+++L + ++ E++P G LF YL + + L A+E+ AL YL
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYL 117
Query: 188 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYF 247
HS I +RD+K NILLD++ K+ DFG ++ + D+T + GT YL PE
Sbjct: 118 HS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRTWT---LCGTPEYLAPEVI 170
Query: 248 RSSQFTDKSDVYSFGVVLVELLTGQKP 274
+S D ++ G+++ E+L G P
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 4e-18
Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 22/212 (10%)
Query: 78 RILGQGGQGTVYKGM-LADGRIIAVKK---SKVVDESKLEEFINEVVILSQINHRNVVKL 133
R +G G G VY + ++A+KK S K ++ I EV L Q+ H N ++
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 134 LGCCLEVEVPLLVYEFIPNGT--LFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSA 191
GC L LV E+ + + P +E+ + I + LAYLHS
Sbjct: 81 KGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIA-----AICHGALQGLAYLHS-- 133
Query: 192 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRS-- 249
HRDIK+ NILL E K+ADFG++ ++ + V GT ++ PE +
Sbjct: 134 -HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMD 187
Query: 250 -SQFTDKSDVYSFGVVLVELLTGQKPISSIWA 280
Q+ K DV+S G+ +EL + P+ ++ A
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 5e-18
Identities = 60/237 (25%), Positives = 111/237 (46%), Gaps = 30/237 (12%)
Query: 56 IDRCRIFNSKELDKATDYFNMNRILGQGGQGTVYKGMLAD---GRIIAVKKSKVVDESKL 112
I R R+ +L + +G G ++ G+L D G+ V V D +
Sbjct: 3 ISRDRV-TLSDLLQ------------EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASE 49
Query: 113 EE---FINEVVILSQINHRNVVKLLGCCLEV-EVPLLVYEFIPNGTLFQYLHDPYE---- 164
+ + E +L ++H+N++ +L C+E E P ++Y ++ G L +L
Sbjct: 50 IQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEAN 109
Query: 165 -ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 223
+L+ + + +A ++A ++YLH + H+DI + N ++DE+ + KI D SR
Sbjct: 110 NPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRD 166
Query: 224 IAIDQTH-VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSI 278
+ H + ++ E + +++ SDV+SFGV+L EL+T GQ P I
Sbjct: 167 LFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI 223
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 6e-18
Identities = 68/218 (31%), Positives = 110/218 (50%), Gaps = 22/218 (10%)
Query: 74 FNMNRILGQGGQGTVYKGMLAD-GRIIAVKKSKV-VDESKLEEFIN----EVVILSQINH 127
+ + ++LG+G G VY AD GR +AVK+ D + + +N E+ +L + H
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 128 RNVVKLLGCCLEVEVPLL--VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALA 185
+V+ GC + E L E++P G++ L Y +LT + R ++ + ++
Sbjct: 64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL-KAYG--ALTENVTRRYTRQILQGVS 120
Query: 186 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR---SIAIDQTHVSTKVQGTFGYL 242
YLHS+ I HRDIK NIL D K+ DFG S+ +I + T + + V GT ++
Sbjct: 121 YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTPYWM 176
Query: 243 DPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWA 280
PE + K+DV+S +VE+LT + P WA
Sbjct: 177 SPEVISGEGYGRKADVWSVACTVVEMLTEKPP----WA 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 8e-18
Identities = 55/183 (30%), Positives = 102/183 (55%), Gaps = 13/183 (7%)
Query: 98 IIAVKKSKV-VDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLF 156
++AVK + +++ +F+ E+ I+S++ N+++LL C+ + ++ E++ NG L
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 157 QYL--HDPYEEL------SLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD 208
Q+L H+P E ++++ + +AT++A + YL S L HRD+ + N L+
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVG 164
Query: 209 EKYRAKIADFGTSRSI-AIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVE 267
+ Y KIADFG SR++ + D + + ++ E +FT SDV++FGV L E
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWE 224
Query: 268 LLT 270
+LT
Sbjct: 225 ILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 9e-18
Identities = 72/274 (26%), Positives = 121/274 (44%), Gaps = 25/274 (9%)
Query: 74 FNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKL 133
+ + LG G G V+ +AVK K S +E F+ E ++ + H +VKL
Sbjct: 8 LKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKL 66
Query: 134 LGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYL 193
+ E ++ EF+ G+L +L E + + ++AE +A++ Y+
Sbjct: 67 -HAVVTKEPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRNYI 124
Query: 194 PIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFT 253
HRD+++ NIL+ KIADFG +R I ++ + + PE FT
Sbjct: 125 ---HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 181
Query: 254 DKSDVYSFGVVLVELLT-GQKPISSIWANEG-RNLTTYFVECIEENCLFDIIDDQVRKSG 311
KSDV+SFG++L+E++T G+ P + E R L + ENC
Sbjct: 182 IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENC------------- 228
Query: 312 EAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345
EE+ ++ RC + RPT + + L+
Sbjct: 229 -PEELY---NIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-17
Identities = 60/216 (27%), Positives = 108/216 (50%), Gaps = 12/216 (5%)
Query: 74 FNMNRILGQG--GQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVV 131
+N+ R++G+G G+ + + + +D + + S +E+ E V+L+++ H N+V
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61
Query: 132 KLLGCCLEVEVPL-LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSS 190
E + L +V E+ G L Q + +L + L+ ++ + ++H
Sbjct: 62 AFKES-FEADGHLYIVMEYCDGGDLMQKIKLQRGKL-FPEDTILQWFVQMCLGVQHIHEK 119
Query: 191 AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSS 250
L HRDIKS NI L + + K+ DFG++R + + T V GT Y+ PE + +
Sbjct: 120 RVL---HRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENM 175
Query: 251 QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNL 286
+ +KSD++S G +L EL T + P AN +NL
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHPFQ---ANSWKNL 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 2e-17
Identities = 79/291 (27%), Positives = 132/291 (45%), Gaps = 46/291 (15%)
Query: 79 ILGQGGQGTVYKGMLA-DGRII--AVKKSK-VVDESKLEEFINEVVILSQINHR-NVVKL 133
++G+G G V K + DG + A+K+ K + +F E+ +L ++ H N++ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 134 LGCCLEVEVPLLVYEFIPNGTLFQYLH-------DPY------EELSLTWEMRLRIATEV 180
LG C L E+ P+G L +L DP +L+ + L A +V
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 181 AEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR--SIAIDQTHVSTKVQGT 238
A + YL ++ HRD+ + NIL+ E Y AKIADFG SR + + +T V+
Sbjct: 122 ARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR-- 176
Query: 239 FGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANE-GRNLTTYFVECIEE 296
++ E S +T SDV+S+GV+L E+++ G P + E L +
Sbjct: 177 --WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 234
Query: 297 NCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347
NC DD+V ++M ++C RP+ ++ + L R+
Sbjct: 235 NC-----DDEVY------DLM------RQCWREKPYERPSFAQILVSLNRM 268
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-17
Identities = 64/206 (31%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 80 LGQGGQGTVYKGMLA-DGRIIAVKK----SKVVDESKLEEFINEVVILSQINHRNVVKLL 134
+G G G VY + ++AVKK K +E K ++ I EV L Q+ H N ++
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNE-KWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 135 GCCLEVEVPLLVYEFIPNGT--LFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAY 192
GC L+ LV E+ L + P +E+ + I + LAYLHS
Sbjct: 88 GCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-----AITHGALQGLAYLHSHNM 142
Query: 193 LPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRS--- 249
+ HRDIK+ NILL E + K+ADFG++ + + V GT ++ PE +
Sbjct: 143 I---HRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDE 194
Query: 250 SQFTDKSDVYSFGVVLVELLTGQKPI 275
Q+ K DV+S G+ +EL + P+
Sbjct: 195 GQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 3e-17
Identities = 70/255 (27%), Positives = 114/255 (44%), Gaps = 43/255 (16%)
Query: 78 RILGQGGQGTVYKGMLADGR-------IIAVKKSKVVDESKLEEFINEVVILSQINHRNV 130
++LG+G G V +LA+ + + +KK ++ + +E + E +L+
Sbjct: 1 KVLGKGSFGKV---LLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPF 57
Query: 131 VKLLGCCLEVEVPL-LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRI-ATEVAEALAYLH 188
+ L C + + L V E++ G L ++ E R R A E+ L +LH
Sbjct: 58 LTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR-SGRFD---EPRARFYAAEIVLGLQFLH 113
Query: 189 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR-SIAIDQTHVSTKVQGTFGYLDPEYF 247
I +RD+K N+LLD + KIADFG + I T ++ GT Y+ PE
Sbjct: 114 ERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEIL 168
Query: 248 RSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFD-IIDDQ 306
+ D ++ GV+L E+L GQ P EG + E+ LF I++D+
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQSPF------EGDD----------EDELFQSILEDE 212
Query: 307 VR----KSGEAEEIM 317
VR S EA+ I+
Sbjct: 213 VRYPRWLSKEAKSIL 227
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 3e-17
Identities = 57/206 (27%), Positives = 99/206 (48%), Gaps = 9/206 (4%)
Query: 74 FNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKV---VDESKLEEFINEVVILSQINHRN 129
F + + +G+G VY+ L DG +A+KK ++ +D + I E+ +L Q+NH N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRL-RIATEVAEALAYLH 188
V+K +E +V E G L + + ++ L E + + ++ AL ++H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 189 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFR 248
S + HRDIK N+ + K+ D G R + +T + + GT Y+ PE
Sbjct: 124 SRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERIH 179
Query: 249 SSQFTDKSDVYSFGVVLVELLTGQKP 274
+ + KSD++S G +L E+ Q P
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 3e-17
Identities = 65/209 (31%), Positives = 97/209 (46%), Gaps = 26/209 (12%)
Query: 78 RILGQGGQGTVYKGMLADGR---IIAVKK---SKVVDESKLEEFINEVVILSQINHRNVV 131
R +G G G VY D R ++A+KK S K ++ I EV L +I H N +
Sbjct: 31 REIGHGSFGAVY--FARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSI 88
Query: 132 KLLGCCLEVEVPLLVYEFIPNGT--LFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS 189
+ GC L LV E+ L + P +E+ + I + LAYLHS
Sbjct: 89 EYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-----AITHGALQGLAYLHS 143
Query: 190 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRS 249
+ HRDIK+ NILL E + K+ADFG++ + + V GT ++ PE +
Sbjct: 144 HNMI---HRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVILA 195
Query: 250 ---SQFTDKSDVYSFGVVLVELLTGQKPI 275
Q+ K DV+S G+ +EL + P+
Sbjct: 196 MDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 3e-17
Identities = 88/312 (28%), Positives = 132/312 (42%), Gaps = 59/312 (18%)
Query: 78 RILGQGGQGTVYKGMLA----DGRIIAVK---KSKVVDESKLEEFINEVVILS-QINHRN 129
R+LG+G G V MLA GR+ AVK K ++ + +E + E ILS NH
Sbjct: 1 RVLGKGSFGKV---MLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPF 57
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRI-ATEVAEALAYLH 188
+ +L C + V EF+ G L ++ ++ E R R A E+ AL +LH
Sbjct: 58 LTQLYCCFQTPDRLFFVMEFVNGGDLMFHI----QKSRRFDEARARFYAAEITSALMFLH 113
Query: 189 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFR 248
I +RD+K N+LLD + K+ADFG + + ST GT Y+ PE +
Sbjct: 114 DKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST-FCGTPDYIAPEILQ 169
Query: 249 SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFD-IIDDQV 307
+ D ++ GV+L E+L G P E E+ LF+ I++D+V
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAPF----------------EAENEDDLFEAILNDEV 213
Query: 308 RKSG----EAEEIMA---VSDVAKR--CLNSYGRN----RPTMKEVAMELE--------- 345
+A +I+ + R L G P KE+ E
Sbjct: 214 VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPF 273
Query: 346 RIRANSRDDENN 357
R R SR+D +N
Sbjct: 274 RPRIKSREDVSN 285
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 5e-17
Identities = 71/275 (25%), Positives = 128/275 (46%), Gaps = 40/275 (14%)
Query: 99 IAVK--KSKVVDESKLEEFINEVVILSQIN-HRNVVKLLGCCLEVEVPLLV-YEFIPNGT 154
+AVK K D+ L + I+E+ ++ I H+N++ LLG C + E PL V E+ G
Sbjct: 47 VAVKMLKDNATDKD-LADLISEMELMKLIGKHKNIINLLGVCTQ-EGPLYVIVEYAAKGN 104
Query: 155 LFQYLH---DPYEELS----------LTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIK 201
L ++L P + + L+++ + A +VA + YL S + HRD+
Sbjct: 105 LREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCI---HRDLA 161
Query: 202 STNILLDEKYRAKIADFGTSRSI-AIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYS 260
+ N+L+ E KIADFG +R + ID ++ + ++ PE +T +SDV+S
Sbjct: 162 ARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWS 221
Query: 261 FGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAV 319
FG+++ E+ T G P I E LF ++ + R + +
Sbjct: 222 FGILMWEIFTLGGSPYPGIPVEE----------------LFKLLREGHRMDKPSNCTHEL 265
Query: 320 SDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDD 354
+ + C ++ RPT K++ L+++ A ++
Sbjct: 266 YMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEE 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 5e-17
Identities = 70/203 (34%), Positives = 97/203 (47%), Gaps = 17/203 (8%)
Query: 84 GQGTVYKGMLA----DGRIIAVK--KSKVVDESKLEEFI--NEVVILSQINHRNVVKLLG 135
G+G+ K +LA DG+ AVK + K+V K ++ I V+L + H +V L
Sbjct: 4 GKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHY 63
Query: 136 CCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRI-ATEVAEALAYLHSSAYLP 194
E V +F+ G LF +L E S E R R A E+A AL YLHS +
Sbjct: 64 SFQTTEKLYFVLDFVNGGELFFHLQ---RERSFP-EPRARFYAAEIASALGYLHS---IN 116
Query: 195 IYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTD 254
I +RD+K NILLD + + DFG + I Q+ +T GT YL PE R + +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175
Query: 255 KSDVYSFGVVLVELLTGQKPISS 277
D + G VL E+L G P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYC 198
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 6e-17
Identities = 60/217 (27%), Positives = 108/217 (49%), Gaps = 25/217 (11%)
Query: 73 YFNMNRILGQGGQGTVYKGML-ADGR---IIAVKKSKV-VDESKLEEFINEVVILSQINH 127
+ ++G G G V +G L G+ +A+K K E + +F++E I+ Q +H
Sbjct: 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 64
Query: 128 RNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLH---DPYEELSLTWEMRLRIATEVAEAL 184
N++ L G + +++ EF+ NG L +L + + L +R +A +
Sbjct: 65 PNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR-----GIAAGM 119
Query: 185 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI---AIDQTHVST---KVQGT 238
YL Y+ HRD+ + NIL++ K++DFG SR + D T+ S+ K+
Sbjct: 120 KYLSEMNYV---HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKI--P 174
Query: 239 FGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKP 274
+ PE +FT SDV+S+G+V+ E+++ G++P
Sbjct: 175 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 6e-17
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 9/206 (4%)
Query: 74 FNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKV---VDESKLEEFINEVVILSQINHRN 129
F + + +G+G VY+ L D + +A+KK ++ +D ++ + E+ +L Q+NH N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRL-RIATEVAEALAYLH 188
V+K L +E +V E G L Q + ++ L E + + ++ A+ ++H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 189 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFR 248
S + HRDIK N+ + K+ D G R + T + V GT Y+ PE
Sbjct: 124 SRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIH 179
Query: 249 SSQFTDKSDVYSFGVVLVELLTGQKP 274
+ + KSD++S G +L E+ Q P
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 8e-17
Identities = 62/227 (27%), Positives = 105/227 (46%), Gaps = 35/227 (15%)
Query: 74 FNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFI--------NEVVILSQI 125
+ + + +G+G G +Y LA + + + V+ E L + EV++L+++
Sbjct: 2 YEIIKKIGEGSFGKIY---LAKAKSDS--EHCVIKEIDLTKMPVKEKEASKKEVILLAKM 56
Query: 126 NHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPY-----EELSLTWEMRLRIATEV 180
H N+V E +V E+ G L + ++ E+ L+W ++
Sbjct: 57 KHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQI 110
Query: 181 AEALAYLHSSAYLPIYHRDIKSTNILLDEKYR-AKIADFGTSRSIAIDQTHVSTKVQGTF 239
+ L ++H I HRDIKS NI L + AK+ DFG +R + D ++ GT
Sbjct: 111 SLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTP 166
Query: 240 GYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNL 286
YL PE ++ + +K+D++S G VL EL T + P EG NL
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPF------EGNNL 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-16
Identities = 53/183 (28%), Positives = 87/183 (47%), Gaps = 18/183 (9%)
Query: 101 VKKSKVVDESKLEEFINEVVILSQINHRNVVKLL--GCCLEVEVPLLVYEFIPNGTLFQY 158
++ +E + F E + +++ H N+V LL G + V+E++P TL +
Sbjct: 11 LRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGRTLREV 69
Query: 159 LHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL---DEKYRAKI 215
L + +L R+ +V +ALA H+ I HRD+K NI++ + AK+
Sbjct: 70 LAA---DGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRPHAKV 123
Query: 216 ADFGTS------RSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELL 269
DFG R + +T+V GT Y PE R T SD+Y++G++ +E L
Sbjct: 124 LDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECL 183
Query: 270 TGQ 272
TGQ
Sbjct: 184 TGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 11/208 (5%)
Query: 72 DYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVV--DESKLEEFINEVVILSQINHR 128
DY + +I G+G G VYKG G+I+A+KK ++ +E I E+ +L ++ H
Sbjct: 1 DYTKIEKI-GEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHP 59
Query: 129 NVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLH 188
N+V L ++ L++EF+ + L +YL + + E+ ++ + + + H
Sbjct: 60 NIVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 189 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFR 248
S L HRD+K N+L+D K K+ADFG +R+ I V T T Y PE
Sbjct: 119 SRRVL---HRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYTHEVVTLWYRAPEVLL 174
Query: 249 SSQ-FTDKSDVYSFGVVLVELLTGQKPI 275
S ++ D++S G + E+ T +KP+
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 64/207 (30%), Positives = 96/207 (46%), Gaps = 19/207 (9%)
Query: 73 YFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKV-VDESKLEEF-INEVVILSQI---N 126
Y + I G+G GTVYK L GR +A+KK +V + E + + E+ +L Q+
Sbjct: 1 YEELAEI-GEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFE 59
Query: 127 HRNVVKLLGCCLEVEVP-----LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVA 181
H N+V+LL C LV+E + + L YL + L E + ++
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL-SKCPKPGLPPETIKDLMRQLL 117
Query: 182 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 241
+ +LHS I HRD+K NIL+ + KIADFG +R + + S V T Y
Sbjct: 118 RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV--TLWY 172
Query: 242 LDPEYFRSSQFTDKSDVYSFGVVLVEL 268
PE S + D++S G + EL
Sbjct: 173 RAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 2e-16
Identities = 60/206 (29%), Positives = 93/206 (45%), Gaps = 21/206 (10%)
Query: 85 QGTVYKGMLADGRIIA--VKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEV 142
G ++GM + R++ ++ S DE L F+ EV ++NH NV++ LG C+E
Sbjct: 13 LGEAHRGM-SKARVVVKELRASATPDEQLL--FLQEVQPYRELNHPNVLQCLGQCIESIP 69
Query: 143 PLLVYEFIPNGTLFQYLHDPYEELSLTWEMRL--RIATEVAEALAYLHSSAYLPIYHRDI 200
LLV EF P G L YL ++ + + R+A EVA L +LH + ++ H D+
Sbjct: 70 YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFI---HSDL 126
Query: 201 KSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFG--YLDPEYFRSSQ------- 251
N L KI D+G + + + TK +L PE
Sbjct: 127 ALRNCQLTADLSVKIGDYGLALE-QYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKD 185
Query: 252 FTDKSDVYSFGVVLVELLT-GQKPIS 276
T KS+++S GV + EL T +P
Sbjct: 186 QTKKSNIWSLGVTMWELFTAADQPYP 211
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 2e-16
Identities = 74/276 (26%), Positives = 116/276 (42%), Gaps = 28/276 (10%)
Query: 72 DYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKL--EEFINEVVILSQINHRN 129
+ LG+G G+V K L + +I K+ D + ++ + E+ I
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 130 VVKLLGCCLEVEVPLL--VYEFIPNGTLFQYLHDPYEELSLTWEMRL-RIATEVAEALAY 186
+VK G L+ + E+ G+L + E L +IA V + L+Y
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 187 LHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEY 246
LHS I HRDIK +NILL K + K+ DFG S + T GT Y+ PE
Sbjct: 121 LHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---GTSFYMAPER 174
Query: 247 FRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGR------NLTTYFVECIEENCLF 300
+ ++ SDV+S G+ L+E+ + P EG L +Y V + L
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNRFPFPP----EGEPPLGPIELLSYIVN-MPNPELK 229
Query: 301 DIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPT 336
D + ++ S E ++ + K+CL RPT
Sbjct: 230 DEPGNGIKWSEEFKDFI------KQCLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 67/210 (31%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 80 LGQGGQGTVYKGMLAD-GRIIAVK---KSKVVDESKLEEFINEVVILSQINHRNVVKLLG 135
+GQGG G V+ D G I+A+K KS + +++ + E IL+ +VKLL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 136 CCLEVEVPLLVYEFIPNG---TLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAY 192
+ E L E++P G TL L E+ R +A E+ EA+ LH Y
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSED-----HARFYMA-EMFEAVDALHELGY 122
Query: 193 LPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQF 252
+ HRD+K N L+D K+ DFG S+ I + + V G+ Y+ PE R +
Sbjct: 123 I---HRDLKPENFLIDASGHIKLTDFGLSKGI-VTYAN---SVVGSPDYMAPEVLRGKGY 175
Query: 253 TDKSDVYSFGVVLVELLTGQKPISSIWANE 282
D +S G +L E L G P S NE
Sbjct: 176 DFTVDYWSLGCMLYEFLCGFPPFSGSTPNE 205
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 67/252 (26%), Positives = 104/252 (41%), Gaps = 54/252 (21%)
Query: 74 FNMNRILGQGGQGTVYKGMLA----DGRIIAVK---KSKVVDESKLEEFINEVVILSQIN 126
F + +++G+G G V+ L G++ A+K KS ++ +++ E IL+ +
Sbjct: 3 FEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD 59
Query: 127 HRNVVKLLGCCLEVEVPL-LVYEFIPNGTLFQYL--HDPYEELSLTWEMRLRIATEVAEA 183
+VKL + E L LV E++P G L L D + E R IA E+ A
Sbjct: 60 SPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEE----TARFYIA-ELVLA 113
Query: 184 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA------------------ 225
L +H ++ HRDIK NIL+D K+ADFG + +
Sbjct: 114 LDSVHKLGFI---HRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 226 -IDQTHVSTKVQ---------GTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPI 275
Q GT Y+ PE R + + + D +S GV+L E+L G P
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230
Query: 276 SSIWANEGRNLT 287
S + T
Sbjct: 231 YS----DTLQET 238
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 3e-16
Identities = 66/206 (32%), Positives = 99/206 (48%), Gaps = 12/206 (5%)
Query: 74 FNMNRILGQGGQGTVYKGML-ADGRIIAVKK--SKVVDESKLEEF-INEVVILSQINHRN 129
F R+LG+GG G V + A G++ A KK K + + K E +NE IL ++N R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTL-FQYLHDPYEELSLTWEMRLRIATEVAEALAYLH 188
VV L + LV + G L F H E + A E+ L LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYH--MGEAGFEEGRAVFYAAEICCGLEDLH 119
Query: 189 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFR 248
I +RD+K NILLD+ +I+D G + + QT + +V GT GY+ PE +
Sbjct: 120 QER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVK 174
Query: 249 SSQFTDKSDVYSFGVVLVELLTGQKP 274
+ ++T D ++ G +L E++ GQ P
Sbjct: 175 NERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 3e-16
Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 22/207 (10%)
Query: 78 RILGQGGQGTVYKGM-LADGRIIAVKK---SKVVDESKLEEFINEVVILSQINHRNVVKL 133
R +G G G VY + + ++A+KK S K ++ I EV L ++ H N ++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 134 LGCCLEVEVPLLVYEFIPNGT--LFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSA 191
GC L LV E+ L + P +E+ + + + LAYLHS
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-----AVTHGALQGLAYLHSHN 135
Query: 192 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRS-- 249
+ HRD+K+ NILL E K+ DFG++ +A V GT ++ PE +
Sbjct: 136 MI---HRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAMD 187
Query: 250 -SQFTDKSDVYSFGVVLVELLTGQKPI 275
Q+ K DV+S G+ +EL + P+
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 4e-16
Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 24/215 (11%)
Query: 72 DYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVD---ESKLEEFINEVVILSQINHR 128
+++ + LG G G VYK + ++A +KV+D E +LE+++ E+ IL+ +H
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAA--AKVIDTKSEEELEDYMVEIDILASCDHP 62
Query: 129 NVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLH 188
N+VKLL ++ EF G + + + E LT + + EAL YLH
Sbjct: 63 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLH 120
Query: 189 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS----RSIAIDQTHVSTKVQGTFGYLDP 244
+ I HRD+K+ NIL K+ADFG S R+I + + GT ++ P
Sbjct: 121 ENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAP 172
Query: 245 EYFRSSQFTD-----KSDVYSFGVVLVELLTGQKP 274
E D K+DV+S G+ L+E+ + P
Sbjct: 173 EVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 8e-16
Identities = 55/196 (28%), Positives = 100/196 (51%), Gaps = 12/196 (6%)
Query: 80 LGQGGQGTVYKGM-LADGRIIAVKKSKVVDESK--LEEFINEVVILSQINHRNVVKLLGC 136
+G+G G VYK G ++A+KK ++ E++ I E+ +L ++NH N+VKLL
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 137 CLEVEVPLLVYEFIPNGTLFQYLH-DPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPI 195
LV+EF+ + L +++ P + L + ++ + LA+ HS L
Sbjct: 68 IHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLP--LIKSYLFQLLQGLAFCHSHRVL-- 122
Query: 196 YHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQF-TD 254
HRD+K N+L++ + K+ADFG +R+ + + +V T Y PE ++ +
Sbjct: 123 -HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYYST 180
Query: 255 KSDVYSFGVVLVELLT 270
D++S G + E++T
Sbjct: 181 AVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 9e-16
Identities = 64/242 (26%), Positives = 103/242 (42%), Gaps = 56/242 (23%)
Query: 69 KATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEF----INEVVILS 123
K DY + LG+G G VYK + GR++A+KK + +E + F + E+ IL
Sbjct: 6 KLRDY-EILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILK 62
Query: 124 QINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQ----YLHDPYEELSLTWEM-RLRIAT 178
++ H NVV L+ + E P+ + + Y+ PY + L+ + +
Sbjct: 63 KLKHPNVVPLID---------MAVER-PDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKL 112
Query: 179 EVA----------EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228
+ E + YLH + L HRDIK+ NIL+D + KIADFG +R
Sbjct: 113 TESQIKCYMLQLLEGINYLHENHIL---HRDIKAANILIDNQGILKIADFGLARPY---- 165
Query: 229 THVSTKVQGTFGYLDPEY--------FRS-------SQFTDKSDVYSFGVVLVELLTGQK 273
+G G +Y +R ++T D++ G V E+ T +
Sbjct: 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR-R 224
Query: 274 PI 275
PI
Sbjct: 225 PI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 17/203 (8%)
Query: 80 LGQGGQGTVYKGM-LADGRIIAVKKSKV--VDESKLEEFINEVVILSQINHRNVVKLLGC 136
+G+G G VYK G I+A+KK ++ DE I E+ +L ++NH N+V+LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 137 CLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIY 196
LV+EF+ + L +Y+ D L + ++ + +AY HS +
Sbjct: 67 VHSENKLYLVFEFL-DLDLKKYM-DSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VL 121
Query: 197 HRDIKSTNILLDEKYRAKIADFGTSRSIAI---DQTHVSTKVQGTFGYLDPE-YFRSSQF 252
HRD+K N+L+D + K+ADFG +R+ + TH T Y PE S Q+
Sbjct: 122 HRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEILLGSRQY 177
Query: 253 TDKSDVYSFGVVLVELLTGQKPI 275
+ D++S G + E++ ++P+
Sbjct: 178 STPVDIWSIGCIFAEMVN-RRPL 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-15
Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 16/210 (7%)
Query: 72 DYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNV 130
DY + R+ G G G VYK L G + AVK K+ E+ ++ + H N+
Sbjct: 10 DYELIQRV-GSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 131 VKLLGCCLEVEVPLLVYEFIPNGTLFQYLH--DPYEELSLTWEMRLRIATEVAEALAYLH 188
V G L E + E+ G+L H P EL + + R E + LAYLH
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCR-----ETLQGLAYLH 123
Query: 189 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYF- 247
S + HRDIK NILL + K+ADFG + I + + GT ++ PE
Sbjct: 124 SKGKM---HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAA 179
Query: 248 --RSSQFTDKSDVYSFGVVLVELLTGQKPI 275
++ + D+++ G+ +EL Q P+
Sbjct: 180 VEKNGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-15
Identities = 60/217 (27%), Positives = 109/217 (50%), Gaps = 25/217 (11%)
Query: 80 LGQGGQGTVYKGML---ADG---RIIAVKKSKVVDESKL-EEFINEVVILSQINHRNVVK 132
LG+ G VYKG L A G + +A+K K E L EEF +E ++ S++ H N+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 133 LLGCCLEVEVPLLVYEFIPNGTLFQYL--HDPYEELSLTWEMR-----------LRIATE 179
LLG + + +++ + + L ++L P+ ++ T + + + I T+
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 180 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI-AIDQTHVSTKVQGT 238
+A + +L S + H+D+ + N+L+ +K KI+D G R + A D +
Sbjct: 133 IAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189
Query: 239 FGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKP 274
++ PE +F+ SD++S+GVVL E+ + G +P
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 2e-15
Identities = 57/198 (28%), Positives = 93/198 (46%), Gaps = 10/198 (5%)
Query: 80 LGQGGQGTVYKGMLADGRIIAVKK--SKVVDESKLEEFINEVVILSQINHRNVVKLLGCC 137
LG G G V K +I +K + + + I E+ +L + N +V G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 138 LEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYH 197
+ E + G+L Q L E + E+ +++ V LAYL I H
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLK---EAKRIPEEILGKVSIAVLRGLAYLREKH--QIMH 127
Query: 198 RDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSD 257
RD+K +NIL++ + K+ DFG S + ID ++ GT Y+ PE + + ++ +SD
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQL-IDS--MANSFVGTRSYMSPERLQGTHYSVQSD 184
Query: 258 VYSFGVVLVELLTGQKPI 275
++S G+ LVEL G+ PI
Sbjct: 185 IWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 56/222 (25%), Positives = 99/222 (44%), Gaps = 32/222 (14%)
Query: 78 RILGQGGQGTVYKGM-LADGRIIAVKK-SKVVDESKL--EEFINEVVILSQINHRNVVKL 133
R++G+GG G VY R +A+KK + + E+ L + F+ E I + + H +V +
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 134 LGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMR--------LRIATEVAEALA 185
C + + +I TL L +++ SL+ E+ L I ++ +
Sbjct: 68 YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127
Query: 186 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH--------------- 230
Y+HS L HRD+K NILL I D+G + +++
Sbjct: 128 YVHSKGVL---HRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 231 --VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT 270
+ K+ GT Y+ PE ++ +D+Y+ GV+L ++LT
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-15
Identities = 62/219 (28%), Positives = 101/219 (46%), Gaps = 27/219 (12%)
Query: 74 FNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQINH-RNVV 131
F + ++G G G VYKG + G++ A+K V + + EE E+ +L + +H RN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 66
Query: 132 KLLGCCLEVEVP------LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALA 185
G ++ P LV EF G++ + + +L E I E+ L+
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN-TLKEEWIAYICREILRGLS 125
Query: 186 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS----RSIAIDQTHVSTKVQGTFGY 241
+LH + HRDIK N+LL E K+ DFG S R++ T + GT +
Sbjct: 126 HLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPYW 177
Query: 242 LDPEYFRSSQFTD-----KSDVYSFGVVLVELLTGQKPI 275
+ PE + D KSD++S G+ +E+ G P+
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 69/218 (31%), Positives = 107/218 (49%), Gaps = 35/218 (16%)
Query: 70 ATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEE-----FINEVVILS 123
AT Y N+ + LG+G TVYKG+ +G+++A+K V K EE I E +L
Sbjct: 4 ATSYLNLEK-LGEGSYATVYKGISRINGQLVALK----VISMKTEEGVPFTAIREASLLK 58
Query: 124 QINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQY-------LHDPYEELSLTWEMRLRI 176
+ H N+V L E V+E++ + L QY LH PY +++ LR
Sbjct: 59 GLKHANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLH-PYNVRLFMFQL-LR- 114
Query: 177 ATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI-DQTHVSTKV 235
LAY+H I HRD+K N+L+ K+ADFG +R+ +I QT+ S V
Sbjct: 115 ------GLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV 165
Query: 236 QGTFGYLDPEYFR-SSQFTDKSDVYSFGVVLVELLTGQ 272
T Y P+ ++ ++ D++ G + +E+L GQ
Sbjct: 166 --TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 67/219 (30%), Positives = 108/219 (49%), Gaps = 26/219 (11%)
Query: 69 KATDYFNMNRILGQGGQGTV----YKGMLADGRIIAVK---KSKVVDESKLEEFINEVVI 121
KA D F++ +++G+G G V +K + ++ A+K K +++ S F E I
Sbjct: 41 KAED-FDVIKVIGRGAFGEVQLVRHK---SSKQVYAMKLLSKFEMIKRSDSAFFWEERDI 96
Query: 122 LSQINHRNVVKLLGCCLEVEVPL-LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEV 180
++ N +V+L + + L +V E++P G L + + Y+ + W R A EV
Sbjct: 97 MAHANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLVNLMSN-YD-IPEKWA-RFYTA-EV 151
Query: 181 AEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS-RSIAIDQTHVSTKVQGTF 239
AL +HS ++ HRD+K N+LLD+ K+ADFGT + A T V GT
Sbjct: 152 VLALDAIHSMGFI---HRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTP 207
Query: 240 GYLDPEYFRS----SQFTDKSDVYSFGVVLVELLTGQKP 274
Y+ PE +S + + D +S GV L E+L G P
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 3e-15
Identities = 62/211 (29%), Positives = 93/211 (44%), Gaps = 32/211 (15%)
Query: 80 LGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQINHRNVVKLLG 135
+G G G VYK G ++AVK ++ +E+K +VV+ S + +VK G
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSH-DCPYIVKCYG 81
Query: 136 CCL-EVEVPLLVYEFIPNGTLFQYL----HDPYEELSLTWEMRLRIATEVAEALAYL--- 187
+ + +V + E + T L P E L ++ + +AL YL
Sbjct: 82 YFITDSDV-FICMELM--STCLDKLLKRIQGPIPEDILG-----KMTVAIVKALHYLKEK 133
Query: 188 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYF 247
H + HRD+K +NILLD K+ DFG S + + T+ G Y+ PE
Sbjct: 134 HG-----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPERI 186
Query: 248 RSSQFTDK----SDVYSFGVVLVELLTGQKP 274
K +DV+S G+ LVEL TGQ P
Sbjct: 187 DPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-15
Identities = 65/232 (28%), Positives = 104/232 (44%), Gaps = 32/232 (13%)
Query: 74 FNMNRILGQGGQGTVY----KGMLADGRIIA---VKKSKVVDESKLEEFINEVVILSQIN 126
F++ ++G+G G V K A G I A +KKS ++ + + F E ILS N
Sbjct: 3 FDVKSLVGRGHFGEVQVVREK---ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59
Query: 127 HRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLH---DPYEELSLTWEMRLRIATEVAEA 183
+ +L + + LV E+ P G L L+ D ++E +M E+ A
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDE-----DMAQFYLAELVLA 114
Query: 184 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 243
+ +H Y+ HRDIK N+L+D K+ADFG++ + ++ S GT Y+
Sbjct: 115 IHSVHQMGYV---HRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIA 171
Query: 244 PEYFRSSQFTDKS------DVYSFGVVLVELLTGQKPISSIWANEGRNLTTY 289
PE + K D +S GV+ E++ G+ P EG + TY
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH-----EGTSAKTY 218
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-15
Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 74 FNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVK 132
F + + +G G G VYK + G + A+K K+ E++++ H N+V
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVA 70
Query: 133 LLGCCLEVEVPLLVYEFIPNGTLFQYLH--DPYEELSLTWEMRLRIATEVAEALAYLHSS 190
G L + + EF G+L H P E + + ++ E + L YLHS
Sbjct: 71 YFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAY-----VSRETLQGLYYLHSK 125
Query: 191 AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYF--- 247
+ HRDIK NILL + K+ADFG S I + + GT ++ PE
Sbjct: 126 GKM---HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVE 181
Query: 248 RSSQFTDKSDVYSFGVVLVELLTGQKPI 275
R + D+++ G+ +EL Q P+
Sbjct: 182 RKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 4e-15
Identities = 67/203 (33%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 84 GQGTVYKGMLA----DGRIIAVK--KSKVVDESKLEEFI--NEVVILSQINHRNVVKLLG 135
G+G+ K +LA DG AVK + K + + K + I V+L + H +V L
Sbjct: 4 GKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHY 63
Query: 136 CCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRI-ATEVAEALAYLHSSAYLP 194
E V +++ G LF H E L E R R A EVA A+ YLHS L
Sbjct: 64 SFQTAEKLYFVLDYVNGGELF--FHLQRERCFL--EPRARFYAAEVASAIGYLHS---LN 116
Query: 195 IYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTD 254
I +RD+K NILLD + + DFG + ++ ++ GT YL PE R +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKE-GVEPEETTSTFCGTPEYLAPEVLRKEPYDR 175
Query: 255 KSDVYSFGVVLVELLTGQKPISS 277
D + G VL E+L G P S
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYS 198
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 5e-15
Identities = 75/261 (28%), Positives = 112/261 (42%), Gaps = 46/261 (17%)
Query: 74 FNMNRILGQGGQGTVYKGMLADGR-------IIAVKKSKVVDESKLEEFINEVVILSQIN 126
F +LG+G G V +LA+ + I A+KK ++ ++E + E I N
Sbjct: 1 FRCLAVLGRGHFGKV---LLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETAN 57
Query: 127 ---HRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRI-ATEVAE 182
H +V L C + V E+ G L ++H + S E R A V
Sbjct: 58 SERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT--DVFS---EPRAVFYAACVVL 112
Query: 183 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS-IAIDQTHVSTKVQGTFGY 241
L YLH + I +RD+K N+LLD + KIADFG + + ST GT +
Sbjct: 113 GLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR-TST-FCGTPEF 167
Query: 242 LDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFD 301
L PE + +T D + GV++ E+L G+ P +E +FD
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG----------------DDEEEVFD 211
Query: 302 -IIDDQVRK----SGEAEEIM 317
I++D+VR S EA IM
Sbjct: 212 SIVNDEVRYPRFLSREAISIM 232
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 66/206 (32%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 78 RILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINE-VVILSQINHRNVVK 132
+++G+G G V ADG+ AVK K ++ + + + + E V+L + H +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 133 LLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRI-ATEVAEALAYLHSSA 191
L + V +++ G LF +L E S E R R A E+A AL YLHS
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQ---RERSFP-EPRARFYAAEIASALGYLHS-- 114
Query: 192 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQ 251
L I +RD+K NILLD + + DFG + I+ + ++ GT YL PE R
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKE-GIEHSKTTSTFCGTPEYLAPEVLRKQP 172
Query: 252 FTDKSDVYSFGVVLVELLTGQKPISS 277
+ D + G VL E+L G P S
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYS 198
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 6e-15
Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 80 LGQGGQGTVYKGMLAD-GRIIAVKK-SKVVDESKLEEFINEV-VILSQINHRNVVKLLGC 136
+G+G GTV K + G I+AVK+ VDE + + + ++ V++ + +VK G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 137 CLEVEVPLLVYEF--IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLP 194
+ E I ++Y+++ + + E+ +IA +AL YL L
Sbjct: 72 LFREGDCWICMELMDISLDKFYKYVYE-VLKSVIPEEILGKIAVATVKALNYLKEE--LK 128
Query: 195 IYHRDIKSTNILLDEKYRAKIADFGTS----RSIAIDQTHVSTKVQGTFGYLDPEYFRSS 250
I HRD+K +NILLD K+ DFG S SIA T+ G Y+ PE S
Sbjct: 129 IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA------KTRDAGCRPYMAPERIDPS 182
Query: 251 Q---FTDKSDVYSFGVVLVELLTGQKP 274
+ +SDV+S G+ L E+ TG+ P
Sbjct: 183 ARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 6e-15
Identities = 68/305 (22%), Positives = 132/305 (43%), Gaps = 36/305 (11%)
Query: 56 IDRCRIFNSKELD-KATDYFNMNRILGQGGQGTVYKGMLADGRII--AVKKSKVVDESKL 112
I R I + K ++ D + ++ + Q ++YKG+ + +I KK + +
Sbjct: 4 ITRSYINDIKCIESDDIDKYTS-VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLI 62
Query: 113 EEFINEVVILSQINHRNVVKLLGCCLEVEVPL----LVYEFIPNGTLFQYLHDPYEELSL 168
+ NE+ L +I+ N++K+ G +++ L L+ E+ G L + L +E L
Sbjct: 63 DITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL---DKEKDL 119
Query: 169 TWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228
+++ +L +A + + L L+ P ++++ S + L+ E Y+ KI G + ++
Sbjct: 120 SFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSP- 176
Query: 229 THVSTKVQGTFGYLDPEYFRS--SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNL 286
K Y + S++T K D+YS GVVL E+ TG+ P NL
Sbjct: 177 ---PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF--------ENL 225
Query: 287 TTYFVECIEENCLFD-IIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345
TT ++D II+ + + + + + C + RP +KE+ L
Sbjct: 226 TT--------KEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277
Query: 346 RIRAN 350
+
Sbjct: 278 LYKFY 282
|
Length = 283 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 6e-15
Identities = 64/216 (29%), Positives = 100/216 (46%), Gaps = 21/216 (9%)
Query: 74 FNMNRILGQGGQGTVY---------KGMLADGRIIAVKKSKVVDESKLEEFI-NEVVILS 123
F + ++LG G G V+ G L +++ KK+ +V ++K E E +L
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVL--KKATIVQKAKTTEHTRTERQVLE 59
Query: 124 QINHRNVVKLLGCCLEVEVPL-LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAE 182
I + L + + L L+ ++I G LF +L E E+++ E+
Sbjct: 60 HIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQ--RERFKEQEVQIYSG-EIVL 116
Query: 183 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYL 242
AL +LH L I +RDIK NILLD + DFG S+ D+ + GT Y+
Sbjct: 117 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173
Query: 243 DPEYFRSSQFT-DKS-DVYSFGVVLVELLTGQKPIS 276
P+ R DK+ D +S GV++ ELLTG P +
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT 209
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 6e-15
Identities = 58/204 (28%), Positives = 105/204 (51%), Gaps = 26/204 (12%)
Query: 80 LGQGGQGTVYKGM-LADGRIIAVKKSKV-VDESKLEEFINEVVILSQINHRNVVKLLGCC 137
LG+G TVYKG G I+A+K+ + +E I E+ ++ ++ H N+V+L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV- 66
Query: 138 LEVEVPL-LVYEFIPNGTLFQYLH--------DPYEELSLTWEMRLRIATEVAEALAYLH 188
+ E L LV+E++ + L +Y+ DP S T+++ + +A+ H
Sbjct: 67 IHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQL--------LKGIAFCH 117
Query: 189 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFR 248
+ L HRD+K N+L++++ K+ADFG +R+ I S +V T Y P+
Sbjct: 118 ENRVL---HRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLL 173
Query: 249 SSQ-FTDKSDVYSFGVVLVELLTG 271
S+ ++ D++S G ++ E++TG
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 7e-15
Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 18/205 (8%)
Query: 78 RILGQGGQGTVYKGMLADGR-----IIAVKKSKVVDESKLEEFINEVVILSQINHRNVVK 132
++LG+G G V L G+ + A+KK V+ + +E + E +L+ +
Sbjct: 1 KVLGKGSFGKVLLAEL-KGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59
Query: 133 LLGCCLEVEVPLL-VYEFIPNGTLFQYLHDP--YEELSLTWEMRLRIATEVAEALAYLHS 189
L C + + L V EF+ G L ++ D ++ T+ A E+ L +LHS
Sbjct: 60 HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF-----YAAEIVCGLQFLHS 114
Query: 190 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRS 249
I +RD+K N++LD KIADFG + ST GT Y+ PE +
Sbjct: 115 KG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQG 170
Query: 250 SQFTDKSDVYSFGVVLVELLTGQKP 274
++T D +SFGV+L E+L GQ P
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 7e-15
Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 27/219 (12%)
Query: 74 FNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQINH-RNVV 131
F + ++G G G VYKG + G++ A+K V ++ + EE E+ +L + +H RN+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIA 76
Query: 132 KLLGCCLEVEVP------LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALA 185
G ++ P LV EF G++ + + +L + I E+ LA
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN-ALKEDWIAYICREILRGLA 135
Query: 186 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS----RSIAIDQTHVSTKVQGTFGY 241
+LH+ + HRDIK N+LL E K+ DFG S R++ T + GT +
Sbjct: 136 HLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPYW 187
Query: 242 LDPEYFRSSQFTD-----KSDVYSFGVVLVELLTGQKPI 275
+ PE + D +SD++S G+ +E+ G P+
Sbjct: 188 MAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 7e-15
Identities = 61/216 (28%), Positives = 89/216 (41%), Gaps = 33/216 (15%)
Query: 82 QGGQGTVYKGMLADGR-------IIAVKKSKVVDESKLEEFINEVVIL-SQINHRNVVKL 133
+G G+VY LA R I +KKS ++ ++++ E I+ Q V KL
Sbjct: 6 KGAFGSVY---LAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62
Query: 134 LGCCLEVEVPLLVYEFIPNG---TLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSS 190
+ LV E++ G +L + L L W + EV + LH
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLIKTLG----GLPEDWAKQY--IAEVVLGVEDLHQR 116
Query: 191 AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSS 250
I HRDIK N+L+D+ K+ DFG SR+ + K GT YL PE
Sbjct: 117 G---IIHRDIKPENLLIDQTGHLKLTDFGLSRNG-----LENKKFVGTPDYLAPETILGV 168
Query: 251 QFTDKSDVYSFGVVLVELLTGQKPISS-----IWAN 281
SD +S G V+ E L G P + ++ N
Sbjct: 169 GDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDN 204
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 7e-15
Identities = 55/198 (27%), Positives = 96/198 (48%), Gaps = 11/198 (5%)
Query: 79 ILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFI--NEVVILSQINHRNVVKLLG 135
++G+G G V K + G+I+A+KK ++ K+ + I E+ +L Q+ H N+V L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 136 CCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPI 195
+ LV+EF+ + L P L + ++ + + HS I
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSHN---I 121
Query: 196 YHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYF-RSSQFTD 254
HRDIK NIL+ + K+ DFG +R++A V T T Y PE +++
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTDYVATRWYRAPELLVGDTKYGR 180
Query: 255 KSDVYSFGVVLVELLTGQ 272
D+++ G ++ E+LTG+
Sbjct: 181 AVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 8e-15
Identities = 59/206 (28%), Positives = 102/206 (49%), Gaps = 19/206 (9%)
Query: 80 LGQGGQGTVYKGM-LADGRIIAVKKSKV-VDESKLEEFINEVVILSQINHRNVVKLLGCC 137
LG+G G+VYK + G +A+K+ ++ +DESK + I E+ IL + +V G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 138 LEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRL-RIATEVAEALAYLHSSAYLPIY 196
+ E++ G+L L+ E L RI V + L +L I
Sbjct: 69 FIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNII 125
Query: 197 HRDIKSTNILLDEKYRAKIADFGTSRSI--AIDQTHVSTKVQGTFGYLDPEYFRS----- 249
HRD+K TN+L++ + K+ DFG S ++ ++ +T++ G Y+ PE +S
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERIKSGGPNQ 180
Query: 250 -SQFTDKSDVYSFGVVLVELLTGQKP 274
+T +SDV+S G+ ++E+ G+ P
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 8e-15
Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 78 RILGQGGQGTVYKGMLADGR-------IIAVKKSKVVDESKLEEFINEVVILSQINHRNV 130
++LG+G G V MLA+ + I A+KK V+++ +E + E +L+
Sbjct: 1 KVLGKGSFGKV---MLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPF 57
Query: 131 VKLLGCCLEVEVPLL-VYEFIPNGTLFQYLHDPYEELSLTW-EMRLRI-ATEVAEALAYL 187
+ L C + + L V E++ G L ++ S + E R R A E+ L +L
Sbjct: 58 LTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQS-----SGRFDEARARFYAAEIICGLQFL 112
Query: 188 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYF 247
H I +RD+K N+LLD+ KIADFG + + ST GT Y+ PE
Sbjct: 113 HKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPEIL 168
Query: 248 RSSQFTDKSDVYSFGVVLVELLTGQKPIS 276
+ ++ + D +SFGV+L E+L GQ P
Sbjct: 169 KGQKYNESVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 24/217 (11%)
Query: 74 FNMNRILGQGGQGTVY---------KGMLADGRIIAVKKSKVVDESKLEEFI-NEVVILS 123
F + ++LG G G V+ G L +++ +K+ +V ++K E E +L
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVL--QKAALVQKAKTVEHTRTERNVLE 59
Query: 124 QINHRNVVKLLGCCLEVEVPL-LVYEFIPNGTLFQYLH--DPYEELSLTWEMRLRIATEV 180
+ + L + E L L+ +++ G +F +L+ D + E E+R E+
Sbjct: 60 HVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED----EVRFYSG-EI 114
Query: 181 AEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFG 240
AL +LH L I +RDIK NILLD + + DFG S+ ++ + GT
Sbjct: 115 ILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIE 171
Query: 241 YLDPEYFRSSQFTDKS-DVYSFGVVLVELLTGQKPIS 276
Y+ PE R K+ D +S G+++ ELLTG P +
Sbjct: 172 YMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFT 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 4e-14
Identities = 77/283 (27%), Positives = 110/283 (38%), Gaps = 77/283 (27%)
Query: 72 DYFNMNRILGQGGQGTV--------YKGMLADGRIIAVKKSKV-VDESKLEEFINEVVIL 122
D + ++LG G G V K + +AVK K S+ + ++E+ IL
Sbjct: 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCN--TVAVKMLKEGATASEHKALMSELKIL 64
Query: 123 SQI-NHRNVVKLLGCCLEVEVPLLV-YEFIPNGTLFQYLH------DPYEELS------- 167
I NH NVV LLG C + PL+V EF G L +L PY E S
Sbjct: 65 IHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRF 124
Query: 168 ----------------------------------------------LTWEMRLRIATEVA 181
LT E + + +VA
Sbjct: 125 RAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVA 184
Query: 182 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVST-KVQGTFG 240
+ +L S + HRD+ + NILL E KI DFG +R I D +V +
Sbjct: 185 RGMEFLASRKCI---HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241
Query: 241 YLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANE 282
++ PE +T +SDV+SFGV+L E+ + G P + NE
Sbjct: 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE 284
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 4e-14
Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 18/209 (8%)
Query: 74 FNMNRILGQGGQGTVYKGML-ADGRIIAVKK--SKVVDESKLEEF-INEVVILSQINHRN 129
F R+LG+GG G V + A G++ A KK K + + K E +NE IL ++N R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHD----PYEELSLTWEMRLRIATEVAEALA 185
VV L + LV + G L ++++ ++E E + A E+ L
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDE-----ERAVFYAAEITCGLE 116
Query: 186 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE 245
LH I +RD+K NILLD+ +I+D G + I +T + +V GT GY+ PE
Sbjct: 117 DLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYMAPE 171
Query: 246 YFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
++ ++T D + G ++ E++ G+ P
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 4e-14
Identities = 51/215 (23%), Positives = 99/215 (46%), Gaps = 13/215 (6%)
Query: 66 ELDKATDYFNMNRILGQGGQGTVYKGMLA-DGR---IIAVKKSKV-VDESKLEEFINEVV 120
ELD + + RILG G G + +G L + +A+ + + + F+ E +
Sbjct: 1 ELDNKS--IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEAL 58
Query: 121 ILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEV 180
L Q +H N+V+L G ++V E++ NG L +L E L + + +
Sbjct: 59 TLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRK--HEGQLVAGQLMGMLPGL 116
Query: 181 AEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFG 240
A + YL Y+ H+ + + +L++ KI+ F + + + + +
Sbjct: 117 ASGMKYLSEMGYV---HKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL 173
Query: 241 YLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKP 274
+ PE + F+ SDV+SFG+V+ E+++ G++P
Sbjct: 174 WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 4e-14
Identities = 66/206 (32%), Positives = 95/206 (46%), Gaps = 14/206 (6%)
Query: 78 RILGQGGQGTVYKGM-LADGRIIAVK--KSKVVDESKLEEFI--NEVVILSQINHRNVVK 132
+++G+G G V A+ + AVK + K + + K E+ I V+L + H +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 133 LLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRI-ATEVAEALAYLHSSA 191
L + V ++I G LF +L E L E R R A E+A AL YLHS
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQR--ERCFL--EPRARFYAAEIASALGYLHS-- 114
Query: 192 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQ 251
L I +RD+K NILLD + + DFG + I+ ++ GT YL PE
Sbjct: 115 -LNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 252 FTDKSDVYSFGVVLVELLTGQKPISS 277
+ D + G VL E+L G P S
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYS 198
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 5e-14
Identities = 62/218 (28%), Positives = 109/218 (50%), Gaps = 31/218 (14%)
Query: 72 DYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEF----INEVVILSQIN 126
+Y +NRI +G G VY+ G I+A+KK K+ E + E F + E+ IL ++
Sbjct: 6 EYEKLNRI-EEGTYGVVYRARDKKTGEIVALKKLKM--EKEKEGFPITSLREINILLKLQ 62
Query: 127 HRNVVKLLGCCLEVEVP------LLVYEFIPNG--TLFQYLHDPYEELSLTWEMRLRIAT 178
H N+V + EV V +V E++ + +L + + P+ + + M
Sbjct: 63 HPNIVTVK----EVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLML----- 113
Query: 179 EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGT 238
++ +A+LH + L HRD+K++N+LL+ + KI DFG +R T++ T
Sbjct: 114 QLLSGVAHLHDNWIL---HRDLKTSNLLLNNRGILKICDFGLAREYG-SPLKPYTQLVVT 169
Query: 239 FGYLDPE-YFRSSQFTDKSDVYSFGVVLVELLTGQKPI 275
Y PE + +++ D++S G + ELLT +KP+
Sbjct: 170 LWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 6e-14
Identities = 59/232 (25%), Positives = 98/232 (42%), Gaps = 37/232 (15%)
Query: 73 YFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVV----DESKLEEFIN---------- 117
Y LG+G G V K G+I+A+KK K++ D +K + +
Sbjct: 10 YIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR 69
Query: 118 EVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIA 177
E+ I+++I H N++ L+ +E + LV + I L + + ++ LT I
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMD-IMASDLKKVVDR---KIRLTESQVKCIL 125
Query: 178 TEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQG 237
++ L LH ++ HRD+ NI ++ K KIADFG +R +
Sbjct: 126 LQILNGLNVLHKWYFM---HRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 238 -------------TFGYLDPE-YFRSSQFTDKSDVYSFGVVLVELLTGQKPI 275
T Y PE + ++ D++S G + ELLTG KP+
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPL 233
|
Length = 335 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 6e-14
Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 74 FNMNRILGQGGQGTVYKGML-ADGRIIAVKK--SKVVDESKLEEF-INEVVILSQINHRN 129
F R+LG+GG G V + A G++ A K+ K + + K E +NE IL ++N +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHD----PYEELSLTWEMRLRIATEVAEALA 185
VV L + LV + G L ++++ +EE E L A E+ L
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEE-----ERALFYAAEILCGLE 116
Query: 186 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE 245
LH +RD+K NILLD+ +I+D G + + I + GT GY+ PE
Sbjct: 117 DLHREN---TVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPE 171
Query: 246 YFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
+ ++T D + G ++ E++ GQ P
Sbjct: 172 VLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 6e-14
Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 21/206 (10%)
Query: 79 ILGQGGQGTVYKGMLAD-GRIIAVK---KSKVVDESKLEEFINEVVILSQINHRNVVKLL 134
I+G+GG G VY AD G++ A+K K ++ + +NE ++LS ++ + ++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 135 GCCLEVEVP---LLVYEFIPNGTLFQYL--HDPYEELSLTWEMRLRIATEVAEALAYLHS 189
P + + + G L +L H + E EMR ATE+ L ++H+
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEK----EMRF-YATEIILGLEHMHN 115
Query: 190 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRS 249
+ +RD+K NILLDE +I+D G + + + H S GT GY+ PE +
Sbjct: 116 RF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQK 169
Query: 250 SQFTDKS-DVYSFGVVLVELLTGQKP 274
D S D +S G +L +LL G P
Sbjct: 170 GTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 8e-14
Identities = 81/251 (32%), Positives = 114/251 (45%), Gaps = 54/251 (21%)
Query: 59 CRIFNSK-ELDKATD------YFNMNRILGQGGQGTV-YKGMLADGRIIAVKKSKVVD-E 109
CR F D+AT Y+ ++R+LG G GTV ++DG AVK VVD E
Sbjct: 13 CRTFPDTFAKDEATAKEQAKKYW-ISRVLGSGATGTVLCAKRVSDGEPFAVK---VVDME 68
Query: 110 SKLEEFIN----EVVILSQINHRNVVKLLGCCLE------------VEVPLLVYEFIPNG 153
E N EV L + ++VK C E V + LV ++ G
Sbjct: 69 GMSEADKNRAQAEVCCLLNCDFFSIVK----CHEDFAKKDPRNPENVLMIALVLDYANAG 124
Query: 154 TLFQYLHD------PYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL 207
L Q + + E E L + +V A+ ++HS + HRDIKS NILL
Sbjct: 125 DLRQEIKSRAKTNRTFRE----HEAGL-LFIQVLLAVHHVHSKHMI---HRDIKSANILL 176
Query: 208 DEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFG----YLDPEYFRSSQFTDKSDVYSFGV 263
K+ DFG S+ A VS V TF Y+ PE +R ++ K+D++S GV
Sbjct: 177 CSNGLVKLGDFGFSKMYA---ATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGV 233
Query: 264 VLVELLTGQKP 274
+L ELLT ++P
Sbjct: 234 LLYELLTLKRP 244
|
Length = 496 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 36/101 (35%), Positives = 57/101 (56%), Gaps = 5/101 (4%)
Query: 175 RIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTK 234
+I+ V L YL I HRD+K +NIL++ + K+ DFG S + ID ++
Sbjct: 103 KISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDS--MANS 157
Query: 235 VQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPI 275
GT Y+ PE + + +T +SD++S G+ LVE+ G+ PI
Sbjct: 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 69/238 (28%), Positives = 106/238 (44%), Gaps = 30/238 (12%)
Query: 74 FNMNRILGQGGQGTVYKGMLADGR-------IIAVKKSKVVDESKLEEFINEVVILSQIN 126
FN +LG+G G V MLA+ + I +KK V+ + +E + E +L+
Sbjct: 2 FNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSG 58
Query: 127 HRNVVKLLGCCLEVEVPL-LVYEFIPNGTLFQYLHD--PYEELSLTWEMRLRIATEVAEA 183
+ L C + L V E++ G L + ++E + A E+A
Sbjct: 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVF-----YAAEIAIG 113
Query: 184 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKV-QGTFGYL 242
L +LHS I +RD+K N++LD + KIADFG + D V+TK GT Y+
Sbjct: 114 LFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--VTTKTFCGTPDYI 168
Query: 243 DPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLF 300
PE + D ++FGV+L E+L GQ P EG + F +E N +
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF------EGEDEDELFQSIMEHNVAY 220
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 23/209 (11%)
Query: 80 LGQGGQGTVYKGM-LADGRIIAVKKSKV-VDESKLE-EFINEVVIL---SQINHRNVVKL 133
+G G GTVYK G +A+K +V +E L + EV +L +H N+V+L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 134 LGCCL------EVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYL 187
+ C E +V L V+E + + L YL D L E + + L +L
Sbjct: 68 MDVCATSRTDRETKVTL-VFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 188 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS-TKVQGTFGYLDPEY 246
H++ I HRD+K NIL+ + K+ADFG +R I ++ T V T Y PE
Sbjct: 125 HANC---IVHRDLKPENILVTSGGQVKLADFGLAR---IYSCQMALTPVVVTLWYRAPEV 178
Query: 247 FRSSQFTDKSDVYSFGVVLVELLTGQKPI 275
S + D++S G + E+ +KP+
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 58/224 (25%), Positives = 95/224 (42%), Gaps = 12/224 (5%)
Query: 78 RILGQGGQGTVYKGMLADGRII----AVKKSKVVDESKLEEFINEVVILSQINHRNVVKL 133
R++G+G V L I VKK V D+ ++ E + Q + +
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 134 LGCCLEVEVPL-LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAY 192
L C + L LV E++ G L ++ + L E A E+ AL +LH
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHERG- 116
Query: 193 LPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQF 252
I +RD+K N+LLD K+ D+G + + ++ GT Y+ PE R ++
Sbjct: 117 --IIYRDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGDTTSTFCGTPNYIAPEILRGEEY 173
Query: 253 TDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEE 296
D ++ GV++ E++ G+ P I N N Y + I E
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE 217
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 60/235 (25%), Positives = 96/235 (40%), Gaps = 46/235 (19%)
Query: 62 FNSKELDKAT----DYFNMNRILGQGGQGTVYKGMLADGRI-IAVKKSKVVDESKLEEF- 115
F +EL+K D + +G G G V +A+KK +S
Sbjct: 1 FYRQELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS--AIHA 58
Query: 116 ---INEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTL--FQ--YLHDPYEELSL 168
E+ +L ++H NV+ LL F P +L FQ YL L
Sbjct: 59 KRTYRELRLLKHMDHENVIGLLDV------------FTPASSLEDFQDVYLVTHLMGADL 106
Query: 169 TWEMRLR---------IATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 219
++ + + ++ L Y+HS+ I HRD+K +NI ++E KI DFG
Sbjct: 107 NNIVKCQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163
Query: 220 TSRSIAIDQT-HVSTKVQGTFGYLDPE-YFRSSQFTDKSDVYSFGVVLVELLTGQ 272
+R + T +V+T+ Y PE + D++S G ++ ELLTG+
Sbjct: 164 LARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 80 LGQGGQGTVYKG--MLADGRIIAVKKSKV--VDESKLEEFINEVVILSQIN---HRNVVK 132
+G+G G V+K + GR +A+K+ +V +E I EV +L + H NVV+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 133 LLGCCL----EVEVPL-LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYL 187
L C + E L LV+E + + L YL D E + E + ++ L +L
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDFL 126
Query: 188 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYF 247
HS + HRD+K NIL+ + K+ADFG +R + T V T Y PE
Sbjct: 127 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEVL 181
Query: 248 RSSQFTDKSDVYSFGVVLVELLTGQKPI 275
S + D++S G + E+ +KP+
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 59/199 (29%), Positives = 90/199 (45%), Gaps = 11/199 (5%)
Query: 80 LGQGGQGTVYKGMLADGRII----AVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLG 135
+G+G G V + D + I ++K+ +V S++ + E +L+Q+N +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 136 CCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPI 195
E LV FI G LF +L E R A E+ AL LH +
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQR--EGRFDLSRARFYTA-ELLCALENLHK---FNV 114
Query: 196 YHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDK 255
+RD+K NILLD + + DFG + + + + GT YL PE +T
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPELLLGHGYTKA 173
Query: 256 SDVYSFGVVLVELLTGQKP 274
D ++ GV+L E+LTG P
Sbjct: 174 VDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 61/208 (29%), Positives = 107/208 (51%), Gaps = 13/208 (6%)
Query: 69 KATDYFNMNRILGQGGQGTVYKG--MLADGRIIAVKKSKVVDESKLE-EFINEVVILSQI 125
K Y +++ LG+G TVYKG L D ++A+K+ ++ E I EV +L +
Sbjct: 4 KLETYIKLDK-LGEGTYATVYKGRSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDL 61
Query: 126 NHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALA 185
H N+V L + LV+E++ + L QYL D +++ ++L + ++ L
Sbjct: 62 KHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMH-NVKLFL-FQLLRGLN 118
Query: 186 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE 245
Y H L HRD+K N+L++E+ K+ADFG +R+ +I S +V T Y P+
Sbjct: 119 YCHRRKVL---HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPD 174
Query: 246 -YFRSSQFTDKSDVYSFGVVLVELLTGQ 272
S+ ++ + D++ G + E+ TG+
Sbjct: 175 ILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-13
Identities = 85/318 (26%), Positives = 138/318 (43%), Gaps = 52/318 (16%)
Query: 78 RILGQGGQGTVYKGMLADGR-------IIAVKKSKVVDESKLEEFINEVVILSQINHRNV 130
++LG+G G V MLA+ + I +KK ++ + ++ + E IL+
Sbjct: 1 KVLGKGSFGKV---MLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPF 57
Query: 131 VKLLGCCLEVEVPLL-VYEFIPNGTL-FQYLHDPYEELSLTWEMRLRI-ATEVAEALAYL 187
+ L CC + + L V E++ G L FQ + E R R A EV AL +L
Sbjct: 58 LTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFD-----EPRSRFYAAEVTLALMFL 112
Query: 188 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYF 247
H + +RD+K NILLD + K+ADFG + I +T GT Y+ PE
Sbjct: 113 HRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKE-GILNGVTTTTFCGTPDYIAPEIL 168
Query: 248 RSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307
+ ++ D ++ GV++ E++ GQ P E N F + ++ L+ V
Sbjct: 169 QELEYGPSVDWWALGVLMYEMMAGQPPF------EADNEDDLFESILHDDVLY-----PV 217
Query: 308 RKSGEAEEIMA---VSDVAKR--CLNSYG-----RNRPTMKEV---AMELERI------R 348
S EA I+ + KR C+ S G + P KE+ +E +I +
Sbjct: 218 WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPK 277
Query: 349 ANSRDDENNIQKCYGKVE 366
++ D NN + + K E
Sbjct: 278 IKTKRDVNNFDQDFTKEE 295
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 66/237 (27%), Positives = 106/237 (44%), Gaps = 25/237 (10%)
Query: 74 FNMNRILGQGGQGTVYKGMLADGRI--IAVK---KSKVVDESKLEEFINEVVILSQINHR 128
FN R LG G G V + +A+K KSK++ + +++ +E IL+ INH
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHP 91
Query: 129 NVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLH 188
V L G + LV EF+ G F +L ++ A ++ YL
Sbjct: 92 FCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR---RNKRFPNDVGCFYAAQIVLIFEYLQ 148
Query: 189 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFR 248
S L I +RD+K N+LLD+ K+ DFG ++ + T T + GT Y+ PE
Sbjct: 149 S---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV---DTRTYT-LCGTPEYIAPEILL 201
Query: 249 SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNL-------TTYFVECIEENC 298
+ +D ++ G+ + E+L G P +ANE + YF + ++ NC
Sbjct: 202 NVGHGKAADWWTLGIFIYEILVGCPP---FYANEPLLIYQKILEGIIYFPKFLDNNC 255
|
Length = 340 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 66/256 (25%), Positives = 114/256 (44%), Gaps = 30/256 (11%)
Query: 78 RILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKL--- 133
R LG G G V+ + +D + +AVKK + D ++ + E+ I+ +++H N+VK+
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 134 -----------LGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAE 182
+G E+ +V E++ L + E+ L+ E ++
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMETD-----LANVLEQGPLSEEHARLFMYQLLR 125
Query: 183 ALAYLHSSAYLPIYHRDIKSTNILLD-EKYRAKIADFGTSRSIAIDQTHVSTKVQG--TF 239
L Y+HS+ L HRD+K N+ ++ E KI DFG +R + +H +G T
Sbjct: 126 GLKYIHSANVL---HRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182
Query: 240 GYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEE-- 296
Y P S + +T D+++ G + E+LTG+ + E L V + E
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREED 242
Query: 297 -NCLFDIIDDQVRKSG 311
N L ++I VR G
Sbjct: 243 RNELLNVIPSFVRNDG 258
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 3e-13
Identities = 62/203 (30%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 78 RILGQGGQGTVY----KGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKL 133
++LG+G G V+ KG I A+KK V+ + +E + E +LS +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 134 LGCCLEVEVPLL-VYEFIPNGTLFQYLHDPYE-ELSLTWEMRLRIATEVAEALAYLHSSA 191
L C + + L V E++ G L ++ ++ +L A E+ L +LHS
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRA----TFYAAEIICGLQFLHSKG 116
Query: 192 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQ 251
I +RD+K NILLD KIADFG + + T GT Y+ PE +
Sbjct: 117 ---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIAPEILLGQK 172
Query: 252 FTDKSDVYSFGVVLVELLTGQKP 274
+ D +SFGV+L E+L GQ P
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 74 FNMNRILGQGGQGTVYKGMLADGR-------IIAVKKSKVVDESKLEEFINEVVILSQIN 126
FN +LG+G G V MLA+ + I +KK ++ + +E + E +L+
Sbjct: 2 FNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPG 58
Query: 127 HRNVVKLLGCCLEVEVPL-LVYEFIPNGTLFQYLHD--PYEELSLTWEMRLRIATEVAEA 183
+ L C + L V E++ G L ++ ++E + A E+A
Sbjct: 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVF-----YAAEIAIG 113
Query: 184 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 243
L +LHS I +RD+K N++LD + KIADFG + T GT Y+
Sbjct: 114 LFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT-FCGTPDYIA 169
Query: 244 PEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
PE + D ++FGV+L E+L GQ P
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 65/210 (30%), Positives = 104/210 (49%), Gaps = 20/210 (9%)
Query: 74 FNMNRILGQGGQGTVYKGML-ADGRIIAVKK--SKVVDESKLEEF-INEVVILSQINHRN 129
F R+LG+GG G V + A G++ A KK K + + K E +NE IL ++N R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQY----LHDP-YEELSLTWEMRLRIATEVAEAL 184
VV L E + L + I NG ++ + +P ++E + + A E+ L
Sbjct: 62 VVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDE-----QRAIFYAAELCCGL 115
Query: 185 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDP 244
L I +RD+K NILLD++ +I+D G + I +T V +V GT GY+ P
Sbjct: 116 EDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAP 170
Query: 245 EYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
E + ++T D + G ++ E++ GQ P
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 3e-13
Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 21/198 (10%)
Query: 84 GQGTVYKGMLA----DGRIIAVKKSKVVDESKLE--EFINEVVILSQINHRNVVKLLGCC 137
G+G+ K +L DG+ +K+ + S E E EV +LS + H N+V+
Sbjct: 9 GEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF 68
Query: 138 LEVEVPLLVYEFIPNGTLFQYLHDPY-----EELSLTWEMRLRIATEVAEALAYLHSSAY 192
E +V ++ G L++ ++ E+ L W +++ +A L ++H
Sbjct: 69 EENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHVHDRK- 121
Query: 193 LPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQF 252
I HRDIKS NI L + K+ DFG +R + ++ GT YL PE + +
Sbjct: 122 --ILHRDIKSQNIFLTKDGTIKLGDFGIARVLN-STVELARTCIGTPYYLSPEICENRPY 178
Query: 253 TDKSDVYSFGVVLVELLT 270
+KSD+++ G VL E+ T
Sbjct: 179 NNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 25/213 (11%)
Query: 69 KATDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLE-EFINEVVILSQIN 126
KA Y + + LG+G TVYKG +G+++A+K ++ +E I E +L +
Sbjct: 3 KADSYEKLEK-LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLK 61
Query: 127 HRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQY-------LHDPYEELSLTWEMRLRIATE 179
H N+V L E LV+E++ + L QY LH +L L +R
Sbjct: 62 HANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLR------ 114
Query: 180 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF 239
L+Y+H I HRD+K N+L+ + K+ADFG +R+ ++ S +V T
Sbjct: 115 ---GLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TL 167
Query: 240 GYLDPE-YFRSSQFTDKSDVYSFGVVLVELLTG 271
Y P+ S++++ D++ G + VE++ G
Sbjct: 168 WYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 58/208 (27%), Positives = 108/208 (51%), Gaps = 13/208 (6%)
Query: 69 KATDYFNMNRILGQGGQGTVYKG--MLADGRIIAVKKSKVVDESKLE-EFINEVVILSQI 125
K Y + + LG+G TV+KG L + ++A+K+ ++ E I EV +L +
Sbjct: 4 KMETYIKLEK-LGEGTYATVFKGRSKLTEN-LVALKEIRLEHEEGAPCTAIREVSLLKDL 61
Query: 126 NHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALA 185
H N+V L + LV+E++ + L QY+ D +S+ +++ + ++ LA
Sbjct: 62 KHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMH-NVKIFL-YQILRGLA 118
Query: 186 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE 245
Y H L HRD+K N+L++E+ K+ADFG +R+ ++ S +V T Y P+
Sbjct: 119 YCHRRKVL---HRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPD 174
Query: 246 YFR-SSQFTDKSDVYSFGVVLVELLTGQ 272
SS+++ + D++ G + E+ +G+
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 66/262 (25%), Positives = 117/262 (44%), Gaps = 20/262 (7%)
Query: 78 RILGQGGQGTVYKGMLAD-GRIIA---VKKSKVVDESKLEEFINEVVILSQINHRNVVKL 133
R++G+G V L RI A VKK V D+ ++ E + Q ++ +
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 134 LGCCLEVEVPLL-VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAY 192
L C + E L V E++ G L ++ + L E + E++ AL YLH
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG- 116
Query: 193 LPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQF 252
I +RD+K N+LLD + K+ D+G + + ++ GT Y+ PE R +
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 253 TDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGE 312
D ++ GV++ E++ G+ P + +++ + T E+ LF +I ++ +
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT-------EDYLFQVILEKQIRIPR 226
Query: 313 AEEIMAVSDVAKRCLNSYGRNR 334
+ + A S V K LN + R
Sbjct: 227 SLSVKAAS-VLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 68/223 (30%), Positives = 111/223 (49%), Gaps = 34/223 (15%)
Query: 69 KATDYFNMNRILGQGGQGTV----YKGMLADGRIIAVK---KSKVVDESKLEEFINEVVI 121
KA DY ++ +++G+G G V +K + ++ A+K K +++ S F E I
Sbjct: 41 KAEDY-DVVKVIGRGAFGEVQLVRHK---SSQKVYAMKLLSKFEMIKRSDSAFFWEERDI 96
Query: 122 LSQINHRNVVKLLGCCLEVEVPL-LVYEFIPNGTLFQYL--HDPYEELSLTWEMRLRIAT 178
++ N VV+L C + + L +V E++P G L + +D E+ + +
Sbjct: 97 MAFANSPWVVQLF-CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFY------TA 149
Query: 179 EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT---HVSTKV 235
EV AL +HS + + HRD+K N+LLD+ K+ADFGT + +D+T T V
Sbjct: 150 EVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGT--CMKMDETGMVRCDTAV 204
Query: 236 QGTFGYLDPEYFRSS----QFTDKSDVYSFGVVLVELLTGQKP 274
GT Y+ PE +S + + D +S GV L E+L G P
Sbjct: 205 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 5e-13
Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 26/214 (12%)
Query: 79 ILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEF----INEVVILSQINHRNVVKL 133
+GQG G V+K +I+A+KK + +E E F + E+ IL + H NVV L
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNL 76
Query: 134 LGCCLEVEVP--------LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALA 185
+ C P LV+EF + L L + + +L+ E++ ++ + L
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLS-EIK-KVMKMLLNGLY 133
Query: 186 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI---DQTHVSTKVQGTFGYL 242
Y+H + I HRD+K+ NIL+ + K+ADFG +R+ ++ + + T T Y
Sbjct: 134 YIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYR 190
Query: 243 DPEYFRSS-QFTDKSDVYSFGVVLVELLTGQKPI 275
PE + D++ G ++ E+ T + PI
Sbjct: 191 PPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 6e-13
Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 21/206 (10%)
Query: 79 ILGQGGQGTVYKGMLAD-GRIIAVK---KSKVVDESKLEEFINEVVILSQINHRNVVKLL 134
I+G+GG G VY AD G++ A+K K ++ + +NE ++LS ++ + ++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 135 GCCLEVEVP---LLVYEFIPNGTLFQYL--HDPYEELSLTWEMRLRIATEVAEALAYLHS 189
P + + + G L +L H + E EMR A E+ L ++H+
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA----EMRF-YAAEIILGLEHMHN 115
Query: 190 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRS 249
+ +RD+K NILLDE +I+D G + + + H S GT GY+ PE +
Sbjct: 116 RF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQK 169
Query: 250 SQFTDKS-DVYSFGVVLVELLTGQKP 274
D S D +S G +L +LL G P
Sbjct: 170 GVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 7e-13
Identities = 50/213 (23%), Positives = 98/213 (46%), Gaps = 30/213 (14%)
Query: 79 ILGQGGQGTVYKGM-LADGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRN-VVKLL 134
+G+G G VYK G+++A+KK+++ +E + E+ +L ++ +V+LL
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 135 GCCLEVEVPL------LVYEFIPNGTLFQYL-------HDPYEELSLTWEMRLRIATEVA 181
VE LV+E++ + L +++ P ++ ++
Sbjct: 68 -DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIK-----SFMYQLL 120
Query: 182 EALAYLHSSAYLPIYHRDIKSTNILLD-EKYRAKIADFGTSRSIAIDQTHVSTKVQGTFG 240
+ +A+ H + HRD+K N+L+D +K KIAD G R+ +I + ++ T
Sbjct: 121 KGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TLW 176
Query: 241 YLDPE-YFRSSQFTDKSDVYSFGVVLVELLTGQ 272
Y PE S+ ++ D++S G + E+ Q
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 9e-13
Identities = 57/201 (28%), Positives = 99/201 (49%), Gaps = 12/201 (5%)
Query: 80 LGQGGQGTVYKGM-LADGRIIAVKKSKV--VDESKLEEFINEVVILSQINHRNVVKLLGC 136
+G+G G VYK IA+KK ++ DE I E+ +L ++ H N+V+L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 137 CLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIY 196
+ LV+E++ + L +++ D + + + ++ +AY HS L
Sbjct: 70 VHSEKRLYLVFEYL-DLDLKKHM-DSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVL--- 124
Query: 197 HRDIKSTNILLDEKYRA-KIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSS-QFTD 254
HRD+K N+L+D + A K+ADFG +R+ I + +V T Y PE S ++
Sbjct: 125 HRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEILLGSRHYST 183
Query: 255 KSDVYSFGVVLVELLTGQKPI 275
D++S G + E++ QKP+
Sbjct: 184 PVDIWSVGCIFAEMVN-QKPL 203
|
Length = 294 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 9e-13
Identities = 45/216 (20%), Positives = 87/216 (40%), Gaps = 29/216 (13%)
Query: 78 RILGQGGQGTVYKGMLADGRIIAVKKS--KVVDESKLEEFINEVVILSQINHRNVVKLLG 135
+ + K ++AVKK + L+ E++ Q+ H N++ +
Sbjct: 8 KCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVT 66
Query: 136 CCLEVEVPLLVYEFIPNGT----LFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSA 191
+ +V + G+ L + + EL++ + ++ +V AL Y+HS
Sbjct: 67 SFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILK-----DVLNALDYIHSKG 121
Query: 192 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI---------AIDQTHVSTKVQGTFGYL 242
++ HR +K+++ILL + ++ S S+ D S K +L
Sbjct: 122 FI---HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP---WL 175
Query: 243 DPEYFRSS--QFTDKSDVYSFGVVLVELLTGQKPIS 276
PE + + + +KSD+YS G+ EL G P
Sbjct: 176 SPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 9e-13
Identities = 53/198 (26%), Positives = 93/198 (46%), Gaps = 10/198 (5%)
Query: 80 LGQGGQGTVYKGMLADGRIIAVKK--SKVVDESKLEEFINEVVILSQINHRNVVKLLGCC 137
LG G G V+K +I +K + + + I E+ +L + N +V G
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 138 LEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYH 197
+ E + G+L Q L + ++ +++ V + L YL I H
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKH--KIMH 127
Query: 198 RDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSD 257
RD+K +NIL++ + K+ DFG S + ID ++ GT Y+ PE + + ++ +SD
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQL-IDS--MANSFVGTRSYMSPERLQGTHYSVQSD 184
Query: 258 VYSFGVVLVELLTGQKPI 275
++S G+ LVE+ G+ PI
Sbjct: 185 IWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 9e-13
Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 15/208 (7%)
Query: 78 RILGQGGQGTVYKGMLADG----RIIAVK---KSKVVDESKLEEFIN-EVVILSQINHRN 129
++LG+GG G V++ G +I A+K K+ +V K E IL + H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS 189
+V L+ L+ E++ G LF +L E + +E++ AL +LH
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQ 118
Query: 190 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRS 249
I +RD+K NILLD + K+ DFG + +I + V+ GT Y+ PE
Sbjct: 119 ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKE-SIHEGTVTHTFCGTIEYMAPEILMR 174
Query: 250 SQFTDKSDVYSFGVVLVELLTGQKPISS 277
S D +S G ++ ++LTG P ++
Sbjct: 175 SGHGKAVDWWSLGALMYDMLTGAPPFTA 202
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 74 FNMNRILGQGGQGTVYKGMLADGR-------IIAVKKSKVVDESKLEEFINEVVILSQIN 126
FN +LG+G G V MLA+ + I +KK V+ + +E + E +L+ +
Sbjct: 2 FNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD 58
Query: 127 HRNVVKLLGCCLE-VEVPLLVYEFIPNGTLFQYLHD--PYEELSLTWEMRLRIATEVAEA 183
+ L C + V+ V E++ G L ++ ++E + A E++
Sbjct: 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVF-----YAAEISVG 113
Query: 184 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 243
L +LH I +RD+K N++LD + KIADFG + +D T GT Y+
Sbjct: 114 LFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT-FCGTPDYIA 169
Query: 244 PEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
PE + D +++GV+L E+L GQ P
Sbjct: 170 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 13/208 (6%)
Query: 69 KATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-DESKLEEFINEVVILSQIN 126
K Y +++ LG+G TV+KG ++A+K+ ++ +E I EV +L +
Sbjct: 3 KLETYVKLDK-LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLK 61
Query: 127 HRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIAT-EVAEALA 185
H N+V L LV+E++ + L QYL + +S+ ++I ++ L+
Sbjct: 62 HANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSM---HNVKIFMFQLLRGLS 117
Query: 186 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE 245
Y H I HRD+K N+L++EK K+ADFG +R+ ++ S +V T Y P+
Sbjct: 118 YCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPD 173
Query: 246 -YFRSSQFTDKSDVYSFGVVLVELLTGQ 272
S++++ D++ G +L E+ TG+
Sbjct: 174 VLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 62/226 (27%), Positives = 97/226 (42%), Gaps = 43/226 (19%)
Query: 79 ILGQGGQGT---VYKGML---ADGRIIAVKKSKVVDESKLEEF----INEVVILSQINHR 128
I G G+GT VYK DG+ A+KK K D+ + E+ +L ++ H
Sbjct: 4 IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKG-DKEQYTGISQSACREIALLRELKHE 62
Query: 129 NVVKLLGCCLEVEVPL--LVYEFIPNGTLFQYLHD----------PYEELSLTWEMRLRI 176
NVV L+ LE L++++ + L+Q + P SL W
Sbjct: 63 NVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLW------ 115
Query: 177 ATEVAEALAYLHSSAYLPIYHRDIKSTNILL----DEKYRAKIADFGTSRSI--AIDQTH 230
++ + YLHS+ + HRD+K NIL+ E+ KI D G +R +
Sbjct: 116 --QILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA 170
Query: 231 VSTKVQGTFGYLDPEYFRSSQ-FTDKSDVYSFGVVLVELLTGQKPI 275
V T Y PE ++ +T D+++ G + ELLT +PI
Sbjct: 171 DLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-LEPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-12
Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 36/208 (17%)
Query: 80 LGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEF-INEVV-------ILSQINHRNVV 131
LG+G GTVY ++ D + +A ++ KV+ E + E NE V +LS+++H +V
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 132 KLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLT-----------WEMRLRIATEV 180
K LE + ++ E+ + L EEL T W ++L +
Sbjct: 66 KFHASFLERDAFCIITEYCEG----RDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH- 120
Query: 181 AEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFG 240
Y+H I HRD+K+ NI L + KI DFG SR + + ++T GT
Sbjct: 121 -----YMHQRR---ILHRDLKAKNIFL-KNNLLKIGDFGVSR-LLMGSCDLATTFTGTPY 170
Query: 241 YLDPEYFRSSQFTDKSDVYSFGVVLVEL 268
Y+ PE + + KSD++S G +L E+
Sbjct: 171 YMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 73 YFNMNRILGQGGQGTVYKGMLAD-GRIIAVKKSKV--VDESKLEEFINEVVILSQINHRN 129
Y + +I G+G GTV+K + I+A+K+ ++ DE + E+ +L ++ H+N
Sbjct: 2 YEKLEKI-GEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYLH------DPYEELSLTWEMRLRIATEVAEA 183
+V+L + LV+E+ + L +Y DP S +++ L+
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQL-LK-------G 111
Query: 184 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 243
LA+ HS L HRD+K N+L+++ K+ADFG +R+ I S +V T Y
Sbjct: 112 LAFCHSHNVL---HRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRP 167
Query: 244 PEYFRSSQFTDKS-DVYSFGVVLVELLTGQKPI 275
P+ ++ S D++S G + EL +P+
Sbjct: 168 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 1e-12
Identities = 48/188 (25%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 118 EVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIP--NGTLFQYLHDPYEELSLTWEMRLR 175
E ++L +NH +V+++ + + +V +P + L+ YL L + + L
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPI--DQALI 161
Query: 176 IATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKV 235
I ++ E L YLH+ I HRD+K+ NI +++ + I D G ++ + + +
Sbjct: 162 IEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--L 216
Query: 236 QGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIE 295
GT PE ++ K+D++S G+VL E+L P S+I+ + Y C
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA--YP-STIFEDPPSTPEEYVKSC-- 271
Query: 296 ENCLFDII 303
+ L II
Sbjct: 272 HSHLLKII 279
|
Length = 357 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 59/209 (28%), Positives = 93/209 (44%), Gaps = 22/209 (10%)
Query: 74 FNMNRILGQGGQGTV----YKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRN 129
F M LG G G V +KG I +KK +++ +++ E IL +++H
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHD----PYEELSLTWEMRLRIATEVAEALA 185
+V ++ + + EF+ G LF +L P + E+ A
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKF-------YHAELVLAFE 132
Query: 186 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE 245
YLHS I +RD+K N+LLD K K+ DFG ++ + D+T + GT YL PE
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP-DRTFT---LCGTPEYLAPE 185
Query: 246 YFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
+S D ++ GV+L E + G P
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 2e-12
Identities = 68/230 (29%), Positives = 106/230 (46%), Gaps = 66/230 (28%)
Query: 80 LGQGGQGTVYKGMLAD---GRIIAVKKSKVVDESKLEEFIN---------EVVILSQI-N 126
LG+G G V+K + D ++A+KK + D F N E++ L ++ +
Sbjct: 15 LGKGAYGIVWKAI--DRRTKEVVALKK--IFDA-----FRNATDAQRTFREIMFLQELGD 65
Query: 127 HRNVVKLLGCCLEVEVP--------LLVYEF--------IPNGTLFQYLHDPYEELSLTW 170
H N+VKLL V LV+E+ I L + +H Y
Sbjct: 66 HPNIVKLL------NVIKAENDKDIYLVFEYMETDLHAVIRANIL-EDVHKRY------- 111
Query: 171 EMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA----I 226
I ++ +AL Y+HS + HRD+K +NILL+ R K+ADFG +RS++
Sbjct: 112 -----IMYQLLKALKYIHSGNVI---HRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163
Query: 227 DQTHVSTKVQGTFGYLDPE-YFRSSQFTDKSDVYSFGVVLVELLTGQKPI 275
+ V T T Y PE S+++T D++S G +L E+L G KP+
Sbjct: 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG-KPL 212
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 55/215 (25%), Positives = 104/215 (48%), Gaps = 24/215 (11%)
Query: 80 LGQGGQGTVYKGM---LADGRIIAVKKS--KVVDESK---LEEFINEVVILSQINHRNVV 131
LGQG ++KG+ + D + + KV+D+S E F ++SQ++H+++V
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 132 KLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSA 191
G C+ + ++V E++ G+L YL ++++W +L +A ++A AL +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120
Query: 192 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD------PE 245
+ H ++ + N+LL R + G I + +S V L+ PE
Sbjct: 121 ---LTHGNVCAKNVLL---IREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPE 174
Query: 246 YFRSSQ-FTDKSDVYSFGVVLVELLTG-QKPISSI 278
+ Q + +D +SFG L E+ +G KP+S++
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL 209
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 61/237 (25%), Positives = 104/237 (43%), Gaps = 20/237 (8%)
Query: 78 RILGQGGQGTVYKGML-ADGRIIA---VKKSKVVDESKLEEFINEVVILSQI-NHRNVVK 132
R++G+G V L RI A +KK V D+ ++ E + NH +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 133 LLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAY 192
L C V EF+ G L ++ + L E + E++ AL +LH
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHERG- 116
Query: 193 LPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQF 252
I +RD+K N+LLD + K+ D+G + I ++ GT Y+ PE R +
Sbjct: 117 --IIYRDLKLDNVLLDAEGHIKLTDYGMCKE-GIRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 253 TDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDII-DDQVR 308
D ++ GV++ E++ G+ P + ++ + T E+ LF +I + Q+R
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNT-------EDYLFQVILEKQIR 223
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (162), Expect = 3e-12
Identities = 43/152 (28%), Positives = 69/152 (45%), Gaps = 16/152 (10%)
Query: 126 NHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLH--DPYEELSLTWEMRLRIATEVAEA 183
++ N +KL ++ +L+ ++I +G LF L E E++ I ++ EA
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEA----EVKK-IIRQLVEA 121
Query: 184 LAYLHSSAYLPIYHRDIKSTNILLDE-KYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYL 242
L LH + H DIK N+L D K R + D+G + I + GT Y
Sbjct: 122 LNDLHKHNII---HNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYF 173
Query: 243 DPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
PE + + D ++ GV+ ELLTG+ P
Sbjct: 174 SPEKIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 37/104 (35%), Positives = 57/104 (54%), Gaps = 8/104 (7%)
Query: 175 RIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTK 234
+IA + +AL YLHS L + HRD+K +N+L++ + K+ DFG S + +D T
Sbjct: 107 KIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYL-VDSV-AKTI 162
Query: 235 VQGTFGYLDPEYF----RSSQFTDKSDVYSFGVVLVELLTGQKP 274
G Y+ PE + KSDV+S G+ ++EL TG+ P
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (162), Expect = 5e-12
Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 41/224 (18%)
Query: 74 FNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLE--EFINEVVILSQINHRNV 130
+ + + +G G G V + GR +A+KK V + ++ + E+ +L + H N+
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 131 VKLLGCCLEVEVPL---------LVYEFIPNGT-LFQYLHDPYEELS------LTWEMRL 174
+ LL ++ P +V E + T L + + P + L+ +++ L
Sbjct: 62 IGLL----DILRPPSPEDFNDVYIVTELME--TDLHKVIKSP-QPLTDDHIQYFLYQI-L 113
Query: 175 RIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTK 234
R L YLHS+ + HRD+K +NIL++ KI DFG +R + D+
Sbjct: 114 R-------GLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL 163
Query: 235 VQG--TFGYLDPEYFRSSQFTDKS-DVYSFGVVLVELLTGQKPI 275
+ T Y PE SS K+ D++S G + ELLT KP+
Sbjct: 164 TEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR-KPL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 5e-12
Identities = 60/198 (30%), Positives = 95/198 (47%), Gaps = 11/198 (5%)
Query: 78 RILGQGGQGTV-YKGMLADGRIIAVKKSKVVDESKLEEFI--NEVVILSQINHRNVVKLL 134
R++G+G G V DG+ +KK + + S+ E E +LSQ+ H N+V
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65
Query: 135 GCCLEVEVPLL--VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAY 192
E E LL V F G L+ L + +L L + ++A AL YLH
Sbjct: 66 ES-WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKL-LPENQVVEWFVQIAMALQYLHEKH- 122
Query: 193 LPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQF 252
I HRD+K+ N+ L K+ D G +R + +Q +++ + GT Y+ PE F + +
Sbjct: 123 --ILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLIGTPYYMSPELFSNKPY 179
Query: 253 TDKSDVYSFGVVLVELLT 270
KSDV++ G + E+ T
Sbjct: 180 NYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 6e-12
Identities = 63/223 (28%), Positives = 112/223 (50%), Gaps = 31/223 (13%)
Query: 80 LGQGGQGTVYKGML---ADGRIIA-VKKSKVV------DESKLEEFINEVVILSQINHRN 129
LGQG +YKG+L +D I+ ++ VV D F ++SQ++H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS 189
+VKL G C+ E ++V E++ G L +LH +SL W +L +A ++A AL YL
Sbjct: 63 LVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 190 SAYLPIYHRDIKSTNILL-----DEKYR--AKIADFGTSRSIAIDQTHVSTKVQGTFGYL 242
+ H ++ NIL+ +E Y K++D G ++ + V ++
Sbjct: 120 KK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE-----RIPWI 171
Query: 243 DPEYFR--SSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANE 282
PE R + T +D +SFG L+E+ + G++P+S++ ++E
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE 214
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 7e-12
Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 80 LGQGGQGTVYK-GMLADGRIIAVKK--SKVVDESKLEEF-INEVVILSQINHRNVVKLLG 135
LG+GG G V + A G++ A KK K + + K E+ +NE IL +++ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 136 CCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRI-ATEVAEALAYLHSSAYLP 194
E + L + + NG +Y E E R A ++ L +LH
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFP-EARAIFYAAQIICGLEHLHQ---RR 115
Query: 195 IYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTD 254
I +RD+K N+LLD+ +I+D G + + + + GT GY+ PE + +
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELK-GGKKIKGRA-GTPGYMAPEVLQGEVYDF 173
Query: 255 KSDVYSFGVVLVELLTGQKP 274
D ++ G L E++ G+ P
Sbjct: 174 SVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 65/251 (25%), Positives = 123/251 (49%), Gaps = 25/251 (9%)
Query: 36 NFKKNGGLLLQQQL---NSIGGSIDRCRIFNSKELDKATDYFNMNRILGQGGQGTVYKGM 92
F+ N L +++ N+ G D ++ ++ + + I+G G G VY+ +
Sbjct: 27 KFEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAI 86
Query: 93 LAD-GRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKL-----LGCCLEVEVPL-- 144
D +A+KK V+ + + + E++I+ +NH N++ L C + E +
Sbjct: 87 CIDTSEKVAIKK--VLQDPQYKN--RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142
Query: 145 -LVYEFIPNGTLFQYL-HDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKS 202
+V EFIP T+ +Y+ H +L + + ++ ALAY+HS I HRD+K
Sbjct: 143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKP 198
Query: 203 TNILLDEK-YRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE-YFRSSQFTDKSDVYS 260
N+L+D + K+ DFG+++++ Q VS + F Y PE ++ +T D++S
Sbjct: 199 QNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY-ICSRF-YRAPELMLGATNYTTHIDLWS 256
Query: 261 FGVVLVELLTG 271
G ++ E++ G
Sbjct: 257 LGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 16/214 (7%)
Query: 69 KATDYFNMNRILGQGGQGTV----YKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQ 124
KA DY + +++G+G G V +K + + K +++ S F E I++
Sbjct: 41 KAEDY-EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99
Query: 125 INHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEAL 184
N VV+L + +V E++P G L + + ++ W R A EV AL
Sbjct: 100 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWA-RFYTA-EVVLAL 155
Query: 185 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDP 244
+HS ++ HRD+K N+LLD+ K+ADFGT + + GT Y+ P
Sbjct: 156 DAIHSMGFI---HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 212
Query: 245 EYFRSS----QFTDKSDVYSFGVVLVELLTGQKP 274
E +S + + D +S GV L E+L G P
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 1e-11
Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 44/215 (20%)
Query: 78 RILGQGGQGT---VYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQIN------- 126
+ILG+ G+GT V K G+ A+K K +S + +V L +I
Sbjct: 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS-----LEQVNNLREIQALRRLSP 56
Query: 127 HRNVVKLLGC-------CLEVEVPLL---VYEFIPNGTLFQYLHDPYEELSLTWEMRLRI 176
H N+++L+ L + L+ +YE I P E + M
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKG------RKRPLPEKRVKSYM---- 106
Query: 177 ATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQ 236
++ ++L ++H + I+HRDIK NIL+ K+ADFG+ R I + T+
Sbjct: 107 -YQLLKSLDHMHRNG---IFHRDIKPENILIK-DDILKLADFGSCRGIYSKPPY--TEYI 159
Query: 237 GTFGYLDPEYFRSSQF-TDKSDVYSFGVVLVELLT 270
T Y PE + + K D+++ G V E+L+
Sbjct: 160 STRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 58/192 (30%), Positives = 96/192 (50%), Gaps = 28/192 (14%)
Query: 100 AVKKSKVV-------DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPN 152
+ K KVV DE + +E+ L+ +H +VK + LL+ E+
Sbjct: 90 SDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSG 149
Query: 153 GTLFQYL------HDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNIL 206
G L + + H P++E +E+ L + ++ AL +HS + HRD+KS NI
Sbjct: 150 GDLNKQIKQRLKEHLPFQE----YEVGL-LFYQIVLALDEVHSRKMM---HRDLKSANIF 201
Query: 207 LDEKYRAKIADFGTSR----SIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFG 262
L K+ DFG S+ S+++D V++ GT YL PE + +++ K+D++S G
Sbjct: 202 LMPTGIIKLGDFGFSKQYSDSVSLD---VASSFCGTPYYLAPELWERKRYSKKADMWSLG 258
Query: 263 VVLVELLTGQKP 274
V+L ELLT +P
Sbjct: 259 VILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 17/200 (8%)
Query: 80 LGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFIN-----EVVILSQINHRNVVKL 133
+G+G G V+K + G+I+A+KK ES+ + I E+ +L Q+ H N+V L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKK---FVESEDDPVIKKIALREIRMLKQLKHPNLVNL 65
Query: 134 LGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYL 193
+ LV+E+ + L + +P + + +I + +A+ + H +
Sbjct: 66 IEVFRRKRKLHLVFEYCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKHNCI 122
Query: 194 PIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYF-RSSQF 252
HRD+K NIL+ ++ + K+ DFG +R I T T Y PE +Q+
Sbjct: 123 ---HRDVKPENILITKQGQIKLCDFGFAR-ILTGPGDDYTDYVATRWYRAPELLVGDTQY 178
Query: 253 TDKSDVYSFGVVLVELLTGQ 272
DV++ G V ELLTGQ
Sbjct: 179 GPPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 54/188 (28%), Positives = 94/188 (50%), Gaps = 26/188 (13%)
Query: 164 EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 223
+EL+L E L + +VA+ +++L S + HRD+ + NILL KI DFG +R
Sbjct: 207 DELALDTEDLLSFSYQVAKGMSFLASKNCI---HRDLAARNILLTHGRITKICDFGLARD 263
Query: 224 IAIDQTHVSTKVQGT----FGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSI 278
I D +V V+G ++ PE + +T +SDV+S+G++L E+ + G P
Sbjct: 264 IRNDSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYP-- 318
Query: 279 WANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMK 338
G + + F + I+E + ++ + S E +IM K C ++ RPT K
Sbjct: 319 ----GMPVDSKFYKMIKEG--YRMLSPECAPS-EMYDIM------KSCWDADPLKRPTFK 365
Query: 339 EVAMELER 346
++ +E+
Sbjct: 366 QIVQLIEQ 373
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 55/198 (27%), Positives = 88/198 (44%), Gaps = 14/198 (7%)
Query: 84 GQGTVYKGML----ADGRIIA---VKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGC 136
G+GT K +L A G+ A +KK ++ + ++ + E +L H + L
Sbjct: 4 GKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYS 63
Query: 137 CLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIY 196
+ V E++ G LF +L E + + E+ AL YLHS I
Sbjct: 64 FQTKDRLCFVMEYVNGGELFFHLS---RERVFSEDRTRFYGAEIVSALDYLHSGK---IV 117
Query: 197 HRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKS 256
+RD+K N++LD+ KI DFG + D + T GT YL PE + +
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLEDNDYGRAV 176
Query: 257 DVYSFGVVLVELLTGQKP 274
D + GVV+ E++ G+ P
Sbjct: 177 DWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-11
Identities = 57/202 (28%), Positives = 90/202 (44%), Gaps = 16/202 (7%)
Query: 84 GQGTVYKGML----ADGRIIAVK---KSKVVDESKLEEFINEVVILSQINHRNVVKLLGC 136
G+GT K +L A G+ A+K K ++ + ++ + E +L H + L
Sbjct: 4 GKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYS 63
Query: 137 CLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRI-ATEVAEALAYLHSSAYLPI 195
+ V E+ G LF +L E + E R R E+ AL YLHS +
Sbjct: 64 FQTHDRLCFVMEYANGGELFFHLS---RERVFS-EDRARFYGAEIVSALGYLHSCD---V 116
Query: 196 YHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDK 255
+RD+K N++LD+ KI DFG + D + T GT YL PE + +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYGRA 175
Query: 256 SDVYSFGVVLVELLTGQKPISS 277
D + GVV+ E++ G+ P +
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-11
Identities = 65/218 (29%), Positives = 93/218 (42%), Gaps = 34/218 (15%)
Query: 80 LGQGGQGTVYKGMLADGRIIA--VKKSKVVDESKLEE--FINEVVILSQINHRNVVKLLG 135
+G G G V G + G A V K V S E+ F+ E + H N+++ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 136 CCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRL--RIATEVAEALAYLHSSAYL 193
C EV LLV EF P G L YL + +T + R+A E+A L +LH + ++
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFI 122
Query: 194 PIYHRDIKSTNILLDEKYRAKIADFGTSRS-------IAIDQTHVSTK---------VQG 237
H D+ N LL KI D+G S + + DQ V + V G
Sbjct: 123 ---HSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 238 TFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKP 274
+D T +S+V+S GV + EL G +P
Sbjct: 180 NLLVVDQ--------TKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 58/198 (29%), Positives = 87/198 (43%), Gaps = 14/198 (7%)
Query: 84 GQGTVYKGML----ADGRIIAVK---KSKVVDESKLEEFINEVVILSQINHRNVVKLLGC 136
G+GT K +L A GR A+K K ++ + ++ + E +L H + L
Sbjct: 4 GKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA 63
Query: 137 CLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIY 196
+ V E+ G LF +L E T E E+ AL YLHS +
Sbjct: 64 FQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VV 117
Query: 197 HRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKS 256
+RDIK N++LD+ KI DFG + D + T GT YL PE + +
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYGRAV 176
Query: 257 DVYSFGVVLVELLTGQKP 274
D + GVV+ E++ G+ P
Sbjct: 177 DWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 6e-11
Identities = 57/222 (25%), Positives = 95/222 (42%), Gaps = 39/222 (17%)
Query: 74 FNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKL-EEFINEVVILSQINHRNVV 131
+ +G+G G V G +A+KK + + + E+ IL + H N++
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENII 66
Query: 132 KLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPY--EELSLTWEMRLRIATE---------- 179
+L + I + F+ +D Y +EL T +L I T+
Sbjct: 67 GIL-------------DIIRPPS-FESFNDVYIVQELMETDLYKL-IKTQHLSNDHIQYF 111
Query: 180 ---VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS--TK 234
+ L Y+HS+ L HRD+K +N+LL+ KI DFG +R + H T+
Sbjct: 112 LYQILRGLKYIHSANVL---HRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTE 168
Query: 235 VQGTFGYLDPE-YFRSSQFTDKSDVYSFGVVLVELLTGQKPI 275
T Y PE S +T D++S G +L E+L+ +P+
Sbjct: 169 YVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 7e-11
Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 24/203 (11%)
Query: 80 LGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEE-------FINEVVILSQINHRNVV 131
LG+G TVYKG G+++A+K E +LE I E +L + H N+V
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALK------EIRLEHEEGAPFTAIREASLLKDLKHANIV 66
Query: 132 KLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIAT-EVAEALAYLHSS 190
L + LV+E++ + L QY+ D LS+ +R+ ++ LAY H
Sbjct: 67 TLHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMH---NVRLFLFQLLRGLAYCHQR 122
Query: 191 AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFR-S 249
L HRD+K N+L+ E+ K+ADFG +R+ ++ S +V T Y P+ S
Sbjct: 123 RVL---HRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-TLWYRPPDVLLGS 178
Query: 250 SQFTDKSDVYSFGVVLVELLTGQ 272
++++ D++ G + E+ TG+
Sbjct: 179 TEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 9e-11
Identities = 75/297 (25%), Positives = 124/297 (41%), Gaps = 69/297 (23%)
Query: 74 FNMNRILGQGGQGTV-YKGMLADGRIIAVK---KSKVVDESKLEEFINEVVILSQINHRN 129
F+ +++G+G G V G+I A+K KS++ + +L E +L++ +
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPW 62
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYL--HDPYEELSLTWEMRLRIATEVAEALAYL 187
VV L + + L+ EF+P G L L +D + E +T R +A E A+ +
Sbjct: 63 VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSE-DVT---RFYMA-ECVLAIEAV 117
Query: 188 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS-------------------------- 221
H ++ HRDIK NIL+D K++DFG S
Sbjct: 118 HKLGFI---HRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRID 174
Query: 222 --RSIAIDQTH--VSTKVQ----------------GTFGYLDPEYFRSSQFTDKSDVYSF 261
S+A+D + +S+K Q GT Y+ PE F + + D +S
Sbjct: 175 NRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234
Query: 262 GVVLVELLTGQKPISSIWANEG-RNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIM 317
G ++ E L G P S ++E R + + E F D + S EAE+++
Sbjct: 235 GAIMFECLIGWPPFCSENSHETYRKIINW-----RETLYF---PDDIHLSVEAEDLI 283
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 9e-11
Identities = 38/113 (33%), Positives = 63/113 (55%), Gaps = 11/113 (9%)
Query: 174 LRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVST 233
LR +++VA+ + +L S + HRD+ + N+LL + AKI DFG +R I D +V
Sbjct: 215 LRFSSQVAQGMDFLASKNCI---HRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV-- 269
Query: 234 KVQGT----FGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWAN 281
V+G ++ PE +T +SDV+S+G++L E+ + G+ P I N
Sbjct: 270 -VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN 321
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 9e-11
Identities = 67/232 (28%), Positives = 100/232 (43%), Gaps = 34/232 (14%)
Query: 65 KELDKATDYFNMNRILGQGGQGTVYK-GMLADGRIIAVKKSKVVDESKLEEFINEVVILS 123
+ L TD + + +G+G G VYK DG + AVK + + EE E IL
Sbjct: 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNILQ 73
Query: 124 QI-NHRNVVKLLGCCLEVEVPL-----LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIA 177
+ NH NVVK G + + + LV E G++ + + + L
Sbjct: 74 SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----------KGLLICG 122
Query: 178 TEVAEAL-AYLHSSAYL--------PIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228
+ EA+ +Y+ A L I HRD+K NILL + K+ DFG S + +
Sbjct: 123 QRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 182
Query: 229 THVSTKVQGTFGYLDPEYFRSSQFTDKS-----DVYSFGVVLVELLTGQKPI 275
+T V GT ++ PE Q D S DV+S G+ +EL G P+
Sbjct: 183 LRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 80 LGQGGQGTVYK-GMLADGRIIAVKK--SKVVDESK-LEEFINEVVILSQINHRNVVKLLG 135
LG+GG G V M A G++ A KK K + + K E + E IL++++ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59
Query: 136 CCLEVEVPL-LVYEFIPNGTLFQYLHDPYEELSLTWEMR-LRIATEVAEALAYLHSSAYL 193
+ + L LV + G L ++++ EE E R ++ L +LH
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR-- 117
Query: 194 PIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTK-VQGTFGYLDPEYFRSSQF 252
I +RD+K N+LLD +I+D G + + Q+ TK GT G++ PE + ++
Sbjct: 118 -IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGYAGTPGFMAPELLQGEEY 174
Query: 253 TDKSDVYSFGVVLVELLTGQKP 274
D ++ GV L E++ + P
Sbjct: 175 DFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 64/248 (25%), Positives = 104/248 (41%), Gaps = 61/248 (24%)
Query: 78 RILGQGGQGTVYKGMLAD-GRIIAVK---KSKVVDESKLEEFINEVVILSQINHRNVVKL 133
+++G+G G V D G I A+K KS+++++ ++ E IL++ ++ VVKL
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66
Query: 134 LGCCLEVEVPL-LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATE------VAEALAY 186
+ E L L+ E++P G + L M+ TE +AE +
Sbjct: 67 Y-YSFQDENYLYLIMEYLPGGDMMTLL------------MKKDTFTEEETRFYIAETILA 113
Query: 187 LHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG---------------------TSRSIA 225
+ S L HRDIK N+LLD K K++DFG S +
Sbjct: 114 IDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLD 173
Query: 226 IDQTHVSTKVQ----------------GTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELL 269
+S+K + GT Y+ PE F + + + D +S GV++ E+L
Sbjct: 174 FISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233
Query: 270 TGQKPISS 277
G P S
Sbjct: 234 VGYPPFCS 241
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 63/226 (27%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 71 TDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQI-NHR 128
+D + + +G+G G V+K + +G AVK + + EE E IL + +H
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHP 75
Query: 129 NVVKLLGCCLEVEVP-----LLVYEFIPNGTL------FQYLHDPYEELSLTWEMRLRIA 177
NVVK G + +V LV E G++ F + EE + + I
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY-----IL 130
Query: 178 TEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQG 237
E L +LH + + HRD+K NILL + K+ DFG S + + +T V G
Sbjct: 131 HEALMGLQHLHVNKTI---HRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-G 186
Query: 238 TFGYLDPEYFRSSQFTDKS-----DVYSFGVVLVELLTGQKPISSI 278
T ++ PE Q D + DV+S G+ +EL G P++ +
Sbjct: 187 TPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 51/166 (30%), Positives = 76/166 (45%), Gaps = 16/166 (9%)
Query: 118 EVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGT--LFQYLHDPYEELSLTWEMRLR 175
E+ IL I+HR ++ L+ +V +P LF Y+ D L L E +
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTYV-DRSGPLPL--EQAIT 189
Query: 176 IATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKV 235
I + EALAYLH I HRD+K+ NI LDE A + DFG + +D + +
Sbjct: 190 IQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGA--ACKLDAHPDTPQC 244
Query: 236 QGTFGYLD---PEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSI 278
G G L+ PE + K+D++S G+VL E+ +
Sbjct: 245 YGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290
|
Length = 392 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 43/213 (20%)
Query: 80 LGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKL--EEFINEVVILSQINHRNVVKLLGC 136
+G G G+V + G +A+KK +S++ + E+ +L + H NV+ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL-- 80
Query: 137 CLEVEVPLLVYEFIPNGTLFQ--YLHDPYEELSLTWEMRLRIATEVAE--------ALAY 186
+V +G FQ YL PY + L M ++ + + L Y
Sbjct: 81 --DVFTSA------VSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKY 132
Query: 187 LHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEY 246
+HS+ I HRD+K N+ ++E KI DFG +R + T GY+ +
Sbjct: 133 IHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMT----------GYVVTRW 179
Query: 247 FRSSQ-------FTDKSDVYSFGVVLVELLTGQ 272
+R+ + + D++S G ++ E+LTG+
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 54/203 (26%), Positives = 93/203 (45%), Gaps = 20/203 (9%)
Query: 78 RILGQGGQGTVYKGM-LADGRIIAVKK--SKVVDESKLEEFINEVVILSQINHRNVVKLL 134
+ +G G QG V G +AVKK +++ + E+V+L +NH+N++ LL
Sbjct: 27 KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86
Query: 135 GCCL------EVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLH 188
E + LV E + + L Q +H + L E + ++ + +LH
Sbjct: 87 NVFTPQKSLEEFQDVYLVMELM-DANLCQVIH-----MELDHERMSYLLYQMLCGIKHLH 140
Query: 189 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFR 248
S+ I HRD+K +NI++ KI DFG +R+ + + T T Y PE
Sbjct: 141 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--FMMTPYVVTRYYRAPEVIL 195
Query: 249 SSQFTDKSDVYSFGVVLVELLTG 271
+ + D++S G ++ EL+ G
Sbjct: 196 GMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 4e-10
Identities = 51/192 (26%), Positives = 88/192 (45%), Gaps = 28/192 (14%)
Query: 109 ESKLEEFINEVVILSQINHRNVVKLLGCCLEV--EVPLLVYEFIPNGTLFQYLHDPYEEL 166
E + + + EV ++ ++ H+N+V+ + L + ++ EF G L + + Y+
Sbjct: 53 EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMF 112
Query: 167 SLTWEMRL-RIATEVAEALAYLHSSAYLP----IYHRDIKSTNILLDEKYR--------- 212
E + I ++ ALAY H+ P + HRD+K NI L R
Sbjct: 113 GKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172
Query: 213 --------AKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYF--RSSQFTDKSDVYSFG 262
AKI DFG S++I I+ ++ GT Y PE + + DKSD+++ G
Sbjct: 173 NNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALG 230
Query: 263 VVLVELLTGQKP 274
++ EL +G+ P
Sbjct: 231 CIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 5e-10
Identities = 42/177 (23%), Positives = 83/177 (46%), Gaps = 15/177 (8%)
Query: 117 NEVVILSQINHRNVVKLLGCCLEVEVPLLV---YEFIPNGTLFQYLHD---PYEELSLTW 170
NE++ L ++NH N++K+ ++ Y+F L+ +++D +++ L
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWKDRPLLK 267
Query: 171 EMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230
+ R I ++ A+ Y+H + HRDIK NI L+ + + DFGT+ ++
Sbjct: 268 QTR-AIMKQLLCAVEYIHDKKLI---HRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA 323
Query: 231 VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQ-KPISSIWANEGRNL 286
GT PE + + +D++S G++L+++L+ PI G+ L
Sbjct: 324 FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380
|
Length = 501 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 5e-10
Identities = 39/120 (32%), Positives = 61/120 (50%), Gaps = 5/120 (4%)
Query: 165 ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 224
+ LT E + + +VA + +L S + HRD+ + NILL E KI DFG +R I
Sbjct: 167 KEPLTLEDLISYSFQVARGMEFLASRKCI---HRDLAARNILLSENNVVKICDFGLARDI 223
Query: 225 AIDQTHV-STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANE 282
D +V + ++ PE +T +SDV+SFGV+L E+ + G P + +E
Sbjct: 224 YKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE 283
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 7e-10
Identities = 58/244 (23%), Positives = 101/244 (41%), Gaps = 44/244 (18%)
Query: 72 DYFNMNRILGQGGQGTVYKGMLAD-GRIIAVK---KSKVVDESKLEEFINEVVILSQINH 127
D F +++G+G G V D G I A+K K+ ++++ ++ E IL + +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 128 RNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYL 187
VVK+ + L+ EF+P G + L ++ +L+ E E A+ +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLL---MKKDTLSEEATQFYIAETVLAIDAI 117
Query: 188 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFG---------------------------- 219
H ++ HRDIK N+LLD K K++DFG
Sbjct: 118 HQLGFI---HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 220 ------TSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQK 273
+ + ++ ++ GT Y+ PE F + + D +S GV++ E+L G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 274 PISS 277
P S
Sbjct: 235 PFCS 238
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 9e-10
Identities = 34/100 (34%), Positives = 53/100 (53%), Gaps = 5/100 (5%)
Query: 180 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF 239
+AE + +HS L HRDIK N+LLD ++ADFG+ + D T S+ GT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTP 167
Query: 240 GYLDPEYFRS-----SQFTDKSDVYSFGVVLVELLTGQKP 274
Y+ PE ++ ++ + D +S GV + E+L G+ P
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 9e-10
Identities = 45/188 (23%), Positives = 83/188 (44%), Gaps = 24/188 (12%)
Query: 164 EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 223
E +L++ + + +VA + +L S + HRD+ + N+L+ E KI DFG +R
Sbjct: 232 ESPALSYMDLVGFSYQVANGMEFLASKNCV---HRDLAARNVLICEGKLVKICDFGLARD 288
Query: 224 IAIDQTHVSTKVQGTF---GYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIW 279
I D ++S TF ++ PE ++ +T SDV+SFG++L E+ T G P +
Sbjct: 289 IMRDSNYISKG--STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346
Query: 280 ANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKE 339
NE ++ I R + A + ++ ++C RP +
Sbjct: 347 MNE---------------QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQ 391
Query: 340 VAMELERI 347
+ + +
Sbjct: 392 LVHLVGDL 399
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 9e-10
Identities = 56/198 (28%), Positives = 87/198 (43%), Gaps = 13/198 (6%)
Query: 84 GQGTVYKGML----ADGRIIA---VKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGC 136
G+GT K +L A GR A +KK +V + ++ + E +L H + L
Sbjct: 4 GKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS 63
Query: 137 CLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIY 196
+ V E+ G LF +L E + + E+ AL YLHS +
Sbjct: 64 FQTHDRLCFVMEYANGGELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEK--NVV 118
Query: 197 HRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKS 256
+RD+K N++LD+ KI DFG + D + T GT YL PE + +
Sbjct: 119 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYGRAV 177
Query: 257 DVYSFGVVLVELLTGQKP 274
D + GVV+ E++ G+ P
Sbjct: 178 DWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 5/100 (5%)
Query: 180 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF 239
+AE + + S L HRDIK N+LLD+ ++ADFG+ + D T S GT
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTP 167
Query: 240 GYLDPEYFRS-----SQFTDKSDVYSFGVVLVELLTGQKP 274
Y+ PE ++ ++ + D +S GV + E+L G+ P
Sbjct: 168 DYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 40/226 (17%)
Query: 73 YFNMNRILGQGGQGTV----YKGMLADGRIIAVKK-SKVVDESKL-EEFINEVVILSQI- 125
+ + + LGQG G V ++ +A+KK + V + L + + E+ +L
Sbjct: 1 RYELIKELGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELKLLRHFR 59
Query: 126 NHRNVVKLLGCCLEVEVP-------LLVYEFIPNGTLFQYLHD--PYEEL---SLTWEMR 173
H+N+ C ++++ L +YE + L Q + P + S +++
Sbjct: 60 GHKNIT----CLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQI- 114
Query: 174 LRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVST 233
L L Y+HS+ L HRD+K N+L++ KI DFG +R + + +
Sbjct: 115 LC-------GLKYIHSANVL---HRDLKPGNLLVNADCELKICDFGLARGFSENPGENAG 164
Query: 234 KVQG---TFGYLDPEYFRSSQ-FTDKSDVYSFGVVLVELLTGQKPI 275
+ T Y PE S Q +T DV+S G +L ELL G+KP+
Sbjct: 165 FMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 63/238 (26%), Positives = 97/238 (40%), Gaps = 42/238 (17%)
Query: 72 DYFNMNRILGQGGQGTVYKGMLAD-GRIIAVK---KSKVVDESKLEEFINEVVILSQINH 127
+F ++LG+G G V+ L G++ A+K K +++ +K++ + E IL+ ++H
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 128 RNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLH-DPYEELSLTWEMRLRI-ATEVAEALA 185
+ L LV ++ P G LF+ L P + LS E R A EV AL
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLS---EEVARFYAAEVLLALE 117
Query: 186 YLHSSAYLPIYHRDIKSTNILLDE-------------------KYRAKIADFGTSRSIAI 226
YLH +Y RD+K NILL E +K G+ RS
Sbjct: 118 YLHLLGI--VY-RDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174
Query: 227 DQTHVSTKVQ----------GTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
T + GT Y+ PE D ++ G++L E+L G P
Sbjct: 175 SIPS-ETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 19/205 (9%)
Query: 80 LGQGGQGTVYKGMLAD-GRIIAVK---KSKVVDESKLEEFINEVVILSQINHRNVVKLLG 135
+G+G G VY+ D RI A+K K ++V + ++ I E IL + ++G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 136 CCLEVEVP---LLVYEFIPNGTLFQYLHDP--YEELSLTWEMRLRIATEVAEALAYLHSS 190
+ LV +++ G LF +L + E + IA E+ AL +LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSED----RAKFYIA-ELVLALEHLHKY 115
Query: 191 AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSS 250
I +RD+K NILLD + DFG S++ D +T GT YL PE
Sbjct: 116 ---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT-FCGTTEYLAPEVLLDE 171
Query: 251 Q-FTDKSDVYSFGVVLVELLTGQKP 274
+ +T D +S GV++ E+ G P
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 52/205 (25%), Positives = 88/205 (42%), Gaps = 25/205 (12%)
Query: 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNIL 206
Y+ + + L D E LT L +VA + +L S + HRD+ + N+L
Sbjct: 214 YKGSNDSEVKNLLSDDGSE-GLTTLDLLSFTYQVARGMEFLASKNCV---HRDLAARNVL 269
Query: 207 LDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF---GYLDPEYFRSSQFTDKSDVYSFGV 263
L + KI DFG +R I D +VS TF ++ PE + +T SDV+S+G+
Sbjct: 270 LAQGKIVKICDFGLARDIMHDSNYVSKG--STFLPVKWMAPESIFDNLYTTLSDVWSYGI 327
Query: 264 VLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDV 322
+L E+ + G P + I ++ ++ I R + V D+
Sbjct: 328 LLWEIFSLGGTPYPGM---------------IVDSTFYNKIKSGYRMAKPDHATQEVYDI 372
Query: 323 AKRCLNSYGRNRPTMKEVAMELERI 347
+C NS RP+ ++ +E +
Sbjct: 373 MVKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 51/217 (23%), Positives = 92/217 (42%), Gaps = 35/217 (16%)
Query: 78 RILGQGGQGTVYKGM-LADGRIIAVKK-SKVVDESKL-EEFINEVVILSQINHRNVVKLL 134
+G G G V + G+ +A+KK D L + + E+ IL H N++ +
Sbjct: 11 ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIR 70
Query: 135 GCCLEVEVPLLVYEFIPNGTLFQ--YL----------HDPYEELSLTWEMRLRIATEVAE 182
P G F+ Y+ H + + LT E ++
Sbjct: 71 DI------------LRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLR 118
Query: 183 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA---IDQTHVSTKVQGTF 239
L Y+HS+ + HRD+K +N+L++E +I DFG +R ++ + + T+ T
Sbjct: 119 GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175
Query: 240 GYLDPE-YFRSSQFTDKSDVYSFGVVLVELLTGQKPI 275
Y PE ++T D++S G + E+L G++ +
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 39/117 (33%), Positives = 61/117 (52%), Gaps = 5/117 (4%)
Query: 168 LTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227
LT E + + +VA+ + +L S + HRD+ + NILL E KI DFG +R I D
Sbjct: 176 LTLEDLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSENNVVKICDFGLARDIYKD 232
Query: 228 QTHVST-KVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANE 282
+V + ++ PE +T +SDV+SFGV+L E+ + G P + +E
Sbjct: 233 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 289
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 36/102 (35%), Positives = 50/102 (49%), Gaps = 10/102 (9%)
Query: 184 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 243
L YLHS+ I HRDIK N+L++ KI DFG +R D++ T+ T Y
Sbjct: 116 LKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRA 172
Query: 244 PEYFRSSQ-FTDKSDVYSFGVVLVELLTG------QKPISSI 278
PE S+ +T D++S G + ELL Q PI +
Sbjct: 173 PEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQL 214
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 4e-09
Identities = 60/242 (24%), Positives = 101/242 (41%), Gaps = 44/242 (18%)
Query: 74 FNMNRILGQGGQGTVYKGMLAD-GRIIAVK---KSKVVDESKLEEFINEVVILSQINHRN 129
F +++G+G G V D G + A+K K+ ++++ ++ E IL + +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS 189
VVK+ + L+ EF+P G + L ++ +LT E E A+ +H
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLL---MKKDTLTEEETQFYIAETVLAIDSIHQ 119
Query: 190 SAYLPIYHRDIKSTNILLDEKYRAKIADFG----------------TSRSIAIDQT---- 229
++ HRDIK N+LLD K K++DFG + S+ D T
Sbjct: 120 LGFI---HRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176
Query: 230 --------------HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPI 275
++ GT Y+ PE F + + D +S GV++ E+L G P
Sbjct: 177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 276 SS 277
S
Sbjct: 237 CS 238
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 7e-09
Identities = 54/210 (25%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 74 FNMNRILGQGGQGTVYKGMLADG-RIIAVK---KSKVVDESKLEEFINEVVILSQINHRN 129
F + +++G+G G V L + ++ A+K K +++ ++ F E +L +++
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS 189
+ L + LV ++ G L L +E+ L +M E+ A+ +H
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLL-SKFED-RLPEDMARFYLAEMVIAIDSVHQ 120
Query: 190 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRS 249
Y+ HRDIK NIL+D ++ADFG+ + D T S+ GT Y+ PE ++
Sbjct: 121 LHYV---HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 250 -----SQFTDKSDVYSFGVVLVELLTGQKP 274
++ + D +S GV + E+L G+ P
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 8e-09
Identities = 31/104 (29%), Positives = 54/104 (51%), Gaps = 21/104 (20%)
Query: 179 EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGT 238
++ L Y+HS+ + HRD+K +NIL++E KI DFG +R I ++
Sbjct: 116 QILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR---IQDPQMT------ 163
Query: 239 FGYLDPEYFRSSQ-------FTDKSDVYSFGVVLVELLTGQKPI 275
GY+ Y+R+ + + + D++S G + E+L G KP+
Sbjct: 164 -GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPL 205
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 1e-08
Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 37/214 (17%)
Query: 73 YFNMNRILGQGGQGTV---YKGMLADGRIIAVKK--SKVVDESKLEEFINEVVILSQINH 127
Y N+ I G G QG V Y +L R +A+KK +++ + E+V++ +NH
Sbjct: 19 YQNLKPI-GSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 128 RNVVKLLGCCLEVEVPLLVYEFIPNGTL--FQ--YLHDPYEELSLTWEMRLRIATEVAEA 183
+N++ LL F P +L FQ YL + +L +++ + E
Sbjct: 76 KNIISLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSY 123
Query: 184 LAY--------LHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKV 235
L Y LHS+ I HRD+K +NI++ KI DFG +R+ + + T
Sbjct: 124 LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPY 178
Query: 236 QGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELL 269
T Y PE + + D++S G ++ E++
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 51/202 (25%), Positives = 93/202 (46%), Gaps = 9/202 (4%)
Query: 74 FNMNRILGQGGQGTVYKGMLADGR-IIAVKKSKVVDESK--LEEFINEVVILSQINHRNV 130
F + ++G+G G V K + + I+A+KK K +E++ E + E+ +L + N+
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62
Query: 131 VKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSS 190
V+L LV+E++ L + EE+ ++ + + + + +H
Sbjct: 63 VELKEAFRRRGKLYLVFEYVEKNML-----ELLEEMP-NGVPPEKVRSYIYQLIKAIHWC 116
Query: 191 AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSS 250
I HRDIK N+L+ K+ DFG +R+++ T+ T Y PE +
Sbjct: 117 HKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA 176
Query: 251 QFTDKSDVYSFGVVLVELLTGQ 272
+ D++S G +L EL GQ
Sbjct: 177 PYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 59/232 (25%), Positives = 103/232 (44%), Gaps = 38/232 (16%)
Query: 61 IFNSKELDKA-----TDYFNMNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKL-- 112
F +EL+K Y N++ + G G G+V G +AVKK +S +
Sbjct: 2 TFYRQELNKTIWEVPERYQNLSPV-GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 60
Query: 113 EEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYL-----HDPYEELS 167
+ E+ +L + H NV+ LL +V P E + L +L ++ +
Sbjct: 61 KRTYRELRLLKHMKHENVIGLL----DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 116
Query: 168 LTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227
LT + + ++ L Y+HS+ I HRD+K +N+ ++E KI DFG +R +
Sbjct: 117 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 173
Query: 228 QTHVSTKVQGTFGYLDPEYFRSSQ-------FTDKSDVYSFGVVLVELLTGQ 272
T GY+ ++R+ + + D++S G ++ ELLTG+
Sbjct: 174 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 36/98 (36%), Positives = 55/98 (56%), Gaps = 10/98 (10%)
Query: 183 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS---TKVQGTF 239
AL Y+H++ ++HRD+K NIL + + KI DFG +R +A + T + T T
Sbjct: 115 ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLAR-VAFNDTPTAIFWTDYVATR 170
Query: 240 GYLDPEYFRS--SQFTDKSDVYSFGVVLVELLTGQKPI 275
Y PE S S++T D++S G + E+LTG KP+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPL 207
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 61/222 (27%), Positives = 102/222 (45%), Gaps = 55/222 (24%)
Query: 80 LGQGGQGTVYKGMLADGRI---IAVKKSKVVDESKL--EEFINEVVILSQINHRNVVKLL 134
+G G GTV + D R +A+KK +S+L + E+ +L + H NV+ LL
Sbjct: 23 VGSGAYGTVCSAL--DRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 135 GCCLEVEVPLLVYEFIPNGTLFQYLHDPY----------------EELSLTWEMRLR-IA 177
F P+ +L ++ HD Y E+LS E R++ +
Sbjct: 81 DV------------FTPDLSLDRF-HDFYLVMPFMGTDLGKLMKHEKLS---EDRIQFLV 124
Query: 178 TEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQG 237
++ + L Y+H++ I HRD+K N+ ++E KI DFG +R +++ G
Sbjct: 125 YQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-------QTDSEMTG 174
Query: 238 ---TFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPI 275
T Y PE + +T D++S G ++ E+LTG KP+
Sbjct: 175 YVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG-KPL 215
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 44/162 (27%), Positives = 67/162 (41%), Gaps = 17/162 (10%)
Query: 116 INEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMR-- 173
E IL INH ++++L G + L+ L +Y D Y L+ +
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLI--------LPRYKTDLYCYLAAKRNIAIC 182
Query: 174 --LRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS-RSIAIDQTH 230
L I V A+ YLH + I HRDIK+ NI ++ + DFG + + I+
Sbjct: 183 DILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239
Query: 231 VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQ 272
GT PE + D++S G+VL E+ T
Sbjct: 240 YYGWA-GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 4e-08
Identities = 53/203 (26%), Positives = 83/203 (40%), Gaps = 16/203 (7%)
Query: 80 LGQGGQGTVYKGMLADGRIIA---VKKSKVVDESK-LEEFINEVVILSQINHRNVVKLLG 135
+G G G V + +A VK+ K SK EF+ + + H N+++ LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 136 CCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRL-RIATEVAEALAYLHSSAYLP 194
C+E LLV+E+ G L YL + + L R+A E+A + ++H +L
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFL- 121
Query: 195 IYHRDIKSTNILLDEKYRAKIADFGTSRS-IAIDQTHVSTKVQGTFGYLDPEYFRS---- 249
H D+ N L K+ D+G S D +L PE
Sbjct: 122 --HSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGG 179
Query: 250 ---SQFTDKSDVYSFGVVLVELL 269
++ T S+V++ GV L EL
Sbjct: 180 LITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 5e-08
Identities = 55/217 (25%), Positives = 97/217 (44%), Gaps = 37/217 (17%)
Query: 73 YFNMNRILGQGGQGTV---YKGMLADGRIIAVKK--SKVVDESKLEEFINEVVILSQINH 127
Y N+ I G G QG V Y +L R +A+KK +++ + E+V++ +NH
Sbjct: 26 YQNLKPI-GSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 128 RNVVKLLGCCLEVEVPLLVYEFIPNGTL--FQYLHDPYE----------ELSLTWEMRLR 175
+N++ LL F P +L FQ ++ E ++ L E
Sbjct: 83 KNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY 130
Query: 176 IATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKV 235
+ ++ + +LHS+ I HRD+K +NI++ KI DFG +R+ + + T
Sbjct: 131 LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPY 185
Query: 236 QGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQ 272
T Y PE + + D++S G ++ E++ G
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 8e-08
Identities = 51/202 (25%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 80 LGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFINEVV------ILSQINHRNVVK 132
LG+GG G V + + G++ A KK +D+ +L++ E + IL ++N +V
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKK---LDKKRLKKKSGEKMALLEKEILEKVNSPFIVN 57
Query: 133 LLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAY 192
L E + L + + NG +Y E L E + + ++ + +LHS
Sbjct: 58 L-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS--- 113
Query: 193 LPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQF 252
+ I +RD+K N+LLD++ +++D G + + + T+ GT GY+ PE + +
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKEEPY 171
Query: 253 TDKSDVYSFGVVLVELLTGQKP 274
+ D ++ G + E++ G+ P
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 9e-08
Identities = 50/197 (25%), Positives = 80/197 (40%), Gaps = 30/197 (15%)
Query: 96 GRIIAVKKSKV--VDESKLEEFINEVVILSQINHRNVVKL-----LGCCLEVEVPLLVYE 148
G ++ V+ + + E L+ NEVV+ H N++ G L V P + Y
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY- 83
Query: 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD 208
G+ L + E ++ + I L YLH + Y+ HR+IK+++IL+
Sbjct: 84 ----GSANSLLKTYFPE-GMSEALIGNILFGALRGLNYLHQNGYI---HRNIKASHILIS 135
Query: 209 EKYRAKIADF---------GTSRSIAIDQTHVSTKVQGTFGYLDPEYFRS--SQFTDKSD 257
++ G + D ST V +L PE R + KSD
Sbjct: 136 GDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP---WLSPELLRQDLYGYNVKSD 192
Query: 258 VYSFGVVLVELLTGQKP 274
+YS G+ EL TG+ P
Sbjct: 193 IYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-07
Identities = 46/174 (26%), Positives = 69/174 (39%), Gaps = 22/174 (12%)
Query: 129 NVVKLLGCCLEVEVPLLVYEFIPNGTLFQY----LHDPYEELSLTWEMRLRIATEVAEAL 184
N+V L + + LV + G L+ + L+ P EE W A E+ AL
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIP-EECVKRW------AAEMVVAL 98
Query: 185 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA--IDQTHVSTKVQGTFGYL 242
LH I RD+ NILLD++ ++ F + D V Y
Sbjct: 99 DALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YC 149
Query: 243 DPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEE 296
PE S+ T+ D +S G +L ELLTG+ + + + T E + E
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSE 203
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 35/93 (37%), Positives = 52/93 (55%), Gaps = 6/93 (6%)
Query: 184 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 243
L Y+HS+ L HRD+K +N+LL+ KI DFG +R+ + ++ V T Y
Sbjct: 121 LKYIHSANVL---HRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRA 176
Query: 244 PE-YFRSSQFTDKSDVYSFGVVLVELLTGQKPI 275
PE S++T DV+S G + ELL G+KP+
Sbjct: 177 PELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 1e-07
Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 33/218 (15%)
Query: 80 LGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLE-EFINEVVILSQINHRNVVKLLGCCL 138
+G+G G VYK DG+ K ++ + + E+ +L ++ H NV+ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIAL----- 63
Query: 139 EVEVPLLVYEFIPNGTLFQYL-HDPY-------------EELSLTWEMRLRIATEVAEAL 184
+ L + LF Y HD + + + L M + ++ + +
Sbjct: 64 --QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 185 AYLHSSAYLPIYHRDIKSTNILL----DEKYRAKIADFGTSRSIAIDQTHVST--KVQGT 238
YLH++ L HRD+K NIL+ E+ R KIAD G +R ++ V T
Sbjct: 122 HYLHANWVL---HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178
Query: 239 FGYLDPEYFRSSQ-FTDKSDVYSFGVVLVELLTGQKPI 275
F Y PE ++ +T D+++ G + ELLT + PI
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PI 215
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 55/222 (24%), Positives = 99/222 (44%), Gaps = 47/222 (21%)
Query: 73 YFNMNRILGQGGQGTV---YKGMLADGRIIAVKK--SKVVDESKLEEFINEVVILSQINH 127
Y N+ + +G G QG V Y + G+ +A+KK + + + E+V++ +NH
Sbjct: 18 YQNL-KPIGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNH 74
Query: 128 RNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWE-----------MRL-- 174
+N++ LL F P +L + ++++ L E M L
Sbjct: 75 KNIIGLLNV------------FTPQKSL-----EEFQDVYLVMELMDANLCQVIQMDLDH 117
Query: 175 -RIATEVAEALA---YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230
R++ + + L +LHS+ I HRD+K +NI++ KI DFG +R A
Sbjct: 118 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFM 173
Query: 231 VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQ 272
++ V T Y PE + + D++S G ++ E++ G
Sbjct: 174 MTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 54/218 (24%), Positives = 102/218 (46%), Gaps = 32/218 (14%)
Query: 80 LGQGGQGTVYKGMLA-----DGRIIAVKKS-----KVVDESKLE---EFINEVVILSQIN 126
LG+G + +Y G+L + + +K KV+D S + F ++ Q++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 127 HRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAY 186
H+++V L G C+ ++V EF+ G L ++H + L+ W + ++A ++A AL+Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120
Query: 187 LHSSAYLPIYHRDIKSTNILL-----DEKYRA--KIADFGTSRSIAIDQTHVSTKVQGTF 239
L + H ++ + NILL D + K++D G ++ Q V
Sbjct: 121 LEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE-----RI 172
Query: 240 GYLDPEYFRSSQ-FTDKSDVYSFGVVLVEL-LTGQKPI 275
++ PE S+ + +D +SFG L E+ G+ P+
Sbjct: 173 PWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPL 210
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 43/155 (27%), Positives = 74/155 (47%), Gaps = 14/155 (9%)
Query: 74 FNMNRILGQGGQGTVYKGMLA-DGRIIAVK---KSKVVDESKLEEFINEVVILSQINHRN 129
F + + + +G G VY G + ++ AVK K+ +++++ + + E L+
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYLH--DPYEELSLTWEMRLRIATEVAEALAYL 187
+V L LV E++ G + LH ++E EM ++ +EVA AL YL
Sbjct: 66 IVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDE-----EMAVKYISEVALALDYL 120
Query: 188 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 222
H I HRD+K N+L+ + K+ DFG S+
Sbjct: 121 HRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 5e-07
Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 33/218 (15%)
Query: 80 LGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLE-EFINEVVILSQINHRNVVKLLGCCL 138
+G+G G VYK DG+ K ++ + + E+ +L ++ H NV+ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISL----- 63
Query: 139 EVEVPLLVYEFIPNGTLFQYL-HDPY-------------EELSLTWEMRLRIATEVAEAL 184
+ L + LF Y HD + + + L M + ++ + +
Sbjct: 64 --QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 185 AYLHSSAYLPIYHRDIKSTNILL----DEKYRAKIADFGTSRSIAIDQTHVST--KVQGT 238
YLH++ L HRD+K NIL+ E+ R KIAD G +R ++ V T
Sbjct: 122 HYLHANWVL---HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178
Query: 239 FGYLDPEYFRSSQ-FTDKSDVYSFGVVLVELLTGQKPI 275
F Y PE ++ +T D+++ G + ELLT + PI
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 7e-07
Identities = 58/224 (25%), Positives = 95/224 (42%), Gaps = 34/224 (15%)
Query: 74 FNMNRILGQGGQGTVYKGMLADGR----IIAVKKSKVVDESKLEEFINEVVILSQINHRN 129
F +++ G G VY + R + + K ++ +++++ E IL+ +
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62
Query: 130 VVKLLGCCLEVEVPL-LVYEFIPNG---TLFQYLHDPYEELSLTWEM-RLRIATEVAEAL 184
VV + C E + L +V E++ G TL + + +L +M R+ A E AL
Sbjct: 63 VVSMF-CSFETKRHLCMVMEYVEGGDCATLLKNIG------ALPVDMARMYFA-ETVLAL 114
Query: 185 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR-------------SIAIDQTHV 231
YLH+ I HRD+K N+L+ K+ DFG S+ I D
Sbjct: 115 EYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREF 171
Query: 232 STK-VQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
K V GT Y+ PE + D ++ G++L E L G P
Sbjct: 172 LDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 8e-07
Identities = 53/218 (24%), Positives = 86/218 (39%), Gaps = 52/218 (23%)
Query: 101 VKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYL- 159
++K+ V+ ++ E IL++ ++ VVKL + + V ++IP G + L
Sbjct: 34 LRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI 93
Query: 160 -HDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADF 218
+EE L R IA E+ A+ +H ++ HRDIK NIL+D K+ DF
Sbjct: 94 RLGIFEE-DLA---RFYIA-ELTCAIESVHKMGFI---HRDIKPDNILIDRDGHIKLTDF 145
Query: 219 G-----------------------------------TSRSIAIDQTHV--STKVQ----- 236
G R +++ +
Sbjct: 146 GLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLV 205
Query: 237 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
GT Y+ PE + +T D +S GV+L E+L GQ P
Sbjct: 206 GTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 50/226 (22%), Positives = 83/226 (36%), Gaps = 64/226 (28%)
Query: 101 VKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLH 160
++K V++ +++ E IL++ ++ VVKL + + V ++IP G + L
Sbjct: 34 LRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL- 92
Query: 161 DPYEELSLTWEMRLRIATE------VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAK 214
+R+ + E +AE + S + HRDIK NIL+D K
Sbjct: 93 -----------IRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIK 141
Query: 215 IADFG----------------------------------------------TSRSIAIDQ 228
+ DFG R+ Q
Sbjct: 142 LTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQ 201
Query: 229 THVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
++ + GT Y+ PE +T D +S GV+L E+L GQ P
Sbjct: 202 RCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 56/232 (24%), Positives = 99/232 (42%), Gaps = 44/232 (18%)
Query: 80 LGQGGQGTVYKGML-----------------------ADGRIIAVKKSKVVDESKLE--- 113
LGQG + +Y G L +GR + V KV+D S +
Sbjct: 3 LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVV-LKVLDPSHRDIAL 61
Query: 114 EFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMR 173
F ++SQ++H ++ + G C+ ++V EF+ +G L L + + W++
Sbjct: 62 AFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKI- 120
Query: 174 LRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVST 233
+A ++A AL+YL + H ++ + NILL R +A+ GTS I + VS
Sbjct: 121 -TVAQQLASALSYLEDKN---LVHGNVCAKNILLA---RLGLAE-GTSPFIKLSDPGVSF 172
Query: 234 KVQG------TFGYLDPEYFRS-SQFTDKSDVYSFGVVLVEL-LTGQKPISS 277
++ PE + + +D +SFG L+E+ G+ P+
Sbjct: 173 TALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE 224
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 6e-06
Identities = 57/253 (22%), Positives = 94/253 (37%), Gaps = 68/253 (26%)
Query: 78 RILGQGGQGTVYKGMLADGRII----AVKKSKVVDESKLEEFINEVVILSQINHRNVVKL 133
+ LG G G V D + + ++K V+ +++ E IL++ ++ VV+L
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 134 LGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATE------VAEALAYL 187
+ + V ++IP G + L +R+ I E +AE +
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLL------------IRMGIFPEDLARFYIAELTCAV 114
Query: 188 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS------------------RSIAID-- 227
S + HRDIK NIL+D K+ DFG R ++D
Sbjct: 115 ESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFS 174
Query: 228 --------------------------QTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSF 261
Q ++ + GT Y+ PE + +T D +S
Sbjct: 175 NEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234
Query: 262 GVVLVELLTGQKP 274
GV+L E+L GQ P
Sbjct: 235 GVILYEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 9e-06
Identities = 40/167 (23%), Positives = 76/167 (45%), Gaps = 29/167 (17%)
Query: 118 EVVILSQINHRNVVKLLGCCLEVEVPLLVYE-----FIPNGTLFQYLHDPYEELSLTWEM 172
E+ +L + H NV+ LL +V P E ++ + L++ + L+ E
Sbjct: 64 ELRLLKHMKHENVIGLL----DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEH 119
Query: 173 RLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 232
+ ++ L Y+HS+ I HRD+K +N+ ++E +I DFG +R + T
Sbjct: 120 VQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT--- 173
Query: 233 TKVQGTFGYLDPEYFRSSQ-------FTDKSDVYSFGVVLVELLTGQ 272
GY+ ++R+ + + D++S G ++ ELL G+
Sbjct: 174 -------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-05
Identities = 36/147 (24%), Positives = 60/147 (40%), Gaps = 15/147 (10%)
Query: 78 RILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVV--KLLG 135
++L G VY D + +K + K + EV IL + + + K+L
Sbjct: 4 KLLKGGLTNRVYLLGTKDEDYV-LKINP--SREKGADREREVAILQLLARKGLPVPKVLA 60
Query: 136 CCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPI 195
L+ E+I TL + ++ E + IA ++AE LA LH L +
Sbjct: 61 SGESDGWSYLLMEWIEGETLDE----------VSEEEKEDIAEQLAELLAKLHQLPLLVL 110
Query: 196 YHRDIKSTNILLDEKYRAKIADFGTSR 222
H D+ NIL+D+ I D+ +
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYAG 137
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 60/254 (23%), Positives = 92/254 (36%), Gaps = 70/254 (27%)
Query: 72 DYFNMNRILGQGGQGTVYKGMLAD-----GRIIAVKKSKVVDESKLEEFINEVVILSQIN 126
D F + + LG+G G VYK L + +KK+ + +E ++NE V +
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKAT--EYGAVEIWMNERV---RRA 186
Query: 127 HRN-VVKLLGCCLEV-----EVPL-LVYEFIPNGTLFQYLHD---PY--EEL-------- 166
N + LE E LV+ + TL + PY E
Sbjct: 187 CPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDL 246
Query: 167 --SLTWEMRL--RIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA-KIADFGTS 221
L E ++ I ++ AL LHS+ I HRD+K NI+ E + KI D G
Sbjct: 247 PKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLG-- 301
Query: 222 RSIAIDQTHVSTKVQGTFGYLDP------EYFRSSQ---------------------FTD 254
A V LDP +Y S+Q D
Sbjct: 302 ---AAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD 358
Query: 255 KSDVYSFGVVLVEL 268
+ D+YS G++ +++
Sbjct: 359 RFDIYSAGLIFLQM 372
|
Length = 566 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 33/129 (25%), Positives = 52/129 (40%), Gaps = 27/129 (20%)
Query: 160 HDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD----------- 208
H P+ L +I + AL Y H+ +L H D+K NIL++
Sbjct: 225 HGPFSHRHLA-----QIIFQTGVALDYFHTELHL--MHTDLKPENILMETSDTVVDPVTN 277
Query: 209 -----EKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGV 263
+ R +I D G D+ H T + T Y PE + +D++S G
Sbjct: 278 RALPPDPCRVRICDLGG----CCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGC 333
Query: 264 VLVELLTGQ 272
++ EL TG+
Sbjct: 334 IIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 9e-05
Identities = 54/211 (25%), Positives = 86/211 (40%), Gaps = 44/211 (20%)
Query: 74 FNMNRILGQGGQGTVYKGMLAD--GRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVV 131
F ++R L G +G V++ D R++ VK +E +L +++H V+
Sbjct: 171 FAIHRALTPGSEGCVFESSHPDYPQRVV-VKAGWYASSV------HEARLLRRLSHPAVL 223
Query: 132 KLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLR---------IATEVAE 182
LL + + LV L +Y D Y L RLR +A ++
Sbjct: 224 ALLDVRVVGGLTCLV--------LPKYRSDLYTYLG----ARLRPLGLAQVTAVARQLLS 271
Query: 183 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGT------SRSIAIDQTHVSTKVQ 236
A+ Y+H I HRDIK+ N+L++ + DFG S S T +
Sbjct: 272 AIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS-----TPFHYGIA 323
Query: 237 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLVE 267
GT PE +T D++S G+V+ E
Sbjct: 324 GTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 36/113 (31%), Positives = 49/113 (43%), Gaps = 9/113 (7%)
Query: 72 DYFNMNRILGQGGQGTVYK------GMLADGRIIAVKKSKV-VDESKLEEFINEVVILSQ 124
D + + LG+G G V + A R +AVK K S+ + + E+ IL
Sbjct: 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIH 66
Query: 125 I-NHRNVVKLLGCCLEVEVPLLV-YEFIPNGTLFQYLHDPYEELSLTWEMRLR 175
I +H NVV LLG C + PL+V E+ G L YL E S R
Sbjct: 67 IGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTR 119
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 8e-04
Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 34/218 (15%)
Query: 76 MNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVI-------------- 121
+++++G GG G VY+ A I + ++ + E + E ++
Sbjct: 16 IDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWK 75
Query: 122 -LSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEEL---SLTWEMRL--R 175
+ I+H + K GC + + Y FI L + L + +E+ +L
Sbjct: 76 NIHNIDHLGIPKYYGCG-SFKRCRMYYRFI----LLEKLVENTKEIFKRIKCKNKKLIKN 130
Query: 176 IATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS-TK 234
I ++ L Y+H I H DIK NI++D R I D+G + I H+ +K
Sbjct: 131 IMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSK 187
Query: 235 VQ-----GTFGYLDPEYFRSSQFTDKSDVYSFGVVLVE 267
Q GT Y + + T + D+ S G +++
Sbjct: 188 EQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 34/97 (35%), Positives = 45/97 (46%), Gaps = 9/97 (9%)
Query: 72 DYFNMNRILGQGGQGTVYKG------MLADGRIIAVKKSKV-VDESKLEEFINEVVILSQ 124
D + + LG+G G V + A R +AVK K S+ ++E+ IL
Sbjct: 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 66
Query: 125 INHR-NVVKLLGCCLEVEVPLLV-YEFIPNGTLFQYL 159
I H NVV LLG C + PL+V EF G L YL
Sbjct: 67 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYL 103
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 50/194 (25%), Positives = 82/194 (42%), Gaps = 34/194 (17%)
Query: 112 LEEFINEVVILSQ--------INHRNVVKLLGCCLEVEVPLLVYEFIPNGT----LFQYL 159
LE NE+V Q NH N+V + +V F+ G+ + +
Sbjct: 35 LEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHF 94
Query: 160 HDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNIL--LDEK-----YR 212
D EL++ + I V +AL Y+H Y+ HR +K+++IL +D K R
Sbjct: 95 MDGMSELAIAY-----ILQGVLKALDYIHHMGYV---HRSVKASHILISVDGKVYLSGLR 146
Query: 213 AKIA--DFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSS--QFTDKSDVYSFGVVLVEL 268
+ ++ + G + D S KV +L PE + + + KSD+YS G+ EL
Sbjct: 147 SNLSMINHGQRLRVVHDFPKYSVKV---LPWLSPEVLQQNLQGYDAKSDIYSVGITACEL 203
Query: 269 LTGQKPISSIWANE 282
G P + A +
Sbjct: 204 ANGHVPFKDMPATQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 374 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.89 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.88 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.87 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.85 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.83 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.8 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.78 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.77 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.76 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.71 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.7 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.68 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.64 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.59 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.55 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.55 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.55 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.41 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.39 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.38 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.31 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.29 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.29 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.29 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.27 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.15 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.11 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.09 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.06 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.03 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.95 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.74 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.72 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.72 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.69 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.54 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.53 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.48 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.41 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.38 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.33 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.3 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.18 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.11 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.98 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.96 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.93 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.85 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.82 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.8 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.69 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.67 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.62 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.53 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.46 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.43 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.42 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.39 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.36 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.31 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.27 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.09 | |
| PLN02236 | 344 | choline kinase | 96.91 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.87 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.78 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.53 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.32 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.28 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.25 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.73 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.68 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.68 | |
| PF02439 | 38 | Adeno_E3_CR2: Adenovirus E3 region protein CR2; In | 95.14 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.04 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.99 | |
| PTZ00296 | 442 | choline kinase; Provisional | 94.27 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.01 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 93.99 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-55 Score=397.57 Aligned_cols=291 Identities=45% Similarity=0.716 Sum_probs=256.4
Q ss_pred cceecChHHHHHhhcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeee
Q 017262 58 RCRIFNSKELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCC 137 (374)
Q Consensus 58 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~ 137 (374)
..+.|+..++..+|++|...+.||+|+||.||+|...+|..||||++.........+|.+|++++.+++|||+++++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56779999999999999999999999999999999999999999988765443145599999999999999999999999
Q ss_pred eecc-cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEe
Q 017262 138 LEVE-VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIA 216 (374)
Q Consensus 138 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~ 216 (374)
.+.+ ..++|+||+++|+|.++|...... .++|..+++|+.++|+||+|||+...++|+||||||+|||+|+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9988 599999999999999999874333 89999999999999999999999987889999999999999999999999
Q ss_pred ecccccccccCCceeeecc-cccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHH
Q 017262 217 DFGTSRSIAIDQTHVSTKV-QGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIE 295 (374)
Q Consensus 217 Dfg~~~~~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 295 (374)
|||+++...... ...... .||.+|+|||++..+..+.|+||||||++++||++|+.|...........+.+|....+.
T Consensus 220 DFGLa~~~~~~~-~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 220 DFGLAKLGPEGD-TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred CccCcccCCccc-cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 999996543211 112222 799999999999999999999999999999999999998876554555669999999999
Q ss_pred hcccccccccccc-CCCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 017262 296 ENCLFDIIDDQVR-KSGEA-EEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350 (374)
Q Consensus 296 ~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~ 350 (374)
...+.+++|+.+. ..++. .....+..++.+|++.+|++||+|.+|+++|+.+...
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 9999999999987 55554 6778899999999999999999999999999776543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-52 Score=361.30 Aligned_cols=250 Identities=26% Similarity=0.389 Sum_probs=211.7
Q ss_pred CCCcCceEeeeCeEEEEEEEec-CCcEEEEEEecc-CChhHHHHHHHHHHHHhhCCCCceeeeeeeeeeccc-ceEEEEe
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV-VDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEV-PLLVYEF 149 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~lv~e~ 149 (374)
+.+..+.||+|..|+||++.++ +++.+|+|.+.. .++...+++.+|+++++..+|||||.++|+|.+... ..++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 4566688999999999999976 578899998854 456677899999999999999999999999999984 9999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS-SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
|++|+|+.++.. .+.+++....+++.++++||.|||+ .+ |+||||||+|+|++..|.+||||||.+..+..+
T Consensus 160 MDgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred cCCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 999999999984 4679999999999999999999996 66 999999999999999999999999999887543
Q ss_pred ceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccccc
Q 017262 229 THVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVR 308 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (374)
......||..|||||.+.+..|+.++||||||+.++|+.+|+.||..... ....+.+.+.....+ ..
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~-~~~~~~~Ll~~Iv~~----------pp 299 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP-PYLDIFELLCAIVDE----------PP 299 (364)
T ss_pred --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC-CCCCHHHHHHHHhcC----------CC
Confidence 55677899999999999999999999999999999999999999986521 112222222222211 11
Q ss_pred CCCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 309 KSGEA-EEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 309 ~~~~~-~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
...+. ..++++++++..||+.||.+|||++++++
T Consensus 300 P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 300 PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 22233 36778999999999999999999999987
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-51 Score=370.90 Aligned_cols=265 Identities=36% Similarity=0.561 Sum_probs=220.8
Q ss_pred CCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCC--hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc-cceEEEEee
Q 017262 74 FNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVD--ESKLEEFINEVVILSQINHRNVVKLLGCCLEVE-VPLLVYEFI 150 (374)
Q Consensus 74 ~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~ 150 (374)
..+.+.||+|+||+||+|.++....||+|.+.... ......|.+|+.+|.+++|||||+++|+|.+.. ..++||||+
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 44556699999999999999866669999887643 222568999999999999999999999999887 789999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCC-cEEEeecccccccccCCc
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY-RAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~~~ 229 (374)
++|+|.+++... ....+++..++.++.+|++||.|||+.+. |+||||||+|+|++.++ ++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 999999999864 36789999999999999999999999983 99999999999999998 99999999998765322
Q ss_pred eeeecccccccccCccccc--cCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccc
Q 017262 230 HVSTKVQGTFGYLDPEYFR--SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (374)
...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||...... .... ..+....
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~------~~~~---------~v~~~~~ 263 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV------QVAS---------AVVVGGL 263 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH------HHHH---------HHHhcCC
Confidence 2333367999999999999 568999999999999999999999999865431 1111 2222334
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCCCcch
Q 017262 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDDENN 357 (374)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~~~~~ 357 (374)
+...+...+..+..|+.+||..||+.||++.+++..|+.+..........
T Consensus 264 Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~~~~ 313 (362)
T KOG0192|consen 264 RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSAGPE 313 (362)
T ss_pred CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcccCcc
Confidence 44445557778999999999999999999999999999998866644333
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-51 Score=371.71 Aligned_cols=257 Identities=32% Similarity=0.506 Sum_probs=227.3
Q ss_pred CCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeecCC
Q 017262 74 FNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNG 153 (374)
Q Consensus 74 ~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 153 (374)
+...+.||+|.||.||.|.++....||+|.++.... ..+.|.+|+++|++|+|+|||+++++|..++..+||||||+.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 445678999999999999998888999998877533 3367889999999999999999999999988999999999999
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceeee
Q 017262 154 TLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVST 233 (374)
Q Consensus 154 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 233 (374)
+|.+||... .+..+...+.+.++.|||+|++||++++ +|||||.++||||++++.+||+|||+++...++......
T Consensus 287 sLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~ 362 (468)
T KOG0197|consen 287 SLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE 362 (468)
T ss_pred cHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence 999999863 4678899999999999999999999999 999999999999999999999999999965555555555
Q ss_pred cccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCC
Q 017262 234 KVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGE 312 (374)
Q Consensus 234 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (374)
...-+..|.|||.+..+.+|.||||||||++||||+| |+.||+.....+ +.+.++.+.+...|
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e----------------v~~~le~GyRlp~P 426 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE----------------VLELLERGYRLPRP 426 (468)
T ss_pred CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH----------------HHHHHhccCcCCCC
Confidence 5556778999999999999999999999999999999 999998765443 34556677777888
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhC
Q 017262 313 AEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANS 351 (374)
Q Consensus 313 ~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~ 351 (374)
..+|..+.+++..||..+|++|||++.+...|+.+....
T Consensus 427 ~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 427 EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 899999999999999999999999999999999886543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=369.30 Aligned_cols=247 Identities=26% Similarity=0.423 Sum_probs=214.8
Q ss_pred cCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEecc---CChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKV---VDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
.+|...+.||+|+|+++|.++. ..|..||+|++.. ......+.+.+|+++.++|+|||||+++++|++.++.|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999997 7799999998765 34666788999999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
|+|+.++|.++++ ....+++.+++.++.||+.||.|||+++ |+|||||..|+|++++.++||+|||+|..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999998 5678999999999999999999999999 999999999999999999999999999988754
Q ss_pred CceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (374)
. ....+..|||.|.|||++....++..+||||+||+||-|++|++||+.. .+.+-+......+
T Consensus 172 ~-Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk------~vkety~~Ik~~~---------- 234 (592)
T KOG0575|consen 172 G-ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK------TVKETYNKIKLNE---------- 234 (592)
T ss_pred c-cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc------hHHHHHHHHHhcC----------
Confidence 3 4456678999999999999999999999999999999999999999642 2222222222111
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
-..|...+....+||.++|+.||.+|||+++|+.
T Consensus 235 -Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 235 -YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred -cccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1123355567889999999999999999999986
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-51 Score=354.48 Aligned_cols=253 Identities=27% Similarity=0.390 Sum_probs=206.7
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCCh-------hHHHHHHHHHHHHhhCCCCceeeeeeeeeecc
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDE-------SKLEEFINEVVILSQINHRNVVKLLGCCLEVE 141 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 141 (374)
..+.|.+.+.||+|+||.|-+|.. ++|+.||||.++.... .......+|+++|++++|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 467889999999999999999995 5799999998764211 11223569999999999999999999999999
Q ss_pred cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCC---CcEEEeec
Q 017262 142 VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK---YRAKIADF 218 (374)
Q Consensus 142 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~---~~~kl~Df 218 (374)
..|+||||++||.|.+++- .+..+.+.....++.|++.|+.|||++| |+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999999998 4567888888999999999999999999 9999999999999765 78999999
Q ss_pred ccccccccCCceeeecccccccccCccccccCC---CCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHH
Q 017262 219 GTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQ---FTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIE 295 (374)
Q Consensus 219 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 295 (374)
|+|+..+ ....+.+.+|||.|.|||++.+.. +..++|+|||||++|-+++|.+||+...... . ..+.+.
T Consensus 324 GlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--s----l~eQI~ 395 (475)
T KOG0615|consen 324 GLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--S----LKEQIL 395 (475)
T ss_pred chhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--c----HHHHHh
Confidence 9999875 556678889999999999997654 2348899999999999999999998544321 1 111111
Q ss_pred hccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 296 ENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.++... ....-...+.+..+||.+||..||++|||+.|+++
T Consensus 396 ~G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 396 KGRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cCcccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 111110 01122355678999999999999999999999986
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=346.15 Aligned_cols=248 Identities=28% Similarity=0.442 Sum_probs=203.9
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
.++|.+.+.||.|+|++||+|+++ ++..||||.+... .....+.+..|+.+|+.++|||||.+++++..++..|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 467888899999999999999965 5789999988765 5667778899999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCC------CcEEEeecccc
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK------YRAKIADFGTS 221 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~------~~~kl~Dfg~~ 221 (374)
|||+||+|.+|++ ..+.+++..+..++.|++.||++||+++ |+||||||+|||++.+ -.+||+|||++
T Consensus 89 EyC~gGDLs~yi~---~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIR---RRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999998 4568999999999999999999999999 9999999999999764 46899999999
Q ss_pred cccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccc
Q 017262 222 RSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFD 301 (374)
Q Consensus 222 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (374)
+.+. .........|+|.|||||++...+|+.|+|+||+|+++|++++|+.||...+..+ .+......+...
T Consensus 163 R~L~--~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e------L~~~~~k~~~~~- 233 (429)
T KOG0595|consen 163 RFLQ--PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE------LLLYIKKGNEIV- 233 (429)
T ss_pred hhCC--chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH------HHHHHhcccccc-
Confidence 9886 3445567789999999999999999999999999999999999999997544332 222111111111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 017262 302 IIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEV 340 (374)
Q Consensus 302 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~v 340 (374)
...+......+.+|+...+..+|.+|-+..+.
T Consensus 234 -------~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~ 265 (429)
T KOG0595|consen 234 -------PVLPAELSNPLRELLISLLQRNPKDRISFEDF 265 (429)
T ss_pred -------CchhhhccCchhhhhhHHHhcCccccCchHHh
Confidence 12222333345577777777777777655543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-51 Score=338.02 Aligned_cols=258 Identities=26% Similarity=0.384 Sum_probs=209.1
Q ss_pred cCCCcCceEeeeCeEEEEEEE-ecCCcEEEEEEecc--CChhHHHHHHHHHHHHhhCCCCceeeeee-eeeeccc-ceEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKV--VDESKLEEFINEVVILSQINHRNVVKLLG-CCLEVEV-PLLV 146 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~-~~~~~~~-~~lv 146 (374)
.+|++.+.||.|.||+||++. ..+|..+|.|.++. .+....+....|+.+|++|+|||||++++ .+.++.. .++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 357788999999999999998 56899999998764 34566778899999999999999999998 4555554 8999
Q ss_pred EEeecCCcccccccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCEEEeccCCCceEECCCCcEEEeeccccccc
Q 017262 147 YEFIPNGTLFQYLHDPY-EELSLTWEMRLRIATEVAEALAYLHSSAY-LPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 224 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 224 (374)
||+|.+|+|...++..+ ....+++..+++++.|++.||.++|++-. ..|+||||||.||+++.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999887532 45679999999999999999999999320 12999999999999999999999999999987
Q ss_pred ccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccc
Q 017262 225 AIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIID 304 (374)
Q Consensus 225 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (374)
... .......+|||.||+||.+.+..|+.+|||||+||++|||+.-+.||.+. ++... .+.+++.....
T Consensus 179 ~s~-~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L-~~KI~qgd~~~--- 247 (375)
T KOG0591|consen 179 SSK-TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSL-CKKIEQGDYPP--- 247 (375)
T ss_pred cch-hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHH-HHHHHcCCCCC---
Confidence 643 33456678999999999999999999999999999999999999999642 33332 22222222211
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017262 305 DQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345 (374)
Q Consensus 305 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~ 345 (374)
-.....+..+.+||.-|+..||..||+.-.+++.+.
T Consensus 248 -----~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 248 -----LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred -----CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 122456788999999999999999999655544443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=327.32 Aligned_cols=264 Identities=24% Similarity=0.333 Sum_probs=210.9
Q ss_pred cCCCcCceEeeeCeEEEEEEEecC-CcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 148 (374)
+.|+...++|+|+||.||++++++ |+.||||++... ++...+-.++|+++|++++|+|+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 357777899999999999999765 899999987543 34455667899999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
||+..-|.+ +.. ....++...+.+++.|++.|+.|+|+++ ++||||||+|||++.+|.+||||||+|+.+.. .
T Consensus 82 ~~dhTvL~e-Le~--~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-p 154 (396)
T KOG0593|consen 82 YCDHTVLHE-LER--YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-P 154 (396)
T ss_pred ecchHHHHH-HHh--ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-C
Confidence 998866655 433 3457899999999999999999999999 99999999999999999999999999998764 3
Q ss_pred ceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccC--------CChHHHHHHHHHhccc
Q 017262 229 THVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEG--------RNLTTYFVECIEENCL 299 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~ 299 (374)
....+.++.|.+|+|||.+.+ ..|+..+||||+||++.||++|..-|++.++.+. .++..-..+....+..
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 344577889999999999887 6799999999999999999999999987665431 1111122222222322
Q ss_pred ccccc-ccc-----cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 300 FDIID-DQV-----RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 300 ~~~~~-~~~-----~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
+.-+. +.. ....-+..+..+.++++.||..||++|++.+++++
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 22111 111 11122344568899999999999999999999986
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=337.04 Aligned_cols=243 Identities=29% Similarity=0.406 Sum_probs=205.4
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEecc---CChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceE
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV---VDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLL 145 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 145 (374)
..+.|++.++||+|+||+||.++.+ .++.+|+|+++. ......+...+|..+|.+++||+|++++-.|++.+.+|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 3578999999999999999999965 488999997764 234556788899999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccc
Q 017262 146 VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 225 (374)
|+||+.||.|...|+ +++.+++..+.-++.+|+.||.|||+++ |+||||||+|||+|++|+++|+|||+++...
T Consensus 103 Vld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 999999999999998 5778999999999999999999999999 9999999999999999999999999998644
Q ss_pred cCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccc
Q 017262 226 IDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDD 305 (374)
Q Consensus 226 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (374)
.. .......+||+.|||||++.+..|+..+|.||||+++|||++|..||.... ...+........
T Consensus 177 ~~-~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~------~~~~~~~I~~~k-------- 241 (357)
T KOG0598|consen 177 KD-GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED------VKKMYDKILKGK-------- 241 (357)
T ss_pred cC-CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc------HHHHHHHHhcCc--------
Confidence 32 223344789999999999999999999999999999999999999996432 233332222221
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 017262 306 QVRKSGEAEEIMAVSDVAKRCLNSYGRNRP 335 (374)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 335 (374)
....+.-.+...++++.++|..||++|.
T Consensus 242 --~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 --LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred --CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 1122333455788999999999999995
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-49 Score=370.22 Aligned_cols=263 Identities=30% Similarity=0.482 Sum_probs=226.5
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec------CCcEEEEEEeccCChh-HHHHHHHHHHHHhhCCCCceeeeeeeeeecccc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVVDES-KLEEFINEVVILSQINHRNVVKLLGCCLEVEVP 143 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 143 (374)
..+....+.||+|+||+||+|... +...||||.++..... ...+|.+|++++..++|||||+++|+|..++..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 445566788999999999999843 3568999999877665 778999999999999999999999999999999
Q ss_pred eEEEEeecCCcccccccCCC-------C----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCc
Q 017262 144 LLVYEFIPNGTLFQYLHDPY-------E----ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR 212 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~-------~----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~ 212 (374)
++|+|||..|+|.+||.... . ..+++..+.+.||.|||.|+.||-++. .+||||..+|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence 99999999999999996421 1 223888999999999999999999999 999999999999999999
Q ss_pred EEEeecccccccccCCceeee-cccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHH
Q 017262 213 AKIADFGTSRSIAIDQTHVST-KVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYF 290 (374)
Q Consensus 213 ~kl~Dfg~~~~~~~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~ 290 (374)
|||+|||+++.....+.+... ...-+.+|||||.+..+++|++|||||+|++|||+++ |..||.+...++ +
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-------V 714 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-------V 714 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-------H
Confidence 999999999987766666544 4556779999999999999999999999999999999 999998776654 3
Q ss_pred HHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCC
Q 017262 291 VECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSR 352 (374)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~ 352 (374)
.+.+..+. + ...+..+|..+.+|+..||+.+|++||+++||-..|+...+..+
T Consensus 715 Ie~i~~g~--------l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 715 IECIRAGQ--------L-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred HHHHHcCC--------c-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 33333322 2 45677888899999999999999999999999999999877655
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=334.52 Aligned_cols=259 Identities=29% Similarity=0.437 Sum_probs=208.0
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecC-CcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc--cceEEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVE--VPLLVY 147 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~ 147 (374)
..+|...+.||+|+||.||++...+ |...|+|.+...+....+.+.+|+.+|++++|||||+.+|...... .+++.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 3457788999999999999999654 8999999887654444677899999999999999999999855444 588999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECC-CCcEEEeeccccccccc
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE-KYRAKIADFGTSRSIAI 226 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~ 226 (374)
||+++|+|.+++.+. +..+++..+..++.|+++||+|||+++ ++|+||||+|||++. ++.+||+|||++.....
T Consensus 96 Ey~~~GsL~~~~~~~--g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRY--GGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eccCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 999999999999853 227999999999999999999999999 999999999999999 79999999999987653
Q ss_pred --CCceeeecccccccccCccccccCC-CCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccc
Q 017262 227 --DQTHVSTKVQGTFGYLDPEYFRSSQ-FTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDII 303 (374)
Q Consensus 227 --~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (374)
..........||+.|||||++..+. ...++|||||||++.||+||..||... .....++......
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~------- 238 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGRE------- 238 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhcc-------
Confidence 1222234567999999999999643 345999999999999999999999753 1111111111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 017262 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIR 348 (374)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~ 348 (374)
...+..+...+....+++.+|+..+|+.|||+.+++.---...
T Consensus 239 --~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 239 --DSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred --CCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 1112445556778899999999999999999999998654443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-47 Score=337.43 Aligned_cols=264 Identities=26% Similarity=0.318 Sum_probs=209.7
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCC--hhHHHHHHHHHHHHhhCCCCceeeeeeeeeec--ccceE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVD--ESKLEEFINEVVILSQINHRNVVKLLGCCLEV--EVPLL 145 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 145 (374)
.+.|+.+++||+|+||.||+|+. .+|+.||+|++.... +.......+||.+|++|+||||+++.+...+. ...|+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 45677788999999999999994 579999999987754 44556678999999999999999999999877 58899
Q ss_pred EEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccc
Q 017262 146 VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 225 (374)
|+|||+. +|.-++.. ..-.+++.++..++.|++.||.|||+++ |.|||||.+|||||.+|.+||+|||+++++.
T Consensus 196 VFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999966 66666654 4568999999999999999999999999 9999999999999999999999999999888
Q ss_pred cCCceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHH-------HHhc
Q 017262 226 IDQTHVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVEC-------IEEN 297 (374)
Q Consensus 226 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-------~~~~ 297 (374)
.......+..+.|.+|+|||++.+ ..|+.+.|+||.||||.||+.|+..|++....+.- ...+..+ +...
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl--~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQL--HKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHH--HHHHHHhCCCChhccccc
Confidence 777667788889999999999876 46999999999999999999999999876654321 0000000 0001
Q ss_pred cccccccccccCCC-------CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 298 CLFDIIDDQVRKSG-------EAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 298 ~~~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.+.....-.....+ ....+....+|+..||..||.+|.|+.++++
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11100000000011 1122457889999999999999999999886
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-48 Score=358.13 Aligned_cols=263 Identities=24% Similarity=0.430 Sum_probs=229.5
Q ss_pred cCCCcCceEeeeCeEEEEEEEecC----CcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLAD----GRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
....+.++||.|.||.|++|.++- ...||||.++.. ...+...|+.|+.+|-+++||||+++.|+........+|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 455688999999999999999642 458999999875 456677899999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
.|||++|+|+.||.. +.+.++..++..++++|+.|+.||.+.+ ++||||.++||||+.+..+|++|||+++.+.+
T Consensus 709 TEyMENGsLDsFLR~--~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhhCCcHHHHHhh--cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence 999999999999987 4567999999999999999999999999 99999999999999999999999999998865
Q ss_pred CCceeeec--ccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccc
Q 017262 227 DQTHVSTK--VQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDII 303 (374)
Q Consensus 227 ~~~~~~~~--~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (374)
+.....+. -..+.+|.|||.+...+++.++||||+|++|||.++ |+.||=+.+..+ ....+
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd----------------VIkaI 847 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD----------------VIKAI 847 (996)
T ss_pred CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH----------------HHHHH
Confidence 44222222 234678999999999999999999999999999887 999986554433 44566
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCCCc
Q 017262 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDDE 355 (374)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~~~ 355 (374)
+...+...|.++|..+.+|+..||+.|-.+||.+.+++..|.++..+-.+-.
T Consensus 848 e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk 899 (996)
T KOG0196|consen 848 EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLK 899 (996)
T ss_pred HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhc
Confidence 7777888899999999999999999999999999999999999988655443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=338.51 Aligned_cols=263 Identities=23% Similarity=0.312 Sum_probs=207.4
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCCh-hHHHHHHHHHHHHhhCC-CCceeeeeeeeeecc-cceEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDE-SKLEEFINEVVILSQIN-HRNVVKLLGCCLEVE-VPLLV 146 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~-~~~lv 146 (374)
.++|.+.+.||.|+||.||+|+. ..|..||||+++..-. .+.-.-++|+..|++++ ||||+++.+++.+.+ .+++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 56789999999999999999994 5688999998765322 12223368999999998 999999999999888 89999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
|||| ..+|.+.+.+ .+..+++..+..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+|||+|+....
T Consensus 89 fE~M-d~NLYqLmK~--R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 89 FEFM-DCNLYQLMKD--RNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred HHhh-hhhHHHHHhh--cCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc
Confidence 9999 6699999987 3778999999999999999999999999 99999999999999999999999999997653
Q ss_pred CCceeeecccccccccCccccc-cCCCCccchhhhHHHHHHHHHhCCCCCCccccccC----------CChHHHHH---H
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFR-SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEG----------RNLTTYFV---E 292 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~----------~~~~~~~~---~ 292 (374)
....+.++.|.+|+|||++. .+.|+.+.|+||+||+++|+.+-+.-|++....+. .....|.. .
T Consensus 163 --kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 163 --KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred --CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 33456778999999999864 67799999999999999999999999987654321 00001110 0
Q ss_pred HHH-hccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 293 CIE-ENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 293 ~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
... +-.+.......+. ..-+..+.++.+||.+|++.||++||||.++++
T Consensus 241 a~~mnf~~P~~~~~~l~-~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLK-DLLPNASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred HHHhccCCCcCCCCChH-HhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 000 0011111111111 112236788999999999999999999999987
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=309.98 Aligned_cols=263 Identities=24% Similarity=0.296 Sum_probs=208.1
Q ss_pred cCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCCh--hHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDE--SKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 148 (374)
++|...+.+|+|.||.||+|+. ..|+.||||+++..+. .......+|++.|+.++|+||+.++++|.+.+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4678889999999999999995 5699999999876533 234567899999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
|+ ..+|...+.+ ....++..++..++.++++|++|||++. |.||||||.|+|++++|.+||+|||+++.....+
T Consensus 82 fm-~tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FM-PTDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ec-cccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 99 5589999987 5668999999999999999999999999 9999999999999999999999999999877544
Q ss_pred ceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHH--------HHhccc
Q 017262 229 THVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVEC--------IEENCL 299 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~ 299 (374)
... ...+.|.+|+|||.+.+ ..|+..+|+||.||++.||+-|.+-|++.++-+. +...+... -+...+
T Consensus 156 ~~~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQ--L~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 156 RIQ-THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQ--LSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred ccc-ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHH--HHHHHHHcCCCCcccCcccccc
Confidence 332 33368999999998765 5799999999999999999999988876554321 11111000 000011
Q ss_pred ccccc-----ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 300 FDIID-----DQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 300 ~~~~~-----~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
.+... ........+.++....+|+.+|+.+||.+|+|+.|+++.
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11111 111111233455677999999999999999999999874
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=340.94 Aligned_cols=250 Identities=26% Similarity=0.425 Sum_probs=214.4
Q ss_pred hcCCCcCceEeeeCeEEEEEEE-ecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 71 TDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
..+|...+.||+|+.|.||.|. ...++.||+|++........+-+.+|+.+|+..+|+|||++++.+...+.+++||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 4578888899999999999998 456889999999887777778899999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
++||+|.+.+. ...+++.++..++.++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 352 m~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 352 MEGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred cCCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 99999999885 446999999999999999999999999 99999999999999999999999999987765433
Q ss_pred eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccC
Q 017262 230 HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (374)
.....+|||.|||||++....|+.+.||||||++++||+-|+.||-... .+.. ... +. .......
T Consensus 425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~-----PlrA-lyL-Ia-------~ng~P~l 489 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN-----PLRA-LYL-IA-------TNGTPKL 489 (550)
T ss_pred -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC-----hHHH-HHH-Hh-------hcCCCCc
Confidence 4456679999999999999999999999999999999999999996311 1111 100 01 1122233
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 310 SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 310 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..+...+..+.+++.+||..|+.+||++.|+|+
T Consensus 490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 445667789999999999999999999999987
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=335.01 Aligned_cols=252 Identities=29% Similarity=0.397 Sum_probs=208.9
Q ss_pred HHhhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeeccc
Q 017262 68 DKATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEV 142 (374)
Q Consensus 68 ~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 142 (374)
.+...+|..++.||.|+|++|++|+.. .++.+|||++... ......-+..|-+.|.+| .||.|++++..|.++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 444678999999999999999999954 5899999976542 222234456788999999 79999999999999999
Q ss_pred ceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccc
Q 017262 143 PLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 222 (374)
Q Consensus 143 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 222 (374)
+|+|+||+++|+|.++|. .-+.+++...+.++.+|+.||+|||++| ||||||||+|||+|+|+++||+|||.++
T Consensus 149 LYFvLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred eEEEEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccc
Confidence 999999999999999998 4578999999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCce----------e--eecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHH
Q 017262 223 SIAIDQTH----------V--STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYF 290 (374)
Q Consensus 223 ~~~~~~~~----------~--~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 290 (374)
.+.+.... . ....+||..|.+||++..+..+..+|+|+|||++|+|+.|.+||..... .-.+
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne------yliF 296 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE------YLIF 296 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH------HHHH
Confidence 87543221 1 1447899999999999999999999999999999999999999964332 1122
Q ss_pred HHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 291 VECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
....+ +.-.+++..++.+.+|+++.|..||++|+|+++|.+
T Consensus 297 qkI~~-----------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 297 QKIQA-----------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred HHHHH-----------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 22111 112233344467889999999999999999988776
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=324.67 Aligned_cols=264 Identities=24% Similarity=0.384 Sum_probs=212.8
Q ss_pred HHhhcCCCcCceEeeeCeEEEEEEE-ecCCcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceE
Q 017262 68 DKATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLL 145 (374)
Q Consensus 68 ~~~~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 145 (374)
....+.|++...||.|..++||+|. ...+..||||++.... ....+.+.+|+..++.++||||++.+.+|..+..+|+
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWv 101 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWV 101 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEE
Confidence 3446789999999999999999999 4567999999987643 3336889999999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccc
Q 017262 146 VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 225 (374)
||+||.+|++.+.+...... .+++..+..+++++++||.|||.+| .||||||+.||||+++|.|||+|||.+..+.
T Consensus 102 VmpfMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred eehhhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 99999999999999866544 5999999999999999999999999 9999999999999999999999999887665
Q ss_pred cCCce---eeecccccccccCcccccc--CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccc
Q 017262 226 IDQTH---VSTKVQGTFGYLDPEYFRS--SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLF 300 (374)
Q Consensus 226 ~~~~~---~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (374)
..... ......|+++|||||++.. ..|+.|+||||||++..||.+|+.||...... ......+.+.. +
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm------kvLl~tLqn~p-p 250 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM------KVLLLTLQNDP-P 250 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH------HHHHHHhcCCC-C
Confidence 43311 1245689999999999653 46999999999999999999999999754322 12222222221 1
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 301 DIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
...-.....+........+.+++..||..||++|||++++++
T Consensus 251 ~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 251 TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 111112222222233458999999999999999999999987
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-46 Score=339.77 Aligned_cols=261 Identities=29% Similarity=0.460 Sum_probs=206.1
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe------cCCcEEEEEEeccCC-hhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecc-
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML------ADGRIIAVKKSKVVD-ESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVE- 141 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~- 141 (374)
.++|++.+.||+|+||.||+|.. .++..||+|.+.... ......+.+|+.+++.+ +||||+++++++...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46789999999999999999974 235679999886532 33456788999999999 8999999999887654
Q ss_pred cceEEEEeecCCcccccccCCCC---------------------------------------------------------
Q 017262 142 VPLLVYEFIPNGTLFQYLHDPYE--------------------------------------------------------- 164 (374)
Q Consensus 142 ~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 164 (374)
..+++|||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 57899999999999988864211
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce-eeecccccccc
Q 017262 165 --ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH-VSTKVQGTFGY 241 (374)
Q Consensus 165 --~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y 241 (374)
...+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++........ ......+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 134778889999999999999999998 999999999999999999999999999765432221 12233466789
Q ss_pred cCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHH
Q 017262 242 LDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVS 320 (374)
Q Consensus 242 ~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 320 (374)
+|||++.+..++.++||||||+++|||++ |..||....... . +......+. ....+...+..+.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-----~-~~~~~~~~~---------~~~~~~~~~~~l~ 307 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-----E-FCQRLKDGT---------RMRAPENATPEIY 307 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-----H-HHHHHhcCC---------CCCCCCCCCHHHH
Confidence 99999998899999999999999999997 999997533211 1 111111111 1112233456789
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 017262 321 DVAKRCLNSYGRNRPTMKEVAMELERIRA 349 (374)
Q Consensus 321 ~li~~cl~~~p~~Rps~~~vl~~L~~~~~ 349 (374)
+|+.+||+.||++|||+.++++.|+++..
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-46 Score=337.78 Aligned_cols=256 Identities=25% Similarity=0.372 Sum_probs=211.4
Q ss_pred HhhcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccC----Ch-hHHHHHHHHHHHHhhCC-CCceeeeeeeeeecc
Q 017262 69 KATDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV----DE-SKLEEFINEVVILSQIN-HRNVVKLLGCCLEVE 141 (374)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~ 141 (374)
...++|.+.+.||+|+||+|+.|.. .++..||+|.+... .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4467899999999999999999985 46899999965542 11 23456668999999998 999999999999999
Q ss_pred cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCC-CcEEEeeccc
Q 017262 142 VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK-YRAKIADFGT 220 (374)
Q Consensus 142 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfg~ 220 (374)
..++||||+.+|+|.+++. ..+.+.+..+..++.|++.|++|||++| |+||||||+|+|++.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~---~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIV---NKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHH---HcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 9999999999999999998 4568999999999999999999999999 9999999999999999 9999999999
Q ss_pred ccccccCCceeeecccccccccCccccccCC-CC-ccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcc
Q 017262 221 SRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQ-FT-DKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENC 298 (374)
Q Consensus 221 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 298 (374)
+.... ..........|++.|+|||++.+.. |+ .++||||+|++||.|++|..||... +....+.. +.
T Consensus 168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~------~~~~l~~k-i~--- 236 (370)
T KOG0583|consen 168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS------NVPNLYRK-IR--- 236 (370)
T ss_pred ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc------cHHHHHHH-Hh---
Confidence 98763 2344556778999999999999877 76 7899999999999999999999752 22222221 11
Q ss_pred ccccccccccCCCCHHH-HHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 017262 299 LFDIIDDQVRKSGEAEE-IMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRA 349 (374)
Q Consensus 299 ~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~ 349 (374)
... ...+... +..+.+|+++||..||.+|+|+.+++ .-.-++.
T Consensus 237 -----~~~--~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 237 -----KGE--FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred -----cCC--ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 111 1122222 66889999999999999999999999 5555554
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=332.04 Aligned_cols=248 Identities=26% Similarity=0.370 Sum_probs=203.8
Q ss_pred HhhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccce
Q 017262 69 KATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPL 144 (374)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 144 (374)
...++|++++.||+|+||.||+|+.+ .|..+|+|+++.. ...+...++.|-.+|...++|+||+++-.|.+.+.+|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 34678999999999999999999965 5899999988764 3456677889999999999999999999999999999
Q ss_pred EEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccc
Q 017262 145 LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 224 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 224 (374)
|||||++||++..+|. ....+++..+..++.+++.|+.-+|+.| ++||||||+|+|||..|++||+|||++..+
T Consensus 218 LiMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchh
Confidence 9999999999999998 5779999999999999999999999999 999999999999999999999999998533
Q ss_pred ccC----------------------Cce------------------------eeecccccccccCccccccCCCCccchh
Q 017262 225 AID----------------------QTH------------------------VSTKVQGTFGYLDPEYFRSSQFTDKSDV 258 (374)
Q Consensus 225 ~~~----------------------~~~------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Di 258 (374)
... +.. .....+|||.|+|||++.+..|+..+|.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 210 000 0112459999999999999999999999
Q ss_pred hhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 017262 259 YSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPT 336 (374)
Q Consensus 259 ~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 336 (374)
||||||+|||+.|.+||......+ -+.....- ...+..........+..+||.+|+. ||+.|.-
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~------T~rkI~nw-------r~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQE------TYRKIVNW-------RETLKFPEEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHHH-------hhhccCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 999999999999999997544332 11111111 1112222233344688999999999 9999965
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=323.78 Aligned_cols=246 Identities=22% Similarity=0.378 Sum_probs=201.1
Q ss_pred ceEeeeCeEEEEEEEecCCcEEEEEEeccCChhH---HHHHHHHHHHHhhCCCCceeeeeeeeee----cccceEEEEee
Q 017262 78 RILGQGGQGTVYKGMLADGRIIAVKKSKVVDESK---LEEFINEVVILSQINHRNVVKLLGCCLE----VEVPLLVYEFI 150 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~ 150 (374)
..||+|+++.||+|.. +|+.||+|.+....... ...+.+|+.++++++||||+++++++.+ ....+++|||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 68899999887543322 4677899999999999999999999876 34678999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSS-AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
++|+|.+++.. ...+++.....++.+++.||.|||+. + ++||||||+||++++++.+||+|||++.......
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 99999999974 45788999999999999999999985 6 7799999999999999999999999987653221
Q ss_pred eeeecccccccccCcccccc--CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccc
Q 017262 230 HVSTKVQGTFGYLDPEYFRS--SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (374)
....++..|+|||.+.+ ..++.++||||||+++|||++|..||..... .+........ ..
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~------~~~~~~i~~~---------~~ 239 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT------KEIYDLIINK---------NN 239 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhc---------CC
Confidence 22357889999999976 6789999999999999999999999975322 1212111111 11
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 017262 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRA 349 (374)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~ 349 (374)
+...+...+..+.+++.+||+.||++|||+.++++.|+.++.
T Consensus 240 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 240 SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 122233456689999999999999999999999999998864
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=327.59 Aligned_cols=249 Identities=26% Similarity=0.423 Sum_probs=213.1
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 148 (374)
...|+..+.||+|.||.||+|.. ..++.||+|++.... ......+.+|+.+|.+++++||.+.|+.+..+..++++||
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 34577778999999999999995 458899999987653 3446788899999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
||.||++.+.+. .+..+.+..+.-++++++.|+.|||.++ .+|||||+.|||+..+|.+||+|||.+..+....
T Consensus 92 y~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 92 YCGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HhcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh
Confidence 999999999997 4555688888899999999999999999 9999999999999999999999999998776544
Q ss_pred ceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccccc
Q 017262 229 THVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVR 308 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (374)
... ...+|||.|||||++.+..|+.++||||||++.+||.+|.+|+.+..... ..-++.....
T Consensus 166 ~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr----------------vlflIpk~~P 228 (467)
T KOG0201|consen 166 KRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR----------------VLFLIPKSAP 228 (467)
T ss_pred hcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce----------------EEEeccCCCC
Confidence 433 77889999999999998899999999999999999999999998654422 2222333333
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 309 KSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 309 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
+......++.+.+++..||..||+.||+|.++++
T Consensus 229 P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 229 PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 3334466778999999999999999999999987
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=302.07 Aligned_cols=268 Identities=24% Similarity=0.354 Sum_probs=218.8
Q ss_pred HHHHhhcCCCcCceEeeeCeEEEEEEE-ecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc---
Q 017262 66 ELDKATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVE--- 141 (374)
Q Consensus 66 ~~~~~~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--- 141 (374)
.+....++|.+.+.||+|||+-||+++ ..++..+|+|++...+..+.+..++|++..++++|||+++++++...+.
T Consensus 15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 344556899999999999999999999 5678999999998888888899999999999999999999999876443
Q ss_pred --cceEEEEeecCCcccccccCCCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeec
Q 017262 142 --VPLLVYEFIPNGTLFQYLHDPYE-ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADF 218 (374)
Q Consensus 142 --~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 218 (374)
..|++++|...|+|.+.+..... +..+++.+++.|+.++++||++||+.. +|++||||||.|||+++++.+++.||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEec
Confidence 48999999999999999876443 447999999999999999999999998 57999999999999999999999999
Q ss_pred ccccccccCCcee--------eecccccccccCccccccC---CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChH
Q 017262 219 GTSRSIAIDQTHV--------STKVQGTFGYLDPEYFRSS---QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLT 287 (374)
Q Consensus 219 g~~~~~~~~~~~~--------~~~~~g~~~y~aPE~~~~~---~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~ 287 (374)
|.++...-.-... -.....|..|+|||.+... ..++++|||||||++|.|+.|..||.......
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G----- 248 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG----- 248 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC-----
Confidence 9986542111110 0123478899999998643 46889999999999999999999997544321
Q ss_pred HHHHHHHHhccccc-cccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 017262 288 TYFVECIEENCLFD-IIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIR 348 (374)
Q Consensus 288 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~ 348 (374)
+.+.- +.++..........++.+.++|++|++.||.+||++.+++..+..+.
T Consensus 249 ---------gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 249 ---------GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ---------CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11222 22233334444457889999999999999999999999999988764
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=334.55 Aligned_cols=265 Identities=28% Similarity=0.466 Sum_probs=216.9
Q ss_pred hHHHHHhhcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc
Q 017262 64 SKELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVE 141 (374)
Q Consensus 64 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 141 (374)
.++.+...+.+.+.+.||+|.||+||+|.+.+ .||||.++.. .+.+.+.|++|+..+++-+|.||+-|.|+|....
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 35556666777889999999999999999853 3999988775 4567789999999999999999999999999877
Q ss_pred cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccc
Q 017262 142 VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 221 (374)
Q Consensus 142 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 221 (374)
. .+|+.+|+|.+|+.+++. .+..+.....+.|+.|+++|+.|||.++ |+|+|||..|||+.++++|||+|||++
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv--~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHV--QETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred e-eeeehhccCchhhhhccc--hhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccce
Confidence 7 999999999999999987 4567889999999999999999999999 999999999999999999999999998
Q ss_pred cccccCC-ceeeecccccccccCcccccc---CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhc
Q 017262 222 RSIAIDQ-THVSTKVQGTFGYLDPEYFRS---SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEEN 297 (374)
Q Consensus 222 ~~~~~~~-~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 297 (374)
..-.... ........|...|||||++.. .+|+..+||||||+++|||++|..||.. ...+.
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dq-------------- 600 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQ-------------- 600 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhh--------------
Confidence 7543221 111223347789999999864 4689999999999999999999999982 22221
Q ss_pred cccccccccccC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhC
Q 017262 298 CLFDIIDDQVRK---SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANS 351 (374)
Q Consensus 298 ~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~ 351 (374)
.++.+-.+.+.. .....++.++.+|+..||.+++++||++.+++..|+.+....
T Consensus 601 IifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 601 IIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred eEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 022221221111 123456778999999999999999999999999999998854
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=321.37 Aligned_cols=255 Identities=21% Similarity=0.389 Sum_probs=206.0
Q ss_pred cCCCcCceEeeeCeEEEEEEEec----CCcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA----DGRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
++|++.+.||+|+||.||+|.+. .+..+++|.++... ......+.+|+..+++++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46889999999999999999853 35689999877643 34456788999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
|||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++++|||.+.....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 9999999999998752 357899999999999999999999999 99999999999999999999999998765332
Q ss_pred CCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccc
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDD 305 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (374)
..........++..|+|||.+.+..++.++||||||+++||+++ |..||......+ ........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~-------~~~~~~~~-------- 224 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD-------VIKAVEDG-------- 224 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCC--------
Confidence 22111122335678999999999999999999999999999775 999996543221 11111111
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 017262 306 QVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347 (374)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~ 347 (374)
.....+...+..+.+++.+||+.+|++|||++++.+.|+++
T Consensus 225 -~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 -FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11122334566889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=306.90 Aligned_cols=236 Identities=28% Similarity=0.383 Sum_probs=202.9
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
++|+..+.||.|+||+|.+++.+ +|..+|+|.+... ...+.+...+|..+|+.+.||+++++++.+.+.+..++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46788899999999999999965 5889999987653 3456677889999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
||.+||-|..++. ..+.+++..++-++.||+.||+|||+.+ |++|||||+|||+|.+|.+||+|||+++.....
T Consensus 124 eyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 9999999999998 5678999999999999999999999999 999999999999999999999999999876432
Q ss_pred CceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (374)
....+|||.|+|||.+....|+.++|.||||+++|||+.|..||..... ...+ ..++...+
T Consensus 198 ----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~------~~iY---------~KI~~~~v 258 (355)
T KOG0616|consen 198 ----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP------IQIY---------EKILEGKV 258 (355)
T ss_pred ----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh------HHHH---------HHHHhCcc
Confidence 4557899999999999999999999999999999999999999975433 1111 12222222
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCC
Q 017262 308 RKSGEAEEIMAVSDVAKRCLNSYGRNR 334 (374)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~p~~R 334 (374)
.+|.-.+..+.+|++++|+.|-+.|
T Consensus 259 --~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 --KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 2444555678899999999999988
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=330.95 Aligned_cols=246 Identities=28% Similarity=0.436 Sum_probs=211.5
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 148 (374)
++|.+.+.||+|.||.||+|+.+ +.+.||+|.+... ...+...+.+|+++++.++||||+.++++|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46888899999999999999954 5789999977553 34557789999999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
|+.| +|..++. ..+.++++.+..++.+++.||.|||+.+ |.|||+||.|||++.++.+|+||||+++.... .
T Consensus 82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST-N 153 (808)
T ss_pred hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc-C
Confidence 9976 9999998 5778999999999999999999999999 99999999999999999999999999987654 4
Q ss_pred ceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccccc
Q 017262 229 THVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVR 308 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (374)
....+...|||.|||||...+..|+..+|+|||||++||+++|++||-.. .....+.....+.
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I~~d~----------- 216 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSILKDP----------- 216 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHHhcCC-----------
Confidence 55567778999999999999999999999999999999999999999532 2222222222111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 309 KSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 309 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
...+...+..+..+++..|..||..|.|..+++.
T Consensus 217 v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 217 VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred CCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 1234467778999999999999999999999875
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=358.31 Aligned_cols=264 Identities=30% Similarity=0.525 Sum_probs=223.0
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecC--Cc----EEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLAD--GR----IIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVP 143 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 143 (374)
....+..+.||+|+||.||.|...+ +. .||+|.+... +..+..+|.+|..+|+.++||||++++|++.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3455677899999999999999654 33 4888887654 566778999999999999999999999999999999
Q ss_pred eEEEEeecCCcccccccCCC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecc
Q 017262 144 LLVYEFIPNGTLFQYLHDPY----EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 219 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 219 (374)
++++|||++|+|..||.+.+ ....++....+.++.+||+|+.||++++ .+||||..+|+|++....+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999998742 2456888999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCceeeecc-cccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhc
Q 017262 220 TSRSIAIDQTHVSTKV-QGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEEN 297 (374)
Q Consensus 220 ~~~~~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 297 (374)
+|+.....+.+..... .-+..|||||.+..+.++.|+||||||+++||++| |..||+.....+ ..
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~------v~------- 914 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE------VL------- 914 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH------HH-------
Confidence 9997666555554433 44568999999999999999999999999999999 999998654332 11
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCC
Q 017262 298 CLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRD 353 (374)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~ 353 (374)
....... +.+.|..++..+.+++..||+.+|++||++..+++.+..+......
T Consensus 915 --~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 915 --LDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred --HHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 1122222 6677888888999999999999999999999999998888765543
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=318.23 Aligned_cols=256 Identities=25% Similarity=0.442 Sum_probs=208.8
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEee
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFI 150 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 150 (374)
.++|++.+.||+|+||.||+|...++..+++|.+.... ...+.+.+|+.+++.++|+||+++++++.+.+..++++||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 45788999999999999999998888889999876543 23567889999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 230 (374)
++++|.+++... ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999998643 3456888999999999999999999998 999999999999999999999999999765432222
Q ss_pred eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccccccC
Q 017262 231 VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309 (374)
Q Consensus 231 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (374)
......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .... .... ...
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~------~~~~-~~~~---------~~~ 223 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD------VMSA-LQRG---------YRM 223 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH------HHHH-HHcC---------CCC
Confidence 2223345678999999988889999999999999999998 999996432211 1111 1111 111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 017262 310 SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347 (374)
Q Consensus 310 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~ 347 (374)
......+..+.+++.+|++.+|++|||++++.+.|+++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 12223456788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-45 Score=333.73 Aligned_cols=263 Identities=31% Similarity=0.486 Sum_probs=217.4
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEecC--C--cE-EEEEEecc---CChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLAD--G--RI-IAVKKSKV---VDESKLEEFINEVVILSQINHRNVVKLLGCCLEVE 141 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~~--~--~~-vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 141 (374)
..++..+.++||+|+||.||+|..+. + .. ||+|..+. ........+.+|++++++++||||++++|++....
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE 234 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 34455667899999999999999643 2 23 89998875 44777889999999999999999999999999999
Q ss_pred cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccc
Q 017262 142 VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 221 (374)
Q Consensus 142 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 221 (374)
..++|||+|.||+|.++|... ...++..+...++.+.+.||+|||+++ ++||||.++|+|++.++.+||+|||++
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~--~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKN--KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccc
Confidence 999999999999999999863 336999999999999999999999999 999999999999999999999999998
Q ss_pred cccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhcccc
Q 017262 222 RSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLF 300 (374)
Q Consensus 222 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (374)
+... ..........-+..|+|||.+....++.++||||||+++||+++ |..||.+....+ +...
T Consensus 310 ~~~~-~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~-------v~~k------- 374 (474)
T KOG0194|consen 310 RAGS-QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE-------VKAK------- 374 (474)
T ss_pred cCCc-ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH-------HHHH-------
Confidence 7543 11111112235678999999999999999999999999999999 888997654332 1111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCC
Q 017262 301 DIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRD 353 (374)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~ 353 (374)
+.....+...+...+..+..++.+|+..+|++||||.++.+.|+.+......
T Consensus 375 -I~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 375 -IVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred -HHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 1123333444556677888999999999999999999999999999887664
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=319.80 Aligned_cols=257 Identities=30% Similarity=0.488 Sum_probs=214.0
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
...+|++.+.||.|+||.||+|...++..+++|.+..........+..|+.+++.++||||+++++++.+.+..+++|||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 45678899999999999999999888999999998877666677889999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||.+........
T Consensus 84 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999999999754 3456899999999999999999999999 99999999999999999999999999976543221
Q ss_pred eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhcccccccccccc
Q 017262 230 HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVR 308 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (374)
......++..|+|||.+....++.++||||||+++|+|++ |+.||..... ...+.... ....
T Consensus 160 -~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~------~~~~~~~~----------~~~~ 222 (261)
T cd05148 160 -LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN------HEVYDQIT----------AGYR 222 (261)
T ss_pred -cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH------HHHHHHHH----------hCCc
Confidence 1223346678999999988889999999999999999998 8999964331 11111111 1111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 017262 309 KSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347 (374)
Q Consensus 309 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~ 347 (374)
...+...+..+.+++.+|++.+|++|||+.++++.|+.+
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 222344556889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=342.66 Aligned_cols=262 Identities=24% Similarity=0.378 Sum_probs=221.3
Q ss_pred HhhcCCCcCceEeeeCeEEEEEEEecCC-cEEEEEEeccCChhHHHHHHHHHHHHhhCC-CCceeeeeee-eee------
Q 017262 69 KATDYFNMNRILGQGGQGTVYKGMLADG-RIIAVKKSKVVDESKLEEFINEVVILSQIN-HRNVVKLLGC-CLE------ 139 (374)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~-~~~------ 139 (374)
....++++.+.|-+|||+.||.|....+ ..+|+|++-..+....+.+.+|+++|+.|+ |+|||.+++. ...
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 3456778999999999999999997765 999999988888889999999999999996 9999999993 221
Q ss_pred cccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecc
Q 017262 140 VEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 219 (374)
Q Consensus 140 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 219 (374)
.-..+|.||||.+|.|-+++...... .|++.++++|+.++++|+++||... +||||||||-+||||+.+++.||||||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccc
Confidence 12467999999999999999865433 4999999999999999999999998 779999999999999999999999999
Q ss_pred cccccccCCcee--------eecccccccccCcccc---ccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHH
Q 017262 220 TSRSIAIDQTHV--------STKVQGTFGYLDPEYF---RSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTT 288 (374)
Q Consensus 220 ~~~~~~~~~~~~--------~~~~~g~~~y~aPE~~---~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~ 288 (374)
.+.......... .-...-|+.|+|||.+ .+...++|+|||+|||+||-|+....||+...
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg--------- 262 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG--------- 262 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc---------
Confidence 986543222110 1123478999999986 46678999999999999999999999997432
Q ss_pred HHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhC
Q 017262 289 YFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANS 351 (374)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~ 351 (374)
...+++........+..+..+.+||+.||+.||.+||++.++++.+-+++...
T Consensus 263 ----------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 263 ----------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ----------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 23566777777777889999999999999999999999999999999987643
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=315.78 Aligned_cols=251 Identities=26% Similarity=0.398 Sum_probs=211.7
Q ss_pred HHhhcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEecc---CChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccc
Q 017262 68 DKATDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKV---VDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVP 143 (374)
Q Consensus 68 ~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 143 (374)
.....+|++.+.||+|+||.|-+|.. ..|+.||||.++. .+..+.-.+.+|+++|..|+||||+.++.+|.+.+..
T Consensus 49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKI 128 (668)
T KOG0611|consen 49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKI 128 (668)
T ss_pred cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence 34467899999999999999999984 7799999997654 3455566788999999999999999999999999999
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccc
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 223 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 223 (374)
.+||||..+|.|.+|+. ..+.+++.++.++++||.+|+.|+|.++ ++|||||.+|||+|+++++||+|||++..
T Consensus 129 vivMEYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNl 202 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNL 202 (668)
T ss_pred EEEEEecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhh
Confidence 99999999999999998 5778999999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCceeeecccccccccCccccccCCCC-ccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccc
Q 017262 224 IAIDQTHVSTKVQGTFGYLDPEYFRSSQFT-DKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDI 302 (374)
Q Consensus 224 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (374)
+. ........+|+|.|.+||.+.+.+|. +.+|.||||++||-|+.|..||.+... ...+. .+..+...
T Consensus 203 y~--~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh------k~lvr-QIs~GaYr-- 271 (668)
T KOG0611|consen 203 YA--DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH------KRLVR-QISRGAYR-- 271 (668)
T ss_pred hc--cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH------HHHHH-Hhhccccc--
Confidence 65 33445678899999999999998874 789999999999999999999975332 22221 22222221
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 017262 303 IDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMEL 344 (374)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L 344 (374)
.++-+....-||++||..||++|.|+.++..-.
T Consensus 272 ---------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 272 ---------EPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ---------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 112223566799999999999999999998654
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=321.86 Aligned_cols=263 Identities=25% Similarity=0.401 Sum_probs=203.6
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecC-----------------CcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceee
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLAD-----------------GRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVK 132 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~ 132 (374)
.++|.+.+.||+|+||.||++...+ +..+|+|.+... .......+.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578899999999999999997532 336999987754 3344567899999999999999999
Q ss_pred eeeeeeecccceEEEEeecCCcccccccCCC----------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEE
Q 017262 133 LLGCCLEVEVPLLVYEFIPNGTLFQYLHDPY----------------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIY 196 (374)
Q Consensus 133 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~ 196 (374)
+++++.+.+..+++|||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999998875321 1134678899999999999999999999 99
Q ss_pred EeccCCCceEECCCCcEEEeecccccccccCCce-eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh--CCC
Q 017262 197 HRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT--GQK 273 (374)
Q Consensus 197 H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~--g~~ 273 (374)
|+||||+|||++.++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999765433322 1223445788999999988889999999999999999987 566
Q ss_pred CCCccccccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017262 274 PISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345 (374)
Q Consensus 274 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~ 345 (374)
||....... .............. ......++..+..+.+|+.+||+.+|++|||+.++.+.|+
T Consensus 241 p~~~~~~~~---~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDEQ---VIENAGEFFRDQGR------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHHH---HHHHHHHHhhhccc------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 776433211 11111111111100 0011122334568899999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-44 Score=314.98 Aligned_cols=255 Identities=29% Similarity=0.467 Sum_probs=207.6
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEee
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFI 150 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 150 (374)
..|.+.+.||.|+||.||+|... .++.+++|..... ......+.+|+..++.++||||+++++++..++..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 35778899999999999999965 4788999987654 334567889999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 230 (374)
++++|.+++... ....+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999999998643 2346899999999999999999999998 999999999999999999999999998765433222
Q ss_pred eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccccccC
Q 017262 231 VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309 (374)
Q Consensus 231 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (374)
.......+..|+|||.+.+..++.++||||||+++|+|++ |..||+.... ...... .. .....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~------~~~~~~-~~---------~~~~~ 224 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYEL-LE---------KGYRM 224 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHH-HH---------CCCCC
Confidence 2222334668999999998899999999999999999998 9999864321 111111 11 11122
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 017262 310 SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347 (374)
Q Consensus 310 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~ 347 (374)
..+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 23334556899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=314.27 Aligned_cols=256 Identities=27% Similarity=0.443 Sum_probs=208.4
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEee
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFI 150 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 150 (374)
.++|++.+.||+|++|.||+|...+++.+++|.+..... ..+.+.+|+.++++++||||+++++++...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 456889999999999999999987788899998875432 3467889999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 230 (374)
++++|.+++.... ...+++..+..++.|++.||.+||+.+ ++|+||+|+||++++++.++|+|||++.........
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999997532 346899999999999999999999998 999999999999999999999999999876532221
Q ss_pred eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccccccC
Q 017262 231 VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309 (374)
Q Consensus 231 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (374)
.......+..|+|||.+.+..++.++||||||+++|+|++ |+.||....... .. ..... ....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~-~~~~~---------~~~~ 223 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE------VL-QQVDQ---------GYRM 223 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH------HH-HHHHc---------CCCC
Confidence 1111223457999999998889999999999999999999 999996432111 11 11111 1111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 017262 310 SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347 (374)
Q Consensus 310 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~ 347 (374)
..+...+..+.+++.+|++.+|++||++.++++.|+.+
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 22334456899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=313.93 Aligned_cols=251 Identities=27% Similarity=0.426 Sum_probs=203.3
Q ss_pred cCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeec
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIP 151 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 151 (374)
++|++.+.||+|+||.||++...++..+++|....... ....+.+|+.++++++||||+++++++...+..+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 45788899999999999999988888899998764332 34578889999999999999999999999999999999999
Q ss_pred CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCcee
Q 017262 152 NGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV 231 (374)
Q Consensus 152 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 231 (374)
+|+|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||.+..........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 99999988742 346889999999999999999999999 9999999999999999999999999987654322222
Q ss_pred eecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccccccCC
Q 017262 232 STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKS 310 (374)
Q Consensus 232 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (374)
.....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||..... ...+....... +..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~------~~~~~~i~~~~----------~~~ 221 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN------YEVVEMISRGF----------RLY 221 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHCCC----------CCC
Confidence 222335668999999998889999999999999999999 8999864321 11111111111 111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 017262 311 GEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMEL 344 (374)
Q Consensus 311 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L 344 (374)
.+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 222 ~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1222345789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=321.80 Aligned_cols=261 Identities=26% Similarity=0.383 Sum_probs=217.4
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhH-HHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESK-LEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
.+...+.++||+|-||.|.++....+..||+|.++...... .+.|.+|+++|.+++||||+.++++|..++.+++++||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 45567889999999999999999888999999998765544 48999999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+++|+|..|+.+... ..+......+|+.||+.|++||.+.+ ++||||.++|+|++.++++||+|||+++.+...+.
T Consensus 617 mEnGDLnqFl~ahea-pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 617 MENGDLNQFLSAHEL-PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HhcCcHHHHHHhccC-cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCc
Confidence 999999999986422 22455677889999999999999998 99999999999999999999999999998776666
Q ss_pred eeee-cccccccccCccccccCCCCccchhhhHHHHHHHHHh--CCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 230 HVST-KVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT--GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 230 ~~~~-~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
+... ..+-+..|||||.+..++++.++|+|+||+++||+++ .+.||+...++.. .+- ...+.+..
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven---------~~~~~~~~ 760 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VEN---------AGEFFRDQ 760 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHh---------hhhhcCCC
Confidence 5543 4556779999999999999999999999999999876 8889987665431 110 11122221
Q ss_pred c---cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 017262 307 V---RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347 (374)
Q Consensus 307 ~---~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~ 347 (374)
. -...|.-++..+.+|+.+||+.+-++|||++++...|...
T Consensus 761 ~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 761 GRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1 2234556778899999999999999999999998887654
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=317.28 Aligned_cols=265 Identities=21% Similarity=0.237 Sum_probs=202.5
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC--hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 148 (374)
++|++.+.||+|+||.||++..+ +++.+|+|++.... ......+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36899999999999999999975 57889999876532 3334677889999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
|++++++..+.. ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999887765543 2456899999999999999999999999 9999999999999999999999999998754333
Q ss_pred ceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccC---------CChHHHHHHHHHhccc
Q 017262 229 THVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEG---------RNLTTYFVECIEENCL 299 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~---------~~~~~~~~~~~~~~~~ 299 (374)
........|++.|+|||++.+..++.++|||||||++|+|++|+.||......+. ................
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 3233345689999999999988899999999999999999999999975432110 0000000000000000
Q ss_pred ccccccccc------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 300 FDIIDDQVR------KSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 300 ~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.....+... .......+..+.+|+++||+.||++|||++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000 0011124567999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=331.16 Aligned_cols=259 Identities=29% Similarity=0.458 Sum_probs=204.5
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe------cCCcEEEEEEeccCC-hhHHHHHHHHHHHHhhC-CCCceeeeeeeeeeccc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML------ADGRIIAVKKSKVVD-ESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEV 142 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 142 (374)
.++|++.+.||+|+||.||+|.. ..+..+|+|.++... ......+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45789999999999999999973 235689999886432 34456788999999999 89999999999999999
Q ss_pred ceEEEEeecCCcccccccCCC-----------------------------------------------------------
Q 017262 143 PLLVYEFIPNGTLFQYLHDPY----------------------------------------------------------- 163 (374)
Q Consensus 143 ~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------- 163 (374)
.++||||+++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999998885421
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce
Q 017262 164 -------------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230 (374)
Q Consensus 164 -------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 230 (374)
....+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 0124788899999999999999999998 999999999999999999999999999765432221
Q ss_pred e-eecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhcccccccccccc
Q 017262 231 V-STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVR 308 (374)
Q Consensus 231 ~-~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (374)
. .....++..|+|||.+.+..++.++||||||+++|+|++ |..||....... . +......+ .+
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-----~-~~~~~~~~---------~~ 335 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-----K-FYKMIKEG---------YR 335 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-----H-HHHHHHhC---------cc
Confidence 1 122335667999999999999999999999999999998 888986432211 1 11111111 11
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 017262 309 KSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347 (374)
Q Consensus 309 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~ 347 (374)
...+...+..+.+|+.+||+.||++|||+.++++.|++.
T Consensus 336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 111222345789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=329.75 Aligned_cols=247 Identities=28% Similarity=0.427 Sum_probs=211.1
Q ss_pred cCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
+-|++++.||.|+.|.|.+|++ ..|+.+|||.+... .......+.+|+-+|+.+.|||++.+++++.+..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4578899999999999999996 46999999987654 3344566789999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
||+++|-|.+++. ..+++++.++.+++.||+.|+.|+|..+ |+||||||+|+|+|..+++||+|||+|....
T Consensus 92 Eyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~-- 163 (786)
T KOG0588|consen 92 EYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV-- 163 (786)
T ss_pred EecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc--
Confidence 9999999999998 5778999999999999999999999999 9999999999999999999999999997543
Q ss_pred CceeeecccccccccCccccccCCCC-ccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRSSQFT-DKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
......+.+|+|.|.|||++.+.+|. .++||||+|++||.|++|+.||. ++++...+.. +..+.
T Consensus 164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd------DdNir~LLlK-V~~G~-------- 228 (786)
T KOG0588|consen 164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD------DDNIRVLLLK-VQRGV-------- 228 (786)
T ss_pred CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC------CccHHHHHHH-HHcCc--------
Confidence 23345566899999999999999885 68999999999999999999996 3344433322 22221
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 307 VRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
.+.|...+.++++|+.+|+..||+.|.|+++|++-
T Consensus 229 --f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 229 --FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred --ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 22345666789999999999999999999999874
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=331.30 Aligned_cols=260 Identities=28% Similarity=0.466 Sum_probs=205.3
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec------CCcEEEEEEeccC-ChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeeccc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVV-DESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEV 142 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 142 (374)
.++|++.+.||+|+||.||+|... ++..||+|.+... .......+.+|+.+++.+ +|+||+++++++...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 457889999999999999998742 2357999988653 334456788999999999 89999999999999999
Q ss_pred ceEEEEeecCCcccccccCCC-----------------------------------------------------------
Q 017262 143 PLLVYEFIPNGTLFQYLHDPY----------------------------------------------------------- 163 (374)
Q Consensus 143 ~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------- 163 (374)
.+++|||+++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999998875311
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCcee-eec
Q 017262 164 --------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV-STK 234 (374)
Q Consensus 164 --------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~ 234 (374)
....+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||++.......... ...
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 1124788899999999999999999998 9999999999999999999999999987654322211 122
Q ss_pred ccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCH
Q 017262 235 VQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEA 313 (374)
Q Consensus 235 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (374)
..+++.|+|||++.+..++.++||||||+++|+|++ |..||....... . ....... ......+.
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-----~-~~~~~~~---------~~~~~~~~ 338 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-----K-FYKMVKR---------GYQMSRPD 338 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-----H-HHHHHHc---------ccCccCCC
Confidence 335668999999998899999999999999999997 999997532211 1 1111111 11111122
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 017262 314 EEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIR 348 (374)
Q Consensus 314 ~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~ 348 (374)
..+..+.+++.+||+.+|++|||+.++++.|+++.
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 23467899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=316.36 Aligned_cols=249 Identities=36% Similarity=0.579 Sum_probs=196.5
Q ss_pred cCceEeeeCeEEEEEEEec-----CCcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 76 MNRILGQGGQGTVYKGMLA-----DGRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 76 ~~~~lg~G~~g~v~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
+.+.||.|.||.||+|.+. .+..|+||.++.. .......+.+|++.+++++||||+++++++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999976 2568999998654 344578899999999999999999999999988889999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+++|+|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||+++||++++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999853 2467899999999999999999999998 99999999999999999999999999987632222
Q ss_pred -eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccccc
Q 017262 230 -HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307 (374)
Q Consensus 230 -~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (374)
...........|+|||.+.+..++.++||||||+++|||++ |+.||..... .+..... ... .
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~------~~~~~~~-~~~---------~ 222 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN------EEIIEKL-KQG---------Q 222 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH------HHHHHHH-HTT---------E
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccccc-ccc---------c
Confidence 22233457789999999999889999999999999999999 7889864422 1112111 111 1
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 017262 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMEL 344 (374)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L 344 (374)
+...+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 223 ~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 223 RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1222333456788999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=317.03 Aligned_cols=250 Identities=24% Similarity=0.311 Sum_probs=200.1
Q ss_pred CCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCC---hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 74 FNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVD---ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 74 ~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
|+..+.||+|+||.||++.. .+++.+|+|.+.... ......+.+|+.+++.++|+|++++++++.+.+..++++||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 67789999999999999996 568999999876432 22334677899999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+++|+|..++... ....+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.++|+|||++.......
T Consensus 82 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 82 MNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred cCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 9999998877542 2346899999999999999999999999 9999999999999999999999999987643221
Q ss_pred eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccC
Q 017262 230 HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (374)
......|++.|+|||.+.+..++.++|||||||++|+|++|+.||....... ........... ...
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~----------~~~ 222 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV---KREEVDRRVKE----------DQE 222 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch---hHHHHHHHhhc----------ccc
Confidence 2234468999999999999999999999999999999999999997533211 01111111100 011
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 017262 310 SGEAEEIMAVSDVAKRCLNSYGRNRPT-----MKEVAM 342 (374)
Q Consensus 310 ~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~vl~ 342 (374)
..+...+..+.+|+.+||+.||++||+ ++++++
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 223334567889999999999999997 677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=318.38 Aligned_cols=244 Identities=24% Similarity=0.330 Sum_probs=201.2
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC---hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
++|++.+.||+|+||.||+|... +++.+|+|.+.... ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36889999999999999999965 68899999876432 234456889999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
||+++++|.+++. ....+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLR---NSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 9999999999987 3457899999999999999999999999 999999999999999999999999998765321
Q ss_pred CceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (374)
.....|++.|+|||.+.+..++.++|||||||++|+|++|..||..... ......... ..
T Consensus 155 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~------~~~~~~i~~-~~--------- 214 (291)
T cd05612 155 ----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP------FGIYEKILA-GK--------- 214 (291)
T ss_pred ----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHh-CC---------
Confidence 1234589999999999988899999999999999999999999964321 111111111 11
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 017262 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPT-----MKEVAM 342 (374)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~vl~ 342 (374)
...+...+..+.+|+++||+.||.+||+ ++++++
T Consensus 215 -~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 215 -LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred -cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 1122233557889999999999999995 777765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=358.46 Aligned_cols=272 Identities=26% Similarity=0.447 Sum_probs=216.5
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
...+...+.||+|+||.||+|.. .++..||+|++....... ..|++.+++++||||++++++|.+.+..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 45577888999999999999996 578899999886543221 2468899999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+++|+|.+++. .++|..+..++.|++.||+|||.....+++||||||+||+++.++..++. ||.......
T Consensus 765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--- 834 (968)
T PLN00113 765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--- 834 (968)
T ss_pred CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---
Confidence 99999999985 37899999999999999999996544459999999999999999888775 555433221
Q ss_pred eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccC
Q 017262 230 HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (374)
.....+++.|+|||++.+..++.++||||||+++|||++|+.||.... ........|.............+++....
T Consensus 835 --~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 835 --DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred --CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHHHhcCccchhheeCccccC
Confidence 112357899999999999999999999999999999999999995432 23345555655444433344444544432
Q ss_pred --CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCCCcchhh
Q 017262 310 --SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDDENNIQ 359 (374)
Q Consensus 310 --~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~~~~~~~ 359 (374)
..+......+.+++.+|++.+|++|||+.++++.|+.+....++...+++
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~~~~~~~ 963 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSSCVTGLK 963 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccccccccCcc
Confidence 23456667889999999999999999999999999999887776665443
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=316.10 Aligned_cols=263 Identities=27% Similarity=0.432 Sum_probs=213.2
Q ss_pred cCCCcCceEeeeCeEEEEEEEec------CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLL 145 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 145 (374)
++|.+.+.||+|+||.||++... ++..+++|............+.+|++.+++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45788899999999999999742 345688898877666666788999999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCc
Q 017262 146 VYEFIPNGTLFQYLHDPY-------------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR 212 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~ 212 (374)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999986421 1235889999999999999999999999 999999999999999999
Q ss_pred EEEeecccccccccCCc-eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHH
Q 017262 213 AKIADFGTSRSIAIDQT-HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYF 290 (374)
Q Consensus 213 ~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~ 290 (374)
++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+ ..
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------~~ 235 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE------VI 235 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------HH
Confidence 99999999876543221 12233446788999999998899999999999999999998 999986433211 11
Q ss_pred HHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCC
Q 017262 291 VECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRD 353 (374)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~ 353 (374)
+....... ...+...+..+.+++.+||+.+|++|||+.+++++|+.+....+.
T Consensus 236 -~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~~ 288 (291)
T cd05094 236 -ECITQGRV---------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATPI 288 (291)
T ss_pred -HHHhCCCC---------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcCc
Confidence 11111111 111223456789999999999999999999999999999886654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=324.52 Aligned_cols=253 Identities=25% Similarity=0.355 Sum_probs=204.8
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
++|++.+.||+|+||.||+|... +++.+|+|.+... .......+..|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46889999999999999999975 4889999987643 2234567888999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
||+++++|.+++. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999997 3457899999999999999999999999 99999999999999999999999999875432
Q ss_pred CceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (374)
......|++.|+|||.+.+..++.++|||||||++|+|++|..||...... +.+....... .......
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~~i~~~~---~~~~~~~ 221 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN------ETWENLKYWK---ETLQRPV 221 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH------HHHHHHHhcc---ccccCCC
Confidence 233456899999999999889999999999999999999999999743321 1111111100 1111111
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
........+..+.+++.+||..+|++||+++++++.
T Consensus 222 ~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 111112345678899999999999999999999863
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=315.23 Aligned_cols=263 Identities=29% Similarity=0.462 Sum_probs=211.4
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec------CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccce
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPL 144 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 144 (374)
..+|.+.+.||+|+||.||++... ++..+++|.+..........+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 356888999999999999999742 24568899887666666778999999999999999999999999999999
Q ss_pred EEEEeecCCcccccccCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEE
Q 017262 145 LVYEFIPNGTLFQYLHDPY----------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAK 214 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~k 214 (374)
+++||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999886321 1235899999999999999999999999 99999999999999999999
Q ss_pred EeecccccccccCCce-eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHH
Q 017262 215 IADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVE 292 (374)
Q Consensus 215 l~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~ 292 (374)
|+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... ... .
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~------~~~-~ 233 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN------EVI-E 233 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------HHH-H
Confidence 9999998765432221 1223345778999999998889999999999999999998 89998643321 111 1
Q ss_pred HHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCC
Q 017262 293 CIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSR 352 (374)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~ 352 (374)
........ ..+...+..+.+|+.+||+.||.+|||+.++.+.|+.+.....
T Consensus 234 ~i~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~ 284 (288)
T cd05093 234 CITQGRVL---------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASP 284 (288)
T ss_pred HHHcCCcC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhcc
Confidence 11111111 1111234578999999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=308.16 Aligned_cols=282 Identities=23% Similarity=0.301 Sum_probs=216.9
Q ss_pred HHHHhhcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEec--cCChhHHHHHHHHHHHHhhCCCCceeeeeeeeee---
Q 017262 66 ELDKATDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSK--VVDESKLEEFINEVVILSQINHRNVVKLLGCCLE--- 139 (374)
Q Consensus 66 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--- 139 (374)
+......+|...+.||+|+||.|+.+.. .+|..||+|++. ..+....+...+|+.+|+.++|+||+.+.+++..
T Consensus 16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 4445567777789999999999999995 468999999987 4567777888999999999999999999999875
Q ss_pred --cccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEee
Q 017262 140 --VEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIAD 217 (374)
Q Consensus 140 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~D 217 (374)
-+..|+|+|+| +.+|...++ .+..++...+..++.|+++||.|+|+.+ |+||||||+|+|++.++.+|++|
T Consensus 96 ~~f~DvYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~D 168 (359)
T KOG0660|consen 96 DKFNDVYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICD 168 (359)
T ss_pred cccceeEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecc
Confidence 23679999999 779999887 4556999999999999999999999999 99999999999999999999999
Q ss_pred cccccccccC-CceeeecccccccccCccccc-cCCCCccchhhhHHHHHHHHHhCCCCCCccccccC--------CChH
Q 017262 218 FGTSRSIAID-QTHVSTKVQGTFGYLDPEYFR-SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEG--------RNLT 287 (374)
Q Consensus 218 fg~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~--------~~~~ 287 (374)
||+|+..... .....+.++.|.+|.|||.+. ...|+.+.||||.||++.||++|+.-|++....+. ....
T Consensus 169 FGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~ 248 (359)
T KOG0660|consen 169 FGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS 248 (359)
T ss_pred ccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC
Confidence 9999876532 233457778999999999875 56799999999999999999999999986543221 1111
Q ss_pred HHHHHHHHhcccccccccccc------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHHHHhhCCCC
Q 017262 288 TYFVECIEENCLFDIIDDQVR------KSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM--ELERIRANSRDD 354 (374)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~--~L~~~~~~~~~~ 354 (374)
......+........+..... ...-+...+...+|+++||..||.+|+|++|+++ -|........++
T Consensus 249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence 111111111111111111110 0112245568889999999999999999999987 455544433333
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=325.91 Aligned_cols=245 Identities=29% Similarity=0.506 Sum_probs=213.9
Q ss_pred CceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeecCCccc
Q 017262 77 NRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLF 156 (374)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~ 156 (374)
.+-||.|+.|.||+|+.. +..||||+++...+ .+|+-|++|+||||+.|.|+|....-+|||||||..|-|.
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 356999999999999986 56799998764333 4688899999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceeeeccc
Q 017262 157 QYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQ 236 (374)
Q Consensus 157 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 236 (374)
+.|. .+..++......|..+||.|+.|||.+. |||||||.=||||+.+..+||+|||-++.+... ...-...
T Consensus 201 ~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFa 272 (904)
T KOG4721|consen 201 EVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFA 272 (904)
T ss_pred HHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhh
Confidence 9998 5678999999999999999999999999 999999999999999999999999999876543 2233457
Q ss_pred ccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCHHHH
Q 017262 237 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEI 316 (374)
Q Consensus 237 g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (374)
||..|||||++.+.+.+.|+||||||++||||+||+.||.+..... -++.+-...+....+..++
T Consensus 273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA---------------IIwGVGsNsL~LpvPstcP 337 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA---------------IIWGVGSNSLHLPVPSTCP 337 (904)
T ss_pred hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe---------------eEEeccCCcccccCcccCc
Confidence 9999999999999999999999999999999999999997544322 1445555666667788899
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCC
Q 017262 317 MAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSR 352 (374)
Q Consensus 317 ~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~ 352 (374)
..|.-|++.||+..|..||++.+++.-|+-..++.-
T Consensus 338 ~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell 373 (904)
T KOG4721|consen 338 DGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELL 373 (904)
T ss_pred hHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHh
Confidence 999999999999999999999999999988776654
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=310.79 Aligned_cols=255 Identities=24% Similarity=0.458 Sum_probs=206.7
Q ss_pred cCCCcCceEeeeCeEEEEEEEecC----CcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLAD----GRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
++|++.+.||+|+||.||+|.+.. ...+++|..... .......+.+|+.++++++||||+++++++...+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568899999999999999998642 457899987654 334456788999999999999999999999998999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
|||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 9999999999998752 347899999999999999999999998 99999999999999999999999999987652
Q ss_pred CCce-eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhcccccccc
Q 017262 227 DQTH-VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIID 304 (374)
Q Consensus 227 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (374)
.... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... .. ......
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~------~~-~~~~~~------- 224 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD------VI-KAVEDG------- 224 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH------HH-HHHHcC-------
Confidence 2222 1222335678999999998899999999999999999998 999986432211 11 111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 017262 305 DQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347 (374)
Q Consensus 305 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~ 347 (374)
.....+...+..+.+++.+|++.+|++||+++++++.|+++
T Consensus 225 --~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 225 --YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11112233456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=311.28 Aligned_cols=252 Identities=27% Similarity=0.424 Sum_probs=203.6
Q ss_pred cCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeec
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIP 151 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 151 (374)
++|.+.+.||+|+||.||.|...++..+++|.+..... ....+.+|+.++++++||||+++++++.+.+..+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 45788899999999999999987777799998775432 34678899999999999999999999998888999999999
Q ss_pred CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCcee
Q 017262 152 NGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV 231 (374)
Q Consensus 152 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 231 (374)
+++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||.+..........
T Consensus 83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 99999998752 336899999999999999999999999 9999999999999999999999999987654332222
Q ss_pred eecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccccccCC
Q 017262 232 STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKS 310 (374)
Q Consensus 232 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (374)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ..... ..... ...
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------~~~~~-~~~~~---------~~~ 221 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS------ETVEK-VSQGL---------RLY 221 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH------HHHHH-HhcCC---------CCC
Confidence 222335678999999998889999999999999999998 99998643321 11111 11111 111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017262 311 GEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345 (374)
Q Consensus 311 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~ 345 (374)
.+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 11123468899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=314.20 Aligned_cols=263 Identities=25% Similarity=0.353 Sum_probs=208.3
Q ss_pred HHHHhhcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCC--------------hhHHHHHHHHHHHHhhCCCCce
Q 017262 66 ELDKATDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVD--------------ESKLEEFINEVVILSQINHRNV 130 (374)
Q Consensus 66 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--------------~~~~~~~~~e~~~l~~l~h~ni 130 (374)
+-...-+.|++.+.||+|.||.|-+|.. .+++.||+|++.... ....+...+|+.+|++++||||
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 3344457899999999999999999995 468999999775421 1223578899999999999999
Q ss_pred eeeeeeeeec--ccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEEC
Q 017262 131 VKLLGCCLEV--EVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD 208 (374)
Q Consensus 131 v~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~ 208 (374)
|+++++..+. +..|+|+|||..|.+...-. ....+++.+++++++++..||+|||.++ |+||||||+|+|++
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLS 244 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEc
Confidence 9999998754 47899999999887654332 2333999999999999999999999999 99999999999999
Q ss_pred CCCcEEEeecccccccccC----CceeeecccccccccCccccccCC----CCccchhhhHHHHHHHHHhCCCCCCcccc
Q 017262 209 EKYRAKIADFGTSRSIAID----QTHVSTKVQGTFGYLDPEYFRSSQ----FTDKSDVYSFGVVLVELLTGQKPISSIWA 280 (374)
Q Consensus 209 ~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Di~slG~~l~el~~g~~p~~~~~~ 280 (374)
++|++||+|||.+...... .........|||.|+|||...++. .+.+.||||+|++||.|+.|+.||-....
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~ 324 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE 324 (576)
T ss_pred CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence 9999999999998765222 111223467999999999987633 35688999999999999999999964322
Q ss_pred ccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 017262 281 NEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRA 349 (374)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~ 349 (374)
... ...+++..+.....++..+.+.+||++||..||+.|.+..+|..-...-+.
T Consensus 325 ------~~l---------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 325 ------LEL---------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred ------HHH---------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 222 233445555555555677889999999999999999999998776554443
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=319.46 Aligned_cols=262 Identities=27% Similarity=0.379 Sum_probs=204.5
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 148 (374)
.++|++.+.||+|+||.||++... ++..+|+|.+... .......+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 467999999999999999999965 5788899987654 33445678999999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ +++|+||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 9999999999873 456899999999999999999999863 2999999999999999999999999998755322
Q ss_pred ceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHH---hc--------
Q 017262 229 THVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIE---EN-------- 297 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~-------- 297 (374)
......|++.|+|||.+.+..++.++|||||||++|+|++|+.||......+ +...+..... ..
T Consensus 158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCcc
Confidence 1233468999999999998899999999999999999999999996433211 0000000000 00
Q ss_pred ----------------------c-ccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 298 ----------------------C-LFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 298 ----------------------~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
. .................+..+.+|+.+||+.||++|||++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0 000000000011112345679999999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=323.89 Aligned_cols=251 Identities=23% Similarity=0.356 Sum_probs=214.4
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC--hhHHHHHHHHHHHHhhCCCCceeeeeeeeeeccc-ceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEV-PLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~lv~ 147 (374)
++|...+.+|+|+||.++..+.+ +++.+++|.+.... ........+|+.+++++.|||||.+.+.|..++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57889999999999999999854 57889999876643 3334477899999999999999999999999888 89999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
+||+||+|.+.+...+ +..++++.+..|+.|++.|+.|||++. |.|||||+.|||++.++.+||+|||+++.+...
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999998753 567999999999999999999999888 999999999999999999999999999987754
Q ss_pred CceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (374)
. .......|||.|++||.+.+.+|+.|+|||||||++|||++-+.+|...+ +...+.+.. ...
T Consensus 160 ~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~------m~~Li~ki~----------~~~ 222 (426)
T KOG0589|consen 160 D-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN------MSELILKIN----------RGL 222 (426)
T ss_pred h-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc------hHHHHHHHh----------hcc
Confidence 4 34566789999999999999999999999999999999999999996432 222222211 111
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
....+...+.++..|++.|++.+|..||++.+++..
T Consensus 223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 233455667789999999999999999999999986
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=324.37 Aligned_cols=244 Identities=25% Similarity=0.321 Sum_probs=200.4
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
++|.+.+.||+|+||.||+|... +++.+|+|.+... .......+.+|+.++++++||||+++++++.+.+..+++|
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56889999999999999999975 5789999987642 2234467889999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
||+++++|.+++.. ...+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++......
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999999873 457889999999999999999999999 999999999999999999999999999765322
Q ss_pred CceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (374)
. ....|++.|+|||.+.+..++.++|||||||++|+|++|..||..... ...... .....
T Consensus 172 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~~~~-i~~~~--------- 231 (329)
T PTZ00263 172 T----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP------FRIYEK-ILAGR--------- 231 (329)
T ss_pred c----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH------HHHHHH-HhcCC---------
Confidence 1 234689999999999999899999999999999999999999964321 111111 11111
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 017262 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPT-----MKEVAM 342 (374)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~vl~ 342 (374)
...+...+..+.+|+.+||+.||++||+ +++++.
T Consensus 232 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 232 -LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred -cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1112223457889999999999999997 576663
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=323.00 Aligned_cols=241 Identities=24% Similarity=0.303 Sum_probs=197.3
Q ss_pred ceEeeeCeEEEEEEEe-cCCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeecCC
Q 017262 78 RILGQGGQGTVYKGML-ADGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNG 153 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 153 (374)
+.||+|+||.||++.. .+|+.+|+|.+... .......+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999986 46889999987642 2334456788999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceeee
Q 017262 154 TLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVST 233 (374)
Q Consensus 154 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 233 (374)
+|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...... .....
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~ 153 (323)
T cd05571 81 ELFFHLS---RERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMK 153 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCccc
Confidence 9999887 3457899999999999999999999999 999999999999999999999999998753221 12223
Q ss_pred cccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCH
Q 017262 234 KVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEA 313 (374)
Q Consensus 234 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (374)
...||+.|+|||.+.+..++.++|||||||++|||++|..||..... ........ .. ....+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~~~-~~----------~~~~p~ 216 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELIL-ME----------EIRFPR 216 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH------HHHHHHHH-cC----------CCCCCC
Confidence 45689999999999999999999999999999999999999964321 11111111 11 012233
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 017262 314 EEIMAVSDVAKRCLNSYGRNRP-----TMKEVAM 342 (374)
Q Consensus 314 ~~~~~l~~li~~cl~~~p~~Rp-----s~~~vl~ 342 (374)
..+..+.+|+.+||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 4456788999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=314.93 Aligned_cols=256 Identities=30% Similarity=0.487 Sum_probs=206.6
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecC------CcEEEEEEeccCChh-HHHHHHHHHHHHhhCCCCceeeeeeeeeecccc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLAD------GRIIAVKKSKVVDES-KLEEFINEVVILSQINHRNVVKLLGCCLEVEVP 143 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 143 (374)
.+.|.+.+.||+|+||.||+|...+ +..+++|.+...... ....+.+|+++++.++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3468888999999999999998643 478999988765443 457889999999999999999999999999999
Q ss_pred eEEEEeecCCcccccccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCc
Q 017262 144 LLVYEFIPNGTLFQYLHDPY-----------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR 212 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~ 212 (374)
+++|||+++++|.+++.... ....+++..+..++.|++.|+.|||+++ ++|+||+|+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999986421 2345788999999999999999999999 999999999999999999
Q ss_pred EEEeecccccccccCCc-eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHH
Q 017262 213 AKIADFGTSRSIAIDQT-HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYF 290 (374)
Q Consensus 213 ~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~ 290 (374)
++|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+ ..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~------~~ 234 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE------VI 234 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH------HH
Confidence 99999999875432221 11223345788999999999999999999999999999998 999986433211 11
Q ss_pred HHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017262 291 VECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345 (374)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~ 345 (374)
.....+. ....+...+..+.+++.+||+.||++|||+.|+++.|+
T Consensus 235 -~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 235 -ECITQGR---------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred -HHHHcCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1111111 11122334567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=314.08 Aligned_cols=256 Identities=30% Similarity=0.467 Sum_probs=206.6
Q ss_pred cCCCcCceEeeeCeEEEEEEEecC------CcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccce
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLAD------GRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPL 144 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 144 (374)
++|++.+.||+|+||.||+|.... ...+++|.+.... ......+.+|+..+++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467888999999999999998543 2578999876433 344567889999999999999999999999888999
Q ss_pred EEEEeecCCcccccccCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCC
Q 017262 145 LVYEFIPNGTLFQYLHDPYE-------------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY 211 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~ 211 (374)
+++||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999864311 146888999999999999999999999 99999999999999999
Q ss_pred cEEEeecccccccccCCc-eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHH
Q 017262 212 RAKIADFGTSRSIAIDQT-HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTY 289 (374)
Q Consensus 212 ~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~ 289 (374)
.++|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |..||...... +
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~------~- 234 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ------E- 234 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH------H-
Confidence 999999999876543222 12233446788999999988889999999999999999998 99998653321 1
Q ss_pred HHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 017262 290 FVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELER 346 (374)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~ 346 (374)
....+... .....+...+..+.+|+.+||+.||++||++.++++.|+.
T Consensus 235 ~~~~i~~~---------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 235 VIEMIRSR---------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcC---------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11111111 1122334556789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=334.86 Aligned_cols=251 Identities=22% Similarity=0.288 Sum_probs=205.0
Q ss_pred CCCcCceEeeeCeEEEEEEEec-C-CcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEee
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-D-GRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFI 150 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 150 (374)
.|.+.+.||+|+||.||+|... + +..+++|............+..|+.+++.++||||+++++++...+..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4889999999999999999854 3 5778888776666666677888999999999999999999999999999999999
Q ss_pred cCCcccccccCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 151 PNGTLFQYLHDP-YEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 151 ~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
++|+|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999887542 13456889999999999999999999998 99999999999999999999999999986543222
Q ss_pred -eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccccc
Q 017262 230 -HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVR 308 (374)
Q Consensus 230 -~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (374)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ......... ...
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~~-~~~--------- 288 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVLY-GKY--------- 288 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHh-CCC---------
Confidence 123345689999999999999999999999999999999999999964321 111111111 100
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 309 KSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 309 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
...+...+..+.+++.+||..+|++||++.+++.
T Consensus 289 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 289 DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1122334567899999999999999999999875
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=313.67 Aligned_cols=264 Identities=22% Similarity=0.295 Sum_probs=198.2
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
++|.+.+.||.|+||.||+|... +++.+|+|.+.... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56899999999999999999965 57899999876432 22334677899999999999999999999988899999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+++ +|.+++.. ....+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~- 157 (288)
T cd07871 85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT- 157 (288)
T ss_pred CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence 975 88888764 2345789999999999999999999999 9999999999999999999999999987543222
Q ss_pred eeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCC---------ChHHHHHHHHHhccc
Q 017262 230 HVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGR---------NLTTYFVECIEENCL 299 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~---------~~~~~~~~~~~~~~~ 299 (374)
.......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||......+.. ...............
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 12233457899999999865 56899999999999999999999999754322100 000000000000000
Q ss_pred cccccccccCC----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 300 FDIIDDQVRKS----GEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 300 ~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.....+..... ..+..+..+.+|+.+||+.||.+|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 11111110000 01123457889999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=317.48 Aligned_cols=258 Identities=25% Similarity=0.483 Sum_probs=205.8
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCc----EEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGR----IIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLL 145 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 145 (374)
.+|++.+.||+|+||.||+|.+. ++. .+|+|.+... .......+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46889999999999999999854 333 4899987654 344556788999999999999999999998764 5789
Q ss_pred EEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccc
Q 017262 146 VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 225 (374)
+++|+++|+|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 99999999999998752 346889999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCcee-eecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccc
Q 017262 226 IDQTHV-STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDII 303 (374)
Q Consensus 226 ~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (374)
...... .....++..|+|||.+.+..++.++||||||+++|||++ |..||...... . +.......
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~------~-~~~~~~~~------ 227 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS------E-ISSILEKG------ 227 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH------H-HHHHHhCC------
Confidence 333221 122234678999999999999999999999999999997 99998643221 1 11111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhC
Q 017262 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANS 351 (374)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~ 351 (374)
.....+...+..+.+++.+||..+|++|||+.+++..|..+..+.
T Consensus 228 ---~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 228 ---ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred ---CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 111112233457889999999999999999999999999887644
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=308.95 Aligned_cols=251 Identities=28% Similarity=0.450 Sum_probs=202.0
Q ss_pred cCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeec
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIP 151 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 151 (374)
.+|++.+.||+|+||.||++.+.++..+++|....... ....+.+|++++++++||||+++++++...+..++++||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 35788899999999999999987777899998754322 23567889999999999999999999998889999999999
Q ss_pred CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCcee
Q 017262 152 NGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV 231 (374)
Q Consensus 152 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 231 (374)
+++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||+++.........
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 99999998742 336899999999999999999999999 9999999999999999999999999987654322221
Q ss_pred eecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccccccCC
Q 017262 232 STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKS 310 (374)
Q Consensus 232 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (374)
.....++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+ .... ... .....
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~-~~~---------~~~~~ 221 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE------VVES-VSA---------GYRLY 221 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH------HHHH-HHc---------CCcCC
Confidence 122224457999999998899999999999999999999 899986432211 1111 111 11112
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 017262 311 GEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMEL 344 (374)
Q Consensus 311 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L 344 (374)
.+...+..+.+++.+||..+|++|||+.++++.|
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 2223466899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=307.90 Aligned_cols=255 Identities=27% Similarity=0.408 Sum_probs=205.5
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEee
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFI 150 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 150 (374)
.++|++.+.||+|+||.||+|...++..+++|.+..... ....+.+|+.+++.++||||+++++.+. .+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 356899999999999999999987777899998875332 2357889999999999999999999874 45679999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 230 (374)
++++|.+++... ....+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||.+.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999999743 2346789999999999999999999998 999999999999999999999999999765433322
Q ss_pred eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccccccC
Q 017262 231 VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309 (374)
Q Consensus 231 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (374)
......++..|+|||...+..++.++||||||+++|+|++ |..||...... .... .... ....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~------~~~~-~~~~---------~~~~ 222 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLD-QVER---------GYRM 222 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH------HHHH-HHhc---------CCCC
Confidence 2223346678999999988889999999999999999999 88898643221 1111 1111 1111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 017262 310 SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347 (374)
Q Consensus 310 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~ 347 (374)
..+...+..+.+++.+|++.+|++||++.++++.|+..
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 22345567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=325.11 Aligned_cols=262 Identities=28% Similarity=0.426 Sum_probs=207.7
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEecC------CcEEEEEEeccCC-hhHHHHHHHHHHHHhhCC-CCceeeeeeeeeecc
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLAD------GRIIAVKKSKVVD-ESKLEEFINEVVILSQIN-HRNVVKLLGCCLEVE 141 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~ 141 (374)
..++|.+.+.||+|+||.||+|.... +..||+|++.... ....+.+.+|+.++++++ ||||+++++++.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 35678899999999999999998532 3469999886543 344567899999999996 999999999999999
Q ss_pred cceEEEEeecCCcccccccCCC----------------------------------------------------------
Q 017262 142 VPLLVYEFIPNGTLFQYLHDPY---------------------------------------------------------- 163 (374)
Q Consensus 142 ~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------- 163 (374)
..++||||+++|+|.+++....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999999999998875321
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEEC
Q 017262 164 -----------------------------------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD 208 (374)
Q Consensus 164 -----------------------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~ 208 (374)
....+++..+..++.|++.||+|||+.+ ++|+||||+||+++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 0124778888999999999999999998 99999999999999
Q ss_pred CCCcEEEeecccccccccCCce-eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCCh
Q 017262 209 EKYRAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNL 286 (374)
Q Consensus 209 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~ 286 (374)
.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~---- 347 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS---- 347 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH----
Confidence 9999999999998765432221 1222346788999999998889999999999999999997 999987432111
Q ss_pred HHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 017262 287 TTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRA 349 (374)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~ 349 (374)
.+...... ......+...+..+.+++.+||+.+|++|||+.++.+.|+++..
T Consensus 348 --~~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 348 --TFYNKIKS---------GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred --HHHHHHhc---------CCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 01111111 11122233456689999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=307.67 Aligned_cols=254 Identities=28% Similarity=0.441 Sum_probs=204.6
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEee
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFI 150 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 150 (374)
.++|++.+.||+|+||.||+|...++..+++|.+..... ....+.+|+.++++++|+|++++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 346888999999999999999988888899998875433 2356889999999999999999999875 45688999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 230 (374)
++++|.+++... ....+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 83 SKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 999999998753 2346899999999999999999999998 999999999999999999999999999765432222
Q ss_pred eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccccccC
Q 017262 231 VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309 (374)
Q Consensus 231 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (374)
......++..|+|||.+.+..++.++|+||||+++|+|++ |..||..... .+.... ... ....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~------~~~~~~-~~~---------~~~~ 222 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN------REVLEQ-VER---------GYRM 222 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH------HHHHHH-HHc---------CCCC
Confidence 2222335668999999988889999999999999999999 8999964321 111111 111 1111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 017262 310 SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELER 346 (374)
Q Consensus 310 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~ 346 (374)
..+...+..+.+++.+|+..+|++|||+.++.+.|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 2233445679999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=308.19 Aligned_cols=254 Identities=27% Similarity=0.457 Sum_probs=205.9
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEee
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFI 150 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 150 (374)
.+.|++.+.||+|+||.||+|...+++.+++|.+..... ....+.+|+.++++++|+|++++++++. .+..++++||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 467889999999999999999988899999998875433 3467889999999999999999998864 45789999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 230 (374)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 83 ENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 999999988653 3457899999999999999999999998 999999999999999999999999998765432222
Q ss_pred eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccccccC
Q 017262 231 VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309 (374)
Q Consensus 231 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (374)
......++..|+|||.+....++.++||||||+++|+|++ |+.||...... ..... .... ...
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~-~~~~---------~~~ 222 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP------EVIQN-LERG---------YRM 222 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH------HHHHH-HHcC---------CCC
Confidence 2223345678999999998889999999999999999999 99999643321 11111 1111 111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 017262 310 SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELER 346 (374)
Q Consensus 310 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~ 346 (374)
..+...+..+.+++.+|++.+|++|||+++++..|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1222345579999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=322.79 Aligned_cols=243 Identities=26% Similarity=0.353 Sum_probs=205.3
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccce
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVPL 144 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 144 (374)
.-++|.+.++||+|+||+|+++..+ +++.+|||.++.. ...+......|..++... +||.+++++.+|...++.|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 3468999999999999999999965 5789999988764 455667778888888877 4999999999999999999
Q ss_pred EEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccc
Q 017262 145 LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 224 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 224 (374)
+||||+.||++..+. ....+++..+.-++..++.||.|||+++ ||+||||.+|||+|.+|.+||+|||+++..
T Consensus 446 fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccccc
Confidence 999999999955544 3568999999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccc
Q 017262 225 AIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIID 304 (374)
Q Consensus 225 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (374)
.. .....++..|||.|+|||++.+..|+.++|.|||||+||||+.|+.||++.+.++ .+.....++
T Consensus 519 m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee------~FdsI~~d~------- 584 (694)
T KOG0694|consen 519 MG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE------VFDSIVNDE------- 584 (694)
T ss_pred CC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHhcCC-------
Confidence 42 2335567889999999999999999999999999999999999999998544332 232222211
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 017262 305 DQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTM 337 (374)
Q Consensus 305 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 337 (374)
..+|...+.+...+++++|+.||++|.-+
T Consensus 585 ----~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 585 ----VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ----CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 22555667788999999999999999766
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=318.39 Aligned_cols=245 Identities=24% Similarity=0.324 Sum_probs=200.2
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecC--CcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLAD--GRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLL 145 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~--~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 145 (374)
.++|++.+.||+|+||.||+|...+ +..+|+|.+... .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 4568999999999999999998543 368999987542 23345678899999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccc
Q 017262 146 VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 225 (374)
||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++....
T Consensus 109 v~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 9999999999999973 457899999999999999999999999 9999999999999999999999999997653
Q ss_pred cCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccc
Q 017262 226 IDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDD 305 (374)
Q Consensus 226 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (374)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|..||..... ........ ..
T Consensus 183 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~------~~~~~~i~-~~-------- 243 (340)
T PTZ00426 183 TR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP------LLIYQKIL-EG-------- 243 (340)
T ss_pred CC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH------HHHHHHHh-cC--------
Confidence 21 2334689999999999988899999999999999999999999964321 11111111 11
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 017262 306 QVRKSGEAEEIMAVSDVAKRCLNSYGRNRP-----TMKEVAM 342 (374)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~vl~ 342 (374)
. ...+...+..+.+++++|++.+|++|+ +++++++
T Consensus 244 ~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 244 I--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred C--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 0 112223345688999999999999995 7888765
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=325.54 Aligned_cols=251 Identities=26% Similarity=0.352 Sum_probs=204.2
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
++|.+.+.||+|+||.||+|... +++.+|+|.+... .......+..|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999965 6889999987643 2244567889999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 99999999999974 367899999999999999999999998 999999999999999999999999998765433
Q ss_pred C----------------------------ceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccc
Q 017262 228 Q----------------------------THVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIW 279 (374)
Q Consensus 228 ~----------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~ 279 (374)
. ........||+.|+|||.+.+..++.++|||||||++|+|++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 112234568999999999999999999999999999999999999997533
Q ss_pred cccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 017262 280 ANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPT-MKEVAM 342 (374)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-~~~vl~ 342 (374)
.. ......... ............+..+.+||.+|+. +|.+||+ ++++++
T Consensus 235 ~~------~~~~~i~~~-------~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 235 LQ------ETYNKIINW-------KESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred HH------HHHHHHhcc-------CCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 11 111111110 0111111111245688899999997 9999999 999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=321.15 Aligned_cols=259 Identities=21% Similarity=0.260 Sum_probs=198.0
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
..+|.+.+.||+|+||.||++... .++.+|+|... ...+.+|+.++++++||||+++++++......++++|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 467999999999999999999964 57889999643 23567899999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+. ++|..++.. ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 94 688887763 456899999999999999999999998 99999999999999999999999999875433222
Q ss_pred eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCC-ChHHHHHHHHHhc-c---------
Q 017262 230 HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGR-NLTTYFVECIEEN-C--------- 298 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~-~--------- 298 (374)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||......... .....+....... .
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 2334456999999999999989999999999999999999999887533221110 0000000000000 0
Q ss_pred ---cccc---------ccccccC--CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 299 ---LFDI---------IDDQVRK--SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 299 ---~~~~---------~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
+... ..+..+. ......+..+.+|+.+||+.||++|||++|+++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 0000000 001134568899999999999999999999985
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=318.40 Aligned_cols=241 Identities=25% Similarity=0.302 Sum_probs=196.2
Q ss_pred ceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeecCC
Q 017262 78 RILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNG 153 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 153 (374)
+.||+|+||.||++... +|+.+|+|.+... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999964 6889999987642 2334556778999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceeee
Q 017262 154 TLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVST 233 (374)
Q Consensus 154 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 233 (374)
+|..++. ....+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++...... .....
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~ 153 (323)
T cd05595 81 ELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMK 153 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCccc
Confidence 9998886 3457899999999999999999999999 999999999999999999999999998753221 12223
Q ss_pred cccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCH
Q 017262 234 KVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEA 313 (374)
Q Consensus 234 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (374)
...|++.|+|||.+.+..++.++|||||||++|+|++|+.||...... ........ .. ...+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~~~~-~~----------~~~p~ 216 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELILM-EE----------IRFPR 216 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHhc-CC----------CCCCC
Confidence 356899999999999889999999999999999999999999643221 11111111 00 11223
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 017262 314 EEIMAVSDVAKRCLNSYGRNRP-----TMKEVAM 342 (374)
Q Consensus 314 ~~~~~l~~li~~cl~~~p~~Rp-----s~~~vl~ 342 (374)
..+..+.+++.+||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 3456788999999999999998 7888775
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=318.49 Aligned_cols=261 Identities=30% Similarity=0.460 Sum_probs=205.6
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec------CCcEEEEEEeccCC-hhHHHHHHHHHHHHhhC-CCCceeeeeeeeeec-c
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVVD-ESKLEEFINEVVILSQI-NHRNVVKLLGCCLEV-E 141 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~ 141 (374)
.++|++.+.||+|+||.||+|... .++.||+|++.... ......+..|+.+++++ +|+||+++++++... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 357899999999999999999742 24689999886532 33456788899999999 899999999988754 4
Q ss_pred cceEEEEeecCCcccccccCCCC---------------------------------------------------------
Q 017262 142 VPLLVYEFIPNGTLFQYLHDPYE--------------------------------------------------------- 164 (374)
Q Consensus 142 ~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 164 (374)
..++++||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999988753211
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCcee-eeccccccccc
Q 017262 165 -ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV-STKVQGTFGYL 242 (374)
Q Consensus 165 -~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~ 242 (374)
...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++..+....... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 136789999999999999999999998 9999999999999999999999999998754322221 22334567899
Q ss_pred CccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHH
Q 017262 243 DPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSD 321 (374)
Q Consensus 243 aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 321 (374)
|||++.+..++.++|||||||++|+|++ |..||......+ ......... .....+...+..+.+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~---------~~~~~~~~~~~~~~~ 307 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRLKEG---------TRMRAPEYATPEIYS 307 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHHhcc---------CCCCCCccCCHHHHH
Confidence 9999999999999999999999999998 999996432211 111111111 111122334567899
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 017262 322 VAKRCLNSYGRNRPTMKEVAMELERIRA 349 (374)
Q Consensus 322 li~~cl~~~p~~Rps~~~vl~~L~~~~~ 349 (374)
++.+||+.+|++||++.++++.|+++.+
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=316.20 Aligned_cols=199 Identities=28% Similarity=0.445 Sum_probs=174.2
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 148 (374)
.++|++.+.||+|+||.||++... ++..+++|.+... .......+.+|+++++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468999999999999999999975 5788888877653 33445678899999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSS-AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. + ++|+||||+|||+++++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 9999999999873 45688999999999999999999985 5 999999999999999999999999998754321
Q ss_pred CceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSI 278 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 278 (374)
......|++.|+|||++.+..++.++|+|||||++|+|++|+.||...
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 123346889999999999888999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=315.61 Aligned_cols=239 Identities=26% Similarity=0.304 Sum_probs=194.2
Q ss_pred EeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeecCCcc
Q 017262 80 LGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTL 155 (374)
Q Consensus 80 lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 155 (374)
||+|+||.||++... +++.+|+|.+... .......+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999975 5788999987642 334456778899999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceeeecc
Q 017262 156 FQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKV 235 (374)
Q Consensus 156 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 235 (374)
.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....... ......
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 153 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTF 153 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Cccccc
Confidence 999873 457899999999999999999999999 9999999999999999999999999987543222 223345
Q ss_pred cccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCHHH
Q 017262 236 QGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEE 315 (374)
Q Consensus 236 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (374)
.||+.|+|||.+.+..++.++|||||||++|+|++|..||.... ........... ....+...
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~------~~~~~~~~~~~-----------~~~~~~~~ 216 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN------VNEMYRKILQE-----------PLRFPDGF 216 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC------HHHHHHHHHcC-----------CCCCCCcC
Confidence 68999999999999999999999999999999999999996432 22222211111 11223344
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 316 IMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 316 ~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
+..+.+++.+||+.||++||++..+.+
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~~e 243 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGAQE 243 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCHHH
Confidence 567889999999999999986543333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=310.04 Aligned_cols=257 Identities=27% Similarity=0.457 Sum_probs=203.5
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEec------CCcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeeccc
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEV 142 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 142 (374)
..++|++.+.||+|+||.||+|... .+..+|+|.+... .......+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567999999999999999998753 2467999987543 23445678899999999999999999999998889
Q ss_pred ceEEEEeecCCcccccccCCCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEE
Q 017262 143 PLLVYEFIPNGTLFQYLHDPYE-------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKI 215 (374)
Q Consensus 143 ~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl 215 (374)
.+++|||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999864221 234678889999999999999999998 999999999999999999999
Q ss_pred eecccccccccCCceee-ecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHH
Q 017262 216 ADFGTSRSIAIDQTHVS-TKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVEC 293 (374)
Q Consensus 216 ~Dfg~~~~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~ 293 (374)
+|||++........... ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... . ....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~------~-~~~~ 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE------Q-VLRF 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------H-HHHH
Confidence 99999876543222211 22345778999999998889999999999999999999 78898643221 1 1111
Q ss_pred HHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017262 294 IEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345 (374)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~ 345 (374)
....... ..+...+..+.+++.+|++.+|++|||+.++++.|+
T Consensus 234 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 234 VMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 1111111 112234557899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=317.79 Aligned_cols=241 Identities=24% Similarity=0.306 Sum_probs=196.6
Q ss_pred ceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeecCC
Q 017262 78 RILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNG 153 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 153 (374)
+.||+|+||.||++... +++.+|+|.+... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999964 5889999987643 2334567788999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceeee
Q 017262 154 TLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVST 233 (374)
Q Consensus 154 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 233 (374)
+|..++. ....+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++...... .....
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~ 153 (328)
T cd05593 81 ELFFHLS---RERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMK 153 (328)
T ss_pred CHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc-ccccc
Confidence 9998886 3457899999999999999999999999 999999999999999999999999998753221 12223
Q ss_pred cccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCH
Q 017262 234 KVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEA 313 (374)
Q Consensus 234 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (374)
...|++.|+|||.+.+..++.++|||||||++|+|++|..||...... ........ . ....+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~~~~~~~-~----------~~~~p~ 216 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILM-E----------DIKFPR 216 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------HHHHHhcc-C----------CccCCC
Confidence 456899999999999889999999999999999999999999643221 11111100 0 011223
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 017262 314 EEIMAVSDVAKRCLNSYGRNRP-----TMKEVAM 342 (374)
Q Consensus 314 ~~~~~l~~li~~cl~~~p~~Rp-----s~~~vl~ 342 (374)
..+..+.+++.+||..||++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 3456788999999999999997 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=306.04 Aligned_cols=256 Identities=29% Similarity=0.452 Sum_probs=208.3
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
..++|.+.+.||+|+||.||+|...++..+++|.+..... ....+.+|+.++++++|+|++++++++......+++|||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 3567899999999999999999988888899998875433 346788999999999999999999999988899999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+++++|.+++... ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 83 ~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 83 MSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred cCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999999999753 2346899999999999999999999998 99999999999999999999999999876543222
Q ss_pred eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhcccccccccccc
Q 017262 230 HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVR 308 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (374)
.......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...... ........ ...
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~------~~~~~~~~----------~~~ 222 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR------EVLEQVER----------GYR 222 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHc----------CCC
Confidence 21222234568999999998889999999999999999998 99999643221 11111111 111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 017262 309 KSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELER 346 (374)
Q Consensus 309 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~ 346 (374)
...+...+..+.+++.+|++.+|++||+++++.+.|+.
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 11222335678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=302.83 Aligned_cols=247 Identities=31% Similarity=0.472 Sum_probs=199.6
Q ss_pred ceEeeeCeEEEEEEEecCCcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeecCCccc
Q 017262 78 RILGQGGQGTVYKGMLADGRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLF 156 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~ 156 (374)
++||+|+||.||+|...+++.+++|...... ......+.+|+.+++.++||||+++++++...+..+++|||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3689999999999998888999999876543 333456889999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceeeeccc
Q 017262 157 QYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQ 236 (374)
Q Consensus 157 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 236 (374)
+++... ...+++..+..++.|++.+|.|+|+.+ ++|+||+|+||++++++.+||+|||++...............
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 988642 346889999999999999999999998 999999999999999999999999998654322221112223
Q ss_pred ccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCHHH
Q 017262 237 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEE 315 (374)
Q Consensus 237 g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (374)
++..|+|||.+.+..++.++||||||+++|++++ |..||....... ........ .....+...
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-------~~~~~~~~---------~~~~~~~~~ 219 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-------AREQVEKG---------YRMSCPQKC 219 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHHcC---------CCCCCCCCC
Confidence 4667999999998889999999999999999998 999996432211 11111111 111222334
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017262 316 IMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345 (374)
Q Consensus 316 ~~~l~~li~~cl~~~p~~Rps~~~vl~~L~ 345 (374)
+..+.+++.+|++.+|++|||+.++++.|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 568999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=311.07 Aligned_cols=262 Identities=29% Similarity=0.453 Sum_probs=205.0
Q ss_pred cCCCcCceEeeeCeEEEEEEEe-----cCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeec--ccce
Q 017262 72 DYFNMNRILGQGGQGTVYKGML-----ADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEV--EVPL 144 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 144 (374)
..|++.+.||+|+||.||++.. .++..+++|.+..........+.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4678889999999999999974 24788999998877777777899999999999999999999987543 4678
Q ss_pred EEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccc
Q 017262 145 LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 224 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 224 (374)
+++||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++...
T Consensus 84 lv~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 99999999999999864 2346899999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCceee--ecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccC---------CChHHHHHHH
Q 017262 225 AIDQTHVS--TKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEG---------RNLTTYFVEC 293 (374)
Q Consensus 225 ~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~---------~~~~~~~~~~ 293 (374)
........ ....++..|+|||.+.+..++.++||||||+++|||++|..|+........ ........+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 43322211 112234569999999988899999999999999999998877543221100 0000001111
Q ss_pred HHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 017262 294 IEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347 (374)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~ 347 (374)
+........+...+..+.+|+.+||+.+|++|||+.++++.|+.+
T Consensus 239 ---------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 ---------LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred ---------HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 111111122234456799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=307.96 Aligned_cols=259 Identities=25% Similarity=0.419 Sum_probs=203.5
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCc----EEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGR----IIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLL 145 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 145 (374)
++|++.+.||+|+||.||+|.+. +++ .+++|...... ......+..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 45778899999999999999864 343 47777765432 2334677788889999999999999998754 46789
Q ss_pred EEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccc
Q 017262 146 VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 225 (374)
++||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 9999999999999974 2456899999999999999999999998 9999999999999999999999999997654
Q ss_pred cCCce-eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccc
Q 017262 226 IDQTH-VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDII 303 (374)
Q Consensus 226 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (374)
..... ......++..|+|||.+.+..++.++||||||+++|||++ |..||....... ..+....+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~--- 230 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-------VPDLLEKGERL--- 230 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCCcC---
Confidence 32221 2233446778999999998899999999999999999998 999996432211 11222221111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCC
Q 017262 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSR 352 (374)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~ 352 (374)
..+...+..+.+++.+|+..+|++|||+.++++.|..+..+.+
T Consensus 231 ------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~ 273 (279)
T cd05111 231 ------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPP 273 (279)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCc
Confidence 1111223467889999999999999999999999999887553
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=310.61 Aligned_cols=261 Identities=26% Similarity=0.468 Sum_probs=205.8
Q ss_pred cCCCcCceEeeeCeEEEEEEEecC-C--cEEEEEEecc-CChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccceEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLAD-G--RIIAVKKSKV-VDESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~~-~--~~vavK~~~~-~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 146 (374)
++|++.+.||+|+||.||+|...+ + ..+++|.++. ........+.+|+.++.++ +||||+++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 468899999999999999998654 3 2467887764 2344456788999999999 799999999999998899999
Q ss_pred EEeecCCcccccccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcE
Q 017262 147 YEFIPNGTLFQYLHDPY-------------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA 213 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~ 213 (374)
+||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999986421 1135889999999999999999999998 9999999999999999999
Q ss_pred EEeecccccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHH
Q 017262 214 KIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVE 292 (374)
Q Consensus 214 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~ 292 (374)
||+|||++...... ........+..|+|||.+.+..++.++||||||+++|+|++ |..||..... ......
T Consensus 159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~------~~~~~~ 230 (297)
T cd05089 159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC------AELYEK 230 (297)
T ss_pred EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHH
Confidence 99999998642211 11111223457999999998889999999999999999997 9999964322 111111
Q ss_pred HHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCC
Q 017262 293 CIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRD 353 (374)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~ 353 (374)
.. .......+...+..+.+|+.+|++.+|.+|||+.++++.|+.+......
T Consensus 231 ~~----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 231 LP----------QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred Hh----------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 11 1111122233456789999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=307.96 Aligned_cols=260 Identities=25% Similarity=0.413 Sum_probs=209.2
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecC-----CcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeee-cccc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLAD-----GRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLE-VEVP 143 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~ 143 (374)
.++|.+.+.||+|+||.||+|...+ +..+++|.+... .......+.+|+.+++.++||||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 5678899999999999999999765 678899987643 44556778899999999999999999998776 4678
Q ss_pred eEEEEeecCCcccccccCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeec
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEE-----LSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADF 218 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 218 (374)
+++++|+++++|.+++...... ..+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 8999999999999998653222 56899999999999999999999998 999999999999999999999999
Q ss_pred ccccccccCCcee-eecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHh
Q 017262 219 GTSRSIAIDQTHV-STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEE 296 (374)
Q Consensus 219 g~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 296 (374)
|+++.+....... .....++..|+|||.+.+..++.++||||||+++|++++ |+.||..... ..+... ...
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~~~-~~~ 234 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP------FEMAAY-LKD 234 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH------HHHHHH-HHc
Confidence 9997654333222 122345678999999988889999999999999999999 9999964322 111111 111
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 017262 297 NCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRA 349 (374)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~ 349 (374)
. .....+...+..+.+++.+|++.+|++|||+.++++.|+.+..
T Consensus 235 ~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 235 G---------YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred C---------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1 1111122345678999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=290.12 Aligned_cols=249 Identities=27% Similarity=0.362 Sum_probs=209.8
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCC---hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVD---ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
-++|++++.||+|.||.||.|+. +++..+|+|++.... .....++.+|+++-..|+||||++++++|.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 35789999999999999999995 457889999876532 22345788999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
+||.++|.|...|.+. ....+++.....++.|+|.|+.|+|.++ |+||||||+|+|++.++.+|++|||.+....
T Consensus 101 lEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 9999999999999854 3557889999999999999999999999 9999999999999999999999999986532
Q ss_pred CCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
........||..|.|||...+..++..+|+|++|++.||++.|..||......+ -+.....
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e------tYkrI~k----------- 236 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE------TYKRIRK----------- 236 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH------HHHHHHH-----------
Confidence 334456679999999999999999999999999999999999999997544221 1111111
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 307 VRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
....++...+....++|.+|+..+|.+|.+..|+++-
T Consensus 237 ~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 237 VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ccccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1223445666788999999999999999999998763
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=311.78 Aligned_cols=261 Identities=28% Similarity=0.449 Sum_probs=208.5
Q ss_pred HhhcCCCcCceEeeeCeEEEEEEEecC------CcEEEEEEeccC-ChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeec
Q 017262 69 KATDYFNMNRILGQGGQGTVYKGMLAD------GRIIAVKKSKVV-DESKLEEFINEVVILSQI-NHRNVVKLLGCCLEV 140 (374)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~v~~~~~~~------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 140 (374)
...++|++.+.||+|+||.||++...+ ...+++|..... .......+.+|+.+++++ +|+||+++++++...
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 334578889999999999999998642 367899987653 334456788999999999 799999999999999
Q ss_pred ccceEEEEeecCCcccccccCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEE
Q 017262 141 EVPLLVYEFIPNGTLFQYLHDP-------------YEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL 207 (374)
Q Consensus 141 ~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill 207 (374)
+..+++|||+++|+|..++... .....+++..++.++.|++.||+|||+.+ ++|+||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 9999999999999999998532 13456889999999999999999999998 9999999999999
Q ss_pred CCCCcEEEeecccccccccCCcee-eecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCC
Q 017262 208 DEKYRAKIADFGTSRSIAIDQTHV-STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRN 285 (374)
Q Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~ 285 (374)
++++.+||+|||++.......... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---- 241 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE---- 241 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH----
Confidence 999999999999998654332221 122335678999999988889999999999999999997 99998643321
Q ss_pred hHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 017262 286 LTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIR 348 (374)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~ 348 (374)
.... ... .......+...+..+.+|+.+|+..+|++|||+.++++.|+.+.
T Consensus 242 --~~~~-~~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 242 --ELFK-LLK---------EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred --HHHH-HHH---------cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1111 111 11112223344567889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=308.71 Aligned_cols=258 Identities=28% Similarity=0.448 Sum_probs=205.8
Q ss_pred CCCcCceEeeeCeEEEEEEEecC------CcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceE
Q 017262 73 YFNMNRILGQGGQGTVYKGMLAD------GRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLL 145 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 145 (374)
+|++.+.||+|+||.||+|.... ...+++|...... ......+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47788999999999999998532 3568888776433 3445678899999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCc
Q 017262 146 VYEFIPNGTLFQYLHDPY---------------------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTN 204 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~N 204 (374)
++||+.+++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||+|+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999875321 1235788999999999999999999998 9999999999
Q ss_pred eEECCCCcEEEeecccccccccCCcee-eecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcccccc
Q 017262 205 ILLDEKYRAKIADFGTSRSIAIDQTHV-STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANE 282 (374)
Q Consensus 205 ill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~ 282 (374)
|++++++.+||+|||++.......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 999999999999999987654322221 122335678999999988889999999999999999998 99998643221
Q ss_pred CCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 017262 283 GRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRA 349 (374)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~ 349 (374)
. +...... ......+...+..+.+++.+|++.+|++||++.++++.|+++..
T Consensus 237 -----~-~~~~~~~---------~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 237 -----R-LFNLLKT---------GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred -----H-HHHHHhC---------CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 1 1111111 11122233445688999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=303.94 Aligned_cols=253 Identities=28% Similarity=0.437 Sum_probs=203.5
Q ss_pred cCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeec
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIP 151 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 151 (374)
++|.+.+.||.|++|.||+|...++..+++|....... ....+.+|+.++++++|||++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 56888899999999999999987777899998765332 3456888999999999999999998875 456889999999
Q ss_pred CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCcee
Q 017262 152 NGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV 231 (374)
Q Consensus 152 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 231 (374)
+++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..........
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 99999999753 2345889999999999999999999998 9999999999999999999999999997654322222
Q ss_pred eecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccccccCC
Q 017262 232 STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKS 310 (374)
Q Consensus 232 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (374)
.....++..|+|||...+..++.++||||||+++|+|++ |..||......+ .. ...... ....
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~-~~~~~~---------~~~~ 223 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE------VL-EQVERG---------YRMP 223 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HH-HHHHcC---------CCCC
Confidence 222345678999999988889999999999999999999 999997533211 11 111111 1112
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 017262 311 GEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELER 346 (374)
Q Consensus 311 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~ 346 (374)
.+...+..+.+++.+||+.+|++||+++++++.|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 233456689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=309.05 Aligned_cols=260 Identities=23% Similarity=0.375 Sum_probs=197.4
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCCh-hHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE-SKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 148 (374)
.++|++.+.||+|+||.||+|... +++.+|+|.+..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467999999999999999999975 688999998765332 223456789999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
|++ ++|.+++.. ....+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||++.......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 995 577777754 3456889999999999999999999999 9999999999999999999999999987543221
Q ss_pred ceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHH---hc-------
Q 017262 229 THVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIE---EN------- 297 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~------- 297 (374)
.......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||..... .......... ..
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 231 (303)
T cd07869 158 -HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD-----IQDQLERIFLVLGTPNEDTWPG 231 (303)
T ss_pred -ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc-----HHHHHHHHHHHhCCCChhhccc
Confidence 22233457899999999865 4578899999999999999999999975322 1111111110 00
Q ss_pred --cccccccccccCCCC---------HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 298 --CLFDIIDDQVRKSGE---------AEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 298 --~~~~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..............+ ...+..+.+|+.+||+.||++|||++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000000000000 012346789999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=312.63 Aligned_cols=263 Identities=29% Similarity=0.442 Sum_probs=209.5
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec--------CCcEEEEEEeccC-ChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeec
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA--------DGRIIAVKKSKVV-DESKLEEFINEVVILSQI-NHRNVVKLLGCCLEV 140 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 140 (374)
.++|.+.+.||+|+||.||++... ++..+|+|.+... .......+..|+.+++.+ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 467899999999999999999752 2346999988753 234456788899999999 799999999999999
Q ss_pred ccceEEEEeecCCcccccccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEE
Q 017262 141 EVPLLVYEFIPNGTLFQYLHDPY-------------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL 207 (374)
Q Consensus 141 ~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill 207 (374)
+..++++||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 99999999999999999997532 1235889999999999999999999998 9999999999999
Q ss_pred CCCCcEEEeecccccccccCCcee-eecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCC
Q 017262 208 DEKYRAKIADFGTSRSIAIDQTHV-STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRN 285 (374)
Q Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~ 285 (374)
+.++.+||+|||++.......... .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~------ 247 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------ 247 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC------
Confidence 999999999999987653222111 111224568999999998889999999999999999998 888885322
Q ss_pred hHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCC
Q 017262 286 LTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSR 352 (374)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~ 352 (374)
....+.. ... ......+...+..+.+++.+|+..+|++|||+.++++.|+++.....
T Consensus 248 ~~~~~~~-~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 248 VEELFKL-LKE---------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred HHHHHHH-HHc---------CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 1221211 111 11122333455688899999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=318.93 Aligned_cols=260 Identities=30% Similarity=0.509 Sum_probs=228.3
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecC---C--cEEEEEEecc-CChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccce
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLAD---G--RIIAVKKSKV-VDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPL 144 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~---~--~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 144 (374)
.......+.||.|-||.||.|...+ | -.||||..+. ..+...+.|+.|..+|++++||||++++|+|.+ ...+
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~W 466 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMW 466 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-ccee
Confidence 3445567889999999999999532 3 3578887765 456667899999999999999999999999975 4678
Q ss_pred EEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccc
Q 017262 145 LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 224 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 224 (374)
+|||.++-|-|..|++. +...++......++.||+.||+|||+.. .+||||..+|||+.+..-+||+|||+++.+
T Consensus 467 ivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred EEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhc
Confidence 99999999999999987 4556888889999999999999999999 999999999999999999999999999999
Q ss_pred ccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccc
Q 017262 225 AIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDII 303 (374)
Q Consensus 225 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (374)
.++..+..+...-+..|||||.+.-..++.++|||.||+.+||++. |..||......+ ....+
T Consensus 542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD----------------VI~~i 605 (974)
T KOG4257|consen 542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD----------------VIGHI 605 (974)
T ss_pred cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc----------------eEEEe
Confidence 8877777776666779999999999999999999999999999988 999998654433 56677
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCC
Q 017262 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSR 352 (374)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~ 352 (374)
+.+.+...|+.+|+.+..|+.+||.++|.+||.+.++...|+.+.+...
T Consensus 606 EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek 654 (974)
T KOG4257|consen 606 ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEK 654 (974)
T ss_pred cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhh
Confidence 7888888999999999999999999999999999999999999987443
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=308.92 Aligned_cols=256 Identities=27% Similarity=0.444 Sum_probs=203.6
Q ss_pred cCCCcCceEeeeCeEEEEEEEe-----cCCcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceE
Q 017262 72 DYFNMNRILGQGGQGTVYKGML-----ADGRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLL 145 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 145 (374)
+.|++.+.||+|+||.||+|.. .++..+++|.+... .......+.+|+.+++.++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4578889999999999999984 24578999988643 33444678899999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCC
Q 017262 146 VYEFIPNGTLFQYLHDPY--------------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY 211 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~--------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~ 211 (374)
+|||+++++|.+++.... ....+++..++.++.|++.||+|||+++ ++|+||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999885221 1235788999999999999999999999 99999999999999999
Q ss_pred cEEEeecccccccccCCce-eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHH
Q 017262 212 RAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTY 289 (374)
Q Consensus 212 ~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~ 289 (374)
.+||+|||++......... ......++..|+|||.+.+..++.++|+||||+++|||++ |..||...... .
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~-------~ 234 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ-------E 234 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-------H
Confidence 9999999999765433221 1223345678999999988889999999999999999998 99898643211 1
Q ss_pred HHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 017262 290 FVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELER 346 (374)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~ 346 (374)
..+....... ...+...+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 235 ~~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEMVRKRQL---------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1122221111 11222345678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=321.26 Aligned_cols=251 Identities=25% Similarity=0.366 Sum_probs=200.5
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
++|++.+.||+|+||.||+|... +++.+|+|++... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46889999999999999999965 5889999988643 2334456788999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999999873 457899999999999999999999999 999999999999999999999999998654321
Q ss_pred Cce-------------------------------------eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh
Q 017262 228 QTH-------------------------------------VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT 270 (374)
Q Consensus 228 ~~~-------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~ 270 (374)
... ......||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 100 0112358999999999999899999999999999999999
Q ss_pred CCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 017262 271 GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPT---MKEVAM 342 (374)
Q Consensus 271 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps---~~~vl~ 342 (374)
|..||..... ........... ...........+..+.+|+.+|+. +|.+|++ +.++++
T Consensus 235 G~~Pf~~~~~------~~~~~~i~~~~-------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 235 GYPPFCSDNP------QETYRKIINWK-------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCCH------HHHHHHHHcCC-------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9999974332 11111111100 001111111235578899999996 9999997 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=316.78 Aligned_cols=251 Identities=23% Similarity=0.304 Sum_probs=199.1
Q ss_pred CCCcCceEeeeCeEEEEEEEe----cCCcEEEEEEeccC----ChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccc
Q 017262 73 YFNMNRILGQGGQGTVYKGML----ADGRIIAVKKSKVV----DESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVP 143 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 143 (374)
+|++.+.||+|+||.||++.. .++..+|+|.+... .......+..|+.+++.+ +||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478899999999999999885 35789999987542 223345677899999999 599999999999999999
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccc
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 223 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 223 (374)
+++|||+++|+|.+++. ....+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 99999999999999987 3457899999999999999999999999 99999999999999999999999999976
Q ss_pred cccCCceeeecccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccc
Q 017262 224 IAIDQTHVSTKVQGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDI 302 (374)
Q Consensus 224 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (374)
.............||+.|+|||.+.+. .++.++|||||||++|+|++|..||....... .... +......
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~~~~-~~~~~~~------ 225 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN--TQSE-VSRRILK------ 225 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC--CHHH-HHHHHhc------
Confidence 543333333345689999999998765 47889999999999999999999996432211 1111 1111110
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 017262 303 IDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRP-----TMKEVAM 342 (374)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~vl~ 342 (374)
.....+...+..+.+++.+||+.||++|| +++++++
T Consensus 226 ----~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 ----CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 01112233456788999999999999999 6667764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=302.94 Aligned_cols=247 Identities=29% Similarity=0.456 Sum_probs=197.7
Q ss_pred ceEeeeCeEEEEEEEec-CCcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeecCCcc
Q 017262 78 RILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTL 155 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 155 (374)
+.||+|+||.||+|... +++.+++|..... .......+.+|++++++++||||+++++++...+..++|+||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36899999999999964 6888999976543 344456789999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceee-ec
Q 017262 156 FQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS-TK 234 (374)
Q Consensus 156 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-~~ 234 (374)
.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........... ..
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 999864 2346889999999999999999999999 99999999999999999999999999875432111111 11
Q ss_pred ccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCH
Q 017262 235 VQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEA 313 (374)
Q Consensus 235 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (374)
...+..|+|||.+.+..++.++||||||+++|+|++ |..||....... ...... .......+.
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~~~~---------~~~~~~~~~ 219 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREAIE---------QGVRLPCPE 219 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHHHHH---------cCCCCCCcc
Confidence 123457999999998889999999999999999998 888886432211 111111 111122233
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017262 314 EEIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345 (374)
Q Consensus 314 ~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~ 345 (374)
..+..+.+++.+|++.+|++|||+.+++++|.
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 44568899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=309.16 Aligned_cols=255 Identities=28% Similarity=0.422 Sum_probs=205.3
Q ss_pred cCCCcCceEeeeCeEEEEEEEec------CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLL 145 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 145 (374)
++|...+.||+|+||.||++... ++..+++|............+.+|++.++.++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46778899999999999999632 356788998877666777789999999999999999999999999899999
Q ss_pred EEEeecCCcccccccCCCC------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcE
Q 017262 146 VYEFIPNGTLFQYLHDPYE------------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA 213 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~ 213 (374)
++||+++++|.+++..... ...+++..++.++.|++.|++|||+.+ ++|+||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999864321 135889999999999999999999999 9999999999999999999
Q ss_pred EEeecccccccccCCcee-eecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHH
Q 017262 214 KIADFGTSRSIAIDQTHV-STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFV 291 (374)
Q Consensus 214 kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~ 291 (374)
||+|||++.......... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+ ...
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~~ 235 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE------AIE 235 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH------HHH
Confidence 999999987554322211 122335678999999998889999999999999999998 999986433211 111
Q ss_pred HHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017262 292 ECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345 (374)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~ 345 (374)
. .. .......+...+..+.+++.+||+.+|++||++.++++.|+
T Consensus 236 ~-~~---------~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 236 C-IT---------QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred H-HH---------cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1 11 11111222234567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=296.83 Aligned_cols=262 Identities=23% Similarity=0.266 Sum_probs=203.0
Q ss_pred cCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCChhH--HHHHHHHHHHHhhCCCCceeeeeeeeeec--ccceEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESK--LEEFINEVVILSQINHRNVVKLLGCCLEV--EVPLLV 146 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv 146 (374)
++|+..+.|++|+||.||+|++ +++..||+|+++...... --..++|+.+|.+.+|||||.+-.+.... +..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 4577788999999999999996 468899999988754322 22457899999999999999999988754 478999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
||||+. +|...+... ..++...++.-++.|+++|++|||.+. |+||||||+|+|++..|.+|++|||+|+.++.
T Consensus 156 Me~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999965 788877653 357889999999999999999999999 99999999999999999999999999998765
Q ss_pred CCceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHH--Hhc------
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECI--EEN------ 297 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~------ 297 (374)
+ ....+..+.|.+|+|||.+.+ ..|+++.|+||+||++.||+++++-|++.+..+ .+...+...- .+.
T Consensus 230 p-~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d--Ql~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 230 P-LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID--QLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred C-cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH--HHHHHHHHhCCCccccCCCcc
Confidence 4 334566788999999999876 569999999999999999999999987654322 1211111110 000
Q ss_pred --------cccccccccccCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 298 --------CLFDIIDDQVRKSGEAE-EIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 298 --------~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.+.......++..+... .+..-.+|+..+|.+||.+|.|+++.++
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 01111111122222222 3466779999999999999999999986
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=304.61 Aligned_cols=260 Identities=23% Similarity=0.351 Sum_probs=209.1
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEecc---CChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV---VDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
++|++.+.||+|+||.||+|... +++.+++|.+.. ........+.+|+++++.++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999964 688999997654 23444567889999999999999999999999999999999
Q ss_pred EeecCCcccccccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 148 EFIPNGTLFQYLHDPY-EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
||+++++|.+++.... ....+++..+..++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998875322 2345889999999999999999999998 99999999999999999999999999876543
Q ss_pred CCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ....+.. ......
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~-~~~~~~-------- 224 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQ-KIEQCD-------- 224 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHH-HHhcCC--------
Confidence 221 12234578899999999888899999999999999999999999864221 1112111 111111
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 017262 307 VRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIR 348 (374)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~ 348 (374)
.........+..+.+++.+||..+|++|||+.++++.|+.++
T Consensus 225 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 225 YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 111122344567999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=331.38 Aligned_cols=259 Identities=25% Similarity=0.320 Sum_probs=207.4
Q ss_pred HHHHHhhcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc
Q 017262 65 KELDKATDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVE 141 (374)
Q Consensus 65 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 141 (374)
.......++|.+.+.||+|+||+||+|.. .+++.+|+|.+... .......+.+|+..+..++|+|++++++.+...+
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 34455568999999999999999999985 46899999987643 3445567889999999999999999988775432
Q ss_pred --------cceEEEEeecCCcccccccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCc
Q 017262 142 --------VPLLVYEFIPNGTLFQYLHDPY-EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR 212 (374)
Q Consensus 142 --------~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~ 212 (374)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGL 181 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCC
Confidence 3579999999999999886422 3457899999999999999999999998 999999999999999999
Q ss_pred EEEeecccccccccCCc-eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHH
Q 017262 213 AKIADFGTSRSIAIDQT-HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFV 291 (374)
Q Consensus 213 ~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 291 (374)
+||+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ....+.
T Consensus 182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~------~~~~~~ 255 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN------MEEVMH 255 (496)
T ss_pred EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC------HHHHHH
Confidence 99999999976543221 22234568999999999999999999999999999999999999996432 222222
Q ss_pred HHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 292 ECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..... .....+...+..+.+++.+||+.+|++||++.+++.
T Consensus 256 ~~~~~----------~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 256 KTLAG----------RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred HHhcC----------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 11111 011123344568999999999999999999999976
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=322.93 Aligned_cols=253 Identities=23% Similarity=0.336 Sum_probs=202.0
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceE
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLL 145 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 145 (374)
..++|++.+.||+|+||.||++... +++.+|+|.+... .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3567899999999999999999965 5889999987542 22334557789999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccc
Q 017262 146 VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 225 (374)
||||+++|+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999998853 35888999999999999999999999 9999999999999999999999999987654
Q ss_pred cCCceeeecccccccccCccccccC----CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccc
Q 017262 226 IDQTHVSTKVQGTFGYLDPEYFRSS----QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFD 301 (374)
Q Consensus 226 ~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (374)
...........||+.|+|||.+.+. .++.++|||||||++|||++|..||..... ...+........
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~~--- 264 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMDHKN--- 264 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH------HHHHHHHHcCCC---
Confidence 3322223445699999999998653 478899999999999999999999964321 111221111110
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 017262 302 IIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRN--RPTMKEVAM 342 (374)
Q Consensus 302 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--Rps~~~vl~ 342 (374)
..........+..+.+|+.+||+.+|++ |||+++++.
T Consensus 265 ----~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 265 ----SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred ----cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 0111112234568889999999999988 999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=303.24 Aligned_cols=246 Identities=29% Similarity=0.446 Sum_probs=197.8
Q ss_pred eEeeeCeEEEEEEEe---cCCcEEEEEEeccCC--hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeecCC
Q 017262 79 ILGQGGQGTVYKGML---ADGRIIAVKKSKVVD--ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNG 153 (374)
Q Consensus 79 ~lg~G~~g~v~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 153 (374)
.||+|+||.||+|.+ .++..+++|.+.... ....+.+.+|+.+++.++||||+++++++. .+..+++|||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999974 357889999876432 344567889999999999999999999875 45678999999999
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceee-
Q 017262 154 TLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS- 232 (374)
Q Consensus 154 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~- 232 (374)
+|.+++.. ...+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99999863 456899999999999999999999999 99999999999999999999999999976654332211
Q ss_pred -ecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccccccCC
Q 017262 233 -TKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKS 310 (374)
Q Consensus 233 -~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (374)
....+++.|+|||.+....++.++|+||||+++|||++ |..||...... . ....... .....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~-~~~~i~~---------~~~~~ 218 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN------E-VTQMIES---------GERME 218 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHHC---------CCCCC
Confidence 12234578999999988889999999999999999998 99999743221 1 1111111 11122
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 017262 311 GEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347 (374)
Q Consensus 311 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~ 347 (374)
.+...+..+.++|.+|++.||++||++.+|.+.|++.
T Consensus 219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 3334556889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=316.81 Aligned_cols=263 Identities=23% Similarity=0.332 Sum_probs=196.2
Q ss_pred CCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc-----cce
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVE-----VPL 144 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~ 144 (374)
+|++.+.||+|+||.||+|... ++..||+|++... .......+.+|+.+++.++||||+++++++...+ ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999964 6889999987642 2334456889999999999999999999886432 479
Q ss_pred EEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccc
Q 017262 145 LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 224 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 224 (374)
+||||++ ++|.+++. ....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++...
T Consensus 81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 68888886 3456899999999999999999999999 999999999999999999999999998754
Q ss_pred ccCCc--eeeecccccccccCcccccc--CCCCccchhhhHHHHHHHHHhCCCCCCccccccC---------CChHHHHH
Q 017262 225 AIDQT--HVSTKVQGTFGYLDPEYFRS--SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEG---------RNLTTYFV 291 (374)
Q Consensus 225 ~~~~~--~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~---------~~~~~~~~ 291 (374)
..... .......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ........
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 32221 11234568999999999875 6789999999999999999999999975332110 00000000
Q ss_pred HHHHhcccccccc---ccccC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 292 ECIEENCLFDIID---DQVRK---SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 292 ~~~~~~~~~~~~~---~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
.. .......... ..... ...+..+..+.+++.+||+.||++|||++++++.
T Consensus 234 ~i-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RV-RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred Hh-hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00 0000000000 00000 0001234567899999999999999999999963
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=318.69 Aligned_cols=252 Identities=23% Similarity=0.307 Sum_probs=203.3
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
++|.+.+.||+|+||.||++... +++.+|+|.+... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46889999999999999999964 6889999987653 2234456788999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999999742 357899999999999999999999999 999999999999999999999999999876543
Q ss_pred CceeeecccccccccCccccc------cCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFR------SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFD 301 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (374)
.........||+.|+|||++. ...++.++|||||||++|+|++|..||..... ...+.........
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------~~~~~~i~~~~~~-- 227 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS------AKTYNNIMNFQRF-- 227 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH------HHHHHHHHcCCCc--
Confidence 333334456899999999986 45678899999999999999999999964321 1122221111111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 302 IIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 302 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.........+..+.+|+.+|++ +|++|||+.+++.
T Consensus 228 -----~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 228 -----LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred -----cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 1111122345678899999998 9999999999885
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=302.63 Aligned_cols=251 Identities=29% Similarity=0.477 Sum_probs=206.0
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEee
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFI 150 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 150 (374)
.++|++.+.||.|+||.||+|... |+.+++|....... ..+.+.+|+.+++.++|+||+++++++.+.+..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 356888999999999999999875 78899998876544 5678899999999999999999999999888999999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 230 (374)
++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 999999998743 2236899999999999999999999999 99999999999999999999999999876532111
Q ss_pred eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccccccC
Q 017262 231 VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309 (374)
Q Consensus 231 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (374)
....+..|+|||.+....++.++|+||||+++|+|++ |..||...... . ........ ...
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~-~~~~~~~~---------~~~ 218 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------D-VVPHVEKG---------YRM 218 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH------H-HHHHHhcC---------CCC
Confidence 2234567999999988889999999999999999997 99998643221 1 11111111 111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 017262 310 SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347 (374)
Q Consensus 310 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~ 347 (374)
..+...+..+.+++.+|+..+|++|||+++++++|+++
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 12233456889999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=311.77 Aligned_cols=269 Identities=26% Similarity=0.431 Sum_probs=211.5
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec--------CCcEEEEEEeccC-ChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeec
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA--------DGRIIAVKKSKVV-DESKLEEFINEVVILSQI-NHRNVVKLLGCCLEV 140 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 140 (374)
.++|.+.+.||+|+||.||++... +...+++|.+... .......+..|+.+++++ +||||+++++++.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 457888999999999999999742 2456888987643 334456788999999999 699999999999988
Q ss_pred ccceEEEEeecCCcccccccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEE
Q 017262 141 EVPLLVYEFIPNGTLFQYLHDPY-------------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL 207 (374)
Q Consensus 141 ~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill 207 (374)
+..++++||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 89999999999999999986421 1245889999999999999999999998 9999999999999
Q ss_pred CCCCcEEEeecccccccccCCcee-eecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCC
Q 017262 208 DEKYRAKIADFGTSRSIAIDQTHV-STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRN 285 (374)
Q Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~ 285 (374)
++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~----- 242 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV----- 242 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH-----
Confidence 999999999999997654322111 112224567999999998889999999999999999999 8889864321
Q ss_pred hHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCCCcchh
Q 017262 286 LTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDDENNI 358 (374)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~~~~~~ 358 (374)
...+. ..... .....+...+..+.+++.+|++.+|++|||+.++++.|..+.....+....+
T Consensus 243 -~~~~~-~~~~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~~ 304 (314)
T cd05099 243 -EELFK-LLREG---------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEYLDL 304 (314)
T ss_pred -HHHHH-HHHcC---------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcCCceee
Confidence 11111 11111 1112233445578899999999999999999999999999988766555443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=305.06 Aligned_cols=258 Identities=29% Similarity=0.450 Sum_probs=207.0
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecC----CcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLAD----GRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLL 145 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 145 (374)
.++|.+.+.||+|+||.||+|...+ ...+++|...... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3568888999999999999998643 2468889776554 4556788999999999999999999998875 56789
Q ss_pred EEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccc
Q 017262 146 VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 225 (374)
+|||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 99999999999999752 346899999999999999999999998 9999999999999999999999999987654
Q ss_pred cCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhcccccccc
Q 017262 226 IDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIID 304 (374)
Q Consensus 226 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (374)
...........++..|+|||.+....++.++||||||+++|++++ |..||......+ .... ....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~------~~~~-~~~~------- 224 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND------VIGR-IENG------- 224 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH------HHHH-HHcC-------
Confidence 433222233335568999999988889999999999999999986 999996543221 1111 1111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 017262 305 DQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350 (374)
Q Consensus 305 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~ 350 (374)
.....+...+..+.+++.+|+..+|++|||+.++++.|+.+...
T Consensus 225 --~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 225 --ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred --CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11112334456899999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=303.49 Aligned_cols=251 Identities=26% Similarity=0.428 Sum_probs=202.9
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC-----hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-----ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLL 145 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 145 (374)
++|.+.+.||+|++|.||.+... +++.+++|.+.... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 56899999999999999999864 58899999875432 2234568889999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccc
Q 017262 146 VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 225 (374)
++||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999998873 456889999999999999999999999 9999999999999999999999999987653
Q ss_pred cCCceee--ecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccc
Q 017262 226 IDQTHVS--TKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDII 303 (374)
Q Consensus 226 ~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (374)
....... ....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ...... . .
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~-~---------~ 220 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA-----MAAIFK-I---------A 220 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch-----HHHHHH-H---------h
Confidence 2221111 234578899999999998899999999999999999999999964321 111111 0 1
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
........+...+..+.+++.+||..+|++|||+.++++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 221 TQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1111122333455678899999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=304.11 Aligned_cols=256 Identities=25% Similarity=0.461 Sum_probs=205.6
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecC-C---cEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLAD-G---RIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLL 145 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 145 (374)
.++|+..+.||+|+||.||+|.... + ..+++|..... .....+.+..|+++++.++|||++++.+++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3467888999999999999999643 3 36889987654 34445678899999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccc
Q 017262 146 VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 225 (374)
+|||+++++|.+++.. ....+++..+..++.|++.|++|||+.+ ++|+||||+||++++++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999999864 2356899999999999999999999998 9999999999999999999999999987654
Q ss_pred cCCceeee--cccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhcccccc
Q 017262 226 IDQTHVST--KVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDI 302 (374)
Q Consensus 226 ~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (374)
........ ....++.|+|||.+.+..++.++||||||+++|+|++ |..||..... ....... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~------~~~~~~i-~~------ 225 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN------HEVMKAI-ND------ 225 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH------HHHHHHH-hc------
Confidence 32222111 1223457999999998889999999999999999997 9999964322 1111111 11
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 017262 303 IDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347 (374)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~ 347 (374)
......+...+..+.+++.+|++.+|++||++.++++.|+++
T Consensus 226 ---~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 226 ---GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111122233456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=302.09 Aligned_cols=246 Identities=27% Similarity=0.446 Sum_probs=197.0
Q ss_pred EeeeCeEEEEEEEec---CCcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeecCCcc
Q 017262 80 LGQGGQGTVYKGMLA---DGRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTL 155 (374)
Q Consensus 80 lg~G~~g~v~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 155 (374)
||+|+||.||+|.+. .+..+|+|...... ......+.+|+.++++++||||+++++++. .+..++||||+++++|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence 899999999999754 34568999876543 333467889999999999999999999885 4577899999999999
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceee--e
Q 017262 156 FQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS--T 233 (374)
Q Consensus 156 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~--~ 233 (374)
.+++.. ....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++........... .
T Consensus 82 ~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 82 NKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 999864 2447899999999999999999999998 99999999999999999999999999876543322211 1
Q ss_pred cccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCC
Q 017262 234 KVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGE 312 (374)
Q Consensus 234 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (374)
...+++.|+|||.+....++.++||||||+++|++++ |..||....... +..... .......+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~---------~~~~~~~~ 220 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-------VMSFIE---------QGKRLDCP 220 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHH---------CCCCCCCC
Confidence 1223578999999988889999999999999999996 999997543211 111111 11122233
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 017262 313 AEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347 (374)
Q Consensus 313 ~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~ 347 (374)
...+..+.+++.+||+.+|++||++.++.+.|+.+
T Consensus 221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 34566888999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=302.98 Aligned_cols=254 Identities=26% Similarity=0.448 Sum_probs=206.0
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEee
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFI 150 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 150 (374)
.++|.+.+.||+|+||.||++...++..+++|.+... ......+.+|+.+++.++|+||+++++++.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 5678999999999999999999877888999987653 2344678899999999999999999999887 7789999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 230 (374)
++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||.+.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 999999999753 2456788999999999999999999998 999999999999999999999999998765432222
Q ss_pred eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccccccC
Q 017262 231 VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309 (374)
Q Consensus 231 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (374)
......++..|+|||.+....++.++|+||||+++|++++ |..||....... ........ ...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~---------~~~ 222 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-------VIRALERG---------YRM 222 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhCC---------CCC
Confidence 2222345677999999998889999999999999999998 999997432211 11111111 111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 017262 310 SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELER 346 (374)
Q Consensus 310 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~ 346 (374)
..+...+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus 223 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1223445678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=304.15 Aligned_cols=255 Identities=27% Similarity=0.497 Sum_probs=199.2
Q ss_pred CCcCceEeeeCeEEEEEEEecCC-c--EEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeec------cc
Q 017262 74 FNMNRILGQGGQGTVYKGMLADG-R--IIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEV------EV 142 (374)
Q Consensus 74 ~~~~~~lg~G~~g~v~~~~~~~~-~--~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~ 142 (374)
|.+.+.||+|+||.||+|...++ . .+|+|.++.. .......+..|+.+++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 35678999999999999997543 2 5889977643 355567888999999999999999999987432 24
Q ss_pred ceEEEEeecCCcccccccCCC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecc
Q 017262 143 PLLVYEFIPNGTLFQYLHDPY---EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 219 (374)
Q Consensus 143 ~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 219 (374)
.++++||+++|+|.+++.... ....+++..+..++.|++.||+|||+++ ++|+||||+||++++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 689999999999998874211 2345889999999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCceee-ecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhc
Q 017262 220 TSRSIAIDQTHVS-TKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEEN 297 (374)
Q Consensus 220 ~~~~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 297 (374)
++........... ....+++.|+|||...+..++.++||||||+++|+|++ |+.||...... ... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~-~~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS------EIY-DYLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH------HHH-HHHHcC
Confidence 9986543322111 22235678999999998899999999999999999999 88998643221 111 111111
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 017262 298 CLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347 (374)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~ 347 (374)
.. ...+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 231 ~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NR---------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11 111223455789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=320.19 Aligned_cols=253 Identities=24% Similarity=0.342 Sum_probs=197.2
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
++|++.+.||+|+||+||++... +++.+|+|.+... .......+..|+.++.+++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46889999999999999999865 5889999988643 2333456788999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
||+++|+|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 9999999999997 3457999999999999999999999999 999999999999999999999999998754321
Q ss_pred Cc----------------------------------eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCC
Q 017262 228 QT----------------------------------HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQK 273 (374)
Q Consensus 228 ~~----------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~ 273 (374)
.. .......||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 10 00123468999999999999999999999999999999999999
Q ss_pred CCCccccccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcc--cCCCCCCCHHHHHHH
Q 017262 274 PISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLN--SYGRNRPTMKEVAME 343 (374)
Q Consensus 274 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~~p~~Rps~~~vl~~ 343 (374)
||..... ...+....... ...........+..+.+++.+|+. .++..||+++++++.
T Consensus 235 Pf~~~~~------~~~~~~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 235 PFCSETP------QETYKKVMNWK-------ETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCH------HHHHHHHHcCc-------CcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 9964322 11111111100 000011111234567788888664 233346899999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=310.32 Aligned_cols=258 Identities=24% Similarity=0.333 Sum_probs=194.0
Q ss_pred cCCCcCceEeeeCeEEEEEEEec--CCcEEEEEEeccCC--hhHHHHHHHHHHHHhhC---CCCceeeeeeeeee-----
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA--DGRIIAVKKSKVVD--ESKLEEFINEVVILSQI---NHRNVVKLLGCCLE----- 139 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~----- 139 (374)
++|++.+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36889999999999999999863 46789999876432 22234556677777665 69999999998852
Q ss_pred cccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecc
Q 017262 140 VEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 219 (374)
Q Consensus 140 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 219 (374)
....++++||++ ++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 346789999996 6888888643 2346899999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcc-
Q 017262 220 TSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENC- 298 (374)
Q Consensus 220 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~- 298 (374)
++...... .......|++.|+|||.+.+..++.++||||||+++|+|++|..||......+ .+....+...
T Consensus 156 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~------~~~~i~~~~~~ 227 (290)
T cd07862 156 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD------QLGKILDVIGL 227 (290)
T ss_pred ceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH------HHHHHHHHhCC
Confidence 99765432 22334568999999999988889999999999999999999999997543211 1111111000
Q ss_pred -----ccc-------cccccccC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 299 -----LFD-------IIDDQVRK---SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 299 -----~~~-------~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
... ........ ...+..+..+.+|+.+||+.||++|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000 00000000 001123457789999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=321.86 Aligned_cols=251 Identities=22% Similarity=0.310 Sum_probs=197.5
Q ss_pred CCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEE
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 148 (374)
.|...+.||+|+||+||+|... +++.+|+|++... .......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999864 5789999988643 23445678899999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999999873 456899999999999999999999999 9999999999999999999999999975331100
Q ss_pred c----------------------------------------------eeeecccccccccCccccccCCCCccchhhhHH
Q 017262 229 T----------------------------------------------HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFG 262 (374)
Q Consensus 229 ~----------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG 262 (374)
. .......||+.|+|||.+.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 001234699999999999988899999999999
Q ss_pred HHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhc--ccCCCCCCCHHHH
Q 017262 263 VVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCL--NSYGRNRPTMKEV 340 (374)
Q Consensus 263 ~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl--~~~p~~Rps~~~v 340 (374)
|++|||++|..||....... ........ ............+..+.+|+.+|+ ..+|..||++.++
T Consensus 236 ~il~elltG~~Pf~~~~~~~------~~~~i~~~-------~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTE------TQLKVINW-------ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHH------HHHHHHcc-------ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 99999999999997433211 11111110 001111111234457888998844 5566669999999
Q ss_pred HH
Q 017262 341 AM 342 (374)
Q Consensus 341 l~ 342 (374)
+.
T Consensus 303 l~ 304 (381)
T cd05626 303 KA 304 (381)
T ss_pred hc
Confidence 86
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=310.68 Aligned_cols=264 Identities=27% Similarity=0.463 Sum_probs=206.3
Q ss_pred cCCCcCceEeeeCeEEEEEEEecC-Cc--EEEEEEeccC-ChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccceEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLAD-GR--IIAVKKSKVV-DESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 146 (374)
++|++.+.||+|+||.||+|.+++ +. .+++|..... .......+.+|++++.++ +||||+++++++.+++..+++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 468888999999999999999653 43 4577766543 334456788899999999 899999999999999999999
Q ss_pred EEeecCCcccccccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcE
Q 017262 147 YEFIPNGTLFQYLHDPY-------------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA 213 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~ 213 (374)
+||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999986421 1235789999999999999999999998 9999999999999999999
Q ss_pred EEeecccccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHH
Q 017262 214 KIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVE 292 (374)
Q Consensus 214 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~ 292 (374)
||+|||++...... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... +....
T Consensus 164 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~~ 235 (303)
T cd05088 164 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYEK 235 (303)
T ss_pred EeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH------HHHHH
Confidence 99999998632211 11111224567999999988889999999999999999998 99999643221 11111
Q ss_pred HHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCCCcc
Q 017262 293 CIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDDEN 356 (374)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~~~~ 356 (374)
. . .......+...+..+.+|+.+|++.+|++||++.++++.|+.+........+
T Consensus 236 ~-~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~~~ 289 (303)
T cd05088 236 L-P---------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVN 289 (303)
T ss_pred H-h---------cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhhhh
Confidence 1 1 1111112223455788999999999999999999999999998776654433
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=306.55 Aligned_cols=256 Identities=30% Similarity=0.430 Sum_probs=203.0
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecC------CcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLAD------GRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVP 143 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 143 (374)
.++|.+.+.||+|++|.||+|...+ +..+++|...... ......+..|+.+++.++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4678899999999999999999753 5678888776443 33446788999999999999999999999988899
Q ss_pred eEEEEeecCCcccccccCCCC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCC---cEEEe
Q 017262 144 LLVYEFIPNGTLFQYLHDPYE----ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY---RAKIA 216 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~---~~kl~ 216 (374)
+++|||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999865321 235899999999999999999999999 99999999999998654 59999
Q ss_pred ecccccccccCCcee-eecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHH
Q 017262 217 DFGTSRSIAIDQTHV-STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECI 294 (374)
Q Consensus 217 Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 294 (374)
|||++.......... ......+..|+|||++.+..++.++|||||||++|+|++ |..||....... ... ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~------~~~-~~ 234 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE------VME-FV 234 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHH-HH
Confidence 999997653222111 112233568999999998899999999999999999997 999997533221 111 11
Q ss_pred HhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017262 295 EENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345 (374)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~ 345 (374)
. .......+...+..+.+++.+|++.+|++|||+.++++.|.
T Consensus 235 ~---------~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 T---------GGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred H---------cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1 11112223344568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=315.09 Aligned_cols=241 Identities=26% Similarity=0.362 Sum_probs=195.2
Q ss_pred ceEeeeCeEEEEEEEe----cCCcEEEEEEeccC----ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 78 RILGQGGQGTVYKGML----ADGRIIAVKKSKVV----DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
+.||+|+||.||++.. ..++.+|+|.+... .......+..|+.+++.++||||+++++++..++..+++|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999985 35788999987642 223345677899999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+++++|.+++. ....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 82 LSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred CCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 99999999887 3456888999999999999999999999 9999999999999999999999999987533222
Q ss_pred eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccC
Q 017262 230 HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (374)
.......|++.|+|||++.+..++.++||||||+++|+|++|+.||..... ......... . ..
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~------~~~~~~~~~-~----------~~ 217 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR------KKTIDKILK-G----------KL 217 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH------HHHHHHHHc-C----------CC
Confidence 122335689999999999988899999999999999999999999964321 111111111 1 01
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 017262 310 SGEAEEIMAVSDVAKRCLNSYGRNRP-----TMKEVAM 342 (374)
Q Consensus 310 ~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~vl~ 342 (374)
..+...+..+.+++.+||+.+|++|| +++++++
T Consensus 218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 12233455788999999999999999 7888766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=304.12 Aligned_cols=255 Identities=27% Similarity=0.482 Sum_probs=202.3
Q ss_pred CCcCceEeeeCeEEEEEEEecC----CcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeeccc-----
Q 017262 74 FNMNRILGQGGQGTVYKGMLAD----GRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEV----- 142 (374)
Q Consensus 74 ~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----- 142 (374)
|.+.+.||+|+||.||.|.... +..+|+|.++.. .......+.+|++.++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999998642 367999987753 33445678999999999999999999998865544
Q ss_pred -ceEEEEeecCCcccccccCCC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeec
Q 017262 143 -PLLVYEFIPNGTLFQYLHDPY---EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADF 218 (374)
Q Consensus 143 -~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 218 (374)
.++++||+++++|..++.... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 789999999999998885421 2346899999999999999999999998 999999999999999999999999
Q ss_pred ccccccccCCceee-ecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHh
Q 017262 219 GTSRSIAIDQTHVS-TKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEE 296 (374)
Q Consensus 219 g~~~~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 296 (374)
|+++.......... ....++..|+|||.+.+..++.++||||||+++|||++ |..||...... .... ....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~------~~~~-~~~~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH------EIYD-YLRH 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH------HHHH-HHHc
Confidence 99876543332211 12234678999999988889999999999999999999 88998643221 1111 1111
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 017262 297 NCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347 (374)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~ 347 (374)
. .....+...+..+.+++.+|++.||++|||+.++++.|+++
T Consensus 231 ~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 G---------NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred C---------CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1 11122334556899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=309.13 Aligned_cols=258 Identities=29% Similarity=0.453 Sum_probs=206.4
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec------CCcEEEEEEeccCC-hhHHHHHHHHHHHHhhC-CCCceeeeeeeeeeccc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVVD-ESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEV 142 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 142 (374)
.++|.+.+.||+|+||.||++... .+..+|+|.+.... ......+.+|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 457899999999999999999742 24578999876543 34456788999999999 79999999999999999
Q ss_pred ceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccc
Q 017262 143 PLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 222 (374)
Q Consensus 143 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 222 (374)
.++++||+++++|.+++... ....+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 99999999999999998743 2334899999999999999999999998 9999999999999999999999999987
Q ss_pred ccccCCce-eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhcccc
Q 017262 223 SIAIDQTH-VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLF 300 (374)
Q Consensus 223 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (374)
........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... .+......
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~------~~~~~~~~---- 259 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS------KFYKLIKE---- 259 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH------HHHHHHHc----
Confidence 65433221 1222345778999999998889999999999999999998 999986433211 11111111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 017262 301 DIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347 (374)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~ 347 (374)
......+...+..+.+++.+|++.+|++|||+.++++.|+++
T Consensus 260 -----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 260 -----GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -----CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 111112223355799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=320.73 Aligned_cols=255 Identities=23% Similarity=0.337 Sum_probs=201.9
Q ss_pred HhhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccce
Q 017262 69 KATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPL 144 (374)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 144 (374)
...++|++.+.||+|+||.||++... +++.+|+|.+... .......+.+|+.+++.++||||+++++++.+++..+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999975 5788999987532 2233456778999999999999999999999999999
Q ss_pred EEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccc
Q 017262 145 LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 224 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 224 (374)
+||||+++|+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++...
T Consensus 120 lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence 99999999999998863 35889999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCceeeecccccccccCccccccC----CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccc
Q 017262 225 AIDQTHVSTKVQGTFGYLDPEYFRSS----QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLF 300 (374)
Q Consensus 225 ~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (374)
............||+.|+|||++.+. .++.++|||||||++|+|++|..||.... ....+........
T Consensus 193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~------~~~~~~~i~~~~~-- 264 (370)
T cd05621 193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS------LVGTYSKIMDHKN-- 264 (370)
T ss_pred ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCc--
Confidence 43333233455699999999998754 37889999999999999999999996432 1222222221111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 017262 301 DIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRN--RPTMKEVAME 343 (374)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--Rps~~~vl~~ 343 (374)
..........+..+.+++.+|+..++.+ |||+.++++.
T Consensus 265 -----~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 265 -----SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -----ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0111122234567889999999855543 8899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=303.30 Aligned_cols=255 Identities=25% Similarity=0.432 Sum_probs=204.9
Q ss_pred cCCCcCceEeeeCeEEEEEEEec----CCcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA----DGRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
.+|++.+.||+|+||.||+|... .+..+++|.+.... ......+.+|+.++++++||||+++++++.+++..+++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 56888999999999999999863 23378899876532 34456888999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
|||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999999752 346899999999999999999999999 99999999999999999999999999986654
Q ss_pred CCceeee--cccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccc
Q 017262 227 DQTHVST--KVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDII 303 (374)
Q Consensus 227 ~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (374)
....... ...++..|+|||.+.+..++.++|+||||+++|++++ |..||...... +..... ...
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~------~~~~~~-~~~------ 225 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ------DVIKAI-EEG------ 225 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH------HHHHHH-hCC------
Confidence 3322221 1223568999999998889999999999999999886 99998643321 111111 111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 017262 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347 (374)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~ 347 (374)
.....+...+..+.+++.+|++.+|++||++.++++.|+++
T Consensus 226 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 ---YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ---CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 11112233456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=320.15 Aligned_cols=271 Identities=28% Similarity=0.465 Sum_probs=233.4
Q ss_pred HHHHHhhcCCCcCceEeeeCeEEEEEEEecC-CcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccc
Q 017262 65 KELDKATDYFNMNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVP 143 (374)
Q Consensus 65 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 143 (374)
.+.+....+..+.++||-|.||.||-|.|+. .-.||||.++.+ .....+|+.|+.+|+.++|||+|+++|+|.....+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 3444445567788999999999999999864 567899988764 45678999999999999999999999999999999
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccc
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 223 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 223 (374)
|||+|||..|+|.+||.+. +...++....+.++.||++|++||..++ .|||||..+|+|+.++..+|++|||+++.
T Consensus 339 YIiTEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred EEEEecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence 9999999999999999875 4556778888999999999999999999 99999999999999999999999999998
Q ss_pred cccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhcccccc
Q 017262 224 IAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDI 302 (374)
Q Consensus 224 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (374)
...+.........-+..|.|||.+....++.|+|||+||++|||+.| |-.||++... .+ ...+
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl------Sq----------VY~L 478 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQ----------VYGL 478 (1157)
T ss_pred hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH------HH----------HHHH
Confidence 76555444444445678999999999999999999999999999999 8889975432 22 3355
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCCCcc
Q 017262 303 IDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDDEN 356 (374)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~~~~ 356 (374)
++...+.+.+..+++.+.+|++.||+.+|.+||++.|+-+.++.|..+..-.++
T Consensus 479 LEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSisdE 532 (1157)
T KOG4278|consen 479 LEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSISDE 532 (1157)
T ss_pred HhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccccccHH
Confidence 667777888889999999999999999999999999999999999887765543
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=305.38 Aligned_cols=259 Identities=28% Similarity=0.479 Sum_probs=205.3
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCc----EEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccce
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGR----IIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPL 144 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 144 (374)
.++|++.+.||+|+||+||+|.+. ++. .||+|.+... .......+.+|+.+++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 356888899999999999999853 444 4789987653 34445678899999999999999999999875 4578
Q ss_pred EEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccc
Q 017262 145 LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 224 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 224 (374)
++++|+++|+|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++..
T Consensus 85 l~~~~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 99999999999999874 2346899999999999999999999999 999999999999999999999999999766
Q ss_pred ccCCcee-eecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhcccccc
Q 017262 225 AIDQTHV-STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDI 302 (374)
Q Consensus 225 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (374)
....... .....+++.|+|||...+..++.++||||||+++|||++ |..||....... .......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~------ 226 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE-------IPDLLEK------ 226 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHC------
Confidence 4322221 122235678999999998889999999999999999998 999986432211 1111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhC
Q 017262 303 IDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANS 351 (374)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~ 351 (374)
......+...+..+.+++.+||..||++||++.++++.|+.+....
T Consensus 227 ---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 227 ---GERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ---CCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 1111222334567889999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=301.47 Aligned_cols=259 Identities=26% Similarity=0.406 Sum_probs=210.3
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEecc---CChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV---VDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
++|++.+.||+|+||.||+|... +++.+++|.++. .+......+.+|++++++++|+|++++++++...+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999976 789999997753 23344567889999999999999999999999999999999
Q ss_pred EeecCCcccccccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 148 EFIPNGTLFQYLHDPY-EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
||+++++|..++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999886422 3456899999999999999999999999 99999999999999999999999999876533
Q ss_pred CCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.... .+....... ....
T Consensus 159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~-~~~~--------- 223 (267)
T cd08224 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKK-IEKC--------- 223 (267)
T ss_pred CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHhh-hhcC---------
Confidence 221 1223457889999999988889999999999999999999999986432 111111111 1111
Q ss_pred ccCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 017262 307 VRKSG-EAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIR 348 (374)
Q Consensus 307 ~~~~~-~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~ 348 (374)
..... ....+..+.+++.+||..+|++|||+.+++++|+.+.
T Consensus 224 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 224 DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 11111 2245568899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=307.15 Aligned_cols=268 Identities=28% Similarity=0.410 Sum_probs=203.8
Q ss_pred CCCcCceEeeeCeEEEEEEEe-----cCCcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc--cce
Q 017262 73 YFNMNRILGQGGQGTVYKGML-----ADGRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVE--VPL 144 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~ 144 (374)
+|...+.||+|+||+||++.. .++..+|+|...... ......+.+|+++++.++||||+++++++...+ ..+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred hceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 348889999999999988652 357789999886543 334567889999999999999999999886543 578
Q ss_pred EEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccc
Q 017262 145 LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 224 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 224 (374)
++|||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++...
T Consensus 85 lv~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 85 LIMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EEecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccccc
Confidence 99999999999999863 35899999999999999999999999 999999999999999999999999998765
Q ss_pred ccCCcee--eecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccc
Q 017262 225 AIDQTHV--STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDI 302 (374)
Q Consensus 225 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (374)
....... .....++..|+|||.+.+..++.++||||||+++|+|++|..||......... .............+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE-MIGPKQGQMTVVRLIEL 236 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh-hhcccccccchhhhhhh
Confidence 4322111 12223566799999998888999999999999999999999998643321100 00000000000011111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 017262 303 IDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIR 348 (374)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~ 348 (374)
.+.......+...+..+.+++.+||+.+|++|||++++++.|+.+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1122222223345678999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=309.25 Aligned_cols=263 Identities=27% Similarity=0.437 Sum_probs=209.3
Q ss_pred HhhcCCCcCceEeeeCeEEEEEEEec--------CCcEEEEEEeccC-ChhHHHHHHHHHHHHhhC-CCCceeeeeeeee
Q 017262 69 KATDYFNMNRILGQGGQGTVYKGMLA--------DGRIIAVKKSKVV-DESKLEEFINEVVILSQI-NHRNVVKLLGCCL 138 (374)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 138 (374)
...++|.+.+.||+|+||.||+|... ++..+++|..... .......+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 33567889999999999999999741 2457899987643 234557788999999999 8999999999999
Q ss_pred ecccceEEEEeecCCcccccccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCce
Q 017262 139 EVEVPLLVYEFIPNGTLFQYLHDPY-------------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNI 205 (374)
Q Consensus 139 ~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Ni 205 (374)
.....+++|||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 9999999999999999999986431 1245788899999999999999999999 99999999999
Q ss_pred EECCCCcEEEeecccccccccCCcee-eecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccC
Q 017262 206 LLDEKYRAKIADFGTSRSIAIDQTHV-STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEG 283 (374)
Q Consensus 206 ll~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~ 283 (374)
++++++.+||+|||++.......... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---- 244 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---- 244 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC----
Confidence 99999999999999997654322221 222345678999999988889999999999999999998 788885432
Q ss_pred CChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 017262 284 RNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350 (374)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~ 350 (374)
........ ... .....+...+..+.+++.+||..+|++|||+.++++.|+++...
T Consensus 245 --~~~~~~~~-~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 245 --VEELFKLL-KEG---------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred --HHHHHHHH-HcC---------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 22222211 111 11122234556889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=311.98 Aligned_cols=248 Identities=25% Similarity=0.387 Sum_probs=196.5
Q ss_pred ceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccceEEEEeecC
Q 017262 78 RILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVPLLVYEFIPN 152 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 152 (374)
+.||+|+||.||++... +++.+|+|.++.. .......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999965 5789999988642 233445678899999998 799999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceee
Q 017262 153 GTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 232 (374)
Q Consensus 153 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 232 (374)
|+|.+++. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...... ....
T Consensus 81 g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~ 153 (329)
T cd05588 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTT 153 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC-CCcc
Confidence 99998886 3457999999999999999999999999 999999999999999999999999998643211 1222
Q ss_pred ecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcccccc--CCChHHHHHHHHHhccccccccccccCC
Q 017262 233 TKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANE--GRNLTTYFVECIEENCLFDIIDDQVRKS 310 (374)
Q Consensus 233 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (374)
....||+.|+|||++.+..++.++|+|||||++|+|++|+.||....... ......+..+....... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~----------~ 223 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI----------R 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC----------C
Confidence 34568999999999999999999999999999999999999996433222 11122222222211111 1
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCC------HHHHHH
Q 017262 311 GEAEEIMAVSDVAKRCLNSYGRNRPT------MKEVAM 342 (374)
Q Consensus 311 ~~~~~~~~l~~li~~cl~~~p~~Rps------~~~vl~ 342 (374)
.+...+..+.+++.+||+.||++||| +.++++
T Consensus 224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 12234457889999999999999998 556653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=300.16 Aligned_cols=252 Identities=28% Similarity=0.345 Sum_probs=211.3
Q ss_pred cCCCcCceEeeeCeEEEEEEEecC-CcEEEEEEeccCC---hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVD---ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
+.|++.+.||+|.-|+||++..++ +..+|+|++.... .....+...|-++|+.++||.++.+|..|..++..|++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 457778899999999999999765 5889999886543 344556778999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc-
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI- 226 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~- 226 (374)
|||+||+|....+.. .+..+++..++-++.+++.||+|||..| ||.|||||+||||.++|++-|+||.++..+..
T Consensus 157 eyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 999999999988765 6778999999999999999999999999 99999999999999999999999998644311
Q ss_pred --------------------------------CCc----------------------eeeecccccccccCccccccCCC
Q 017262 227 --------------------------------DQT----------------------HVSTKVQGTFGYLDPEYFRSSQF 252 (374)
Q Consensus 227 --------------------------------~~~----------------------~~~~~~~g~~~y~aPE~~~~~~~ 252 (374)
... ......+||..|.|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 000 11123569999999999999999
Q ss_pred CccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCC
Q 017262 253 TDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGR 332 (374)
Q Consensus 253 ~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~ 332 (374)
+.++|.|+||+++|||+.|..||.+....+. +..++...+.....+..+..+.+||+++|..||+
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~T---------------l~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKET---------------LRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhh---------------HHHHhcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence 9999999999999999999999987654432 3445555555555557788999999999999999
Q ss_pred CCCC----HHHHHH
Q 017262 333 NRPT----MKEVAM 342 (374)
Q Consensus 333 ~Rps----~~~vl~ 342 (374)
+|.. +.||.+
T Consensus 378 kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKR 391 (459)
T ss_pred hhhccccchHHhhc
Confidence 9988 666543
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=313.88 Aligned_cols=244 Identities=25% Similarity=0.330 Sum_probs=194.2
Q ss_pred CCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHH---hhCCCCceeeeeeeeeecccceEE
Q 017262 74 FNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVIL---SQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 74 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
|++.+.||+|+||.||+|... +++.+|+|.+... .......+..|..++ +.++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 677899999999999999864 5889999988643 223345566666655 566899999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
|||+++++|..++. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999988875 346899999999999999999999999 99999999999999999999999999865322
Q ss_pred CCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
.. .......|++.|+|||.+.+..++.++|||||||++|+|++|+.||..... ...........
T Consensus 154 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~------~~~~~~i~~~~--------- 217 (324)
T cd05589 154 FG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE------EEVFDSIVNDE--------- 217 (324)
T ss_pred CC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC---------
Confidence 11 222345689999999999998999999999999999999999999974322 11111111111
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 017262 307 VRKSGEAEEIMAVSDVAKRCLNSYGRNRPT-----MKEVAM 342 (374)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~vl~ 342 (374)
...+...+..+.+++.+||+.||++||+ +.++++
T Consensus 218 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 218 --VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 1122334567889999999999999994 555554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=315.91 Aligned_cols=248 Identities=25% Similarity=0.346 Sum_probs=194.8
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
++|+..+.||+|+||.||+|... +++.||+|.+... .......+.+|+++++.++|+||+++++++.+.+..+++|||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45677789999999999999965 6889999987643 233456788999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+++++|.... ...+..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||++.......
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~- 222 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM- 222 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence 9999986532 3457778899999999999999999 9999999999999999999999999987654221
Q ss_pred eeeecccccccccCcccccc-----CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccc
Q 017262 230 HVSTKVQGTFGYLDPEYFRS-----SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIID 304 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (374)
.......|+..|+|||.+.. ...+.++|||||||++|||++|+.||...... ..........
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~---~~~~~~~~~~---------- 289 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG---DWASLMCAIC---------- 289 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc---cHHHHHHHHh----------
Confidence 11233468999999998753 22356899999999999999999999732211 1111111100
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 305 DQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 305 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
.......+...+..+.+|+.+||+.||++|||+.++++.
T Consensus 290 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 290 MSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001112233445679999999999999999999999874
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=306.27 Aligned_cols=256 Identities=28% Similarity=0.421 Sum_probs=205.3
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecC------CcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLAD------GRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVP 143 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 143 (374)
.++|.+.+.||+|+||.||+|...+ +..+++|...... ......+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4578889999999999999998642 3689999876543 34456788999999999999999999999999999
Q ss_pred eEEEEeecCCcccccccCCCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEe
Q 017262 144 LLVYEFIPNGTLFQYLHDPYE-------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIA 216 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~ 216 (374)
+++|||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999864321 234788899999999999999999998 9999999999999999999999
Q ss_pred ecccccccccCCce-eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHH
Q 017262 217 DFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECI 294 (374)
Q Consensus 217 Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 294 (374)
|||+++........ ......++..|+|||.+.+..++.++||||||+++|++++ |..||...... .... ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~------~~~~-~~ 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE------EVLK-FV 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH------HHHH-HH
Confidence 99998765433221 1223346788999999988889999999999999999998 99998643221 1111 11
Q ss_pred HhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017262 295 EENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345 (374)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~ 345 (374)
.... ....+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 235 ~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 235 IDGG---------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred hcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1111 11122233668899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=302.40 Aligned_cols=260 Identities=25% Similarity=0.365 Sum_probs=208.8
Q ss_pred cCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
++|++.+.||+|+||.||++.. .++..+++|.+... +......+.+|+.+++.++||||+++++++.+.+..++++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999995 57889999976542 2334567889999999999999999999999999999999
Q ss_pred EeecCCcccccccCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 148 EFIPNGTLFQYLHDP-YEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 148 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
||+++++|.+++... .....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988632 13456899999999999999999999999 99999999999999999999999999876543
Q ss_pred CCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ...... ... ...
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~-~~~--------~~~ 224 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCK-KIE--------QCD 224 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhh-hhh--------cCC
Confidence 221 122345888999999998888999999999999999999999998642211 111111 000 001
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 017262 307 VRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIR 348 (374)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~ 348 (374)
.........+..+.+++.+|+..+|++|||+.++++.++++.
T Consensus 225 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 225 YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 111112245668999999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=302.73 Aligned_cols=254 Identities=24% Similarity=0.359 Sum_probs=202.3
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
.++|++.+.||+|+||.||+|.. .+++.+++|............+.+|+.++++++||||+++++++...+..++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35789999999999999999996 46788999988765555556788999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI- 160 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc-
Confidence 999999998863 457899999999999999999999998 9999999999999999999999999987653221
Q ss_pred eeeecccccccccCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 230 HVSTKVQGTFGYLDPEYFR---SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
.......+++.|+|||.+. ...++.++|+||||+++|+|++|..||......... . ....... ..+
T Consensus 161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-----~--~~~~~~~---~~~- 229 (267)
T cd06646 161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-----F--LMSKSNF---QPP- 229 (267)
T ss_pred cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-----e--eeecCCC---CCC-
Confidence 1123345788999999874 345788999999999999999999998643221100 0 0000000 000
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 307 VRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
........+..+.+++.+||+.+|++|||++++++.
T Consensus 230 -~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 230 -KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred -CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 011122345689999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=315.93 Aligned_cols=241 Identities=25% Similarity=0.304 Sum_probs=195.1
Q ss_pred ceEeeeCeEEEEEEEe-cCCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeecCC
Q 017262 78 RILGQGGQGTVYKGML-ADGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNG 153 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 153 (374)
+.||+|+||.||++.. .++..+|+|.+... .......+..|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999986 46889999987642 2334456778999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceee
Q 017262 154 TLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS-SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 232 (374)
Q Consensus 154 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 232 (374)
+|..++. ....+++..+..++.|++.||+|||+ .+ ++||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~ 153 (325)
T cd05594 81 ELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATM 153 (325)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-ccc
Confidence 9998886 34578999999999999999999997 67 9999999999999999999999999987533221 222
Q ss_pred ecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCC
Q 017262 233 TKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGE 312 (374)
Q Consensus 233 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (374)
....|++.|+|||++.+..++.++|||||||++|+|++|..||...... ..... .... ....+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~------~~~~~-i~~~----------~~~~p 216 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFEL-ILME----------EIRFP 216 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH------HHHHH-HhcC----------CCCCC
Confidence 3446899999999999889999999999999999999999999643221 11111 1110 01122
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 017262 313 AEEIMAVSDVAKRCLNSYGRNRP-----TMKEVAM 342 (374)
Q Consensus 313 ~~~~~~l~~li~~cl~~~p~~Rp-----s~~~vl~ 342 (374)
...+..+.+++.+||+.||++|+ ++.++++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 23455788999999999999996 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=300.16 Aligned_cols=249 Identities=27% Similarity=0.411 Sum_probs=204.4
Q ss_pred CCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
+|.+.+.||+|++|.||+|... ++..+++|.+... .......+.+|+++++.++|||++++++++.+.+..++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999965 5889999987542 345567788999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999998753 2457899999999999999999999998 99999999999999999999999999876543222
Q ss_pred eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccC
Q 017262 230 HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (374)
......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...... .... .... ....
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~-~~~~---------~~~~ 219 (256)
T cd08529 157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG------ALIL-KIIR---------GVFP 219 (256)
T ss_pred -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH------HHHH-HHHc---------CCCC
Confidence 223345788999999999888999999999999999999999999744311 1111 1111 1111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 310 SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 310 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..+...+..+.+++.+|++.+|++||++.++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 222245568999999999999999999999886
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=300.06 Aligned_cols=248 Identities=30% Similarity=0.472 Sum_probs=197.9
Q ss_pred ceEeeeCeEEEEEEEecC----CcEEEEEEeccCCh-hHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeecC
Q 017262 78 RILGQGGQGTVYKGMLAD----GRIIAVKKSKVVDE-SKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPN 152 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 152 (374)
+.||+|+||.||+|.... +..+++|....... .....+.+|+.++++++|||++++++++. .+..+++|||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 468999999999998532 26899998775433 34567889999999999999999999876 4567999999999
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceee
Q 017262 153 GTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 232 (374)
Q Consensus 153 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 232 (374)
++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++...........
T Consensus 80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 999999974 347899999999999999999999999 99999999999999999999999999886643332221
Q ss_pred ec--ccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccccccC
Q 017262 233 TK--VQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309 (374)
Q Consensus 233 ~~--~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (374)
.. ..++..|+|||.+.+..++.++||||||+++|+|++ |..||...... +.. ...... ...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~------~~~-~~~~~~---------~~~ 217 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA------EVI-AMLESG---------ERL 217 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH------HHH-HHHHcC---------CcC
Confidence 11 223467999999998889999999999999999998 99999643221 111 111111 111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 017262 310 SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIR 348 (374)
Q Consensus 310 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~ 348 (374)
..+...+..+.+++.+|+..+|++|||+.++++.|+++.
T Consensus 218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 223344568899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=312.36 Aligned_cols=241 Identities=25% Similarity=0.339 Sum_probs=194.4
Q ss_pred CCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCC-ceeeeeeeeeecccceEEE
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHR-NVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~ 147 (374)
+|++.+.||+|+||.||+|... +++.+|+|.+... .......+..|..++..++|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999965 4678999987642 233456678899999999764 6888999999889999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
||+++|+|.+++. ....+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQ---QVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999999886 3456899999999999999999999999 999999999999999999999999998643221
Q ss_pred CceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (374)
. .......|++.|+|||++.+..++.++|||||||++|+|++|+.||..... ......... .
T Consensus 155 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~------~~~~~~i~~-~---------- 216 (324)
T cd05587 155 G-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE------DELFQSIME-H---------- 216 (324)
T ss_pred C-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHc-C----------
Confidence 1 122345689999999999999999999999999999999999999964322 111111111 0
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 017262 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPTM 337 (374)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 337 (374)
....+...+..+.+++.+||..||++|++.
T Consensus 217 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 217 NVSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 111223345578899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=310.51 Aligned_cols=243 Identities=26% Similarity=0.382 Sum_probs=193.1
Q ss_pred ceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccceEEEEeecC
Q 017262 78 RILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVPLLVYEFIPN 152 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 152 (374)
+.||+|+||.||++... +++.+|+|.+... .......+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 5788999987642 333445677888888877 799999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceee
Q 017262 153 GTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 232 (374)
Q Consensus 153 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 232 (374)
|+|..++. ....+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++....... ...
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~ 153 (329)
T cd05618 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTT 153 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Ccc
Confidence 99988886 3457899999999999999999999999 9999999999999999999999999987532211 122
Q ss_pred ecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcccccc--CCChHHHHHHHHHhccccccccccccCC
Q 017262 233 TKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANE--GRNLTTYFVECIEENCLFDIIDDQVRKS 310 (374)
Q Consensus 233 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (374)
....||+.|+|||++.+..++.++||||||+++|+|++|..||....... ......+..+...... ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----------~~ 223 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------IR 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC----------CC
Confidence 34568999999999999999999999999999999999999996432211 1112222222221111 11
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCH
Q 017262 311 GEAEEIMAVSDVAKRCLNSYGRNRPTM 337 (374)
Q Consensus 311 ~~~~~~~~l~~li~~cl~~~p~~Rps~ 337 (374)
.+...+..+.+++.+||+.||++||++
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 223345578899999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=298.62 Aligned_cols=264 Identities=23% Similarity=0.319 Sum_probs=201.5
Q ss_pred cCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCCh--hHHHHHHHHHHHHhhCCCCc-eeeeeeeeeecc------
Q 017262 72 DYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDE--SKLEEFINEVVILSQINHRN-VVKLLGCCLEVE------ 141 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~------ 141 (374)
..|...++||+|+||+||+|+. .+|+.||+|++..... ..-....+|+.+++.++|+| |+.+++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 3455667799999999999995 5689999998876543 23345689999999999999 999999998877
Q ss_pred cceEEEEeecCCcccccccCCCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccc
Q 017262 142 VPLLVYEFIPNGTLFQYLHDPYEE-LSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGT 220 (374)
Q Consensus 142 ~~~lv~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 220 (374)
..++|+||+ ..+|..++...... ..++...+..++.|++.||+|||+++ |+||||||+|+|++++|.+||+|||+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 788999999 56899988754321 46777899999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCceeeecccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHh---
Q 017262 221 SRSIAIDQTHVSTKVQGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEE--- 296 (374)
Q Consensus 221 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--- 296 (374)
|+....+.. ..+..++|.+|+|||++.+. .|+...||||+||+++||++++.-|++..+.+ .+.. +.+....
T Consensus 167 Ara~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~--ql~~-If~~lGtP~e 242 (323)
T KOG0594|consen 167 ARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID--QLFR-IFRLLGTPNE 242 (323)
T ss_pred HHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH--HHHH-HHHHcCCCCc
Confidence 986653322 24556789999999998876 79999999999999999999999998655421 1111 1111110
Q ss_pred ccccccc---cc--cccCCC-C-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 297 NCLFDII---DD--QVRKSG-E-------AEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 297 ~~~~~~~---~~--~~~~~~-~-------~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
..+.... +- ...... + +.......+++.+||+.+|..|.|++.++..
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0111111 00 000000 0 1112478899999999999999999999874
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=307.44 Aligned_cols=255 Identities=24% Similarity=0.375 Sum_probs=202.7
Q ss_pred CCCcCceEeeeCeEEEEEEEecC------CcEEEEEEeccCCh-hHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceE
Q 017262 73 YFNMNRILGQGGQGTVYKGMLAD------GRIIAVKKSKVVDE-SKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLL 145 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 145 (374)
+|.+.+.||+|+||.||+|...+ +..+|+|.+..... .....+.+|+.++..++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 46777899999999999998532 47899998875433 334668899999999999999999999999999999
Q ss_pred EEEeecCCcccccccCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCc
Q 017262 146 VYEFIPNGTLFQYLHDP-------------YEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR 212 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~ 212 (374)
++||+++++|.+++... .....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 99999999999987421 01235788899999999999999999999 999999999999999999
Q ss_pred EEEeecccccccccCCc-eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHH
Q 017262 213 AKIADFGTSRSIAIDQT-HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYF 290 (374)
Q Consensus 213 ~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~ 290 (374)
+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||..... .+..
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~ 236 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------QDVI 236 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH------HHHH
Confidence 99999999876543222 11233346789999999988889999999999999999998 8888864322 1111
Q ss_pred HHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 017262 291 VECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELER 346 (374)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~ 346 (374)
.. ..... ....+...+..+.+|+.+|++.+|++||++++++..|+.
T Consensus 237 ~~-i~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 EM-IRNRQ---------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HH-HHcCC---------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11 11111 112233455678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=320.70 Aligned_cols=252 Identities=23% Similarity=0.351 Sum_probs=197.6
Q ss_pred cCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
++|.+.+.||+|+||.||++.. .+++.+|+|.+... .......+.+|+++++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3688999999999999999985 46889999987542 2334567788999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
||+++|+|.+++. ....+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLI---KYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999999987 3457899999999999999999999999 999999999999999999999999998632210
Q ss_pred Cce----------------------------------------------eeecccccccccCccccccCCCCccchhhhH
Q 017262 228 QTH----------------------------------------------VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSF 261 (374)
Q Consensus 228 ~~~----------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Di~sl 261 (374)
... ......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 0012358999999999998899999999999
Q ss_pred HHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCC---CCHH
Q 017262 262 GVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNR---PTMK 338 (374)
Q Consensus 262 G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---ps~~ 338 (374)
||++|||++|..||..... ...+....... ...........+..+.+|+.+|+. +|.+| +|+.
T Consensus 235 Gvil~elltG~~Pf~~~~~------~~~~~~i~~~~-------~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 235 GAIMFECLIGWPPFCSENS------HETYRKIINWR-------ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred chhhhhhhcCCCCCCCCCH------HHHHHHHHccC-------CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 9999999999999964322 11111111100 001111111234578899999997 77765 5998
Q ss_pred HHHHH
Q 017262 339 EVAME 343 (374)
Q Consensus 339 ~vl~~ 343 (374)
+++..
T Consensus 301 ~~l~h 305 (377)
T cd05629 301 EIKSH 305 (377)
T ss_pred HHhcC
Confidence 88774
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=310.91 Aligned_cols=240 Identities=24% Similarity=0.351 Sum_probs=191.2
Q ss_pred ceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccceEEEEeecC
Q 017262 78 RILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVPLLVYEFIPN 152 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 152 (374)
+.||+|+||.||+|... +++.||+|.++.. ..........|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 4788999987642 223334455667777654 899999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceee
Q 017262 153 GTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 232 (374)
Q Consensus 153 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 232 (374)
|+|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....... ...
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~ 153 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKA 153 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccc
Confidence 999998873 457899999999999999999999998 9999999999999999999999999987543222 223
Q ss_pred ecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCC
Q 017262 233 TKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGE 312 (374)
Q Consensus 233 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (374)
....||+.|+|||.+.+..++.++|||||||++|+|++|..||..... ...+...... ....+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~-----------~~~~~ 216 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE------DELFDSILND-----------RPHFP 216 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcC-----------CCCCC
Confidence 345689999999999988899999999999999999999999974322 1111111110 11122
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 017262 313 AEEIMAVSDVAKRCLNSYGRNRPTMK-EVA 341 (374)
Q Consensus 313 ~~~~~~l~~li~~cl~~~p~~Rps~~-~vl 341 (374)
...+..+.+++.+||+.+|++||++. +++
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 33455788999999999999999875 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=312.00 Aligned_cols=236 Identities=27% Similarity=0.377 Sum_probs=191.6
Q ss_pred ceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccceEEEEeecC
Q 017262 78 RILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVPLLVYEFIPN 152 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 152 (374)
+.||+|+||.||+|... +++.+|+|.+... .......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 5789999987642 233455677888888876 699999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceee
Q 017262 153 GTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 232 (374)
Q Consensus 153 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 232 (374)
|+|.+++. ....+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++....... ...
T Consensus 81 g~L~~~i~---~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~ 153 (320)
T cd05590 81 GDLMFHIQ---KSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTT 153 (320)
T ss_pred chHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccc
Confidence 99999887 3457899999999999999999999999 9999999999999999999999999987532221 222
Q ss_pred ecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCC
Q 017262 233 TKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGE 312 (374)
Q Consensus 233 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (374)
....|++.|+|||.+.+..++.++|||||||++|+|++|+.||..... ......... .. ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------~~~~~~i~~-~~----------~~~~ 216 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEAILN-DE----------VVYP 216 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH------HHHHHHHhc-CC----------CCCC
Confidence 345689999999999988999999999999999999999999974332 111211111 10 1122
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCH
Q 017262 313 AEEIMAVSDVAKRCLNSYGRNRPTM 337 (374)
Q Consensus 313 ~~~~~~l~~li~~cl~~~p~~Rps~ 337 (374)
...+..+.+++.+||+.||++||++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 2345678899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=302.16 Aligned_cols=255 Identities=25% Similarity=0.451 Sum_probs=203.6
Q ss_pred cCCCcCceEeeeCeEEEEEEEecC-C---cEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLAD-G---RIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
..|++.+.||+|+||.||+|.... + ..+++|.+... .......+..|+.+++.++||||+++++++.++...+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357788999999999999999643 3 36999987654 455567899999999999999999999999998899999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
+||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999998752 456899999999999999999999998 99999999999999999999999999876543
Q ss_pred CCcee--eeccc--ccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccc
Q 017262 227 DQTHV--STKVQ--GTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFD 301 (374)
Q Consensus 227 ~~~~~--~~~~~--g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (374)
..... ..... .+..|+|||.+.+..++.++||||||+++||+++ |..||...... .... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~------~~~~-~i~~----- 226 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ------DVIN-AIEQ----- 226 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH------HHHH-HHHc-----
Confidence 22111 11111 2457999999998899999999999999999886 99998643211 1111 1111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 017262 302 IIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347 (374)
Q Consensus 302 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~ 347 (374)
......+...+..+.+++.+||..+|++||++++++..|+.+
T Consensus 227 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 227 ----DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 011112234456788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=320.34 Aligned_cols=250 Identities=23% Similarity=0.300 Sum_probs=196.4
Q ss_pred CCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEE
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 148 (374)
+|+..+.||+|+||+||+|... +++.+|+|.+... .......+.+|+.++++++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999964 5788999987643 23345678899999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999999873 456889999999999999999999999 9999999999999999999999999975321000
Q ss_pred ----------------------------------------------ceeeecccccccccCccccccCCCCccchhhhHH
Q 017262 229 ----------------------------------------------THVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFG 262 (374)
Q Consensus 229 ----------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG 262 (374)
........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0001124589999999999998999999999999
Q ss_pred HHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCC---HHH
Q 017262 263 VVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPT---MKE 339 (374)
Q Consensus 263 ~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps---~~~ 339 (374)
|++|||++|+.||...... ......... ............++.+.+++.+|+ .+|.+|++ +.+
T Consensus 236 vil~elltG~~Pf~~~~~~------~~~~~i~~~-------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e 301 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPL------ETQMKVINW-------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADE 301 (382)
T ss_pred HHHHHHHhCCCCCCCCCHH------HHHHHHHcc-------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence 9999999999999743221 111111110 011111112234557788888876 59999987 777
Q ss_pred HHH
Q 017262 340 VAM 342 (374)
Q Consensus 340 vl~ 342 (374)
++.
T Consensus 302 i~~ 304 (382)
T cd05625 302 IKA 304 (382)
T ss_pred Hhc
Confidence 664
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=300.00 Aligned_cols=251 Identities=28% Similarity=0.467 Sum_probs=201.6
Q ss_pred cCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeec
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIP 151 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 151 (374)
.+|++.+.||+|+||.||++.+.++..+++|.+..... ....+.+|++++++++|||++++++++......++++||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 46788899999999999999987788899998765332 23568899999999999999999999998889999999999
Q ss_pred CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCcee
Q 017262 152 NGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV 231 (374)
Q Consensus 152 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 231 (374)
+++|.+++.. ....+++..+..++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 83 ~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 9999999864 2346889999999999999999999998 9999999999999999999999999987654322211
Q ss_pred eecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccccccCC
Q 017262 232 STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKS 310 (374)
Q Consensus 232 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (374)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ....... ... .+..
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~~~~-~~~---------~~~~ 221 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN------SEVVETI-NAG---------FRLY 221 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH------HHHHHHH-hCC---------CCCC
Confidence 122234568999999998889999999999999999998 9999864321 1111111 110 0111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 017262 311 GEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMEL 344 (374)
Q Consensus 311 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L 344 (374)
.+...+..+.+|+.+||+.+|++|||+.++++.|
T Consensus 222 ~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 222 KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1112345789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=305.61 Aligned_cols=251 Identities=24% Similarity=0.311 Sum_probs=200.6
Q ss_pred CCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC---hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEE
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 148 (374)
.|++.+.||+|+||+||++... +++.+|+|.+.... ......+.+|+.+++.++||||+++++++...+..+++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999964 68899999876432 2223456789999999999999999999999899999999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
|+++|+|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999887642 2346899999999999999999999998 9999999999999999999999999987643222
Q ss_pred ceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccccc
Q 017262 229 THVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVR 308 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (374)
......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||....... ....+..... ...
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~~~~----------~~~ 221 (285)
T cd05605 157 --TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVERRVK----------EDQ 221 (285)
T ss_pred --ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHHHhh----------hcc
Confidence 1223468899999999998889999999999999999999999997532211 0011111110 011
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 017262 309 KSGEAEEIMAVSDVAKRCLNSYGRNRP-----TMKEVAM 342 (374)
Q Consensus 309 ~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~vl~ 342 (374)
...+...+..+.+|+.+||..||++|| +++++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 223334566789999999999999999 7888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=305.30 Aligned_cols=260 Identities=27% Similarity=0.412 Sum_probs=203.9
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEecC------CcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeeccc
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLAD------GRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEV 142 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 142 (374)
..++|++.+.||+|+||.||+|..++ +..+|+|.+.... ......+.+|+..++.++||||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45689999999999999999997532 4578999876433 2334567889999999999999999999998889
Q ss_pred ceEEEEeecCCcccccccCCCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEE
Q 017262 143 PLLVYEFIPNGTLFQYLHDPYE-------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKI 215 (374)
Q Consensus 143 ~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl 215 (374)
.+++|||+++|+|.+++..... ....++..+..++.|++.||.|||+++ ++|+||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999964211 234567788999999999999999999 999999999999999999999
Q ss_pred eecccccccccCCcee-eecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHH
Q 017262 216 ADFGTSRSIAIDQTHV-STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVEC 293 (374)
Q Consensus 216 ~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~ 293 (374)
+|||+++......... .....++..|+|||.+.+..++.++|+||||+++|||++ |..||...... +.....
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~------~~~~~~ 234 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------QVLKFV 234 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHH
Confidence 9999987554322211 122235678999999998889999999999999999998 78898643221 111111
Q ss_pred HHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 017262 294 IEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIR 348 (374)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~ 348 (374)
.. ... ...+...+..+.+++.+|++.+|++|||+.++++.|++..
T Consensus 235 ~~-~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 235 MD-GGY---------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred Hc-CCC---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 11 111 1112233468999999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=317.43 Aligned_cols=264 Identities=27% Similarity=0.425 Sum_probs=207.5
Q ss_pred HHHhhcCCCcCceEeeeCeEEEEEEEec------CCcEEEEEEeccCC-hhHHHHHHHHHHHHhhCC-CCceeeeeeeee
Q 017262 67 LDKATDYFNMNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVVD-ESKLEEFINEVVILSQIN-HRNVVKLLGCCL 138 (374)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~ 138 (374)
.....++|.+.+.||+|+||.||+|.+. .+..||+|++.... ......+.+|+.++.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 3344556888899999999999999864 24579999987543 333457889999999997 999999999999
Q ss_pred ecccceEEEEeecCCcccccccCCC-------------------------------------------------------
Q 017262 139 EVEVPLLVYEFIPNGTLFQYLHDPY------------------------------------------------------- 163 (374)
Q Consensus 139 ~~~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------- 163 (374)
..+..++|+||+++|+|.+++....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 9889999999999999999886421
Q ss_pred ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCC
Q 017262 164 ----------------------------------------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKST 203 (374)
Q Consensus 164 ----------------------------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~ 203 (374)
....+++..++.++.|++.||+|||+.+ ++|+||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc
Confidence 1124677788999999999999999988 999999999
Q ss_pred ceEECCCCcEEEeecccccccccCCce-eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccc
Q 017262 204 NILLDEKYRAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWAN 281 (374)
Q Consensus 204 Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~ 281 (374)
|||+++++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 999999999999999999765322211 1122346788999999998889999999999999999998 88998643211
Q ss_pred cCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 017262 282 EGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIR 348 (374)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~ 348 (374)
+ ....... ...+...+...+..+.+|+.+||..+|.+||++.++++.|+.+.
T Consensus 349 ~------~~~~~~~---------~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 E------QFYNAIK---------RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred H------HHHHHHH---------cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1 1111111 11111223334568999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=299.15 Aligned_cols=250 Identities=22% Similarity=0.351 Sum_probs=203.2
Q ss_pred CCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEee
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFI 150 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 150 (374)
+|++.+.||.|+||.||++... +++.+++|.+... .....+.+..|+.+++.++|+|++++++.+.+.+..++++||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788899999999999999965 5888999987543 3445567889999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 230 (374)
++++|.+++... ....+++..++.++.|++.||.|||+++ ++|+||+|+||++++++.++++|||.+....... .
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~ 155 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-A 155 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc-c
Confidence 999999888643 3446889999999999999999999999 9999999999999999999999999987654322 1
Q ss_pred eeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCC
Q 017262 231 VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKS 310 (374)
Q Consensus 231 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (374)
......+++.|+|||++.+..++.++|+||||+++|+|++|..||.... ........ ..+.. ..
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~------~~~~~~~~-~~~~~---------~~ 219 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS------WKNLILKV-CQGSY---------KP 219 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC------HHHHHHHH-hcCCC---------CC
Confidence 2233568889999999998889999999999999999999999996422 11111111 11111 11
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 311 GEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 311 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
.+...+..+.+++.+||+.||++|||+.+++..
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 223345578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=308.65 Aligned_cols=244 Identities=26% Similarity=0.368 Sum_probs=195.7
Q ss_pred ceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccceEEEEeecC
Q 017262 78 RILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVPLLVYEFIPN 152 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 152 (374)
+.||+|+||.||++... +++.+|+|.+... .......+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 5788999988753 233455678899999888 699999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceee
Q 017262 153 GTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 232 (374)
Q Consensus 153 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 232 (374)
++|..++. ....+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (327)
T cd05617 81 GDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTT 153 (327)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cce
Confidence 99998886 3457999999999999999999999999 9999999999999999999999999987532211 222
Q ss_pred ecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCC
Q 017262 233 TKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGE 312 (374)
Q Consensus 233 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (374)
....||+.|+|||.+.+..++.++||||||+++|+|++|..||.............+..+....... ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----------~~p 223 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI----------RIP 223 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC----------CCC
Confidence 3456899999999999999999999999999999999999999754433332333333322222111 122
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH
Q 017262 313 AEEIMAVSDVAKRCLNSYGRNRPTMK 338 (374)
Q Consensus 313 ~~~~~~l~~li~~cl~~~p~~Rps~~ 338 (374)
...+..+.+++.+||+.||++||++.
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 23345688999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=299.98 Aligned_cols=250 Identities=28% Similarity=0.481 Sum_probs=196.5
Q ss_pred ceEeeeCeEEEEEEEecC-Cc--EEEEEEeccC-ChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccceEEEEeecC
Q 017262 78 RILGQGGQGTVYKGMLAD-GR--IIAVKKSKVV-DESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVPLLVYEFIPN 152 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 152 (374)
+.||+|+||.||+|...+ +. .+++|..... .......+.+|++++.++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999754 33 4678877643 344556788999999999 799999999999999999999999999
Q ss_pred CcccccccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecc
Q 017262 153 GTLFQYLHDPY-------------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 219 (374)
Q Consensus 153 g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 219 (374)
++|.+++.... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999986421 1235789999999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhcc
Q 017262 220 TSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENC 298 (374)
Q Consensus 220 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 298 (374)
++..... .........+..|+|||++.+..++.++||||||+++|+|++ |..||..... .........
T Consensus 158 l~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~------~~~~~~~~~--- 226 (270)
T cd05047 158 LSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELYEKLPQ--- 226 (270)
T ss_pred Cccccch--hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH------HHHHHHHhC---
Confidence 9853221 111111223567999999988889999999999999999997 9999964321 111111111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 017262 299 LFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIR 348 (374)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~ 348 (374)
......+...+..+.+++.+|++.+|.+|||+.++++.|+++.
T Consensus 227 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 227 -------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -------CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 1111122234457889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=299.03 Aligned_cols=249 Identities=29% Similarity=0.483 Sum_probs=200.2
Q ss_pred cCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeee-ecccceEEEEee
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCL-EVEVPLLVYEFI 150 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~ 150 (374)
++|.+.+.||+|+||.||++... |..+++|...... ....+.+|+.++++++|+|++++++++. ..+..++++||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46888999999999999999765 6778999876532 3457889999999999999999999765 445789999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 230 (374)
++++|.+++... ....+++..++.++.|++.||+|||+++ ++|+||||+||++++++.+||+|||++.......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 999999998753 2345889999999999999999999999 9999999999999999999999999987543211
Q ss_pred eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccccccC
Q 017262 231 VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309 (374)
Q Consensus 231 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (374)
....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.... ....... .... ...
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~------~~~~~~~-~~~~---------~~~ 218 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKDVVPR-VEKG---------YKM 218 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC------HHHHHHH-HhcC---------CCC
Confidence 12234568999999998889999999999999999997 999986422 1111111 1111 111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 017262 310 SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347 (374)
Q Consensus 310 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~ 347 (374)
..+...+..+.+++.+|++.+|++|||+.++++.|+.+
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 22234456889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=302.73 Aligned_cols=248 Identities=22% Similarity=0.309 Sum_probs=194.1
Q ss_pred EeeeCeEEEEEEEec-CCcEEEEEEeccCC---hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeecCCcc
Q 017262 80 LGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTL 155 (374)
Q Consensus 80 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 155 (374)
||+|+||.||++... +|+.+|+|.+.... ......+..|++++++++||||+++++++.+....+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999864 58999999875421 22234556799999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceeeecc
Q 017262 156 FQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKV 235 (374)
Q Consensus 156 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 235 (374)
.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~ 154 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQR 154 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeecc
Confidence 9887543 3345889999999999999999999999 9999999999999999999999999987654322 22334
Q ss_pred cccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCHHH
Q 017262 236 QGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEE 315 (374)
Q Consensus 236 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (374)
.|++.|+|||++.+..++.++|||||||++|+|++|..||....... .......... ..... ......
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~~~---------~~~~~-~~~~~~ 222 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRRTL---------EDEVK-FEHQNF 222 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHHhh---------ccccc-cccccC
Confidence 68999999999998889999999999999999999999996432211 1111111100 00110 011134
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017262 316 IMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345 (374)
Q Consensus 316 ~~~l~~li~~cl~~~p~~Rps~~~vl~~L~ 345 (374)
+..+.+|+.+||+.||++||++.++++.+.
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 557899999999999999999987764443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=299.21 Aligned_cols=249 Identities=32% Similarity=0.502 Sum_probs=204.3
Q ss_pred ceEeeeCeEEEEEEEecC----CcEEEEEEeccCChh-HHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeecC
Q 017262 78 RILGQGGQGTVYKGMLAD----GRIIAVKKSKVVDES-KLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPN 152 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 152 (374)
+.||+|+||.||+|...+ +..+++|.+...... ....+.+|+..++.++|+|++++++++.+....++++||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999999654 788999988765433 367888999999999999999999999998899999999999
Q ss_pred CcccccccCCCC------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 153 GTLFQYLHDPYE------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 153 g~L~~~l~~~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
++|.+++..... ...+++..+..++.|++.||+|||+++ ++|+||+|+||++++++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999975311 367999999999999999999999998 99999999999999999999999999987653
Q ss_pred CCc-eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhcccccccc
Q 017262 227 DQT-HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIID 304 (374)
Q Consensus 227 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (374)
... .......+++.|+|||.+....++.++||||||+++|+|++ |..||..... ...... ...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~-~~~-------- 222 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN------EEVLEY-LRK-------- 222 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH------HHHHHH-HHc--------
Confidence 321 22233457889999999988889999999999999999999 6999975421 111111 111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017262 305 DQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345 (374)
Q Consensus 305 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~ 345 (374)
......+...+..+.+++.+|+..+|++|||+.++++.|+
T Consensus 223 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 223 -GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1122233444678999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=302.54 Aligned_cols=256 Identities=23% Similarity=0.385 Sum_probs=204.9
Q ss_pred cCCCcCceEeeeCeEEEEEEEec------CCcEEEEEEeccCChh-HHHHHHHHHHHHhhCCCCceeeeeeeeeecccce
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVVDES-KLEEFINEVVILSQINHRNVVKLLGCCLEVEVPL 144 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 144 (374)
++|.+.+.||.|+||.||+|..+ +.+.+++|........ ....+.+|+.++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888899999999999999854 2467888877654433 4577899999999999999999999999888999
Q ss_pred EEEEeecCCcccccccCCCCC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeec
Q 017262 145 LVYEFIPNGTLFQYLHDPYEE------LSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADF 218 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 218 (374)
++|||+++++|.+++...... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998753211 26899999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhc
Q 017262 219 GTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEEN 297 (374)
Q Consensus 219 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 297 (374)
|++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ..+. .....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~------~~~~-~~~~~ 234 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE------EVLN-RLQAG 234 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH------HHHH-HHHcC
Confidence 9987544333222333456778999999988888999999999999999999 88898643221 1111 11111
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017262 298 CLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345 (374)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~ 345 (374)
.. ....+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 235 ~~--------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KL--------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred Cc--------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11 11122234568999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=313.70 Aligned_cols=263 Identities=23% Similarity=0.249 Sum_probs=198.7
Q ss_pred CCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc-----cce
Q 017262 73 YFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVE-----VPL 144 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~ 144 (374)
+|++.+.||+|+||.||++.. .+++.+|+|++... +......+.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478889999999999999996 46899999987642 3344567889999999999999999999998766 689
Q ss_pred EEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccc
Q 017262 145 LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 224 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 224 (374)
+++||+. ++|.+++. ....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++...
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 57777775 3457899999999999999999999999 999999999999999999999999999765
Q ss_pred ccCCceeeecccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCccccccC----------CChHHHHHH-
Q 017262 225 AIDQTHVSTKVQGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLVELLTGQKPISSIWANEG----------RNLTTYFVE- 292 (374)
Q Consensus 225 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~----------~~~~~~~~~- 292 (374)
............+++.|+|||.+.+. .++.++|||||||++|+|++|+.||........ .....+...
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 44333333445678999999998764 578999999999999999999999975432110 000000000
Q ss_pred -----HHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 293 -----CIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 293 -----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
........ ..............+..+.+|+.+||+.||++|||+.+++..
T Consensus 234 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 234 EGARAHILRGPHK-PPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHHhCCCC-CCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000000 000000001111235578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=320.74 Aligned_cols=251 Identities=24% Similarity=0.318 Sum_probs=197.5
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC---hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
++|++.+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++++++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999964 58899999875421 233456788999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 99999999999973 456889999999999999999999999 999999999999999999999999997532100
Q ss_pred C------------------------------------------ceeeecccccccccCccccccCCCCccchhhhHHHHH
Q 017262 228 Q------------------------------------------THVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVL 265 (374)
Q Consensus 228 ~------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l 265 (374)
. ........||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 0001124689999999999999999999999999999
Q ss_pred HHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCC---CHHHHHH
Q 017262 266 VELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRP---TMKEVAM 342 (374)
Q Consensus 266 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp---s~~~vl~ 342 (374)
|+|++|+.||...... ......... ............+..+.+++.+|+ .+|.+|+ |+.++++
T Consensus 235 yell~G~~Pf~~~~~~------~~~~~i~~~-------~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 235 YEMLVGQPPFLADTPA------ETQLKVINW-------ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred eehhhCCCCCCCCCHH------HHHHHHhcc-------CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 9999999999753321 111111100 001111111234456788999877 5999999 8888875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=296.34 Aligned_cols=247 Identities=30% Similarity=0.479 Sum_probs=199.8
Q ss_pred ceEeeeCeEEEEEEEecCCcEEEEEEeccCChh-HHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeecCCccc
Q 017262 78 RILGQGGQGTVYKGMLADGRIIAVKKSKVVDES-KLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLF 156 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~ 156 (374)
++||+|+||.||++...+++.+++|........ ....+.+|++++++++|+||+++++++.+....++++||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 468999999999999877999999987754333 5567899999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceee-ecc
Q 017262 157 QYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS-TKV 235 (374)
Q Consensus 157 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~ 235 (374)
+++... ...+++..+..++.+++.||+|||+++ ++|+||+|+||+++.++.++|+|||++........... ...
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 998642 346889999999999999999999999 99999999999999999999999999875532221111 112
Q ss_pred cccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCHH
Q 017262 236 QGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAE 314 (374)
Q Consensus 236 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (374)
..+..|+|||.+.+..++.++|+||||+++|+|++ |..||....... ...... .......+..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-------~~~~~~---------~~~~~~~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-------TRERIE---------SGYRMPAPQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-------HHHHHh---------cCCCCCCCcc
Confidence 24567999999988889999999999999999999 888886433211 111111 1111122334
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017262 315 EIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345 (374)
Q Consensus 315 ~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~ 345 (374)
.+..+.+++.+|++.+|++|||+.++++.|+
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 4568999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=316.90 Aligned_cols=259 Identities=23% Similarity=0.331 Sum_probs=202.9
Q ss_pred HHHHHhhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeec
Q 017262 65 KELDKATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEV 140 (374)
Q Consensus 65 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 140 (374)
.+.....++|++.+.||+|+||.||++... +++.+|+|.+... .......+.+|+.+++.++||||+++++++.+.
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 344455688999999999999999999965 5788999987532 223345677899999999999999999999999
Q ss_pred ccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccc
Q 017262 141 EVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGT 220 (374)
Q Consensus 141 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 220 (374)
+..++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 999999999999999998863 35888999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCceeeecccccccccCccccccC----CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHh
Q 017262 221 SRSIAIDQTHVSTKVQGTFGYLDPEYFRSS----QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEE 296 (374)
Q Consensus 221 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 296 (374)
+...............||+.|+|||++.+. .++.++|||||||++|+|++|..||.... ....+......
T Consensus 189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~------~~~~~~~i~~~ 262 (371)
T cd05622 189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS------LVGTYSKIMNH 262 (371)
T ss_pred eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC------HHHHHHHHHcC
Confidence 986643333333455699999999998653 37889999999999999999999996432 22222222211
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 017262 297 NCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRN--RPTMKEVAME 343 (374)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--Rps~~~vl~~ 343 (374)
... .........+..+.++|.+|++.++.+ ||+++++++.
T Consensus 263 ~~~-------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 263 KNS-------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CCc-------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 111 111112244567889999999844433 6788888774
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=304.61 Aligned_cols=263 Identities=26% Similarity=0.393 Sum_probs=202.0
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecC---------------CcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeee
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLAD---------------GRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLL 134 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~ 134 (374)
.++|++.+.||+|+||.||++...+ ...+++|..... .......+.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578999999999999999987532 225889987653 344456788999999999999999999
Q ss_pred eeeeecccceEEEEeecCCcccccccCCC---------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCce
Q 017262 135 GCCLEVEVPLLVYEFIPNGTLFQYLHDPY---------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNI 205 (374)
Q Consensus 135 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Ni 205 (374)
+++...+..+++|||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999999885421 1124688899999999999999999999 99999999999
Q ss_pred EECCCCcEEEeecccccccccCCcee-eecccccccccCccccccCCCCccchhhhHHHHHHHHHh--CCCCCCcccccc
Q 017262 206 LLDEKYRAKIADFGTSRSIAIDQTHV-STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT--GQKPISSIWANE 282 (374)
Q Consensus 206 ll~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~--g~~p~~~~~~~~ 282 (374)
++++++.+||+|||++.......... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 99999999999999987654322211 222345678999999988889999999999999999998 667776433211
Q ss_pred CCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017262 283 GRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345 (374)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~ 345 (374)
......+..... ........+...+..+.+|+.+|++.+|++|||+.++++.|+
T Consensus 241 ---~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 ---VIENTGEFFRNQ------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred ---HHHHHHHhhhhc------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 000011101100 001111112234568999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=293.84 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=203.1
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEecc--CChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKV--VDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
++.|++.+.||+|.|+.|+++.. ..|+.+++|.+.. ......+.+.+|+.+.+.++||||+++.+...+....|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 45677888999999999999875 4688888886543 33446788899999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECC---CCcEEEeeccccccc
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE---KYRAKIADFGTSRSI 224 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfg~~~~~ 224 (374)
|+++|++|..-|- .+..+++..+-++++||+.+|.|+|.++ |+|||+||+|+++-+ .-.+||+|||++..+
T Consensus 90 e~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 9999999987765 3456788889999999999999999999 999999999999953 446999999999887
Q ss_pred ccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccc
Q 017262 225 AIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIID 304 (374)
Q Consensus 225 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (374)
. .........|||.|||||++...+|+..+|||+.|+++|-|+.|.+||.+.+. ...+.+... +.. -++
T Consensus 164 ~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~------~rlye~I~~-g~y--d~~ 232 (355)
T KOG0033|consen 164 N--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------HRLYEQIKA-GAY--DYP 232 (355)
T ss_pred C--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH------HHHHHHHhc-ccc--CCC
Confidence 6 34445567899999999999999999999999999999999999999964221 111211111 100 011
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 305 DQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 305 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
+. .-+...+...+|+++||..||++|.|+.|.+.
T Consensus 233 ~~----~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 233 SP----EWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred Cc----ccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 11 12244567889999999999999999999876
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=313.83 Aligned_cols=238 Identities=28% Similarity=0.330 Sum_probs=193.2
Q ss_pred ceEeeeCeEEEEEEEe----cCCcEEEEEEeccCC--hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeec
Q 017262 78 RILGQGGQGTVYKGML----ADGRIIAVKKSKVVD--ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIP 151 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 151 (374)
+.||+|+||.||++.. .+|+.+|+|.+.... ......+..|++++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 357899999876432 2234456789999999999999999999999999999999999
Q ss_pred CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCcee
Q 017262 152 NGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV 231 (374)
Q Consensus 152 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 231 (374)
+++|.+++. ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++....... ..
T Consensus 82 ~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~ 154 (318)
T cd05582 82 GGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KK 154 (318)
T ss_pred CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cc
Confidence 999999886 3456899999999999999999999999 9999999999999999999999999987654322 12
Q ss_pred eecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCC
Q 017262 232 STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSG 311 (374)
Q Consensus 232 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (374)
.....|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ........ .. ....
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~------~~~~~~i~-~~----------~~~~ 217 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR------KETMTMIL-KA----------KLGM 217 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH------HHHHHHHH-cC----------CCCC
Confidence 2345689999999999988899999999999999999999999964321 11111111 11 0112
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 017262 312 EAEEIMAVSDVAKRCLNSYGRNRPTMKE 339 (374)
Q Consensus 312 ~~~~~~~l~~li~~cl~~~p~~Rps~~~ 339 (374)
+...+..+.+|+.+||+.||++||++.+
T Consensus 218 p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 2334567889999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=298.95 Aligned_cols=252 Identities=34% Similarity=0.536 Sum_probs=200.9
Q ss_pred CCcCceEeeeCeEEEEEEEecC-CcEEEEEEeccCChhHHH--HHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEee
Q 017262 74 FNMNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLE--EFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFI 150 (374)
Q Consensus 74 ~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 150 (374)
|++.+.||+|+||+||++.... ++.+|+|........... ...+|+..+++++||||+++++++.+.+..+++||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5678999999999999999764 668999998876544433 3456999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 230 (374)
++++|.+++. ....+++..+..++.|++.||++||+.+ ++|+||||+||+++.++.++|+|||.+.... ....
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNE 153 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST-STTS
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc-cccc
Confidence 9999999997 4567899999999999999999999999 9999999999999999999999999987542 2233
Q ss_pred eeecccccccccCccccc-cCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccC
Q 017262 231 VSTKVQGTFGYLDPEYFR-SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309 (374)
Q Consensus 231 ~~~~~~g~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (374)
......+++.|+|||.+. +..++.++|+||||+++|+|++|..||....... ............ ......
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~---~~~~~~~~~~~~----~~~~~~-- 224 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD---QLEIIEKILKRP----LPSSSQ-- 224 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH---HHHHHHHHHHTH----HHHHTT--
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchh---hhhhhhhccccc----cccccc--
Confidence 344566899999999998 8889999999999999999999999997541111 111111111000 000000
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 310 SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 310 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
........+.+++.+||+.||++|||+.++++
T Consensus 225 -~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 225 -QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp -SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred -ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00011268999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=296.38 Aligned_cols=268 Identities=24% Similarity=0.356 Sum_probs=210.6
Q ss_pred hHHHHHhhcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhC--CCCceeeeeeeeeecc
Q 017262 64 SKELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQI--NHRNVVKLLGCCLEVE 141 (374)
Q Consensus 64 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~~ 141 (374)
.--.+...+...+.+.||+|.||.||+|.++ |..||||++... +...+.+|.++.+.. +|+||+.|++.-..+.
T Consensus 203 lLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~ 278 (513)
T KOG2052|consen 203 LLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDN 278 (513)
T ss_pred hHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence 3445566778899999999999999999996 677999988743 346788899998875 8999999998866443
Q ss_pred ----cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-----cCCCCEEEeccCCCceEECCCCc
Q 017262 142 ----VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS-----SAYLPIYHRDIKSTNILLDEKYR 212 (374)
Q Consensus 142 ----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-----~~~~~i~H~dlk~~Nill~~~~~ 212 (374)
+++||++|.+.|||.+||. ...++....++++..++.||+|||. +|.+.|.|||||+.||||..+++
T Consensus 279 gs~TQLwLvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~ 354 (513)
T KOG2052|consen 279 GSWTQLWLVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 354 (513)
T ss_pred CceEEEEEeeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc
Confidence 6799999999999999996 4689999999999999999999995 46678999999999999999999
Q ss_pred EEEeecccccccccCCc---eeeecccccccccCccccccCC----C--CccchhhhHHHHHHHHHhC----------CC
Q 017262 213 AKIADFGTSRSIAIDQT---HVSTKVQGTFGYLDPEYFRSSQ----F--TDKSDVYSFGVVLVELLTG----------QK 273 (374)
Q Consensus 213 ~kl~Dfg~~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~----~--~~~~Di~slG~~l~el~~g----------~~ 273 (374)
+.|+|+|+|........ ...+..+||.+|||||++...- + -..+||||||+++||+.-. +.
T Consensus 355 C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~ 434 (513)
T KOG2052|consen 355 CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQL 434 (513)
T ss_pred EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcC
Confidence 99999999976543322 2245678999999999986532 1 1368999999999999852 46
Q ss_pred CCCccccccCCChHHHHHHHHHhccccccccccccCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 017262 274 PISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSG-----EAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIR 348 (374)
Q Consensus 274 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~ 348 (374)
||-+.-+.+.. .+...+. +...++++.. ..+....+.++++.||..||..|-|+-.+.+.|.++.
T Consensus 435 Pyyd~Vp~DPs--~eeMrkV--------VCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 435 PYYDVVPSDPS--FEEMRKV--------VCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred CcccCCCCCCC--HHHHhcc--------eeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 66544433221 1111111 1223333332 3466778999999999999999999999999999987
Q ss_pred h
Q 017262 349 A 349 (374)
Q Consensus 349 ~ 349 (374)
.
T Consensus 505 ~ 505 (513)
T KOG2052|consen 505 N 505 (513)
T ss_pred c
Confidence 5
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=309.41 Aligned_cols=241 Identities=24% Similarity=0.341 Sum_probs=194.8
Q ss_pred ceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccceEEEEeecC
Q 017262 78 RILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVPLLVYEFIPN 152 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 152 (374)
+.||+|+||.||++... +++.+|+|.+... .......+..|..+++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 4789999987643 233455677888999888 699999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceee
Q 017262 153 GTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 232 (374)
Q Consensus 153 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 232 (374)
++|..++. ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++....... ...
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (318)
T cd05570 81 GDLMFHIQ---RSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTT 153 (318)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Ccc
Confidence 99998886 3457999999999999999999999999 9999999999999999999999999986532211 122
Q ss_pred ecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCC
Q 017262 233 TKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGE 312 (374)
Q Consensus 233 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (374)
....|++.|+|||.+.+..++.++|||||||++|+|++|..||..... ......... . ....+
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~------~~~~~~i~~-~----------~~~~~ 216 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE------DELFQSILE-D----------EVRYP 216 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH------HHHHHHHHc-C----------CCCCC
Confidence 334589999999999999999999999999999999999999964321 111111111 1 01122
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 017262 313 AEEIMAVSDVAKRCLNSYGRNRPTM-----KEVAM 342 (374)
Q Consensus 313 ~~~~~~l~~li~~cl~~~p~~Rps~-----~~vl~ 342 (374)
...+..+.+|+.+||..||++|||+ .++++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 2345678999999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=297.92 Aligned_cols=251 Identities=26% Similarity=0.422 Sum_probs=199.3
Q ss_pred cCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 72 DYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
++|++.+.||+|+||.||+|.. .+++.+++|..... .......+.+|+.++++++||||+++++++...+..++++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3578889999999999999985 46889999987653 344456788999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+++++|..+. .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 9999986542 4678889999999999999999999 999999999999999999999999998765322
Q ss_pred eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccC
Q 017262 230 HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (374)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||.............-......... ...
T Consensus 149 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------~~~ 219 (279)
T cd06619 149 -IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED--------PPV 219 (279)
T ss_pred -cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC--------CCC
Confidence 22334688999999999988899999999999999999999999975433221111111111111110 000
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 310 SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 310 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
......+..+.+++.+|++.+|++||+++++++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1112234578899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=307.01 Aligned_cols=255 Identities=24% Similarity=0.347 Sum_probs=199.2
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEecc---CChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV---VDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
++|++.+.||+|+||.||++... +++.+|+|.+.. ........+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46889999999999999999965 588999998764 22334556888999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
||+++|+|.+++.. ....+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999999864 2456899999999999999999999999 999999999999999999999999998765433
Q ss_pred CceeeecccccccccCcccccc-----CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRS-----SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDI 302 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (374)
.........||+.|+|||++.. ..++.++|||||||++|+|++|+.||.... ..+..............
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~------~~~~~~~i~~~~~~~~~ 229 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMNHKEHFQF 229 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC------HHHHHHHHHcCCCcccC
Confidence 3333333468999999999863 457889999999999999999999996422 22222222111110000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcccCCC--CCCCHHHHHHH
Q 017262 303 IDDQVRKSGEAEEIMAVSDVAKRCLNSYGR--NRPTMKEVAME 343 (374)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~--~Rps~~~vl~~ 343 (374)
.......+..+.+++++|+..+++ .||+++++++.
T Consensus 230 ------~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 230 ------PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ------CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 011122456788999998865443 37899888875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=307.03 Aligned_cols=241 Identities=23% Similarity=0.340 Sum_probs=194.3
Q ss_pred ceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccceEEEEeecC
Q 017262 78 RILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVPLLVYEFIPN 152 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 152 (374)
+.||+|+||.||+|... +++.+|+|.+... .......+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46899999999999965 4789999987642 233445677888888876 799999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceee
Q 017262 153 GTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 232 (374)
Q Consensus 153 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 232 (374)
++|..++. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....... ...
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~ 153 (321)
T cd05591 81 GDLMFQIQ---RSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTT 153 (321)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC-ccc
Confidence 99998886 3457899999999999999999999999 9999999999999999999999999987543222 223
Q ss_pred ecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCC
Q 017262 233 TKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGE 312 (374)
Q Consensus 233 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (374)
....|++.|+|||++.+..++.++||||||+++|+|++|+.||..... ........... ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~------~~~~~~i~~~~-----------~~~p 216 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE------DDLFESILHDD-----------VLYP 216 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH------HHHHHHHHcCC-----------CCCC
Confidence 345689999999999988999999999999999999999999974332 12221111111 1112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-------CHHHHHH
Q 017262 313 AEEIMAVSDVAKRCLNSYGRNRP-------TMKEVAM 342 (374)
Q Consensus 313 ~~~~~~l~~li~~cl~~~p~~Rp-------s~~~vl~ 342 (374)
...+..+.+++.+||+.+|++|| +++++++
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 22345788999999999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=303.28 Aligned_cols=257 Identities=27% Similarity=0.454 Sum_probs=203.9
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec------CCcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVP 143 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 143 (374)
.++|++.+.||+|+||.||+|... ++..+++|.+.... ......+.+|+.++++++||||+++++++.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457889999999999999999853 46789999876543 33456788999999999999999999999998999
Q ss_pred eEEEEeecCCcccccccCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCc
Q 017262 144 LLVYEFIPNGTLFQYLHDPY-------------------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTN 204 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~N 204 (374)
++++||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||+|+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999986321 1234788899999999999999999998 9999999999
Q ss_pred eEECCCCcEEEeecccccccccCCce-eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcccccc
Q 017262 205 ILLDEKYRAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANE 282 (374)
Q Consensus 205 ill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~ 282 (374)
|++++++.++|+|||++......... .......+..|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~- 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE- 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 99999999999999998754322211 1122234667999999988899999999999999999997 88888543221
Q ss_pred CCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 017262 283 GRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELER 346 (374)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~ 346 (374)
+... ........ ..+...+..+.+++.+|++.+|++|||+.|+++.|++
T Consensus 240 -----~~~~-~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 -----EVIY-YVRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -----HHHH-HHhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1111 11111111 1122345678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=307.70 Aligned_cols=240 Identities=26% Similarity=0.349 Sum_probs=191.6
Q ss_pred ceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccceEEEEeecC
Q 017262 78 RILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVPLLVYEFIPN 152 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 152 (374)
+.||+|+||.||+|... +++.+|+|.+... ..........|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 4788999987643 123344566777788764 899999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceee
Q 017262 153 GTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 232 (374)
Q Consensus 153 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 232 (374)
|+|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++....... ...
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKT 153 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cce
Confidence 999999873 456889999999999999999999999 9999999999999999999999999987532222 122
Q ss_pred ecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCC
Q 017262 233 TKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGE 312 (374)
Q Consensus 233 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (374)
....||+.|+|||++.+..++.++|||||||++|+|++|..||..... ...... ..... ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~------~~~~~~-i~~~~----------~~~~ 216 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE------EELFQS-IRMDN----------PCYP 216 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH------HHHHHH-HHhCC----------CCCC
Confidence 345689999999999988999999999999999999999999964322 111111 11110 1112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 017262 313 AEEIMAVSDVAKRCLNSYGRNRPTMK-EVA 341 (374)
Q Consensus 313 ~~~~~~l~~li~~cl~~~p~~Rps~~-~vl 341 (374)
...+..+.+++.+||+.||++||++. ++.
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 23445788999999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=303.11 Aligned_cols=262 Identities=29% Similarity=0.437 Sum_probs=203.7
Q ss_pred cCCCcCceEeeeCeEEEEEEEe-----cCCcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeec--ccc
Q 017262 72 DYFNMNRILGQGGQGTVYKGML-----ADGRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEV--EVP 143 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 143 (374)
..|.+.+.||+|+||.||.+.. .++..+++|.+.... ......+.+|+.+++.++|||++++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578889999999999999973 347789999876543 34456788999999999999999999998775 467
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccc
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 223 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 223 (374)
+++|||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 8999999999999998642 346899999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCce--eeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcccccc--------CCChHHHHHHH
Q 017262 224 IAIDQTH--VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANE--------GRNLTTYFVEC 293 (374)
Q Consensus 224 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~--------~~~~~~~~~~~ 293 (374)
....... ......++..|+|||.+.+..++.++||||||+++|+|+++..|........ ...........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6433221 1123446778999999988889999999999999999999876643221100 00001111111
Q ss_pred HHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 017262 294 IEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347 (374)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~ 347 (374)
.... .....+...+..+.+|+.+|++.+|++|||++++++.|+.+
T Consensus 239 ~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEG---------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcC---------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1111 11122233456899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=303.59 Aligned_cols=250 Identities=26% Similarity=0.416 Sum_probs=205.0
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
..+|++.+.||+|+||.||+|.. .+++.+++|.+..........+.+|+.+++.++|||++++++.+......++|+||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 45789999999999999999995 46889999988766555667888999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+++++|.+++.. ..+++.++..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred cCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 999999998853 35789999999999999999999999 99999999999999999999999999876433221
Q ss_pred eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccC
Q 017262 230 HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (374)
......+++.|+|||.+.+..++.++||||||+++|+|++|+.||....... ... ..... .....
T Consensus 172 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-----~~~-~~~~~--------~~~~~ 236 (296)
T cd06654 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-----ALY-LIATN--------GTPEL 236 (296)
T ss_pred -ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-----hHH-HHhcC--------CCCCC
Confidence 1233458889999999998889999999999999999999999996432211 111 11000 00011
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 310 SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 310 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..+...+..+.+++.+||..+|++|||+.+++.
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 123345567899999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=299.37 Aligned_cols=265 Identities=25% Similarity=0.329 Sum_probs=200.5
Q ss_pred CCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc-----cceEE
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVE-----VPLLV 146 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~lv 146 (374)
.|...+++|.|+||.||.|... .+..+|||+......-. .+|+++|+.++|||||++.-+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4677789999999999999965 46899999877654321 36999999999999999998886432 34589
Q ss_pred EEeecCCcccccccCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCC-CcEEEeeccccccc
Q 017262 147 YEFIPNGTLFQYLHDP-YEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK-YRAKIADFGTSRSI 224 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfg~~~~~ 224 (374)
|||++. +|.+++... ..+..++...+.-+..||++||+|||+.+ |+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999965 777777631 13567888888999999999999999998 9999999999999965 99999999999988
Q ss_pred ccCCceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHH--------
Q 017262 225 AIDQTHVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIE-------- 295 (374)
Q Consensus 225 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 295 (374)
..+... ..+..|..|+|||.+.+ ..|+.+.||||.||++.||+-|+.-|++.+..+ .+... .....
T Consensus 177 ~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d--QL~eI-ik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 177 VKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD--QLVEI-IKVLGTPTREDIK 251 (364)
T ss_pred ccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH--HHHHH-HHHhCCCCHHHHh
Confidence 654433 45567889999999876 569999999999999999999999998644322 11111 11111
Q ss_pred -------hccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHHHHhh
Q 017262 296 -------ENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM--ELERIRAN 350 (374)
Q Consensus 296 -------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~--~L~~~~~~ 350 (374)
+.....+.......-.....+++..+|+.++|.++|++|.++.+++. .+..++..
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 11112222222111233445678899999999999999999999985 45555544
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=331.11 Aligned_cols=264 Identities=23% Similarity=0.350 Sum_probs=207.4
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
++|++.+.||+|+||.||+|... .++.||+|++... .......+.+|+.++++++||||+++++++.+.+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999965 5889999987643 2334567889999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecc
Q 017262 148 EFIPNGTLFQYLHDPYE--------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 219 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 219 (374)
||+++++|.+++..... ....++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998863211 234566788999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCc-----------------eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcccccc
Q 017262 220 TSRSIAIDQT-----------------HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANE 282 (374)
Q Consensus 220 ~~~~~~~~~~-----------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~ 282 (374)
++........ .......||+.|+|||.+.+..++.++|||||||++|||++|..||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9976521110 01122468999999999999999999999999999999999999996522111
Q ss_pred CCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHHHHhhCC
Q 017262 283 GRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNR-PTMKEVAMELERIRANSR 352 (374)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R-ps~~~vl~~L~~~~~~~~ 352 (374)
. ... ... ............+..+.+++.+|++.||++| ++++++++.|+...+..+
T Consensus 239 i-----~~~-----~~i----~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p 295 (932)
T PRK13184 239 I-----SYR-----DVI----LSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSP 295 (932)
T ss_pred h-----hhh-----hhc----cChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCc
Confidence 0 000 000 0000001112345678899999999999999 577888888988876543
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=310.25 Aligned_cols=262 Identities=30% Similarity=0.436 Sum_probs=203.3
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe------cCCcEEEEEEeccCC-hhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecc-
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML------ADGRIIAVKKSKVVD-ESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVE- 141 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~- 141 (374)
.++|++.+.||+|+||.||+|.. .+++.+|+|.+.... ......+.+|+.++.++ +||||+++++++...+
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35789999999999999999973 346789999887533 33456788999999999 6899999999886544
Q ss_pred cceEEEEeecCCcccccccCCCC---------------------------------------------------------
Q 017262 142 VPLLVYEFIPNGTLFQYLHDPYE--------------------------------------------------------- 164 (374)
Q Consensus 142 ~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 164 (374)
..+++|||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 57899999999999988753210
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce-eeeccc
Q 017262 165 -------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH-VSTKVQ 236 (374)
Q Consensus 165 -------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~ 236 (374)
...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++......... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 124678888999999999999999998 999999999999999999999999998765322211 122234
Q ss_pred ccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCHHH
Q 017262 237 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEE 315 (374)
Q Consensus 237 g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (374)
+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... . ......... ....+...
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~-~~~~~~~~~---------~~~~~~~~ 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----E-FCRRLKEGT---------RMRAPDYT 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-----H-HHHHHhccC---------CCCCCCCC
Confidence 5678999999988889999999999999999997 999986432111 1 111111111 11111123
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 017262 316 IMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350 (374)
Q Consensus 316 ~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~ 350 (374)
+..+.+++.+||..+|++|||+.++++.|+.+.+.
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 35788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=306.36 Aligned_cols=241 Identities=24% Similarity=0.334 Sum_probs=194.3
Q ss_pred CCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccceEEE
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 147 (374)
+|.+.+.||+|+||.||+|... +++.+|+|.+... .......+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999965 4678999987643 223334566788888777 5899999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
||+++|+|.+++. ....+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQ---QVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999998886 3456899999999999999999999999 999999999999999999999999998753321
Q ss_pred CceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (374)
. .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||..... ......... .
T Consensus 155 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~------~~~~~~i~~-~---------- 216 (323)
T cd05616 155 G-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIME-H---------- 216 (323)
T ss_pred C-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH------HHHHHHHHh-C----------
Confidence 1 222345689999999999999999999999999999999999999964322 111111111 1
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 017262 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPTM 337 (374)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 337 (374)
....+...+..+.+++.+|++.+|++|++.
T Consensus 217 ~~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 217 NVAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 011223345678899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=299.38 Aligned_cols=257 Identities=27% Similarity=0.477 Sum_probs=205.1
Q ss_pred cCCCcCceEeeeCeEEEEEEEecC-Cc----EEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLAD-GR----IIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLL 145 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 145 (374)
++|++.+.||+|+||.||+|...+ |. .+++|...... ......+.+|+..+++++|||++++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 567888999999999999998643 32 58888776543 3445678899999999999999999999987 78899
Q ss_pred EEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccc
Q 017262 146 VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 225 (374)
++||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++....
T Consensus 86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 99999999999998752 345899999999999999999999988 9999999999999999999999999997665
Q ss_pred cCCceee-ecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccc
Q 017262 226 IDQTHVS-TKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDII 303 (374)
Q Consensus 226 ~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (374)
....... ....++..|+|||.+....++.++|+||||+++||+++ |..||..... .+. .......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~-~~~~~~~------ 227 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA------VEI-PDLLEKG------ 227 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH------HHH-HHHHhCC------
Confidence 3322211 12224568999999988889999999999999999998 9999864322 111 1111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 017262 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350 (374)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~ 350 (374)
.....+...+..+.+++.+||..+|++|||+.++++.|+++...
T Consensus 228 ---~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 228 ---ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 11112222345688999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=301.54 Aligned_cols=246 Identities=22% Similarity=0.277 Sum_probs=194.3
Q ss_pred EeeeCeEEEEEEEec-CCcEEEEEEeccCC---hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeecCCcc
Q 017262 80 LGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTL 155 (374)
Q Consensus 80 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 155 (374)
||+|+||+||++... +++.+|+|.+.... ......+..|+.+++.++|+||+++.+++......+++|||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 689999999999864 68899999876432 22335677899999999999999999999998899999999999999
Q ss_pred cccccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceeeec
Q 017262 156 FQYLHDPY-EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTK 234 (374)
Q Consensus 156 ~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 234 (374)
..++.... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 88774321 3456899999999999999999999999 99999999999999999999999999876543222 2233
Q ss_pred ccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCHH
Q 017262 235 VQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAE 314 (374)
Q Consensus 235 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (374)
..|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... ....... ..... ....+..
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~~~~~~---------~~~~~--~~~~~~~ 223 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQ---------RILND--SVTYPDK 223 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch--hHHHHHH---------hhccc--CCCCccc
Confidence 468999999999999999999999999999999999999997432211 0011000 00111 1122334
Q ss_pred HHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 017262 315 EIMAVSDVAKRCLNSYGRNRP-----TMKEVAM 342 (374)
Q Consensus 315 ~~~~l~~li~~cl~~~p~~Rp-----s~~~vl~ 342 (374)
.+..+.+++.+||+.||++|| +++++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 566789999999999999999 5666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=308.13 Aligned_cols=264 Identities=28% Similarity=0.428 Sum_probs=209.0
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecC--------CcEEEEEEeccC-ChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeec
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLAD--------GRIIAVKKSKVV-DESKLEEFINEVVILSQI-NHRNVVKLLGCCLEV 140 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 140 (374)
..+|++.+.||+|+||.||++.... +..+++|..... .......+.+|+.+++++ +||||+++++++...
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 3568999999999999999997421 236889977643 334467889999999999 799999999999998
Q ss_pred ccceEEEEeecCCcccccccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEE
Q 017262 141 EVPLLVYEFIPNGTLFQYLHDPY-------------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL 207 (374)
Q Consensus 141 ~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill 207 (374)
+..++++||+++|+|.+++.... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence 89999999999999999986421 2345788999999999999999999998 9999999999999
Q ss_pred CCCCcEEEeecccccccccCCcee-eecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCC
Q 017262 208 DEKYRAKIADFGTSRSIAIDQTHV-STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRN 285 (374)
Q Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~ 285 (374)
+.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------ 241 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP------ 241 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC------
Confidence 999999999999987654322111 122234567999999999999999999999999999998 888986432
Q ss_pred hHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCC
Q 017262 286 LTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRD 353 (374)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~ 353 (374)
......... . ......+...+..+.+++.+|++.+|++|||+.++++.|+.+......
T Consensus 242 ~~~~~~~~~-~---------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~ 299 (334)
T cd05100 242 VEELFKLLK-E---------GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST 299 (334)
T ss_pred HHHHHHHHH-c---------CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCC
Confidence 122221111 1 111122233455788999999999999999999999999999876654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=308.37 Aligned_cols=240 Identities=25% Similarity=0.341 Sum_probs=191.7
Q ss_pred ceEeeeCeEEEEEEEec-CCcEEEEEEeccCC---hhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccceEEEEeecC
Q 017262 78 RILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVPLLVYEFIPN 152 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 152 (374)
+.||+|+||.||+|... +|..+|+|.++... .........|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999975 57899999876421 23345566788888765 899999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceee
Q 017262 153 GTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 232 (374)
Q Consensus 153 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 232 (374)
|+|..++. ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++...... ....
T Consensus 81 g~L~~~i~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~ 153 (316)
T cd05620 81 GDLMFHIQ---DKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRA 153 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCce
Confidence 99999886 3457899999999999999999999999 999999999999999999999999998643221 1223
Q ss_pred ecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCC
Q 017262 233 TKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGE 312 (374)
Q Consensus 233 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (374)
....|++.|+|||.+.+..++.++||||||+++|+|++|..||..... ...... .... ....+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~------~~~~~~-~~~~----------~~~~~ 216 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE------DELFES-IRVD----------TPHYP 216 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHH-HHhC----------CCCCC
Confidence 445689999999999999999999999999999999999999964321 111111 1111 01112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 017262 313 AEEIMAVSDVAKRCLNSYGRNRPTMK-EVA 341 (374)
Q Consensus 313 ~~~~~~l~~li~~cl~~~p~~Rps~~-~vl 341 (374)
...+..+.+++.+||..||++||++. +++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 22445788999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=302.00 Aligned_cols=263 Identities=25% Similarity=0.405 Sum_probs=202.7
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-----------------CCcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceee
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-----------------DGRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVK 132 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~ 132 (374)
.++|++.+.||+|+||.||++... ++..+++|..... .......+.+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 356899999999999999998532 2346889987754 3444568899999999999999999
Q ss_pred eeeeeeecccceEEEEeecCCcccccccCCC--------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCc
Q 017262 133 LLGCCLEVEVPLLVYEFIPNGTLFQYLHDPY--------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTN 204 (374)
Q Consensus 133 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~N 204 (374)
+++++.+.+..+++|||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 9999999999999999999999999986432 1234778899999999999999999999 9999999999
Q ss_pred eEECCCCcEEEeecccccccccCCcee-eecccccccccCccccccCCCCccchhhhHHHHHHHHHh--CCCCCCccccc
Q 017262 205 ILLDEKYRAKIADFGTSRSIAIDQTHV-STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT--GQKPISSIWAN 281 (374)
Q Consensus 205 ill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~--g~~p~~~~~~~ 281 (374)
|+++.++.++|+|||++.......... .....+++.|+|||...++.++.++|+||||+++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999987654322211 122334678999999888889999999999999999998 77888643321
Q ss_pred cCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017262 282 EGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345 (374)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~ 345 (374)
+. ............ .......+...+..+.+|+.+||+.||++|||+.++++.|+
T Consensus 241 ~~---~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 QV---IENTGEFFRDQG------RQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HH---HHHHHHHHhhcc------ccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11 111111111000 00011122334568999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=296.44 Aligned_cols=251 Identities=31% Similarity=0.477 Sum_probs=194.3
Q ss_pred ceEeeeCeEEEEEEEecC----CcEEEEEEecc-CChhHHHHHHHHHHHHhhCCCCceeeeeeeee-ecccceEEEEeec
Q 017262 78 RILGQGGQGTVYKGMLAD----GRIIAVKKSKV-VDESKLEEFINEVVILSQINHRNVVKLLGCCL-EVEVPLLVYEFIP 151 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~----~~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~ 151 (374)
+.||+|+||.||+|...+ ...+++|.... ........+.+|+.+++.++|||++++++++. .++..++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998532 35789998754 33455678889999999999999999999775 4456789999999
Q ss_pred CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCcee
Q 017262 152 NGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV 231 (374)
Q Consensus 152 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 231 (374)
+++|.+++... ....++..+..++.|++.||+|||+.+ ++|+||+|+|||+++++.+||+|||++..........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999998742 334677888999999999999999998 9999999999999999999999999987543321111
Q ss_pred ---eecccccccccCccccccCCCCccchhhhHHHHHHHHHhC-CCCCCccccccCCChHHHHHHHHHhccccccccccc
Q 017262 232 ---STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTG-QKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307 (374)
Q Consensus 232 ---~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (374)
.....++..|+|||.+.+..++.++||||||+++|||++| ..||..... ........ .. .
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~~~~~~~~-~~---------~ 219 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS------FDITVYLL-QG---------R 219 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHh-cC---------C
Confidence 1123456789999999888899999999999999999995 556653221 11111111 11 0
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 017262 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRA 349 (374)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~ 349 (374)
....+...+..+.+++.+||..+|++||++.++++.|+++..
T Consensus 220 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 220 RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 111122234578899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=309.54 Aligned_cols=237 Identities=26% Similarity=0.360 Sum_probs=189.2
Q ss_pred ceEeeeCeEEEEEEEec-CCcEEEEEEeccCC---hhHHHHHHHHHH-HHhhCCCCceeeeeeeeeecccceEEEEeecC
Q 017262 78 RILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVV-ILSQINHRNVVKLLGCCLEVEVPLLVYEFIPN 152 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 152 (374)
+.||+|+||+||+|... +|+.+|+|.+.... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999975 68899999876421 222334445544 56789999999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceee
Q 017262 153 GTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 232 (374)
Q Consensus 153 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 232 (374)
|+|..++. ....+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++...... ....
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~ 153 (323)
T cd05575 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTT 153 (323)
T ss_pred CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCcc
Confidence 99999887 3457899999999999999999999999 999999999999999999999999998653221 1223
Q ss_pred ecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCC
Q 017262 233 TKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGE 312 (374)
Q Consensus 233 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (374)
....|++.|+|||++.+..++.++|||||||++|+|++|..||..... .......... . ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~---------~--~~~~ 216 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------AEMYDNILNK---------P--LRLK 216 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH------HHHHHHHHcC---------C--CCCC
Confidence 345689999999999999999999999999999999999999964321 1211111111 0 1112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH
Q 017262 313 AEEIMAVSDVAKRCLNSYGRNRPTMK 338 (374)
Q Consensus 313 ~~~~~~l~~li~~cl~~~p~~Rps~~ 338 (374)
+..+..+.+++.+||+.||++||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 23356788999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=301.60 Aligned_cols=263 Identities=28% Similarity=0.426 Sum_probs=204.3
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecC-----------------CcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceee
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLAD-----------------GRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVK 132 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~ 132 (374)
.++|++.+.||+|+||.||+|...+ +..+++|.+.... ......+.+|+.++++++|||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578999999999999999988543 2457899876543 345678889999999999999999
Q ss_pred eeeeeeecccceEEEEeecCCcccccccCCC--------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCc
Q 017262 133 LLGCCLEVEVPLLVYEFIPNGTLFQYLHDPY--------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTN 204 (374)
Q Consensus 133 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~N 204 (374)
+++++..++..++++|++++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999899999999999999999986432 1236899999999999999999999998 9999999999
Q ss_pred eEECCCCcEEEeecccccccccCCce-eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh--CCCCCCccccc
Q 017262 205 ILLDEKYRAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT--GQKPISSIWAN 281 (374)
Q Consensus 205 ill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~--g~~p~~~~~~~ 281 (374)
|+++.++.++|+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ +..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 99999999999999998765432221 2233446778999999988889999999999999999998 67787543211
Q ss_pred cCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017262 282 EGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345 (374)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~ 345 (374)
. .+..... .............+...+..+.+++.+|++.+|++|||+.++++.|+
T Consensus 241 ~------~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 Q------VIENAGH---FFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred H------HHHHHHh---ccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1 1111110 00000111111122334568999999999999999999999998885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=305.20 Aligned_cols=252 Identities=28% Similarity=0.380 Sum_probs=211.5
Q ss_pred HhhcCCCcCceEeeeCeEEEEEEEecC-CcEEEEEEeccCCh---hHHHHHHHHHHHHhhCC-CCceeeeeeeeeecccc
Q 017262 69 KATDYFNMNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDE---SKLEEFINEVVILSQIN-HRNVVKLLGCCLEVEVP 143 (374)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~ 143 (374)
.....|++.+.||.|.||.||.+..+. |+.+|+|.+..... .....+.+|+.+|+++. ||||+.+.+.+.+.+..
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 345679999999999999999999765 99999998765433 23468899999999998 99999999999999999
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCC----CcEEEeecc
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK----YRAKIADFG 219 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~----~~~kl~Dfg 219 (374)
++|||++.||.|.+.+... .+++..+..++.|++.++.|||+.| ++||||||+|+|+... +.+|++|||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 9999999999999999854 3999999999999999999999999 9999999999999633 579999999
Q ss_pred cccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccc
Q 017262 220 TSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCL 299 (374)
Q Consensus 220 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (374)
++..... ........||+.|+|||++....|+..+||||+|+++|.|++|..||........ +. .+....+
T Consensus 185 la~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~------~~-~i~~~~~ 255 (382)
T KOG0032|consen 185 LAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI------FL-AILRGDF 255 (382)
T ss_pred CceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH------HH-HHHcCCC
Confidence 9988765 4556777899999999999999999999999999999999999999975443221 11 1111111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 300 FDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
......-...+..+.++|++|+..||..|+|+.++++
T Consensus 256 ------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 256 ------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred ------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 1122233455678899999999999999999999998
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=318.05 Aligned_cols=267 Identities=22% Similarity=0.334 Sum_probs=194.6
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeec--------
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEV-------- 140 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-------- 140 (374)
..++|.+.+.||+|+||.||+|... .++.||+|++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3567999999999999999999964 57899999875432 2234799999999999999998876432
Q ss_pred ccceEEEEeecCCcccccccCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCC-cEEEeec
Q 017262 141 EVPLLVYEFIPNGTLFQYLHDP-YEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY-RAKIADF 218 (374)
Q Consensus 141 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~-~~kl~Df 218 (374)
...++||||+++ +|.+++... .....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 135689999975 565555321 13457899999999999999999999999 99999999999998664 7999999
Q ss_pred ccccccccCCceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHh-
Q 017262 219 GTSRSIAIDQTHVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEE- 296 (374)
Q Consensus 219 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 296 (374)
|+++...... ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||......+ .+.... .....
T Consensus 216 Gla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~i~-~~~~~p 290 (440)
T PTZ00036 216 GSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--QLVRII-QVLGTP 290 (440)
T ss_pred ccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHH-HHhCCC
Confidence 9998654322 2233468999999999865 468999999999999999999999997543211 000000 00000
Q ss_pred --------------ccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHHHHh
Q 017262 297 --------------NCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM--ELERIRA 349 (374)
Q Consensus 297 --------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~--~L~~~~~ 349 (374)
-.+.......+....+...+..+.+|+.+||+.+|.+|||+.++++ .+..++.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 0000000011111122234567899999999999999999999984 4455443
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=297.57 Aligned_cols=246 Identities=27% Similarity=0.424 Sum_probs=213.6
Q ss_pred CCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeecC
Q 017262 74 FNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPN 152 (374)
Q Consensus 74 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 152 (374)
|.+.++||+|+||.||+|.++ .|+.+|+|++.. .++.+++..|+.++++++.|++|++||.+.....+++|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 567789999999999999965 599999999877 45678899999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceee
Q 017262 153 GTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 232 (374)
Q Consensus 153 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 232 (374)
|+..+.+.. .+.++++.++..++...++||+|||... -+|||||+.|||++-+|.+||+|||.+..+.+.. ...
T Consensus 113 GSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AKR 186 (502)
T KOG0574|consen 113 GSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AKR 186 (502)
T ss_pred CcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH-Hhh
Confidence 999999876 5678999999999999999999999988 7899999999999999999999999998776433 234
Q ss_pred ecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccc-ccccccCCC
Q 017262 233 TKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDI-IDDQVRKSG 311 (374)
Q Consensus 233 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 311 (374)
+...|||.|||||++..-.|+.++||||||++..||..|+.||.+.-.... ++.+ ..+......
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA---------------IFMIPT~PPPTF~K 251 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA---------------IFMIPTKPPPTFKK 251 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce---------------eEeccCCCCCCCCC
Confidence 556799999999999999999999999999999999999999986543321 1111 123333456
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 312 EAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 312 ~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
+...+..+.++++.||-.+|++|.|+.++++
T Consensus 252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 7788899999999999999999999999886
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=295.90 Aligned_cols=251 Identities=31% Similarity=0.511 Sum_probs=203.0
Q ss_pred CCcCceEeeeCeEEEEEEEecC-----CcEEEEEEeccCChh-HHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 74 FNMNRILGQGGQGTVYKGMLAD-----GRIIAVKKSKVVDES-KLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 74 ~~~~~~lg~G~~g~v~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
+++.+.||.|+||.||++...+ +..+++|.+...... ....+..|+..++.++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567899999999999999754 378999988765433 5678899999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
||+++++|.+++.... ...+++..+..++.|++.||++||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 9999999999987431 112899999999999999999999998 999999999999999999999999999776544
Q ss_pred CceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
.........+++.|+|||.+.+..++.++|+||||+++++|++ |..||.... ........ ....
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~------~~~~~~~~-~~~~-------- 221 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS------NEEVLEYL-KKGY-------- 221 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHH-hcCC--------
Confidence 3322222336789999999988889999999999999999998 788886422 11111111 1111
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 017262 307 VRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMEL 344 (374)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L 344 (374)
....+...+..+.+++.+|++.+|++|||+.++++.|
T Consensus 222 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 -RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1122223566899999999999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=298.98 Aligned_cols=252 Identities=24% Similarity=0.376 Sum_probs=201.2
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEee
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFI 150 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 150 (374)
++|.+.+.||+|+||.||+|... +++.+++|.++.........+.+|+.+++.++||||+++++.+...+..++++||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46778889999999999999864 58899999887765556667889999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 230 (374)
++++|.+++. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 89 ~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~~ 161 (267)
T cd06645 89 GGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT-IA 161 (267)
T ss_pred CCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc-cc
Confidence 9999999886 3457899999999999999999999999 999999999999999999999999998765322 12
Q ss_pred eeecccccccccCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccc
Q 017262 231 VSTKVQGTFGYLDPEYFR---SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307 (374)
Q Consensus 231 ~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (374)
......|++.|+|||.+. ...++.++|+||||+++|+|++|..||....... . ........ .. ....
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-----~-~~~~~~~~-~~---~~~~ 231 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-----A-LFLMTKSN-FQ---PPKL 231 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-----h-HHhhhccC-CC---CCcc
Confidence 223446889999999974 4558889999999999999999999986432111 0 00000000 00 0000
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
......+..+.+++.+|++.+|++|||++++++
T Consensus 232 --~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 232 --KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred --cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 011123457889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=295.50 Aligned_cols=240 Identities=23% Similarity=0.390 Sum_probs=189.5
Q ss_pred ceEeeeCeEEEEEEEecC-------------CcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccce
Q 017262 78 RILGQGGQGTVYKGMLAD-------------GRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPL 144 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 144 (374)
+.||+|+||.||+|.... ...+++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 2257888876655555667889999999999999999999999988999
Q ss_pred EEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCc-------EEEee
Q 017262 145 LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR-------AKIAD 217 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~-------~kl~D 217 (374)
++|||+++++|..++.. ....+++..++.++.|++.||+|||+.+ ++|+||||+|||++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999988864 2456899999999999999999999999 999999999999987654 89999
Q ss_pred cccccccccCCceeeecccccccccCccccc-cCCCCccchhhhHHHHHHHHH-hCCCCCCccccccCCChHHHHHHHHH
Q 017262 218 FGTSRSIAIDQTHVSTKVQGTFGYLDPEYFR-SSQFTDKSDVYSFGVVLVELL-TGQKPISSIWANEGRNLTTYFVECIE 295 (374)
Q Consensus 218 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~-~g~~p~~~~~~~~~~~~~~~~~~~~~ 295 (374)
||++...... ....++..|+|||.+. +..++.++||||||+++|+|+ +|..||......+ ......
T Consensus 156 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------~~~~~~ 223 (262)
T cd05077 156 PGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-------KERFYE 223 (262)
T ss_pred CCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-------HHHHHh
Confidence 9998654321 2234778899999886 466899999999999999998 5888876432211 000000
Q ss_pred hccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017262 296 ENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345 (374)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~ 345 (374)
. ... .....+..+.+|+.+||+.||++||++.++++.|+
T Consensus 224 -~--------~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 224 -G--------QCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred -c--------Ccc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0 000 01112356889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=296.43 Aligned_cols=250 Identities=28% Similarity=0.480 Sum_probs=201.3
Q ss_pred CCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCC------hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 73 YFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVD------ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
+|.+.+.||+|+||.||+|...+++.+|+|.+.... ......+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 478889999999999999998888999999876432 22345688999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 999999999999963 346889999999999999999999998 99999999999999999999999999875432
Q ss_pred CC-----ceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccc
Q 017262 227 DQ-----THVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFD 301 (374)
Q Consensus 227 ~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (374)
.. ........++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ...... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~-~~~~~---- 224 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR-----LAAMFY-IGAHR---- 224 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh-----HHHHHH-hhhcc----
Confidence 11 1112234588899999999988899999999999999999999999964321 111110 00000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 302 IIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 302 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
......+...+..+.+++++||..+|++||++.+++.
T Consensus 225 ----~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 225 ----GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ----CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0011122334567899999999999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=294.67 Aligned_cols=250 Identities=26% Similarity=0.382 Sum_probs=205.0
Q ss_pred CCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 73 YFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
+|+..+.||.|+||.||.+.. .++..+++|.+... +......+.+|+.++++++|+||+++++++.+.+..++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588899999999999999985 45888999986643 345567788999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999987532 456899999999999999999999998 99999999999999999999999999876543332
Q ss_pred eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccC
Q 017262 230 HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (374)
......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.... .......... ... .
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~------~~~~~~~~~~-~~~---------~ 219 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN------PLNLVVKIVQ-GNY---------T 219 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHc-CCC---------C
Confidence 2334558899999999988888999999999999999999999986422 1222221111 111 1
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 310 SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 310 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
..+...+..+.+++.+|+..+|++||+++++++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 1123345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=317.93 Aligned_cols=252 Identities=30% Similarity=0.513 Sum_probs=217.7
Q ss_pred CceEeeeCeEEEEEEEe-cCC----cEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEee
Q 017262 77 NRILGQGGQGTVYKGML-ADG----RIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFI 150 (374)
Q Consensus 77 ~~~lg~G~~g~v~~~~~-~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 150 (374)
.++||+|+||+||+|.+ .+| -+||+|.+... ..+...++++|+.+|.+++|||+++++++|..+. ..||++|+
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 47899999999999985 334 36888876543 4555678999999999999999999999998765 78999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 230 (374)
+.|+|.+|++. .+..+.....+.|..||++||.|||.++ ++||||.++||||.+...+|+.|||+++.+..+...
T Consensus 780 P~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 780 PLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred ccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 99999999987 4567888999999999999999999999 999999999999999999999999999988765544
Q ss_pred ee-ecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhcccccccccccc
Q 017262 231 VS-TKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVR 308 (374)
Q Consensus 231 ~~-~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (374)
.. ....-.+.|||-|.+....|+.++||||||+++||++| |..|+......+ +.+++....+
T Consensus 855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e----------------I~dlle~geR 918 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE----------------IPDLLEKGER 918 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH----------------hhHHHhcccc
Confidence 33 33345678999999999999999999999999999999 999998766554 4455566666
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 017262 309 KSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350 (374)
Q Consensus 309 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~ 350 (374)
...|+..+..+..++.+||..|+..||+++++...+.++..+
T Consensus 919 LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 919 LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 777888888999999999999999999999999999998664
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=294.49 Aligned_cols=249 Identities=30% Similarity=0.471 Sum_probs=204.7
Q ss_pred cCCCcCceEeeeCeEEEEEEEecC-CcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEee
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFI 150 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 150 (374)
++|++.+.||+|+||.||+|...+ ++.+++|.+..... ...+.+|+++++.++|||++++++++.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578899999999999999999765 78999998875432 678899999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 230 (374)
++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 99999999864 3457899999999999999999999998 99999999999999999999999999876543321
Q ss_pred eeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCC
Q 017262 231 VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKS 310 (374)
Q Consensus 231 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (374)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||........ .. .... .......
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~-----~~--~~~~-------~~~~~~~ 220 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA-----IF--MIPN-------KPPPTLS 220 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh-----hh--hhcc-------CCCCCCC
Confidence 22334478899999999988899999999999999999999999974332110 00 0000 0001111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 311 GEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 311 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.+...+..+.+++.+|++.+|++|||++++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 23344567899999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=294.90 Aligned_cols=254 Identities=25% Similarity=0.391 Sum_probs=206.6
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
.++|++.+.||.|+||.||+|... +++.+++|............+.+|+.++++++||||+++++++.+.+..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 357889999999999999999964 5788999988876666778899999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 155 (262)
T cd06613 82 CGGGSLQDIYQV--TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI- 155 (262)
T ss_pred CCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence 999999998874 2357899999999999999999999998 9999999999999999999999999987654321
Q ss_pred eeeecccccccccCccccccC---CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 230 HVSTKVQGTFGYLDPEYFRSS---QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~~---~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|..||....... . ... ...... ..
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~-----~-~~~-~~~~~~-----~~ 223 (262)
T cd06613 156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR-----A-LFL-ISKSNF-----PP 223 (262)
T ss_pred hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-----H-HHH-HHhccC-----CC
Confidence 122334578899999998776 78899999999999999999999996433111 0 000 001100 00
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 307 VRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.........+..+.+++.+||..+|.+|||+.+++.
T Consensus 224 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 224 PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 011123445678999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=296.37 Aligned_cols=248 Identities=28% Similarity=0.500 Sum_probs=200.2
Q ss_pred CCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCCh---------hHHHHHHHHHHHHhhCCCCceeeeeeeeeeccc
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE---------SKLEEFINEVVILSQINHRNVVKLLGCCLEVEV 142 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 142 (374)
+|.+.+.||+|++|.||+|... +++.+++|.+..... .....+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778899999999999999864 578899997754322 123567889999999999999999999999999
Q ss_pred ceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccc
Q 017262 143 PLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 222 (374)
Q Consensus 143 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 222 (374)
.++++||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||.+.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999973 456889999999999999999999998 9999999999999999999999999987
Q ss_pred ccccCCce-----eeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhc
Q 017262 223 SIAIDQTH-----VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEEN 297 (374)
Q Consensus 223 ~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 297 (374)
........ ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...... .... .. ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~-~~-~~- 226 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-----QAIF-KI-GE- 226 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-----HHHH-HH-hc-
Confidence 66422111 112245788999999999888999999999999999999999999743211 1110 00 00
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 298 CLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
......+...+..+.+++.+||+.+|++||++.++++
T Consensus 227 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 --------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred --------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1112223345568899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=300.89 Aligned_cols=249 Identities=27% Similarity=0.423 Sum_probs=205.6
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
.++|++.+.||+|+||.||++.. .+++.+++|.+..........+.+|+.+++.++|+|++++++++...+..++|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 46789999999999999999996 46899999988766555567788999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+++++|.+++.. ..+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999998853 45789999999999999999999998 99999999999999999999999999876543221
Q ss_pred eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccc-ccccc
Q 017262 230 HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDII-DDQVR 308 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 308 (374)
......+++.|+|||.+.+..++.++|+||||+++|+|++|..||........ ..... .....
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~---------------~~~~~~~~~~~ 234 (297)
T cd06656 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---------------LYLIATNGTPE 234 (297)
T ss_pred -CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh---------------eeeeccCCCCC
Confidence 12334588899999999988899999999999999999999999964322110 00000 01111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 309 KSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 309 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
...+...+..+.+++.+||..+|++||+++++++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 235 LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1123344567889999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=299.56 Aligned_cols=252 Identities=27% Similarity=0.388 Sum_probs=203.2
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
.+.|++.+.||.|+||.||+|... ++..+++|.....+......+.+|+.+++.++|||++++++++..+...++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 367889999999999999999975 4789999998877777778899999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+++++|..++.+ ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...... .
T Consensus 91 ~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~ 164 (292)
T cd06644 91 CPGGAVDAIMLE--LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-L 164 (292)
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc-c
Confidence 999999887754 2456899999999999999999999998 999999999999999999999999988654321 1
Q ss_pred eeeecccccccccCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccc
Q 017262 230 HVSTKVQGTFGYLDPEYFR-----SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIID 304 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (374)
.......+++.|+|||.+. ...++.++|+||||+++|+|++|..||..... ........... .
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~-~----- 232 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSE-P----- 232 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHHHHHHhcCC-C-----
Confidence 1223345788999999984 34467899999999999999999999864221 11111111110 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 305 DQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 305 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
+ ....+...+..+.+++.+||+.+|++||+++++++
T Consensus 233 ~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 233 P--TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred c--cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 11122344557889999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=302.55 Aligned_cols=261 Identities=27% Similarity=0.388 Sum_probs=201.6
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
++|++.+.||+|+||.||++... ++..+++|.+... .......+.+|++++++++||||+++++++.+++..++++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36889999999999999999965 5778888887654 334456788999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS-SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
+++++|.+++.. ...+++..+..++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 999999999973 4568999999999999999999998 46 999999999999999999999999998654321
Q ss_pred ceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccc---------
Q 017262 229 THVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCL--------- 299 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------- 299 (374)
......+++.|+|||.+.+..++.++|+||||+++|+|++|..||....... ..............
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcccccC
Confidence 1233468899999999988889999999999999999999999986432111 00000000000000
Q ss_pred ---------------cccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 017262 300 ---------------FDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMEL 344 (374)
Q Consensus 300 ---------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L 344 (374)
................+..+.+++.+||..+|++|||+.++++.-
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 000000000001112455789999999999999999999998763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=299.49 Aligned_cols=263 Identities=24% Similarity=0.318 Sum_probs=197.7
Q ss_pred CCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC--hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
+|++.+.||+|++|.||+|... ++..+++|.+.... ......+.+|+.++++++|||++++++++.+++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999965 68899999876432 23346778899999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
++ ++|.+++........+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 678888765434467899999999999999999999999 9999999999999999999999999987543322
Q ss_pred eeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHH-----------HHhc
Q 017262 230 HVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVEC-----------IEEN 297 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-----------~~~~ 297 (374)
.......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ......... ....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcchhhH
Confidence 11223356889999998865 457889999999999999999999997432210 000000000 0000
Q ss_pred cccccc---cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 298 CLFDII---DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 298 ~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
...... ............+..+.+++.+||..||++|||+.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000 000000011124567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=304.55 Aligned_cols=264 Identities=20% Similarity=0.305 Sum_probs=197.4
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
++|.+.+.||+|+||.||+|... +++.+|+|.+.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56889999999999999999965 57889999876533 22334577899999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+++ +|.+++.. ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 975 77777754 2345889999999999999999999999 99999999999999999999999999875432221
Q ss_pred eeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCC---------hHHHHHHHHHhccc
Q 017262 230 HVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRN---------LTTYFVECIEENCL 299 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~---------~~~~~~~~~~~~~~ 299 (374)
......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||......+... ..............
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 160 -TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred -ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 1223457889999998865 568899999999999999999999997543321100 00000000000000
Q ss_pred ccccccccc----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 300 FDIIDDQVR----KSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 300 ~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
...-.+... .......+..+.+|+.+||+.||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000 0011234567889999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=306.29 Aligned_cols=241 Identities=25% Similarity=0.333 Sum_probs=190.1
Q ss_pred ceEeeeCeEEEEEEEec-CCcEEEEEEeccCC---hhHHHHHHHHH-HHHhhCCCCceeeeeeeeeecccceEEEEeecC
Q 017262 78 RILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEV-VILSQINHRNVVKLLGCCLEVEVPLLVYEFIPN 152 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 152 (374)
+.||+|+||.||+|... +++.+|+|.+.... ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999965 56789999876421 12223334444 456888999999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceee
Q 017262 153 GTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 232 (374)
Q Consensus 153 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 232 (374)
++|.+++. ....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~~L~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~ 153 (325)
T cd05602 81 GELFYHLQ---RERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTT 153 (325)
T ss_pred CcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCc
Confidence 99999887 3456888999999999999999999999 9999999999999999999999999987543221 223
Q ss_pred ecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCC
Q 017262 233 TKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGE 312 (374)
Q Consensus 233 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (374)
....|++.|+|||++.+..++.++|||||||++|+|++|..||..... ...+..... .. ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~-~~----------~~~~ 216 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILN-KP----------LQLK 216 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH------HHHHHHHHh-CC----------cCCC
Confidence 345689999999999999999999999999999999999999964322 111111111 10 1122
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 313 AEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 313 ~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
+..+..+.+++.+||+.+|.+||++.+.+.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 234567889999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=307.43 Aligned_cols=263 Identities=22% Similarity=0.325 Sum_probs=196.6
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc-----
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVE----- 141 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 141 (374)
..++|++.+.||+|+||.||++... +|..+|+|.+... .......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999964 5889999987642 3344567889999999999999999999986543
Q ss_pred -cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccc
Q 017262 142 -VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGT 220 (374)
Q Consensus 142 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 220 (374)
..+++|||+++ +|...+. ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 46899999965 5555553 24788899999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccC---------CChHHHH-
Q 017262 221 SRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEG---------RNLTTYF- 290 (374)
Q Consensus 221 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~---------~~~~~~~- 290 (374)
+..... ........+|+.|+|||.+.+..++.++||||||+++|+|++|+.||........ .....+.
T Consensus 170 a~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (359)
T cd07876 170 ARTACT--NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247 (359)
T ss_pred cccccc--CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence 875432 1222345689999999999999999999999999999999999999975432110 0000000
Q ss_pred ------HHHHHhccccc------cccccc---cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 291 ------VECIEENCLFD------IIDDQV---RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 291 ------~~~~~~~~~~~------~~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
........... ...... ........+..+.+|+.+||..||++|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000000 000000 000111224578999999999999999999999983
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=295.38 Aligned_cols=248 Identities=27% Similarity=0.458 Sum_probs=199.8
Q ss_pred ceEeeeCeEEEEEEEecC--C--cEEEEEEeccCCh-hHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeecC
Q 017262 78 RILGQGGQGTVYKGMLAD--G--RIIAVKKSKVVDE-SKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPN 152 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 152 (374)
+.||+|++|.||+|.+.+ + ..+++|.+..... ...+.+.+|+..+++++||||+++++.+.. ...++++||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 3689998877655 566788999999999999999999999988 888999999999
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCcee-
Q 017262 153 GTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV- 231 (374)
Q Consensus 153 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~- 231 (374)
++|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++..........
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999975322 56899999999999999999999998 9999999999999999999999999998765322211
Q ss_pred -eecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccccccC
Q 017262 232 -STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309 (374)
Q Consensus 232 -~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (374)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+ ......... ...
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~---------~~~ 220 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ------ILKKIDKEG---------ERL 220 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhcC---------CcC
Confidence 122346788999999998899999999999999999998 999986432211 111111110 111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017262 310 SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345 (374)
Q Consensus 310 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~ 345 (374)
..+...+..+.+++.+|++.+|++|||+.++++.|.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 122234568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=314.40 Aligned_cols=251 Identities=25% Similarity=0.359 Sum_probs=196.9
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
++|++.+.||+|+||.||++... +++.+|+|.+... .......+..|+.++.+++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888999999999999999965 5889999988642 2334567788999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
||+++|+|.+++. ....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++......
T Consensus 81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999999987 3457899999999999999999999999 999999999999999999999999998654211
Q ss_pred Cc----------------------------------eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCC
Q 017262 228 QT----------------------------------HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQK 273 (374)
Q Consensus 228 ~~----------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~ 273 (374)
.. .......||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 10 00113468999999999999999999999999999999999999
Q ss_pred CCCccccccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 017262 274 PISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPT---MKEVAM 342 (374)
Q Consensus 274 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps---~~~vl~ 342 (374)
||...... .......... ...........+..+.+||.+|+. +|.+|++ +.++++
T Consensus 235 Pf~~~~~~------~~~~~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 235 PFCSETPQ------ETYRKVMNWK-------ETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCCHH------HHHHHHHcCC-------CceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 99643321 1111111100 000011111234578889999874 9999986 455554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=299.38 Aligned_cols=250 Identities=26% Similarity=0.369 Sum_probs=200.4
Q ss_pred CCCcCceEeeeCeEEEEEEEecC-CcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeec
Q 017262 73 YFNMNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIP 151 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 151 (374)
.|++.+.||+|+||.||+|.... +..+++|............+.+|+++++.++|||++++++++...+..++++||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 36777899999999999999754 67888888876666667788999999999999999999999999999999999999
Q ss_pred CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCcee
Q 017262 152 NGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV 231 (374)
Q Consensus 152 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 231 (374)
+++|..++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 86 ~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~-~~~ 159 (282)
T cd06643 86 GGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQR 159 (282)
T ss_pred CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccc-ccc
Confidence 9999888764 2457899999999999999999999998 999999999999999999999999998654321 122
Q ss_pred eecccccccccCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 232 STKVQGTFGYLDPEYFR-----SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 232 ~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
.....+++.|+|||.+. +..++.++|+||||+++|+|++|..||..... ........... ..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~~~-~~------ 226 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSE-PP------ 226 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH------HHHHHHHhhcC-CC------
Confidence 23345889999999974 34577899999999999999999999864321 11111111110 00
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 307 VRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
....+...+..+.+++.+||+.+|.+|||+.++++
T Consensus 227 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 227 -TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred -CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01122234567899999999999999999998865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=300.96 Aligned_cols=262 Identities=28% Similarity=0.440 Sum_probs=207.2
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-----CCcEEEEEEeccCChh-HHHHHHHHHHHHhhCCCCceeeeeeeeee--cccc
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-----DGRIIAVKKSKVVDES-KLEEFINEVVILSQINHRNVVKLLGCCLE--VEVP 143 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~ 143 (374)
+.|++.+.||+|+||.||++... .+..+|+|.+...... ....+.+|++.++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45778899999999999999853 3678999988765443 56789999999999999999999999877 5578
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccc
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 223 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 223 (374)
++++||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999999752 336899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCcee--eecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCC--------ChHHHHHHH
Q 017262 224 IAIDQTHV--STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGR--------NLTTYFVEC 293 (374)
Q Consensus 224 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~--------~~~~~~~~~ 293 (374)
........ .....++..|+|||.+.+..++.++||||||+++|+|++|..|+......... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 65322211 11233556799999998888999999999999999999999998643322110 001111111
Q ss_pred HHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 017262 294 IEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347 (374)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~ 347 (374)
.. .......+...+..+.+++.+|++.+|++|||+.+++++|+.+
T Consensus 239 ~~---------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LK---------EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HH---------cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11 1111222334456899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=299.59 Aligned_cols=250 Identities=26% Similarity=0.329 Sum_probs=198.8
Q ss_pred CCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC---hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 74 FNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 74 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
|+..+.||+|+||.||++... +++.+|+|.+.... ......+..|+.++++++|+|++++++.+.+.+..+++|||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 677789999999999999965 58899999875432 22334577899999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05630 82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 156 (285)
T ss_pred cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence 9999999988542 2346899999999999999999999998 9999999999999999999999999987543222
Q ss_pred eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccC
Q 017262 230 HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (374)
......|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... ........... ...
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~---~~~~~~~~~~~----------~~~ 222 (285)
T cd05630 157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI---KREEVERLVKE----------VQE 222 (285)
T ss_pred -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc---hHHHHHhhhhh----------hhh
Confidence 1223468999999999998899999999999999999999999997532211 00111111000 001
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 017262 310 SGEAEEIMAVSDVAKRCLNSYGRNRPT-----MKEVAM 342 (374)
Q Consensus 310 ~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~vl~ 342 (374)
..+...+..+.+|+.+||+.||++||| ++++++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 122233457889999999999999999 778876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=298.95 Aligned_cols=252 Identities=26% Similarity=0.411 Sum_probs=201.8
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
++|++.+.||+|+||.||++... ++..+++|.+... .......+.+|+.++++++||||+++++++...+..++++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36888999999999999999975 6889999987653 344557888999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSS-AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
+++++|..++........+++..+..++.|++.||.|||+. + ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999999887533344789999999999999999999974 6 9999999999999999999999999987543221
Q ss_pred ceeeecccccccccCccccccCC------CCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccc
Q 017262 229 THVSTKVQGTFGYLDPEYFRSSQ------FTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDI 302 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~~~~~------~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (374)
.....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...... ........ .
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~---------~ 222 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA---NIFAQLSA---------I 222 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh---hHHHHHHH---------H
Confidence 22234788999999985443 578999999999999999999999643211 11111110 0
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 303 IDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
. .......+...+..+.+++.+||+.+|++||++.+++.
T Consensus 223 ~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 223 V-DGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred h-hcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 1 11112233446678899999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=298.54 Aligned_cols=253 Identities=25% Similarity=0.434 Sum_probs=198.7
Q ss_pred HhhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeec------
Q 017262 69 KATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQI-NHRNVVKLLGCCLEV------ 140 (374)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~------ 140 (374)
.+++.|++.+.||+|+||.||+|... +++.+++|...... .....+..|+.+++++ +|||++++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45677889999999999999999965 57889999876543 3345778899999998 699999999998753
Q ss_pred ccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccc
Q 017262 141 EVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGT 220 (374)
Q Consensus 141 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 220 (374)
...++++||+++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 3578999999999999998753 2346899999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCceeeecccccccccCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHH
Q 017262 221 SRSIAIDQTHVSTKVQGTFGYLDPEYFR-----SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIE 295 (374)
Q Consensus 221 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 295 (374)
+....... .......|++.|+|||++. ...++.++|+||||+++|+|++|..||...... ..... . .
T Consensus 158 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-----~~~~~-~-~ 229 (272)
T cd06637 158 SAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-----RALFL-I-P 229 (272)
T ss_pred ceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-----HHHHH-H-h
Confidence 87643221 1223456889999999986 335788999999999999999999999632211 11110 0 0
Q ss_pred hccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 296 ENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
. ...........+..+.+|+.+||..+|.+|||+.++++
T Consensus 230 ~--------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 230 R--------NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred c--------CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0 00111112234457899999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=307.33 Aligned_cols=254 Identities=24% Similarity=0.326 Sum_probs=198.5
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
++|.+.+.||+|+||.||+++.. +++.+|+|.+... .......+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999965 5788999987542 2233455788999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
||+++|+|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 Ey~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999974 2357899999999999999999999999 999999999999999999999999999766543
Q ss_pred CceeeecccccccccCcccccc-----CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRS-----SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDI 302 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (374)
.........|++.|+|||++.+ ..++.++||||||+++|+|++|+.||.... ................
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~------~~~~~~~i~~~~~~~~- 228 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMNHEERFQ- 228 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC------HHHHHHHHHcCCCccc-
Confidence 3333334569999999999875 467889999999999999999999996422 1121221111110000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 017262 303 IDDQVRKSGEAEEIMAVSDVAKRCLNSYGRN--RPTMKEVAM 342 (374)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--Rps~~~vl~ 342 (374)
........+..+.+++.+|+...+++ |++++++++
T Consensus 229 -----~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 229 -----FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred -----CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 00111234567889999999876554 467887765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=305.89 Aligned_cols=241 Identities=24% Similarity=0.345 Sum_probs=194.0
Q ss_pred CCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCC-CCceeeeeeeeeecccceEEE
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQIN-HRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 147 (374)
+|+..+.||+|+||+||+|... +++.||+|.+... .......+..|..+++.+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3678899999999999999965 5889999987642 2333456778888988886 577888999999989999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
||+++|+|.+++. ....+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||++......
T Consensus 81 Ey~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999999886 3457999999999999999999999999 999999999999999999999999998754322
Q ss_pred CceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (374)
. .......||+.|+|||++.+..++.++||||||+++|+|++|..||..... ...........
T Consensus 155 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~------~~~~~~i~~~~---------- 217 (323)
T cd05615 155 G-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE------DELFQSIMEHN---------- 217 (323)
T ss_pred C-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC----------
Confidence 2 122334589999999999988899999999999999999999999974322 11111111110
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 017262 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPTM 337 (374)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 337 (374)
...+...+..+.+++.+||+.+|++|++.
T Consensus 218 -~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 -VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 11223345578899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=309.65 Aligned_cols=200 Identities=28% Similarity=0.391 Sum_probs=173.8
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCC-C-----Cceeeeeeeeeecccce
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQIN-H-----RNVVKLLGCCLEVEVPL 144 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~~~~~~~~~~~~~ 144 (374)
.+|.+.+.||+|+||.|.+|.+. .++.||||+++.. .....+...|+.+|..++ | -|+|+++++|...++.|
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 37899999999999999999965 5899999999864 445567788999999996 4 38999999999999999
Q ss_pred EEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCC--CcEEEeeccccc
Q 017262 145 LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK--YRAKIADFGTSR 222 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~--~~~kl~Dfg~~~ 222 (374)
+|+|.+ ..+|.+++..+ ...+++...++.++.||+.||..||+.+ |||+||||+||||.+. ..+||+|||.|+
T Consensus 265 iVfELL-~~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 265 IVFELL-STNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eeehhh-hhhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccc
Confidence 999999 67999999876 4556999999999999999999999998 9999999999999754 479999999998
Q ss_pred ccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccc
Q 017262 223 SIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWAN 281 (374)
Q Consensus 223 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~ 281 (374)
..... ...+.-+..|+|||++.+.+|+.+.|||||||+++||++|.+-|++....
T Consensus 340 ~~~q~----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~ 394 (586)
T KOG0667|consen 340 FESQR----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEY 394 (586)
T ss_pred ccCCc----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHH
Confidence 65321 12455677899999999999999999999999999999998888765543
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=293.17 Aligned_cols=249 Identities=23% Similarity=0.359 Sum_probs=201.0
Q ss_pred CCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc-cceEEEE
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVE-VPLLVYE 148 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e 148 (374)
.|++.+.||.|++|.||++... +++.+++|.+... .......+.+|++++++++|+|++++++.+...+ ..++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788999999999999999965 4788999987643 2344567889999999999999999999876444 6789999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
|+++++|.+++... ....+++.++..++.|++.|+++||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999998753 2346899999999999999999999999 9999999999999999999999999987654322
Q ss_pred ceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccccc
Q 017262 229 THVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVR 308 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (374)
.......+++.|+|||.+.+..++.++|+||||+++++|++|+.||.... .......... .. .
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~------~~~~~~~~~~-~~---------~ 219 (257)
T cd08223 157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD------MNSLVYRIIE-GK---------L 219 (257)
T ss_pred -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHHh-cC---------C
Confidence 22234457899999999999999999999999999999999999986322 1111111111 11 1
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 309 KSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 309 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
...+...+..+.+++.+|++.+|++|||+.++++
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1223345568999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=306.63 Aligned_cols=255 Identities=22% Similarity=0.316 Sum_probs=198.9
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
++|++.+.||+|+||.||++... .++.+|+|.+... .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36889999999999999999965 4678999987532 2233445788999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
||+++|+|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~--~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 99999999999974 2456899999999999999999999999 999999999999999999999999998765433
Q ss_pred CceeeecccccccccCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFR-----SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDI 302 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (374)
.........||+.|+|||++. ...++.++|||||||++|||++|+.||.... ....+...........
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~------~~~~~~~i~~~~~~~~- 228 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMNHKERFQ- 228 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC------HHHHHHHHhCCCcccc-
Confidence 333333456999999999986 3457889999999999999999999996432 2222222211110000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 017262 303 IDDQVRKSGEAEEIMAVSDVAKRCLNSYGRN--RPTMKEVAME 343 (374)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--Rps~~~vl~~ 343 (374)
........+..+.+|+.+|+..+++. |+++.++++.
T Consensus 229 -----~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 -----FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -----CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 01111234567889999999665444 6889888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=299.40 Aligned_cols=257 Identities=23% Similarity=0.298 Sum_probs=191.7
Q ss_pred CCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC--hhHHHHHHHHHHHHhhC---CCCceeeeeeeeeec-----c
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQI---NHRNVVKLLGCCLEV-----E 141 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~-----~ 141 (374)
+|++.+.||+|+||.||+|... +++.+|+|.+.... ......+.+|+.+++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4888999999999999999965 58899999876432 22223455677776665 799999999988642 3
Q ss_pred cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccc
Q 017262 142 VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 221 (374)
Q Consensus 142 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 221 (374)
..++++||++ ++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 5789999997 4788877643 2345899999999999999999999999 999999999999999999999999998
Q ss_pred cccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhc----
Q 017262 222 RSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEEN---- 297 (374)
Q Consensus 222 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---- 297 (374)
...... .......+++.|+|||.+.+..++.++|||||||++|+|++|..||...... ..........
T Consensus 156 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~------~~~~~~~~~~~~~~ 227 (288)
T cd07863 156 RIYSCQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA------DQLGKIFDLIGLPP 227 (288)
T ss_pred ccccCc--ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH------HHHHHHHHHhCCCC
Confidence 765422 1223345789999999999888999999999999999999999998643221 1111111100
Q ss_pred --ccccc-------ccccc---cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 298 --CLFDI-------IDDQV---RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 298 --~~~~~-------~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..... ..... .....+..+..+.+++.+||+.||++|||+.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 228 EDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000 00000 00111234567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=295.92 Aligned_cols=247 Identities=29% Similarity=0.445 Sum_probs=202.6
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
++|++.+.||.|++|.||+|... +++.+++|.+.... ......+.+|+.+++.++|+|++++.+++.++...++++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888899999999999999965 58899999876543 34456788999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+++++|.+++.. ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 999999999863 27899999999999999999999999 9999999999999999999999999997765332
Q ss_pred eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccC
Q 017262 230 HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (374)
.......+++.|+|||.+.+..++.++||||||+++|+|++|..||...... ... ...... ...
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~------~~~-~~~~~~---------~~~ 216 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM------RVL-FLIPKN---------NPP 216 (274)
T ss_pred cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH------HHH-HHhhhc---------CCC
Confidence 2223345788999999999888999999999999999999999999643211 111 111111 011
Q ss_pred CCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 310 SGEAE-EIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 310 ~~~~~-~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..+.. .+..+.+++.+||..+|++|||++++++
T Consensus 217 ~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 217 SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11111 4557889999999999999999999977
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=294.08 Aligned_cols=248 Identities=27% Similarity=0.427 Sum_probs=204.4
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
..|+..+.||.|+||.||+|... ++..+++|.+.... ......+.+|+.+++.++||||+++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45777889999999999999965 57889999876533 44567788999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+++++|.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06640 84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc-
Confidence 999999998863 46889999999999999999999998 9999999999999999999999999987654322
Q ss_pred eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccC
Q 017262 230 HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (374)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||....... .. ..+......
T Consensus 156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~------~~----------~~~~~~~~~ 219 (277)
T cd06640 156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR------VL----------FLIPKNNPP 219 (277)
T ss_pred cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh------Hh----------hhhhcCCCC
Confidence 12223457888999999988889999999999999999999999986432211 00 011111122
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 310 SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 310 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
......+..+.+++.+||+.+|++||++.+++..
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 3344567789999999999999999999999775
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=307.91 Aligned_cols=241 Identities=27% Similarity=0.370 Sum_probs=190.4
Q ss_pred ceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHH-HHhhCCCCceeeeeeeeeecccceEEEEeecC
Q 017262 78 RILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVV-ILSQINHRNVVKLLGCCLEVEVPLLVYEFIPN 152 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 152 (374)
+.||+|+||+||+|... +|+.+|+|.+... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999964 6889999987642 2223344555554 56778999999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceee
Q 017262 153 GTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 232 (374)
Q Consensus 153 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 232 (374)
|+|..++. ....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~ 153 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTT 153 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCc
Confidence 99998886 3557899999999999999999999999 999999999999999999999999998653221 1222
Q ss_pred ecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCC
Q 017262 233 TKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGE 312 (374)
Q Consensus 233 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (374)
....|++.|+|||.+.+..++.++|||||||++|+|++|..||.... ....+...... .. ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~------~~~~~~~~~~~---------~~--~~~ 216 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD------VAEMYDNILHK---------PL--VLR 216 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC------HHHHHHHHHcC---------Cc--cCC
Confidence 34568999999999999999999999999999999999999996432 11212111111 00 111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 313 AEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 313 ~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
+..+..+.+++.+|++.+|++||++.+.++
T Consensus 217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 217 PGASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred CCCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 224457889999999999999999864433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=300.30 Aligned_cols=250 Identities=25% Similarity=0.409 Sum_probs=204.7
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
.++|++.+.||.|++|.||+|.. .+++.+++|.+..........+.+|+..++.++|||++++++++...+..++++||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 35689999999999999999985 56889999988765555567788999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+++++|..++.. ..+++.++..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 98 LAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred cCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 999999998853 35899999999999999999999999 99999999999999999999999999876543222
Q ss_pred eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccC
Q 017262 230 HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (374)
......+++.|+|||.+.+..++.++|+||||+++|+|++|..||....... ....... ... ...
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~------~~~~~~~-~~~-------~~~ 235 (296)
T cd06655 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALYLIAT-NGT-------PEL 235 (296)
T ss_pred -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHh-cCC-------ccc
Confidence 1233458889999999998889999999999999999999999996432211 1111111 000 011
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 310 SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 310 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..+...+..+.++|.+||..+|++|||+.++++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 122334567889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=293.14 Aligned_cols=255 Identities=25% Similarity=0.381 Sum_probs=201.3
Q ss_pred HHhhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 68 DKATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 68 ~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
+.+++++.....||+|+||.||+|... ++..+++|..........+.+.+|+.+++.++|+||+++++++...+..+++
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 344556666678999999999999954 5778999988776666777899999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECC-CCcEEEeecccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSL--TWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE-KYRAKIADFGTSRS 223 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l--~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~~~ 223 (374)
+||+++++|.+++.... ..+ ++..+..++.|++.||+|||+.+ ++|+||+|+||+++. ++.++|+|||++..
T Consensus 84 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 84 MEQVPGGSLSALLRSKW--GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EecCCCCCHHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 99999999999987532 234 78888999999999999999998 999999999999976 67999999999875
Q ss_pred cccCCceeeecccccccccCccccccCC--CCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccc
Q 017262 224 IAIDQTHVSTKVQGTFGYLDPEYFRSSQ--FTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFD 301 (374)
Q Consensus 224 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (374)
...... ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||........ ..+..
T Consensus 159 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~---------- 224 (268)
T cd06624 159 LAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKV---------- 224 (268)
T ss_pred cccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhh----------
Confidence 532221 122335788999999986543 78899999999999999999999864321110 00000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 302 IIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 302 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.........+...+..+.+++.+||+.+|++|||+.+++.
T Consensus 225 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 225 -GMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred -hhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0001111223345567889999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=298.41 Aligned_cols=253 Identities=28% Similarity=0.377 Sum_probs=205.1
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
.++|++.+.||.|+||.||++... ++..+++|............+..|++++++++|||++++++.+......+++|||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 456889999999999999999964 5889999998877777778899999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLE--LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 999999999864 2456899999999999999999999999 99999999999999999999999998865433221
Q ss_pred eeeecccccccccCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccc
Q 017262 230 HVSTKVQGTFGYLDPEYFR-----SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIID 304 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (374)
......+++.|+|||.+. ...++.++|+||||+++|+|++|..||...... ...... .....
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~~~~~-~~~~~----- 225 (280)
T cd06611 159 -KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RVLLKI-LKSEP----- 225 (280)
T ss_pred -ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HHHHHH-hcCCC-----
Confidence 223345888999999975 344678999999999999999999999643211 111111 11100
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 305 DQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 305 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
.....+...+..+.+++.+||..+|.+||++.++++.
T Consensus 226 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 --PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred --CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0111223345678899999999999999999999763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=300.54 Aligned_cols=258 Identities=29% Similarity=0.517 Sum_probs=202.0
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCc----EEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGR----IIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLL 145 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 145 (374)
++|+..+.||+|+||.||+|.+. ++. .+++|...... ......+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45778889999999999999864 343 46888776543 33345688999999999999999999998754 5679
Q ss_pred EEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccc
Q 017262 146 VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 225 (374)
++||+++|+|.+++.. ....+++..++.++.|++.||.|||+++ ++|+||||+||++++++.+||+|||++....
T Consensus 86 v~e~~~~g~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 9999999999999874 2346889999999999999999999998 9999999999999999999999999998654
Q ss_pred cCCcee-eecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccc
Q 017262 226 IDQTHV-STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDII 303 (374)
Q Consensus 226 ~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (374)
...... .....++..|+|||.+.+..++.++||||||+++|||++ |..||....... .......+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~----- 228 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-------IPDLLEKGE----- 228 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHCCC-----
Confidence 322211 122335678999999998889999999999999999997 999986432111 111111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhC
Q 017262 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANS 351 (374)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~ 351 (374)
....+...+..+.+++.+|+..+|++||++.++++.|+.+..+.
T Consensus 229 ----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 229 ----RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 11112223457889999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=293.46 Aligned_cols=247 Identities=28% Similarity=0.505 Sum_probs=199.0
Q ss_pred cCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeec
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIP 151 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 151 (374)
++|++.+.||+|+||.||++.. .++.+++|...... ....+.+|+.+++.++|||++++++++... ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4588899999999999999875 56789999876532 345788999999999999999999998654 5799999999
Q ss_pred CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCcee
Q 017262 152 NGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV 231 (374)
Q Consensus 152 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 231 (374)
+++|.+++... ....+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 99999998753 2346889999999999999999999998 999999999999999999999999998654321
Q ss_pred eecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccccccCC
Q 017262 232 STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKS 310 (374)
Q Consensus 232 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (374)
......+..|+|||.+.+..++.++|+||||+++|+|++ |..||...... .. ...... .....
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~-~~~~~~---------~~~~~ 217 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK------EV-KECVEK---------GYRME 217 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH------HH-HHHHhC---------CCCCC
Confidence 112234568999999988889999999999999999998 99998643321 11 111111 11122
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 017262 311 GEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELER 346 (374)
Q Consensus 311 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~ 346 (374)
.+...+..+.+++.+|++.+|++||+++++++.|++
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 233445688899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=292.16 Aligned_cols=247 Identities=26% Similarity=0.416 Sum_probs=201.2
Q ss_pred CCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC-----hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-----ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
+|...+.||+|++|.||+|... ++..+++|.+.... ......+.+|+.+++.++|+|++++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777899999999999999976 78899999875533 33556788999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999873 346889999999999999999999998 99999999999999999999999999876543
Q ss_pred CCceeeecccccccccCccccccCC-CCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccc
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFRSSQ-FTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDD 305 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (374)
.. ......+++.|+|||.+.... ++.++|+||||+++|+|++|+.||..... ...........
T Consensus 155 ~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~-------- 218 (258)
T cd06632 155 FS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSK-------- 218 (258)
T ss_pred cc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH------HHHHHHHHhcc--------
Confidence 22 223445888999999987766 89999999999999999999999964321 11111111100
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 306 QVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.....+...+..+.+++.+||+.+|++||++.+++.
T Consensus 219 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 219 -ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 011122334567889999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=297.25 Aligned_cols=246 Identities=28% Similarity=0.446 Sum_probs=200.4
Q ss_pred CCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEee
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFI 150 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 150 (374)
.|+..+.||+|+||.||+|... ++..+++|...... ......+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4566678999999999999864 57789999876433 344567889999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 230 (374)
++++|.+++. ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 85 ~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 85 GGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 9999999885 346889999999999999999999998 99999999999999999999999999876543221
Q ss_pred eeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCC
Q 017262 231 VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKS 310 (374)
Q Consensus 231 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (374)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||....... ..... .......
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-------~~~~~---------~~~~~~~ 220 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-------VLFLI---------PKNSPPT 220 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-------HHhhh---------hcCCCCC
Confidence 1223457889999999998889999999999999999999999986432211 00001 1111112
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 311 GEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 311 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.....+..+.+++.+|++.+|++|||+.++++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 22344567889999999999999999999998
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=302.51 Aligned_cols=264 Identities=23% Similarity=0.322 Sum_probs=197.5
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
++|.+.+.||.|+||.||+|... ++..+|+|.+.... ......+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56889999999999999999865 57889999876432 22334677899999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
++ ++|.+++.. ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 86 ~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDD--CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 96 588887764 2446889999999999999999999999 99999999999999999999999999875432221
Q ss_pred eeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCC---------ChHHHHHHHHHhccc
Q 017262 230 HVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGR---------NLTTYFVECIEENCL 299 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~---------~~~~~~~~~~~~~~~ 299 (374)
......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||......+.. ...............
T Consensus 160 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 160 -TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred -cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 1223356889999998865 45788999999999999999999999754321100 000000000000000
Q ss_pred cccccccccC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 300 FDIIDDQVRK----SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 300 ~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
...-.+.... ......+..+.+||.+||+.||.+|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000000 011123557889999999999999999999885
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=296.11 Aligned_cols=249 Identities=31% Similarity=0.473 Sum_probs=197.4
Q ss_pred ceEeeeCeEEEEEEEecC-------CcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 78 RILGQGGQGTVYKGMLAD-------GRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
+.||+|+||.||+|...+ +..+++|.+.... ......+.+|+.+++.++||||+++++++...+..++++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998643 2578888765432 34456788999999999999999999999988899999999
Q ss_pred ecCCcccccccCCC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCC-----cEEEeeccc
Q 017262 150 IPNGTLFQYLHDPY----EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY-----RAKIADFGT 220 (374)
Q Consensus 150 ~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~-----~~kl~Dfg~ 220 (374)
+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986422 2235788999999999999999999998 99999999999999877 899999999
Q ss_pred ccccccCCce-eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhcc
Q 017262 221 SRSIAIDQTH-VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENC 298 (374)
Q Consensus 221 ~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 298 (374)
+......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~------~~~~-~~~--- 227 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ------EVLQ-HVT--- 227 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH------HHHH-HHh---
Confidence 8765332211 1122345678999999998899999999999999999998 99998643221 1111 111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017262 299 LFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345 (374)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~ 345 (374)
.......+...+..+.+++.+||+.+|++||++.++++.|+
T Consensus 228 ------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 228 ------AGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ------cCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11112233345678899999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=300.94 Aligned_cols=252 Identities=27% Similarity=0.393 Sum_probs=202.0
Q ss_pred cCCCcCceEeeeCeEEEEEEEecC-CcEEEEEEeccCCh---hHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDE---SKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
++|++.+.||+|++|.||++...+ ++.+++|.+..... .....+..|+++++.++||||+++++.+.+.+..+++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 368889999999999999999764 88999998765432 24567889999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
||+.+++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999988643 3457899999999999999999999998 999999999999999999999999998654321
Q ss_pred Cce----------------------------eeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccc
Q 017262 228 QTH----------------------------VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIW 279 (374)
Q Consensus 228 ~~~----------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~ 279 (374)
... ......|+..|+|||.+.+..++.++||||||+++|+|++|..||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110 1112357889999999998889999999999999999999999996433
Q ss_pred cccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 017262 280 ANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPT----MKEVAM 342 (374)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps----~~~vl~ 342 (374)
... .+.. ..............+..+.+++.+|+..+|++||| +++++.
T Consensus 237 ~~~------~~~~---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RDE------TFSN---------ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHH------HHHH---------HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 211 1111 11111111112225678999999999999999999 666655
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=279.99 Aligned_cols=249 Identities=30% Similarity=0.447 Sum_probs=203.0
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC-----h---hHHHHHHHHHHHHhhC-CCCceeeeeeeeeec
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-----E---SKLEEFINEVVILSQI-NHRNVVKLLGCCLEV 140 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-----~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 140 (374)
...|...+.||.|..+.|.++..+ .|+..|+|++.... + .-.+.-.+|+.+|+++ .||||+++.+++..+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 456788899999999999888754 57888988765421 1 1223456899999999 599999999999999
Q ss_pred ccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccc
Q 017262 141 EVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGT 220 (374)
Q Consensus 141 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 220 (374)
...++|+|.|+.|.|.+++. ..-.++++...+++.|+..|++|||..+ |+||||||+|||++++.++||+|||+
T Consensus 96 sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred chhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccce
Confidence 99999999999999999998 5668999999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCceeeecccccccccCccccccC------CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHH
Q 017262 221 SRSIAIDQTHVSTKVQGTFGYLDPEYFRSS------QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECI 294 (374)
Q Consensus 221 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~------~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 294 (374)
++.+.++ ......+|||+|+|||.+.+. .|+..+|+|++|++||.|+.|..||-..... ..
T Consensus 170 a~~l~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm-------lM---- 236 (411)
T KOG0599|consen 170 ACQLEPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM-------LM---- 236 (411)
T ss_pred eeccCCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH-------HH----
Confidence 9987643 344667899999999998643 4788999999999999999999998421110 01
Q ss_pred HhccccccccccccCCCC--HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 295 EENCLFDIIDDQVRKSGE--AEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
+..+..+......+ .+.+....+||.+||+.||.+|.|++|++.
T Consensus 237 ----LR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 237 ----LRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred ----HHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 12222233222222 244567889999999999999999999986
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=309.52 Aligned_cols=261 Identities=23% Similarity=0.296 Sum_probs=198.5
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec---CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA---DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
..+|.+.+.||+|+||.||++... .+..+++|.+... ....+|+.++++++||||+++++++......+++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999753 3567889977543 23457999999999999999999999989999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
|++. ++|.+++. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++......
T Consensus 166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9995 67888874 4567999999999999999999999999 999999999999999999999999998765433
Q ss_pred Cce-eeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccc-----
Q 017262 228 QTH-VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFD----- 301 (374)
Q Consensus 228 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 301 (374)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..............+...........
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 222 22345689999999999999999999999999999999999999965433221111111111110000000
Q ss_pred --------cccccccCCCC-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 302 --------IIDDQVRKSGE-------AEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 302 --------~~~~~~~~~~~-------~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
......+.... ...+..+.++|.+||..||++|||+.+++..
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 1224578899999999999999999999874
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=299.35 Aligned_cols=248 Identities=23% Similarity=0.354 Sum_probs=212.5
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCCh--hHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDE--SKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
.+-|.+.+.||+|.|..|-+|++ -.|..||||++..... -.-..+.+|+..|+.++|||||++|++......+|+|+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 46688889999999999999884 4689999998865432 33457889999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEEC-CCCcEEEeeccccccccc
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD-EKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~~~~~~~ 226 (374)
|.-++|+|.+||.. ....+.+....+++.||+.|+.|+|+.. ++||||||+||++. .-|-+||+|||++..+.+
T Consensus 97 ELGD~GDl~DyImK--He~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMK--HEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EecCCchHHHHHHh--hhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 99999999999986 4668999999999999999999999998 99999999998774 668899999999977654
Q ss_pred CCceeeecccccccccCccccccCCCC-ccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccc
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFRSSQFT-DKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDD 305 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (374)
+ .......|+..|-|||.+.+..|+ +++||||||++||.|++|+.||+...+.+. +-.++|.
T Consensus 172 G--~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------------LTmImDC 234 (864)
T KOG4717|consen 172 G--KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------------LTMIMDC 234 (864)
T ss_pred c--chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------------hhhhhcc
Confidence 3 334566799999999999998886 678999999999999999999987665442 3334444
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 306 QVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
. -..|...+.++.+||..||..||++|.+.+++..
T Consensus 235 K--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 235 K--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred c--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 3 3457778889999999999999999999999875
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=296.42 Aligned_cols=250 Identities=25% Similarity=0.308 Sum_probs=197.3
Q ss_pred CCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC---hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 74 FNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 74 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
|+..+.||+|+||+||++... +++.+|+|.+.... ......+.+|+.+++.++|+|++.+.+++..++..++++||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999864 68899999876432 22334577899999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 9999999888643 2346999999999999999999999999 9999999999999999999999999986543221
Q ss_pred eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccC
Q 017262 230 HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (374)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||........ ........... ..
T Consensus 157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~~~~~~----------~~ 222 (285)
T cd05632 157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDRRVLET----------EE 222 (285)
T ss_pred -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhhhcc----------cc
Confidence 12334689999999999988899999999999999999999999974322110 00111100000 01
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 017262 310 SGEAEEIMAVSDVAKRCLNSYGRNRPT-----MKEVAM 342 (374)
Q Consensus 310 ~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~vl~ 342 (374)
..+...+..+.+|+.+|++.||++||+ +.+++.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 122234457889999999999999999 556555
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=304.93 Aligned_cols=237 Identities=27% Similarity=0.367 Sum_probs=188.3
Q ss_pred ceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHH-HHhhCCCCceeeeeeeeeecccceEEEEeecC
Q 017262 78 RILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVV-ILSQINHRNVVKLLGCCLEVEVPLLVYEFIPN 152 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 152 (374)
+.||+|+||.||+|... +++.+|+|.+... .......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 5789999987642 1222344555544 67889999999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceee
Q 017262 153 GTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 232 (374)
Q Consensus 153 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 232 (374)
++|..++. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....... ...
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (321)
T cd05603 81 GELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETT 153 (321)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccc
Confidence 99988886 3456889999999999999999999998 9999999999999999999999999987532221 222
Q ss_pred ecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCC
Q 017262 233 TKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGE 312 (374)
Q Consensus 233 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (374)
....|++.|+|||.+.+..++.++|||||||++|+|++|..||.... .......... .. ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~i~~---------~~--~~~~ 216 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD------VSQMYDNILH---------KP--LQLP 216 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC------HHHHHHHHhc---------CC--CCCC
Confidence 34568999999999998889999999999999999999999996432 1111111111 10 1122
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH
Q 017262 313 AEEIMAVSDVAKRCLNSYGRNRPTMK 338 (374)
Q Consensus 313 ~~~~~~l~~li~~cl~~~p~~Rps~~ 338 (374)
...+..+.+++.+||+.+|.+||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 23455788999999999999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=304.33 Aligned_cols=264 Identities=21% Similarity=0.275 Sum_probs=197.3
Q ss_pred HhhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc----
Q 017262 69 KATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVE---- 141 (374)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---- 141 (374)
...++|.+.+.||+|+||.||++... .++.+|+|.+... .......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34578999999999999999999864 5788999987643 3344567788999999999999999999886432
Q ss_pred --cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecc
Q 017262 142 --VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 219 (374)
Q Consensus 142 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 219 (374)
..+++|||+++ +|.+.+. ..+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence 46899999965 5655554 24788899999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccC---------CChHH--
Q 017262 220 TSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEG---------RNLTT-- 288 (374)
Q Consensus 220 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~---------~~~~~-- 288 (374)
++..... ........+|+.|+|||.+.+..++.++|||||||++|+|++|+.||........ .....
T Consensus 165 ~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 165 LARTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred ccccCCC--ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9976432 2223345689999999999988999999999999999999999999975331110 00000
Q ss_pred -----HHHHHHHhccc-cccc-----ccccc---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 289 -----YFVECIEENCL-FDII-----DDQVR---KSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 289 -----~~~~~~~~~~~-~~~~-----~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
......+.... .... ..... ...+......+.+|+.+||..||++|||+.++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000110000 0000 00000 00111234578899999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=304.28 Aligned_cols=263 Identities=21% Similarity=0.308 Sum_probs=196.7
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeec------
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEV------ 140 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 140 (374)
..++|.+.+.||+|+||.||++... .++.+|+|++... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999964 5788999987643 334456788999999999999999999987543
Q ss_pred ccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccc
Q 017262 141 EVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGT 220 (374)
Q Consensus 141 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 220 (374)
...++||||+++ +|..++. ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 346999999965 6666664 24788899999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccC---------CChHHH--
Q 017262 221 SRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEG---------RNLTTY-- 289 (374)
Q Consensus 221 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~---------~~~~~~-- 289 (374)
+...... .......+++.|+|||++.+..++.++|||||||++|+|++|+.||......+. .....+
T Consensus 173 a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 173 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250 (364)
T ss_pred ccccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 9764322 222345689999999999999999999999999999999999999975432110 000000
Q ss_pred -----HHHHHHhccccc------cccccc---cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 290 -----FVECIEENCLFD------IIDDQV---RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 290 -----~~~~~~~~~~~~------~~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
............ ...... ...........+.+|+.+||+.||++|||+.++++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000000 000000 000111223578899999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=294.93 Aligned_cols=239 Identities=22% Similarity=0.371 Sum_probs=187.7
Q ss_pred eEeeeCeEEEEEEEecC-------------------------CcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeee
Q 017262 79 ILGQGGQGTVYKGMLAD-------------------------GRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKL 133 (374)
Q Consensus 79 ~lg~G~~g~v~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~ 133 (374)
.||+|+||.||+|.... ...+++|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997421 13578888766555555678889999999999999999
Q ss_pred eeeeeecccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCC--
Q 017262 134 LGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY-- 211 (374)
Q Consensus 134 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~-- 211 (374)
++++.+....++||||+++++|..++.. ....+++..+..++.|++.||+|||+++ ++||||||+||+++.++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999998864 3456889999999999999999999998 99999999999997643
Q ss_pred -----cEEEeecccccccccCCceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHH-hCCCCCCccccccCC
Q 017262 212 -----RAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELL-TGQKPISSIWANEGR 284 (374)
Q Consensus 212 -----~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~-~g~~p~~~~~~~~~~ 284 (374)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|..||......+
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-- 229 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE-- 229 (274)
T ss_pred cCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--
Confidence 3899999987543221 12346788999998865 56899999999999999985 6999986543221
Q ss_pred ChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017262 285 NLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345 (374)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~ 345 (374)
...+ .... . ..+......+.+++.+||+.+|++|||+.++++.|+
T Consensus 230 -~~~~----~~~~---------~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 -KERF----YEKK---------H--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred -HHHH----HHhc---------c--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1111 1100 0 011112246889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=288.82 Aligned_cols=253 Identities=26% Similarity=0.366 Sum_probs=191.1
Q ss_pred ceEeeeCeEEEEEEEecC---CcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeecCC
Q 017262 78 RILGQGGQGTVYKGMLAD---GRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNG 153 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 153 (374)
+.||+|+||.||+|...+ +..+++|.+.... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998643 3578899876543 233457888999999999999999999999888999999999999
Q ss_pred cccccccCCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCcee
Q 017262 154 TLFQYLHDPY--EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV 231 (374)
Q Consensus 154 ~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 231 (374)
+|.+++.... .....++..+..++.|++.|++|||+.+ ++|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999986422 2234567788899999999999999999 9999999999999999999999999986543222211
Q ss_pred -eecccccccccCccccccC-------CCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhcccccc
Q 017262 232 -STKVQGTFGYLDPEYFRSS-------QFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDI 302 (374)
Q Consensus 232 -~~~~~g~~~y~aPE~~~~~-------~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (374)
.....+++.|+|||.+.+. .++.++|+||||+++|||++ |..||......+. ...... ......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~------~~~~~~-~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV------LTYTVR-EQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH------HHHHhh-cccCCC
Confidence 1234567889999998642 35789999999999999996 9999975432210 111111 111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017262 303 IDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345 (374)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~ 345 (374)
..+.. ....+..+.+++..|+ .+|++|||++++...|+
T Consensus 231 ~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11111 1123446788999998 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=304.01 Aligned_cols=191 Identities=24% Similarity=0.415 Sum_probs=163.1
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
..+|.+.+.||+|+||.||+|... ++..+|+|..... ....|+.++++++||||+++++++...+..++|+|+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 457999999999999999999975 4678888864432 234689999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+. ++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 139 ~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 210 (357)
T PHA03209 139 YS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-- 210 (357)
T ss_pred cC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence 94 678887764 3457899999999999999999999999 999999999999999999999999998753221
Q ss_pred eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCC
Q 017262 230 HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPI 275 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~ 275 (374)
.......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1223346899999999999999999999999999999999865554
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=290.78 Aligned_cols=249 Identities=22% Similarity=0.355 Sum_probs=202.5
Q ss_pred CCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
+|++.+.||+|+||.+|.+... +++.+++|.+... .......+.+|+.++++++||||+++++++...+..++++||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788999999999999999854 6789999987643 334456788999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+++++|.+++... ....+++..++.++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~- 155 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV- 155 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch-
Confidence 9999999988643 2346789999999999999999999998 9999999999999999999999999987654322
Q ss_pred eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccC
Q 017262 230 HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (374)
.......+++.|+|||.+.+..++.++|+||||+++++|++|..||.... ............ ..
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~------~~~~~~~~~~~~----------~~ 219 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN------MKNLVLKIIRGS----------YP 219 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC------HHHHHHHHhcCC----------CC
Confidence 11223457889999999998889999999999999999999999986321 122222111111 11
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 310 SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 310 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..+...+..+.++|.+|++.+|++||++.++++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 122344567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=290.27 Aligned_cols=249 Identities=27% Similarity=0.410 Sum_probs=198.0
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC-----ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeec--ccc
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-----DESKLEEFINEVVILSQINHRNVVKLLGCCLEV--EVP 143 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 143 (374)
.+|++.+.||+|+||.||.|... ++..+++|.+... .......+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46889999999999999999964 5889999977532 123456788899999999999999999998764 457
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccc
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 223 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 223 (374)
++++||+++++|.+++.. ...+++...+.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 899999999999999863 345788999999999999999999999 99999999999999999999999999875
Q ss_pred cccCCc--eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccc
Q 017262 224 IAIDQT--HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFD 301 (374)
Q Consensus 224 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (374)
...... .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... ... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~-~~~~-------- 221 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA-----MAA-IFKI-------- 221 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch-----HHH-HHHH--------
Confidence 432111 112234588899999999888899999999999999999999999963211 111 1110
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 302 IIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 302 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.........+...+..+.+++.+|+. +|++||+++++++
T Consensus 222 -~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 222 -ATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -hcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 11111222345566788899999994 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=298.48 Aligned_cols=256 Identities=18% Similarity=0.280 Sum_probs=193.8
Q ss_pred cCceEeee--CeEEEEEEEe-cCCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEee
Q 017262 76 MNRILGQG--GQGTVYKGML-ADGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFI 150 (374)
Q Consensus 76 ~~~~lg~G--~~g~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 150 (374)
+.++||+| +|++||++.. .+|+.||+|.+... .......+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 7899999986 46889999988653 2334456778999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 230 (374)
++++|.+++... ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTH-FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999999998643 2345899999999999999999999999 999999999999999999999999865433211110
Q ss_pred ------eeecccccccccCcccccc--CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccc
Q 017262 231 ------VSTKVQGTFGYLDPEYFRS--SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDI 302 (374)
Q Consensus 231 ------~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (374)
......++..|+|||++.+ ..++.++|||||||++|+|++|..||....... ...... .......
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~~~-~~~~~~~ 230 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ------MLLEKL-NGTVPCL 230 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH------HHHHHh-cCCcccc
Confidence 0112346678999999876 458899999999999999999999997432211 000000 0000000
Q ss_pred cc------------------------------------ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 303 ID------------------------------------DQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 303 ~~------------------------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.+ ...........++.+.+|+.+||+.||++|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00 00000112234568999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=291.11 Aligned_cols=252 Identities=26% Similarity=0.441 Sum_probs=202.5
Q ss_pred CCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCC------hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceE
Q 017262 73 YFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVD------ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLL 145 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 145 (374)
+|+..+.||+|++|.||++.. .+++.+++|.+.... ......+.+|+..+++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999985 568899999876432 2235678899999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCC-cEEEeeccccccc
Q 017262 146 VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY-RAKIADFGTSRSI 224 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~~~~~ 224 (374)
++||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++ .++|+|||.+...
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999873 457889999999999999999999999 99999999999998776 5999999998765
Q ss_pred ccCCce---eeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccc
Q 017262 225 AIDQTH---VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFD 301 (374)
Q Consensus 225 ~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (374)
...... ......++..|+|||.+.+..++.++|+||||+++++|++|..||....... .......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~--------- 222 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN---HLALIFK--------- 222 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc---hHHHHHH---------
Confidence 432111 1223457889999999988889999999999999999999999996432211 1111110
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 302 IIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 302 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..........+...+..+.+++.+|+..+|++|||+.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 223 IASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 01111123344456678999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=290.68 Aligned_cols=249 Identities=26% Similarity=0.420 Sum_probs=196.0
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC-----hhHHHHHHHHHHHHhhCCCCceeeeeeeeeec--ccc
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-----ESKLEEFINEVVILSQINHRNVVKLLGCCLEV--EVP 143 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 143 (374)
.+|...+.||+|+||.||+|... .+..+++|.+.... ......+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36889999999999999999864 58899999875421 23345688899999999999999999988753 467
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccc
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 223 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 223 (374)
++++||+++++|.+++.. ...+++...+.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999999873 346889999999999999999999998 99999999999999999999999999875
Q ss_pred cccCCc--eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccc
Q 017262 224 IAIDQT--HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFD 301 (374)
Q Consensus 224 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (374)
...... .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... ... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-----~~~-~~~~-------- 221 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-----MAA-IFKI-------- 221 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch-----HHH-HHHH--------
Confidence 432111 111224578899999999988899999999999999999999999964321 111 1110
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 302 IIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 302 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.........+......+.+++ +|+..+|++||++++++.
T Consensus 222 -~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 222 -ATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -hcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 011111223344456677888 688899999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=290.50 Aligned_cols=238 Identities=24% Similarity=0.454 Sum_probs=189.0
Q ss_pred ceEeeeCeEEEEEEEecCCc-----------EEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 78 RILGQGGQGTVYKGMLADGR-----------IIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
+.||+|+||.||+|...+.. .+++|........ ...+.+|+.+++.++||||+++++++.. ...+++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999976433 4677766554333 5788899999999999999999999988 778999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCC-------cEEEeecc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY-------RAKIADFG 219 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~-------~~kl~Dfg 219 (374)
+||+++++|.+++... ...+++..+..++.|++.||+|||+++ ++|+||||+||+++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999999752 226899999999999999999999998 99999999999999887 79999999
Q ss_pred cccccccCCceeeecccccccccCccccccC--CCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHh
Q 017262 220 TSRSIAIDQTHVSTKVQGTFGYLDPEYFRSS--QFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEE 296 (374)
Q Consensus 220 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 296 (374)
++..... .....++..|+|||++.+. .++.++||||||+++|+|++ |..||....... ...++ ..
T Consensus 154 ~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~~~~~----~~ 221 (259)
T cd05037 154 IPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KERFY----QD 221 (259)
T ss_pred ccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---HHHHH----hc
Confidence 9876432 1223466789999998876 78999999999999999999 577776543111 11111 00
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017262 297 NCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345 (374)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~ 345 (374)
... . +......+.+++.+||..+|++|||+.++++.|+
T Consensus 222 ~~~--------~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 QHR--------L---PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCC--------C---CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 0 0001157889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=299.70 Aligned_cols=197 Identities=26% Similarity=0.392 Sum_probs=159.0
Q ss_pred CceEeeeCeEEEEEEEec---CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeee--cccceEEEEeec
Q 017262 77 NRILGQGGQGTVYKGMLA---DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLE--VEVPLLVYEFIP 151 (374)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~ 151 (374)
.+.||+|+||.||+|... ++..+|+|.+..... ...+.+|+.++++++||||+++++++.. +...++++||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 357999999999999864 457899998765322 2456789999999999999999999864 346789999995
Q ss_pred CCcccccccCCC------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEE----CCCCcEEEeecccc
Q 017262 152 NGTLFQYLHDPY------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL----DEKYRAKIADFGTS 221 (374)
Q Consensus 152 ~g~L~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill----~~~~~~kl~Dfg~~ 221 (374)
++|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 47766654211 2235889999999999999999999999 9999999999999 45678999999999
Q ss_pred cccccCCc--eeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccc
Q 017262 222 RSIAIDQT--HVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIW 279 (374)
Q Consensus 222 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~ 279 (374)
........ .......+|+.|+|||.+.+ ..++.++||||+||++|+|++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 76543221 12234568999999999876 458999999999999999999999997443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=295.13 Aligned_cols=240 Identities=23% Similarity=0.414 Sum_probs=189.4
Q ss_pred ceEeeeCeEEEEEEEecC--------CcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 78 RILGQGGQGTVYKGMLAD--------GRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
+.||.|+||.||+|.... ...+++|..........+.+.+|+.+++.++|||++++++++...+..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 368999999999998642 234777877655555567788999999999999999999999998999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCc--------EEEeecccc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR--------AKIADFGTS 221 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~--------~kl~Dfg~~ 221 (374)
+++|+|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999999752 346899999999999999999999999 999999999999987765 699999988
Q ss_pred cccccCCceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCC-CCCCccccccCCChHHHHHHHHHhccc
Q 017262 222 RSIAIDQTHVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQ-KPISSIWANEGRNLTTYFVECIEENCL 299 (374)
Q Consensus 222 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (374)
...... ....++..|+|||.+.+ ..++.++||||||+++|+|++|. .||....... .. .....
T Consensus 156 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~------~~-~~~~~--- 220 (258)
T cd05078 156 ITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK------KL-QFYED--- 220 (258)
T ss_pred cccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH------HH-HHHHc---
Confidence 654321 22347788999999976 45789999999999999999984 5654322111 00 00110
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017262 300 FDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345 (374)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~ 345 (374)
....+......+.+++.+||+.+|++|||++++++.|+
T Consensus 221 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 --------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred --------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 01122223357889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=289.87 Aligned_cols=256 Identities=28% Similarity=0.443 Sum_probs=205.6
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
++|++.+.||.|+||+||+|... ++..+++|++.... ......+.+|++.++.++|+|++++++.+...+..++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46889999999999999999954 57889999876432 33567889999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+++++|.+++........+++..+..++.|++.||++||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999975433357899999999999999999999999 99999999999999999999999999876654332
Q ss_pred e---eeecccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccc
Q 017262 230 H---VSTKVQGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDD 305 (374)
Q Consensus 230 ~---~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (374)
. ......++..|+|||.+... .++.++|+||||+++|+|++|+.||....... .+....... ..
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~~~~------~~ 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLMLTLQND------PP 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------hHHHHhcCC------CC
Confidence 2 22334588999999998776 78999999999999999999999996433211 111111110 00
Q ss_pred cccCC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 306 QVRKS-GEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 306 ~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..... .....+..+.+++.+|+..||++|||+++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11111 11244567899999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=294.27 Aligned_cols=255 Identities=25% Similarity=0.380 Sum_probs=203.4
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
++|++.+.||+|+||+||++... +++.+++|...... ......+.+|+++++.++||||+++++++...+..++|+||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46788899999999999999965 57889999766532 34456788999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS-SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
+++++|.+++.. ...+++..+..++.+++.||.|||+ .+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 999999998863 4568999999999999999999997 46 9999999999999999999999999986542211
Q ss_pred ceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCC-----ChHHHHHHHHHhccccccc
Q 017262 229 THVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGR-----NLTTYFVECIEENCLFDII 303 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 303 (374)
.....++..|+|||++.+..++.++|+|||||++|+|++|..||......... ...........
T Consensus 159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 227 (284)
T cd06620 159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ-------- 227 (284)
T ss_pred ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh--------
Confidence 12346889999999998888999999999999999999999999854432110 11111111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 017262 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMEL 344 (374)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L 344 (374)
...........+..+.+|+.+|++.||++|||+.++++..
T Consensus 228 -~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 228 -EPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred -ccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 1001111122456789999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=289.07 Aligned_cols=269 Identities=28% Similarity=0.415 Sum_probs=202.6
Q ss_pred CCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhh--CCCCceeeeeeeeeecc----cceEE
Q 017262 73 YFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQ--INHRNVVKLLGCCLEVE----VPLLV 146 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~----~~~lv 146 (374)
..+..++||+|.||.||+|.+. ++.||||++. ..+.+.|.+|-.+.+. ++|+||++|++.-.... .++||
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred chhhHHHhhcCccceeehhhcc-CceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 3456678999999999999985 4889999876 4556778878777665 47999999999876554 78999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------CCCEEEeccCCCceEECCCCcEEEeeccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSA------YLPIYHRDIKSTNILLDEKYRAKIADFGT 220 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~------~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 220 (374)
++|.+.|+|.+||. ...++|....+++..+++||+|||+.. .++|+|||||.+||||.+|++..|+|||+
T Consensus 287 t~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eeeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 99999999999996 458999999999999999999999753 35799999999999999999999999999
Q ss_pred ccccccCCcee-eecccccccccCccccccCC-CC-----ccchhhhHHHHHHHHHhCCCCCCc--------ccc---cc
Q 017262 221 SRSIAIDQTHV-STKVQGTFGYLDPEYFRSSQ-FT-----DKSDVYSFGVVLVELLTGQKPISS--------IWA---NE 282 (374)
Q Consensus 221 ~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~-~~-----~~~Di~slG~~l~el~~g~~p~~~--------~~~---~~ 282 (374)
|..+....... ....+||.+|||||++.+.- +. .+.||||+|.++|||++...-+.. ... +.
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 98876443222 23367999999999987642 22 368999999999999986543321 111 01
Q ss_pred CCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCC
Q 017262 283 GRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRD 353 (374)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~ 353 (374)
...+.+ ....+-..+....+....... .....+++.++.||..||+.|.|+.=+-+.+..+....+.
T Consensus 443 hPt~e~-mq~~VV~kK~RP~~p~~W~~h---~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 443 HPTLEE-MQELVVRKKQRPKIPDAWRKH---AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred CCCHHH-HHHHHHhhccCCCChhhhhcC---ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 112222 222222222221111111111 3456799999999999999999999999999988776653
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=290.08 Aligned_cols=251 Identities=28% Similarity=0.450 Sum_probs=201.7
Q ss_pred CCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCCh--hHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE--SKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
+|.+.+.||+|+||.||+|... +++.+++|.+..... .....+.+|+.+++.++|+||+++++.+.+.+..++++||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999864 688999998776544 3677899999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999999873 445789999999999999999999999 99999999999999999999999999877643332
Q ss_pred eee---ecccccccccCccccccCC---CCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccc
Q 017262 230 HVS---TKVQGTFGYLDPEYFRSSQ---FTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDII 303 (374)
Q Consensus 230 ~~~---~~~~g~~~y~aPE~~~~~~---~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (374)
... ....+++.|+|||.+.+.. ++.++||||||+++|++++|..||...... ...... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-----~~~~~~-~~~~------ 222 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-----FQIMFH-VGAG------ 222 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-----HHHHHH-HhcC------
Confidence 221 1345788999999998766 889999999999999999999999643211 110000 0000
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
...........+..+.+++.+|++.+|.+|||+.+++.
T Consensus 223 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 223 -HKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -CCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00001111123567889999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=300.41 Aligned_cols=263 Identities=20% Similarity=0.233 Sum_probs=195.8
Q ss_pred HHHhhcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCC--hhHHHHHHHHHHHHhhCCCCceeeeeeeeeec---
Q 017262 67 LDKATDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVD--ESKLEEFINEVVILSQINHRNVVKLLGCCLEV--- 140 (374)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--- 140 (374)
.....++|.+.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 334567899999999999999999986 467899999876432 23345677899999999999999999987543
Q ss_pred ---ccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEee
Q 017262 141 ---EVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIAD 217 (374)
Q Consensus 141 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~D 217 (374)
...+++++++ +++|.+++. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcC
Confidence 3468999988 788888774 346899999999999999999999999 99999999999999999999999
Q ss_pred cccccccccCCceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccC---------CChH
Q 017262 218 FGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEG---------RNLT 287 (374)
Q Consensus 218 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~---------~~~~ 287 (374)
||++...... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||........ ....
T Consensus 162 fg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07878 162 FGLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP 237 (343)
T ss_pred CccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 9999764321 233468999999999876 5688999999999999999999999964321110 0000
Q ss_pred HHHHHHHHhccccccccccccCCC-------CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 288 TYFVECIEENCLFDIIDDQVRKSG-------EAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
........ ........ ...... .....+.+.+|+.+||..||++|||+.+++..
T Consensus 238 ~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 238 EVLKKISS-EHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHhcch-hhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 00000000 000000 00123457899999999999999999999963
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=307.74 Aligned_cols=244 Identities=30% Similarity=0.419 Sum_probs=201.7
Q ss_pred CCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEE
Q 017262 73 YFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 148 (374)
.|...+-||.|+||.||.|.. ++...||||++... ....++.+..|+..|++++|||++.+.||+..+...|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 466678899999999999995 56789999998764 34557888999999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
||- |+-.+.+.- ...++.+.++..|+.+.+.||+|||+.+ .||||||+.|||+++.|.|||+|||.+....+
T Consensus 107 YCl-GSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-- 178 (948)
T KOG0577|consen 107 YCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP-- 178 (948)
T ss_pred HHh-ccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence 994 455555543 2457889999999999999999999999 99999999999999999999999999876543
Q ss_pred ceeeecccccccccCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccc
Q 017262 229 THVSTKVQGTFGYLDPEYFR---SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDD 305 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (374)
.+..+|||.|||||++. .+.|+.++||||||++..||...++|+-+++.... .-.+..+.. +
T Consensus 179 ---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA-------LYHIAQNes-----P 243 (948)
T KOG0577|consen 179 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------LYHIAQNES-----P 243 (948)
T ss_pred ---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH-------HHHHHhcCC-----C
Confidence 34568999999999974 57899999999999999999999999875543221 001111111 1
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 306 QVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.-..++++..|+.++..||+.-|.+|||.++++.
T Consensus 244 ---tLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 244 ---TLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred ---CCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 1125678889999999999999999999999886
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=291.34 Aligned_cols=253 Identities=27% Similarity=0.412 Sum_probs=200.5
Q ss_pred CCCcCceEeeeCeEEEEEEEecC--CcEEEEEEeccC----------ChhHHHHHHHHHHHHhh-CCCCceeeeeeeeee
Q 017262 73 YFNMNRILGQGGQGTVYKGMLAD--GRIIAVKKSKVV----------DESKLEEFINEVVILSQ-INHRNVVKLLGCCLE 139 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~ 139 (374)
.|++.+.||+|+||.||+|.... ++.+++|.+... .......+..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999765 678999976532 22334567788888865 799999999999999
Q ss_pred cccceEEEEeecCCcccccccCC-CCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCEEEeccCCCceEECCCCcEEEee
Q 017262 140 VEVPLLVYEFIPNGTLFQYLHDP-YEELSLTWEMRLRIATEVAEALAYLHS-SAYLPIYHRDIKSTNILLDEKYRAKIAD 217 (374)
Q Consensus 140 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~i~H~dlk~~Nill~~~~~~kl~D 217 (374)
++..++++||+++++|.+++... .....+++..++.++.|++.||.|||+ .+ ++|+||+|+||++++++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999887432 134568999999999999999999996 56 99999999999999999999999
Q ss_pred cccccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhc
Q 017262 218 FGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEEN 297 (374)
Q Consensus 218 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 297 (374)
||.+....... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ...... ....
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~------~~~~~~-~~~~ 228 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM------LSLATK-IVEA 228 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH------HHHHHH-Hhhc
Confidence 99997654332 23445688899999999988899999999999999999999999863221 111111 1111
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017262 298 CLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345 (374)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~ 345 (374)
.. ........+..+.+++.+|++.||++||++.++..+++
T Consensus 229 ~~--------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 VY--------EPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cC--------CcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11 11111123457899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=295.29 Aligned_cols=273 Identities=26% Similarity=0.360 Sum_probs=214.5
Q ss_pred CcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeecCC
Q 017262 75 NMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNG 153 (374)
Q Consensus 75 ~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 153 (374)
.....||+|+||.||++... +++.+++|.+..........+.+|+.+++.++|||++++++++...+..++++||++++
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~ 103 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG 103 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence 33457999999999999864 68899999887655555667889999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceeee
Q 017262 154 TLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVST 233 (374)
Q Consensus 154 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 233 (374)
+|..++. ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 104 ~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~ 175 (297)
T cd06659 104 ALTDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRK 175 (297)
T ss_pred CHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc-cccc
Confidence 9998774 346889999999999999999999999 9999999999999999999999999986543222 1223
Q ss_pred cccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCH
Q 017262 234 KVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEA 313 (374)
Q Consensus 234 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (374)
...++..|+|||.+.+..++.++||||||+++|+|++|+.||...... .... ....... . ......
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~-~~~~~~~-----~--~~~~~~ 241 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV------QAMK-RLRDSPP-----P--KLKNAH 241 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHH-HHhccCC-----C--CccccC
Confidence 345889999999999888999999999999999999999999642211 1111 1111100 0 001112
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCCCcchhhhcccchhhhh
Q 017262 314 EEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDDENNIQKCYGKVEYIC 369 (374)
Q Consensus 314 ~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (374)
..+..+.+++.+|++.+|++||+++++++.---.....++...+....+..-.|+|
T Consensus 242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (297)
T cd06659 242 KISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECLVPLIQQYRKRTSTC 297 (297)
T ss_pred CCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCcccccchHHHHhhhccCC
Confidence 23457889999999999999999999999655555555666666666665555555
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=306.44 Aligned_cols=260 Identities=22% Similarity=0.294 Sum_probs=195.6
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
...|.+.+.||+|+||.||++... .++.|++|.... ..+.+|+.++++++|+||+++++++...+..++++|+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 346999999999999999999975 478899995432 3456899999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+ .++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 242 ~-~~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 Y-RSDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred c-CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 9 4688887764 2346899999999999999999999999 99999999999999999999999999976543222
Q ss_pred e-eeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcccc-ccCCChHHHHHHHHHhcccc-----cc
Q 017262 230 H-VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWA-NEGRNLTTYFVECIEENCLF-----DI 302 (374)
Q Consensus 230 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~-----~~ 302 (374)
. ......||+.|+|||++.+..++.++|||||||++|||++|..|+-.... .........+...+...... ..
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 1 12235689999999999999999999999999999999998776533221 11111111111111111100 00
Q ss_pred cc------------ccccC--CC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 303 ID------------DQVRK--SG-----EAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 303 ~~------------~~~~~--~~-----~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.. ..... .. .......+.+||.+||+.||++|||+.|+++
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 00 00000 00 0122346889999999999999999999986
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=288.48 Aligned_cols=248 Identities=25% Similarity=0.379 Sum_probs=200.4
Q ss_pred CCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
+|+..+.||+|+||.||++... +++.+++|.+... .......+.+|+.++++++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5788899999999999999864 5788999987643 334567888999999999999999999999988899999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCC-CcEEEeecccccccccCC
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK-YRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfg~~~~~~~~~ 228 (374)
+++++|.+++... ....+++..+..++.+++.||+|||+++ ++|+||+|+||+++++ +.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999999753 2345899999999999999999999998 9999999999999855 468999999987654321
Q ss_pred ceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccccc
Q 017262 229 THVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVR 308 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (374)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ......... .. .
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~------~~~~~~~~~-~~---------~ 218 (256)
T cd08220 157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL------PALVLKIMS-GT---------F 218 (256)
T ss_pred --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch------HHHHHHHHh-cC---------C
Confidence 22234578899999999988889999999999999999999999864321 111111111 11 1
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 309 KSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 309 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
...+...+..+.+++.+||+.+|++|||+.+++.
T Consensus 219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1112234557889999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=294.78 Aligned_cols=244 Identities=27% Similarity=0.359 Sum_probs=200.4
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
++|++.+.||+|+||.||++... +++.+++|.+... .......+.+|++++++++||||+++++++.+.+..+++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36889999999999999999965 5889999987643 2334567889999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999999873 457899999999999999999999998 999999999999999999999999998765433
Q ss_pred CceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (374)
.....+++.|+|||.+.+...+.++||||||+++|+|++|..||..... ........ ..
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~-~~---------- 213 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP------IQIYEKIL-EG---------- 213 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHh-cC----------
Confidence 2334588999999999888889999999999999999999999964331 11111111 11
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 017262 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRP-----TMKEVAM 342 (374)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~vl~ 342 (374)
....+...+..+.+++.+||..+|++|| ++++++.
T Consensus 214 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 214 KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 0112223356888999999999999998 6666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=290.32 Aligned_cols=262 Identities=23% Similarity=0.294 Sum_probs=199.4
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC--hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 148 (374)
++|++.+.||+|++|.||+|... +++.+++|.+.... ......+.+|+.++++++|||++++++++...+..++++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999976 58899999875432 2233567899999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
|+++++|..++.. ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 9999988887653 346899999999999999999999998 9999999999999999999999999997654322
Q ss_pred ceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHH----------HHHHhc
Q 017262 229 THVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFV----------ECIEEN 297 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~----------~~~~~~ 297 (374)
. ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||......+. ...... .....+
T Consensus 155 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 155 D-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ--LYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred c-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCChHHhhhcccc
Confidence 1 1223457789999999875 5578999999999999999999999975432110 000000 000000
Q ss_pred cccc-cccccccCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 298 CLFD-IIDDQVRKSG-----EAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 298 ~~~~-~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.... ...+...... ....+..+.+|+.+||+.+|++|||+.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000 0000000000 1123567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=290.73 Aligned_cols=255 Identities=28% Similarity=0.485 Sum_probs=198.7
Q ss_pred CCcCceEeeeCeEEEEEEEec----CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc------
Q 017262 74 FNMNRILGQGGQGTVYKGMLA----DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVE------ 141 (374)
Q Consensus 74 ~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 141 (374)
|.+.+.||+|+||.||+|... .+..+++|.+... .....+.+.+|+.++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999853 3678999987653 3445667889999999999999999999886532
Q ss_pred cceEEEEeecCCcccccccCCC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeec
Q 017262 142 VPLLVYEFIPNGTLFQYLHDPY---EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADF 218 (374)
Q Consensus 142 ~~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 218 (374)
..+++++|+++|+|..++.... ....+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2368899999999988764321 2235788999999999999999999998 999999999999999999999999
Q ss_pred ccccccccCCce-eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHh
Q 017262 219 GTSRSIAIDQTH-VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEE 296 (374)
Q Consensus 219 g~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 296 (374)
|++......... ......+++.|++||.+.+..++.++||||||+++|+|++ |..||...... .........
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~------~~~~~~~~~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS------EIYNYLIKG 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH------HHHHHHHcC
Confidence 998765432221 1122335678999999998889999999999999999999 88898643221 111111111
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 017262 297 NCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347 (374)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~ 347 (374)
.. ...+...+..+.+++.+|++.+|++|||+.++++.|+.+
T Consensus 232 ~~----------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NR----------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred Cc----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 10 111223445899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=322.84 Aligned_cols=260 Identities=23% Similarity=0.359 Sum_probs=200.2
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeec--ccce
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEV--EVPL 144 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 144 (374)
..++|.+.+.||.|+||+||++... .+..+++|.+... .......+..|+.++++++||||++++++|.+. ..+|
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 3468999999999999999999965 4678888877643 344567788999999999999999999988654 4688
Q ss_pred EEEEeecCCcccccccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCC----CCEEEeccCCCceEECC----------
Q 017262 145 LVYEFIPNGTLFQYLHDPY-EELSLTWEMRLRIATEVAEALAYLHSSAY----LPIYHRDIKSTNILLDE---------- 209 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~----~~i~H~dlk~~Nill~~---------- 209 (374)
+||||+++++|.++|.... ....+++..++.|+.||+.||+|||+.+. .+|+|+||||+|||++.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 9999999999999986422 23579999999999999999999998541 23999999999999964
Q ss_pred -------CCcEEEeecccccccccCCceeeecccccccccCcccccc--CCCCccchhhhHHHHHHHHHhCCCCCCcccc
Q 017262 210 -------KYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRS--SQFTDKSDVYSFGVVLVELLTGQKPISSIWA 280 (374)
Q Consensus 210 -------~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~p~~~~~~ 280 (374)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||....
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~- 247 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN- 247 (1021)
T ss_pred cccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC-
Confidence 2348999999997653221 2234568999999999854 458899999999999999999999996322
Q ss_pred ccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHHH
Q 017262 281 NEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM--ELERI 347 (374)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~--~L~~~ 347 (374)
.....+........ ......+..+.+||.+||..+|.+||++.+++. .+..+
T Consensus 248 ----~~~qli~~lk~~p~-----------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 248 ----NFSQLISELKRGPD-----------LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred ----cHHHHHHHHhcCCC-----------CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 22222221111100 001123457889999999999999999999984 44433
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=289.17 Aligned_cols=250 Identities=26% Similarity=0.399 Sum_probs=201.9
Q ss_pred CCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeee--cccceEEE
Q 017262 73 YFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLE--VEVPLLVY 147 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 147 (374)
+|++.+.||.|+||.||++.. .++..+++|.+... .......+..|+.+++.++|||++++++++.. ....++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999985 46788999987643 34555678899999999999999999998764 34578999
Q ss_pred EeecCCcccccccCCC-CCCCCCHHHHHHHHHHHHHHHHHHh-----hcCCCCEEEeccCCCceEECCCCcEEEeecccc
Q 017262 148 EFIPNGTLFQYLHDPY-EELSLTWEMRLRIATEVAEALAYLH-----SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 221 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH-----~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 221 (374)
||+++++|.+++.... ....+++..++.++.|++.||.||| +.+ ++|+||+|+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999999999986421 2457899999999999999999999 666 999999999999999999999999999
Q ss_pred cccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccc
Q 017262 222 RSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFD 301 (374)
Q Consensus 222 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (374)
........ ......+++.|+|||.+.+..++.++|+||||+++++|++|..||..... .. ..+.....
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~-~~~~~~~~---- 225 (265)
T cd08217 158 KILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ------LQ-LASKIKEG---- 225 (265)
T ss_pred ccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH------HH-HHHHHhcC----
Confidence 87653332 12334689999999999988899999999999999999999999974321 11 11111111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 302 IIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 302 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.....+...+..+.+++.+|++.+|++|||++++++
T Consensus 226 -----~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 226 -----KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred -----CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 112233345678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=305.65 Aligned_cols=240 Identities=26% Similarity=0.294 Sum_probs=186.0
Q ss_pred EeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhC---CCCceeeeeeeeeecccceEEEEeecC
Q 017262 80 LGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQI---NHRNVVKLLGCCLEVEVPLLVYEFIPN 152 (374)
Q Consensus 80 lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~ 152 (374)
||+|+||+||+|... +++.+|+|.+... ..........|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999965 5889999987542 122233455666776655 699999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceee
Q 017262 153 GTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 232 (374)
Q Consensus 153 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 232 (374)
|+|.+++. ....+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++....... ...
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~ 153 (330)
T cd05586 81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTT 153 (330)
T ss_pred ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCc
Confidence 99998887 3557899999999999999999999999 9999999999999999999999999987533222 222
Q ss_pred ecccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCC
Q 017262 233 TKVQGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSG 311 (374)
Q Consensus 233 ~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (374)
....||+.|+|||.+.+. .++.++|||||||++|+|++|..||..... ...... ...... . ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~------~~~~~~-i~~~~~--------~-~~ 217 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT------QQMYRN-IAFGKV--------R-FP 217 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH------HHHHHH-HHcCCC--------C-CC
Confidence 345689999999998754 478999999999999999999999964321 111111 111100 0 01
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 017262 312 EAEEIMAVSDVAKRCLNSYGRNRPT----MKEVAM 342 (374)
Q Consensus 312 ~~~~~~~l~~li~~cl~~~p~~Rps----~~~vl~ 342 (374)
....+..+.+++.+||+.||++||+ +.++++
T Consensus 218 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 218 KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1123457889999999999999985 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=286.72 Aligned_cols=252 Identities=26% Similarity=0.353 Sum_probs=189.4
Q ss_pred eEeeeCeEEEEEEEecC---CcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeecCCc
Q 017262 79 ILGQGGQGTVYKGMLAD---GRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGT 154 (374)
Q Consensus 79 ~lg~G~~g~v~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~ 154 (374)
.||+|+||.||+|...+ ...+++|.+.... ......+.+|+..++.++||||+++++.+.+....+++|||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 3467888765433 3344567899999999999999999999999999999999999999
Q ss_pred ccccccCCCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCcee-
Q 017262 155 LFQYLHDPYE--ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV- 231 (374)
Q Consensus 155 L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~- 231 (374)
|.+++..... ....++.....++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999875322 233567888999999999999999999 9999999999999999999999999986543222111
Q ss_pred eecccccccccCcccccc-------CCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccc
Q 017262 232 STKVQGTFGYLDPEYFRS-------SQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDII 303 (374)
Q Consensus 232 ~~~~~g~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (374)
.....+++.|+|||++.. ..++.++||||||+++|+|++ |..||......+ ......... .....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~~-~~~~~ 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ------VLKQVVREQ-DIKLP 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhhcc-CccCC
Confidence 122345678999998743 356789999999999999999 788886433211 111111111 11111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017262 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345 (374)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~ 345 (374)
.+ ..+...+..+.+++..|+ .+|++|||++++++.|.
T Consensus 232 ~~----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KP----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CC----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11 122234456778899998 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=292.24 Aligned_cols=251 Identities=25% Similarity=0.403 Sum_probs=204.7
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
.++|.+.+.||+|+||.||++... +++.+++|.+..........+.+|+.+++.++|||++++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 367899999999999999999854 6788999988765555567788999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999999863 35788999999999999999999999 99999999999999999999999998875543222
Q ss_pred eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccC
Q 017262 230 HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (374)
......+++.|+|||.+....++.++|+||||+++|++++|..||......... ... ........
T Consensus 171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~------~~~--------~~~~~~~~ 235 (293)
T cd06647 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLI--------ATNGTPEL 235 (293)
T ss_pred -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe------eeh--------hcCCCCCC
Confidence 223345888999999998888999999999999999999999999753321110 000 00011111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 310 SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 310 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
..+...+..+.+++.+||..+|++||++.+++..
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1223345678899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=311.33 Aligned_cols=264 Identities=20% Similarity=0.248 Sum_probs=191.2
Q ss_pred HHHhhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCC------Cceeeeeeeeee
Q 017262 67 LDKATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINH------RNVVKLLGCCLE 139 (374)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~~~~~~~~ 139 (374)
+....++|.+.+.||+|+||+||+|... .++.||+|++.... ........|+.+++.++| .+++++++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3445688999999999999999999964 57889999886432 223445667777777654 458888888875
Q ss_pred c-ccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCEEEeccCCCceEECCCC------
Q 017262 140 V-EVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS-SAYLPIYHRDIKSTNILLDEKY------ 211 (374)
Q Consensus 140 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~i~H~dlk~~Nill~~~~------ 211 (374)
. ...++||+++ +++|.+++. ....+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIM---KHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccc
Confidence 4 4678999988 778888776 34578999999999999999999998 47 99999999999998765
Q ss_pred ----------cEEEeecccccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccc
Q 017262 212 ----------RAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWAN 281 (374)
Q Consensus 212 ----------~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~ 281 (374)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred cccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 49999999875422 1223456899999999999999999999999999999999999999754321
Q ss_pred cCC---------ChHHHHHHH--------HHh-ccccccccccc-----c--CCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 017262 282 EGR---------NLTTYFVEC--------IEE-NCLFDIIDDQV-----R--KSGEAEEIMAVSDVAKRCLNSYGRNRPT 336 (374)
Q Consensus 282 ~~~---------~~~~~~~~~--------~~~-~~~~~~~~~~~-----~--~~~~~~~~~~l~~li~~cl~~~p~~Rps 336 (374)
+.. ....|...+ ... ..+....++.. . ..........+.+||.+||+.||++|||
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 100 000111000 000 00000000000 0 0000112356889999999999999999
Q ss_pred HHHHHH
Q 017262 337 MKEVAM 342 (374)
Q Consensus 337 ~~~vl~ 342 (374)
++|+++
T Consensus 432 a~e~L~ 437 (467)
T PTZ00284 432 ARQMTT 437 (467)
T ss_pred HHHHhc
Confidence 999986
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=290.08 Aligned_cols=252 Identities=27% Similarity=0.400 Sum_probs=204.0
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
++|+..+.||.|++|.||++... +++.+++|.+.... ......+.+|++++++++||||+++++.+...+..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35778889999999999999975 58899999876543 34556788999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS-SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
+++++|.+++... ...+++..+..++.|++.||+|||+ .+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEV--QGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 9999999998753 2678999999999999999999999 88 9999999999999999999999999987653222
Q ss_pred ceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccccc
Q 017262 229 THVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVR 308 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (374)
.. ...++..|+|||.+.+..++.++||||||+++|+|++|..||....... .............. .
T Consensus 156 ~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~----------~ 221 (265)
T cd06605 156 AK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNEP----------P 221 (265)
T ss_pred hh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcCC----------C
Confidence 11 1557889999999998899999999999999999999999997543211 12222221111111 1
Q ss_pred CCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 309 KSGEAE-EIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 309 ~~~~~~-~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
...+.. .+..+.++|.+|+..+|++|||+.+++.
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 222 PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 111122 5667899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=291.15 Aligned_cols=259 Identities=25% Similarity=0.323 Sum_probs=201.9
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 148 (374)
++|++.+.||+|+||.||+|... +++.+++|.+... .......+.+|+++++.++|+||+++++++...+..++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999975 5789999977643 33345678899999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
|++++++..+.. ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 999887776654 3445899999999999999999999999 9999999999999999999999999987765433
Q ss_pred ceeeecccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHH------------
Q 017262 229 THVSTKVQGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIE------------ 295 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------------ 295 (374)
........++..|+|||.+.+. .++.++|+||||+++|+|++|..||......+ .......
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID------QLYLIQKCLGPLPPSHQEL 228 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHHHhCCCCHHHhhh
Confidence 3233345678899999999887 78999999999999999999999997432211 0100000
Q ss_pred --hcc-c-----cccccc-cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 296 --ENC-L-----FDIIDD-QVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 296 --~~~-~-----~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
... . ...... ......+...+..+.++|++||..+|++|||++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 229 FSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000 0 000000 0000112223678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=295.03 Aligned_cols=264 Identities=25% Similarity=0.355 Sum_probs=198.9
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC--hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 148 (374)
++|++.+.||+|+||.||+|... +++.+++|...... ......+.+|+++++.++||||+++++++...+..++++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36888999999999999999975 48899999765432 2234567889999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
|+++++|..+... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999999887653 345899999999999999999999998 9999999999999999999999999987654332
Q ss_pred ceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccC--------CChHHHHHHHHHhccc
Q 017262 229 THVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEG--------RNLTTYFVECIEENCL 299 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~ 299 (374)
.......++..|+|||.+.+ ..++.++||||||+++|+|++|..||......+. ..+.............
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 155 -EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred -cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence 22233457889999999875 4478899999999999999999999864322110 0000000000000000
Q ss_pred c-cccccccc-----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 300 F-DIIDDQVR-----KSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 300 ~-~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
. ....+... ....+..+..+.+++.+||+.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0 00000000 0011234567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=287.72 Aligned_cols=251 Identities=27% Similarity=0.401 Sum_probs=206.9
Q ss_pred CCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCCh-hHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEee
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE-SKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFI 150 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 150 (374)
+|++.+.||.|++|.||+|... +++.+++|.+..... .....+.+|+..+.+++|+|++++++++...+..++++||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 6888899999999999999976 489999998876543 45678899999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS-SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
++++|.+++.. ...+++..++.++.|++.|++|||+ .+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 82 DGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 99999999974 3678999999999999999999999 88 99999999999999999999999999876543222
Q ss_pred eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccC
Q 017262 230 HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (374)
. .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ............ ...
T Consensus 156 ~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~---~~~~~~~~~~~~----------~~~ 221 (264)
T cd06623 156 Q-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP---SFFELMQAICDG----------PPP 221 (264)
T ss_pred c-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc---CHHHHHHHHhcC----------CCC
Confidence 2 22345788999999999888999999999999999999999999754321 111111111111 111
Q ss_pred CCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 310 SGEAE-EIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 310 ~~~~~-~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
..+.. .+..+.+++.+|+..+|++|||+.++++.
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 12222 55689999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=295.72 Aligned_cols=249 Identities=25% Similarity=0.392 Sum_probs=200.1
Q ss_pred CCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeec
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIP 151 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 151 (374)
.|.....||+|+||.||++... ++..+++|.+..........+.+|+..++.++|+|++++++.+...+..+++|||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 3444567999999999999864 588999998876656666778899999999999999999999999999999999999
Q ss_pred CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCcee
Q 017262 152 NGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV 231 (374)
Q Consensus 152 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 231 (374)
+++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....... ..
T Consensus 103 ~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~ 174 (292)
T cd06658 103 GGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PK 174 (292)
T ss_pred CCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc-cc
Confidence 9999998852 35889999999999999999999998 9999999999999999999999999986543222 12
Q ss_pred eecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCC
Q 017262 232 STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSG 311 (374)
Q Consensus 232 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (374)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ...+.. ... ...... ..
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------~~~~~~-~~~-----~~~~~~--~~ 240 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP------LQAMRR-IRD-----NLPPRV--KD 240 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHH-HHh-----cCCCcc--cc
Confidence 2334588999999999888899999999999999999999999864221 111111 100 011111 11
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 312 EAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 312 ~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
....+..+.+++.+|+..+|++|||++++++.
T Consensus 241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 12334578899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=289.67 Aligned_cols=253 Identities=26% Similarity=0.420 Sum_probs=197.9
Q ss_pred CCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCCh----------hHHHHHHHHHHHHhhCCCCceeeeeeeeeecc
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE----------SKLEEFINEVVILSQINHRNVVKLLGCCLEVE 141 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 141 (374)
+|.+.+.||.|+||.||+|... +++.+++|.+..... ...+.+.+|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4778899999999999999854 588999997653211 12346788999999999999999999999999
Q ss_pred cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccc
Q 017262 142 VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 221 (374)
Q Consensus 142 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 221 (374)
..++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 99999999999999999874 357899999999999999999999998 999999999999999999999999998
Q ss_pred cccccCCce-eeecccccccccCccccccCC--CCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcc
Q 017262 222 RSIAIDQTH-VSTKVQGTFGYLDPEYFRSSQ--FTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENC 298 (374)
Q Consensus 222 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 298 (374)
......... ......++..|+|||.+.... ++.++|+||||+++|++++|..||..... ..... .... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~-~~~~-~~ 228 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-----IAAMF-KLGN-KR 228 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-----HHHHH-Hhhc-cc
Confidence 754322111 123345788999999987654 78999999999999999999999853221 11111 1000 00
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 299 LFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.. ...........+..+.+++.+|+..+|++|||+++++.
T Consensus 229 ~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 229 SA----PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cC----CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 00 11111122234568999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=291.72 Aligned_cols=258 Identities=26% Similarity=0.418 Sum_probs=201.1
Q ss_pred hHHHHHhhcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCChhHHHHHHHHHHHHhhC-CCCceeeeeeeeee--
Q 017262 64 SKELDKATDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQI-NHRNVVKLLGCCLE-- 139 (374)
Q Consensus 64 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~-- 139 (374)
..++....+.|++.+.||+|+||.||+|.. .+++.+++|...... .....+..|+.+++++ +|+|++++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 345555678899999999999999999996 457889999876543 3345678899999998 69999999999853
Q ss_pred ----cccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEE
Q 017262 140 ----VEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKI 215 (374)
Q Consensus 140 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl 215 (374)
.+..+++|||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 35679999999999999988653 2346888899999999999999999999 999999999999999999999
Q ss_pred eecccccccccCCceeeecccccccccCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHH
Q 017262 216 ADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFR-----SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYF 290 (374)
Q Consensus 216 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 290 (374)
+|||++........ ......+++.|+|||.+. ...++.++|+||||+++|+|++|..||....... ...
T Consensus 163 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~-----~~~ 236 (282)
T cd06636 163 VDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR-----ALF 236 (282)
T ss_pred eeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh-----hhh
Confidence 99999875432111 123345888999999875 3457889999999999999999999996432211 000
Q ss_pred HHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 291 VECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
. ..............+..+.+++.+||+.||.+|||+.++++
T Consensus 237 -~---------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 -L---------IPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -h---------HhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 00011111112234568999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=293.83 Aligned_cols=258 Identities=21% Similarity=0.301 Sum_probs=194.7
Q ss_pred CCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC--hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
+|++.+.||+|+||.||+|... +|+.+++|.+.... ......+.+|+.++++++||||+++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999965 58899999876432 22235677899999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
++ ++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 96 467776653 2456899999999999999999999999 99999999999999999999999999876543221
Q ss_pred eeeecccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHh------------
Q 017262 230 HVSTKVQGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEE------------ 296 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------ 296 (374)
......+++.|+|||.+.+. .++.++||||||+++|+|++|..|+...... ..........
T Consensus 155 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07839 155 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-----DDQLKRIFRLLGTPTEESWPGV 228 (284)
T ss_pred -CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH-----HHHHHHHHHHhCCCChHHhHHh
Confidence 12234578899999998764 4789999999999999999999886432211 1111100000
Q ss_pred cccccc-----cccc-ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 297 NCLFDI-----IDDQ-VRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 297 ~~~~~~-----~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
...... .... ......+..+..+.+++.+||+.||.+|||+++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000000 0000 000111234568889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=290.02 Aligned_cols=258 Identities=23% Similarity=0.286 Sum_probs=200.6
Q ss_pred CCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC--hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
+|++.+.||.|++|.||+|... +|+.+++|.+.... ......+.+|+.++++++|||++++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999964 68899999876543 33456788999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+ +++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 99999988652 356899999999999999999999999 99999999999999999999999999876654332
Q ss_pred eeeecccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcc----------
Q 017262 230 HVSTKVQGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENC---------- 298 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------- 298 (374)
.......++..|+|||.+.+. .++.++||||||+++++|++|..||....... . +......-.
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-----~-~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE-----Q-LAIVFRTLGTPNEETWPGL 228 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH-----H-HHHHHHHcCCCChHHHhhc
Confidence 223344688899999998654 46899999999999999999988876432211 0 111110000
Q ss_pred -----ccccccccc----cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 299 -----LFDIIDDQV----RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 299 -----~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
......... .....++.+..+.+++.+||+.+|++|||+++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred cCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000000000 00011133478999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=292.79 Aligned_cols=261 Identities=25% Similarity=0.347 Sum_probs=201.0
Q ss_pred hHHHHHhhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhC-CCCceeeeeeeee---
Q 017262 64 SKELDKATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQI-NHRNVVKLLGCCL--- 138 (374)
Q Consensus 64 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~--- 138 (374)
...+....++|++.+.||+|+||.||++... +++.+++|....... ....+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3455667889999999999999999999864 578899998764322 235677899999999 6999999999874
Q ss_pred --ecccceEEEEeecCCcccccccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEE
Q 017262 139 --EVEVPLLVYEFIPNGTLFQYLHDPY-EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKI 215 (374)
Q Consensus 139 --~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl 215 (374)
.++..+++|||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence 3456899999999999998875321 3456889999999999999999999998 999999999999999999999
Q ss_pred eecccccccccCCceeeecccccccccCcccccc-----CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHH
Q 017262 216 ADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRS-----SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYF 290 (374)
Q Consensus 216 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 290 (374)
+|||++....... .......|++.|+|||.+.. ..++.++||||||+++|+|++|+.||...... ....
T Consensus 166 ~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~-----~~~~ 239 (286)
T cd06638 166 VDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM-----RALF 239 (286)
T ss_pred ccCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh-----HHHh
Confidence 9999987654322 12233458899999999753 44788999999999999999999998643211 1110
Q ss_pred HHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 291 VECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
... ..... ....+...+..+.+++.+||+.+|++|||+.++++.
T Consensus 240 -~~~-~~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 240 -KIP-RNPPP-------TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred -hcc-ccCCC-------cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 000 00000 001111234578899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=295.19 Aligned_cols=195 Identities=26% Similarity=0.404 Sum_probs=157.7
Q ss_pred ceEeeeCeEEEEEEEecC---CcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeee--cccceEEEEeecC
Q 017262 78 RILGQGGQGTVYKGMLAD---GRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLE--VEVPLLVYEFIPN 152 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~---~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~ 152 (374)
..||+|+||.||+|...+ +..+|+|.+.... ....+.+|+.+++.++||||+++++++.. +...++++||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 579999999999999653 5689999876532 23457789999999999999999999854 4467899999965
Q ss_pred CcccccccCC------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEE----CCCCcEEEeeccccc
Q 017262 153 GTLFQYLHDP------YEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL----DEKYRAKIADFGTSR 222 (374)
Q Consensus 153 g~L~~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill----~~~~~~kl~Dfg~~~ 222 (374)
+|.+++... .....+++..+..++.|++.||.|||+.+ ++||||||+||++ +.++.+||+|||++.
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 666665321 12335889999999999999999999999 9999999999999 566799999999997
Q ss_pred ccccCCce--eeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcc
Q 017262 223 SIAIDQTH--VSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSI 278 (374)
Q Consensus 223 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~ 278 (374)
........ ......+|+.|+|||.+.+ ..++.++||||||+++|+|++|..||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 65432221 1234568899999999876 45789999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=287.77 Aligned_cols=247 Identities=28% Similarity=0.446 Sum_probs=200.9
Q ss_pred CCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEee
Q 017262 73 YFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFI 150 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 150 (374)
-|...+.||.|+||.||+|.. .++..+|+|...... ......+.+|+..+++++||||+++++++..++..++|+||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 467788999999999999986 467899999876432 344567889999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 230 (374)
++++|.+++.. ..+++..+..++.|++.|+.+||+.+ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~ 156 (277)
T cd06641 85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-I 156 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch-h
Confidence 99999998853 46889999999999999999999998 9999999999999999999999999987654321 1
Q ss_pred eeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCC
Q 017262 231 VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKS 310 (374)
Q Consensus 231 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (374)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ... ...... ....
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~-~~~~~~---------~~~~ 220 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM------KVL-FLIPKN---------NPPT 220 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH------HHH-HHHhcC---------CCCC
Confidence 122345788999999998888899999999999999999999998642211 111 111111 1112
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 311 GEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 311 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
.+...+..+.+++.+|+..+|.+||++.+++..
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 223445678899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=290.13 Aligned_cols=255 Identities=27% Similarity=0.429 Sum_probs=200.8
Q ss_pred HhhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecc-----
Q 017262 69 KATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVE----- 141 (374)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~----- 141 (374)
..+++|++.+.||+|++|.||+|... +++.+++|....... ....+.+|+.+++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 34688999999999999999999975 578899998776543 346788999999999 7999999999997644
Q ss_pred -cceEEEEeecCCcccccccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecc
Q 017262 142 -VPLLVYEFIPNGTLFQYLHDPY-EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 219 (374)
Q Consensus 142 -~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 219 (374)
..+++|||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 4799999999999999886432 2457899999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCceeeecccccccccCcccccc-----CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHH
Q 017262 220 TSRSIAIDQTHVSTKVQGTFGYLDPEYFRS-----SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECI 294 (374)
Q Consensus 220 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 294 (374)
++....... .......+++.|+|||.+.. ..++.++||||||+++|+|++|..||...... .. ..+..
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~-~~~~~ 231 (275)
T cd06608 159 VSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-----RA-LFKIP 231 (275)
T ss_pred cceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-----HH-HHHhh
Confidence 987543222 22233458889999998753 34678999999999999999999999642211 11 11111
Q ss_pred HhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 295 EENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.. .......+...+..+.+++.+||+.||++|||+.++++
T Consensus 232 -~~-------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 -RN-------PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -cc-------CCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00 00011122335568899999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=294.08 Aligned_cols=255 Identities=23% Similarity=0.307 Sum_probs=201.0
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC---hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
++|++.+.||+|+||.||++... .++.+++|.+.... ......+.+|+.+++.++||||+++++.+...+..+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999965 47889999876542 233457789999999999999999999999988999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 99999999999963 456899999999999999999999998 999999999999999999999999988642111
Q ss_pred Cc--------------eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHH
Q 017262 228 QT--------------HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVEC 293 (374)
Q Consensus 228 ~~--------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 293 (374)
.. .......++..|+|||.+.+..++.++|+||||+++|+|++|..||..... .......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~------~~~~~~~ 228 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP------EELFGQV 228 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHH
Confidence 00 011123477889999999888899999999999999999999999964321 1222211
Q ss_pred HHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 017262 294 IEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELER 346 (374)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~ 346 (374)
.... .. ........+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 229 ~~~~-~~-------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 229 ISDD-IE-------WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred Hhcc-cC-------CCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1111 00 001111345578899999999999999997766666655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=293.13 Aligned_cols=248 Identities=28% Similarity=0.417 Sum_probs=196.8
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
.+.|...+.||+|+||.||+|... +++.+++|.+... .......+.+|+++++.++|||++++.+++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356888899999999999999965 5889999987543 234456788999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
+||++ |+|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 94 ~e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 99996 566666543 2346899999999999999999999998 99999999999999999999999999865432
Q ss_pred CCceeeecccccccccCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccc
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFR---SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDII 303 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (374)
. ....+++.|+|||.+. ...++.++||||||+++|+|++|..||....... .... ....
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~------~~~~-~~~~------ 229 (307)
T cd06607 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYH-IAQN------ 229 (307)
T ss_pred C-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH------HHHH-HhcC------
Confidence 2 2235788999999874 4568889999999999999999999986432111 0000 0000
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 017262 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMEL 344 (374)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L 344 (374)
..........+..+.+++.+||+.+|++||++.+++...
T Consensus 230 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 230 --DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred --CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 001111223556799999999999999999999998743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=302.67 Aligned_cols=244 Identities=25% Similarity=0.466 Sum_probs=195.5
Q ss_pred CCCcCceEeeeCeEEEEEEEecC-CcEEEEEEecc----CChhHHHHHHHHHHHHhhCCCCceeeeeeeeeeccc--ceE
Q 017262 73 YFNMNRILGQGGQGTVYKGMLAD-GRIIAVKKSKV----VDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEV--PLL 145 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--~~l 145 (374)
+......||+|+|-+||+|.+.. |-.||=-.++. .++...+.|..|+.+|+.|+||||+++++++.+... ..+
T Consensus 41 y~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~ 120 (632)
T KOG0584|consen 41 YLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINF 120 (632)
T ss_pred eeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeee
Confidence 33455789999999999999753 54454211111 235566889999999999999999999999987765 679
Q ss_pred EEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECC-CCcEEEeeccccccc
Q 017262 146 VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE-KYRAKIADFGTSRSI 224 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~~~~ 224 (374)
|+|.+..|+|..|+. ..+.++...+..|++||++||.|||++. +||+|||||-+||||+. .|.|||+|+|+|...
T Consensus 121 iTEL~TSGtLr~Y~k---k~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 121 ITELFTSGTLREYRK---KHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred eeecccCCcHHHHHH---HhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 999999999999998 4567888899999999999999999998 78999999999999975 589999999999876
Q ss_pred ccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhc---cccc
Q 017262 225 AIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEEN---CLFD 301 (374)
Q Consensus 225 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 301 (374)
..+. .....|||.|||||... ..|+..+||||||+.|+||+|+.+||+.-. +..+.+......- .+..
T Consensus 197 r~s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-----n~AQIYKKV~SGiKP~sl~k 267 (632)
T KOG0584|consen 197 RKSH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT-----NPAQIYKKVTSGIKPAALSK 267 (632)
T ss_pred hccc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC-----CHHHHHHHHHcCCCHHHhhc
Confidence 4322 33368999999999998 789999999999999999999999997433 3333333322211 1111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 302 IIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 302 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
+- .+.++++|.+|+.. .++|||+.|+|+
T Consensus 268 V~------------dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 268 VK------------DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred cC------------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 11 23688999999999 999999999986
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=291.49 Aligned_cols=259 Identities=22% Similarity=0.325 Sum_probs=194.7
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCCh-hHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE-SKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
++|++.+.||+|++|.||+|..+ +++.+++|.+..... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57889999999999999999975 678999998765322 2224567899999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+.+ +|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 974 888888642 346889999999999999999999999 99999999999999999999999999865432111
Q ss_pred eeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHh------cc----
Q 017262 230 HVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEE------NC---- 298 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------~~---- 298 (374)
......++..|+|||.+.+ ..++.++||||+|+++|+|++|..||...... .+.+....+. ..
T Consensus 159 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07844 159 -TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV-----EDQLHKIFRVLGTPTEETWPGV 232 (291)
T ss_pred -cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH-----HHHHHHHHHhcCCCChhhhhhh
Confidence 1122346788999999865 45789999999999999999999999644311 1101100000 00
Q ss_pred --ccccccccccC-------CC--CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 299 --LFDIIDDQVRK-------SG--EAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 299 --~~~~~~~~~~~-------~~--~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
........... .. .......+.+++.+||+.+|++|||+.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000000000 00 0011257789999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=306.05 Aligned_cols=251 Identities=27% Similarity=0.374 Sum_probs=207.1
Q ss_pred cCCCcCceEeeeCeEEEEEEEecCCc-EEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEee
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLADGR-IIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFI 150 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~~~~-~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 150 (374)
+.|+++.-||.|+||.||+|..++.. ..|.|.+...+......+.-|+++|..++||+|+++++.|...+.+++..|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 34667778999999999999987644 44578888778888999999999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 230 (374)
.||..+..+.. -+..+++.++..++.|++.||.|||+++ |||||||+.|||++.+|.++|+|||.+..... ...
T Consensus 112 ~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~q 185 (1187)
T KOG0579|consen 112 GGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQ 185 (1187)
T ss_pred CCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh-HHh
Confidence 99999888765 4678999999999999999999999999 99999999999999999999999999854321 222
Q ss_pred eeecccccccccCcccccc-----CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccc
Q 017262 231 VSTKVQGTFGYLDPEYFRS-----SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDD 305 (374)
Q Consensus 231 ~~~~~~g~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (374)
......|||.|||||+..+ .+|+.++||||||++|.||..+.+|....... ..+... .....+
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM------RVllKi-aKSePP----- 253 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKI-AKSEPP----- 253 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH------HHHHHH-hhcCCC-----
Confidence 3355779999999999754 57899999999999999999999997643321 111111 111111
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 306 QVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..-.|..++..+.+++.+||..||..||++.++++
T Consensus 254 --TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 254 --TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred --cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 11235567788999999999999999999999986
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=284.44 Aligned_cols=252 Identities=23% Similarity=0.324 Sum_probs=188.6
Q ss_pred eEeeeCeEEEEEEEecCC---cEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeecCCc
Q 017262 79 ILGQGGQGTVYKGMLADG---RIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGT 154 (374)
Q Consensus 79 ~lg~G~~g~v~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~ 154 (374)
.||+|+||.||++...++ ..+++|...... ......+.+|+..++.++||||+++++.+.+....+++|||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999975433 345666655433 3445688999999999999999999999999889999999999999
Q ss_pred ccccccCCCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC-ceee
Q 017262 155 LFQYLHDPYE-ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ-THVS 232 (374)
Q Consensus 155 L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~ 232 (374)
|.+++..... ....++..+..++.|++.||+|||+.+ ++|+||||+|||++.++.++|+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999875321 234667788899999999999999998 9999999999999999999999999875432111 1122
Q ss_pred ecccccccccCcccccc-------CCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhcccccccc
Q 017262 233 TKVQGTFGYLDPEYFRS-------SQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIID 304 (374)
Q Consensus 233 ~~~~g~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (374)
....++..|+|||++.. ..++.++||||||+++|||++ |..||..... ...+....... .....+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~~~-~~~~~~ 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVIKDQ-QVKLFK 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhhc-ccccCC
Confidence 33457889999998753 245789999999999999997 5668754322 11222222111 112222
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017262 305 DQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345 (374)
Q Consensus 305 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~ 345 (374)
+... ...+..+.+++..|+ .+|++||+++++++.|.
T Consensus 232 ~~~~----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLE----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccC----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 2221 123456788999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=290.84 Aligned_cols=262 Identities=26% Similarity=0.349 Sum_probs=203.1
Q ss_pred cChHHHHHhhcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCChhHHHHHHHHHHHHhhC-CCCceeeeeeeeee
Q 017262 62 FNSKELDKATDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQI-NHRNVVKLLGCCLE 139 (374)
Q Consensus 62 ~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 139 (374)
+....+..+.++|.+.+.||+|+||.||++.. .+++.+++|.+..... ....+.+|+.+++++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 34456667789999999999999999999996 4688899998765322 235667899999999 79999999999875
Q ss_pred cc-----cceEEEEeecCCcccccccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcE
Q 017262 140 VE-----VPLLVYEFIPNGTLFQYLHDPY-EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA 213 (374)
Q Consensus 140 ~~-----~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~ 213 (374)
.+ ..++|+||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 43 5799999999999999875321 3456899999999999999999999998 9999999999999999999
Q ss_pred EEeecccccccccCCceeeecccccccccCccccccC-----CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHH
Q 017262 214 KIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSS-----QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTT 288 (374)
Q Consensus 214 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~ 288 (374)
||+|||++........ ......++..|+|||.+... .++.++||||||+++|+|++|+.||...... ..
T Consensus 168 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-----~~ 241 (291)
T cd06639 168 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-----KT 241 (291)
T ss_pred EEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-----HH
Confidence 9999999876542221 12234578899999997643 3688999999999999999999999643211 11
Q ss_pred HHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 289 YFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.... ...... ....+...+..+.++|.+|++.+|++||++.++++
T Consensus 242 -~~~~-~~~~~~-------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 242 -LFKI-PRNPPP-------TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred -HHHH-hcCCCC-------CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1111 111111 11112234457899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=304.78 Aligned_cols=246 Identities=28% Similarity=0.448 Sum_probs=204.9
Q ss_pred eEeeeCeEEEEEEEecCC-cEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeecCCcccc
Q 017262 79 ILGQGGQGTVYKGMLADG-RIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQ 157 (374)
Q Consensus 79 ~lg~G~~g~v~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~ 157 (374)
+||+|+||+||.|++.+. ..+|||-+...+....+.+.+|+.+-++++|.|||+++|++..++..-+.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 699999999999997664 5688998888777778889999999999999999999999999998889999999999999
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEEC-CCCcEEEeecccccccccCCceeeeccc
Q 017262 158 YLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD-EKYRAKIADFGTSRSIAIDQTHVSTKVQ 236 (374)
Q Consensus 158 ~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 236 (374)
.+......-.=.+...-.+..||++||.|||.+. |+|||||-+|||++ -.|.+||+|||-++.+..-+ .......
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-P~TETFT 737 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-PCTETFT 737 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCC-ccccccc
Confidence 9986433222267788889999999999999999 99999999999995 67899999999998765322 2234466
Q ss_pred ccccccCccccccC--CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCHH
Q 017262 237 GTFGYLDPEYFRSS--QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAE 314 (374)
Q Consensus 237 g~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (374)
||..|||||++..+ .|+.++|||||||++.||.||++||-....... . .+.+---...+..|.+
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA----A----------MFkVGmyKvHP~iPee 803 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA----A----------MFKVGMYKVHPPIPEE 803 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH----h----------hhhhcceecCCCCcHH
Confidence 99999999999765 488999999999999999999999975443221 0 1111112234566788
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 315 EIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 315 ~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.+.....+|.+|+.++|.+||++++++.
T Consensus 804 lsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 804 LSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 8899999999999999999999999986
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=287.54 Aligned_cols=246 Identities=24% Similarity=0.419 Sum_probs=198.5
Q ss_pred CCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccC-ChhHHHHHHHHHHHHhhCC---CCceeeeeeeeeecccceEEE
Q 017262 73 YFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV-DESKLEEFINEVVILSQIN---HRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~ 147 (374)
.|+..+.||.|+||.||+|.. .++..+++|.+... .......+.+|+.++++++ |||++++++++......+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477888999999999999996 46889999987653 3344567888999999996 999999999999988999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999998853 37899999999999999999999999 999999999999999999999999998766543
Q ss_pred CceeeecccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
.. ......|+..|+|||.+.++ .++.++|+||||+++|+|++|..||....... ... .....
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~------~~~-~~~~~--------- 217 (277)
T cd06917 155 SS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR------AMM-LIPKS--------- 217 (277)
T ss_pred cc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh------hhh-ccccC---------
Confidence 32 22334588899999988654 46889999999999999999999996432211 000 00000
Q ss_pred ccCCCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 307 VRKSGEA-EEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 307 ~~~~~~~-~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.....+. ..+..+.+++.+||+.+|++||++.+++.
T Consensus 218 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 218 KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 0011111 14567889999999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=305.42 Aligned_cols=251 Identities=26% Similarity=0.469 Sum_probs=214.0
Q ss_pred CcCceEeeeCeEEEEEEEecC--Cc--EEEEEEeccCChh-HHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 75 NMNRILGQGGQGTVYKGMLAD--GR--IIAVKKSKVVDES-KLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 75 ~~~~~lg~G~~g~v~~~~~~~--~~--~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
...++||+|.||.|+.|.|.. |+ .||||.+...... ....|++|+.+|.+|+|+|++++||+..+ ....+|+|.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 445789999999999999753 43 6799999876655 56789999999999999999999999987 677899999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
++.|+|.+.|.+. ....+.......++.||+.|+.||.+++ +|||||..+|+|+-....+||+|||+.+.+...+.
T Consensus 192 aplGSLldrLrka-~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 192 APLGSLLDRLRKA-KKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred cccchHHHHHhhc-cccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 9999999999873 4556778888999999999999999999 99999999999999999999999999998764433
Q ss_pred -eee-ecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 230 -HVS-TKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 230 -~~~-~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
+.+ ........|+|||.+....++.++|||++|+++|||++ |+.||.+..... +-..+|..
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q----------------IL~~iD~~ 331 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ----------------ILKNIDAG 331 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH----------------HHHhcccc
Confidence 223 33446778999999999999999999999999999999 899997654332 33455666
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 017262 307 VRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELER 346 (374)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~ 346 (374)
.+...+..+++.+.+++..||..+|.+|||+..+.+.+-.
T Consensus 332 erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 332 ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 6777888899999999999999999999999999854433
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=288.17 Aligned_cols=247 Identities=27% Similarity=0.356 Sum_probs=202.7
Q ss_pred CCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEE
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 148 (374)
+|++.+.||.|+||.||++... ++..+++|.+... .....+.+.+|++++++++||||+++++++.+....++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999975 5889999987643 22456788999999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 9999999999874 357899999999999999999999998 9999999999999999999999999987654322
Q ss_pred ceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccccc
Q 017262 229 THVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVR 308 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (374)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ....+...... ..
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~----------~~ 218 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IRDQIRAKQET----------AD 218 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----HHHHHHHHhcc----------cc
Confidence 223345788999999999888999999999999999999999999754321 11111111110 11
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCH--HHHH
Q 017262 309 KSGEAEEIMAVSDVAKRCLNSYGRNRPTM--KEVA 341 (374)
Q Consensus 309 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~--~~vl 341 (374)
...+...+..+.+++.+||+.+|.+||++ ++++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 22333455789999999999999999999 5544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=281.65 Aligned_cols=249 Identities=31% Similarity=0.475 Sum_probs=204.4
Q ss_pred CCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeec
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIP 151 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 151 (374)
+|...+.||+|++|.||++... ++..+++|+...........+.+|++.++.++|+|++++++++...+..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999975 688999999877655566789999999999999999999999999999999999999
Q ss_pred CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCcee
Q 017262 152 NGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV 231 (374)
Q Consensus 152 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 231 (374)
+++|.+++... ...+++..+..++.|++.||.+||+.+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 99999998752 257899999999999999999999988 99999999999999999999999999876654332
Q ss_pred eecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCC
Q 017262 232 STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSG 311 (374)
Q Consensus 232 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (374)
.....++..|+|||.+.+..++.++|+||||+++++|++|..||...... ..... ........ ...
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~-~~~~~~~~-------~~~ 219 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM------KALFK-IATNGPPG-------LRN 219 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH------HHHHH-HHhcCCCC-------cCc
Confidence 23445888999999998888999999999999999999999998643211 11110 00010110 011
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 312 EAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 312 ~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
....+..+.+++.+|++.||++|||+.++++
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1122567999999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=285.81 Aligned_cols=264 Identities=24% Similarity=0.398 Sum_probs=222.6
Q ss_pred HHHhhcCCCcCceEeeeCeEEEEEEEecCC------cEEEEEEecc-CChhHHHHHHHHHHHHhhCCCCceeeeeeeeee
Q 017262 67 LDKATDYFNMNRILGQGGQGTVYKGMLADG------RIIAVKKSKV-VDESKLEEFINEVVILSQINHRNVVKLLGCCLE 139 (374)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~------~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 139 (374)
+.....+++..-++-+|+||+||.|.+++. +.+.+|.++. .++.+...++.|.-.+..+.|||+.++.+++.+
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 334456788888899999999999976543 3456665543 456677889999999999999999999999865
Q ss_pred c-ccceEEEEeecCCccccccc-----CCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcE
Q 017262 140 V-EVPLLVYEFIPNGTLFQYLH-----DPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA 213 (374)
Q Consensus 140 ~-~~~~lv~e~~~~g~L~~~l~-----~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~ 213 (374)
+ ..+++++.++.-|+|..|+. +....+.++..+...++.|++.|++|||+++ ++|.||..+|+++|+..++
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqV 435 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQV 435 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeE
Confidence 4 57899999999999999998 5555667888999999999999999999999 9999999999999999999
Q ss_pred EEeecccccccccCCceeeec-ccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHH
Q 017262 214 KIADFGTSRSIAIDQTHVSTK-VQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFV 291 (374)
Q Consensus 214 kl~Dfg~~~~~~~~~~~~~~~-~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~ 291 (374)
||+|-.+++.+.+.+.+.... ...+..||+||.+.+..|+.++|+||||+++|||+| |+.|+......+
T Consensus 436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE--------- 506 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE--------- 506 (563)
T ss_pred EeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH---------
Confidence 999999999988777665543 446778999999999999999999999999999999 999997544433
Q ss_pred HHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 017262 292 ECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRA 349 (374)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~ 349 (374)
....+.++.+...|.++|.++..++.-||...|++||+++++..-|.++-.
T Consensus 507 -------m~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 507 -------MEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred -------HHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 222344555566677888999999999999999999999999999988754
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=285.12 Aligned_cols=260 Identities=25% Similarity=0.321 Sum_probs=201.2
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc--cceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVE--VPLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~ 147 (374)
++|...+.||.|++|.||++... +++.+++|.+.... ......+.+|++++++++||||+++++++.+.. ..+++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36788899999999999999974 57889999876533 234567889999999999999999999986543 679999
Q ss_pred EeecCCcccccccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 148 EFIPNGTLFQYLHDPY-EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999988765321 3456889999999999999999999999 99999999999999999999999999865432
Q ss_pred CCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|..||....... ....+.. ............+.
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~- 231 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-LGPIELL-SYIVNMPNPELKDE- 231 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC-CChHHHH-HHHhcCCchhhccC-
Confidence 21 123447888999999998899999999999999999999999997543211 1111111 11111111111000
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 307 VRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.......+..+.+++.+||..+|++|||+.++++
T Consensus 232 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 232 --PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred --CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0111234568899999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=288.57 Aligned_cols=247 Identities=24% Similarity=0.358 Sum_probs=200.3
Q ss_pred CCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeecC
Q 017262 74 FNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPN 152 (374)
Q Consensus 74 ~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 152 (374)
|...+.||+|++|.||++.. .+++.+++|.+........+.+.+|+.+++.++|||++++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457999999999999985 46889999988766555667788999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceee
Q 017262 153 GTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 232 (374)
Q Consensus 153 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 232 (374)
++|.+++.. ..+++..+..++.|++.||+|||+++ ++||||+|+||+++.++.++|+|||.+........ ..
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~ 172 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RR 172 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cc
Confidence 999998863 46889999999999999999999999 99999999999999999999999998765432221 22
Q ss_pred ecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCC
Q 017262 233 TKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGE 312 (374)
Q Consensus 233 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (374)
....|++.|+|||.+.+..++.++|+||||+++|+|++|..||.... ........... .. .. ...+
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~------~~~~~~~~~~~-~~-----~~--~~~~ 238 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP------PLQAMKRIRDN-LP-----PK--LKNL 238 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC------HHHHHHHHHhc-CC-----CC--Cccc
Confidence 33458899999999988889999999999999999999999986422 11111111111 00 00 1112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 313 AEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 313 ~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
...+..+.+++.+||+.+|++|||+.++++
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 239 HKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 224567999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=286.08 Aligned_cols=249 Identities=23% Similarity=0.386 Sum_probs=200.8
Q ss_pred CCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
+|.+.+.||.|+||.||++... +|..+++|.+... .......+.+|+.+++.++|+|++++++.+.+.+..++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4788899999999999999965 5788999987653 223446778999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCc-EEEeecccccccccCC
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR-AKIADFGTSRSIAIDQ 228 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~-~kl~Dfg~~~~~~~~~ 228 (374)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++. ++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999999988653 2346799999999999999999999998 999999999999998864 6999999987654322
Q ss_pred ceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccccc
Q 017262 229 THVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVR 308 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (374)
.......|++.|+|||.+.+..++.++|+||||+++++|++|..||.... .......... ...
T Consensus 157 -~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~-~~~--------- 219 (257)
T cd08225 157 -ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKICQ-GYF--------- 219 (257)
T ss_pred -ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhc-ccC---------
Confidence 22233458889999999988889999999999999999999999986432 2222222111 111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 309 KSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 309 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
....+..+..+.+++.+|+..+|++|||+.++++
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 220 APISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1112234457999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=288.53 Aligned_cols=257 Identities=22% Similarity=0.331 Sum_probs=196.0
Q ss_pred CCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC--hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
+|+..+.||.|++|.||+|... +++.+++|.+.... ......+.+|++++++++||||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999864 58899999876432 22345788999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+. ++|..++... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 95 5788877643 3457899999999999999999999998 99999999999999999999999999875532221
Q ss_pred eeeecccccccccCccccccCC-CCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhc-----------
Q 017262 230 HVSTKVQGTFGYLDPEYFRSSQ-FTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEEN----------- 297 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 297 (374)
......+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||....... . ..+..+..
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-----~-~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07860 156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-----Q-LFRIFRTLGTPDEVVWPGV 228 (284)
T ss_pred -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-----H-HHHHHHHhCCCChhhhhhh
Confidence 122334678899999887644 6889999999999999999999997433211 0 11111000
Q ss_pred --------cccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 298 --------CLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 298 --------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.......... ....+..+..+.++|.+|++.||++|||+++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 229 TSLPDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hHHHHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000 0001123456789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=288.12 Aligned_cols=252 Identities=25% Similarity=0.410 Sum_probs=204.8
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEE
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 148 (374)
.++.|+..+.||+|++|.||+|... ++..+++|.+..... ....+.+|++.++.++|+|++++++++...+..++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888899999999999999976 688999998876544 45678899999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
|+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~--~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQN--FVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 99999999999753 137999999999999999999999988 9999999999999999999999999886544322
Q ss_pred ceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccccc
Q 017262 229 THVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVR 308 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (374)
. ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...... ...... ..... ..
T Consensus 171 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~------~~~~~~-~~~~~-------~~ 235 (286)
T cd06614 171 S-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL------RALFLI-TTKGI-------PP 235 (286)
T ss_pred h-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH------HHHHHH-HhcCC-------CC
Confidence 1 223344788999999998888999999999999999999999998632211 111111 01100 01
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 309 KSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 309 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.......+..+.+++.+|++.+|.+|||+.+++.
T Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 236 LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1112224567899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=288.62 Aligned_cols=251 Identities=25% Similarity=0.398 Sum_probs=192.8
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC-hhHHHHHHHHHHH-HhhCCCCceeeeeeeeeecccceEEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVI-LSQINHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e 148 (374)
++|++.+.||+|+||.||++... +|+.||+|.+.... ......+..|+.. ++..+|||++++++++..++..++++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36888999999999999999965 58999999876532 2233455556664 666789999999999999999999999
Q ss_pred eecCCcccccccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 149 FIPNGTLFQYLHDPY-EELSLTWEMRLRIATEVAEALAYLHSS-AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
|++ ++|.+++.... ....+++..++.++.|++.||+|||++ + ++|+||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 67777765321 345789999999999999999999997 7 99999999999999999999999999876532
Q ss_pred CCceeeecccccccccCcccccc----CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccc
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFRS----SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDI 302 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (374)
. .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||..... ............ ..
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~~-~~-- 226 (283)
T cd06617 157 S--VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT-----PFQQLKQVVEEP-SP-- 226 (283)
T ss_pred c--cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc-----CHHHHHHHHhcC-CC--
Confidence 1 11233457889999998864 4468899999999999999999999863211 111111111110 00
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 303 IDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.......+..+.+++.+||..+|++|||+.++++
T Consensus 227 ------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 227 ------QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111224567899999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=287.48 Aligned_cols=257 Identities=25% Similarity=0.292 Sum_probs=198.3
Q ss_pred CCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChh-----HHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDES-----KLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
+|.+.+.||+|++|.||+|... +++.+++|.+...... ....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778899999999999999965 6889999988654322 345567899999999999999999999998899999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
|||+ +++|.+++... ...+++..+..++.|+++||+|||+++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDK--SIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 99999999753 236899999999999999999999999 99999999999999999999999999976543
Q ss_pred CCceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHh---------
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEE--------- 296 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------- 296 (374)
... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||......+ ........
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~------~~~~~~~~~~~~~~~~~ 227 (298)
T cd07841 155 PNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID------QLGKIFEALGTPTEENW 227 (298)
T ss_pred CCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH------HHHHHHHHcCCCchhhh
Confidence 221 1223346788999998854 457899999999999999999987776433211 01111100
Q ss_pred ---ccccccccccccCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 297 ---NCLFDIIDDQVRKS-----GEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 297 ---~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.............. .....+..+.+++.+||+.+|++|||+.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred hhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 00000000000001 11233568899999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=285.19 Aligned_cols=260 Identities=22% Similarity=0.312 Sum_probs=194.9
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 148 (374)
+++|.+.+.||+|+||.||+|... ++..+++|.+.... ......+.+|+.+++.++|+||+++.+++.+.+..++++|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 567999999999999999999864 58899999876532 2223456789999999999999999999999889999999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
|+. ++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 84 YMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred ccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 995 566666643 2345788889999999999999999998 9999999999999999999999999987543221
Q ss_pred ceeeecccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhc----------
Q 017262 229 THVSTKVQGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEEN---------- 297 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 297 (374)
. ......+++.|+|||.+.+. .++.++||||||+++|+|++|..||...... .+.+.+.+...
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07870 158 Q-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV-----FEQLEKIWTVLGVPTEDTWPG 231 (291)
T ss_pred C-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH-----HHHHHHHHHHcCCCChhhhhh
Confidence 1 12233468899999998754 5788999999999999999999999743321 11111111100
Q ss_pred --cccccccccccCCC---------CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 298 --CLFDIIDDQVRKSG---------EAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 298 --~~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.............. ....+..+.+++.+|+..||++|||+.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000000000 0012457889999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=290.57 Aligned_cols=266 Identities=23% Similarity=0.294 Sum_probs=196.0
Q ss_pred CCCcCceEeeeCeEEEEEEEec---CCcEEEEEEeccCC---hhHHHHHHHHHHHHhhCCCCceeeeeeeeeec--ccce
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA---DGRIIAVKKSKVVD---ESKLEEFINEVVILSQINHRNVVKLLGCCLEV--EVPL 144 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 144 (374)
+|.+.+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+.+++.++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999965 47899999887632 33446678899999999999999999999988 7889
Q ss_pred EEEEeecCCcccccccCCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECC----CCcEEEeec
Q 017262 145 LVYEFIPNGTLFQYLHDPY--EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE----KYRAKIADF 218 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~----~~~~kl~Df 218 (374)
+|+||+++ +|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 5655554321 2236899999999999999999999999 999999999999999 999999999
Q ss_pred ccccccccCCc--eeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHH---HHH
Q 017262 219 GTSRSIAIDQT--HVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTY---FVE 292 (374)
Q Consensus 219 g~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~---~~~ 292 (374)
|++........ .......+++.|+|||.+.+ ..++.++||||||+++++|++|+.||.............. ...
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99876543222 11233457889999998765 4578999999999999999999999975443321000000 000
Q ss_pred H---------------HHhccccccccccccCCCC---------H--HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 293 C---------------IEENCLFDIIDDQVRKSGE---------A--EEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 293 ~---------------~~~~~~~~~~~~~~~~~~~---------~--~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
. .+........+.......+ . ..+..+.+++.+||+.||++|||+.++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 0000000000000000011 0 23356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=283.49 Aligned_cols=242 Identities=26% Similarity=0.324 Sum_probs=196.3
Q ss_pred EeeeCeEEEEEEEec-CCcEEEEEEeccCC---hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeecCCcc
Q 017262 80 LGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTL 155 (374)
Q Consensus 80 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 155 (374)
||.|++|.||++... +++.+++|.+.... ....+.+.+|+.+++.++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999975 48899999876432 23456788999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceeeecc
Q 017262 156 FQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKV 235 (374)
Q Consensus 156 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 235 (374)
.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~ 152 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTF 152 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccc
Confidence 999974 345899999999999999999999998 9999999999999999999999999987664332 22334
Q ss_pred cccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCHHH
Q 017262 236 QGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEE 315 (374)
Q Consensus 236 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (374)
.+++.|+|||.+.+..++.++|+||||+++|+|++|..||..... +......... ........+...
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~---------~~~~~~~~~~~~ 219 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE----DPMEIYNDIL---------KGNGKLEFPNYI 219 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC----CHHHHHHHHh---------ccCCCCCCCccc
Confidence 578899999999888899999999999999999999999975432 1111111111 111122233334
Q ss_pred HHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 017262 316 IMAVSDVAKRCLNSYGRNRPT-----MKEVAM 342 (374)
Q Consensus 316 ~~~l~~li~~cl~~~p~~Rps-----~~~vl~ 342 (374)
+..+.+++.+||+.+|++||+ ++|+++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 678999999999999999999 666654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=286.39 Aligned_cols=262 Identities=23% Similarity=0.290 Sum_probs=197.2
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCCh--hHHHHHHHHHHHHhhCCCCceeeeeeeeeec--ccceEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE--SKLEEFINEVVILSQINHRNVVKLLGCCLEV--EVPLLV 146 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv 146 (374)
++|++.+.||.|+||.||+|... +++.+++|.++.... .....+.+|+.++++++||||+++++++... +..+++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999975 578899998865432 2233567899999999999999999998877 789999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
+||++ ++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 85 ~e~~~-~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99996 4888887642 336899999999999999999999999 99999999999999999999999999876543
Q ss_pred CCceeeecccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHH----------HH
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVEC----------IE 295 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~----------~~ 295 (374)
... ......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||........ ........ ..
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 159 PLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ--LNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred Ccc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCchHHHHHhh
Confidence 321 12334578899999998654 468899999999999999999999974332110 00000000 00
Q ss_pred h------ccccccccccccCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 296 E------NCLFDIIDDQVRKSGEAE-EIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 296 ~------~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
. ...............+.. .+..+.+++.+||+.+|++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 000000011111111211 3567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=309.28 Aligned_cols=268 Identities=18% Similarity=0.222 Sum_probs=187.5
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEecC--CcEEEEE------------------EeccCChhHHHHHHHHHHHHhhCCCCc
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLAD--GRIIAVK------------------KSKVVDESKLEEFINEVVILSQINHRN 129 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~e~~~l~~l~h~n 129 (374)
..++|++.+.||+|+||+||++..+. +...+.| ... ........+.+|+.++++++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 35789999999999999999987532 1111111 111 11223456789999999999999
Q ss_pred eeeeeeeeeecccceEEEEeecCCcccccccCCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEE
Q 017262 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPY--EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL 207 (374)
Q Consensus 130 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill 207 (374)
|+++++++.+.+..+++++++. ++|.+++.... .........+..++.|++.||.|||+++ |+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999999999999999999984 56666654321 1222345677889999999999999999 9999999999999
Q ss_pred CCCCcEEEeecccccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCC-CCccccccCCCh
Q 017262 208 DEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP-ISSIWANEGRNL 286 (374)
Q Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p-~~~~~~~~~~~~ 286 (374)
+.++.+||+|||++...............|++.|+|||++.+..++.++|||||||++|||++|..+ +..........+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 9999999999999987654333333445799999999999999999999999999999999998754 432211110011
Q ss_pred HHHH-----------------HHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 287 TTYF-----------------VECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 287 ~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
...+ ...+....+................+..+.+++.+||+.||++|||+.|++.
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 1100 0000000000000000000000012346778899999999999999999986
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=292.71 Aligned_cols=253 Identities=25% Similarity=0.344 Sum_probs=204.2
Q ss_pred HhhcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEec--cCChhHHHHHHHHHHHHhhCC-CCceeeeeeeeeecccceE
Q 017262 69 KATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSK--VVDESKLEEFINEVVILSQIN-HRNVVKLLGCCLEVEVPLL 145 (374)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l 145 (374)
.....|++.+.||+||.+.||++...+.+.+|+|++. ..+......|.+|+..|.+++ |.+|++++++-..++.+|+
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 4457799999999999999999999888889988654 356667788999999999994 9999999999999999999
Q ss_pred EEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccc
Q 017262 146 VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 225 (374)
||||- ..+|..+|... ....+...+..+..||+.++.++|.+| |||.||||.|+|+-. |.+||+|||+|....
T Consensus 438 vmE~G-d~DL~kiL~k~--~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKK--KSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred Eeecc-cccHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 99976 66899988763 223333478889999999999999999 999999999999865 599999999998877
Q ss_pred cCCcee-eecccccccccCccccccCC-----------CCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHH
Q 017262 226 IDQTHV-STKVQGTFGYLDPEYFRSSQ-----------FTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVEC 293 (374)
Q Consensus 226 ~~~~~~-~~~~~g~~~y~aPE~~~~~~-----------~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 293 (374)
.+.+.. ....+||+.||+||.+.... .+.++|||||||+||+|+.|+.||......
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~------------ 578 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ------------ 578 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH------------
Confidence 655443 45578999999999985433 457899999999999999999999632210
Q ss_pred HHhccccccccccccCCCCHHHH-HHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 294 IEENCLFDIIDDQVRKSGEAEEI-MAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~-~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..++..+.++....+++.--. .++.++++.||..||++|||..++++
T Consensus 579 --~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 579 --IAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred --HHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 112444555544444333211 23999999999999999999999986
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=281.13 Aligned_cols=250 Identities=28% Similarity=0.409 Sum_probs=205.6
Q ss_pred CCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC--hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
+|.+.+.||.|+||.||++... ++..+++|.+.... ......+.+|+++++.++|||++++.+.+...+..++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999965 58899999887643 35567788999999999999999999999999999999999
Q ss_pred ecCCcccccccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 150 IPNGTLFQYLHDPY-EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 150 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
+++++|.+++.... ....+++..+..++.+++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999987532 1467899999999999999999999998 9999999999999999999999999987654432
Q ss_pred ceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccccc
Q 017262 229 THVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVR 308 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (374)
.......+++.|+|||...+..++.++|+||+|+++++|++|..||.... .......... .. .
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~------~~~~~~~~~~-~~---------~ 220 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN------LLELALKILK-GQ---------Y 220 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc------HHHHHHHHhc-CC---------C
Confidence 22334468889999999988889999999999999999999999986432 1222221111 11 1
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 309 KSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 309 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
...+...+..+.+++.+||..+|++|||+.++++
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1122244567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=282.05 Aligned_cols=248 Identities=25% Similarity=0.364 Sum_probs=203.3
Q ss_pred CCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
+|++.+.||.|+||.||++... +++.+++|.+... .......+.+|+++++.++|+||+++.+++.+....++++||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999854 6788999987653 334456778899999999999999999999999999999999
Q ss_pred ecCCcccccccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 150 IPNGTLFQYLHDPY-EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 150 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
+++++|.+++.... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999886421 2356899999999999999999999999 999999999999999999999999998766443
Q ss_pred ceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccccc
Q 017262 229 THVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVR 308 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (374)
......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...... . +...... ...
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------~-~~~~~~~---------~~~ 218 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ------D-LRYKVQR---------GKY 218 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------H-HHHHHhc---------CCC
Confidence 222345788999999999888999999999999999999999999643321 1 1111111 111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 309 KSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 309 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
...+...+..+.+++.+|++.+|++|||+.++++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1223355678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=285.21 Aligned_cols=259 Identities=21% Similarity=0.319 Sum_probs=198.7
Q ss_pred CCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEee
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFI 150 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 150 (374)
+|++.+.||.|++|.||+|... +|..+++|.+.... ......+.+|+.++++++||||+++++++.+.+..++|+||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788899999999999999975 58899999877543 233456778999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 230 (374)
++ +|.+++........+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 75 78888765433456899999999999999999999998 99999999999999999999999999875432211
Q ss_pred eeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhc------------
Q 017262 231 VSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEEN------------ 297 (374)
Q Consensus 231 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------ 297 (374)
......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||......+ ......+..
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED------QLLKIFRIMGTPTESTWPGIS 229 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH------HHHHHHHHhCCCChhhHHHHh
Confidence 1223446889999998865 457889999999999999999999997543211 111111000
Q ss_pred ccccccccc------ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 298 CLFDIIDDQ------VRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 298 ~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
......... ......+..+..+.+++.+|++.||.+||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000000 000111234567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=288.75 Aligned_cols=253 Identities=28% Similarity=0.410 Sum_probs=199.5
Q ss_pred CCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEE
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 148 (374)
.|...+.||+|+||.||++... ++..+++|.+... .......+.+|+.+++.++|||++++++++.+++..++++|
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 4777889999999999999964 6889999987643 23345678899999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
|+++ +|.+.+.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 106 ~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 106 YCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP-- 177 (317)
T ss_pred CCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence 9965 66666643 2456899999999999999999999999 99999999999999999999999998865432
Q ss_pred ceeeecccccccccCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccc
Q 017262 229 THVSTKVQGTFGYLDPEYFR---SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDD 305 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (374)
.....+++.|+|||.+. ...++.++||||||+++|+|++|..||...... ........ .
T Consensus 178 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~---------~ 239 (317)
T cd06635 178 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQ---------N 239 (317)
T ss_pred ---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHHh---------c
Confidence 12335788999999974 456889999999999999999999998642111 11111111 1
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhC
Q 017262 306 QVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANS 351 (374)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~ 351 (374)
..........+..+.+++.+||+.+|.+||++.++++.........
T Consensus 240 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 240 ESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred cCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 1111122344567899999999999999999999998765554443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=278.77 Aligned_cols=250 Identities=29% Similarity=0.454 Sum_probs=205.6
Q ss_pred CCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC--hhHHHHHHHHHHHHhhCCCCceeeeeeeeeec--ccceEEE
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQINHRNVVKLLGCCLEV--EVPLLVY 147 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 147 (374)
+|...+.||+|++|.||+|... +++.+++|...... ......+.+|+..+++++||||+++++.+.+. +..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677899999999999999976 68899999876544 25567889999999999999999999999988 7899999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 99999999999874 338899999999999999999999998 999999999999999999999999998776543
Q ss_pred Cce-eeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 228 QTH-VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 228 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
... ......++..|+|||.+.....+.++||||||+++++|++|..||.... ........ .....
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~---------~~~~~ 220 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYK---------IGSSG 220 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHh---------ccccC
Confidence 321 1233458889999999988889999999999999999999999997533 11111111 11111
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 307 VRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.....+...+..+.+++.+|+..+|++||++.+++.
T Consensus 221 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 221 EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 122233444678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=279.41 Aligned_cols=247 Identities=26% Similarity=0.435 Sum_probs=203.4
Q ss_pred CCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCCh--hHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE--SKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
+|++.+.||+|++|.||++... +++.+++|....... .....+.+|++++++++|||++++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999865 578899998876543 4567889999999999999999999999998999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+++++|.+++.. ...+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 999999999874 357899999999999999999999998 99999999999999999999999999987654332
Q ss_pred eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccC
Q 017262 230 HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (374)
. .....++..|+|||...+..++.++|+|+||+++|+|++|..||..... ...... . .. ....
T Consensus 155 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~~~~~~-~-~~---------~~~~ 217 (254)
T cd06627 155 D-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----MAALFR-I-VQ---------DDHP 217 (254)
T ss_pred c-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHH-H-hc---------cCCC
Confidence 2 2334578899999999887789999999999999999999999864321 111111 0 00 0111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 310 SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 310 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..+...+..+.+++.+||..+|++|||+.+++.
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 222334568889999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=285.62 Aligned_cols=257 Identities=25% Similarity=0.345 Sum_probs=197.3
Q ss_pred CCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC--hhHHHHHHHHHHHHhhCCCCceeeeeeeeeec--ccceEEEE
Q 017262 74 FNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQINHRNVVKLLGCCLEV--EVPLLVYE 148 (374)
Q Consensus 74 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 148 (374)
|++.+.||.|++|.||+|... +++.+++|.+.... ......+.+|+.+++.++|||++++++++... +..++++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999976 47899999887652 34456788999999999999999999999887 78999999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
|+++ +|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9974 888887642 257899999999999999999999998 9999999999999999999999999998765433
Q ss_pred ceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHh------ccccc
Q 017262 229 THVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEE------NCLFD 301 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~ 301 (374)
........++..|+|||.+.+ ..++.++||||||+++|+|++|..||....... ......+. .....
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE------QLEKIFELCGSPTDENWPG 228 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHHHhCCCchhhccc
Confidence 222333456788999998764 457899999999999999999999996433211 11111110 00000
Q ss_pred c--------------ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 302 I--------------IDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 302 ~--------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
. .............+..+.+++.+||+.+|.+||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 0000000001112567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=284.17 Aligned_cols=245 Identities=27% Similarity=0.375 Sum_probs=196.4
Q ss_pred EeeeCeEEEEEEEecC-CcEEEEEEeccCCh---hHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeecCCcc
Q 017262 80 LGQGGQGTVYKGMLAD-GRIIAVKKSKVVDE---SKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTL 155 (374)
Q Consensus 80 lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 155 (374)
||.|+||.||++...+ ++.+++|.+..... .....+.+|+.++++++||||+++++.+...+..++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 5899999999999764 89999998765433 4556788999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc------
Q 017262 156 FQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT------ 229 (374)
Q Consensus 156 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~------ 229 (374)
.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 999874 347899999999999999999999999 99999999999999999999999999876443211
Q ss_pred -eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccccc
Q 017262 230 -HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVR 308 (374)
Q Consensus 230 -~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (374)
.......++..|+|||.......+.++|+||||+++|++++|..||..... ...+..... ... .
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~-~~~--------~ 219 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP------EEIFQNILN-GKI--------E 219 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhc-CCc--------C
Confidence 122334578899999999888889999999999999999999999964321 121211111 110 1
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017262 309 KSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345 (374)
Q Consensus 309 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~ 345 (374)
.......+..+.+++.+|++.+|++|||+.++.+.|+
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 220 WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 1111113568899999999999999999966665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=280.31 Aligned_cols=249 Identities=27% Similarity=0.404 Sum_probs=198.5
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC-----ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeec--ccc
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-----DESKLEEFINEVVILSQINHRNVVKLLGCCLEV--EVP 143 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 143 (374)
.+|.+.+.||+|+||.||+|... ++..+++|.+... .......+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46889999999999999999964 5889999976432 233456788999999999999999999998764 357
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccc
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 223 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 223 (374)
++++||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999998863 346889999999999999999999999 99999999999999999999999999876
Q ss_pred cccCC--ceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccc
Q 017262 224 IAIDQ--THVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFD 301 (374)
Q Consensus 224 ~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (374)
..... ........++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... ... +.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~-~~~--------- 220 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA-----MAA-IFK--------- 220 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH-----HHH-HHH---------
Confidence 53211 1111234588899999999988889999999999999999999999964321 111 111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 302 IIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 302 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..........+...+..+.+++.+|+. +|..|||+.+++.
T Consensus 221 ~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 221 IATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 111111223445566789999999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=289.86 Aligned_cols=263 Identities=21% Similarity=0.311 Sum_probs=197.6
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEecc--CChhHHHHHHHHHHHHhhCCCCceeeeeeeeeec------
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV--VDESKLEEFINEVVILSQINHRNVVKLLGCCLEV------ 140 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 140 (374)
..++|++.+.||+|+||.||+|... +++.+|+|.+.. ........+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999964 688999998753 2334456777899999999999999999988643
Q ss_pred ccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccc
Q 017262 141 EVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGT 220 (374)
Q Consensus 141 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 220 (374)
...++|+||+. ++|.+.+.. .+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 24689999995 577777652 2888899999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccC---------CChHHHHH
Q 017262 221 SRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEG---------RNLTTYFV 291 (374)
Q Consensus 221 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~---------~~~~~~~~ 291 (374)
+...... .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||........ .....+..
T Consensus 165 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 165 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred ceeCCCC--CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 9765322 122334578899999999999999999999999999999999999974321100 00000000
Q ss_pred -------HHHHhcc------ccccccccc----cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 292 -------ECIEENC------LFDIIDDQV----RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 292 -------~~~~~~~------~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
....... +........ ....+...+..+.+++.+||+.||++|||+.+++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 000000000 001122345678899999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=295.46 Aligned_cols=271 Identities=21% Similarity=0.282 Sum_probs=202.6
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc-----c
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVE-----V 142 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~ 142 (374)
.++|.+.+.||+|+||+||+|... ++..+++|.+... .......+.+|+.+++.++|+||+++++++.... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457899999999999999999964 5889999987642 2333456778999999999999999999886442 4
Q ss_pred ceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccc
Q 017262 143 PLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 222 (374)
Q Consensus 143 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 222 (374)
.++++||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999995 688888763 457999999999999999999999999 9999999999999999999999999987
Q ss_pred ccccCCceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHH------
Q 017262 223 SIAIDQTHVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIE------ 295 (374)
Q Consensus 223 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------ 295 (374)
...... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||....... ..........
T Consensus 157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~ 232 (337)
T cd07858 157 TTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH---QLKLITELLGSPSEED 232 (337)
T ss_pred ccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCChHH
Confidence 654322 22233457889999998865 468899999999999999999999996432110 0000000000
Q ss_pred -----hccccccc-------cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHHhhCCC
Q 017262 296 -----ENCLFDII-------DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME--LERIRANSRD 353 (374)
Q Consensus 296 -----~~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~--L~~~~~~~~~ 353 (374)
.......+ .... ....+..+..+.+++.+||+.+|++|||++++++. ++.+......
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~ 303 (337)
T cd07858 233 LGFIRNEKARRYIRSLPYTPRQSF-ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDE 303 (337)
T ss_pred hhhcCchhhhHHHHhcCcccccCH-HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccC
Confidence 00000000 0000 00112345678999999999999999999999976 6665544433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=283.98 Aligned_cols=257 Identities=25% Similarity=0.336 Sum_probs=195.5
Q ss_pred CCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC--hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEee
Q 017262 74 FNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFI 150 (374)
Q Consensus 74 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 150 (374)
|++.+.||.|++|.||+|... +|..+++|++.... ......+.+|++.++.++|||++++++++.+.+..++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 577889999999999999864 68999999876543 223356788999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 230 (374)
+ ++|.+++.... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 4 68988886432 246899999999999999999999998 99999999999999999999999999875432211
Q ss_pred eeecccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHh-cc----------
Q 017262 231 VSTKVQGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEE-NC---------- 298 (374)
Q Consensus 231 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~---------- 298 (374)
......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||....... .... ..+. ..
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~~~~-~~~~~~~~~~~~~~~~~ 228 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-----QLFR-IFRTLGTPDEDVWPGVT 228 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHH-HHHHhCCCChHHhhhhh
Confidence 11223468899999987654 57889999999999999999999996433211 1000 0000 00
Q ss_pred -ccccccc------cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 299 -LFDIIDD------QVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 299 -~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
....... ..........+..+.+++.+|++.+|++|||++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 229 SLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000 0000111223467889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=283.98 Aligned_cols=259 Identities=20% Similarity=0.261 Sum_probs=191.7
Q ss_pred CCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC-hhHHHHHHHHHHHHhhCC-CCceeeeeeeeeec--ccceEEEE
Q 017262 74 FNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQIN-HRNVVKLLGCCLEV--EVPLLVYE 148 (374)
Q Consensus 74 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e 148 (374)
|++.+.||+|+||.||+|... +++.+++|...... ........+|+..++++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567889999999999999954 68899999876532 222234457888999885 99999999999987 78899999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
|++ ++|.+++.. ....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++. +.+||+|||++.......
T Consensus 81 ~~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 996 577777764 2346899999999999999999999999 999999999999999 999999999997654322
Q ss_pred ceeeecccccccccCccccc-cCCCCccchhhhHHHHHHHHHhCCCCCCccccccC---------CChHHHHHHHHHhcc
Q 017262 229 THVSTKVQGTFGYLDPEYFR-SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEG---------RNLTTYFVECIEENC 298 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~---------~~~~~~~~~~~~~~~ 298 (374)
. .....+++.|+|||.+. +..++.++|||||||++|+|++|..||......+. .....+ ........
T Consensus 154 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 230 (282)
T cd07831 154 P--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV-LKKFRKSR 230 (282)
T ss_pred C--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHH-HHhhcccc
Confidence 1 12345788999999764 45578899999999999999999999975432110 000111 00000000
Q ss_pred cccccccccc----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 299 LFDIIDDQVR----KSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 299 ~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
......+... .......+..+.+++.+||+.+|++|||+++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0000000000 0011234678999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=296.69 Aligned_cols=273 Identities=27% Similarity=0.396 Sum_probs=210.3
Q ss_pred CCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeec------ccce
Q 017262 73 YFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEV------EVPL 144 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~ 144 (374)
.|...+.||+|+||.||+|++ ..|+.||||..... .....+.+.+|+++|++++|+|||+++++-.+. +...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 455667899999999999995 56999999987653 344567788999999999999999999886543 3568
Q ss_pred EEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEEC--CCC--cEEEeeccc
Q 017262 145 LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD--EKY--RAKIADFGT 220 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~--~~~--~~kl~Dfg~ 220 (374)
++||||.+|+|...+.++.+...+++.+.+.+...++.||.|||+++ |+||||||.||++- .+| ..||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999999988899999999999999999999999999 99999999999983 334 479999999
Q ss_pred ccccccCCceeeecccccccccCccccc-cCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccc
Q 017262 221 SRSIAIDQTHVSTKVQGTFGYLDPEYFR-SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCL 299 (374)
Q Consensus 221 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (374)
|+.+.++. ......||+.|.+||... ...|+..+|.|||||++|++.||..||.............|..........
T Consensus 171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v 248 (732)
T KOG4250|consen 171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV 248 (732)
T ss_pred cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence 99876433 667788999999999998 488999999999999999999999999866554321112222211111111
Q ss_pred ccccccccc--------CCCC----HHHHHHHHHHHHHhcccCCCCCC--CHHHHHHHHHHHHhh
Q 017262 300 FDIIDDQVR--------KSGE----AEEIMAVSDVAKRCLNSYGRNRP--TMKEVAMELERIRAN 350 (374)
Q Consensus 300 ~~~~~~~~~--------~~~~----~~~~~~l~~li~~cl~~~p~~Rp--s~~~vl~~L~~~~~~ 350 (374)
......... .+++ ......+-..+..+|..+|.+|. ...+....+..+...
T Consensus 249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 111111111 1112 22334566778888999999998 777777777766553
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=324.81 Aligned_cols=253 Identities=25% Similarity=0.370 Sum_probs=207.1
Q ss_pred HhhcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEecc--CChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceE
Q 017262 69 KATDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKV--VDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLL 145 (374)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 145 (374)
..+-+|.-...||.|.||.||.|.. .+|...|+|-+.. ........+.+|..++..++|||+|+++|+-.+.+..++
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 3455777788999999999999995 5688889995543 333445667899999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccc
Q 017262 146 VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 225 (374)
.||||++|+|.+.+. .++..++.....+..|++.|++|||++| |+||||||.||+++.+|.+|++|||.|..+.
T Consensus 1312 FMEyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEec
Confidence 999999999999987 4555677777889999999999999999 9999999999999999999999999998776
Q ss_pred cCCce---eeecccccccccCccccccCC---CCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccc
Q 017262 226 IDQTH---VSTKVQGTFGYLDPEYFRSSQ---FTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCL 299 (374)
Q Consensus 226 ~~~~~---~~~~~~g~~~y~aPE~~~~~~---~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (374)
..... ......||+.|||||++.+.. ...++|||||||++.||+||+.||.....+.. +
T Consensus 1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a---------------I 1450 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA---------------I 1450 (1509)
T ss_pred CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH---------------H
Confidence 44212 223467999999999997543 56689999999999999999999986543321 2
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 300 FDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..-+...-.+..|...+.+=.+++.+||..||+.|.++.++++
T Consensus 1451 My~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1451 MYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred HhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 2223333344556667888899999999999999988886654
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=284.56 Aligned_cols=253 Identities=25% Similarity=0.349 Sum_probs=193.9
Q ss_pred CCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC-hhHHHHHHHHHHHHhhCC-CCceeeeeeeeeecccceEEEEe
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQIN-HRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
+|...+.||+|+||.||++... +++.+++|.+.... ......+.+|+..+.++. |+||+++++++......++++||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556678999999999999965 57899999876532 344567889999999996 99999999999988899999999
Q ss_pred ecCCcccccc---cCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCEEEeccCCCceEECCCCcEEEeecccccccc
Q 017262 150 IPNGTLFQYL---HDPYEELSLTWEMRLRIATEVAEALAYLHSS-AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 150 ~~~g~L~~~l---~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 225 (374)
+.. ++.++. ... ....+++..+..++.|++.||+|||+. + ++||||||+||+++.++.++|+|||++....
T Consensus 85 ~~~-~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 85 MDI-SLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ccC-CHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 854 444432 211 235789999999999999999999975 6 9999999999999999999999999987654
Q ss_pred cCCceeeecccccccccCccccccC---CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccc
Q 017262 226 IDQTHVSTKVQGTFGYLDPEYFRSS---QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDI 302 (374)
Q Consensus 226 ~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (374)
.... .....++..|+|||.+.+. .++.++||||||+++|+|++|+.||.... .......+... .
T Consensus 160 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~------~ 226 (288)
T cd06616 160 DSIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVK------G 226 (288)
T ss_pred cCCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcC------C
Confidence 3221 1233578899999998766 68899999999999999999999996432 11111111110 0
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 303 IDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
..+..........+..+.+|+.+||+.+|++|||+++++..
T Consensus 227 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 227 DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111222223456689999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=283.45 Aligned_cols=258 Identities=18% Similarity=0.247 Sum_probs=183.1
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecCC----cEEEEEEeccCChhHH-----------HHHHHHHHHHhhCCCCceeeeee
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLADG----RIIAVKKSKVVDESKL-----------EEFINEVVILSQINHRNVVKLLG 135 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~~----~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~~~~ 135 (374)
.++|.+.+.||+|+||.||+|...++ ..+++|.......... .....+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 46899999999999999999996543 4556665433221110 11223444566678999999999
Q ss_pred eeeecc----cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCC
Q 017262 136 CCLEVE----VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY 211 (374)
Q Consensus 136 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~ 211 (374)
++.... ..+++++++. .++.+.+.. ....++..+..++.|++.||+|||+.+ ++||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 876543 2356777663 355555542 234578889999999999999999998 99999999999999999
Q ss_pred cEEEeecccccccccCCce------eeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCC
Q 017262 212 RAKIADFGTSRSIAIDQTH------VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRN 285 (374)
Q Consensus 212 ~~kl~Dfg~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~ 285 (374)
.++|+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++|..||........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~-- 241 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN-- 241 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH--
Confidence 9999999999765432211 11224589999999999999999999999999999999999999975432110
Q ss_pred hHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 017262 286 LTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMEL 344 (374)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L 344 (374)
....... +....+..... .....+..+.+++..|++.+|++||++.++.+.|
T Consensus 242 ~~~~~~~----~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 242 LIHAAKC----DFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHhHH----HHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 0000000 00000111111 1112356789999999999999999999999876
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=288.91 Aligned_cols=259 Identities=24% Similarity=0.295 Sum_probs=195.1
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCCh--hHHHHHHHHHHHHhhCCCCceeeeeeeeeec--ccceE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE--SKLEEFINEVVILSQINHRNVVKLLGCCLEV--EVPLL 145 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 145 (374)
.++|++.+.||+|+||.||+|... +|+.||+|.+..... .....+.+|+.++++++|+|++++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467899999999999999999965 588999998764322 2223456799999999999999999998755 46799
Q ss_pred EEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccc
Q 017262 146 VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 225 (374)
|+||+++ +|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999964 787777642 356899999999999999999999999 9999999999999999999999999997654
Q ss_pred cCCceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhc-----cc
Q 017262 226 IDQTHVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEEN-----CL 299 (374)
Q Consensus 226 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~ 299 (374)
... .......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||......+ .+......- ..
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~------~~~~~~~~~~~~~~~~ 232 (309)
T cd07845 160 LPA-KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE------QLDLIIQLLGTPNESI 232 (309)
T ss_pred Ccc-CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHHhcCCCChhh
Confidence 322 11223345788999999865 557899999999999999999999997543211 111111100 00
Q ss_pred c---------ccccccccC-C----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 300 F---------DIIDDQVRK-S----GEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 300 ~---------~~~~~~~~~-~----~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
. ......... . .....+..+.++|.+||+.||++|||+++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 233 WPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred chhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 000000000 0 00113567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=282.69 Aligned_cols=244 Identities=23% Similarity=0.292 Sum_probs=192.1
Q ss_pred EeeeCeEEEEEEEec-CCcEEEEEEeccCC---hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeecCCcc
Q 017262 80 LGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTL 155 (374)
Q Consensus 80 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 155 (374)
||+|+||+||++... +|+.+++|.+.... ......+..|++++++++|||++++++++...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999854 58899999875422 22344567899999999999999999999998999999999999999
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceeeecc
Q 017262 156 FQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKV 235 (374)
Q Consensus 156 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 235 (374)
.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+..... .......
T Consensus 81 ~~~l~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~ 154 (277)
T cd05577 81 KYHIYNV-GEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG--GKKIKGR 154 (277)
T ss_pred HHHHHHc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhcc--CCccccc
Confidence 9998743 2246899999999999999999999999 99999999999999999999999999876532 1122234
Q ss_pred cccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCHHH
Q 017262 236 QGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEE 315 (374)
Q Consensus 236 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (374)
.++..|+|||.+.+..++.++|+||||+++|+|++|+.||........ .... ..... ......+...
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~----~~~~~------~~~~~~~~~~ 221 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE---KEEL----KRRTL------EMAVEYPDKF 221 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc---HHHH----Hhccc------cccccCCccC
Confidence 578899999999888899999999999999999999999965432110 0000 00000 0111222334
Q ss_pred HHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 017262 316 IMAVSDVAKRCLNSYGRNRP-----TMKEVAM 342 (374)
Q Consensus 316 ~~~l~~li~~cl~~~p~~Rp-----s~~~vl~ 342 (374)
+..+.+++.+||+.+|++|| ++.+++.
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 66789999999999999999 5555653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=284.90 Aligned_cols=243 Identities=26% Similarity=0.396 Sum_probs=196.8
Q ss_pred ceEeeeCeEEEEEEEe-cCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeecCCccc
Q 017262 78 RILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLF 156 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~ 156 (374)
..||+|+||.||++.. .++..+++|++..........+.+|+.+++.++|+|++++++++...+..+++|||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5799999999999986 468899999887655556677889999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceeeeccc
Q 017262 157 QYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQ 236 (374)
Q Consensus 157 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 236 (374)
+++. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......
T Consensus 106 ~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~ 177 (292)
T cd06657 106 DIVT----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLV 177 (292)
T ss_pred HHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccccc
Confidence 8875 335789999999999999999999998 9999999999999999999999999886543222 1123345
Q ss_pred ccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCHHHH
Q 017262 237 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEI 316 (374)
Q Consensus 237 g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (374)
+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...... ..... .... .. ... ......+
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~------~~~~~-~~~~-~~----~~~--~~~~~~~ 243 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------KAMKM-IRDN-LP----PKL--KNLHKVS 243 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-HHhh-CC----ccc--CCcccCC
Confidence 788999999998888899999999999999999999998642211 11111 1100 00 000 0112334
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 317 MAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 317 ~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..+.+++.+||..+|.+||++.+++.
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 57889999999999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=290.72 Aligned_cols=265 Identities=20% Similarity=0.301 Sum_probs=197.9
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC--hhHHHHHHHHHHHHhhCCCCceeeeeeeeee----cccc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQINHRNVVKLLGCCLE----VEVP 143 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~ 143 (374)
.++|++.+.||.|++|.||+|... ++..+++|++.... ......+.+|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478999999999999999999964 58899999876532 2345667789999999999999999998763 3467
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccc
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 223 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 223 (374)
++|+||+. ++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 89999995 688888863 446899999999999999999999998 99999999999999999999999999876
Q ss_pred cccCCce---eeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccC---------CChHHHH
Q 017262 224 IAIDQTH---VSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEG---------RNLTTYF 290 (374)
Q Consensus 224 ~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~---------~~~~~~~ 290 (374)
....... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 5432211 1223468889999999865 4588999999999999999999999964321100 0000000
Q ss_pred HHHHHhccccccccccc-cCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 291 VECIEENCLFDIIDDQV-RKSG-----EAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 291 ~~~~~~~~~~~~~~~~~-~~~~-----~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
............+... .... ....+..+.+++.+||+.+|++|||+.+++..
T Consensus 237 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 237 -NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred -hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000000000000 0001 12346789999999999999999999998873
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=282.04 Aligned_cols=260 Identities=21% Similarity=0.285 Sum_probs=193.7
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC--hhHHHHHHHHHHHHhhCC-CCceeeeeeeeeeccc-----
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQIN-HRNVVKLLGCCLEVEV----- 142 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~----- 142 (374)
++|++.+.||+|+||.||+|... +++.+++|...... ......+.+|+.+++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999965 58899999866532 223356788999999995 6999999999887665
Q ss_pred ceEEEEeecCCcccccccCCCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECC-CCcEEEeecc
Q 017262 143 PLLVYEFIPNGTLFQYLHDPYE--ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE-KYRAKIADFG 219 (374)
Q Consensus 143 ~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg 219 (374)
.+++|||+++ +|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999975 78887754321 346899999999999999999999999 999999999999998 8899999999
Q ss_pred cccccccCCceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHh-c
Q 017262 220 TSRSIAIDQTHVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEE-N 297 (374)
Q Consensus 220 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~ 297 (374)
++........ ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...... .... ..... .
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-----~~~~-~~~~~~~ 229 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL-----QQLL-HIFKLLG 229 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH-----HHHH-HHHHHhC
Confidence 9875532211 1122346788999998865 45789999999999999999999999743221 1111 00000 0
Q ss_pred c-----cccccc-------cccc----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 298 C-----LFDIID-------DQVR----KSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 298 ~-----~~~~~~-------~~~~----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
. ...... +... ....+..+..+.++|.+||..||++|||+.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 230 TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 000000 0000 0011234567899999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=290.76 Aligned_cols=253 Identities=26% Similarity=0.367 Sum_probs=210.8
Q ss_pred HHhhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccce
Q 017262 68 DKATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPL 144 (374)
Q Consensus 68 ~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 144 (374)
..-...|.+.+.||+|.|+.|.+|.+. .+..||+|.+... +....+.+.+|+++|+.++||||++++.+......+|
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 344678999999999999999999954 5889999987654 3344466889999999999999999999999999999
Q ss_pred EEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccc
Q 017262 145 LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 224 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 224 (374)
+||||+.+|.+.+|+. ..+.+.+..+..++.|+.+|++|||+++ |+|||||++|+|++.+.++||+|||++..+
T Consensus 132 lV~eya~~ge~~~yl~---~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLV---KHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFF 205 (596)
T ss_pred EEEEeccCchhHHHHH---hcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceee
Confidence 9999999999999998 4556777899999999999999999999 999999999999999999999999999877
Q ss_pred ccCCceeeecccccccccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccc
Q 017262 225 AIDQTHVSTKVQGTFGYLDPEYFRSSQF-TDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDII 303 (374)
Q Consensus 225 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (374)
. .........|++.|.|||++.+..| .+.+|+||+|+++|-|++|.+||.+....+.+ ...+
T Consensus 206 ~--~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr---------------~rvl 268 (596)
T KOG0586|consen 206 D--YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR---------------PRVL 268 (596)
T ss_pred c--ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc---------------chhe
Confidence 5 3444566789999999999998776 57899999999999999999999754433321 1112
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017262 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345 (374)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~ 345 (374)
-...+. +.-.+..+.+||+++|..+|.+|++++++.+--.
T Consensus 269 ~gk~rI--p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W 308 (596)
T KOG0586|consen 269 RGKYRI--PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW 308 (596)
T ss_pred eeeecc--cceeechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence 222222 2223346789999999999999999999987433
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=281.90 Aligned_cols=241 Identities=23% Similarity=0.293 Sum_probs=186.1
Q ss_pred eEeeeCeEEEEEEEec-CCcEEEEEEeccCC---hhHHHHHHHHHHHHh---hCCCCceeeeeeeeeecccceEEEEeec
Q 017262 79 ILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILS---QINHRNVVKLLGCCLEVEVPLLVYEFIP 151 (374)
Q Consensus 79 ~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~---~l~h~niv~~~~~~~~~~~~~lv~e~~~ 151 (374)
.||+|+||.||++... +++.+|+|.+.... ......+.+|..+++ ..+|||++.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 58899999775421 112223344444443 3479999999999998889999999999
Q ss_pred CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCcee
Q 017262 152 NGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV 231 (374)
Q Consensus 152 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 231 (374)
+++|.+++. ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLS---QHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 999999887 3456999999999999999999999999 9999999999999999999999999986543221
Q ss_pred eecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCC
Q 017262 232 STKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKS 310 (374)
Q Consensus 232 ~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (374)
.....|++.|+|||.+.+ ..++.++||||+|+++|+|++|..||....... . ....... ......
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~-~~~~~~~----------~~~~~~ 217 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---K-HEIDRMT----------LTVNVE 217 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC---H-HHHHHHh----------hcCCcC
Confidence 123458999999999864 558899999999999999999999997433211 1 1111110 011122
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 017262 311 GEAEEIMAVSDVAKRCLNSYGRNRP-----TMKEVAM 342 (374)
Q Consensus 311 ~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~vl~ 342 (374)
.+...+..+.+++.+||..||++|| |++++++
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 3334566889999999999999999 5888766
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=279.38 Aligned_cols=256 Identities=24% Similarity=0.332 Sum_probs=198.8
Q ss_pred CCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCCh--hHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEee
Q 017262 74 FNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE--SKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFI 150 (374)
Q Consensus 74 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 150 (374)
|.+.+.||+|++|.||++... +++.+++|.+..... .....+..|+.++++++|+||+++++++.+.+..++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999964 688899998765432 34567888999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 230 (374)
++ +|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 81 ~~-~l~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~ 153 (283)
T cd05118 81 DT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-R 153 (283)
T ss_pred CC-CHHHHHHh--hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-c
Confidence 65 78777764 2357899999999999999999999999 9999999999999999999999999987665433 1
Q ss_pred eeecccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHh-c-----cccccc
Q 017262 231 VSTKVQGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEE-N-----CLFDII 303 (374)
Q Consensus 231 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~-----~~~~~~ 303 (374)
......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+ . +....+. + ......
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-----~-~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID-----Q-LFKIFRTLGTPDPEVWPKFT 227 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-----H-HHHHHHHcCCCchHhcccch
Confidence 22334578889999998776 78999999999999999999999996543211 0 0000000 0 000000
Q ss_pred c-----------c--cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 304 D-----------D--QVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 304 ~-----------~--~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
+ . ..........+..+.++|.+||+.+|.+||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 228 SLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0 0 0000112245678999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=288.50 Aligned_cols=273 Identities=21% Similarity=0.292 Sum_probs=200.1
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc-----cc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVE-----VP 143 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~ 143 (374)
+++|++.+.||+|+||.||+|.. .+|+.||+|.+.... ......+.+|+.++++++||||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 56899999999999999999985 468899999886432 334466788999999999999999999876443 46
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccc
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 223 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 223 (374)
++++||+++ +|.+.+. ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 899999964 7777664 346899999999999999999999999 99999999999999999999999999876
Q ss_pred cccCCce--eeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccC---------CChHHHHH
Q 017262 224 IAIDQTH--VSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEG---------RNLTTYFV 291 (374)
Q Consensus 224 ~~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~---------~~~~~~~~ 291 (374)
....... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ....+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN 235 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 5432211 1123457899999998754 5688999999999999999999999964321100 00000000
Q ss_pred HHHHhccccccccc-cccCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHHhhCC
Q 017262 292 ECIEENCLFDIIDD-QVRKS-----GEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME--LERIRANSR 352 (374)
Q Consensus 292 ~~~~~~~~~~~~~~-~~~~~-----~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~--L~~~~~~~~ 352 (374)
..... ........ ..... ..+..+..+.+++.+||+.+|++|||+.++++. ++.......
T Consensus 236 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~ 303 (336)
T cd07849 236 CIISL-RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSD 303 (336)
T ss_pred Hhhch-hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCC
Confidence 00000 00000000 00000 011235678999999999999999999999986 666655433
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=283.14 Aligned_cols=248 Identities=28% Similarity=0.405 Sum_probs=202.1
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCC-CCceeeeeeeeeecccceEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQIN-HRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv 146 (374)
++|.+.+.||+|+||.||++... +++.+++|..... .......+..|+.++++++ ||||+++++++.+.+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888999999999999999965 6889999987542 2334467888999999998 99999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
||++++++|.+++.. ...+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999999974 447999999999999999999999999 99999999999999999999999999876543
Q ss_pred CCc-------------------eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChH
Q 017262 227 DQT-------------------HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLT 287 (374)
Q Consensus 227 ~~~-------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~ 287 (374)
... .......++..|+|||......++.++|+||||++++++++|..||..... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~ 228 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE------Y 228 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH------H
Confidence 221 112234578899999999888899999999999999999999999975431 1
Q ss_pred HHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 017262 288 TYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTM----KEVAM 342 (374)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~----~~vl~ 342 (374)
..+.... ......+...+..+.+++.+||+.+|++|||+ ++++.
T Consensus 229 ~~~~~~~-----------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 229 LTFQKIL-----------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHHHH-----------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 1111111 11112233446678999999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=280.68 Aligned_cols=258 Identities=23% Similarity=0.277 Sum_probs=202.1
Q ss_pred CCCcCceEeeeCeEEEEEEEe----cCCcEEEEEEeccCC----hhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccc
Q 017262 73 YFNMNRILGQGGQGTVYKGML----ADGRIIAVKKSKVVD----ESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVP 143 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 143 (374)
+|++.+.||+|++|.||++.. .++..+++|.+.... ......+.+|+.++.++ +||||+++++++......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999884 246789999876422 22345677899999999 599999999999988899
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccc
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 223 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 223 (374)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999998863 456889999999999999999999998 99999999999999999999999999876
Q ss_pred cccCCceeeecccccccccCccccccCC--CCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccc
Q 017262 224 IAIDQTHVSTKVQGTFGYLDPEYFRSSQ--FTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFD 301 (374)
Q Consensus 224 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (374)
.............++..|+|||.+.+.. .+.++|+||||+++|+|++|..||...... .............
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~----- 227 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ--NSQSEISRRILKS----- 227 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc--chHHHHHHHHHcc-----
Confidence 5443332233345788999999987654 788999999999999999999999632211 1111111111100
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 017262 302 IIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRA 349 (374)
Q Consensus 302 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~ 349 (374)
....+...+..+.+++.+||+.+|++|||+.++.+.|+...-
T Consensus 228 ------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~ 269 (288)
T cd05583 228 ------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269 (288)
T ss_pred ------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCccc
Confidence 011222344578899999999999999999988887766543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=285.09 Aligned_cols=264 Identities=27% Similarity=0.373 Sum_probs=196.0
Q ss_pred HhhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC--hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc----
Q 017262 69 KATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQINHRNVVKLLGCCLEVE---- 141 (374)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---- 141 (374)
...++|++.+.||.|+||.||+|... +++.+++|.+.... ......+.+|+.++++++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34567899999999999999999975 57899999876532 223356678999999999999999999987654
Q ss_pred ------cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEE
Q 017262 142 ------VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKI 215 (374)
Q Consensus 142 ------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl 215 (374)
..++++||+++ ++..++.. ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999976 66666654 2346899999999999999999999998 999999999999999999999
Q ss_pred eecccccccccCCceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHH
Q 017262 216 ADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECI 294 (374)
Q Consensus 216 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 294 (374)
+|||++...............++..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... .+. .+....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~--~~~-~~~~~~ 234 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA--QLE-LISRLC 234 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--HHH-HHHHHh
Confidence 9999987654333222222345778999998864 457889999999999999999999996432110 000 011100
Q ss_pred Hhcc---cccc--------ccc------cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 295 EENC---LFDI--------IDD------QVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 295 ~~~~---~~~~--------~~~------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.... .... .+. .... .....+..+.+++.+||+.+|++|||++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 0000 000 0000 01123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=276.51 Aligned_cols=244 Identities=25% Similarity=0.262 Sum_probs=189.5
Q ss_pred ceEeeeCeEEEEEEEec-CCcEEEEEEeccCCh---hHHHHHHHHHHHH-hhCCCCceeeeeeeeeecccceEEEEeecC
Q 017262 78 RILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE---SKLEEFINEVVIL-SQINHRNVVKLLGCCLEVEVPLLVYEFIPN 152 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 152 (374)
+.||.|+||.||+|... +++.+|+|....... .....+..|...+ ...+|+|++++++++...+..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56899999999999864 588999998764322 2223344454444 455899999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceee
Q 017262 153 GTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 232 (374)
Q Consensus 153 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 232 (374)
++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..... .
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~ 150 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----N 150 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----c
Confidence 999999873 456899999999999999999999998 99999999999999999999999998865432 2
Q ss_pred ecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCC
Q 017262 233 TKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGE 312 (374)
Q Consensus 233 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (374)
....+++.|+|||.+.+..++.++||||||+++|+|++|..||..... ...+.... ..... ......
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~-~~~~~------~~~~~~ 217 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP------DAVFDNIL-SRRIN------WPEEVK 217 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHH-hcccC------CCCccc
Confidence 234578899999999888889999999999999999999999964321 11111111 11100 011112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017262 313 AEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345 (374)
Q Consensus 313 ~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~ 345 (374)
...+..+.+++.+||+.+|++||++.++.+.|.
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 234567899999999999999998876655543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=290.93 Aligned_cols=269 Identities=23% Similarity=0.300 Sum_probs=207.1
Q ss_pred CCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC--hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc-----cce
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQINHRNVVKLLGCCLEVE-----VPL 144 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~ 144 (374)
+|.+.+.||.|++|.||+|... +++.+++|++.... ....+.+.+|+.+++.++||||+++.+++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999975 48899999876543 445567889999999999999999999988765 789
Q ss_pred EEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccc
Q 017262 145 LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 224 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 224 (374)
+++||++ ++|.+++.. ...+++..+..++.|++.||++||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 578888863 348999999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCc--eeeecccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHh-----
Q 017262 225 AIDQT--HVSTKVQGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEE----- 296 (374)
Q Consensus 225 ~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 296 (374)
..... .......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||......+ ........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~------~~~~i~~~~~~~~ 227 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID------QLNLIVEVLGTPS 227 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH------HHHHHHHhcCCCC
Confidence 54321 122334578899999999887 78999999999999999999999997544211 01110000
Q ss_pred ---------ccccccccccc------cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHHhhCCCC
Q 017262 297 ---------NCLFDIIDDQV------RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME--LERIRANSRDD 354 (374)
Q Consensus 297 ---------~~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~--L~~~~~~~~~~ 354 (374)
......+.... .....+..+..+.+++.+||+.+|++|||+++++.. ++.+.....+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~ 302 (330)
T cd07834 228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEP 302 (330)
T ss_pred hhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCC
Confidence 00000000000 000112245678999999999999999999999984 66666554333
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=283.82 Aligned_cols=261 Identities=19% Similarity=0.334 Sum_probs=194.5
Q ss_pred eEeee--CeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeecCC
Q 017262 79 ILGQG--GQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNG 153 (374)
Q Consensus 79 ~lg~G--~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 153 (374)
.||+| +||+||.+... +|+.||+|..... .....+.+.+|+.+++.++||||+++++++...+..++++||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 45666 99999999964 6899999987643 3344577889999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCcee--
Q 017262 154 TLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV-- 231 (374)
Q Consensus 154 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-- 231 (374)
+|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++++||+.+..........
T Consensus 85 ~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 85 SANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999887532 345899999999999999999999998 9999999999999999999999998653322111100
Q ss_pred ----eecccccccccCccccccC--CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcc-------
Q 017262 232 ----STKVQGTFGYLDPEYFRSS--QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENC------- 298 (374)
Q Consensus 232 ----~~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 298 (374)
.....++..|+|||++.+. .++.++|||||||++|+|++|..||....... . .........
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~-----~-~~~~~~~~~~~~~~~~ 234 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ-----M-LLQKLKGPPYSPLDIT 234 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH-----H-HHHHhcCCCCCCcccc
Confidence 0112245679999998763 47899999999999999999999997543211 0 000000000
Q ss_pred -----------------------------ccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHHH
Q 017262 299 -----------------------------LFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM--ELERI 347 (374)
Q Consensus 299 -----------------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~--~L~~~ 347 (374)
.................+..+.+|+++||+.||++|||+.++++ -++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 00011111122223456678999999999999999999999975 34444
Q ss_pred Hh
Q 017262 348 RA 349 (374)
Q Consensus 348 ~~ 349 (374)
..
T Consensus 315 ~~ 316 (328)
T cd08226 315 KE 316 (328)
T ss_pred HH
Confidence 33
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=281.69 Aligned_cols=255 Identities=19% Similarity=0.287 Sum_probs=192.7
Q ss_pred cCceEeeeCeEEEEEEEecCCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeecCC
Q 017262 76 MNRILGQGGQGTVYKGMLADGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNG 153 (374)
Q Consensus 76 ~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 153 (374)
+.+.+|.|+++.|+++.. +++.+|+|++... .......+.+|+.+++.++|+||+++++++.+.+..+++|||++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 444555566666665555 6889999987654 4556678999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc----
Q 017262 154 TLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT---- 229 (374)
Q Consensus 154 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~---- 229 (374)
+|.+++.... ...+++..+..++.|++.||+|||+++ ++|+||+|+||+++.++.+|++|||.+........
T Consensus 85 ~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9999987542 346889999999999999999999999 99999999999999999999999998865432111
Q ss_pred --eeeecccccccccCcccccc--CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccc--
Q 017262 230 --HVSTKVQGTFGYLDPEYFRS--SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDII-- 303 (374)
Q Consensus 230 --~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 303 (374)
.......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||....... ..... .. ......+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~-----~~~~~-~~-~~~~~~~~~ 233 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ-----MLLEK-VR-GTVPCLLDK 233 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHH-Hh-ccCcccccc
Confidence 11122346778999999876 358899999999999999999999997432111 11110 00 0000000
Q ss_pred ----------------------cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 304 ----------------------DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 304 ----------------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
...............+.+++.+||..||++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred CchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 000111122344567899999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=274.81 Aligned_cols=246 Identities=23% Similarity=0.297 Sum_probs=190.1
Q ss_pred HHhhcCCCcCceE--eeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccc
Q 017262 68 DKATDYFNMNRIL--GQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVP 143 (374)
Q Consensus 68 ~~~~~~~~~~~~l--g~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 143 (374)
....++|.+.+.+ |+|+||.||++... ++..+++|......... .|+.....+ +|||++++++++...+..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3334567777766 99999999999964 57888998876432211 122222222 799999999999999999
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCC-cEEEeeccccc
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY-RAKIADFGTSR 222 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~~~ 222 (374)
++||||+++++|.+++.. ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++ .++|+|||++.
T Consensus 85 ~iv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 999999999999999974 348999999999999999999999999 99999999999999988 99999999987
Q ss_pred ccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccc
Q 017262 223 SIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDI 302 (374)
Q Consensus 223 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (374)
..... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||....... .....+....
T Consensus 159 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~--------- 223 (267)
T PHA03390 159 IIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ--------- 223 (267)
T ss_pred ecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh---------
Confidence 54322 12357889999999998889999999999999999999999997433221 1111111100
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 017262 303 IDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPT-MKEVAM 342 (374)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-~~~vl~ 342 (374)
. .........+..+.+++.+||+.+|.+||+ ++++++
T Consensus 224 -~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 224 -Q--KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -c--ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0 011122245668899999999999999996 588773
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=280.21 Aligned_cols=259 Identities=21% Similarity=0.294 Sum_probs=194.4
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC--hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 148 (374)
++|++.+.||+|++|.||+|... +++.+++|.+.... ......+.+|+.++++++||||+++++++.+.+..++|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46889999999999999999965 68899999875432 2334567889999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECC-CCcEEEeecccccccccC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE-KYRAKIADFGTSRSIAID 227 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~~ 227 (374)
|++ ++|.+++... ....+++..+..++.|++.||+|||+++ ++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 995 5777776532 2334678888999999999999999998 999999999999985 567999999999754322
Q ss_pred CceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHh--ccccccc-
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEE--NCLFDII- 303 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~- 303 (374)
. .......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||......+ . ....... .......
T Consensus 157 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~-----~-~~~~~~~~~~~~~~~~~ 229 (294)
T PLN00009 157 V-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID-----E-LFKIFRILGTPNEETWP 229 (294)
T ss_pred c-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-----H-HHHHHHHhCCCChhhcc
Confidence 1 11223457889999998865 457899999999999999999999997533211 1 1111000 0000000
Q ss_pred ---------c--ccccC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 304 ---------D--DQVRK----SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 304 ---------~--~~~~~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
. ..... ...+..+..+.+++.+|++.+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 230 GVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00000 011233457889999999999999999999986
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=283.49 Aligned_cols=251 Identities=27% Similarity=0.401 Sum_probs=196.7
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEecc---CChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV---VDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
..|...+.||+|+||.||+|... ++..+++|.+.. ........+.+|+++++.++|+|++++.+++......++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34677788999999999999965 578899998753 23344567888999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
||+. |+|.+.+.. ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9996 577666643 2346889999999999999999999998 999999999999999999999999998754322
Q ss_pred CceeeecccccccccCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFR---SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIID 304 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (374)
....+++.|+|||.+. ...++.++||||||+++|+|++|..||....... .... ......
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~-~~~~~~----- 231 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYH-IAQNES----- 231 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH------HHHH-HhhcCC-----
Confidence 2335788999999974 3567889999999999999999999986422111 0110 111100
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 017262 305 DQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIR 348 (374)
Q Consensus 305 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~ 348 (374)
........+..+.++|.+||+.+|++||++.+++..-.-..
T Consensus 232 ---~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 232 ---PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred ---CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 11112244567889999999999999999999998655444
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=288.09 Aligned_cols=271 Identities=24% Similarity=0.338 Sum_probs=199.7
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEecc--CChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecc--cc
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV--VDESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVE--VP 143 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~--~~ 143 (374)
..++|++.+.||+|+||.||+|... ++..+++|++.. ........+.+|+.+++++ +||||+++++++...+ ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3567889999999999999999965 578899997743 2334455677899999999 9999999999986543 67
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccc
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 223 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 223 (374)
++|+||++ ++|..++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999996 588888863 27888999999999999999999998 99999999999999999999999999876
Q ss_pred cccCCce----eeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccC---------CChHHH
Q 017262 224 IAIDQTH----VSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEG---------RNLTTY 289 (374)
Q Consensus 224 ~~~~~~~----~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~---------~~~~~~ 289 (374)
....... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||......+. ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 5433221 2233458889999998764 4578899999999999999999999964332110 000000
Q ss_pred HHHHHHhcccccccc---cccc---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHHh
Q 017262 290 FVECIEENCLFDIID---DQVR---KSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME--LERIRA 349 (374)
Q Consensus 290 ~~~~~~~~~~~~~~~---~~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~--L~~~~~ 349 (374)
.... ........++ .... .......+..+.+++.+|++.+|++|||+.++++. ++.+..
T Consensus 237 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~ 303 (337)
T cd07852 237 IESI-KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN 303 (337)
T ss_pred HHHH-HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence 0000 0000000000 0000 00111245678999999999999999999999974 444433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=281.80 Aligned_cols=246 Identities=23% Similarity=0.317 Sum_probs=203.2
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
.+.|..-++||+|+||.||.+..+ .|+.+|.|++... ........++|-.+|.+++.+.||.+--.|.+.+.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 567888899999999999999855 5899999866432 233345678899999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
+..|+||+|.-+|.+. ....+++..++-++.+|+.||++||+.+ |+.||+||+|||+|+.|+++|+|+|++..+..
T Consensus 264 LtlMNGGDLkfHiyn~-g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNH-GNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeecc-CCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 9999999999999865 3468999999999999999999999999 99999999999999999999999999987654
Q ss_pred CCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
.. .....+||.+|||||++.+..|+...|.|||||++|||+.|+.||......... +-++..
T Consensus 340 g~--~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~----------------eEvdrr 401 (591)
T KOG0986|consen 340 GK--PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR----------------EEVDRR 401 (591)
T ss_pred CC--ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH----------------HHHHHH
Confidence 33 334448999999999999999999999999999999999999999754332210 011111
Q ss_pred c---cCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 017262 307 V---RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMK 338 (374)
Q Consensus 307 ~---~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 338 (374)
. ...++..-+++..+|.+..|..||++|....
T Consensus 402 ~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 402 TLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred HhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 1 1234455567888999999999999995443
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=272.18 Aligned_cols=248 Identities=24% Similarity=0.321 Sum_probs=205.8
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
.++|...++||+|+||.|.+++. ..++.+|+|+++.. .......-+.|-.+|+..+||.+..+.-.|...+.+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 46888999999999999999995 46899999987653 445566677899999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
|||..||.|.-++. ....+++....-+-..|+.||.|||+++ |+.||||.+|.|+|.+|++||+|||+++.--
T Consensus 247 MeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I- 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI- 319 (516)
T ss_pred EEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc-
Confidence 99999999999998 4678999999999999999999999999 9999999999999999999999999997532
Q ss_pred CCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
.........+|||.|+|||++....|+.++|.|.+|++||||++|+.||.....+. +++++-..
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k----------------LFeLIl~e 383 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK----------------LFELILME 383 (516)
T ss_pred cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH----------------HHHHHHhh
Confidence 23445567889999999999999999999999999999999999999997543322 12211110
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCC--CHHHHHH
Q 017262 307 VRKSGEAEEIMAVSDVAKRCLNSYGRNRP--TMKEVAM 342 (374)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rp--s~~~vl~ 342 (374)
...+|...+++...|+..+|..||++|. ..+++.+
T Consensus 384 -d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakE 420 (516)
T KOG0690|consen 384 -DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKE 420 (516)
T ss_pred -hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHH
Confidence 1123444555778899999999999993 3344444
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=278.63 Aligned_cols=251 Identities=25% Similarity=0.322 Sum_probs=196.4
Q ss_pred CCCcCceEeeeCeEEEEEEEe----cCCcEEEEEEeccCC----hhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccc
Q 017262 73 YFNMNRILGQGGQGTVYKGML----ADGRIIAVKKSKVVD----ESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVP 143 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 143 (374)
+|++.+.||+|+||.||.+.. .+|..+|+|.+.... ......+.+|+.+++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999986 368899999876432 22345677899999999 599999999999988899
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccc
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 223 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 223 (374)
++++||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999999873 456889999999999999999999998 99999999999999999999999999876
Q ss_pred cccCCceeeecccccccccCccccccC--CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccc
Q 017262 224 IAIDQTHVSTKVQGTFGYLDPEYFRSS--QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFD 301 (374)
Q Consensus 224 ~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (374)
.............++..|+|||.+... .++.++||||||+++|+|++|..||...... .............
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~----- 227 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKS----- 227 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhcc-----
Confidence 543322222344588899999998753 4678999999999999999999998642211 1111111111110
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 017262 302 IIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRP-----TMKEVAM 342 (374)
Q Consensus 302 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~vl~ 342 (374)
....+...+..+.+++.+|++.+|++|| ++++++.
T Consensus 228 ------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 228 ------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0112233456788999999999999997 5666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=284.82 Aligned_cols=263 Identities=22% Similarity=0.300 Sum_probs=191.8
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC--hhHHHHHHHHHHHHhhCCCCceeeeeeeeeeccc-----
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEV----- 142 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----- 142 (374)
.++|++.+.||+|+||.||+|... +++.+|+|.+.... ......+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 457899999999999999999965 58899999875432 2223455689999999999999999999876543
Q ss_pred ---ceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecc
Q 017262 143 ---PLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 219 (374)
Q Consensus 143 ---~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 219 (374)
.++++||+. ++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 499999996 477777754 2346899999999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCce---eeecccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHH
Q 017262 220 TSRSIAIDQTH---VSTKVQGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIE 295 (374)
Q Consensus 220 ~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 295 (374)
++......... ......++..|+|||.+.+. .++.++||||||+++|+|++|..||....... ....+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~---~~~~~~~~~~ 241 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH---QLTLISQLCG 241 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhC
Confidence 98765432211 11234577889999988654 47889999999999999999999986433211 0000111000
Q ss_pred h---ccccc-----cccc-cccCCC---------CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 296 E---NCLFD-----IIDD-QVRKSG---------EAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 296 ~---~~~~~-----~~~~-~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
. ..... ..+. ...... +......+.++|.+||..||.+|||++++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0 00000 0000 000000 0011346779999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=275.24 Aligned_cols=256 Identities=27% Similarity=0.354 Sum_probs=194.0
Q ss_pred CCcCceEeeeCeEEEEEEEecC-CcEEEEEEeccCC--hhHHHHHHHHHHHHhhC---CCCceeeeeeeeeeccc-----
Q 017262 74 FNMNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVD--ESKLEEFINEVVILSQI---NHRNVVKLLGCCLEVEV----- 142 (374)
Q Consensus 74 ~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~----- 142 (374)
|++.+.||+|+||.||+|..+. ++.+++|.+.... ......+.+|+.+++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5678899999999999999764 8899999886432 22234566777777666 59999999999988776
Q ss_pred ceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccc
Q 017262 143 PLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 222 (374)
Q Consensus 143 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 222 (374)
.+++|||+++ +|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999964 788877643 2236899999999999999999999998 9999999999999999999999999987
Q ss_pred ccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccc-
Q 017262 223 SIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFD- 301 (374)
Q Consensus 223 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 301 (374)
....... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...... +......+......
T Consensus 156 ~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~------~~~~~~~~~~~~~~~ 227 (287)
T cd07838 156 IYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA------DQLDKIFDVIGLPSE 227 (287)
T ss_pred eccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH------HHHHHHHHHcCCCCh
Confidence 6543221 12334788899999999888999999999999999999999998643321 11111111100000
Q ss_pred ------------ccccccc---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 302 ------------IIDDQVR---KSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 302 ------------~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
....... ....+..+..+.+++.+||+.||++||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 228 EEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000 1112244577889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=281.20 Aligned_cols=243 Identities=29% Similarity=0.413 Sum_probs=191.9
Q ss_pred CCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 74 FNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 74 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
|...+.||+|+||.||+|... ++..+++|.+... .......+.+|+++++.++|||++++++++.+.+..++++||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 566778999999999999964 5788999987643 233445788899999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+. ++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 95 566666653 2446899999999999999999999999 99999999999999999999999998864321
Q ss_pred eeeecccccccccCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 230 HVSTKVQGTFGYLDPEYFR---SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
.....++..|+|||.+. ...++.++||||||+++|+|++|..||...... ........ ...
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~-~~~------- 237 (313)
T cd06633 174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQ-NDS------- 237 (313)
T ss_pred --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHh-cCC-------
Confidence 22345788999999984 456888999999999999999999998643211 11111111 001
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 307 VRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
........+..+.+++.+||+.+|.+||++.+++.
T Consensus 238 -~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 238 -PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred -CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11112223456889999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=308.60 Aligned_cols=254 Identities=27% Similarity=0.400 Sum_probs=191.7
Q ss_pred HhhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeec------
Q 017262 69 KATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEV------ 140 (374)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 140 (374)
+...+|+..+.||+||||.||+++++ ||+.||||++... +......+.+|+..|++|+|||||+++..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34567888899999999999999965 8999999988764 344566788999999999999999987642110
Q ss_pred --------------------------------------------------------------------------------
Q 017262 141 -------------------------------------------------------------------------------- 140 (374)
Q Consensus 141 -------------------------------------------------------------------------------- 140 (374)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------ccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 017262 141 ---------------------------------EVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYL 187 (374)
Q Consensus 141 ---------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~l 187 (374)
..+|+-||||+..+|++++.++... -.....++++++|+.||+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHH
Confidence 0147889999998888888743211 14678899999999999999
Q ss_pred hhcCCCCEEEeccCCCceEECCCCcEEEeecccccccc------c-----------CCceeeecccccccccCccccccC
Q 017262 188 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA------I-----------DQTHVSTKVQGTFGYLDPEYFRSS 250 (374)
Q Consensus 188 H~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~------~-----------~~~~~~~~~~g~~~y~aPE~~~~~ 250 (374)
|++| +|||||||.|||+++++.|||+|||+++... . ......+..+||..|+|||++.+.
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9999 9999999999999999999999999998721 0 011123456799999999998764
Q ss_pred ---CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhc
Q 017262 251 ---QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCL 327 (374)
Q Consensus 251 ---~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 327 (374)
.|+.|+|+||||++++||+. ||+...... .....+..+.++.. .++..+..+.-.++|++|+
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa------~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERA------SILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchHHHH------HHHHhcccCCCCCC------cccccccchHHHHHHHHHh
Confidence 49999999999999999996 565322110 11111111111111 2223333445668999999
Q ss_pred ccCCCCCCCHHHHHH
Q 017262 328 NSYGRNRPTMKEVAM 342 (374)
Q Consensus 328 ~~~p~~Rps~~~vl~ 342 (374)
+.||++||||.|++.
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999985
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=283.71 Aligned_cols=265 Identities=22% Similarity=0.258 Sum_probs=197.8
Q ss_pred HHHhhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeee-ccc
Q 017262 67 LDKATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLE-VEV 142 (374)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~ 142 (374)
+...+++|++.+.||.|+||.||++... ++..+++|++... .......+..|+.+++.++|||++++.+++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3456788999999999999999999854 6889999976532 23344677889999999999999999999875 457
Q ss_pred ceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccc
Q 017262 143 PLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 222 (374)
Q Consensus 143 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 222 (374)
.++++||+ +++|.+++. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.
T Consensus 85 ~~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 85 IYFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccc
Confidence 88999998 568888775 345788888999999999999999999 9999999999999999999999999987
Q ss_pred ccccCCceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccC---------CChHHHHHH
Q 017262 223 SIAIDQTHVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEG---------RNLTTYFVE 292 (374)
Q Consensus 223 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~---------~~~~~~~~~ 292 (374)
.... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||........ ....++...
T Consensus 157 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 157 IQDP----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ccCC----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 5422 1123456888999998765 5689999999999999999999999965332110 000111110
Q ss_pred HHHhccccccccccccCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 293 CIEENCLFDIIDDQVRKSGE-----AEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
...................+ +..+..+.++|.+|++.+|++|||+.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000000001111 1234688999999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=276.25 Aligned_cols=241 Identities=22% Similarity=0.281 Sum_probs=186.1
Q ss_pred eEeeeCeEEEEEEEec-CCcEEEEEEeccCC---hhHHHHHHHHH---HHHhhCCCCceeeeeeeeeecccceEEEEeec
Q 017262 79 ILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEV---VILSQINHRNVVKLLGCCLEVEVPLLVYEFIP 151 (374)
Q Consensus 79 ~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~---~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 151 (374)
.||+|+||.||++... +++.+|+|.+.... ......+..|. ..++..+||||+++++++.+.+..++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4799999999999864 57899999775422 11112233343 34445579999999999999999999999999
Q ss_pred CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCcee
Q 017262 152 NGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV 231 (374)
Q Consensus 152 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 231 (374)
+++|..++. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 999998886 3457999999999999999999999998 9999999999999999999999999987543221
Q ss_pred eecccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCC
Q 017262 232 STKVQGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKS 310 (374)
Q Consensus 232 ~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (374)
.....|+..|+|||.+.++ .++.++||||+|+++|+|++|..||......... . ...... .....
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~---~-~~~~~~----------~~~~~ 217 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---E-IDRMTL----------TMAVE 217 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH---H-HHHHhh----------ccCCC
Confidence 1234588999999998754 6899999999999999999999999754222110 0 100000 00111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 017262 311 GEAEEIMAVSDVAKRCLNSYGRNRP-----TMKEVAM 342 (374)
Q Consensus 311 ~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~vl~ 342 (374)
.+...+..+.+++.+|+..+|.+|| ++.++++
T Consensus 218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 2223456899999999999999999 8988875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=275.45 Aligned_cols=249 Identities=23% Similarity=0.301 Sum_probs=194.4
Q ss_pred CCCcCceEeeeCeEEEEEEEecC-CcEEEEEEecc-----CChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 73 YFNMNRILGQGGQGTVYKGMLAD-GRIIAVKKSKV-----VDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~-----~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
+|.+.+.||+|+||.||++.... +..+++|..+. ........+..|+.+++.++||||+++++++.+.+..+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 57888999999999999998653 34444444332 1223334567799999999999999999999988899999
Q ss_pred EEeecCCcccccccCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccc
Q 017262 147 YEFIPNGTLFQYLHDP-YEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 225 (374)
+||+++++|.+++... .....+++..++.++.|++.||.|||+.+ ++|+||+|+||++++ +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999887532 13457899999999999999999999998 999999999999975 569999999987654
Q ss_pred cCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccc
Q 017262 226 IDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDD 305 (374)
Q Consensus 226 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (374)
... .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.... ..........
T Consensus 157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~~---------- 219 (260)
T cd08222 157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIVE---------- 219 (260)
T ss_pred CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHHc----------
Confidence 322 22233457889999999988888999999999999999999999985321 1111111110
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 306 QVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
......+...+..+.+++.+|++.+|++||++.++++
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 220 GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1111223455668999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=281.65 Aligned_cols=263 Identities=21% Similarity=0.249 Sum_probs=198.5
Q ss_pred ChHHHHHhhcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCC--hhHHHHHHHHHHHHhhCCCCceeeeeeeeee
Q 017262 63 NSKELDKATDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVD--ESKLEEFINEVVILSQINHRNVVKLLGCCLE 139 (374)
Q Consensus 63 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 139 (374)
...++...+++|.+.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++++++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3556777889999999999999999999985 468899999886432 2334567789999999999999999998864
Q ss_pred c------ccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcE
Q 017262 140 V------EVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA 213 (374)
Q Consensus 140 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~ 213 (374)
. ...+++++++ +++|.+++. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCE
Confidence 3 2357788877 788888775 236899999999999999999999999 9999999999999999999
Q ss_pred EEeecccccccccCCceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHH
Q 017262 214 KIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVE 292 (374)
Q Consensus 214 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 292 (374)
||+|||++..... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ....
T Consensus 160 kl~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~------~~~~ 229 (345)
T cd07877 160 KILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID------QLKL 229 (345)
T ss_pred EEecccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHH
Confidence 9999999875432 1233457889999999866 568889999999999999999999996432211 0000
Q ss_pred HHHh--------------cccccc---ccccccC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 293 CIEE--------------NCLFDI---IDDQVRK---SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 293 ~~~~--------------~~~~~~---~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
.... ...... +...... +.....+..+.+++.+|++.+|.+|||+.+++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 230 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000 000000 0000000 0001134568899999999999999999998864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=287.16 Aligned_cols=258 Identities=23% Similarity=0.316 Sum_probs=194.2
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeec---------
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEV--------- 140 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------- 140 (374)
.++|.+.+.||.|+||.||+|... ++..+++|.+..........+.+|+++++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 468999999999999999999964 5889999988776666667888999999999999999999876543
Q ss_pred -----ccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEEC-CCCcEE
Q 017262 141 -----EVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD-EKYRAK 214 (374)
Q Consensus 141 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~-~~~~~k 214 (374)
...++++||++ ++|.+++. ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++ +++.++
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 34689999996 58887775 346889999999999999999999999 99999999999997 456789
Q ss_pred EeecccccccccCCce--eeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHH
Q 017262 215 IADFGTSRSIAIDQTH--VSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFV 291 (374)
Q Consensus 215 l~Dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 291 (374)
|+|||++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....... -..
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~------~~~ 229 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE------QMQ 229 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHH
Confidence 9999998765322111 1122357889999998654 567889999999999999999999996443211 000
Q ss_pred HHHHhcc-------------cccccc-ccccCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 292 ECIEENC-------------LFDIID-DQVRKSG-----EAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 292 ~~~~~~~-------------~~~~~~-~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
....... ...... ....... ....+..+.+++.+||+.||.+|||+.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 230 LILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000000 000000 0000000 1123457889999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=280.79 Aligned_cols=271 Identities=22% Similarity=0.282 Sum_probs=200.2
Q ss_pred HHHHhhcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc-
Q 017262 66 ELDKATDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVE- 141 (374)
Q Consensus 66 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~- 141 (374)
.+....++|.+.+.||+|+||.||++.. .++..||+|.+... .......+.+|+.+++.++||||+++++++..+.
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 3445678899999999999999999985 46889999987542 2333456789999999999999999999987554
Q ss_pred -----cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEe
Q 017262 142 -----VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIA 216 (374)
Q Consensus 142 -----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~ 216 (374)
..++|+||+ +++|.+++. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEe
Confidence 348999999 778888775 346899999999999999999999999 9999999999999999999999
Q ss_pred ecccccccccCCceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccC---------CCh
Q 017262 217 DFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEG---------RNL 286 (374)
Q Consensus 217 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~---------~~~ 286 (374)
|||++...... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||........ ...
T Consensus 161 dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (343)
T cd07880 161 DFGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS 236 (343)
T ss_pred ecccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99998754321 123357889999999876 4578899999999999999999999974322100 000
Q ss_pred HHHHHHHHHhccccccccc--ccc----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH--HHHHHHHh
Q 017262 287 TTYFVECIEENCLFDIIDD--QVR----KSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVA--MELERIRA 349 (374)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~--~~~----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl--~~L~~~~~ 349 (374)
..+. .............. ... .......+..+.+++.+|++.||++|||+.+++ ..++....
T Consensus 237 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 237 KEFV-QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred HHHH-HhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 0000 00000000000000 000 001112345688999999999999999999999 34555443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=276.81 Aligned_cols=252 Identities=23% Similarity=0.373 Sum_probs=193.0
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecC-CcEEEEEEeccCC-hhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccceEEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVD-ESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 147 (374)
-++|++.+.||+|+||.||+|...+ ++.+++|.+.... ......+..|+..+... +||||+++++++.+....+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 4568889999999999999999765 8899999886532 23345566777767666 4999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS-SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
||++ ++|.+++.. ....+++..+..++.|++.||+|||+ .+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 94 e~~~-~~l~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMS-TCLDKLLKR--IQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccC-cCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 9985 466665543 23478999999999999999999997 46 99999999999999999999999999876532
Q ss_pred CCceeeecccccccccCccccccCC----CCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccc
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFRSSQ----FTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDI 302 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (374)
... .....+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||...... .+......... ...
T Consensus 168 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~-~~~- 238 (296)
T cd06618 168 SKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEE-PPS- 238 (296)
T ss_pred CCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCC-CCC-
Confidence 221 22334778999999987553 788999999999999999999999642111 11111111111 000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 303 IDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
.......+..+.+++.+||+.+|++||++++++..
T Consensus 239 ------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 239 ------LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01111234578999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=263.94 Aligned_cols=249 Identities=24% Similarity=0.384 Sum_probs=193.4
Q ss_pred CCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC-ChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccceEEEEee
Q 017262 74 FNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-DESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVPLLVYEFI 150 (374)
Q Consensus 74 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 150 (374)
.+....||.|+.|.|+++..+ .|...|||.+... +.++.+.++..+.++... ++|+||+.+|+|..+...++.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 345567999999999999965 4889999988764 455566777777777666 4899999999999999999999988
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 230 (374)
. .-++..+.. -..++++.-+.++...+.+||.||..++ +|+|||+||+|||+|+.|++||||||++..+.++.
T Consensus 174 s-~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk-- 246 (391)
T KOG0983|consen 174 S-TCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK-- 246 (391)
T ss_pred H-HHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc--
Confidence 3 334444443 2446889899999999999999999887 39999999999999999999999999998776433
Q ss_pred eeecccccccccCcccccc---CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccc
Q 017262 231 VSTKVQGTFGYLDPEYFRS---SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307 (374)
Q Consensus 231 ~~~~~~g~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (374)
..+...|-+.|||||.+.. ..|+.++||||||++++||.||+.||.....+- +......++. ...+..
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF-----e~ltkvln~e--PP~L~~-- 317 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF-----EVLTKVLNEE--PPLLPG-- 317 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH-----HHHHHHHhcC--CCCCCc--
Confidence 3455568999999999864 468899999999999999999999997533221 1112222211 111111
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
....++.+++++..||+.|+.+||...++++
T Consensus 318 ----~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 318 ----HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred ----ccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 1124568999999999999999999999886
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=275.48 Aligned_cols=262 Identities=24% Similarity=0.298 Sum_probs=194.9
Q ss_pred CCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCCh-hHHHHHHHHHHHHhhCC-CCceeeeeeeeeecccceEEEEee
Q 017262 74 FNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE-SKLEEFINEVVILSQIN-HRNVVKLLGCCLEVEVPLLVYEFI 150 (374)
Q Consensus 74 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 150 (374)
|.+.+.||.|++|.||+|... +++.+++|++..... .......+|+..+++++ |||++++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999975 478899998764322 22234457899999998 999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 230 (374)
+++|.+++.... ...+++..+..++.|++.+|.|||+++ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-- 153 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-- 153 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC--
Confidence 888988886432 347899999999999999999999999 9999999999999999999999999987654322
Q ss_pred eeecccccccccCccccc-cCCCCccchhhhHHHHHHHHHhCCCCCCccccccC----------CChHHHHHHHHHhccc
Q 017262 231 VSTKVQGTFGYLDPEYFR-SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEG----------RNLTTYFVECIEENCL 299 (374)
Q Consensus 231 ~~~~~~g~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~----------~~~~~~~~~~~~~~~~ 299 (374)
......++..|+|||.+. +..++.++|+||||+++++|++|+.||......+. .....|..........
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 123345788999999875 45578999999999999999999999965432110 0000011100000001
Q ss_pred ccccccccc---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 300 FDIIDDQVR---KSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 300 ~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
...+..... .......+..+.+++++|++.+|++|||+++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000000000 0001112467999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=300.37 Aligned_cols=266 Identities=27% Similarity=0.432 Sum_probs=217.3
Q ss_pred HHHhhcCCCcCceEeeeCeEEEEEEEec----C----CcEEEEEEeccC-ChhHHHHHHHHHHHHhhC-CCCceeeeeee
Q 017262 67 LDKATDYFNMNRILGQGGQGTVYKGMLA----D----GRIIAVKKSKVV-DESKLEEFINEVVILSQI-NHRNVVKLLGC 136 (374)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~----~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~ 136 (374)
.+...++..+.+.||.|.||.|++|... . ...||||.++.. ...+...+..|+++|+.+ .|+||+.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 3444455567779999999999999842 1 357899987753 345678899999999999 59999999999
Q ss_pred eeecccceEEEEeecCCcccccccCCC-----CC--------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCC
Q 017262 137 CLEVEVPLLVYEFIPNGTLFQYLHDPY-----EE--------LSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKST 203 (374)
Q Consensus 137 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-----~~--------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~ 203 (374)
|...+..++|+||+..|+|..|+...+ .. ..++....+.++.||+.|++||++.. ++||||..+
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhh
Confidence 999889999999999999999998643 01 23889999999999999999999998 999999999
Q ss_pred ceEECCCCcEEEeecccccccccCCceeeeccc--ccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcccc
Q 017262 204 NILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQ--GTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWA 280 (374)
Q Consensus 204 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~--g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~ 280 (374)
|||++.+..+|++|||+++.......+...... -+..|||||.+....++.++||||+|+++||+++ |..||++...
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 999999999999999999876655555433322 3457999999999999999999999999999999 9999975221
Q ss_pred ccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 017262 281 NEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350 (374)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~ 350 (374)
..+. .+.+..+.+...|..++.++.++++.||+.+|++||++.++.+.|+.+...
T Consensus 528 -----~~~l----------~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~ 582 (609)
T KOG0200|consen 528 -----TEEL----------LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD 582 (609)
T ss_pred -----HHHH----------HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence 1111 122334445556667778899999999999999999999999999997543
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=283.57 Aligned_cols=261 Identities=24% Similarity=0.293 Sum_probs=194.0
Q ss_pred cCCC-cCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhH--------------HHHHHHHHHHHhhCCCCceeeeee
Q 017262 72 DYFN-MNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESK--------------LEEFINEVVILSQINHRNVVKLLG 135 (374)
Q Consensus 72 ~~~~-~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~~~~ 135 (374)
++|. +.+.||.|+||.||+|... +++.+|+|.+....... ...+.+|++++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4454 4578999999999999964 68899999875432211 124678999999999999999999
Q ss_pred eeeecccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEE
Q 017262 136 CCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKI 215 (374)
Q Consensus 136 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl 215 (374)
++...+..+++|||++ ++|.+++. ....+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.++|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999996 68888886 3456899999999999999999999999 999999999999999999999
Q ss_pred eecccccccccCC-------------ceeeecccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCccccc
Q 017262 216 ADFGTSRSIAIDQ-------------THVSTKVQGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLVELLTGQKPISSIWAN 281 (374)
Q Consensus 216 ~Dfg~~~~~~~~~-------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~ 281 (374)
+|||++.....+. ........+++.|+|||.+.+. .++.++|+||||+++|+|++|..||......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999987654111 1111223467889999998764 4689999999999999999999999754321
Q ss_pred cCCChHHHHHHHHHhcc---ccccc--------ccccc---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 282 EGRNLTTYFVECIEENC---LFDII--------DDQVR---KSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 282 ~~~~~~~~~~~~~~~~~---~~~~~--------~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
+ ....+........ +.... ..... .......+..+.+++.+||+.+|++|||+++++.
T Consensus 241 ~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 241 D---QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred H---HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1 0111111100000 00000 00000 0001123467889999999999999999999986
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=273.19 Aligned_cols=262 Identities=25% Similarity=0.318 Sum_probs=197.0
Q ss_pred CCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC--hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEee
Q 017262 74 FNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFI 150 (374)
Q Consensus 74 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 150 (374)
|+..+.||+|++|.||+|+.. +++.+++|...... ......+..|+.+++.++|+|++++++++.+.+..++++||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556788999999999999965 48899999877642 334467788999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 230 (374)
+ ++|.+++... ...+++..+..++.|++.||++||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~-~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 7 5899998752 247899999999999999999999999 99999999999999999999999999876543221
Q ss_pred eeecccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCccccccCC---------ChHHHHHHHHHhcccc
Q 017262 231 VSTKVQGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGR---------NLTTYFVECIEENCLF 300 (374)
Q Consensus 231 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~---------~~~~~~~~~~~~~~~~ 300 (374)
......++..|+|||.+.+. .++.++|+||||+++|+|++|..||......... ................
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 22233457789999998766 7899999999999999999999999653321100 0000000000000000
Q ss_pred ccccc---cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 301 DIIDD---QVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 301 ~~~~~---~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..... .......+..+..+.+++.+||..+|++||++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000 0000011122567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=276.34 Aligned_cols=263 Identities=24% Similarity=0.290 Sum_probs=191.6
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCCh--hHHHHHHHHHHHHhhCCCCceeeeeeeeeecc------
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE--SKLEEFINEVVILSQINHRNVVKLLGCCLEVE------ 141 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 141 (374)
.++|++.+.||.|+||.||+|... +++.+++|.+..... .....+.+|+++++.++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999965 578999998754322 22345678999999999999999999875443
Q ss_pred --cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecc
Q 017262 142 --VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 219 (374)
Q Consensus 142 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 219 (374)
..++++||+.+ +|...+.. ....+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 35899999965 56665553 3457999999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCce----------eeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHH
Q 017262 220 TSRSIAIDQTH----------VSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTT 288 (374)
Q Consensus 220 ~~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~ 288 (374)
++......... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||........ ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~---~~ 237 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ---LH 237 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH---HH
Confidence 98765422111 1122356788999998765 4578999999999999999999999964332210 00
Q ss_pred HHHHHHHh---------ccccccccccccCCCC-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 289 YFVECIEE---------NCLFDIIDDQVRKSGE-------AEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 289 ~~~~~~~~---------~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
........ ..+....+.......+ ......+.+++.+||+.+|.+|||+.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00000000 0000000000000000 112357889999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=279.08 Aligned_cols=260 Identities=22% Similarity=0.300 Sum_probs=194.9
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc------
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVE------ 141 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 141 (374)
.++|.+.+.||+|+||.||+|... +|+.+|+|.+... .......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 578999999999999999999964 6889999987642 2223456789999999999999999999987543
Q ss_pred cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccc
Q 017262 142 VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 221 (374)
Q Consensus 142 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 221 (374)
..++++||+. .+|..+.. ..+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++
T Consensus 94 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEecccc-cCHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 3589999985 36655442 35889999999999999999999999 999999999999999999999999998
Q ss_pred cccccCCceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHh----
Q 017262 222 RSIAIDQTHVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEE---- 296 (374)
Q Consensus 222 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---- 296 (374)
...... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...... ..+......
T Consensus 165 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~------~~~~~~~~~~~~~ 234 (342)
T cd07879 165 RHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL------DQLTQILKVTGVP 234 (342)
T ss_pred cCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHhcCCC
Confidence 754321 123457888999999876 46889999999999999999999999743211 111111110
Q ss_pred ----------ccccccccc--c-ccCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHHHHh
Q 017262 297 ----------NCLFDIIDD--Q-VRKS---GEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM--ELERIRA 349 (374)
Q Consensus 297 ----------~~~~~~~~~--~-~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~--~L~~~~~ 349 (374)
......... . .+.. ..+..+..+.+++.+||+.||++||++.+++. .++.+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 235 GPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred CHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 000000000 0 0000 00123456889999999999999999999995 3776654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=264.63 Aligned_cols=252 Identities=23% Similarity=0.355 Sum_probs=200.7
Q ss_pred ceEeeeCeEEEEEEE-ecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCC-CCceeeeeeeeeecccceEEEEeecCCcc
Q 017262 78 RILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQIN-HRNVVKLLGCCLEVEVPLLVYEFIPNGTL 155 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L 155 (374)
+.||+|+|+.|-.++ ..+|..+|||++..........+.+|++++.+.+ |+||++++++|+++...|+|||.|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 689999999999988 6789999999988777777889999999999995 99999999999999999999999999999
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCC---cEEEeecccccccccCC--c-
Q 017262 156 FQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY---RAKIADFGTSRSIAIDQ--T- 229 (374)
Q Consensus 156 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~---~~kl~Dfg~~~~~~~~~--~- 229 (374)
...|. ....+++.++..+..+|+.||.+||++| |.|||+||+|||-.+.. -+||+||.+........ +
T Consensus 164 LshI~---~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQ---KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 99998 5668999999999999999999999999 99999999999997655 48999998865432111 1
Q ss_pred ---eeeecccccccccCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCCcccccc-----CCChHHHHHHHHHh
Q 017262 230 ---HVSTKVQGTFGYLDPEYFR-----SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANE-----GRNLTTYFVECIEE 296 (374)
Q Consensus 230 ---~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~ 296 (374)
.......|+..|||||+.. ...|+.+.|.||||+++|-|++|..||.+....+ +..-..-.
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ------ 311 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ------ 311 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHH------
Confidence 1123356888999999853 2358899999999999999999999998776532 11111111
Q ss_pred ccccccccccccCCCCH----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 297 NCLFDIIDDQVRKSGEA----EEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 297 ~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
+.+++-+..+.. ++|. ..+....+|+..++..++.+|.++.+++.
T Consensus 312 ~~LFesIQEGkY-eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 312 NKLFESIQEGKY-EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHHHhccCC-cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 112222222211 2222 33567889999999999999999998876
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=268.61 Aligned_cols=236 Identities=30% Similarity=0.362 Sum_probs=192.3
Q ss_pred EeeeCeEEEEEEEec-CCcEEEEEEeccCC---hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeecCCcc
Q 017262 80 LGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTL 155 (374)
Q Consensus 80 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 155 (374)
||+|+||.||++... +++.+++|.+.... ......+..|+.+++.++|||++++++.+..++..+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999965 48899999876532 22456788999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceeeecc
Q 017262 156 FQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKV 235 (374)
Q Consensus 156 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 235 (374)
.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~ 153 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTF 153 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCC
Confidence 999974 346899999999999999999999988 9999999999999999999999999987654322 122334
Q ss_pred cccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCHHH
Q 017262 236 QGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEE 315 (374)
Q Consensus 236 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (374)
.++..|+|||...+...+.++|+||||+++|++++|..||..... ......... .....+...
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~-----------~~~~~~~~~ 216 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKILK-----------DPLRFPEFL 216 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhc-----------CCCCCCCCC
Confidence 578899999999888889999999999999999999999964322 111111111 111222233
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHH
Q 017262 316 IMAVSDVAKRCLNSYGRNRPTMKE 339 (374)
Q Consensus 316 ~~~l~~li~~cl~~~p~~Rps~~~ 339 (374)
+..+.+++.+||..||++||++.+
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 567889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=281.02 Aligned_cols=257 Identities=23% Similarity=0.286 Sum_probs=196.8
Q ss_pred HHhhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeeccc--
Q 017262 68 DKATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEV-- 142 (374)
Q Consensus 68 ~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-- 142 (374)
....++|++.+.||+|++|.||+|... +++.+++|.+... .......+.+|+.+++.++|||++++.+++...+.
T Consensus 11 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 11 WEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred ecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 345678999999999999999999975 5789999987642 23344667789999999999999999998876554
Q ss_pred ----ceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeec
Q 017262 143 ----PLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADF 218 (374)
Q Consensus 143 ----~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 218 (374)
.++++||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+||
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccc
Confidence 79999999 6789888853 46899999999999999999999998 999999999999999999999999
Q ss_pred ccccccccCCceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhc
Q 017262 219 GTSRSIAIDQTHVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEEN 297 (374)
Q Consensus 219 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 297 (374)
|++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... ..+....+..
T Consensus 163 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~------~~~~~i~~~~ 232 (343)
T cd07851 163 GLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI------DQLKRIMNLV 232 (343)
T ss_pred ccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHHhc
Confidence 998765322 233457888999999865 46788999999999999999999999643221 1111110000
Q ss_pred --------------cccccccccc---cCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 298 --------------CLFDIIDDQV---RKS---GEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 298 --------------~~~~~~~~~~---~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.....+.... ... .....+..+.+++.+||+.+|++|||+.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 233 GTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred CCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0000000000 000 00123568999999999999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=301.78 Aligned_cols=259 Identities=25% Similarity=0.336 Sum_probs=213.5
Q ss_pred hHHHHHhhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeee
Q 017262 64 SKELDKATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLE 139 (374)
Q Consensus 64 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 139 (374)
..+++...++|.+.++||+|+||.|..++.+ .++.||+|++... ....-.-|..|-.+|..-+.+-|++++-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 3456666789999999999999999999965 5889999988763 23344568889999999999999999999999
Q ss_pred cccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecc
Q 017262 140 VEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 219 (374)
Q Consensus 140 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 219 (374)
.+++|+||||++||+|...+.. ...+++..+.-++..|+-||.-+|+.| +|||||||+|||+|..|++||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 9999999999999999999974 337999999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCceeeecccccccccCcccccc-----CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHH
Q 017262 220 TSRSIAIDQTHVSTKVQGTFGYLDPEYFRS-----SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECI 294 (374)
Q Consensus 220 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 294 (374)
.+-.+..+........+|||.|.+||++.. +.|+..+|.||+|+++|||+.|..||- .+++..-+....
T Consensus 221 sClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY------adslveTY~KIm 294 (1317)
T KOG0612|consen 221 SCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY------ADSLVETYGKIM 294 (1317)
T ss_pred hHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch------HHHHHHHHHHHh
Confidence 998877667777777889999999999752 568999999999999999999999995 234444444333
Q ss_pred HhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 017262 295 EENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPT---MKEVAM 342 (374)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps---~~~vl~ 342 (374)
...... ..+....++....+||++.+. +|+.|-. ++++..
T Consensus 295 ~hk~~l-------~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 295 NHKESL-------SFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred chhhhc-------CCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 332221 112224577889999999984 5677766 766654
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=287.24 Aligned_cols=281 Identities=25% Similarity=0.386 Sum_probs=224.1
Q ss_pred HHHhhcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCChhHHHHHHHHHHHHhhC-CCCceeeeeeeee-----e
Q 017262 67 LDKATDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQI-NHRNVVKLLGCCL-----E 139 (374)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~-----~ 139 (374)
+...++-|++.+.||.|.+|.||+++. ++++..|+|++...... ..+...|.++|+.+ .|||++.+++++. .
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 344467789999999999999999995 46888888887665433 35677899999888 6999999999986 3
Q ss_pred cccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecc
Q 017262 140 VEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 219 (374)
Q Consensus 140 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 219 (374)
++.++||||||.+||.-+.++... +..+.|..+..|++.++.|+.+||++. ++|||||-.|||++.++.|||+|||
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFG 168 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFG 168 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeee
Confidence 568999999999999999998765 778999999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCceeeecccccccccCccccccC-----CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHH
Q 017262 220 TSRSIAIDQTHVSTKVQGTFGYLDPEYFRSS-----QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECI 294 (374)
Q Consensus 220 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 294 (374)
.+..+.. .........|||.|||||++.+. .|+.++|+||||++..||.-|.+|+.++-....
T Consensus 169 vSaQlds-T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra----------- 236 (953)
T KOG0587|consen 169 VSAQLDS-TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA----------- 236 (953)
T ss_pred eeeeeec-ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh-----------
Confidence 9987653 33344567799999999999764 377899999999999999999999875433221
Q ss_pred Hhcccccc-ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH-----------HHHHHHhhCCCCcchhhhcc
Q 017262 295 EENCLFDI-IDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM-----------ELERIRANSRDDENNIQKCY 362 (374)
Q Consensus 295 ~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~-----------~L~~~~~~~~~~~~~~~~~~ 362 (374)
++.+ -++......+......+.++|..||..|...||++.++++ .+....+..-+.........
T Consensus 237 ----LF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~~e~qir~~ik~~~~~~r~~k~~~ 312 (953)
T KOG0587|consen 237 ----LFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQPNERQVRIQIKDHIDRSRKKRGEK 312 (953)
T ss_pred ----hccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccccHHHHHHHHHHHHhhccchhhhc
Confidence 1111 1233333456678889999999999999999999999875 44444444444444444455
Q ss_pred cchhhh
Q 017262 363 GKVEYI 368 (374)
Q Consensus 363 ~~~~~~ 368 (374)
++.|+.
T Consensus 313 e~~e~e 318 (953)
T KOG0587|consen 313 EETEYE 318 (953)
T ss_pred cCccee
Confidence 555443
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=264.27 Aligned_cols=269 Identities=22% Similarity=0.273 Sum_probs=197.2
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecC-----CcEEEEEEeccCC--hhHHHHHHHHHHHHhhCCCCceeeeeeeeee-ccc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLAD-----GRIIAVKKSKVVD--ESKLEEFINEVVILSQINHRNVVKLLGCCLE-VEV 142 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~-----~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~ 142 (374)
...|+....||+|+||.||+|...+ ...+|+|+++... ........+|+.+++.++|||++.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 4568999999999999999996332 2378999876542 2334567899999999999999999999987 678
Q ss_pred ceEEEEeecCCcccccccCC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCC----CcEEEe
Q 017262 143 PLLVYEFIPNGTLFQYLHDP--YEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK----YRAKIA 216 (374)
Q Consensus 143 ~~lv~e~~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~----~~~kl~ 216 (374)
.++++||.+. +|...|+-. .....++...+.+++.||+.|+.|||++- |+||||||.|||+..+ |.|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 8999999976 677766532 23457899999999999999999999999 9999999999999877 899999
Q ss_pred ecccccccccCCcee--eecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCC---hHHHH
Q 017262 217 DFGTSRSIAIDQTHV--STKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRN---LTTYF 290 (374)
Q Consensus 217 Dfg~~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~---~~~~~ 290 (374)
|+|+++.+..+-... ....+.|.+|+|||.+.+ ..|+.+.|||+.||++.||++-++-|......-... ..+-+
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 999999876544332 345678999999999876 569999999999999999999887776443321111 00001
Q ss_pred HHHHH------hcccc---------ccccccccCC-CCH----------HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 291 VECIE------ENCLF---------DIIDDQVRKS-GEA----------EEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 291 ~~~~~------~~~~~---------~~~~~~~~~~-~~~----------~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
....+ +..+. ..+....... .+. .-++...+|+.+||++||.+|.|++++++-
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 11110 00000 0000000000 000 012247789999999999999999998874
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=274.63 Aligned_cols=289 Identities=20% Similarity=0.243 Sum_probs=202.3
Q ss_pred CCCcCceEeeeCeEEEEEEEec-C--CcEEEEEEeccC--ChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeec----cc
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-D--GRIIAVKKSKVV--DESKLEEFINEVVILSQI-NHRNVVKLLGCCLEV----EV 142 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~----~~ 142 (374)
+|++.+.||+|+||.||++... . +..+|+|.+... .......+.+|+.+++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999964 3 678999987642 223345678899999999 599999999875432 35
Q ss_pred ceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccc
Q 017262 143 PLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 222 (374)
Q Consensus 143 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 222 (374)
.+++++++. ++|.+++. ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678888885 68888886 3457899999999999999999999999 9999999999999999999999999997
Q ss_pred ccccCCce---eeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccC---------CChHHH
Q 017262 223 SIAIDQTH---VSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEG---------RNLTTY 289 (374)
Q Consensus 223 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~---------~~~~~~ 289 (374)
........ ......|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||........ ......
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 65432211 1223468899999998765 4688999999999999999999999864331100 000000
Q ss_pred HHHHHHhcc--cccccccccc---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHH--hhCCCCcchhhh
Q 017262 290 FVECIEENC--LFDIIDDQVR---KSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME--LERIR--ANSRDDENNIQK 360 (374)
Q Consensus 290 ~~~~~~~~~--~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~--L~~~~--~~~~~~~~~~~~ 360 (374)
......... .......... ....+..+..+.+++.+|++.||++|||+.+++.. +.+.. ...+.....+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~~~~~~ 313 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFDF 313 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccccccccccC
Confidence 000000000 0000000000 00011124578899999999999999999998752 22221 223334555566
Q ss_pred cccchhhh
Q 017262 361 CYGKVEYI 368 (374)
Q Consensus 361 ~~~~~~~~ 368 (374)
+++..++.
T Consensus 314 ~~~~~~~~ 321 (332)
T cd07857 314 SFESEDSM 321 (332)
T ss_pred CccccccH
Confidence 66665554
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=272.57 Aligned_cols=257 Identities=27% Similarity=0.416 Sum_probs=203.0
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCC-------hhHHHHHHHHHHHHhhCCCCceeeeeeeee-ecc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVD-------ESKLEEFINEVVILSQINHRNVVKLLGCCL-EVE 141 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~ 141 (374)
.++|-+.++||+|+|+.||+|.+ ...+.||+|+-.... ....+...+|..+-+.|+||.||++|++|. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 45778889999999999999994 567888999644321 122345678999999999999999999997 455
Q ss_pred cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEEC---CCCcEEEeec
Q 017262 142 VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD---EKYRAKIADF 218 (374)
Q Consensus 142 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~---~~~~~kl~Df 218 (374)
.+|-|+|||+|.+|+-||. ....+++.++..|+.||+.||.||.... +||+|-||||.|||+. .-|.+||+||
T Consensus 542 sFCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeec
Confidence 7889999999999999998 5668999999999999999999999987 7799999999999995 4578999999
Q ss_pred ccccccccCCce------eeecccccccccCcccccc----CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHH
Q 017262 219 GTSRSIAIDQTH------VSTKVQGTFGYLDPEYFRS----SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTT 288 (374)
Q Consensus 219 g~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~----~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~ 288 (374)
|+++...++... ..+...||.+|++||.+.- ...+.++||||+|+++|+.+.|+.||......
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ------- 690 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ------- 690 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH-------
Confidence 999887543322 2244669999999998753 34788999999999999999999999753321
Q ss_pred HHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 289 YFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
...+..+.+... ........+.++.+...+|++||.+.-++|....++..
T Consensus 691 --QdILqeNTIlkA--tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 691 --QDILQENTILKA--TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred --HHHHhhhchhcc--eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 122222222211 22233344566678889999999999999998888764
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=258.94 Aligned_cols=251 Identities=24% Similarity=0.313 Sum_probs=195.4
Q ss_pred hhcCCCcC-ceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeec----cc
Q 017262 70 ATDYFNMN-RILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQI-NHRNVVKLLGCCLEV----EV 142 (374)
Q Consensus 70 ~~~~~~~~-~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~----~~ 142 (374)
.+++|.+. ++||-|-.|.|..+..+ .++.+|+|.+... ...++|+++-=.. .|||||.+++++.+. ..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45667665 58999999999988854 6889999987643 3456788765444 599999999998643 35
Q ss_pred ceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECC---CCcEEEeecc
Q 017262 143 PLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE---KYRAKIADFG 219 (374)
Q Consensus 143 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfg 219 (374)
+.+|||.|+||.|...+++. ....+++.++-.|+.||+.|+.|||+.+ |.||||||+|+|... |..+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 67999999999999999865 4557999999999999999999999999 999999999999964 5579999999
Q ss_pred cccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccc
Q 017262 220 TSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCL 299 (374)
Q Consensus 220 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (374)
+++.... ........-||.|.|||++....|+...|+||+|+++|-|++|..||-+..... +..-....+.
T Consensus 210 FAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---ispgMk~rI~---- 280 (400)
T KOG0604|consen 210 FAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPGMKRRIR---- 280 (400)
T ss_pred cccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---CChhHHhHhh----
Confidence 9986542 223344567999999999999999999999999999999999999997544321 1111111111
Q ss_pred cccccccccCCC-C-HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 300 FDIIDDQVRKSG-E-AEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 300 ~~~~~~~~~~~~-~-~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
........ . ..+++...++|+.+|..+|++|.|+++++.
T Consensus 281 ----~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 281 ----TGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ----ccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 11111111 1 244678899999999999999999999986
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=239.53 Aligned_cols=260 Identities=22% Similarity=0.315 Sum_probs=196.8
Q ss_pred CCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC--hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEee
Q 017262 74 FNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFI 150 (374)
Q Consensus 74 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 150 (374)
|.-.++||+|+||+||+|+.+ .+..||+|++...+ +..-....+|+-+++.++|.||+++++....++...+|+|||
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 444578999999999999965 47889999876643 344567889999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 230 (374)
..+|..|... -++.++.+.+.+++.|+++||.++|+++ +.|||+||.|.|++.+|.+||+|||+++.++.+-.
T Consensus 84 -dqdlkkyfds--lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr- 156 (292)
T KOG0662|consen 84 -DQDLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR- 156 (292)
T ss_pred -hHHHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE-
Confidence 4578887765 4667999999999999999999999999 99999999999999999999999999987664332
Q ss_pred eeecccccccccCccccccC-CCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHH--Hhccccc---cc
Q 017262 231 VSTKVQGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECI--EENCLFD---II 303 (374)
Q Consensus 231 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~---~~ 303 (374)
..+..+.|.+|.+|.++.+. -|++..|+||-||++.|+.. |++-|++..- .+.+...+...- .++.+.. +.
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv--ddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH--HHHHHHHHHHhCCCccccCCccccCC
Confidence 23445679999999998765 58999999999999999998 5555654321 122222222110 1111111 11
Q ss_pred cccccCCCC---------HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 304 DDQVRKSGE---------AEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 304 ~~~~~~~~~---------~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
|-.....++ +.....=++|+++.+.-+|..|.++++.++
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 111111111 122234568999999999999999998765
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=261.91 Aligned_cols=220 Identities=21% Similarity=0.199 Sum_probs=176.3
Q ss_pred eCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeecCCcccccccC
Q 017262 83 GGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHD 161 (374)
Q Consensus 83 G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 161 (374)
|.+|.||++... +++.+|+|.+.... ....|...+....|||++++++++.+.+..+++|||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999964 68899999886542 223445555566799999999999999999999999999999998863
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceeeecccccccc
Q 017262 162 PYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 241 (374)
Q Consensus 162 ~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y 241 (374)
...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++++|||.+...... .....++..|
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y 148 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMY 148 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccc
Confidence 346899999999999999999999998 999999999999999999999999987654321 1223456789
Q ss_pred cCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHH
Q 017262 242 LDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSD 321 (374)
Q Consensus 242 ~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 321 (374)
+|||......++.++|+||+|+++|+|++|..|+....... ........+...+..+.+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~ 207 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------------------NTHTTLNIPEWVSEEARS 207 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------------------ccccccCCcccCCHHHHH
Confidence 99999988888999999999999999999998875321100 000111122334567889
Q ss_pred HHHHhcccCCCCCCCHH
Q 017262 322 VAKRCLNSYGRNRPTMK 338 (374)
Q Consensus 322 li~~cl~~~p~~Rps~~ 338 (374)
++.+|++.||++||++.
T Consensus 208 li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 208 LLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHccCCHHHhcCCC
Confidence 99999999999999974
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=289.58 Aligned_cols=145 Identities=29% Similarity=0.402 Sum_probs=130.5
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
++|.+.+.||.|+||.||+|... +++.||+|++... .......+..|+.+++.++||||+++++++...+..++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57889999999999999999975 6889999987643 2334467888999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccc
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 222 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 222 (374)
||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999863 446889999999999999999999998 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=277.25 Aligned_cols=240 Identities=23% Similarity=0.263 Sum_probs=193.2
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccceEEEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 148 (374)
++.|.....+|.|+|+.|-.+.. .+++..++|.+.... ....+|+.++... +|||++++.+.+.+..+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 67788888899999999988885 457888999876541 2233577666665 79999999999999999999999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEE-CCCCcEEEeecccccccccC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL-DEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill-~~~~~~kl~Dfg~~~~~~~~ 227 (374)
.+.++-+.+.+... .....++..|+.+|+.|+.|||.+| ++||||||+|||+ ++.++++|+|||.++....+
T Consensus 397 ~l~g~ell~ri~~~----~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSK----PEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHhc----chhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 99998887777632 2223677889999999999999999 9999999999999 69999999999999876544
Q ss_pred CceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (374)
.....-|..|.|||+.....|+.++|+||||++||+|++|+.||.....+. .+.. .-.
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~------ei~~------------~i~ 527 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI------EIHT------------RIQ 527 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH------HHHH------------hhc
Confidence 222245778999999999999999999999999999999999997654431 0111 111
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
...+....+....+|+.+||+.||.+||++.++..-
T Consensus 528 ~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 528 MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred CCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 122235667789999999999999999999998764
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=263.47 Aligned_cols=262 Identities=23% Similarity=0.293 Sum_probs=199.7
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecC-CcEEEEEEeccCChhHHHHHHHHHHHHhhCC-C-Cc----eeeeeeeeeecccc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFINEVVILSQIN-H-RN----VVKLLGCCLEVEVP 143 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-~n----iv~~~~~~~~~~~~ 143 (374)
+.+|.+...+|+|+||.|-.+.++. +..+|+|+++... ...+..+-|+++|+++. + |+ ++.+.++|.-.++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 7899999999999999999998654 6889999887653 33456677999999993 2 22 77888899999999
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECC--------------
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE-------------- 209 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~-------------- 209 (374)
++|+|.+ |-|+.+++..+ +..+++...+..++.|+++++++||+.+ ++|.||||+|||+.+
T Consensus 167 Civfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence 9999999 77999999865 4567899999999999999999999999 999999999999942
Q ss_pred ------CCcEEEeecccccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccC
Q 017262 210 ------KYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEG 283 (374)
Q Consensus 210 ------~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~ 283 (374)
+..++++|||.++...... +..+.|..|.|||++.+-.++.++||||+||+|+|+++|..-|+...+.+.
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 3458999999997643222 455678999999999999999999999999999999999999986653320
Q ss_pred ---------CChHHHHHHH-----HHhcccc-----------ccccccc----cCCCCHHHHHHHHHHHHHhcccCCCCC
Q 017262 284 ---------RNLTTYFVEC-----IEENCLF-----------DIIDDQV----RKSGEAEEIMAVSDVAKRCLNSYGRNR 334 (374)
Q Consensus 284 ---------~~~~~~~~~~-----~~~~~~~-----------~~~~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~R 334 (374)
..+....... ...+++. ...+... .......+...+.+|+++||.+||.+|
T Consensus 318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 1111111111 0011000 0000000 001122445579999999999999999
Q ss_pred CCHHHHHH
Q 017262 335 PTMKEVAM 342 (374)
Q Consensus 335 ps~~~vl~ 342 (374)
+|+.|++.
T Consensus 398 iTl~EAL~ 405 (415)
T KOG0671|consen 398 ITLREALS 405 (415)
T ss_pred ccHHHHhc
Confidence 99999875
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=257.79 Aligned_cols=253 Identities=23% Similarity=0.310 Sum_probs=193.2
Q ss_pred CcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCCh-hHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccceEEEEeec
Q 017262 75 NMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE-SKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVPLLVYEFIP 151 (374)
Q Consensus 75 ~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 151 (374)
+-...||.|+||+|++..++ .|+..|||++..... .+..+++.|.+...+- +.||||+++|.+..++..++.||.|
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM- 145 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM- 145 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-
Confidence 33467999999999998854 689999999886544 5567788888775554 7999999999999999999999999
Q ss_pred CCcccccccCC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 152 NGTLFQYLHDP--YEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 152 ~g~L~~~l~~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
..||+.+.... .....+++.-+.++....+.||.||...- .|+|||+||+|||++..|.+||||||++..+.. +
T Consensus 146 d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~--S 221 (361)
T KOG1006|consen 146 DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD--S 221 (361)
T ss_pred hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH--H
Confidence 55666554321 13456889889999999999999998865 399999999999999999999999999977643 3
Q ss_pred eeeecccccccccCccccccC--CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccc
Q 017262 230 HVSTKVQGTFGYLDPEYFRSS--QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (374)
...+...|...|||||.+... .|+.+|||||||++|||+.||..|+..-. +.-+.+.+.. .+..+.+..
T Consensus 222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-----svfeql~~Vv-~gdpp~l~~--- 292 (361)
T KOG1006|consen 222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-----SVFEQLCQVV-IGDPPILLF--- 292 (361)
T ss_pred HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-----HHHHHHHHHH-cCCCCeecC---
Confidence 333445688899999998643 48999999999999999999999986311 1111111111 111111111
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.....+.+..+..+|.-|+..|.+.||+..++++
T Consensus 293 -~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 293 -DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred -cccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 1112345678999999999999999999998876
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=281.01 Aligned_cols=259 Identities=21% Similarity=0.270 Sum_probs=169.6
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEecC-----CcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeee------ee
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLAD-----GRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGC------CL 138 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~------~~ 138 (374)
..++|.+.+.||+|+||.||+|...+ +..+|+|++...... ..+..+ .++...+.++..+... ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 46789999999999999999999654 688999987643221 111111 1222222222222222 23
Q ss_pred ecccceEEEEeecCCcccccccCCCC-----------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccC
Q 017262 139 EVEVPLLVYEFIPNGTLFQYLHDPYE-----------------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIK 201 (374)
Q Consensus 139 ~~~~~~lv~e~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk 201 (374)
.....++|+||+++++|.+++..... ........+..++.|++.||.|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 45678999999999999988864210 001123446689999999999999998 9999999
Q ss_pred CCceEECC-CCcEEEeecccccccccCCceeeecccccccccCccccccC----------------------CCCccchh
Q 017262 202 STNILLDE-KYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSS----------------------QFTDKSDV 258 (374)
Q Consensus 202 ~~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----------------------~~~~~~Di 258 (374)
|+|||+++ ++.+||+|||++...............+++.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999985 67999999999986654444444556789999999965322 23446799
Q ss_pred hhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcc----ccccccccccC------CCCHHHHHHHHHHHHHhcc
Q 017262 259 YSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENC----LFDIIDDQVRK------SGEAEEIMAVSDVAKRCLN 328 (374)
Q Consensus 259 ~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~ 328 (374)
|||||++|||+++..|+... ...+.......+. +.......... +..........+|+.+||+
T Consensus 363 wSlGviL~el~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSN-------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred HHHHHHHHHHHhCcCCCchH-------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence 99999999999987764321 1111111100000 00000010000 0000112245589999999
Q ss_pred cCCCCCCCHHHHHH
Q 017262 329 SYGRNRPTMKEVAM 342 (374)
Q Consensus 329 ~~p~~Rps~~~vl~ 342 (374)
.||++|||+.++++
T Consensus 436 ~dP~kR~ta~e~L~ 449 (566)
T PLN03225 436 FKGRQRISAKAALA 449 (566)
T ss_pred CCcccCCCHHHHhC
Confidence 99999999999987
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=253.29 Aligned_cols=238 Identities=32% Similarity=0.423 Sum_probs=192.4
Q ss_pred CeEEEEEEEecC-CcEEEEEEeccCChhH-HHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeecCCcccccccC
Q 017262 84 GQGTVYKGMLAD-GRIIAVKKSKVVDESK-LEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHD 161 (374)
Q Consensus 84 ~~g~v~~~~~~~-~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 161 (374)
+||.||+|...+ ++.+++|......... ...+.+|++.+++++|+|++++++++......++++|++++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999764 8899999887655444 67889999999999999999999999998999999999999999999874
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceeeecccccccc
Q 017262 162 PYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 241 (374)
Q Consensus 162 ~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y 241 (374)
...+++..++.++.+++.++.+||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++..|
T Consensus 81 ---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 152 (244)
T smart00220 81 ---RGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEY 152 (244)
T ss_pred ---ccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCC
Confidence 223889999999999999999999998 9999999999999999999999999997765332 23345578899
Q ss_pred cCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHH
Q 017262 242 LDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSD 321 (374)
Q Consensus 242 ~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 321 (374)
+|||.+....++.++||||||++++++++|..||.... ...... +......... .......+..+.+
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~-----~~~~~~-~~~~~~~~~~-------~~~~~~~~~~~~~ 219 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD-----QLLELF-KKIGKPKPPF-------PPPEWKISPEAKD 219 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----cHHHHH-HHHhccCCCC-------ccccccCCHHHHH
Confidence 99999988888999999999999999999999986421 111111 1111110100 0000014467899
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 017262 322 VAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 322 li~~cl~~~p~~Rps~~~vl~ 342 (374)
++.+|+..+|++||++.++++
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHccCCchhccCHHHHhh
Confidence 999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=256.97 Aligned_cols=241 Identities=26% Similarity=0.355 Sum_probs=196.7
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecC-CcEEEEEEeccC---ChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccceE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVV---DESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVPLL 145 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 145 (374)
..+|+...+||+|+||.|.+|..+. ...+|||+++.. +..+.+--..|-.+|+.. +-|.+++++.+|..-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 4578999999999999999998654 578899977653 222222334566677766 46789999999999999999
Q ss_pred EEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccc
Q 017262 146 VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 225 (374)
||||+.||+|--.++ +-+.+.+..+.-++..|+-||-+||++| |+.||||.+||++|.+|++||+|||+++.--
T Consensus 428 VMEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence 999999999999888 5667889999999999999999999999 9999999999999999999999999997643
Q ss_pred cCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccc
Q 017262 226 IDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDD 305 (374)
Q Consensus 226 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (374)
.+. .......|||.|+|||.+...+|+.++|.||+|++||||+.|+.||.+... .+.+....+.+
T Consensus 502 ~~~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE------~elF~aI~ehn-------- 566 (683)
T KOG0696|consen 502 FDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE------DELFQAIMEHN-------- 566 (683)
T ss_pred cCC-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHHcc--------
Confidence 322 234556799999999999999999999999999999999999999975332 23333222221
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 017262 306 QVRKSGEAEEIMAVSDVAKRCLNSYGRNRP 335 (374)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 335 (374)
..+|...+.+..++.+..|..+|.+|.
T Consensus 567 ---vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 567 ---VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ---CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 235566677888999999999999994
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=269.23 Aligned_cols=242 Identities=24% Similarity=0.314 Sum_probs=201.6
Q ss_pred cCCCcCceEeeeCeEEEEEEEecCCc-EEEEEEe---ccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLADGR-IIAVKKS---KVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~~~~-~vavK~~---~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
.+++.+..||-|+||.|=++...+.. .+|+|.+ +..+..+...+..|-.+|...+.|.|+++|..|.++...|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34556678999999999998865543 3666644 4456777788999999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
|-|-||.|+..+. .++.++.....-++..++.|+.|||+++ |+.|||||+|.+++.+|.+||.|||+++.+..+
T Consensus 500 EaClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 9999999999998 5678999999999999999999999999 999999999999999999999999999987643
Q ss_pred CceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (374)
...-+..|||.|.|||.+.+...+.++|.||||+++|||++|.+||+..... ..|.. ++..--
T Consensus 574 --~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm-----ktYn~----------ILkGid 636 (732)
T KOG0614|consen 574 --RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM-----KTYNL----------ILKGID 636 (732)
T ss_pred --CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH-----HHHHH----------HHhhhh
Confidence 3345678999999999999999999999999999999999999999854432 22221 111111
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 017262 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPT 336 (374)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps 336 (374)
....|........+||+++...+|.+|..
T Consensus 637 ~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 637 KIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 22344555667889999999999999965
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=269.70 Aligned_cols=266 Identities=21% Similarity=0.261 Sum_probs=181.4
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEe-----------------cCCcEEEEEEeccCChhHHHHH--------------HHH
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGML-----------------ADGRIIAVKKSKVVDESKLEEF--------------INE 118 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~e 118 (374)
..++|.+.++||+|+||.||+|.. .+++.||+|++..........| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999963 2356799999876544333333 346
Q ss_pred HHHHhhCCCCce-----eeeeeeeee--------cccceEEEEeecCCcccccccCCC---------------------C
Q 017262 119 VVILSQINHRNV-----VKLLGCCLE--------VEVPLLVYEFIPNGTLFQYLHDPY---------------------E 164 (374)
Q Consensus 119 ~~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~---------------------~ 164 (374)
+..+.+++|.++ ++++++|.. .+..++||||+++++|.+++.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 667777766554 667777653 346799999999999999886421 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceeeecccccccccCc
Q 017262 165 ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDP 244 (374)
Q Consensus 165 ~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aP 244 (374)
...+++..+..++.|++.+|.|||+.+ ++||||||+||+++.++.+||+|||++...............+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 123466788899999999999999998 99999999999999999999999999875433222111222357899999
Q ss_pred cccccCCC----------------------CccchhhhHHHHHHHHHhCCC-CCCccccccCCChHHHHHHHHHhccccc
Q 017262 245 EYFRSSQF----------------------TDKSDVYSFGVVLVELLTGQK-PISSIWANEGRNLTTYFVECIEENCLFD 301 (374)
Q Consensus 245 E~~~~~~~----------------------~~~~Di~slG~~l~el~~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (374)
|.+..... ..+.||||+||++++|++|.. ||........ .... .... ...+..
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~-~~~~-~~~~--~~~~r~ 455 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT-ELRQ-YDND--LNRWRM 455 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh-HHhh-ccch--HHHHHh
Confidence 98754321 134799999999999999876 7653211110 0000 0000 000000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcccCC---CCCCCHHHHHH
Q 017262 302 IIDDQVRKSGEAEEIMAVSDVAKRCLNSYG---RNRPTMKEVAM 342 (374)
Q Consensus 302 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p---~~Rps~~~vl~ 342 (374)
..............+....+|+.+||..+| .+|+|++|+++
T Consensus 456 ~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 456 YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 001111111223345678899999999766 68999999875
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=265.75 Aligned_cols=244 Identities=27% Similarity=0.370 Sum_probs=196.3
Q ss_pred CceEeeeCeEEEEEEEec-CCcEEEEEEecc--CChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeecCC
Q 017262 77 NRILGQGGQGTVYKGMLA-DGRIIAVKKSKV--VDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNG 153 (374)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 153 (374)
.+.||+|.||+||-|+.+ +|+.||||.+.. ....+...+++|+.+|+++.||.||.+...|+..+..++|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 378999999999999964 699999997654 3445557899999999999999999999999999999999999955
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCC---CcEEEeecccccccccCCce
Q 017262 154 TLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK---YRAKIADFGTSRSIAIDQTH 230 (374)
Q Consensus 154 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~---~~~kl~Dfg~~~~~~~~~~~ 230 (374)
+..+.|... ..+.+++..-.-++.||+.||.|||.++ |+|+||||+|||+.+. .++||||||+++.+. ...
T Consensus 648 DMLEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg--Eks 721 (888)
T KOG4236|consen 648 DMLEMILSS-EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIG--EKS 721 (888)
T ss_pred hHHHHHHHh-hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecc--hhh
Confidence 555555433 4567888888889999999999999999 9999999999999654 479999999999875 334
Q ss_pred eeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCC
Q 017262 231 VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKS 310 (374)
Q Consensus 231 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (374)
.....+|||.|+|||++.+..|+..-|+||.|+++|--++|..||....+ +.+.+.+..+... ..
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd---------IndQIQNAaFMyP------p~ 786 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED---------INDQIQNAAFMYP------PN 786 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc---------hhHHhhccccccC------CC
Confidence 44566899999999999999999999999999999999999999963221 2222222222110 11
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 311 GEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 311 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.=.+.+....+||..+|+..-.+|-|.+..+.
T Consensus 787 PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 787 PWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred chhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 11244567889999999999999999887654
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=248.32 Aligned_cols=261 Identities=22% Similarity=0.322 Sum_probs=191.5
Q ss_pred CCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC--hhHHHHHHHHHHHHhhCCCCceeeeeeeeeec--------c
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQINHRNVVKLLGCCLEV--------E 141 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------~ 141 (374)
.|+-..+||+|.||.||+|+.+ .|+.|++|+.-..+ ...-....+|+.+|..++|+|++.+++.|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 3444568999999999999954 57788888654322 23334567899999999999999999988532 2
Q ss_pred cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccc
Q 017262 142 VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 221 (374)
Q Consensus 142 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 221 (374)
..|+|+++|+. +|.-.+.+ ....++..++.+++.++..||.|+|... |+|||+||.|+|++.+|.+||+|||++
T Consensus 98 t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccc
Confidence 47999999965 66666654 3457889999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCce---eeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHH---
Q 017262 222 RSIAIDQTH---VSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECI--- 294 (374)
Q Consensus 222 ~~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--- 294 (374)
+.+..+... ..+..+.|..|++||.+.+ ..|+++.|||+-||++.||+++..-+++.+....- ..+....
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql---~~Is~LcGs~ 248 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQL---HLISQLCGSI 248 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHH---HHHHHHhccC
Confidence 766533322 2344567999999999876 56999999999999999999999888765433211 1111111
Q ss_pred --------Hhccccccc------cccccC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 295 --------EENCLFDII------DDQVRK----SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 295 --------~~~~~~~~~------~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
++-++...+ ....+. ..+..-.+...+|+.+++..||.+|+++.+++.
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 001111111 000000 001111236789999999999999999999875
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=262.21 Aligned_cols=206 Identities=26% Similarity=0.377 Sum_probs=176.7
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecC-CcEEEEEEeccCC---hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVD---ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
+.-|..++.||-|+||+|.++...| ...+|+|.+...+ ..+...+..|-.+|..-+++-||++|-.|.+.+.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 4667788999999999999998544 6688999776543 44556778899999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccc-
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA- 225 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~- 225 (374)
|||++||++-.+|. .-+.+.+..++-++.++..|+++.|+.| .|||||||+|||||.+|++||+|||+++-+.
T Consensus 708 MdYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred EeccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccccee
Confidence 99999999999887 4667889999999999999999999999 9999999999999999999999999985431
Q ss_pred --cC-----Cc---------------------------------eeeecccccccccCccccccCCCCccchhhhHHHHH
Q 017262 226 --ID-----QT---------------------------------HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVL 265 (374)
Q Consensus 226 --~~-----~~---------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l 265 (374)
++ .. ......+||+.|+|||++....|+..+|.||.|++|
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 00 00 001225699999999999999999999999999999
Q ss_pred HHHHhCCCCCCcccccc
Q 017262 266 VELLTGQKPISSIWANE 282 (374)
Q Consensus 266 ~el~~g~~p~~~~~~~~ 282 (374)
|||+.|+.||-.....+
T Consensus 862 ~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGE 878 (1034)
T ss_pred HHHhhCCCCccCCCCCc
Confidence 99999999998766554
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=275.70 Aligned_cols=246 Identities=28% Similarity=0.430 Sum_probs=189.5
Q ss_pred CCCcCceEeeeCeEE-EEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccceEEEEee
Q 017262 73 YFNMNRILGQGGQGT-VYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVPLLVYEFI 150 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~-v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 150 (374)
-|...+++|.|+.|+ ||+|.. +|+.||||++- .+...-..+|+..|+.- +||||+++++.-.+.+..|+..|.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll---~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLL---EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEee-CCceehHHHHh---hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 455567899999975 689988 47799999775 34445667899999999 5999999999999999999999999
Q ss_pred cCCcccccccCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECC---C--CcEEEeeccccccc
Q 017262 151 PNGTLFQYLHDP-YEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE---K--YRAKIADFGTSRSI 224 (374)
Q Consensus 151 ~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~---~--~~~kl~Dfg~~~~~ 224 (374)
..+|.+++... ...........+....|+++||++||+.+ |+||||||.||||+. + ..++|+|||+++.+
T Consensus 586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 66999999863 11111111445788999999999999988 999999999999975 2 46899999999988
Q ss_pred ccCCcee--eecccccccccCccccccCCCCccchhhhHHHHHHHHHhC-CCCCCccccccCCChHHHHHHHHHhccccc
Q 017262 225 AIDQTHV--STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTG-QKPISSIWANEGRNLTTYFVECIEENCLFD 301 (374)
Q Consensus 225 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (374)
..+.... .....||.+|+|||++....-+.++|||||||++|+.++| ..||++.-..+...+. .+..+.
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~-------~~~~L~- 733 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT-------GNYTLV- 733 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc-------Ccccee-
Confidence 7554332 3456799999999999998888899999999999999985 8999854433211000 000010
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 302 IIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 302 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
......++ ...+||.+|++++|..||++.+|+.
T Consensus 734 ------~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 734 ------HLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ------eeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 11111112 6789999999999999999999985
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=242.76 Aligned_cols=247 Identities=25% Similarity=0.379 Sum_probs=199.8
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEecc---CChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccceEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV---VDESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 146 (374)
.+|.+.++||+|+|.+|..+.+. ..+.+|+|+++. .+.+...-...|-.+..+- +||.+|-+..+|.....+++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 57889999999999999999854 578899997654 3344445556677777666 799999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
.||.+||+|--.++ ....++++.+.-+...|+.||.|||+.| |+.||||.+|+|+|..|++||+|+|+++.-..
T Consensus 330 ieyv~ggdlmfhmq---rqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEecCcceeeehh---hhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCC
Confidence 99999999988887 5668999999999999999999999999 99999999999999999999999999976432
Q ss_pred CCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcccccc-CCChHHHHHHHHHhccccccccc
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANE-GRNLTTYFVECIEENCLFDIIDD 305 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 305 (374)
.....+...|||.|.|||.+.+..|...+|.|+||++|+||+.|+.||.-..... ..+..+|..+.+-+..+
T Consensus 404 -~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi------ 476 (593)
T KOG0695|consen 404 -PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI------ 476 (593)
T ss_pred -CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc------
Confidence 2334566789999999999999999999999999999999999999997443322 23444554444332211
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 017262 306 QVRKSGEAEEIMAVSDVAKRCLNSYGRNRP 335 (374)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 335 (374)
+ .|...+-....+++..|+.||++|.
T Consensus 477 --r--iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 477 --R--IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred --c--ccceeehhhHHHHHHhhcCCcHHhc
Confidence 1 1222233455789999999999984
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=241.24 Aligned_cols=260 Identities=22% Similarity=0.309 Sum_probs=199.7
Q ss_pred CCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCC--hhHHHHHHHHHHHHhhCCCCceeeeeeeeeec-----ccceE
Q 017262 74 FNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVD--ESKLEEFINEVVILSQINHRNVVKLLGCCLEV-----EVPLL 145 (374)
Q Consensus 74 ~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~l 145 (374)
.+..+.||-|+||.||.+.+ ++|+.+++|++...- -...+.+.+|+.+|..++|.|++..+++..-. +..|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34567899999999999985 689999999876532 23456788999999999999999988876533 24578
Q ss_pred EEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccc
Q 017262 146 VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 225 (374)
++|.| ..+|...|- ....++...+.-+..||++||.|||+.+ |.||||||.|.|++++..+||||||+++...
T Consensus 135 ~TELm-QSDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 135 LTELM-QSDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHH-Hhhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence 88888 668888887 4557888899999999999999999999 9999999999999999999999999999888
Q ss_pred cCCceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcc------
Q 017262 226 IDQTHVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENC------ 298 (374)
Q Consensus 226 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------ 298 (374)
.++...++..+.|..|.|||.+++ ..|+.+.||||.||++.|++..+.-|......+. .+.+.+......
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQ---L~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQ---LQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHH---HHHHHHHhCCCcHHHHHH
Confidence 777777777788999999999887 4699999999999999999999888865443221 111111111100
Q ss_pred -----cccccccccc---------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 299 -----LFDIIDDQVR---------KSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 299 -----~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
..-++....+ ...+.........+...++.++|+.|.+..+.+.-
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH 343 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence 0001111110 01122334466788999999999999999888763
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=226.23 Aligned_cols=206 Identities=25% Similarity=0.381 Sum_probs=167.9
Q ss_pred HHHhhcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccC-ChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccc
Q 017262 67 LDKATDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV-DESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVP 143 (374)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 143 (374)
++...+....+..||+|++|.|-+.++ .+|...|+|.+... +.....+.++|+.+..+. .+|.+|.++|........
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 344445555667899999999988774 57999999987754 334445677888876655 799999999999999999
Q ss_pred eEEEEeecCCcccccccCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccc
Q 017262 144 LLVYEFIPNGTLFQYLHDP-YEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 222 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 222 (374)
++.||.| ..||+.+..+. ..+..+++.-+-+|+..+..||.|||++-+ ++|||+||+|||++.+|++|+||||++.
T Consensus 121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccce
Confidence 9999999 56777665432 256789999999999999999999999853 9999999999999999999999999998
Q ss_pred ccccCCceeeecccccccccCcccccc----CCCCccchhhhHHHHHHHHHhCCCCCCc
Q 017262 223 SIAIDQTHVSTKVQGTFGYLDPEYFRS----SQFTDKSDVYSFGVVLVELLTGQKPISS 277 (374)
Q Consensus 223 ~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~Di~slG~~l~el~~g~~p~~~ 277 (374)
.+.++- ..+-..|...|||||.+.. ..|+.++||||||+++.||.+++.||+.
T Consensus 198 ~L~dSi--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 198 YLVDSI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred eehhhh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 765322 2233457888999999753 3689999999999999999999999963
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=226.30 Aligned_cols=258 Identities=22% Similarity=0.332 Sum_probs=194.1
Q ss_pred hcCCCcCceEeeeCeEEEEEEE-ecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCC-CCceeeeeeeeeecc--cceEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQIN-HRNVVKLLGCCLEVE--VPLLV 146 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~--~~~lv 146 (374)
.++|++.+++|+|.++.||.|. ..++..+++|.++. -..+.+.+|+.+|+.+. ||||++++++..+.. .+.+|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4678999999999999999999 45678899999885 34567889999999997 999999999987654 67899
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCC-CcEEEeecccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK-YRAKIADFGTSRSIA 225 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfg~~~~~~ 225 (374)
+||+++.+...... .++...+..++.++++||.|+|+.| |.|||+||.|+++|.. -.++|+|||++.+..
T Consensus 114 FE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 99998887666443 5777889999999999999999999 9999999999999864 569999999998876
Q ss_pred cCCceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccC-----------CChHHHHHHH
Q 017262 226 IDQTHVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEG-----------RNLTTYFVEC 293 (374)
Q Consensus 226 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~-----------~~~~~~~~~~ 293 (374)
+.... +..+.+..|--||.+.. ..|+.+-|+|||||++..|+..+.||-...+..+ +.+..|+...
T Consensus 185 p~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY 262 (338)
T KOG0668|consen 185 PGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY 262 (338)
T ss_pred CCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence 54433 23345677899999865 4578899999999999999999999864322211 1111122111
Q ss_pred HH--hcccccccccc--------ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 294 IE--ENCLFDIIDDQ--------VRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 294 ~~--~~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.- ...+..++... ...+...-.+++..+|+.+.|..|-.+|||++|++.
T Consensus 263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 00 00011111111 111111122467889999999999999999999875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=238.22 Aligned_cols=132 Identities=27% Similarity=0.392 Sum_probs=111.2
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCC-----C---Cceeeeeeeeeec--
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQIN-----H---RNVVKLLGCCLEV-- 140 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~~~~~~~~~-- 140 (374)
++|-+.++||=|.|++||++.+. ..+.||+|+.+.. ....+....||++|++++ | .+||++++.|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 68889999999999999999964 5678999988754 334466789999999983 3 3699999999754
Q ss_pred --ccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEEC
Q 017262 141 --EVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD 208 (374)
Q Consensus 141 --~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~ 208 (374)
.+.++|+|++ |.+|..+|... .-..++...+.+|+.|++.||.|||... +|||.||||+|||+.
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 4789999999 77888877654 4567999999999999999999999975 599999999999993
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=223.57 Aligned_cols=210 Identities=39% Similarity=0.610 Sum_probs=182.5
Q ss_pred EeeeCeEEEEEEEecC-CcEEEEEEeccCChh-HHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeecCCcccc
Q 017262 80 LGQGGQGTVYKGMLAD-GRIIAVKKSKVVDES-KLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQ 157 (374)
Q Consensus 80 lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~ 157 (374)
||+|.+|.||++...+ ++.+++|........ ....+.+|+..++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999764 889999988765433 35678899999999999999999999999889999999999999999
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECC-CCcEEEeecccccccccCCceeeeccc
Q 017262 158 YLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE-KYRAKIADFGTSRSIAIDQTHVSTKVQ 236 (374)
Q Consensus 158 ~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 236 (374)
++... ...+++..+..++.+++.++++||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 154 (215)
T cd00180 81 LLKEN--EGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV 154 (215)
T ss_pred HHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence 98742 146889999999999999999999998 999999999999999 89999999999876543321 123345
Q ss_pred ccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCHHH
Q 017262 237 GTFGYLDPEYFRSS-QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEE 315 (374)
Q Consensus 237 g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (374)
+...|++||..... .++.++|+|++|+++++|
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 78889999999877 788999999999999999
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 316 IMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 316 ~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 367899999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-33 Score=247.73 Aligned_cols=264 Identities=20% Similarity=0.227 Sum_probs=205.7
Q ss_pred HHhhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCC------CCceeeeeeeeeec
Q 017262 68 DKATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQIN------HRNVVKLLGCCLEV 140 (374)
Q Consensus 68 ~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~~~~~~ 140 (374)
+...++|.+....|+|-|++|..|... .|+.||||++...... ...=+.|+++|++|+ --|+++++..|.+.
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 445678999999999999999999964 4789999999875333 345568999999995 34899999999999
Q ss_pred ccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCC-CcEEEeecc
Q 017262 141 EVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK-YRAKIADFG 219 (374)
Q Consensus 141 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfg 219 (374)
+++|+|+|.+ ..+|.+.|........+....+..++.|+.-||..|...+ |+|.||||+||||++. ..+||||||
T Consensus 507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCc
Confidence 9999999988 7799999987656677888999999999999999999999 9999999999999865 568999999
Q ss_pred cccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHH-----
Q 017262 220 TSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECI----- 294 (374)
Q Consensus 220 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~----- 294 (374)
.|..... ...+++..+..|.|||.+.+-+|+...|+||.||+||||.||+.-|++.+.... ..++.++.
T Consensus 583 SA~~~~e---neitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~M---Lrl~me~KGk~p~ 656 (752)
T KOG0670|consen 583 SASFASE---NEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQM---LRLFMELKGKFPN 656 (752)
T ss_pred ccccccc---ccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHH---HHHHHHhcCCCcH
Confidence 9876543 223455567789999999999999999999999999999999999987665421 11111110
Q ss_pred -------------Hhc-----------------cccccccc-----------cccCCCCHHHHHHHHHHHHHhcccCCCC
Q 017262 295 -------------EEN-----------------CLFDIIDD-----------QVRKSGEAEEIMAVSDVAKRCLNSYGRN 333 (374)
Q Consensus 295 -------------~~~-----------------~~~~~~~~-----------~~~~~~~~~~~~~l~~li~~cl~~~p~~ 333 (374)
+.+ .+...+.+ .-..+........|.+|+.+||..||+.
T Consensus 657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K 736 (752)
T KOG0670|consen 657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK 736 (752)
T ss_pred HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence 000 00000000 0011223345578999999999999999
Q ss_pred CCCHHHHHH
Q 017262 334 RPTMKEVAM 342 (374)
Q Consensus 334 Rps~~~vl~ 342 (374)
|.|..++|+
T Consensus 737 Rit~nqAL~ 745 (752)
T KOG0670|consen 737 RITVNQALK 745 (752)
T ss_pred cCCHHHHhc
Confidence 999998875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=253.64 Aligned_cols=255 Identities=24% Similarity=0.350 Sum_probs=208.3
Q ss_pred HhhcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 69 KATDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
...++|+..+.+|.|+||.||++++ +.++..|+|.++........-..+|+-+++..+||||+.+++.+...+..++.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 3457899999999999999999995 568899999999888888888899999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
|||.+|+|++..+ -.+.+++.++...++..++|++|||+.+ =+|||||-.||++++.|.+|+.|||.+..+...
T Consensus 92 EycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 92 EYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred EecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh
Confidence 9999999999887 4678999999999999999999999999 789999999999999999999999998766532
Q ss_pred CceeeecccccccccCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFR---SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIID 304 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (374)
........||+.|||||+.. .+.|...+|||++|+...|+---+.|....-.. ...+..- ....+
T Consensus 166 -i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm-----r~l~LmT------kS~~q 233 (829)
T KOG0576|consen 166 -IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM-----RALFLMT------KSGFQ 233 (829)
T ss_pred -hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH-----HHHHHhh------ccCCC
Confidence 22334567999999999863 567899999999999999998888775321111 1111000 01111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 305 DQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 305 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
+. .........+.+.++++.|+..+|++|||++.++.
T Consensus 234 pp-~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 234 PP-TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CC-cccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11 11223455678999999999999999999998764
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=230.32 Aligned_cols=260 Identities=22% Similarity=0.314 Sum_probs=192.5
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEecc--CChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc------
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKV--VDESKLEEFINEVVILSQINHRNVVKLLGCCLEVE------ 141 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 141 (374)
..+|.-.+.+|.|.- .|..+.+ -.++.|++|++.. .+........+|..++..++|+||++++.+|.-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 356777778888887 5555553 3578899997543 23445567789999999999999999999987443
Q ss_pred cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccc
Q 017262 142 VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 221 (374)
Q Consensus 142 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 221 (374)
..|+|||+| ..+|...+. ..++=..+..+..|++.|+.|||+.+ |+||||||+||++..++.+|+.|||++
T Consensus 95 e~y~v~e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence 569999999 668888776 23556677899999999999999999 999999999999999999999999999
Q ss_pred cccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccC--------CChHH-HHHH
Q 017262 222 RSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEG--------RNLTT-YFVE 292 (374)
Q Consensus 222 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~--------~~~~~-~~~~ 292 (374)
+.... ...++.++.+..|.|||++.+..+...+||||+||++.||++|..-|.+....+. ..+.. +..+
T Consensus 166 r~e~~--~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 166 RTEDT--DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred cccCc--ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 76433 2567888899999999999988899999999999999999999998874322110 00000 0000
Q ss_pred H-------HHhc------cccccc-cccccC--CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 293 C-------IEEN------CLFDII-DDQVRK--SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 293 ~-------~~~~------~~~~~~-~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
. ..+. .+.+.+ |...+. +.+........+|+.+||..||++|.|+++++.
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 0 0000 011111 111111 112223456889999999999999999999986
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=220.55 Aligned_cols=256 Identities=19% Similarity=0.273 Sum_probs=190.2
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEecC-CcEEEEEEeccCChhHHHHHHHHHHHHhhC-CCCceeeeeee-eeecccceEE
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFINEVVILSQI-NHRNVVKLLGC-CLEVEVPLLV 146 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~-~~~~~~~~lv 146 (374)
..+.|.+.+.+|+|.||.+-++.++. .+.+++|-+... ......|.+|...--.| .|.||+..++. |...+.++++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 35779999999999999999999764 667888877654 34457888888876666 48999988876 5666788899
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEEC--CCCcEEEeeccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD--EKYRAKIADFGTSRSI 224 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~--~~~~~kl~Dfg~~~~~ 224 (374)
+||++.|+|...+. ...+.+.....++.|+++|+.|+|+++ ++|||||.+|||+- +...+||||||+++..
T Consensus 101 qE~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred eccCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccccc
Confidence 99999999998885 357889999999999999999999999 99999999999994 3458999999998654
Q ss_pred ccCCceeeecccccccccCccccccC-----CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccc
Q 017262 225 AIDQTHVSTKVQGTFGYLDPEYFRSS-----QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCL 299 (374)
Q Consensus 225 ~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (374)
+. ......-+..|.|||..... ...+.+|+|.||++++.+++|..||+..+..+. ..|-...+..+..
T Consensus 174 g~----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~---~Y~~~~~w~~rk~ 246 (378)
T KOG1345|consen 174 GT----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK---PYWEWEQWLKRKN 246 (378)
T ss_pred Cc----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc---hHHHHHHHhcccC
Confidence 31 12222345568999976432 246789999999999999999999996555443 2333333333322
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 017262 300 FDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELER 346 (374)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~ 346 (374)
....+. ....++.+.++.++-++.+|++|-...++.++-..
T Consensus 247 ~~~P~~------F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~ 287 (378)
T KOG1345|consen 247 PALPKK------FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKC 287 (378)
T ss_pred ccCchh------hcccCHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence 211111 11223467789999999999999555555554433
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=242.61 Aligned_cols=196 Identities=23% Similarity=0.365 Sum_probs=167.1
Q ss_pred cCCCcCceEeeeCeEEEEEEEecC-CcEEEEEEeccCC--------hhHHHHHHHHHHHHhhCC---CCceeeeeeeeee
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVD--------ESKLEEFINEVVILSQIN---HRNVVKLLGCCLE 139 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~ 139 (374)
..|...+.+|.|+||.|++|.++. ...|++|.+.... ....-.+-.|+.+|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 458889999999999999999754 5678888665421 111123456999999997 9999999999999
Q ss_pred cccceEEEEee-cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeec
Q 017262 140 VEVPLLVYEFI-PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADF 218 (374)
Q Consensus 140 ~~~~~lv~e~~-~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 218 (374)
++++|++||.. ++-+|.++|. ....+++.++.-|+.|++.|+++||+++ |+|||||-+||.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 99999999976 5668899998 4567999999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCceeeecccccccccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCC
Q 017262 219 GTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQF-TDKSDVYSFGVVLVELLTGQKPIS 276 (374)
Q Consensus 219 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~ 276 (374)
|.+.... +......+||..|.|||++.+..| ....|||+||+++|.++..+.||-
T Consensus 715 gsaa~~k---sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTK---SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhc---CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9986543 333455679999999999999887 456899999999999999999984
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=221.09 Aligned_cols=198 Identities=38% Similarity=0.573 Sum_probs=172.2
Q ss_pred CCcCceEeeeCeEEEEEEEecC-CcEEEEEEeccCChh-HHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeec
Q 017262 74 FNMNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDES-KLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIP 151 (374)
Q Consensus 74 ~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 151 (374)
|.+.+.||.|++|.||++...+ ++.+++|........ ....+.+|++.+++++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667899999999999999765 889999988765554 66788999999999999999999999998889999999999
Q ss_pred CCcccccccCCCCCCC-CCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce
Q 017262 152 NGTLFQYLHDPYEELS-LTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230 (374)
Q Consensus 152 ~g~L~~~l~~~~~~~~-l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 230 (374)
+++|.+++... .. +++..+..++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+.........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKK---GGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 99999998742 23 889999999999999999999998 999999999999999999999999998876543211
Q ss_pred eeecccccccccCcccc-ccCCCCccchhhhHHHHHHHHHhCCCCCCc
Q 017262 231 VSTKVQGTFGYLDPEYF-RSSQFTDKSDVYSFGVVLVELLTGQKPISS 277 (374)
Q Consensus 231 ~~~~~~g~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~g~~p~~~ 277 (374)
......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22334577889999998 667788899999999999999999999953
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=222.93 Aligned_cols=263 Identities=22% Similarity=0.322 Sum_probs=195.7
Q ss_pred HHhhcCCCcCceEeeeCeEEEEEEEec----CCcEEEEEEeccCChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeeccc
Q 017262 68 DKATDYFNMNRILGQGGQGTVYKGMLA----DGRIIAVKKSKVVDESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEV 142 (374)
Q Consensus 68 ~~~~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 142 (374)
......|...++||.|+|++||++... .+..||+|.+...+. -..+.+|+++|..+ .+.||+++.+++...+.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 344567899999999999999999854 367899998776433 34678999999999 49999999999999999
Q ss_pred ceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEEC-CCCcEEEeecccc
Q 017262 143 PLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD-EKYRAKIADFGTS 221 (374)
Q Consensus 143 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~~ 221 (374)
..+|+||++.....++.. .++...+..+++.++.||+++|++| |+||||||+|+|.+ ..+.-.|+|||++
T Consensus 110 v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhH
Confidence 999999999988888775 3667889999999999999999999 99999999999997 4567899999998
Q ss_pred cccc-----------------c----------------CCc----------eeeecccccccccCccccc-cCCCCccch
Q 017262 222 RSIA-----------------I----------------DQT----------HVSTKVQGTFGYLDPEYFR-SSQFTDKSD 257 (374)
Q Consensus 222 ~~~~-----------------~----------------~~~----------~~~~~~~g~~~y~aPE~~~-~~~~~~~~D 257 (374)
.... . +.. .......||++|.|||++. ....++++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 6110 0 000 0112356999999999975 466789999
Q ss_pred hhhHHHHHHHHHhCCCCCCccccccCCChHHHHHH-----------------HHH-hc---------cccccccccccC-
Q 017262 258 VYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVE-----------------CIE-EN---------CLFDIIDDQVRK- 309 (374)
Q Consensus 258 i~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~-----------------~~~-~~---------~~~~~~~~~~~~- 309 (374)
|||.|+++..++++..||-...++.. .+.+...- .++ .+ .+....-.....
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~-al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDAD-ALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred eeeccceeehhhccccccccCccccc-hHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 99999999999999999976554421 11110000 000 00 000000000000
Q ss_pred --------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 310 --------SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 310 --------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
....-.+..+.+|+.+|+..||.+|.|++++|+
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 111122347889999999999999999999986
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=256.94 Aligned_cols=196 Identities=19% Similarity=0.192 Sum_probs=138.8
Q ss_pred hhCCC-Cceeeeeeee-------eecccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 017262 123 SQINH-RNVVKLLGCC-------LEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLP 194 (374)
Q Consensus 123 ~~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ 194 (374)
+.++| +||.+++++| .+.+..+.++|++ +++|.+++.. ....+++.+++.++.||+.||.|||+++
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g--- 100 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQG--- 100 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 34455 5777888877 2334567888987 6699999974 3456999999999999999999999999
Q ss_pred EEEeccCCCceEECCCC-------------------cEEEeecccccccccCC---------------ceeeeccccccc
Q 017262 195 IYHRDIKSTNILLDEKY-------------------RAKIADFGTSRSIAIDQ---------------THVSTKVQGTFG 240 (374)
Q Consensus 195 i~H~dlk~~Nill~~~~-------------------~~kl~Dfg~~~~~~~~~---------------~~~~~~~~g~~~ 240 (374)
|+||||||+|||++..+ .+|++|||+++...... ........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 99999999999996544 45555666554321000 000112357889
Q ss_pred ccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHH
Q 017262 241 YLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVS 320 (374)
Q Consensus 241 y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 320 (374)
|+|||++.+..++.++|||||||++|||++|..|+.... ..+.... .. ...+ ..........
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--------~~~~~~~-~~----~~~~-----~~~~~~~~~~ 242 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--------RTMSSLR-HR----VLPP-----QILLNWPKEA 242 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--------HHHHHHH-Hh----hcCh-----hhhhcCHHHH
Confidence 999999999999999999999999999999888864211 0111110 00 0000 0111223456
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 017262 321 DVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 321 ~li~~cl~~~p~~Rps~~~vl~ 342 (374)
+++.+||+.+|.+||++.++++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhh
Confidence 8899999999999999999976
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-28 Score=200.50 Aligned_cols=170 Identities=22% Similarity=0.226 Sum_probs=128.1
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceee
Q 017262 153 GTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 232 (374)
Q Consensus 153 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 232 (374)
|+|.+++.. .+..+++..++.++.|++.||.|||+.+ ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 678888864 2456999999999999999999999965 999999999999999 99987654321
Q ss_pred ecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCC
Q 017262 233 TKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGE 312 (374)
Q Consensus 233 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (374)
..|++.|+|||++.+..++.++|||||||++|||++|+.||..... .............. .... ....+
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~-----~~~~~~~~~~~~~~---~~~~-~~~~~ 132 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE-----LSAILEILLNGMPA---DDPR-DRSNL 132 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch-----hcHHHHHHHHHhcc---CCcc-ccccH
Confidence 2588999999999999999999999999999999999999964321 11111111111000 0000 00112
Q ss_pred HHHHH--HHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 017262 313 AEEIM--AVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350 (374)
Q Consensus 313 ~~~~~--~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~ 350 (374)
..... .+.+++.+||+.+|++|||+.++++.+..+...
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 22333 699999999999999999999999998877654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=203.42 Aligned_cols=249 Identities=22% Similarity=0.379 Sum_probs=199.4
Q ss_pred CCcCceEeeeCeEEEEEEEecCCcEEEEEEecc--CChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeec
Q 017262 74 FNMNRILGQGGQGTVYKGMLADGRIIAVKKSKV--VDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIP 151 (374)
Q Consensus 74 ~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 151 (374)
.....+|.....|..|+|+++.+. +++|++.. ........|..|.-.|+.+.||||..+++.|....++.++..||+
T Consensus 192 lnl~tkl~e~hsgelwrgrwqgnd-ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQGND-IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCcccccccccCcc-hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 345567889999999999997655 55565543 223334678889999999999999999999999999999999999
Q ss_pred CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEe--ecccccccccCCc
Q 017262 152 NGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIA--DFGTSRSIAIDQT 229 (374)
Q Consensus 152 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~--Dfg~~~~~~~~~~ 229 (374)
.|+|...+++. .+-..+..++.+++.++++|++|||+.... |.---|....+++|++.+++|+ |--++..
T Consensus 271 ~gslynvlhe~-t~vvvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltarismad~kfsfq------ 342 (448)
T KOG0195|consen 271 FGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARISMADTKFSFQ------ 342 (448)
T ss_pred chHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhheecccceeeee------
Confidence 99999999865 345677889999999999999999998842 3344788999999999988875 3322211
Q ss_pred eeeecccccccccCccccccCCCC---ccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 230 HVSTKVQGTFGYLDPEYFRSSQFT---DKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~~~~~---~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
.....-.|.||+||.+...+.+ .++|+|||++++||+.|.+.||......+ .-..+.-..
T Consensus 343 --e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme---------------cgmkialeg 405 (448)
T KOG0195|consen 343 --EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME---------------CGMKIALEG 405 (448)
T ss_pred --ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh---------------hhhhhhhcc
Confidence 1112346789999999865533 57999999999999999999998665543 233445567
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 017262 307 VRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIR 348 (374)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~ 348 (374)
++...++..+..+.+|+.-|++.||.+||.+..++-.|++++
T Consensus 406 lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 406 LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 778888899999999999999999999999999999999885
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=195.33 Aligned_cols=266 Identities=15% Similarity=0.200 Sum_probs=210.3
Q ss_pred hcCCCcCceEeeeCeEEEEEEE-ecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCC-CCceeeeeeeeeecccceEEEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQIN-HRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 148 (374)
.-.|.++++||+|+||.++.|+ +-+++.||||.... .+...++..|....+.|. .++|+..+-+...+.+-.+|+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 4579999999999999999999 56789999997654 334567888999999995 7999999988887778889999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCC-----cEEEeecccccc
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY-----RAKIADFGTSRS 223 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~-----~~kl~Dfg~~~~ 223 (374)
.+ |-||++.+.- .++.++.+.+..+|.|++.-++|+|++. +|.|||||+|+||...+ .+.++|||+++.
T Consensus 105 LL-GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 105 LL-GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hh-CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 98 8899987754 5678999999999999999999999999 99999999999997543 489999999998
Q ss_pred cccCCceee------ecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhc
Q 017262 224 IAIDQTHVS------TKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEEN 297 (374)
Q Consensus 224 ~~~~~~~~~------~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 297 (374)
+.++.+... ....||..||+-....+.+.|.+.|+=|||.++++++-|.+||++.....-..-++-+.+.....
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T 258 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST 258 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence 876654432 34569999999999999999999999999999999999999999877654322222222222111
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCC
Q 017262 298 CLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRD 353 (374)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~ 353 (374)
.+..+.. ..|.++..-++-.-+.+-.+-|..+-+...+..+....-.
T Consensus 259 ~i~~Lc~---------g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~ 305 (449)
T KOG1165|consen 259 PIEVLCE---------GFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGE 305 (449)
T ss_pred CHHHHHh---------cCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCC
Confidence 2221111 2345666677777777888889999888888887765543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-25 Score=204.12 Aligned_cols=262 Identities=21% Similarity=0.226 Sum_probs=199.3
Q ss_pred CCCcCceEeeeCeEEEEEEEecCC--cEEEEEEeccCChhHHHHHHHHHHHHhhCCC----Cceeeeeeee-eecccceE
Q 017262 73 YFNMNRILGQGGQGTVYKGMLADG--RIIAVKKSKVVDESKLEEFINEVVILSQINH----RNVVKLLGCC-LEVEVPLL 145 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~~~--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~~~~~~-~~~~~~~l 145 (374)
+|.+.+.||+|+||.||.+...+. ..+|+|............+..|..++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999997653 4788887665433333367778888888862 6889999998 46778899
Q ss_pred EEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCC-----CcEEEeeccc
Q 017262 146 VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK-----YRAKIADFGT 220 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~-----~~~kl~Dfg~ 220 (374)
||+.+ |.+|.++.... ....++...+..++.|++.+|.++|+.| ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~-~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRN-PPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhC-CCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99988 88999977543 2578999999999999999999999999 9999999999999765 4699999999
Q ss_pred cc--ccccCCce--e-----eecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHH
Q 017262 221 SR--SIAIDQTH--V-----STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFV 291 (374)
Q Consensus 221 ~~--~~~~~~~~--~-----~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 291 (374)
++ ........ . .....||..|+++....+...+.+.|+||++.++.++..|..||........ ..-+.
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~---~~~~~ 250 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL---KSKFE 250 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch---HHHHH
Confidence 98 33222211 1 1235599999999999999999999999999999999999999975543221 11111
Q ss_pred HHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhC
Q 017262 292 ECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANS 351 (374)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~ 351 (374)
+....... .. .....+..+.++...+-+.+..++|....+...|+......
T Consensus 251 ~~~~~~~~----~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 251 KDPRKLLT----DR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHhhhhcc----cc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 11111111 00 11222345666777777799999999999999998887765
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-26 Score=186.34 Aligned_cols=266 Identities=17% Similarity=0.214 Sum_probs=207.3
Q ss_pred hcCCCcCceEeeeCeEEEEEEE-ecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCC-CceeeeeeeeeecccceEEEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQINH-RNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e 148 (374)
.+.|.+.++||.|+||.+|.|. ..+|..||+|...... ...++.-|..+.+.+++ ..|+.+..+..+...-.+|||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 5679999999999999999999 5789999999866432 23467789999999974 778888888888888899999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECC---CCcEEEeecccccccc
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE---KYRAKIADFGTSRSIA 225 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfg~~~~~~ 225 (374)
.+ |.+|.+.+.- .+..++...++.++-|++.-++|+|.++ .+||||||+|+|..- ...+.|+|||+|+.+.
T Consensus 92 LL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 98 8899988764 4567889999999999999999999999 999999999999964 3468999999998775
Q ss_pred cCCcee------eecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccc
Q 017262 226 IDQTHV------STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCL 299 (374)
Q Consensus 226 ~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (374)
+..+.. .....||..|.+-....+...+.+.|+=|+|.++.++--|..||++........-.+-+.+..-.-.+
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i 245 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI 245 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence 443322 23456999999988888888899999999999999999999999977665433333333222221111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCC
Q 017262 300 FDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRD 353 (374)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~ 353 (374)
..+ ...+ |.++.-.+.-|-...-++-|...-+-+.+..+..+.+-
T Consensus 246 e~L-----C~G~----P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~ 290 (341)
T KOG1163|consen 246 EVL-----CKGF----PAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNH 290 (341)
T ss_pred HHH-----hCCC----cHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccc
Confidence 111 1112 34677788888888888888888888887777766553
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=203.81 Aligned_cols=167 Identities=19% Similarity=0.161 Sum_probs=129.6
Q ss_pred HHHhhcCCCcCceEeeeCeEEEEEEEec--CCcEEEEEEeccC-----ChhHHHHHHHHHHHHhhCCCCceee-eeeeee
Q 017262 67 LDKATDYFNMNRILGQGGQGTVYKGMLA--DGRIIAVKKSKVV-----DESKLEEFINEVVILSQINHRNVVK-LLGCCL 138 (374)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~-~~~~~~ 138 (374)
.....++|.+.+.||+|+||+||+|... +++.+|+|+.... .......+.+|+++|++++|+|+++ +++
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~--- 89 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA--- 89 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---
Confidence 3445678999999999999999999864 5777899976432 2233566899999999999999985 443
Q ss_pred ecccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEecc-CCCceEECCCCcEEEee
Q 017262 139 EVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDI-KSTNILLDEKYRAKIAD 217 (374)
Q Consensus 139 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dl-k~~Nill~~~~~~kl~D 217 (374)
.+..++||||++|++|... . .. . ...++.+++++|.|||+.+ |+|||| ||+|||++.++.+||+|
T Consensus 90 -~~~~~LVmE~~~G~~L~~~-~---~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 90 -TGKDGLVRGWTEGVPLHLA-R---PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred -cCCcEEEEEccCCCCHHHh-C---cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEE
Confidence 2457999999999998632 1 11 1 1467889999999999999 999999 99999999999999999
Q ss_pred cccccccccCCcee-------eecccccccccCccccccC
Q 017262 218 FGTSRSIAIDQTHV-------STKVQGTFGYLDPEYFRSS 250 (374)
Q Consensus 218 fg~~~~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~ 250 (374)
||+++.+....... .....+++.|+|||.+...
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99998765432111 1345578889999998643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.7e-26 Score=217.48 Aligned_cols=253 Identities=23% Similarity=0.262 Sum_probs=189.0
Q ss_pred CcCceEeeeCeEEEEEEEec-CCcEEEEEEe-----ccCChhHH-HHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 75 NMNRILGQGGQGTVYKGMLA-DGRIIAVKKS-----KVVDESKL-EEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 75 ~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~-----~~~~~~~~-~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
...+++|.|++|.|+..... .....+.|.. ........ ..+..|+.+-..++|||++.....+.+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 46678999999977777643 2333333322 22222222 22667888888899999988888777766666669
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
|||++ +|..++.. ...+...++--++.|++.|+.|+|+.| +.|||+|++|++++.+|.+|++|||.+.....+
T Consensus 401 E~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 99998873 346888889999999999999999999 999999999999999999999999998776533
Q ss_pred Cc---eeeecccccccccCccccccCCCCc-cchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccc
Q 017262 228 QT---HVSTKVQGTFGYLDPEYFRSSQFTD-KSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDII 303 (374)
Q Consensus 228 ~~---~~~~~~~g~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (374)
.. .......|+..|+|||.+.+..|++ ..||||.|+++..|.+|+.||......+... .........-
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--------~~~~~~~~~~ 545 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--------KTNNYSDQRN 545 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--------hhhccccccc
Confidence 33 4556778999999999999999876 5799999999999999999998665544321 0000000111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
............+...+.++.+||+.+|..|.|++++++
T Consensus 546 ~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 546 IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 111111122345667889999999999999999999986
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-23 Score=186.76 Aligned_cols=261 Identities=31% Similarity=0.404 Sum_probs=196.9
Q ss_pred CCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChh---HHHHHHHHHHHHhhCCCC-ceeeeeeeeeecccceEEEEe
Q 017262 74 FNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDES---KLEEFINEVVILSQINHR-NVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 74 ~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~ 149 (374)
|.+.+.||.|+|+.||++... ..+++|.+...... ....+.+|+..++.+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677789999999999999987 67888876653322 467889999999999988 799999999777778999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCC-cEEEeecccccccccCC
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY-RAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~~ 228 (374)
+.++++.+++........++......++.|++.++.|+|+.+ ++|||+||+||+++..+ .++++|||.+.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999976653211136889999999999999999999999 99999999999999988 79999999987554333
Q ss_pred ce-----eeecccccccccCcccccc---CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccc
Q 017262 229 TH-----VSTKVQGTFGYLDPEYFRS---SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLF 300 (374)
Q Consensus 229 ~~-----~~~~~~g~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (374)
.. ......++..|+|||.+.+ ..++...|+|++|++++++++|..||...... ................
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc
Confidence 22 2355679999999999987 57889999999999999999999997643321 0011111111111111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 301 DIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
.................+.+++.+|+..+|..|.+..+....
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 -SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000001112233578899999999999999999887765
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.4e-25 Score=211.65 Aligned_cols=245 Identities=19% Similarity=0.217 Sum_probs=181.1
Q ss_pred CCCcCceEeeeCeEEEEEEEecCCcEEEEEEecc-CChhHHHHHH---HHHHHHhhCCCCceeeeeeeeeecccceEEEE
Q 017262 73 YFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKV-VDESKLEEFI---NEVVILSQINHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~-~~~~~~~~~~---~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 148 (374)
++...+.||.+.|-+|.+|++++|. |++|+.-. .+.-....+. .|++ ...+++||.+++..+...+...|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 6778899999999999999998887 77776433 3233334443 4444 555689999999988888888899999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccc--c
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA--I 226 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~--~ 226 (374)
|.. .+|.+.+. .+.-+...+...|+.|++.||..+|+.| |+|||||.+|||+++-.-+.|+||..-+... .
T Consensus 102 yvk-hnLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 102 YVK-HNLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HHh-hhhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 994 48888887 5667888899999999999999999999 9999999999999999999999998765432 2
Q ss_pred CCc----eeeecccccccccCccccccCC-----------CCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHH
Q 017262 227 DQT----HVSTKVQGTFGYLDPEYFRSSQ-----------FTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYF 290 (374)
Q Consensus 227 ~~~----~~~~~~~g~~~y~aPE~~~~~~-----------~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~ 290 (374)
++. ....+.....+|.|||.+.... .+++.||||+||+++||++ |++||.-
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------------- 241 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------------- 241 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-------------
Confidence 221 1223334556899999875421 5678999999999999999 6888752
Q ss_pred HHHHHhccc-cccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 291 VECIEENCL-FDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 291 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
.+..+-... .......+..-. ...++.++..|++.||+.|.++++.++.
T Consensus 242 SQL~aYr~~~~~~~e~~Le~Ie----d~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 242 SQLLAYRSGNADDPEQLLEKIE----DVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHhHhccCccCHHHHHHhCc----CccHHHHHHHHHccCchhccCHHHHHHh
Confidence 111111111 000000000000 1157899999999999999999999986
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-23 Score=177.32 Aligned_cols=171 Identities=12% Similarity=0.125 Sum_probs=131.9
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHH---HH------HHHHHHHHhhCCCCceeeeeeeeeec
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKL---EE------FINEVVILSQINHRNVVKLLGCCLEV 140 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~---~~------~~~e~~~l~~l~h~niv~~~~~~~~~ 140 (374)
..++|...+++|.|+||.||.+.. ++..+|+|.+........ .. +.+|+..+.++.||+|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 368999999999999999999766 567899998865322221 22 57899999999999999998886543
Q ss_pred --------ccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCc
Q 017262 141 --------EVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR 212 (374)
Q Consensus 141 --------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~ 212 (374)
...+++|||++|.+|.++.. +++ ....+++.++..+|+.| ++|||++|+|++++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 35789999999999977632 222 24569999999999999 99999999999999988
Q ss_pred EEEeecccccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHH
Q 017262 213 AKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELL 269 (374)
Q Consensus 213 ~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 269 (374)
++|+|||.......+... ........+..++|+|+||+++..+.
T Consensus 173 i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999987644211110 01334455678999999999877654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.5e-23 Score=171.28 Aligned_cols=139 Identities=19% Similarity=0.152 Sum_probs=108.6
Q ss_pred CceEeeeCeEEEEEEEecCCcEEEEEEeccCChhH--------------------------HHHHHHHHHHHhhCCCCce
Q 017262 77 NRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESK--------------------------LEEFINEVVILSQINHRNV 130 (374)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~e~~~l~~l~h~ni 130 (374)
...||+|+||.||+|...+|+.||+|+++...... ......|+..+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46799999999999998889999999886532110 0122359999999988776
Q ss_pred eeeeeeeeecccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCEEEeccCCCceEECC
Q 017262 131 VKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYL-HSSAYLPIYHRDIKSTNILLDE 209 (374)
Q Consensus 131 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~l-H~~~~~~i~H~dlk~~Nill~~ 209 (374)
....... ....++||||++++++..... ....++...+..++.|++.+|.++ |+.+ ++||||||+||+++
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 4433322 223489999998887765433 235688999999999999999999 6888 99999999999998
Q ss_pred CCcEEEeeccccccc
Q 017262 210 KYRAKIADFGTSRSI 224 (374)
Q Consensus 210 ~~~~kl~Dfg~~~~~ 224 (374)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=176.75 Aligned_cols=232 Identities=19% Similarity=0.245 Sum_probs=149.1
Q ss_pred CCcCceEeeeCeEEEEEEEecC-CcEEEEEEeccCC---hhHHHHHHHHHHHHhhCCC----------Cceeeeeeeeee
Q 017262 74 FNMNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVD---ESKLEEFINEVVILSQINH----------RNVVKLLGCCLE 139 (374)
Q Consensus 74 ~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h----------~niv~~~~~~~~ 139 (374)
+...+.||.|+++.||.+.+.+ ++.+++|...... ....+++.+|.-....+.+ -.++-.++....
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 4556789999999999999765 8999999754322 2345667776655555322 122222232211
Q ss_pred ---------c---c-----cceEEEEeecCCcccccccCCC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEe
Q 017262 140 ---------V---E-----VPLLVYEFIPNGTLFQYLHDPY----EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHR 198 (374)
Q Consensus 140 ---------~---~-----~~~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~ 198 (374)
. . +.+++|+-+ .++|.+++..-. ....+....++.+..|+++.+++||+.| ++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence 1 1 336677777 678877754211 1122344555778899999999999999 9999
Q ss_pred ccCCCceEECCCCcEEEeecccccccccCCceeeecccccccccCccccccC--------CCCccchhhhHHHHHHHHHh
Q 017262 199 DIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSS--------QFTDKSDVYSFGVVLVELLT 270 (374)
Q Consensus 199 dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--------~~~~~~Di~slG~~l~el~~ 270 (374)
||+|+|++++.+|.++|+||+....... .......+..|.|||..... .++.+.|.|+||+++|.|++
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGT----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTE----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCc----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 9999999999999999999987654321 11113456789999976442 46889999999999999999
Q ss_pred CCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCC
Q 017262 271 GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNR 334 (374)
Q Consensus 271 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 334 (374)
|..||........... ....+. +.++.+.+||..+|+.||.+|
T Consensus 246 ~~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999986544332111 223344 788899999999999999987
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-22 Score=185.15 Aligned_cols=219 Identities=25% Similarity=0.466 Sum_probs=167.7
Q ss_pred HhhCCCCceeeeeeeeeecccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccC
Q 017262 122 LSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIK 201 (374)
Q Consensus 122 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk 201 (374)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. ....+++.-...++++++.||+|+|+.. + -.|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i-~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP-I-GYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc-c-eeeeeec
Confidence 4578899999999999999999999999999999999986 4667889999999999999999999976 2 2999999
Q ss_pred CCceEECCCCcEEEeecccccccccC-CceeeecccccccccCccccccCC-------CCccchhhhHHHHHHHHHhCCC
Q 017262 202 STNILLDEKYRAKIADFGTSRSIAID-QTHVSTKVQGTFGYLDPEYFRSSQ-------FTDKSDVYSFGVVLVELLTGQK 273 (374)
Q Consensus 202 ~~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~-------~~~~~Di~slG~~l~el~~g~~ 273 (374)
+.|+++|....+||+|||+....... .........-...|.|||.+.... .+.++|+||+|++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998765321 111112222456799999987642 4667999999999999999999
Q ss_pred CCCccccccCCChHHHHHHHHHhccccccccccccCCCC--HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhC
Q 017262 274 PISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGE--AEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANS 351 (374)
Q Consensus 274 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~ 351 (374)
||......... .+.+.. ++. .-....++... .+.++.+..++.+||..+|.+||+++.+-..++.+....
T Consensus 157 ~~~~~~~~~~~--~eii~~-~~~-----~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 157 PFDLRNLVEDP--DEIILR-VKK-----GGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred ccccccccCCh--HHHHHH-HHh-----cCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 99864443322 222222 111 01111111111 134447889999999999999999999999999988765
Q ss_pred C
Q 017262 352 R 352 (374)
Q Consensus 352 ~ 352 (374)
.
T Consensus 229 ~ 229 (484)
T KOG1023|consen 229 S 229 (484)
T ss_pred c
Confidence 4
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.3e-22 Score=197.04 Aligned_cols=257 Identities=18% Similarity=0.255 Sum_probs=192.2
Q ss_pred HHHHHhhcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCC---CCceeeeeeeeeecc
Q 017262 65 KELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQIN---HRNVVKLLGCCLEVE 141 (374)
Q Consensus 65 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~ 141 (374)
.+.+.....|.+.+.||+|+||+||.|...+|+.+|+|.-+..+..+. .--.+++.+|+ -+.|..+..+..-.+
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf---YI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF---YICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee---eehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 344555678999999999999999999988899999998876554331 11122333333 345566666666677
Q ss_pred cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEEC-------CCCcEE
Q 017262 142 VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD-------EKYRAK 214 (374)
Q Consensus 142 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~-------~~~~~k 214 (374)
..++|+||.+.|+|.++++ ....+++..+..++.|++..+.+||..+ |||+||||+|++|. +.-.++
T Consensus 768 ~S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred cceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceE
Confidence 8899999999999999998 6778999999999999999999999999 99999999999994 234699
Q ss_pred Eeecccccccc-cCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHH
Q 017262 215 IADFGTSRSIA-IDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVEC 293 (374)
Q Consensus 215 l~Dfg~~~~~~-~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 293 (374)
|+|||.+..+. ..+.......++|..+-.+|...+..++.++|.|.|+-+++-|+.|+.-= ..
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q--~~-------------- 905 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME--VK-------------- 905 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH--hc--------------
Confidence 99999997654 23344556677899999999999999999999999999999999987431 00
Q ss_pred HHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCC
Q 017262 294 IEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSR 352 (374)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~ 352 (374)
++.. ..++..++. .-......+++..+|+.+-..=|...++...|+.......
T Consensus 906 --~g~~-~~~~~~~~R---y~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~ 958 (974)
T KOG1166|consen 906 --NGSS-WMVKTNFPR---YWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEHF 958 (974)
T ss_pred --CCcc-eeccccchh---hhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHHH
Confidence 0000 011111110 0111245578888888555555888888888888877544
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=163.82 Aligned_cols=140 Identities=23% Similarity=0.221 Sum_probs=110.3
Q ss_pred CceEeeeCeEEEEEEEecCCcEEEEEEeccCChh--------------------------HHHHHHHHHHHHhhCCCCce
Q 017262 77 NRILGQGGQGTVYKGMLADGRIIAVKKSKVVDES--------------------------KLEEFINEVVILSQINHRNV 130 (374)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~h~ni 130 (374)
.+.||+|++|.||+|...+|+.||+|.+...... ....+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999987654211 01123578999999999987
Q ss_pred eeeeeeeeecccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCEEEeccCCCceEECC
Q 017262 131 VKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS-SAYLPIYHRDIKSTNILLDE 209 (374)
Q Consensus 131 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~i~H~dlk~~Nill~~ 209 (374)
.....+... ..++||||++++++..... ....++......++.|++.++.++|+ .| ++|+||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 544433322 3489999998875543322 23457788999999999999999999 88 99999999999999
Q ss_pred CCcEEEeecccccccc
Q 017262 210 KYRAKIADFGTSRSIA 225 (374)
Q Consensus 210 ~~~~kl~Dfg~~~~~~ 225 (374)
++.++|+|||++....
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 8899999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.8e-22 Score=173.95 Aligned_cols=197 Identities=21% Similarity=0.242 Sum_probs=141.3
Q ss_pred CCCceeeeeeeeeec---------------------------ccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHH
Q 017262 126 NHRNVVKLLGCCLEV---------------------------EVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIAT 178 (374)
Q Consensus 126 ~h~niv~~~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~ 178 (374)
+||||+.+.+.|.+. ...|+||... ..+|..++.. ...+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc----CCCchHHHHHHHH
Confidence 599999999887542 2457888877 4588888863 3455666778999
Q ss_pred HHHHHHHHHhhcCCCCEEEeccCCCceEEC--CCC--cEEEeeccccccccc-----CCceeeecccccccccCcccccc
Q 017262 179 EVAEALAYLHSSAYLPIYHRDIKSTNILLD--EKY--RAKIADFGTSRSIAI-----DQTHVSTKVQGTFGYLDPEYFRS 249 (374)
Q Consensus 179 ~i~~~l~~lH~~~~~~i~H~dlk~~Nill~--~~~--~~kl~Dfg~~~~~~~-----~~~~~~~~~~g~~~y~aPE~~~~ 249 (374)
|+++|+.|||++| |.|||+|++|||+. +|+ .+.++|||++.-... +.........|...-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 99999999999993 333 578899998743221 11111233457888999999764
Q ss_pred CC------CCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHH
Q 017262 250 SQ------FTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVA 323 (374)
Q Consensus 250 ~~------~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 323 (374)
.+ .-.++|.|+.|.+.||+++...||-+......+ ...| ........+..+++.+++|+
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~-~r~Y--------------qe~qLPalp~~vpp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD-TRTY--------------QESQLPALPSRVPPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec-hhhh--------------hhhhCCCCcccCChHHHHHH
Confidence 32 235899999999999999999999753221111 1111 11111223455667899999
Q ss_pred HHhcccCCCCCCCHHHHHHHHH
Q 017262 324 KRCLNSYGRNRPTMKEVAMELE 345 (374)
Q Consensus 324 ~~cl~~~p~~Rps~~~vl~~L~ 345 (374)
...|+.||++||+..-....|+
T Consensus 491 ~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHhcCCccccCCccHHHhHHH
Confidence 9999999999999887766554
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.8e-21 Score=157.51 Aligned_cols=185 Identities=16% Similarity=0.083 Sum_probs=137.4
Q ss_pred CcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChh----HHHHHHHHHHHHhhCC-CCceeeeeeeeeecccceEEEEe
Q 017262 75 NMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDES----KLEEFINEVVILSQIN-HRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 75 ~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~----~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
.+...|++|+||+|+.+.. .+.+++.+.+...... ....+.+|+++|+++. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4557899999999997665 6677777766654332 1235789999999995 5889999886 346899999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEecc-CCCceEECCCCcEEEeecccccccccCC
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDI-KSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dl-k~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
++|.+|...+. . ....++.|++.+|.++|++| |+|||| ||+|||++.++.++|+|||++.......
T Consensus 80 I~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 99988865432 1 11357789999999999999 999999 7999999999999999999998544322
Q ss_pred ce----e--------eecccccccccCccccccC-CCC-ccchhhhHHHHHHHHHhCCCCCCc
Q 017262 229 TH----V--------STKVQGTFGYLDPEYFRSS-QFT-DKSDVYSFGVVLVELLTGQKPISS 277 (374)
Q Consensus 229 ~~----~--------~~~~~g~~~y~aPE~~~~~-~~~-~~~Di~slG~~l~el~~g~~p~~~ 277 (374)
.. . ......++.|++|+...-- ..+ ...+.++.|..+|.++|+..|+-.
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 10 0 0112256777777764322 233 567888999999999999988643
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-22 Score=187.89 Aligned_cols=224 Identities=27% Similarity=0.310 Sum_probs=180.4
Q ss_pred EeeeCeEEEEEEE----ecCCcEEEEEEeccCCh--hHHHHHHHHHHHHhhCC-CCceeeeeeeeeecccceEEEEeecC
Q 017262 80 LGQGGQGTVYKGM----LADGRIIAVKKSKVVDE--SKLEEFINEVVILSQIN-HRNVVKLLGCCLEVEVPLLVYEFIPN 152 (374)
Q Consensus 80 lg~G~~g~v~~~~----~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~ 152 (374)
+|+|+||.|+++. ...|..+++|.++.... ........|-.++...+ ||.++++.-.+..+...+++.++..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 6899999999865 23467788886554321 11124556788888886 99999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceee
Q 017262 153 GTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 232 (374)
Q Consensus 153 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 232 (374)
|.|...+. ....+++.....+...++-++.++|+.+ ++|+|+|++||+++.+|.+++.|||+++..-.....
T Consensus 82 g~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 82 GDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred chhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence 99988776 5667888888889999999999999999 999999999999999999999999999865432222
Q ss_pred ecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCC
Q 017262 233 TKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGE 312 (374)
Q Consensus 233 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (374)
.||..|||||.+. ....++|.||+|++++||++|..||.. +... .+ .......+
T Consensus 154 ---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~---------~I--l~~~~~~p 207 (612)
T KOG0603|consen 154 ---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMK---------RI--LKAELEMP 207 (612)
T ss_pred ---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHH---------HH--hhhccCCc
Confidence 7899999999998 557899999999999999999999974 0000 01 11123456
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCH
Q 017262 313 AEEIMAVSDVAKRCLNSYGRNRPTM 337 (374)
Q Consensus 313 ~~~~~~l~~li~~cl~~~p~~Rps~ 337 (374)
.+......+++..++..+|..|--.
T Consensus 208 ~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 208 RELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 6777788899999999999999655
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.3e-20 Score=155.11 Aligned_cols=136 Identities=15% Similarity=0.184 Sum_probs=106.0
Q ss_pred CcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhC-----CCCceeeeeeeeeecc---c-ceE
Q 017262 75 NMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQI-----NHRNVVKLLGCCLEVE---V-PLL 145 (374)
Q Consensus 75 ~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~---~-~~l 145 (374)
.-.+.||+|+||.||. +.+....+||+...........+.+|+.+++.+ +||||+++++++.++. . ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3457899999999996 433333468887765444567889999999999 5799999999998764 3 237
Q ss_pred EEEe--ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHH-HHHhhcCCCCEEEeccCCCceEECC----CCcEEEeec
Q 017262 146 VYEF--IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEAL-AYLHSSAYLPIYHRDIKSTNILLDE----KYRAKIADF 218 (374)
Q Consensus 146 v~e~--~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l-~~lH~~~~~~i~H~dlk~~Nill~~----~~~~kl~Df 218 (374)
|+|| +.+++|.+++.+ ..+++. ..++.+++.++ +|||+++ |+||||||+|||++. ++.++|+|+
T Consensus 83 I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 557999999964 235555 35678888777 9999999 999999999999974 347999995
Q ss_pred ccc
Q 017262 219 GTS 221 (374)
Q Consensus 219 g~~ 221 (374)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 544
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.5e-21 Score=173.11 Aligned_cols=172 Identities=25% Similarity=0.388 Sum_probs=132.1
Q ss_pred cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccc
Q 017262 142 VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 221 (374)
Q Consensus 142 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 221 (374)
.+|+.|++|+..+|.++|.........++...+.++.|++.|+.| ++ .+|+|+||.||+...+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999876677778889999999999999999 66 899999999999999999999999998
Q ss_pred cccccCC-----ceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHH
Q 017262 222 RSIAIDQ-----THVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIE 295 (374)
Q Consensus 222 ~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 295 (374)
....... ....+...||..||+||++.+..|+.++||||||++++|++. -..+|.... ....+.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~----------t~~d~r 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA----------TLTDIR 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH----------hhhhhh
Confidence 7654333 233456779999999999999999999999999999999998 333332110 000011
Q ss_pred hccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 017262 296 ENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMK 338 (374)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 338 (374)
.+. +.+....+++ .-..|+.+++.+.|.+||++.
T Consensus 474 ~g~----ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 474 DGI----IPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred cCC----CChHHhhcCc-----HHHHHHHHhcCCCcccCchHH
Confidence 111 1111112222 334799999999999999443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=9e-19 Score=151.27 Aligned_cols=148 Identities=20% Similarity=0.180 Sum_probs=113.8
Q ss_pred HHHhhcCCCcCceEeeeCeEEEEEEE--ecCCcEEEEEEeccCChh------------------------HHHHHHHHHH
Q 017262 67 LDKATDYFNMNRILGQGGQGTVYKGM--LADGRIIAVKKSKVVDES------------------------KLEEFINEVV 120 (374)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~v~~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~ 120 (374)
+.....-|.+.+.||+|++|.||+|. ..+|+.||+|........ ....+..|+.
T Consensus 23 ~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 102 (237)
T smart00090 23 LLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR 102 (237)
T ss_pred HHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence 33334468899999999999999998 567999999987643210 1123567999
Q ss_pred HHhhCCCC--ceeeeeeeeeecccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEe
Q 017262 121 ILSQINHR--NVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHR 198 (374)
Q Consensus 121 ~l~~l~h~--niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~ 198 (374)
.+.++.+. .++++++. ...++||||+++.+|..... ............++.|++.++++||+.+ +++|+
T Consensus 103 ~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~ 173 (237)
T smart00090 103 NLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHG 173 (237)
T ss_pred HHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeC
Confidence 99999753 34444442 23589999999988876653 2334566677899999999999999987 39999
Q ss_pred ccCCCceEECCCCcEEEeeccccccc
Q 017262 199 DIKSTNILLDEKYRAKIADFGTSRSI 224 (374)
Q Consensus 199 dlk~~Nill~~~~~~kl~Dfg~~~~~ 224 (374)
||||+||+++ ++.++|+|||.+...
T Consensus 174 Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 174 DLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred CCChhhEEEE-CCCEEEEEChhhhcc
Confidence 9999999999 889999999998654
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.6e-18 Score=148.24 Aligned_cols=134 Identities=21% Similarity=0.304 Sum_probs=111.7
Q ss_pred ceEeeeCeEEEEEEEecCCcEEEEEEeccCCh--------hHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 78 RILGQGGQGTVYKGMLADGRIIAVKKSKVVDE--------SKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
+.||+|++|.||+|.. .|..+++|....... .....+.+|+.++..+.|+++.....++.+.+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5789999999999987 566788887543211 1123577899999999999988877777777888999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 223 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 223 (374)
++|++|.+++... .. .+..++.+++.+|.++|+.+ ++|+|++|.||+++ ++.++++|||++..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988631 12 78899999999999999999 99999999999999 78999999998753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.7e-19 Score=172.92 Aligned_cols=208 Identities=25% Similarity=0.341 Sum_probs=144.3
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecC-CcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
..+|+.++.|..|++|.||..+++. .+.+|+|.-+. + .+.+- ++....+|.++
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~-----lilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-N-----LILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhccccc-c-----hhhhc--cccccCCccee------------------
Confidence 5689999999999999999998764 56677743221 1 11100 22222333332
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
|+=...+. .-+.++. +++.+++|||+.+ |+|||+||+|.+|+.-|++|++|||+++.......
T Consensus 136 ---gDc~tllk---~~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLLK---NIGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhcc---cCCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 22222232 2223332 2378999999999 99999999999999999999999999865321111
Q ss_pred e--------------eeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHH
Q 017262 230 H--------------VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIE 295 (374)
Q Consensus 230 ~--------------~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 295 (374)
. ......|||.|.|||++....|...+|.|++|+++|+.+.|..||.+.+.+ +.+...+.
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe------elfg~vis 272 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFGQVIS 272 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH------HHHhhhhh
Confidence 0 112347999999999999999999999999999999999999999754433 33333332
Q ss_pred hccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 017262 296 ENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRP 335 (374)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 335 (374)
.. ....+.....+.+.++++.++|+.+|..|-
T Consensus 273 d~--------i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 273 DD--------IEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hh--------ccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 22 122233444556889999999999999993
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.4e-18 Score=143.88 Aligned_cols=144 Identities=22% Similarity=0.239 Sum_probs=111.3
Q ss_pred HHHHhhcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChh----------------------HHHHHHHHHHHHh
Q 017262 66 ELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDES----------------------KLEEFINEVVILS 123 (374)
Q Consensus 66 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~ 123 (374)
++......|.+.+.||+|+||.||++...+|+.+++|........ .......|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 334444457888999999999999999888999999976542210 1123567888898
Q ss_pred hCCCCc--eeeeeeeeeecccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccC
Q 017262 124 QINHRN--VVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIK 201 (374)
Q Consensus 124 ~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk 201 (374)
.+.|++ ++..++ ....+++|||+++++|...... .....++.+++.++.++|+.+ ++|+||+
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~ 152 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLS 152 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCC
Confidence 887774 444443 2455899999999998765431 234678899999999999998 9999999
Q ss_pred CCceEECCCCcEEEeecccccccc
Q 017262 202 STNILLDEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 202 ~~Nill~~~~~~kl~Dfg~~~~~~ 225 (374)
|+||++++++.++|+|||++....
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCC
Confidence 999999999999999999986544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.6e-18 Score=144.60 Aligned_cols=130 Identities=20% Similarity=0.330 Sum_probs=104.9
Q ss_pred eEeeeCeEEEEEEEecCCcEEEEEEeccCC--h------hHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEee
Q 017262 79 ILGQGGQGTVYKGMLADGRIIAVKKSKVVD--E------SKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFI 150 (374)
Q Consensus 79 ~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 150 (374)
.||+|+||.||+|.. ++..+++|...... . .....+.+|++++..+.|+++.....++...+..+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 379999999999985 56778888754321 1 11355678999999999887665555556667789999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccc
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 223 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 223 (374)
+|++|.+++... .. .++.+++.+|.+||+.+ ++|+|++|+||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~---~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEG---ND-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhc---HH-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999998877531 11 78999999999999999 99999999999999 88999999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.1e-18 Score=165.20 Aligned_cols=138 Identities=20% Similarity=0.281 Sum_probs=111.3
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEecc-CC------hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKV-VD------ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVP 143 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~-~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 143 (374)
...|...+.||+|+||.||++.+.+...++.+.... .. ......+.+|+++++.++|++++....++.+....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 445567889999999999999876544333222211 11 12235678999999999999998887777777788
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccc
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 223 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 223 (374)
++||||+++++|.+++. ....++.+++.+|.+||+.+ ++||||||+||++ +++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999988774 34678999999999999999 9999999999999 677999999999864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1e-18 Score=168.96 Aligned_cols=254 Identities=24% Similarity=0.315 Sum_probs=190.9
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecC--CcEEEEEEeccCC--hhHHHHHHHHHHHHhhCC-CCceeeeeeeeeecccceE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLAD--GRIIAVKKSKVVD--ESKLEEFINEVVILSQIN-HRNVVKLLGCCLEVEVPLL 145 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l 145 (374)
...|.+.+.||+|+|+.|-...... ...++.|...... .........|..+-..+. |+|++.+++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 3457788889999999998877643 3445555544432 233344455777777776 9999999999999999999
Q ss_pred EEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCCEEEeccCCCceEECCCC-cEEEeecccccc
Q 017262 146 VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLH-SSAYLPIYHRDIKSTNILLDEKY-RAKIADFGTSRS 223 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH-~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~~~~ 223 (374)
..+|..++++.+.+... .....+....-.++.|+..++.|+| ..+ +.|+|++|+|.+++..+ ..++.|||++..
T Consensus 99 ~~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 99999999999888321 2225666777889999999999999 777 99999999999999999 999999999987
Q ss_pred ccc--CCceeeecccc-cccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccc
Q 017262 224 IAI--DQTHVSTKVQG-TFGYLDPEYFRSS-QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCL 299 (374)
Q Consensus 224 ~~~--~~~~~~~~~~g-~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (374)
... ..........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+......... .
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~--------------~ 240 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR--------------Y 240 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc--------------c
Confidence 765 33334455668 9999999999874 4567899999999999999999999765543311 1
Q ss_pred cccccccc--cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 300 FDIIDDQV--RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 300 ~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
........ .............+++.+++..+|..|.+.+++-.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 241 SSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred eeecccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 11111111 11122233446778999999999999999987754
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.3e-16 Score=133.64 Aligned_cols=137 Identities=23% Similarity=0.260 Sum_probs=97.9
Q ss_pred CceEeeeCeEEEEEEEecCCcEEEEEEeccCChhH--HHH----------------------HHHHHHHHhhCCCCc--e
Q 017262 77 NRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESK--LEE----------------------FINEVVILSQINHRN--V 130 (374)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~e~~~l~~l~h~n--i 130 (374)
.+.||+|+||+||+|...+++.||+|......... ... ...|...+..+.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999876532211 111 124555566654332 3
Q ss_pred eeeeeeeeecccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCEEEeccCCCceEECC
Q 017262 131 VKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS-SAYLPIYHRDIKSTNILLDE 209 (374)
Q Consensus 131 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~i~H~dlk~~Nill~~ 209 (374)
.+.+++ ...+++|||++++++...... ..... .....++.+++.++.++|. .+ ++|+||+|+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~---~~~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLK---DVRLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhh---hhhhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444433 346899999998654322111 00111 5678899999999999999 88 99999999999999
Q ss_pred CCcEEEeecccccccc
Q 017262 210 KYRAKIADFGTSRSIA 225 (374)
Q Consensus 210 ~~~~kl~Dfg~~~~~~ 225 (374)
++.++++|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.68 E-value=5.9e-16 Score=124.77 Aligned_cols=135 Identities=27% Similarity=0.244 Sum_probs=112.7
Q ss_pred cCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCC--CceeeeeeeeeecccceEEEEeecCC
Q 017262 76 MNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINH--RNVVKLLGCCLEVEVPLLVYEFIPNG 153 (374)
Q Consensus 76 ~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g 153 (374)
+.+.||.|.++.||++...+ ..+++|....... ...+..|+..++.++| .++++++++....+..++++||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35679999999999999855 6789998765433 4578889999999976 58899998888778899999999887
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccc
Q 017262 154 TLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 223 (374)
Q Consensus 154 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 223 (374)
.+..+ +......++.+++.+++.+|.....+++|+|++|+||+++.++.++++|||.+..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 76543 4556678899999999999996434599999999999999989999999998853
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.7e-15 Score=131.14 Aligned_cols=134 Identities=20% Similarity=0.295 Sum_probs=101.9
Q ss_pred ceEe-eeCeEEEEEEEecCCcEEEEEEeccC-------------ChhHHHHHHHHHHHHhhCCCCce--eeeeeeeeecc
Q 017262 78 RILG-QGGQGTVYKGMLADGRIIAVKKSKVV-------------DESKLEEFINEVVILSQINHRNV--VKLLGCCLEVE 141 (374)
Q Consensus 78 ~~lg-~G~~g~v~~~~~~~~~~vavK~~~~~-------------~~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~~ 141 (374)
..|| .|+.|+||.+... +..+++|..... +......+.+|+.++..++|+++ +..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4677 7888888888775 566888866421 11223567889999999998875 66776644332
Q ss_pred ----cceEEEEeecC-CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEe
Q 017262 142 ----VPLLVYEFIPN-GTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIA 216 (374)
Q Consensus 142 ----~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~ 216 (374)
..++|+|++++ .+|.+++.. ..++.. .+.+++.++.+||+.| |+|+||||+|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 23599999997 688888753 244543 3578999999999999 9999999999999999999999
Q ss_pred ecccccc
Q 017262 217 DFGTSRS 223 (374)
Q Consensus 217 Dfg~~~~ 223 (374)
|||.+..
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9998864
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=7.9e-16 Score=132.21 Aligned_cols=203 Identities=21% Similarity=0.292 Sum_probs=142.2
Q ss_pred HHHHhhCCCCceeeeeeeeeecc-----cceEEEEeecCCcccccccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 017262 119 VVILSQINHRNVVKLLGCCLEVE-----VPLLVYEFIPNGTLFQYLHDPY-EELSLTWEMRLRIATEVAEALAYLHSSAY 192 (374)
Q Consensus 119 ~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~ 192 (374)
..-|-++.|.||++++.++.+.. ...++.|||..|++..+|++.. ....+......+|+.||+.||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~- 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD- 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence 33455567999999999987544 4679999999999999998632 3456777888899999999999999998
Q ss_pred CCEEEeccCCCceEECCCCcEEEeecccccccccC----CceeeecccccccccCccccccCCCCccchhhhHHHHHHHH
Q 017262 193 LPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID----QTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVEL 268 (374)
Q Consensus 193 ~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el 268 (374)
+|++|+++.-+.|++..+|-+|++--.-.. .... .........+.++|.|||.=.....+.++|||++|+...+|
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 679999999999999999988875322111 1100 01111223367899999987777778899999999999999
Q ss_pred HhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 269 LTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 269 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..+..--....... ..+.--.+-+...-++. -+.++.+|++..|..||+|.+++-
T Consensus 276 ailEiq~tnseS~~-------~~ee~ia~~i~~len~l------------qr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 276 AILEIQSTNSESKV-------EVEENIANVIIGLENGL------------QRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HHheeccCCCccee-------ehhhhhhhheeeccCcc------------ccCcCcccccCCCCCCcchhhhhc
Confidence 98876422111100 00000001111111121 236889999999999999998764
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.55 E-value=8.9e-14 Score=130.55 Aligned_cols=230 Identities=18% Similarity=0.159 Sum_probs=157.1
Q ss_pred ecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeecCCcccccccCCCCCCCCCHHH
Q 017262 93 LADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEM 172 (374)
Q Consensus 93 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~ 172 (374)
..++.++.+...+..+........+-++.|+.++||||+++++.+..++..|+|+|.+ ..|..++.+ ++...
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH------hHHHH
Confidence 4467788888777666655566778899999999999999999999999999999988 455666652 33666
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceeeecccccccccCccccccCCC
Q 017262 173 RLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQF 252 (374)
Q Consensus 173 ~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 252 (374)
+..-+.||+.||.+||+.++ ++|++|....|+|+..|..||++|.++........ .......-..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence 77788999999999987653 99999999999999999999999988754332111 111122233466676654333
Q ss_pred CccchhhhHHHHHHHHHhCCCCCCcccccc-CCCh----HHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhc
Q 017262 253 TDKSDVYSFGVVLVELLTGQKPISSIWANE-GRNL----TTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCL 327 (374)
Q Consensus 253 ~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 327 (374)
-..|.|.|||++++++.|..+- ..... .... ....-+..... +...+ ...+++..|.
T Consensus 182 -~s~D~~~Lg~li~el~ng~~~~--~~~~~~~~~ipk~~~~~~~k~~~~~--------------~~~r~-n~~~~~~~~~ 243 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNGSLLT--KTDLSNTGKIPKALIELYCKKLGAT--------------ELKRP-NKLRFILECR 243 (690)
T ss_pred -cchhhhhHHHHHHHHhCcccCc--chhhhccCccchhHHHHHHHHhccc--------------ccccc-chhhHHHHHH
Confidence 3469999999999999993321 11110 0000 00000000000 00011 1457788888
Q ss_pred ccCCCCCCCHHHHHHHHHHHHhhCC
Q 017262 328 NSYGRNRPTMKEVAMELERIRANSR 352 (374)
Q Consensus 328 ~~~p~~Rps~~~vl~~L~~~~~~~~ 352 (374)
...+.-|-..-++...|++++-...
T Consensus 244 ~~~gff~n~fvd~~~fLeel~lks~ 268 (690)
T KOG1243|consen 244 LLGGFFRNDFVDTLLFLEELRLKSV 268 (690)
T ss_pred hccccccchHHHHHHHHHhcccCcH
Confidence 8888888888888888888765444
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.7e-14 Score=133.30 Aligned_cols=139 Identities=21% Similarity=0.238 Sum_probs=98.2
Q ss_pred ceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHH----------------------------------------HHHHH
Q 017262 78 RILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKL----------------------------------------EEFIN 117 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~~ 117 (374)
+.||.|++|+||+|+..+|+.||||+......... -.+.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 67999999999999999999999998765321110 01344
Q ss_pred HHHHHhhCC-----CCceeeeeeee-eecccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHH-HHHHHhhc
Q 017262 118 EVVILSQIN-----HRNVVKLLGCC-LEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAE-ALAYLHSS 190 (374)
Q Consensus 118 e~~~l~~l~-----h~niv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~-~l~~lH~~ 190 (374)
|+..+.++. ++++ .+-..+ ......++||||++|++|.++.... ....+ ...++.+++. .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~--~~~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALD--EAGLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHH--hcCCC---HHHHHHHHHHHHHHHHHhC
Confidence 555555552 3332 222222 2234578999999999998876421 11122 3446666665 47888998
Q ss_pred CCCCEEEeccCCCceEECCCCcEEEeecccccccc
Q 017262 191 AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 191 ~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 225 (374)
| ++|+|++|.||+++.++.++++|||++..+.
T Consensus 277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred C---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 8 9999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=5.8e-15 Score=137.06 Aligned_cols=248 Identities=23% Similarity=0.241 Sum_probs=181.6
Q ss_pred cCCCcCceEee--eCeEEEEEEEe---cCCcEEEEEEeccCC--hhHHHHHHHHHHHHhhCC-CCceeeeeeeeeecccc
Q 017262 72 DYFNMNRILGQ--GGQGTVYKGML---ADGRIIAVKKSKVVD--ESKLEEFINEVVILSQIN-HRNVVKLLGCCLEVEVP 143 (374)
Q Consensus 72 ~~~~~~~~lg~--G~~g~v~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~ 143 (374)
..|.+.+.+|. |.+|.+|.+.. .++..+++|+-+..- +..-..=.+|+...+.++ |+|.++.+..+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45677788999 99999999885 357888988744322 222223345666666774 99999999999999999
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHH----HHHHHhhcCCCCEEEeccCCCceEECCC-CcEEEeec
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAE----ALAYLHSSAYLPIYHRDIKSTNILLDEK-YRAKIADF 218 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~----~l~~lH~~~~~~i~H~dlk~~Nill~~~-~~~kl~Df 218 (374)
++-+|++ +.+|..+... ....++...++....+..+ |+.++|+.+ ++|.|+||.||+...+ ...+++||
T Consensus 194 fiqtE~~-~~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeeccc-cchhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 9999999 5788887765 3445788888899999999 999999999 9999999999999999 88999999
Q ss_pred ccccccccCCcee----eecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHH
Q 017262 219 GTSRSIAIDQTHV----STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECI 294 (374)
Q Consensus 219 g~~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 294 (374)
|+...+....... .....|...|++||... +.++..+|+|+||.++.+..++..+........
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------------ 334 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS------------ 334 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC------------
Confidence 9988776544221 12235788899999987 456889999999999999998776654221000
Q ss_pred HhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 295 EENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
+..+-......++-......+...+..|+..+|..|++.+.+..
T Consensus 335 ----W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 335 ----WSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ----ccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 00000011111122222335566999999999999999886654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.2e-12 Score=107.64 Aligned_cols=130 Identities=25% Similarity=0.180 Sum_probs=95.5
Q ss_pred CceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCce-eeeeeeeeecccceEEEEeecCCcc
Q 017262 77 NRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNV-VKLLGCCLEVEVPLLVYEFIPNGTL 155 (374)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~L 155 (374)
.+.++.|.++.||++... +..+++|....... ....+..|+..++.+.+.++ ++++.+. ....++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 356889999999998875 67799998654322 12345789999998865554 3455443 3346899999999887
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCEEEeccCCCceEECCCCcEEEeeccccc
Q 017262 156 FQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSA--YLPIYHRDIKSTNILLDEKYRAKIADFGTSR 222 (374)
Q Consensus 156 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 222 (374)
...- . .....+.+++.+|+.||+.+ ...++|+|++|.||+++ ++.++++||+.+.
T Consensus 79 ~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 5430 0 11345678999999999987 12359999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.2e-11 Score=102.60 Aligned_cols=136 Identities=17% Similarity=0.141 Sum_probs=98.1
Q ss_pred ceEeeeCeEEEEEEEecC-------CcEEEEEEeccC-------------C---------hhHHHHH----HHHHHHHhh
Q 017262 78 RILGQGGQGTVYKGMLAD-------GRIIAVKKSKVV-------------D---------ESKLEEF----INEVVILSQ 124 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~-------~~~vavK~~~~~-------------~---------~~~~~~~----~~e~~~l~~ 124 (374)
..||.|--+.||.|...+ +..+|+|..+.. + ......+ .+|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 568999999999998543 478999954331 0 0112223 379999999
Q ss_pred CCC--CceeeeeeeeeecccceEEEEeecCCcccc-cccCCCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCEEEecc
Q 017262 125 INH--RNVVKLLGCCLEVEVPLLVYEFIPNGTLFQ-YLHDPYEELSLTWEMRLRIATEVAEALAYL-HSSAYLPIYHRDI 200 (374)
Q Consensus 125 l~h--~niv~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~l~~~~~~~i~~~i~~~l~~l-H~~~~~~i~H~dl 200 (374)
+.. -++++++++ ...++||||+.++.+.. .+. ...++......+..+++.+|..+ |+.+ ++|+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 953 456667754 45689999997653322 122 22345556677889999999999 8888 999999
Q ss_pred CCCceEECCCCcEEEeecccccccc
Q 017262 201 KSTNILLDEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 201 k~~Nill~~~~~~kl~Dfg~~~~~~ 225 (374)
++.||+++ ++.+.++|||.+....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 4689999999886544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.38 E-value=7.7e-13 Score=125.95 Aligned_cols=144 Identities=19% Similarity=0.176 Sum_probs=92.7
Q ss_pred cCCCcCceEeeeCeEEEEEEEecC-CcEEEEEEeccCChh----------------------------------HHHH--
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDES----------------------------------KLEE-- 114 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~~-- 114 (374)
..|+. +.||+|++|+||+|+.++ |+.||||+....-.. ....
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 789999999999999887 999999988643110 0111
Q ss_pred ----HHHHHHHHhhCC----CCceeeeeeeeee-cccceEEEEeecCCcccccc--cCC-CCCCCCCHHHHHHHHHHHHH
Q 017262 115 ----FINEVVILSQIN----HRNVVKLLGCCLE-VEVPLLVYEFIPNGTLFQYL--HDP-YEELSLTWEMRLRIATEVAE 182 (374)
Q Consensus 115 ----~~~e~~~l~~l~----h~niv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~-~~~~~l~~~~~~~i~~~i~~ 182 (374)
+.+|+..+.++. +.+.+.+-.++.+ ....++||||++|+.+.++- ... .....+....+..++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 233444444442 3333333233322 34568999999999997642 210 001123333333444444
Q ss_pred HHHHHhhcCCCCEEEeccCCCceEECCCC----cEEEeeccccccccc
Q 017262 183 ALAYLHSSAYLPIYHRDIKSTNILLDEKY----RAKIADFGTSRSIAI 226 (374)
Q Consensus 183 ~l~~lH~~~~~~i~H~dlk~~Nill~~~~----~~kl~Dfg~~~~~~~ 226 (374)
...| ++|+|++|.||+++.++ .++++|||+...+..
T Consensus 277 -----f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 -----FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3466 99999999999999888 999999999876643
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.6e-11 Score=96.77 Aligned_cols=143 Identities=20% Similarity=0.263 Sum_probs=104.5
Q ss_pred cCceEeeeCeEEEEEEEecCCcEEEEEE-ecc-------CChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 76 MNRILGQGGQGTVYKGMLADGRIIAVKK-SKV-------VDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 76 ~~~~lg~G~~g~v~~~~~~~~~~vavK~-~~~-------~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
...++-+|+-+.|+++.+. |+..+||. ... +..-......+|+..|.++.--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5678999999999999885 56666663 211 11122345678999999987556555445566666778999
Q ss_pred EeecC-CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCC---cEEEeecccccc
Q 017262 148 EFIPN-GTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY---RAKIADFGTSRS 223 (374)
Q Consensus 148 e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~---~~kl~Dfg~~~~ 223 (374)
||++| .++.+++...... .........++..+-..+.-||..+ ++|+||..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~-~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMED-ESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccC-cccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 4788888654322 2223333788999999999999999 99999999999996554 358999999864
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.2e-11 Score=96.64 Aligned_cols=131 Identities=23% Similarity=0.291 Sum_probs=99.4
Q ss_pred ceEeeeCeEEEEEEEecCCcEEEEEE-ecc-CC------hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 78 RILGQGGQGTVYKGMLADGRIIAVKK-SKV-VD------ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~vavK~-~~~-~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
..+++|+-+.++.+.+.+. .+++|. +.. .. .-....-.+|+.++.++.--.|.-..=+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~-~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGL-PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCc-ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 3578999999999876443 356662 221 11 11123456799999998766666555566677788899999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 223 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 223 (374)
++|..|.+++... ...++..+-.-+.-||..+ |+|+||.++|+.+..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999988742 2457778888899999999 99999999999998775 99999999864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.29 E-value=9.4e-11 Score=107.31 Aligned_cols=215 Identities=20% Similarity=0.248 Sum_probs=149.9
Q ss_pred EEEEEEE-ecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeee----ecccceEEEEeecC-Ccccccc
Q 017262 86 GTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCL----EVEVPLLVYEFIPN-GTLFQYL 159 (374)
Q Consensus 86 g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----~~~~~~lv~e~~~~-g~L~~~l 159 (374)
.+.|++. ..||..+++|+++......-.....-++.++++.|+|+|++.++|. .+...++|++|.++ ++|.+..
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 5778888 5689999999995443333233445688999999999999999886 34467899999875 4665544
Q ss_pred cCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 160 HDP------------YEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 160 ~~~------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
... ..+...++..+|.++.|+..||.++|+.| +.-+-|.|++|+++.+.+++|+..|....+..+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 321 12345788999999999999999999999 888999999999999999999988887655432
Q ss_pred CceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (374)
.. |-+.+ -.+-|.=.||.+++.|.||..--- ..+..... -
T Consensus 447 ~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~-----~~d~~~~s-----------------~ 486 (655)
T KOG3741|consen 447 PT---------------EPLES---QQQNDLRDLGLLLLALATGTENSN-----RTDSTQSS-----------------H 486 (655)
T ss_pred CC---------------cchhH---HhhhhHHHHHHHHHHHhhcccccc-----cccchHHH-----------------H
Confidence 20 11111 125688999999999999854310 00000000 0
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 017262 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMEL 344 (374)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L 344 (374)
........+.++++++.-..+.++++ -++.+++.++
T Consensus 487 ~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 487 LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 01122344456777888888888776 6677776643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.1e-12 Score=119.05 Aligned_cols=250 Identities=20% Similarity=0.208 Sum_probs=178.4
Q ss_pred HhhcCCCcCceEeeeCeEEEEEEEec--CCcEEEEEEeccCChhHHH--HHHHHHHHHhhC-CCCceeeeeeeeeecccc
Q 017262 69 KATDYFNMNRILGQGGQGTVYKGMLA--DGRIIAVKKSKVVDESKLE--EFINEVVILSQI-NHRNVVKLLGCCLEVEVP 143 (374)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~v~~~~~~--~~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 143 (374)
....+|..+..||.|.|+.|+....+ ++..+++|.+...-..... .-..|+.+...+ .|.+++..+..+...+..
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 34567888899999999999988744 5678888865543222222 224566666666 488888888888877888
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCC-CcEEEeeccccc
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK-YRAKIADFGTSR 222 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfg~~~ 222 (374)
|+--|||+++++...+. ....+++...+.+..|++.++.++|+.. .+|+|++|+||++..+ +..+++|||+..
T Consensus 342 ~ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cCchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence 89999999998887763 4557888889999999999999999988 9999999999999886 788999999986
Q ss_pred ccccCCceeeeccccccccc--CccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccc
Q 017262 223 SIAIDQTHVSTKVQGTFGYL--DPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLF 300 (374)
Q Consensus 223 ~~~~~~~~~~~~~~g~~~y~--aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (374)
.+.... .......++. +|+......+-.++|++|||..+.+..++..--.... . ..
T Consensus 416 ~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-~-----------------~~ 473 (524)
T KOG0601|consen 416 RLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-Q-----------------SL 473 (524)
T ss_pred ccceec----ccccccccccccchhhccccccccccccccccccccccccCcccCcccc-c-----------------ce
Confidence 432111 1112233333 5666667778899999999999999998874322110 0 00
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 017262 301 DIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIR 348 (374)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~ 348 (374)
.+. .......+ .....+..+.+.++..++..||.+.++....+..+
T Consensus 474 ~i~-~~~~p~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 474 TIR-SGDTPNLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred eee-cccccCCC-chHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 111 11111111 22256778999999999999999998876655444
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.27 E-value=8.8e-11 Score=101.00 Aligned_cols=142 Identities=23% Similarity=0.270 Sum_probs=109.4
Q ss_pred ceEeeeCeEEEEEEEecCCcEEEEEEeccCCh-hHHHHHHHHHHHHhhCCC--Cceeeeeeeeeecc---cceEEEEeec
Q 017262 78 RILGQGGQGTVYKGMLADGRIIAVKKSKVVDE-SKLEEFINEVVILSQINH--RNVVKLLGCCLEVE---VPLLVYEFIP 151 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~---~~~lv~e~~~ 151 (374)
+.|+.|..+.+|++...+|..+++|....... .....+..|+++++.+.+ .++++++.+..... ..+++|||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987778899998654322 134567889999999975 34567777766532 5689999999
Q ss_pred CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 017262 152 NGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSA---------------------------------------- 191 (374)
Q Consensus 152 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---------------------------------------- 191 (374)
|.++.+.+.. ..++......++.+++++|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988776531 35677788888889999999998531
Q ss_pred -------------CCCEEEeccCCCceEECC--CCcEEEeecccccc
Q 017262 192 -------------YLPIYHRDIKSTNILLDE--KYRAKIADFGTSRS 223 (374)
Q Consensus 192 -------------~~~i~H~dlk~~Nill~~--~~~~kl~Dfg~~~~ 223 (374)
...++|+|+.|.||+++. ++.+.++||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 134799999999999998 66789999987753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=6.4e-10 Score=99.61 Aligned_cols=273 Identities=17% Similarity=0.169 Sum_probs=167.1
Q ss_pred CcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhC-CCCceeeeeee----e--eec-ccceEE
Q 017262 75 NMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQI-NHRNVVKLLGC----C--LEV-EVPLLV 146 (374)
Q Consensus 75 ~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~----~--~~~-~~~~lv 146 (374)
...+.||+|+-+.+|..-.-.+ .+.|+..........+ ....|... .||-+-.-+.+ . .+. ...-+.
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d--~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRD--QVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecchhhc--hhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 4567899999999986432111 3445544433332222 22233333 56643221111 1 111 124577
Q ss_pred EEeecCC-cccccccC---CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccc
Q 017262 147 YEFIPNG-TLFQYLHD---PYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 222 (374)
Q Consensus 147 ~e~~~~g-~L~~~l~~---~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 222 (374)
|+.+.+. ....++.- ...-....|...++.++.++.+.+-||..| .+-+|+.++|+|+++++.+.|.|-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 7777654 22222221 112234678999999999999999999999 8899999999999999999999865433
Q ss_pred ccccCCceeeecccccccccCccccc-----cCCCCccchhhhHHHHHHHHHhC-CCCCCccccccCC-ChHHHHHHHHH
Q 017262 223 SIAIDQTHVSTKVQGTFGYLDPEYFR-----SSQFTDKSDVYSFGVVLVELLTG-QKPISSIWANEGR-NLTTYFVECIE 295 (374)
Q Consensus 223 ~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g-~~p~~~~~~~~~~-~~~~~~~~~~~ 295 (374)
... +.....-.+|.+.|.+||.-. +..-+...|-|.||+++++++.| +.||++....... +..+ ..+.
T Consensus 166 i~~--ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E---~~Ia 240 (637)
T COG4248 166 INA--NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE---TDIA 240 (637)
T ss_pred ecc--CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch---hhhh
Confidence 221 222223345889999999754 34557789999999999999886 9999876543221 1111 0011
Q ss_pred hccccccccccc-----cCCCCH-HHHHHHHHHHHHhccc--CCCCCCCHHHHHHHHHHHHhhCCCCcchhhh
Q 017262 296 ENCLFDIIDDQV-----RKSGEA-EEIMAVSDVAKRCLNS--YGRNRPTMKEVAMELERIRANSRDDENNIQK 360 (374)
Q Consensus 296 ~~~~~~~~~~~~-----~~~~~~-~~~~~l~~li~~cl~~--~p~~Rps~~~vl~~L~~~~~~~~~~~~~~~~ 360 (374)
.+.+...-+... ....+. -.++.+.-|..+|+.. ++.-|||++.++..|..+.++...+...-++
T Consensus 241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~a~H 313 (637)
T COG4248 241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVSAMH 313 (637)
T ss_pred cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhcccc
Confidence 111111111000 011111 2345777888888854 4678999999999999999988877665554
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.3e-11 Score=121.31 Aligned_cols=251 Identities=24% Similarity=0.296 Sum_probs=174.2
Q ss_pred HHHhhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC---hhHHHHHHHHHHHHhhCCCCceeeeeeeeeeccc
Q 017262 67 LDKATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEV 142 (374)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 142 (374)
++...+.+.+.+.+-.|.++.++.+.-. .|...+.+...... ....+....+-.++-...+|.++...-.+.....
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence 4455677788888999999999988743 34334444322211 1111222222223333345666665555556678
Q ss_pred ceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccc
Q 017262 143 PLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 222 (374)
Q Consensus 143 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 222 (374)
.+++++|..+++|..-++. ....+..-....+..+.+++++||+.. +.|+|++|.|.+...++..++.|||...
T Consensus 879 ~~L~~~~~~~~~~~Skl~~---~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~ 952 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHN---SGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLS 952 (1205)
T ss_pred cchhhHHhccCCchhhhhc---CCCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccc
Confidence 8999999999999888874 345666677788888999999999987 8999999999999999999999998321
Q ss_pred ccc-c----C-------------------------CceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCC
Q 017262 223 SIA-I----D-------------------------QTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQ 272 (374)
Q Consensus 223 ~~~-~----~-------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~ 272 (374)
... . + +........+|+.|.+||...+......+|.|++|+.+++.++|.
T Consensus 953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen 953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence 110 0 0 000112345899999999999999999999999999999999999
Q ss_pred CCCCccccccCCChHHHHHHHHHhccccccccccc-cCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 017262 273 KPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV-RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMK 338 (374)
Q Consensus 273 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 338 (374)
.||........ +..+..... ....+...+....+++.+.+..+|.+|-.+.
T Consensus 1033 pp~na~tpq~~---------------f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1033 PPFNAETPQQI---------------FENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCcchhhh---------------hhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 99975443321 111111111 2234555667888999999999999997766
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.5e-09 Score=89.75 Aligned_cols=126 Identities=26% Similarity=0.291 Sum_probs=82.0
Q ss_pred EEEEEEecCCcEEEEEEeccCC--------------h------------hHHHHHHHHHHHHhhCCCC--ceeeeeeeee
Q 017262 87 TVYKGMLADGRIIAVKKSKVVD--------------E------------SKLEEFINEVVILSQINHR--NVVKLLGCCL 138 (374)
Q Consensus 87 ~v~~~~~~~~~~vavK~~~~~~--------------~------------~~~~~~~~e~~~l~~l~h~--niv~~~~~~~ 138 (374)
.||.|...+|..+|+|...... . .......+|++.|.++..- ++++++++-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899998889999999654310 0 0112356899999999765 466776542
Q ss_pred ecccceEEEEeec--CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHH-HhhcCCCCEEEeccCCCceEECCCCcEEE
Q 017262 139 EVEVPLLVYEFIP--NGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAY-LHSSAYLPIYHRDIKSTNILLDEKYRAKI 215 (374)
Q Consensus 139 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~-lH~~~~~~i~H~dlk~~Nill~~~~~~kl 215 (374)
..++||||++ |..+...... .++......++.+++..+.. +|..| ++|+||++.||+++++ .+.+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 4579999998 5555443321 11133455677777775555 57888 9999999999999988 9999
Q ss_pred eecccccccc
Q 017262 216 ADFGTSRSIA 225 (374)
Q Consensus 216 ~Dfg~~~~~~ 225 (374)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.9e-09 Score=93.32 Aligned_cols=139 Identities=14% Similarity=0.122 Sum_probs=97.8
Q ss_pred eEeeeCeEEEEEEEecCCcEEEEEEeccCChhH-H----------HHHHHHHHHHhhCCCCce--eeeeeeeee-----c
Q 017262 79 ILGQGGQGTVYKGMLADGRIIAVKKSKVVDESK-L----------EEFINEVVILSQINHRNV--VKLLGCCLE-----V 140 (374)
Q Consensus 79 ~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~-~----------~~~~~e~~~l~~l~h~ni--v~~~~~~~~-----~ 140 (374)
.+-......|++... +|+.+.+|......... . ..+.+|...+.++...+| ++++.+... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 344444445666555 56789999664332111 1 136789998888854443 344445432 2
Q ss_pred ccceEEEEeecCC-cccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECC-------CCc
Q 017262 141 EVPLLVYEFIPNG-TLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE-------KYR 212 (374)
Q Consensus 141 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~-------~~~ 212 (374)
...++|+|++++. +|.+++.... ....+......++.+++..+.-||..| ++|+|++++|||++. +..
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 2468999999886 8888875321 234566777899999999999999999 999999999999975 467
Q ss_pred EEEeeccccc
Q 017262 213 AKIADFGTSR 222 (374)
Q Consensus 213 ~kl~Dfg~~~ 222 (374)
+.++||+.+.
T Consensus 184 ~~LIDl~r~~ 193 (268)
T PRK15123 184 LSVIDLHRAQ 193 (268)
T ss_pred EEEEECCccc
Confidence 9999999874
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=3.6e-09 Score=90.10 Aligned_cols=138 Identities=22% Similarity=0.232 Sum_probs=100.0
Q ss_pred cCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccC--------------------C--hhHHHHHHHHHHHHhhCCCC-
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVV--------------------D--ESKLEEFINEVVILSQINHR- 128 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~--------------------~--~~~~~~~~~e~~~l~~l~h~- 128 (374)
.-..++..||-|--+.||.|...+|.++++|.=... + ........+|.++|.++...
T Consensus 91 ~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 91 IVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred hHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 345677899999999999999999999999932211 0 11123456899999999755
Q ss_pred -ceeeeeeeeeecccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEE
Q 017262 129 -NVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL 207 (374)
Q Consensus 129 -niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill 207 (374)
.+++.+++ +...+|||+++|-.|...- ++....-.++..|+.-+.-+-..| ++|+|+++-||++
T Consensus 171 ~~VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV 235 (304)
T COG0478 171 VKVPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILV 235 (304)
T ss_pred CCCCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEE
Confidence 77787765 4557999999886664422 122233344555555555555777 9999999999999
Q ss_pred CCCCcEEEeeccccccc
Q 017262 208 DEKYRAKIADFGTSRSI 224 (374)
Q Consensus 208 ~~~~~~kl~Dfg~~~~~ 224 (374)
++||.+.++||--+...
T Consensus 236 ~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 236 TEDGDIVVIDWPQAVPI 252 (304)
T ss_pred ecCCCEEEEeCcccccC
Confidence 99999999999876543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=2.4e-10 Score=108.23 Aligned_cols=150 Identities=24% Similarity=0.296 Sum_probs=106.3
Q ss_pred HHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceeee--------cccccccccCccccccC
Q 017262 179 EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVST--------KVQGTFGYLDPEYFRSS 250 (374)
Q Consensus 179 ~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~--------~~~g~~~y~aPE~~~~~ 250 (374)
+++.|+.|+|..- .++|++|.|++|.++.++.+||++|+.+............ -..-...|.|||.+.+.
T Consensus 107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 4458999999875 3999999999999999999999999987654432211111 12245579999999998
Q ss_pred CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccC
Q 017262 251 QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSY 330 (374)
Q Consensus 251 ~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 330 (374)
..+.++|+||+|+++|.+..|..+.-..... ..... .....+......+....+.++.+=+.+++..+
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~---~~~~~---------~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~ 252 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGG---LLSYS---------FSRNLLNAGAFGYSNNLPSELRESLKKLLNGD 252 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCC---cchhh---------hhhcccccccccccccCcHHHHHHHHHHhcCC
Confidence 8899999999999999999555443221111 11111 11222233333445677788999999999999
Q ss_pred CCCCCCHHHHHH
Q 017262 331 GRNRPTMKEVAM 342 (374)
Q Consensus 331 p~~Rps~~~vl~ 342 (374)
+..||++..+..
T Consensus 253 ~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 253 SAVRPTLDLLLS 264 (700)
T ss_pred cccCcchhhhhc
Confidence 999997776654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.74 E-value=7.2e-08 Score=81.76 Aligned_cols=105 Identities=23% Similarity=0.271 Sum_probs=82.2
Q ss_pred HHHHHHHHHHhhCCCCc--eeeeeeeeeecc----cceEEEEeecCC-cccccccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 017262 113 EEFINEVVILSQINHRN--VVKLLGCCLEVE----VPLLVYEFIPNG-TLFQYLHDPYEELSLTWEMRLRIATEVAEALA 185 (374)
Q Consensus 113 ~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~ 185 (374)
....+|...+..+...+ .++.+.+..... ..++|+|++++. +|.+++... ...+......++.+++..++
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~---~~~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW---EQLDPSQRRELLRALARLIA 132 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh---cccchhhHHHHHHHHHHHHH
Confidence 45678888888875433 345566655432 347999999874 788888742 22666778899999999999
Q ss_pred HHhhcCCCCEEEeccCCCceEECCCC---cEEEeecccccc
Q 017262 186 YLHSSAYLPIYHRDIKSTNILLDEKY---RAKIADFGTSRS 223 (374)
Q Consensus 186 ~lH~~~~~~i~H~dlk~~Nill~~~~---~~kl~Dfg~~~~ 223 (374)
-||..| ++|+|+++.|||++.++ .+.++||+-+..
T Consensus 133 ~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999 99999999999999887 899999987754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.2e-07 Score=78.91 Aligned_cols=139 Identities=19% Similarity=0.133 Sum_probs=100.7
Q ss_pred EeeeCeEEEEEEEecCCcEEEEEEeccC------ChhHHHHHHHHHHHHhhCCCCc--eeeeeeeeeec----ccceEEE
Q 017262 80 LGQGGQGTVYKGMLADGRIIAVKKSKVV------DESKLEEFINEVVILSQINHRN--VVKLLGCCLEV----EVPLLVY 147 (374)
Q Consensus 80 lg~G~~g~v~~~~~~~~~~vavK~~~~~------~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~----~~~~lv~ 147 (374)
-|.||-+.|+.-... |+.+-+|+.... -+-....|.+|+..+.++...+ ++++....... ...+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 456888888886654 446888865421 0334578999999999995333 44544222111 1357999
Q ss_pred EeecC-CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCc--EEEeecccccc
Q 017262 148 EFIPN-GTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR--AKIADFGTSRS 223 (374)
Q Consensus 148 e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~--~kl~Dfg~~~~ 223 (374)
|-+++ -+|.+++.+. ...+.+......++.+++..++-||+.| +.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98854 5788777543 2335677788899999999999999999 999999999999986667 99999986653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.72 E-value=9.8e-08 Score=90.74 Aligned_cols=141 Identities=16% Similarity=0.193 Sum_probs=92.2
Q ss_pred ceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHH------------------------------H----------HHHH
Q 017262 78 RILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKL------------------------------E----------EFIN 117 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~------------------------------~----------~~~~ 117 (374)
+.|+.++-|+||+|++++|+.||||+....-.... + .+..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 57899999999999999999999998765321111 0 1234
Q ss_pred HHHHHhhCC-----CCceeeeeeee-eecccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 017262 118 EVVILSQIN-----HRNVVKLLGCC-LEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSA 191 (374)
Q Consensus 118 e~~~l~~l~-----h~niv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ 191 (374)
|+..+.++. .+++ .+=.++ .-.....++|||++|-.+.+...- .....+...+.....++. +..+-..|
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l--~~~g~d~k~ia~~~~~~f--~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAAL--KSAGIDRKELAELLVRAF--LRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHH--HhcCCCHHHHHHHHHHHH--HHHHHhcC
Confidence 555555542 2332 222222 224566899999999988887432 123455433333322221 22233345
Q ss_pred CCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 192 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 192 ~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
..|.|.+|.||+++.+|.+.+.|||+...+..
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999876643
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.69 E-value=4.5e-07 Score=76.73 Aligned_cols=150 Identities=21% Similarity=0.224 Sum_probs=101.2
Q ss_pred hHHHHHhhcCCCcCce---EeeeCeEEEEEEEecCCcEEEEEEeccCChhHH------------------------HHHH
Q 017262 64 SKELDKATDYFNMNRI---LGQGGQGTVYKGMLADGRIIAVKKSKVVDESKL------------------------EEFI 116 (374)
Q Consensus 64 ~~~~~~~~~~~~~~~~---lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~------------------------~~~~ 116 (374)
.+.+....++..+... |++|.-+.||+|...++..+|+|+......... .-..
T Consensus 37 ~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~ 116 (268)
T COG1718 37 LETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWAR 116 (268)
T ss_pred HHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHH
Confidence 3445555555555555 556667789999988899999997765321111 1124
Q ss_pred HHHHHHhhCC--CCceeeeeeeeeecccceEEEEeecCCc-ccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCC
Q 017262 117 NEVVILSQIN--HRNVVKLLGCCLEVEVPLLVYEFIPNGT-LFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS-SAY 192 (374)
Q Consensus 117 ~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~g~-L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~ 192 (374)
+|+..|+++. +=.+++.+.+.. -.++|||+.... -.-.| ...++.......+..++++.+.-|-. .+
T Consensus 117 kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a~- 187 (268)
T COG1718 117 KEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEAG- 187 (268)
T ss_pred HHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhcC-
Confidence 6788888874 344556666553 369999995431 11111 12233333677778888888888887 66
Q ss_pred CCEEEeccCCCceEECCCCcEEEeecccccccc
Q 017262 193 LPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 193 ~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 225 (374)
++|+||+.-|||+. ++.+.++|||-+....
T Consensus 188 --LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 188 --LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred --cccccchhhheEEE-CCeEEEEECccccccC
Confidence 99999999999999 8899999999886544
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.54 E-value=2.3e-06 Score=71.63 Aligned_cols=136 Identities=17% Similarity=0.228 Sum_probs=87.8
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHH---------HHHHHHHhhCCC---Cceeeeeeeee
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEF---------INEVVILSQINH---RNVVKLLGCCL 138 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~---------~~e~~~l~~l~h---~niv~~~~~~~ 138 (374)
..+|...+++-......|.+-.. +|..+++|..........+.| .+.+..+..+.. .....++-+..
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 56777778877777666666554 567889997655332222222 233444444432 22223222222
Q ss_pred -----ecccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcE
Q 017262 139 -----EVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA 213 (374)
Q Consensus 139 -----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~ 213 (374)
-....+++|||++|..|.+... +++ .++..+..++.-+|+.| +.|+|..|.|++++++ .+
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i 173 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GI 173 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cE
Confidence 1234468999999988766432 222 24456778899999999 9999999999999865 59
Q ss_pred EEeeccccc
Q 017262 214 KIADFGTSR 222 (374)
Q Consensus 214 kl~Dfg~~~ 222 (374)
+++||+..+
T Consensus 174 ~iID~~~k~ 182 (229)
T PF06176_consen 174 RIIDTQGKR 182 (229)
T ss_pred EEEECcccc
Confidence 999998664
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.6e-06 Score=74.49 Aligned_cols=132 Identities=20% Similarity=0.131 Sum_probs=83.4
Q ss_pred ceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCc--eeeeeeeeeecccceEEEEeecCCc-
Q 017262 78 RILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRN--VVKLLGCCLEVEVPLLVYEFIPNGT- 154 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~g~- 154 (374)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-+ +++.+++....+...++||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 46899999999984 24457788765432 2345688999999986433 4677888777777789999998863
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh---------------------------------------c-CCCC
Q 017262 155 LFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS---------------------------------------S-AYLP 194 (374)
Q Consensus 155 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---------------------------------------~-~~~~ 194 (374)
+...+.. +......++..+++.+.-||+ . ....
T Consensus 82 ~~~~~~~-------~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~ 154 (226)
T TIGR02172 82 FSRIISD-------NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST 154 (226)
T ss_pred hhhhhcC-------CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence 2211110 001111111111111111111 1 1124
Q ss_pred EEEeccCCCceEECCCCcEEEeeccccc
Q 017262 195 IYHRDIKSTNILLDEKYRAKIADFGTSR 222 (374)
Q Consensus 195 i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 222 (374)
++|+|+.|.||++++++ +.++||+.+.
T Consensus 155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 155 CLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred eEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 79999999999999888 9999998774
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.3e-05 Score=66.61 Aligned_cols=103 Identities=26% Similarity=0.393 Sum_probs=81.3
Q ss_pred HHHHHHhhCCC-CceeeeeeeeeecccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCE
Q 017262 117 NEVVILSQINH-RNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPI 195 (374)
Q Consensus 117 ~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i 195 (374)
.|.-+++.+.+ +++++++|+|-+ +++.||...+++...-..-..-...+|..+.+++.+++..+.++++...-.+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 58888898975 699999999943 6899999877654211000012346899999999999999999998654458
Q ss_pred EEeccCCCceEECCCCcEEEeecccccc
Q 017262 196 YHRDIKSTNILLDEKYRAKIADFGTSRS 223 (374)
Q Consensus 196 ~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 223 (374)
.-.|++|+|+-+++++++|++|......
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcch
Confidence 8999999999999999999999987644
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.41 E-value=3.1e-08 Score=93.32 Aligned_cols=193 Identities=21% Similarity=0.179 Sum_probs=137.6
Q ss_pred HHHhhcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCc-eeeeeeeeeecccceE
Q 017262 67 LDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRN-VVKLLGCCLEVEVPLL 145 (374)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~l 145 (374)
++..++.+...+-+++++++++++.+....+....+.+... ....-++++|.+++||| .+..++-+..++..++
T Consensus 237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i 311 (829)
T KOG0576|consen 237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI 311 (829)
T ss_pred ccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence 33444555556678899999999987554444445544332 34456899999999999 6666666666778889
Q ss_pred EEEeecCC-cccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccc
Q 017262 146 VYEFIPNG-TLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 224 (374)
Q Consensus 146 v~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 224 (374)
.++++.++ +-..-... ....+...+...+.+.-.++++++|+.. =+|+| ||+..+ +..+..||+....+
T Consensus 312 ~~~i~s~~rs~~~~~~~--se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L 381 (829)
T KOG0576|consen 312 PMRICSTGRSSALEMTV--SEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQL 381 (829)
T ss_pred hhhhhcCCccccccCCh--hhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCccc
Confidence 99999776 22221111 2333445555667777888999999864 36888 777665 68899999988766
Q ss_pred ccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCC
Q 017262 225 AIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPIS 276 (374)
Q Consensus 225 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~ 276 (374)
.... ......+++.++|||+...+.+....|+|++|.-..++.-|..|-.
T Consensus 382 ~~~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 382 TRTM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred Cccc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 5432 3445668999999999999999999999999987777777776644
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.38 E-value=5.2e-06 Score=71.78 Aligned_cols=142 Identities=24% Similarity=0.214 Sum_probs=82.1
Q ss_pred ceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCC--ceeeeeeeeeec---ccceEEEEeecC
Q 017262 78 RILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHR--NVVKLLGCCLEV---EVPLLVYEFIPN 152 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~---~~~~lv~e~~~~ 152 (374)
+.++.|..+.||.....+ ..+++|..... .....+..|..+++.+... .+++++...... ...+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 578999999999999877 58899986543 4456777888888888533 356666644332 245899999999
Q ss_pred Cccccc----------------cc---CC-CCCCCCCHHH---------HHH------------HHHHHHH-HHHHHhhc
Q 017262 153 GTLFQY----------------LH---DP-YEELSLTWEM---------RLR------------IATEVAE-ALAYLHSS 190 (374)
Q Consensus 153 g~L~~~----------------l~---~~-~~~~~l~~~~---------~~~------------i~~~i~~-~l~~lH~~ 190 (374)
..+... +. .. .......... ... ....+.. .+..+++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 887770 10 00 0011111100 000 0111222 23333321
Q ss_pred ----CCCCEEEeccCCCceEEC-CCCcEEEeeccccc
Q 017262 191 ----AYLPIYHRDIKSTNILLD-EKYRAKIADFGTSR 222 (374)
Q Consensus 191 ----~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~~~ 222 (374)
....++|+|+.|.||+++ +++.+-++||+.+.
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 223499999999999999 66667899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.33 E-value=6.9e-06 Score=71.70 Aligned_cols=75 Identities=15% Similarity=0.056 Sum_probs=52.5
Q ss_pred EeeeCe-EEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCC-CCceeeeeeeeeecccceEEEEeecCCcccc
Q 017262 80 LGQGGQ-GTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQIN-HRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQ 157 (374)
Q Consensus 80 lg~G~~-g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~ 157 (374)
|..|.. ..||+.... +..+++|...... .....+|+.+++.+. +--+++++++....+..++||++++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 344555 678888764 4678888765432 345667888888884 4446677887776667899999999987764
Q ss_pred c
Q 017262 158 Y 158 (374)
Q Consensus 158 ~ 158 (374)
.
T Consensus 82 ~ 82 (244)
T cd05150 82 L 82 (244)
T ss_pred h
Confidence 3
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.30 E-value=4.4e-06 Score=79.44 Aligned_cols=139 Identities=17% Similarity=0.146 Sum_probs=90.4
Q ss_pred ceEeeeCeEEEEEEEecCCcEEEEEEeccCChhH----H---------------------------------HHHHHHHH
Q 017262 78 RILGQGGQGTVYKGMLADGRIIAVKKSKVVDESK----L---------------------------------EEFINEVV 120 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~----~---------------------------------~~~~~e~~ 120 (374)
+.|+..+.|+|++|+.++|+.||||+.+..-... . -.|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6799999999999999999999999876531111 0 01334544
Q ss_pred HHhhC----CCCc------eeeeeeeeeecccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 017262 121 ILSQI----NHRN------VVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSS 190 (374)
Q Consensus 121 ~l~~l----~h~n------iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~ 190 (374)
...+. .|-+ |++++..+ ....+++||||+|..+.+.-.- ....++...+..-+.+...-+ +=..
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~i~~~l~~~~~~q--If~~ 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAI--DKRGISPHDILNKLVEAYLEQ--IFKT 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHH--HHcCCCHHHHHHHHHHHHHHH--HHhc
Confidence 44333 3444 33443332 2466899999999877765321 344566655544444432222 2233
Q ss_pred CCCCEEEeccCCCceEECC----CCcEEEeecccccccc
Q 017262 191 AYLPIYHRDIKSTNILLDE----KYRAKIADFGTSRSIA 225 (374)
Q Consensus 191 ~~~~i~H~dlk~~Nill~~----~~~~kl~Dfg~~~~~~ 225 (374)
| .+|+|=.|.||+++. ++.+.+.|||+...+.
T Consensus 321 G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 321 G---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred C---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 4 899999999999984 6789999999987654
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.18 E-value=3.8e-05 Score=78.78 Aligned_cols=80 Identities=14% Similarity=0.283 Sum_probs=56.9
Q ss_pred CceEeeeCeEEEEEEEecCC---cEEEEEEeccCC-hhHHHHHHHHHHHHhhCC-CCce--eeeeeeeeec---ccceEE
Q 017262 77 NRILGQGGQGTVYKGMLADG---RIIAVKKSKVVD-ESKLEEFINEVVILSQIN-HRNV--VKLLGCCLEV---EVPLLV 146 (374)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni--v~~~~~~~~~---~~~~lv 146 (374)
.+.++.|.+..+|+....++ ..+++|+..... ......+.+|+.+++.+. |.++ ++++.++.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46688899999999876553 367777654322 122346789999999995 6665 7778877654 467899
Q ss_pred EEeecCCccc
Q 017262 147 YEFIPNGTLF 156 (374)
Q Consensus 147 ~e~~~~g~L~ 156 (374)
|||++|..+.
T Consensus 123 ME~v~G~~~~ 132 (822)
T PLN02876 123 MEYLEGRIFV 132 (822)
T ss_pred EEecCCcccC
Confidence 9999886543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.11 E-value=5.5e-05 Score=63.20 Aligned_cols=132 Identities=24% Similarity=0.303 Sum_probs=91.2
Q ss_pred CceEeeeCeEEEEEEEecCCcEEEEEEeccCC----------------hhHHHHHHHHHHHHhhCC------CCceeeee
Q 017262 77 NRILGQGGQGTVYKGMLADGRIIAVKKSKVVD----------------ESKLEEFINEVVILSQIN------HRNVVKLL 134 (374)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~niv~~~ 134 (374)
...||+|+.-.||. +.++....||+..... .....+..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 45799999999986 4555567788766544 223456667777666665 78899999
Q ss_pred eeeeecccceEEEEeecC------CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEEC
Q 017262 135 GCCLEVEVPLLVYEFIPN------GTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD 208 (374)
Q Consensus 135 ~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~ 208 (374)
|+..++...-+|+|.+.+ -+|.+++. ...++. .....+. .-..||-+.+ |+.+|++|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELRQALD---EFKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHHHHHH---HHHHHHHHcC---CeecCCCcccEEEE
Confidence 999999889999998743 25666664 334554 3344433 4455666777 99999999999995
Q ss_pred CC--C--cEEEee-cccc
Q 017262 209 EK--Y--RAKIAD-FGTS 221 (374)
Q Consensus 209 ~~--~--~~kl~D-fg~~ 221 (374)
.+ + .+.|+| ||..
T Consensus 153 ~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred ecCCCceEEEEEeCCCCc
Confidence 32 2 466666 5543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.98 E-value=0.0001 Score=63.96 Aligned_cols=75 Identities=19% Similarity=0.220 Sum_probs=46.2
Q ss_pred ceEeeeCeE-EEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCC---ceeeeeeeeeecc---cceEEEEee
Q 017262 78 RILGQGGQG-TVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHR---NVVKLLGCCLEVE---VPLLVYEFI 150 (374)
Q Consensus 78 ~~lg~G~~g-~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~~---~~~lv~e~~ 150 (374)
+.|+.|+.. .||+. +..+++|..... .....+..|.+.++.+... .++++++.....+ ..+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 456766665 58875 234667754432 2234788899999888532 3445554443322 358899999
Q ss_pred cCCccccc
Q 017262 151 PNGTLFQY 158 (374)
Q Consensus 151 ~~g~L~~~ 158 (374)
+|.++.+.
T Consensus 77 ~G~~l~~~ 84 (235)
T cd05155 77 EGETATAA 84 (235)
T ss_pred cCCCCCcc
Confidence 99877543
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.98 E-value=2.6e-05 Score=78.95 Aligned_cols=197 Identities=19% Similarity=0.198 Sum_probs=136.4
Q ss_pred HHHHHHHHHhhCCCCceeeeeeeeeeccc----ceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 017262 114 EFINEVVILSQINHRNVVKLLGCCLEVEV----PLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS 189 (374)
Q Consensus 114 ~~~~e~~~l~~l~h~niv~~~~~~~~~~~----~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~ 189 (374)
...-|.+.+....|+|++.++.+-..... ..+..++|..-++...+. .-..++....+.+..+...|+.++|+
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHHHH
Confidence 33457777888899999999888754432 234567787777777776 45678889999999999999999999
Q ss_pred cCCCCEEEeccCCC---ceEECCCCcEEEe--ecccccccccCCceeeecccccccccCccccccCCCCcc--chhhhHH
Q 017262 190 SAYLPIYHRDIKST---NILLDEKYRAKIA--DFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDK--SDVYSFG 262 (374)
Q Consensus 190 ~~~~~i~H~dlk~~---Nill~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~--~Di~slG 262 (374)
.. +.|.-+..+ +.-.+..+.+..+ ||+.+..+....... ...-+..+.|||......++.+ .|+|.+|
T Consensus 305 ~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 305 LS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--SDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred hc---cceeEEecccccccccCccceeecchhhhcccccCCCcccch--hhcCccccccccccccccchhhhhhHHHHHH
Confidence 86 666666655 5555677777777 898887655333222 1224556778888776665544 7999999
Q ss_pred HHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 263 VVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 263 ~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.....+..|..+-..... ...+.+. .......+...+|+..++++|+++.+++.
T Consensus 380 ll~~~~~~~~~i~~~~~~------------------~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSAV------------------PVSLLDV--------LSTSELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred HHHhhhhhcCcccccccc------------------hhhhhcc--------ccchhhhhhhhhhcchhhhhccchhhhhh
Confidence 999999988765221000 0000100 00114668889999999999999999887
Q ss_pred HH
Q 017262 343 EL 344 (374)
Q Consensus 343 ~L 344 (374)
..
T Consensus 434 ~~ 435 (1351)
T KOG1035|consen 434 HP 435 (1351)
T ss_pred ch
Confidence 43
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.00023 Score=63.99 Aligned_cols=77 Identities=10% Similarity=0.038 Sum_probs=56.2
Q ss_pred cCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCC---Cceeeeeeeeeec---ccceEEEEe
Q 017262 76 MNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINH---RNVVKLLGCCLEV---EVPLLVYEF 149 (374)
Q Consensus 76 ~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~~---~~~~lv~e~ 149 (374)
-.+.||.|..+.||.....+++ +++|..+.. .....+..|...|+.+.- -.++++++++... +..++|||+
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQGN-PMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeeecCCccceeEEEEEcCCCC-EEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 3457999999999998776664 666664331 123577889999998853 3678888877543 568999999
Q ss_pred ecCCcc
Q 017262 150 IPNGTL 155 (374)
Q Consensus 150 ~~~g~L 155 (374)
+++.++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998765
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00059 Score=63.34 Aligned_cols=74 Identities=20% Similarity=0.232 Sum_probs=53.2
Q ss_pred ceEeeeCeEEEEEEEecCC-cEEEEEEeccC-----C--hhHHHHHHHHHHHHhhCC---CCceeeeeeeeeecccceEE
Q 017262 78 RILGQGGQGTVYKGMLADG-RIIAVKKSKVV-----D--ESKLEEFINEVVILSQIN---HRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~-~~vavK~~~~~-----~--~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv 146 (374)
+.||.|.+..||++...+| +.++||.-... . +-.......|.+.|+.+. ..++++++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5689999999999998877 48999974321 1 123456677888888763 3457777776 34567899
Q ss_pred EEeecCC
Q 017262 147 YEFIPNG 153 (374)
Q Consensus 147 ~e~~~~g 153 (374)
||++++.
T Consensus 110 ME~L~~~ 116 (401)
T PRK09550 110 MEDLSDH 116 (401)
T ss_pred EecCCCc
Confidence 9999764
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.85 E-value=9.4e-05 Score=65.04 Aligned_cols=138 Identities=14% Similarity=0.092 Sum_probs=75.8
Q ss_pred EeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCce-eeeeeeeeecccceEEEEeecCCccccc
Q 017262 80 LGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNV-VKLLGCCLEVEVPLLVYEFIPNGTLFQY 158 (374)
Q Consensus 80 lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~L~~~ 158 (374)
+..|-...+|+.. .++..+++|..........-...+|..+++.+...++ ++++.... .++|+||++|..+...
T Consensus 4 ~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 4457777888876 3466788886543222111134678888888864333 34444332 3689999998766532
Q ss_pred -----------------ccCCC-CCCCCCHH-HHHHHHHH---------HHHHHHHHhhc-----CCCCEEEeccCCCce
Q 017262 159 -----------------LHDPY-EELSLTWE-MRLRIATE---------VAEALAYLHSS-----AYLPIYHRDIKSTNI 205 (374)
Q Consensus 159 -----------------l~~~~-~~~~l~~~-~~~~i~~~---------i~~~l~~lH~~-----~~~~i~H~dlk~~Ni 205 (374)
++... ....++.. ....+..+ +...+..+-.. ....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 01100 11111211 11111111 11112222111 012389999999999
Q ss_pred EECCCCcEEEeecccccc
Q 017262 206 LLDEKYRAKIADFGTSRS 223 (374)
Q Consensus 206 ll~~~~~~kl~Dfg~~~~ 223 (374)
++++++ +.++||..+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999877 78999987753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00017 Score=58.01 Aligned_cols=130 Identities=18% Similarity=0.186 Sum_probs=89.7
Q ss_pred CCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCcee-eeeeeeeecccceEEEEeecC
Q 017262 74 FNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVV-KLLGCCLEVEVPLLVYEFIPN 152 (374)
Q Consensus 74 ~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~ 152 (374)
.+..+.|++|++|.||++.+..+ .+|+|.-..++ ....+..|+++|..+.-.++. +++.+..+ ++.|||++|
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G 96 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRGG-EVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDG 96 (201)
T ss_pred hhhhhhhhcccccEEEEeeccCc-eEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcC
Confidence 34567899999999999999754 68888766543 346788999999999766553 45554332 355999988
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccC-CCceEECCCCcEEEeecccccc
Q 017262 153 GTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIK-STNILLDEKYRAKIADFGTSRS 223 (374)
Q Consensus 153 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk-~~Nill~~~~~~kl~Dfg~~~~ 223 (374)
-.|.+.-.. .+.. -...++..-.-|...| |-|+.|+ |...++..+..+.|+||..++.
T Consensus 97 ~~L~~~~~~------~~rk----~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 97 RPLGKLEIG------GDRK----HLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cchhhhhhc------ccHH----HHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 787665431 1222 2334555555566666 9999997 4545555555999999988863
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00025 Score=61.46 Aligned_cols=74 Identities=22% Similarity=0.205 Sum_probs=47.4
Q ss_pred ceEeeeCeEEEEEEEecC--CcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCce-eeeeeeeeecccceEEEEeecCCc
Q 017262 78 RILGQGGQGTVYKGMLAD--GRIIAVKKSKVVDESKLEEFINEVVILSQINHRNV-VKLLGCCLEVEVPLLVYEFIPNGT 154 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~ 154 (374)
+.|..|-...+|+....+ +..+++|........ .....+|+.+++.+...++ +++++.+. ..+++||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 456778888999988664 667888866543221 1233468888888854333 44444332 248999999877
Q ss_pred cc
Q 017262 155 LF 156 (374)
Q Consensus 155 L~ 156 (374)
+.
T Consensus 79 l~ 80 (235)
T cd05157 79 LE 80 (235)
T ss_pred CC
Confidence 64
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00064 Score=56.50 Aligned_cols=125 Identities=29% Similarity=0.464 Sum_probs=87.0
Q ss_pred cCCCcCceEeeeCe-EEEEEEEecCCcEEEEEEecc---CCh------------------hHHHHHHHHHHHHhhCC---
Q 017262 72 DYFNMNRILGQGGQ-GTVYKGMLADGRIIAVKKSKV---VDE------------------SKLEEFINEVVILSQIN--- 126 (374)
Q Consensus 72 ~~~~~~~~lg~G~~-g~v~~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~e~~~l~~l~--- 126 (374)
..++..+.||.|.- |.||++... |+.+|+|.... ..+ .....|..|.....+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67889999999999 999999984 66999998222 100 12235677888877774
Q ss_pred CCce--eeeeeeeeecc------------------cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 017262 127 HRNV--VKLLGCCLEVE------------------VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAY 186 (374)
Q Consensus 127 h~ni--v~~~~~~~~~~------------------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~ 186 (374)
+.++ ++.+|+..-.. ...||.||.+... .++ ..-+.+|.+-+..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHH
Confidence 5566 88888874220 1235666554322 122 2335677778899
Q ss_pred HhhcCCCCEEEeccCCCceEECCCCcEEEeecccc
Q 017262 187 LHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 221 (374)
Q Consensus 187 lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 221 (374)
+|..| |+-+|+++.|.. .-+|+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99999 999999999985 3488999854
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.0012 Score=60.00 Aligned_cols=141 Identities=16% Similarity=0.170 Sum_probs=73.9
Q ss_pred ceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCc--eeeeeee------eeecccceEEEEe
Q 017262 78 RILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRN--VVKLLGC------CLEVEVPLLVYEF 149 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~e~ 149 (374)
+.++.|....+|.....+| .+++|+...... .....|...++.+...+ +++.+.. ....+..+++++|
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 4566677778999886655 578887652222 23334555555552111 3333321 1234567899999
Q ss_pred ecCCccccc-----------c---cCC---CC-----CCCCCH-HHHH------------HHHHH-HHHHHHHHhhc---
Q 017262 150 IPNGTLFQY-----------L---HDP---YE-----ELSLTW-EMRL------------RIATE-VAEALAYLHSS--- 190 (374)
Q Consensus 150 ~~~g~L~~~-----------l---~~~---~~-----~~~l~~-~~~~------------~i~~~-i~~~l~~lH~~--- 190 (374)
++|..+... + +.. .. ...+.+ .... ....+ +...+..+.+.
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 988754311 0 000 00 001111 1111 01111 11122333211
Q ss_pred -CCCCEEEeccCCCceEECCCCcEEEeeccccc
Q 017262 191 -AYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 222 (374)
Q Consensus 191 -~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 222 (374)
-..+++|+|+.|.||+++.+...-++||+.+.
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 12349999999999999976556899998774
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00084 Score=60.37 Aligned_cols=142 Identities=20% Similarity=0.191 Sum_probs=81.7
Q ss_pred CceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCc--eeeeeee------eeecccceEEEE
Q 017262 77 NRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRN--VVKLLGC------CLEVEVPLLVYE 148 (374)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~e 148 (374)
.+.+..|....+|+....++ .+++|..... .......|+.++..+.+.+ +++++.. ....+..+++++
T Consensus 19 i~~i~~G~~n~~y~v~~~~~-~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSG-RYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCCC-cEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 35677777788998876544 6888876542 2245566777777774332 4444432 123345689999
Q ss_pred eecCCcccccc--------------cC---CCCC-----CCCCHHHHH----------HHHHHHHHHHHHHhhc----CC
Q 017262 149 FIPNGTLFQYL--------------HD---PYEE-----LSLTWEMRL----------RIATEVAEALAYLHSS----AY 192 (374)
Q Consensus 149 ~~~~g~L~~~l--------------~~---~~~~-----~~l~~~~~~----------~i~~~i~~~l~~lH~~----~~ 192 (374)
+++|..+...- +. .... ....|.... .....+..++.++.+. ..
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 99987764310 00 0000 011111100 0111233344444431 11
Q ss_pred CCEEEeccCCCceEECCCCcEEEeeccccc
Q 017262 193 LPIYHRDIKSTNILLDEKYRAKIADFGTSR 222 (374)
Q Consensus 193 ~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 222 (374)
..++|+|+.|.|+++++++.+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 248999999999999998777899998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00015 Score=64.03 Aligned_cols=136 Identities=15% Similarity=0.170 Sum_probs=95.3
Q ss_pred CCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCC---------h--------h-----HHHHHHHHHHHHhhCC-C-C
Q 017262 73 YFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVD---------E--------S-----KLEEFINEVVILSQIN-H-R 128 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~---------~--------~-----~~~~~~~e~~~l~~l~-h-~ 128 (374)
-+.+++.||-|.-+.+|.+...+|++.++|.-.... . . ..-...+|...|+.+. | -
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 467889999999999999999999999988321100 0 0 0112346788888774 2 3
Q ss_pred ceeeeeeeeeecccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEEC
Q 017262 129 NVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD 208 (374)
Q Consensus 129 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~ 208 (374)
-+++.+++. ..++|||++.+..|...-+- .+. ..+...+..-+--|-.+| +||+|..--||+++
T Consensus 173 pVPkpiD~~----RH~Vvmelv~g~Pl~~v~~v------~d~---~~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 173 PVPKPIDHN----RHCVVMELVDGYPLRQVRHV------EDP---PTLYDDLMGLIVRLANHG---LIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCccccc----ceeeHHHhhcccceeeeeec------CCh---HHHHHHHHHHHHHHHHcC---ceecccchheeEEe
Confidence 355666654 45799999988887664321 122 233444555566677888 99999999999999
Q ss_pred CCCcEEEeeccccccc
Q 017262 209 EKYRAKIADFGTSRSI 224 (374)
Q Consensus 209 ~~~~~kl~Dfg~~~~~ 224 (374)
+++.++++||--....
T Consensus 237 dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMVST 252 (465)
T ss_pred cCCCEEEeechHhhcc
Confidence 9999999999765443
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0018 Score=58.62 Aligned_cols=143 Identities=17% Similarity=0.195 Sum_probs=79.3
Q ss_pred CceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCc--eeeeeeee------eecccceEEEE
Q 017262 77 NRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRN--VVKLLGCC------LEVEVPLLVYE 148 (374)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~------~~~~~~~lv~e 148 (374)
.+.++.|....+|.....+| .+++|....... ......|..++..+...+ +++++... ...+..+++++
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45667777788998876555 577786544211 233445667776663222 34444321 12345689999
Q ss_pred eecCCccccc--------------ccC---CCCC---C---CCCHHHHH------------HHHHHHHHHHHHHhh----
Q 017262 149 FIPNGTLFQY--------------LHD---PYEE---L---SLTWEMRL------------RIATEVAEALAYLHS---- 189 (374)
Q Consensus 149 ~~~~g~L~~~--------------l~~---~~~~---~---~l~~~~~~------------~i~~~i~~~l~~lH~---- 189 (374)
|++|..+... ++. .... . .-.|.... .....+...++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9988654311 010 0000 0 00111000 011223334555542
Q ss_pred cCCCCEEEeccCCCceEECCCCcEEEeeccccc
Q 017262 190 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 222 (374)
Q Consensus 190 ~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 222 (374)
.-...++|+|+.+.|++++.++.+.++||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 112359999999999999988777899998774
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0039 Score=55.90 Aligned_cols=137 Identities=19% Similarity=0.239 Sum_probs=86.2
Q ss_pred ceEeeeCeEEEEEEEecCCcEEEEEEec-cCChhHHHHHHHHHHHHhhCCC--Cceeeeeeeeeecc--cceEEEEeecC
Q 017262 78 RILGQGGQGTVYKGMLADGRIIAVKKSK-VVDESKLEEFINEVVILSQINH--RNVVKLLGCCLEVE--VPLLVYEFIPN 152 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~vavK~~~-~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~--~~~lv~e~~~~ 152 (374)
+.+..|....+|..... ++.+++.+-. ...........+|+..++.+.- --+...+++|.++. ..+.||++++|
T Consensus 31 ~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veG 109 (321)
T COG3173 31 EEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEG 109 (321)
T ss_pred eeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecc
Confidence 33333444445554443 6677777221 2223344556678888887742 33456677777766 77999999998
Q ss_pred CcccccccCCCCCCCCCHHHHHHHH-HHHHHHHHHHhhcC----------------------------------------
Q 017262 153 GTLFQYLHDPYEELSLTWEMRLRIA-TEVAEALAYLHSSA---------------------------------------- 191 (374)
Q Consensus 153 g~L~~~l~~~~~~~~l~~~~~~~i~-~~i~~~l~~lH~~~---------------------------------------- 191 (374)
..+.+.+... ..+ ..++ ..++..|+-||+-.
T Consensus 110 e~~~~~~~~~----~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~ 181 (321)
T COG3173 110 EVVWSALPPE----SLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLAD 181 (321)
T ss_pred eeccCcCCcc----cch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHH
Confidence 6554443311 111 1222 25666666666421
Q ss_pred ---------------CCCEEEeccCCCceEECCCCcEEEeecccccc
Q 017262 192 ---------------YLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 223 (374)
Q Consensus 192 ---------------~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 223 (374)
...++|+|+.+.|++++.++.+=+.||+++..
T Consensus 182 ~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 182 RLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 13599999999999999988899999999864
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0034 Score=55.73 Aligned_cols=69 Identities=17% Similarity=0.097 Sum_probs=40.2
Q ss_pred eeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCC-C-Cc-eeeeeeeeeecccceEEEEeecCCcc
Q 017262 81 GQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQIN-H-RN-VVKLLGCCLEVEVPLLVYEFIPNGTL 155 (374)
Q Consensus 81 g~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-~n-iv~~~~~~~~~~~~~lv~e~~~~g~L 155 (374)
++|....|+.....+|..+++|.-.. ......+.+|..+|+.+. + |- ++++... +..+++|++++|..+
T Consensus 20 ~~g~~~~v~~i~~~~g~~~VlR~p~~--~~~~~~l~rE~~vL~~L~~~l~vpvP~~~~~----~~~~~~y~~i~G~p~ 91 (276)
T cd05152 20 ESGLDFQVVFAKDTDGVPWVLRIPRR--PDVSERAAAEKRVLALVRKHLPVQVPDWRVH----TPELIAYPKLPGVPA 91 (276)
T ss_pred CCcceeEEEEEEcCCCCeEEEEecCC--HHHHHHHHHHHHHHHHHHhcCCCCCCceeee----cCceEEEeccCCCcc
Confidence 44444566655555688888887643 233456788999999885 2 21 1222211 123567777776554
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0031 Score=56.86 Aligned_cols=142 Identities=20% Similarity=0.237 Sum_probs=96.7
Q ss_pred CcCceEeeeCeEEEEEEEecCCcEEEEEEeccC-----C--------------------hhHH-HHHHHHHHHHhhCCCC
Q 017262 75 NMNRILGQGGQGTVYKGMLADGRIIAVKKSKVV-----D--------------------ESKL-EEFINEVVILSQINHR 128 (374)
Q Consensus 75 ~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~-----~--------------------~~~~-~~~~~e~~~l~~l~h~ 128 (374)
++...|..|--+.||.|...+|..+|||+.+.. + ..-. .-...|+.-|.+++..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 455678899999999999999999999965431 0 0001 1134688888888765
Q ss_pred ceeeeeeeeeecccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEEC
Q 017262 129 NVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD 208 (374)
Q Consensus 129 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~ 208 (374)
.|+-.--+.. ...+|||+|+.... +-.-......++...+..+-.+++.-+.-|.+.. .++|.||+--|+|+.
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH 299 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE
Confidence 5443222221 23469999994211 1111113445777788888888888888887765 399999999999996
Q ss_pred CCCcEEEeeccccccc
Q 017262 209 EKYRAKIADFGTSRSI 224 (374)
Q Consensus 209 ~~~~~kl~Dfg~~~~~ 224 (374)
+ |.+.++|.+-+...
T Consensus 300 d-G~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 300 D-GKLYIIDVSQSVEH 314 (520)
T ss_pred C-CEEEEEEccccccC
Confidence 5 58999999887544
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.36 E-value=1e-05 Score=83.74 Aligned_cols=161 Identities=14% Similarity=0.029 Sum_probs=113.6
Q ss_pred HHHHHHHHhhCCCCceeeeeeeeee--cccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHH-HHHHHHHhhcC
Q 017262 115 FINEVVILSQINHRNVVKLLGCCLE--VEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEV-AEALAYLHSSA 191 (374)
Q Consensus 115 ~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i-~~~l~~lH~~~ 191 (374)
...|..-++...|+++.....-... ....+..++++.+|.+.+.|.....+.+--.........++ .....-+|+..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3344445556678887665554432 23568889999999999888754332222222233333343 56666656543
Q ss_pred CC--CEEEeccCCCceEECCCCcEEEeecccccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHH
Q 017262 192 YL--PIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELL 269 (374)
Q Consensus 192 ~~--~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 269 (374)
+. -.+|+++++-|.++..+.++|++++|+.+...+ .....+...+++.|++|+....-.++.++|+|..|+.+|+..
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp-~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP-VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCc-hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 22 268999999999999999999999999984332 333345556888999999999889999999999999999999
Q ss_pred hCCCCCC
Q 017262 270 TGQKPIS 276 (374)
Q Consensus 270 ~g~~p~~ 276 (374)
-|..+|-
T Consensus 1435 ~~n~~fi 1441 (2724)
T KOG1826|consen 1435 DGNAYFI 1441 (2724)
T ss_pred cccHHHH
Confidence 8887764
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0021 Score=58.00 Aligned_cols=75 Identities=28% Similarity=0.336 Sum_probs=47.3
Q ss_pred ceEeeeCeEEEEEEEecC-------CcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCce-eeeeeeeeecccceEEEEe
Q 017262 78 RILGQGGQGTVYKGMLAD-------GRIIAVKKSKVVDESKLEEFINEVVILSQINHRNV-VKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~ 149 (374)
+.+..|-...+|+....+ ++.+++|...... .......+|..+++.+...++ ++++.++.. ..|++|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 345556667889887654 4778888865432 222345678888888853333 355555432 368999
Q ss_pred ecCCcccc
Q 017262 150 IPNGTLFQ 157 (374)
Q Consensus 150 ~~~g~L~~ 157 (374)
++|..+..
T Consensus 79 i~G~~l~~ 86 (302)
T cd05156 79 IPSRTLTT 86 (302)
T ss_pred eCCCcCCH
Confidence 98877653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0024 Score=56.78 Aligned_cols=73 Identities=23% Similarity=0.224 Sum_probs=47.3
Q ss_pred CceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCC---CCceeeeeeeeeecccceEEEEeecCC
Q 017262 77 NRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQIN---HRNVVKLLGCCLEVEVPLLVYEFIPNG 153 (374)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~g 153 (374)
.+.++-|....+|+.. .+++.+.+|.-. ......|..|.+-|+.|. .-.+++++++....+..++++||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 3568888889999877 567789999766 233356777888888873 456788999888777889999999766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.01 Score=55.15 Aligned_cols=80 Identities=16% Similarity=0.127 Sum_probs=52.6
Q ss_pred CceEeeeCeEEEEEEEecCCcEEEEEEeccC----Ch---hHHHHHHHHHHHHhhCC---CCceeeeeeeeeecccceEE
Q 017262 77 NRILGQGGQGTVYKGMLADGRIIAVKKSKVV----DE---SKLEEFINEVVILSQIN---HRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~----~~---~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv 146 (374)
.+.||.|....||+.... +..++||+-... .. .....-..|...|+.+. ..++++++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 356899999999998864 456889865411 11 12334445677776663 247888888876 456889
Q ss_pred EEeecC--Ccccccc
Q 017262 147 YEFIPN--GTLFQYL 159 (374)
Q Consensus 147 ~e~~~~--g~L~~~l 159 (374)
||++++ ..+.+.+
T Consensus 114 ME~L~~~~~ilr~~L 128 (418)
T PLN02756 114 MRYLEPPHIILRKGL 128 (418)
T ss_pred EeecCCcceehhhhh
Confidence 999976 3454444
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0077 Score=55.34 Aligned_cols=139 Identities=21% Similarity=0.227 Sum_probs=77.8
Q ss_pred eEeeeCeEEEEEEEecC-----CcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCce-eeeeeeeeecccceEEEEeecC
Q 017262 79 ILGQGGQGTVYKGMLAD-----GRIIAVKKSKVVDESKLEEFINEVVILSQINHRNV-VKLLGCCLEVEVPLLVYEFIPN 152 (374)
Q Consensus 79 ~lg~G~~g~v~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~ 152 (374)
.+..|-...+|+....+ ++.+++|..........+ -.+|..+++.+..-++ +++++.+... .|.+|+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 44446677889887432 357888876554322222 2578888888854444 3556655332 58999987
Q ss_pred Cccccc-----------------ccCCC-CCC--CCCHHHHHHHHHHH-----------------HHHHHHH----hh-c
Q 017262 153 GTLFQY-----------------LHDPY-EEL--SLTWEMRLRIATEV-----------------AEALAYL----HS-S 190 (374)
Q Consensus 153 g~L~~~-----------------l~~~~-~~~--~l~~~~~~~i~~~i-----------------~~~l~~l----H~-~ 190 (374)
.+|... ++... ... ...+..+..+..++ ...+..| .. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 666421 11100 010 11122222332211 1111122 21 1
Q ss_pred CCCCEEEeccCCCceEECC-CCcEEEeeccccc
Q 017262 191 AYLPIYHRDIKSTNILLDE-KYRAKIADFGTSR 222 (374)
Q Consensus 191 ~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~~ 222 (374)
....++|+|+++.||++++ ++.+.++||..+.
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1234899999999999986 4689999998774
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.009 Score=54.48 Aligned_cols=79 Identities=20% Similarity=0.169 Sum_probs=49.8
Q ss_pred eEeeeCeEEEEEEEecCC-cEEEEEEecc----C---ChhHHHHHHHHHHHHhhCC--CC-ceeeeeeeeeecccceEEE
Q 017262 79 ILGQGGQGTVYKGMLADG-RIIAVKKSKV----V---DESKLEEFINEVVILSQIN--HR-NVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 79 ~lg~G~~g~v~~~~~~~~-~~vavK~~~~----~---~~~~~~~~~~e~~~l~~l~--h~-niv~~~~~~~~~~~~~lv~ 147 (374)
-||.|....||++...+| +.++||+-.. . -+-......-|.+.|+... .| .+++++.+ +.+...++|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 368899999999997654 5799995321 1 1223345556778887763 34 45555543 455667999
Q ss_pred EeecC-Ccccccc
Q 017262 148 EFIPN-GTLFQYL 159 (374)
Q Consensus 148 e~~~~-g~L~~~l 159 (374)
|+++. ..|++.+
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 99854 3344444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.031 Score=50.61 Aligned_cols=101 Identities=20% Similarity=0.191 Sum_probs=67.1
Q ss_pred cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccc
Q 017262 142 VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 221 (374)
Q Consensus 142 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 221 (374)
..|++|++- |+++.. + ....+++...++.+.+..+.-+..+- +.-|||+.-.|||++ +|++.|+||.++
T Consensus 300 y~yl~~kdh-gt~is~-i------k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 300 YLYLHFKDH-GTPISI-I------KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred EEEEEEecC-Cceeee-e------ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeee
Confidence 345566654 444432 2 23457889999999999998888875 488999999999999 999999999999
Q ss_pred cccccCCceeeecccccccccCccccccCCCCccchhhh
Q 017262 222 RSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYS 260 (374)
Q Consensus 222 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~s 260 (374)
+.-...... ... ..--|-.+.+. -+.+-|||-
T Consensus 369 Rl~~~q~~i-sy~-----rldhp~lF~G~-dd~QFeIYr 400 (488)
T COG5072 369 RLSYSQGII-SYN-----RLDHPDLFNGV-DDYQFEIYR 400 (488)
T ss_pred ecccCCcee-ecc-----ccCchhhhcCc-cceeeeHHH
Confidence 843322221 111 12234444432 256667776
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.031 Score=51.75 Aligned_cols=74 Identities=15% Similarity=0.065 Sum_probs=48.7
Q ss_pred CceEeeeCeEEEEEEEecC-CcEEEEEEecc------CChhHHHHHHHHHHHHhhCC--CC-ceeeeeeeeeecccceEE
Q 017262 77 NRILGQGGQGTVYKGMLAD-GRIIAVKKSKV------VDESKLEEFINEVVILSQIN--HR-NVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~------~~~~~~~~~~~e~~~l~~l~--h~-niv~~~~~~~~~~~~~lv 146 (374)
.+.||-|.-..||++...+ ++.++||+-.. .-+-...+..-|.+.|+... .| ++++++.+ +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 3568999999999999743 56799995321 11233455667888888763 34 45556544 44566788
Q ss_pred EEeecC
Q 017262 147 YEFIPN 152 (374)
Q Consensus 147 ~e~~~~ 152 (374)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 888854
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.071 Score=48.25 Aligned_cols=29 Identities=17% Similarity=0.318 Sum_probs=26.6
Q ss_pred CEEEeccCCCceEECCCCcEEEeeccccc
Q 017262 194 PIYHRDIKSTNILLDEKYRAKIADFGTSR 222 (374)
Q Consensus 194 ~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 222 (374)
+++|+|+.+.|++++.++.+-++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 49999999999999999999999998775
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.035 Score=50.70 Aligned_cols=72 Identities=17% Similarity=0.173 Sum_probs=42.9
Q ss_pred eEeeeCeEEEEEEEecC----CcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCce-eeeeeeeeecccceEEEEeecCC
Q 017262 79 ILGQGGQGTVYKGMLAD----GRIIAVKKSKVVDESKLEEFINEVVILSQINHRNV-VKLLGCCLEVEVPLLVYEFIPNG 153 (374)
Q Consensus 79 ~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g 153 (374)
.|..|-...+|+....+ +..+++|....... ..-.-.+|..+++.+..-++ +++++++.. + ++.+|+++.
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~~-G---~i~~fi~g~ 95 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFGN-G---MIQSFINAR 95 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeCC-c---EeehhhcCC
Confidence 34446667788876443 23788887654322 22223568888888865444 345555532 1 588998776
Q ss_pred cc
Q 017262 154 TL 155 (374)
Q Consensus 154 ~L 155 (374)
+|
T Consensus 96 ~l 97 (330)
T PLN02421 96 TL 97 (330)
T ss_pred CC
Confidence 55
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.25 E-value=0.011 Score=55.84 Aligned_cols=186 Identities=19% Similarity=0.195 Sum_probs=98.4
Q ss_pred EEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc-cceEEEEeecCCcccccccCCCCCC
Q 017262 88 VYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVE-VPLLVYEFIPNGTLFQYLHDPYEEL 166 (374)
Q Consensus 88 v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~ 166 (374)
.+.|....|..+ ..=+..... ..++.-...+++.+.|+|....+++-...- ...+|+|++ +.||.+.+....
T Consensus 5 ~~~a~~~~~~~c-~nglplt~~--s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~--- 77 (725)
T KOG1093|consen 5 TFFAQEKPGDVC-SNGLPLTPN--SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN--- 77 (725)
T ss_pred EEehhcCCCccc-cCCCcCCCc--HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc---
Confidence 345555555543 222222222 245667788999999999999888765433 467899998 778888876321
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceeeecccccccccCccc
Q 017262 167 SLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEY 246 (374)
Q Consensus 167 ~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 246 (374)
+..... + .++ +.|- |++ +.+| .+... | |-.
T Consensus 78 -l~~~s~----------~----~~~---~~~~-----~~~-------~~td-~~~t~-----------------~--~~~ 107 (725)
T KOG1093|consen 78 -LKDESL----------L----AHG---VLHL-----NII-------YITD-HFLTK-----------------Y--PSP 107 (725)
T ss_pred -cchhhh----------c----ccc---ccee-----hhh-------hccc-ccccc-----------------C--CCC
Confidence 211111 1 111 2222 222 2222 11100 0 100
Q ss_pred cccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccc-ccccCCCCHHHHHHHHHHHHH
Q 017262 247 FRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIID-DQVRKSGEAEEIMAVSDVAKR 325 (374)
Q Consensus 247 ~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~ 325 (374)
..+|+|||++|.++.++..|..-+......+ +......-........ .........+....++++..+
T Consensus 108 -----~~pKsdVwsl~~i~~el~L~~~l~~~~~~s~------~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~ 176 (725)
T KOG1093|consen 108 -----IGPKSDVWSLGFIILELYLGISLEAELTESE------YLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKK 176 (725)
T ss_pred -----CCcchhhhhHHHHHHHHHHhhHHHHHHHHHH------HHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhcc
Confidence 1149999999999999999887665332211 1111111000000000 000001233455678899999
Q ss_pred hcccCCCCCCCHHHHH
Q 017262 326 CLNSYGRNRPTMKEVA 341 (374)
Q Consensus 326 cl~~~p~~Rps~~~vl 341 (374)
|+...|..||...++.
T Consensus 177 c~~~~~~ir~l~~~~~ 192 (725)
T KOG1093|consen 177 CLWLEPIIRPLPMELS 192 (725)
T ss_pred CCccccccccchhHHh
Confidence 9999999988665543
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.061 Score=45.35 Aligned_cols=88 Identities=16% Similarity=0.082 Sum_probs=57.5
Q ss_pred HHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 017262 113 EEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAY 192 (374)
Q Consensus 113 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~ 192 (374)
.-|..+..+++++. .|+++..= +.-.+-++.|+|-.-. ..+ ..++..=+++|.-.|+..
T Consensus 103 ~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~------------i~~----~N~i~agi~~L~~fH~~~- 161 (308)
T PF07387_consen 103 ALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK------------INF----SNFITAGIKDLMDFHSEN- 161 (308)
T ss_pred hhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc------------cch----hHHHHHhHHHHHHhhccC-
Confidence 45677888888774 45555511 1224458889883210 011 112222246778888554
Q ss_pred CCEEEeccCCCceEECCCCcEEEeecccc
Q 017262 193 LPIYHRDIKSTNILLDEKYRAKIADFGTS 221 (374)
Q Consensus 193 ~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 221 (374)
...+|||..|+||+-|..|.+||.|-+..
T Consensus 162 ~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 162 QHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred CCeecCCCChhheeecCCCCEEecChhhh
Confidence 34999999999999999999999998764
|
The function of this family is unknown. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.68 E-value=0.21 Score=45.36 Aligned_cols=139 Identities=21% Similarity=0.319 Sum_probs=78.8
Q ss_pred EeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCc------eeeeee----eeeecccceEEEEe
Q 017262 80 LGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRN------VVKLLG----CCLEVEVPLLVYEF 149 (374)
Q Consensus 80 lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~----~~~~~~~~~lv~e~ 149 (374)
|.. .-..+|.....+|+. ++|..... ........|...++.+.-.+ +...-| ........+-+++|
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 444 445788888877776 88877664 23345556777777773211 121111 11111366789999
Q ss_pred ecCCcccc-ccc-----------------CCCC------CCCCCHHH-------------HHHHHHHHHHHHHHHhhcC-
Q 017262 150 IPNGTLFQ-YLH-----------------DPYE------ELSLTWEM-------------RLRIATEVAEALAYLHSSA- 191 (374)
Q Consensus 150 ~~~g~L~~-~l~-----------------~~~~------~~~l~~~~-------------~~~i~~~i~~~l~~lH~~~- 191 (374)
++|..+.. ... +... .....|.. -.....++...+..+.+.-
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 99988773 110 0000 01112210 0113334444444444321
Q ss_pred ----CCC--EEEeccCCCceEECCCCc-EEEeeccccc
Q 017262 192 ----YLP--IYHRDIKSTNILLDEKYR-AKIADFGTSR 222 (374)
Q Consensus 192 ----~~~--i~H~dlk~~Nill~~~~~-~kl~Dfg~~~ 222 (374)
..+ +||+|+.|.||+++.+.. .-+.||+-+.
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 123 899999999999999875 8899998764
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.68 E-value=0.16 Score=43.11 Aligned_cols=74 Identities=20% Similarity=0.228 Sum_probs=52.3
Q ss_pred eEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCC---CCceeeeeeeeeecccceEEEEeecCCcc
Q 017262 79 ILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQIN---HRNVVKLLGCCLEVEVPLLVYEFIPNGTL 155 (374)
Q Consensus 79 ~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~g~L 155 (374)
.+.-|.--..|.... +..++.+|+-. ......|..|+.-|..|. .-.+.+++.+..+.++.|+|+||++-+.+
T Consensus 23 ~v~gG~inea~~v~d-g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~ 98 (286)
T COG3001 23 EVSGGDINEAWRLRD-GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL 98 (286)
T ss_pred ccCCccccceeEeec-CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence 344454455555433 45678888543 455677888888777773 45678889888888999999999988766
Q ss_pred c
Q 017262 156 F 156 (374)
Q Consensus 156 ~ 156 (374)
.
T Consensus 99 d 99 (286)
T COG3001 99 D 99 (286)
T ss_pred C
Confidence 5
|
|
| >PF02439 Adeno_E3_CR2: Adenovirus E3 region protein CR2; InterPro: IPR003470 Early region 3 (E3) of human adenoviruses (Ads) codes for proteins that appear to control viral interactions with the host [] | Back alignment and domain information |
|---|
Probab=95.14 E-value=0.026 Score=32.48 Aligned_cols=16 Identities=13% Similarity=0.212 Sum_probs=6.6
Q ss_pred HHHHHHHHHHHHHHHH
Q 017262 15 LSIGALWLCIIIRKRI 30 (374)
Q Consensus 15 ~~~~~~~~~~~~~~~~ 30 (374)
++++++.+.+++||.+
T Consensus 19 iii~~~~YaCcykk~~ 34 (38)
T PF02439_consen 19 IIICMFYYACCYKKHR 34 (38)
T ss_pred HHHHHHHHHHHHcccc
Confidence 3334444444444433
|
This region called CR1 (conserved region 1) [] is found three times in Human adenovirus 19 (a subgroup D adenovirus) 49 kDa protein in the E3 region. CR1 is also found in the 20.1 Kd protein of subgroup B adenoviruses. The function of this 80 amino acid region is unknown. This region is probably a divergent immunoglobulin domain. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.04 E-value=0.3 Score=45.51 Aligned_cols=74 Identities=22% Similarity=0.311 Sum_probs=43.4
Q ss_pred ceEeeeCeEEEEEEEecCC--cE-----EEEEEeccCChhHHHHHHHHHHHHhhCCCCce-eeeeeeeeecccceEEEEe
Q 017262 78 RILGQGGQGTVYKGMLADG--RI-----IAVKKSKVVDESKLEEFINEVVILSQINHRNV-VKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~ 149 (374)
+.|..|-...+|++...++ .. |.++..... ....-.-.+|+.+++.+...++ +++++.+.. .++.||
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~-~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef 130 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY-NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW 130 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCC-CceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence 3454577788998875433 12 333332111 1111122468889999865544 456666643 599999
Q ss_pred ecCCccc
Q 017262 150 IPNGTLF 156 (374)
Q Consensus 150 ~~~g~L~ 156 (374)
++|.+|.
T Consensus 131 IeGr~l~ 137 (383)
T PTZ00384 131 VEGNTMG 137 (383)
T ss_pred eccccCC
Confidence 9887664
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.99 E-value=0.63 Score=42.42 Aligned_cols=72 Identities=15% Similarity=0.096 Sum_probs=43.2
Q ss_pred eCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCc--eeeee---e--eeeecccceEEEEeecCCcc
Q 017262 83 GGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRN--VVKLL---G--CCLEVEVPLLVYEFIPNGTL 155 (374)
Q Consensus 83 G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~---~--~~~~~~~~~lv~e~~~~g~L 155 (374)
+.-..||.....++..+++|..... ......+..|...+..+.... ++... | ....++..+.++++++|...
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 4446789988877888999976532 223355666777777663211 22211 1 12224567789999987654
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.27 E-value=0.45 Score=45.23 Aligned_cols=74 Identities=12% Similarity=0.107 Sum_probs=43.5
Q ss_pred ceEeeeCeEEEEEEEecC---------CcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCcee-eeeeeeeecccceEEE
Q 017262 78 RILGQGGQGTVYKGMLAD---------GRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVV-KLLGCCLEVEVPLLVY 147 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~ 147 (374)
+.|..|-.-.+|+....+ ++.|.++........-. .-..|..+++.+...+|- ++++.+. -..+.
T Consensus 111 ~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I~ 185 (442)
T PTZ00296 111 NQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFS----GGRIE 185 (442)
T ss_pred EEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeC----CCEEE
Confidence 445556666788877442 35677777654332222 334677777777544443 4555543 24689
Q ss_pred EeecCCccc
Q 017262 148 EFIPNGTLF 156 (374)
Q Consensus 148 e~~~~g~L~ 156 (374)
+|++|.+|.
T Consensus 186 efi~g~~l~ 194 (442)
T PTZ00296 186 EWLYGDPLR 194 (442)
T ss_pred EeeCCccCC
Confidence 999887553
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.01 E-value=1.1 Score=47.36 Aligned_cols=30 Identities=33% Similarity=0.567 Sum_probs=25.1
Q ss_pred CEEEeccCCCceEECCCC--cEE-Eeecccccc
Q 017262 194 PIYHRDIKSTNILLDEKY--RAK-IADFGTSRS 223 (374)
Q Consensus 194 ~i~H~dlk~~Nill~~~~--~~k-l~Dfg~~~~ 223 (374)
.+||+|+.+.|||++.++ .+. |+|||.+..
T Consensus 204 ~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 204 QVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred ceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 399999999999999875 555 999997753
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.99 E-value=0.043 Score=45.27 Aligned_cols=28 Identities=14% Similarity=0.274 Sum_probs=25.0
Q ss_pred EEEeccCCCceEECCCCcEEEeecccccc
Q 017262 195 IYHRDIKSTNILLDEKYRAKIADFGTSRS 223 (374)
Q Consensus 195 i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 223 (374)
.+|+|+.|.|+++++++ ++++||+.+..
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 69999999999998877 89999998753
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 374 | ||||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-47 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-47 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-46 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-46 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-37 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-37 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-36 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-33 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-28 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-28 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-27 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-27 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-26 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-25 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-25 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-25 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-25 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-25 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-25 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-25 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-25 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-25 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-25 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-25 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-24 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-24 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-24 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-24 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-24 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-24 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-24 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-24 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-24 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-24 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-24 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-24 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-24 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-24 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-24 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-24 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-24 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-24 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-24 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-24 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-24 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-24 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-24 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-24 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-24 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-24 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-24 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-24 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-24 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-24 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-24 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-24 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-24 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-24 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-24 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-24 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-24 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-24 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-24 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-24 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-24 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-24 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-24 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-24 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-24 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-23 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-23 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-23 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-23 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-23 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-23 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-23 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-23 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-23 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-22 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-22 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-22 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-22 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-22 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-22 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-22 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-22 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-22 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-22 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-22 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-22 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-22 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 9e-22 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-22 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-22 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-21 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-21 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-21 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-21 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-21 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-21 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-21 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-21 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-21 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-21 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-21 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-21 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-21 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-21 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-21 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-21 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-21 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-21 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-21 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-21 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-21 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-21 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-20 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-20 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-20 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-20 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-20 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-20 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-20 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-20 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-20 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-20 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-20 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-20 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-20 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-20 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-20 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-20 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-20 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-20 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-20 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-20 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-20 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-20 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-20 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-20 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-20 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-20 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-20 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-20 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-20 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-19 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-19 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-19 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-19 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-19 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-19 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-19 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-19 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-19 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-19 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-19 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-19 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-19 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-19 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-19 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-19 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-19 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-19 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-19 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-19 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-19 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-19 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-19 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-19 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-19 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-19 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-19 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-19 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-19 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-19 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 9e-19 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-19 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-18 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-18 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-18 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-18 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-18 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-18 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-18 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-18 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-18 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-18 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-18 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-18 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-18 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-18 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-18 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-18 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-18 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-18 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-18 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-18 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-18 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-18 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-18 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-18 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-18 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-18 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-18 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-18 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-18 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-18 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-18 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-18 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-18 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-18 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-18 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-18 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-18 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-18 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-18 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-18 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-18 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-18 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-18 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-18 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-18 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-18 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-18 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-18 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-18 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-18 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-18 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-18 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-18 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-18 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-18 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-17 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-17 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-17 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-17 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-17 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-17 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-17 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-17 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-17 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-17 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-17 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-17 | ||
| 1oec_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-17 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-17 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-17 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-17 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-17 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-17 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-17 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-17 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-17 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-17 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-17 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-17 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-17 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-17 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-17 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-17 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-17 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-17 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-17 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-17 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-17 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-17 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 8e-17 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-17 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-16 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-16 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-16 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-16 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-16 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-16 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-16 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-16 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-16 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-16 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-16 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-16 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-16 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-16 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-16 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-16 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-16 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-16 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-16 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-16 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-16 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-16 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-16 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-16 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-16 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-16 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-16 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-16 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-16 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-16 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-16 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-16 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-16 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-16 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-16 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-16 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-16 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-16 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-16 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-16 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-16 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-16 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-16 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-16 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-16 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-16 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-16 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-16 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-16 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-16 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-16 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-16 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-16 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-16 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-16 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-16 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-16 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-16 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-16 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-16 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-15 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-15 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-15 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-15 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-15 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-15 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-15 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-15 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-15 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-15 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-15 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-15 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-15 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-15 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-15 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-14 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-14 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-14 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-14 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-14 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-14 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-14 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-13 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-13 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-13 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-13 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-13 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-13 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-13 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-13 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-13 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-13 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-13 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-13 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 8e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-13 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 8e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 9e-13 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-12 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-12 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-12 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-12 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-12 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-12 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-12 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-12 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-12 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-12 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-12 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-12 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-12 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-12 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-12 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-12 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-12 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-12 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-12 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-12 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-12 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-12 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-12 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-12 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-12 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-12 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-12 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-12 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-12 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-12 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-12 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-12 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-12 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-12 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-12 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-12 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-12 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-12 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-12 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-12 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-12 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-12 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-12 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-12 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-12 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-12 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-12 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-12 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-12 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-12 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-12 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-12 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 8e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 8e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-12 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-12 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 9e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-12 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 9e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-11 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-11 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-11 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-11 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-11 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-11 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-11 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-11 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-11 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-11 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-11 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-11 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-11 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-11 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-11 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-11 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-10 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 9e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 9e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-09 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-08 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 8e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 8e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 8e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 9e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 9e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 7e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 8e-07 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-06 |
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1OEC|A Chain A, Fgfr2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 358 bits (920), Expect = e-123
Identities = 115/310 (37%), Positives = 164/310 (52%), Gaps = 5/310 (1%)
Query: 38 KKNGGLLLQQQLNSIGGSIDRCRIFNSKELDKATDYFNMNRILGQGGQGTVYKGMLADGR 97
+ L+S +L++AT+ F+ ++G G G VYKG+L DG
Sbjct: 5 YSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGA 64
Query: 98 IIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQ 157
+A+K+ +EEF E+ LS H ++V L+G C E +L+Y+++ NG L +
Sbjct: 65 KVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKR 124
Query: 158 YLHDPYEE-LSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIA 216
+L+ +S++WE RL I A L YLH+ I HRD+KS NILLDE + KI
Sbjct: 125 HLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKIT 181
Query: 217 DFGTSRSIAI-DQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPI 275
DFG S+ DQTH+ST V+GT GY+DPEYF + T+KSDVYSFGVVL E+L + I
Sbjct: 182 DFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI 241
Query: 276 SSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRP 335
E NL + VE L I+D + E + D A +CL +RP
Sbjct: 242 VQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRP 301
Query: 336 TMKEVAMELE 345
+M +V +LE
Sbjct: 302 SMGDVLWKLE 311
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 332 bits (854), Expect = e-113
Identities = 109/290 (37%), Positives = 169/290 (58%), Gaps = 4/290 (1%)
Query: 60 RIFNSKELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLE-EFINE 118
+ F+ +EL A+D F+ ILG+GG G VYKG LADG ++AVK+ K E +F E
Sbjct: 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTE 77
Query: 119 VVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYE-ELSLTWEMRLRIA 177
V ++S HRN+++L G C+ LLVY ++ NG++ L + E + L W R RIA
Sbjct: 78 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 178 TEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQG 237
A LAYLH I HRD+K+ NILLDE++ A + DFG ++ + THV+T V+G
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 197
Query: 238 TFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPI--SSIWANEGRNLTTYFVECIE 295
T G++ PEY + + ++K+DV+ +GV+L+EL+TGQ+ + + ++ L + ++
Sbjct: 198 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257
Query: 296 ENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345
E L ++D ++ + + EE+ + VA C S RP M EV LE
Sbjct: 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 319 bits (819), Expect = e-108
Identities = 102/308 (33%), Positives = 163/308 (52%), Gaps = 18/308 (5%)
Query: 51 SIGGSIDRCRIFNSKELDKATDYFN------MNRILGQGGQGTVYKGMLADGRIIAVKK- 103
S+ S R F+ EL T+ F+ +G+GG G VYKG + + +AVKK
Sbjct: 4 SLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKL 62
Query: 104 -SKVVDESK--LEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLH 160
+ V ++ ++F E+ ++++ H N+V+LLG + + LVY ++PNG+L L
Sbjct: 63 AAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS 122
Query: 161 DPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGT 220
L+W MR +IA A + +LH + HRDIKS NILLDE + AKI+DFG
Sbjct: 123 CLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGL 179
Query: 221 SRSIAI-DQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIW 279
+R+ QT +++++ GT Y+ PE R + T KSD+YSFGVVL+E++TG +
Sbjct: 180 ARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE-- 236
Query: 280 ANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKE 339
E + L E +E + D+ ++ + A+ VA +CL+ RP +K+
Sbjct: 237 HREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKK 296
Query: 340 VAMELERI 347
V L+ +
Sbjct: 297 VQQLLQEM 304
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 1e-77
Identities = 67/313 (21%), Positives = 115/313 (36%), Gaps = 37/313 (11%)
Query: 62 FNSKELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVI 121
++ L + + + +G G V+K L +AVK + D+ + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 122 LSQINHRNVVKLLGCCLEVEVP----LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIA 177
L + H N+++ +G L+ F G+L +L ++W IA
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----VVSWNELCHIA 127
Query: 178 TEVAEALAYLHSSAY-------LPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230
+A LAYLH I HRDIKS N+LL A IADFG + ++
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 231 VSTKVQ-GTFGYLDPEYFRSS-----QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGR 284
T Q GT Y+ PE + + D+Y+ G+VL EL +
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA----ADGPVD 243
Query: 285 NLTTYFVECIEENCLFDIIDDQVRKSG----------EAEEIMAVSDVAKRCLNSYGRNR 334
F E I ++ + + + V + + + + + C + R
Sbjct: 244 EYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303
Query: 335 PTMKEVAMELERI 347
+ V + ++
Sbjct: 304 LSAGCVGERITQM 316
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 3e-76
Identities = 84/291 (28%), Positives = 133/291 (45%), Gaps = 36/291 (12%)
Query: 76 MNRILGQGGQGTVYKGMLADGRIIAVKKSKVVD--ESKLEEFINEVVILSQINHRNVVKL 133
+ +G G GTV++ G +AVK D ++ EF+ EV I+ ++ H N+V
Sbjct: 41 IKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 134 LGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYL 193
+G + +V E++ G+L++ LH L RL +A +VA+ + YLH+
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP- 158
Query: 194 PIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFT 253
PI HR++KS N+L+D+KY K+ DFG SR A S GT ++ PE R
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA-STFLSSKSAAGTPEWMAPEVLRDEPSN 217
Query: 254 DKSDVYSFGVVLVELLTGQKP--------ISSIWANEGRNLTTYFVECIEENCLFDIIDD 305
+KSDVYSFGV+L EL T Q+P + + + + L I N +
Sbjct: 218 EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE------IPRNL-----NP 266
Query: 306 QVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDDEN 356
QV I+ + C + RP+ + L + ++ N
Sbjct: 267 QVA------AII------EGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 1e-74
Identities = 78/283 (27%), Positives = 129/283 (45%), Gaps = 40/283 (14%)
Query: 74 FNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKL 133
+ ++G+G G V K + +A+K+ + ES+ + FI E+ LS++NH N+VKL
Sbjct: 10 IEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKL 66
Query: 134 LGCCLEVEVPL-LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAY 192
G CL P+ LV E+ G+L+ LH T + + ++ +AYLHS
Sbjct: 67 YGACLN---PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123
Query: 193 LPIYHRDIKSTNILLDEKYR-AKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQ 251
+ HRD+K N+LL KI DFGT+ D T +G+ ++ PE F S
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEGSN 179
Query: 252 FTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIE-------ENCLFDIID 304
+++K DV+S+G++L E++T +KP + G +N I
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKP----FDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI-- 233
Query: 305 DQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347
E +M RC + RP+M+E+ + +
Sbjct: 234 ---------ESLM------TRCWSKDPSQRPSMEEIVKIMTHL 261
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 2e-71
Identities = 79/292 (27%), Positives = 129/292 (44%), Gaps = 51/292 (17%)
Query: 76 MNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDES----KLEEFINEVVILSQINHRNVV 131
+ I+G GG G VY+ G +AVK ++ + +E E + + + H N++
Sbjct: 11 LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 132 KLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSA 191
L G CL+ LV EF G L + L + ++ + A ++A + YLH A
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEA 125
Query: 192 YLPIYHRDIKSTNILLDEKYR--------AKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 243
+PI HRD+KS+NIL+ +K KI DFG +R +T + G + ++
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTTKMSAA-GAYAWMA 182
Query: 244 PEYFRSSQFTDKSDVYSFGVVLVELLTGQKP------ISSIWA--NEGRNLTTYFVECIE 295
PE R+S F+ SDV+S+GV+L ELLTG+ P ++ + L I
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP------IP 236
Query: 296 ENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347
C + ++M + C N +RP+ + +L I
Sbjct: 237 STC-----PEPFA------KLM------EDCWNPDPHSRPSFTNILDQLTTI 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 3e-71
Identities = 84/299 (28%), Positives = 133/299 (44%), Gaps = 57/299 (19%)
Query: 74 FNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDES-------KLEEFINEVVILSQI 125
+ +G+GG G V+KG + D ++A+K + D K +EF EV I+S +
Sbjct: 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 126 NHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALA 185
NH N+VKL G P +V EF+P G L+ L D + W ++LR+ ++A +
Sbjct: 81 NHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIK--WSVKLRLMLDIALGIE 136
Query: 186 YLHSSAYLPIYHRDIKSTNILLDEK-----YRAKIADFGTSRSIAIDQTHVSTKVQGTFG 240
Y+ + PI HRD++S NI L AK+ADFG S+ H + + G F
Sbjct: 137 YMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQ 191
Query: 241 YLDPEYF--RSSQFTDKSDVYSFGVVLVELLTGQKP--------ISSIWA--NEGRNLTT 288
++ PE +T+K+D YSF ++L +LTG+ P I I EG T
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT- 250
Query: 289 YFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347
I E+C + ++ + C + + RP + EL +
Sbjct: 251 -----IPEDCPPRL-----------RNVI------ELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 1e-69
Identities = 66/289 (22%), Positives = 110/289 (38%), Gaps = 47/289 (16%)
Query: 75 NMNRILGQGGQGTVYKGMLADGRIIAVKKSKV--VDESKLEEFINEVVILSQINHRNVVK 132
N L + G ++KG G I VK KV K +F E L +H NV+
Sbjct: 13 NFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71
Query: 133 LLGCCLEVEVPLL--VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSS 190
+LG C P + ++P G+L+ LH+ + ++ A ++A +A+LH+
Sbjct: 72 VLGACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTL 130
Query: 191 AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSS 250
I + S ++++DE A+I+ S S ++ PE +
Sbjct: 131 EP-LIPRHALNSRSVMIDEDMTARISMADVKFSF------QSPGRMYAPAWVAPEALQKK 183
Query: 251 Q---FTDKSDVYSFGVVLVELLTGQKP--------ISSIWANEGRNLTTYFVECIEENCL 299
+D++SF V+L EL+T + P I A EG T I
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT------IPPGI- 236
Query: 300 FDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIR 348
S ++M K C+N RP + LE+++
Sbjct: 237 ----------SPHVSKLM------KICMNEDPAKRPKFDMIVPILEKMQ 269
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 2e-65
Identities = 65/292 (22%), Positives = 115/292 (39%), Gaps = 38/292 (13%)
Query: 76 MNRILGQGGQGTVYKGMLADGRIIAVKKSKV--VDESKLEEFINEVVILSQINHRNVVKL 133
+ ++G+G G VY G G + A++ + +E +L+ F EV+ Q H NVV
Sbjct: 37 IGELIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 134 LGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYL 193
+G C+ ++ TL+ + D ++ L +IA E+ + + YLH+
Sbjct: 95 MGACMSPPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAK--- 149
Query: 194 PIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI----DQTHVSTKVQGTFGYLDPEYFRS 249
I H+D+KS N+ D + I DFG + + G +L PE R
Sbjct: 150 GILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208
Query: 250 SQ---------FTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLF 300
F+ SDV++ G + EL + P + A + +
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-------IIWQMGTGMKP 261
Query: 301 DIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSR 352
++ + K +SD+ C RPT ++ LE++ +R
Sbjct: 262 NLSQIGMGK--------EISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 6e-64
Identities = 79/284 (27%), Positives = 128/284 (45%), Gaps = 37/284 (13%)
Query: 76 MNRILGQGGQGTVYKGMLADGRIIAVKKSKV--VDESKLEEFINEVVILSQINHRNVVKL 133
+ + +G G GTVYKG +AVK V +L+ F NEV +L + H N++
Sbjct: 28 VGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 134 LGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYL 193
+G +V ++ +L+ +LH E + + IA + A + YLH+
Sbjct: 86 MGYSTA-PQLAIVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAK--- 139
Query: 194 PIYHRDIKSTNILLDEKYRAKIADFGTSRSIA-IDQTHVSTKVQGTFGYLDPEYFR---S 249
I HRD+KS NI L E KI DFG + + +H ++ G+ ++ PE R S
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199
Query: 250 SQFTDKSDVYSFGVVLVELLTGQKP------ISSIWANEGRNLTTYFVECIEENCLFDII 303
+ ++ +SDVY+FG+VL EL+TGQ P I GR + + + NC
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNC----- 254
Query: 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347
+++ +M CL RP+ + E+E +
Sbjct: 255 PKRMK------RLM------AECLKKKRDERPSFPRILAEIEEL 286
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 2e-63
Identities = 73/308 (23%), Positives = 122/308 (39%), Gaps = 46/308 (14%)
Query: 60 RIFNSKELDKATDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINE 118
RIF +L +LG+G G K G ++ +K+ DE F+ E
Sbjct: 5 RIFRPSDLI-------HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKE 57
Query: 119 VVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIAT 178
V ++ + H NV+K +G + + + E+I GTL + + W R+ A
Sbjct: 58 VKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSM--DSQYPWSQRVSFAK 115
Query: 179 EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH-------- 230
++A +AYLHS I HRD+ S N L+ E +ADFG +R + ++T
Sbjct: 116 DIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLK 172
Query: 231 -----VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP---ISSIWANE 282
V G ++ PE + +K DV+SFG+VL E++ +
Sbjct: 173 KPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF 232
Query: 283 GRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342
G N+ + NC + + RC + RP+ ++
Sbjct: 233 GLNVRGFLDRYCPPNCP-----------------PSFFPITVRCCDLDPEKRPSFVKLEH 275
Query: 343 ELERIRAN 350
LE +R +
Sbjct: 276 WLETLRMH 283
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 5e-61
Identities = 69/323 (21%), Positives = 119/323 (36%), Gaps = 46/323 (14%)
Query: 62 FNSKELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVI 121
+ E D + ++G+G G VYKG L D R +AVK + + FINE I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNI 58
Query: 122 --LSQINHRNVVKLLGCCLEVEVP-----LLVYEFIPNGTLFQYLHDPYEELSLTWEMRL 174
+ + H N+ + + V LLV E+ PNG+L +YL + W
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH----TSDWVSSC 114
Query: 175 RIATEVAEALAYLHSSAY------LPIYHRDIKSTNILLDEKYRAKIADFGTSR------ 222
R+A V LAYLH+ I HRD+ S N+L+ I+DFG S
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 223 -SIAIDQTHVSTKVQGTFGYLDPEYFRSS-------QFTDKSDVYSFGVVLVELLTGQKP 274
++ + + GT Y+ PE + + D+Y+ G++ E+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 275 ISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK----------SGEAEEIMAVSDVAK 324
+ + + E D+ R+ + + ++ + +
Sbjct: 235 LFP-GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 325 RCLNSYGRNRPTMKEVAMELERI 347
C + R T + + +
Sbjct: 294 DCWDQDAEARLTAQXAEERMAEL 316
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 3e-56
Identities = 59/302 (19%), Positives = 113/302 (37%), Gaps = 43/302 (14%)
Query: 76 MNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVI--LSQINHRNVVKL 133
+ +G+G G V++G G +AVK + + + E + + H N++
Sbjct: 12 LLECVGKGRYGEVWRGSW-QGENVAVK---IFSSRDEKSWFRETELYNTVMLRHENILGF 67
Query: 134 LGCCLEVEVP----LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS 189
+ + L+ + G+L+ YL +L LRI +A LA+LH
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHI 123
Query: 190 SAYL-----PIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV---STKVQGTFGY 241
+ I HRD+KS NIL+ + + IAD G + + + + GT Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 242 LDPE------YFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIE 295
+ PE + D+++FG+VL E+ + + F + +
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV-----EDYKPPFYDVVP 238
Query: 296 ENCLFDIIDDQV---------RKSGEAEEIM-AVSDVAKRCLNSYGRNRPTMKEVAMELE 345
+ F+ + V ++ + +++ + K C R T + L
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
Query: 346 RI 347
+I
Sbjct: 299 KI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 2e-55
Identities = 63/301 (20%), Positives = 112/301 (37%), Gaps = 41/301 (13%)
Query: 76 MNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINE--VVILSQINHRNVVKL 133
M + +G+G G V+ G G +AVK +E + E + + H N++
Sbjct: 41 MVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGF 96
Query: 134 LGCCLEVEVP----LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS 189
+ ++ L+ ++ NG+L+ YL +L + L++A L +LH+
Sbjct: 97 IAADIKGTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHT 152
Query: 190 SAYL-----PIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV---STKVQGTFGY 241
+ I HRD+KS NIL+ + IAD G + D V GT Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 242 LDPE------YFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIE 295
+ PE Q +D+YSFG++L E+ + + Y
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ----LPYHDLVPS 268
Query: 296 ENCLFDIIDDQVRK--------SGEAEEIM-AVSDVAKRCLNSYGRNRPTMKEVAMELER 346
+ D+ + K ++E + + + C +R T V L +
Sbjct: 269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328
Query: 347 I 347
+
Sbjct: 329 M 329
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 1e-53
Identities = 61/305 (20%), Positives = 115/305 (37%), Gaps = 49/305 (16%)
Query: 76 MNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINE--VVILSQINHRNVVKL 133
+ +G+G G V++G G +AVK + + + E + + H N++
Sbjct: 46 LQESIGKGRFGEVWRGKW-RGEEVAVK---IFSSREERSWFREAEIYQTVMLRHENILGF 101
Query: 134 LGCCLEVEVP----LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS 189
+ + LV ++ +G+LF YL+ ++T E +++A A LA+LH
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHM 157
Query: 190 SAYL-----PIYHRDIKSTNILLDEKYRAKIADFGTSR---SIAIDQTHVSTKVQGTFGY 241
I HRD+KS NIL+ + IAD G + S GT Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 242 LDPEYFRSS------QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTY---FVE 292
+ PE S + ++D+Y+ G+V E+ G Y + +
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI--------GGIHEDYQLPYYD 269
Query: 293 CIEENCLFDIIDDQVRKSG----------EAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342
+ + + + V + E + ++ + + C + G R T +
Sbjct: 270 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329
Query: 343 ELERI 347
L ++
Sbjct: 330 TLSQL 334
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-45
Identities = 75/297 (25%), Positives = 125/297 (42%), Gaps = 39/297 (13%)
Query: 66 ELDKATDYFNMNRILGQGGQGTVYKGMLADGRI-IAVKKSKV-VDESKLEEFINEVVILS 123
L+ + + +G+G G V+ G L +AVK + + +F+ E IL
Sbjct: 110 VLNH--EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILK 167
Query: 124 QINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEA 183
Q +H N+V+L+G C + + +V E + G +L E L + L++ + A
Sbjct: 168 QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAG 225
Query: 184 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY-- 241
+ YL S + HRD+ + N L+ EK KI+DFG SR A D + ++
Sbjct: 226 MEYLESKCCI---HRDLAARNCLVTEKNVLKISDFGMSREEA-DGVYAASGGLRQVPVKW 281
Query: 242 LDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVEC-----IE 295
PE +++ +SDV+SFG++L E + G P ++ + T FVE
Sbjct: 282 TAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ----TREFVEKGGRLPCP 337
Query: 296 ENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSR 352
E C +M ++C RP+ + EL+ IR R
Sbjct: 338 ELC-----------PDAVFRLM------EQCWAYEPGQRPSFSTIYQELQSIRKRHR 377
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 5e-45
Identities = 66/296 (22%), Positives = 128/296 (43%), Gaps = 50/296 (16%)
Query: 76 MNRILGQGGQGTVYKGMLADGR-----IIAVKKSKV-VDESKLEEFINEVVILSQINHRN 129
++LG G GTVYKG+ +A+K+ + +E ++E +++ +++ +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS 189
V +LLG CL L+ + +P G L Y+ + + + + L ++A+ + YL
Sbjct: 79 VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGS--QYLLNWCVQIAKGMNYLED 135
Query: 190 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGT---FGYLDPEY 246
+ HRD+ + N+L+ KI DFG ++ + ++ +G ++ E
Sbjct: 136 RRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE--YHAEGGKVPIKWMALES 190
Query: 247 FRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIE--------EN 297
+T +SDV+S+GV + EL+T G KP I A+E +E
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERLPQPPI 243
Query: 298 CLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRD 353
C D+ IM ++C +RP +E+ +E ++ + +
Sbjct: 244 CTIDVY-----------MIM------RKCWMIDADSRPKFRELIIEFSKMARDPQR 282
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-44
Identities = 81/301 (26%), Positives = 138/301 (45%), Gaps = 42/301 (13%)
Query: 66 ELDKATDYFNMNRILGQGGQGTVYKGMLADGRI-IAVKKSKVVDESKLEEFINEVVILSQ 124
E+++ M LG G G VY+G+ + +AVK K D ++EEF+ E ++ +
Sbjct: 216 EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 272
Query: 125 INHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEAL 184
I H N+V+LLG C ++ EF+ G L YL + ++ + L +AT+++ A+
Sbjct: 273 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAM 331
Query: 185 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDP 244
YL ++ HR++ + N L+ E + K+ADFG SR + D + + P
Sbjct: 332 EYLEKKNFI---HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 388
Query: 245 EYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIE-------- 295
E ++F+ KSDV++FGV+L E+ T G P I ++ E +E
Sbjct: 389 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMERP 441
Query: 296 ENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI-RANSRDD 354
E C + E+M + C +RP+ E+ E + + +S D
Sbjct: 442 EGC-----------PEKVYELM------RACWQWNPSDRPSFAEIHQAFETMFQESSISD 484
Query: 355 E 355
E
Sbjct: 485 E 485
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 3e-44
Identities = 77/316 (24%), Positives = 132/316 (41%), Gaps = 60/316 (18%)
Query: 76 MNRILGQGGQGTVYKGMLADG----RIIAVK--KSKVVDESKLEEFINEVVILSQINHRN 129
+ R+LG+G G+V + L +AVK K+ ++ S +EEF+ E + + +H +
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 130 VVKLLGCCLEVE------VPLLVYEFIPNGTLFQYL--HDPYEE-LSLTWEMRLRIATEV 180
V KL+G L +P+++ F+ +G L +L E +L + +R ++
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 181 AEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFG 240
A + YL S ++ HRD+ + N +L E +ADFG SR I + QG
Sbjct: 147 ACGMEYLSSRNFI---HRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY----RQGCAS 199
Query: 241 YL-----DPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECI 294
L E + +T SDV++FGV + E++T GQ P + I E +
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-------IYNYL 252
Query: 295 E--------ENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELER 346
C E ++M +C ++ + RP+ + MELE
Sbjct: 253 IGGNRLKQPPEC-----------MEEVYDLM------YQCWSADPKQRPSFTCLRMELEN 295
Query: 347 IRANSRDDENNIQKCY 362
I + + Y
Sbjct: 296 ILGHLSVLSTSQDPLY 311
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-44
Identities = 77/307 (25%), Positives = 118/307 (38%), Gaps = 50/307 (16%)
Query: 72 DYFNMNRILGQGGQGTVYKGML-----ADGRIIAVKKSKV-VDESKLEEFINEVVILSQI 125
Y R LG+G G V G ++AVK K + E+ IL +
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 126 NHRNVVKLLGCCLEVEVP--LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEA 183
H +++K GCC + LV E++P G+L YL S+ L A ++ E
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEG 146
Query: 184 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF--GY 241
+AYLH+ Y+ HRD+ + N+LLD KI DFG ++++ + + G +
Sbjct: 147 MAYLHAQHYI---HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 203
Query: 242 LDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTY-------FVEC 293
PE + +F SDV+SFGV L ELLT S E
Sbjct: 204 YAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263
Query: 294 IE--------ENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345
+E + C E +M K C + RPT + + L+
Sbjct: 264 LERGERLPRPDKC-----------PAEVYHLM------KNCWETEASFRPTFENLIPILK 306
Query: 346 RIRANSR 352
+ +
Sbjct: 307 TVHEKYQ 313
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-44
Identities = 81/313 (25%), Positives = 136/313 (43%), Gaps = 50/313 (15%)
Query: 66 ELDKATDYFNMNRILGQGGQGTVYKGML-----ADGRIIAVKKSKVVDESKLEEFINEVV 120
+ ++ + + LG+G G+V G ++AVKK + E L +F E+
Sbjct: 37 QFEE--RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 94
Query: 121 ILSQINHRNVVKLLGCCLE-VEVPL-LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIAT 178
IL + H N+VK G C L L+ E++P G+L YL E + L+ +
Sbjct: 95 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTS 152
Query: 179 EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGT 238
++ + + YL + Y+ HRD+ + NIL++ + R KI DFG ++ + D+ + K G
Sbjct: 153 QICKGMEYLGTKRYI---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGE 209
Query: 239 F--GYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNL--TTYF---- 290
+ PE S+F+ SDV+SFGVVL EL T + S A R +
Sbjct: 210 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 269
Query: 291 ---VECIEE--------NCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKE 339
+E ++ C E IM C N+ RP+ ++
Sbjct: 270 FHLIELLKNNGRLPRPDGC-----------PDEIYMIM------TECWNNNVNQRPSFRD 312
Query: 340 VAMELERIRANSR 352
+A+ +++IR
Sbjct: 313 LALRVDQIRDQMA 325
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-44
Identities = 82/313 (26%), Positives = 136/313 (43%), Gaps = 50/313 (15%)
Query: 66 ELDKATDYFNMNRILGQGGQGTVYKGML-----ADGRIIAVKKSKVVDESKLEEFINEVV 120
+ ++ + + LG+G G+V G ++AVKK + E L +F E+
Sbjct: 6 QFEE--RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 63
Query: 121 ILSQINHRNVVKLLGCCLE-VEVPL-LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIAT 178
IL + H N+VK G C L L+ E++P G+L YL E + L+ +
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTS 121
Query: 179 EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGT 238
++ + + YL + Y+ HRD+ + NIL++ + R KI DFG ++ + D+ K G
Sbjct: 122 QICKGMEYLGTKRYI---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178
Query: 239 F--GYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNL--TTYF---- 290
+ PE S+F+ SDV+SFGVVL EL T + S A R +
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238
Query: 291 ---VECIEE--------NCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKE 339
+E ++ C E IM C N+ RP+ ++
Sbjct: 239 FHLIELLKNNGRLPRPDGC-----------PDEIYMIM------TECWNNNVNQRPSFRD 281
Query: 340 VAMELERIRANSR 352
+A+ +++IR N
Sbjct: 282 LALRVDQIRDNMA 294
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 5e-44
Identities = 73/297 (24%), Positives = 130/297 (43%), Gaps = 29/297 (9%)
Query: 72 DYFNMNRILGQGGQGTVYKGML-----ADGRIIAVKKSKVVDESKLEEFINEVVILSQIN 126
+ LG+G G+V G ++AVK+ + + +F E+ IL ++
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 127 HRNVVKLLGCCLE-VEVPL-LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEAL 184
+VK G L LV E++P+G L +L L + L ++++ + +
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDAS--RLLLYSSQICKGM 140
Query: 185 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF--GYL 242
YL S + HRD+ + NIL++ + KIADFG ++ + +D+ + + G +
Sbjct: 141 EYLGSRRCV---HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 197
Query: 243 DPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFD 301
PE + F+ +SDV+SFGVVL EL T K S V + L +
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR--LLE 255
Query: 302 IIDDQVRK------SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSR 352
++++ R E E+M K C ++RP+ + +L+ + + SR
Sbjct: 256 LLEEGQRLPAPPACPAEVHELM------KLCWAPSPQDRPSFSALGPQLDMLWSGSR 306
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-43
Identities = 66/274 (24%), Positives = 113/274 (41%), Gaps = 34/274 (12%)
Query: 78 RILGQGGQGTVYKGM-LADGRIIAVKK---SKVVDESKLEEFINEVVILSQINHRNVVKL 133
+ +G+G VY+ L DG +A+KK ++D + I E+ +L Q+NH NV+K
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 134 LGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMR-LRIATEVAEALAYLHSSAY 192
+E +V E G L + + ++ L E + ++ AL ++HS
Sbjct: 98 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR- 156
Query: 193 LPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQF 252
+ HRDIK N+ + K+ D G R + T + V GT Y+ PE + +
Sbjct: 157 --VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGY 213
Query: 253 TDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGE 312
KSD++S G +L E+ Q P + + NL + L I + +
Sbjct: 214 NFKSDIWSLGCLLYEMAALQSP----FYGDKMNLYS----------LCKKI-----EQCD 254
Query: 313 AEEI------MAVSDVAKRCLNSYGRNRPTMKEV 340
+ + + C+N RP + V
Sbjct: 255 YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-43
Identities = 77/302 (25%), Positives = 130/302 (43%), Gaps = 48/302 (15%)
Query: 72 DYFNMNRILGQGGQGTVYKGMLA-----DGRIIAVKKSKV-VDESKLEEFINEVVILSQI 125
+ R LG+G G V G +AVK K + + + E+ IL +
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 126 NHRNVVKLLGCCLEVEVP--LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEA 183
H N+VK G C E L+ EF+P+G+L +YL +++L +L+ A ++ +
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLK--QQLKYAVQICKG 138
Query: 184 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF--GY 241
+ YL S Y+ HRD+ + N+L++ +++ KI DFG +++I D+ + + K +
Sbjct: 139 MDYLGSRQYV---HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFW 195
Query: 242 LDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTY-------FVEC 293
PE S+F SDV+SFGV L ELLT S + T+ V
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255
Query: 294 IEE--------NCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345
++E NC E ++M ++C NR + + + E
Sbjct: 256 LKEGKRLPCPPNC-----------PDEVYQLM------RKCWEFQPSNRTSFQNLIEGFE 298
Query: 346 RI 347
+
Sbjct: 299 AL 300
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 5e-43
Identities = 75/306 (24%), Positives = 130/306 (42%), Gaps = 59/306 (19%)
Query: 76 MNRILGQGGQGTVYKGMLADGR----IIAVK--KSKVVDESKLEEFINEVVILSQINHRN 129
+ +ILG+G G+V +G L +AVK K + ++EEF++E + +H N
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 130 VVKLLGCCLEVE-----VPLLVYEFIPNGTLFQYL---HDPYEELSLTWEMRLRIATEVA 181
V++LLG C+E+ P+++ F+ G L YL + + L+ ++A
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 182 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 241
+ YL + +L HRD+ + N +L + +ADFG S+ I + QG
Sbjct: 158 LGMEYLSNRNFL---HRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAK 210
Query: 242 L-----DPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIE 295
+ E +T KSDV++FGV + E+ T G P + +E + +
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE-------MYDYLL 263
Query: 296 --------ENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347
E+C E EIM C + +RPT + ++LE++
Sbjct: 264 HGHRLKQPEDC-----------LDELYEIM------YSCWRTDPLDRPTFSVLRLQLEKL 306
Query: 348 RANSRD 353
+ D
Sbjct: 307 LESLPD 312
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 7e-43
Identities = 68/215 (31%), Positives = 112/215 (52%), Gaps = 17/215 (7%)
Query: 66 ELDKATDYFNMNRILGQGGQGTVYKGMLADGRI-IAVKKSKVVDESKLEEFINEVVILSQ 124
E+++ M LG G G VY+G+ + +AVK K D ++EEF+ E ++ +
Sbjct: 9 EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 65
Query: 125 INHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEAL 184
I H N+V+LLG C ++ EF+ G L YL + ++ + L +AT+++ A+
Sbjct: 66 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAM 124
Query: 185 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTK----VQGTFG 240
YL ++ HRD+ + N L+ E + K+ADFG SR + D ++ T
Sbjct: 125 EYLEKKNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT-- 179
Query: 241 YLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKP 274
PE ++F+ KSDV++FGV+L E+ T G P
Sbjct: 180 --APESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 9e-43
Identities = 61/218 (27%), Positives = 106/218 (48%), Gaps = 15/218 (6%)
Query: 65 KELDKATDYFNMNRILGQGGQGTVYKGML--ADGRII--AVKKSKV-VDESKLEEFINEV 119
+E++ ++ +I+G G G V G L R + A+K K E + +F++E
Sbjct: 44 REIEA--SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEA 101
Query: 120 VILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATE 179
I+ Q +H N+++L G + ++V E++ NG+L +L + ++ + +
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI--MQLVGMLRG 159
Query: 180 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF 239
V + YL Y+ HRD+ + N+L+D K++DFG SR + D T G
Sbjct: 160 VGAGMRYLSDLGYV---HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI 216
Query: 240 GYL--DPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKP 274
PE F+ SDV+SFGVV+ E+L G++P
Sbjct: 217 PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-42
Identities = 76/302 (25%), Positives = 128/302 (42%), Gaps = 53/302 (17%)
Query: 75 NMNRILGQGGQGTVYKGMLADGR----IIAVKKSKVV-DESKLEEFINEVVILSQINHRN 129
+ N ++G+G G VY G L D AVK + D ++ +F+ E +I+ +H N
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 130 VVKLLGCCLEVEVPLL-VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLH 188
V+ LLG CL E L V ++ +G L ++ + ++ + + +VA+ + YL
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLA 145
Query: 189 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYL------ 242
S ++ HRD+ + N +LDEK+ K+ADFG +R + V G
Sbjct: 146 SKKFV---HRDLAARNCMLDEKFTVKVADFGLARDM---YDKEYYSVHNKTGAKLPVKWM 199
Query: 243 DPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIE------ 295
E ++ +FT KSDV+SFGV+L EL+T G P + + +
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQGRRLL 252
Query: 296 --ENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRD 353
E C E+M +C + RP+ E+ + I +
Sbjct: 253 QPEYC-----------PDPLYEVM------LKCWHPKAEMRPSFSELVSRISAIFSTFIG 295
Query: 354 DE 355
+
Sbjct: 296 EH 297
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-42
Identities = 75/301 (24%), Positives = 129/301 (42%), Gaps = 51/301 (16%)
Query: 75 NMNRILGQGGQGTVYKGMLADGR----IIAVKKSKVV-DESKLEEFINEVVILSQINHRN 129
+ N ++G+G G VY G L D AVK + D ++ +F+ E +I+ +H N
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 130 VVKLLGCCLEVEVPLL-VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLH 188
V+ LLG CL E L V ++ +G L ++ + ++ + + +VA+ + +L
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLA 209
Query: 189 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYL-----D 243
S ++ HRD+ + N +LDEK+ K+ADFG +R + + T L
Sbjct: 210 SKKFV---HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN--KTGAKLPVKWMA 264
Query: 244 PEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIE------- 295
E ++ +FT KSDV+SFGV+L EL+T G P + + +
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQGRRLLQ 317
Query: 296 -ENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDD 354
E C E+M +C + RP+ E+ + I + +
Sbjct: 318 PEYC-----------PDPLYEVM------LKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360
Query: 355 E 355
Sbjct: 361 H 361
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-42
Identities = 64/214 (29%), Positives = 105/214 (49%), Gaps = 17/214 (7%)
Query: 66 ELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQI 125
EL + + + + LG G G V G +AVK K +EF E + ++
Sbjct: 4 ELKR--EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKE-GSMSEDEFFQEAQTMMKL 60
Query: 126 NHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALA 185
+H +VK G C + +V E+I NG L YL L L + +V E +A
Sbjct: 61 SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMA 118
Query: 186 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ--THVSTK--VQGTFGY 241
+L S ++ HRD+ + N L+D K++DFG +R + DQ + V TK V+ +
Sbjct: 119 FLESHQFI---HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS--- 172
Query: 242 LDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKP 274
PE F +++ KSDV++FG+++ E+ + G+ P
Sbjct: 173 -APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 1e-42
Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 9/210 (4%)
Query: 66 ELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQI 125
E+ + + + LG G G V+ G +AVK K + F+ E ++ Q+
Sbjct: 9 EVPR--ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQL 65
Query: 126 NHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALA 185
H+ +V+L + E ++ E++ NG+L +L P + LT L +A ++AE +A
Sbjct: 66 QHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMA 123
Query: 186 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE 245
++ Y+ HRD+++ NIL+ + KIADFG +R I ++ + + PE
Sbjct: 124 FIEERNYI---HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180
Query: 246 YFRSSQFTDKSDVYSFGVVLVELLT-GQKP 274
FT KSDV+SFG++L E++T G+ P
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-42
Identities = 62/214 (28%), Positives = 107/214 (50%), Gaps = 17/214 (7%)
Query: 66 ELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQI 125
E+D + LG G G V G +A+K K +EFI E ++ +
Sbjct: 20 EIDP--KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNL 76
Query: 126 NHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALA 185
+H +V+L G C + ++ E++ NG L YL + L + +V EA+
Sbjct: 77 SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAME 134
Query: 186 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ--THVSTK--VQGTFGY 241
YL S +L HRD+ + N L++++ K++DFG SR + D+ + V +K V+ +
Sbjct: 135 YLESKQFL---HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS--- 188
Query: 242 LDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKP 274
PE S+F+ KSD+++FGV++ E+ + G+ P
Sbjct: 189 -PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-42
Identities = 80/311 (25%), Positives = 131/311 (42%), Gaps = 65/311 (20%)
Query: 76 MNRILGQGGQGTVYKGMLADGR------IIAVKKSKVVDESKLEEFINEVVILSQINHRN 129
+ LG+G G V+ + ++AVK K ES ++F E +L+ + H++
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYL--HDPYEEL----------SLTWEMRLRIA 177
+V+ G C E L+V+E++ +G L ++L H P +L L L +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 178 TEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI-AIDQTHVSTKVQ 236
++VA + YL ++ HRD+ + N L+ + KI DFG SR I + D V +
Sbjct: 165 SQVAAGMVYLAGLHFV---HRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGR-- 219
Query: 237 GTFGYL-----DPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYF 290
L PE +FT +SDV+SFGVVL E+ T G++P + E
Sbjct: 220 ---TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE-------A 269
Query: 291 VECIE--------ENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342
++CI C E IM + C + R ++K+V
Sbjct: 270 IDCITQGRELERPRAC-----------PPEVYAIM------RGCWQREPQQRHSIKDVHA 312
Query: 343 ELERIRANSRD 353
L+ +
Sbjct: 313 RLQALAQAPPV 323
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-42
Identities = 56/284 (19%), Positives = 114/284 (40%), Gaps = 34/284 (11%)
Query: 66 ELDKATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESK--LEEFINEVVIL 122
+ + + +G+G TVYKG+ +A + + +K + F E +L
Sbjct: 20 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEML 79
Query: 123 SQINHRNVVKLLGCCLEVEVP----LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIAT 178
+ H N+V+ +LV E + +GTL YL + ++
Sbjct: 80 KGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCR 136
Query: 179 EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY-RAKIADFGTSRSIAIDQTHVSTKVQG 237
++ + L +LH+ PI HRD+K NI + KI D G + + + + V G
Sbjct: 137 QILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLA---TLKRASFAKAVIG 192
Query: 238 TFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFV--ECIE 295
T ++ PE + ++ + DVY+FG+ ++E+ T + P ++ Y ++
Sbjct: 193 TPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYP----YSECQNAAQIYRRVTSGVK 247
Query: 296 ENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKE 339
+ +V+ ++ + C+ R ++K+
Sbjct: 248 PASFDKVAIPEVK------------EIIEGCIRQNKDERYSIKD 279
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-42
Identities = 63/218 (28%), Positives = 109/218 (50%), Gaps = 15/218 (6%)
Query: 65 KELDKATDYFNMNRILGQGGQGTVYKGML--ADGRII--AVKKSKV-VDESKLEEFINEV 119
KELD ++++++G G G V G L + I A+K KV E + +F+ E
Sbjct: 40 KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 120 VILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATE 179
I+ Q +H N+++L G + + ++V E++ NG+L +L + T + +
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRG 155
Query: 180 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF 239
+A + YL Y+ HRD+ + NIL++ K++DFG R + D T G
Sbjct: 156 IASGMKYLSDMGYV---HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI 212
Query: 240 GYL--DPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKP 274
PE +FT SDV+S+G+VL E+++ G++P
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-42
Identities = 65/213 (30%), Positives = 115/213 (53%), Gaps = 19/213 (8%)
Query: 66 ELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQI 125
L+ + + +G+G G V G G +AVK K +++ + F+ E +++Q+
Sbjct: 17 ALNM--KELKLLQTIGKGEFGDVMLGD-YRGNKVAVKCIK--NDATAQAFLAEASVMTQL 71
Query: 126 NHRNVVKLLGCCLEVEVPL-LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEAL 184
H N+V+LLG +E + L +V E++ G+L YL L + L+ + +V EA+
Sbjct: 72 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAM 130
Query: 185 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTK--VQGTFGYL 242
YL + ++ HRD+ + N+L+ E AK++DFG ++ + T + K V+ T
Sbjct: 131 EYLEGNNFV---HRDLAARNVLVSEDNVAKVSDFGLTKEAS--STQDTGKLPVKWT---- 181
Query: 243 DPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKP 274
PE R +F+ KSDV+SFG++L E+ + G+ P
Sbjct: 182 APEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 4e-42
Identities = 63/219 (28%), Positives = 109/219 (49%), Gaps = 16/219 (7%)
Query: 65 KELDKATDYFNMNRILGQGGQGTVYKGMLADGRI-----IAVKKSKV-VDESKLEEFINE 118
E+ +++G G G VYKGML +A+K K E + +F+ E
Sbjct: 39 TEIHP--SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGE 96
Query: 119 VVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIAT 178
I+ Q +H N+++L G + + +++ E++ NG L ++L + E S+ + +
Sbjct: 97 AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSV--LQLVGMLR 154
Query: 179 EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGT 238
+A + YL + Y+ HRD+ + NIL++ K++DFG SR + D T G
Sbjct: 155 GIAAGMKYLANMNYV---HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 211
Query: 239 FGY--LDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKP 274
PE +FT SDV+SFG+V+ E++T G++P
Sbjct: 212 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 4e-42
Identities = 66/296 (22%), Positives = 127/296 (42%), Gaps = 50/296 (16%)
Query: 76 MNRILGQGGQGTVYKGMLADGR-----IIAVKKSKV-VDESKLEEFINEVVILSQINHRN 129
++LG G GTVYKG+ +A+K+ + +E ++E +++ +++ +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS 189
V +LLG CL L+ + +P G L Y+ + + + + L ++A+ + YL
Sbjct: 79 VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGS--QYLLNWCVQIAKGMNYLED 135
Query: 190 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGT---FGYLDPEY 246
+ HRD+ + N+L+ KI DFG ++ + ++ +G ++ E
Sbjct: 136 RRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE--YHAEGGKVPIKWMALES 190
Query: 247 FRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIE--------EN 297
+T +SDV+S+GV + EL+T G KP I A+E +E
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERLPQPPI 243
Query: 298 CLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRD 353
C D+ IM +C +RP +E+ +E ++ + +
Sbjct: 244 CTIDVY-----------MIM------VKCWMIDADSRPKFRELIIEFSKMARDPQR 282
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 5e-42
Identities = 62/307 (20%), Positives = 125/307 (40%), Gaps = 52/307 (16%)
Query: 65 KELDKATDYFNMNRILGQGGQGTVYKGMLADGR-----IIAVKKSKV-VDESKLEEFINE 118
+ + ++LG G GTV+KG+ + +K + + +
Sbjct: 8 RIFKE--TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDH 65
Query: 119 VVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIAT 178
++ + ++H ++V+LLG C LV +++P G+L ++ L ++ L
Sbjct: 66 MLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGP--QLLLNWGV 122
Query: 179 EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGT 238
++A+ + YL + HR++ + N+LL + ++ADFG + + D +
Sbjct: 123 QIAKGMYYLEEHGMV---HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY--SEA 177
Query: 239 ---FGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECI 294
++ E ++T +SDV+S+GV + EL+T G +P + + E + +
Sbjct: 178 KTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-------VPDLL 230
Query: 295 E--------ENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELER 346
E + C D+ +M +C RPT KE+A E R
Sbjct: 231 EKGERLAQPQICTIDVY-----------MVM------VKCWMIDENIRPTFKELANEFTR 273
Query: 347 IRANSRD 353
+ +
Sbjct: 274 MARDPPR 280
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 5e-42
Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 9/210 (4%)
Query: 66 ELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQI 125
E+ + + + LGQG G V+ G +A+K K E F+ E ++ ++
Sbjct: 263 EIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKL 319
Query: 126 NHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALA 185
H +V+L E E +V E++ G+L +L L + +A ++A +A
Sbjct: 320 RHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMA 377
Query: 186 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE 245
Y+ Y+ HRD+++ NIL+ E K+ADFG +R I ++ + + PE
Sbjct: 378 YVERMNYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 434
Query: 246 YFRSSQFTDKSDVYSFGVVLVELLT-GQKP 274
+FT KSDV+SFG++L EL T G+ P
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTTKGRVP 464
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 5e-42
Identities = 65/214 (30%), Positives = 107/214 (50%), Gaps = 17/214 (7%)
Query: 66 ELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQI 125
+D + +G G G V+ G + +A+K + E+FI E ++ ++
Sbjct: 4 VIDP--SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKL 60
Query: 126 NHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALA 185
+H +V+L G CLE LV EF+ +G L YL + E L + +V E +A
Sbjct: 61 SHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAA--ETLLGMCLDVCEGMA 118
Query: 186 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ--THVSTK--VQGTFGY 241
YL + + HRD+ + N L+ E K++DFG +R + DQ + TK V+
Sbjct: 119 YLEEACVI---HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA--- 172
Query: 242 LDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKP 274
PE F S+++ KSDV+SFGV++ E+ + G+ P
Sbjct: 173 -SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 7e-42
Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 76 MNRILGQGGQGTVYKGML--ADGRIIAV-----KKSKVVDESKLEEFINEVVILSQINHR 128
+ LG G G V +G G+ ++V K + +++FI EV + ++HR
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 129 NVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLH 188
N+++L G L +V E P G+L L L R A +VAE + YL
Sbjct: 82 NLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLL--GTLSRYAVQVAEGMGYLE 138
Query: 189 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY--LDPEY 246
S ++ HRD+ + N+LL + KI DFG R++ + H + + PE
Sbjct: 139 SKRFI---HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 195
Query: 247 FRSSQFTDKSDVYSFGVVLVELLT-GQKP 274
++ F+ SD + FGV L E+ T GQ+P
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 7e-42
Identities = 65/213 (30%), Positives = 114/213 (53%), Gaps = 19/213 (8%)
Query: 66 ELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQI 125
L+ + + +G+G G V G G +AVK K +++ + F+ E +++Q+
Sbjct: 189 ALNM--KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQL 243
Query: 126 NHRNVVKLLGCCLEVEVPL-LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEAL 184
H N+V+LLG +E + L +V E++ G+L YL L + L+ + +V EA+
Sbjct: 244 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAM 302
Query: 185 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTK--VQGTFGYL 242
YL + ++ HRD+ + N+L+ E AK++DFG ++ T + K V+ T
Sbjct: 303 EYLEGNNFV---HRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPVKWT---- 353
Query: 243 DPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKP 274
PE R +F+ KSDV+SFG++L E+ + G+ P
Sbjct: 354 APEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-41
Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 78 RILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGC 136
+LG+G G VY G L++ IA+K+ D + E+ + + H+N+V+ LG
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 137 CLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIAT-EVAEALAYLHSSAYLPI 195
E + E +P G+L L + L E + T ++ E L YLH + I
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN-EQTIGFYTKQILEGLKYLHDNQ---I 143
Query: 196 YHRDIKSTNILLDEKY-RAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQ--F 252
HRDIK N+L++ KI+DFGTS+ +A T GT Y+ PE +
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGY 202
Query: 253 TDKSDVYSFGVVLVELLTGQKPISSIWAN 281
+D++S G ++E+ TG+ P +
Sbjct: 203 GKAADIWSLGCTIIEMATGKPP----FYE 227
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-41
Identities = 73/309 (23%), Positives = 125/309 (40%), Gaps = 64/309 (20%)
Query: 76 MNRILGQGGQGTVYKGMLADGR------IIAVKKSKVVDESKLEEFINEVVILSQINHRN 129
+ R LG+G G V+ + ++AVK K + ++F E +L+ + H +
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYL-------------HDPYEELSLTWEMRLRI 176
+VK G C + + ++V+E++ +G L ++L + L L I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 177 ATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQ 236
A+++A + YL S ++ HRD+ + N L+ KI DFG SR + +
Sbjct: 139 ASQIASGMVYLASQHFV---HRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV---- 191
Query: 237 GTFGYL-----DPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYF 290
G L PE +FT +SDV+SFGV+L E+ T G++P + E
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------V 244
Query: 291 VECIE--------ENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342
+ECI C E ++M C + R +KE+
Sbjct: 245 IECITQGRVLERPRVC-----------PKEVYDVM------LGCWQREPQQRLNIKEIYK 287
Query: 343 ELERIRANS 351
L + +
Sbjct: 288 ILHALGKAT 296
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-41
Identities = 73/300 (24%), Positives = 128/300 (42%), Gaps = 59/300 (19%)
Query: 76 MNRILGQGGQGTVYKGMLADGR------IIAVKKSKV-VDESKLEEFINEVVILSQINHR 128
M+R LGQG G VY+G+ +A+K + EF+NE ++ + N
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 129 NVVKLLGCCLEVEVPLLVYEFIPNGTLFQYL-------HDPYEELSLTWEMRLRIATEVA 181
+VV+LLG + + L++ E + G L YL + + +++A E+A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 182 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 241
+ +AYL+++ ++ HRD+ + N ++ E + KI DFG +R I + +G G
Sbjct: 149 DGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKGGKGL 201
Query: 242 L-----DPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIE 295
L PE + FT SDV+SFGVVL E+ T ++P + + + +
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-------VLRFVM 254
Query: 296 --------ENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347
+NC E+M + C + RP+ E+ ++
Sbjct: 255 EGGLLDKPDNC-----------PDMLFELM------RMCWQYNPKMRPSFLEIISSIKEE 297
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-41
Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 9/210 (4%)
Query: 66 ELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQI 125
E+ + + + LGQG G V+ G +A+K K E F+ E ++ ++
Sbjct: 180 EIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKL 236
Query: 126 NHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALA 185
H +V+L E E +V E++ G+L +L L + +A ++A +A
Sbjct: 237 RHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMA 294
Query: 186 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE 245
Y+ Y+ HRD+++ NIL+ E K+ADFG +R I ++ + + PE
Sbjct: 295 YVERMNYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 351
Query: 246 YFRSSQFTDKSDVYSFGVVLVELLT-GQKP 274
+FT KSDV+SFG++L EL T G+ P
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVP 381
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-41
Identities = 62/207 (29%), Positives = 113/207 (54%), Gaps = 15/207 (7%)
Query: 76 MNRILGQGGQGTVYKGMLADGRI---IAVK--KSKVVDESKLEEFINEVVILSQINHRNV 130
++ LG G GTV KG ++ +AVK K++ D + +E + E ++ Q+++ +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 131 VKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSS 190
V+++G C E +LV E G L +YL + + + + + +V+ + YL S
Sbjct: 81 VRMIGICEA-ESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEES 136
Query: 191 AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF--GYLDPEYFR 248
++ HRD+ + N+LL ++ AKI+DFG S+++ D+ + + G + + PE
Sbjct: 137 NFV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193
Query: 249 SSQFTDKSDVYSFGVVLVELLT-GQKP 274
+F+ KSDV+SFGV++ E + GQKP
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-41
Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 14/215 (6%)
Query: 66 ELDKATDYFNMNRILGQGGQGTVYKGML--ADGRII--AVKKSKV-VDESKLEEFINEVV 120
E+ + + + R +G+G G V++G+ + + A+K K +S E+F+ E +
Sbjct: 11 EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 68
Query: 121 ILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEV 180
+ Q +H ++VKL+G E ++ E G L +L L L + A ++
Sbjct: 69 TMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQL 125
Query: 181 AEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFG 240
+ ALAYL S ++ HRDI + N+L+ K+ DFG SR + + ++K +
Sbjct: 126 STALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 182
Query: 241 YLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKP 274
++ PE +FT SDV+ FGV + E+L G KP
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-41
Identities = 63/209 (30%), Positives = 107/209 (51%), Gaps = 15/209 (7%)
Query: 76 MNRILGQGGQGTVYKGMLADGR----IIAVKKSKVV-DESKLEEFINEVVILSQINHRNV 130
+R++G+G G VY G D A+K + + ++E F+ E +++ +NH NV
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 131 VKLLGCCLEVE-VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS 189
+ L+G L E +P ++ ++ +G L Q++ P ++ + +VA + YL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVK--DLISFGLQVARGMEYLAE 142
Query: 190 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI-AIDQTHVSTKVQGTF--GYLDPEY 246
++ HRD+ + N +LDE + K+ADFG +R I + V + E
Sbjct: 143 QKFV---HRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199
Query: 247 FRSSQFTDKSDVYSFGVVLVELLT-GQKP 274
++ +FT KSDV+SFGV+L ELLT G P
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-41
Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 9/211 (4%)
Query: 72 DYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKV--VDESKLEEFINEVVILSQINHR 128
+ + + +G G G K +DG+I+ K+ + E++ + ++EV +L ++ H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 129 NVVKLLGCCLEVEVPLL--VYEFIPNGTLFQYLHDPYEELSLTWEMR-LRIATEVAEALA 185
N+V+ ++ L V E+ G L + +E E LR+ T++ AL
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 186 YLHS--SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 243
H + HRD+K N+ LD K K+ DFG +R + D + T V GT Y+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMS 184
Query: 244 PEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
PE + +KSD++S G +L EL P
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-41
Identities = 68/206 (33%), Positives = 109/206 (52%), Gaps = 14/206 (6%)
Query: 76 MNRILGQGGQGTVYKGML--ADGRII--AVK--KSKVVDESKLEEFINEVVILSQINHRN 129
+NRILG+G G VY+G+ G I AVK K ++K E+F++E VI+ ++H +
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK-EKFMSEAVIMKNLDHPH 74
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS 189
+VKL+G E E ++ E P G L YL L + + + ++ +A+AYL S
Sbjct: 75 IVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMAYLES 131
Query: 190 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRS 249
+ HRDI NIL+ K+ DFG SR I + + ++ + ++ PE
Sbjct: 132 INCV---HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF 188
Query: 250 SQFTDKSDVYSFGVVLVELLT-GQKP 274
+FT SDV+ F V + E+L+ G++P
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-41
Identities = 62/297 (20%), Positives = 113/297 (38%), Gaps = 44/297 (14%)
Query: 74 FNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVK 132
+ + LG+GG V L DG A+K+ ++ EE E + NH N+++
Sbjct: 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 133 LLGCCLEVEVP----LLVYEFIPNGTLFQYL------HDPYEELSLTWEMRLRIATEVAE 182
L+ CL L+ F GTL+ + + E + L + +
Sbjct: 91 LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQI-----LWLLLGICR 145
Query: 183 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR--SIAIDQTHVSTKVQ---- 236
L +H+ HRD+K TNILL ++ + + D G+ I ++ + + +Q
Sbjct: 146 GLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202
Query: 237 --GTFGYLDPEYF---RSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFV 291
T Y PE F +++DV+S G VL ++ G+ P + V
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY------DMVFQKGDSV 256
Query: 292 ECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIR 348
+N L + S +++ + RP + + +LE ++
Sbjct: 257 ALAVQNQLSIPQSPRH--SSALWQLL------NSMMTVDPHQRPHIPLLLSQLEALQ 305
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 9e-41
Identities = 77/319 (24%), Positives = 133/319 (41%), Gaps = 73/319 (22%)
Query: 76 MNRILGQGGQGTVYKGMLADGR------IIAVKKSKV-VDESKLEEFINEVVILSQINHR 128
+ + LG+G G V K + +AVK K S+L + ++E +L Q+NH
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 129 NVVKLLGCCLEVEVPLLVYEFIPNGTLFQYL---------------------HDPYEELS 167
+V+KL G C + LL+ E+ G+L +L D +E +
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 168 LTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227
LT + A ++++ + YL + HRD+ + NIL+ E + KI+DFG SR + +
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKLV---HRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 228 QTHVSTKVQGTFGYL-----DPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWAN 281
++ V+ + G + E +T +SDV+SFGV+L E++T G P I
Sbjct: 204 DSY----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259
Query: 282 EGRNLTTYFVECIE--------ENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRN 333
++ +NC S E +M +C
Sbjct: 260 R-------LFNLLKTGHRMERPDNC-----------SEEMYRLM------LQCWKQEPDK 295
Query: 334 RPTMKEVAMELERIRANSR 352
RP +++ +LE++ R
Sbjct: 296 RPVFADISKDLEKMMVKRR 314
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-40
Identities = 55/220 (25%), Positives = 97/220 (44%), Gaps = 20/220 (9%)
Query: 62 FNSKELDKATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKV--VDESKLEEFINE 118
+ ++K + + +G+G G DGR +K+ + + + EE E
Sbjct: 18 LYFQSMEK----YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRRE 73
Query: 119 VVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYL----HDPYEELSLTWEMRL 174
V +L+ + H N+V+ E +V ++ G LF+ + ++E + L
Sbjct: 74 VAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQE-----DQIL 128
Query: 175 RIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTK 234
++ AL ++H I HRDIKS NI L + ++ DFG +R +
Sbjct: 129 DWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC 185
Query: 235 VQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
+ GT YL PE + + +KSD+++ G VL EL T +
Sbjct: 186 I-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-40
Identities = 82/316 (25%), Positives = 126/316 (39%), Gaps = 66/316 (20%)
Query: 76 MNRILGQGGQGTVYKGMLAD------GRIIAVKKSK-VVDESKLEEFINEVVILSQI-NH 127
+ + LG+G G V + R +AVK K S+ ++E+ IL I +H
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 128 RNVVKLLGCCLEVEVPLLV-YEFIPNGTLFQYL-------------HDPYEELSLTWEMR 173
NVV LLG C + PL+V EF G L YL + + LT E
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 174 LRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVST 233
+ + +VA+ + +L S + HRD+ + NILL EK KI DFG +R I D +
Sbjct: 151 ICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFGLARDIYKDPDY--- 204
Query: 234 KVQGTFGYL-----DPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLT 287
V+ L PE +T +SDV+SFGV+L E+ + G P + +E
Sbjct: 205 -VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---- 259
Query: 288 TYFVECIE--------ENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKE 339
F ++ + + E + M C + RPT E
Sbjct: 260 --FCRRLKEGTRMRAPDYT-----------TPEMYQTM------LDCWHGEPSQRPTFSE 300
Query: 340 VAMELERIRANSRDDE 355
+ L + + +
Sbjct: 301 LVEHLGNLLQANAQQD 316
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-40
Identities = 46/205 (22%), Positives = 82/205 (40%), Gaps = 23/205 (11%)
Query: 78 RILGQGGQGTVYKG--MLADGRIIAVKK-SKVVDESKLEEFINEVVILSQINHRNVVKLL 134
+ GG G +Y +GR + +K D + E L+++ H ++V++
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 135 -----GCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS 189
V +V E++ +L + L + E+ AL+YLHS
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLHS 200
Query: 190 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRS 249
+ + + D+K NI+L E+ + K+ D G I+ + GT G+ PE R+
Sbjct: 201 ---IGLVYNDLKPENIMLTEE-QLKLIDLGAVS--RINSFGY---LYGTPGFQAPEIVRT 251
Query: 250 SQFTDKSDVYSFGVVLVELLTGQKP 274
T +D+Y+ G L L
Sbjct: 252 GP-TVATDIYTVGRTLAALTLDLPT 275
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-40
Identities = 59/202 (29%), Positives = 109/202 (53%), Gaps = 13/202 (6%)
Query: 80 LGQGGQGTVYKGML--ADGRI-IAVKKSKV-VDESKLEEFINEVVILSQINHRNVVKLLG 135
LG G G+V +G+ +I +A+K K +++ EE + E I+ Q+++ +V+L+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 136 CCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPI 195
C E +LV E G L ++L + + + +V+ + YL ++
Sbjct: 78 VCQA-EALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKNFV-- 132
Query: 196 YHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF--GYLDPEYFRSSQFT 253
HRD+ + N+LL ++ AKI+DFG S+++ D ++ + + G + + PE +F+
Sbjct: 133 -HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 254 DKSDVYSFGVVLVELLT-GQKP 274
+SDV+S+GV + E L+ GQKP
Sbjct: 192 SRSDVWSYGVTMWEALSYGQKP 213
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-40
Identities = 76/317 (23%), Positives = 131/317 (41%), Gaps = 68/317 (21%)
Query: 76 MNRILGQGGQGTVYKGMLADGR--------IIAVKKSK-VVDESKLEEFINEVVILSQI- 125
+ + LG+G G V +AVK K E L + ++E+ ++ I
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 126 NHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYL-------------HDPYEELSLTWEM 172
H+N++ LLG C + ++ E+ G L +YL + E +T++
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 173 RLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 232
+ ++A + YL S + HRD+ + N+L+ E KIADFG +R I +
Sbjct: 205 LVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARDINNIDYY-- 259
Query: 233 TKVQGTFGYL-----DPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNL 286
+ T G L PE +T +SDV+SFGV++ E+ T G P I E
Sbjct: 260 --KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---- 313
Query: 287 TTYFVECIE--------ENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMK 338
+ ++ NC + E +M + C ++ RPT K
Sbjct: 314 ---LFKLLKEGHRMDKPANC-----------TNELYMMM------RDCWHAVPSQRPTFK 353
Query: 339 EVAMELERIRANSRDDE 355
++ +L+RI + ++E
Sbjct: 354 QLVEDLDRILTLTTNEE 370
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-40
Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 9/210 (4%)
Query: 66 ELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQI 125
E+ + + + + LG G G V+ +AVK K +E F+ E ++ +
Sbjct: 184 EIPR--ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTL 240
Query: 126 NHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALA 185
H +VKL + E ++ EF+ G+L +L E + + ++AE +A
Sbjct: 241 QHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMA 298
Query: 186 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE 245
++ Y+ HRD+++ NIL+ KIADFG +R I ++ + + PE
Sbjct: 299 FIEQRNYI---HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 355
Query: 246 YFRSSQFTDKSDVYSFGVVLVELLT-GQKP 274
FT KSDV+SFG++L+E++T G+ P
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIP 385
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 3e-40
Identities = 79/299 (26%), Positives = 121/299 (40%), Gaps = 47/299 (15%)
Query: 76 MNRILGQGGQGTVYKGMLADGR------IIAVKKSKVV-DESKLEEFINEVVILSQINHR 128
+ R LG G G VY+G ++ +AVK V E +F+ E +I+S+ NH+
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 129 NVVKLLGCCLEVEVPLLVYEFIPNGTLFQYL----HDPYEELSLTWEMRLRIATEVAEAL 184
N+V+ +G L+ ++ E + G L +L P + SL L +A ++A
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 185 AYLHSSAYLPIYHRDIKSTNILLD---EKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 241
YL + ++ HRDI + N LL AKI DFG +R I + G
Sbjct: 154 QYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK----GGCAM 206
Query: 242 L-----DPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTT--YFVEC 293
L PE F FT K+D +SFGV+L E+ + G P S E T ++
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP 266
Query: 294 IEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSR 352
+NC G IM +C +RP + +E +
Sbjct: 267 P-KNC-----------PGPVYRIM------TQCWQHQPEDRPNFAIILERIEYCTQDPD 307
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 6e-40
Identities = 61/202 (30%), Positives = 97/202 (48%), Gaps = 12/202 (5%)
Query: 78 RILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQINHRNVVKL 133
LG GG TVY +A+K E L+ F EV SQ++H+N+V +
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 134 LGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYL 193
+ E + LV E+I TL +Y+ L+ + + ++ + + + H
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHDMR-- 131
Query: 194 PIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVST-KVQGTFGYLDPEYFRSSQF 252
I HRDIK NIL+D KI DFG +++++ + + T V GT Y PE +
Sbjct: 132 -IVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEAT 189
Query: 253 TDKSDVYSFGVVLVELLTGQKP 274
+ +D+YS G+VL E+L G+ P
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPP 211
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 6e-40
Identities = 76/317 (23%), Positives = 131/317 (41%), Gaps = 68/317 (21%)
Query: 76 MNRILGQGGQGTVYKGMLADGR--------IIAVKKSK-VVDESKLEEFINEVVILSQI- 125
+ + LG+G G V +AVK K E L + ++E+ ++ I
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 126 NHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYL-------------HDPYEELSLTWEM 172
H+N++ LLG C + ++ E+ G L +YL + E +T++
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 173 RLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 232
+ ++A + YL S + HRD+ + N+L+ E KIADFG +R I +
Sbjct: 159 LVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARDINNIDYY-- 213
Query: 233 TKVQGTFGYL-----DPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNL 286
+ T G L PE +T +SDV+SFGV++ E+ T G P I E
Sbjct: 214 --KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---- 267
Query: 287 TTYFVECIE--------ENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMK 338
+ ++ NC + E +M + C ++ RPT K
Sbjct: 268 ---LFKLLKEGHRMDKPANC-----------TNELYMMM------RDCWHAVPSQRPTFK 307
Query: 339 EVAMELERIRANSRDDE 355
++ +L+RI + ++E
Sbjct: 308 QLVEDLDRILTLTTNEE 324
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 8e-40
Identities = 79/299 (26%), Positives = 121/299 (40%), Gaps = 47/299 (15%)
Query: 76 MNRILGQGGQGTVYKGMLADGR------IIAVKKSKVV-DESKLEEFINEVVILSQINHR 128
+ R LG G G VY+G ++ +AVK V E +F+ E +I+S+ NH+
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 129 NVVKLLGCCLEVEVPLLVYEFIPNGTLFQYL----HDPYEELSLTWEMRLRIATEVAEAL 184
N+V+ +G L+ ++ E + G L +L P + SL L +A ++A
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 185 AYLHSSAYLPIYHRDIKSTNILLD---EKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 241
YL + ++ HRDI + N LL AKI DFG +R I + G
Sbjct: 195 QYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK----GGCAM 247
Query: 242 L-----DPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTT--YFVEC 293
L PE F FT K+D +SFGV+L E+ + G P S E T ++
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP 307
Query: 294 IEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSR 352
+NC G IM +C +RP + +E +
Sbjct: 308 P-KNC-----------PGPVYRIM------TQCWQHQPEDRPNFAIILERIEYCTQDPD 348
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-39
Identities = 48/235 (20%), Positives = 96/235 (40%), Gaps = 46/235 (19%)
Query: 66 ELDKATDYFNMNRILGQGGQGTVYKGMLADGRI--------IAVKKSKVVDESKLEEFIN 117
++ + N LGQG ++KG+ + + +K + E F
Sbjct: 4 KIRN--EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE 61
Query: 118 EVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIA 177
++S+++H+++V G C+ + +LV EF+ G+L YL +++ W+ L +A
Sbjct: 62 AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVA 119
Query: 178 TEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR--------AKIADFGTSRSIAIDQT 229
++A A+ +L + + H ++ + NILL + K++D G S ++
Sbjct: 120 KQLAAAMHFLEENTLI---HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD- 175
Query: 230 HVSTKVQGTFGYLDP---------EYFRSSQFTDKSDVYSFGVVLVELLT-GQKP 274
+ E + +D +SFG L E+ + G KP
Sbjct: 176 ----------ILQERIPWVPPECIENPK--NLNLATDKWSFGTTLWEICSGGDKP 218
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-39
Identities = 72/323 (22%), Positives = 128/323 (39%), Gaps = 73/323 (22%)
Query: 76 MNRILGQGGQGTVYKGMLADGR------IIAVKKSKV-VDESKLEEFINEVVILSQINHR 128
R +G+G G V++ ++AVK K +F E ++++ ++
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 129 NVVKLLGCCLEVEVPLLVYEFIPNGTLFQYL--HDPYEEL-------------------S 167
N+VKLLG C + L++E++ G L ++L P+
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 168 LTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227
L+ +L IA +VA +AYL ++ HRD+ + N L+ E KIADFG SR+I
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERKFV---HRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 228 QTHVSTKVQGTFGYL-----DPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWAN 281
+ + PE +++T +SDV+++GVVL E+ + G +P +
Sbjct: 228 DYY----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 283
Query: 282 EGRNLTTYFVECIE--------ENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRN 333
E + + ENC E +M + C + +
Sbjct: 284 E-------VIYYVRDGNILACPENC-----------PLELYNLM------RLCWSKLPAD 319
Query: 334 RPTMKEVAMELERIRANSRDDEN 356
RP+ + L+R+ +
Sbjct: 320 RPSFCSIHRILQRMCERAEGTVG 342
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 147 bits (371), Expect = 2e-39
Identities = 60/202 (29%), Positives = 109/202 (53%), Gaps = 13/202 (6%)
Query: 80 LGQGGQGTVYKGML--ADGRI-IAVKKSKV-VDESKLEEFINEVVILSQINHRNVVKLLG 135
LG G G+V +G+ +I +A+K K +++ EE + E I+ Q+++ +V+L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 136 CCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPI 195
C E +LV E G L ++L EE+ + +V+ + YL ++
Sbjct: 404 VCQA-EALMLVMEMAGGGPLHKFLVGKREEI--PVSNVAELLHQVSMGMKYLEEKNFV-- 458
Query: 196 YHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY--LDPEYFRSSQFT 253
HR++ + N+LL ++ AKI+DFG S+++ D ++ + + G + PE +F+
Sbjct: 459 -HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 254 DKSDVYSFGVVLVELLT-GQKP 274
+SDV+S+GV + E L+ GQKP
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKP 539
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 6e-39
Identities = 80/319 (25%), Positives = 130/319 (40%), Gaps = 68/319 (21%)
Query: 76 MNRILGQGGQGTVYKGMLAD--------GRIIAVKKSK-VVDESKLEEFINEVVILSQI- 125
+ + LG+G G V +AVK K E L + I+E+ ++ I
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 126 NHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYL-------------HDPYEELSLTWEM 172
H+N++ LLG C + ++ E+ G L +YL E L+ +
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 173 RLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 232
+ A +VA + YL S + HRD+ + N+L+ E KIADFG +R I +
Sbjct: 193 LVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY-- 247
Query: 233 TKVQGTFGYL-----DPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNL 286
+ T G L PE +T +SDV+SFGV+L E+ T G P + E
Sbjct: 248 --KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---- 301
Query: 287 TTYFVECIE--------ENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMK 338
+ ++ NC + E +M + C ++ RPT K
Sbjct: 302 ---LFKLLKEGHRMDKPSNC-----------TNELYMMM------RDCWHAVPSQRPTFK 341
Query: 339 EVAMELERIRANSRDDENN 357
++ +L+RI A + + E
Sbjct: 342 QLVEDLDRIVALTSNQEMG 360
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 6e-39
Identities = 62/216 (28%), Positives = 107/216 (49%), Gaps = 14/216 (6%)
Query: 65 KELDKATDYFNMNRILGQGGQGTVYKGML--ADGRII--AVKKSKV-VDESKLEEFINEV 119
E+ + + + R +G+G G V++G+ + + A+K K +S E+F+ E
Sbjct: 385 YEIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 442
Query: 120 VILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATE 179
+ + Q +H ++VKL+G E ++ E G L +L L L + A +
Sbjct: 443 LTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDL--ASLILYAYQ 499
Query: 180 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF 239
++ ALAYL S ++ HRDI + N+L+ K+ DFG SR + + ++K +
Sbjct: 500 LSTALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 556
Query: 240 GYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKP 274
++ PE +FT SDV+ FGV + E+L G KP
Sbjct: 557 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 8e-39
Identities = 54/227 (23%), Positives = 86/227 (37%), Gaps = 23/227 (10%)
Query: 63 NSKELDKATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVI 121
E + + +G+G G V++ G AVKK V E+V
Sbjct: 49 VDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKK---VRLEVFRV--EELVA 103
Query: 122 LSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIAT-EV 180
+ ++ +V L G E + E + G+L Q + L E R +
Sbjct: 104 CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI-KQMGCLP---EDRALYYLGQA 159
Query: 181 AEALAYLHSSAYLPIYHRDIKSTNILLDEK-YRAKIADFGTSRSIAIDQTHVSTK----V 235
E L YLH+ I H D+K+ N+LL RA + DFG + + D S +
Sbjct: 160 LEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 216
Query: 236 QGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANE 282
GT ++ PE K D++S +++ +L G P W
Sbjct: 217 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP----WTQY 259
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-38
Identities = 80/315 (25%), Positives = 128/315 (40%), Gaps = 67/315 (21%)
Query: 76 MNRILGQGGQGTVYKGMLADGR------IIAVKKSK-VVDESKLEEFINEVVILSQI-NH 127
+ LG G G V + +AVK K ++ E ++E+ +LS + NH
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 128 RNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYL---------------HDPYEELSLTWEM 172
N+V LLG C L++ E+ G L +L +EL+L E
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 173 RLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 232
L + +VA+ +A+L S + HRD+ + NILL KI DFG +R I D +V
Sbjct: 147 LLSFSYQVAKGMAFLASKNCI---HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 233 TKVQGTFGYL-----DPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNL 286
L PE + +T +SDV+S+G+ L EL + G P + +
Sbjct: 204 K----GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--- 256
Query: 287 TTYFVECIE--------ENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMK 338
F + I+ E+ E +IM K C ++ RPT K
Sbjct: 257 ---FYKMIKEGFRMLSPEHA-----------PAEMYDIM------KTCWDADPLKRPTFK 296
Query: 339 EVAMELERIRANSRD 353
++ +E+ + S +
Sbjct: 297 QIVQLIEKQISESTN 311
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-38
Identities = 52/203 (25%), Positives = 81/203 (39%), Gaps = 14/203 (6%)
Query: 78 RILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQINHRNVVKL 133
R++G+GG G VY+ RI+A+K ++ D E ++ +VV +
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 134 LGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYL 193
+ I L L L + I ++ AL H++
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAAG-- 154
Query: 194 PIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVST--KVQGTFGYLDPEYFRSSQ 251
HRD+K NIL+ A + DFG + A ++ GT Y+ PE F S
Sbjct: 155 -ATHRDVKPENILVSADDFAYLVDFGIAS--ATTDEKLTQLGNTVGTLYYMAPERFSESH 211
Query: 252 FTDKSDVYSFGVVLVELLTGQKP 274
T ++D+Y+ VL E LTG P
Sbjct: 212 ATYRADIYALTCVLYECLTGSPP 234
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-38
Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 27/214 (12%)
Query: 78 RILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGC 136
++G GG G V+K DG+ +K+ V + E+ EV L++++H N+V GC
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKR---VKYNN-EKAEREVKALAKLDHVNIVHYNGC 72
Query: 137 CLEVEVPL----------------LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEV 180
+ + EF GTL Q++ L + L + ++
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK-RRGEKLDKVLALELFEQI 131
Query: 181 AEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFG 240
+ + Y+HS + +RD+K +NI L + + KI DFG S+ D T+ +GT
Sbjct: 132 TKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--TRSKGTLR 186
Query: 241 YLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
Y+ PE S + + D+Y+ G++L ELL
Sbjct: 187 YMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-38
Identities = 70/314 (22%), Positives = 119/314 (37%), Gaps = 63/314 (20%)
Query: 76 MNRILGQGGQGTVYKGMLADGR------IIAVKKSK-VVDESKLEEFINEVVILSQI-NH 127
+ LG G G V + +AVK K + E ++E+ I+S + H
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 128 RNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHD-----------PYEELSLTWEMRLRI 176
N+V LLG C L++ E+ G L +L + + L
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 177 ATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQ 236
+++VA+ +A+L S + HRD+ + N+LL + AKI DFG +R I D ++
Sbjct: 170 SSQVAQGMAFLASKNCI---HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK--- 223
Query: 237 GTFGYL-----DPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYF 290
L PE +T +SDV+S+G++L E+ + G P I N F
Sbjct: 224 -GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK------F 276
Query: 291 VECIE--------ENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342
+ ++ IM + C +RPT +++
Sbjct: 277 YKLVKDGYQMAQPAFA-----------PKNIYSIM------QACWALEPTHRPTFQQICS 319
Query: 343 ELERIRANSRDDEN 356
L+ R + +
Sbjct: 320 FLQEQAQEDRRERD 333
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-38
Identities = 67/312 (21%), Positives = 122/312 (39%), Gaps = 41/312 (13%)
Query: 46 QQQLNSIGGSIDRCRIFNSKELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVK--- 102
+S G + ++ K Y ++ + +G GG V++ + +I A+K
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMSVKGRIY-SILKQIGSGGSSKVFQVLNEKKQIYAIKYVN 61
Query: 103 KSKVVDESKLEEFINEVVILSQINHRN--VVKLLGCCLEVEVPLLVYEFIPNGTLFQYLH 160
+ D L+ + NE+ L+++ + +++L + + +V E N L +L
Sbjct: 62 LEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLK 119
Query: 161 DPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGT 220
++ S+ R + EA+ +H I H D+K N L+ + K+ DFG
Sbjct: 120 ---KKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGI 172
Query: 221 SRSIAIDQTHVSTKVQ-GTFGYLDPE-----------YFRSSQFTDKSDVYSFGVVLVEL 268
+ + D T V Q GT Y+ PE S+ + KSDV+S G +L +
Sbjct: 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 232
Query: 269 LTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLN 328
G+ P + ++ L IID + DV K CL
Sbjct: 233 TYGKTP----FQQIINQISK----------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLK 278
Query: 329 SYGRNRPTMKEV 340
+ R ++ E+
Sbjct: 279 RDPKQRISIPEL 290
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 7e-38
Identities = 52/218 (23%), Positives = 95/218 (43%), Gaps = 28/218 (12%)
Query: 78 RILGQGGQGTVYKGM-LADGRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLG 135
+ LG+GG G V++ D A+K+ ++ + E E+ + EV L+++ H +V+
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 136 CCLE---------VEVPLLVY---EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEA 183
LE + +Y + L +++ + L I ++AEA
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130
Query: 184 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQ------- 236
+ +LHS + HRD+K +NI K+ DFG ++ D+ +
Sbjct: 131 VEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 237 ----GTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT 270
GT Y+ PE + ++ K D++S G++L ELL
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 8e-38
Identities = 75/310 (24%), Positives = 123/310 (39%), Gaps = 66/310 (21%)
Query: 76 MNRILGQGGQGTVYKGMLADG---RIIAVKKSKV-VDESKLEEFINEVVILSQI-NHRNV 130
++G+G G V K + A+K+ K + +F E+ +L ++ +H N+
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 131 VKLLGCCLEVEVPLLVYEFIPNGTLFQYL-------------HDPYEELSLTWEMRLRIA 177
+ LLG C L E+ P+G L +L +L+ + L A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 178 TEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQG 237
+VA + YL ++ HRD+ + NIL+ E Y AKIADFG SR V+
Sbjct: 149 ADVARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRGQ-------EVYVKK 198
Query: 238 TFGYL-----DPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFV 291
T G L E S +T SDV+S+GV+L E+++ G P + E
Sbjct: 199 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LY 251
Query: 292 ECIE--------ENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343
E + NC E ++M ++C RP+ ++ +
Sbjct: 252 EKLPQGYRLEKPLNC-----------DDEVYDLM------RQCWREKPYERPSFAQILVS 294
Query: 344 LERIRANSRD 353
L R+ +
Sbjct: 295 LNRMLEERKT 304
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 1e-37
Identities = 67/207 (32%), Positives = 99/207 (47%), Gaps = 16/207 (7%)
Query: 78 RILGQGGQGTVYKGM-LADGRIIAVK--KSKVV-DESKLEEFINEVVILSQINHRNVVKL 133
ILG GG V+ L D R +AVK ++ + D S F E + +NH +V +
Sbjct: 18 EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 134 L--GC--CLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS 189
G +P +V E++ TL +H E +T + + + + +AL + H
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQ 134
Query: 190 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV--STKVQGTFGYLDPEYF 247
+ I HRD+K NI++ K+ DFG +R+IA V + V GT YL PE
Sbjct: 135 NG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 248 RSSQFTDKSDVYSFGVVLVELLTGQKP 274
R +SDVYS G VL E+LTG+ P
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-37
Identities = 75/322 (23%), Positives = 123/322 (38%), Gaps = 72/322 (22%)
Query: 76 MNRILGQGGQGTVYKGMLADGR------IIAVKKSK-VVDESKLEEFINEVVILSQI-NH 127
++LG G G V +AVK K D S+ E ++E+ +++Q+ +H
Sbjct: 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 128 RNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYL--------------------HDPYEELS 167
N+V LLG C L++E+ G L YL + +
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 168 LTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227
LT+E L A +VA+ + +L + + HRD+ + N+L+ KI DFG +R I D
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKSCV---HRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 228 QTHVSTKVQGTFGYL-----DPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWAN 281
+V L PE +T KSDV+S+G++L E+ + G P I +
Sbjct: 226 SNYVVR----GNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281
Query: 282 EGRNLTTYFVECIE--------ENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRN 333
F + I+ + E IM + C R
Sbjct: 282 AN------FYKLIQNGFKMDQPFYA-----------TEEIYIIM------QSCWAFDSRK 318
Query: 334 RPTMKEVAMELERIRANSRDDE 355
RP+ + L A++ +
Sbjct: 319 RPSFPNLTSFLGCQLADAEEAM 340
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-37
Identities = 52/206 (25%), Positives = 82/206 (39%), Gaps = 15/206 (7%)
Query: 74 FNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESK--LEEFINEVVILSQI-NHRN 129
F LG G G V+K DGR+ AVK+S + EV ++ H
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLR-IATEVAEALAYLH 188
V+L E + L E +L Q+ L E ++ + ALA+LH
Sbjct: 119 CVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLP---EAQVWGYLRDTLLALAHLH 174
Query: 189 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFR 248
S + H D+K NI L + R K+ DFG + + G Y+ PE +
Sbjct: 175 SQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE--GDPRYMAPELLQ 229
Query: 249 SSQFTDKSDVYSFGVVLVELLTGQKP 274
+ +DV+S G+ ++E+ +
Sbjct: 230 -GSYGTAADVFSLGLTILEVACNMEL 254
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-37
Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 34/226 (15%)
Query: 74 FNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVK 132
F +LGQG G V K D R A+KK + E KL ++EV++L+ +NH+ VV+
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVR 66
Query: 133 LLGCCLEVEVPL-------------LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATE 179
LE + + E+ NGTL+ +H E L+ + R+ +
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQ 124
Query: 180 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQ--- 236
+ EAL+Y+HS I HRD+K NI +DE KI DFG ++++ + Q
Sbjct: 125 ILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 237 ----------GTFGYLDPEYFRSSQFTD-KSDVYSFGVVLVELLTG 271
GT Y+ E + + K D+YS G++ E++
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 5e-37
Identities = 63/283 (22%), Positives = 114/283 (40%), Gaps = 38/283 (13%)
Query: 74 FNMNRILGQGGQGTVYKGMLADGRIIAVK--KSKVVDESKLEEFINEVVILSQINH--RN 129
+++ + +G GG V++ + +I A+K + D L+ + NE+ L+++
Sbjct: 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS 189
+++L + + +V E N L +L ++ S+ R + EA+ +H
Sbjct: 71 IIRLYDYEITDQYIYMVMEC-GNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 190 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQ-GTFGYLDPE--- 245
I H D+K N L+ + K+ DFG + + D T V Q GT Y+ PE
Sbjct: 127 HG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182
Query: 246 --------YFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEEN 297
S+ + KSDV+S G +L + G+ P + ++
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIINQISK--------- 229
Query: 298 CLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEV 340
L IID + DV K CL + R ++ E+
Sbjct: 230 -LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 5e-37
Identities = 62/283 (21%), Positives = 113/283 (39%), Gaps = 38/283 (13%)
Query: 74 FNMNRILGQGGQGTVYKGMLADGRIIAVK--KSKVVDESKLEEFINEVVILSQINH--RN 129
+++ + +G GG V++ + +I A+K + D L+ + NE+ L+++
Sbjct: 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS 189
+++L + + +V E N L +L ++ S+ R + EA+ +H
Sbjct: 118 IIRLYDYEITDQYIYMVMEC-GNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 190 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQ-GTFGYLDPE--- 245
I H D+K N L+ + K+ DFG + + D T V Q G Y+ PE
Sbjct: 174 HG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229
Query: 246 --------YFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEEN 297
S+ + KSDV+S G +L + G+ P + ++
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIINQISK--------- 276
Query: 298 CLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEV 340
L IID + DV K CL + R ++ E+
Sbjct: 277 -LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 318
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-37
Identities = 56/226 (24%), Positives = 100/226 (44%), Gaps = 35/226 (15%)
Query: 76 MNRILGQGGQGTVYKGMLADGR------IIAVK--KSKVVDESKLEEFINEVVILSQINH 127
LG+ G VYKG L +A+K K K + EEF +E ++ +++ H
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR-EEFRHEAMLRARLQH 71
Query: 128 RNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLH-------------DPYEELSLTWEMRL 174
NVV LLG + + +++ + +G L ++L D + +L +
Sbjct: 72 PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 175 RIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTK 234
+ ++A + YL S + H+D+ + N+L+ +K KI+D G R + +
Sbjct: 132 HLVAQIAAGMEYLSSHHVV---HKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKL-- 186
Query: 235 VQGTFGYL-----DPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKP 274
L PE +F+ SD++S+GVVL E+ + G +P
Sbjct: 187 --LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-36
Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 21/219 (9%)
Query: 72 DYFNMNRILGQGGQGTVYKGM-LADGRIIAVKK-SKVVDESKLEEFINEVVILSQINHRN 129
+ ++ ILGQG V++G G + A+K + + ++ + E +L ++NH+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 130 VVKLLGC--CLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYL 187
+VKL +L+ EF P G+L+ L +P L L + +V + +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 188 HSSAYLPIYHRDIKSTNILL----DEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 243
+ I HR+IK NI+ D + K+ DFG +R + D + GT YL
Sbjct: 129 RENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEYLH 183
Query: 244 PEYFRSS--------QFTDKSDVYSFGVVLVELLTGQKP 274
P+ + + ++ D++S GV TG P
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-36
Identities = 64/269 (23%), Positives = 109/269 (40%), Gaps = 23/269 (8%)
Query: 69 KATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKK-SKVVDESKLEEFINEVVILSQIN 126
+ + M LG GG G V + + G +A+K+ + + E + E+ I+ ++N
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70
Query: 127 HRNVVKLL------GCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEV 180
H NVV ++PLL E+ G L +YL+ L + +++
Sbjct: 71 HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130
Query: 181 AEALAYLHSSAYLPIYHRDIKSTNILLD---EKYRAKIADFGTSRSIAIDQTHVSTKVQG 237
+ AL YLH + I HRD+K NI+L ++ KI D G ++ + DQ + T+ G
Sbjct: 131 SSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVG 185
Query: 238 TFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEEN 297
T YL PE ++T D +SFG + E +TG +P +
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF------LPNWQPVQWHG-KVRE 238
Query: 298 CLFDIIDDQVRKSGEAEEIMAVSDVAKRC 326
+ I +G + +
Sbjct: 239 KSNEHIVVYDDLTGAVKFSSVLPTPNHLS 267
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 1e-35
Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 21/219 (9%)
Query: 72 DYFNMNRILGQGGQGTVYKGM-LADGRIIAVKK-SKVVDESKLEEFINEVVILSQINHRN 129
+ ++ ILGQG V++G G + A+K + + ++ + E +L ++NH+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 130 VVKLLGC--CLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYL 187
+VKL +L+ EF P G+L+ L +P L L + +V + +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 188 HSSAYLPIYHRDIKSTNILL----DEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 243
+ I HR+IK NI+ D + K+ DFG +R + D + GT YL
Sbjct: 129 RENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEYLH 183
Query: 244 PEYFRSS--------QFTDKSDVYSFGVVLVELLTGQKP 274
P+ + + ++ D++S GV TG P
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 6e-35
Identities = 60/278 (21%), Positives = 110/278 (39%), Gaps = 33/278 (11%)
Query: 74 FNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQIN-HRNVVK 132
F +LG G +GT+ + D R +AV K + EV +L + + H NV++
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAV---KRILPECFSFADREVQLLRESDEHPNVIR 82
Query: 133 LLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAY 192
+ + + E TL +Y+ + + + + + LA+LHS
Sbjct: 83 YFCTEKDRQFQYIAIELCA-ATLQEYVEQK--DFAHLGLEPITLLQQTTSGLAHLHS--- 136
Query: 193 LPIYHRDIKSTNILLDEK-----YRAKIADFGTSRSIAIDQ--THVSTKVQGTFGYLDPE 245
L I HRD+K NIL+ +A I+DFG + +A+ + + V GT G++ PE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 246 YFRSSQF---TDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDI 302
T D++S G V +++ + R + C D
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP--FGKSLQRQA-----NILLGACSLDC 249
Query: 303 IDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEV 340
+ + + A ++ ++ + + RP+ K V
Sbjct: 250 LHPEKHEDVIAR------ELIEKMIAMDPQKRPSAKHV 281
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-35
Identities = 33/311 (10%), Positives = 69/311 (22%), Gaps = 52/311 (16%)
Query: 66 ELDKATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVI 121
L + + L G + V+ + A+K S+LE
Sbjct: 56 LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFA 115
Query: 122 LSQINHRNVVKLLGCCLEVEVP--------------------------LLVYEFIPNGTL 155
+++ + + + LL+ + L
Sbjct: 116 AARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA-ASVDL 174
Query: 156 FQYLHD----PYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY 211
+ ++ A L S + H N+ +
Sbjct: 175 ELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDG 231
Query: 212 RAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSS--QFTDKSDVYSFGVVLVELL 269
R + D + Y E+ +S FT + + G+ + +
Sbjct: 232 RLMLGDVSALWKV----GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287
Query: 270 TGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNS 329
P ++ + + + V + R LN
Sbjct: 288 CLFLP---FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPD-----FVKTLIGRFLNF 339
Query: 330 YGRNRPTMKEV 340
R R E
Sbjct: 340 DRRRRLLPLEA 350
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 8e-35
Identities = 66/212 (31%), Positives = 103/212 (48%), Gaps = 10/212 (4%)
Query: 68 DKATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQIN 126
D + +I G+G G V GR +AVK + + + E NEVVI+
Sbjct: 42 DPRLLLDSYVKI-GEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ 100
Query: 127 HRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAY 186
H NVV++ L E ++ EF+ G L D ++ L E + V +ALAY
Sbjct: 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAY 156
Query: 187 LHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEY 246
LH+ + HRDIKS +ILL R K++DFG I+ D + V GT ++ PE
Sbjct: 157 LHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEV 212
Query: 247 FRSSQFTDKSDVYSFGVVLVELLTGQKPISSI 278
S + + D++S G++++E++ G+ P S
Sbjct: 213 ISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD 244
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-34
Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 9/209 (4%)
Query: 71 TDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRN 129
+ +GQG GTVY M +A G+ +A+++ + + K E INE++++ + + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS 189
+V L L + +V E++ G+L D E + + E +AL +LHS
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 190 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRS 249
+ + HRDIKS NILL K+ DFG I +Q+ ST V GT ++ PE
Sbjct: 135 NQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTR 190
Query: 250 SQFTDKSDVYSFGVVLVELLTGQKPISSI 278
+ K D++S G++ +E++ G+ P +
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-34
Identities = 66/211 (31%), Positives = 97/211 (45%), Gaps = 25/211 (11%)
Query: 74 FNMNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQINHRN 129
F + R LG+G G VY I+A+K K+++ + EV I S + H N
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYL--HDPYEELSLTWEMRLRIATEVAEALAYL 187
+++L G + L+ E+ P GT+++ L ++E TE+A AL+Y
Sbjct: 71 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE----QRTA-TYITELANALSYC 125
Query: 188 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQ----GTFGYLD 243
HS + HRDIK N+LL KIADFG S H + + GT YL
Sbjct: 126 HSKR---VIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDYLP 175
Query: 244 PEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
PE +K D++S GV+ E L G+ P
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-33
Identities = 51/226 (22%), Positives = 90/226 (39%), Gaps = 33/226 (14%)
Query: 74 FNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKV--VDESKLEEFINEVVILSQI-NHRN 129
F+ +G G G+V+K + DG I A+K+SK + + EV + + H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLR-IATEVAEALAYLH 188
VV+ E + L+ E+ G+L + + Y +S E L+ + +V L Y+H
Sbjct: 73 VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 189 SSAYLPIYHRDIKSTNILLDE-------------------KYRAKIADFGTSRSIAIDQT 229
S + + H DIK +NI + K KI D G I+ Q
Sbjct: 133 SMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV 189
Query: 230 HVSTKVQGTFGYLDPEYFRSSQ-FTDKSDVYSFGVVLVELLTGQKP 274
G +L E + + K+D+++ + +V +
Sbjct: 190 EE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-33
Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 74 FNMNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQINHRN 129
F + +LG+G VY+ + G +A+K K + ++ NEV I Q+ H +
Sbjct: 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 130 VVKLLGCCLEVEVPL-LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLH 188
+++L E + LV E NG + +YL + + S E R ++ + YLH
Sbjct: 73 ILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS-ENEAR-HFMHQIITGMLYLH 129
Query: 189 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQ------GTFGYL 242
S I HRD+ +N+LL KIADFG + T + + GT Y+
Sbjct: 130 SHG---ILHRDLTLSNLLLTRNMNIKIADFGLA-------TQLKMPHEKHYTLCGTPNYI 179
Query: 243 DPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
PE S +SDV+S G + LL G+ P
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 6e-33
Identities = 62/295 (21%), Positives = 113/295 (38%), Gaps = 43/295 (14%)
Query: 78 RILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQI-NHRNVVKLLG 135
R+L +GG VY+ + GR A+K+ +E K I EV + ++ H N+V+
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 136 CCLEVEVP-------LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLH 188
+ L+ + G L ++L L+ + L+I + A+ ++H
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 189 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQ-----------G 237
PI HRD+K N+LL + K+ DFG++ +I+ + + +
Sbjct: 154 RQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 238 TFGYLDPEYFRSSQ---FTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECI 294
T Y PE +K D+++ G +L L Q P F
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP---------------F---- 253
Query: 295 EENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRA 349
E+ I++ + + + + L R ++ EV +L+ I A
Sbjct: 254 EDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-33
Identities = 65/210 (30%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 74 FNMNRILGQGGQGTVYKGMLA----DGRIIAVK---KSKVVDESKLEEFINEVVILSQIN 126
F++ R LG+G G VY LA + I+A+K KS++ E + E+ I S +
Sbjct: 16 FDIGRPLGKGKFGNVY---LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72
Query: 127 HRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYL--HDPYEELSLTWEMRLRIATEVAEAL 184
H N++++ + + L+ EF P G L++ L H ++E E+A+AL
Sbjct: 73 HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE----QRSA-TFMEELADAL 127
Query: 185 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDP 244
Y H + HRDIK N+L+ K KIADFG S + GT YL P
Sbjct: 128 HYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC---GTLDYLPP 181
Query: 245 EYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
E +K D++ GV+ E L G P
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 9e-33
Identities = 63/239 (26%), Positives = 111/239 (46%), Gaps = 23/239 (9%)
Query: 47 QQLNSIGGSIDRCRIFNSKELDKATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSK 105
Q N + + + + + + ++ G+G G+VYK + G+I+A+K+
Sbjct: 6 QLRNPPRRQLKKLDEDSLTK-QPEEVFDVLEKL-GEGSYGSVYKAIHKETGQIVAIKQVP 63
Query: 106 VVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGT---LFQYLHDP 162
V ES L+E I E+ I+ Q + +VVK G + +V E+ G+ + + +
Sbjct: 64 V--ESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT 121
Query: 163 YEELSLTWEMRLRIAT---EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 219
E IAT + L YLH HRDIK+ NILL+ + AK+ADFG
Sbjct: 122 LTEDE--------IATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFG 170
Query: 220 TSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSI 278
+ + +T + GT ++ PE + + +D++S G+ +E+ G+ P + I
Sbjct: 171 VAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 9e-33
Identities = 52/210 (24%), Positives = 85/210 (40%), Gaps = 21/210 (10%)
Query: 74 FNMNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQINHRN 129
+ R LG+GG ++ + A K KS ++ + E+ E+ I + H++
Sbjct: 43 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 102
Query: 130 VVKLLGCCLEVEVPLLVY---EFIPNGTLFQYL--HDPYEELSLTWEMRLRIATEVAEAL 184
VV G E V+ E +L + E E R ++
Sbjct: 103 VVGFHGF---FEDNDFVFVVLELCRRRSLLELHKRRKALTE----PEAR-YYLRQIVLGC 154
Query: 185 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDP 244
YLH + + HRD+K N+ L+E KI DFG + + D + GT Y+ P
Sbjct: 155 QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAP 210
Query: 245 EYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
E + + DV+S G ++ LL G+ P
Sbjct: 211 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-32
Identities = 64/221 (28%), Positives = 109/221 (49%), Gaps = 19/221 (8%)
Query: 64 SKELDKATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKV-VDESKLEEFINEVVI 121
+ + D + + +I G+G G V+KG+ +++A+K + E ++E+ E+ +
Sbjct: 15 NLKADPEELFTKLEKI-GKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITV 73
Query: 122 LSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQ-YLHDPYEELSLTWEMRLRIAT-- 178
LSQ + V K G L+ ++ E++ G+ P +E IAT
Sbjct: 74 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ--------IATIL 125
Query: 179 -EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQG 237
E+ + L YLHS HRDIK+ N+LL E K+ADFG + + Q +T V G
Sbjct: 126 REILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-G 181
Query: 238 TFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSI 278
T ++ PE + S + K+D++S G+ +EL G+ P S +
Sbjct: 182 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 2e-32
Identities = 33/240 (13%), Positives = 66/240 (27%), Gaps = 42/240 (17%)
Query: 74 FNMNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQINH-- 127
+LGQ + G V ++ + +++ EV+ L +
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 128 --------------RNVVKLLGCCLEVEV-----------PLLVYEFI--PNGTLFQYLH 160
++VK + V +Y + T + L
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 161 D-PYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 219
SL RL++ +V LA LH + H ++ +I+LD++ + F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFE 256
Query: 220 TSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQ-----FTDKSDVYSFGVVLVELLTGQKP 274
+ Q T D ++ G+ + + P
Sbjct: 257 HLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 73/293 (24%), Positives = 117/293 (39%), Gaps = 41/293 (13%)
Query: 61 IFNSKELDKATDYFNMNRILGQGGQGTVYKG-MLADGRIIAVK---KSKVVDESKLEEFI 116
+F +D + R+LG+G G V G+ AVK K +V ++ E +
Sbjct: 15 MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 74
Query: 117 NEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYL--HDPYEELSLTWEMRL 174
EV +L Q++H N++KL + LV E G LF + + E
Sbjct: 75 REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE-----VDAA 129
Query: 175 RIATEVAEALAYLHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSIAIDQTHV 231
RI +V + Y+H I HRD+K N+LL + +I DFG S + +
Sbjct: 130 RIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH--FEASKK 184
Query: 232 STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFV 291
GT Y+ PE + + +K DV+S GV+L LL+G P + G N
Sbjct: 185 MKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFN------GANEYDILK 237
Query: 292 ECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAK----RCLNSYGRNRPTMKEV 340
+ + F+ + VS+ AK + L R + ++
Sbjct: 238 KVEKGKYTFE-----------LPQWKKVSESAKDLIRKMLTYVPSMRISARDA 279
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-32
Identities = 52/210 (24%), Positives = 85/210 (40%), Gaps = 21/210 (10%)
Query: 74 FNMNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQINHRN 129
+ R LG+GG ++ + A K KS ++ + E+ E+ I + H++
Sbjct: 17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 76
Query: 130 VVKLLGCCLEVEVPLLVY---EFIPNGTLFQYL--HDPYEELSLTWEMRLRIATEVAEAL 184
VV G E V+ E +L + E E R ++
Sbjct: 77 VVGFHGF---FEDNDFVFVVLELCRRRSLLELHKRRKALTE----PEAR-YYLRQIVLGC 128
Query: 185 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDP 244
YLH + + HRD+K N+ L+E KI DFG + + D + GT Y+ P
Sbjct: 129 QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAP 184
Query: 245 EYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
E + + DV+S G ++ LL G+ P
Sbjct: 185 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-32
Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 18/217 (8%)
Query: 71 TDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRN 129
+ + + LG G G VYK G + A K + E +LE++I E+ IL+ +H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIAT---EVAEALAY 186
+VKLLG ++ EF P G + + + L+ I ++ EAL +
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ-----IQVVCRQMLEALNF 132
Query: 187 LHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE- 245
LHS I HRD+K+ N+L+ + ++ADFG S + + GT ++ PE
Sbjct: 133 LHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEV 188
Query: 246 ----YFRSSQFTDKSDVYSFGVVLVELLTGQKPISSI 278
+ + + K+D++S G+ L+E+ + P +
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-32
Identities = 73/308 (23%), Positives = 117/308 (37%), Gaps = 42/308 (13%)
Query: 46 QQQLNSIGGSIDRCRIFNSKELDKATDYFNMNRILGQGGQGTVYKG-MLADGRIIAVK-- 102
++ L G +F + + ++ + + LG G G V A+K
Sbjct: 11 RENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKII 70
Query: 103 -KSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYL-- 159
K+ V S + + EV +L ++H N++KL + LV E G LF +
Sbjct: 71 RKTSVSTSSN-SKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH 129
Query: 160 HDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL---DEKYRAKIA 216
+ E I +V + YLH I HRD+K N+LL ++ KI
Sbjct: 130 RMKFNE-----VDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIV 181
Query: 217 DFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPIS 276
DFG S + + GT Y+ PE R + +K DV+S GV+L LL G P
Sbjct: 182 DFGLSAV--FENQKKMKERLGTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAGYPPFG 238
Query: 277 SIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAK----RCLNSYGR 332
G+ + + FD + E VS+ AK + L +
Sbjct: 239 ------GQTDQEILRKVEKGKYTFD-----------SPEWKNVSEGAKDLIKQMLQFDSQ 281
Query: 333 NRPTMKEV 340
R + ++
Sbjct: 282 RRISAQQA 289
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 64/305 (20%), Positives = 113/305 (37%), Gaps = 62/305 (20%)
Query: 72 DYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQI-NHRNV 130
+ +ILG G GTV GR +AVK + + + E+ +L++ +H NV
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVK---RMLIDFCDIALMEIKLLTESDDHPNV 71
Query: 131 VKLLGCCLEVEVPLLVY---EFIPNGTLFQYL--HDPYEELSLTWEMR--LRIATEVAEA 183
++ +Y E N L + + +E + + + ++A
Sbjct: 72 IRYYCSE---TTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 184 LAYLHSSAYLPIYHRDIKSTNILLDEK-------------YRAKIADFGTSRSIAIDQTH 230
+A+LHS L I HRD+K NIL+ R I+DFG + + Q+
Sbjct: 128 VAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184
Query: 231 VSTKVQ---GTFGYLDPEYFRSSQF-------TDKSDVYSFGVVLVELLT-GQKPISSIW 279
T + GT G+ PE S T D++S G V +L+ G+ P +
Sbjct: 185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244
Query: 280 ANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAK----RCLNSYGRNRP 335
+ E + +F + + ++ A + ++ RP
Sbjct: 245 SRESNII----------RGIFSL------DEMKCLHDRSLIAEATDLISQMIDHDPLKRP 288
Query: 336 TMKEV 340
T +V
Sbjct: 289 TAMKV 293
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 2e-31
Identities = 42/235 (17%), Positives = 74/235 (31%), Gaps = 23/235 (9%)
Query: 60 RIFNSKELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKS---KVVDESKLEEF- 115
I E + ++ +LG+G VY+ D K+ KV + EF
Sbjct: 53 AIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFY 112
Query: 116 --INEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHD--PYEELSLTWE 171
+ L +K L +LV E GTL ++ E +
Sbjct: 113 IGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQG 172
Query: 172 MRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA-----------KIADFGT 220
+ + A + + +H I H DIK N +L + + D G
Sbjct: 173 LVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQ 229
Query: 221 SRSI-AIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
S + + + T T G+ E + + + D + + +L G
Sbjct: 230 SIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-31
Identities = 47/232 (20%), Positives = 86/232 (37%), Gaps = 32/232 (13%)
Query: 67 LDKATDYFNMNRILGQGGQ--GTVYKGM-LADGRIIAVKKSKV--VDESKLEEFINEVVI 121
L + Y + I G+G + TV G + V++ + + E+ +
Sbjct: 21 LPEGGCYELLTVI-GKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHV 79
Query: 122 LSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLF----QYLHDPYEELSLTWEMRLRIA 177
NH N+V + +V F+ G+ + D EL+ IA
Sbjct: 80 SKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA--------IA 131
Query: 178 T---EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTK 234
V +AL Y+H Y+ HR +K+++IL+ + ++ ++ S+
Sbjct: 132 YILQGVLKALDYIHHMGYV---HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVV 188
Query: 235 VQ------GTFGYLDPEYFRSSQ--FTDKSDVYSFGVVLVELLTGQKPISSI 278
+L PE + + + KSD+YS G+ EL G P +
Sbjct: 189 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-31
Identities = 62/228 (27%), Positives = 100/228 (43%), Gaps = 22/228 (9%)
Query: 63 NSKELDKATDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKV-VDESKLEEFINEVV 120
K + D F LG G G V+K G ++A K + + + + I E+
Sbjct: 24 KQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ 83
Query: 121 ILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHD--PYEELSLTWEMRLRIAT 178
+L + N +V G + E + G+L Q L E L +++
Sbjct: 84 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSI 138
Query: 179 EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS----RSIAIDQTHVSTK 234
V + L YL I HRD+K +NIL++ + K+ DFG S S+A + V
Sbjct: 139 AVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFV--- 191
Query: 235 VQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANE 282
GT Y+ PE + + ++ +SD++S G+ LVE+ G+ PI A E
Sbjct: 192 --GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 237
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-30
Identities = 61/226 (26%), Positives = 99/226 (43%), Gaps = 22/226 (9%)
Query: 68 DKATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVD----ESKLEEFINEVVIL 122
DY I G G V +A+K ++ ++ ++E + E+ +
Sbjct: 12 INRDDYELQEVI-GSGATAVVQAAYCAPKKEKVAIK---RINLEKCQTSMDELLKEIQAM 67
Query: 123 SQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEM--RLRIAT-- 178
SQ +H N+V + + LV + + G++ + + + IAT
Sbjct: 68 SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127
Query: 179 -EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQG 237
EV E L YLH + + HRD+K+ NILL E +IADFG S +A KV+
Sbjct: 128 REVLEGLEYLHKNGQI---HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK 184
Query: 238 TF-G---YLDPEYF-RSSQFTDKSDVYSFGVVLVELLTGQKPISSI 278
TF G ++ PE + + K+D++SFG+ +EL TG P
Sbjct: 185 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY 230
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 37/254 (14%), Positives = 77/254 (30%), Gaps = 53/254 (20%)
Query: 66 ELDKATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVI 121
EL + +LGQ + G V ++ + +++ EV+
Sbjct: 67 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLR 126
Query: 122 LSQI-------------------------NHRNVVKLLGCCLEVEVP--LLVYEFI--PN 152
L + + ++++ ++ V +Y +
Sbjct: 127 LRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNL 186
Query: 153 GTLFQYLHD-PYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY 211
T + L SL RL++ +V LA LH + H ++ +I+LD++
Sbjct: 187 QTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRG 243
Query: 212 RAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYF-----------RSSQFTDKSDVYS 260
+ F + G+ PE R + T D ++
Sbjct: 244 GVFLTGFEHLVRDGARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298
Query: 261 FGVVLVELLTGQKP 274
G+V+ + P
Sbjct: 299 LGLVIYWIWCADLP 312
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 51/228 (22%), Positives = 99/228 (43%), Gaps = 36/228 (15%)
Query: 74 FNMNRILGQGGQGTVYKGMLA--DGRIIAVK-----------------KSKVVDESKLEE 114
+ + R L QG + L D + A+K K+ +SK ++
Sbjct: 33 YRIIRTLNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 115 FINEVVILSQINHRNVVKLLGCCLEVEVPL-LVYEFIPNGTLFQYLH-----DPYEELSL 168
F NE+ I++ I + + G + + ++YE++ N ++ ++ D +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 169 TWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228
++ I V + +Y+H+ I HRD+K +NIL+D+ R K++DFG S
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGES---EYMV 203
Query: 229 THVSTKVQGTFGYLDPEYFRSSQFTD--KSDVYSFGVVLVELLTGQKP 274
+GT+ ++ PE+F + + K D++S G+ L + P
Sbjct: 204 DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 77/303 (25%), Positives = 115/303 (37%), Gaps = 51/303 (16%)
Query: 61 IFNSKELDKATDYFNMNRILGQGGQGTVYKG-MLADGRIIAVK---KSKVVD-------- 108
++ K+ K + + R LG G G V A+K KS+
Sbjct: 25 MYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNK 84
Query: 109 --ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYL--HDPYE 164
E EE NE+ +L ++H N++KL + + LV EF G LF+ + ++
Sbjct: 85 NIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFD 144
Query: 165 ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTS 221
E I ++ + YLH I HRDIK NILL + KI DFG S
Sbjct: 145 E-----CDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLS 196
Query: 222 RSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWAN 281
+ + GT Y+ PE + + +K DV+S GV++ LL G P
Sbjct: 197 SF--FSKDYKLRDRLGTAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYPPFG----- 248
Query: 282 EGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAK----RCLNSYGRNRPTM 337
G+N + + FD + +SD AK L R T
Sbjct: 249 -GQNDQDIIKKVEKGKYYFD-----------FNDWKNISDEAKELIKLMLTYDYNKRCTA 296
Query: 338 KEV 340
+E
Sbjct: 297 EEA 299
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-30
Identities = 61/220 (27%), Positives = 98/220 (44%), Gaps = 28/220 (12%)
Query: 71 TDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESK---LEEFINEVVILSQIN 126
F+ R +G G G VY + + ++A+KK + ++ I EV L ++
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 127 HRNVVKLLGCCLEVEVPLLVYEFIPNG--TLFQYLHDPYEELSLTWEMRLRIAT---EVA 181
H N ++ GC L LV E+ L + P +E+ IA
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE--------IAAVTHGAL 164
Query: 182 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 241
+ LAYLHS + HRD+K+ NILL E K+ DFG++ +A + V GT +
Sbjct: 165 QGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYW 216
Query: 242 LDPE---YFRSSQFTDKSDVYSFGVVLVELLTGQKPISSI 278
+ PE Q+ K DV+S G+ +EL + P+ ++
Sbjct: 217 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 256
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-29
Identities = 31/201 (15%), Positives = 63/201 (31%), Gaps = 44/201 (21%)
Query: 80 LGQGGQGTVYKGMLAD---GRIIAVK---KSKVVDESKLEEFINEVVILSQINHRNVVKL 133
G ++ + D R +A+ V+ + L+E ++ + LS+I+ V ++
Sbjct: 39 HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 134 LGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYL 193
L L+V E+I G+L + + +R +A A H +
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA--- 148
Query: 194 PIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFT 253
+ + + + +A T +P+
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPATMPD------------------ANPQ-------- 182
Query: 254 DKSDVYSFGVVLVELLTGQKP 274
D+ G L LL + P
Sbjct: 183 --DDIRGIGASLYALLVNRWP 201
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-29
Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 74 FNMNRILGQGGQGTVYKGMLA----DGRIIAVK---KSKVVDESKLEEFINEVVILSQIN 126
F +ILG+G TV +LA R A+K K ++ E+K+ E ++S+++
Sbjct: 32 FKFGKILGEGSFSTV---VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 88
Query: 127 HRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRI-ATEVAEALA 185
H VKL + E + NG L +Y+ + S E R E+ AL
Sbjct: 89 HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFD-ETCTRFYTAEIVSALE 144
Query: 186 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTK-VQGTFGYLDP 244
YLH I HRD+K NILL+E +I DFGT++ ++ + GT Y+ P
Sbjct: 145 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201
Query: 245 EYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
E SD+++ G ++ +L+ G P
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 73/283 (25%), Positives = 112/283 (39%), Gaps = 42/283 (14%)
Query: 71 TDYFNMNRILGQGGQGTVYKG-MLADGRIIAVK---KSKVVDESKLEEFINEVVILSQIN 126
+ +N+ +LG+G G V K + AVK K+ ++ + EV +L +++
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT-STILREVELLKKLD 79
Query: 127 HRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYL--HDPYEELSLTWEMRLRIATEVAEAL 184
H N++KL + +V E G LF + + E RI +V +
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-----HDAARIIKQVFSGI 134
Query: 185 AYLHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 241
Y+H I HRD+K NILL ++ KI DFG S Q GT Y
Sbjct: 135 TYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDRIGTAYY 189
Query: 242 LDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFD 301
+ PE R + + +K DV+S GV+L LL+G P G+N FD
Sbjct: 190 IAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFY------GKNEYDILKRVETGKYAFD 242
Query: 302 IIDDQVRKSGEAEEIMAVSDVAK----RCLNSYGRNRPTMKEV 340
+ +SD AK + L + R T +
Sbjct: 243 -----------LPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 75/322 (23%), Positives = 122/322 (37%), Gaps = 63/322 (19%)
Query: 51 SIGGSIDRCRIFNSKELDKAT-------DYFNMNRILGQGGQGTVYKGM-LADGRIIAVK 102
++ S ++ +F +D + D + M++ LG G G V + +A++
Sbjct: 107 ALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIR 166
Query: 103 ---KSKVV-----DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGT 154
K K + E+ IL ++NH ++K+ + +V E + G
Sbjct: 167 IISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGE 225
Query: 155 LFQYL--HDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL---DE 209
LF + + +E ++ A+ YLH I HRD+K N+LL +E
Sbjct: 226 LFDKVVGNKRLKE-----ATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEE 277
Query: 210 KYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQF---TDKSDVYSFGVVLV 266
KI DFG S+ + + + + T GT YL PE S D +S GV+L
Sbjct: 278 DCLIKITDFGHSKILG-ETSLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 335
Query: 267 ELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGE----AEEIMAVSDV 322
L+G P F E + L D I SG+ E VS+
Sbjct: 336 ICLSGYPP---------------FSEHRTQVSLKDQI-----TSGKYNFIPEVWAEVSEK 375
Query: 323 AK----RCLNSYGRNRPTMKEV 340
A + L + R T +E
Sbjct: 376 ALDLVKKLLVVDPKARFTTEEA 397
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 51/210 (24%), Positives = 93/210 (44%), Gaps = 16/210 (7%)
Query: 71 TDYFNMNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQIN 126
DY+++ LG G G V++ + A GR+ K +D+ NE+ I++Q++
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLH 106
Query: 127 HRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAY 186
H ++ L + +L+ EF+ G LF + E+ ++ + + E L +
Sbjct: 107 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKH 164
Query: 187 LHSSAYLPIYHRDIKSTNILLDEKYRA--KIADFGTSRSIAIDQTHVSTKVQGTFGYLDP 244
+H I H DIK NI+ + K + KI DFG + ++ + T + P
Sbjct: 165 MHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATK--LNPDEIVKVTTATAEFAAP 219
Query: 245 EYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
E +D+++ GV+ LL+G P
Sbjct: 220 EIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 56/225 (24%), Positives = 101/225 (44%), Gaps = 12/225 (5%)
Query: 57 DRCRIFNSKELDKAT-DYFNMNRILGQGGQGTVYKGMLAD-GRIIAVK---KSKVVDESK 111
R + E D+F R+LG+GG G V+ + G++ A K K ++
Sbjct: 169 LRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKG 228
Query: 112 LEEFINEVVILSQINHRNVVKLLGCCLEVEVPL-LVYEFIPNGTLFQYLHDPYEELSLTW 170
+ + E IL++++ R +V L E + L LV + G + ++++ E+
Sbjct: 229 YQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ 287
Query: 171 EMRLRI-ATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229
E R ++ L +LH I +RD+K N+LLD+ +I+D G + + QT
Sbjct: 288 EPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT 344
Query: 230 HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
GT G++ PE ++ D ++ GV L E++ + P
Sbjct: 345 KTKGYA-GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-28
Identities = 53/224 (23%), Positives = 101/224 (45%), Gaps = 21/224 (9%)
Query: 67 LDKATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKV-VDESKLEEFINEV-VILS 123
++ D LG+G G V K + G+I+AVK+ + V+ + + + ++ + +
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 124 QINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRL-RIATEVAE 182
++ V G + E + + +L ++ ++ E L +IA + +
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 183 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS----RSIAIDQTHVSTKVQGT 238
AL +LHS L + HRD+K +N+L++ + K+ DFG S +A D G
Sbjct: 121 ALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKD-----IDA-GC 172
Query: 239 FGYLDPE----YFRSSQFTDKSDVYSFGVVLVELLTGQKPISSI 278
Y+ PE ++ KSD++S G+ ++EL + P S
Sbjct: 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW 216
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 64/232 (27%), Positives = 104/232 (44%), Gaps = 22/232 (9%)
Query: 60 RIFNSKELDKATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKV-VDESKLEEFIN 117
+I + D + +G+G G+V K + G+I+AVK+ + VDE + ++ +
Sbjct: 10 KISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLM 69
Query: 118 EV-VILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTW-EMRL- 174
++ V++ + +V+ G + E + + + ++ Y L E L
Sbjct: 70 DLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILG 128
Query: 175 RIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS----RSIAIDQTH 230
+I +AL +L + L I HRDIK +NILLD K+ DFG S SIA
Sbjct: 129 KITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA----- 181
Query: 231 VSTKVQGTFGYLDPEYFRSSQFTD----KSDVYSFGVVLVELLTGQKPISSI 278
T+ G Y+ PE S +SDV+S G+ L EL TG+ P
Sbjct: 182 -KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-27
Identities = 61/211 (28%), Positives = 92/211 (43%), Gaps = 19/211 (9%)
Query: 71 TDYFNMNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQIN 126
F +LG G V+ G++ A+K KS +S LE NE+ +L +I
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIK 64
Query: 127 HRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAY 186
H N+V L LV + + G LF + E T + + +V A+ Y
Sbjct: 65 HENIVTLEDIYESTTHYYLVMQLVSGGELFDRI---LERGVYTEKDASLVIQQVLSAVKY 121
Query: 187 LHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 243
LH I HRD+K N+L +E + I DFG S+ ++Q + + GT GY+
Sbjct: 122 LHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSK---MEQNGIMSTACGTPGYVA 175
Query: 244 PEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
PE ++ D +S GV+ LL G P
Sbjct: 176 PEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-27
Identities = 59/245 (24%), Positives = 99/245 (40%), Gaps = 28/245 (11%)
Query: 48 QLNSIGGSIDRCRIFNSKELDKATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKV 106
S G I + + D N+ + G G G V+K G +IAVK+ +
Sbjct: 2 SSGSSGKQTGYLTIGGQRYQAEINDLENLGEM-GSGTCGQVWKMRFRKTGHVIAVKQMRR 60
Query: 107 -VDESKLEEFINEV-VILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYL--HDP 162
++ + + + ++ V+L + +V+ G + + E + P
Sbjct: 61 SGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGP 120
Query: 163 YEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS- 221
E L ++ + +AL YL + HRD+K +NILLDE+ + K+ DFG S
Sbjct: 121 IPERILG-----KMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISG 173
Query: 222 ---RSIAIDQTHVSTKVQGTFGYLDPE-----YFRSSQFTDKSDVYSFGVVLVELLTGQK 273
A + G Y+ PE + ++DV+S G+ LVEL TGQ
Sbjct: 174 RLVDDKA------KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQF 227
Query: 274 PISSI 278
P +
Sbjct: 228 PYKNC 232
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 51/210 (24%), Positives = 89/210 (42%), Gaps = 16/210 (7%)
Query: 71 TDYFNMNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQIN 126
D+++++ LG G G V++ A G A K D+ E E+ +S +
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQTMSVLR 212
Query: 127 HRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAY 186
H +V L + +++YEF+ G LF+ + D E ++ + + +V + L +
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCH 270
Query: 187 LHSSAYLPIYHRDIKSTNILLDEK--YRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDP 244
+H H D+K NI+ K K+ DFG + +D GT + P
Sbjct: 271 MHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH--LDPKQSVKVTTGTAEFAAP 325
Query: 245 EYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
E +D++S GV+ LL+G P
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-27
Identities = 63/224 (28%), Positives = 101/224 (45%), Gaps = 25/224 (11%)
Query: 71 TDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQI-NHR 128
F + ++G G G VYKG + G++ A+K V + EE E+ +L + +HR
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHR 81
Query: 129 NVVKLLGCCLEVEVPL------LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIAT---E 179
N+ G ++ P LV EF G++ L + +L E IA E
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEW---IAYICRE 137
Query: 180 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF 239
+ L++LH + HRDIK N+LL E K+ DFG S + +T + GT
Sbjct: 138 ILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTP 193
Query: 240 GYLDPEYFRSSQFTD-----KSDVYSFGVVLVELLTGQKPISSI 278
++ PE + D KSD++S G+ +E+ G P+ +
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-27
Identities = 65/282 (23%), Positives = 110/282 (39%), Gaps = 37/282 (13%)
Query: 72 DYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQI-NHRN 129
D ++ LG+G K + + AVK ++ + E+ L H N
Sbjct: 11 DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVK---IISKRMEANTQKEITALKLCEGHPN 67
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS 189
+VKL + LV E + G LF+ + ++ + I ++ A++++H
Sbjct: 68 IVKLHEVFHDQLHTFLVMELLNGGELFERIK---KKKHFSETEASYIMRKLVSAVSHMHD 124
Query: 190 SAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEY 246
+ + HRD+K N+L ++ KI DFG +R D + T T Y PE
Sbjct: 125 ---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPEL 180
Query: 247 FRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306
+ + + D++S GV+L +L+GQ P +++ T VE + I
Sbjct: 181 LNQNGYDESCDLWSLGVILYTMLSGQVP---FQSHDRSLTCTSAVE------IMKKI--- 228
Query: 307 VRKSGE----AEEIMAVSDVAK----RCLNSYGRNRPTMKEV 340
K G+ E VS AK L R M +
Sbjct: 229 --KKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGL 268
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-27
Identities = 54/219 (24%), Positives = 90/219 (41%), Gaps = 24/219 (10%)
Query: 71 TDYFNMNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKL--EEFINEVVILSQ 124
D + + ++G+G V + + G+ AVK +K L E+ E I
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 125 INHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYL------HDPYEELSLTWEMRLRIAT 178
+ H ++V+LL + +V+EF+ L + Y E + MR
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR----- 137
Query: 179 EVAEALAYLHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSIAIDQTHVSTKV 235
++ EAL Y H I HRD+K +LL + K+ FG + + +V
Sbjct: 138 QILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV 194
Query: 236 QGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
GT ++ PE + + DV+ GV+L LL+G P
Sbjct: 195 -GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 8e-27
Identities = 68/285 (23%), Positives = 107/285 (37%), Gaps = 44/285 (15%)
Query: 71 TDYFNMNRILGQGGQGTVYKG-MLADGRIIAVK---KSKVVDESKLEEFINEVVILSQIN 126
D F R LG G G V+ + G +K K + + +E+ E+ +L ++
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLD 78
Query: 127 HRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEEL-SLTWEMRLRIATEVAEALA 185
H N++K+ + +V E G L + + +L+ + ++ ALA
Sbjct: 79 HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALA 138
Query: 186 YLHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYL 242
Y HS + H+D+K NIL KI DFG + ST GT Y+
Sbjct: 139 YFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL--FKSDEHSTNAAGTALYM 193
Query: 243 DPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDI 302
PE F+ T K D++S GVV+ LLTG P G + +
Sbjct: 194 APEVFKRD-VTFKCDIWSAGVVMYFLLTGCLPF------TGTS----------LEEVQQK 236
Query: 303 IDDQVRKSGE---AEEIMAVSDVAK----RCLNSYGRNRPTMKEV 340
E A E ++ A + L RP+ +V
Sbjct: 237 A-----TYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQV 276
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-27
Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 23/217 (10%)
Query: 71 TDYFNMNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKL---EEFINEVVILS 123
D++++ LG G V K + G A K K + + EE EV IL
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 124 QINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYL--HDPYEELSLTWEMRLRIATEVA 181
Q+ H NV+ L +L+ E + G LF +L + E T ++ ++
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-----QIL 125
Query: 182 EALAYLHSSAYLPIYHRDIKSTNILL----DEKYRAKIADFGTSRSIAIDQTHVSTKVQG 237
+ + YLH+ I H D+K NI+L K+ DFG + I+ + G
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNIFG 180
Query: 238 TFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
T ++ PE ++D++S GV+ LL+G P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-26
Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 17/211 (8%)
Query: 71 TDYFNMNRILGQGGQGTVYKG-MLADGRIIAVK---KSKVVDESKLEEFINEVVILSQIN 126
+ +N+ +LG+G G V K + AVK K+ ++ + EV +L +++
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT-STILREVELLKKLD 79
Query: 127 HRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAY 186
H N++KL + +V E G LF + + + RI +V + Y
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYTGGELFDEI---IKRKRFSEHDAARIIKQVFSGITY 136
Query: 187 LHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 243
+H I HRD+K NILL ++ KI DFG S Q GT Y+
Sbjct: 137 MHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDRIGTAYYIA 191
Query: 244 PEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
PE R + + +K DV+S GV+L LL+G P
Sbjct: 192 PEVLRGT-YDEKCDVWSAGVILYILLSGTPP 221
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 51/211 (24%), Positives = 82/211 (38%), Gaps = 19/211 (9%)
Query: 71 TDYFNMNRILGQGGQGTVYKG-MLADGRIIAVK---KSKVVDESKLEEFINEVVILSQIN 126
Y+ + +G+G G V A K K V D + + E+ I+ ++
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK---QEIEIMKSLD 64
Query: 127 HRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAY 186
H N+++L + LV E G LF+ + + RI +V A+AY
Sbjct: 65 HPNIIRLYETFEDNTDIYLVMELCTGGELFERV---VHKRVFRESDAARIMKDVLSAVAY 121
Query: 187 LHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 243
H L + HRD+K N L K+ DFG + + GT Y+
Sbjct: 122 CHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMMRTKVGTPYYVS 176
Query: 244 PEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
P+ + + D +S GV++ LL G P
Sbjct: 177 PQVLEGL-YGPECDEWSAGVMMYVLLCGYPP 206
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 57/217 (26%), Positives = 89/217 (41%), Gaps = 26/217 (11%)
Query: 74 FNMNRILGQGGQGTVYKGMLA----DGRIIAVK---KSKVVDESKLEEFINEVVILSQIN 126
F + +++G+G V + G++ A+K K ++ ++ F E +L +
Sbjct: 63 FEILKVIGRGAFSEV---AVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD 119
Query: 127 HRNVVKLLGCCLEVEVPL-LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRI-ATEVAEAL 184
R + +L + E L LV E+ G L L E + R E+ A+
Sbjct: 120 RRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIP---AEMARFYLAEIVMAI 175
Query: 185 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDP 244
+H L HRDIK NILLD ++ADFG+ + D T S GT YL P
Sbjct: 176 DSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSP 232
Query: 245 EYFRSSQFTDKSDVY-------SFGVVLVELLTGQKP 274
E ++ + Y + GV E+ GQ P
Sbjct: 233 EILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 16/211 (7%)
Query: 71 TDYFNMNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQIN 126
+D +++ LG+G V + + G A K K+ ++ E I ++
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF-QKLEREARICRKLQ 63
Query: 127 HRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAY 186
H N+V+L E LV++ + G LF+ + + ++ E++AY
Sbjct: 64 HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV---AREFYSEADASHCIQQILESIAY 120
Query: 187 LHSSAYLPIYHRDIKSTNILLDEKYRA---KIADFGTSRSIAIDQTHVSTKVQGTFGYLD 243
HS I HR++K N+LL K + K+ADFG + + + + GT GYL
Sbjct: 121 CHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGFAGTPGYLS 175
Query: 244 PEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
PE + ++ D+++ GV+L LL G P
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 64/227 (28%), Positives = 103/227 (45%), Gaps = 13/227 (5%)
Query: 54 GSIDRCRIFNSKELDKAT-DYFNMNRILGQGGQGTVYKGMLAD-GRIIAVK---KSKVVD 108
+R + E T + F R+LG+GG G V + G++ A K K ++
Sbjct: 165 IYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK 224
Query: 109 ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPL-LVYEFIPNGTLFQYLHDPYEELS 167
+NE IL ++N R VV L E + L LV + G L +++ +
Sbjct: 225 RKGEAMALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGF 283
Query: 168 LTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227
A E+ L LH I +RD+K NILLD+ +I+D G + +
Sbjct: 284 PEARAVFYAA-EICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339
Query: 228 QTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
QT + +V GT GY+ PE ++ ++T D ++ G +L E++ GQ P
Sbjct: 340 QT-IKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 18/212 (8%)
Query: 71 TDYFNMNR--ILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQ 124
++ +++ ILG G G V+K A G +A K + D+ EE NE+ +++Q
Sbjct: 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK---EEVKNEISVMNQ 142
Query: 125 INHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEAL 184
++H N+++L +LV E++ G LF + D E +LT + ++ E +
Sbjct: 143 LDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIID--ESYNLTELDTILFMKQICEGI 200
Query: 185 AYLHSSAYLPIYHRDIKSTNILLDEKYRA--KIADFGTSRSIAIDQTHVSTKVQGTFGYL 242
++H + I H D+K NIL + KI DFG +R GT +L
Sbjct: 201 RHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARR--YKPREKLKVNFGTPEFL 255
Query: 243 DPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
PE + +D++S GV+ LL+G P
Sbjct: 256 APEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 23/217 (10%)
Query: 71 TDYFNMNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKL---EEFINEVVILS 123
D++++ LG G V K + G A K K + + EE EV IL
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 124 QINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYL--HDPYEELSLTWEMRLRIATEVA 181
Q+ H N++ L +L+ E + G LF +L + E T ++ ++
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-----QIL 125
Query: 182 EALAYLHSSAYLPIYHRDIKSTNILL----DEKYRAKIADFGTSRSIAIDQTHVSTKVQG 237
+ + YLH+ I H D+K NI+L K+ DFG + I+ + G
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNIFG 180
Query: 238 TFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
T ++ PE ++D++S GV+ LL+G P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-26
Identities = 58/229 (25%), Positives = 99/229 (43%), Gaps = 16/229 (6%)
Query: 53 GGSIDRCRIFNSKELDKATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVD 108
G + R F K +D +++ LG+G V + + G A K K+
Sbjct: 10 GQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA 69
Query: 109 ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSL 168
++ E I ++ H N+V+L E LV++ + G LF+ +
Sbjct: 70 RDF-QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI---VAREFY 125
Query: 169 TWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA---KIADFGTSRSIA 225
+ ++ E++AY HS I HR++K N+LL K + K+ADFG + +
Sbjct: 126 SEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV- 181
Query: 226 IDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
+ + GT GYL PE + ++ D+++ GV+L LL G P
Sbjct: 182 -NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-26
Identities = 62/217 (28%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 71 TDYFNMNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKL---EEFINEVVILS 123
DY++ LG G V K + G A K K + + E+ EV IL
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 124 QINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYL--HDPYEELSLTWEMRLRIATEVA 181
+I H NV+ L +L+ E + G LF +L + E T ++ ++
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK-----QIL 124
Query: 182 EALAYLHSSAYLPIYHRDIKSTNILL----DEKYRAKIADFGTSRSIAIDQTHVSTKVQG 237
+ YLHS L I H D+K NI+L K R KI DFG + ID + + G
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEFKNIFG 179
Query: 238 TFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
T ++ PE ++D++S GV+ LL+G P
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 4e-26
Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 23/217 (10%)
Query: 71 TDYFNMNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKL---EEFINEVVILS 123
D++ M LG G V K G+ A K K ++ + EE EV IL
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 124 QINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYL--HDPYEELSLTWEMRLRIATEVA 181
+I H N++ L +L+ E + G LF +L + E T ++ ++
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK-----QIL 118
Query: 182 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRA----KIADFGTSRSIAIDQTHVSTKVQG 237
+ + YLHS I H D+K NI+L +K K+ DFG + I+ + + G
Sbjct: 119 DGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNEFKNIFG 173
Query: 238 TFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
T ++ PE ++D++S GV+ LL+G P
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-26
Identities = 64/229 (27%), Positives = 110/229 (48%), Gaps = 33/229 (14%)
Query: 64 SKELDKATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFIN-- 117
KE + + + +LG GG G+VY G+ ++D +A+K K ++ D +L
Sbjct: 35 GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 94
Query: 118 -EVVILSQINHR--NVVKLLGCCLEV-EVP---LLVYEFI-PNGTLFQYL--HDPYEELS 167
EVV+L +++ V++LL + E P +L+ E P LF ++ +E
Sbjct: 95 MEVVLLKKVSSGFSGVIRLL----DWFERPDSFVLILERPEPVQDLFDFITERGALQEE- 149
Query: 168 LTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD-EKYRAKIADFGTSRSIAI 226
R +V EA+ + H+ + HRDIK NIL+D + K+ DFG+ A+
Sbjct: 150 ---LAR-SFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG---AL 199
Query: 227 DQTHVSTKVQGTFGYLDPEYFRSSQFT-DKSDVYSFGVVLVELLTGQKP 274
+ V T GT Y PE+ R ++ + V+S G++L +++ G P
Sbjct: 200 LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 50/209 (23%), Positives = 94/209 (44%), Gaps = 15/209 (7%)
Query: 71 TDYFNMNRILGQGGQGTVYKGM-LADGRIIAVK--KSKVVDESKLEEFINEVVILSQINH 127
+ + + LG+G G V++ + + + K K K D+ ++ E+ IL+ H
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARH 60
Query: 128 RNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYL 187
RN++ L +E ++++EFI +F+ ++ L + +V EAL +L
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFL 118
Query: 188 HSSAYLPIYHRDIKSTNILLDEKYRA--KIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE 245
HS I H DI+ NI+ + + KI +FG +R + + Y PE
Sbjct: 119 HS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR--QLKPGDNFRLLFTAPEYYAPE 173
Query: 246 YFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
+ + +D++S G ++ LL+G P
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 74/295 (25%), Positives = 117/295 (39%), Gaps = 56/295 (18%)
Query: 65 KELDKATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKK-SKVVDESKLEEFINEVVIL 122
D +D+F + LG+G VY+ + A+K K VD+ + E+ +L
Sbjct: 46 SNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR---TEIGVL 102
Query: 123 SQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYL--HDPYEELSLTWEMRLRIATE- 179
+++H N++KL LV E + G LF + Y E R A +
Sbjct: 103 LRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSE---------RDAADA 153
Query: 180 ---VAEALAYLHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSIAIDQTHVST 233
+ EA+AYLH I HRD+K N+L KIADFG S+ + + +
Sbjct: 154 VKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMK 208
Query: 234 KVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVEC 293
V GT GY PE R + + D++S G++ LL G +P F +
Sbjct: 209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP---------------FYDE 253
Query: 294 IEENCLFDIIDDQVRKSGE----AEEIMAVSDVAK----RCLNSYGRNRPTMKEV 340
+ +F I + E + VS AK + + + R T +
Sbjct: 254 RGDQFMFRRI-----LNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQA 303
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 17/211 (8%)
Query: 72 DYFNMNRILGQGGQGTVYKGMLAD-GRIIAVK---KSKVVDESKLEEFINEVVILSQINH 127
D+F + R +G+G G V D ++ A+K K K V+ +++ E+ I+ + H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 128 RNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRI-ATEVAEALAY 186
+V L + E +V + + G L +L + + E +++ E+ AL Y
Sbjct: 75 PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL---QQNVHFK-EETVKLFICELVMALDY 130
Query: 187 LHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEY 246
L + I HRD+K NILLDE I DF + + + + + GT Y+ PE
Sbjct: 131 LQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEM 185
Query: 247 FRSSQFT--DKS-DVYSFGVVLVELLTGQKP 274
F S + + D +S GV ELL G++P
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 54/215 (25%), Positives = 94/215 (43%), Gaps = 24/215 (11%)
Query: 74 FNMNRILGQGGQGTVYKGMLA----DGRIIAVK---KSKVVDESKLEEFINEVVILSQIN 126
F + +++G+G G V + ++ A+K K +++ ++ F E +L +
Sbjct: 76 FEILKVIGRGAFGEV---AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD 132
Query: 127 HRNVVKLLGCCLEVEVPL-LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRI-ATEVAEAL 184
+ + L + + L LV ++ G L L + L E R E+ A+
Sbjct: 133 SKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLP---EEMARFYLAEMVIAI 188
Query: 185 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDP 244
+H L HRDIK NIL+D ++ADFG+ + D T S+ GT Y+ P
Sbjct: 189 DSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 245
Query: 245 EYFRSSQFTDKS-----DVYSFGVVLVELLTGQKP 274
E ++ + D +S GV + E+L G+ P
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 26/208 (12%)
Query: 78 RILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQINHRNVVKL 133
+ +G+G V + GR +A+K K+++ + + L++ EV I+ +NH N+VKL
Sbjct: 21 KTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 134 LGCCLEV-EVP---LLVYEFIPNGTLFQYL--HDPYEELSLTWEMRLRIATEVAEALAYL 187
EV E L+ E+ G +F YL H +E E R ++ A+ Y
Sbjct: 80 F----EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK----EAR-SKFRQIVSAVQYC 130
Query: 188 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYF 247
H I HRD+K+ N+LLD KIADFG S + + G Y PE F
Sbjct: 131 HQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAFC-GAPPYAAPELF 185
Query: 248 RSSQFT-DKSDVYSFGVVLVELLTGQKP 274
+ ++ + DV+S GV+L L++G P
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVSGSLP 213
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-25
Identities = 75/295 (25%), Positives = 115/295 (38%), Gaps = 56/295 (18%)
Query: 71 TDYFNMNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEE-----FINEVVI 121
D + M++ LG G G V + +A+K K K S E E+ I
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 122 LSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYL--HDPYEELSLTWEMRLRIATE 179
L ++NH ++K+ + +V E + G LF + + +E + +
Sbjct: 69 LKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEA----TCK-LYFYQ 122
Query: 180 VAEALAYLHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSIAIDQTHVSTKVQ 236
+ A+ YLH I HRD+K N+LL +E KI DFG S+ + +T + +
Sbjct: 123 MLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRTLC 177
Query: 237 GTFGYLDPEYFRSSQ---FTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVEC 293
GT YL PE S + D +S GV+L L+G P F E
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP---------------FSEH 222
Query: 294 IEENCLFDIIDDQVRKSGE----AEEIMAVSDVAK----RCLNSYGRNRPTMKEV 340
+ L D I SG+ E VS+ A + L + R T +E
Sbjct: 223 RTQVSLKDQI-----TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA 272
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-25
Identities = 66/232 (28%), Positives = 108/232 (46%), Gaps = 35/232 (15%)
Query: 63 NSKELDKATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFIN- 117
K+ + + + +LG+GG GTV+ G L D +A+K +++V+ S L + +
Sbjct: 22 GGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTC 81
Query: 118 --EVVILSQIN----HRNVVKLLGCCLEV-EVP---LLVYEF-IPNGTLFQYL--HDPYE 164
EV +L ++ H V++LL + E +LV E +P LF Y+ P
Sbjct: 82 PLEVALLWKVGAGGGHPGVIRLL----DWFETQEGFMLVLERPLPAQDLFDYITEKGPLG 137
Query: 165 ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY-RAKIADFGTSRS 223
E R +V A+ + HS + HRDIK NIL+D + AK+ DFG+
Sbjct: 138 EG----PSR-CFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSG-- 187
Query: 224 IAIDQTHVSTKVQGTFGYLDPEYFRSSQFT-DKSDVYSFGVVLVELLTGQKP 274
A+ T GT Y PE+ Q+ + V+S G++L +++ G P
Sbjct: 188 -ALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 5e-25
Identities = 48/264 (18%), Positives = 88/264 (33%), Gaps = 73/264 (27%)
Query: 78 RILGQGGQGTVYKGM-LADGRIIAVK----------KSKVVDESKL-------------- 112
+ +G+GG G V++ D A+K + KV+ E K
Sbjct: 12 QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 71
Query: 113 ----------------------------------EEFINEVVILSQINHRNVVKLLGCCL 138
+ ++ + + +N V L
Sbjct: 72 AWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSS 131
Query: 139 EVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHR 198
+ + L +++ + L I ++AEA+ +LHS + HR
Sbjct: 132 PKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLM---HR 188
Query: 199 DIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQ-----------GTFGYLDPEYF 247
D+K +NI K+ DFG ++ D+ + GT Y+ PE
Sbjct: 189 DLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQI 248
Query: 248 RSSQFTDKSDVYSFGVVLVELLTG 271
+ ++ K D++S G++L ELL
Sbjct: 249 HGNNYSHKVDIFSLGLILFELLYS 272
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 6e-25
Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 74 FNMNRILGQGGQGTVYK-GMLADGRIIAVK---KSKVVDESKLEEFINEVVILSQINHRN 129
+ + +++G+G G V + ++ A+K K +++ S F E I++ N
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRI-ATEVAEALAYLH 188
VV+L + +V E++P G L + + ++ E R EV AL +H
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVP---EKWARFYTAEVVLALDAIH 185
Query: 189 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFR 248
S + HRD+K N+LLD+ K+ADFGT + + GT Y+ PE +
Sbjct: 186 S---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 242
Query: 249 SSQFT---DKS-DVYSFGVVLVELLTGQKP 274
S + D +S GV L E+L G P
Sbjct: 243 SQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 52/213 (24%), Positives = 95/213 (44%), Gaps = 19/213 (8%)
Query: 71 TDYFNMNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQIN 126
T+ + + LG+G V + + + G+ A K+ ++ E I +
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDH-QKLEREARICRLLK 68
Query: 127 HRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYL--HDPYEELSLTWEMRLRIATEVAEAL 184
H N+V+L E L+++ + G LF+ + + Y E + ++ ++ EA+
Sbjct: 69 HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ-----QILEAV 123
Query: 185 AYLHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 241
+ H + + HR++K N+LL + K+ADFG + + +Q GT GY
Sbjct: 124 LHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGY 179
Query: 242 LDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
L PE R + D+++ GV+L LL G P
Sbjct: 180 LSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-25
Identities = 60/227 (26%), Positives = 92/227 (40%), Gaps = 37/227 (16%)
Query: 71 TDYFNMNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVD------ESKLEEFINEVV 120
+ + ILG+G V + + + AVK + + E + EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 121 ILSQIN-HRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYL--HDPYEELSLTWEMRLRIA 177
IL +++ H N+++L LV++ + G LF YL E +
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE---------KET 126
Query: 178 TEV----AEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVST 233
++ E + LH L I HRD+K NILLD+ K+ DFG S +D
Sbjct: 127 RKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDPGEKLR 181
Query: 234 KVQGTFGYLDPEYFRSSQFTDKS------DVYSFGVVLVELLTGQKP 274
+V GT YL PE S + D++S GV++ LL G P
Sbjct: 182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-25
Identities = 58/263 (22%), Positives = 100/263 (38%), Gaps = 53/263 (20%)
Query: 62 FNSKELDKATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVK-----KSKVVDESKLEEF 115
F L + +++ +GQG G V + I A+K K + ++ +E
Sbjct: 16 FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERI 75
Query: 116 INEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRL- 174
EV ++ +++H N+ +L + + LV E G L L+ ++ + M +
Sbjct: 76 KTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVV 135
Query: 175 ------------------------------------RIATEVAEALAYLHSSAYLPIYHR 198
I ++ AL YLH+ I HR
Sbjct: 136 KTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHR 192
Query: 199 DIKSTNILL--DEKYRAKIADFGTSRSIAI---DQTHVSTKVQGTFGYLDPEYFRSSQ-- 251
DIK N L ++ + K+ DFG S+ + + T GT ++ PE ++
Sbjct: 193 DIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES 252
Query: 252 FTDKSDVYSFGVVLVELLTGQKP 274
+ K D +S GV+L LL G P
Sbjct: 253 YGPKCDAWSAGVLLHLLLMGAVP 275
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 21/213 (9%)
Query: 72 DYFNMNRILGQGGQGTVYKGMLAD-GRIIAVK---KSKVVDESKLEEFINEVVILSQIN- 126
+ F+++RI+G+GG G VY AD G++ A+K K ++ + +NE ++LS ++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 127 --HRNVVKLLGCCLEVEVPL-LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRI-ATEVAE 182
+V + L + + + G L +L + + E +R A E+
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFS-EADMRFYAAEIIL 303
Query: 183 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYL 242
L ++H+ + +RD+K NILLDE +I+D G + + + H V GT GY+
Sbjct: 304 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYM 357
Query: 243 DPEYFRSSQFTDKS-DVYSFGVVLVELLTGQKP 274
PE + D S D +S G +L +LL G P
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 5e-24
Identities = 52/216 (24%), Positives = 87/216 (40%), Gaps = 29/216 (13%)
Query: 76 MNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFIN-EVVILSQINHRNV 130
M +LG+G G V + + AVK K K+ E + E+ +L ++ H+NV
Sbjct: 9 MGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV 68
Query: 131 VKLLGCCLEV---EVPL---LVYEFIPNGT--LFQYL-HDPYEELSLTWEMRLRIATEVA 181
++L+ +V E +V E+ G + + + + ++
Sbjct: 69 IQLV----DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPV----CQAH-GYFCQLI 119
Query: 182 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI-AIDQTHVSTKVQGTFG 240
+ L YLHS I H+DIK N+LL KI+ G + ++ QG+
Sbjct: 120 DGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA 176
Query: 241 YLDPEYFRSSQFTD--KSDVYSFGVVLVELLTGQKP 274
+ PE K D++S GV L + TG P
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-24
Identities = 57/223 (25%), Positives = 95/223 (42%), Gaps = 36/223 (16%)
Query: 71 TDYFNMNRILGQGGQGTVYKGM-LADGRIIAVK---KSKV-----VDESKLEEFINEVVI 121
++ ++G+G V + + A G AVK + E E E I
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 122 LSQI-NHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYL--HDPYEELSLTWEMRLRIAT 178
L Q+ H +++ L+ LV++ + G LF YL E +
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSE---------KETR 203
Query: 179 EV----AEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTK 234
+ EA+++LH+ I HRD+K NILLD+ + +++DFG S ++ +
Sbjct: 204 SIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCH--LEPGEKLRE 258
Query: 235 VQGTFGYLDPEYFRSSQFTD------KSDVYSFGVVLVELLTG 271
+ GT GYL PE + S + D+++ GV+L LL G
Sbjct: 259 LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 6e-24
Identities = 73/302 (24%), Positives = 123/302 (40%), Gaps = 51/302 (16%)
Query: 71 TDYFNMNR-ILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQI 125
D + + +LG+G V + L + AVK K S++ EV +L Q
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF---REVEMLYQC 67
Query: 126 -NHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHD--PYEELSLTWEMRLRIATEVAE 182
HRNV++L+ E + LV+E + G++ ++H + EL + ++ +VA
Sbjct: 68 QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ-----DVAS 122
Query: 183 ALAYLHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSIAIDQTHVSTKVQ--- 236
AL +LH+ I HRD+K NIL ++ KI DF I ++
Sbjct: 123 ALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179
Query: 237 ---GTFGYLDPEYFRSSQFTDKS-----DVYSFGVVLVELLTGQKPISSIWANEGRNLTT 288
G+ Y+ PE + D++S GV+L LL+G P G +
Sbjct: 180 TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP---FVGRCGSDCGW 236
Query: 289 YFVECIE--ENCLFDIIDDQVRKSGE----AEEIMAVSDVAK----RCLNSYGRNRPTMK 338
E +N LF+ I + G+ ++ +S AK + L + R +
Sbjct: 237 DRGEACPACQNMLFESI-----QEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAA 291
Query: 339 EV 340
+V
Sbjct: 292 QV 293
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 7e-24
Identities = 62/234 (26%), Positives = 96/234 (41%), Gaps = 50/234 (21%)
Query: 78 RILGQGGQGTVYKGM-LADGRIIAVK---KSKVV-----------------------DES 110
+G+G G V D A+K K K++
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 111 KLEEFINEVVILSQINHRNVVKLLGCCLEV-EVPL-----LVYEFIPNGTLFQYL-HDPY 163
+E+ E+ IL +++H NVVKL+ EV + P +V+E + G + + P
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLV----EVLDDPNEDHLYMVFELVNQGPVMEVPTLKPL 134
Query: 164 EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 223
E + R ++ + + YLH Y I HRDIK +N+L+ E KIADFG S
Sbjct: 135 SE----DQAR-FYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 224 IAIDQTHVSTKVQGTFGYLDPEYFRSSQFT---DKSDVYSFGVVLVELLTGQKP 274
+S V GT ++ PE ++ DV++ GV L + GQ P
Sbjct: 187 FKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-24
Identities = 61/240 (25%), Positives = 110/240 (45%), Gaps = 35/240 (14%)
Query: 50 NSIGGSIDRCRIFNSKELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDE 109
+ + + K ++ + +++G G G V++ L + +A+K KV+ +
Sbjct: 18 LDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIK--KVLQD 75
Query: 110 SKLEEFIN-EVVILSQINHRNVVKLLGCCLEV-----EVPL-LVYEFIPNGTLFQYLHDP 162
+ F N E+ I+ + H NVV L EV L LV E++P T+++
Sbjct: 76 ---KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRH- 130
Query: 163 YEELSLTWEMRLRIATE--------VAEALAYLHSSAYLPIYHRDIKSTNILLD-EKYRA 213
+++ + + +LAY+HS + I HRDIK N+LLD
Sbjct: 131 ------YAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVL 181
Query: 214 KIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE-YFRSSQFTDKSDVYSFGVVLVELLTGQ 272
K+ DFG+++ + + +VS + Y PE F ++ +T D++S G V+ EL+ GQ
Sbjct: 182 KLIDFGSAKILIAGEPNVSYIC--SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 9e-24
Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 25/213 (11%)
Query: 73 YFNMNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQINHR 128
++ + LG G G V G G +AVK + K+ + + E+ L H
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 129 NVVKLLGCCLEV-EVP---LLVYEFIPNGTLFQYL--HDPYEELSLTWEMRLRIATEVAE 182
+++KL +V P +V E++ G LF Y+ H EE+ E R R+ ++
Sbjct: 72 HIIKLY----QVISTPTDFFMVMEYVSGGELFDYICKHGRVEEM----EAR-RLFQQILS 122
Query: 183 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYL 242
A+ Y H + HRD+K N+LLD AKIADFG S ++ D + T G+ Y
Sbjct: 123 AVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRTSC-GSPNYA 177
Query: 243 DPEYFRSSQFT-DKSDVYSFGVVLVELLTGQKP 274
PE + + D++S GV+L LL G P
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGTLP 210
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-23
Identities = 62/230 (26%), Positives = 103/230 (44%), Gaps = 23/230 (10%)
Query: 54 GSIDRCRIFNSKELDKAT-DYFNMNRILGQGGQGTVYKGMLA----DGRIIAVK---KSK 105
D + + + + A D F+ + LG G G V ML G A+K K K
Sbjct: 22 AKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQK 78
Query: 106 VVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEE 165
VV ++E +NE IL +N +VKL + +V E++ G +F +L
Sbjct: 79 VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---I 135
Query: 166 LSLTWEMRLRI-ATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 224
+ E R A ++ YLHS L + +RD+K N+L+D++ ++ DFG ++ +
Sbjct: 136 GRFS-EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 225 AIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
+T + GT L PE S + D ++ GV++ E+ G P
Sbjct: 192 -KGRTWT---LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-23
Identities = 61/286 (21%), Positives = 109/286 (38%), Gaps = 47/286 (16%)
Query: 71 TDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQ-INHR 128
TD + + +G G + + A AVK ++D+SK + E+ IL + H
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVK---IIDKSKRDPT-EEIEILLRYGQHP 76
Query: 129 NVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHD--PYEELSLTWEMRLRIATEVAEALAY 186
N++ L + + +V E + G L + + E + + + + + Y
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLF-----TITKTVEY 131
Query: 187 LHSSAYLPIYHRDIKSTNILLDEKYRA----KIADFGTSRSIAIDQTHVSTKVQGTFGYL 242
LH+ + HRD+K +NIL ++ +I DFG ++ + + + T T ++
Sbjct: 132 LHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFV 187
Query: 243 DPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDI 302
PE + D++S GV+L +LTG P +
Sbjct: 188 APEVLERQGYDAACDIWSLGVLLYTMLTGYTP---FANGPDDT----------PEEILAR 234
Query: 303 IDDQVRKSGE----AEEIMAVSDVAK----RCLNSYGRNRPTMKEV 340
I SG+ +VSD AK + L+ R T V
Sbjct: 235 I-----GSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALV 275
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-23
Identities = 52/224 (23%), Positives = 93/224 (41%), Gaps = 16/224 (7%)
Query: 60 RIFNSKELDKATDYFNMN-RILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEE 114
+ ++ +++ + + LG+G V + + + G+ A K K + + + E
Sbjct: 16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCR-AE 74
Query: 115 FINEVVILSQINHR-NVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMR 173
++E+ +L V+ L +L+ E+ G +F E ++
Sbjct: 75 ILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAE-MVSENDV 133
Query: 174 LRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSIAIDQTH 230
+R+ ++ E + YLH I H D+K NILL KI DFG SR I
Sbjct: 134 IRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI--GHAC 188
Query: 231 VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
++ GT YL PE T +D+++ G++ LLT P
Sbjct: 189 ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-23
Identities = 68/217 (31%), Positives = 111/217 (51%), Gaps = 39/217 (17%)
Query: 78 RILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFIN-EVVILSQINHRNVVKLLG 135
+++G G G VY+ L D G ++A+KK V+ + + F N E+ I+ +++H N+V+L
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKR---FKNRELQIMRKLDHCNIVRLRY 114
Query: 136 CCLEV-----EVPL-LVYEFIPNGTLFQYLHD--------PYEEL-SLTWEMRLRIATEV 180
EV L LV +++P T+++ P + +++ R
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL-FR----- 167
Query: 181 AEALAYLHSSAYLPIYHRDIKSTNILLD-EKYRAKIADFGTSRSIAIDQTHVSTKVQGTF 239
+LAY+HS I HRDIK N+LLD + K+ DFG+++ + + +VS +
Sbjct: 168 --SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SR 220
Query: 240 GYLDPEY-FRSSQFTDKSDVYSFGVVLVELLTGQKPI 275
Y PE F ++ +T DV+S G VL ELL GQ PI
Sbjct: 221 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PI 256
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 4e-23
Identities = 61/210 (29%), Positives = 93/210 (44%), Gaps = 20/210 (9%)
Query: 74 FNMNRILGQGGQGTVYKGMLA----DGRIIAVK---KSKVVDESKLEEFINEVVILSQIN 126
F ++LG+G G V +L GR A+K K +V + ++ + E +L
Sbjct: 150 FEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 206
Query: 127 HRNVVKLLGCCLEVEVPL-LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRI-ATEVAEAL 184
H + L + L V E+ G LF +L E + E R R E+ AL
Sbjct: 207 HPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLS---RERVFS-EDRARFYGAEIVSAL 261
Query: 185 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDP 244
YLHS + +RD+K N++LD+ KI DFG + D + T GT YL P
Sbjct: 262 DYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAP 318
Query: 245 EYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
E + + D + GVV+ E++ G+ P
Sbjct: 319 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 5e-23
Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 25/216 (11%)
Query: 73 YFNMNRILGQGGQGTVYKGM-LADGRIIAVK---KSKV-----VDESKLEEFINEVVILS 123
++ LG G G V+ + + + VK K KV +++ KL + E+ ILS
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 124 QINHRNVVKLLGCCLEVEVPL-LVYEFIPNGT-LFQYL--HDPYEELSLTWEMRLRIATE 179
++ H N++K+L E + LV E +G LF ++ H +E I +
Sbjct: 85 RVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEP----LAS-YIFRQ 138
Query: 180 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF 239
+ A+ YL I HRDIK NI++ E + K+ DFG++ + + T GT
Sbjct: 139 LVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYTFC-GTI 193
Query: 240 GYLDPEYFRSSQFT-DKSDVYSFGVVLVELLTGQKP 274
Y PE + + + +++S GV L L+ + P
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 6e-23
Identities = 64/222 (28%), Positives = 99/222 (44%), Gaps = 24/222 (10%)
Query: 78 RILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFIN----EVVILSQINHRNVVK 132
+ LG+G G V + +AVK +VD + + E+ I +NH NVVK
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 133 LLGCCLEVEVPLLVYEFIPNGTLFQYL--HDPYEELSLTWEMRLRIATEVAEALAYLHSS 190
G E + L E+ G LF + E + + R ++ + YLH
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQ-RFFHQLMAGVVYLHG- 123
Query: 191 AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA-IDQTHVSTKVQGTFGYLDPEYFRS 249
+ I HRDIK N+LLDE+ KI+DFG + ++ + K+ GT Y+ PE +
Sbjct: 124 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 250 SQFT-DKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYF 290
+F + DV+S G+VL +L G+ P W + Y
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELP----WDQPSDSCQEYS 219
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-22
Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 24/228 (10%)
Query: 72 DYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFIN----EVVILSQIN 126
+ +++ + LG+G G V + +AVK +VD + + E+ I +N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLN 63
Query: 127 HRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYL--HDPYEELSLTWEMRLRIATEVAEAL 184
H NVVK G E + L E+ G LF + E + + R ++ +
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQ-RFFHQLMAGV 118
Query: 185 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA-IDQTHVSTKVQGTFGYLD 243
YLH + I HRDIK N+LLDE+ KI+DFG + ++ + K+ GT Y+
Sbjct: 119 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 244 PEYFRSSQFT-DKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYF 290
PE + +F + DV+S G+VL +L G+ P W + Y
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELP----WDQPSDSCQEYS 219
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 3e-22
Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 25/213 (11%)
Query: 73 YFNMNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQINHR 128
++ + LG G G V G G +AVK + K+ + + E+ L H
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 129 NVVKLLGCCLEV-EVP---LLVYEFIPNGTLFQYL--HDPYEELSLTWEMRLRIATEVAE 182
+++KL +V P +V E++ G LF Y+ + +E E R R+ ++
Sbjct: 77 HIIKLY----QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEK----ESR-RLFQQILS 127
Query: 183 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYL 242
+ Y H + HRD+K N+LLD AKIADFG S ++ D + T G+ Y
Sbjct: 128 GVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRTSC-GSPNYA 182
Query: 243 DPEYFRSSQFT-DKSDVYSFGVVLVELLTGQKP 274
PE + + D++S GV+L LL G P
Sbjct: 183 APEVISGRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 6e-22
Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 30/213 (14%)
Query: 74 FNMNRILGQGGQGTVYKGMLA----DGRIIAVK---KSKVVDESKLEEFINEVVILSQIN 126
F + R LG G G V L +GR A+K K VV ++E +E ++LS +
Sbjct: 8 FQILRTLGTGSFGRV---HLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 64
Query: 127 HRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRI-ATEVAEALA 185
H ++++ G + + ++ ++I G LF L + + A EV AL
Sbjct: 65 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL---RKSQRFP-NPVAKFYAAEVCLALE 120
Query: 186 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTF-G---Y 241
YLHS I +RD+K NILLD+ KI DFG ++ + D T+ T G Y
Sbjct: 121 YLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYV-PDVTY-------TLCGTPDY 169
Query: 242 LDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
+ PE + + D +SFG+++ E+L G P
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 9e-22
Identities = 70/209 (33%), Positives = 104/209 (49%), Gaps = 17/209 (8%)
Query: 74 FNMNRILGQGGQGTVY----KGMLADGRIIAVK--KSKVVDESKLEEFINEVVILSQINH 127
F + ++LGQG G V+ ++ A+K K + E IL ++NH
Sbjct: 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85
Query: 128 RNVVKLLGCCLEVEVPL-LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRI-ATEVAEALA 185
+VKL + E L L+ +F+ G LF L +E+ T E ++ E+A AL
Sbjct: 86 PFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFT-EEDVKFYLAELALALD 140
Query: 186 YLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE 245
+LHS L I +RD+K NILLDE+ K+ DFG S+ +ID + GT Y+ PE
Sbjct: 141 HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPE 196
Query: 246 YFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
T +D +SFGV++ E+LTG P
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 1e-21
Identities = 57/213 (26%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 68 DKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEF----INEVVILS 123
Y + ++ G+G G VYK + GRI+A+K+ ++ E E I E+ +L
Sbjct: 18 GLMEKYQKLEKV-GEGTYGVVYKAKDSQGRIVALKRIRLDAED--EGIPSTAIREISLLK 74
Query: 124 QINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEA 183
+++H N+V L+ LV+EF+ L + L + L + ++++ ++
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDS-QIKI-YLYQLLRG 131
Query: 184 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 243
+A+ H I HRD+K N+L++ K+ADFG +R+ I + +V T Y
Sbjct: 132 VAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRA 187
Query: 244 PEY-FRSSQFTDKSDVYSFGVVLVELLTGQKPI 275
P+ S +++ D++S G + E++TG KP+
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITG-KPL 219
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 1e-21
Identities = 63/220 (28%), Positives = 101/220 (45%), Gaps = 28/220 (12%)
Query: 69 KATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFIN-----EVVIL 122
+A Y ++ + G+G TVYK +I+A+KK K+ S+ ++ IN E+ +L
Sbjct: 8 RAKRYEKLDFL-GEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLL 66
Query: 123 SQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEEL------SLTWEMRLRI 176
+++H N++ LL LV++F+ L + D L + M L+
Sbjct: 67 QELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTPSHIKAYML-MTLQ- 123
Query: 177 ATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQ 236
L YLH L HRD+K N+LLDE K+ADFG ++S + +V
Sbjct: 124 ------GLEYLHQHWIL---HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV 174
Query: 237 GTFGYLDPEY-FRSSQFTDKSDVYSFGVVLVELLTGQKPI 275
T Y PE F + + D+++ G +L ELL P
Sbjct: 175 -TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR-VPF 212
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 1e-21
Identities = 55/216 (25%), Positives = 101/216 (46%), Gaps = 28/216 (12%)
Query: 72 DYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEF----INEVVILSQIN 126
Y + +I G+G GTV+K I+A+K+ ++ D+ E + E+ +L ++
Sbjct: 3 KYEKLEKI-GEGTYGTVFKAKNRETHEIVALKRVRLDDDD--EGVPSSALREICLLKELK 59
Query: 127 HRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEEL------SLTWEMRLRIATEV 180
H+N+V+L + LV+EF L +Y +L S +++ L+
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQL-LK----- 112
Query: 181 AEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFG 240
L + HS + HRD+K N+L++ K+A+FG +R+ I S +V T
Sbjct: 113 --GLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLW 166
Query: 241 YLDPEY-FRSSQFTDKSDVYSFGVVLVELLTGQKPI 275
Y P+ F + ++ D++S G + EL +P+
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 3e-21
Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 21/210 (10%)
Query: 74 FNMNRILGQGGQGTVYKGMLA----DGRIIAVK---KSKVVDESKLEEFINEVVILSQIN 126
F+ ++LG+G G V +L GR A+K K ++ + ++ + E +L
Sbjct: 7 FDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 127 HRNVVKLLGCCLEVEVPL-LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRI-ATEVAEAL 184
H + L + L V E+ G LF +L E T E R R E+ AL
Sbjct: 64 HPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLS---RERVFT-EERARFYGAEIVSAL 118
Query: 185 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDP 244
YLHS + +RDIK N++LD+ KI DFG + D + T GT YL P
Sbjct: 119 EYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAP 174
Query: 245 EYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
E + + D + GVV+ E++ G+ P
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 3e-21
Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 25/214 (11%)
Query: 74 FNMNRILGQGGQGTVYKGMLA-------DGRIIAVK---KSKVVDESK-LEEFINEVVIL 122
F + R+LG+GG G V G+I A+K K+ +V +K E IL
Sbjct: 19 FELLRVLGKGGYGKV---FQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNIL 75
Query: 123 SQINHRNVVKLLGCCLEVEVPL-LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRI-ATEV 180
++ H +V L+ + L L+ E++ G LF L E E E+
Sbjct: 76 EEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLE---REGIFM-EDTACFYLAEI 130
Query: 181 AEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFG 240
+ AL +LH I +RD+K NI+L+ + K+ DFG + +I V+ GT
Sbjct: 131 SMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCGTIE 186
Query: 241 YLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
Y+ PE S D +S G ++ ++LTG P
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 4e-21
Identities = 56/220 (25%), Positives = 110/220 (50%), Gaps = 21/220 (9%)
Query: 69 KATDYFNMNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDES--KLEEFINEVVILSQI 125
K D F + R+ GQG GTV G G +A+KK V+ + + E + + L+ +
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK--VIQDPRFRNRE-LQIMQDLAVL 76
Query: 126 NHRNVVKLL------GCCLEVEVPL-LVYEFIPNGTLFQYL-HDPYEELSLTWEMRLRIA 177
+H N+V+L G ++ L +V E++P+ TL + + +++ +
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 178 TEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK-YRAKIADFGTSRSIAIDQTHVSTKVQ 236
++ ++ LH + + + HRDIK N+L++E K+ DFG+++ ++ + +V+
Sbjct: 136 FQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC- 193
Query: 237 GTFGYLDPEY-FRSSQFTDKSDVYSFGVVLVELLTGQKPI 275
+ Y PE F + +T D++S G + E++ G+ PI
Sbjct: 194 -SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE-PI 231
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 5e-21
Identities = 65/311 (20%), Positives = 113/311 (36%), Gaps = 61/311 (19%)
Query: 55 SIDRCRIFNSKELDKATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLE 113
K+ DY +++LG G G V + A+K ++
Sbjct: 45 QFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK---MLQ--DCP 99
Query: 114 EFINEVVILSQI-NHRNVVKLLGCCLEVEVP----LLVYEFIPNGTLFQYL----HDPYE 164
+ EV + + ++V+++ + L+V E + G LF + +
Sbjct: 100 KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT 159
Query: 165 ELSLTWEMRLRIATEV----AEALAYLHSSAYLPIYHRDIKSTNILL---DEKYRAKIAD 217
E R A+E+ EA+ YLHS + I HRD+K N+L K+ D
Sbjct: 160 E---------REASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTD 207
Query: 218 FGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISS 277
FG ++ + ++T T Y+ PE ++ D++S GV++ LL G P
Sbjct: 208 FGFAKETTSHNS-LTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP--- 262
Query: 278 IWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGE----AEEIMAVSDVAK----RCLNS 329
++N G + I + G+ E VS+ K L +
Sbjct: 263 FYSNHGLA---------ISPGMKTRI-----RMGQYEFPNPEWSEVSEEVKMLIRNLLKT 308
Query: 330 YGRNRPTMKEV 340
R T+ E
Sbjct: 309 EPTQRMTITEF 319
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 5e-21
Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 72 DYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFIN--EVVILSQINHR 128
Y N+ + G+G G V K GRI+A+KK D+ K+ + I E+ +L Q+ H
Sbjct: 26 KYENLGLV-GEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 129 NVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLH 188
N+V LL C + + LV+EF+ + T+ L L ++ + ++ + + H
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQ-VVQ-KYLFQIINGIGFCH 141
Query: 189 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEY-F 247
S + HRDIK NIL+ + K+ DFG +R++A +V T Y PE
Sbjct: 142 SHNII---HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPELLV 197
Query: 248 RSSQFTDKSDVYSFGVVLVELLTGQ 272
++ DV++ G ++ E+ G+
Sbjct: 198 GDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 6e-21
Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 68 DKATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEF----INEVVIL 122
D+ + Y + +I GQG G V+K G+ +A+KK + +E E F + E+ IL
Sbjct: 14 DEVSKYEKLAKI-GQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKIL 70
Query: 123 SQINHRNVVKLLGCCLEVEVPL--------LVYEFIPNGTLFQYLHDPYEELSLTWEMRL 174
+ H NVV L+ C P LV++F + L L + + +L+ E++
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLS-EIK- 127
Query: 175 RIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTK 234
R+ + L Y+H + L HRD+K+ N+L+ K+ADFG +R+ ++ + +
Sbjct: 128 RVMQMLLNGLYYIHRNKIL---HRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 235 -----VQGTFGYLDPEY-FRSSQFTDKSDVYSFGVVLVELLTGQKPI 275
V T Y PE + D++ G ++ E+ T PI
Sbjct: 185 YTNRVV--TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR-SPI 228
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 90.6 bits (226), Expect = 6e-21
Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 72 DYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEF----INEVVILSQINH 127
Y + +I G+G G VYK G A+KK ++ E E I E+ IL ++ H
Sbjct: 3 KYHGLEKI-GEGTYGVVYKAQNNYGETFALKKIRLEKED--EGIPSTTIREISILKELKH 59
Query: 128 RNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEEL------SLTWEMRLRIATEVA 181
N+VKL + +LV+E + L + L L S ++ L
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQL-LN------ 111
Query: 182 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 241
+AY H + HRD+K N+L++ + KIADFG +R+ I + ++ T Y
Sbjct: 112 -GIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWY 166
Query: 242 LDPEY-FRSSQFTDKSDVYSFGVVLVELLTGQKPI 275
P+ S +++ D++S G + E++ G P+
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG-TPL 200
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 7e-21
Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 76 MNR-----ILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFIN--EVVILSQINH 127
M + +G+G G V+K G+I+A+KK ++ + + I E+ +L Q+ H
Sbjct: 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 128 RNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYL 187
N+V LL LV+E+ + T+ L + ++ I + +A+ +
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEH-LVK-SITWQTLQAVNFC 118
Query: 188 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEY- 246
H + HRD+K NIL+ + K+ DFG +R + + +V T Y PE
Sbjct: 119 HKHNCI---HRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPELL 174
Query: 247 FRSSQFTDKSDVYSFGVVLVELLTGQ 272
+Q+ DV++ G V ELL+G
Sbjct: 175 VGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 8e-21
Identities = 58/218 (26%), Positives = 109/218 (50%), Gaps = 19/218 (8%)
Query: 67 LDKATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEF----INEVVI 121
+ ++ + + ++ G G TVYKG+ G +A+K+ K+ E E I E+ +
Sbjct: 1 MSSSSQFKQLEKL-GNGTYATVYKGLNKTTGVYVALKEVKLDSE---EGTPSTAIREISL 56
Query: 122 LSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELS---LTWEMRLRIAT 178
+ ++ H N+V+L LV+EF+ N L +Y+ + L +
Sbjct: 57 MKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQW 115
Query: 179 EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGT 238
++ + LA+ H + I HRD+K N+L++++ + K+ DFG +R+ I S++V T
Sbjct: 116 QLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-T 171
Query: 239 FGYLDPEY-FRSSQFTDKSDVYSFGVVLVELLTGQKPI 275
Y P+ S ++ D++S G +L E++TG KP+
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITG-KPL 208
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 26/208 (12%)
Query: 78 RILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQINHRNVVKL 133
LG+G G V + +A+K + + E+ L + H +++KL
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 134 LGCCLEV-EVP---LLVYEFIPNGTLFQYL--HDPYEELSLTWEMRLRIATEVAEALAYL 187
+V P ++V E+ G LF Y+ E E R R ++ A+ Y
Sbjct: 75 Y----DVITTPTDIVMVIEYA-GGELFDYIVEKKRMTE----DEGR-RFFQQIICAIEYC 124
Query: 188 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYF 247
H I HRD+K N+LLD+ KIADFG S +I D + T G+ Y PE
Sbjct: 125 HR---HKIVHRDLKPENLLLDDNLNVKIADFGLS-NIMTDGNFLKTSC-GSPNYAAPEVI 179
Query: 248 RSSQFT-DKSDVYSFGVVLVELLTGQKP 274
+ + DV+S G+VL +L G+ P
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 1e-20
Identities = 57/232 (24%), Positives = 100/232 (43%), Gaps = 28/232 (12%)
Query: 64 SKELDKATDYFN-MNRILGQGGQGTVYKGM---LADGRIIAVKKSKVVDESKLEEFINEV 119
S E ++ D F +G+G G VYK D + A+K+ + E+
Sbjct: 12 SSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE--GTGISMSACREI 69
Query: 120 VILSQINHRNVVKLLGCCLE-VEVPL-LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIA 177
+L ++ H NV+ L L + + L++++ + L+ + + ++L
Sbjct: 70 ALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRG 128
Query: 178 T------EVAEALAYLHSSAYLPIYHRDIKSTNILL----DEKYRAKIADFGTSRSIAI- 226
++ + + YLH++ L HRD+K NIL+ E+ R KIAD G +R
Sbjct: 129 MVKSLLYQILDGIHYLHANWVL---HRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 185
Query: 227 --DQTHVSTKVQGTFGYLDPEY-FRSSQFTDKSDVYSFGVVLVELLTGQKPI 275
+ V TF Y PE + +T D+++ G + ELLT +PI
Sbjct: 186 LKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPI 235
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-20
Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 29/216 (13%)
Query: 72 DYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEF----INEVVILSQIN 126
+ + LG+G TVYKG ++A+K+ ++ E E I EV +L +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLK 58
Query: 127 HRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEEL------SLTWEMRLRIATEV 180
H N+V L + LV+E++ L QYL D + + LR
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLF-QLLR----- 111
Query: 181 AEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFG 240
LAY H + HRD+K N+L++E+ K+ADFG +R+ +I +V T
Sbjct: 112 --GLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLW 165
Query: 241 YLDPEY-FRSSQFTDKSDVYSFGVVLVELLTGQKPI 275
Y P+ S+ ++ + D++ G + E+ TG +P+
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATG-RPL 200
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-20
Identities = 77/305 (25%), Positives = 129/305 (42%), Gaps = 58/305 (19%)
Query: 74 FNMNRILGQGGQGTVYKGMLA----DGRIIAVK---KSKVVDESKLEEFINEVVILSQI- 125
F++ R++G+G V +L RI A+K K V D+ ++ E + Q
Sbjct: 11 FDLLRVIGRGSYAKV---LLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 67
Query: 126 NHRNVVKLLGCCLEVEVPL-LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRI-ATEVAEA 183
NH +V L C + E L V E++ G L ++ + L E R + E++ A
Sbjct: 68 NHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLP-EEHARFYSAEISLA 122
Query: 184 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 243
L YLH I +RD+K N+LLD + K+ D+G + ST GT Y+
Sbjct: 123 LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIA 178
Query: 244 PEYFRSSQFTDKSDVYSFGVVLVELLTGQKP---ISSIWANEGRNLTTYFVECIEENCLF 300
PE R + D ++ GV++ E++ G+ P + S + E+ LF
Sbjct: 179 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT----------EDYLF 228
Query: 301 D-IIDDQVR----KSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDDE 355
I++ Q+R S +A ++ K LN ++ P ER+ + +
Sbjct: 229 QVILEKQIRIPRSLSVKAASVL------KSFLN---KD-PK--------ERLGCHPQTGF 270
Query: 356 NNIQK 360
+IQ
Sbjct: 271 ADIQG 275
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-20
Identities = 71/237 (29%), Positives = 110/237 (46%), Gaps = 22/237 (9%)
Query: 52 IGGSIDRCRIFNSKELDKAT-DYFNMNRILGQGGQGTVY---KGMLAD-GRIIAVK---K 103
+ + + +K + F + ++LG G G V+ K D G++ A+K K
Sbjct: 33 LTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKK 92
Query: 104 SKVVDESKLEEFI-NEVVILSQINHRN-VVKLLGCCLEVEVPL-LVYEFIPNGTLFQYLH 160
+ +V ++K E E +L I +V L + E L L+ ++I G LF +L
Sbjct: 93 ATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHL- 150
Query: 161 DPYEELSLTWEMRLRI-ATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 219
+ T E ++I E+ AL +LH L I +RDIK NILLD + DFG
Sbjct: 151 --SQRERFT-EHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFG 204
Query: 220 TSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQF-TDKS-DVYSFGVVLVELLTGQKP 274
S+ D+T + GT Y+ P+ R DK+ D +S GV++ ELLTG P
Sbjct: 205 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 3e-20
Identities = 62/289 (21%), Positives = 108/289 (37%), Gaps = 52/289 (17%)
Query: 72 DYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQI-NHRN 129
DY ++LG G G V + G+ A+K ++ +S EV Q +
Sbjct: 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALK---LLYDSPKAR--QEVDHHWQASGGPH 83
Query: 130 VVKLLGCCLEVEVP----LLVYEFIPNGTLFQYL----HDPYEELSLTWEMRLRIATEVA 181
+V +L + L++ E + G LF + + E I ++
Sbjct: 84 IVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTE-----REAAEIMRDIG 138
Query: 182 EALAYLHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSIAIDQTHVSTKVQGT 238
A+ +LHS I HRD+K N+L ++ K+ DFG ++ Q + T T
Sbjct: 139 TAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNALQTPC-YT 192
Query: 239 FGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENC 298
Y+ PE ++ D++S GV++ LL G P ++N
Sbjct: 193 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP---FYSN-------------TGQA 236
Query: 299 LFDIIDDQVRK---SGEAEEIMAVSDVAK----RCLNSYGRNRPTMKEV 340
+ + ++R E VS+ AK L + R T+ +
Sbjct: 237 ISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQF 285
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 4e-20
Identities = 76/305 (24%), Positives = 129/305 (42%), Gaps = 58/305 (19%)
Query: 74 FNMNRILGQGGQGTVYKGMLA----DGRIIAVK---KSKVVDESKLEEFINEVVILSQI- 125
F++ R++G+G V +L RI A++ K V D+ ++ E + Q
Sbjct: 54 FDLLRVIGRGSYAKV---LLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS 110
Query: 126 NHRNVVKLLGCCLEVEVPL-LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRI-ATEVAEA 183
NH +V L C + E L V E++ G L ++ + L E R + E++ A
Sbjct: 111 NHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLP-EEHARFYSAEISLA 165
Query: 184 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 243
L YLH I +RD+K N+LLD + K+ D+G + ST GT Y+
Sbjct: 166 LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIA 221
Query: 244 PEYFRSSQFTDKSDVYSFGVVLVELLTGQKP---ISSIWANEGRNLTTYFVECIEENCLF 300
PE R + D ++ GV++ E++ G+ P + S + E+ LF
Sbjct: 222 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT----------EDYLF 271
Query: 301 D-IIDDQVR----KSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDDE 355
I++ Q+R S +A ++ K LN ++ P ER+ + +
Sbjct: 272 QVILEKQIRIPRSLSVKAASVL------KSFLN---KD-PK--------ERLGCHPQTGF 313
Query: 356 NNIQK 360
+IQ
Sbjct: 314 ADIQG 318
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 5e-20
Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 74 FNMNRILGQGGQGTVYKGMLA----DGRIIAVK---KSKVVDESKLEEFINEVVILSQ-I 125
F+ +++G+G G V +LA + AVK K ++ + + + ++E +L + +
Sbjct: 40 FHFLKVIGKGSFGKV---LLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV 96
Query: 126 NHRNVVKLLGCCLEVEVPL-LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRI-ATEVAEA 183
H +V L + L V ++I G LF +L E E R R A E+A A
Sbjct: 97 KHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQ---RERCFL-EPRARFYAAEIASA 151
Query: 184 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 243
L YLHS L I +RD+K NILLD + + DFG + I+ ++ GT YL
Sbjct: 152 LGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNSTTSTFCGTPEYLA 207
Query: 244 PEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
PE + D + G VL E+L G P
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 74 FNMNRILGQGGQGTVYKGMLA----DGRIIAVK---KSKVVDESKLEEFINEVVILSQIN 126
FN +LG+G G V ML+ + AVK K V+ + +E + E +L+
Sbjct: 343 FNFLMVLGKGSFGKV---MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 399
Query: 127 HRNVVKLLGCCLEVEVPL-LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRI-ATEVAEAL 184
+ L C + L V E++ G L ++ E A E+A L
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ---VGRFK-EPHAVFYAAEIAIGL 455
Query: 185 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDP 244
+L S I +RD+K N++LD + KIADFG + D T GT Y+ P
Sbjct: 456 FFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAP 511
Query: 245 EYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
E + D ++FGV+L E+L GQ P
Sbjct: 512 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-19
Identities = 55/218 (25%), Positives = 90/218 (41%), Gaps = 47/218 (21%)
Query: 78 RILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQINHRNVVKL 133
+ +G G G ++AVK + +DE ++ E++ + H N+V+
Sbjct: 26 KDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE-NVQ---REIINHRSLRHPNIVRF 81
Query: 134 LGCCLEVEVPL------LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVA------ 181
EV L ++ E+ G L++ + + R + + A
Sbjct: 82 K------EVILTPTHLAIIMEYASGGELYERICN-----------AGRFSEDEARFFFQQ 124
Query: 182 --EALAYLHSSAYLPIYHRDIKSTNILLDEKY--RAKIADFGTSRSIAIDQTHVSTKVQG 237
++Y HS + I HRD+K N LLD R KI DFG S+S + + V G
Sbjct: 125 LLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTV-G 179
Query: 238 TFGYLDPEYFRSSQFT-DKSDVYSFGVVLVELLTGQKP 274
T Y+ PE ++ +DV+S GV L +L G P
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 3e-19
Identities = 59/218 (27%), Positives = 89/218 (40%), Gaps = 23/218 (10%)
Query: 72 DYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFIN-----EVVILSQI 125
Y + I G G GTVYK G +A+K +V + + EV +L ++
Sbjct: 10 RYEPVAEI-GVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRL 68
Query: 126 N---HRNVVKLLGCCLEVEVPL-----LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIA 177
H NVV+L+ C LV+E + L YL D L E +
Sbjct: 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL-DKAPPPGLPAETIKDLM 126
Query: 178 TEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQG 237
+ L +LH++ + HRD+K NIL+ K+ADFG +R + V
Sbjct: 127 RQFLRGLDFLHANCIV---HRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV-- 181
Query: 238 TFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPI 275
T Y PE S + D++S G + E+ KP+
Sbjct: 182 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR-KPL 218
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-19
Identities = 67/211 (31%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 74 FNMNRILGQGGQGTVYKGMLA----DGRIIAVK---KSKVVDESKLEEFINEVVILSQI- 125
F R+LG+G G V MLA G + AVK K ++ + +E + E ILS
Sbjct: 25 FEFIRVLGKGSFGKV---MLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR 81
Query: 126 NHRNVVKLLGCCLEVEVPL-LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRI-ATEVAEA 183
NH + +L CC + L V EF+ G L ++ + E R R A E+ A
Sbjct: 82 NHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQ---KSRRFD-EARARFYAAEIISA 136
Query: 184 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 243
L +LH I +RD+K N+LLD + K+ADFG + + +T GT Y+
Sbjct: 137 LMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC-GTPDYIA 192
Query: 244 PEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
PE + + D ++ GV+L E+L G P
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 4e-19
Identities = 52/220 (23%), Positives = 94/220 (42%), Gaps = 33/220 (15%)
Query: 72 DYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEF----INEVVILSQIN 126
Y + ++ G+G G VYK + +A+K+ ++ E + E I EV +L ++
Sbjct: 35 RYRRITKL-GEGTYGEVYKAIDTVTNETVAIKRIRL--EHEEEGVPGTAIREVSLLKELQ 91
Query: 127 HRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLH-----DPYEELSLTWEMRLRIATEVA 181
HRN+++L L++E+ N L +Y+ S +++
Sbjct: 92 HRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQL--------I 142
Query: 182 EALAYLHSSAYLPIYHRDIKSTNILLDEKYRA-----KIADFGTSRSIAIDQTHVSTKVQ 236
+ + HS L HRD+K N+LL + KI DFG +R+ I + ++
Sbjct: 143 NGVNFCHSRRCL---HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII 199
Query: 237 GTFGYLDPEY-FRSSQFTDKSDVYSFGVVLVELLTGQKPI 275
T Y PE S ++ D++S + E+L P+
Sbjct: 200 -TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK-TPL 237
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 5e-19
Identities = 53/248 (21%), Positives = 104/248 (41%), Gaps = 52/248 (20%)
Query: 67 LDKATDYFNMNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFIN-EVVILSQ 124
L+ ++ +++ + LG G G V + + G+ A+KK V+ + + + N E+ I+
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKK--VLQDPR---YKNRELDIMKV 56
Query: 125 INHRNVVKLLGC----------------------CLEVEVPLLVYEFIPNGTLFQYLH-- 160
++H N++KL+ V I N + +YL+
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 161 ------DPYEELSLTWEMRLRIATE--------VAEALAYLHSSAYLPIYHRDIKSTNIL 206
++ L I + A+ ++HS L I HRDIK N+L
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLL 173
Query: 207 LD-EKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE-YFRSSQFTDKSDVYSFGVV 264
++ + K+ DFG+++ + + V+ + Y PE ++++T D++S G V
Sbjct: 174 VNSKDNTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATEYTPSIDLWSIGCV 231
Query: 265 LVELLTGQ 272
EL+ G+
Sbjct: 232 FGELILGK 239
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 6e-19
Identities = 51/215 (23%), Positives = 94/215 (43%), Gaps = 31/215 (14%)
Query: 72 DYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQI-NHRN 129
DY + ++ G+G V++ + + + + VK K V + K E+ IL + N
Sbjct: 37 DYQLVRKL-GRGKYSEVFEAINITNNEKVVVKILKPVKKKK---IKREIKILENLRGGPN 92
Query: 130 VVKLLGCCLEVE--VPLLVYEFIPNGTLFQYLH--DPYEELSLTWEMRLRIATEVAEALA 185
++ L + P LV+E + N Q Y+ +E+ L+ AL
Sbjct: 93 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEI-LK-------ALD 144
Query: 186 YLHSSAYLPIYHRDIKSTNILLDEKYRA-KIADFGTSRSIAIDQT---HVSTKVQGTFGY 241
Y HS I HRD+K N+++D ++R ++ D+G + Q V+++ +
Sbjct: 145 YCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----F 196
Query: 242 LDPEYFRSSQFTDKS-DVYSFGVVLVELLTGQKPI 275
PE Q D S D++S G +L ++ ++P
Sbjct: 197 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 8e-19
Identities = 61/211 (28%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 74 FNMNRILGQGGQGTVYKGMLA----DGRIIAVK---KSKVVDESKLEEFINEVVILSQI- 125
FN +LG+G G V ML+ + AVK K V+ + +E + E +L+
Sbjct: 22 FNFLMVLGKGSFGKV---MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 78
Query: 126 NHRNVVKLLGCCLEVEVPL-LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRI-ATEVAEA 183
+ +L C + L V E++ G L ++ + E A E+A
Sbjct: 79 KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ---QVGRFK-EPHAVFYAAEIAIG 133
Query: 184 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 243
L +L S I +RD+K N++LD + KIADFG + D T GT Y+
Sbjct: 134 LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIA 189
Query: 244 PEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
PE + D ++FGV+L E+L GQ P
Sbjct: 190 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-18
Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 74 FNMNRILGQGGQGTVYKGMLA----DGRIIAVK---KSKVVDESKLEEFINEVVILSQ-I 125
F ++++LG+G G V LA + A+K K V+ + +E + E +LS
Sbjct: 19 FILHKMLGKGSFGKV---FLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 75
Query: 126 NHRNVVKLLGCCLEVEVPL-LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRI-ATEVAEA 183
H + + C + + L V E++ G L ++ R A E+
Sbjct: 76 EHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFD-LSRATFYAAEIILG 130
Query: 184 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 243
L +LHS I +RD+K NILLD+ KIADFG + + + GT Y+
Sbjct: 131 LQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAKTNTFCGTPDYIA 186
Query: 244 PEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
PE ++ D +SFGV+L E+L GQ P
Sbjct: 187 PEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-18
Identities = 62/218 (28%), Positives = 93/218 (42%), Gaps = 25/218 (11%)
Query: 72 DYFNMNRILGQGGQGTVYKG--MLADGRIIAVKKSKVVDESKLEEF----INEVVILSQI 125
Y + I G+G G V+K + GR +A+K+ +V E I EV +L +
Sbjct: 12 QYECVAEI-GEGAYGKVFKARDLKNGGRFVALKRVRVQTGE--EGMPLSTIREVAVLRHL 68
Query: 126 N---HRNVVKLLGCCLEVEVPL-----LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIA 177
H NVV+L C LV+E + L YL D E + E +
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPGVPTETIKDMM 126
Query: 178 TEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQG 237
++ L +LHS + HRD+K NIL+ + K+ADFG +R + S V
Sbjct: 127 FQLLRGLDFLHSHRVV---HRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-- 181
Query: 238 TFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPI 275
T Y PE S + D++S G + E+ KP+
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR-KPL 218
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 52/235 (22%), Positives = 91/235 (38%), Gaps = 52/235 (22%)
Query: 71 TDYFNMNRILGQGGQGTVYKGMLADGRIIAVKK--SKVVDESKLEEFIN---------EV 119
+ + R + G G V G+ ++G +A+K+ + V D + + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 120 VILSQINHRNVVKLLGCCLEVEVPL---------LVYEFIPNGTLFQYLHDPYEELS--- 167
+L+ +H N++ L ++ V LV E + L Q +HD +S
Sbjct: 81 RLLNHFHHPNILGLR----DIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQH 135
Query: 168 ---LTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 224
+ + L L LH + + HRD+ NILL + I DF +R
Sbjct: 136 IQYFMYHI-LL-------GLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLARED 184
Query: 225 AIDQT---HVSTKVQGTFGYLDPEY-FRSSQFTDKSDVYSFGVVLVELLTGQKPI 275
D +V+ + Y PE + FT D++S G V+ E+ K +
Sbjct: 185 TADANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR-KAL 233
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 2e-17
Identities = 50/202 (24%), Positives = 79/202 (39%), Gaps = 44/202 (21%)
Query: 164 EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 223
+ LT E + + +VA+ + +L S + HRD+ + NILL EK KI DFG +R
Sbjct: 186 YKDFLTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFGLARD 242
Query: 224 IAIDQTHVSTKVQGTFGYLD-----PEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISS 277
I D +V L PE +T +SDV+SFGV+L E+ + G P
Sbjct: 243 IYKDPDYVRKGD----ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 298
Query: 278 IWANEGRNLTTYFVECIE--------ENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNS 329
+ +E F ++ + + E + M C +
Sbjct: 299 VKIDEE------FCRRLKEGTRMRAPDYT-----------TPEMYQTM------LDCWHG 335
Query: 330 YGRNRPTMKEVAMELERIRANS 351
RPT E+ L + +
Sbjct: 336 EPSQRPTFSELVEHLGNLLQAN 357
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 51/221 (23%), Positives = 92/221 (41%), Gaps = 35/221 (15%)
Query: 71 TDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLE--EFINEVVILSQINH 127
+ + +G G QG V R +A+KK +++ E+V++ +NH
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 128 RNVVKLLGCCLEVEVPL----------LVYEFIPNGTLFQYLHDPYEEL---SLTWEMRL 174
+N++ LL V P +V E + L Q + + L ++M L
Sbjct: 84 KNIIGLL----NVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQM-L 137
Query: 175 RIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTK 234
+ +LHS+ I HRD+K +NI++ KI DFG +R+ + + T
Sbjct: 138 C-------GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTP 185
Query: 235 VQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPI 275
T Y PE + + D++S G ++ E++ G +
Sbjct: 186 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG-GVL 225
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 52/221 (23%), Positives = 92/221 (41%), Gaps = 35/221 (15%)
Query: 71 TDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLE--EFINEVVILSQINH 127
+ + +G G QG V R +A+KK +++ E+V++ +NH
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 128 RNVVKLLGCCLEVEVPL----------LVYEFIPNGTLFQYLHDPYEEL---SLTWEMRL 174
+N++ L L V P LV E + L Q + + L ++M L
Sbjct: 121 KNIISL----LNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQM-L 174
Query: 175 RIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTK 234
+ +LHS+ I HRD+K +NI++ KI DFG +R+ + + T
Sbjct: 175 C-------GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTP 222
Query: 235 VQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPI 275
T Y PE + + D++S G ++ E++ K +
Sbjct: 223 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH-KIL 262
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-15
Identities = 56/223 (25%), Positives = 94/223 (42%), Gaps = 40/223 (17%)
Query: 71 TDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKK-SKVVDESKLEEFI-NEVVILSQINH 127
+ +G G G+V + G +A+KK S+ + E+++L + H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 128 RNVVKLLGCCLEVEVPL----------LVYEFIPNGTLFQYLHDPYEEL---SLTWEMRL 174
NV+ LL +V P LV F+ L + + + E L ++M L
Sbjct: 83 ENVIGLL----DVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQM-L 136
Query: 175 RIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH-VST 233
+ L Y+HS+ + HRD+K N+ ++E KI DFG +R + T V T
Sbjct: 137 K-------GLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVT 186
Query: 234 KVQGTFGYLDPE-YFRSSQFTDKSDVYSFGVVLVELLTGQKPI 275
+ Y PE + D++S G ++ E+LTG K +
Sbjct: 187 RW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG-KTL 223
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-15
Identities = 59/302 (19%), Positives = 102/302 (33%), Gaps = 74/302 (24%)
Query: 60 RIFNSKELDKATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINE 118
K+ DY +++LG G G V + A+K ++ + E
Sbjct: 6 SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK---MLQ--DCPKARRE 60
Query: 119 VVILSQI-NHRNVVKLLGCCLEVEVP----LLVYEFIPNGTLFQYL----HDPYEELSLT 169
V + + ++V+++ + L+V E + G LF + + E +
Sbjct: 61 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 120
Query: 170 WEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSIAI 226
M+ + EA+ YLHS + I HRD+K N+L K+ DFG
Sbjct: 121 EIMK-----SIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFG------- 165
Query: 227 DQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNL 286
E ++ D++S GV++ LL G P ++N G
Sbjct: 166 ---------------FAKE-TTGEKYDKSCDMWSLGVIMYILLCGYPP---FYSNHGLA- 205
Query: 287 TTYFVECIEENCLFDIIDDQVRKSGE----AEEIMAVSDVAK----RCLNSYGRNRPTMK 338
+ I + G+ E VS+ K L + R T+
Sbjct: 206 --------ISPGMKTRI-----RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTIT 252
Query: 339 EV 340
E
Sbjct: 253 EF 254
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 9e-15
Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 34/220 (15%)
Query: 71 TDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLE--EFINEVVILSQINH 127
Y ++ + G G G V + G +A+KK +S+L E+ +L + H
Sbjct: 25 AVYRDLQPV-GSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 128 RNVVKLLGCCLEVEVPL----------LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIA 177
NV+ LL +V P LV F+ L + L + +
Sbjct: 84 ENVIGLL----DVFTPDETLDDFTDFYLVMPFMGTD-----LGKLMKHEKLGEDRIQFLV 134
Query: 178 TEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT-HVSTKVQ 236
++ + L Y+H++ I HRD+K N+ ++E KI DFG +R + T +V T+
Sbjct: 135 YQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW- 190
Query: 237 GTFGYLDPEY-FRSSQFTDKSDVYSFGVVLVELLTGQKPI 275
Y PE ++T D++S G ++ E++TG K +
Sbjct: 191 ----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITG-KTL 225
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 43/216 (19%)
Query: 78 RILGQGGQGTVYKGM-LADGRIIAVK--KSKVVDESKLEEFINEVVILSQINHR------ 128
+++G+G G V K + +A+K +++ + + E+ IL + +
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTM 159
Query: 129 NVVKLLGC-------CLEVEVPLL---VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIAT 178
NV+ +L C+ E LL +YE I FQ L L + A
Sbjct: 160 NVIHMLENFTFRNHICMTFE--LLSMNLYELIKKNK-FQGFS-----LPLVR----KFAH 207
Query: 179 EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA--KIADFGTSRSIAIDQTHVSTKVQ 236
+ + L LH I H D+K NILL ++ R+ K+ DFG+S + V T +Q
Sbjct: 208 SILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYTYIQ 261
Query: 237 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQ 272
F Y PE +++ D++S G +L ELLTG
Sbjct: 262 SRF-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 50/321 (15%), Positives = 110/321 (34%), Gaps = 77/321 (23%)
Query: 71 TDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKK-----SKVVDESKLEEFINEVVILSQ 124
D + + ++G+G G VY + +A+KK ++D ++ + E+ IL++
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRI---LREITILNR 81
Query: 125 INHRNVVKLLGCCLEVEVPL---------LVYEFIPNGT-LFQYLHDPYEELS------L 168
+ +++L ++ +P +V E + L + P L+ +
Sbjct: 82 LKSDYIIRLY----DLIIPDDLLKFDELYIVLEIA--DSDLKKLFKTP-IFLTEEHIKTI 134
Query: 169 TWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228
+ + L ++H S I HRD+K N LL++ K+ DFG +R+I ++
Sbjct: 135 LYNL-LL-------GENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183
Query: 229 THVSTKVQGTFGYLDP----------EY------------FRSSQFTDKSDVYSFGVVLV 266
P + +T D++S G +
Sbjct: 184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFA 243
Query: 267 ELLTGQKPISSIWANE-----GRNLTTYFVECIEENCLFDIIDDQVRK------SGEAEE 315
ELL + + N G + + + DQ+ + ++
Sbjct: 244 ELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDD 303
Query: 316 IMAV-SDVAKRCLNSYGRNRP 335
+ + + + + +P
Sbjct: 304 LKNINKPEVIKYIKLFPHRKP 324
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 4e-14
Identities = 57/223 (25%), Positives = 93/223 (41%), Gaps = 39/223 (17%)
Query: 71 TDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLE--EFINEVVILSQINH 127
+ + +G G G+V G +AVKK +S + E+ +L + H
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 128 RNVVKLLGCCLEVEVPLLVYEFIPNGTL--FQ--YLHDPYEELSLTWEMRLRIATE---- 179
NV+ LL F P +L F YL L ++ + T+
Sbjct: 88 ENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 135
Query: 180 -----VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT-HVST 233
+ L Y+HS+ I HRD+K +N+ ++E KI DFG +R A + T +V+T
Sbjct: 136 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVAT 192
Query: 234 KVQGTFGYLDPE-YFRSSQFTDKSDVYSFGVVLVELLTGQKPI 275
+ Y PE + D++S G ++ ELLTG + +
Sbjct: 193 RW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-RTL 229
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 8e-14
Identities = 57/246 (23%), Positives = 90/246 (36%), Gaps = 74/246 (30%)
Query: 71 TDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFIN---------EVV 120
+ F + +LG+G G V G I+A+KK +E F E+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK--------IEPFDKPLFALRTLREIK 61
Query: 121 ILSQINHRNVVKLLGCCLEVEVPL---------LVYEF--------IPNGTL----FQYL 159
IL H N++ + ++ P ++ E I L QY
Sbjct: 62 ILKHFKHENIITIF----NIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF 117
Query: 160 HDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 219
++ LR A+ LH S + HRD+K +N+L++ K+ DFG
Sbjct: 118 ---------IYQT-LR-------AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFG 157
Query: 220 TSRSIAIDQTHVSTKVQGTFG---------YLDPEY-FRSSQFTDKSDVYSFGVVLVELL 269
+R I S G Y PE S++++ DV+S G +L EL
Sbjct: 158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217
Query: 270 TGQKPI 275
+PI
Sbjct: 218 LR-RPI 222
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 9e-14
Identities = 55/234 (23%), Positives = 95/234 (40%), Gaps = 57/234 (24%)
Query: 71 TDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFIN---------EVV 120
+ +G+G G V + +A+KK + F + E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK--------ISPFEHQTYCQRTLREIK 77
Query: 121 ILSQINHRNVVKLLGCCLEVEVPL---------LVYEFIPNGT-LFQYLHDPYEELS--- 167
IL + H N++ + ++ +V + + T L++ L + LS
Sbjct: 78 ILLRFRHENIIGIN----DIIRAPTIEQMKDVYIVQDLM--ETDLYKLLKT--QHLSNDH 129
Query: 168 ---LTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 224
+++ LR L Y+HS+ + HRD+K +N+LL+ KI DFG +R
Sbjct: 130 ICYFLYQI-LR-------GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 178
Query: 225 AIDQTHVS--TKVQGTFGYLDPEY-FRSSQFTDKSDVYSFGVVLVELLTGQKPI 275
D H T+ T Y PE S +T D++S G +L E+L+ +PI
Sbjct: 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 9e-14
Identities = 60/228 (26%), Positives = 102/228 (44%), Gaps = 45/228 (19%)
Query: 68 DKATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVK----KSKVVDESKLEEFINEVVIL 122
+K D + ++ ++G+G G V K + +A+K K ++++++E V +L
Sbjct: 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIE-----VRLL 104
Query: 123 SQINHR------NVVKLLGC-------CLEVEVPLL---VYEFIPNGTLFQYLHDPYEEL 166
+N +V L CL E +L +Y+ + N T F+ + L
Sbjct: 105 ELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE--MLSYNLYDLLRN-TNFRGVS-----L 156
Query: 167 SLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA--KIADFGTSRSI 224
+LT + A ++ AL +L + L I H D+K NILL R+ KI DFG+S
Sbjct: 157 NLTR----KFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGSS--- 208
Query: 225 AIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQ 272
+ +Q F Y PE + D++S G +LVE+ TG+
Sbjct: 209 CQLGQRIYQYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-13
Identities = 54/228 (23%), Positives = 97/228 (42%), Gaps = 36/228 (15%)
Query: 71 TDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRN 129
+ + LG GG G V+ + + +A+KK + D ++ + E+ I+ +++H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQ----YLHDPYEELSLTWEMRLRIATE------ 179
+VK+ E+ P G+L + Y+ Y E L + E
Sbjct: 70 IVKVF----EILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLF 125
Query: 180 ---VAEALAYLHSSAYLPIYHRDIKSTNILLD-EKYRAKIADFGTSRSIAIDQTH----- 230
+ L Y+HS+ + HRD+K N+ ++ E KI DFG +R + +H
Sbjct: 126 MYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 231 --VSTKVQGTFGYLDPE-YFRSSQFTDKSDVYSFGVVLVELLTGQKPI 275
+ TK Y P + +T D+++ G + E+LTG K +
Sbjct: 183 EGLVTK-----WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KTL 224
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 2e-13
Identities = 58/330 (17%), Positives = 117/330 (35%), Gaps = 87/330 (26%)
Query: 71 TDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKK-----SKVVDESKLEEFINEVVILSQ 124
D + + ++G G G V + + R++A+KK ++D ++ + E+ IL++
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRI---LREIAILNR 108
Query: 125 INHRNVVKLLGCCLEVEVPL---------LVYEFIPNGT-LFQYLHDPYEELS------L 168
+NH +VVK+L ++ +P +V E + + P L+ L
Sbjct: 109 LNHDHVVKVL----DIVIPKDVEKFDELYVVLEIA--DSDFKKLFRTP-VYLTELHIKTL 161
Query: 169 TWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228
+ + L + Y+HS+ I HRD+K N L+++ K+ DFG +R++ +
Sbjct: 162 LYNL-LV-------GVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210
Query: 229 THVSTKVQGTFGYLDP---------------EY------------FRSSQFTDKSDVYSF 261
S + +T+ DV+S
Sbjct: 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSI 270
Query: 262 GVVLVELLTGQKPISSIWANEGRNL---TTYFVECIEENCLFDIIDDQVRKSGEAEEIMA 318
G + ELL K + + + L ++ F ++ D + I
Sbjct: 271 GCIFAELLNMIKE-NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFN 329
Query: 319 V-------------SDVAKRCLNSYGRNRP 335
+ + AKR + + +
Sbjct: 330 ILGTPSEEDIEALEKEDAKRYIRIFPKREG 359
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 47/228 (20%), Positives = 90/228 (39%), Gaps = 53/228 (23%)
Query: 78 RILGQGGQGTVYKGM-LADGRIIAVK--KSKVVDESKLEEFINEVVILSQIN-------- 126
R LG G TV+ + + +A+K + + E +E+ +L ++N
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKED 81
Query: 127 ---HRNVVKLLGC-----------CLEVEVPLLVYEFI-PNGTLFQYLHD-PYEELSLTW 170
+++KLL + V+E + N L + + + L +
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVM-------VFEVLGEN--LLALIKKYEHRGIPLIY 132
Query: 171 EMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA------KIADFGTSRSI 224
++ +I+ ++ L Y+H I H DIK N+L++ KIAD G +
Sbjct: 133 -VK-QISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW- 187
Query: 225 AIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQ 272
H + +Q Y PE + + +D++S ++ EL+TG
Sbjct: 188 --YDEHYTNSIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 60/251 (23%), Positives = 103/251 (41%), Gaps = 74/251 (29%)
Query: 71 TDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKK-----SKVVDESKLEEFINEVVILSQ 124
+ + + LG+G G V+K + G ++AVKK D + E++IL++
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRT---FREIMILTE 64
Query: 125 IN-HRNVVKLLGCCLEVEVPL------LVYEF--------IPNGTL----FQYLHDPYEE 165
++ H N+V LL V LV+++ I L QY+
Sbjct: 65 LSGHENIVNLL----NVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYV------ 114
Query: 166 LSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 225
+++ ++ + YLHS + HRD+K +NILL+ + K+ADFG SRS
Sbjct: 115 ---VYQL-IK-------VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFV 160
Query: 226 IDQTHVSTKVQGTFGYLDP---------EY------------FRSSQFTDKSDVYSFGVV 264
+ + + +Y S+++T D++S G +
Sbjct: 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCI 220
Query: 265 LVELLTGQKPI 275
L E+L G KPI
Sbjct: 221 LGEILCG-KPI 230
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 5e-11
Identities = 71/374 (18%), Positives = 117/374 (31%), Gaps = 114/374 (30%)
Query: 68 DKATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVK--KSKVVDESKLEEFINEVVILSQ 124
D +++ R LG G TV+ + + +A+K KS E E ++E+ +L
Sbjct: 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS---AEHYTETALDEIRLLKS 89
Query: 125 I--------NHRNVVKLLGCCLEVEVPL-----LVYEFIPNG-TLFQYLHDPYEELSLTW 170
+ N VV+LL ++ +V+E G L +++ L
Sbjct: 90 VRNSDPNDPNREMVVQLLDD-FKISGVNGTHICMVFE--VLGHHLLKWIIK-SNYQGLPL 145
Query: 171 EMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL----------------------- 207
+I +V + L YLH+ I H DIK NILL
Sbjct: 146 PCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAP 203
Query: 208 --------------------------DEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 241
EK + KIAD G + H + +Q T Y
Sbjct: 204 PPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC---WVHKHFTEDIQ-TRQY 259
Query: 242 LDPEYFRSSQFTDKSDVYSFGVVLVELLTGQK-------------------------PIS 276
E S + +D++S + EL TG +
Sbjct: 260 RSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVP 319
Query: 277 SIWANEGRNLTTYF--------VECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLN 328
G+ +F + ++ LF+++ ++ S EE +D L
Sbjct: 320 RKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQ--EEAAGFTDFLLPMLE 377
Query: 329 SYGRNRPTMKEVAM 342
R T E
Sbjct: 378 LIPEKRATAAECLR 391
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 60.3 bits (145), Expect = 2e-10
Identities = 32/204 (15%), Positives = 61/204 (29%), Gaps = 54/204 (26%)
Query: 70 ATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDE--------SKLEEFINEVVI 121
T+ +G+G G V++ + AD +A+K + EE + E++I
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 122 LSQI---------NHRNVVKLLGCCL----------------------EVEVPL------ 144
++ + L + P
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 145 --LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKS 202
+V EF G + + + I ++ +LA + L HRD+
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKL----SSLATAKSILHQLTASLAVAEA--SLRFEHRDLHW 190
Query: 203 TNILLDEKYRAKIADFGTSRSIAI 226
N+LL + K+ +S I
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTI 214
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 4e-10
Identities = 59/241 (24%), Positives = 86/241 (35%), Gaps = 71/241 (29%)
Query: 78 RILGQGGQGTVYKGM-LADGRIIAVK----KSKVVDESKLEEFINEVVILSQINHR---- 128
R +G G G V + + + AVK K +K+E IL +I +
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE-----ADILKKIQNDDINN 95
Query: 129 -NVVKLLGC-------CLEVEVPLL---VYEFI-PNGTLFQYLHDPYEELSLTWEMRLRI 176
N+VK G CL E L +YE I N + H +
Sbjct: 96 NNIVKYHGKFMYYDHMCLIFE--PLGPSLYEIITRNN--YNGFH-----IEDIK----LY 142
Query: 177 ATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA----------------------- 213
E+ +AL YL + + H D+K NILLD+ Y
Sbjct: 143 CIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199
Query: 214 --KIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTG 271
K+ DFG + + + + Y PE + + SD++SFG VL EL TG
Sbjct: 200 GIKLIDFGCA---TFKSDYHGSIINTRQ-YRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255
Query: 272 Q 272
Sbjct: 256 S 256
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 51/240 (21%), Positives = 83/240 (34%), Gaps = 65/240 (27%)
Query: 74 FNMNRILGQGGQGTVYKGM--LADGRIIAVK----KSKVVDESKLEEFINEVVILSQINH 127
+ + LG+G G V + + +A+K K + ++LE + +L +I
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE-----INVLKKIKE 75
Query: 128 R------NVVKLLGC-------CLEVEVPLL---VYEFIPNGTLFQYLHDPYEELSLTWE 171
+ V + C+ E LL +EF+ FQ L
Sbjct: 76 KDKENKFLCVLMSDWFNFHGHMCIAFE--LLGKNTFEFLKENN-FQPYP-----LPHVR- 126
Query: 172 MRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA------------------ 213
+A ++ AL +LH + H D+K NIL
Sbjct: 127 ---HMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180
Query: 214 -KIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQ 272
++ADFG++ D H +T V Y PE + DV+S G +L E G
Sbjct: 181 IRVADFGSA---TFDHEHHTTIVATRH-YRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 57/241 (23%), Positives = 92/241 (38%), Gaps = 67/241 (27%)
Query: 74 FNMNRILGQGGQGTVYKG--MLADGRIIAVK----KSKVVDESKLEEFINEVVILSQINH 127
+ + LG+G G V + A GR +AVK + + ++ E + +L +N
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE-----IQVLEHLNT 70
Query: 128 R------NVVKLLGC-------CLEVEVPLL---VYEFI-PNGTLFQYLHDPYEELSLTW 170
V++L C+ E LL Y+FI NG F L
Sbjct: 71 TDPNSTFRCVQMLEWFEHHGHICIVFE--LLGLSTYDFIKENG--FLPFR-----LDHIR 121
Query: 171 EMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL-DEKYRA---------------- 213
++A ++ +++ +LHS + H D+K NIL Y
Sbjct: 122 ----KMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP 174
Query: 214 --KIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTG 271
K+ DFG++ D H ST V Y PE + ++ DV+S G +L+E G
Sbjct: 175 DIKVVDFGSA---TYDDEHHSTLVSTRH-YRAPEVILALGWSQPCDVWSIGCILIEYYLG 230
Query: 272 Q 272
Sbjct: 231 F 231
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 55/219 (25%), Positives = 93/219 (42%), Gaps = 33/219 (15%)
Query: 74 FNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQIN-HRNVV 131
F + R +G G G +Y G + +A+K V ++K + + E I + +
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLLYESKIYRILQGGTGIP 66
Query: 132 KLLGCCLEVEVPLLVYEFI-PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSS 190
+ +E + +LV + + P+ L + +LSL + L +A ++ + ++HS
Sbjct: 67 NVRWFGVEGDYNVLVMDLLGPS--LEDLFNFCSRKLSL--KTVLMLADQMINRVEFVHSK 122
Query: 191 AYLPIYHRDIKSTNILLDEKYRAK---IADFGTSRSIAIDQTHV------STKVQGTFGY 241
++L HRDIK N L+ RA I DFG ++ TH + + GT Y
Sbjct: 123 SFL---HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
Query: 242 ------LDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
L E R + D+ S G VL+ L G P
Sbjct: 180 ASVNTHLGIEQSR------RDDLESLGYVLMYFLRGSLP 212
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 45/234 (19%), Positives = 76/234 (32%), Gaps = 54/234 (23%)
Query: 78 RILGQGGQGTVYKGM-LADGRIIAVKKSKV--------VDESKLEEFINEVVILSQINHR 128
+ +G GG G +Y A KV E K + + + + + R
Sbjct: 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIER 102
Query: 129 NVVKLLGCCLEVEVPLLVY--EFIPNGTLF------------QYLHDPYEELSLTWEMRL 174
+ LG +PL G + Q + L
Sbjct: 103 KQLDYLG------IPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKK--STVL 154
Query: 175 RIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKI--ADFGTSRSIAIDQTHVS 232
++ + + L Y+H + Y+ H DIK+ N+LL K ++ AD+G S + H
Sbjct: 155 QLGIRMLDVLEYIHENEYV---HGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQ 211
Query: 233 TK------VQGTFGY------LDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
+ GT + R +SDV G ++ L G+ P
Sbjct: 212 YQENPRKGHNGTIEFTSLDAHKGVALSR------RSDVEILGYCMLRWLCGKLP 259
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 44/235 (18%), Positives = 80/235 (34%), Gaps = 53/235 (22%)
Query: 78 RILGQGGQGTVYKGMLADGRIIAVKKSKVV-----------DESKLEEFINEVVILSQIN 126
+GQGG G +Y + + VV E K + + + +
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 127 HRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQY-----------LHDPYEELS--LTWEMR 173
+K LG VP + + Y L YE + + +
Sbjct: 101 RTRKLKYLG------VPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTV 154
Query: 174 LRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKI--ADFGTSRSIAIDQTHV 231
L+++ + + L Y+H Y+ H DIK++N+LL+ K ++ D+G + + H
Sbjct: 155 LQLSLRILDILEYIHEHEYV---HGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211
Query: 232 ------STKVQGTFGY------LDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
GT + R + D+ G +++ LTG P
Sbjct: 212 AYAADPKRCHDGTIEFTSIDAHNGVAPSR------RGDLEILGYCMIQWLTGHLP 260
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 8e-08
Identities = 40/222 (18%), Positives = 78/222 (35%), Gaps = 37/222 (16%)
Query: 74 FNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQI-NHRNVV 131
+ + R +G+G G +++G L + + +A+K S + +E + +
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGIP 69
Query: 132 KLLGCCLEVEVPLLVYEFI-PN-GTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS 189
+ E +LV + + P+ L + S+ + A ++ + +H
Sbjct: 70 NVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG---RKFSV--KTVAMAAKQMLARVQSIHE 124
Query: 190 SAYLPIYHRDIKSTNILLDEKYRAK-----IADFGTSRSIAIDQTHV------STKVQGT 238
+ + +RDIK N L+ + DFG + T + GT
Sbjct: 125 KSLV---YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 181
Query: 239 FGY------LDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
Y L E R + D+ + G V + L G P
Sbjct: 182 ARYMSINTHLGREQSR------RDDLEALGHVFMYFLRGSLP 217
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 8e-08
Identities = 52/219 (23%), Positives = 91/219 (41%), Gaps = 33/219 (15%)
Query: 74 FNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQINH-RNVV 131
+ + R +G G G +Y G +A G +A+K V ++K + E I + +
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIP 68
Query: 132 KLLGCCLEVEVPLLVYEFI-PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSS 190
+ C E + ++V E + P+ L + + SL + L +A ++ + Y+HS
Sbjct: 69 TIRWCGAEGDYNVMVMELLGPS--LEDLFNFCSRKFSL--KTVLLLADQMISRIEYIHSK 124
Query: 191 AYLPIYHRDIKSTNILLDEKYRAK---IADFGTSRSI--AIDQTHVSTK----VQGTFGY 241
++ HRD+K N L+ + I DFG ++ A H+ + + GT Y
Sbjct: 125 NFI---HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181
Query: 242 ------LDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
L E R + D+ S G VL+ G P
Sbjct: 182 ASINTHLGIEQSR------RDDLESLGYVLMYFNLGSLP 214
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 4e-07
Identities = 35/235 (14%), Positives = 80/235 (34%), Gaps = 53/235 (22%)
Query: 78 RILGQGGQGTVYKGM---------LADGRIIAVK----KSKVVDESKLEEFINEVVILSQ 124
+ QG +Y+ + ++K ++ +E + + + +++
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 125 INHRNVVKLLGCCLEVEVPLLVYEFIPNG-------TLF----QYLHDPYEELSLTWEMR 173
LL +P + + Q D + L+
Sbjct: 108 WKKLYSTPLLA------IPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSV 161
Query: 174 LRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKI--ADFGTSRSIAIDQTHV 231
L++A + +AL +LH + Y+ H ++ + NI +D + ++++ A +G + HV
Sbjct: 162 LQVACRLLDALEFLHENEYV---HGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHV 218
Query: 232 STKVQ------GTFGY------LDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
+ G + R +SD+ S G +++ L G P
Sbjct: 219 AYVEGSRSPHEGDLEFISMDLHKGCGPSR------RSDLQSLGYCMLKWLYGFLP 267
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 43/221 (19%), Positives = 80/221 (36%), Gaps = 35/221 (15%)
Query: 74 FNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQI-NHRNVV 131
F + + +G G G + G L +A+K + +S+ + E Q+ + +
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPM--KSRAPQLHLEYRFYKQLGSGDGIP 68
Query: 132 KLLGCCLEVEVPLLVYEFI-PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSS 190
++ + +V E + P+ L SL + L IA ++ + Y+HS
Sbjct: 69 QVYYFGPCGKYNAMVLELLGPS--LEDLFDLCDRTFSL--KTVLMIAIQLISRMEYVHSK 124
Query: 191 AYLPIYHRDIKSTNILLDEKYRAK-----IADFGTSRSIAIDQTHV------STKVQGTF 239
+ +RD+K N L+ I DF ++ +T + GT
Sbjct: 125 NLI---YRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTA 181
Query: 240 GY------LDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
Y L E R + D+ + G + + L G P
Sbjct: 182 RYMSINTHLGKEQSR------RDDLEALGHMFMYFLRGSLP 216
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 3e-06
Identities = 55/365 (15%), Positives = 110/365 (30%), Gaps = 103/365 (28%)
Query: 28 KRIKQKEKNFKKNGGLLLQQQLNSIGGS------IDRCR-----------IF--NSKELD 68
+++Q + +L+ + GS +D C IF N K +
Sbjct: 138 LKLRQALLELRPAKNVLID----GVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCN 193
Query: 69 KATDYFNM-NRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFI------NEVVI 121
M ++L Q +D +K +++L + N +++
Sbjct: 194 SPETVLEMLQKLLYQIDPNWT---SRSD-HSSNIKLRIHSIQAELRRLLKSKPYENCLLV 249
Query: 122 LSQINHRNVVKL--LGCCLEVEVPLL-------VYEFIPNGTLFQYLHDPYEELSLTWEM 172
L + + L C +L V +F+ T H + S+T
Sbjct: 250 LLNVQNAKAWNAFNLSC------KILLTTRFKQVTDFLSAAT---TTHISLDHHSMTLT- 299
Query: 173 RLRIATEVAEALA-YLHSSAY-LPIYHRDIKSTNILL----DEKYRAKIADFGTSRSIAI 226
EV L YL LP R++ +TN E R +A + + +
Sbjct: 300 ----PDEVKSLLLKYLDCRPQDLP---REVLTTNPRRLSIIAESIRDGLATWDNWKHVNC 352
Query: 227 DQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGV----VLVELLTGQKPISSIWANE 282
D+ ++T ++ + L+P +R F V + + +S IW
Sbjct: 353 DK--LTTIIESSLNVLEPAEYR-KMFDR------LSVFPPSAHIPTIL----LSLIWF-- 397
Query: 283 GRNLTTYFVECIEENC-------------LFDIIDDQVRKSGEAEEIMAVSDVAKRCLNS 329
++ V + I + + E A+ + ++
Sbjct: 398 --DVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALH---RSIVDH 452
Query: 330 YGRNR 334
Y +
Sbjct: 453 YNIPK 457
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 374 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.74 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.36 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.22 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.15 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.05 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.79 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.66 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.57 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.5 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.43 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.38 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.05 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.0 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.98 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.83 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.8 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.53 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.41 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.34 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.22 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.18 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.18 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.03 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.0 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.98 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.72 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.44 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 94.92 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 94.76 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.67 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.35 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 93.2 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 90.96 | |
| 2knc_B | 79 | Integrin beta-3; transmembrane signaling, protein | 87.7 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 87.4 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 85.97 | |
| 2klu_A | 70 | T-cell surface glycoprotein CD4; cell membrane, di | 82.21 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-60 Score=425.83 Aligned_cols=263 Identities=27% Similarity=0.412 Sum_probs=220.2
Q ss_pred cCCCcCceEeeeCeEEEEEEEec------CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLL 145 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 145 (374)
++|.+.+.||+|+||+||+|.+. ++..||||+++..+....+.|.+|+++|++++|||||+++++|.+.+..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56788899999999999999864 467899999988777778899999999999999999999999999999999
Q ss_pred EEEeecCCcccccccCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEE
Q 017262 146 VYEFIPNGTLFQYLHDP----------YEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKI 215 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl 215 (374)
|||||++|+|.++|... .....+++.+++.++.|++.||+|||+++ |+||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 99999999999999642 12457999999999999999999999998 999999999999999999999
Q ss_pred eecccccccccCCceee-ecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHH
Q 017262 216 ADFGTSRSIAIDQTHVS-TKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVEC 293 (374)
Q Consensus 216 ~Dfg~~~~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~ 293 (374)
+|||+|+.......... ....||+.|||||++.+..|+.++|||||||++|||+| |+.||...... +....
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~------~~~~~- 242 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN------EVIEC- 242 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHH-
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHH-
Confidence 99999987654333322 33568999999999999999999999999999999998 89999754322 22222
Q ss_pred HHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCC
Q 017262 294 IEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRD 353 (374)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~ 353 (374)
+..+. ....+...+..+.+|+.+||+.||++|||++++.+.|+++....+.
T Consensus 243 i~~~~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p~ 293 (299)
T 4asz_A 243 ITQGR---------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASPV 293 (299)
T ss_dssp HHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCC
T ss_pred HHcCC---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCCc
Confidence 22211 1223445567899999999999999999999999999999876654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-59 Score=425.85 Aligned_cols=262 Identities=27% Similarity=0.411 Sum_probs=213.4
Q ss_pred cCCCcCceEeeeCeEEEEEEEec------CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLL 145 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 145 (374)
++|.+.+.||+|+||+||+|.++ ++..||||+++..+....+.|.+|+++|++++|||||+++++|.+.+..++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56778899999999999999864 478899999988777778899999999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcE
Q 017262 146 VYEFIPNGTLFQYLHDPY------------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA 213 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~ 213 (374)
|||||++|+|.+++.... ....+++.+++.++.|++.||+|||+++ |+||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 999999999999987532 1346999999999999999999999998 9999999999999999999
Q ss_pred EEeecccccccccCCce-eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHH
Q 017262 214 KIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFV 291 (374)
Q Consensus 214 kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~ 291 (374)
||+|||+++........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||...... +.+.
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~------~~~~ 271 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT------EAID 271 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH------HHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH------HHHH
Confidence 99999999876543322 2345679999999999999999999999999999999999 89999754322 2222
Q ss_pred HHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCC
Q 017262 292 ECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSR 352 (374)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~ 352 (374)
.... + .+...+..+++.+.+|+.+||+.||++|||+.++++.|+.+.+..+
T Consensus 272 ~i~~-g---------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp 322 (329)
T 4aoj_A 272 CITQ-G---------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPP 322 (329)
T ss_dssp HHHH-T---------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC
T ss_pred HHHc-C---------CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCc
Confidence 2111 1 1223344556789999999999999999999999999999987543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-59 Score=417.53 Aligned_cols=257 Identities=24% Similarity=0.378 Sum_probs=212.4
Q ss_pred cCCCcCceEeeeCeEEEEEEEec------CCcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccce
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPL 144 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 144 (374)
+.+++.+.||+|+||+||+|.+. +++.||||+++... ....+.|.+|+.++++++|||||+++|+|.+.+..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34567789999999999999863 46789999986543 334578999999999999999999999999999999
Q ss_pred EEEEeecCCcccccccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCC
Q 017262 145 LVYEFIPNGTLFQYLHDPY-------------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY 211 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~ 211 (374)
+|||||++|+|.++|.... ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 9999999999999996421 1246899999999999999999999999 99999999999999999
Q ss_pred cEEEeecccccccccCCc-eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHH
Q 017262 212 RAKIADFGTSRSIAIDQT-HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTY 289 (374)
Q Consensus 212 ~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~ 289 (374)
.+||+|||+++....... .......||+.|||||++.+..++.++|||||||++|||+| |..||...... +.
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~------~~ 256 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------DV 256 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH------HH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH------HH
Confidence 999999999987654332 23345679999999999999999999999999999999998 89999754322 21
Q ss_pred HHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 017262 290 FVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347 (374)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~ 347 (374)
. ..+..+ .+...+..++..+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 257 ~-~~i~~~---------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 257 V-EMIRNR---------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp H-HHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred H-HHHHcC---------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 2 222221 12233445667899999999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-57 Score=406.30 Aligned_cols=264 Identities=28% Similarity=0.424 Sum_probs=210.1
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 148 (374)
.+++.+.+.||+|+||+||+|++++ .+|||.++.. +....+.|.+|+.++++++||||+++++++.+ +..++|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 4677889999999999999998754 5899987653 45556789999999999999999999998864 56899999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
||++|+|.+++.. ....+++.++..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 112 y~~gGsL~~~l~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 112 WCEGSSLYKHLHV--QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp CCSSCBHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred cCCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 9999999999975 3457999999999999999999999998 9999999999999999999999999998754322
Q ss_pred -ceeeecccccccccCcccccc---CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccc
Q 017262 229 -THVSTKVQGTFGYLDPEYFRS---SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIID 304 (374)
Q Consensus 229 -~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (374)
........||+.|||||++.+ ..|+.++|||||||++|||+||+.||...... ..+......+...
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~------~~~~~~~~~~~~~---- 256 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR------DQIIFMVGRGYAS---- 256 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHTTCCC----
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcCCCC----
Confidence 223345679999999999864 45899999999999999999999999743321 1122222221111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCC
Q 017262 305 DQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRD 353 (374)
Q Consensus 305 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~ 353 (374)
+ .....+..++..+.+|+.+||+.||++|||+.++++.|+.++...+.
T Consensus 257 p-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk 304 (307)
T 3omv_A 257 P-DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK 304 (307)
T ss_dssp C-CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred C-CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence 0 11122334567899999999999999999999999999999876653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-58 Score=418.89 Aligned_cols=251 Identities=23% Similarity=0.363 Sum_probs=205.6
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
-++|++.+.||+|+||+||+|... +|+.||+|++... .......+.+|+.+|++++||||+++++++.+.+..|+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 368999999999999999999964 6899999988643 4555678999999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
|||+||+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 103 Ey~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp ECCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred eCCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 999999999999642 3456799999999999999999999999 999999999999999999999999999876432
Q ss_pred CceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (374)
........||+.|||||++.+..|+.++|||||||++|||++|+.||... +..+.+....... ..
T Consensus 179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~------~~~~~~~~i~~~~-~~------- 243 (350)
T 4b9d_A 179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG------SMKNLVLKIISGS-FP------- 243 (350)
T ss_dssp -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS------SHHHHHHHHHHTC-CC-------
T ss_pred -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc------CHHHHHHHHHcCC-CC-------
Confidence 12234467999999999999999999999999999999999999999643 2333333322221 11
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..+...+..+.+||.+||+.||++|||++|+++
T Consensus 244 --~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 244 --PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 122344567899999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-58 Score=412.77 Aligned_cols=267 Identities=20% Similarity=0.247 Sum_probs=217.7
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
.+.|.+.+.||+|+||+||+|+++ +|+.||+|+++.... ..+|+.+++.++|||||++++++.+.+..|+||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 456888899999999999999965 589999999875322 24699999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCC-cEEEeecccccccccCC
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY-RAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~~ 228 (374)
|+||+|.+++. ..+.+++..+..++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||+|+......
T Consensus 132 ~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 99999999997 4567999999999999999999999999 99999999999999987 69999999998765432
Q ss_pred ce----eeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccc
Q 017262 229 TH----VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIID 304 (374)
Q Consensus 229 ~~----~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (374)
.. ......||+.|||||++.+..|+.++|||||||++|||++|+.||........ . ....... .
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~---~~i~~~~-~----- 273 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL---C---LKIASEP-P----- 273 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC---H---HHHHHSC-C-----
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---H---HHHHcCC-C-----
Confidence 21 12335699999999999999999999999999999999999999975443221 1 1111111 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCCCcchhhhcc
Q 017262 305 DQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDDENNIQKCY 362 (374)
Q Consensus 305 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~~~~~~~~~~ 362 (374)
.....++..++.+.+||.+||+.||++|||+.|+++.|.........-..+|-..+
T Consensus 274 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 274 --PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp --GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred --CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 01123344567889999999999999999999999999999888776666655443
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-57 Score=411.15 Aligned_cols=249 Identities=25% Similarity=0.369 Sum_probs=210.0
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEee
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFI 150 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 150 (374)
+.|++.+.||+|+||+||+|... +|+.||+|++........+.+.+|+.+|++++||||+++++++.+.+..|+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999975 68999999987655555567889999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 230 (374)
++|+|.+++. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+.... .
T Consensus 154 ~gg~L~~~l~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~ 225 (346)
T 4fih_A 154 EGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-P 225 (346)
T ss_dssp TTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-C
T ss_pred CCCcHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC-C
Confidence 9999999886 346999999999999999999999999 9999999999999999999999999998765432 2
Q ss_pred eeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCC
Q 017262 231 VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKS 310 (374)
Q Consensus 231 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (374)
......||+.|||||++.+..|+.++|||||||++|||++|+.||.... ....+....... . ....
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~------~~~~~~~i~~~~-~-------~~~~ 291 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP------PLKAMKMIRDNL-P-------PRLK 291 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHSS-C-------CCCS
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHHHHcCC-C-------CCCC
Confidence 3445679999999999999999999999999999999999999996432 222222221111 0 0111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 311 GEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 311 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.....++.+.+||.+||+.||++|||+.|+++
T Consensus 292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 22344568899999999999999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-57 Score=414.66 Aligned_cols=273 Identities=29% Similarity=0.413 Sum_probs=222.3
Q ss_pred ChHHHHHhhcCCCcCceEeeeCeEEEEEEEecC------CcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCC-Cceeeee
Q 017262 63 NSKELDKATDYFNMNRILGQGGQGTVYKGMLAD------GRIIAVKKSKVV-DESKLEEFINEVVILSQINH-RNVVKLL 134 (374)
Q Consensus 63 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h-~niv~~~ 134 (374)
...+.+...++|++.+.||+|+||+||+|.+.. ++.||+|.+... .....+.+.+|+.+|.+++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 344555667889999999999999999998643 357999988754 34456789999999999965 8999999
Q ss_pred eeeeec-ccceEEEEeecCCcccccccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEecc
Q 017262 135 GCCLEV-EVPLLVYEFIPNGTLFQYLHDPY-------------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDI 200 (374)
Q Consensus 135 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dl 200 (374)
++|.+. +..++|||||++|+|.++|.... ....+++..++.++.||+.||+|||+++ |+||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCcc
Confidence 999765 56899999999999999996421 1345899999999999999999999999 999999
Q ss_pred CCCceEECCCCcEEEeecccccccccCCc-eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcc
Q 017262 201 KSTNILLDEKYRAKIADFGTSRSIAIDQT-HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSI 278 (374)
Q Consensus 201 k~~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~ 278 (374)
||+|||+++++.+||+|||+|+....+.. .......||+.|||||++.+..|+.++|||||||++|||+| |+.||...
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987654433 33445679999999999999999999999999999999998 99999754
Q ss_pred ccccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCC
Q 017262 279 WANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRD 353 (374)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~ 353 (374)
...+ .+...+..+ .+...+...++.+.+|+.+||+.||++|||+.++++.|+++.+....
T Consensus 292 ~~~~------~~~~~i~~g---------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~~ 351 (353)
T 4ase_A 292 KIDE------EFCRRLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 351 (353)
T ss_dssp CCSH------HHHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC-
T ss_pred CHHH------HHHHHHHcC---------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhhC
Confidence 3221 122222222 22233444566899999999999999999999999999999876543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-57 Score=403.81 Aligned_cols=247 Identities=25% Similarity=0.357 Sum_probs=209.9
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
++|++.+.||+|+||+||+|+.. +|+.||+|.+... +....+.+.+|+++|++++||||+++++++.+.+..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 56999999999999999999964 6899999988642 2334567899999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
|||+||+|.+++. ..+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999997 4567999999999999999999999999 999999999999999999999999999876543
Q ss_pred C-ceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 228 Q-THVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 228 ~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
. ........||+.|||||++.+..|+.++|||||||++|+|++|+.||...+ ....+.......
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~------~~~~~~~i~~~~--------- 250 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN------EGLIFAKIIKLE--------- 250 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTC---------
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHcCC---------
Confidence 3 233456789999999999999999999999999999999999999996432 223232222211
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 017262 307 VRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVA 341 (374)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl 341 (374)
...+...++.+.+||.+||+.||++|||++|++
T Consensus 251 --~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 251 --YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp --CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred --CCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 112233456789999999999999999999874
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-56 Score=393.62 Aligned_cols=247 Identities=24% Similarity=0.402 Sum_probs=199.2
Q ss_pred CCcCceEeeeCeEEEEEEEec-CCcEEEEEEecc--CChhHHHHHHHHHHHHhhCCCCceeeeeeeeee----cccceEE
Q 017262 74 FNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV--VDESKLEEFINEVVILSQINHRNVVKLLGCCLE----VEVPLLV 146 (374)
Q Consensus 74 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv 146 (374)
|++.+.||+|+||+||+|.+. ++..||+|.+.. ......+.+.+|+.++++++|||||++++++.+ .+..|+|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 467778999999999999965 588999998754 345556789999999999999999999999875 3457999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECC-CCcEEEeecccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE-KYRAKIADFGTSRSIA 225 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~~~~~ 225 (374)
||||++|+|.+++. ....+++..+..++.||+.||+|||+++ ++|+||||||+|||++. ++.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999999997 4567999999999999999999999987 45999999999999984 7999999999997543
Q ss_pred cCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccc
Q 017262 226 IDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDD 305 (374)
Q Consensus 226 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (374)
. .......||+.|||||++.+ .|+.++|||||||++|||+||+.||.... ....... .+..+....
T Consensus 184 ~---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~-----~~~~~~~-~i~~~~~~~---- 249 (290)
T 3fpq_A 184 A---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-----NAAQIYR-RVTSGVKPA---- 249 (290)
T ss_dssp T---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-----SHHHHHH-HHTTTCCCG----
T ss_pred C---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----cHHHHHH-HHHcCCCCC----
Confidence 2 22345679999999999865 69999999999999999999999996422 2222221 111111111
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 306 QVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..+...++.+.+||.+||+.||++|||++++++
T Consensus 250 ----~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 250 ----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111122346889999999999999999999874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-56 Score=412.03 Aligned_cols=250 Identities=25% Similarity=0.365 Sum_probs=210.9
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
.++|++.+.||+|+||.||+|... +|+.||||++........+.+.+|+.+|+.++|||||++++++.+.+..|+||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 357999999999999999999975 5899999998776555566788999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
|+||+|.+++. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+|+.+....
T Consensus 230 ~~gG~L~~~i~----~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~- 301 (423)
T 4fie_A 230 LEGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV- 301 (423)
T ss_dssp CTTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-
T ss_pred CCCCcHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC-
Confidence 99999999985 346999999999999999999999999 9999999999999999999999999998765432
Q ss_pred eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccC
Q 017262 230 HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (374)
.......||+.|||||++.+..|+.++|||||||++|||++|+.||.... ....+....... .. ..
T Consensus 302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~------~~~~~~~i~~~~-~~-------~~ 367 (423)
T 4fie_A 302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP------PLKAMKMIRDNL-PP-------RL 367 (423)
T ss_dssp CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHSC-CC-------CC
T ss_pred ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHHHHcCC-CC-------CC
Confidence 23445679999999999999999999999999999999999999996432 222222221111 10 11
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 310 SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 310 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
......+..+.+||.+||..||++|||+.|+++
T Consensus 368 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 368 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 122234568899999999999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-56 Score=390.04 Aligned_cols=245 Identities=24% Similarity=0.359 Sum_probs=192.6
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
++|++.+.||+|+||+||+|... +|+.||+|.+... .......+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999964 6899999988643 2334567899999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
||+ +|+|.+++. ....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIV---QRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHH---HSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 689999887 4567999999999999999999999999 999999999999999999999999999865432
Q ss_pred CceeeecccccccccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRSSQF-TDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
.......||+.|||||++.+..+ +.++|||||||++|+|++|+.||... +....+..... ...
T Consensus 166 --~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~------~~~~~~~~i~~-~~~------- 229 (275)
T 3hyh_A 166 --NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE------SIPVLFKNISN-GVY------- 229 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHH-TCC-------
T ss_pred --CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC------CHHHHHHHHHc-CCC-------
Confidence 23345679999999999998876 57999999999999999999999643 22222222221 111
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 307 VRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..+...++.+.+|+.+||+.||++|||++|+++
T Consensus 230 ---~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 ---TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 122234567889999999999999999999876
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-55 Score=392.86 Aligned_cols=270 Identities=23% Similarity=0.299 Sum_probs=202.4
Q ss_pred cCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc----cceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVE----VPLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~ 147 (374)
++|.+.+.||+|+||+||+|++ +|+.||||++...... ......|+..+.+++||||+++++++.+++ ..++||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4577889999999999999998 5889999998653222 122234566667889999999999998764 468999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCEEEeccCCCceEECCCCcEEEeeccccc
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSA-----YLPIYHRDIKSTNILLDEKYRAKIADFGTSR 222 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~-----~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 222 (374)
|||++|+|.+++. ...+++..+..++.|++.||+|||++. .++|+||||||+|||++.++.+||+|||+++
T Consensus 81 Ey~~~gsL~~~l~----~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 9999999999996 346899999999999999999999871 2349999999999999999999999999998
Q ss_pred ccccCCcee---eecccccccccCccccccC------CCCccchhhhHHHHHHHHHhCCCCCCccccccC--------CC
Q 017262 223 SIAIDQTHV---STKVQGTFGYLDPEYFRSS------QFTDKSDVYSFGVVLVELLTGQKPISSIWANEG--------RN 285 (374)
Q Consensus 223 ~~~~~~~~~---~~~~~g~~~y~aPE~~~~~------~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~--------~~ 285 (374)
......... .....||+.|||||++.+. .++.++|||||||++|||+||..||........ ..
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 765433222 2345799999999998754 367899999999999999999887754332211 01
Q ss_pred hHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 017262 286 LTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350 (374)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~ 350 (374)
.................+.. ...+.+.+..+.+|+.+||+.||++|||+.++++.|+++.++
T Consensus 237 ~~~~~~~~~~~~~~rp~~p~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 237 SVEEMRKVVCEQKLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCG---GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hHHHHHHHHhcccCCCCCCc---cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 11111111111111111110 112335677899999999999999999999999999998764
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-56 Score=394.80 Aligned_cols=242 Identities=28% Similarity=0.316 Sum_probs=195.6
Q ss_pred cCCCcCceEeeeCeEEEEEEEec----CCcEEEEEEeccCC--hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA----DGRIIAVKKSKVVD--ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLL 145 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 145 (374)
++|++.+.||+|+||+||+|+.. .++.||+|.+.... ......+.+|+.+|++++||||+++++++.+.+..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999852 46799999876431 2223467789999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccc
Q 017262 146 VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 225 (374)
|||||+||+|.+++. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999997 4567999999999999999999999999 9999999999999999999999999998654
Q ss_pred cCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccc
Q 017262 226 IDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDD 305 (374)
Q Consensus 226 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (374)
... .......||+.|||||++.+..|+.++|||||||++|||++|+.||...+ ..+.+.......
T Consensus 178 ~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~------~~~~~~~i~~~~-------- 242 (304)
T 3ubd_A 178 DHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD------RKETMTMILKAK-------- 242 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCC--------
T ss_pred CCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC------HHHHHHHHHcCC--------
Confidence 322 23345679999999999999999999999999999999999999997432 222222222211
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 017262 306 QVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTM 337 (374)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 337 (374)
...+...++.+.+||.+||+.||++|||+
T Consensus 243 ---~~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 243 ---LGMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred ---CCCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 12233455688999999999999999996
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=388.37 Aligned_cols=250 Identities=23% Similarity=0.355 Sum_probs=190.5
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc--------
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVE-------- 141 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------- 141 (374)
++|++.+.||+|+||+||+|+.+ +|+.||+|++.... ....+.+.+|+.+|++++||||+++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 35889999999999999999964 68999999886543 344567899999999999999999999987654
Q ss_pred ----cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEee
Q 017262 142 ----VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIAD 217 (374)
Q Consensus 142 ----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~D 217 (374)
..|+|||||++|+|.+++.........++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999986443445667788999999999999999999 99999999999999999999999
Q ss_pred cccccccccCCce-----------eeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCCh
Q 017262 218 FGTSRSIAIDQTH-----------VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNL 286 (374)
Q Consensus 218 fg~~~~~~~~~~~-----------~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~ 286 (374)
||+|+........ ..+...||+.|||||++.+..|+.++|||||||++|||++ ||..... .
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~-----~ 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME-----R 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH-----H
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH-----H
Confidence 9999876533211 1233569999999999999999999999999999999996 7753211 0
Q ss_pred HHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 287 TTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.... ......... ......++.+.+||.+||+.||++|||+.++++
T Consensus 234 ~~~~-~~~~~~~~p---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 VRTL-TDVRNLKFP---------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHH-HHHHTTCCC---------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHH-HHHhcCCCC---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0001 111111111 011233456788999999999999999999876
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=368.78 Aligned_cols=286 Identities=39% Similarity=0.616 Sum_probs=249.8
Q ss_pred cChHHHHHhhcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc
Q 017262 62 FNSKELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVE 141 (374)
Q Consensus 62 ~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 141 (374)
++..++...+++|++.+.||+|+||.||+|...+++.||+|+...........+.+|+.+++.++||||+++++++.+.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 44556677889999999999999999999998889999999988776667788999999999999999999999999999
Q ss_pred cceEEEEeecCCcccccccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccc
Q 017262 142 VPLLVYEFIPNGTLFQYLHDPY-EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGT 220 (374)
Q Consensus 142 ~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 220 (374)
..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999999997532 2346899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCC-ceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccc
Q 017262 221 SRSIAIDQ-THVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCL 299 (374)
Q Consensus 221 ~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (374)
+....... ........||+.|+|||.+.+..++.++||||||+++|+|++|+.||......+......|.........+
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence 97654322 22233455899999999999899999999999999999999999999877666666677776666666667
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 017262 300 FDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350 (374)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~ 350 (374)
...+++......+...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 777777777778889999999999999999999999999999999998764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-51 Score=378.22 Aligned_cols=259 Identities=21% Similarity=0.285 Sum_probs=201.7
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeee------cc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLE------VE 141 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~ 141 (374)
.++|++.+.||+|+||+||+|... +|+.||||++... .......+.+|+.+|+.++||||+++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 467999999999999999999964 6899999998653 34455678899999999999999999998764 35
Q ss_pred cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccc
Q 017262 142 VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 221 (374)
Q Consensus 142 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 221 (374)
..|+|||||+ |+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 6799999995 67999887 4568999999999999999999999999 999999999999999999999999999
Q ss_pred cccccCC---ceeeecccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhc
Q 017262 222 RSIAIDQ---THVSTKVQGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEEN 297 (374)
Q Consensus 222 ~~~~~~~---~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 297 (374)
+.+.... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+.. +.+.......
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~------~~l~~I~~~~ 279 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV------HQLQLIMMVL 279 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH------HHHHHHHHHH
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH------HHHHHHHHhc
Confidence 8764322 2233456899999999998775 5689999999999999999999999754321 1111111100
Q ss_pred c-cc-cc------------cccc-ccCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 298 C-LF-DI------------IDDQ-VRKSGE-----AEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 298 ~-~~-~~------------~~~~-~~~~~~-----~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
. .. .. +... .....+ +..+..+.+||.+||..||++|||+.|+++
T Consensus 280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 280 GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp CCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 00 00 0000 000001 123457889999999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-51 Score=372.71 Aligned_cols=198 Identities=22% Similarity=0.371 Sum_probs=170.1
Q ss_pred HhhcCCCcCceEeeeCeEEEEEEEec----CCcEEEEEEeccCChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccc
Q 017262 69 KATDYFNMNRILGQGGQGTVYKGMLA----DGRIIAVKKSKVVDESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVP 143 (374)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 143 (374)
...++|++.+.||+|+||+||+|+.+ .++.||+|++.... ....+.+|+++|+.+ +||||+++++++.+.+..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 45678999999999999999999853 46789999876543 335678899999998 699999999999999999
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCC-CcEEEeeccccc
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK-YRAKIADFGTSR 222 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfg~~~ 222 (374)
|+||||+++|+|.+++. .+++.++..++.|++.||+|||++| |+||||||+|||++.+ +.+||+|||+|+
T Consensus 96 ~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 99999999999999884 4899999999999999999999999 9999999999999876 799999999997
Q ss_pred ccccCCc---------------------------eeeecccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCC
Q 017262 223 SIAIDQT---------------------------HVSTKVQGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLVELLTGQKP 274 (374)
Q Consensus 223 ~~~~~~~---------------------------~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p 274 (374)
....... .......||+.|+|||++.+. .|+.++||||+||++|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 5432211 112345699999999998765 589999999999999999999999
Q ss_pred CCc
Q 017262 275 ISS 277 (374)
Q Consensus 275 ~~~ 277 (374)
|..
T Consensus 247 f~~ 249 (361)
T 4f9c_A 247 FYK 249 (361)
T ss_dssp SSC
T ss_pred CCC
Confidence 964
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=392.80 Aligned_cols=252 Identities=22% Similarity=0.301 Sum_probs=211.1
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
.++|++.+.||+|+||.||+|..+ +|+.||+|.+........+.+.+|+.+|+.++||||+++++++.+.+..|+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 368999999999999999999965 6899999998877777778899999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCC--CcEEEeecccccccccC
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK--YRAKIADFGTSRSIAID 227 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~--~~~kl~Dfg~~~~~~~~ 227 (374)
|+||+|.+++.. ....+++.++..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++.+...
T Consensus 236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999999864 3457999999999999999999999999 9999999999999854 89999999999876543
Q ss_pred CceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (374)
. ......||+.|||||++.+..|+.++|||||||++|+|++|..||...... ..+..... ... ..
T Consensus 311 ~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~------~~~~~i~~-~~~------~~ 375 (573)
T 3uto_A 311 Q--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETLRNVKS-CDW------NM 375 (573)
T ss_dssp S--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHT-TCC------CC
T ss_pred C--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHHh-CCC------CC
Confidence 2 234457999999999999999999999999999999999999999753321 22221111 110 00
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
........+..+.+||.+||..||++|||+.|+++
T Consensus 376 ~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 376 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111234557889999999999999999999976
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=365.75 Aligned_cols=290 Identities=37% Similarity=0.599 Sum_probs=246.3
Q ss_pred cceecChHHHHHhhcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChh-HHHHHHHHHHHHhhCCCCceeeeeee
Q 017262 58 RCRIFNSKELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDES-KLEEFINEVVILSQINHRNVVKLLGC 136 (374)
Q Consensus 58 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~ 136 (374)
..+.++..++....++|++.+.||+|+||.||+|...+++.||+|++...... ....+.+|+.+++.++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 45678899999999999999999999999999999888999999988754322 22368899999999999999999999
Q ss_pred eeecccceEEEEeecCCcccccccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEE
Q 017262 137 CLEVEVPLLVYEFIPNGTLFQYLHDPY-EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKI 215 (374)
Q Consensus 137 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl 215 (374)
+.+.+..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+....+++||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 999999999999999999999997543 2345999999999999999999999991112999999999999999999999
Q ss_pred eecccccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcccc--ccCCChHHHHHHH
Q 017262 216 ADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWA--NEGRNLTTYFVEC 293 (374)
Q Consensus 216 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~ 293 (374)
+|||++...............||+.|+|||.+.+..++.++||||||+++|+|++|..||..... ........+....
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 99999987665555555566799999999999988899999999999999999999999964322 2233455555555
Q ss_pred HHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 017262 294 IEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347 (374)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~ 347 (374)
..........+.......+...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 556666677777777788899999999999999999999999999999999874
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-50 Score=387.25 Aligned_cols=249 Identities=21% Similarity=0.265 Sum_probs=201.0
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC------ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV------DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVP 143 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 143 (374)
-++|++.+.||+|+||+||+|+.. +|+.||+|++... ..........++.+++.++||||++++++|.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 367999999999999999999965 5899999988532 111122233446777788999999999999999999
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccc
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 223 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 223 (374)
|+|||||+||+|.++|. ..+.+++..+..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~---~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 99999999999999997 4567999999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccc
Q 017262 224 IAIDQTHVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDI 302 (374)
Q Consensus 224 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (374)
..... .....||+.|||||++.. ..|+.++|+|||||++|||++|..||....... .......... .
T Consensus 342 ~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~---~~~i~~~i~~-~----- 409 (689)
T 3v5w_A 342 FSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHEIDRMTLT-M----- 409 (689)
T ss_dssp CSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC---HHHHHHHHHH-C-----
T ss_pred cCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHhhcC-C-----
Confidence 64322 334579999999999964 579999999999999999999999997543222 1111111111 1
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 017262 303 IDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPT-----MKEVAM 342 (374)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~vl~ 342 (374)
....+...++.+.+||.+||+.||++|++ ++++++
T Consensus 410 -----~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 410 -----AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred -----CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 11223345567899999999999999998 577664
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-49 Score=354.24 Aligned_cols=263 Identities=25% Similarity=0.398 Sum_probs=217.8
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
.++|.+.+.||+|+||+||+|... ++..+|+|.+...+......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 357888999999999999999975 5889999998877778888999999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+++++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 89 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHH--CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 999999999974 2457999999999999999999999999 99999999999999999999999999986543222
Q ss_pred ee-------------eecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHh
Q 017262 230 HV-------------STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEE 296 (374)
Q Consensus 230 ~~-------------~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 296 (374)
.. .....||+.|+|||.+.+..++.++||||||+++|+|++|..||.............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~-------- 235 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-------- 235 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC--------
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh--------
Confidence 11 114569999999999999999999999999999999999999987544322111000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCC
Q 017262 297 NCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSR 352 (374)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~ 352 (374)
.........+...+..+.+++.+||+.||++|||+.++++.|+.++....
T Consensus 236 ------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 236 ------VRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp ------HHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ------hhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 00001111122334578899999999999999999999999999987654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-49 Score=354.66 Aligned_cols=270 Identities=30% Similarity=0.429 Sum_probs=209.5
Q ss_pred HHHhhcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccce
Q 017262 67 LDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPL 144 (374)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 144 (374)
+....++|++.+.||+|+||.||+|.. +++.+|+|.+... .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence 334467899999999999999999987 5788999987654 3455678899999999999999999999999999999
Q ss_pred EEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccc
Q 017262 145 LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 224 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 224 (374)
+||||+++++|.+++........+++..++.++.|++.||+|||+.+ .+++||||||+||+++.++.+||+|||++...
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 99999999999999975332334999999999999999999999987 45999999999999999999999999999754
Q ss_pred ccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccc
Q 017262 225 AIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIID 304 (374)
Q Consensus 225 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (374)
... ........||+.|+|||.+.+..++.++||||||+++|+|++|+.||...... .........
T Consensus 190 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~------~~~~~~~~~-------- 254 (309)
T 3p86_A 190 AST-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA------QVVAAVGFK-------- 254 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHHHHHS--------
T ss_pred ccc-ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhc--------
Confidence 322 22233456899999999999999999999999999999999999999754321 111111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCCC
Q 017262 305 DQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDD 354 (374)
Q Consensus 305 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~~ 354 (374)
......+...+..+.+|+.+||+.||++|||+.++++.|+.+..+...+
T Consensus 255 -~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 255 -CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp -CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred -CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 1112233345567899999999999999999999999999998765443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=354.45 Aligned_cols=263 Identities=25% Similarity=0.427 Sum_probs=214.8
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec----CCcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA----DGRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLL 145 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 145 (374)
.++|.+.+.||+|+||.||+|... .+..||+|.+... .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467899999999999999999974 3456999998764 45556789999999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccc
Q 017262 146 VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 225 (374)
||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 128 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999965 3457999999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCce--eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhcccccc
Q 017262 226 IDQTH--VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDI 302 (374)
Q Consensus 226 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (374)
..... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||....... .... ..
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~------~~~~-~~------- 268 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD------VISS-VE------- 268 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH------HHHH-HH-------
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH------HHHH-HH-------
Confidence 33222 2233346778999999998999999999999999999999 999996543221 1111 11
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCCC
Q 017262 303 IDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDD 354 (374)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~~ 354 (374)
.......+...+..+.+|+.+||..||++|||+.++++.|+.+..+..+.
T Consensus 269 --~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~ 318 (325)
T 3kul_A 269 --EGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESL 318 (325)
T ss_dssp --TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC--
T ss_pred --cCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccc
Confidence 11122233345568999999999999999999999999999998865543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=341.84 Aligned_cols=284 Identities=35% Similarity=0.579 Sum_probs=230.7
Q ss_pred cceecChHHHHHhhcCCCcC------ceEeeeCeEEEEEEEecCCcEEEEEEeccC----ChhHHHHHHHHHHHHhhCCC
Q 017262 58 RCRIFNSKELDKATDYFNMN------RILGQGGQGTVYKGMLADGRIIAVKKSKVV----DESKLEEFINEVVILSQINH 127 (374)
Q Consensus 58 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~v~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h 127 (374)
+...|+..++..++++|... +.||+|+||.||+|.. +++.+|+|++... .....+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 44668889999999988877 8999999999999987 5788999987642 23456788999999999999
Q ss_pred CceeeeeeeeeecccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEE
Q 017262 128 RNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL 207 (374)
Q Consensus 128 ~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill 207 (374)
|||+++++++.+.+..+++|||+++++|.+++........+++..++.++.|++.||.|||+.+ ++|+||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999999976544567999999999999999999999999 9999999999999
Q ss_pred CCCCcEEEeecccccccccCCc-eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCCh
Q 017262 208 DEKYRAKIADFGTSRSIAIDQT-HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNL 286 (374)
Q Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~ 286 (374)
+.++.+||+|||++........ .......|++.|+|||.+.+ .++.++||||||+++|+|++|..||....... ..
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~ 243 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--LL 243 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS--BT
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH--HH
Confidence 9999999999999976543222 22334568999999998865 57899999999999999999999997654322 12
Q ss_pred HHHHHHHHHhc-cccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 017262 287 TTYFVECIEEN-CLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRA 349 (374)
Q Consensus 287 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~ 349 (374)
..+........ .+...++.. ....+...+..+.+++.+||+.||++|||+.++++.|+++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 244 LDIKEEIEDEEKTIEDYIDKK-MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp THHHHHHHTTSCCHHHHSCSS-CSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHHhhhhhhhhhhhcccc-ccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 22222211111 122222222 234567788899999999999999999999999999999864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-49 Score=347.18 Aligned_cols=258 Identities=28% Similarity=0.440 Sum_probs=215.8
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEee
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFI 150 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 150 (374)
.++|++.+.||+|+||.||+|...+++.+|+|++...... .+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC-HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 4678899999999999999999988899999998764333 367889999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 230 (374)
++++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 88 ~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 88 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 99999999975 3456899999999999999999999999 999999999999999999999999999865443333
Q ss_pred eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccccccC
Q 017262 231 VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309 (374)
Q Consensus 231 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (374)
......+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... .......... ...
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~------~~~~~~~~~~----------~~~ 226 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVVEDISTG----------FRL 226 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTT----------CCC
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH------HHHHHHHhcC----------ccC
Confidence 3344557788999999999999999999999999999999 9999974332 1222111111 111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 017262 310 SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350 (374)
Q Consensus 310 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~ 350 (374)
..+...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 22233456789999999999999999999999999999764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=345.09 Aligned_cols=258 Identities=26% Similarity=0.412 Sum_probs=215.2
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEee
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFI 150 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 150 (374)
.++|++.+.||+|+||.||+|...++..+|+|.+..... ....+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 567899999999999999999998888999999876433 3367889999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 230 (374)
++++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 86 ~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCCcHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 99999999974 2346999999999999999999999999 999999999999999999999999999876554444
Q ss_pred eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccccccC
Q 017262 231 VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309 (374)
Q Consensus 231 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (374)
......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... .......... ..
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~----------~~ 224 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS------EVVLKVSQGH----------RL 224 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHHHTTC----------CC
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH------HHHHHHHcCC----------CC
Confidence 4444557788999999998889999999999999999999 99999643321 1111111111 11
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 017262 310 SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350 (374)
Q Consensus 310 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~ 350 (374)
..+...+..+.+++.+||+.||++|||+.++++.|+.++..
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 225 YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 12222345789999999999999999999999999988654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=359.02 Aligned_cols=263 Identities=28% Similarity=0.454 Sum_probs=216.0
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec--------CCcEEEEEEeccC-ChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeec
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA--------DGRIIAVKKSKVV-DESKLEEFINEVVILSQI-NHRNVVKLLGCCLEV 140 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 140 (374)
.++|.+.+.||+|+||.||+|... ++..||+|.+... .......+.+|+.+++.+ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467899999999999999999852 3457999998754 344567889999999999 899999999999999
Q ss_pred ccceEEEEeecCCcccccccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEE
Q 017262 141 EVPLLVYEFIPNGTLFQYLHDPY-------------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL 207 (374)
Q Consensus 141 ~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill 207 (374)
+..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 99999999999999999987432 1245899999999999999999999999 9999999999999
Q ss_pred CCCCcEEEeecccccccccCCce-eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCC
Q 017262 208 DEKYRAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRN 285 (374)
Q Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~ 285 (374)
+.++.+||+|||++......... ......+++.|+|||++.+..++.++||||||+++|||++ |..||......+
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--- 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence 99999999999999865433221 2233457889999999999999999999999999999999 999997543222
Q ss_pred hHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCC
Q 017262 286 LTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSR 352 (374)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~ 352 (374)
.. .... .......+...+..+.+++.+||+.||++|||+.++++.|+++.....
T Consensus 314 ---~~-~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 314 ---LF-KLLK---------EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp ---HH-HHHH---------TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ---HH-HHHh---------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 11 1111 111223334456689999999999999999999999999999987544
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=362.55 Aligned_cols=262 Identities=28% Similarity=0.439 Sum_probs=215.5
Q ss_pred HHhhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceE
Q 017262 68 DKATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLL 145 (374)
Q Consensus 68 ~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 145 (374)
....++|.+.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 344567889999999999999999976 6899999988754 33445678899999999999999999999999899999
Q ss_pred EEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccc
Q 017262 146 VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 225 (374)
||||+++|+|.+++.. ....+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++....
T Consensus 190 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp EEECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred EEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 9999999999999974 3446899999999999999999999999 9999999999999999999999999997644
Q ss_pred cCCceee-ecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccc
Q 017262 226 IDQTHVS-TKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDII 303 (374)
Q Consensus 226 ~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (374)
....... ....+++.|+|||.+.+..++.++||||||+++|||++ |..||....... .......
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~-------~~~~~~~------- 330 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-------TREFVEK------- 330 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH-------HHHHHHT-------
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHc-------
Confidence 3221111 12235778999999998899999999999999999998 999997543221 1111211
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 017262 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350 (374)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~ 350 (374)
..+...+...+..+.+|+.+||+.||++|||+.++++.|+.++..
T Consensus 331 --~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 331 --GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp --TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 112223334556889999999999999999999999999999764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=353.67 Aligned_cols=272 Identities=28% Similarity=0.449 Sum_probs=213.0
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe-----cCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeec--ccc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML-----ADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEV--EVP 143 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 143 (374)
.++|++.+.||+|+||.||+|.. .+++.||+|++........+.+.+|+.++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46789999999999999999984 35789999999887777778899999999999999999999998654 458
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccc
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 223 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 223 (374)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 9999999999999999752 345899999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCce--eeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcccccc-----CCChHHHHHHHHHh
Q 017262 224 IAIDQTH--VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANE-----GRNLTTYFVECIEE 296 (374)
Q Consensus 224 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~ 296 (374)
....... ......++..|+|||.+.+..++.++||||||+++|+|++|..||....... ..........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~---- 239 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF---- 239 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH----
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH----
Confidence 6433221 2233457788999999999999999999999999999999999986432210 0000000000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCC
Q 017262 297 NCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSR 352 (374)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~ 352 (374)
.....+........+...+..+.+|+.+||+.||++|||+.++++.|+.++.+.+
T Consensus 240 -~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~ 294 (295)
T 3ugc_A 240 -HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294 (295)
T ss_dssp -HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred -HHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence 0011111122223344556789999999999999999999999999999988654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=341.51 Aligned_cols=250 Identities=26% Similarity=0.406 Sum_probs=209.4
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
.++|++.+.||+|+||+||+|.. .+++.||+|.+..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46899999999999999999995 56899999998765555567789999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+++++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 999999999863 36899999999999999999999999 99999999999999999999999999876553332
Q ss_pred eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccC
Q 017262 230 HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (374)
......||+.|+|||.+.+..++.++||||||+++|+|++|..||..... ............ ...
T Consensus 172 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~~~~~~~--------~~~ 236 (297)
T 3fxz_A 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNGT--------PEL 236 (297)
T ss_dssp -CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHHCS--------CCC
T ss_pred -ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC--------CCC
Confidence 23445699999999999999999999999999999999999999964322 111111111111 011
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 310 SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 310 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..+...+..+.+|+.+||+.||++|||+.++++
T Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 123344567899999999999999999999986
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=346.87 Aligned_cols=267 Identities=27% Similarity=0.413 Sum_probs=211.8
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
.++|++.+.||+|+||.||+|... ++..+|+|.+... .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467999999999999999999964 6889999987542 344567889999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
|||+++++|.+++. ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~g~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 99999999999997 3457999999999999999999999999 99999999999999999999999999987654
Q ss_pred CCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
..........||+.|+|||.+.+..++.++||||||+++|+|++|+.||...... ......... ... .
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~-~~~-----~ 231 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKHIQD-SVP-----N 231 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHHHSS-CCC-----C
T ss_pred ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhhc-cCC-----C
Confidence 4333344566999999999999999999999999999999999999999753321 111111111 111 0
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHHHhhCCCCc
Q 017262 307 VRKSGEAEEIMAVSDVAKRCLNSYGRNRP-TMKEVAMELERIRANSRDDE 355 (374)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-s~~~vl~~L~~~~~~~~~~~ 355 (374)
.........+..+.+++.+||+.||++|| +++++.+.|+.+........
T Consensus 232 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~ 281 (294)
T 4eqm_A 232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANE 281 (294)
T ss_dssp HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTC
T ss_pred cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCc
Confidence 11112223456789999999999999998 99999999998876554433
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-48 Score=356.80 Aligned_cols=260 Identities=25% Similarity=0.449 Sum_probs=204.4
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec----CCcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA----DGRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLL 145 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 145 (374)
.++|.+.+.||+|+||.||+|... ++..||+|.++.. .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 468999999999999999999864 4678999998764 34556789999999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccc
Q 017262 146 VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 225 (374)
||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++....
T Consensus 124 v~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999975 3457999999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCceee--ecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhcccccc
Q 017262 226 IDQTHVS--TKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDI 302 (374)
Q Consensus 226 ~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (374)
....... ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ... ...
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~------~~~-~~i-------- 263 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ------DVI-KAV-------- 263 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH------HHH-HHH--------
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH------HHH-HHH--------
Confidence 3322211 22235678999999999999999999999999999998 99999643321 111 111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhC
Q 017262 303 IDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANS 351 (374)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~ 351 (374)
........+...+..+.+++.+||+.||++|||+.++++.|+.+..+.
T Consensus 264 -~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 264 -DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp -HTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred -HcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 111222233345668999999999999999999999999999997653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=344.49 Aligned_cols=260 Identities=25% Similarity=0.405 Sum_probs=213.5
Q ss_pred HhhcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEE
Q 017262 69 KATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 148 (374)
...++|++.+.||+|+||.||++...++..+|+|.+...... ...+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 345678999999999999999999988889999998765333 3678899999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
|+++++|.+++... ...+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++.......
T Consensus 100 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 100 YMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp CCTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred ccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 99999999999752 456999999999999999999999999 9999999999999999999999999998654433
Q ss_pred ceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccccc
Q 017262 229 THVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (374)
........+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...... ..... ... ..
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~------~~~~~-~~~---------~~ 238 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------ETAEH-IAQ---------GL 238 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHH-HHT---------TC
T ss_pred cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh------HHHHH-Hhc---------cc
Confidence 333334457788999999998899999999999999999998 99999753322 11111 111 11
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 017262 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350 (374)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~ 350 (374)
....+...+..+.+++.+||+.+|++|||+.++++.|+.+...
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 239 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 1122223345788999999999999999999999999998764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=344.80 Aligned_cols=248 Identities=25% Similarity=0.379 Sum_probs=208.3
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
..++|++.+.||+|+||.||+|.. .+|+.||+|++... +......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 356899999999999999999997 57899999987643 455667888999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
|||+++++|.+++. ....+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 93 MEYASGGEVFDYLV---AHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp ECCCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EECCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 99999999999997 3457999999999999999999999999 99999999999999999999999999976543
Q ss_pred CCceeeecccccccccCccccccCCCC-ccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccc
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFRSSQFT-DKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDD 305 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (374)
. .......||+.|+|||.+.+..++ .++|||||||++|+|++|+.||.... .......... ...
T Consensus 167 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~i~~-~~~------ 231 (328)
T 3fe3_A 167 G--GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------LKELRERVLR-GKY------ 231 (328)
T ss_dssp S--CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHH-CCC------
T ss_pred C--CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHHh-CCC------
Confidence 2 223456799999999999888765 78999999999999999999996432 2222222211 111
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 306 QVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..+...+..+.+|+.+||+.||++|||++++++
T Consensus 232 ----~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 232 ----RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp ----CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred ----CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 122234557889999999999999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=369.88 Aligned_cols=267 Identities=24% Similarity=0.412 Sum_probs=218.9
Q ss_pred HHHHHhhcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccce
Q 017262 65 KELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPL 144 (374)
Q Consensus 65 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 144 (374)
...+...++|.+.+.||+|+||.||+|...++..||+|.++... ...+.+.+|+.++++++||||+++++++. .+..+
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence 33445567889999999999999999999888999999987643 34678999999999999999999999986 56789
Q ss_pred EEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccc
Q 017262 145 LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 224 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 224 (374)
+||||+++|+|.+++... ....+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++..
T Consensus 259 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp EEECCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred EEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 999999999999999743 2236889999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccc
Q 017262 225 AIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDII 303 (374)
Q Consensus 225 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (374)
............+++.|+|||.+....++.++||||||+++|||++ |+.||...... +.... +..
T Consensus 335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~------~~~~~-i~~------- 400 (454)
T 1qcf_A 335 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP------EVIRA-LER------- 400 (454)
T ss_dssp CCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHHH-HHH-------
T ss_pred CCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH------HHHHH-HHc-------
Confidence 4322222233446788999999998999999999999999999999 99999754322 11111 111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCC
Q 017262 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRD 353 (374)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~ 353 (374)
..+...+...+..+.+|+.+||+.||++|||++++++.|+.+.....+
T Consensus 401 --~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~ 448 (454)
T 1qcf_A 401 --GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATES 448 (454)
T ss_dssp --TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCC
T ss_pred --CCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcccc
Confidence 112223344566899999999999999999999999999998765543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=347.86 Aligned_cols=273 Identities=23% Similarity=0.320 Sum_probs=212.8
Q ss_pred HHHhhcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeeccc----
Q 017262 67 LDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEV---- 142 (374)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---- 142 (374)
+....++|++.+.||+|+||.||+|... ++.||+|++..... .......|+.++++++||||+++++++.+...
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cccchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 3344578999999999999999999876 78999999875433 33455668999999999999999999987543
Q ss_pred ceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc----------CCCCEEEeccCCCceEECCCCc
Q 017262 143 PLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSS----------AYLPIYHRDIKSTNILLDEKYR 212 (374)
Q Consensus 143 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~----------~~~~i~H~dlk~~Nill~~~~~ 212 (374)
.++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+. + ++||||||+|||++.++.
T Consensus 97 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~ 169 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLT 169 (322)
T ss_dssp EEEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCC
T ss_pred EEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCe
Confidence 6999999999999999963 4599999999999999999999998 7 999999999999999999
Q ss_pred EEEeecccccccccCCce-eeecccccccccCccccccC-----CCCccchhhhHHHHHHHHHhCCCCCCccccccCCCh
Q 017262 213 AKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFRSS-----QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNL 286 (374)
Q Consensus 213 ~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~ 286 (374)
+||+|||++......... ......||+.|+|||++.+. .++.++||||||+++|+|++|+.||...........
T Consensus 170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 249 (322)
T 3soc_A 170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249 (322)
T ss_dssp EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence 999999999776543322 22335689999999998863 456788999999999999999999986544322111
Q ss_pred HH---------HHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhC
Q 017262 287 TT---------YFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANS 351 (374)
Q Consensus 287 ~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~ 351 (374)
.. ..............+... ......+..+.+|+.+||+.||++|||+.++++.|+.++...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDY---WQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp HHHHCSSCCHHHHHHHHTTSCCCCCCCGG---GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred hhhhccCCchhhhhhhhhcccCCCCcccc---ccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 11 111111111111111110 112345677999999999999999999999999999998754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=346.52 Aligned_cols=268 Identities=26% Similarity=0.431 Sum_probs=218.8
Q ss_pred hHHHHHhhcCCCcCceEeeeCeEEEEEEEe------cCCcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeee
Q 017262 64 SKELDKATDYFNMNRILGQGGQGTVYKGML------ADGRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGC 136 (374)
Q Consensus 64 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~ 136 (374)
..+.....++|.+.+.||+|+||.||+|.. .++..+|+|.+... .......+.+|+.++++++||||++++++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 94 (314)
T 2ivs_A 15 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGA 94 (314)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence 334444567899999999999999999985 23578999988753 34556788999999999999999999999
Q ss_pred eeecccceEEEEeecCCcccccccCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCE
Q 017262 137 CLEVEVPLLVYEFIPNGTLFQYLHDPYE---------------------ELSLTWEMRLRIATEVAEALAYLHSSAYLPI 195 (374)
Q Consensus 137 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i 195 (374)
+.+.+..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+++ +
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i 171 (314)
T 2ivs_A 95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---L 171 (314)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---C
Confidence 9999999999999999999999874321 234899999999999999999999999 9
Q ss_pred EEeccCCCceEECCCCcEEEeecccccccccCCcee-eecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCC
Q 017262 196 YHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV-STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQK 273 (374)
Q Consensus 196 ~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~ 273 (374)
+|+||||+||+++.++.+||+|||++.......... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..
T Consensus 172 vH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 172 VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp ECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred cccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999998765433222 233457889999999998889999999999999999999 999
Q ss_pred CCCccccccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 017262 274 PISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350 (374)
Q Consensus 274 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~ 350 (374)
||....... ........ .....+...+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 252 p~~~~~~~~-------~~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 252 PYPGIPPER-------LFNLLKTG---------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp SSTTCCGGG-------HHHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCHHH-------HHHHhhcC---------CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 997543322 11111111 11223334556899999999999999999999999999998764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=340.71 Aligned_cols=265 Identities=26% Similarity=0.433 Sum_probs=215.8
Q ss_pred HHhhcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 68 DKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 68 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
....++|++.+.||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.++++++||||+++++++. .+..++||
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 86 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIIT 86 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEE
Confidence 344578899999999999999999988888999998875432 3467889999999999999999999986 45689999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
||+++++|.+++... ....+++..++.++.|++.||+|||+++ ++|+||||+||++++++.+||+|||++......
T Consensus 87 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 87 EYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp ECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred ecCCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 999999999999742 2236899999999999999999999999 999999999999999999999999999876544
Q ss_pred CceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
.........+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... .... .....
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~-~~~~~--------- 226 (279)
T 1qpc_A 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP------EVIQ-NLERG--------- 226 (279)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHH-HHHTT---------
T ss_pred ccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH------HHHH-HHhcc---------
Confidence 3333344457789999999998889999999999999999999 99999753321 1111 11111
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCCC
Q 017262 307 VRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDD 354 (374)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~~ 354 (374)
.....+...+..+.+++.+||+.||++|||+.++++.|+.+......+
T Consensus 227 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 274 (279)
T 1qpc_A 227 YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 274 (279)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC---
T ss_pred cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCC
Confidence 111222344568899999999999999999999999999998765543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-48 Score=354.99 Aligned_cols=272 Identities=29% Similarity=0.430 Sum_probs=219.4
Q ss_pred cChHHHHHhhcCCCcCceEeeeCeEEEEEEEe------cCCcEEEEEEeccC-ChhHHHHHHHHHHHHhhC-CCCceeee
Q 017262 62 FNSKELDKATDYFNMNRILGQGGQGTVYKGML------ADGRIIAVKKSKVV-DESKLEEFINEVVILSQI-NHRNVVKL 133 (374)
Q Consensus 62 ~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~ 133 (374)
+.........++|.+.+.||+|+||.||+|.+ .+++.||+|.+... .......+.+|+.+++++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 44566677788999999999999999999973 23578999998764 344557789999999999 79999999
Q ss_pred eeeeeecc-cceEEEEeecCCcccccccCCCC------------------------------------------------
Q 017262 134 LGCCLEVE-VPLLVYEFIPNGTLFQYLHDPYE------------------------------------------------ 164 (374)
Q Consensus 134 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------ 164 (374)
++++.+.+ ..++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99998765 48999999999999999975321
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC-
Q 017262 165 ---------------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ- 228 (374)
Q Consensus 165 ---------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~- 228 (374)
...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 112899999999999999999999999 9999999999999999999999999998654332
Q ss_pred ceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccccc
Q 017262 229 THVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (374)
........+|+.|+|||++.+..++.++||||||+++|+|++ |..||....... .+....... .
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~~~~~---------~ 313 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEG---------T 313 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHHHHT---------C
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH------HHHHHHHcC---------C
Confidence 233345568899999999999999999999999999999998 999997533211 111222211 1
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhC
Q 017262 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANS 351 (374)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~ 351 (374)
....+...+..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 314 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 314 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 11222334557899999999999999999999999999998754
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=340.73 Aligned_cols=260 Identities=27% Similarity=0.419 Sum_probs=201.9
Q ss_pred HhhcCCCcCceEeeeCeEEEEEEEecC----CcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccc
Q 017262 69 KATDYFNMNRILGQGGQGTVYKGMLAD----GRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVP 143 (374)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 143 (374)
...++|++.+.||+|+||.||+|.... +..+|+|..... .......+.+|+.++++++||||+++++++. ++..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 345689999999999999999998643 457999987653 3445677899999999999999999999984 5678
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccc
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 223 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 223 (374)
++||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 91 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccc
Confidence 999999999999999974 2446899999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhcccccc
Q 017262 224 IAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDI 302 (374)
Q Consensus 224 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (374)
.............+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+ .. ......
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~------~~-~~i~~~----- 233 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VI-GRIENG----- 233 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG------HH-HHHHTT-----
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH------HH-HHHHcC-----
Confidence 65433333344457789999999998999999999999999999997 999997543322 11 111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 017262 303 IDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350 (374)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~ 350 (374)
.....+...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 234 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 234 ----ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11122334556889999999999999999999999999998764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=338.64 Aligned_cols=258 Identities=28% Similarity=0.441 Sum_probs=214.4
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEee
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFI 150 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 150 (374)
.++|++.+.||+|+||.||+|...+++.+|+|.+...... .+.+.+|+.++++++||||+++++++.+.+..+++|||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 4578899999999999999999988889999998765433 367889999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 230 (374)
++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 86 ~~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 86 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp TTCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCcHHHHHhh--CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 99999999974 2456899999999999999999999999 999999999999999999999999999765432222
Q ss_pred eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccccccC
Q 017262 231 VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309 (374)
Q Consensus 231 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (374)
......+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... ...... .... ...
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~-i~~~---------~~~ 224 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVVED-ISTG---------FRL 224 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHH-HHTT---------CCC
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH------HHHHHH-HhcC---------CcC
Confidence 2333457788999999998899999999999999999999 8999974322 111111 1111 111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 017262 310 SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350 (374)
Q Consensus 310 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~ 350 (374)
..+...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 12223456789999999999999999999999999999763
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=352.96 Aligned_cols=271 Identities=28% Similarity=0.439 Sum_probs=220.3
Q ss_pred HHhhcCCCcCceEeeeCeEEEEEEEec--------CCcEEEEEEeccC-ChhHHHHHHHHHHHHhhC-CCCceeeeeeee
Q 017262 68 DKATDYFNMNRILGQGGQGTVYKGMLA--------DGRIIAVKKSKVV-DESKLEEFINEVVILSQI-NHRNVVKLLGCC 137 (374)
Q Consensus 68 ~~~~~~~~~~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~ 137 (374)
....++|.+.+.||+|+||.||+|... .+..+|+|++... .......+.+|+++++++ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 444678999999999999999999852 2357999988754 345567889999999999 899999999999
Q ss_pred eecccceEEEEeecCCcccccccCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCc
Q 017262 138 LEVEVPLLVYEFIPNGTLFQYLHDPYE-------------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTN 204 (374)
Q Consensus 138 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~N 204 (374)
.+.+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcce
Confidence 999999999999999999999874321 245899999999999999999999999 9999999999
Q ss_pred eEECCCCcEEEeecccccccccCCc-eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcccccc
Q 017262 205 ILLDEKYRAKIADFGTSRSIAIDQT-HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANE 282 (374)
Q Consensus 205 ill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~ 282 (374)
||++.++.+||+|||++........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~-- 299 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-- 299 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999999986653322 22333457889999999999999999999999999999999 9999974332
Q ss_pred CCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCCCcch
Q 017262 283 GRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDDENN 357 (374)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~~~~~ 357 (374)
.... ...... .....+...+..+.+|+.+||+.||++|||+.++++.|+++..........
T Consensus 300 ----~~~~-~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~ 360 (382)
T 3tt0_A 300 ----EELF-KLLKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMG 360 (382)
T ss_dssp ----HHHH-HHHHTT---------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC--
T ss_pred ----HHHH-HHHHcC---------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCC
Confidence 1222 112111 112223344567899999999999999999999999999999877655543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=340.57 Aligned_cols=261 Identities=26% Similarity=0.377 Sum_probs=214.0
Q ss_pred ecChHHHHHhhcC----------CCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCc
Q 017262 61 IFNSKELDKATDY----------FNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRN 129 (374)
Q Consensus 61 ~~~~~~~~~~~~~----------~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n 129 (374)
.++.+++..+++. |...+.||+|+||.||+|... +|+.||+|.+..........+.+|+.++++++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 4566666666543 677789999999999999976 68999999987766666778899999999999999
Q ss_pred eeeeeeeeeecccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECC
Q 017262 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE 209 (374)
Q Consensus 130 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~ 209 (374)
|+++++++...+..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTL 176 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence 99999999999999999999999999998863 46899999999999999999999999 999999999999999
Q ss_pred CCcEEEeecccccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHH
Q 017262 210 KYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTY 289 (374)
Q Consensus 210 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~ 289 (374)
++.+||+|||++........ ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... ...
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~------~~~ 249 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP------VQA 249 (321)
T ss_dssp TCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHH
T ss_pred CCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHH
Confidence 99999999999876543222 23445699999999999999999999999999999999999999964322 222
Q ss_pred HHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 290 FVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
...... ..... .......+..+.+++.+||+.||++|||+.++++.
T Consensus 250 ~~~~~~-~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 250 MKRLRD-SPPPK-------LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHH-SSCCC-------CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHhc-CCCCC-------cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 221111 11100 01122334578899999999999999999999873
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=336.65 Aligned_cols=254 Identities=29% Similarity=0.488 Sum_probs=199.0
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCCh----hHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDE----SKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
.++|++.+.||+|+||.||+|... ++.+|+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 467899999999999999999975 78899998765432 2246788999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECC--------CCcEEEeec
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE--------KYRAKIADF 218 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~--------~~~~kl~Df 218 (374)
|||+++++|.+++. ...+++..++.++.|++.||+|||+++..+++|+||||+||+++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999985 347899999999999999999999998556899999999999986 778999999
Q ss_pred ccccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcc
Q 017262 219 GTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENC 298 (374)
Q Consensus 219 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 298 (374)
|++....... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... ... ...
T Consensus 161 g~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~-~~~--- 227 (271)
T 3dtc_A 161 GLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA------VAY-GVA--- 227 (271)
T ss_dssp CC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH------HHH-HHH---
T ss_pred Cccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHH-hhh---
Confidence 9997654322 223468999999999999999999999999999999999999997533211 111 111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 017262 299 LFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347 (374)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~ 347 (374)
........+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus 228 -----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 228 -----MNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -----TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -----cCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 11112223334456899999999999999999999999999754
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=344.74 Aligned_cols=269 Identities=28% Similarity=0.433 Sum_probs=200.4
Q ss_pred HHHhhcCCCcCceEeeeCeEEEEEEEecCCc----EEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeec
Q 017262 67 LDKATDYFNMNRILGQGGQGTVYKGMLADGR----IIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEV 140 (374)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~----~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 140 (374)
.....++|++.+.||+|+||.||+|...... .||+|.+... .....+.+.+|+.++++++||||+++++++...
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 3344678999999999999999999965432 7999988654 345567899999999999999999999999877
Q ss_pred ccc------eEEEEeecCCcccccccCCC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCC
Q 017262 141 EVP------LLVYEFIPNGTLFQYLHDPY---EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY 211 (374)
Q Consensus 141 ~~~------~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~ 211 (374)
+.. ++++||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDM 174 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTS
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCC
Confidence 655 89999999999999986421 1226899999999999999999999999 99999999999999999
Q ss_pred cEEEeecccccccccCCce-eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHH
Q 017262 212 RAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTY 289 (374)
Q Consensus 212 ~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~ 289 (374)
.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+ .
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~------~ 248 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE------I 248 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG------H
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH------H
Confidence 9999999999765433322 2233457789999999999999999999999999999999 999997544322 1
Q ss_pred HHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCCC
Q 017262 290 FVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDD 354 (374)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~~ 354 (374)
...... ......+...+..+.+|+.+||+.||++|||+.++++.|+++.....-.
T Consensus 249 ~~~~~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~ 303 (323)
T 3qup_A 249 YNYLIG----------GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVL 303 (323)
T ss_dssp HHHHHT----------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----
T ss_pred HHHHhc----------CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhc
Confidence 111111 1112223345568999999999999999999999999999998755433
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=363.78 Aligned_cols=264 Identities=26% Similarity=0.404 Sum_probs=211.7
Q ss_pred HHhhcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 68 DKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 68 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
+...++|++.+.||+|+||.||+|.+.++..||+|.+..... ..+.+.+|+.++++++||||+++++++.+ +..++||
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 344567889999999999999999998888899999876432 34678999999999999999999999876 6789999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
||+++|+|.+++... ....+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++.....
T Consensus 258 e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp CCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred hhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 999999999999742 2346899999999999999999999999 999999999999999999999999999876543
Q ss_pred CceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
.........++..|+|||.+.+..++.++||||||+++|||++ |..||...... +... .... .
T Consensus 334 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~------~~~~-~i~~---------~ 397 (452)
T 1fmk_A 334 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLD-QVER---------G 397 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHH-HHHT---------T
T ss_pred ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH------HHHH-HHHc---------C
Confidence 3233334457789999999999999999999999999999999 99999754321 1111 1111 1
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCC
Q 017262 307 VRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRD 353 (374)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~ 353 (374)
.+...+...+..+.+|+.+||+.||++|||++++++.|+.+......
T Consensus 398 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 398 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 12223445567899999999999999999999999999998765543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=343.08 Aligned_cols=252 Identities=26% Similarity=0.397 Sum_probs=203.6
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCCh-hHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE-SKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 148 (374)
.++|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999975 688999998765432 234567899999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
|+++++|.+++. ....+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999997 4557999999999999999999999999 9999999999999999999999999997654332
Q ss_pred c-eeeecccccccccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 229 T-HVSTKVQGTFGYLDPEYFRSSQF-TDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 229 ~-~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
. .......||+.|+|||++.+..+ +.++||||||+++|+|++|..||....... ..+.......
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~~~~~~~--------- 225 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-----QEYSDWKEKK--------- 225 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS-----HHHHHHHTTC---------
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH-----HHHHHHhccc---------
Confidence 2 22345679999999999987765 778999999999999999999997543221 1111111111
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 307 VRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.........+..+.+|+.+||+.||++|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 226 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 011111233457889999999999999999999976
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-47 Score=357.67 Aligned_cols=254 Identities=29% Similarity=0.479 Sum_probs=210.6
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc-cceEEEE
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVE-VPLLVYE 148 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e 148 (374)
..++|++.+.||+|+||.||+|... ++.||+|.++... ..+.+.+|+.++++++||||+++++++...+ ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 3567889999999999999999985 6799999987643 4567899999999999999999999987665 7899999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
|+++|+|.+++... ....+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++.....
T Consensus 268 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 342 (450)
T ss_dssp CCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred ecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence 99999999999753 2334799999999999999999999999 999999999999999999999999999754321
Q ss_pred ceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccccc
Q 017262 229 THVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (374)
.....+++.|+|||.+.+..++.++||||||+++|||++ |..||......+ .. .... ...
T Consensus 343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~----~~i~---------~~~ 403 (450)
T 1k9a_A 343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV----PRVE---------KGY 403 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HH----HHHH---------TTC
T ss_pred ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHH---------cCC
Confidence 122357889999999999999999999999999999998 999997544322 11 1111 112
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 017262 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350 (374)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~ 350 (374)
+...+...+..+.+|+.+||+.||++|||+.++++.|+.++..
T Consensus 404 ~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 404 KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 2233445567899999999999999999999999999999764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=340.16 Aligned_cols=263 Identities=29% Similarity=0.461 Sum_probs=221.0
Q ss_pred HhhcCCCcCceEeeeCeEEEEEEEecC-CcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 69 KATDYFNMNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
...++|++.+.||+|+||.||+|.+.. +..+|+|.+... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 346779999999999999999999764 788999988754 345578899999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
||+++++|.+++... ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 89 e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 89 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp ECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 999999999999743 3456899999999999999999999999 999999999999999999999999999876655
Q ss_pred CceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
.........+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... .... +...
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~-------~~~~---------~~~~ 228 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYEL---------LEKD 228 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-------HHHH---------HHTT
T ss_pred ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHH---------Hhcc
Confidence 4444455567889999999999999999999999999999999 999997543222 1111 1111
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCC
Q 017262 307 VRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSR 352 (374)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~ 352 (374)
.....+...+..+.+|+.+||+.||++|||+.++++.|+.+.....
T Consensus 229 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~ 274 (288)
T 3kfa_A 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274 (288)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 2222334455689999999999999999999999999999987543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=366.82 Aligned_cols=260 Identities=28% Similarity=0.461 Sum_probs=217.2
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEecC-CcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEE
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 148 (374)
..++|++.+.||+|+||.||+|.+.. +..||+|.+..... ....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 45678889999999999999999765 78999999876433 45789999999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
|+++|+|.+++... ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 297 ~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 297 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred ccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 99999999999743 2456899999999999999999999999 9999999999999999999999999998765433
Q ss_pred ceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccccc
Q 017262 229 THVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (374)
........++..|+|||.+.+..++.++||||||+++|||++ |..||....... +... +....
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~-------~~~~---------~~~~~ 436 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYEL---------LEKDY 436 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-------HHHH---------HHTTC
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH-------HHHH---------HHcCC
Confidence 333334456789999999999999999999999999999999 999997544322 1111 11222
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 017262 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350 (374)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~ 350 (374)
+...+...+..+.+|+.+||+.||++|||+.++++.|+.+...
T Consensus 437 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 2233445567899999999999999999999999999988643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=346.53 Aligned_cols=252 Identities=25% Similarity=0.339 Sum_probs=206.1
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChh------HHHHHHHHHHHHhhCCCCceeeeeeeeeeccc
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDES------KLEEFINEVVILSQINHRNVVKLLGCCLEVEV 142 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 142 (374)
..++|++.+.||+|+||.||+|... +|+.+|+|.+...... ....+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3568999999999999999999975 5889999987654321 34678899999999999999999999999999
Q ss_pred ceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCC----cEEEeec
Q 017262 143 PLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY----RAKIADF 218 (374)
Q Consensus 143 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~----~~kl~Df 218 (374)
.++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 9999999999999999973 557999999999999999999999999 99999999999998877 7999999
Q ss_pred ccccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcc
Q 017262 219 GTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENC 298 (374)
Q Consensus 219 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 298 (374)
|++...... .......||+.|+|||++.+..++.++||||||+++|+|++|..||..... ...+.... ...
T Consensus 164 G~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~------~~~~~~i~-~~~ 234 (361)
T 2yab_A 164 GLAHEIEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANIT-AVS 234 (361)
T ss_dssp SSCEECCTT--CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHH-TTC
T ss_pred CCceEcCCC--CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHH-hcC
Confidence 999876432 223445699999999999998999999999999999999999999964322 11121111 110
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 299 LFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.. ..... ....+..+.+||.+||..||++|||+.++++
T Consensus 235 ~~--~~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 235 YD--FDEEF----FSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CC--CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CC--CCchh----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 00000 0123457889999999999999999999985
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=335.68 Aligned_cols=268 Identities=25% Similarity=0.401 Sum_probs=218.2
Q ss_pred hcCCCcCc-eEeeeCeEEEEEEEec---CCcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceE
Q 017262 71 TDYFNMNR-ILGQGGQGTVYKGMLA---DGRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLL 145 (374)
Q Consensus 71 ~~~~~~~~-~lg~G~~g~v~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 145 (374)
.++|.+.+ .||+|+||.||+|... ++..+|+|.+... .......+.+|+.++++++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 34566665 9999999999999853 5778999998764 345567889999999999999999999999 5567899
Q ss_pred EEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccc
Q 017262 146 VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 225 (374)
||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 87 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 9999999999999974 3456999999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCcee--eecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhcccccc
Q 017262 226 IDQTHV--STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDI 302 (374)
Q Consensus 226 ~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (374)
...... .....+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......+ ........
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~i~~~----- 229 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQG----- 229 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-------HHHHHHTT-----
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHhcC-----
Confidence 433322 223346889999999998889999999999999999998 999997543211 11111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCCCcchhhh
Q 017262 303 IDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDDENNIQK 360 (374)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~~~~~~~~ 360 (374)
.....+...+..+.+++.+||+.+|++|||+.++++.|+.+..+...+.+.-++
T Consensus 230 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~~~ 283 (287)
T 1u59_A 230 ----KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHH 283 (287)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSSCCC
T ss_pred ----CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccCCcc
Confidence 112233445668999999999999999999999999999998877766554443
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=335.61 Aligned_cols=270 Identities=24% Similarity=0.360 Sum_probs=215.4
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc--cceEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVE--VPLLV 146 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv 146 (374)
.++|.+.+.||+|+||+||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 467899999999999999999975 48899999887533 334567789999999999999999999998665 67899
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEE----CCCCcEEEeeccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL----DEKYRAKIADFGTSR 222 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill----~~~~~~kl~Dfg~~~ 222 (374)
|||+++++|.+++........+++..++.++.|++.||+|||+.+ ++||||||+||++ +.++.+||+|||++.
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999986544455999999999999999999999999 9999999999999 788889999999998
Q ss_pred ccccCCceeeecccccccccCccccc--------cCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHH
Q 017262 223 SIAIDQTHVSTKVQGTFGYLDPEYFR--------SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECI 294 (374)
Q Consensus 223 ~~~~~~~~~~~~~~g~~~y~aPE~~~--------~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 294 (374)
...... ......||+.|+|||++. +..++.++||||||+++|+|++|..||....... ..........
T Consensus 165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~ 240 (319)
T 4euu_A 165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR--RNKEVMYKII 240 (319)
T ss_dssp ECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGG--GCHHHHHHHH
T ss_pred ecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccc--hhHHHHHHHh
Confidence 765332 223456899999999986 5678999999999999999999999997543322 1222222222
Q ss_pred Hhccccc---c---------c--cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 017262 295 EENCLFD---I---------I--DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347 (374)
Q Consensus 295 ~~~~~~~---~---------~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~ 347 (374)
....... . . ............+..+.+++.+||+.||++|||++|+++...+-
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 2221100 0 0 01112234578888999999999999999999999999987754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=335.12 Aligned_cols=261 Identities=23% Similarity=0.361 Sum_probs=203.5
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhh--CCCCceeeeeeeeeec----ccce
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQ--INHRNVVKLLGCCLEV----EVPL 144 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~----~~~~ 144 (374)
.++|++.+.||+|+||+||+|.. +++.||+|++... ....+..|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 56899999999999999999988 6889999988643 33455667777766 7999999999987643 4578
Q ss_pred EEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCEEEeccCCCceEECCCCcEEEe
Q 017262 145 LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLH--------SSAYLPIYHRDIKSTNILLDEKYRAKIA 216 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH--------~~~~~~i~H~dlk~~Nill~~~~~~kl~ 216 (374)
+||||+++|+|.+++. ...+++..++.++.|++.||+||| +.+ ++||||||+|||++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 9999999999999995 347999999999999999999999 777 9999999999999999999999
Q ss_pred ecccccccccCCcee---eecccccccccCccccccC------CCCccchhhhHHHHHHHHHhC----------CCCCCc
Q 017262 217 DFGTSRSIAIDQTHV---STKVQGTFGYLDPEYFRSS------QFTDKSDVYSFGVVLVELLTG----------QKPISS 277 (374)
Q Consensus 217 Dfg~~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~------~~~~~~Di~slG~~l~el~~g----------~~p~~~ 277 (374)
|||++.......... .....||+.|+|||.+.+. .++.++||||||+++|||++| ..||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 999997655433322 2334699999999999876 455799999999999999999 788765
Q ss_pred cccccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 017262 278 IWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347 (374)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~ 347 (374)
...... .... .............. .....+...+..+.+|+.+||+.||++|||+.++++.|+++
T Consensus 236 ~~~~~~-~~~~-~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 236 VVPNDP-SFED-MRKVVCVDQQRPNI---PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TSCSSC-CHHH-HHHHHTTSCCCCCC---CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCc-chhh-hhHHHhccCCCCCC---ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 433221 1111 11111111111000 00112335678899999999999999999999999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=342.24 Aligned_cols=268 Identities=29% Similarity=0.453 Sum_probs=218.4
Q ss_pred HHHhhcCCCcCceEeeeCeEEEEEEEe------cCCcEEEEEEeccCC-hhHHHHHHHHHHHHhhC-CCCceeeeeeeee
Q 017262 67 LDKATDYFNMNRILGQGGQGTVYKGML------ADGRIIAVKKSKVVD-ESKLEEFINEVVILSQI-NHRNVVKLLGCCL 138 (374)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 138 (374)
.....++|.+.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++++ +||||+++++++.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 344467899999999999999999984 246789999887543 34567889999999999 8999999999999
Q ss_pred ecccceEEEEeecCCcccccccCCCC---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCC
Q 017262 139 EVEVPLLVYEFIPNGTLFQYLHDPYE---------------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKST 203 (374)
Q Consensus 139 ~~~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~ 203 (374)
+.+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+++ ++|+||||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~ 174 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR 174 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccc
Confidence 99999999999999999999874321 225899999999999999999999999 999999999
Q ss_pred ceEECCCCcEEEeecccccccccCCce-eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccc
Q 017262 204 NILLDEKYRAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWAN 281 (374)
Q Consensus 204 Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~ 281 (374)
||+++.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 999999999999999999876543332 2334457889999999999999999999999999999999 99999754321
Q ss_pred cCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCC
Q 017262 282 EGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSR 352 (374)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~ 352 (374)
. ......... .....+...+..+.+++.+||+.||++|||+.++++.|+++..+..
T Consensus 255 ~------~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 255 S------KFYKMIKEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp H------HHHHHHHHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred h------HHHHHhccC---------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 1 111111111 1122233445688999999999999999999999999999987654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=342.77 Aligned_cols=251 Identities=23% Similarity=0.323 Sum_probs=207.0
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
.++|.+.+.||+|+||.||+|... +++.+|+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 578999999999999999999975 57889999887543 4456788999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECC--CCcEEEeecccccccccC
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE--KYRAKIADFGTSRSIAID 227 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~--~~~~kl~Dfg~~~~~~~~ 227 (374)
+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+|||++. ++.+||+|||++......
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999999974 3346999999999999999999999999 999999999999987 789999999999876533
Q ss_pred CceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (374)
. ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... ........... .. .....
T Consensus 158 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~-~~--~~~~~ 226 (321)
T 1tki_A 158 D--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN------QQIIENIMNAE-YT--FDEEA 226 (321)
T ss_dssp C--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTC-CC--CCHHH
T ss_pred C--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHHcCC-CC--CChhh
Confidence 2 23445689999999999988899999999999999999999999964332 22222222111 10 00000
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
....+..+.+|+.+||..||++|||+.++++
T Consensus 227 ----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 227 ----FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----hccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0123457889999999999999999999987
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=347.82 Aligned_cols=267 Identities=25% Similarity=0.418 Sum_probs=215.5
Q ss_pred HHHhhcCCCcCceEeeeCeEEEEEEEecC------CcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeee
Q 017262 67 LDKATDYFNMNRILGQGGQGTVYKGMLAD------GRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLE 139 (374)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 139 (374)
+....++|++.+.||+|+||.||+|...+ ++.||+|.+... .......+.+|+.++++++||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 34456889999999999999999999743 478999998754 34456788999999999999999999999999
Q ss_pred cccceEEEEeecCCcccccccCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEe
Q 017262 140 VEVPLLVYEFIPNGTLFQYLHDPYE---------------------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHR 198 (374)
Q Consensus 140 ~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~ 198 (374)
.+..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+++ ++||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 9999999999999999999864211 257899999999999999999999999 9999
Q ss_pred ccCCCceEECCCCcEEEeecccccccccCCc-eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCC
Q 017262 199 DIKSTNILLDEKYRAKIADFGTSRSIAIDQT-HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPIS 276 (374)
Q Consensus 199 dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~ 276 (374)
||||+||+++.++.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999976543222 22234567899999999998899999999999999999999 999997
Q ss_pred ccccccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCC
Q 017262 277 SIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSR 352 (374)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~ 352 (374)
..... ... ........ ...+...+..+.+|+.+||+.||++|||+.++++.|+++.....
T Consensus 279 ~~~~~------~~~-~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 279 GMAHE------EVI-YYVRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp TSCHH------HHH-HHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CCChH------HHH-HHHhCCCc---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 43321 111 11222111 12233445688999999999999999999999999999876443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=344.96 Aligned_cols=258 Identities=25% Similarity=0.483 Sum_probs=204.9
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCc----EEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccce
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGR----IIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPL 144 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 144 (374)
.++|++.+.||+|+||+||+|.+. +++ ++++|.+... .......+.+|+.++++++||||+++++++.+. ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeE
Confidence 356889999999999999999964 344 3588876543 234457889999999999999999999999875 478
Q ss_pred EEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccc
Q 017262 145 LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 224 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 224 (374)
++++|+++|+|.+++.. ....+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHH--STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 99999999999999975 3457999999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCce-eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhcccccc
Q 017262 225 AIDQTH-VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDI 302 (374)
Q Consensus 225 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (374)
...... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||....... ......
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~~~------- 233 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILE------- 233 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHH-------
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH-------HHHHHH-------
Confidence 543322 2233456889999999999999999999999999999999 999997543322 111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 017262 303 IDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350 (374)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~ 350 (374)
.......+...+..+.+++.+||+.||++|||+.++++.|+.+..+
T Consensus 234 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 234 --KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp --TTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred --cCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 1122223344556899999999999999999999999999998753
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=346.47 Aligned_cols=268 Identities=27% Similarity=0.424 Sum_probs=213.1
Q ss_pred HHHhhcCCCcCceEeeeCeEEEEEEEe------cCCcEEEEEEeccC-ChhHHHHHHHHHHHHhhC-CCCceeeeeeeee
Q 017262 67 LDKATDYFNMNRILGQGGQGTVYKGML------ADGRIIAVKKSKVV-DESKLEEFINEVVILSQI-NHRNVVKLLGCCL 138 (374)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 138 (374)
.+...++|.+.+.||+|+||.||+|.. .++..||+|.+... .......+.+|+.+++++ +||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 344567899999999999999999996 23568999988753 233456788999999999 8999999999999
Q ss_pred ecccceEEEEeecCCcccccccCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEe
Q 017262 139 EVEVPLLVYEFIPNGTLFQYLHDPYE--------------------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHR 198 (374)
Q Consensus 139 ~~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~ 198 (374)
..+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+ ++||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence 99999999999999999999975321 134799999999999999999999999 9999
Q ss_pred ccCCCceEECCCCcEEEeecccccccccCCce-eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCC
Q 017262 199 DIKSTNILLDEKYRAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPIS 276 (374)
Q Consensus 199 dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~ 276 (374)
||||+||+++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 99999999999999999999999876543322 2334557889999999999999999999999999999998 999997
Q ss_pred ccccccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCC
Q 017262 277 SIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSR 352 (374)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~ 352 (374)
...... .+...... ......+...+..+.+|+.+||+.||++|||+.++++.|+.+.....
T Consensus 277 ~~~~~~------~~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 277 GIPVDA------NFYKLIQN---------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp TCCCSH------HHHHHHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred cCCcHH------HHHHHHhc---------CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 543211 11111111 11222233445689999999999999999999999999999876544
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=352.57 Aligned_cols=262 Identities=27% Similarity=0.400 Sum_probs=213.1
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec------CCcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVP 143 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 143 (374)
.++|.+.+.||+|+||.||+|... ++..||+|.+... .......+.+|+.++++++||||+++++++.+.+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467899999999999999999843 3668999998653 445556788999999999999999999999999999
Q ss_pred eEEEEeecCCcccccccCCC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCC---cEEEe
Q 017262 144 LLVYEFIPNGTLFQYLHDPY----EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY---RAKIA 216 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~---~~kl~ 216 (374)
++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999997432 2246899999999999999999999999 99999999999999555 59999
Q ss_pred ecccccccccCC-ceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHH
Q 017262 217 DFGTSRSIAIDQ-THVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECI 294 (374)
Q Consensus 217 Dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 294 (374)
|||+++...... ........+|+.|+|||.+.+..++.++|||||||++|||++ |..||...... .... ..
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~------~~~~-~i 299 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EVLE-FV 299 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHH-HH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHH-HH
Confidence 999997553222 122234557899999999999999999999999999999998 99999753321 1111 11
Q ss_pred HhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhC
Q 017262 295 EENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANS 351 (374)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~ 351 (374)
... .....+...+..+.+|+.+||+.||++|||+.++++.|+.+..+.
T Consensus 300 ~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 300 TSG---------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp HTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred HcC---------CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 111 112223344567899999999999999999999999999998754
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=332.89 Aligned_cols=267 Identities=15% Similarity=0.164 Sum_probs=214.4
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccceEEEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 148 (374)
.++|++.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+|+..++.+ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 56799999999999999999996 568999999876432 234577899999999 79999999999999999999999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCc-----EEEeecccccc
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR-----AKIADFGTSRS 223 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~-----~kl~Dfg~~~~ 223 (374)
|+ +++|.+++.. ....+++..++.++.|++.||+|||+++ ++||||||+||+++.++. +||+|||++..
T Consensus 87 ~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 9999999974 2446999999999999999999999999 999999999999987776 99999999987
Q ss_pred cccCCce------eeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhc
Q 017262 224 IAIDQTH------VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEEN 297 (374)
Q Consensus 224 ~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 297 (374)
....... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||..............+.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 6543221 2344569999999999999999999999999999999999999998644322111111111111111
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCCC
Q 017262 298 CLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDD 354 (374)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~~ 354 (374)
..... ....+..+.+++.+||+.||++|||++++++.|+++.......
T Consensus 241 ~~~~~---------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~ 288 (298)
T 1csn_A 241 PLREL---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 288 (298)
T ss_dssp CHHHH---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred cHHHH---------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence 11000 1123457899999999999999999999999999998876543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=359.35 Aligned_cols=262 Identities=23% Similarity=0.317 Sum_probs=211.0
Q ss_pred hHHHHHhhcCCCcCceEeeeCeEEEEEEEecC-CcEEEEEEeccCC---hhHHHHHHHHHHHHhhCCCCceeeeeeeeee
Q 017262 64 SKELDKATDYFNMNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVD---ESKLEEFINEVVILSQINHRNVVKLLGCCLE 139 (374)
Q Consensus 64 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 139 (374)
..++....++|++.+.||+|+||+||+|...+ ++.+|+|++.... ......+.+|..++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 34555667899999999999999999999764 7889999886421 1122347889999999999999999999999
Q ss_pred cccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecc
Q 017262 140 VEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 219 (374)
Q Consensus 140 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 219 (374)
.+..++||||+++|+|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence 9999999999999999999975 2457999999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCceeeecccccccccCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHH
Q 017262 220 TSRSIAIDQTHVSTKVQGTFGYLDPEYFR-----SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECI 294 (374)
Q Consensus 220 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 294 (374)
+++..............||+.|+|||++. ...++.++|||||||++|||++|+.||.... ..+.+....
T Consensus 221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~------~~~~~~~i~ 294 (437)
T 4aw2_A 221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIM 294 (437)
T ss_dssp TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHH
T ss_pred hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC------hhHHHHhhh
Confidence 99876655544455567999999999987 4568999999999999999999999997432 222222222
Q ss_pred HhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 017262 295 EENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRN--RPTMKEVAM 342 (374)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--Rps~~~vl~ 342 (374)
....... ........+..+.+||++||..+|++ ||+++++++
T Consensus 295 ~~~~~~~------~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 295 NHKERFQ------FPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp THHHHCC------CCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred hcccccc------CCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 1110000 00111224557889999999888888 999999886
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=337.41 Aligned_cols=263 Identities=21% Similarity=0.317 Sum_probs=202.8
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCC--hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVD--ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
..++|++.+.||+|+||+||+|...+++.+|+|++.... ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 357899999999999999999999889999999886532 233467889999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
||+++ +|.+++.. ....+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++......
T Consensus 99 e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 99 EFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp ECCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred cCCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 99975 77777764 3456999999999999999999999999 999999999999999999999999999865432
Q ss_pred CceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccc------
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLF------ 300 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 300 (374)
. .......+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||......+ ....+..........
T Consensus 173 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 173 V-RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD---QLPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp C-C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT---HHHHHHHHHCCCCTTTSGGGT
T ss_pred c-ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHHCCCChHHhhhhh
Confidence 2 22334568999999999876 568999999999999999999999997544322 111111111110000
Q ss_pred ----------ccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 301 ----------DIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 301 ----------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
............+..+..+.+|+.+||+.||++|||++++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000000000001123457889999999999999999999985
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=339.70 Aligned_cols=248 Identities=25% Similarity=0.297 Sum_probs=206.3
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
.++|++.+.||+|+||+||+|... +|+.+|+|.+... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 357899999999999999999975 5899999988643 223456788999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
|||+++|+|.+++. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999999987 3457899999999999999999999999 99999999999999999999999999975432
Q ss_pred CCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
. ........||+.|+|||++.+..++.++|+||||+++|||++|..||.... .......... ..
T Consensus 158 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~------~~~~~~~i~~-~~-------- 221 (337)
T 1o6l_A 158 D-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------HERLFELILM-EE-------- 221 (337)
T ss_dssp T-TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHH-CC--------
T ss_pred C-CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC------HHHHHHHHHc-CC--------
Confidence 2 222344579999999999999999999999999999999999999996432 1222222111 11
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 017262 307 VRKSGEAEEIMAVSDVAKRCLNSYGRNRP-----TMKEVAM 342 (374)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~vl~ 342 (374)
...+...+..+.+||.+||+.||++|| +++++++
T Consensus 222 --~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 222 --IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 112233456789999999999999999 8998876
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=333.22 Aligned_cols=255 Identities=24% Similarity=0.364 Sum_probs=208.5
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeec--ccceEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEV--EVPLLV 146 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv 146 (374)
.++|.+.+.||+|+||.||+|... ++.+|+|.+... .......+.+|+.++++++||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 457899999999999999999985 788999988754 345567899999999999999999999999877 678999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
|||+++|+|.+++... ....+++..++.++.|++.||+|||+.+ .+++|+||||+||+++.++.++++|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred ecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 9999999999999753 2336899999999999999999999987 4599999999999999999999999988754322
Q ss_pred CCceeeecccccccccCccccccCCCCc---cchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccc
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFRSSQFTD---KSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDII 303 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~---~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (374)
....+|+.|+|||.+.+..++. ++||||||+++|+|++|+.||...... ........
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~-------- 225 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM------EIGMKVAL-------- 225 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH------HHHHHHHH--------
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH------HHHHHHHh--------
Confidence 2235899999999998765544 799999999999999999999743321 11111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 017262 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRA 349 (374)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~ 349 (374)
.......+...+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 226 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 226 -EGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp -SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred -cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 111222333455689999999999999999999999999998853
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=335.14 Aligned_cols=259 Identities=29% Similarity=0.433 Sum_probs=208.2
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEecC----CcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccce
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLAD----GRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPL 144 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 144 (374)
..++|.+.+.||+|+||.||+|...+ +..+|+|.+... .......+.+|+.+++.++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 35678999999999999999998543 236999988754 44556788999999999999999999999864 4678
Q ss_pred EEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccc
Q 017262 145 LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 224 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 224 (374)
++|||+++++|.+++.. ....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++...
T Consensus 89 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 99999999999999974 3456899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccc
Q 017262 225 AIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDII 303 (374)
Q Consensus 225 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (374)
............+++.|+|||.+.+..++.++||||||+++|+|++ |+.||....... . . ......
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~---~-~~~~~~------ 230 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---V---I-GVLEKG------ 230 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---H---H-HHHHHT------
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---H---H-HHHhcC------
Confidence 5443333444557889999999998899999999999999999998 999997433322 1 1 111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 017262 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350 (374)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~ 350 (374)
.....+...+..+.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus 231 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 231 ---DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 11112223456789999999999999999999999999999764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=341.01 Aligned_cols=266 Identities=27% Similarity=0.443 Sum_probs=215.7
Q ss_pred HhhcCCCcCceEeeeCeEEEEEEEec--------CCcEEEEEEeccC-ChhHHHHHHHHHHHHhhC-CCCceeeeeeeee
Q 017262 69 KATDYFNMNRILGQGGQGTVYKGMLA--------DGRIIAVKKSKVV-DESKLEEFINEVVILSQI-NHRNVVKLLGCCL 138 (374)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 138 (374)
...++|.+.+.||+|+||.||+|... ++..||+|.+... .......+.+|+.+++++ +||||+++++++.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 34578999999999999999999863 4678999988754 344567889999999999 8999999999999
Q ss_pred ecccceEEEEeecCCcccccccCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCce
Q 017262 139 EVEVPLLVYEFIPNGTLFQYLHDPYE-------------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNI 205 (374)
Q Consensus 139 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Ni 205 (374)
+.+..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceE
Confidence 99999999999999999999975321 235899999999999999999999999 99999999999
Q ss_pred EECCCCcEEEeecccccccccCCcee-eecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccC
Q 017262 206 LLDEKYRAKIADFGTSRSIAIDQTHV-STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEG 283 (374)
Q Consensus 206 ll~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~ 283 (374)
+++.++.+||+|||++.......... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--- 265 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--- 265 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH---
Confidence 99999999999999998765433222 233457889999999998889999999999999999999 9999964322
Q ss_pred CChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCC
Q 017262 284 RNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRD 353 (374)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~ 353 (374)
...... .... .....+...+..+.+++.+||+.+|++|||+.++++.|+++......
T Consensus 266 ---~~~~~~-~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 266 ---EELFKL-LKEG---------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp ---HHHHHH-HHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred ---HHHHHH-HhcC---------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 222211 1111 11122334456789999999999999999999999999999876543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=334.98 Aligned_cols=249 Identities=23% Similarity=0.368 Sum_probs=197.3
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCCh--------------------------hHHHHHHHHHHHHh
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE--------------------------SKLEEFINEVVILS 123 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~ 123 (374)
.++|++.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 367999999999999999999964 588999998765321 12356889999999
Q ss_pred hCCCCceeeeeeeeee--cccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccC
Q 017262 124 QINHRNVVKLLGCCLE--VEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIK 201 (374)
Q Consensus 124 ~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk 201 (374)
+++||||+++++++.+ .+..++||||+++++|.+++. ...+++..+..++.|++.||+|||+++ ++|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999986 557899999999999998764 457999999999999999999999999 9999999
Q ss_pred CCceEECCCCcEEEeecccccccccCCceeeecccccccccCccccccCC---CCccchhhhHHHHHHHHHhCCCCCCcc
Q 017262 202 STNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQ---FTDKSDVYSFGVVLVELLTGQKPISSI 278 (374)
Q Consensus 202 ~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~Di~slG~~l~el~~g~~p~~~~ 278 (374)
|+||+++.++.+||+|||++........ ......||+.|+|||.+.+.. ++.++||||||+++|+|++|..||...
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 9999999999999999999987653322 234456999999999998655 377899999999999999999999643
Q ss_pred ccccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 279 WANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
. ........ ..... ........+..+.+|+.+||+.||++|||+.++++
T Consensus 244 ~------~~~~~~~~-~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 244 R------IMCLHSKI-KSQAL--------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp S------HHHHHHHH-HHCCC--------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred c------HHHHHHHH-hcccC--------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 2 11211111 11111 11111234457899999999999999999999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=342.06 Aligned_cols=252 Identities=22% Similarity=0.307 Sum_probs=209.0
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
.++|++.+.||+|+||.||+|... +++.+|+|.+..........+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 468999999999999999999975 5889999998876666667889999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECC--CCcEEEeecccccccccC
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE--KYRAKIADFGTSRSIAID 227 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~--~~~~kl~Dfg~~~~~~~~ 227 (374)
+++|+|.+++.. ....+++..++.++.|++.||+|||+.+ ++||||||+|||++. ++.+||+|||++......
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999999975 3446999999999999999999999999 999999999999974 578999999999876533
Q ss_pred CceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (374)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......... ... ..
T Consensus 205 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~i~~-~~~------~~ 269 (387)
T 1kob_A 205 EI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD------LETLQNVKR-CDW------EF 269 (387)
T ss_dssp SC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHH-CCC------CC
T ss_pred cc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH------HHHHHHHHh-CCC------CC
Confidence 22 2334699999999999999999999999999999999999999974322 111211111 111 01
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
........+..+.+||.+||+.||++|||+.++++
T Consensus 270 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 270 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 11122234567899999999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=332.69 Aligned_cols=263 Identities=29% Similarity=0.487 Sum_probs=208.7
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecC----CcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeee-ecccce
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLAD----GRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCL-EVEVPL 144 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~ 144 (374)
..+|++.+.||+|+||.||+|...+ ...+++|.+... .......+.+|+.++++++||||+++++++. ..+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 4568899999999999999998643 235888987653 4455678899999999999999999999865 455789
Q ss_pred EEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccc
Q 017262 145 LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 224 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 224 (374)
++|||+++++|.+++.. ....+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++...
T Consensus 104 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999975 3456899999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCc---eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhcccc
Q 017262 225 AIDQT---HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLF 300 (374)
Q Consensus 225 ~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (374)
..... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......+ ... .....
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~----~~~~~--- 248 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITV----YLLQG--- 248 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHH----HHHTT---
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHH----HHhcC---
Confidence 43322 12233457889999999999999999999999999999999 556665432211 111 11111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCCC
Q 017262 301 DIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDD 354 (374)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~~ 354 (374)
.....+...+..+.+++.+||+.||++|||+.++++.|+.+.......
T Consensus 249 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~ 296 (298)
T 3f66_A 249 ------RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296 (298)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCS
T ss_pred ------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 111122233457899999999999999999999999999998866543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=340.50 Aligned_cols=264 Identities=24% Similarity=0.437 Sum_probs=208.8
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecC-----CcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccce
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLAD-----GRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPL 144 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 144 (374)
.++|.+.+.||+|+||.||+|.... +..||+|.+... .......+.+|+.++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 4678888999999999999998643 236999988754 3445567899999999999999999999999999999
Q ss_pred EEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccc
Q 017262 145 LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 224 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 224 (374)
+||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++...
T Consensus 123 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999974 3457999999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCce--eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccc
Q 017262 225 AIDQTH--VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFD 301 (374)
Q Consensus 225 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (374)
...... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... .... .....
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------~~~~-~~~~~---- 266 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH------EVMK-AINDG---- 266 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHH-HHHTT----
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH------HHHH-HHHCC----
Confidence 433221 1222346788999999998899999999999999999999 99999643321 1111 11111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCCCc
Q 017262 302 IIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDDE 355 (374)
Q Consensus 302 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~~~ 355 (374)
.....+...+..+.+++.+||+.||++||++.++++.|+.+........
T Consensus 267 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~~ 315 (333)
T 1mqb_A 267 -----FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLK 315 (333)
T ss_dssp -----CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGG
T ss_pred -----CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhhh
Confidence 1112233455688999999999999999999999999999987554433
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=337.55 Aligned_cols=273 Identities=26% Similarity=0.393 Sum_probs=215.7
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe-----cCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeee--ecccc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML-----ADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCL--EVEVP 143 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~ 143 (374)
.++|++.+.||+|+||.||+|.. .++..||+|.+........+.+.+|+.++++++||||+++++++. +.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 35788999999999999999983 457899999998877777788999999999999999999999887 44568
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccc
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 223 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 223 (374)
++||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 102 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 899999999999999974 2346999999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCce--eeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcccccc--------CCChHHHHHHH
Q 017262 224 IAIDQTH--VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANE--------GRNLTTYFVEC 293 (374)
Q Consensus 224 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~--------~~~~~~~~~~~ 293 (374)
....... ......+++.|+|||.+.+..++.++||||||+++|+|++|..||....... .........
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 254 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL-- 254 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH--
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH--
Confidence 6533322 2233458888999999999889999999999999999999999986443211 000011111
Q ss_pred HHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCCCcch
Q 017262 294 IEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDDENN 357 (374)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~~~~~ 357 (374)
..+........+...+..+.+|+.+||+.||++|||+.++++.|+.+..........
T Consensus 255 -------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~ 311 (327)
T 3lxl_A 255 -------ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETH 311 (327)
T ss_dssp -------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----------
T ss_pred -------HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcccc
Confidence 111222223334455678999999999999999999999999999998776655543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=338.92 Aligned_cols=274 Identities=29% Similarity=0.432 Sum_probs=219.7
Q ss_pred cChHHHHHhhcCCCcCceEeeeCeEEEEEEEe------cCCcEEEEEEeccC-ChhHHHHHHHHHHHHhhC-CCCceeee
Q 017262 62 FNSKELDKATDYFNMNRILGQGGQGTVYKGML------ADGRIIAVKKSKVV-DESKLEEFINEVVILSQI-NHRNVVKL 133 (374)
Q Consensus 62 ~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~ 133 (374)
+...+.....++|++.+.||+|+||.||+|.. .+++.||+|.+... .......+.+|+.+++++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34555666678999999999999999999984 34678999988754 334556789999999999 79999999
Q ss_pred eeeeeecc-cceEEEEeecCCcccccccCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEec
Q 017262 134 LGCCLEVE-VPLLVYEFIPNGTLFQYLHDPYE-------------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRD 199 (374)
Q Consensus 134 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~d 199 (374)
++++...+ ..+++|||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+|
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 99988755 58999999999999999975322 123889999999999999999999999 99999
Q ss_pred cCCCceEECCCCcEEEeecccccccccCCc-eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCc
Q 017262 200 IKSTNILLDEKYRAKIADFGTSRSIAIDQT-HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISS 277 (374)
Q Consensus 200 lk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~ 277 (374)
|||+||+++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999986643332 23344567889999999999999999999999999999998 9999975
Q ss_pred cccccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCC
Q 017262 278 IWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRD 353 (374)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~ 353 (374)
..... . +........ ....+...+..+.+++.+||+.||++|||+.++++.|+.+.+....
T Consensus 254 ~~~~~-----~-~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 314 (316)
T 2xir_A 254 VKIDE-----E-FCRRLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 314 (316)
T ss_dssp CCCSH-----H-HHHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred cchhH-----H-HHHHhccCc---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcc
Confidence 33211 1 111122111 1112223455789999999999999999999999999999876553
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=343.80 Aligned_cols=267 Identities=25% Similarity=0.419 Sum_probs=215.8
Q ss_pred HHHHhhcCCCcCceEeeeCeEEEEEEEecC------CcEEEEEEeccC-ChhHHHHHHHHHHHHhhC-CCCceeeeeeee
Q 017262 66 ELDKATDYFNMNRILGQGGQGTVYKGMLAD------GRIIAVKKSKVV-DESKLEEFINEVVILSQI-NHRNVVKLLGCC 137 (374)
Q Consensus 66 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~ 137 (374)
+.+...++|.+.+.||+|+||.||+|.... ...+|+|.+... .......+.+|+.+++.+ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 345556889999999999999999999643 247999988754 344567789999999999 899999999999
Q ss_pred eecccceEEEEeecCCcccccccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceE
Q 017262 138 LEVEVPLLVYEFIPNGTLFQYLHDPY-----------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNIL 206 (374)
Q Consensus 138 ~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nil 206 (374)
.+.+..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||||+||+
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence 99999999999999999999986421 1346899999999999999999999999 999999999999
Q ss_pred ECCCCcEEEeecccccccccCCc-eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCC
Q 017262 207 LDEKYRAKIADFGTSRSIAIDQT-HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGR 284 (374)
Q Consensus 207 l~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~ 284 (374)
++.++.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-- 274 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-- 274 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--
Confidence 99999999999999986543332 22334457889999999999999999999999999999998 999997533211
Q ss_pred ChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 017262 285 NLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350 (374)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~ 350 (374)
.+....... .....+...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 275 ----~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 275 ----KFYKLVKDG---------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp ----HHHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHHHHHhcC---------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 111111111 11112223356789999999999999999999999999998763
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=341.38 Aligned_cols=247 Identities=23% Similarity=0.334 Sum_probs=203.8
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCC---hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVD---ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
.++|.+.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36799999999999999999996 568899999876421 12235688999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
|||+ +|+|.+++. ....+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIV---EKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 788888886 3457999999999999999999999999 99999999999999999999999999976543
Q ss_pred CCceeeecccccccccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccc
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFRSSQF-TDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDD 305 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (374)
.. ......||+.|+|||.+.+..+ +.++||||||+++|+|++|..||........ ...+..
T Consensus 161 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----------------~~~i~~ 222 (336)
T 3h4j_B 161 GN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----------------FKKVNS 222 (336)
T ss_dssp SB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----------------BCCCCS
T ss_pred Cc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----------------HHHHHc
Confidence 22 2344569999999999988776 7899999999999999999999975432221 111111
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 306 QVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
. ....+...+..+.+|+.+||+.||++|||++++++.
T Consensus 223 ~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 223 C-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp S-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred C-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 1 112233445678999999999999999999999873
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=351.06 Aligned_cols=253 Identities=21% Similarity=0.287 Sum_probs=205.6
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC--hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
..++|++.+.||+|+||.||+|... +|+.+|+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 3567999999999999999999864 68899999876543 34456788999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEEC---CCCcEEEeecccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD---EKYRAKIADFGTSRS 223 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfg~~~~ 223 (374)
|||+++|+|.+++. ....+++..+..++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 89 ~E~~~gg~L~~~i~---~~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIV---AREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 99999999999887 3567999999999999999999999999 99999999999998 567899999999976
Q ss_pred cccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccc
Q 017262 224 IAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDII 303 (374)
Q Consensus 224 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (374)
..... .......||+.|+|||++.+..++.++||||||+++|+|++|..||..... ........ ..... .
T Consensus 163 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~------~~~~~~i~-~~~~~-~- 232 (444)
T 3soa_A 163 VEGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ------HRLYQQIK-AGAYD-F- 232 (444)
T ss_dssp CCTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHH-HTCCC-C-
T ss_pred ecCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH------HHHHHHHH-hCCCC-C-
Confidence 55332 223445799999999999999999999999999999999999999964322 22222221 11110 0
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
........++.+.+|+.+||+.||++|||+.++++
T Consensus 233 ----~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 233 ----PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp ----CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00111234567889999999999999999999987
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=340.23 Aligned_cols=251 Identities=22% Similarity=0.345 Sum_probs=200.4
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc-------
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVE------- 141 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------- 141 (374)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 456899999999999999999976 78999999886533 345678899999999999999999999986543
Q ss_pred --------------------------------------------------cceEEEEeecCCcccccccCCCCCCCCCHH
Q 017262 142 --------------------------------------------------VPLLVYEFIPNGTLFQYLHDPYEELSLTWE 171 (374)
Q Consensus 142 --------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~ 171 (374)
..+++|||+++++|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 278999999999999999875555566778
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc-----------eeeeccccccc
Q 017262 172 MRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT-----------HVSTKVQGTFG 240 (374)
Q Consensus 172 ~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-----------~~~~~~~g~~~ 240 (374)
.++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999999 99999999999999999999999999987654321 12233569999
Q ss_pred ccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHH
Q 017262 241 YLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVS 320 (374)
Q Consensus 241 y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 320 (374)
|+|||.+.+..++.++||||||+++|+|++|..|+.... . .......... .......++.+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~--------~-~~~~~~~~~~---------~~~~~~~~~~~~ 303 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV--------R-IITDVRNLKF---------PLLFTQKYPQEH 303 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH--------H-HHHHHHTTCC---------CHHHHHHCHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH--------H-HHHHhhccCC---------CcccccCChhHH
Confidence 999999999999999999999999999999877642110 0 0000111100 111223446788
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 017262 321 DVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 321 ~li~~cl~~~p~~Rps~~~vl~ 342 (374)
+|+.+||+.||++|||+.++++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCCCCcCCCHHHHhh
Confidence 9999999999999999999985
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=337.62 Aligned_cols=251 Identities=27% Similarity=0.363 Sum_probs=205.2
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCCh------hHHHHHHHHHHHHhhCCCCceeeeeeeeeecccc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE------SKLEEFINEVVILSQINHRNVVKLLGCCLEVEVP 143 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 143 (374)
.++|.+.+.||+|+||.||+|... +++.+|+|.+..... .....+.+|+.++++++||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 456899999999999999999975 588999998765322 1356788999999999999999999999999999
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCC----cEEEeecc
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY----RAKIADFG 219 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~----~~kl~Dfg 219 (374)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 999999999999999973 457999999999999999999999999 99999999999999887 89999999
Q ss_pred cccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccc
Q 017262 220 TSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCL 299 (374)
Q Consensus 220 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (374)
++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... ........... .
T Consensus 164 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~~~~~~-~ 234 (326)
T 2y0a_A 164 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANVSAVN-Y 234 (326)
T ss_dssp TCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHHTC-C
T ss_pred CCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH------HHHHHHHHhcC-C
Confidence 998764322 22345699999999999989999999999999999999999999964322 11111111111 0
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 300 FDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
. ..... ....+..+.+|+.+||+.||++|||+.++++
T Consensus 235 ~--~~~~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 235 E--FEDEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp C--CCHHH----HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred C--cCccc----cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 00000 0122457889999999999999999999986
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=341.98 Aligned_cols=248 Identities=25% Similarity=0.355 Sum_probs=201.5
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccceE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVPLL 145 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 145 (374)
.++|++.+.||+|+||.||+|... +++.+|+|.+... .......+..|..+++.+ +||||+++++++.+.+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 578999999999999999999965 5889999988643 233456678899999988 79999999999999999999
Q ss_pred EEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccc
Q 017262 146 VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 225 (374)
||||+++|+|.+++. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 102 v~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQ---KSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 999999999999997 3467999999999999999999999999 9999999999999999999999999997533
Q ss_pred cCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccc
Q 017262 226 IDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDD 305 (374)
Q Consensus 226 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (374)
. .........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+.......
T Consensus 176 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~-------- 240 (353)
T 3txo_A 176 C-NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEAILNDE-------- 240 (353)
T ss_dssp C----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC--------
T ss_pred c-CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH------HHHHHHHHcCC--------
Confidence 2 22233445799999999999988999999999999999999999999974332 22222222211
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 017262 306 QVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTM------KEVAM 342 (374)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~------~~vl~ 342 (374)
...+...+..+.+|+.+||+.||++||++ +++++
T Consensus 241 ---~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 241 ---VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ---CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 11223345578899999999999999998 66654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=336.33 Aligned_cols=261 Identities=28% Similarity=0.464 Sum_probs=205.8
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEee
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFI 150 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 150 (374)
.++|++.+.||+|+||.||+|... ++.+|+|.+... ...+.+.+|+.++++++||||+++++++. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 356889999999999999999885 678999988643 44578899999999999999999999886 4589999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCCCEEEeccCCCceEECCCCc-EEEeeccccccccc
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS---SAYLPIYHRDIKSTNILLDEKYR-AKIADFGTSRSIAI 226 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~~~~i~H~dlk~~Nill~~~~~-~kl~Dfg~~~~~~~ 226 (374)
++++|.+++........+++..++.++.|++.||+|||+ ++ ++||||||+||+++.++. +||+|||++.....
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 999999999864333457899999999999999999999 56 999999999999998886 79999999875432
Q ss_pred CCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
. .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...... ....... .....
T Consensus 159 ~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~-~~~~~-------- 221 (307)
T 2eva_A 159 H----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP----AFRIMWA-VHNGT-------- 221 (307)
T ss_dssp ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS----HHHHHHH-HHTTC--------
T ss_pred c----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc----HHHHHHH-HhcCC--------
Confidence 1 22345899999999999999999999999999999999999999743221 1111111 11111
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCCCcch
Q 017262 307 VRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDDENN 357 (374)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~~~~~ 357 (374)
........+..+.+++.+||+.||++|||+.++++.|+.+....+.....
T Consensus 222 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~ 271 (307)
T 2eva_A 222 -RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271 (307)
T ss_dssp -CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSC
T ss_pred -CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCc
Confidence 11122234457889999999999999999999999999998877655443
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=343.14 Aligned_cols=253 Identities=22% Similarity=0.331 Sum_probs=206.7
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
..++|++.+.||+|+||.||+|... +++.+|+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3567999999999999999999965 5889999988653 345567889999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCC---CcEEEeecccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK---YRAKIADFGTSRS 223 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~---~~~kl~Dfg~~~~ 223 (374)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.+ +.+||+|||++..
T Consensus 107 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 999999999998873 457899999999999999999999999 9999999999999865 4599999999976
Q ss_pred cccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccc
Q 017262 224 IAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDII 303 (374)
Q Consensus 224 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (374)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ........ ..... .
T Consensus 181 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~------~~~~~~i~-~~~~~-~- 249 (362)
T 2bdw_A 181 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------HRLYAQIK-AGAYD-Y- 249 (362)
T ss_dssp CTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-HTCCC-C-
T ss_pred ecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHH-hCCCC-C-
Confidence 54322 23345699999999999998999999999999999999999999964322 12222111 11110 0
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
........+..+.+||.+||+.||++|||+.++++.
T Consensus 250 ----~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 ----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp ----CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ----CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000012334578899999999999999999999863
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=337.38 Aligned_cols=269 Identities=25% Similarity=0.459 Sum_probs=205.5
Q ss_pred HHHHhhcCCCcCceEeeeCeEEEEEEEec----CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeee
Q 017262 66 ELDKATDYFNMNRILGQGGQGTVYKGMLA----DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLE 139 (374)
Q Consensus 66 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 139 (374)
++....++|.+.+.||+|+||.||+|... .+..+|+|.+... .......+.+|+.++++++||||+++++++.+
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 34445678999999999999999999854 2458999987654 34556788999999999999999999999986
Q ss_pred cc-----cceEEEEeecCCcccccccCC---CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCC
Q 017262 140 VE-----VPLLVYEFIPNGTLFQYLHDP---YEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY 211 (374)
Q Consensus 140 ~~-----~~~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~ 211 (374)
.+ ..+++|||+++++|.+++... .....+++..++.++.|++.||.|||+++ ++||||||+||+++.++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDM 184 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTS
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCC
Confidence 55 348999999999999998421 13457999999999999999999999999 99999999999999999
Q ss_pred cEEEeecccccccccCCce-eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHH
Q 017262 212 RAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTY 289 (374)
Q Consensus 212 ~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~ 289 (374)
.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... .
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~ 258 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE------M 258 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG------H
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH------H
Confidence 9999999999765433222 2233457889999999999999999999999999999999 899997543322 1
Q ss_pred HHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCC
Q 017262 290 FVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRD 353 (374)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~ 353 (374)
...... . .....+...+..+.+++.+||+.||++|||+.++++.|+.+....++
T Consensus 259 ~~~~~~-~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp~ 312 (313)
T 3brb_A 259 YDYLLH-G---------HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD 312 (313)
T ss_dssp HHHHHT-T---------CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred HHHHHc-C---------CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 111111 1 11122334456799999999999999999999999999999887664
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=339.71 Aligned_cols=274 Identities=27% Similarity=0.396 Sum_probs=214.0
Q ss_pred CCCcCceEeeeCeEEEEEEEec-----CCcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeec--ccce
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-----DGRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEV--EVPL 144 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 144 (374)
+|++.+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++++++||||+++++++.+. ...+
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 3489999999999999988642 57899999987643 45567789999999999999999999999874 4678
Q ss_pred EEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccc
Q 017262 145 LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 224 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 224 (374)
+||||+++++|.+++.. ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++...
T Consensus 112 lv~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EEECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccc
Confidence 99999999999999963 35899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCce--eeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccc
Q 017262 225 AIDQTH--VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDI 302 (374)
Q Consensus 225 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (374)
...... ......+++.|+|||.+.+..++.++||||||+++|+|++|..||......... ...+.............
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE-LIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HHCSCCHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhh-hhcccccchhHHHHHHH
Confidence 543322 223455788899999999988999999999999999999999998643221000 00000000000011122
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCCC
Q 017262 303 IDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDD 354 (374)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~~ 354 (374)
+........+...+..+.+|+.+||+.||++|||+.++++.|+.+......+
T Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 2222233344455678999999999999999999999999999998765543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=336.74 Aligned_cols=264 Identities=15% Similarity=0.190 Sum_probs=212.6
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccceEEEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 148 (374)
.++|++.+.||+|+||.||+|.. .+++.||+|.+..... ...+.+|+.+++++ +||||+++++++.+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46799999999999999999996 5688999998765432 24578899999999 99999999999999999999999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCc-----EEEeecccccc
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR-----AKIADFGTSRS 223 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~-----~kl~Dfg~~~~ 223 (374)
|+ +++|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+|||++.++. +||+|||++..
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999998742 457999999999999999999999999 999999999999999887 99999999987
Q ss_pred cccCCcee------eecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhc
Q 017262 224 IAIDQTHV------STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEEN 297 (374)
Q Consensus 224 ~~~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 297 (374)
........ .....||+.|+|||.+.+..++.++||||||+++|+|++|..||...... .....+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~---~~~~~~~~i~~~~ 236 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD---TLKERYQKIGDTK 236 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS---SHHHHHHHHHHHH
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc---cHHHHHHHHHhhh
Confidence 65433221 23456999999999999999999999999999999999999999865322 2222222111110
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCC
Q 017262 298 CLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSR 352 (374)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~ 352 (374)
..... .... ...+ .+.+++.+||+.+|.+||++.++.+.|+.+.....
T Consensus 237 -~~~~~-~~~~----~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~ 284 (330)
T 2izr_A 237 -RATPI-EVLC----ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG 284 (330)
T ss_dssp -HHSCH-HHHT----TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred -ccCCH-HHHh----ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 00000 0000 0122 78999999999999999999999999999987653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=338.89 Aligned_cols=258 Identities=25% Similarity=0.488 Sum_probs=203.7
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCc----EEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccce
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGR----IIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPL 144 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 144 (374)
.++|++.+.||+|+||.||+|.+. +++ ++++|.+... .......+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 467999999999999999999964 344 3577766532 3445678899999999999999999999998654 78
Q ss_pred EEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccc
Q 017262 145 LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 224 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 224 (374)
++++++++|+|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++...
T Consensus 93 ~v~~~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 99999999999999975 3456999999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCce-eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhcccccc
Q 017262 225 AIDQTH-VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDI 302 (374)
Q Consensus 225 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (374)
...... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||....... ......
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------~~~~~~------- 233 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILE------- 233 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHH-------
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHH-------
Confidence 433222 2233456889999999999999999999999999999999 999997544322 111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 017262 303 IDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350 (374)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~ 350 (374)
.......+...+..+.+++.+||+.||++|||+.++++.|+.+..+
T Consensus 234 --~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 234 --KGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp --TTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred --cCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1112223334556789999999999999999999999999999753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=343.09 Aligned_cols=258 Identities=24% Similarity=0.441 Sum_probs=204.6
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCc----EEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccce
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGR----IIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPL 144 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 144 (374)
.++|++.+.||+|+||.||+|.+. +++ ++++|.+.... ......+.+|+.++++++||||+++++++. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 357889999999999999999964 344 37788765432 233346678999999999999999999886 45788
Q ss_pred EEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccc
Q 017262 145 LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 224 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 224 (374)
+|+||+++|+|.+++.. ....+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++...
T Consensus 91 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEECCTTCBSHHHHHS--SGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEeCCCCCHHHHHHH--ccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence 99999999999999975 2457899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCce-eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhcccccc
Q 017262 225 AIDQTH-VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDI 302 (374)
Q Consensus 225 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (374)
...... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... ........
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~----- 233 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-------VPDLLEKG----- 233 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH-------HHHHHHTT-----
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH-------HHHHHHcC-----
Confidence 543322 2344567889999999999999999999999999999999 999997543221 11111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 017262 303 IDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350 (374)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~ 350 (374)
.....+...+..+.+++.+||+.||++|||+.++++.|+.+..+
T Consensus 234 ----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 234 ----ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp ----CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred ----CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11112222344678999999999999999999999999998653
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=343.13 Aligned_cols=250 Identities=25% Similarity=0.380 Sum_probs=200.9
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccceE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVPLL 145 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 145 (374)
.++|++.+.||+|+||+||+|+.. +++.+|+|++... .......+..|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467999999999999999999975 5788999987643 233345677899999887 89999999999999999999
Q ss_pred EEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccc
Q 017262 146 VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 225 (374)
||||+++|+|..++. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 999999999999987 3457999999999999999999999999 9999999999999999999999999997533
Q ss_pred cCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcccccc--CCChHHHHHHHHHhccccccc
Q 017262 226 IDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANE--GRNLTTYFVECIEENCLFDII 303 (374)
Q Consensus 226 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 303 (374)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||....... .........+......
T Consensus 205 ~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----- 278 (396)
T 4dc2_A 205 RP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----- 278 (396)
T ss_dssp CT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC-----
T ss_pred cC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc-----
Confidence 22 223445679999999999999999999999999999999999999996433221 1111222222222211
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 017262 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTM 337 (374)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 337 (374)
...+...+..+.+||.+||+.||++||++
T Consensus 279 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 279 -----IRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -----cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 11233345678899999999999999996
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=333.36 Aligned_cols=262 Identities=28% Similarity=0.418 Sum_probs=211.3
Q ss_pred HHhhcCCCcCc-eEeeeCeEEEEEEEe---cCCcEEEEEEeccCC--hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc
Q 017262 68 DKATDYFNMNR-ILGQGGQGTVYKGML---ADGRIIAVKKSKVVD--ESKLEEFINEVVILSQINHRNVVKLLGCCLEVE 141 (374)
Q Consensus 68 ~~~~~~~~~~~-~lg~G~~g~v~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 141 (374)
....++|.+.+ .||+|+||.||+|.. ..++.+|+|.+.... ......+.+|+.+++.++||||+++++++ ..+
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 33456788887 999999999999964 246789999886542 33457789999999999999999999999 566
Q ss_pred cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccc
Q 017262 142 VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 221 (374)
Q Consensus 142 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 221 (374)
..++||||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CcEEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 78999999999999999973 456999999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCceee--ecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhcc
Q 017262 222 RSIAIDQTHVS--TKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENC 298 (374)
Q Consensus 222 ~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 298 (374)
........... ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... ........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~- 236 (291)
T 1xbb_A 165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKG- 236 (291)
T ss_dssp EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTT-
T ss_pred eeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcC-
Confidence 87654333222 22346788999999998889999999999999999999 999997543211 11122211
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCC
Q 017262 299 LFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSR 352 (374)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~ 352 (374)
.....+...+..+.+++.+||+.||++|||+.++++.|+.+..+..
T Consensus 237 --------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 237 --------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp --------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred --------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 1122333455689999999999999999999999999999977543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=329.36 Aligned_cols=262 Identities=27% Similarity=0.424 Sum_probs=209.8
Q ss_pred CCCcCceEeeeCeEEEEEEEecC-C---cEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccc-eEE
Q 017262 73 YFNMNRILGQGGQGTVYKGMLAD-G---RIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVP-LLV 146 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~lv 146 (374)
.|...+.||+|+||.||+|...+ + ..+|+|.+... .......+.+|+.+++.++||||+++++++.+.+.. +++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45667899999999999998533 2 37999988754 345567889999999999999999999999876655 999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
+||+.+++|.+++.. ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999975 3457899999999999999999999999 99999999999999999999999999976543
Q ss_pred CCc---eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCC-CccccccCCChHHHHHHHHHhcccccc
Q 017262 227 DQT---HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPI-SSIWANEGRNLTTYFVECIEENCLFDI 302 (374)
Q Consensus 227 ~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (374)
... .......+++.|+|||.+.+..++.++||||||+++|+|++|..|+ ....... ........
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~-------~~~~~~~~----- 244 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-------LTHFLAQG----- 244 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG-------HHHHHHTT-----
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH-------HHHHhhcC-----
Confidence 221 1223345788999999999999999999999999999999965554 3222111 11111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCCCc
Q 017262 303 IDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDDE 355 (374)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~~~ 355 (374)
.....+...+..+.+++.+||+.||++|||+.++++.|+++........
T Consensus 245 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~ 293 (298)
T 3pls_A 245 ----RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293 (298)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred ----CCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence 1122233345678999999999999999999999999999988776544
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=331.33 Aligned_cols=264 Identities=28% Similarity=0.429 Sum_probs=210.2
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe-----cCCcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeec--cc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML-----ADGRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEV--EV 142 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~ 142 (374)
.++|++.+.||+|+||.||+|.+ .+++.||+|.+... .......+.+|+.+++.++||||+++++++.+. +.
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 35688999999999999999983 45889999988743 233457788999999999999999999999876 56
Q ss_pred ceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccc
Q 017262 143 PLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 222 (374)
Q Consensus 143 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 222 (374)
.++||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.
T Consensus 100 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 7899999999999999954 3456999999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCc--eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccc--------cCCChHHHHHH
Q 017262 223 SIAIDQT--HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWAN--------EGRNLTTYFVE 292 (374)
Q Consensus 223 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~--------~~~~~~~~~~~ 292 (374)
....... .......+|..|+|||.+.+..++.++||||||+++|+|++|..|+...... ...........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 7654332 2233456888899999999999999999999999999999999987533211 00001111111
Q ss_pred HHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 017262 293 CIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIR 348 (374)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~ 348 (374)
.+........+...+..+.+|+.+||+.||++|||+.++++.|+.+.
T Consensus 255 ---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 255 ---------TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp ---------HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---------HHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 11112222334455678999999999999999999999999999875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-47 Score=364.88 Aligned_cols=263 Identities=26% Similarity=0.414 Sum_probs=215.5
Q ss_pred HHhhcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 68 DKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 68 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
+...++|++.+.||+|+||.||+|.+.++..||+|.+..... ..+.+.+|+.+|++++||||+++++++.+ +..++||
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~ 340 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 340 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence 344567889999999999999999998888899999876432 34678999999999999999999999876 6789999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
||+++|+|.+++... ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 341 e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp CCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred ehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 999999999999742 2346899999999999999999999999 999999999999999999999999999865432
Q ss_pred CceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
.........++..|+|||.+.+..++.++||||||+++|||++ |..||...... +.. ..+.. .
T Consensus 417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~------~~~-~~i~~---------~ 480 (535)
T 2h8h_A 417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVL-DQVER---------G 480 (535)
T ss_dssp HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH------HHH-HHHHT---------T
T ss_pred ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------HHH-HHHHc---------C
Confidence 2222233446788999999999999999999999999999999 99999754321 111 11111 1
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCC
Q 017262 307 VRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSR 352 (374)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~ 352 (374)
.+...+...+..+.+||.+||+.||++|||+.++++.|+.+.....
T Consensus 481 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 481 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 1222333456688999999999999999999999999998876544
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=329.05 Aligned_cols=258 Identities=23% Similarity=0.308 Sum_probs=199.7
Q ss_pred cCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCCh--hHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDE--SKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
++|++.+.||+|+||.||+|...+++.+|+|++..... .....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 47899999999999999999998899999998865432 2246788999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+++ +|.+++.. ....+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (288)
T ss_dssp CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence 975 88888864 3457899999999999999999999999 9999999999999999999999999997654221
Q ss_pred eeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHh---cc---ccc-
Q 017262 230 HVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEE---NC---LFD- 301 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~---~~~- 301 (374)
.......+|+.|+|||.+.+ ..++.++||||||+++|+|++|..||...... ......... .. ...
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA------DQLMRIFRILGTPNSKNWPNV 228 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHHHCCCCTTTSTTG
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHHHCCCChhhchhh
Confidence 22234468999999999875 45899999999999999999999999753321 111111110 00 000
Q ss_pred ----cccccc-------cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 302 ----IIDDQV-------RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 302 ----~~~~~~-------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..+... ........+..+.+|+.+||+.||++|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 00111234567889999999999999999999875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=334.54 Aligned_cols=268 Identities=22% Similarity=0.344 Sum_probs=211.8
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeee----cccce
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLE----VEVPL 144 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~ 144 (374)
..++|++.+.||+|+||.||++.. .+++.||+|.+..........+.+|+.+++.++||||+++++++.. ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 457899999999999999999996 5689999998877777777889999999999999999999999873 34778
Q ss_pred EEEEeecCCcccccccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccc
Q 017262 145 LVYEFIPNGTLFQYLHDPY-EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 223 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 223 (374)
+|+||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 9999999999999886421 2457899999999999999999999999 99999999999999999999999999875
Q ss_pred cccCCce--------eeecccccccccCccccccCC---CCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHH
Q 017262 224 IAIDQTH--------VSTKVQGTFGYLDPEYFRSSQ---FTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVE 292 (374)
Q Consensus 224 ~~~~~~~--------~~~~~~g~~~y~aPE~~~~~~---~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 292 (374)
....... ......|++.|+|||.+.+.. ++.++||||||+++|+|++|+.||........ .....
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~--- 259 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVALA--- 259 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHHH---
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhHH---
Confidence 4321110 012234799999999987554 68899999999999999999999964322111 11111
Q ss_pred HHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCCC
Q 017262 293 CIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDD 354 (374)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~~ 354 (374)
.............+..+.+++.+||+.||++|||+.++++.|+.+....+.+
T Consensus 260 ----------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 311 (317)
T 2buj_A 260 ----------VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311 (317)
T ss_dssp ----------HHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC-
T ss_pred ----------hhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCC
Confidence 0111111222344568999999999999999999999999999987655543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=341.43 Aligned_cols=267 Identities=18% Similarity=0.268 Sum_probs=204.6
Q ss_pred hhcCCCcCceEeee--CeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccce
Q 017262 70 ATDYFNMNRILGQG--GQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPL 144 (374)
Q Consensus 70 ~~~~~~~~~~lg~G--~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 144 (374)
..++|++.+.||+| +||.||+|... +++.||+|.+... .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 35679999999999 99999999976 6899999987643 3455677889999999999999999999999999999
Q ss_pred EEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccc
Q 017262 145 LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 224 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 224 (374)
+||||+++|+|.+++... ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.+...
T Consensus 103 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 999999999999998743 2356999999999999999999999999 999999999999999999999999988654
Q ss_pred ccCCce------eeecccccccccCcccccc--CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHH--
Q 017262 225 AIDQTH------VSTKVQGTFGYLDPEYFRS--SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECI-- 294 (374)
Q Consensus 225 ~~~~~~------~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-- 294 (374)
...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ .........
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~ 256 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPC 256 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH--HHHC-------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHhcCCCCc
Confidence 322111 1122468899999999987 5789999999999999999999999975432210 000000000
Q ss_pred --H------------------hcccccccc---------ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 295 --E------------------ENCLFDIID---------DQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 295 --~------------------~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
. ......... .......+...+..+.+|+.+||+.||++|||+.++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 0 000000000 00000122334567999999999999999999999985
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=351.82 Aligned_cols=258 Identities=23% Similarity=0.338 Sum_probs=208.6
Q ss_pred HHHHHhhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC---hhHHHHHHHHHHHHhhCCCCceeeeeeeeeec
Q 017262 65 KELDKATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQINHRNVVKLLGCCLEV 140 (374)
Q Consensus 65 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 140 (374)
.++....++|++.+.||+|+||+||+|... +++.+|+|++.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 345556788999999999999999999975 58899999876421 11223477899999999999999999999999
Q ss_pred ccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccc
Q 017262 141 EVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGT 220 (374)
Q Consensus 141 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 220 (374)
+..++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 999999999999999998863 36899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCceeeecccccccccCccccccCC----CCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHh
Q 017262 221 SRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQ----FTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEE 296 (374)
Q Consensus 221 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 296 (374)
+...............||+.|+|||++.+.. ++.++||||||+++|||++|+.||.... ....+......
T Consensus 215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~------~~~~~~~i~~~ 288 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS------LVGTYSKIMNH 288 (410)
T ss_dssp CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHTH
T ss_pred eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC------hhhHHHHHHhc
Confidence 9876544444445667999999999997655 7889999999999999999999996432 22222222211
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 017262 297 NCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRN--RPTMKEVAM 342 (374)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--Rps~~~vl~ 342 (374)
.. ..........+..+.+||.+||+.+|.+ ||+++++++
T Consensus 289 ~~-------~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 289 KN-------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HH-------HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred cc-------cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 10 0011111134457889999999999988 999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=332.14 Aligned_cols=255 Identities=30% Similarity=0.550 Sum_probs=204.9
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCChhH-------HHHHHHHHHHHhhCCCCceeeeeeeeeeccc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESK-------LEEFINEVVILSQINHRNVVKLLGCCLEVEV 142 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 142 (374)
.++|++.+.||+|+||.||+|.. .+++.+|+|.+....... .+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 46899999999999999999997 468899999876533211 167889999999999999999999986544
Q ss_pred ceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCc-----EEEee
Q 017262 143 PLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR-----AKIAD 217 (374)
Q Consensus 143 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~-----~kl~D 217 (374)
++||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ .+++|+||||+||+++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 799999999999988865 3457999999999999999999999987 45999999999999988776 99999
Q ss_pred cccccccccCCceeeecccccccccCccccc--cCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHH
Q 017262 218 FGTSRSIAIDQTHVSTKVQGTFGYLDPEYFR--SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIE 295 (374)
Q Consensus 218 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 295 (374)
||++..... ......||+.|+|||.+. ...++.++||||||+++|+|++|+.||....... .........
T Consensus 173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~~ 244 (287)
T 4f0f_A 173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINMIRE 244 (287)
T ss_dssp CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH----HHHHHHHHH
T ss_pred CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH----HHHHHHHhc
Confidence 999975332 234456899999999984 4567899999999999999999999997533221 111111111
Q ss_pred hccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 017262 296 ENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347 (374)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~ 347 (374)
.......+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus 245 ---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 245 ---------EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ---------SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ---------cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1112223334556899999999999999999999999999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=336.10 Aligned_cols=249 Identities=25% Similarity=0.384 Sum_probs=202.2
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccceEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 146 (374)
++|++.+.||+|+||.||+|... +++.+|+|.+... .......+.+|..+++++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 56899999999999999999975 5889999987643 344566788999999988 899999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
|||+++|+|.+++. ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 99999999999987 3457999999999999999999999999 99999999999999999999999999975332
Q ss_pred CCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccC--CChHHHHHHHHHhcccccccc
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEG--RNLTTYFVECIEENCLFDIID 304 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 304 (374)
. ........||+.|+|||++.+..++.++|+|||||++|||++|..||........ ...............
T Consensus 163 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~------ 235 (345)
T 3a8x_A 163 P-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------ 235 (345)
T ss_dssp T-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC------
T ss_pred C-CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC------
Confidence 2 2223455799999999999999999999999999999999999999964322111 011112222221111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 017262 305 DQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTM 337 (374)
Q Consensus 305 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 337 (374)
...+...+..+.+|+.+||+.||++||++
T Consensus 236 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 236 ----IRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ----CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 11223345678999999999999999996
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=342.27 Aligned_cols=270 Identities=27% Similarity=0.443 Sum_probs=214.7
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe-----cCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc--cc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML-----ADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVE--VP 143 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~ 143 (374)
.++|++.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 46789999999999999999983 368899999998777777788999999999999999999999987654 78
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccc
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 223 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 223 (374)
++||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHH--STTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 999999999999999975 2346899999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCcee--eecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcccccc-----CCChHHHHHHHHHh
Q 017262 224 IAIDQTHV--STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANE-----GRNLTTYFVECIEE 296 (374)
Q Consensus 224 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~ 296 (374)
........ .....++..|+|||.+.+..++.++||||||+++|+|++|..||....... ..........
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~---- 270 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF---- 270 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHH----
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHH----
Confidence 65433222 223457778999999998889999999999999999999999986431100 0000000000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 017262 297 NCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350 (374)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~ 350 (374)
.+...+........+...+..+.+++.+||+.||++|||+.++++.|+.++..
T Consensus 271 -~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 271 -HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp -HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 00111111112223344566899999999999999999999999999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=324.35 Aligned_cols=270 Identities=19% Similarity=0.237 Sum_probs=214.3
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeee-eecccceEEE
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCC-LEVEVPLLVY 147 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~ 147 (374)
..++|++.+.||+|+||.||+|.. .+++.||+|.+..... ...+.+|+.+++.++|++++..+..+ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 357899999999999999999996 5789999998765432 24578999999999988876666655 4566779999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEEC---CCCcEEEeeccccccc
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD---EKYRAKIADFGTSRSI 224 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfg~~~~~ 224 (374)
||+ +++|.+++.. ....+++..++.++.|++.||+|||+++ ++||||||+||+++ .++.+||+|||++...
T Consensus 85 e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 85 ELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Eec-CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 999 9999999864 2457999999999999999999999999 99999999999994 8889999999999876
Q ss_pred ccCCce------eeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcc
Q 017262 225 AIDQTH------VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENC 298 (374)
Q Consensus 225 ~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 298 (374)
...... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||..............+........
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 543321 12345699999999999999999999999999999999999999986554443333322222111111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCCCcc
Q 017262 299 LFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDDEN 356 (374)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~~~~ 356 (374)
.. .. ....+..+.+++.+||+.||++|||+.++++.|+.+.........
T Consensus 239 ~~-----~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~ 287 (296)
T 3uzp_A 239 IE-----VL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 287 (296)
T ss_dssp HH-----HH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSS
T ss_pred hH-----HH----HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccc
Confidence 00 00 112345788999999999999999999999999999887765433
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=342.61 Aligned_cols=254 Identities=23% Similarity=0.325 Sum_probs=203.9
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC-----hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccce
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-----ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPL 144 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 144 (374)
.++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 467999999999999999999964 68999999875421 123567889999999999999999999999999999
Q ss_pred EEEEeecCCcccccccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCc---EEEeeccc
Q 017262 145 LVYEFIPNGTLFQYLHDPY-EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR---AKIADFGT 220 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~---~kl~Dfg~ 220 (374)
+||||+++++|.+++.... ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988775421 2345899999999999999999999999 999999999999986654 99999999
Q ss_pred ccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccc
Q 017262 221 SRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLF 300 (374)
Q Consensus 221 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (374)
+....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.... ...+..... ....
T Consensus 180 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~i~~-~~~~ 250 (351)
T 3c0i_A 180 AIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-------ERLFEGIIK-GKYK 250 (351)
T ss_dssp CEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-------HHHHHHHHH-TCCC
T ss_pred eeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-------HHHHHHHHc-CCCC
Confidence 98765322 22344569999999999999999999999999999999999999997532 111111111 1110
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 301 DIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
...... ...+..+.+|+.+||+.||++|||+.++++
T Consensus 251 --~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 251 --MNPRQW----SHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp --CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --CCcccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000000 123457889999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=327.22 Aligned_cols=268 Identities=19% Similarity=0.238 Sum_probs=209.5
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeee-eecccceEEE
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCC-LEVEVPLLVY 147 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~ 147 (374)
..++|++.+.||+|+||.||+|.. .+++.||+|....... ...+.+|+.+++.++|++++..+..+ ...+..+++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999996 5688999997654322 23577899999999988877766665 5566789999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEE---CCCCcEEEeeccccccc
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSI 224 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfg~~~~~ 224 (374)
||+ +++|.+++.. ....+++..++.++.|++.||+|||+++ ++||||||+|||+ +.++.+||+|||++...
T Consensus 85 e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 9999999864 2456999999999999999999999999 9999999999999 78899999999999876
Q ss_pred ccCCce------eeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcc
Q 017262 225 AIDQTH------VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENC 298 (374)
Q Consensus 225 ~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 298 (374)
...... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 543321 22345689999999999999999999999999999999999999987655443333322221111111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCCC
Q 017262 299 LFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDD 354 (374)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~~ 354 (374)
... . ....+..+.+++.+||+.||++|||+.++++.|+.+.......
T Consensus 239 ~~~-----~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~ 285 (296)
T 4hgt_A 239 IEV-----L----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp HHH-----H----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred hhh-----h----hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCC
Confidence 100 0 0112457899999999999999999999999999998876543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=343.21 Aligned_cols=262 Identities=29% Similarity=0.497 Sum_probs=201.7
Q ss_pred cCCCcCceEeeeCeEEEEEEEec--CC--cEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeee-cccceE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA--DG--RIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLE-VEVPLL 145 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~--~~--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~l 145 (374)
..|.+.+.||+|+||.||+|... ++ ..+|+|.+... .......+.+|+.++++++||||+++++++.. .+..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 34677889999999999999864 22 36789987643 34566789999999999999999999998754 457899
Q ss_pred EEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccc
Q 017262 146 VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 225 (374)
||||+++|+|.+++.. ....+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++...
T Consensus 169 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999975 3456889999999999999999999999 9999999999999999999999999998654
Q ss_pred cCCce---eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccc
Q 017262 226 IDQTH---VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFD 301 (374)
Q Consensus 226 ~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (374)
..... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+ .... ....
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~----~~~~---- 312 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY----LLQG---- 312 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHH----HHTT----
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHH----HHcC----
Confidence 32211 1233457789999999999999999999999999999999 777886543222 1111 1111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCCC
Q 017262 302 IIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDD 354 (374)
Q Consensus 302 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~~ 354 (374)
.....+...+..+.+++.+||+.||++|||+.++++.|+.+.......
T Consensus 313 -----~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 313 -----RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred -----CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 111122334567899999999999999999999999999998876644
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=331.14 Aligned_cols=272 Identities=24% Similarity=0.354 Sum_probs=207.9
Q ss_pred HHHHHhhcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhC--CCCceeeeeeeeeec--
Q 017262 65 KELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQI--NHRNVVKLLGCCLEV-- 140 (374)
Q Consensus 65 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~-- 140 (374)
.......++|++.+.||+|+||.||+|... ++.||+|.+... ....+..|.+++... +||||+++++++...
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 334455678999999999999999999986 889999988643 234445566666555 899999999999877
Q ss_pred --ccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc--------CCCCEEEeccCCCceEECCC
Q 017262 141 --EVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSS--------AYLPIYHRDIKSTNILLDEK 210 (374)
Q Consensus 141 --~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--------~~~~i~H~dlk~~Nill~~~ 210 (374)
...++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+. + ++||||||+|||++.+
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~ 178 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKN 178 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTT
T ss_pred CCCceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCC
Confidence 678999999999999999963 3699999999999999999999998 7 9999999999999999
Q ss_pred CcEEEeecccccccccCCcee---eecccccccccCccccccCCCCcc------chhhhHHHHHHHHHhC----------
Q 017262 211 YRAKIADFGTSRSIAIDQTHV---STKVQGTFGYLDPEYFRSSQFTDK------SDVYSFGVVLVELLTG---------- 271 (374)
Q Consensus 211 ~~~kl~Dfg~~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~------~Di~slG~~l~el~~g---------- 271 (374)
+.+||+|||++.......... .....||+.|+|||++.+...+.+ +||||||+++|||++|
T Consensus 179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~ 258 (337)
T 3mdy_A 179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258 (337)
T ss_dssp SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence 999999999997654332221 124569999999999987766655 9999999999999999
Q ss_pred CCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhC
Q 017262 272 QKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANS 351 (374)
Q Consensus 272 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~ 351 (374)
..||........ .................... ...+...+..+.+|+.+||+.||++|||+.++++.|+.+..+.
T Consensus 259 ~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 259 QLPYHDLVPSDP--SYEDMREIVCIKKLRPSFPN---RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp CCTTTTTSCSSC--CHHHHHHHHTTSCCCCCCCG---GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cccHhhhcCCCC--chhhhHHHHhhhccCccccc---cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 666654332221 11112211111111111100 0112367788999999999999999999999999999998865
Q ss_pred C
Q 017262 352 R 352 (374)
Q Consensus 352 ~ 352 (374)
.
T Consensus 334 ~ 334 (337)
T 3mdy_A 334 D 334 (337)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=342.85 Aligned_cols=250 Identities=24% Similarity=0.336 Sum_probs=204.2
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
.++|++.+.||+|+||.||++... +++.+|+|.+... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 367899999999999999999965 5789999987542 223456788999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
|||+++|+|..++. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQ---QNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999997 3557999999999999999999999999 99999999999999999999999999986543
Q ss_pred CCceeeecccccccccCcccccc---CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccc
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFRS---SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDII 303 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (374)
. .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... ....... ....
T Consensus 168 ~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~---~~~~~~~-~~~~------ 235 (384)
T 4fr4_A 168 E--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS---SKEIVHT-FETT------ 235 (384)
T ss_dssp T--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC---HHHHHHH-HHHC------
T ss_pred C--CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc---HHHHHHH-Hhhc------
Confidence 2 23345679999999999864 458999999999999999999999997433221 1121111 1111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 017262 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPT-MKEVAM 342 (374)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-~~~vl~ 342 (374)
....+...+..+.+||.+||+.||++||+ ++++++
T Consensus 236 ----~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 236 ----VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ----ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 11223344568899999999999999999 666553
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=331.99 Aligned_cols=244 Identities=26% Similarity=0.366 Sum_probs=204.5
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC---hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
++|++.+.||+|+||.||+|... +|+.+|+|.+.... ......+.+|..+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 57899999999999999999975 68999999886431 233567788999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
||+++|+|.+++. ....+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++......
T Consensus 86 e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 86 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 9999999999997 3557999999999999999999999999 999999999999999999999999999765321
Q ss_pred CceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (374)
.....||+.|+|||++.+..++.++|+||||+++|+|++|..||..... ...+.......
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~---------- 219 (318)
T 1fot_A 160 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILNAE---------- 219 (318)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHCC----------
T ss_pred ----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC----------
Confidence 2345699999999999999999999999999999999999999964322 22222222111
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 017262 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRP-----TMKEVAM 342 (374)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~vl~ 342 (374)
...+...+..+.+++.+||+.||++|| +++++++
T Consensus 220 -~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 220 -LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 112233456788999999999999999 8888875
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=328.09 Aligned_cols=259 Identities=20% Similarity=0.304 Sum_probs=200.8
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 148 (374)
++|++.+.||+|+||+||+|... +++.+|+|.+... .......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 47899999999999999999975 5889999987643 33445778899999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
|++++ |.+++.. ....+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~-l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQD-LKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEE-HHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCCC-HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 99764 4444432 3467999999999999999999999999 9999999999999999999999999998654322
Q ss_pred ceeeecccccccccCccccccCC-CCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccc------cc
Q 017262 229 THVSTKVQGTFGYLDPEYFRSSQ-FTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCL------FD 301 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~ 301 (374)
.......||+.|+|||.+.+.. ++.++||||||+++|+|++|..||.... ............... ..
T Consensus 156 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~-----~~~~~~~~i~~~~~~~~~~~~~~ 229 (292)
T 3o0g_A 156 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-----DVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp -SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS-----SHHHHHHHHHHHHCCCCTTTCTT
T ss_pred -ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC-----CHHHHHHHHHHHhCCCChhhhhh
Confidence 2234456899999999997765 7999999999999999999888864221 122222222111000 00
Q ss_pred cc------------cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 302 II------------DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 302 ~~------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.. .........+..+..+.+|+.+||+.||++|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00 000011122245567889999999999999999999875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=333.28 Aligned_cols=255 Identities=27% Similarity=0.460 Sum_probs=203.2
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeec-ccceEEEE
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEV-EVPLLVYE 148 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e 148 (374)
..++|++.+.||+|+||.||++... |+.+|+|.+.... ..+.+.+|+.++++++||||+++++++.+. +..++|||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred ChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 3567999999999999999999875 7889999887543 456788999999999999999999997654 47899999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
|+++++|.+++... ....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++......
T Consensus 96 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~- 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 170 (278)
T ss_dssp CCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred cCCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc-
Confidence 99999999999742 1223789999999999999999999999 999999999999999999999999998754322
Q ss_pred ceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccccc
Q 017262 229 THVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (374)
.....+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... .. ... ....
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~------~~-~~~---------~~~~ 231 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VV-PRV---------EKGY 231 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG------HH-HHH---------TTTC
T ss_pred ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH------HH-HHH---------hcCC
Confidence 122357889999999999999999999999999999998 999997543221 11 111 1111
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhC
Q 017262 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANS 351 (374)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~ 351 (374)
....+...+..+.+++.+||+.||++|||+.++++.|+.++...
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 232 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 22233445668999999999999999999999999999997643
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=341.96 Aligned_cols=273 Identities=15% Similarity=0.207 Sum_probs=209.5
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEecC------CcEEEEEEeccCChhHH-----------HHHHHHHHHHhhCCCCceee
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLAD------GRIIAVKKSKVVDESKL-----------EEFINEVVILSQINHRNVVK 132 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~ 132 (374)
..++|.+.+.||+|+||.||+|.+.+ ++.||+|.+........ .....|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999999754 47899998776543211 12345666778889999999
Q ss_pred eeeeeeec----ccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEEC
Q 017262 133 LLGCCLEV----EVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD 208 (374)
Q Consensus 133 ~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~ 208 (374)
+++++... ...++||||+ +++|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99999865 4579999999 9999999974 3457999999999999999999999999 99999999999998
Q ss_pred --CCCcEEEeecccccccccCCcee------eecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcccc
Q 017262 209 --EKYRAKIADFGTSRSIAIDQTHV------STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWA 280 (374)
Q Consensus 209 --~~~~~kl~Dfg~~~~~~~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~ 280 (374)
.++.+||+|||+++......... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 88999999999997664332211 1234599999999999999999999999999999999999999975322
Q ss_pred ccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCCC
Q 017262 281 NEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDD 354 (374)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~~ 354 (374)
.. ......... ....+...++..+. ....+..+.+++.+||+.+|++||++.++++.|+.+.......
T Consensus 267 ~~--~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~ 334 (364)
T 3op5_A 267 DP--KYVRDSKIR-YRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK 334 (364)
T ss_dssp CH--HHHHHHHHH-HHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred CH--HHHHHHHHH-hhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 11 111111111 11122222222221 1123457889999999999999999999999999998865443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=339.77 Aligned_cols=269 Identities=26% Similarity=0.426 Sum_probs=217.3
Q ss_pred cChHHHHHhhcCCCcCceEeeeCeEEEEEEEec------CCcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeee
Q 017262 62 FNSKELDKATDYFNMNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLL 134 (374)
Q Consensus 62 ~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~ 134 (374)
+...+.....++|++.+.||+|+||.||+|... .++.+|+|.+... .......+.+|+.+++.++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 444556666788999999999999999999864 3678999988654 334556788999999999999999999
Q ss_pred eeeeecccceEEEEeecCCcccccccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEE
Q 017262 135 GCCLEVEVPLLVYEFIPNGTLFQYLHDPY-------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL 207 (374)
Q Consensus 135 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill 207 (374)
+++.+.+..++||||+++++|.+++.... ....+++..++.++.|++.||.|||+++ ++||||||+||++
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEE
Confidence 99999999999999999999999986421 1245789999999999999999999999 9999999999999
Q ss_pred CCCCcEEEeecccccccccCCcee-eecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCC
Q 017262 208 DEKYRAKIADFGTSRSIAIDQTHV-STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRN 285 (374)
Q Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~ 285 (374)
+.++.+||+|||++.......... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---- 247 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---- 247 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH----
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH----
Confidence 999999999999997654332222 223456889999999999999999999999999999999 89998653321
Q ss_pred hHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 017262 286 LTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRA 349 (374)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~ 349 (374)
... ........ ...+...+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 248 --~~~-~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 248 --QVL-RFVMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp --HHH-HHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred --HHH-HHHHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 111 11111111 12233445678999999999999999999999999987644
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=342.46 Aligned_cols=253 Identities=21% Similarity=0.296 Sum_probs=196.1
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
.++|.+.+.||+|+||.||++... +++.||+|.+...... ...+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 568999999999999999999975 6889999988754332 35678999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCc--EEEeecccccccccC
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR--AKIADFGTSRSIAID 227 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~--~kl~Dfg~~~~~~~~ 227 (374)
+++|+|.+++. ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++. +||+|||+++....
T Consensus 98 ~~~~~L~~~l~---~~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~- 170 (361)
T 3uc3_A 98 ASGGELYERIC---NAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 170 (361)
T ss_dssp CCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc-
Confidence 99999999986 3457999999999999999999999999 999999999999987765 99999999874322
Q ss_pred CceeeecccccccccCccccccCCCCcc-chhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRSSQFTDK-SDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||....... ........... ..
T Consensus 171 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~~~~~---------~~ 238 (361)
T 3uc3_A 171 -HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--DYRKTIQRILS---------VK 238 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--CHHHHHHHHHT---------TC
T ss_pred -cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhc---------CC
Confidence 122234569999999999988887665 899999999999999999997543322 22222221111 11
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 307 VRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
.........+..+.+||.+||+.||++|||+.++++-
T Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 239 YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 1111112234678899999999999999999999873
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=329.39 Aligned_cols=256 Identities=22% Similarity=0.392 Sum_probs=204.6
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecC-C-------cEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeeccc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLAD-G-------RIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEV 142 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 142 (374)
.++|.+.+.||+|+||.||+|.... + ..+++|.+........+.+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4578999999999999999998643 3 4799999877666777889999999999999999999999999999
Q ss_pred ceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCc--------EE
Q 017262 143 PLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR--------AK 214 (374)
Q Consensus 143 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~--------~k 214 (374)
.++||||+++++|.+++.. ....+++..++.++.|++.||+|||+++ ++||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 9999999999999999974 2334899999999999999999999999 999999999999998887 99
Q ss_pred EeecccccccccCCceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCC-CCCccccccCCChHHHHHH
Q 017262 215 IADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQK-PISSIWANEGRNLTTYFVE 292 (374)
Q Consensus 215 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~-p~~~~~~~~~~~~~~~~~~ 292 (374)
|+|||++...... ....+++.|+|||.+.+ ..++.++||||||+++|+|++|.. ||..... ......
T Consensus 162 l~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~------~~~~~~ 230 (289)
T 4fvq_A 162 LSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS------QRKLQF 230 (289)
T ss_dssp ECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH------HHHHHH
T ss_pred eccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch------HHHHHH
Confidence 9999998654321 23457889999999987 678999999999999999999554 4432211 111111
Q ss_pred HHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCCC
Q 017262 293 CIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDD 354 (374)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~~ 354 (374)
....... +...+..+.+|+.+||+.||++|||+.++++.|+.+.....+.
T Consensus 231 ~~~~~~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~ 280 (289)
T 4fvq_A 231 YEDRHQL------------PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280 (289)
T ss_dssp HHTTCCC------------CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC------
T ss_pred hhccCCC------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCC
Confidence 1111111 1111336889999999999999999999999999987755443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=349.85 Aligned_cols=261 Identities=23% Similarity=0.287 Sum_probs=208.5
Q ss_pred hHHHHHhhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC---hhHHHHHHHHHHHHhhCCCCceeeeeeeeee
Q 017262 64 SKELDKATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQINHRNVVKLLGCCLE 139 (374)
Q Consensus 64 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 139 (374)
.++.....++|++.+.||+|+||.||++..+ +++.||+|++.... ......+.+|..++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 4455566789999999999999999999975 68999999886421 2223457889999999999999999999999
Q ss_pred cccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecc
Q 017262 140 VEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 219 (374)
Q Consensus 140 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 219 (374)
.+..|+||||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSK--FGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHH--HSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEcCCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeech
Confidence 9999999999999999999974 2347999999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCceeeecccccccccCccccc-------cCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHH
Q 017262 220 TSRSIAIDQTHVSTKVQGTFGYLDPEYFR-------SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVE 292 (374)
Q Consensus 220 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 292 (374)
++...............||+.|+|||++. ...++.++|||||||++|||++|+.||..... ...+..
T Consensus 208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~ 281 (412)
T 2vd5_A 208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST------AETYGK 281 (412)
T ss_dssp TCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHH
T ss_pred hheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH------HHHHHH
Confidence 99876554444444567999999999987 35689999999999999999999999964322 222222
Q ss_pred HHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCC---CCHHHHHH
Q 017262 293 CIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNR---PTMKEVAM 342 (374)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---ps~~~vl~ 342 (374)
......... ....+...+..+.+||.+||. +|.+| |+++++++
T Consensus 282 i~~~~~~~~------~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 282 IVHYKEHLS------LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHTHHHHCC------CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHhcccCcC------CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 211100000 001112345688999999999 99998 58888865
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=332.32 Aligned_cols=248 Identities=25% Similarity=0.357 Sum_probs=195.8
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe----cCCcEEEEEEeccCC----hhHHHHHHHHHHHHhhCCCCceeeeeeeeeeccc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML----ADGRIIAVKKSKVVD----ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEV 142 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 142 (374)
.++|++.+.||+|+||.||++.. .+++.+|+|.+.... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46799999999999999999996 468999999887532 2334567889999999999999999999999999
Q ss_pred ceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccc
Q 017262 143 PLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 222 (374)
Q Consensus 143 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 222 (374)
.++||||+++++|.+++. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLE---REGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 999999999999999997 3457899999999999999999999999 9999999999999999999999999987
Q ss_pred ccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccc
Q 017262 223 SIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDI 302 (374)
Q Consensus 223 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (374)
...... .......||+.|+|||.+.+..++.++||||||+++|+|++|..||..... ...........
T Consensus 170 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~~----- 237 (327)
T 3a62_A 170 ESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR------KKTIDKILKCK----- 237 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHTC-----
T ss_pred ccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCC-----
Confidence 543222 223445699999999999998999999999999999999999999974322 22222221111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 017262 303 IDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRP-----TMKEVAM 342 (374)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~vl~ 342 (374)
...+...+..+.+|+.+||+.||++|| ++.++++
T Consensus 238 ------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 238 ------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 112233456789999999999999999 6677765
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=338.77 Aligned_cols=245 Identities=22% Similarity=0.270 Sum_probs=205.0
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC---hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
.++|++.+.||+|+||.||+|... +|+.+|+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 357899999999999999999975 68999999876432 23356788999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
|||+++|+|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 120 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 999999999999973 457999999999999999999999999 99999999999999999999999999986543
Q ss_pred CCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
. .....||+.|+|||++.+..++.++||||||+++|+|++|..||.... ....+..... ..
T Consensus 194 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~------~~~~~~~i~~-~~-------- 254 (350)
T 1rdq_E 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ------PIQIYEKIVS-GK-------- 254 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHH-CC--------
T ss_pred C----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC------HHHHHHHHHc-CC--------
Confidence 2 233568999999999999999999999999999999999999996432 2222222221 11
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 017262 307 VRKSGEAEEIMAVSDVAKRCLNSYGRNRPT-----MKEVAM 342 (374)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~vl~ 342 (374)
...+...+..+.+||.+||+.||++||+ ++++++
T Consensus 255 --~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 255 --VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 1122334567899999999999999998 777765
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=340.65 Aligned_cols=273 Identities=24% Similarity=0.352 Sum_probs=217.7
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc--cceEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVE--VPLLV 146 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv 146 (374)
.++|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++.+.+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 467899999999999999999975 48999999887532 233567789999999999999999999998765 67999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEE----CCCCcEEEeeccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL----DEKYRAKIADFGTSR 222 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill----~~~~~~kl~Dfg~~~ 222 (374)
|||+++|+|.+++........+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++.
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999986544455999999999999999999999999 9999999999999 778889999999998
Q ss_pred ccccCCceeeecccccccccCcccccc--------CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHH
Q 017262 223 SIAIDQTHVSTKVQGTFGYLDPEYFRS--------SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECI 294 (374)
Q Consensus 223 ~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 294 (374)
...... ......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ..........
T Consensus 165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~--~~~~~~~~~~ 240 (396)
T 4eut_A 165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR--RNKEVMYKII 240 (396)
T ss_dssp ECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT--TCHHHHHHHH
T ss_pred EccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc--chHHHHHHHh
Confidence 654322 2234568999999999865 567889999999999999999999997543322 2223333333
Q ss_pred Hhcccccc------c--------cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 017262 295 EENCLFDI------I--------DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350 (374)
Q Consensus 295 ~~~~~~~~------~--------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~ 350 (374)
........ . ............+..+.+++.+||+.||++|||+.++++.++.+...
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 22211000 0 00111234467888999999999999999999999999999998764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=335.51 Aligned_cols=263 Identities=27% Similarity=0.468 Sum_probs=209.9
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcE--EEEEEeccC-ChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccceEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRI--IAVKKSKVV-DESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 146 (374)
++|++.+.||+|+||.||+|... ++.. +++|.+... .......+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57899999999999999999964 4554 488877643 334456788999999999 899999999999999999999
Q ss_pred EEeecCCcccccccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcE
Q 017262 147 YEFIPNGTLFQYLHDPY-------------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA 213 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~ 213 (374)
|||+++++|.+++.... ....+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999997531 2347899999999999999999999999 9999999999999999999
Q ss_pred EEeecccccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHH
Q 017262 214 KIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVE 292 (374)
Q Consensus 214 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~ 292 (374)
||+|||++..... ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... ....
T Consensus 182 kL~Dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------~~~~- 252 (327)
T 1fvr_A 182 KIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYE- 252 (327)
T ss_dssp EECCTTCEESSCE--ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHH-
T ss_pred EEcccCcCccccc--cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH------HHHH-
Confidence 9999999874321 111233446889999999998889999999999999999998 99999653321 1111
Q ss_pred HHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCCCc
Q 017262 293 CIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDDE 355 (374)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~~~ 355 (374)
.. ........+...+..+.+|+.+||+.||++|||+.++++.|+.+........
T Consensus 253 ~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~ 306 (327)
T 1fvr_A 253 KL---------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 306 (327)
T ss_dssp HG---------GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSB
T ss_pred Hh---------hcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCcc
Confidence 11 1111222333455689999999999999999999999999999988765443
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=330.65 Aligned_cols=263 Identities=27% Similarity=0.378 Sum_probs=202.5
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccc---
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVP--- 143 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~--- 143 (374)
.++|++.+.||+|+||.||+|.. .+++.||+|.+... +......+.+|+.++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 56899999999999999999996 56889999998654 334456788999999999999999999999876654
Q ss_pred -eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccc
Q 017262 144 -LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 222 (374)
Q Consensus 144 -~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 222 (374)
++||||+++++|.+++. ....+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 99999999999999997 3457999999999999999999999999 9999999999999999999999999997
Q ss_pred ccccCCc--eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccc
Q 017262 223 SIAIDQT--HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLF 300 (374)
Q Consensus 223 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (374)
....... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... ..............
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~~~ 238 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIP 238 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCC
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCCCCC
Confidence 6543322 122335689999999999999999999999999999999999999964322 22222222221111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHHHHHHHhhCC
Q 017262 301 DIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMK-EVAMELERIRANSR 352 (374)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~-~vl~~L~~~~~~~~ 352 (374)
.. . .....+..+.+++.+||+.||++||++. ++.+.|.++....+
T Consensus 239 ~~---~----~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~ 284 (311)
T 3ork_A 239 PS---A----RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEP 284 (311)
T ss_dssp HH---H----HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCC
T ss_pred cc---c----ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCC
Confidence 00 0 0112345788999999999999998655 55567776655444
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=326.25 Aligned_cols=247 Identities=22% Similarity=0.320 Sum_probs=205.1
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEecC-CcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEE
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 148 (374)
..++|.+.+.||+|+||.||+|.... +..+++|++........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 35679999999999999999999754 67899998876555566789999999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEE---CCCCcEEEeecccccccc
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfg~~~~~~ 225 (374)
|+++++|.+++. ....+++..++.++.|++.||+|||+++ ++|+||||+||++ +.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVV---HKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 999999999887 3456899999999999999999999999 9999999999999 788999999999997654
Q ss_pred cCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccc
Q 017262 226 IDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDD 305 (374)
Q Consensus 226 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (374)
... ......+|+.|+|||.+.+. ++.++||||||+++|+|++|..||...... ....... ....
T Consensus 161 ~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~-~~~~------ 224 (277)
T 3f3z_A 161 PGK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS------EVMLKIR-EGTF------ 224 (277)
T ss_dssp TTS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH-HCCC------
T ss_pred Ccc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH------HHHHHHH-hCCC------
Confidence 322 23345689999999998754 899999999999999999999999753321 1111111 1111
Q ss_pred cccCCCCH----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 306 QVRKSGEA----EEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 306 ~~~~~~~~----~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..+. ..+..+.+|+.+||+.||++|||+.++++
T Consensus 225 ----~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 225 ----TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp ----CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ----CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 23467899999999999999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=360.97 Aligned_cols=260 Identities=25% Similarity=0.398 Sum_probs=208.4
Q ss_pred CCCcCc-eEeeeCeEEEEEEEec---CCcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 73 YFNMNR-ILGQGGQGTVYKGMLA---DGRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 73 ~~~~~~-~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
++.+.+ .||+|+||.||+|.+. ++..||+|.++... ......+.+|+.++++++||||+++++++.. +..++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 334444 7999999999999864 45679999987643 3456789999999999999999999999976 5689999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
||+++|+|.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 415 E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 415 EMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp ECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred EeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 99999999999975 3456999999999999999999999999 999999999999999999999999999876433
Q ss_pred Cceee--ecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhcccccccc
Q 017262 228 QTHVS--TKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIID 304 (374)
Q Consensus 228 ~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (374)
..... ....+++.|+|||++.+..++.++||||||+++|||++ |+.||......+ +...+..
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~-------- 554 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQ-------- 554 (613)
T ss_dssp ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-------HHHHHHT--------
T ss_pred CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHc--------
Confidence 22211 22335689999999999999999999999999999998 999997544322 1111221
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCCC
Q 017262 305 DQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDD 354 (374)
Q Consensus 305 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~~ 354 (374)
..+...+...+..+.+|+.+||+.+|++|||+.++++.|+.+..+....
T Consensus 555 -~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~ 603 (613)
T 2ozo_A 555 -GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 603 (613)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCS
T ss_pred -CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccc
Confidence 1222334456678999999999999999999999999999998766543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=339.22 Aligned_cols=273 Identities=16% Similarity=0.193 Sum_probs=203.8
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec----CCcEEEEEEeccCChhH-----------HHHHHHHHHHHhhCCCCceeeeee
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA----DGRIIAVKKSKVVDESK-----------LEEFINEVVILSQINHRNVVKLLG 135 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~~~~ 135 (374)
.++|.+.+.||+|+||.||+|... .+..+|+|......... ...+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467999999999999999999975 56789999876543221 123567889999999999999999
Q ss_pred eeee----cccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCC
Q 017262 136 CCLE----VEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY 211 (374)
Q Consensus 136 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~ 211 (374)
++.. ....++||||+ +++|.+++.. ...+++..++.++.|++.||+|||+.+ ++||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9987 67889999999 9999999974 348999999999999999999999999 99999999999998877
Q ss_pred --cEEEeecccccccccCCce------eeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccC
Q 017262 212 --RAKIADFGTSRSIAIDQTH------VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEG 283 (374)
Q Consensus 212 --~~kl~Dfg~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~ 283 (374)
.+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 9999999999776432211 11345689999999999999999999999999999999999999964221110
Q ss_pred CChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCCCcc
Q 017262 284 RNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDDEN 356 (374)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~~~~ 356 (374)
.......... ......+... ......+..+.+++.+||+.||++|||+.++++.|+.+.......+.
T Consensus 269 --~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~d~ 335 (345)
T 2v62_A 269 --AVQTAKTNLL-DELPQSVLKW---APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGPLDF 335 (345)
T ss_dssp --HHHHHHHHHH-HTTTHHHHHH---SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCCCCCC
T ss_pred --HHHHHHHhhc-ccccHHHHhh---ccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcccCCCc
Confidence 0000110000 0111111100 00113345789999999999999999999999999987664444333
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=338.91 Aligned_cols=261 Identities=23% Similarity=0.305 Sum_probs=202.8
Q ss_pred HHHHhhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC-----ChhHHHHHHHHHHHHhhCCCCceeeeeeeeee
Q 017262 66 ELDKATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-----DESKLEEFINEVVILSQINHRNVVKLLGCCLE 139 (374)
Q Consensus 66 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 139 (374)
.+....++|++.+.||+|+||.||+|... ++..+|+|.+... .......+.+|+.++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 34556778999999999999999999964 5789999987542 34556788999999999999999999999999
Q ss_pred cccceEEEEeecCCcccccccCCC-------------------------------------CCCCCCHHHHHHHHHHHHH
Q 017262 140 VEVPLLVYEFIPNGTLFQYLHDPY-------------------------------------EELSLTWEMRLRIATEVAE 182 (374)
Q Consensus 140 ~~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~i~~ 182 (374)
.+..++||||+++|+|.+++.... ....+++..++.++.|++.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 999999999999999999885210 0122467788899999999
Q ss_pred HHHHHhhcCCCCEEEeccCCCceEECCCC--cEEEeecccccccccCC---ceeeecccccccccCcccccc--CCCCcc
Q 017262 183 ALAYLHSSAYLPIYHRDIKSTNILLDEKY--RAKIADFGTSRSIAIDQ---THVSTKVQGTFGYLDPEYFRS--SQFTDK 255 (374)
Q Consensus 183 ~l~~lH~~~~~~i~H~dlk~~Nill~~~~--~~kl~Dfg~~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~--~~~~~~ 255 (374)
||+|||+.+ ++||||||+||+++.++ .+||+|||++....... ........||+.|+|||.+.+ ..++.+
T Consensus 180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999999999 99999999999998776 89999999998654322 122345569999999999875 678999
Q ss_pred chhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 017262 256 SDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRP 335 (374)
Q Consensus 256 ~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 335 (374)
+||||||+++|+|++|..||...... +............. .......+..+.+|+.+||+.||++||
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~------~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDA------DTISQVLNKKLCFE-------NPNYNVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCTT-------SGGGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcccccC-------CcccccCCHHHHHHHHHHcCCChhHCC
Confidence 99999999999999999999754322 22222222111100 001112345788999999999999999
Q ss_pred CHHHHHH
Q 017262 336 TMKEVAM 342 (374)
Q Consensus 336 s~~~vl~ 342 (374)
|+.++++
T Consensus 324 s~~~~l~ 330 (345)
T 3hko_A 324 DAMRALQ 330 (345)
T ss_dssp CHHHHHH
T ss_pred CHHHHhc
Confidence 9999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=327.57 Aligned_cols=262 Identities=22% Similarity=0.268 Sum_probs=202.6
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
-++|.+.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.++++++||||+++++++.+.+..+++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 578999999999999999999965 6889999988653 233457788999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
+||+++++|.+++. ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLR---RQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 99999999999997 3457999999999999999999999999 99999999999999999999999999876654
Q ss_pred CCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
..........+++.|+|||.+.+..++.++||||||+++|+|++|..||...... ........... .
T Consensus 187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~-~----- 253 (309)
T 2h34_A 187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIP-R----- 253 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCC-C-----
T ss_pred cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCC-C-----
Confidence 3333344556899999999999999999999999999999999999999743221 11121111110 0
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHHHhhCC
Q 017262 307 VRKSGEAEEIMAVSDVAKRCLNSYGRNRP-TMKEVAMELERIRANSR 352 (374)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-s~~~vl~~L~~~~~~~~ 352 (374)
....+...+..+.+++.+||+.||++|| |++++++.|+.......
T Consensus 254 -~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 254 -PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp -GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred -ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 0112233445788999999999999999 99999999998866543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=324.65 Aligned_cols=261 Identities=30% Similarity=0.485 Sum_probs=199.8
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
..++|++.+.||+|+||.||+|...+ .+|+|.+... .....+.+.+|+.++++++||||+++++++ ..+..++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 35789999999999999999998654 4999987654 345567899999999999999999999965 456789999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 99 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 99 QWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp ECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred EecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccc
Confidence 99999999999965 3457999999999999999999999999 999999999999999999999999999765432
Q ss_pred C-ceeeecccccccccCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccc
Q 017262 228 Q-THVSTKVQGTFGYLDPEYFR---SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDII 303 (374)
Q Consensus 228 ~-~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (374)
. ........||+.|+|||.+. +..++.++||||||+++|+|++|+.||...... ................
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~ 247 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR------DQIIEMVGRGSLSPDL 247 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH------HHHHHHHHHTSCCCCT
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH------HHHHHHhcccccCcch
Confidence 2 22234456899999999986 567888999999999999999999999753321 1222222222221111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 017262 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRA 349 (374)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~ 349 (374)
.......+..+.+|+.+||+.||++|||+.++++.|+++..
T Consensus 248 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 248 -----SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp -----TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -----hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 11122345689999999999999999999999999998753
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=339.28 Aligned_cols=252 Identities=25% Similarity=0.375 Sum_probs=199.8
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCC--CceeeeeeeeeecccceE
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVV--DESKLEEFINEVVILSQINH--RNVVKLLGCCLEVEVPLL 145 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~l 145 (374)
..++|++.+.||+|+||.||++...+++.||+|++... .......+.+|+.+++.++| |||+++++++.+.+..++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 35679999999999999999999988999999987643 34455788999999999976 999999999999999999
Q ss_pred EEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccc
Q 017262 146 VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 225 (374)
||| +.+++|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++ ++.+||+|||++....
T Consensus 87 v~e-~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 87 VME-CGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEC-CCSEEHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEe-CCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999 55889999997 4567999999999999999999999999 99999999999997 5789999999998765
Q ss_pred cCCce-eeecccccccccCcccccc-----------CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHH
Q 017262 226 IDQTH-VSTKVQGTFGYLDPEYFRS-----------SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVEC 293 (374)
Q Consensus 226 ~~~~~-~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 293 (374)
..... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||..... ......
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~-- 231 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLH-- 231 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHH--
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHHH--
Confidence 33322 2344569999999999865 6788999999999999999999999964321 111111
Q ss_pred HHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 294 IEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
..++.......+...+..+.+|+.+||+.||++|||+.++++.
T Consensus 232 -------~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 232 -------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp -------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -------HHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1112222222233334578899999999999999999999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=337.32 Aligned_cols=249 Identities=24% Similarity=0.336 Sum_probs=204.2
Q ss_pred HhhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC---hhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccc
Q 017262 69 KATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVP 143 (374)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 143 (374)
...++|.+.+.||+|+||.||+|..+ +++.||+|.+.... ......+..|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34678999999999999999999975 58899999886431 23345677899999877 899999999999999999
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccc
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 223 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 223 (374)
++||||+++|+|.+++. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 99999999999999997 3457999999999999999999999999 99999999999999999999999999975
Q ss_pred cccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccc
Q 017262 224 IAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDII 303 (374)
Q Consensus 224 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (374)
..... .......||+.|+|||++.+..++.++|+|||||++|+|++|..||..... ...+.......
T Consensus 168 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~------ 234 (345)
T 1xjd_A 168 NMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE------EELFHSIRMDN------ 234 (345)
T ss_dssp CCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC------
T ss_pred cccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHHhCC------
Confidence 43222 223456799999999999999999999999999999999999999964322 22222211111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 017262 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMK-EVA 341 (374)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~-~vl 341 (374)
...+...+..+.+||.+||+.||++||++. +++
T Consensus 235 -----~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 -----PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -----CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -----CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 112223456788999999999999999997 654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=336.70 Aligned_cols=211 Identities=26% Similarity=0.304 Sum_probs=181.9
Q ss_pred ceecChHHHHHhhcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCChhHHHHHHHHHHHHhhCC-----CCceee
Q 017262 59 CRIFNSKELDKATDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQIN-----HRNVVK 132 (374)
Q Consensus 59 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~ 132 (374)
...++..+.....++|.+.+.||+|+||.||+|.. .+++.||+|.+... ......+..|+.+++.+. ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 34455555666678999999999999999999997 46889999998743 344566788999999996 999999
Q ss_pred eeeeeeecccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECC---
Q 017262 133 LLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE--- 209 (374)
Q Consensus 133 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~--- 209 (374)
+++++...+..++||||+ +++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTC
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccc
Confidence 999999999999999999 99999998743 2345899999999999999999999999 999999999999975
Q ss_pred ----------------------CCcEEEeecccccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHH
Q 017262 210 ----------------------KYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVE 267 (374)
Q Consensus 210 ----------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~e 267 (374)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 251 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence 789999999999764322 234568999999999999999999999999999999
Q ss_pred HHhCCCCCCccc
Q 017262 268 LLTGQKPISSIW 279 (374)
Q Consensus 268 l~~g~~p~~~~~ 279 (374)
|++|+.||....
T Consensus 252 ll~g~~pf~~~~ 263 (360)
T 3llt_A 252 LYTGSLLFRTHE 263 (360)
T ss_dssp HHHSSCSCCCSS
T ss_pred HHHCCCCCCCCc
Confidence 999999997543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=334.27 Aligned_cols=249 Identities=24% Similarity=0.321 Sum_probs=204.4
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEecC-CcEEEEEEeccC---ChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccce
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVV---DESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVPL 144 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 144 (374)
..++|++.+.||+|+||.||+|.... ++.||+|.+... .......+..|..++..+ +||||+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 35789999999999999999999764 788999988643 123446678899999988 7999999999999999999
Q ss_pred EEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccc
Q 017262 145 LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 224 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 224 (374)
+||||+++|+|.+++. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 98 lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQ---QVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 9999999999999997 3457999999999999999999999999 999999999999999999999999999754
Q ss_pred ccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccc
Q 017262 225 AIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIID 304 (374)
Q Consensus 225 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (374)
... ........||+.|+|||++.+..++.++|+||||+++|||++|+.||.... ....+.......
T Consensus 172 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~------~~~~~~~i~~~~------- 237 (353)
T 2i0e_A 172 IWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED------EDELFQSIMEHN------- 237 (353)
T ss_dssp CCT-TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCC-------
T ss_pred ccC-CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC------HHHHHHHHHhCC-------
Confidence 322 222344579999999999999999999999999999999999999996432 222222222211
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 017262 305 DQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTM-----KEVAM 342 (374)
Q Consensus 305 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~-----~~vl~ 342 (374)
...+...+..+.+||.+||+.||++||++ +++++
T Consensus 238 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 238 ----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ----CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11233445688999999999999999964 66654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=340.29 Aligned_cols=246 Identities=25% Similarity=0.301 Sum_probs=198.4
Q ss_pred CceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeecCCcc
Q 017262 77 NRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTL 155 (374)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 155 (374)
.+.||+|+||.||+|... +|+.||+|.+..........+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 568999999999999964 6899999999877666778899999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEE--CCCCcEEEeecccccccccCCceeee
Q 017262 156 FQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL--DEKYRAKIADFGTSRSIAIDQTHVST 233 (374)
Q Consensus 156 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill--~~~~~~kl~Dfg~~~~~~~~~~~~~~ 233 (374)
.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++....... ...
T Consensus 174 ~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~~ 246 (373)
T 2x4f_A 174 FDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KLK 246 (373)
T ss_dssp HHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BCC
T ss_pred HHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--ccc
Confidence 998864 3446899999999999999999999999 9999999999999 677899999999998764332 223
Q ss_pred cccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCH
Q 017262 234 KVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEA 313 (374)
Q Consensus 234 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (374)
...||+.|+|||++.+..++.++|||||||++|+|++|..||..... ...+....... .. . .. ....
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~~~~i~~~~-~~-~-~~----~~~~ 313 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND------AETLNNILACR-WD-L-ED----EEFQ 313 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTC-CC-S-CS----GGGT
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhcc-CC-C-Ch----hhhc
Confidence 34699999999999988999999999999999999999999974332 22222222211 00 0 00 0112
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 314 EEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 314 ~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..+..+.+||.+||+.||++|||+.++++
T Consensus 314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 314 DISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 23457899999999999999999999987
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=322.71 Aligned_cols=252 Identities=26% Similarity=0.393 Sum_probs=205.2
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 148 (374)
.++|++.+.||+|+||.||+|... +++.+|+|.+... .......+.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 457899999999999999999975 6889999987643 23445778899999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
|+++++|.+++. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 999999999997 3457999999999999999999999999 9999999999999999999999999997654322
Q ss_pred c-eeeecccccccccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 229 T-HVSTKVQGTFGYLDPEYFRSSQF-TDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 229 ~-~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
. .......|++.|+|||.+.+..+ +.++||||||+++|+|++|..||....... ...........
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~-------- 226 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-----QEYSDWKEKKT-------- 226 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-----HHHHHHHTTCT--------
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-----HHHHHhhhccc--------
Confidence 2 22344568999999999987665 778999999999999999999997543221 01111111110
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 307 VRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
........+..+.+|+.+||+.||++|||+.++++
T Consensus 227 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 227 -YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp -TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 01111233557889999999999999999999875
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=334.38 Aligned_cols=250 Identities=22% Similarity=0.293 Sum_probs=180.3
Q ss_pred CceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCC-CCceeeeeeeeeecccceEEEEeecCCc
Q 017262 77 NRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQIN-HRNVVKLLGCCLEVEVPLLVYEFIPNGT 154 (374)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~ 154 (374)
.+.||+|+||.||+|... +++.+|+|.+... ....+.+|+.+++.+. ||||+++++++.+.+..++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 378999999999999975 5899999988642 3456778999999997 9999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCC---cEEEeecccccccccCCcee
Q 017262 155 LFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY---RAKIADFGTSRSIAIDQTHV 231 (374)
Q Consensus 155 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~---~~kl~Dfg~~~~~~~~~~~~ 231 (374)
|.+++. ....+++..+..++.|++.||+|||+++ ++||||||+|||++.++ .+||+|||++....... ..
T Consensus 93 L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~ 165 (325)
T 3kn6_A 93 LFERIK---KKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QP 165 (325)
T ss_dssp HHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-Cc
Confidence 999997 4567999999999999999999999999 99999999999997665 89999999997654322 22
Q ss_pred eecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCC
Q 017262 232 STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSG 311 (374)
Q Consensus 232 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (374)
.....||+.|+|||.+.+..++.++||||||+++|+|++|..||......................... .....
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~------~~~~~ 239 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS------FEGEA 239 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC------CCSHH
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC------CCccc
Confidence 344568999999999999999999999999999999999999997644322111111111111111110 00000
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 312 EAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 312 ~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
....+..+.+|+.+||+.||++|||+.++++
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 1124568899999999999999999999874
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=338.14 Aligned_cols=267 Identities=23% Similarity=0.341 Sum_probs=198.3
Q ss_pred HHHhhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCC-CCceeeeeeeee------
Q 017262 67 LDKATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQIN-HRNVVKLLGCCL------ 138 (374)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~------ 138 (374)
+.....+|++.+.||+|+||.||+|... +++.||+|++..........+.+|+.+++++. ||||+++++++.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 3444568999999999999999999964 68899999987777777788999999999996 999999999984
Q ss_pred --ecccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEe
Q 017262 139 --EVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIA 216 (374)
Q Consensus 139 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~ 216 (374)
.....++++||++ |+|.+++........+++..++.++.|++.||+|||+.+ .+++|+||||+|||++.++.+||+
T Consensus 103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBC
T ss_pred ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEe
Confidence 3335789999995 788888864334567999999999999999999999986 359999999999999999999999
Q ss_pred ecccccccccCCcee-----------eecccccccccCcccc---ccCCCCccchhhhHHHHHHHHHhCCCCCCcccccc
Q 017262 217 DFGTSRSIAIDQTHV-----------STKVQGTFGYLDPEYF---RSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANE 282 (374)
Q Consensus 217 Dfg~~~~~~~~~~~~-----------~~~~~g~~~y~aPE~~---~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~ 282 (374)
|||++.......... .....+|+.|+|||++ .+..++.++||||||+++|+|++|..||.......
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~ 260 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR 260 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence 999998765322211 1134589999999998 56678999999999999999999999996432211
Q ss_pred CCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCCC
Q 017262 283 GRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDD 354 (374)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~~ 354 (374)
..............+..+.+|+.+||+.||++|||+.++++.|+.+.......
T Consensus 261 -------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~ 313 (337)
T 3ll6_A 261 -------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN 313 (337)
T ss_dssp ------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred -------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCC
Confidence 11111111111222335789999999999999999999999999998865543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=336.79 Aligned_cols=253 Identities=25% Similarity=0.354 Sum_probs=192.0
Q ss_pred HHhhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 68 DKATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 68 ~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
....++|++.+.||+|+||.||+|... +++.||+|.+.... ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 445678999999999999999999976 47899999887542 345678899999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECC---CCcEEEeecccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE---KYRAKIADFGTSRS 223 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfg~~~~ 223 (374)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+|||++. ++.+||+|||++..
T Consensus 127 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 127 LELVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp ECCCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred EEeCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 999999999999973 456899999999999999999999999 999999999999975 88999999999976
Q ss_pred cccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccc
Q 017262 224 IAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDII 303 (374)
Q Consensus 224 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (374)
.... .......||+.|+|||.+.+..++.++|||||||++|+|++|..||...... ...+.... .....
T Consensus 201 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~i~-~~~~~--- 269 (349)
T 2w4o_A 201 VEHQ--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD-----QFMFRRIL-NCEYY--- 269 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-----HHHHHHHH-TTCCC---
T ss_pred cCcc--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc-----HHHHHHHH-hCCCc---
Confidence 5422 2233456899999999999989999999999999999999999999643221 11111111 11110
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.........+..+.+|+.+||+.||++|||+.++++
T Consensus 270 ---~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 270 ---FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp ---CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001111234567889999999999999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=337.30 Aligned_cols=248 Identities=26% Similarity=0.397 Sum_probs=201.6
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCC---hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVD---ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
.+.|...+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35688999999999999999996 568899999886532 33456788999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
|||++ |+|.+++.. ....+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 133 ~e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99996 677777753 3457899999999999999999999999 99999999999999999999999999976543
Q ss_pred CCceeeecccccccccCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccc
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFR---SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDII 303 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (374)
. ....||+.|+|||++. ...++.++||||||+++|+|++|..||..... ........... ..
T Consensus 207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~~~~~~-~~--- 271 (348)
T 1u5q_A 207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNE-SP--- 271 (348)
T ss_dssp B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSC-CC---
T ss_pred C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcC-CC---
Confidence 2 2346899999999984 56789999999999999999999999964322 11111111111 11
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 017262 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMEL 344 (374)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L 344 (374)
...+...+..+.+|+.+||+.||++|||+.++++..
T Consensus 272 -----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 272 -----ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred -----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 111223345788999999999999999999998743
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=331.39 Aligned_cols=244 Identities=24% Similarity=0.264 Sum_probs=192.3
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 147 (374)
++|++.+.||+|+||+||+|... +++.||+|++... ..........|+..+..+ +||||+++++++.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999976 6899999987643 233344555666666555 8999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
||+ +++|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 137 e~~-~~~L~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEA--WGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHH--HCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 6788888764 2456999999999999999999999999 999999999999999999999999998765432
Q ss_pred CceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (374)
.......||+.|+|||++.+ .++.++||||||+++|||++|..|+..... .. ....... ..
T Consensus 211 --~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---------~~-~~~~~~~----~~-- 271 (311)
T 3p1a_A 211 --GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---------WQ-QLRQGYL----PP-- 271 (311)
T ss_dssp ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---------HH-HHTTTCC----CH--
T ss_pred --CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---------HH-HHhccCC----Cc--
Confidence 22334568999999999875 789999999999999999999766542111 00 1111100 00
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..+...+..+.+++.+||+.||++|||+.++++
T Consensus 272 --~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 272 --EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp --HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 011123467899999999999999999999985
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=344.49 Aligned_cols=247 Identities=25% Similarity=0.353 Sum_probs=205.6
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC---hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
.++|.+.+.||+|+||.||+|... +|+.||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 367899999999999999999975 68999999886432 22346788999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
|||+++|+|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 95 ~E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999997 3557999999999999999999999999 99999999999999999999999999987543
Q ss_pred CCceeeecccccccccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccc
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFRSSQF-TDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDD 305 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (374)
. .......||+.|+|||.+.+..+ +.++||||||+++|+|++|..||..... ......... ..
T Consensus 169 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~------~~~~~~i~~-~~------- 232 (476)
T 2y94_A 169 G--EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV------PTLFKKICD-GI------- 232 (476)
T ss_dssp T--CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS------HHHHHHHHT-TC-------
T ss_pred c--ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH------HHHHHHHhc-CC-------
Confidence 2 22344569999999999988765 6899999999999999999999964322 222222111 11
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 306 QVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
...+...+..+.+|+.+||+.||++|||+.++++
T Consensus 233 ---~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 233 ---FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 1112233457889999999999999999999987
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=329.97 Aligned_cols=270 Identities=24% Similarity=0.342 Sum_probs=205.5
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEecc---CChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceE
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKV---VDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLL 145 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 145 (374)
..++|++.+.||+|+||.||+|.. .+++.+|+|.+.. .+......+.+|+.++++++||||+++++++.+.+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 346799999999999999999996 4689999998865 235556788999999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccc
Q 017262 146 VYEFIPNGTLFQYLHDPY-EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 224 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 224 (374)
||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++...
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 999999999999886321 2456899999999999999999999999 999999999999999999999999998765
Q ss_pred ccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccc
Q 017262 225 AIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIID 304 (374)
Q Consensus 225 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (374)
.... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||..... ....... .........
T Consensus 187 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~-~~~~~~~~~--- 257 (310)
T 2wqm_A 187 SSKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCK-KIEQCDYPP--- 257 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C----CHHHHHH-HHHTTCSCC---
T ss_pred cCCC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----hHHHHHH-HhhcccCCC---
Confidence 4322 222344689999999999999999999999999999999999999964221 1112111 111111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCCCcc
Q 017262 305 DQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDDEN 356 (374)
Q Consensus 305 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~~~~ 356 (374)
......+..+.+|+.+||+.||++|||+.++++.|+++.+....+.+
T Consensus 258 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~ 304 (310)
T 2wqm_A 258 -----LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE 304 (310)
T ss_dssp -----CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC----
T ss_pred -----CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhh
Confidence 11123455789999999999999999999999999999987776544
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=325.13 Aligned_cols=264 Identities=22% Similarity=0.277 Sum_probs=199.6
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC--hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 148 (374)
++|++.+.||+|+||.||+|... +++.+|+|++.... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57999999999999999999975 48999999875533 3345678899999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
|+++++|.+++. ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 999999999886 3457999999999999999999999999 9999999999999999999999999997654322
Q ss_pred ceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCCh--------HHHHHHHHHhccc
Q 017262 229 THVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNL--------TTYFVECIEENCL 299 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~--------~~~~~~~~~~~~~ 299 (374)
.......+|+.|+|||.+.+ ..++.++||||||+++|+|++|..||......+.... .............
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 157 -DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred -cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence 22334568999999999876 6689999999999999999999999975443211000 0000001111111
Q ss_pred ccccccccc-CCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 300 FDIIDDQVR-KSG-----EAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 300 ~~~~~~~~~-~~~-----~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
......... ... .+..+..+.+|+.+||+.||++|||++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000000 000 0234557889999999999999999999985
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=324.06 Aligned_cols=251 Identities=22% Similarity=0.346 Sum_probs=205.8
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
.++|++.+.||+|+||.||+|... +++.+|+|.+... .......+.+|+.++++++||||+++++++.+.+..+++|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 578999999999999999999965 5889999987543 4455678889999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCc---EEEeeccccccc
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR---AKIADFGTSRSI 224 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~---~kl~Dfg~~~~~ 224 (374)
||+++++|.+++. ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 9999999988887 3457999999999999999999999999 999999999999986655 999999999765
Q ss_pred ccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccc
Q 017262 225 AIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIID 304 (374)
Q Consensus 225 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (374)
.... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||..... ....... .......
T Consensus 159 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~~~~~~~-~~~~~~~--- 226 (284)
T 3kk8_A 159 NDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------HRLYAQI-KAGAYDY--- 226 (284)
T ss_dssp CSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHH-HHTCCCC---
T ss_pred ccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch------hHHHHHH-HhccccC---
Confidence 4322 22345689999999999999999999999999999999999999964322 1112111 1111110
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 305 DQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 305 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
........+..+.+|+.+||+.||++|||+.++++
T Consensus 227 ---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 227 ---PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp ---CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 01111233457889999999999999999999987
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=340.30 Aligned_cols=251 Identities=24% Similarity=0.372 Sum_probs=199.5
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCC--CCceeeeeeeeeecccceEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVV--DESKLEEFINEVVILSQIN--HRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv 146 (374)
.++|.+.+.||+|+||.||++...+++.||+|.+... .......+.+|+.++++++ ||||+++++++...+..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 4569999999999999999999888999999987643 4455678899999999996 59999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
|| +.+++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||++.....
T Consensus 135 ~E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 568899999973 457899999999999999999999999 99999999999995 57999999999987653
Q ss_pred CCce-eeecccccccccCcccccc-----------CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHH
Q 017262 227 DQTH-VSTKVQGTFGYLDPEYFRS-----------SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECI 294 (374)
Q Consensus 227 ~~~~-~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 294 (374)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ....+..
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~~-- 279 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHA-- 279 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHH--
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHHHH--
Confidence 3322 2344579999999999865 3688999999999999999999999964321 1111111
Q ss_pred HhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 295 EENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
.++.......+...+..+.+|+.+||+.||++|||+.++++.
T Consensus 280 -------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 280 -------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp -------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -------HhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 112222222222224578899999999999999999999863
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=330.43 Aligned_cols=251 Identities=26% Similarity=0.347 Sum_probs=205.1
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCCh------hHHHHHHHHHHHHhhCCCCceeeeeeeeeecccc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE------SKLEEFINEVVILSQINHRNVVKLLGCCLEVEVP 143 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 143 (374)
.++|++.+.||+|+||.||+|... +|+.+|+|.+..... .....+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467999999999999999999975 588999998765322 1356788999999999999999999999999999
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCC----cEEEeecc
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY----RAKIADFG 219 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~----~~kl~Dfg 219 (374)
++||||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999973 457899999999999999999999999 99999999999999888 79999999
Q ss_pred cccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccc
Q 017262 220 TSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCL 299 (374)
Q Consensus 220 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (374)
++....... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||..... ........ ....
T Consensus 165 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~i~-~~~~ 235 (321)
T 2a2a_A 165 LAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANIT-SVSY 235 (321)
T ss_dssp TCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHH-TTCC
T ss_pred cceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHH-hccc
Confidence 998654322 22345689999999999999999999999999999999999999964322 11111111 1100
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 300 FDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
....... ...+..+.+|+.+||+.||++|||+.++++
T Consensus 236 --~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 --DFDEEFF----SHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp --CCCHHHH----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred --ccChhhh----cccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000000 123457889999999999999999999986
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=323.30 Aligned_cols=249 Identities=24% Similarity=0.369 Sum_probs=184.7
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCC---hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVD---ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
.++|.+.+.||+|+||.||+|.. .+++.+|+|.+.... ......+.+|+.++++++||||+++++++.+.+..+++
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 45789999999999999999996 468999999886432 12246788999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999999975 3457899999999999999999999999 99999999999999999999999999976543
Q ss_pred CCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||........ ........
T Consensus 165 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---------------~~~~~~~~ 228 (278)
T 3cok_A 165 PHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT---------------LNKVVLAD 228 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSSC
T ss_pred CCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH---------------HHHHhhcc
Confidence 222 22335689999999999988899999999999999999999999975432211 00000000
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 307 VRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
...+...+..+.+++.+||+.||++|||+.++++
T Consensus 229 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 229 --YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred --cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 1122334567889999999999999999999885
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=328.28 Aligned_cols=273 Identities=23% Similarity=0.354 Sum_probs=213.7
Q ss_pred hHHHHHhhcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhh--CCCCceeeeeeeeeecc
Q 017262 64 SKELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQ--INHRNVVKLLGCCLEVE 141 (374)
Q Consensus 64 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~ 141 (374)
........++|.+.+.||+|+||.||+|.. +++.||+|.+... ....+.+|.+++.. ++||||+++++++...+
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 334455567899999999999999999998 4889999988643 34567788998887 68999999999998776
Q ss_pred ----cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCEEEeccCCCceEECC
Q 017262 142 ----VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLH--------SSAYLPIYHRDIKSTNILLDE 209 (374)
Q Consensus 142 ----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH--------~~~~~~i~H~dlk~~Nill~~ 209 (374)
..++||||+++|+|.+++.. ..+++..++.++.|++.||+||| +.+ ++|+||||+||+++.
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKK 182 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECT
T ss_pred CccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECC
Confidence 78999999999999999963 46899999999999999999999 777 999999999999999
Q ss_pred CCcEEEeecccccccccCCce---eeecccccccccCccccccCC------CCccchhhhHHHHHHHHHhC---------
Q 017262 210 KYRAKIADFGTSRSIAIDQTH---VSTKVQGTFGYLDPEYFRSSQ------FTDKSDVYSFGVVLVELLTG--------- 271 (374)
Q Consensus 210 ~~~~kl~Dfg~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~------~~~~~Di~slG~~l~el~~g--------- 271 (374)
++.+||+|||++......... ......||+.|+|||.+.+.. ++.++||||||+++|+|++|
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 262 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262 (342)
T ss_dssp TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence 999999999999776543322 223456999999999987652 34689999999999999999
Q ss_pred -CCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 017262 272 -QKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350 (374)
Q Consensus 272 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~ 350 (374)
..||........ ....+. ...........+... ......+..+.+|+.+||+.||++|||+.++++.|+.+..+
T Consensus 263 ~~~p~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 263 YQLPYYDLVPSDP-SVEEMR-KVVCEQKLRPNIPNR---WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp CCCTTTTTSCSSC-CHHHHH-HHHTTSCCCCCCCGG---GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cccCccccCcCcc-cHHHHH-HHHHHHHhCCCCccc---ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 778865433221 122211 111111111111110 12346778899999999999999999999999999999875
Q ss_pred CC
Q 017262 351 SR 352 (374)
Q Consensus 351 ~~ 352 (374)
..
T Consensus 338 ~~ 339 (342)
T 1b6c_B 338 EG 339 (342)
T ss_dssp TC
T ss_pred hc
Confidence 43
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=333.75 Aligned_cols=262 Identities=27% Similarity=0.409 Sum_probs=208.5
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe------cCCcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML------ADGRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVP 143 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 143 (374)
.++|.+.+.||+|+||.||+|.. .++..||+|.+... .......+.+|+.++++++||||+++++++.+.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 57899999999999999999984 24678999998643 345566789999999999999999999999999999
Q ss_pred eEEEEeecCCcccccccCCC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECC---CCcEEEe
Q 017262 144 LLVYEFIPNGTLFQYLHDPY----EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE---KYRAKIA 216 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~---~~~~kl~ 216 (374)
++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 99999999999999997432 1245899999999999999999999999 999999999999984 4469999
Q ss_pred ecccccccccCCc-eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHH
Q 017262 217 DFGTSRSIAIDQT-HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECI 294 (374)
Q Consensus 217 Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 294 (374)
|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... .... ...
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------~~~~-~~~ 258 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------QEVL-EFV 258 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHH-HHH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH------HHHH-HHH
Confidence 9999875543222 22234557889999999998999999999999999999998 9999964322 1111 111
Q ss_pred HhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhC
Q 017262 295 EENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANS 351 (374)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~ 351 (374)
... .....+...+..+.+++.+||+.||++|||+.++++.|+.+..+.
T Consensus 259 ~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 259 TSG---------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp HTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred hcC---------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 111 111223344567899999999999999999999999999987643
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=332.01 Aligned_cols=256 Identities=25% Similarity=0.356 Sum_probs=199.9
Q ss_pred hcCCCcC-ceEeeeCeEEEEEEEe-cCCcEEEEEEeccCChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccceEEE
Q 017262 71 TDYFNMN-RILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 71 ~~~~~~~-~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 147 (374)
.+.|.+. +.||+|+||.||+|.. .+++.||+|.+..........+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4568874 7899999999999995 46899999998766556667889999999985 7999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCc---EEEeeccccccc
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR---AKIADFGTSRSI 224 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~---~kl~Dfg~~~~~ 224 (374)
||+++++|.+++.. ...+++..+..++.|++.||+|||+++ ++||||||+||+++.++. +||+|||++...
T Consensus 91 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 99999999999973 457899999999999999999999999 999999999999998776 999999998765
Q ss_pred ccCCc------eeeecccccccccCcccccc-----CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCC-----h--
Q 017262 225 AIDQT------HVSTKVQGTFGYLDPEYFRS-----SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRN-----L-- 286 (374)
Q Consensus 225 ~~~~~------~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~-----~-- 286 (374)
..... .......||+.|+|||.+.+ ..++.++||||||+++|+|++|..||......+... .
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 32211 11223458999999999875 557899999999999999999999997654322110 0
Q ss_pred -HHHHHHHHHhccccccccccccCCCCH----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 287 -TTYFVECIEENCLFDIIDDQVRKSGEA----EEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 287 -~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
............. ..+. ..+..+.+|+.+||+.||++|||+.++++
T Consensus 245 ~~~~~~~~i~~~~~----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 245 CQNMLFESIQEGKY----------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHCCC----------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHhccCc----------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 0111111111111 1111 23457899999999999999999999987
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=329.28 Aligned_cols=261 Identities=23% Similarity=0.363 Sum_probs=188.9
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 148 (374)
.++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 457899999999999999999964 58899999886543 2334678899999999999999999999999999999999
Q ss_pred eecCCcccccccCCC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccc
Q 017262 149 FIPNGTLFQYLHDPY---EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 225 (374)
|++ ++|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 58888875321 2246899999999999999999999999 9999999999999999999999999998654
Q ss_pred cCCceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHh-cc----c
Q 017262 226 IDQTHVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEE-NC----L 299 (374)
Q Consensus 226 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~----~ 299 (374)
... .......+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||......+ ......+. +. .
T Consensus 160 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~~~~~~~~~~~ 232 (317)
T 2pmi_A 160 IPV-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE------QLKLIFDIMGTPNESL 232 (317)
T ss_dssp SCC-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHHHCSCCTTT
T ss_pred CCc-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHHHhCCCChhH
Confidence 322 22234568999999999876 468999999999999999999999997543221 11111110 00 0
Q ss_pred cccc------ccc------------ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 300 FDII------DDQ------------VRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 300 ~~~~------~~~------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.... ... .........+..+.+|+.+||+.||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0000 000 000011123457899999999999999999999875
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=324.47 Aligned_cols=247 Identities=29% Similarity=0.394 Sum_probs=201.6
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC---hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
.++|++.+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467899999999999999999865 46789999875422 22245688999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
|||+++++|.+++. ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 99999999999987 3457899999999999999999999999 99999999999999999999999998865432
Q ss_pred CCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
.......|++.|+|||.+.+..++.++||||||+++|+|++|..||..... ......... .
T Consensus 162 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~--------- 222 (279)
T 3fdn_A 162 ---SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------QETYKRISR-V--------- 222 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHH-T---------
T ss_pred ---ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH------HHHHHHHHh-C---------
Confidence 222345689999999999999999999999999999999999999964322 111111111 1
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 307 VRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
....+...+..+.+|+.+||+.||++|||+.++++.
T Consensus 223 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 223 -EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp -CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred -CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 111223345578899999999999999999999974
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=331.32 Aligned_cols=273 Identities=24% Similarity=0.374 Sum_probs=201.0
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHH--HhhCCCCceeeeeeeeee-----cccc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVI--LSQINHRNVVKLLGCCLE-----VEVP 143 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~~~~~~~~-----~~~~ 143 (374)
.++|++.+.||+|+||.||+|.. +++.||+|++.... ...+..|.++ +..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46899999999999999999977 67899999986533 2334444444 455899999999986542 2356
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc---------CCCCEEEeccCCCceEECCCCcEE
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSS---------AYLPIYHRDIKSTNILLDEKYRAK 214 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---------~~~~i~H~dlk~~Nill~~~~~~k 214 (374)
++||||+++|+|.+++.. ...++..++.++.|++.||+|||+. + |+||||||+|||++.++.+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred EEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence 899999999999999963 3458999999999999999999998 7 99999999999999999999
Q ss_pred EeecccccccccCCc-------eeeecccccccccCcccccc-------CCCCccchhhhHHHHHHHHHhCCCCCCcccc
Q 017262 215 IADFGTSRSIAIDQT-------HVSTKVQGTFGYLDPEYFRS-------SQFTDKSDVYSFGVVLVELLTGQKPISSIWA 280 (374)
Q Consensus 215 l~Dfg~~~~~~~~~~-------~~~~~~~g~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~g~~p~~~~~~ 280 (374)
|+|||++........ .......||+.|+|||++.+ ..++.++||||||+++|||++|..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999986643221 11234469999999999976 3566789999999999999999777643322
Q ss_pred ccC-C----------ChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 017262 281 NEG-R----------NLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRA 349 (374)
Q Consensus 281 ~~~-~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~ 349 (374)
... . ..................+.. ........+..+.+||.+||+.||++|||+.++++.|+.+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE--AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT--TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCc--ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 111 0 001111111111111111101 111233567789999999999999999999999999999987
Q ss_pred hCCCCcc
Q 017262 350 NSRDDEN 356 (374)
Q Consensus 350 ~~~~~~~ 356 (374)
....+..
T Consensus 319 ~~~~~~~ 325 (336)
T 3g2f_A 319 IWERNKS 325 (336)
T ss_dssp CCCC---
T ss_pred HHHhccc
Confidence 6654443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=358.33 Aligned_cols=251 Identities=29% Similarity=0.440 Sum_probs=203.5
Q ss_pred ceEeeeCeEEEEEEEec---CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeecC
Q 017262 78 RILGQGGQGTVYKGMLA---DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPN 152 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~---~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 152 (374)
+.||+|+||.||+|.+. .++.||+|+++.. +....+.+.+|+.++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 4678999988753 33446789999999999999999999999864 567899999999
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce--
Q 017262 153 GTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH-- 230 (374)
Q Consensus 153 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-- 230 (374)
|+|.+++. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 454 g~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 99999997 4567999999999999999999999999 999999999999999999999999999876543322
Q ss_pred eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccccccC
Q 017262 231 VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309 (374)
Q Consensus 231 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (374)
......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+ +...+.. ....
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~---------~~~~ 591 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEK---------GERM 591 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHT---------TCCC
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHc---------CCCC
Confidence 2233446789999999999999999999999999999998 999997543321 1112221 1122
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhC
Q 017262 310 SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANS 351 (374)
Q Consensus 310 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~ 351 (374)
..+...+..+.+|+.+||+.||++|||+.++++.|+.+..+.
T Consensus 592 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 592 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 233445678999999999999999999999999999987654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=327.62 Aligned_cols=251 Identities=25% Similarity=0.424 Sum_probs=205.5
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeee----------
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLE---------- 139 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---------- 139 (374)
.++|++.+.||+|+||.||+|... +++.+|+|.+.... ..+.+|+.++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 457899999999999999999976 68999999887643 245689999999999999999998864
Q ss_pred ------cccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcE
Q 017262 140 ------VEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA 213 (374)
Q Consensus 140 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~ 213 (374)
....++||||+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence 34579999999999999999643 2457899999999999999999999999 9999999999999999999
Q ss_pred EEeecccccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHH
Q 017262 214 KIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVEC 293 (374)
Q Consensus 214 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 293 (374)
||+|||++....... ......+++.|+|||.+.+..++.++||||||+++|+|++|..|+.... ... ..
T Consensus 162 kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--------~~~-~~ 230 (284)
T 2a19_B 162 KIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--------KFF-TD 230 (284)
T ss_dssp EECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--------HHH-HH
T ss_pred EECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--------HHH-HH
Confidence 999999997664332 2234468999999999999999999999999999999999998864211 111 11
Q ss_pred HHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCC
Q 017262 294 IEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSR 352 (374)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~ 352 (374)
..... .+...+..+.+++.+||+.||++|||+.++++.|+.+..+..
T Consensus 231 ~~~~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 231 LRDGI------------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp HHTTC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred hhccc------------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 11111 112233468899999999999999999999999999876544
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=347.27 Aligned_cols=248 Identities=24% Similarity=0.296 Sum_probs=196.4
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
.++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999964 5889999988642 334456678899999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCEEEeccCCCceEECCCCcEEEeecccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS-SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 225 (374)
|||+++|+|.+++. ....+++..+..++.|++.||+|||+ .+ |+||||||+|||++.++.+||+|||++....
T Consensus 227 ~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999999987 35579999999999999999999998 88 9999999999999999999999999997543
Q ss_pred cCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccc
Q 017262 226 IDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDD 305 (374)
Q Consensus 226 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (374)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ...........
T Consensus 301 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~-------- 365 (446)
T 4ejn_A 301 KD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILMEE-------- 365 (446)
T ss_dssp C------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC--------
T ss_pred CC-CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH------HHHHHHHHhCC--------
Confidence 22 2233456799999999999999999999999999999999999999964322 22222111111
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 017262 306 QVRKSGEAEEIMAVSDVAKRCLNSYGRNRP-----TMKEVAM 342 (374)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~vl~ 342 (374)
...+...+..+.+||.+||+.||++|| |++++++
T Consensus 366 ---~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 366 ---IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 112233456789999999999999999 9999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=325.40 Aligned_cols=251 Identities=28% Similarity=0.440 Sum_probs=207.8
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 148 (374)
.+.|++.+.||+|+||.||+|... +++.+|+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 456899999999999999999864 68899999886543 3456788999999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
|+++++|.+++. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999999986 346899999999999999999999999 9999999999999999999999999997654322
Q ss_pred ceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccccc
Q 017262 229 THVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVR 308 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (374)
.......|++.|+|||.+.+..++.++||||||+++|+|++|..||...... .... ...... .
T Consensus 174 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~-~~~~~~---------~ 236 (303)
T 3a7i_A 174 -IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM------KVLF-LIPKNN---------P 236 (303)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHH-HHHHSC---------C
T ss_pred -cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH------HHHH-HhhcCC---------C
Confidence 2234456899999999999999999999999999999999999999643221 1111 111111 1
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017262 309 KSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345 (374)
Q Consensus 309 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~ 345 (374)
...+...+..+.+|+.+||+.||++|||+.++++...
T Consensus 237 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 237 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 1122233457889999999999999999999988543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=334.25 Aligned_cols=260 Identities=24% Similarity=0.352 Sum_probs=192.4
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEecc--CChhHHHHHHHHHHHHhhCC-CCceeeeeeeeeecc--cc
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV--VDESKLEEFINEVVILSQIN-HRNVVKLLGCCLEVE--VP 143 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~--~~ 143 (374)
..++|++.+.||+|+||.||+|... +++.||+|++.. ........+.+|+.+++.+. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 3578999999999999999999964 689999998754 34556677889999999997 999999999997544 67
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccc
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 223 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 223 (374)
|+||||++ ++|..++. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~lv~e~~~-~~L~~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIR----ANILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHH----HTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999996 68888886 347899999999999999999999999 99999999999999999999999999976
Q ss_pred cccC--------------------CceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcccccc
Q 017262 224 IAID--------------------QTHVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANE 282 (374)
Q Consensus 224 ~~~~--------------------~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~ 282 (374)
.... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 5321 1122344579999999999876 678999999999999999999999997543211
Q ss_pred CCChHHHHHHHHHhccccc--cc----------------------ccccc------------CCCCHHHHHHHHHHHHHh
Q 017262 283 GRNLTTYFVECIEENCLFD--II----------------------DDQVR------------KSGEAEEIMAVSDVAKRC 326 (374)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~--~~----------------------~~~~~------------~~~~~~~~~~l~~li~~c 326 (374)
.+......-.... .+ ..... .......+..+.+|+.+|
T Consensus 239 ------~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~ 312 (388)
T 3oz6_A 239 ------QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKL 312 (388)
T ss_dssp ------HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHH
T ss_pred ------HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHh
Confidence 1111111000000 00 00000 000112345788999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 017262 327 LNSYGRNRPTMKEVAME 343 (374)
Q Consensus 327 l~~~p~~Rps~~~vl~~ 343 (374)
|+.||++|||++++++-
T Consensus 313 L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 313 LQFNPNKRISANDALKH 329 (388)
T ss_dssp CCSSGGGSCCHHHHTTS
T ss_pred hccCcccCCCHHHHhCC
Confidence 99999999999999864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=333.18 Aligned_cols=268 Identities=15% Similarity=0.207 Sum_probs=208.8
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecC---------CcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceee---------
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLAD---------GRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVK--------- 132 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~--------- 132 (374)
.++|.+.+.||+|+||.||+|.... ++.+|+|.+... ..+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4689999999999999999999763 789999988753 35778999999999999987
Q ss_pred ------eeeeeee-cccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCce
Q 017262 133 ------LLGCCLE-VEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNI 205 (374)
Q Consensus 133 ------~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Ni 205 (374)
+++++.. .+..++||||+ +++|.+++... ....+++..++.++.|++.||+|||+++ ++||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 5666665 56789999999 99999999743 2367999999999999999999999999 99999999999
Q ss_pred EECCCC--cEEEeecccccccccCCce------eeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCc
Q 017262 206 LLDEKY--RAKIADFGTSRSIAIDQTH------VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISS 277 (374)
Q Consensus 206 ll~~~~--~~kl~Dfg~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~ 277 (374)
|++.++ .+||+|||++......... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 8999999999766533221 11334699999999999998999999999999999999999999975
Q ss_pred cccccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCCC
Q 017262 278 IWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDD 354 (374)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~~ 354 (374)
..... .......... . ........... .....+..+.+|+.+||+.||++|||+.++++.|+.+.......
T Consensus 271 ~~~~~-~~~~~~~~~~-~-~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 271 CLPNT-EDIMKQKQKF-V-DKPGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS 341 (352)
T ss_dssp GTTCH-HHHHHHHHHH-H-HSCCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred CCcCH-HHHHHHHHhc-c-CChhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence 43111 0111111111 1 11111111100 00122457889999999999999999999999999998876643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=342.93 Aligned_cols=256 Identities=21% Similarity=0.283 Sum_probs=195.4
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc-----
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVE----- 141 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 141 (374)
..++|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+.+++.++||||+++++++...+
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3578999999999999999999964 5889999988653 4555678889999999999999999999997554
Q ss_pred -cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccc
Q 017262 142 -VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGT 220 (374)
Q Consensus 142 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 220 (374)
..++||||++++ |.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 140 ~~~~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 140 QDVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp CEEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred CeEEEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEe
Confidence 459999999764 5555542 4889999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHH-----
Q 017262 221 SRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIE----- 295 (374)
Q Consensus 221 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----- 295 (374)
++.... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.... +.+....+
T Consensus 211 a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~------~~~~~i~~~lg~p 282 (464)
T 3ttj_A 211 ARTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI------DQWNKVIEQLGTP 282 (464)
T ss_dssp C-------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHHHCSC
T ss_pred eeecCC--CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHhcCCC
Confidence 986543 22334567999999999999999999999999999999999999999754321 11111111
Q ss_pred -----------------hccc------cccccccccCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 296 -----------------ENCL------FDIIDDQVRKS---GEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 296 -----------------~~~~------~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.... ........... .....+..+.+|+.+||..||++|||++|+++
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp CHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000 00000000000 01122567999999999999999999999987
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=331.15 Aligned_cols=261 Identities=17% Similarity=0.222 Sum_probs=212.0
Q ss_pred HHHHhhcCCCcCceEeeeCeEEEEEEE------ecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCC---CCceeeeeee
Q 017262 66 ELDKATDYFNMNRILGQGGQGTVYKGM------LADGRIIAVKKSKVVDESKLEEFINEVVILSQIN---HRNVVKLLGC 136 (374)
Q Consensus 66 ~~~~~~~~~~~~~~lg~G~~g~v~~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~ 136 (374)
++....++|.+.+.||+|+||.||+|. ..+++.||+|.+..... ..+..|+.+++.++ |+||++++++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 344556789999999999999999994 44688999999876543 45667777777776 9999999999
Q ss_pred eeecccceEEEEeecCCcccccccCCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECC-----
Q 017262 137 CLEVEVPLLVYEFIPNGTLFQYLHDPY--EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE----- 209 (374)
Q Consensus 137 ~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~----- 209 (374)
+...+..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+++ |+||||||+|||++.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCc
Confidence 999999999999999999999996321 2457999999999999999999999999 999999999999998
Q ss_pred ------CCcEEEeeccccccccc-CCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcccccc
Q 017262 210 ------KYRAKIADFGTSRSIAI-DQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANE 282 (374)
Q Consensus 210 ------~~~~kl~Dfg~~~~~~~-~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~ 282 (374)
++.+||+|||++..... ..........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 292 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence 89999999999976542 23334455679999999999999999999999999999999999999996433211
Q ss_pred CCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHHHHhhCCC
Q 017262 283 GRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNR-PTMKEVAMELERIRANSRD 353 (374)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R-ps~~~vl~~L~~~~~~~~~ 353 (374)
..+....... .....+.+++..|++.+|.+| |++.++.+.|+.+.....+
T Consensus 293 ------------------~~~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~~ 343 (365)
T 3e7e_A 293 ------------------CKPEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT 343 (365)
T ss_dssp ------------------EEECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHTT
T ss_pred ------------------eeechhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhhh
Confidence 0011111111 124567799999999999999 7899999999998876543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=327.70 Aligned_cols=259 Identities=27% Similarity=0.438 Sum_probs=200.3
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec--CCc--EEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA--DGR--IIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVP 143 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 143 (374)
.++|++.+.||+|+||.||+|.+. +++ .||+|.+... .....+.+.+|+.++++++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 457899999999999999999853 233 6899987643 3345678899999999999999999999998654 8
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccc
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 223 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 223 (374)
++++||+++++|.+++.. ....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHh--ccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 899999999999999874 2356899999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCcee--eecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhcccc
Q 017262 224 IAIDQTHV--STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLF 300 (374)
Q Consensus 224 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (374)
........ .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||..... ..........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~~---- 240 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------SQILHKIDKE---- 240 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTS----
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH------HHHHHHHHcc----
Confidence 65433221 233457888999999998889999999999999999999 9999975432 1112111111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 017262 301 DIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350 (374)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~ 350 (374)
......+...+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 241 -----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 241 -----GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp -----CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred -----CCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 111122334456899999999999999999999999999988653
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=327.32 Aligned_cols=250 Identities=25% Similarity=0.342 Sum_probs=203.4
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
.++|.+.+.||+|+||.||++... +|+.+|+|.+..........+.+|+.+++.++||||+++++++.+.+..+++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 467899999999999999999975 6899999998866555556788999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEE---CCCCcEEEeeccccccccc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfg~~~~~~~ 226 (374)
+++++|.+++. ....+++..+..++.|++.||.|||+.+ ++|+||||+||++ +.++.+||+|||++.....
T Consensus 88 ~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRIL---ERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 99999999886 3457899999999999999999999999 9999999999999 7889999999999875432
Q ss_pred CCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
. ......|++.|+|||.+.+..++.++||||||+++|+|++|..||..... ...... .......
T Consensus 162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~-i~~~~~~------ 225 (304)
T 2jam_A 162 G---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE------SKLFEK-IKEGYYE------ 225 (304)
T ss_dssp B---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHH-HHHCCCC------
T ss_pred C---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHH-HHcCCCC------
Confidence 1 22334589999999999999999999999999999999999999964322 111211 1111110
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 307 VRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.........+..+.+++.+||+.||++|||+.++++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 226 FESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 011112234567899999999999999999999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=333.16 Aligned_cols=243 Identities=23% Similarity=0.358 Sum_probs=202.5
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCCh--------hHHHHHHHHHHHHhhCCCCceeeeeeeeeec
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDE--------SKLEEFINEVVILSQINHRNVVKLLGCCLEV 140 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 140 (374)
..++|++.+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 457899999999999999999995 4688999998765421 1234567899999999999999999999999
Q ss_pred ccceEEEEeecCC-cccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecc
Q 017262 141 EVPLLVYEFIPNG-TLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 219 (374)
Q Consensus 141 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 219 (374)
+..++||||+.+| +|.+++. ....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHH---TCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999776 9999987 3457999999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCceeeecccccccccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcc
Q 017262 220 TSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQF-TDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENC 298 (374)
Q Consensus 220 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 298 (374)
++....... ......||+.|+|||.+.+..+ +.++||||||+++|+|++|..||.......
T Consensus 176 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---------------- 237 (335)
T 3dls_A 176 SAAYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV---------------- 237 (335)
T ss_dssp TCEECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT----------------
T ss_pred cceECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH----------------
Confidence 998764332 2234568999999999988776 789999999999999999999996432211
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 299 LFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
.... ..+...+..+.+|+.+||+.||++|||+.++++.
T Consensus 238 -----~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 238 -----EAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -----TTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -----hhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0100 1112234578899999999999999999999873
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=336.90 Aligned_cols=200 Identities=25% Similarity=0.382 Sum_probs=168.8
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeec-----c
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEV-----E 141 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~ 141 (374)
..++|.+.+.||+|+||.||+|... +++.||+|++... .......+.+|+.+++.++||||+++++++... +
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 3578999999999999999999965 5788999988653 345567889999999999999999999999766 4
Q ss_pred cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccc
Q 017262 142 VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 221 (374)
Q Consensus 142 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 221 (374)
..|+||||++ ++|.+++. ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp CEEEEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 6899999995 69999987 4557999999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCc---------------------eeeecccccccccCcccc-ccCCCCccchhhhHHHHHHHHHhCCCCCC
Q 017262 222 RSIAIDQT---------------------HVSTKVQGTFGYLDPEYF-RSSQFTDKSDVYSFGVVLVELLTGQKPIS 276 (374)
Q Consensus 222 ~~~~~~~~---------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~g~~p~~ 276 (374)
+....... .......||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 87643221 123556799999999986 56679999999999999999998666554
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=322.53 Aligned_cols=249 Identities=22% Similarity=0.334 Sum_probs=206.8
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
.++|.+.+.||+|+||.||++... +++.+|+|.+... .......+.+|+.+++.++||||+++++++.+.+..+++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467899999999999999999976 4788999987543 345567788999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
|||+++++|.+++. ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 99999999999886 3457899999999999999999999999 99999999999999999999999999976543
Q ss_pred CCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
.. .......|++.|+|||.+.+..++.++||||||+++|+|++|..||..... ......... ..
T Consensus 168 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~-~~-------- 231 (294)
T 2rku_A 168 DG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KETYLRIKK-NE-------- 231 (294)
T ss_dssp TT-CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHT-TC--------
T ss_pred Cc-cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhh-cc--------
Confidence 22 223345689999999999988899999999999999999999999964332 111111111 10
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 307 VRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
...+...+..+.+++.+||+.||++|||+.++++.
T Consensus 232 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 232 --YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11122334578899999999999999999999874
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=335.63 Aligned_cols=249 Identities=24% Similarity=0.322 Sum_probs=195.4
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC---hhHHHHHHHHHHH-HhhCCCCceeeeeeeeeecccceE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVI-LSQINHRNVVKLLGCCLEVEVPLL 145 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~l 145 (374)
.++|++.+.||+|+||.||+|+.. +++.+|+|.+.... ......+..|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 467999999999999999999975 57899999876432 2334456667766 567899999999999999999999
Q ss_pred EEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccc
Q 017262 146 VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 225 (374)
||||+++|+|.+++. ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQ---RERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 999999999999987 3457899999999999999999999999 9999999999999999999999999997643
Q ss_pred cCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccc
Q 017262 226 IDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDD 305 (374)
Q Consensus 226 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (374)
.. ........||+.|+|||++.+..++.++|+|||||++|||++|..||..... ...+...... .
T Consensus 191 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~-~------- 255 (373)
T 2r5t_A 191 EH-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILNK-P------- 255 (373)
T ss_dssp CC-CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH------HHHHHHHHHS-C-------
T ss_pred cC-CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHhc-c-------
Confidence 22 2233456799999999999999999999999999999999999999964322 2222222221 1
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 306 QVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
...+...+..+.+||.+||+.||++||++.+.++.
T Consensus 256 ---~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ 290 (373)
T 2r5t_A 256 ---LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFME 290 (373)
T ss_dssp ---CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHH
T ss_pred ---cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHH
Confidence 11222345578899999999999999998644333
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=331.09 Aligned_cols=252 Identities=23% Similarity=0.296 Sum_probs=192.2
Q ss_pred hcCCCcC-ceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHh-hCCCCceeeeeeeeee----cccc
Q 017262 71 TDYFNMN-RILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILS-QINHRNVVKLLGCCLE----VEVP 143 (374)
Q Consensus 71 ~~~~~~~-~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~----~~~~ 143 (374)
.++|.+. +.||+|+||+||++... +++.||+|.+... ..+.+|+.++. ..+||||+++++++.. .+..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3456665 78999999999999965 5889999998642 35667888874 4589999999999875 5578
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECC---CCcEEEeeccc
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE---KYRAKIADFGT 220 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfg~ 220 (374)
++||||+++|+|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 135 ~lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 9999999999999999753 2346999999999999999999999999 999999999999997 78999999999
Q ss_pred ccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCC-ChHHHHHHHHHhccc
Q 017262 221 SRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGR-NLTTYFVECIEENCL 299 (374)
Q Consensus 221 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~ 299 (374)
+...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||......... .... .+.....
T Consensus 211 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~----~i~~~~~ 284 (400)
T 1nxk_A 211 AKETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT----RIRMGQY 284 (400)
T ss_dssp CEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHH----HHHHTCC
T ss_pred ccccCCC--CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHH----HHHcCcc
Confidence 9865422 2234456899999999999999999999999999999999999999754432211 1111 1111111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 300 FDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
. .........+..+.+||.+||+.||++|||+.++++-
T Consensus 285 ~------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 285 E------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp C------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred c------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 0000112345678999999999999999999999874
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=346.68 Aligned_cols=253 Identities=25% Similarity=0.313 Sum_probs=207.2
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
.++|++.+.||+|+||.||+|... +|+.||+|.+... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999975 6899999988642 122345678999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
|||+++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 263 mEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 9999999999998753 2345999999999999999999999999 99999999999999999999999999987643
Q ss_pred CCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
.. ......||+.|+|||++.+..++.++|||||||++|||++|..||....... ...... ......
T Consensus 339 ~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~--~~~~i~-~~i~~~--------- 404 (576)
T 2acx_A 339 GQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--KREEVE-RLVKEV--------- 404 (576)
T ss_dssp TC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC--CHHHHH-HHHHHC---------
T ss_pred Cc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch--hHHHHH-HHhhcc---------
Confidence 32 2334579999999999999899999999999999999999999997543211 111111 111111
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 017262 307 VRKSGEAEEIMAVSDVAKRCLNSYGRNRP-----TMKEVAM 342 (374)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~vl~ 342 (374)
....+...+..+.+||.+||+.||++|| +++++++
T Consensus 405 -~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 405 -PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred -cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 1122233456889999999999999999 6788875
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=323.57 Aligned_cols=260 Identities=24% Similarity=0.306 Sum_probs=197.7
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCC-----hhHHHHHHHHHHHHhhC---CCCceeeeeeeeeec
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVD-----ESKLEEFINEVVILSQI---NHRNVVKLLGCCLEV 140 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~ 140 (374)
..++|++.+.||+|+||+||+|.. .+++.||+|.+.... ......+.+|+.+++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357899999999999999999996 568899999876432 11123556677777766 499999999999875
Q ss_pred c-----cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEE
Q 017262 141 E-----VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKI 215 (374)
Q Consensus 141 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl 215 (374)
. ..+++|||++ ++|.+++... ....+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 4789999996 5999998754 2335999999999999999999999999 999999999999999999999
Q ss_pred eecccccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHH
Q 017262 216 ADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIE 295 (374)
Q Consensus 216 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 295 (374)
+|||++..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||...... .......+
T Consensus 162 ~Dfg~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~------~~~~~i~~ 233 (308)
T 3g33_A 162 ADFGLARIYSY--QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA------DQLGKIFD 233 (308)
T ss_dssp CSCSCTTTSTT--CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH------HHHHHHHH
T ss_pred eeCccccccCC--CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHH
Confidence 99999976542 22234567899999999999999999999999999999999999999653321 11222211
Q ss_pred hcccc------ccc---cccccC--C-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 296 ENCLF------DII---DDQVRK--S-----GEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 296 ~~~~~------~~~---~~~~~~--~-----~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..... ... ...... . ..+..+..+.+|+.+||+.||++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 10000 000 000000 0 01123467899999999999999999999875
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=336.92 Aligned_cols=253 Identities=27% Similarity=0.331 Sum_probs=192.1
Q ss_pred HhhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC--------hhHHHHHHHHHHHHhhCCCCceeeeeeeeee
Q 017262 69 KATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--------ESKLEEFINEVVILSQINHRNVVKLLGCCLE 139 (374)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 139 (374)
...++|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 34678999999999999999999965 57899999876421 1122357899999999999999999999754
Q ss_pred cccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCC---CcEEEe
Q 017262 140 VEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK---YRAKIA 216 (374)
Q Consensus 140 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~---~~~kl~ 216 (374)
+..++||||+++|+|.+++. ....+++..+..++.|++.||+|||+++ ++||||||+|||++.+ +.+||+
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred -CceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 45789999999999999987 4567999999999999999999999999 9999999999999754 459999
Q ss_pred ecccccccccCCceeeecccccccccCcccccc---CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHH
Q 017262 217 DFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRS---SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVEC 293 (374)
Q Consensus 217 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 293 (374)
|||++..... ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||....... .... .
T Consensus 285 DFG~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~----~ 356 (419)
T 3i6u_A 285 DFGHSKILGE--TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKD----Q 356 (419)
T ss_dssp CSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHH----H
T ss_pred ecccceecCC--CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHH----H
Confidence 9999986543 223344569999999999853 567889999999999999999999997533221 1111 1
Q ss_pred HHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 294 IEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
........ . +.. ....+..+.+|+.+||+.||++|||+.++++
T Consensus 357 i~~~~~~~-~-~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 357 ITSGKYNF-I-PEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHTTCCCC-C-HHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhcCCCCC-C-chh----hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 11111100 0 000 0123457899999999999999999999886
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=356.34 Aligned_cols=262 Identities=26% Similarity=0.413 Sum_probs=209.9
Q ss_pred HHHhhcCCCcCceEeeeCeEEEEEEEecC----CcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc
Q 017262 67 LDKATDYFNMNRILGQGGQGTVYKGMLAD----GRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVE 141 (374)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 141 (374)
.....++|++.+.||+|+||.||+|.... +..+|+|..... .......+.+|+.++++++||||+++++++. ++
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 34445778999999999999999998643 457999987653 3445578899999999999999999999985 45
Q ss_pred cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccc
Q 017262 142 VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 221 (374)
Q Consensus 142 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 221 (374)
..++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred ceEEEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCC
Confidence 78999999999999999974 2346899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhcccc
Q 017262 222 RSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLF 300 (374)
Q Consensus 222 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (374)
...............+++.|+|||.+.+..++.++||||||+++|||++ |..||...... +..... ...
T Consensus 539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~------~~~~~i-~~~--- 608 (656)
T 2j0j_A 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN------DVIGRI-ENG--- 608 (656)
T ss_dssp CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHH-HHT---
T ss_pred eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH------HHHHHH-HcC---
Confidence 8765444333344557889999999998999999999999999999997 99999753322 112111 111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 017262 301 DIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350 (374)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~ 350 (374)
.....+...+..+.+|+.+||+.||++|||+.++++.|+.+...
T Consensus 609 ------~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 609 ------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 11122334556889999999999999999999999999998653
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=322.52 Aligned_cols=252 Identities=24% Similarity=0.373 Sum_probs=200.6
Q ss_pred CCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeec
Q 017262 73 YFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIP 151 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 151 (374)
+|.....||+|+||.||+|.. .++..||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 455556999999999999996 4578999999887666667789999999999999999999999999999999999999
Q ss_pred CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECC-CCcEEEeecccccccccCCce
Q 017262 152 NGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE-KYRAKIADFGTSRSIAIDQTH 230 (374)
Q Consensus 152 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~~~~~ 230 (374)
+++|.+++........+++..+..++.|++.||.|||+.+ ++|+||+|+||+++. ++.+||+|||++....... .
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~ 178 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-P 178 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC-C
Confidence 9999999975433446778999999999999999999999 999999999999987 8999999999997654322 1
Q ss_pred eeecccccccccCccccccCC--CCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccccc
Q 017262 231 VSTKVQGTFGYLDPEYFRSSQ--FTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVR 308 (374)
Q Consensus 231 ~~~~~~g~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (374)
......|++.|+|||.+.+.. ++.++||||||+++|+|++|..||....... ......... ...
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~---------~~~ 244 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ-----AAMFKVGMF---------KVH 244 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH-----HHHHHHHHH---------CCC
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh-----HHHHhhccc---------ccc
Confidence 223456899999999987643 7899999999999999999999996432211 111110000 111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 309 KSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 309 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
...+...+..+.+++.+||+.||++|||+.++++
T Consensus 245 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 245 PEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1223344567889999999999999999999875
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=321.94 Aligned_cols=258 Identities=27% Similarity=0.348 Sum_probs=205.3
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCCh------hHHHHHHHHHHHHhhCCCCceeeeeeeeeecccc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE------SKLEEFINEVVILSQINHRNVVKLLGCCLEVEVP 143 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 143 (374)
.++|++.+.||+|+||.||+|... +++.+|+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 356899999999999999999976 588999998765321 1357789999999999999999999999999999
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCC----cEEEeecc
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY----RAKIADFG 219 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~----~~kl~Dfg 219 (374)
++||||+++++|.+++. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLA---EKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 99999999999999997 3457899999999999999999999999 99999999999998877 89999999
Q ss_pred cccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccc
Q 017262 220 TSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCL 299 (374)
Q Consensus 220 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (374)
++....... ......+++.|+|||.+.+..++.++||||||+++|+|++|..||...... ...... .....
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~-~~~~~ 228 (283)
T 3bhy_A 158 IAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ------ETLTNI-SAVNY 228 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHH-HTTCC
T ss_pred cceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH------HHHHHh-Hhccc
Confidence 997654322 223446899999999999889999999999999999999999999653321 111111 11100
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHHHHh
Q 017262 300 FDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM--ELERIRA 349 (374)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~--~L~~~~~ 349 (374)
...... ....+..+.+++.+||+.||++|||+.++++ .++.++.
T Consensus 229 --~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 229 --DFDEEY----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp --CCCHHH----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred --CCcchh----cccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 000000 0122457889999999999999999999997 4555544
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=315.98 Aligned_cols=250 Identities=24% Similarity=0.392 Sum_probs=199.6
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeee----cccc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLE----VEVP 143 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~ 143 (374)
.+.|.+.+.||+|+||.||+|... ++..+++|.+... .......+.+|+.+++.++||||+++++++.. ....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 445788899999999999999964 5778999987643 45566788999999999999999999999875 3467
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEEC-CCCcEEEeeccccc
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD-EKYRAKIADFGTSR 222 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~~~ 222 (374)
++||||+++++|.+++. ....+++..++.++.|++.||.|||+.+ .+++|+||||+||+++ .++.+||+|||++.
T Consensus 105 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEEecCCCCHHHHHH---HccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 99999999999999997 3457899999999999999999999986 3599999999999998 78999999999997
Q ss_pred ccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccc
Q 017262 223 SIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDI 302 (374)
Q Consensus 223 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (374)
..... ......|++.|+|||.+. ..++.++||||||+++|+|++|+.||.... ............. ...
T Consensus 181 ~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-----~~~~~~~~~~~~~-~~~- 249 (290)
T 1t4h_A 181 LKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQ-----NAAQIYRRVTSGV-KPA- 249 (290)
T ss_dssp GCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS-----SHHHHHHHHTTTC-CCG-
T ss_pred ccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcC-----cHHHHHHHHhccC-Ccc-
Confidence 54322 223446899999999887 458999999999999999999999996432 2222222111111 110
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 303 IDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..+...++.+.+++.+||+.||++|||+.++++
T Consensus 250 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 250 -------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 111112346889999999999999999999885
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=332.93 Aligned_cols=252 Identities=19% Similarity=0.272 Sum_probs=201.8
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccceEEE
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 147 (374)
..++|++.+.||+|+||.||++... +++.+|+|.+..... ...+|++++.++ +||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3567999999999999999999975 588999998865432 234688888887 7999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCC----CcEEEeecccccc
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK----YRAKIADFGTSRS 223 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~----~~~kl~Dfg~~~~ 223 (374)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||+.++ +.+||+|||++..
T Consensus 96 E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 99999999999973 457999999999999999999999999 9999999999998543 3599999999986
Q ss_pred cccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccc
Q 017262 224 IAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDII 303 (374)
Q Consensus 224 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (374)
...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... ......+.. +......
T Consensus 170 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~~~~-i~~~~~~--- 241 (342)
T 2qr7_A 170 LRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD---DTPEEILAR-IGSGKFS--- 241 (342)
T ss_dssp CBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT---SCHHHHHHH-HHHCCCC---
T ss_pred CcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc---CCHHHHHHH-HccCCcc---
Confidence 543322 23345689999999999888889999999999999999999999974321 222222222 2222111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.........+..+.+|+.+||+.||++|||+.++++
T Consensus 242 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 ---LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ---CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111122334567899999999999999999999886
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=321.69 Aligned_cols=246 Identities=27% Similarity=0.348 Sum_probs=204.0
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC---hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
.++|.+.+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+.+++.++||||+++++++.+.+..+++
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 357899999999999999999975 57789999875432 22246788999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 999999999999873 457899999999999999999999999 99999999999999999999999999865432
Q ss_pred CCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
. ......|++.|+|||.+.+..++.++||||||+++|+|++|..||...... ........ .
T Consensus 167 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~-~--------- 227 (284)
T 2vgo_A 167 L---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT------ETHRRIVN-V--------- 227 (284)
T ss_dssp S---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHT-T---------
T ss_pred c---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh------HHHHHHhc-c---------
Confidence 2 223456899999999999999999999999999999999999999643321 11111111 1
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 307 VRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
....+...+..+.+++.+||+.||++|||+.++++
T Consensus 228 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 228 -DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp -CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 01122334567889999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=333.49 Aligned_cols=261 Identities=24% Similarity=0.358 Sum_probs=194.0
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhH-HHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESK-LEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
++|.+.+.||+|+||.||+|... +++.||+|.+....... ...+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57899999999999999999975 68899999886543221 12345799999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
++ ++|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 154 (324)
T 3mtl_A 82 LD-KDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 154 (324)
T ss_dssp CS-EEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence 96 588888864 3456899999999999999999999999 9999999999999999999999999997654322
Q ss_pred eeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhc---cccccccc
Q 017262 230 HVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEEN---CLFDIIDD 305 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 305 (374)
.......+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||......+ ....+....... ........
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGC
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHhchhhhcc
Confidence 22334468999999999876 568999999999999999999999997543221 011111110000 00000000
Q ss_pred ---------cccC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 306 ---------QVRK----SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 306 ---------~~~~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.... ......+..+.+|+.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000 001123457889999999999999999999987
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=327.99 Aligned_cols=255 Identities=26% Similarity=0.411 Sum_probs=204.2
Q ss_pred HHHhhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC--------hhHHHHHHHHHHHHhhC-CCCceeeeeee
Q 017262 67 LDKATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--------ESKLEEFINEVVILSQI-NHRNVVKLLGC 136 (374)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~niv~~~~~ 136 (374)
.....++|.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|+.+++++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3444578999999999999999999975 68999999876532 12245678899999999 79999999999
Q ss_pred eeecccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEe
Q 017262 137 CLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIA 216 (374)
Q Consensus 137 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~ 216 (374)
+...+..++||||+++++|.+++. ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLT---EKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEE
Confidence 999999999999999999999997 3457999999999999999999999999 9999999999999999999999
Q ss_pred ecccccccccCCceeeecccccccccCcccccc------CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHH
Q 017262 217 DFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRS------SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYF 290 (374)
Q Consensus 217 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 290 (374)
|||++....... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||..... ....
T Consensus 243 DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~------~~~~ 314 (365)
T 2y7j_A 243 DFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ------ILML 314 (365)
T ss_dssp CCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHH
T ss_pred ecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH------HHHH
Confidence 999997665322 2344569999999999863 3578899999999999999999999964321 1111
Q ss_pred HHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 291 VECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.. ........ ..... ...+..+.+|+.+||+.||++|||+.++++
T Consensus 315 ~~-i~~~~~~~--~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 315 RM-IMEGQYQF--SSPEW----DDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HH-HHHTCCCC--CHHHH----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HH-HHhCCCCC--CCccc----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11 11111100 00000 012356889999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=320.11 Aligned_cols=245 Identities=22% Similarity=0.294 Sum_probs=198.8
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccceEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 146 (374)
.++|++.+.||+|+||.||+|... +++.+|+|.+... .......+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467899999999999999999975 6899999987653 344556788999999999 899999999999999999999
Q ss_pred EEeecCCcccccccCCCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCC---------------
Q 017262 147 YEFIPNGTLFQYLHDPYE-ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK--------------- 210 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~--------------- 210 (374)
|||+++++|.+++..... ...+++..++.++.|++.||+|||+++ ++||||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999974211 256899999999999999999999999 9999999999999844
Q ss_pred ----CcEEEeecccccccccCCceeeecccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCccccccCCC
Q 017262 211 ----YRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRN 285 (374)
Q Consensus 211 ----~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~ 285 (374)
..+||+|||++....... ...||+.|+|||.+.+. .++.++||||||+++|+|++|..|+.....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----- 236 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----- 236 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH-----
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH-----
Confidence 479999999997654322 23489999999999765 566899999999999999999877642210
Q ss_pred hHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 286 LTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
. ........ ...+...+..+.+++.+||+.||++|||+.++++
T Consensus 237 ----~-~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 237 ----W-HEIRQGRL---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ----H-HHHHTTCC---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----H-HHHHcCCC---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 1 11111111 1122234567899999999999999999999875
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=329.08 Aligned_cols=263 Identities=24% Similarity=0.395 Sum_probs=204.6
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 148 (374)
.++|++.+.||+|+||.||+|... ++..+|+|.+... .......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467899999999999999999975 6889999988754 44556788999999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSS-AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
|+++++|.+++. ....+++..+..++.|++.||+|||+. + ++|+||||+||+++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999999997 345789999999999999999999996 7 999999999999999999999999998754321
Q ss_pred CceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChH--------------------
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLT-------------------- 287 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~-------------------- 287 (374)
......||+.|+|||.+.+..++.++||||||+++|+|++|+.||............
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 223456899999999999999999999999999999999999999754322100000
Q ss_pred ---HHHHHHHHhccccc----cccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 288 ---TYFVECIEENCLFD----IIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 288 ---~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.+............ ..............+..+.+|+.+||+.||++|||+.++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00000000000000 00000011111223557899999999999999999999987
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=325.95 Aligned_cols=259 Identities=22% Similarity=0.316 Sum_probs=205.0
Q ss_pred HHHHHhhcCCCcC-ceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCC-CCceeeeeeeeee
Q 017262 65 KELDKATDYFNMN-RILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQIN-HRNVVKLLGCCLE 139 (374)
Q Consensus 65 ~~~~~~~~~~~~~-~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~ 139 (374)
...+...++|.+. +.||+|+||.||+|... +++.||+|.+... .......+.+|+.+++.+. ||||+++++++.+
T Consensus 21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~ 100 (327)
T 3lm5_A 21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN 100 (327)
T ss_dssp BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence 3344556677777 89999999999999965 5899999987653 2334567889999999994 6999999999999
Q ss_pred cccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECC---CCcEEEe
Q 017262 140 VEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE---KYRAKIA 216 (374)
Q Consensus 140 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~---~~~~kl~ 216 (374)
.+..++||||+++|+|.+++... ....+++..++.++.|++.||+|||+.+ ++||||||+||+++. ++.+||+
T Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 101 TSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp SSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEEC
T ss_pred CCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEe
Confidence 99999999999999999998643 3457999999999999999999999999 999999999999987 7899999
Q ss_pred ecccccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHh
Q 017262 217 DFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEE 296 (374)
Q Consensus 217 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 296 (374)
|||++...... .......||+.|+|||.+.+..++.++||||||+++|+|++|..||...... .........
T Consensus 177 Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~ 248 (327)
T 3lm5_A 177 DFGMSRKIGHA--CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ------ETYLNISQV 248 (327)
T ss_dssp CGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHT
T ss_pred eCccccccCCc--cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch------HHHHHHHhc
Confidence 99999865432 2223456999999999999999999999999999999999999999653321 111111111
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 297 NCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
. ...........+..+.+|+.+||+.||++|||++++++
T Consensus 249 ~-------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 249 N-------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp C-------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred c-------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 0 11111222334567889999999999999999999975
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=323.67 Aligned_cols=258 Identities=25% Similarity=0.369 Sum_probs=204.6
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeee--cccceE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLE--VEVPLL 145 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l 145 (374)
.++|++.+.||+|+||.||++... +++.+++|.+... .....+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467899999999999999999975 6889999988653 34556788999999999999999999998854 457899
Q ss_pred EEEeecCCcccccccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCEEEeccCCCceEECCCCcEEEeeccccc
Q 017262 146 VYEFIPNGTLFQYLHDPY-EELSLTWEMRLRIATEVAEALAYLHSSA--YLPIYHRDIKSTNILLDEKYRAKIADFGTSR 222 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 222 (374)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ..+++|+||||+||+++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999987432 2345899999999999999999999976 1239999999999999999999999999987
Q ss_pred ccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccc
Q 017262 223 SIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDI 302 (374)
Q Consensus 223 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (374)
...... .......|++.|+|||.+.+..++.++||||||+++|+|++|..||..... .. ...........
T Consensus 165 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~-~~~~i~~~~~~-- 234 (279)
T 2w5a_A 165 ILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ------KE-LAGKIREGKFR-- 234 (279)
T ss_dssp HC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HH-HHHHHHHTCCC--
T ss_pred eecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH------HH-HHHHHhhcccc--
Confidence 654322 112334689999999999988999999999999999999999999975432 11 11222222111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017262 303 IDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELE 345 (374)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~ 345 (374)
..+...+..+.+++.+||+.||++|||+.++++.+.
T Consensus 235 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 235 -------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred -------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 122234567899999999999999999999998654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=338.56 Aligned_cols=194 Identities=26% Similarity=0.431 Sum_probs=155.5
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEecc--CChhHHHHHHHHHHHHhhCCCCceeeeeeeeeec-----cc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKV--VDESKLEEFINEVVILSQINHRNVVKLLGCCLEV-----EV 142 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~ 142 (374)
.++|++.+.||+|+||.||+|... +++.||+|++.. .+......+.+|+.+|+.++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 478999999999999999999965 688999998864 3445567889999999999999999999998543 46
Q ss_pred ceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccc
Q 017262 143 PLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 222 (374)
Q Consensus 143 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 222 (374)
.|+||||+ +++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 132 ~~lv~e~~-~~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 79999998 578988887 4557999999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCc--------------------------eeeecccccccccCcccc-ccCCCCccchhhhHHHHHHHHHhC
Q 017262 223 SIAIDQT--------------------------HVSTKVQGTFGYLDPEYF-RSSQFTDKSDVYSFGVVLVELLTG 271 (374)
Q Consensus 223 ~~~~~~~--------------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~g 271 (374)
....... .......||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 7542211 123445689999999986 566799999999999999999993
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=338.91 Aligned_cols=250 Identities=18% Similarity=0.190 Sum_probs=193.3
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEecc---CChhHHHHHHHHHH---HHhhCCCCceeeee-------e
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKV---VDESKLEEFINEVV---ILSQINHRNVVKLL-------G 135 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~---~~~~~~~~~~~e~~---~l~~l~h~niv~~~-------~ 135 (374)
..++|.+.+.||+|+||.||+|.. .+|+.||+|++.. ......+.+.+|+. .+++++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 357789999999999999999996 5689999998863 34455678889994 55555899999998 5
Q ss_pred eeeecc-----------------cceEEEEeecCCcccccccCCC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 017262 136 CCLEVE-----------------VPLLVYEFIPNGTLFQYLHDPY----EELSLTWEMRLRIATEVAEALAYLHSSAYLP 194 (374)
Q Consensus 136 ~~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ 194 (374)
++.+.+ ..+++|||+ +|+|.+++.... ....+++..++.++.|++.||+|||+++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 554442 278999999 689999997421 1123445888899999999999999999
Q ss_pred EEEeccCCCceEECCCCcEEEeecccccccccCCceeeecccccccccCccccccC-----------CCCccchhhhHHH
Q 017262 195 IYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSS-----------QFTDKSDVYSFGV 263 (374)
Q Consensus 195 i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~~Di~slG~ 263 (374)
|+||||||+|||++.++.+||+|||++.... .......| +.|+|||++.+. .++.++|||||||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETT----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecC----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999997532 22344557 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH-
Q 017262 264 VLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM- 342 (374)
Q Consensus 264 ~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~- 342 (374)
++|+|++|+.||........ ....... ....+..+.+|+.+||+.||++|||+.++++
T Consensus 302 il~elltg~~Pf~~~~~~~~---------------~~~~~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGG---------------SEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHHSSCCC------CC---------------SGGGGSS------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHHCCCCCcccccccc---------------hhhhhhh------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 99999999999965432221 1111110 1123457889999999999999999999986
Q ss_pred -HHHHHHh
Q 017262 343 -ELERIRA 349 (374)
Q Consensus 343 -~L~~~~~ 349 (374)
.++.+..
T Consensus 361 p~f~~~~~ 368 (377)
T 3byv_A 361 PEYEQLRT 368 (377)
T ss_dssp HHHHHHHH
T ss_pred hHHHHHHH
Confidence 4454443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=319.09 Aligned_cols=252 Identities=26% Similarity=0.348 Sum_probs=197.6
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 148 (374)
.++|.+.+.||+|+||.||++... ++..+|+|.+... .......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 457899999999999999999964 5889999987653 23345788899999999999999999999999999999999
Q ss_pred eecCCcccccccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEE---CCCCcEEEeeccccccc
Q 017262 149 FIPNGTLFQYLHDPY-EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSI 224 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfg~~~~~ 224 (374)
|+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||||+||++ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999999999885321 2457999999999999999999999999 9999999999999 45678999999999765
Q ss_pred ccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccc
Q 017262 225 AIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIID 304 (374)
Q Consensus 225 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (374)
... .......|++.|+|||.+. ..++.++||||||+++|+|++|..||..... ................
T Consensus 178 ~~~--~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~------~~~~~~~~~~~~~~~~-- 246 (285)
T 3is5_A 178 KSD--EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL------EEVQQKATYKEPNYAV-- 246 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCCCC--
T ss_pred CCc--ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH------HHHHhhhccCCccccc--
Confidence 432 2234456899999999986 5689999999999999999999999975332 1111111111100000
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 305 DQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 305 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.....++.+.+|+.+||+.||++|||+.++++
T Consensus 247 ------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 ------ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp --------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ------ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00112457889999999999999999999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=323.78 Aligned_cols=248 Identities=22% Similarity=0.336 Sum_probs=206.7
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
.++|.+.+.||+|+||.||++... +++.+++|.+... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 568999999999999999999975 4788999987543 345567888999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
|||+++++|.+++. ....+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.....
T Consensus 120 ~e~~~~~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 99999999999886 3457999999999999999999999999 99999999999999999999999999986543
Q ss_pred CCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
.. .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ........... .
T Consensus 194 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~-~------- 258 (335)
T 2owb_A 194 DG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KETYLRIKKNE-Y------- 258 (335)
T ss_dssp TT-CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTC-C-------
T ss_pred Cc-ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH------HHHHHHHhcCC-C-------
Confidence 22 223345689999999999998899999999999999999999999964322 22222111111 0
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 307 VRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..+...+..+.+|+.+||+.||++|||+.++++
T Consensus 259 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 ---SIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112233457889999999999999999999987
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=325.86 Aligned_cols=262 Identities=24% Similarity=0.258 Sum_probs=197.5
Q ss_pred HhhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChh-----HHHHHHHHHHHHhhCCCCceeeeeeeeeeccc
Q 017262 69 KATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDES-----KLEEFINEVVILSQINHRNVVKLLGCCLEVEV 142 (374)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 142 (374)
...++|++.+.||+|+||.||+|... +|+.||+|.+...... ....+.+|+.+++.++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999965 5899999988653221 12467899999999999999999999999999
Q ss_pred ceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccc
Q 017262 143 PLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 222 (374)
Q Consensus 143 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 222 (374)
.++||||+++ +|.+++.. ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 87 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999975 88888865 3456888999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCceeeecccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcc---
Q 017262 223 SIAIDQTHVSTKVQGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENC--- 298 (374)
Q Consensus 223 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 298 (374)
...... .......+|+.|+|||.+.+. .++.++||||||+++|+|++|..||..... ...+....+...
T Consensus 161 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~------~~~~~~i~~~~~~~~ 233 (346)
T 1ua2_A 161 SFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD------LDQLTRIFETLGTPT 233 (346)
T ss_dssp TTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHHHCCCC
T ss_pred eccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHHHcCCCC
Confidence 654322 223445689999999998654 588999999999999999999999865332 111222221100
Q ss_pred ---ccc------cccccccCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 299 ---LFD------IIDDQVRKSGE-----AEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 299 ---~~~------~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
... .+........+ ...+..+.+||.+||+.||++|||+.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000 00000000111 2234689999999999999999999999873
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=326.80 Aligned_cols=254 Identities=22% Similarity=0.278 Sum_probs=196.3
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc-----
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVE----- 141 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 141 (374)
..++|++.+.||+|+||.||+|.. .+|+.||+|++... .......+.+|+.+++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 457899999999999999999997 46899999988542 3445677889999999999999999999997653
Q ss_pred -cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccc
Q 017262 142 -VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGT 220 (374)
Q Consensus 142 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 220 (374)
..++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 8899998863 46899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhc-c
Q 017262 221 SRSIAIDQTHVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEEN-C 298 (374)
Q Consensus 221 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~ 298 (374)
++..... .....+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||......+ .+....... .
T Consensus 175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~l~~i~~~~g~ 244 (367)
T 1cm8_A 175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD------QLKEIMKVTGT 244 (367)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHHHCC
T ss_pred ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHHhcCC
Confidence 9865322 334568999999999877 679999999999999999999999997543211 111111100 0
Q ss_pred --------------------ccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 299 --------------------LFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 299 --------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
+....... ........+..+.+|+.+||..||++|||+.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 245 PPAEFVQRLQSDEAKNYMKGLPELEKKD-FASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp CCHHHHHTCSCHHHHHHHHHSCCCCCCC-GGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHhhhHHHHHHHHhCCCCCCCC-HHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 00000000 01112234567899999999999999999999987
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=327.81 Aligned_cols=265 Identities=21% Similarity=0.275 Sum_probs=199.5
Q ss_pred hHHHHHhhcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccC-----------ChhHHHHHHHHHHHHhhCCCCceee
Q 017262 64 SKELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVV-----------DESKLEEFINEVVILSQINHRNVVK 132 (374)
Q Consensus 64 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~-----------~~~~~~~~~~e~~~l~~l~h~niv~ 132 (374)
..++....++|.+.+.||+|+||.||+|...+|..||+|++... +......+.+|+.++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 45677888999999999999999999999888999999987542 2223478899999999999999999
Q ss_pred eeeeeeecc-----cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEE
Q 017262 133 LLGCCLEVE-----VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL 207 (374)
Q Consensus 133 ~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill 207 (374)
+++++...+ ..++||||++ |+|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||||+||++
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL 167 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence 999985432 5699999997 677777764 3457999999999999999999999999 9999999999999
Q ss_pred CCCCcEEEeecccccccccCCceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCCh
Q 017262 208 DEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNL 286 (374)
Q Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~ 286 (374)
+.++.+||+|||++...... .......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||......
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----- 240 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY----- 240 (362)
T ss_dssp CTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----
T ss_pred cCCCCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH-----
Confidence 99999999999999754322 22344568999999999876 67899999999999999999999999754321
Q ss_pred HHHHHHHHHhcccc--------------ccccccc-------cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 287 TTYFVECIEENCLF--------------DIIDDQV-------RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 287 ~~~~~~~~~~~~~~--------------~~~~~~~-------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.......+..... ....... .....+..+..+.+|+.+||+.||++|||+.++++
T Consensus 241 -~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 241 -NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp -HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 1111111100000 0000000 00011223457899999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=328.34 Aligned_cols=258 Identities=22% Similarity=0.361 Sum_probs=204.8
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChh-----------------HHHHHHHHHHHHhhCCCCceeee
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDES-----------------KLEEFINEVVILSQINHRNVVKL 133 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~e~~~l~~l~h~niv~~ 133 (374)
.++|.+.+.||+|+||.||+|.. +++.||+|.+...... ....+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 47899999999999999999999 8999999987643211 12788999999999999999999
Q ss_pred eeeeeecccceEEEEeecCCccccc------ccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCEEEeccCCCceE
Q 017262 134 LGCCLEVEVPLLVYEFIPNGTLFQY------LHDPYEELSLTWEMRLRIATEVAEALAYLHS-SAYLPIYHRDIKSTNIL 206 (374)
Q Consensus 134 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~i~H~dlk~~Nil 206 (374)
++++.+.+..++||||+++++|.++ +... ....+++..++.++.|++.||.|||+ .+ ++|+||+|+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999999 5432 25679999999999999999999999 88 999999999999
Q ss_pred ECCCCcEEEeecccccccccCCceeeecccccccccCccccccC-CCCc-cchhhhHHHHHHHHHhCCCCCCccccccCC
Q 017262 207 LDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSS-QFTD-KSDVYSFGVVLVELLTGQKPISSIWANEGR 284 (374)
Q Consensus 207 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~-~~Di~slG~~l~el~~g~~p~~~~~~~~~~ 284 (374)
++.++.+||+|||++...... ......|++.|+|||.+.+. .++. ++||||||+++|+|++|..||......
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--- 258 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--- 258 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS---
T ss_pred EcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH---
Confidence 999999999999999765432 33445689999999999877 6666 999999999999999999999753321
Q ss_pred ChHHHHHHHHHhcccccccc---------ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 285 NLTTYFVECIEENCLFDIID---------DQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..... ...........+ ...........+..+.+|+.+||+.||++|||+.++++
T Consensus 259 --~~~~~-~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 --VELFN-NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp --HHHHH-HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --HHHHH-HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11111 111111100000 00000011344568899999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=346.33 Aligned_cols=250 Identities=26% Similarity=0.352 Sum_probs=205.0
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC---hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
.++|++.+.||+|+||.||+|... +++.+|+|++.... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467999999999999999999975 68999999875432 34467889999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEE---CCCCcEEEeecccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRS 223 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfg~~~~ 223 (374)
|||+.+++|.+++. ....+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++..
T Consensus 105 ~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEII---SRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHH---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 99999999999887 3457999999999999999999999999 9999999999999 5678999999999976
Q ss_pred cccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccc
Q 017262 224 IAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDII 303 (374)
Q Consensus 224 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (374)
..... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||..... ...... +........
T Consensus 179 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~-i~~~~~~~~- 247 (484)
T 3nyv_A 179 FEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE------YDILKK-VEKGKYTFE- 247 (484)
T ss_dssp BCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHH-HHHCCCCCC-
T ss_pred ccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH------HHHHHH-HHcCCCCCC-
Confidence 54322 2344569999999999875 689999999999999999999999975332 222222 222111100
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.......+..+.+||.+||+.||++|||+.++++
T Consensus 248 -----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 248 -----LPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp -----SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 0011234567889999999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=344.31 Aligned_cols=250 Identities=25% Similarity=0.350 Sum_probs=199.0
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC--hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
.++|++.+.||+|+||+||+|... ++..+|+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457999999999999999999975 68899999876532 333567889999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECC---CCcEEEeeccccccc
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE---KYRAKIADFGTSRSI 224 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfg~~~~~ 224 (374)
||+++|+|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||++...
T Consensus 116 e~~~~g~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEII---HRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 9999999999887 3457999999999999999999999999 999999999999976 455999999999876
Q ss_pred ccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccc
Q 017262 225 AIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIID 304 (374)
Q Consensus 225 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (374)
... .......||+.|+|||++. ..++.++|||||||++|+|++|..||..... ....... ...... ..
T Consensus 190 ~~~--~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i-~~~~~~--~~ 257 (494)
T 3lij_A 190 ENQ--KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD------QEILRKV-EKGKYT--FD 257 (494)
T ss_dssp BTT--BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHH-HHTCCC--CC
T ss_pred CCC--ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHH-HhCCCC--CC
Confidence 432 2234456999999999986 5689999999999999999999999975432 2222221 111111 00
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 305 DQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 305 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.... ...+..+.+||.+||+.||++|||+.++++
T Consensus 258 ~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 258 SPEW----KNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp SGGG----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chhc----ccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 1111 123457889999999999999999999985
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=333.99 Aligned_cols=254 Identities=26% Similarity=0.332 Sum_probs=204.3
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe----cCCcEEEEEEeccCC----hhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML----ADGRIIAVKKSKVVD----ESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVE 141 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 141 (374)
.++|++.+.||+|+||.||++.. .+++.||+|++.... ......+.+|+.+++.+ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36899999999999999999997 368999999876421 12234566799999999 6999999999999999
Q ss_pred cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccc
Q 017262 142 VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 221 (374)
Q Consensus 142 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 221 (374)
..++||||+++++|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 9999999999999999997 3457999999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCceeeecccccccccCcccccc--CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccc
Q 017262 222 RSIAIDQTHVSTKVQGTFGYLDPEYFRS--SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCL 299 (374)
Q Consensus 222 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (374)
...............||+.|+|||++.+ ..++.++||||||+++|+|++|..||....... ............
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~--- 281 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--SQAEISRRILKS--- 281 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--CHHHHHHHHHHC---
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc--hHHHHHHHHhcc---
Confidence 8665444444445679999999999985 347899999999999999999999997433221 222222211111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 017262 300 FDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRP-----TMKEVAME 343 (374)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~vl~~ 343 (374)
....+...+..+.+||.+||..||++|| |++++++.
T Consensus 282 --------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 282 --------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp --------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred --------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 1122334456788999999999999999 88888763
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=324.73 Aligned_cols=266 Identities=25% Similarity=0.367 Sum_probs=201.3
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
..++|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 3567999999999999999999975 4889999987543 334456678999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
|||+++++|.+++. ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 103 ~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 103 FEFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp EECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 99999999988876 3456999999999999999999999999 99999999999999999999999999976543
Q ss_pred CCceeeecccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCccccccCC--------ChHHHHHHHHHhc
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGR--------NLTTYFVECIEEN 297 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~--------~~~~~~~~~~~~~ 297 (374)
.. .......+++.|+|||.+.+. .++.++||||||+++|+|++|+.||......+.. .............
T Consensus 177 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 177 PG-EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred Cc-cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence 22 223345689999999999875 6899999999999999999999999754322100 0000000111111
Q ss_pred cc-cccccccccCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 298 CL-FDIIDDQVRKSGE-----AEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 298 ~~-~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.. .....+......+ +..+..+.+|+.+||+.||++|||+.++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 11 0000111111111 134568999999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=321.03 Aligned_cols=253 Identities=25% Similarity=0.380 Sum_probs=201.1
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEE
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 148 (374)
..++|++.+.||+|+||.||+|... +++.+++|.+..........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4578999999999999999999976 588999999877666667889999999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
|+++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT- 170 (302)
T ss_dssp CCTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-
T ss_pred eCCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc-
Confidence 9999999998864 2456999999999999999999999999 999999999999999999999999987543211
Q ss_pred ceeeecccccccccCcccc-----ccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccc
Q 017262 229 THVSTKVQGTFGYLDPEYF-----RSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDII 303 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~-----~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (374)
........|++.|+|||.+ .+..++.++||||||+++|+|++|..||..... ............ ..
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~-~~-- 241 (302)
T 2j7t_A 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSDP-PT-- 241 (302)
T ss_dssp HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCC-CC--
T ss_pred ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH------HHHHHHHhccCC-cc--
Confidence 1112334689999999998 356788999999999999999999999974332 122222211111 10
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
...+...+..+.+++.+||+.||++|||+.++++
T Consensus 242 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 242 -----LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -----CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -----cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1112234557899999999999999999999876
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=328.42 Aligned_cols=259 Identities=23% Similarity=0.299 Sum_probs=192.9
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCCh--hHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE--SKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
..++|++.+.||+|+||+||+|... +++.||+|.+..... .....+.+|+.++++++||||+++++++.+.+..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 3568999999999999999999954 688999998865432 2345677999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEE-----CCCCcEEEeecccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL-----DEKYRAKIADFGTS 221 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill-----~~~~~~kl~Dfg~~ 221 (374)
|||++ ++|.+++. ....+++..+..++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 112 ~e~~~-~~L~~~~~---~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 112 FEYAE-NDLKKYMD---KNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EECCS-EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EecCC-CCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 99997 59999887 3456999999999999999999999999 9999999999999 45556999999999
Q ss_pred cccccCCceeeecccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccc
Q 017262 222 RSIAIDQTHVSTKVQGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLF 300 (374)
Q Consensus 222 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (374)
....... .......+|+.|+|||++.+. .++.++|||||||++|+|++|..||...... +............
T Consensus 185 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~~~~~~~ 257 (329)
T 3gbz_A 185 RAFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI------DQLFKIFEVLGLP 257 (329)
T ss_dssp HHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHHHCCC
T ss_pred cccCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH------HHHHHHHHHhCCC
Confidence 7654322 223344689999999999874 4899999999999999999999999753321 1121111110000
Q ss_pred c------cc------c--ccccCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 301 D------II------D--DQVRKS-----GEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 301 ~------~~------~--~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
. .. . +..... .+...+..+.+|+.+||+.||++|||+.++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0 00 0 000000 00113467889999999999999999999875
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=341.13 Aligned_cols=252 Identities=28% Similarity=0.344 Sum_probs=201.9
Q ss_pred HhhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCCh-------------hHHHHHHHHHHHHhhCCCCceeeee
Q 017262 69 KATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE-------------SKLEEFINEVVILSQINHRNVVKLL 134 (374)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~~~ 134 (374)
...++|.+.+.||+|+||+||+|... +++.+|+|.+..... .....+.+|+.++++++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 34678999999999999999999975 578999998765321 2346788999999999999999999
Q ss_pred eeeeecccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCC---
Q 017262 135 GCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY--- 211 (374)
Q Consensus 135 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~--- 211 (374)
+++.+.+..++||||+++|+|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQII---NRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCS
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCc
Confidence 99999999999999999999999887 3457999999999999999999999999 99999999999998776
Q ss_pred cEEEeecccccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHH
Q 017262 212 RAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFV 291 (374)
Q Consensus 212 ~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 291 (374)
.+||+|||++...... .......||+.|+|||.+. ..++.++||||||+++|+|++|..||..... .....
T Consensus 187 ~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~ 257 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKD--YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND------QDIIK 257 (504)
T ss_dssp SEEECCCTTCEECCTT--SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHH
T ss_pred cEEEEECCCCEEcCCC--CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHH
Confidence 6999999999866432 2234456999999999987 4689999999999999999999999975332 22222
Q ss_pred HHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 292 ECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
. +....... ..... ...+..+.+|+.+||+.||++|||+.++++
T Consensus 258 ~-i~~~~~~~--~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 258 K-VEKGKYYF--DFNDW----KNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp H-HHHCCCCC--CHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred H-HHcCCCCC--Ccccc----CCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 2 11111110 00000 123457899999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=343.97 Aligned_cols=252 Identities=25% Similarity=0.327 Sum_probs=202.8
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
..++|++.+.||+|+||+||+|... +++.||+|.+... .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3467999999999999999999975 6889999987532 223456788999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEEC---CCCcEEEeecccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD---EKYRAKIADFGTSRS 223 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfg~~~~ 223 (374)
|||+++++|.+++. ....+++..+..++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 100 ~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 99999999999887 3457999999999999999999999999 99999999999995 456799999999976
Q ss_pred cccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccc
Q 017262 224 IAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDII 303 (374)
Q Consensus 224 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (374)
.... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||..... ....... ........
T Consensus 174 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i-~~~~~~~~- 242 (486)
T 3mwu_A 174 FQQN--TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE------YDILKRV-ETGKYAFD- 242 (486)
T ss_dssp BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHH-HHTCCCSC-
T ss_pred CCCC--CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHH-HhCCCCCC-
Confidence 5432 22344569999999999875 589999999999999999999999964332 2222222 11111100
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
.......+..+.+||.+||+.||++|||+.++++.
T Consensus 243 -----~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 243 -----LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -----SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -----CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00112334578899999999999999999999974
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=328.07 Aligned_cols=259 Identities=25% Similarity=0.401 Sum_probs=200.5
Q ss_pred ChHHHHHhhcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCChhHHHHHHHHHHHHhhC-CCCceeeeeeeeee-
Q 017262 63 NSKELDKATDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQI-NHRNVVKLLGCCLE- 139 (374)
Q Consensus 63 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~- 139 (374)
...++....++|++.+.||+|+||.||+|.. .+++.||+|.+..... ....+.+|+.+++++ +||||+++++++..
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 3445556678999999999999999999997 4688999998865432 346788999999999 79999999999986
Q ss_pred -----cccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEE
Q 017262 140 -----VEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAK 214 (374)
Q Consensus 140 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~k 214 (374)
.+..++||||+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+|
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEE
Confidence 45789999999999999999753 2357899999999999999999999999 99999999999999999999
Q ss_pred EeecccccccccCCceeeecccccccccCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHH
Q 017262 215 IADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFR-----SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTY 289 (374)
Q Consensus 215 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~ 289 (374)
|+|||++....... .......|++.|+|||.+. +..++.++||||||+++|+|++|..||...... ..
T Consensus 170 l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~ 242 (326)
T 2x7f_A 170 LVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------RA 242 (326)
T ss_dssp ECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HH
T ss_pred EeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------HH
Confidence 99999987654221 1223446899999999987 566889999999999999999999999643321 11
Q ss_pred HHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 290 FVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.... ....... ..+...+..+.+|+.+||..||++|||+.++++
T Consensus 243 ~~~~-~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 243 LFLI-PRNPAPR--------LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHH-HHSCCCC--------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHh-hcCcccc--------CCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1111 1111111 111223457899999999999999999999987
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=314.56 Aligned_cols=247 Identities=25% Similarity=0.350 Sum_probs=196.3
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC---hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
.++|.+.+.||+|+||.||+|... +++.+|+|.+.... ......+.+|+..++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 467999999999999999999975 68999999876432 22345788999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999999973 456899999999999999999999999 99999999999999999999999999976543
Q ss_pred CCceeeecccccccccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccc
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFRSSQF-TDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDD 305 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (374)
.. ......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||.... ....... .....
T Consensus 164 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~-~~~~~------- 227 (276)
T 2h6d_A 164 GE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH------VPTLFKK-IRGGV------- 227 (276)
T ss_dssp ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHH-HHHCC-------
T ss_pred Cc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc------HHHHHHH-hhcCc-------
Confidence 22 2234468999999999987765 689999999999999999999996432 1222211 11111
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 306 QVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
...+...+..+.+++.+||+.||++|||+.++++
T Consensus 228 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 228 ---FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 0112233457889999999999999999999987
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=332.83 Aligned_cols=265 Identities=19% Similarity=0.286 Sum_probs=208.9
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCC-CceeeeeeeeeecccceEEEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQINH-RNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e 148 (374)
.++|.+.+.||+|+||.||+|.. .+++.||||.+...... ..+..|+++++.++| +++..+..++...+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 57899999999999999999996 56899999987654322 357789999999986 556666666677778899999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEE---CCCCcEEEeecccccccc
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL---DEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfg~~~~~~ 225 (374)
|+ +++|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 84 ~~-g~sL~~ll~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 9999999964 2457999999999999999999999999 9999999999999 588999999999998765
Q ss_pred cCCce------eeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccc
Q 017262 226 IDQTH------VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCL 299 (374)
Q Consensus 226 ~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (374)
..... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||........ ...+....... .
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~---~~~~~~i~~~~-~ 233 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK---KQKYEKISEKK-V 233 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH---HHHHHHHHHHH-H
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH---HHHHHHHhhcc-c
Confidence 43322 12255699999999999999999999999999999999999999986543321 11111111110 1
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCC
Q 017262 300 FDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSR 352 (374)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~ 352 (374)
...+.. +.. ..+..+.+|+.+||+.+|++||++.++++.|+.+.....
T Consensus 234 ~~~~~~-l~~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~ 281 (483)
T 3sv0_A 234 ATSIEA-LCR----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG 281 (483)
T ss_dssp HSCHHH-HHT----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cccHHH-Hhc----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence 111100 001 123578999999999999999999999999999977553
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=339.20 Aligned_cols=250 Identities=22% Similarity=0.306 Sum_probs=204.6
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC---hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
.++|.+.+.||+|+||.||+|... +|+.||+|++.... ......+..|+.++++++||||+++++++.+.+..|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367889999999999999999975 58999999886432 23346788999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccc
Q 017262 147 YEFIPNGTLFQYLHDPY-EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 225 (374)
|||+++|+|.+++.... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999987532 2456999999999999999999999999 9999999999999999999999999998754
Q ss_pred cCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccc
Q 017262 226 IDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDD 305 (374)
Q Consensus 226 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (374)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..............
T Consensus 341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~--~~~~~~~~~i~~~~-------- 409 (543)
T 3c4z_A 341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK--VENKELKQRVLEQA-------- 409 (543)
T ss_dssp TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC--CCHHHHHHHHHHCC--------
T ss_pred CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc--hhHHHHHHHHhhcc--------
Confidence 3322 223457999999999999999999999999999999999999999754321 12222222221111
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 017262 306 QVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTM 337 (374)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 337 (374)
...+...+..+.+||.+||+.||++||++
T Consensus 410 ---~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 410 ---VTYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp ---CCCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred ---cCCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 12233445688899999999999999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=324.40 Aligned_cols=264 Identities=24% Similarity=0.364 Sum_probs=187.5
Q ss_pred HhhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 69 KATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
...++|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34678999999999999999999954 68899999876532 33456788999999999999999999999999999999
Q ss_pred EEeecCCcccccccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccc
Q 017262 147 YEFIPNGTLFQYLHDP-----YEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 221 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~-----~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 221 (374)
|||+++++|.+++... .....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999988631 12456899999999999999999999999 999999999999999999999999998
Q ss_pred cccccCCc----eeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHh
Q 017262 222 RSIAIDQT----HVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEE 296 (374)
Q Consensus 222 ~~~~~~~~----~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 296 (374)
........ .......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||....... ........
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~ 242 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK------VLMLTLQN 242 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG------HHHHHHTS
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh------HHHHHhcc
Confidence 76543221 11234568999999999875 568999999999999999999999997543221 11111111
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 297 NCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..................+..+.+++.+||+.||++|||+.++++
T Consensus 243 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 243 -DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp -SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 111111110111111223457889999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=322.31 Aligned_cols=252 Identities=27% Similarity=0.388 Sum_probs=201.0
Q ss_pred HhhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 69 KATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
...++|++.+.||+|+||.||+|... +|+.||+|.+.... ....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34678999999999999999999975 58999999887543 3467889999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 104 e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 99999999999863 3457899999999999999999999999 999999999999999999999999999765432
Q ss_pred CceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (374)
. .......|++.|+|||.+.+..++.++||||||+++|+|++|..||...... ...... ......
T Consensus 179 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~-~~~~~~------- 243 (314)
T 3com_A 179 M-AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM------RAIFMI-PTNPPP------- 243 (314)
T ss_dssp B-SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHH-HHSCCC-------
T ss_pred c-cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH------HHHHHH-hcCCCc-------
Confidence 2 2233456899999999999989999999999999999999999999743221 111111 111110
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
....+...+..+.+|+.+||+.||++|||+.++++
T Consensus 244 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 244 TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 01112233567899999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=331.46 Aligned_cols=257 Identities=25% Similarity=0.291 Sum_probs=194.5
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeeccc------ce
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEV------PL 144 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------~~ 144 (374)
..+|.+.+.||+|+||.||+|...++..+|+|++...... ..+|+.+++.++||||+++++++...+. .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 4579999999999999999999887777999977543221 2369999999999999999999965443 78
Q ss_pred EEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEEC-CCCcEEEeecccccc
Q 017262 145 LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD-EKYRAKIADFGTSRS 223 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~~~~ 223 (374)
+||||++++.+............+++..+..++.|++.||+|||+.+ |+||||||+|||++ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999987654433321113567999999999999999999999999 99999999999999 799999999999987
Q ss_pred cccCCceeeecccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHh------
Q 017262 224 IAIDQTHVSTKVQGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEE------ 296 (374)
Q Consensus 224 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------ 296 (374)
..... ......+|+.|+|||.+.+. .++.++|||||||++|+|++|+.||......+ ........
T Consensus 192 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~------~l~~i~~~~g~p~~ 263 (394)
T 4e7w_A 192 LIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID------QLVEIIKVLGTPSR 263 (394)
T ss_dssp CCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHHHCCCCH
T ss_pred ccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHHHhCCCCH
Confidence 54322 22345689999999998764 58999999999999999999999997543221 11111110
Q ss_pred ------c------cccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 297 ------N------CLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 297 ------~------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
+ .+............+...+..+.+|+.+||+.||++|||+.++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 264 EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 0 000000000000112234568999999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=326.23 Aligned_cols=261 Identities=21% Similarity=0.308 Sum_probs=192.7
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc------
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVE------ 141 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 141 (374)
.++|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999964 5889999988642 3455677889999999999999999999997654
Q ss_pred cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccc
Q 017262 142 VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 221 (374)
Q Consensus 142 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 221 (374)
..++||||++ ++|.+++. ..+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCC-CCHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 6799999996 47777775 24889999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccC---------C-------C
Q 017262 222 RSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEG---------R-------N 285 (374)
Q Consensus 222 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~---------~-------~ 285 (374)
...... .......||+.|+|||.+.+..++.++|||||||++|+|++|..||......+. . .
T Consensus 175 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 252 (371)
T 2xrw_A 175 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred cccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 765422 223445689999999999999999999999999999999999999975432110 0 0
Q ss_pred hHHHHHHHHHhcccc------ccccccccCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 286 LTTYFVECIEENCLF------DIIDDQVRKS---GEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 286 ~~~~~~~~~~~~~~~------~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
+.............. .......... .....+..+.+|+.+||..||++|||++++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 000000001110000 0000000000 11234678999999999999999999999987
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=317.76 Aligned_cols=252 Identities=27% Similarity=0.375 Sum_probs=204.0
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC---------hhHHHHHHHHHHHHhhCC-CCceeeeeeeee
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---------ESKLEEFINEVVILSQIN-HRNVVKLLGCCL 138 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~ 138 (374)
..++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3578999999999999999999975 58899999886543 123456789999999995 999999999999
Q ss_pred ecccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeec
Q 017262 139 EVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADF 218 (374)
Q Consensus 139 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 218 (374)
+.+..++||||+++++|.+++. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence 9999999999999999999997 3457999999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCceeeecccccccccCccccc------cCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHH
Q 017262 219 GTSRSIAIDQTHVSTKVQGTFGYLDPEYFR------SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVE 292 (374)
Q Consensus 219 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 292 (374)
|++....... ......+++.|+|||.+. ...++.++||||||+++|+|++|..||..... ......
T Consensus 169 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~ 240 (298)
T 1phk_A 169 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------MLMLRM 240 (298)
T ss_dssp TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHH
T ss_pred cchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH------HHHHHH
Confidence 9997654322 223456899999999985 45678999999999999999999999964322 111111
Q ss_pred HHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 293 CIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
... .... .........+..+.+++.+||+.||++|||+.++++
T Consensus 241 ~~~-~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 241 IMS-GNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHH-TCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred Hhc-CCcc------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 111 1110 000111234567899999999999999999999875
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=328.00 Aligned_cols=262 Identities=24% Similarity=0.262 Sum_probs=202.7
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCC--------CCceeeeeeeee---
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQIN--------HRNVVKLLGCCL--- 138 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~~~~~~--- 138 (374)
.++|.+.+.||+|+||+||+|... +++.||+|.+... ......+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 478999999999999999999864 5889999998743 445567889999999985 788999999987
Q ss_pred -ecccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCEEEeccCCCceEECCCC-----
Q 017262 139 -EVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSS-AYLPIYHRDIKSTNILLDEKY----- 211 (374)
Q Consensus 139 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~i~H~dlk~~Nill~~~~----- 211 (374)
+....++||||+ +++|.+++... ....+++..++.++.|++.||+|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 455789999999 45555555432 235699999999999999999999998 8 99999999999999775
Q ss_pred --------------------------------------------cEEEeecccccccccCCceeeecccccccccCcccc
Q 017262 212 --------------------------------------------RAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYF 247 (374)
Q Consensus 212 --------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 247 (374)
.+||+|||++...... .....||+.|+|||++
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhh
Confidence 7999999999765432 2334689999999999
Q ss_pred ccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHh-cccc-----------ccccc----------
Q 017262 248 RSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEE-NCLF-----------DIIDD---------- 305 (374)
Q Consensus 248 ~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~-----------~~~~~---------- 305 (374)
.+..++.++|||||||++|+|++|+.||...................+. +... .....
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 9999999999999999999999999999765443322111111111110 0000 00000
Q ss_pred ---------cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 306 ---------QVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 306 ---------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
......+...+..+.+|+.+||+.||++|||+.++++
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0011345677889999999999999999999999985
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=319.75 Aligned_cols=251 Identities=26% Similarity=0.327 Sum_probs=196.0
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC--------hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD--------ESKLEEFINEVVILSQINHRNVVKLLGCCLEVE 141 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 141 (374)
.++|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++...+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 467999999999999999999965 57899999876432 122345789999999999999999999987654
Q ss_pred cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCc---EEEeec
Q 017262 142 VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR---AKIADF 218 (374)
Q Consensus 142 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~---~kl~Df 218 (374)
.++||||+++++|.+++. ....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++. +||+||
T Consensus 89 -~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp -EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred -eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence 899999999999999887 3557999999999999999999999999 999999999999987664 999999
Q ss_pred ccccccccCCceeeecccccccccCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHH
Q 017262 219 GTSRSIAIDQTHVSTKVQGTFGYLDPEYFR---SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIE 295 (374)
Q Consensus 219 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 295 (374)
|++...... .......|++.|+|||.+. ...++.++||||||+++|+|++|..||....... .+... ..
T Consensus 162 g~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~----~~ 233 (322)
T 2ycf_A 162 GHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQ----IT 233 (322)
T ss_dssp TTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHH----HH
T ss_pred ccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHH----HH
Confidence 999765422 1223456899999999974 4668899999999999999999999997543221 11111 11
Q ss_pred hccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 296 ENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
...... .+... ...+..+.+|+.+||+.||++|||+.++++
T Consensus 234 ~~~~~~--~~~~~----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 234 SGKYNF--IPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HTCCCC--CHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hCcccc--Cchhh----hhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 111100 00000 123457889999999999999999999985
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=332.90 Aligned_cols=254 Identities=13% Similarity=0.085 Sum_probs=183.0
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC---hhHHHHHHHHHHHHhhC--CCCceeeee-------eee
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQI--NHRNVVKLL-------GCC 137 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l--~h~niv~~~-------~~~ 137 (374)
...|.+.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 456899999999999999999965 68999999887643 23455677785544444 699988755 444
Q ss_pred eec-----------------ccceEEEEeecCCcccccccCCCCCCCCCHHHH------HHHHHHHHHHHHHHhhcCCCC
Q 017262 138 LEV-----------------EVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMR------LRIATEVAEALAYLHSSAYLP 194 (374)
Q Consensus 138 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~------~~i~~~i~~~l~~lH~~~~~~ 194 (374)
... ...++||||++ |+|.+++... ...+++..+ ..++.|++.||+|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 332 23799999998 8999999752 223444455 678899999999999999
Q ss_pred EEEeccCCCceEECCCCcEEEeecccccccccCCceeeecccccccccCcccccc--CCCCccchhhhHHHHHHHHHhCC
Q 017262 195 IYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRS--SQFTDKSDVYSFGVVLVELLTGQ 272 (374)
Q Consensus 195 i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~ 272 (374)
|+||||||+|||++.++.+||+|||++..... ......+++.|+|||++.+ ..++.++|||||||++|+|++|+
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999986532 1224457799999999987 67999999999999999999999
Q ss_pred CCCCccccccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 273 KPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 273 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.||............ ....................+..+.+|+.+||+.||++|||+.++++
T Consensus 291 ~Pf~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 291 LPFGLVTPGIKGSWK--------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CSTTBCCTTCTTCCC--------BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCcCcccccchh--------hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999865433211000 00000111111111222345668999999999999999999999975
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=327.57 Aligned_cols=263 Identities=21% Similarity=0.291 Sum_probs=198.3
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCC--hhHHHHHHHHHHHHhhCCCCceeeeeeeeeec-------
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVD--ESKLEEFINEVVILSQINHRNVVKLLGCCLEV------- 140 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------- 140 (374)
.++|++.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 35799999999999999999997 468999999875432 22345678999999999999999999999873
Q ss_pred -ccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecc
Q 017262 141 -EVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 219 (374)
Q Consensus 141 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 219 (374)
+..++||||+++ +|.+.+.. ....+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 457899999975 66666654 3456999999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCC---ceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHH
Q 017262 220 TSRSIAIDQ---THVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIE 295 (374)
Q Consensus 220 ~~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 295 (374)
++....... ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||....... ....+.....
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~ 246 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH---QLALISQLCG 246 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhC
Confidence 997654222 222344568999999999876 558999999999999999999999997543221 0011111000
Q ss_pred hcc--cccccc---------ccccCCCCH-------HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 296 ENC--LFDIID---------DQVRKSGEA-------EEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 296 ~~~--~~~~~~---------~~~~~~~~~-------~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
... .....+ ......... ..++.+.+|+.+||+.||++|||+.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 000 000000 000000000 01346889999999999999999999987
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=323.44 Aligned_cols=265 Identities=19% Similarity=0.274 Sum_probs=202.4
Q ss_pred HHHhhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeec----
Q 017262 67 LDKATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEV---- 140 (374)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---- 140 (374)
.....++|++.+.||+|+||.||+|... ++..||+|++... .......+.+|+.++++++||||+++++++...
T Consensus 22 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 101 (364)
T 3qyz_A 22 VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101 (364)
T ss_dssp BCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred eccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence 3344678999999999999999999965 6788999988753 344457888999999999999999999998754
Q ss_pred -ccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecc
Q 017262 141 -EVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 219 (374)
Q Consensus 141 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 219 (374)
...++|+||++ ++|.+++. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 102 ~~~~~iv~e~~~-~~L~~~l~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg 173 (364)
T 3qyz_A 102 MKDVYIVQDLME-TDLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFG 173 (364)
T ss_dssp CCCEEEEEECCS-EEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcccC-cCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCc
Confidence 35789999996 58888885 346999999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCcee--eecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHh
Q 017262 220 TSRSIAIDQTHV--STKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEE 296 (374)
Q Consensus 220 ~~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 296 (374)
++.......... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+. ...+......
T Consensus 174 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~ 250 (364)
T 3qyz_A 174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILGS 250 (364)
T ss_dssp TCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH---HHHHHHHHCS
T ss_pred ceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH---HHHHHHHhCC
Confidence 998665332221 244579999999998654 4589999999999999999999999975433221 1111000000
Q ss_pred cccc-----------ccc-cccccCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 297 NCLF-----------DII-DDQVRKSG-----EAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 297 ~~~~-----------~~~-~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.... ... ........ ....+..+.+|+.+||+.||++|||+.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 251 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000 000 00000000 1123457899999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=324.42 Aligned_cols=256 Identities=22% Similarity=0.263 Sum_probs=184.8
Q ss_pred HhhcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeec-----
Q 017262 69 KATDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEV----- 140 (374)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----- 140 (374)
...++|++.+.||+|+||.||+|.. .+|+.||+|++... .......+.+|+.+++.++||||+++++++...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 4457899999999999999999995 46889999998653 345567888999999999999999999998654
Q ss_pred -ccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecc
Q 017262 141 -EVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 219 (374)
Q Consensus 141 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 219 (374)
...++++|++ +++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp CCCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC--
T ss_pred CCeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecc
Confidence 4579999999 7899998863 46999999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhc-
Q 017262 220 TSRSIAIDQTHVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEEN- 297 (374)
Q Consensus 220 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~- 297 (374)
+++.... ......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||......+ .+......-
T Consensus 178 ~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~l~~i~~~~g 247 (367)
T 2fst_X 178 LARHTAD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID------QLKLILRLVG 247 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHHHC
T ss_pred ccccccc----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHHHhC
Confidence 9976432 1334568999999999876 678999999999999999999999997543211 111111100
Q ss_pred c-cc------------ccccccc-cCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 298 C-LF------------DIIDDQV-RKSGE-----AEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 298 ~-~~------------~~~~~~~-~~~~~-----~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
. .. ..+.... ....+ ...++.+.+|+.+||+.||++|||+.++++
T Consensus 248 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 248 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp SCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 0 00 0000000 00000 122457899999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=319.60 Aligned_cols=257 Identities=21% Similarity=0.296 Sum_probs=199.2
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCChhHHHHHHHHHHHHhhCC-CCceeeeeeeeee--cccceEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQIN-HRNVVKLLGCCLE--VEVPLLV 146 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~lv 146 (374)
.++|++.+.||+|+||.||+|.. .+++.||+|.+.... ...+.+|+.++++++ ||||+++++++.+ ....+++
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 46799999999999999999986 568899999987533 457889999999997 9999999999987 5578999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCC-cEEEeecccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY-RAKIADFGTSRSIA 225 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~~~~~~ 225 (374)
|||+++++|.+++. .+++..+..++.|++.||+|||+++ ++||||||+|||++.++ .+||+|||++....
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999999885 3889999999999999999999999 99999999999999776 89999999998654
Q ss_pred cCCceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHH--------HHHHHHh
Q 017262 226 IDQTHVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTY--------FVECIEE 296 (374)
Q Consensus 226 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~--------~~~~~~~ 296 (374)
... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||........ .+... .......
T Consensus 183 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l~~~~~~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 183 PGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRIAKVLGTEDLYDYIDK 259 (330)
T ss_dssp TTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHHHHHHHCHHHHHHHHHH
T ss_pred CCC--ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HHHHHHHhcCCchhhhHHHH
Confidence 322 2334568999999999877 6789999999999999999999999953222110 00000 0000000
Q ss_pred ccc--------------cccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 297 NCL--------------FDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 297 ~~~--------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
... ................+..+.+||.+||+.||++|||++++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 0000011111112224568999999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=328.27 Aligned_cols=266 Identities=22% Similarity=0.305 Sum_probs=198.2
Q ss_pred HHhhcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeec------
Q 017262 68 DKATDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEV------ 140 (374)
Q Consensus 68 ~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 140 (374)
....++|++.+.||+|+||.||+|.. .+|+.||+|++...... ..+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999996 56899999987654222 23699999999999999999998543
Q ss_pred --------------------------------ccceEEEEeecCCcccccccCC-CCCCCCCHHHHHHHHHHHHHHHHHH
Q 017262 141 --------------------------------EVPLLVYEFIPNGTLFQYLHDP-YEELSLTWEMRLRIATEVAEALAYL 187 (374)
Q Consensus 141 --------------------------------~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~l 187 (374)
...++||||++ ++|.+.+... .....+++..+..++.|++.||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 23789999997 5766666421 1356799999999999999999999
Q ss_pred hhcCCCCEEEeccCCCceEEC-CCCcEEEeecccccccccCCceeeecccccccccCccccccC-CCCccchhhhHHHHH
Q 017262 188 HSSAYLPIYHRDIKSTNILLD-EKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSS-QFTDKSDVYSFGVVL 265 (374)
Q Consensus 188 H~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l 265 (374)
|+.+ |+||||||+||+++ .++.+||+|||++....... ......+|+.|+|||.+.+. .++.++|||||||++
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 9999 99999999999997 68899999999998654332 23345689999999998764 489999999999999
Q ss_pred HHHHhCCCCCCccccccCCChHHHHHHHHHh------------c------cccccccccccCCCCHHHHHHHHHHHHHhc
Q 017262 266 VELLTGQKPISSIWANEGRNLTTYFVECIEE------------N------CLFDIIDDQVRKSGEAEEIMAVSDVAKRCL 327 (374)
Q Consensus 266 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------~------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 327 (374)
|+|++|+.||......+ ........ + .+............+...+..+.+|+.+||
T Consensus 233 ~ell~g~~pf~~~~~~~------~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 306 (383)
T 3eb0_A 233 GELILGKPLFSGETSID------QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQIL 306 (383)
T ss_dssp HHHHHSSCSSCCSSHHH------HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC
T ss_pred HHHHhCCCCCCCCChHH------HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHc
Confidence 99999999997543221 11111110 0 000000011111122334567899999999
Q ss_pred ccCCCCCCCHHHHHH--HHHHHHh
Q 017262 328 NSYGRNRPTMKEVAM--ELERIRA 349 (374)
Q Consensus 328 ~~~p~~Rps~~~vl~--~L~~~~~ 349 (374)
+.||++|||+.++++ -++.++.
T Consensus 307 ~~dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 307 RYEPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp CSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred cCChhhCCCHHHHhcCHHHHHHHh
Confidence 999999999999985 3444433
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=316.08 Aligned_cols=251 Identities=23% Similarity=0.287 Sum_probs=198.5
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC----hhHHHHHHHHHHHHhhCCCCceeeeeeeee--ecccc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD----ESKLEEFINEVVILSQINHRNVVKLLGCCL--EVEVP 143 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~ 143 (374)
.++|.+.+.||+|+||.||++... ++..+|+|.+.... ......+.+|+.++++++||||+++++++. +.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999964 57899999886532 234567899999999999999999999984 44578
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccc
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 223 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 223 (374)
++||||++++ |.+++... ....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999876 66655432 3457999999999999999999999999 99999999999999999999999999986
Q ss_pred cccCC-ceeeecccccccccCccccccCC--CCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccc
Q 017262 224 IAIDQ-THVSTKVQGTFGYLDPEYFRSSQ--FTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLF 300 (374)
Q Consensus 224 ~~~~~-~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (374)
..... ........|++.|+|||.+.+.. ++.++||||||+++|+|++|..||.... ....... +.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~-i~~~~~- 230 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN------IYKLFEN-IGKGSY- 230 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHH-HHHCCC-
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch------HHHHHHH-HhcCCC-
Confidence 54322 22234456899999999987644 4779999999999999999999996432 2222221 111111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 301 DIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
..+...+..+.+++.+||+.||++|||+.++++.
T Consensus 231 ---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 ---------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ---------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1222344578899999999999999999999874
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=319.40 Aligned_cols=252 Identities=23% Similarity=0.339 Sum_probs=188.0
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCC-h-hHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVD-E-SKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
.++|++.+.||+|+||.||+|.. .+++.+|+|.+.... . .....+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 56799999999999999999996 468899999886542 2 22334445555688889999999999999999999999
Q ss_pred EeecCCcccccccCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCEEEeccCCCceEECCCCcEEEeecccccccc
Q 017262 148 EFIPNGTLFQYLHDP-YEELSLTWEMRLRIATEVAEALAYLHSS-AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 148 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 225 (374)
||++ |+|.+++... .....+++..++.++.|++.||+|||++ + ++|+||||+||+++.++.+||+|||++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9996 5877776531 1345799999999999999999999998 8 9999999999999999999999999997654
Q ss_pred cCCceeeecccccccccCcccc----ccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccc
Q 017262 226 IDQTHVSTKVQGTFGYLDPEYF----RSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFD 301 (374)
Q Consensus 226 ~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (374)
... ......||+.|+|||.+ .+..++.++||||||+++|+|++|..||.... ..............
T Consensus 162 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~--- 231 (290)
T 3fme_A 162 DDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG-----TPFQQLKQVVEEPS--- 231 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS-----CHHHHHHHHHHSCC---
T ss_pred ccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC-----chHHHHHHHhccCC---
Confidence 322 22334689999999996 55678999999999999999999999996422 11222222222111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 302 IIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 302 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
........+..+.+++.+||+.||++|||+.++++
T Consensus 232 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 ------PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ------CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 11112234567899999999999999999999987
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=322.79 Aligned_cols=258 Identities=24% Similarity=0.365 Sum_probs=201.8
Q ss_pred hHHHHHhhcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCC--CCceeeeeeeeee
Q 017262 64 SKELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVV--DESKLEEFINEVVILSQIN--HRNVVKLLGCCLE 139 (374)
Q Consensus 64 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~ 139 (374)
...+....++|++.+.||+|+||.||++...+++.+|+|.+... .......+.+|+.++++++ ||||+++++++.+
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 44455557789999999999999999999888999999987643 4455678899999999997 5999999999999
Q ss_pred cccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecc
Q 017262 140 VEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 219 (374)
Q Consensus 140 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 219 (374)
.+..+++|| +.+++|.+++. ....+++..++.++.|++.||.|||+.+ ++|+||||+||++++ +.+||+|||
T Consensus 100 ~~~~~lv~e-~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg 171 (313)
T 3cek_A 100 DQYIYMVME-CGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFG 171 (313)
T ss_dssp SSEEEEEEC-CCSEEHHHHHH---HCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCS
T ss_pred CCEEEEEEe-cCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecc
Confidence 999999999 56889999997 3457899999999999999999999999 999999999999964 899999999
Q ss_pred cccccccCCce-eeecccccccccCcccccc-----------CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChH
Q 017262 220 TSRSIAIDQTH-VSTKVQGTFGYLDPEYFRS-----------SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLT 287 (374)
Q Consensus 220 ~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~ 287 (374)
++......... ......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||...... .
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~ 246 (313)
T 3cek_A 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----I 246 (313)
T ss_dssp SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----H
T ss_pred ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-----H
Confidence 99866433222 2234568999999999875 46788999999999999999999999643211 1
Q ss_pred HHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 288 TYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
...... .+.......+...+..+.+++.+||+.||++|||+.++++.
T Consensus 247 ~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 247 SKLHAI---------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHHHH---------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHH---------HhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 111111 11111122222234578899999999999999999999874
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=351.37 Aligned_cols=249 Identities=24% Similarity=0.321 Sum_probs=205.5
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccce
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVPL 144 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 144 (374)
..++|++.+.||+|+||.||+|... +++.||+|++... .......+..|..++..+ +||||+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3568999999999999999999965 5788999988642 223345678899999988 7999999999999999999
Q ss_pred EEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccc
Q 017262 145 LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 224 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 224 (374)
+||||+++|+|.+++. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQ---QVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 9999999999999997 3457999999999999999999999999 999999999999999999999999999864
Q ss_pred ccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccc
Q 017262 225 AIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIID 304 (374)
Q Consensus 225 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (374)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .+.+......
T Consensus 493 ~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~-------- 557 (674)
T 3pfq_A 493 IWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIMEH-------- 557 (674)
T ss_dssp CCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHSS--------
T ss_pred ccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH------HHHHHHHHhC--------
Confidence 3222 233456799999999999999999999999999999999999999975322 2222222211
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 017262 305 DQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTM-----KEVAM 342 (374)
Q Consensus 305 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~-----~~vl~ 342 (374)
. ..++...+..+.+||.+||+.||++||++ +++++
T Consensus 558 -~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 558 -N--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp -C--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred -C--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1 12233455688999999999999999998 55553
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=314.67 Aligned_cols=251 Identities=28% Similarity=0.467 Sum_probs=194.1
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeee----------
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLE---------- 139 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---------- 139 (374)
.++|++.+.||+|+||.||+|... +++.+|+|.+... ......+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 467899999999999999999964 6899999988643 4455788999999999999999999998865
Q ss_pred ---cccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEe
Q 017262 140 ---VEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIA 216 (374)
Q Consensus 140 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~ 216 (374)
.+..++||||+++++|.+++.. ....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 3567899999999999999974 2346788999999999999999999999 9999999999999999999999
Q ss_pred ecccccccccCC-------------ceeeecccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcccccc
Q 017262 217 DFGTSRSIAIDQ-------------THVSTKVQGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLVELLTGQKPISSIWANE 282 (374)
Q Consensus 217 Dfg~~~~~~~~~-------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~ 282 (374)
|||++....... ........|++.|+|||.+.+. .++.++||||||+++|+|++ ||.....
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~-- 233 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME-- 233 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH--
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh--
Confidence 999997654221 1122345689999999999764 68999999999999999998 5542111
Q ss_pred CCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 283 GRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
...... ..... ........+...+..+.+++.+||+.||++|||+.++++
T Consensus 234 ---~~~~~~-~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 234 ---RVNILK-KLRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp ---HHHHHH-HHHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---HHHHHH-hcccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 011111 11111 111122234445567899999999999999999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=329.03 Aligned_cols=200 Identities=23% Similarity=0.318 Sum_probs=172.2
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhC------CCCceeeeeeeeeeccc
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQI------NHRNVVKLLGCCLEVEV 142 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~~~~~~~~~ 142 (374)
...+|++.+.||+|+||.||+|... +++.||+|.+... ......+.+|+.+++.+ +|+||+++++++...+.
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 3567999999999999999999865 5889999998753 34446677888888877 57799999999999999
Q ss_pred ceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCc--EEEeeccc
Q 017262 143 PLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR--AKIADFGT 220 (374)
Q Consensus 143 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~--~kl~Dfg~ 220 (374)
.++||||+. ++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 999999995 6888888643 2345899999999999999999999999 999999999999999887 99999999
Q ss_pred ccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccc
Q 017262 221 SRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIW 279 (374)
Q Consensus 221 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~ 279 (374)
+..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 249 a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 249 SCYEHQ----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp CEETTC----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ceecCC----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 975432 2234568999999999999999999999999999999999999997543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=316.02 Aligned_cols=258 Identities=22% Similarity=0.312 Sum_probs=195.6
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecC-CcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeee-----------
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCL----------- 138 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----------- 138 (374)
.++|.+.+.||+|+||.||+|.... ++.||+|.+...+......+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 5789999999999999999999764 8899999988777777788999999999999999999998873
Q ss_pred ---ecccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEEC-CCCcEE
Q 017262 139 ---EVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD-EKYRAK 214 (374)
Q Consensus 139 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~-~~~~~k 214 (374)
+....++||||++ |+|.+++. ...+++..++.++.|++.||+|||+++ ++|+||||+||+++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3457799999997 69999885 346899999999999999999999999 99999999999997 577999
Q ss_pred EeecccccccccCCc--eeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHH
Q 017262 215 IADFGTSRSIAIDQT--HVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFV 291 (374)
Q Consensus 215 l~Dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 291 (374)
|+|||++........ .......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...... ....
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------~~~~ 235 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL------EQMQ 235 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH------HHHH
Confidence 999999986543211 12234457899999998865 67899999999999999999999999754321 1111
Q ss_pred HHHHhccc-------------ccccccccc-CCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 292 ECIEENCL-------------FDIIDDQVR-KSG-----EAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 292 ~~~~~~~~-------------~~~~~~~~~-~~~-----~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
........ ......... ... ....+..+.+|+.+||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 236 LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 11111000 000000000 000 1123567899999999999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=313.40 Aligned_cols=259 Identities=21% Similarity=0.300 Sum_probs=202.3
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe--cCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCC------ceeeeeeeeeeccc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML--ADGRIIAVKKSKVVDESKLEEFINEVVILSQINHR------NVVKLLGCCLEVEV 142 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~~~~~~~~~~~ 142 (374)
.++|++.+.||+|+||.||+|.. .+++.||+|.+... ......+.+|+.+++.++|+ +++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999986 35789999998753 34456788999999998765 49999999999999
Q ss_pred ceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECC-------------
Q 017262 143 PLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE------------- 209 (374)
Q Consensus 143 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~------------- 209 (374)
.++||||+ +++|.+++... ....+++..+..++.|++.||+|||+++ ++||||||+||+++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 88999988743 2346899999999999999999999999 999999999999987
Q ss_pred ------CCcEEEeecccccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccC
Q 017262 210 ------KYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEG 283 (374)
Q Consensus 210 ------~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~ 283 (374)
++.+||+|||++...... .....||+.|+|||.+.+..++.++||||||+++|+|++|..||......+.
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred ccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 668999999999764322 2345689999999999999999999999999999999999999975432210
Q ss_pred CChHHHHHHHHHh--------ccccccc---------------------c-ccccCCCCHHHHHHHHHHHHHhcccCCCC
Q 017262 284 RNLTTYFVECIEE--------NCLFDII---------------------D-DQVRKSGEAEEIMAVSDVAKRCLNSYGRN 333 (374)
Q Consensus 284 ~~~~~~~~~~~~~--------~~~~~~~---------------------~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~ 333 (374)
...+...... ....... . .......+...+..+.+|+.+||+.||++
T Consensus 243 ---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 243 ---LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp ---HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred ---HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 0000000000 0000000 0 00011223456778999999999999999
Q ss_pred CCCHHHHHH
Q 017262 334 RPTMKEVAM 342 (374)
Q Consensus 334 Rps~~~vl~ 342 (374)
|||+.++++
T Consensus 320 Rpt~~ell~ 328 (339)
T 1z57_A 320 RITLREALK 328 (339)
T ss_dssp SCCHHHHTT
T ss_pred ccCHHHHhc
Confidence 999999875
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=319.65 Aligned_cols=262 Identities=21% Similarity=0.245 Sum_probs=201.6
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCChhHHHHHHHHHHHHhhCC-----------CCceeeeeeeee
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQIN-----------HRNVVKLLGCCL 138 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~ 138 (374)
.++|.+.+.||+|+||.||+|.. .+++.||+|.+... ......+.+|+.++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 46899999999999999999996 46889999998743 344567888999999886 899999999998
Q ss_pred ecc----cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCEEEeccCCCceEEC-----
Q 017262 139 EVE----VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSS-AYLPIYHRDIKSTNILLD----- 208 (374)
Q Consensus 139 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~i~H~dlk~~Nill~----- 208 (374)
..+ ..+++||++ +++|.+++... ....+++..+..++.|++.||+|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 688999999 89999998743 244699999999999999999999998 8 99999999999994
Q ss_pred -CCCcEEEeecccccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChH
Q 017262 209 -EKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLT 287 (374)
Q Consensus 209 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~ 287 (374)
..+.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|+|++|..||............
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 4458999999999765422 23346899999999999999999999999999999999999999755432221111
Q ss_pred HHHHHHHHh-ccccc--------------------ccc----------ccccCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 017262 288 TYFVECIEE-NCLFD--------------------IID----------DQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPT 336 (374)
Q Consensus 288 ~~~~~~~~~-~~~~~--------------------~~~----------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 336 (374)
.......+. +.... .+. .......+...+..+.+||.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 111111110 00000 000 00112355678889999999999999999999
Q ss_pred HHHHHH
Q 017262 337 MKEVAM 342 (374)
Q Consensus 337 ~~~vl~ 342 (374)
+.++++
T Consensus 328 ~~ell~ 333 (373)
T 1q8y_A 328 AGGLVN 333 (373)
T ss_dssp HHHHHT
T ss_pred HHHHhh
Confidence 999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=328.08 Aligned_cols=256 Identities=26% Similarity=0.336 Sum_probs=192.2
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc------cc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVE------VP 143 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~ 143 (374)
..+|++.+.||+|+||.||+|... +++.||+|++..... ...+|+++++.++||||+++++++.... ..
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 346899999999999999999975 589999998765322 2346999999999999999999985422 36
Q ss_pred eEEEEeecCCcccccccC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCC-CcEEEeecccc
Q 017262 144 LLVYEFIPNGTLFQYLHD-PYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK-YRAKIADFGTS 221 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfg~~ 221 (374)
++||||+++ +|.+.+.. ......+++..+..++.|++.||+|||+++ |+||||||+|||++.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence 799999975 55544432 113567999999999999999999999999 9999999999999955 67899999999
Q ss_pred cccccCCceeeecccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHh----
Q 017262 222 RSIAIDQTHVSTKVQGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEE---- 296 (374)
Q Consensus 222 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---- 296 (374)
+...... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||...... +.+......
T Consensus 205 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~------~~l~~i~~~lg~p 276 (420)
T 1j1b_A 205 KQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV------DQLVEIIKVLGTP 276 (420)
T ss_dssp EECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHHHCSC
T ss_pred hhcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHHhCCC
Confidence 8654322 22345689999999998764 7899999999999999999999999754321 111111110
Q ss_pred --------c-ccccccccccc-----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 297 --------N-CLFDIIDDQVR-----KSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 297 --------~-~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
. .......+... ...+...+..+.+|+.+||..||++|||+.++++
T Consensus 277 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0 00000000000 0012234568999999999999999999999985
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=313.25 Aligned_cols=253 Identities=26% Similarity=0.334 Sum_probs=203.1
Q ss_pred HHhhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccce
Q 017262 68 DKATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPL 144 (374)
Q Consensus 68 ~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 144 (374)
....++|++.+.||+|+||.||+|... +++.+|+|.+... .......+.+|+.++++++||||+++++++.+.+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 344578999999999999999999975 6889999987543 2344678889999999999999999999999999999
Q ss_pred EEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCC---CcEEEeecccc
Q 017262 145 LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK---YRAKIADFGTS 221 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~---~~~kl~Dfg~~ 221 (374)
+++||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.+ +.+||+|||++
T Consensus 98 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 98 IVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 99999999999988863 457899999999999999999999999 9999999999999754 47999999998
Q ss_pred cccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccc
Q 017262 222 RSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFD 301 (374)
Q Consensus 222 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (374)
....... ......+++.|+|||.+.+ .++.++||||||+++|+|++|..||..... ..... .........
T Consensus 172 ~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~-~~~~~~~~~ 241 (287)
T 2wei_A 172 TCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE------YDILK-RVETGKYAF 241 (287)
T ss_dssp GTBCCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHH-HHHHCCCCC
T ss_pred eeecCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH------HHHHH-HHHcCCCCC
Confidence 7654322 2233458899999999875 489999999999999999999999975332 12121 222211110
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 302 IIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 302 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.. ......+..+.+++.+||+.||++|||+.++++
T Consensus 242 ~~------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 242 DL------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CS------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Cc------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 00 001123457889999999999999999999987
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=327.03 Aligned_cols=266 Identities=25% Similarity=0.407 Sum_probs=203.4
Q ss_pred hHHHHHhhcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc
Q 017262 64 SKELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVE 141 (374)
Q Consensus 64 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 141 (374)
..+.....++|++.+.||+|+||.||+|...+ .+++|.+... .......+.+|+.++++++||||+++++++.+.+
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 34445557889999999999999999998764 3889987643 2233356778999999999999999999999999
Q ss_pred cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccc
Q 017262 142 VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 221 (374)
Q Consensus 142 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 221 (374)
..++++||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++ ++.+||+|||++
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLF 176 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred ceEEEeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCc
Confidence 99999999999999999975 3446899999999999999999999999 99999999999998 679999999998
Q ss_pred cccccCC----ceeeecccccccccCcccccc---------CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHH
Q 017262 222 RSIAIDQ----THVSTKVQGTFGYLDPEYFRS---------SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTT 288 (374)
Q Consensus 222 ~~~~~~~----~~~~~~~~g~~~y~aPE~~~~---------~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~ 288 (374)
....... ........|++.|+|||.+.+ ..++.++||||||+++|+|++|..||...... .
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~ 250 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE------A 250 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH------H
T ss_pred cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------H
Confidence 6543211 112233458999999999864 35788999999999999999999999743321 1
Q ss_pred HHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCC
Q 017262 289 YFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSR 352 (374)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~ 352 (374)
... .......... .....+..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 251 ~~~-~~~~~~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 251 IIW-QMGTGMKPNL--------SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp HHH-HHHTTCCCCC--------CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred HHH-HhccCCCCCC--------CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 111 1111111111 111233468899999999999999999999999999987654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=317.90 Aligned_cols=254 Identities=22% Similarity=0.301 Sum_probs=196.8
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccc---
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVP--- 143 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~--- 143 (374)
..++|.+.+.||+|+||.||+|... +|+.||+|++... .......+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 4578999999999999999999965 5889999988653 344467888999999999999999999999877654
Q ss_pred ---eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccc
Q 017262 144 ---LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGT 220 (374)
Q Consensus 144 ---~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 220 (374)
++||||++ ++|.+++. ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999996 68887774 24899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccc
Q 017262 221 SRSIAIDQTHVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCL 299 (374)
Q Consensus 221 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (374)
+..... ......+|+.|+|||.+.+ ..++.++||||||+++|+|++|..||...... +...........
T Consensus 191 a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~~~ 260 (371)
T 4exu_A 191 ARHADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL------DQLTQILKVTGV 260 (371)
T ss_dssp C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHHHCC
T ss_pred cccccc----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHHHhCC
Confidence 975432 2234568999999999887 67899999999999999999999999753321 111111110000
Q ss_pred c--c------------c---ccccccC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 300 F--D------------I---IDDQVRK---SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 300 ~--~------------~---~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
. . . +...... ......+..+.+|+.+||+.||++|||+.++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 261 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp CCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 0 0 0 0000000 001123568899999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=316.73 Aligned_cols=259 Identities=21% Similarity=0.252 Sum_probs=198.8
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeec-----cc
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEV-----EV 142 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~ 142 (374)
..++|.+.+.||+|+||.||+|... +|+.||+|.+... .......+.+|+.++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3578999999999999999999975 5889999988653 344456788999999999999999999988754 56
Q ss_pred ceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccc
Q 017262 143 PLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 222 (374)
Q Consensus 143 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 222 (374)
.+++|||++ ++|.+++.. ..+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++.
T Consensus 89 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 799999996 688888863 46899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCce---------eeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHH
Q 017262 223 SIAIDQTH---------VSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVE 292 (374)
Q Consensus 223 ~~~~~~~~---------~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 292 (374)
........ ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||...... .....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~ 234 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR------HQLLL 234 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH------HHHHH
Confidence 65432211 1123468999999998764 67899999999999999999999999754321 11111
Q ss_pred HHHhcccc---------------ccccccc-cC-----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 293 CIEENCLF---------------DIIDDQV-RK-----SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 293 ~~~~~~~~---------------~~~~~~~-~~-----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
........ ....... .. ...+..+..+.+|+.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 11000000 0000000 00 001234567889999999999999999999987
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=325.83 Aligned_cols=266 Identities=22% Similarity=0.290 Sum_probs=182.0
Q ss_pred hcCCCc-CceEeeeCeEEEEEEEec---CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeee--cccce
Q 017262 71 TDYFNM-NRILGQGGQGTVYKGMLA---DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLE--VEVPL 144 (374)
Q Consensus 71 ~~~~~~-~~~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~ 144 (374)
.+.|.+ .++||+|+||.||+|... +++.||+|.+..... ...+.+|+.++++++||||+++++++.. ....+
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 345665 458999999999999965 478899999875432 2467899999999999999999999964 56789
Q ss_pred EEEEeecCCcccccccCC------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEE----CCCCcEE
Q 017262 145 LVYEFIPNGTLFQYLHDP------YEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL----DEKYRAK 214 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill----~~~~~~k 214 (374)
+||||++ ++|.+++... .....+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+|
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEE
Confidence 9999996 5777766421 12235899999999999999999999999 9999999999999 6788999
Q ss_pred EeecccccccccCCc--eeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccC---CChHH
Q 017262 215 IADFGTSRSIAIDQT--HVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEG---RNLTT 288 (374)
Q Consensus 215 l~Dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~---~~~~~ 288 (374)
|+|||++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ ....+
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 999999987643221 22344678999999999887 4589999999999999999999999975433210 00011
Q ss_pred HHHHHHHhcccc------cc------------ccccccCCCC---------HHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 017262 289 YFVECIEENCLF------DI------------IDDQVRKSGE---------AEEIMAVSDVAKRCLNSYGRNRPTMKEVA 341 (374)
Q Consensus 289 ~~~~~~~~~~~~------~~------------~~~~~~~~~~---------~~~~~~l~~li~~cl~~~p~~Rps~~~vl 341 (374)
.+......-... .. .......... ...+..+.+||.+||+.||++|||+++++
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 111111100000 00 0000000000 01134688999999999999999999998
Q ss_pred H
Q 017262 342 M 342 (374)
Q Consensus 342 ~ 342 (374)
+
T Consensus 333 ~ 333 (405)
T 3rgf_A 333 Q 333 (405)
T ss_dssp T
T ss_pred c
Confidence 7
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=314.08 Aligned_cols=261 Identities=24% Similarity=0.332 Sum_probs=199.3
Q ss_pred HhhcCCCcCceEeeeCeEEEEEEEe--cCCcEEEEEEeccCC--hhHHHHHHHHHHHHhhC---CCCceeeeeeeee---
Q 017262 69 KATDYFNMNRILGQGGQGTVYKGML--ADGRIIAVKKSKVVD--ESKLEEFINEVVILSQI---NHRNVVKLLGCCL--- 138 (374)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~v~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~--- 138 (374)
...++|++.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3457899999999999999999997 457899999875432 11223455677776665 8999999999987
Q ss_pred --ecccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEe
Q 017262 139 --EVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIA 216 (374)
Q Consensus 139 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~ 216 (374)
.....++||||++ |+|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 4567899999997 6999988643 2345899999999999999999999999 9999999999999999999999
Q ss_pred ecccccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHh
Q 017262 217 DFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEE 296 (374)
Q Consensus 217 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 296 (374)
|||++....... ......+++.|+|||.+.+..++.++||||||+++|+|++|..||...... .........
T Consensus 163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~i~~~ 234 (326)
T 1blx_A 163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV------DQLGKILDV 234 (326)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHH
T ss_pred cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHHH
Confidence 999997654221 223456899999999999989999999999999999999999999754321 111111111
Q ss_pred cc------ccccc----------cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 297 NC------LFDII----------DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 297 ~~------~~~~~----------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.. ..... ............+..+.+|+.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 235 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 00000 000001112234567889999999999999999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=312.96 Aligned_cols=253 Identities=21% Similarity=0.279 Sum_probs=196.8
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeeccc-----
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEV----- 142 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----- 142 (374)
.++|.+.+.||+|+||.||+|... +|+.||+|.+... .......+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467999999999999999999964 6899999988653 34445778899999999999999999999987654
Q ss_pred -ceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccc
Q 017262 143 -PLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 221 (374)
Q Consensus 143 -~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 221 (374)
.+++|||++ ++|.+++.. .+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999996 688887742 4899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccc
Q 017262 222 RSIAIDQTHVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLF 300 (374)
Q Consensus 222 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (374)
...... .....+|+.|+|||.+.+ ..++.++||||||+++|+|++|..||...... .............
T Consensus 174 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------~~~~~i~~~~~~~ 243 (353)
T 3coi_A 174 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL------DQLTQILKVTGVP 243 (353)
T ss_dssp TC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH------HHHHHHHHHHCBC
T ss_pred cCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHHhCCC
Confidence 764321 234568999999999876 67899999999999999999999999754321 1111111100000
Q ss_pred -----------------cccccc---ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 301 -----------------DIIDDQ---VRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 301 -----------------~~~~~~---~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..+... .........+..+.+|+.+||+.||++|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 244 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp CHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 001122345668999999999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=319.28 Aligned_cols=267 Identities=20% Similarity=0.259 Sum_probs=190.3
Q ss_pred hHHHHHhhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeeccc
Q 017262 64 SKELDKATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEV 142 (374)
Q Consensus 64 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 142 (374)
........++|++.+.||+|+||.||+|... +++.||+|++.... .......+++..++.++||||+++++++...+.
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 3455666789999999999999999999975 58899999875532 223456678888899999999999999976443
Q ss_pred -------ceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHh--hcCCCCEEEeccCCCceEECC-CCc
Q 017262 143 -------PLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLH--SSAYLPIYHRDIKSTNILLDE-KYR 212 (374)
Q Consensus 143 -------~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH--~~~~~~i~H~dlk~~Nill~~-~~~ 212 (374)
.++||||++++.+............+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++.
T Consensus 94 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp SCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTE
T ss_pred ccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCc
Confidence 7899999987533322211114567899999999999999999999 888 999999999999996 899
Q ss_pred EEEeecccccccccCCceeeecccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHH
Q 017262 213 AKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFV 291 (374)
Q Consensus 213 ~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 291 (374)
+||+|||++....... ......||+.|+|||++.+. .++.++||||||+++|+|++|+.||...... ....
T Consensus 171 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~------~~~~ 242 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA------GQLH 242 (360)
T ss_dssp EEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH
T ss_pred EEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH------HHHH
Confidence 9999999998665332 22345689999999998654 4899999999999999999999999754322 1111
Q ss_pred HHHHh---------------cccccccc------ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 292 ECIEE---------------NCLFDIID------DQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 292 ~~~~~---------------~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..... .......+ ...........+..+.+|+.+||+.||++|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11110 00000000 00011122234678999999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=314.82 Aligned_cols=253 Identities=25% Similarity=0.353 Sum_probs=179.9
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC-hhHHHHHHHHHH-HHhhCCCCceeeeeeeeeecccceEE
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVV-ILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
..++|.+.+.||+|+||.||+|... +++.||+|.+.... ......+..|+. +++.++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 3578999999999999999999975 68899999886543 334445556666 67778999999999999999999999
Q ss_pred EEeecCCcccccccCC--CCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCEEEeccCCCceEECCCCcEEEeecccccc
Q 017262 147 YEFIPNGTLFQYLHDP--YEELSLTWEMRLRIATEVAEALAYLHSS-AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 223 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 223 (374)
|||+++ +|.+++... .....+++..+..++.|++.||.|||+. + ++|+||||+||+++.++.+||+|||++..
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 999975 777766421 1245789999999999999999999998 8 99999999999999999999999999976
Q ss_pred cccCCceeeecccccccccCcccc----ccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccc
Q 017262 224 IAIDQTHVSTKVQGTFGYLDPEYF----RSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCL 299 (374)
Q Consensus 224 ~~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (374)
..... ......|++.|+|||.+ .+..++.++||||||+++|+|++|..||........ ..
T Consensus 176 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------------~~ 239 (327)
T 3aln_A 176 LVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD--------------QL 239 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------------------
T ss_pred ccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH--------------HH
Confidence 54322 22334689999999998 456789999999999999999999999975321100 00
Q ss_pred ccccc---ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 300 FDIID---DQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 300 ~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..... ...........+..+.+|+.+||+.||++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 240 TQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 11111 11111111234567899999999999999999999987
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=314.90 Aligned_cols=253 Identities=21% Similarity=0.257 Sum_probs=174.1
Q ss_pred hhcCCCcC-ceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeee----cccc
Q 017262 70 ATDYFNMN-RILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLE----VEVP 143 (374)
Q Consensus 70 ~~~~~~~~-~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~ 143 (374)
..++|.+. +.||+|+||.||+|... +++.||+|.+.... . ...+....++.++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-K---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-H---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-H---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 35678885 46999999999999976 68999999986531 1 11223334667799999999999876 4457
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECC---CCcEEEeeccc
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE---KYRAKIADFGT 220 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfg~ 220 (374)
++||||+++|+|.+++... ....+++..++.++.|++.||.|||+++ ++||||||+||+++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 9999999999999999753 2347999999999999999999999999 999999999999976 45599999999
Q ss_pred ccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccc
Q 017262 221 SRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLF 300 (374)
Q Consensus 221 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (374)
+...... ......+|+.|+|||.+.+..++.++||||||+++|+|++|..||.......... ........
T Consensus 178 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~---- 247 (336)
T 3fhr_A 178 AKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP---GMKRRIRL---- 247 (336)
T ss_dssp CEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred ceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh---hHHHhhhc----
Confidence 9765322 2234468999999999988889999999999999999999999997543322100 00000000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 301 DIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.............+..+.+|+.+||+.||++|||+.++++
T Consensus 248 --~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 248 --GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000111111234567899999999999999999999998
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=313.97 Aligned_cols=245 Identities=27% Similarity=0.398 Sum_probs=191.8
Q ss_pred HHHHhhcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCChh------HHHHHHHHHHHHhhC----CCCceeeee
Q 017262 66 ELDKATDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDES------KLEEFINEVVILSQI----NHRNVVKLL 134 (374)
Q Consensus 66 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l----~h~niv~~~ 134 (374)
+.....++|++.+.||+|+||.||+|.. .+++.||+|.+...... ....+.+|+.++.++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 3445568899999999999999999986 46889999988654321 223455789999988 899999999
Q ss_pred eeeeecccceEEEEe-ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEEC-CCCc
Q 017262 135 GCCLEVEVPLLVYEF-IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD-EKYR 212 (374)
Q Consensus 135 ~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~-~~~~ 212 (374)
+++.+.+..++++|+ +.+++|.+++.. ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++ .++.
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCe
Confidence 999999999999999 789999999973 456999999999999999999999999 99999999999999 8899
Q ss_pred EEEeecccccccccCCceeeecccccccccCccccccCCCC-ccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHH
Q 017262 213 AKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFT-DKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFV 291 (374)
Q Consensus 213 ~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 291 (374)
+||+|||++....... .....|++.|+|||.+.+..+. .++||||||+++|+|++|+.||.....
T Consensus 179 ~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----------- 244 (312)
T 2iwi_A 179 AKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE----------- 244 (312)
T ss_dssp EEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----------
T ss_pred EEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----------
Confidence 9999999998654322 2345689999999999877664 489999999999999999999964211
Q ss_pred HHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 292 ECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.... ....+...+..+.+++.+||+.||++|||+.++++
T Consensus 245 -~~~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 245 -ILEA-----------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -HHHT-----------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -Hhhh-----------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0010 01122234557889999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=313.58 Aligned_cols=202 Identities=26% Similarity=0.375 Sum_probs=171.0
Q ss_pred HHhhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCC-CC-----ceeeeeeeeeec
Q 017262 68 DKATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQIN-HR-----NVVKLLGCCLEV 140 (374)
Q Consensus 68 ~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~~~~~~~~~ 140 (374)
....++|++.+.||+|+||+||+|... +++.||+|++... ......+..|+.+++.++ |+ +++++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 344678999999999999999999965 5789999998753 344567778888888885 44 499999999999
Q ss_pred ccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh--cCCCCEEEeccCCCceEEC--CCCcEEEe
Q 017262 141 EVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS--SAYLPIYHRDIKSTNILLD--EKYRAKIA 216 (374)
Q Consensus 141 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~--~~~~~i~H~dlk~~Nill~--~~~~~kl~ 216 (374)
+..++||||++ ++|.+++... ....+++..+..++.|++.||.|||+ .+ |+||||||+|||++ .++.+||+
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEEC
T ss_pred CceEEEEecCC-CCHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEE
Confidence 99999999995 5999988743 23468999999999999999999995 45 99999999999995 57889999
Q ss_pred ecccccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccc
Q 017262 217 DFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIW 279 (374)
Q Consensus 217 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~ 279 (374)
|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 204 DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 204 DFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999865422 234568999999999999999999999999999999999999997543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=325.61 Aligned_cols=253 Identities=24% Similarity=0.333 Sum_probs=189.2
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccceEEEEe
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
.+.|...+.||+|+||+||.+...+|+.||+|++... ..+.+.+|+.+++++ +||||+++++++.+.+..++||||
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 3455667899999999998777778999999988643 235677899999876 899999999999999999999999
Q ss_pred ecCCcccccccCCCCCC----CCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCC-------------Cc
Q 017262 150 IPNGTLFQYLHDPYEEL----SLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK-------------YR 212 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~----~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~-------------~~ 212 (374)
++ |+|.+++....... ..++..++.++.|++.||+|||+++ |+||||||+|||++.+ +.
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceE
Confidence 95 69999997532111 1133345789999999999999999 9999999999999654 48
Q ss_pred EEEeecccccccccCCce---eeecccccccccCcccccc-------CCCCccchhhhHHHHHHHHHh-CCCCCCccccc
Q 017262 213 AKIADFGTSRSIAIDQTH---VSTKVQGTFGYLDPEYFRS-------SQFTDKSDVYSFGVVLVELLT-GQKPISSIWAN 281 (374)
Q Consensus 213 ~kl~Dfg~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~ 281 (374)
+||+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |..||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 999999999876543322 1234569999999999865 568999999999999999999 99999643221
Q ss_pred cCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 282 EGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
. ....... . . ........+...+..+.+|+.+||+.||++|||+.++++
T Consensus 247 ~--------~~i~~~~-~-~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 247 E--------SNIIRGI-F-S--LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp H--------HHHHHTC-C-C--CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H--------HHHhcCC-C-C--cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1 0111110 0 0 011122235567789999999999999999999999985
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=317.67 Aligned_cols=248 Identities=27% Similarity=0.404 Sum_probs=199.0
Q ss_pred ChHHHHHhhcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCChh------HHHHHHHHHHHHhhCC--CCceeee
Q 017262 63 NSKELDKATDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDES------KLEEFINEVVILSQIN--HRNVVKL 133 (374)
Q Consensus 63 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~~ 133 (374)
...+.....++|++.+.||+|+||.||+|.. .+++.||+|.+...... ....+.+|+.++++++ ||||+++
T Consensus 34 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~ 113 (320)
T 3a99_A 34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 113 (320)
T ss_dssp ------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred cccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEE
Confidence 3445556678899999999999999999985 46889999987653211 1234567999999996 5999999
Q ss_pred eeeeeecccceEEEEeecC-CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEEC-CCC
Q 017262 134 LGCCLEVEVPLLVYEFIPN-GTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD-EKY 211 (374)
Q Consensus 134 ~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~-~~~ 211 (374)
++++.+.+..++++|++.+ ++|.+++. ....+++..++.++.|++.||+|||+.+ ++||||||+|||++ +++
T Consensus 114 ~~~~~~~~~~~lv~e~~~~~~~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~ 187 (320)
T 3a99_A 114 LDWFERPDSFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRG 187 (320)
T ss_dssp EEEEECSSEEEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTT
T ss_pred EEEEecCCcEEEEEEcCCCCccHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCC
Confidence 9999999999999999976 89999987 3457899999999999999999999999 99999999999999 789
Q ss_pred cEEEeecccccccccCCceeeecccccccccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHH
Q 017262 212 RAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQF-TDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYF 290 (374)
Q Consensus 212 ~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 290 (374)
.+||+|||++...... ......||+.|+|||.+.+..+ +.++||||||+++|+|++|..||.....
T Consensus 188 ~~kL~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---------- 254 (320)
T 3a99_A 188 ELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------- 254 (320)
T ss_dssp EEEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------
T ss_pred CEEEeeCccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh----------
Confidence 9999999999765432 2233468999999999987765 6789999999999999999999964211
Q ss_pred HHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 291 VECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.... .. ..+...+..+.+|+.+||+.||++|||+.++++
T Consensus 255 --~~~~-~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 255 --IIRG-QV----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp --HHHC-CC----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --hhcc-cc----------cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0010 00 111223457889999999999999999999976
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=308.07 Aligned_cols=259 Identities=20% Similarity=0.262 Sum_probs=198.7
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CC-cEEEEEEeccCChhHHHHHHHHHHHHhhCCCCc------eeeeeeeeeeccc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DG-RIIAVKKSKVVDESKLEEFINEVVILSQINHRN------VVKLLGCCLEVEV 142 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~~ 142 (374)
.++|++.+.||+|+||.||+|... ++ ..||+|.+... ......+.+|+.+++.++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 578999999999999999999964 34 68999998753 344567888999999997665 8999999999999
Q ss_pred ceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEE---------------
Q 017262 143 PLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL--------------- 207 (374)
Q Consensus 143 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill--------------- 207 (374)
.++||||+ +++|.+++... ....+++..++.++.|++.||+|||+++ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 55666666532 2346899999999999999999999999 9999999999999
Q ss_pred ----CCCCcEEEeecccccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccC
Q 017262 208 ----DEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEG 283 (374)
Q Consensus 208 ----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~ 283 (374)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|+|++|..||......+.
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 56789999999999764322 2345689999999999999999999999999999999999999975432210
Q ss_pred CChHHHHHHHHHh--------cccccc-ccc---------------------cccCCCCHHHHHHHHHHHHHhcccCCCC
Q 017262 284 RNLTTYFVECIEE--------NCLFDI-IDD---------------------QVRKSGEAEEIMAVSDVAKRCLNSYGRN 333 (374)
Q Consensus 284 ~~~~~~~~~~~~~--------~~~~~~-~~~---------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~ 333 (374)
...+...... ...... ... ..........+..+.+|+.+||+.||++
T Consensus 248 ---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 248 ---LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp ---HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred ---HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 0000000000 000000 000 0011223345678999999999999999
Q ss_pred CCCHHHHHH
Q 017262 334 RPTMKEVAM 342 (374)
Q Consensus 334 Rps~~~vl~ 342 (374)
|||+.++++
T Consensus 325 Rpt~~e~l~ 333 (355)
T 2eu9_A 325 RITLAEALL 333 (355)
T ss_dssp SCCHHHHTT
T ss_pred CcCHHHHhc
Confidence 999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=324.08 Aligned_cols=250 Identities=24% Similarity=0.330 Sum_probs=188.3
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccceEEEE
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 148 (374)
...+|.+.+.||+|+||+|+.....+++.||||++..... ..+.+|+.+++.+ +||||+++++++.+.+..++|||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 3456899999999999997766666889999998865332 2346799999999 79999999999999999999999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECC-----CCcEEEeecccccc
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE-----KYRAKIADFGTSRS 223 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~-----~~~~kl~Dfg~~~~ 223 (374)
|++ |+|.+++... .....+..++.++.|++.||+|||+.+ |+||||||+|||++. ...+||+|||++..
T Consensus 99 ~~~-g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 99 LCA-ATLQEYVEQK--DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp CCS-EEHHHHHHSS--SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred CCC-CCHHHHHHhc--CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 995 6999998753 233455567889999999999999999 999999999999953 33588999999987
Q ss_pred cccCCc--eeeecccccccccCccccc---cCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhc
Q 017262 224 IAIDQT--HVSTKVQGTFGYLDPEYFR---SSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEEN 297 (374)
Q Consensus 224 ~~~~~~--~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 297 (374)
...... .......||+.|+|||++. ...++.++|||||||++|+|++ |..||....... ........
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-------~~~~~~~~ 245 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-------ANILLGAC 245 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-------HHHHTTCC
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-------HHHHhccC
Confidence 653321 2234456999999999997 4567889999999999999999 999985422111 11110000
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 298 CLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
. ..........+..+.+||.+||+.||++|||+.++++
T Consensus 246 ~-------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 246 S-------LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp C-------CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C-------ccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0 0011122345567889999999999999999999984
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=303.73 Aligned_cols=263 Identities=23% Similarity=0.347 Sum_probs=186.0
Q ss_pred HHhhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCCh-hH-HHHHHHHHHHHhhCCCCceeeeeeeeeecccce
Q 017262 68 DKATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE-SK-LEEFINEVVILSQINHRNVVKLLGCCLEVEVPL 144 (374)
Q Consensus 68 ~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 144 (374)
....++|++.+.||+|+||.||+|... +++.||+|.+..... .. ...+.++..+++.++||||+++++++.+.+..+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 100 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF 100 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence 334567899999999999999999975 689999998865432 22 233445556788889999999999999999999
Q ss_pred EEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCEEEeccCCCceEECCCCcEEEeecccccc
Q 017262 145 LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSS-AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 223 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 223 (374)
+||||+ ++++..+... ....+++..+..++.|++.||.|||+. + ++|+||||+||+++.++.+||+|||++..
T Consensus 101 lv~e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp EEECCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred EEEecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 999999 5555554432 245789999999999999999999995 8 99999999999999999999999999876
Q ss_pred cccCCceeeecccccccccCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcc
Q 017262 224 IAIDQTHVSTKVQGTFGYLDPEYFR-----SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENC 298 (374)
Q Consensus 224 ~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 298 (374)
..... ......+++.|+|||.+. ...++.++||||||+++|+|++|+.||.... ..............
T Consensus 175 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~ 247 (318)
T 2dyl_A 175 LVDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK-----TDFEVLTKVLQEEP 247 (318)
T ss_dssp --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC-----SHHHHHHHHHHSCC
T ss_pred ccCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC-----ccHHHHHHHhccCC
Confidence 54322 223446899999999984 4568899999999999999999999997422 11222222222111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHHHHhhC
Q 017262 299 LFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM--ELERIRANS 351 (374)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~--~L~~~~~~~ 351 (374)
. . .......+..+.+++.+||+.||.+|||+.++++ .+++.....
T Consensus 248 ~-~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~ 294 (318)
T 2dyl_A 248 P-L-------LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLE 294 (318)
T ss_dssp C-C-------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHHSC
T ss_pred C-C-------CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhccccc
Confidence 0 0 0011123457889999999999999999999987 344444333
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=332.83 Aligned_cols=240 Identities=21% Similarity=0.322 Sum_probs=196.6
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec--CCcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeeccc-----
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA--DGRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEV----- 142 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~--~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----- 142 (374)
.++|++.+.||+|+||.||+|.+. +++.||+|.+... .......+.+|+.++++++||||+++++++.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 478999999999999999999975 5889999987643 34555678899999999999999999999987765
Q ss_pred ceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccc
Q 017262 143 PLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 222 (374)
Q Consensus 143 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 222 (374)
.|+||||+++++|.+++.. .+++..++.++.|++.||.|||+++ |+||||||+|||++.+ .+||+|||++.
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999987752 6899999999999999999999999 9999999999999986 99999999998
Q ss_pred ccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccc
Q 017262 223 SIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDI 302 (374)
Q Consensus 223 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (374)
..... ....||+.|+|||++.+.. +.++||||||+++|+|++|..||........ .
T Consensus 230 ~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------------~-- 285 (681)
T 2pzi_A 230 RINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------------P-- 285 (681)
T ss_dssp ETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------------C--
T ss_pred hcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc----------------c--
Confidence 65432 3446999999999987654 8899999999999999999988764221110 0
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHHH
Q 017262 303 IDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRP-TMKEVAMELERIR 348 (374)
Q Consensus 303 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-s~~~vl~~L~~~~ 348 (374)
........+..+.+||.+||+.||++|| +++++.+.|..+.
T Consensus 286 -----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 286 -----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp -----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 0011122346788999999999999998 5677777777664
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=330.24 Aligned_cols=271 Identities=25% Similarity=0.370 Sum_probs=207.1
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeee------ccc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLE------VEV 142 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~ 142 (374)
.++|++.+.||+|+||.||+|... +|+.||+|.+... .......+.+|+.++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 368999999999999999999964 5889999987653 45556788999999999999999999998765 667
Q ss_pred ceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCc---EEEeecc
Q 017262 143 PLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR---AKIADFG 219 (374)
Q Consensus 143 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~---~kl~Dfg 219 (374)
.++||||+++|+|.+++........+++..++.++.|++.||+|||+.+ ++||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999986544557899999999999999999999999 999999999999987665 9999999
Q ss_pred cccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHH----HH
Q 017262 220 TSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVEC----IE 295 (374)
Q Consensus 220 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~----~~ 295 (374)
++....... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||....... .|.... ..
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-----~~~~~i~~~~~~ 242 (676)
T 3qa8_A 170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-----QWHGKVREKSNE 242 (676)
T ss_dssp CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-----HSSTTCC-----
T ss_pred ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh-----hhhhhhhcccch
Confidence 998754322 2344568999999999999999999999999999999999999996532110 000000 00
Q ss_pred hccccccccc--------cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH-----HHHHHHHHHhhC
Q 017262 296 ENCLFDIIDD--------QVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKE-----VAMELERIRANS 351 (374)
Q Consensus 296 ~~~~~~~~~~--------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~-----vl~~L~~~~~~~ 351 (374)
.......... ..........+..+.+++.+||+.||++|||+.+ +.+.++.+....
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 0000000000 0111234457789999999999999999999988 566777766543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=294.69 Aligned_cols=233 Identities=15% Similarity=0.134 Sum_probs=186.4
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecC-CcEEEEEEeccCC---hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVD---ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
.++|++.+.||+|+||.||+|.... ++.||+|.+.... ......+.+|+..+++++||||+++++++.+.+..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 4679999999999999999999754 8999999987542 34457889999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
|||+++++|.+++.. + ....++..++.|++.||+|||+++ |+||||||+|||++.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence 999999999999853 1 356678899999999999999999 9999999999999999999998543
Q ss_pred CCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
|++ .++.++||||||+++|+|++|+.||.......... .........
T Consensus 175 --------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~------------~~~~~~~~~ 221 (286)
T 3uqc_A 175 --------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA------------PAERDTAGQ 221 (286)
T ss_dssp --------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE------------ECCBCTTSC
T ss_pred --------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH------------HHHHHhccC
Confidence 333 26889999999999999999999998644322100 000000000
Q ss_pred cc--CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCC
Q 017262 307 VR--KSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSR 352 (374)
Q Consensus 307 ~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~ 352 (374)
.. .......+..+.+++.+||+.||++| |+.++++.|+.+.....
T Consensus 222 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 222 PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 00 01112345678999999999999999 99999999999887544
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=291.15 Aligned_cols=227 Identities=23% Similarity=0.312 Sum_probs=178.4
Q ss_pred hcCCCcC-ceEeeeCeEEEEEEEe-cCCcEEEEEEeccCChhHHHHHHHHHHHH-hhCCCCceeeeeeeeee----cccc
Q 017262 71 TDYFNMN-RILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVIL-SQINHRNVVKLLGCCLE----VEVP 143 (374)
Q Consensus 71 ~~~~~~~-~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~----~~~~ 143 (374)
.++|.+. +.||+|+||.||+|.. .+++.||+|.+... ..+.+|+.++ +..+||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3456666 7899999999999996 46889999998642 3566788887 66689999999999987 6678
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECC---CCcEEEeeccc
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE---KYRAKIADFGT 220 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfg~ 220 (374)
++||||+++++|.+++... ....+++..++.++.|++.||+|||+.+ ++||||||+||+++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 9999999999999999753 2346999999999999999999999999 999999999999998 78999999999
Q ss_pred ccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccc
Q 017262 221 SRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLF 300 (374)
Q Consensus 221 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (374)
+.... +..++.++||||||+++|+|++|..||......... ....
T Consensus 167 a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~------------~~~~ 211 (299)
T 3m2w_A 167 AKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------------PGMK 211 (299)
T ss_dssp CEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------------CCSC
T ss_pred ccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh------------HHHH
Confidence 86432 244678999999999999999999999654322100 0000
Q ss_pred ccccccccCCCC----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 301 DIIDDQVRKSGE----AEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 301 ~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..+... ....+ ...+..+.+|+.+||+.||++|||+.++++
T Consensus 212 ~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 212 TRIRMG-QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp CSSCTT-CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhhc-cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000000 01111 123568999999999999999999999997
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=301.08 Aligned_cols=242 Identities=17% Similarity=0.213 Sum_probs=182.7
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCC--------hhHHHHHHHHHHHHhhCC---------CCceeee
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVD--------ESKLEEFINEVVILSQIN---------HRNVVKL 133 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~niv~~ 133 (374)
.++|++.+.||+|+||+||+|+. +|+.||+|++.... ......+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46788999999999999999998 67999999887542 233467889999998886 5555555
Q ss_pred ee-----------------eeee-------------cccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHH
Q 017262 134 LG-----------------CCLE-------------VEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEA 183 (374)
Q Consensus 134 ~~-----------------~~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~ 183 (374)
.+ ++.+ .+..++||||+++|++.+.+.+ ..+++..++.++.|++.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 44 4443 6788999999999977777642 468999999999999999
Q ss_pred HHHHh-hcCCCCEEEeccCCCceEECCCC--------------------cEEEeecccccccccCCceeeeccccccccc
Q 017262 184 LAYLH-SSAYLPIYHRDIKSTNILLDEKY--------------------RAKIADFGTSRSIAIDQTHVSTKVQGTFGYL 242 (374)
Q Consensus 184 l~~lH-~~~~~~i~H~dlk~~Nill~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~ 242 (374)
|+||| +.+ |+||||||+|||++.++ .+||+|||+++..... ...||+.|+
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~ 244 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSM 244 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeeccc
Confidence 99999 898 99999999999999887 8999999999865432 236899999
Q ss_pred CccccccCCCCccchhhhHHHH-HHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHH
Q 017262 243 DPEYFRSSQFTDKSDVYSFGVV-LVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSD 321 (374)
Q Consensus 243 aPE~~~~~~~~~~~Di~slG~~-l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 321 (374)
|||++.+.. +.++||||||++ .+++++|..||.... ............. ..............++.+.+
T Consensus 245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~------~~~~~~~~~~~~~---~~~~~~~~~~~~~~s~~~~d 314 (336)
T 2vuw_A 245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL------WLHYLTDKMLKQM---TFKTKCNTPAMKQIKRKIQE 314 (336)
T ss_dssp CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH------HHHHHHHHHHHTC---CCSSCCCSHHHHHHHHHHHH
T ss_pred ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh------hhhHHHHhhhhhh---ccCcccchhhhhhcCHHHHH
Confidence 999998766 889999998777 778888999984210 0000111110000 00111111123467889999
Q ss_pred HHHHhcccCCCCCCCHHHHH
Q 017262 322 VAKRCLNSYGRNRPTMKEVA 341 (374)
Q Consensus 322 li~~cl~~~p~~Rps~~~vl 341 (374)
||.+||+.| |+.+++
T Consensus 315 li~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 315 FHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHGGGSS-----SHHHHH
T ss_pred HHHHHhccC-----CHHHHH
Confidence 999999976 888887
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=301.27 Aligned_cols=243 Identities=17% Similarity=0.188 Sum_probs=180.7
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCCh---hHHHHHHHHHHHHhhCCC-Cceeee---------e-
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDE---SKLEEFINEVVILSQINH-RNVVKL---------L- 134 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h-~niv~~---------~- 134 (374)
....|...+.||+|+||.||+|.+ .+|+.||||++..... ...+.+.+|+.+++.++| +|.... .
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 345577889999999999999995 4689999998874322 225678899999999977 322111 1
Q ss_pred -----------eeeee-----cccceEEEEeecCCcccccccC----CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 017262 135 -----------GCCLE-----VEVPLLVYEFIPNGTLFQYLHD----PYEELSLTWEMRLRIATEVAEALAYLHSSAYLP 194 (374)
Q Consensus 135 -----------~~~~~-----~~~~~lv~e~~~~g~L~~~l~~----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ 194 (374)
.++.. ....+++|+++ +++|.+++.. ......+++..++.++.|++.||+|||+++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 11111 11345666655 7899988841 113456788899999999999999999999
Q ss_pred EEEeccCCCceEECCCCcEEEeecccccccccCCceeeecccccccccCcccc----------ccCCCCccchhhhHHHH
Q 017262 195 IYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYF----------RSSQFTDKSDVYSFGVV 264 (374)
Q Consensus 195 i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~----------~~~~~~~~~Di~slG~~ 264 (374)
|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||+
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 999999999999999999999999998764322 344557 999999999 55568889999999999
Q ss_pred HHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 265 LVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 265 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
+|+|++|+.||........ ....+... . ..+..+.+|+.+||+.||++|||+.++++
T Consensus 307 l~elltg~~Pf~~~~~~~~---------------~~~~~~~~--~----~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGG---------------SEWIFRSC--K----NIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSC---------------SGGGGSSC--C----CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHCCCCCCCcchhhh---------------HHHHHhhc--c----cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999999975443221 11111110 1 22357899999999999999999877754
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-32 Score=266.62 Aligned_cols=184 Identities=20% Similarity=0.145 Sum_probs=128.9
Q ss_pred EeeeCeEEEEEEE-ecCCcEEEEEEeccCC----------hhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccceEEE
Q 017262 80 LGQGGQGTVYKGM-LADGRIIAVKKSKVVD----------ESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 80 lg~G~~g~v~~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 147 (374)
.+.|++|.+..++ ...|+.+++|.+.... ....+++.+|+++|+++ +|+||+++++++.+++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 3445555444433 2347789999875431 23345789999999999 6999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
||++|++|.++|.+ .+.++.. .|+.||+.||+|+|++| |+||||||+|||++++|.+||+|||+++.....
T Consensus 322 Eyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp ECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred ecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 99999999999984 4567654 47899999999999999 999999999999999999999999999876433
Q ss_pred CceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCC
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p 274 (374)
. .......||+.|+|||++.+ .+..++|+||+|++++++.++..|
T Consensus 393 ~-~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 C-SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred C-ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 2 23345679999999999975 457789999999998887665544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-28 Score=238.18 Aligned_cols=184 Identities=15% Similarity=0.227 Sum_probs=144.1
Q ss_pred CcCceEeeeCeEEEEEEEecCCcEEEEEEeccCC---h-----hHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 75 NMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVD---E-----SKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 75 ~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~---~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
...+.||+|+||.||+|.. .+..+++|+..... . ...+.+.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999954 46778888643321 1 1234578999999999999999776666677888999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
|||+++++|.+++.. +..++.|++.||.|||+++ |+||||||+|||++. .+||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999973 4689999999999999999 999999999999999 999999999987654
Q ss_pred CCcee------eecccccccccCcccccc--CCCCccchhhhHHHHHHHHHhCCCCC
Q 017262 227 DQTHV------STKVQGTFGYLDPEYFRS--SQFTDKSDVYSFGVVLVELLTGQKPI 275 (374)
Q Consensus 227 ~~~~~------~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~p~ 275 (374)
..... .....||+.|+|||++.. ..|+..+|+|+..+-..+-+.++.+|
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 32211 234579999999999987 56888899999998888888777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-25 Score=198.38 Aligned_cols=151 Identities=19% Similarity=0.175 Sum_probs=122.7
Q ss_pred HHHHhhcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCCh------------------hHHHHHHHHHHHHhhCCC
Q 017262 66 ELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDE------------------SKLEEFINEVVILSQINH 127 (374)
Q Consensus 66 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h 127 (374)
.+......|.+.+.||+|+||.||+|...+|+.+|+|.+..... .....+.+|+.++++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 34445667778899999999999999997799999998864321 23467889999999999
Q ss_pred CceeeeeeeeeecccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEE
Q 017262 128 RNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL 207 (374)
Q Consensus 128 ~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill 207 (374)
| +++.+++. .+..++||||+++++|.+ +.. .....++.|++.||.|||+.+ ++||||||+|||+
T Consensus 163 -~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl 226 (282)
T 1zar_A 163 -G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLV 226 (282)
T ss_dssp -T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred -C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEE
Confidence 5 66666554 467799999999999998 531 124469999999999999999 9999999999999
Q ss_pred CCCCcEEEeecccccccccCCceeeecccccccccCccccc
Q 017262 208 DEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFR 248 (374)
Q Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 248 (374)
+ ++.+||+|||++.. +..++|||.+.
T Consensus 227 ~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp E-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred E-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 9 99999999999863 34578899875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=4e-21 Score=168.20 Aligned_cols=139 Identities=20% Similarity=0.218 Sum_probs=106.9
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe-cCCcE--EEEEEeccCChh------------------------HHHHHHHHHHHHh
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML-ADGRI--IAVKKSKVVDES------------------------KLEEFINEVVILS 123 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~ 123 (374)
...|.+.+.||+|+||.||+|.. .+|+. +|+|..+..... ....+.+|+..+.
T Consensus 46 ~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 125 (258)
T 1zth_A 46 GYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLE 125 (258)
T ss_dssp TSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHH
T ss_pred CCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHH
Confidence 34467889999999999999997 67888 999986543111 1235788999999
Q ss_pred hCCCCce--eeeeeeeeecccceEEEEeecC-C----cccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCCE
Q 017262 124 QINHRNV--VKLLGCCLEVEVPLLVYEFIPN-G----TLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLH-SSAYLPI 195 (374)
Q Consensus 124 ~l~h~ni--v~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH-~~~~~~i 195 (374)
++.|+++ +.+++. +..++||||+.+ | +|.++... .++..+..++.|++.||.||| +.+ +
T Consensus 126 ~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---i 192 (258)
T 1zth_A 126 RAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---L 192 (258)
T ss_dssp HHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---E
T ss_pred HHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 9988764 334432 467899999942 4 45444321 234467889999999999999 888 9
Q ss_pred EEeccCCCceEECCCCcEEEeeccccccc
Q 017262 196 YHRDIKSTNILLDEKYRAKIADFGTSRSI 224 (374)
Q Consensus 196 ~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 224 (374)
+||||||+|||++. .++|+|||++...
T Consensus 193 vHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 193 VHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp ECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred EeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.74 E-value=1.9e-18 Score=157.29 Aligned_cols=144 Identities=13% Similarity=0.141 Sum_probs=102.7
Q ss_pred HHhhcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCC--------------hhHHHH--------HHHHHHHHhhC
Q 017262 68 DKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVD--------------ESKLEE--------FINEVVILSQI 125 (374)
Q Consensus 68 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--------------~~~~~~--------~~~e~~~l~~l 125 (374)
.....-|.+.+.||+|++|.||+|...+|+.||+|..+... ...... ...|...|.++
T Consensus 91 ~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL 170 (397)
T 4gyi_A 91 AARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL 170 (397)
T ss_dssp HHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH
Confidence 33344589999999999999999999899999999764310 000111 23456666666
Q ss_pred CCCceeeeeeeeeecccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCce
Q 017262 126 NHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNI 205 (374)
Q Consensus 126 ~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Ni 205 (374)
.+.++.-..-+ .....++||||++|++|...... .....++.|++.+|.+||+.| |+||||||.||
T Consensus 171 ~~~gv~vp~p~--~~~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NI 236 (397)
T 4gyi_A 171 YEEGFPVPEPI--AQSRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKHG---LIHGDFNEFNI 236 (397)
T ss_dssp HHTTCSCCCEE--EEETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSE
T ss_pred HhcCCCCCeee--eccCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHE
Confidence 44443211111 11244799999999988775532 123568899999999999999 99999999999
Q ss_pred EECCCC----------cEEEeecccccccc
Q 017262 206 LLDEKY----------RAKIADFGTSRSIA 225 (374)
Q Consensus 206 ll~~~~----------~~kl~Dfg~~~~~~ 225 (374)
|+++++ .+.|+||+-+....
T Consensus 237 Ll~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 237 LIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred EEeCCCCcccccccccceEEEEeCCcccCC
Confidence 998776 38999999876543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=1.2e-12 Score=114.43 Aligned_cols=145 Identities=17% Similarity=0.093 Sum_probs=111.2
Q ss_pred HhhcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCC-CCceeeeeeeeeecccceEEE
Q 017262 69 KATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQIN-HRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 147 (374)
..-+.|.+...++.|+.+.||++... ++.+++|............+.+|+.+++.+. +..++++++++.+.+..++||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 33456888888888889999998754 6789999876421122235788999999884 677889999998888899999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------------------------------------
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSA------------------------------------ 191 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~------------------------------------ 191 (374)
|+++|.+|.+.+.. ......++.+++.+|+.||+..
T Consensus 90 e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 90 SEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp ECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 99999998876421 1123467889999999999811
Q ss_pred --------------------CCCEEEeccCCCceEECCCCcEEEeeccccc
Q 017262 192 --------------------YLPIYHRDIKSTNILLDEKYRAKIADFGTSR 222 (374)
Q Consensus 192 --------------------~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 222 (374)
...++|+|++|.||+++++..+.|+||+.+.
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 0238999999999999876566799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.22 E-value=1e-11 Score=108.22 Aligned_cols=137 Identities=18% Similarity=0.183 Sum_probs=100.2
Q ss_pred cCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCc--eeeeeeeeeecccceEEEEe
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRN--VVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~ 149 (374)
..+.+....+.|..+.||++...+|..+++|..... ....+..|+.+++.+.+.+ +++++++....+..+++|||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 344443333455669999998777888999986543 2245678999998885444 56688888777788999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--------------------------------------
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSA-------------------------------------- 191 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~-------------------------------------- 191 (374)
++|.+|. ... .+ ...++.+++..|..||+..
T Consensus 97 i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 97 VPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp CSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred cCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 9998884 221 11 2356778888888888753
Q ss_pred -----------------CCCEEEeccCCCceEECCCCcEEEeeccccc
Q 017262 192 -----------------YLPIYHRDIKSTNILLDEKYRAKIADFGTSR 222 (374)
Q Consensus 192 -----------------~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 222 (374)
...++|+|++|.||++++++.+.|+||+.+.
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999877667799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.15 E-value=1.5e-10 Score=105.94 Aligned_cols=142 Identities=14% Similarity=0.211 Sum_probs=105.3
Q ss_pred cCceEeeeCeEEEEEEEecCCcEEEEEEec--cCC-hhHHHHHHHHHHHHhhCC--CCceeeeeeeeeec---ccceEEE
Q 017262 76 MNRILGQGGQGTVYKGMLADGRIIAVKKSK--VVD-ESKLEEFINEVVILSQIN--HRNVVKLLGCCLEV---EVPLLVY 147 (374)
Q Consensus 76 ~~~~lg~G~~g~v~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~---~~~~lv~ 147 (374)
..+.++.|.++.||+....+ ..+++|+.. ... ......+.+|+.+++.+. +..+++++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 34678899999999988754 568888765 321 122346778999999986 45578888888766 3579999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------------------------------------
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSA------------------------------------ 191 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~------------------------------------ 191 (374)
||++|..+.+... ..++......++.+++..|+.||+..
T Consensus 121 e~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9999988754221 24678888899999999999999831
Q ss_pred -------------------CCCEEEeccCCCceEECCCCc--EEEeecccccc
Q 017262 192 -------------------YLPIYHRDIKSTNILLDEKYR--AKIADFGTSRS 223 (374)
Q Consensus 192 -------------------~~~i~H~dlk~~Nill~~~~~--~kl~Dfg~~~~ 223 (374)
...++|+|++|.||+++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 134999999999999997753 68999998754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.05 E-value=1.9e-10 Score=102.63 Aligned_cols=183 Identities=22% Similarity=0.229 Sum_probs=121.6
Q ss_pred CceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhC-CCCc--eeeeeeeeeecc---cceEEEEee
Q 017262 77 NRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQI-NHRN--VVKLLGCCLEVE---VPLLVYEFI 150 (374)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~n--iv~~~~~~~~~~---~~~lv~e~~ 150 (374)
.+.++.|....||+.. ..+++|.... ......+.+|+..++.+ .+.. +++++......+ ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3568999999999863 4588887543 23456788999999888 3333 345554443333 458999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC---------------------------------------
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSA--------------------------------------- 191 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--------------------------------------- 191 (374)
+|.+|.+... ..++..+...++.+++..++.||+..
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9988865332 24677788888999999999998621
Q ss_pred ----------------CCCEEEeccCCCceEECC--CCcEEEeecccccccccCCceeeecccccccc---cCccccc--
Q 017262 192 ----------------YLPIYHRDIKSTNILLDE--KYRAKIADFGTSRSIAIDQTHVSTKVQGTFGY---LDPEYFR-- 248 (374)
Q Consensus 192 ----------------~~~i~H~dlk~~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y---~aPE~~~-- 248 (374)
...++|+|++|.||++++ +..+.++||+.+..... ..... ....+ ..|+...
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~-~~Dl~----~~~~~~~~~~~~~~~~~ 248 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDP-DNDFI----SLMEDDEEYGMEFVSKI 248 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECT-THHHH----TTCCTTTSCCHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCCh-HHHHH----HHHhhccccCHHHHHHH
Confidence 134899999999999998 55678999998764321 11100 00011 2222211
Q ss_pred --c-CCC---------CccchhhhHHHHHHHHHhCCCCC
Q 017262 249 --S-SQF---------TDKSDVYSFGVVLVELLTGQKPI 275 (374)
Q Consensus 249 --~-~~~---------~~~~Di~slG~~l~el~~g~~p~ 275 (374)
. +.. ....+.|++|.++|.+.+|..+|
T Consensus 249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0 111 11258999999999999998876
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.57 E-value=5e-07 Score=80.46 Aligned_cols=135 Identities=18% Similarity=0.164 Sum_probs=94.9
Q ss_pred ceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCC---ceeeeeeeee-ecccceEEEEeecCC
Q 017262 78 RILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHR---NVVKLLGCCL-EVEVPLLVYEFIPNG 153 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~~g 153 (374)
+.++.|....||+. +..+++|... .......+..|..+|+.+.+. .+++++.++. ..+..+++|++++|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 56788888999987 4557888743 234456788999999999642 3566666664 345678999999998
Q ss_pred cccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------------------------------------------
Q 017262 154 TLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSA------------------------------------------ 191 (374)
Q Consensus 154 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~------------------------------------------ 191 (374)
++.+... ..++......++.++...|+.||+..
T Consensus 99 ~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 99 ILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp ECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred ECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 8866322 12355555666666666666666432
Q ss_pred ---------------CCCEEEeccCCCceEECC---CCc-EEEeecccccc
Q 017262 192 ---------------YLPIYHRDIKSTNILLDE---KYR-AKIADFGTSRS 223 (374)
Q Consensus 192 ---------------~~~i~H~dlk~~Nill~~---~~~-~kl~Dfg~~~~ 223 (374)
...++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 123699999999999987 455 48999997753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=5e-07 Score=78.83 Aligned_cols=133 Identities=23% Similarity=0.216 Sum_probs=95.5
Q ss_pred EeeeCeE-EEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCC-CCceeeeeeeeeecccceEEEEeecCCccc
Q 017262 80 LGQGGQG-TVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQIN-HRNVVKLLGCCLEVEVPLLVYEFIPNGTLF 156 (374)
Q Consensus 80 lg~G~~g-~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~ 156 (374)
+..|..+ .||+.... ++..+++|.... .....+.+|...|+.+. +--+.++++++.+.+..++|||+++|.++.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 4445444 68887754 456788887653 34567788999998884 334778899998888999999999998876
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC---------------------------------------------
Q 017262 157 QYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSA--------------------------------------------- 191 (374)
Q Consensus 157 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--------------------------------------------- 191 (374)
+.... .......+..+++..|+.||+..
T Consensus 109 ~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 109 QVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred ccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 65431 11223456677777777777532
Q ss_pred ----------CCCEEEeccCCCceEECCCCcEEEeeccccc
Q 017262 192 ----------YLPIYHRDIKSTNILLDEKYRAKIADFGTSR 222 (374)
Q Consensus 192 ----------~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 222 (374)
.+.++|+|+.+.||+++.++.+-|+||+.+.
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 0127999999999999987777799999875
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=7.2e-07 Score=81.19 Aligned_cols=81 Identities=4% Similarity=-0.033 Sum_probs=54.9
Q ss_pred ceE-eeeCeEEEEEEEec-------CCcEEEEEEeccCC---hhHHHHHHHHHHHHhhCC-C--Cceeeeeeeeeec---
Q 017262 78 RIL-GQGGQGTVYKGMLA-------DGRIIAVKKSKVVD---ESKLEEFINEVVILSQIN-H--RNVVKLLGCCLEV--- 140 (374)
Q Consensus 78 ~~l-g~G~~g~v~~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~--- 140 (374)
+.| +.|....+|+.... ++..+++|...... ......+..|+.+++.+. + -.+++++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 567 78888999987754 25678888754321 001135667888888874 3 3567788777654
Q ss_pred ccceEEEEeecCCccccc
Q 017262 141 EVPLLVYEFIPNGTLFQY 158 (374)
Q Consensus 141 ~~~~lv~e~~~~g~L~~~ 158 (374)
+..+++||+++|.++.+.
T Consensus 106 g~~~~v~e~l~G~~l~~~ 123 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPDV 123 (357)
T ss_dssp SSCEEEEECCCCBCCCBT
T ss_pred CCceEEEEecCCCChhhc
Confidence 356899999999887653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.05 E-value=9.7e-06 Score=74.85 Aligned_cols=75 Identities=15% Similarity=0.154 Sum_probs=48.7
Q ss_pred CceEeeeCeEEEEEEEec-CCcEEEEEEeccCCh-------hHHHHHHHHHHHHhhCCC--C-ceeeeeeeeeecccceE
Q 017262 77 NRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE-------SKLEEFINEVVILSQINH--R-NVVKLLGCCLEVEVPLL 145 (374)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~-niv~~~~~~~~~~~~~l 145 (374)
.+.+|.|..+.||++... +++.+++|....... .....+..|.++++.+.. + .+++++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 357899999999999754 467899997543211 112345678888887742 3 34455543 3456789
Q ss_pred EEEeecCC
Q 017262 146 VYEFIPNG 153 (374)
Q Consensus 146 v~e~~~~g 153 (374)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.00 E-value=2.5e-05 Score=70.37 Aligned_cols=140 Identities=16% Similarity=0.175 Sum_probs=77.0
Q ss_pred ceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCC--Cceeeeee------eeeecccceEEEEe
Q 017262 78 RILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINH--RNVVKLLG------CCLEVEVPLLVYEF 149 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~------~~~~~~~~~lv~e~ 149 (374)
+.|+.|..+.||+....+| .+++|..... . ..+..|..+++.+.. -.+++++. +....+..+++++|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3455567889999887655 4888887652 2 233345555555421 12334433 12245567899999
Q ss_pred ecCCcccc--------------ccc---CCC--C-C-----CCCCHHH-------------------------------H
Q 017262 150 IPNGTLFQ--------------YLH---DPY--E-E-----LSLTWEM-------------------------------R 173 (374)
Q Consensus 150 ~~~g~L~~--------------~l~---~~~--~-~-----~~l~~~~-------------------------------~ 173 (374)
++|.++.. .++ ... . . ..-.|.. .
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 99876531 011 000 0 0 0012211 0
Q ss_pred HHHHHHHHHHHHHHhh--------c--CCCCEEEeccCCCceEECCCCcEEEeeccccc
Q 017262 174 LRIATEVAEALAYLHS--------S--AYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 222 (374)
Q Consensus 174 ~~i~~~i~~~l~~lH~--------~--~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 222 (374)
..+...+..++.+|++ . ....++|+|+++.||+++.++.+.++||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1111223445666653 1 12349999999999999888899999998764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.98 E-value=5.4e-05 Score=66.53 Aligned_cols=79 Identities=19% Similarity=0.131 Sum_probs=57.1
Q ss_pred CCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCC-C--CceeeeeeeeeecccceEEEEe
Q 017262 73 YFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQIN-H--RNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~~~lv~e~ 149 (374)
...-.+.+|.|..+.||+....||+.+++|+...........+..|+..|+.+. . --+++++++ +..+++||+
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEe
Confidence 444557789999999999999999999999866544433456778999998884 2 124455543 245789999
Q ss_pred ecCCcc
Q 017262 150 IPNGTL 155 (374)
Q Consensus 150 ~~~g~L 155 (374)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 977644
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.83 E-value=0.00018 Score=63.85 Aligned_cols=75 Identities=16% Similarity=0.070 Sum_probs=58.7
Q ss_pred CceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCC---CCceeeeeeeeeecccceEEEEeecCC
Q 017262 77 NRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQIN---HRNVVKLLGCCLEVEVPLLVYEFIPNG 153 (374)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~g 153 (374)
.+.|+.|....+|+... ++..+++|..... ....+..|...|+.+. ...+++++.++...+..+++||++++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 35689999999999876 4667888876532 3566788999888883 356888888887778899999999987
Q ss_pred cc
Q 017262 154 TL 155 (374)
Q Consensus 154 ~L 155 (374)
.+
T Consensus 117 ~~ 118 (312)
T 3jr1_A 117 KN 118 (312)
T ss_dssp CC
T ss_pred CC
Confidence 65
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.80 E-value=3e-05 Score=72.15 Aligned_cols=76 Identities=8% Similarity=0.076 Sum_probs=45.8
Q ss_pred CEEEeccCCCceEECCCCcEEEeecccccccccCCceeeecc-cccccccCccccccCC---CCccchhhhHHHHHHHHH
Q 017262 194 PIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKV-QGTFGYLDPEYFRSSQ---FTDKSDVYSFGVVLVELL 269 (374)
Q Consensus 194 ~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~-~g~~~y~aPE~~~~~~---~~~~~Di~slG~~l~el~ 269 (374)
.++|+|++|.||+++.++ +.++||+.+..-.. ........ .-...|++|+...... .....++.++...+|+.+
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p-~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 310 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPM-GFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF 310 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEEECH-HHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCcccccCch-HHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence 499999999999998876 99999998864321 11100000 0123456666553211 112345567777788777
Q ss_pred hC
Q 017262 270 TG 271 (374)
Q Consensus 270 ~g 271 (374)
.+
T Consensus 311 ~~ 312 (420)
T 2pyw_A 311 NK 312 (420)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.53 E-value=0.0002 Score=59.05 Aligned_cols=103 Identities=15% Similarity=0.072 Sum_probs=66.6
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCceee
Q 017262 153 GTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS 232 (374)
Q Consensus 153 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 232 (374)
-+|.+.|.. .+.+++++++|.++.|.+.+|.-+-.... + ..+=+.|..|++..+|+|.+.+ ..+.
T Consensus 33 vSL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc----------
Confidence 367777764 46789999999999999999887622110 0 1333457899999999998764 1110
Q ss_pred ecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCC
Q 017262 233 TKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274 (374)
Q Consensus 233 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p 274 (374)
.....+.|||... ...+.+.=|||||+++|.-+--..|
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1123466888764 3456788999999999998864443
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00075 Score=59.52 Aligned_cols=72 Identities=15% Similarity=0.087 Sum_probs=44.0
Q ss_pred CceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCce-eeeeeeeeecccceEEEEee-cCCc
Q 017262 77 NRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNV-VKLLGCCLEVEVPLLVYEFI-PNGT 154 (374)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~~g~ 154 (374)
.+.|+.|....+|+. ..+++|........ ......|+..++.+...++ ++++..+ .+.-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 578889999999998 34788876542111 1122457777777642222 4555443 34457899999 6655
Q ss_pred cc
Q 017262 155 LF 156 (374)
Q Consensus 155 L~ 156 (374)
+.
T Consensus 95 l~ 96 (301)
T 3dxq_A 95 MS 96 (301)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.34 E-value=0.0025 Score=56.59 Aligned_cols=156 Identities=12% Similarity=0.153 Sum_probs=82.3
Q ss_pred hHHHHHhhcCCCcC-----ceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCc--eeeeeee
Q 017262 64 SKELDKATDYFNMN-----RILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRN--VVKLLGC 136 (374)
Q Consensus 64 ~~~~~~~~~~~~~~-----~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~ 136 (374)
.+++...-..|.+. +.|+.|....+|+....+| .+++|..... .....+..|..+++.+...+ +++++..
T Consensus 9 ~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~ 85 (322)
T 2ppq_A 9 EDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPR 85 (322)
T ss_dssp HHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred HHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCC
Confidence 44444444456542 3466687889999887666 5778876642 11123445777776663212 3333322
Q ss_pred ------eeecccceEEEEeecCCccccc--------------ccC---CCCCC---CCC---HHHHHH------------
Q 017262 137 ------CLEVEVPLLVYEFIPNGTLFQY--------------LHD---PYEEL---SLT---WEMRLR------------ 175 (374)
Q Consensus 137 ------~~~~~~~~lv~e~~~~g~L~~~--------------l~~---~~~~~---~l~---~~~~~~------------ 175 (374)
....+..++++++++|..+... ++. ..... ... |.....
T Consensus 86 ~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~ 165 (322)
T 2ppq_A 86 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG 165 (322)
T ss_dssp TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred CCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhh
Confidence 1223456899999988665321 000 00000 011 111000
Q ss_pred HHHHHHHHHHHHhhc----CCCCEEEeccCCCceEECCCCcEEEeeccccc
Q 017262 176 IATEVAEALAYLHSS----AYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 222 (374)
Q Consensus 176 i~~~i~~~l~~lH~~----~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 222 (374)
+...+...+..++.. ....++|+|+.+.||+++.+..+.++||+.+.
T Consensus 166 l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 166 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 001133445555432 12348999999999999887666899998764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0019 Score=60.44 Aligned_cols=74 Identities=14% Similarity=0.029 Sum_probs=46.5
Q ss_pred ceEeeeCeEEEEEEEecC-CcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCce-eeeeeeeeecccceEEEEeecCCcc
Q 017262 78 RILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFINEVVILSQINHRNV-VKLLGCCLEVEVPLLVYEFIPNGTL 155 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~L 155 (374)
+.|+.|-...+|+....+ +..+++|......... -....|..+++.+...++ +++++.+.. ..|+||++|.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence 457778889999988765 4678888764321111 111478888888864444 567776632 359999988665
Q ss_pred c
Q 017262 156 F 156 (374)
Q Consensus 156 ~ 156 (374)
.
T Consensus 189 ~ 189 (458)
T 2qg7_A 189 S 189 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.18 E-value=0.001 Score=61.77 Aligned_cols=73 Identities=18% Similarity=0.240 Sum_probs=48.6
Q ss_pred ceEeeeCeEEEEEEEecC--------CcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCce-eeeeeeeeecccceEEEE
Q 017262 78 RILGQGGQGTVYKGMLAD--------GRIIAVKKSKVVDESKLEEFINEVVILSQINHRNV-VKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e 148 (374)
+.|+.|....+|+....+ +..+++|+...... ...+..|..+++.+...++ +++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 467788889999998653 46888887743211 1345578888888853333 566665542 38999
Q ss_pred eecCCccc
Q 017262 149 FIPNGTLF 156 (374)
Q Consensus 149 ~~~~g~L~ 156 (374)
|++|.+|.
T Consensus 153 ~l~G~~l~ 160 (429)
T 1nw1_A 153 YIPSRPLS 160 (429)
T ss_dssp CCCEEECC
T ss_pred EeCCcccC
Confidence 99875553
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0015 Score=58.47 Aligned_cols=30 Identities=27% Similarity=0.434 Sum_probs=26.2
Q ss_pred CEEEeccCCCceEECCC----CcEEEeecccccc
Q 017262 194 PIYHRDIKSTNILLDEK----YRAKIADFGTSRS 223 (374)
Q Consensus 194 ~i~H~dlk~~Nill~~~----~~~kl~Dfg~~~~ 223 (374)
.++|+|+.+.||+++.+ +.+.++||+.+..
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 49999999999999874 6799999998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0037 Score=56.11 Aligned_cols=31 Identities=23% Similarity=0.354 Sum_probs=26.9
Q ss_pred CCEEEeccCCCceEECCCCcEEEeecccccc
Q 017262 193 LPIYHRDIKSTNILLDEKYRAKIADFGTSRS 223 (374)
Q Consensus 193 ~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 223 (374)
..++|+|+.+.||+++.++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3499999999999999888899999987643
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0059 Score=54.28 Aligned_cols=77 Identities=14% Similarity=0.068 Sum_probs=48.1
Q ss_pred ceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCc--eeeeeee-----eeecccceEEEEee
Q 017262 78 RILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRN--VVKLLGC-----CLEVEVPLLVYEFI 150 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~-----~~~~~~~~lv~e~~ 150 (374)
..++ |....||+....+|+.+++|...... .....+..|..+++.+.... +++++.. ....+..+++++++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3466 77788998877677779999876321 12345566777777774222 3444443 12234557899999
Q ss_pred cCCccc
Q 017262 151 PNGTLF 156 (374)
Q Consensus 151 ~~g~L~ 156 (374)
+|..+.
T Consensus 110 ~G~~~~ 115 (328)
T 1zyl_A 110 GGRQFE 115 (328)
T ss_dssp CCEECC
T ss_pred CCCCCC
Confidence 886543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0027 Score=57.76 Aligned_cols=140 Identities=18% Similarity=0.216 Sum_probs=80.0
Q ss_pred ceEeeeCeEEEEEEEec--------CCcEEEEEEeccCChhHHHHHHHHHHHHhhCC-CCceeeeeeeeeecccceEEEE
Q 017262 78 RILGQGGQGTVYKGMLA--------DGRIIAVKKSKVVDESKLEEFINEVVILSQIN-HRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 148 (374)
+.+..|-...+|+.... +++.+++|+.... ........+|..+++.+. +.-.+++++.+.+ .+|+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 45666777788998764 2468888875332 122445668999988884 3223566766543 29999
Q ss_pred eecCCccccc-cc----------------CC--CCCCCCC--HHHHHHHHHHHHH-------------------HHHH--
Q 017262 149 FIPNGTLFQY-LH----------------DP--YEELSLT--WEMRLRIATEVAE-------------------ALAY-- 186 (374)
Q Consensus 149 ~~~~g~L~~~-l~----------------~~--~~~~~l~--~~~~~~i~~~i~~-------------------~l~~-- 186 (374)
|++|.+|..- +. .. .-..... +.++.++..++.. .+..
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998666421 11 00 0011111 3444445443321 1222
Q ss_pred --HhhcC-CCCEEEeccCCCceEECCC----CcEEEeeccccc
Q 017262 187 --LHSSA-YLPIYHRDIKSTNILLDEK----YRAKIADFGTSR 222 (374)
Q Consensus 187 --lH~~~-~~~i~H~dlk~~Nill~~~----~~~kl~Dfg~~~ 222 (374)
|...+ ...++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 22221 2348999999999999876 789999998774
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.72 E-value=0.0035 Score=56.93 Aligned_cols=73 Identities=12% Similarity=0.113 Sum_probs=42.6
Q ss_pred ceEeeeCeEEEEEEEecC---------CcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCc-eeeeeeeeeecccceEEE
Q 017262 78 RILGQGGQGTVYKGMLAD---------GRIIAVKKSKVVDESKLEEFINEVVILSQINHRN-VVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~ 147 (374)
+.++.|....+|+....+ +..+++|....... .......|..+++.+...+ .+++++.. .-++++
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence 456777778899988654 26788887654221 1112356788887774333 34566543 237899
Q ss_pred EeecCCcc
Q 017262 148 EFIPNGTL 155 (374)
Q Consensus 148 e~~~~g~L 155 (374)
+|++|.++
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99988654
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.92 E-value=0.017 Score=33.96 Aligned_cols=6 Identities=17% Similarity=0.152 Sum_probs=2.3
Q ss_pred HHHHHH
Q 017262 26 IRKRIK 31 (374)
Q Consensus 26 ~~~~~~ 31 (374)
+.||++
T Consensus 33 ~~RRRr 38 (44)
T 2l2t_A 33 YVRRKS 38 (44)
T ss_dssp HHHTTC
T ss_pred Hhhhhh
Confidence 333333
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=94.76 E-value=0.037 Score=32.47 Aligned_cols=6 Identities=33% Similarity=0.412 Sum_probs=2.3
Q ss_pred HHHHHH
Q 017262 26 IRKRIK 31 (374)
Q Consensus 26 ~~~~~~ 31 (374)
+.||++
T Consensus 34 ~~RRR~ 39 (44)
T 2jwa_A 34 LIKRRQ 39 (44)
T ss_dssp HHHHHC
T ss_pred heehhh
Confidence 333333
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.67 E-value=0.11 Score=47.83 Aligned_cols=74 Identities=11% Similarity=0.049 Sum_probs=46.2
Q ss_pred ceEeeeCeEEEEEEEecC--------CcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCc-eeeeeeeeeecccceEEEE
Q 017262 78 RILGQGGQGTVYKGMLAD--------GRIIAVKKSKVVDESKLEEFINEVVILSQINHRN-VVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e 148 (374)
+.+..|-...+|+....+ +..+++++....... .-...+|..+++.+...+ .+++++.+ .-+.|++
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF----PEGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEEE
Confidence 456667778899988653 577888876442211 112346888887774222 34556533 2378999
Q ss_pred eecCCccc
Q 017262 149 FIPNGTLF 156 (374)
Q Consensus 149 ~~~~g~L~ 156 (374)
|++|.+|.
T Consensus 151 fI~G~~l~ 158 (424)
T 3mes_A 151 FIDGEPLT 158 (424)
T ss_dssp CCCSEECC
T ss_pred EeCCccCC
Confidence 99987653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.35 E-value=0.097 Score=47.94 Aligned_cols=29 Identities=38% Similarity=0.502 Sum_probs=24.6
Q ss_pred EEEeccCCCceEE------CCCCcEEEeecccccc
Q 017262 195 IYHRDIKSTNILL------DEKYRAKIADFGTSRS 223 (374)
Q Consensus 195 i~H~dlk~~Nill------~~~~~~kl~Dfg~~~~ 223 (374)
++|+|+.+.||++ +++..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567799999988753
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=93.20 E-value=0.27 Score=40.42 Aligned_cols=116 Identities=8% Similarity=0.080 Sum_probs=76.2
Q ss_pred CCCceeeeeeeeeecccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCce
Q 017262 126 NHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNI 205 (374)
Q Consensus 126 ~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Ni 205 (374)
.||++++. .+-.+.+...+.++.- .+...|-. -..++...+++++.+++....++++ -+|--++|+|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~--~~~~~f~~----ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIN--DNHTPFDN----IKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCC--TTSEEGGG----GGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcC--cccCCHHH----HHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence 57877765 3444555544544443 33333321 2357888999999999998866655 36889999999
Q ss_pred EECCCCcEEEeecccccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCC
Q 017262 206 LLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPIS 276 (374)
Q Consensus 206 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~ 276 (374)
+++.++.+++.-.|+...+ +|. ..+...=.-..=+++..+++++..|.
T Consensus 111 ~f~~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EECTTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEcCCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999877764322 221 11111222246678889999998875
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=90.96 E-value=0.41 Score=39.42 Aligned_cols=114 Identities=11% Similarity=0.100 Sum_probs=73.7
Q ss_pred CCCceeeeeeeeeecccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHH-HHhhcCCCCEEEeccCCCc
Q 017262 126 NHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALA-YLHSSAYLPIYHRDIKSTN 204 (374)
Q Consensus 126 ~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~-~lH~~~~~~i~H~dlk~~N 204 (374)
.||++ --.+-.+++...+.++.-+++.=...+ ..++...+++++.+++.... ++++ -+|--++|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 57777 233334555555656554333222222 35788899999999988777 5555 4688999999
Q ss_pred eEECCCCcEEEeecccccccccCCceeeecccccccccCccccccCCCCccchh-hhHHHHHHHHHhCCCCCC
Q 017262 205 ILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDV-YSFGVVLVELLTGQKPIS 276 (374)
Q Consensus 205 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di-~slG~~l~el~~g~~p~~ 276 (374)
++++.++.+++.-.|+-.. ++|..+ + ..|. -..=+++..++.++..|.
T Consensus 115 L~f~~~~~p~i~hRGi~~~------------------lpP~e~-----~-ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKES------------------LPPDEW-----D-DERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp EEECTTCCEEESCCEETTT------------------BSSCSC-----C-HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EEEeCCCcEEEEEcCCccc------------------CCCCCC-----C-HHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999988776432 222221 1 1122 245678888888888774
|
| >2knc_B Integrin beta-3; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.70 E-value=0.89 Score=30.67 Aligned_cols=21 Identities=29% Similarity=0.176 Sum_probs=8.9
Q ss_pred hhhHHHHHHHHHHHHHHHHHH
Q 017262 4 AGIGTGLGGLFLSIGALWLCI 24 (374)
Q Consensus 4 ~~i~~~~~~~~~~~~~~~~~~ 24 (374)
++|+.++.+.+++++++++++
T Consensus 11 ~~Iv~gvi~gilliGllllli 31 (79)
T 2knc_B 11 LVVLLSVMGAILLIGLAALLI 31 (79)
T ss_dssp HHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHHHHHHHHHHHH
Confidence 344444444444444444333
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=87.40 E-value=0.25 Score=28.07 Aligned_cols=7 Identities=29% Similarity=0.363 Sum_probs=2.9
Q ss_pred hhhHHHH
Q 017262 4 AGIGTGL 10 (374)
Q Consensus 4 ~~i~~~~ 10 (374)
++|++++
T Consensus 14 AGiVvG~ 20 (38)
T 2k1k_A 14 VAVIFGL 20 (38)
T ss_dssp HHHHHHH
T ss_pred eeeehHH
Confidence 3444433
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=85.97 E-value=0.41 Score=28.02 Aligned_cols=28 Identities=11% Similarity=-0.062 Sum_probs=14.9
Q ss_pred hhHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 017262 5 GIGTGLGGLFLSIGALWLCIIIRKRIKQ 32 (374)
Q Consensus 5 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 32 (374)
+.++++..+++++.++++++.+|+.+++
T Consensus 16 ~~vVGvll~vi~~l~~~~~~RRR~~~~k 43 (44)
T 2jwa_A 16 SAVVGILLVVVLGVVFGILIKRRQQKIR 43 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHCSCCC
T ss_pred HHHHHHHHHHHHHHHHHhheehhhhhcc
Confidence 3333444444444455667777776554
|
| >2klu_A T-cell surface glycoprotein CD4; cell membrane, disulfide bond, HOST- virus interaction, immune response, immunoglobulin domain, lipoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=82.21 E-value=0.32 Score=30.90 Aligned_cols=9 Identities=44% Similarity=0.534 Sum_probs=3.5
Q ss_pred HHHHHHhhh
Q 017262 26 IRKRIKQKE 34 (374)
Q Consensus 26 ~~~~~~~~~ 34 (374)
+|.|+++.+
T Consensus 34 crhRrrqAe 42 (70)
T 2klu_A 34 SRHRRRQAE 42 (70)
T ss_dssp SSCCSSSCT
T ss_pred HHHHHHHHH
Confidence 343444333
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 374 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-73 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-68 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-67 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-66 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-65 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-65 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-65 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-64 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-62 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-62 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-62 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-62 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-62 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-62 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-61 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-61 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-61 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-60 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-60 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-60 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-59 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-59 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-58 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-58 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-58 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-58 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-57 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-55 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-54 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-54 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-54 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-54 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-53 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-52 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-51 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-50 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-50 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-47 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-46 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-45 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-45 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-44 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-43 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-42 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-42 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-41 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-38 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-35 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-33 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-29 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-19 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (581), Expect = 1e-73
Identities = 70/283 (24%), Positives = 118/283 (41%), Gaps = 21/283 (7%)
Query: 72 DYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVV 131
+ + +G G GTVYKG + + +L+ F NEV +L + H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 132 KLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSA 191
+G +V ++ +L+ +LH E + IA + A+ + YLH
Sbjct: 68 LFMGYSTA-PQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLH--- 121
Query: 192 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA-IDQTHVSTKVQGTFGYLDPEYFRSS 250
I HRD+KS NI L E KI DFG + + +H ++ G+ ++ PE R
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 251 Q---FTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307
++ +SDVY+FG+VL EL+TGQ P N + + L +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPY------SNINNRDQIIFMVGRGYLSPDLSKVR 235
Query: 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350
+ A+ + CL RP ++ +E + +
Sbjct: 236 SNCPK-----AMKRLMAECLKKKRDERPLFPQILASIELLARS 273
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 2e-68
Identities = 66/280 (23%), Positives = 117/280 (41%), Gaps = 21/280 (7%)
Query: 72 DYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVV 131
+ + LG G G V+ G +AVK K + F+ E ++ Q+ H+ +V
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLV 71
Query: 132 KLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSA 191
+L + E ++ E++ NG+L +L P + LT L +A ++AE +A++
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE-- 127
Query: 192 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQ 251
HRD+++ NIL+ + KIADFG +R I ++ + + PE
Sbjct: 128 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 252 FTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSG 311
FT KSDV+SFG++L E++T + N + ++ R
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------------VIQNLERGYRMVR 231
Query: 312 EAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANS 351
+ + + C +RPT + LE +
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 1e-67
Identities = 71/275 (25%), Positives = 118/275 (42%), Gaps = 21/275 (7%)
Query: 74 FNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKL 133
+ +G G G V+ G + +A+K + E+FI E ++ +++H +V+L
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 134 LGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYL 193
G CLE LV+EF+ +G L YL + E L + +V E +AYL
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFA--AETLLGMCLDVCEGMAYLEE---A 120
Query: 194 PIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFT 253
+ HRD+ + N L+ E K++DFG +R + DQ ST + + PE F S+++
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 254 DKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEA 313
KSDV+SFGV++ E+ + K E + + + I R
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKI---------------PYENRSNSEVVEDISTGFRLYKPR 225
Query: 314 EEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIR 348
V + C +RP + +L I
Sbjct: 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 208 bits (530), Expect = 8e-66
Identities = 75/296 (25%), Positives = 135/296 (45%), Gaps = 24/296 (8%)
Query: 66 ELDKATDYFNMNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFINEVVILSQ 124
E+++ M LG G G VY+G+ +AVK K D ++EEF+ E ++ +
Sbjct: 13 EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 69
Query: 125 INHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEAL 184
I H N+V+LLG C ++ EF+ G L YL + + ++ + L +AT+++ A+
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAM 128
Query: 185 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDP 244
YL HRD+ + N L+ E + K+ADFG SR + D + + P
Sbjct: 129 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 185
Query: 245 EYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIID 304
E ++F+ KSDV++FGV+L E+ T I+ + ++++++
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMS---------------PYPGIDLSQVYELLE 230
Query: 305 DQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDDENNIQK 360
R V ++ + C +RP+ E+ E + S + ++K
Sbjct: 231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES-SISDEVEK 285
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 1e-65
Identities = 73/278 (26%), Positives = 132/278 (47%), Gaps = 27/278 (9%)
Query: 74 FNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKL 133
+ + +G+G G V G G +AVK K +++ + F+ E +++Q+ H N+V+L
Sbjct: 9 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQL 65
Query: 134 LGCCLEVEVPL-LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAY 192
LG +E + L +V E++ G+L YL + L + L+ + +V EA+ YL +
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN-- 122
Query: 193 LPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQF 252
HRD+ + N+L+ E AK++DFG ++ + Q + + PE R +F
Sbjct: 123 -NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG----KLPVKWTAPEALREKKF 177
Query: 253 TDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGE 312
+ KSDV+SFG++L E+ + + + V +E+ D D
Sbjct: 178 STKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKGYKMDAPDGCPP---- 227
Query: 313 AEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350
AV +V K C + RP+ ++ +LE I+ +
Sbjct: 228 -----AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 1e-65
Identities = 69/303 (22%), Positives = 125/303 (41%), Gaps = 37/303 (12%)
Query: 67 LDKATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKK-SKVVDESKLEEFINEVVILSQ 124
++ D F LG G G V+K G ++A K + + + I E+ +L +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 125 INHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEAL 184
N +V G + E + G+L Q L + + ++ +++ V + L
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGL 117
Query: 185 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDP 244
YL I HRD+K +NIL++ + K+ DFG S + ++ GT Y+ P
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSP 172
Query: 245 EYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANE---------------------- 282
E + + ++ +SD++S G+ LVE+ G+ PI A E
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 283 -GRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVS----DVAKRCLNSYGRNRPTM 337
GR L++Y ++ +F+++D V + S D +CL R +
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292
Query: 338 KEV 340
K++
Sbjct: 293 KQL 295
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 5e-65
Identities = 67/280 (23%), Positives = 119/280 (42%), Gaps = 21/280 (7%)
Query: 72 DYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVV 131
+ + LGQG G V+ G +A+K K S E F+ E ++ ++ H +V
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLV 75
Query: 132 KLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSA 191
+L E +V E++ G+L +L + L + +A ++A +AY+
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVE--- 130
Query: 192 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQ 251
+ HRD+++ NIL+ E K+ADFG +R I ++ + + PE +
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190
Query: 252 FTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSG 311
FT KSDV+SFG++L EL T + + + D ++ R
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVERGYRMPC 235
Query: 312 EAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANS 351
E ++ D+ +C RPT + + LE ++
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 3e-64
Identities = 64/274 (23%), Positives = 113/274 (41%), Gaps = 21/274 (7%)
Query: 74 FNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKL 133
+ LG G G V G +A+K K +EFI E ++ ++H +V+L
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 134 LGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYL 193
G C + ++ E++ NG L YL + + L + +V EA+ YL
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQ--TQQLLEMCKDVCEAMEYLE---SK 119
Query: 194 PIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFT 253
HRD+ + N L++++ K++DFG SR + D+ S + + PE S+F+
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 254 DKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEA 313
KSD+++FGV++ E+ + K + N + I +R
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERFTNSE---------------TAEHIAQGLRLYRPH 224
Query: 314 EEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347
V + C + RPT K + + +
Sbjct: 225 LASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 2e-62
Identities = 66/295 (22%), Positives = 129/295 (43%), Gaps = 30/295 (10%)
Query: 64 SKELDKATDYFNMNRILGQGGQGTVYKGMLADG-----RIIAVKK-SKVVDESKLEEFIN 117
+ E+ +++G G G VYKGML +A+K E + +F+
Sbjct: 1 TTEIH--PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLG 58
Query: 118 EVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIA 177
E I+ Q +H N+++L G + + +++ E++ NG L ++L + E S + +
Sbjct: 59 EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFS--VLQLVGML 116
Query: 178 TEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ--THVSTKV 235
+A + YL + + HRD+ + NIL++ K++DFG SR + D T+ ++
Sbjct: 117 RGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 173
Query: 236 QGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIE 295
+ + PE +FT SDV+SFG+V+ E++T + +
Sbjct: 174 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER---------------PYWELS 218
Query: 296 ENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350
+ + I+D R + A+ + +C RP ++ L+++
Sbjct: 219 NHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 200 bits (508), Expect = 2e-62
Identities = 67/312 (21%), Positives = 126/312 (40%), Gaps = 47/312 (15%)
Query: 65 KELDKATDYFNMNRILGQGGQGTVYKGML------ADGRIIAVKK-SKVVDESKLEEFIN 117
L+ + R +G+G G V++ ++AVK + +F
Sbjct: 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR 65
Query: 118 EVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELS---------- 167
E ++++ ++ N+VKLLG C + L++E++ G L ++L
Sbjct: 66 EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125
Query: 168 -----------LTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIA 216
L+ +L IA +VA +AYL HRD+ + N L+ E KIA
Sbjct: 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIA 182
Query: 217 DFGTSRSIA-IDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPI 275
DFG SR+I D ++ PE +++T +SDV+++GVVL E+ +
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ- 241
Query: 276 SSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRP 335
+ E ++ + D + E + + ++ + C + +RP
Sbjct: 242 -------------PYYGMAHEEVIYYVRDGNILACPE-NCPLELYNLMRLCWSKLPADRP 287
Query: 336 TMKEVAMELERI 347
+ + L+R+
Sbjct: 288 SFCSIHRILQRM 299
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 3e-62
Identities = 76/296 (25%), Positives = 134/296 (45%), Gaps = 30/296 (10%)
Query: 73 YFNMNRILGQGGQGTVYKGMLAD----GRIIAVKK-SKVVDESKLEEFINEVVILSQINH 127
+ N ++G+G G VY G L D AVK +++ D ++ +F+ E +I+ +H
Sbjct: 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 128 RNVVKLLGCCLEVE-VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAY 186
NV+ LLG CL E PL+V ++ +G L ++ E + T + + +VA+ + +
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKF 145
Query: 187 LHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA---IDQTHVSTKVQGTFGYLD 243
L HRD+ + N +LDEK+ K+ADFG +R + D H T + ++
Sbjct: 146 LA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 244 PEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDII 303
E ++ +FT KSDV+SFGV+L EL+T P + + +
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP---------------PYPDVNTFDITVYL 247
Query: 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDDENNIQ 359
R + +V +C + RP+ E+ + I ++ E+ +
Sbjct: 248 LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF-STFIGEHYVH 302
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 199 bits (506), Expect = 5e-62
Identities = 64/308 (20%), Positives = 130/308 (42%), Gaps = 40/308 (12%)
Query: 62 FNSKELDKAT---------DYFNMNRILGQGGQGTVYKGMLA----DGRIIAVKK-SKVV 107
F ++ ++A + +++G G G V G L +A+K
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 108 DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELS 167
E + +F++E I+ Q +H NV+ L G + +++ EF+ NG+L +L +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ-- 124
Query: 168 LTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227
T + + +A + YL + HRD+ + NIL++ K++DFG SR + D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 228 QTHVSTK----VQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANE 282
+ + + + PE + +FT SDV+S+G+V+ E+++ G++P + +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241
Query: 283 GRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342
+ + I+ R + A+ + C +RP ++
Sbjct: 242 ----------------VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285
Query: 343 ELERIRAN 350
L+++ N
Sbjct: 286 TLDKMIRN 293
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 5e-62
Identities = 71/279 (25%), Positives = 127/279 (45%), Gaps = 31/279 (11%)
Query: 77 NRILGQGGQGTVYKGMLAD---GRIIAVK--KSKVVDESKLEEFINEVVILSQINHRNVV 131
++ LG G GTV KG + +AVK K++ D + +E + E ++ Q+++ +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 132 KLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSA 191
+++G C E E +LV E G L +YL + + + + +V+ + YL
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLE--- 124
Query: 192 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTK--VQGTFGYLDPEYFRS 249
HRD+ + N+LL ++ AKI+DFG S+++ D+ + + + + PE
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 250 SQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVR 308
+F+ KSDV+SFGV++ E + GQKP + +E + +++ R
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----------------VTAMLEKGER 228
Query: 309 KSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347
A + D+ C NRP V + L
Sbjct: 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 9e-62
Identities = 73/306 (23%), Positives = 127/306 (41%), Gaps = 41/306 (13%)
Query: 72 DYFNMNRILGQGGQGTVYKGMLA------DGRIIAVKK-SKVVDESKLEEFINEVVILSQ 124
+ + + LG G G V + +AVK ++ E ++E+ +LS
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 125 I-NHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHD---------------PYEELSL 168
+ NH N+V LLG C L++ E+ G L +L +EL+L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 169 TWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228
E L + +VA+ +A+L S HRD+ + NILL KI DFG +R I D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 229 TH-VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLT 287
+ V + ++ PE + +T +SDV+S+G+ L EL +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS------------- 246
Query: 288 TYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347
+ ++ + +I + R + D+ K C ++ RPT K++ +E+
Sbjct: 247 -PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
Query: 348 RANSRD 353
+ S +
Sbjct: 306 ISESTN 311
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 1e-61
Identities = 58/277 (20%), Positives = 121/277 (43%), Gaps = 32/277 (11%)
Query: 73 YFNMNRILGQGGQGTVYKGMLAD-GRIIAVKK--SKVVDESKLEEFINEVVILSQINHRN 129
+ + +G+G TVYKG+ + +A + + + +S+ + F E +L + H N
Sbjct: 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69
Query: 130 VVKLLGCCLEV----EVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALA 185
+V+ + +LV E + +GTL YL + ++ ++ + L
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQ 126
Query: 186 YLHSSAYLPIYHRDIKSTNILL-DEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDP 244
+LH+ PI HRD+K NI + KI D G + + + + V GT ++ P
Sbjct: 127 FLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLAT---LKRASFAKAVIGTPEFMAP 182
Query: 245 EYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIID 304
E + ++ + DVY+FG+ ++E+ T + P + EC ++ +
Sbjct: 183 EMYE-EKYDESVDVYAFGMCMLEMATSEYP---------------YSECQNAAQIYRRVT 226
Query: 305 DQVRKSGEAEEIM-AVSDVAKRCLNSYGRNRPTMKEV 340
V+ + + + V ++ + C+ R ++K++
Sbjct: 227 SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 1e-61
Identities = 75/280 (26%), Positives = 122/280 (43%), Gaps = 26/280 (9%)
Query: 69 KATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVK--KSKVVDESKLEEFINEVVILSQI 125
+A DY + +G G G K +DG+I+ K + E++ + ++EV +L ++
Sbjct: 2 RAEDY-EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60
Query: 126 NHRNVVKLLGCCLEVE--VPLLVYEFIPNGTLFQYLHDPYEEL-SLTWEMRLRIATEVAE 182
H N+V+ ++ +V E+ G L + +E L E LR+ T++
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 183 ALAYLH--SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFG 240
AL H S + HRD+K N+ LD K K+ DFG +R + T + GT
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKAFVGTPY 179
Query: 241 YLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLF 300
Y+ PE + +KSD++S G +L EL P ++ E I E
Sbjct: 180 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGKFR 232
Query: 301 DIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEV 340
I R S E EI+ R LN +RP+++E+
Sbjct: 233 RIPY---RYSDELNEII------TRMLNLKDYHRPSVEEI 263
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 2e-61
Identities = 60/294 (20%), Positives = 112/294 (38%), Gaps = 29/294 (9%)
Query: 78 RILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCC 137
+G+G G V++G G +AVK E + E+ + H N++ +
Sbjct: 9 ESIGKGRFGEVWRGKW-RGEEVAVKIFSS-REERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 138 LE----VEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAY- 192
+ LV ++ +G+LF YL+ ++T E +++A A LA+LH
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 193 ----LPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS---TKVQGTFGYLDPE 245
I HRD+KS NIL+ + IAD G + + GT Y+ PE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 246 YFRSS------QFTDKSDVYSFGVVLVELLTGQKPISSI----WANEGRNLTTYFVECIE 295
S + ++D+Y+ G+V E+ + VE +
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 296 ENCLFDIIDDQVRKSGEAEEIM-AVSDVAKRCLNSYGRNRPTMKEVAMELERIR 348
+ + + ++ E + ++ + + C + G R T + L ++
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 9e-61
Identities = 69/291 (23%), Positives = 127/291 (43%), Gaps = 30/291 (10%)
Query: 65 KELDKATDYFNM-NRILGQGGQGTVYKGMLA---DGRIIAVKK-SKVVDESKLEEFINEV 119
K+L D + + LG G G+V +G+ +A+K + +++ EE + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 120 VILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATE 179
I+ Q+++ +V+L+G C + E +LV E G L ++L EE+ + +
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIP--VSNVAELLHQ 117
Query: 180 VAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTK--VQG 237
V+ + YL HRD+ + N+LL ++ AKI+DFG S+++ D ++ + + +
Sbjct: 118 VSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 238 TFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEE 296
+ PE +F+ +SDV+S+GV + E L+ GQKP + E
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------------- 220
Query: 297 NCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347
+ I+ R E + + C +RP V +
Sbjct: 221 --VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 1e-60
Identities = 77/273 (28%), Positives = 114/273 (41%), Gaps = 30/273 (10%)
Query: 72 DYFNMNRILGQGGQGTVYKGML-ADGRIIAVK---KSKVVDESKLEEFINEVVILSQINH 127
+ F + R LG+G G VY I+A+K K+++ + EV I S + H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 128 RNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYL 187
N+++L G + L+ E+ P GT+++ L + TE+A AL+Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYC 122
Query: 188 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYF 247
HS + HRDIK N+LL KIADFG S + + GT YL PE
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMI 176
Query: 248 RSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307
+K D++S GV+ E L G+ P + E TY E D + +
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-----TYKRISRVEFTFPDFVTEGA 231
Query: 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEV 340
R D+ R L RP ++EV
Sbjct: 232 R------------DLISRLLKHNPSQRPMLREV 252
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 2e-60
Identities = 70/272 (25%), Positives = 122/272 (44%), Gaps = 25/272 (9%)
Query: 71 TDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRN 129
+ +GQG GTVY M +A G+ +A+++ + + K E INE++++ + + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS 189
+V L L + +V E++ G+L + + + E +AL +LHS
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEFLHS 134
Query: 190 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRS 249
+ HRDIKS NILL K+ DFG I +Q+ ST V GT ++ PE
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTR 190
Query: 250 SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309
+ K D++S G++ +E++ G+ P ++ L+ I + +
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPP---------------YLNENPLRALYLIATNGTPE 235
Query: 310 SGEAEEI-MAVSDVAKRCLNSYGRNRPTMKEV 340
E++ D RCL+ R + KE+
Sbjct: 236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 193 bits (492), Expect = 7e-60
Identities = 66/280 (23%), Positives = 108/280 (38%), Gaps = 33/280 (11%)
Query: 68 DKATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILS 123
D F+ R +G G G VY + + ++A+K S K ++ I EV L
Sbjct: 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 124 QINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEA 183
++ H N ++ GC L LV E+ + L + +
Sbjct: 71 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQG 127
Query: 184 LAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 243
LAYLHS + HRD+K+ NILL E K+ DFG++ +A + V GT ++
Sbjct: 128 LAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMA 179
Query: 244 PEYFRSS---QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLF 300
PE + Q+ K DV+S G+ +EL + P + L+
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---------------LFNMNAMSALY 224
Query: 301 DIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEV 340
I ++ + CL ++RPT + +
Sbjct: 225 HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 3e-59
Identities = 67/303 (22%), Positives = 118/303 (38%), Gaps = 46/303 (15%)
Query: 72 DYFNMNRILGQGGQGTVYKGML------ADGRIIAVKK-SKVVDESKLEEFINEVVILSQ 124
+ ++LG G G V +AVK + D S+ E ++E+ +++Q
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 125 I-NHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELS---------------- 167
+ +H N+V LLG C L++E+ G L YL E+ S
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 168 ----LTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 223
LT+E L A +VA+ + +L HRD+ + N+L+ KI DFG +R
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 224 IAIDQTHVS-TKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANE 282
I D +V + ++ PE +T KSDV+S+G++L E+ +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP------- 266
Query: 283 GRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342
+ + + +I + + + + + C R RP+ +
Sbjct: 267 -------YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 343 ELE 345
L
Sbjct: 320 FLG 322
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (485), Expect = 5e-59
Identities = 66/283 (23%), Positives = 115/283 (40%), Gaps = 27/283 (9%)
Query: 64 SKELDKATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVIL 122
+++L+ D++ + LG G G VYK + A K E +LE+++ E+ IL
Sbjct: 5 TRDLN-PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDIL 63
Query: 123 SQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAE 182
+ +H N+VKLL ++ EF G + + + LT + + +
Sbjct: 64 ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQTLD 121
Query: 183 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYL 242
AL YLH I HRD+K+ NIL K+ADFG S + + GT ++
Sbjct: 122 ALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWM 177
Query: 243 DPEYFRSSQ-----FTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEEN 297
PE + K+DV+S G+ L+E+ + P + N ++ +
Sbjct: 178 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP------HHELNPMRVLLKIAKSE 231
Query: 298 CLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEV 340
+ S ++ + K+CL R T ++
Sbjct: 232 PPTLAQPSRW--SSNFKDFL------KKCLEKNVDARWTTSQL 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 2e-58
Identities = 61/289 (21%), Positives = 129/289 (44%), Gaps = 29/289 (10%)
Query: 69 KATDYFNMNRILGQGGQGTVYKGMLAD-----GRIIAVKK-SKVVDESKLEEFINEVVIL 122
K T++ ++LG G GTVYKG+ +A+K+ + +E ++E ++
Sbjct: 7 KETEF-KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 123 SQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAE 182
+ +++ +V +LLG CL L+ + +P G L Y+ + + + + L ++A+
Sbjct: 66 ASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIG--SQYLLNWCVQIAK 122
Query: 183 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI-AIDQTHVSTKVQGTFGY 241
+ YL + HRD+ + N+L+ KI DFG ++ + A ++ + + + +
Sbjct: 123 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 242 LDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFD 301
+ E +T +SDV+S+GV + EL+T + I + +
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK---------------PYDGIPASEISS 224
Query: 302 IIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350
I++ R + V + +C +RP +E+ +E ++ +
Sbjct: 225 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 3e-58
Identities = 68/301 (22%), Positives = 119/301 (39%), Gaps = 38/301 (12%)
Query: 74 FNMNRILGQGGQGTVYKGMLADG---RIIAVKK-SKVVDESKLEEFINEVVILSQI-NHR 128
++G+G G V K + A+K+ + + +F E+ +L ++ +H
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 129 NVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPY-------------EELSLTWEMRLR 175
N++ LLG C L E+ P+G L +L +L+ + L
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 176 IATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKV 235
A +VA + YL HRD+ + NIL+ E Y AKIADFG SR + T
Sbjct: 132 FAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TMG 186
Query: 236 QGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIE 295
+ ++ E S +T SDV+S+GV+L E+++ +
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---------------PYCGMT 231
Query: 296 ENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDDE 355
L++ + R V D+ ++C RP+ ++ + L R+ +
Sbjct: 232 CAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 291
Query: 356 N 356
N
Sbjct: 292 N 292
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 4e-58
Identities = 67/281 (23%), Positives = 118/281 (41%), Gaps = 26/281 (9%)
Query: 72 DYFNMNRILGQGGQGTVYKGMLAD----GRIIAVKK-SKVVDESKLEEFINEVVILSQIN 126
+ + R +G+G G V++G+ +A+K +S E+F+ E + + Q +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 127 HRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAY 186
H ++VKL+G E V ++ E G L +L SL + A +++ ALAY
Sbjct: 67 HPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAY 123
Query: 187 LHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEY 246
L S HRDI + N+L+ K+ DFG SR + + ++K + ++ PE
Sbjct: 124 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 180
Query: 247 FRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306
+FT SDV+ FGV + E+L + ++ N + I++
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVK---------------PFQGVKNNDVIGRIENG 225
Query: 307 VRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347
R + + +C RP E+ +L I
Sbjct: 226 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 6e-58
Identities = 64/273 (23%), Positives = 113/273 (41%), Gaps = 24/273 (8%)
Query: 72 DYFNMNRILGQGGQGTVYKGM-LADGRIIAVKK-SKVVDESKLEEFINEVVILSQINHRN 129
+ +++ + LG+G G V + +AVK E E+ I +NH N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS 189
VVK G E + L E+ G LF + ++ + R ++ + YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 190 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID-QTHVSTKVQGTFGYLDPEYFR 248
+ I HRDIK N+LLDE+ KI+DFG + + + + K+ GT Y+ PE +
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 249 SSQF-TDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307
+F + DV+S G+VL +L G+ P + + + +E + ++
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLNPWKKI 232
Query: 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEV 340
++ + L R T+ ++
Sbjct: 233 --DSAPLALL------HKILVENPSARITIPDI 257
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 9e-57
Identities = 67/284 (23%), Positives = 112/284 (39%), Gaps = 29/284 (10%)
Query: 74 FNMNRILGQGGQGTVYKGML----ADGRIIAVK---KSKVVDESKLEEFINEVVILSQIN 126
+ LG G G V +G +AVK + +++FI EV + ++
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 127 HRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAY 186
HRN+++L G L + +V E P G+L L + R A +VAE + Y
Sbjct: 70 HRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGY 126
Query: 187 LHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH--VSTKVQGTFGYLDP 244
L S HRD+ + N+LL + KI DFG R++ + H + + F + P
Sbjct: 127 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 245 EYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIID 304
E ++ F+ SD + FGV L E+ T + ++ L I
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQE--------------PWIGLNGSQILHKIDK 229
Query: 305 DQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIR 348
+ R + + +V +C +RPT + L +
Sbjct: 230 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 182 bits (462), Expect = 7e-55
Identities = 61/273 (22%), Positives = 116/273 (42%), Gaps = 25/273 (9%)
Query: 72 DYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNV 130
D+++++ LG G G V++ A G A K ES E E+ +S + H +
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 131 VKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSS 190
V L + +++YEF+ G LF+ + D + ++ + + +V + L ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHE- 142
Query: 191 AYLPIYHRDIKSTNILLDEKY--RAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFR 248
H D+K NI+ K K+ DFG + + Q+ T GT + PE
Sbjct: 143 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAE 198
Query: 249 SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVR 308
+D++S GV+ LL+G P + E + T V ++C +++ D
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSP----FGGENDDETLRNV----KSCDWNMDDSAFS 250
Query: 309 K-SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEV 340
S + ++ + ++ L + R T+ +
Sbjct: 251 GISEDGKDFI------RKLLLADPNTRMTIHQA 277
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 1e-54
Identities = 82/314 (26%), Positives = 129/314 (41%), Gaps = 41/314 (13%)
Query: 62 FNSKELDKATDYFNMNRILGQGGQGTVYKGM------LADGRIIAVKK-SKVVDESKLEE 114
+++ + + D + + LG+G G V + A R +AVK + S+
Sbjct: 3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 62
Query: 115 FINEVVILSQINHR-NVVKLLGCCLEVEVPL-LVYEFIPNGTLFQYLHDPYEELS----- 167
++E+ IL I H NVV LLG C + PL ++ EF G L YL E
Sbjct: 63 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 122
Query: 168 --------LTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 219
LT E + + +VA+ + +L S HRD+ + NILL EK KI DFG
Sbjct: 123 PEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFG 179
Query: 220 TSRSIAIDQTHV-STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSI 278
+R I D +V + ++ PE +T +SDV+SFGV+L E+ +
Sbjct: 180 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP--- 236
Query: 279 WANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMK 338
G + F ++E D + + C + RPT
Sbjct: 237 --YPGVKIDEEFCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFS 285
Query: 339 EVAMELERI-RANS 351
E+ L + +AN+
Sbjct: 286 ELVEHLGNLLQANA 299
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 1e-54
Identities = 73/291 (25%), Positives = 130/291 (44%), Gaps = 33/291 (11%)
Query: 72 DYFNMNRILGQGGQGTVYKGML------ADGRIIAVKK-SKVVDESKLEEFINEVVILSQ 124
+ M+R LGQG G VY+G+ +A+K ++ + EF+NE ++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 125 INHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELS-------LTWEMRLRIA 177
N +VV+LLG + + L++ E + G L YL ++ + +++A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 178 TEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI-AIDQTHVSTKVQ 236
E+A+ +AYL+++ HRD+ + N ++ E + KI DFG +R I D K
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 237 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEE 296
++ PE + FT SDV+SFGVVL E+ T + +NE + + E
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------QVLRFVME 250
Query: 297 NCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347
L D D+ + ++ + C + RP+ E+ ++
Sbjct: 251 GGLLDKPDNCPDM---------LFELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 178 bits (453), Expect = 2e-54
Identities = 75/289 (25%), Positives = 121/289 (41%), Gaps = 30/289 (10%)
Query: 71 TDYFNMNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQIN 126
+D + + ILG GG V+ L R +AVK D S F E + +N
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 127 HRNVVKLLGCCLEVE----VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAE 182
H +V + +P +V E++ TL +H +T + + + + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQ 122
Query: 183 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV--STKVQGTFG 240
AL + H I HRD+K NI++ K+ DFG +R+IA V + V GT
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 241 YLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLF 300
YL PE R +SDVYS G VL E+LTG+ P G + + + + E+ +
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF------TGDSPVSVAYQHVREDPIP 233
Query: 301 DIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRP-TMKEVAMELERIR 348
+ S + + ++ + L NR T E+ +L R+
Sbjct: 234 PSARHE-GLSADLDAVV------LKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 2e-54
Identities = 68/277 (24%), Positives = 111/277 (40%), Gaps = 28/277 (10%)
Query: 69 KATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQ 124
K + F +ILG+G TV LA R A+K K ++ E+K+ E ++S+
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 125 INHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEAL 184
++H VKL + E + NG L +Y+ S E+ AL
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSAL 121
Query: 185 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID-QTHVSTKVQGTFGYLD 243
YLH I HRD+K NILL+E +I DFGT++ ++ + + + GT Y+
Sbjct: 122 EYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178
Query: 244 PEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDII 303
PE SD+++ G ++ +L+ G P F E II
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPP---------------FRAGNEYLIFQKII 223
Query: 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEV 340
+ + D+ ++ L R +E+
Sbjct: 224 KLEYDFPEKFFP--KARDLVEKLLVLDATKRLGCEEM 258
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 3e-53
Identities = 75/308 (24%), Positives = 125/308 (40%), Gaps = 44/308 (14%)
Query: 66 ELDKATDYFNMNRILGQGGQGTVYKGML--------ADGRIIAVKK-SKVVDESKLEEFI 116
EL + D + + LG+G G V +AVK E L + I
Sbjct: 9 ELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI 66
Query: 117 NEVVILSQI-NHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLH-------------DP 162
+E+ ++ I H+N++ LLG C + ++ E+ G L +YL
Sbjct: 67 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 126
Query: 163 YEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 222
E L+ + + A +VA + YL S HRD+ + N+L+ E KIADFG +R
Sbjct: 127 NPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLAR 183
Query: 223 SIAIDQTHVSTKVQ-GTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWAN 281
I + T ++ PE +T +SDV+SFGV+L E+ T
Sbjct: 184 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS------- 236
Query: 282 EGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVA 341
+ LF ++ + R + + + + C ++ RPT K++
Sbjct: 237 --------PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 288
Query: 342 MELERIRA 349
+L+RI A
Sbjct: 289 EDLDRIVA 296
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 175 bits (444), Expect = 3e-52
Identities = 62/272 (22%), Positives = 110/272 (40%), Gaps = 23/272 (8%)
Query: 72 DYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNV 130
DY+++ LG G G V++ + A GR+ K NE+ I++Q++H +
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 131 VKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSS 190
+ L + +L+ EF+ G LF + E+ ++ + + E L ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHE- 145
Query: 191 AYLPIYHRDIKSTNILLDEKY--RAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFR 248
I H DIK NI+ + K KI DFG + + D+ T T + PE
Sbjct: 146 --HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVD 201
Query: 249 SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVR 308
+D+++ GV+ LL+G P + E ++ ++ D
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-------TLQNVKRCDWEFDEDAFSS 254
Query: 309 KSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEV 340
S EA++ + K L R R T+ +
Sbjct: 255 VSPEAKDFI------KNLLQKEPRKRLTVHDA 280
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 171 bits (435), Expect = 2e-51
Identities = 63/278 (22%), Positives = 107/278 (38%), Gaps = 20/278 (7%)
Query: 65 KELDKATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKK-SKVVDESKLEEFINEVVIL 122
K+ + D ++ +LG G V +++A+K +K E K NE+ +L
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 123 SQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAE 182
+I H N+V L L+ + + G LF + E+ T R+ +V +
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVLD 118
Query: 183 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYL 242
A+ YLH + + LDE + I+DFG S+ D V + GT GY+
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYV 176
Query: 243 DPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDI 302
PE ++ D +S GV+ LL G P N F + ++ FD
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF------YDENDAKLFEQILKAEYEFDS 230
Query: 303 IDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEV 340
S A++ + + + R T ++
Sbjct: 231 PYWD-DISDSAKDFI------RHLMEKDPEKRFTCEQA 261
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 3e-50
Identities = 62/281 (22%), Positives = 114/281 (40%), Gaps = 31/281 (11%)
Query: 65 KELDKATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILS 123
KEL + + + LG+G G V++ + + + K K V + E+ IL+
Sbjct: 1 KEL---YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILN 56
Query: 124 QINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEA 183
HRN++ L +E ++++EFI +F+ ++ L + +V EA
Sbjct: 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEA 114
Query: 184 LAYLHSSAYLPIYHRDIKSTNILLDEK--YRAKIADFGTSRSIAIDQTHVSTKVQGTFGY 241
L +LHS I H DI+ NI+ + KI +FG +R + + Y
Sbjct: 115 LQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEY 169
Query: 242 LDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFD 301
PE + + +D++S G ++ LL+G P F+ + + +
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP---------------FLAETNQQIIEN 214
Query: 302 IIDDQVRKSGEAEEIM--AVSDVAKRCLNSYGRNRPTMKEV 340
I++ + EA + + D R L ++R T E
Sbjct: 215 IMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 166 bits (422), Expect = 6e-50
Identities = 72/286 (25%), Positives = 116/286 (40%), Gaps = 38/286 (13%)
Query: 72 DYFNMNRILGQGGQGTVYKGM-LADGRIIAVKK---------SKVVDESKLEEFINEVVI 121
+ + ILG+G V + + + AVK S + E + EV I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 122 LSQIN-HRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEV 180
L +++ H N+++L LV++ + G LF YL E+++L+ + +I +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRAL 119
Query: 181 AEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFG 240
E + LH L I HRD+K NILLD+ K+ DFG S +D +V GT
Sbjct: 120 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSC--QLDPGEKLREVCGTPS 174
Query: 241 YLDPEYFRSSQ------FTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECI 294
YL PE S + + D++S GV++ LL G P R +
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF------WHRKQMLMLRMIM 228
Query: 295 EENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEV 340
N F + S ++++ R L + R T +E
Sbjct: 229 SGNYQFG-SPEWDDYSDTVKDLV------SRFLVVQPQKRYTAEEA 267
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 3e-47
Identities = 63/276 (22%), Positives = 111/276 (40%), Gaps = 31/276 (11%)
Query: 74 FNMNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILS-QINHR 128
F ++++LG+G G V+ + A+K K V+ + +E + E +LS H
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 129 NVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLH 188
+ + E V E++ G L ++ ++ A E+ L +LH
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLH 120
Query: 189 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFR 248
S I +RD+K NILLD+ KIADFG + + +T GT Y+ PE
Sbjct: 121 S---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILL 176
Query: 249 SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLF-DIIDDQV 307
++ D +SFGV+L E+L GQ P G++ F +N + ++ +
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQSPF------HGQDEEELFHSIRMDNPFYPRWLEKEA 230
Query: 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343
+ D+ + R ++ +
Sbjct: 231 K------------DLLVKLFVREPEKRLGVRGDIRQ 254
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 157 bits (399), Expect = 5e-46
Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 14/205 (6%)
Query: 74 FNMNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQINHRN 129
F + R LG G G V+ +GR A+K K VV ++E +E ++LS + H
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS 189
++++ G + + ++ ++I G LF L + A EV AL YLHS
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF---PNPVAKFYAAEVCLALEYLHS 122
Query: 190 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRS 249
I +RD+K NILLD+ KI DFG ++ + V+ + GT Y+ PE +
Sbjct: 123 ---KDIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEVVST 175
Query: 250 SQFTDKSDVYSFGVVLVELLTGQKP 274
+ D +SFG+++ E+L G P
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYTP 200
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 157 bits (397), Expect = 3e-45
Identities = 59/274 (21%), Positives = 110/274 (40%), Gaps = 31/274 (11%)
Query: 72 DYFNMNRILGQGGQGTVYKGMLAD-GRIIAVK---KSKVVDESKLEEFINEVV---ILSQ 124
+ F+++RI+G+GG G VY AD G++ A+K K ++ + +NE + ++S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 125 INHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEAL 184
+ +V + + + + + G L +L + A E+ L
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF---SEADMRFYAAEIILGL 120
Query: 185 AYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDP 244
++H+ + +RD+K NILLDE +I+D G + + + H GT GY+ P
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAP 174
Query: 245 EYFRSSQ-FTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDII 303
E + + +D +S G +L +LL G P + I+ L +
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--------KHEIDRMTLTMAV 226
Query: 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTM 337
+ S E ++ + L R
Sbjct: 227 ELPDSFSPELRSLL------EGLLQRDVNRRLGC 254
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 6e-45
Identities = 59/278 (21%), Positives = 107/278 (38%), Gaps = 29/278 (10%)
Query: 72 DYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQI-NHRN 129
DY +++LG G G V + A+K + + EV + + +
Sbjct: 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPH 66
Query: 130 VVKLLGCCLEV----EVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALA 185
+V+++ + + L+V E + G LF + D + + T I + EA+
Sbjct: 67 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQ 125
Query: 186 YLHSSAYLPIYHRDIKSTNILLD---EKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYL 242
YLHS I HRD+K N+L K+ DFG ++ + + T Y+
Sbjct: 126 YLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYV 180
Query: 243 DPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDI 302
PE ++ D++S GV++ LL G P ++N G ++ I
Sbjct: 181 APEVLGPEKYDKSCDMWSLGVIMYILLCGYPP---FYSNHGLAISPGMKTRIRMGQYEFP 237
Query: 303 IDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEV 340
+ S E + ++ + L + R T+ E
Sbjct: 238 NPEWSEVSEEVKMLI------RNLLKTEPTQRMTITEF 269
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 154 bits (389), Expect = 6e-45
Identities = 59/283 (20%), Positives = 107/283 (37%), Gaps = 20/283 (7%)
Query: 72 DYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKV--VDESKLEEFINEVVILSQINHRN 129
+ ++ +G+G G VYK G A+KK ++ DE I E+ IL ++ H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 130 VVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS 189
+VKL + +LV+E + E L ++ +AY H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 190 SAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRS 249
+ HRD+K N+L++ + KIADFG +R+ I + ++ + S
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 250 SQFTDKSDVYSFGVVLVELLTGQKP------------ISSIWANEGRNLTTYFVECIEEN 297
+++ D++S G + E++ G I I E + +
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 298 CLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEV 340
F + + +S + D+ + L R T K+
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 1e-44
Identities = 54/289 (18%), Positives = 107/289 (37%), Gaps = 22/289 (7%)
Query: 71 TDYFNMNRILGQGGQGTVYKGM-LADGRIIAVKK-SKVVDESKLEEFINEVVILSQINHR 128
+ +G+G G V + +A+KK S ++ + + E+ IL + H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 129 NVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLH 188
N++ + + + ++ + L+ + L+ + ++ L Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 189 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVS--TKVQGTFGYLDPEY 246
S + HRD+K +N+LL+ KI DFG +R D H T+ T Y PE
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 247 FRSSQFTDKS-DVYSFGVVLVELLTGQKP---------ISSIWANEGRNLTTYFVECIEE 296
+S+ KS D++S G +L E+L+ + ++ I G I
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 297 NCLFDIIDDQVRKSGEAEEIM-----AVSDVAKRCLNSYGRNRPTMKEV 340
++ + + D+ + L R +++
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-44
Identities = 62/307 (20%), Positives = 109/307 (35%), Gaps = 30/307 (9%)
Query: 69 KATDYFNMNRILGQGGQGTVYKG--MLADGRIIAVK--KSKVVDESKLEEFINEVVILSQ 124
+A + +G+G G V+K + GR +A+K + + +E I EV +L
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 125 I---NHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQ---YLHDPYEELSLTWEMRLRIAT 178
+ H NVV+L C + + Q D E + E +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 179 EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGT 238
++ L +LHS + HRD+K NIL+ + K+ADFG +R + T V T
Sbjct: 124 QLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVT 178
Query: 239 FGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP------ISSIWANEGRNLTTYFVE 292
Y PE S + D++S G + E+ + + + +
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 293 CIEENCLFDIIDDQVRKSGEAEEIMAVSDVAK----RCLNSYGRNRPTMKEVAM-----E 343
+ L + + + ++ K +CL R + +
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298
Query: 344 LERIRAN 350
LER + N
Sbjct: 299 LERCKEN 305
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 2e-44
Identities = 74/293 (25%), Positives = 117/293 (39%), Gaps = 39/293 (13%)
Query: 61 IFNSKELDKATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESK---LE 113
+F + +D DY++ LG G V K + G A K K + + E
Sbjct: 2 VFRQENVD---DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE 58
Query: 114 EFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMR 173
+ EV IL +I H NV+ L +L+ E + G LF + E+ SLT E
Sbjct: 59 DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDF---LAEKESLTEEEA 115
Query: 174 LRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE----KYRAKIADFGTSRSIAIDQT 229
++ + YLHS L I H D+K NI+L + K R KI DFG + I D
Sbjct: 116 TEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFG 170
Query: 230 HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTY 289
+ + GT ++ PE ++D++S GV+ LL+G P
Sbjct: 171 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP--------------- 215
Query: 290 FVECIEENCLFDIIDDQVRKSGEAEEIM--AVSDVAKRCLNSYGRNRPTMKEV 340
F+ ++ L ++ E D +R L + R T+++
Sbjct: 216 FLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 1e-43
Identities = 53/285 (18%), Positives = 107/285 (37%), Gaps = 22/285 (7%)
Query: 72 DYFNMNRILGQGGQGTVYKGM-LADGRIIAVK--KSKVVDESKLEEFINEVVILSQINHR 128
+ F +G+G G VYK G ++A+K + E I E+ +L ++NH
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 129 NVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLH 188
N+VKLL LV+EF+ + + ++ + LA+ H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIP--LPLIKSYLFQLLQGLAFCH 119
Query: 189 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFR 248
S + HRD+K N+L++ + K+ADFG +R+ + + +V +
Sbjct: 120 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 249 SSQFTDKSDVYSFGVVLVELLTGQKP---------ISSIWANEGRNLTTYFVECIEENCL 299
++ D++S G + E++T + + I+ G +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 300 FDIIDDQVRKSGEAEEIMAVSDVAK----RCLNSYGRNRPTMKEV 340
R+ ++ + + + + + L+ R + K
Sbjct: 237 KPSFPKWARQD-FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 1e-43
Identities = 61/281 (21%), Positives = 103/281 (36%), Gaps = 25/281 (8%)
Query: 78 RILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEE-----FINEVVILSQINHRNVV 131
LG+G TVYK +I+A+KK K+ S+ ++ + E+ +L +++H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 132 KLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSA 191
LL LV++F+ L LT + L YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 192 YLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQ 251
I HRD+K N+LLDE K+ADFG ++S + +V T Y PE ++
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGAR 176
Query: 252 FTD-KSDVYSFGVVLVELLTGQKP---------ISSIWANEGRNLTTYFVECIEENCLFD 301
D+++ G +L ELL ++ I+ G + +
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 302 IIDDQVRKSGEAEEIM--AVSDVAKRCLNSYGRNRPTMKEV 340
+ D+ + R T +
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 2e-43
Identities = 66/287 (22%), Positives = 106/287 (36%), Gaps = 28/287 (9%)
Query: 74 FNMNRILGQGGQGTVYKGMLAD-GRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVK 132
+ +++G G G VY+ L D G ++A+KK E+ I+ +++H N+V+
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77
Query: 133 LLGCCLEVEVP------LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAY 186
L LV +++P H + +L ++ +LAY
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 187 LHSSAYLPIYHRDIKSTNILLDEK-YRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPE 245
+HS I HRDIK N+LLD K+ DFG+++ + + +VS + +
Sbjct: 138 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAPEL 193
Query: 246 YFRSSQFTDKSDVYSFGVVLVELLTGQKP------------ISSIWANEGRNLTTYFVEC 293
F ++ +T DV+S G VL ELL GQ I + R
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253
Query: 294 IEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEV 340
E I K + R L R T E
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (375), Expect = 8e-43
Identities = 51/287 (17%), Positives = 99/287 (34%), Gaps = 28/287 (9%)
Query: 72 DYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNV 130
+ + + R +G G G +Y G +A G +A+K V ++K + E I +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVG 64
Query: 131 VKLLG-CCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS 189
+ + C E + ++V E + + + + + L +A ++ + Y+HS
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIHS 121
Query: 190 SAYLPIYHRDIKSTNIL---LDEKYRAKIADFGTSRSIAIDQTHV------STKVQGTFG 240
HRD+K N L + I DFG ++ +TH + + GT
Sbjct: 122 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 241 YLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLF 300
Y + + + D+ S G VL+ G P + A + E+
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA---TKRQKYERISEKKMST 235
Query: 301 DIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347
I E + C + ++P + +
Sbjct: 236 PIEVLCKGYPSEFATYL------NFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 3e-42
Identities = 68/278 (24%), Positives = 123/278 (44%), Gaps = 42/278 (15%)
Query: 74 FNMNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLE---EFINEVVILSQIN 126
+ + +LG GG G+VY G+ ++D +A+K K ++ D +L EVV+L +++
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 127 --HRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEAL 184
V++LL + +L+ E E +L E+ +V EA+
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLEAV 123
Query: 185 AYLHSSAYLPIYHRDIKSTNILLD-EKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLD 243
+ H+ + HRDIK NIL+D + K+ DFG+ + + V T GT Y
Sbjct: 124 RHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGA---LLKDTVYTDFDGTRVYSP 177
Query: 244 PEYFRSSQFTDKS-DVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDI 302
PE+ R ++ +S V+S G++L +++ G P +E +
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH-----------------DEEIIRGQ 220
Query: 303 IDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEV 340
+ + R S E + ++ + CL +RPT +E+
Sbjct: 221 VFFRQRVSSECQHLI------RWCLALRPSDRPTFEEI 252
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 8e-42
Identities = 51/284 (17%), Positives = 107/284 (37%), Gaps = 24/284 (8%)
Query: 74 FNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKV--VDESKLEEFINEVVILSQINHRNV 130
+ +G+G GTV+K I+A+K+ ++ DE + E+ +L ++ H+N+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 131 VKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSS 190
V+L + LV+EF + + E+ ++ + L + H
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL---DPEIVKSFLFQLLKGLGFCH-- 118
Query: 191 AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSS 250
+ HRD+K N+L++ K+A+FG +R+ I S +V + F +
Sbjct: 119 -SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 251 QFTDKSDVYSFGVVLVELLTGQKP----------ISSIWANEGRNLTTYFVECIEENCLF 300
++ D++S G + EL +P + I+ G T + + +
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG-TPTEEQWPSMTKLPDY 236
Query: 301 DIIDDQVRKSGEAEEIMAVSDVAK----RCLNSYGRNRPTMKEV 340
+ + ++ + L R + +E
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 1e-41
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 11/207 (5%)
Query: 72 DYFNMNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINEVVILSQINH 127
+ F+ ++LG+G G V A GR A+K K ++ + ++ + E +L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 128 RNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYL 187
+ L + V E+ G LF +L T E E+ AL YL
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYL 121
Query: 188 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYF 247
HS + +RDIK N++LD+ KI DFG + D + T GT YL PE
Sbjct: 122 HS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVL 177
Query: 248 RSSQFTDKSDVYSFGVVLVELLTGQKP 274
+ + D + GVV+ E++ G+ P
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 141 bits (356), Expect = 2e-39
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 18/216 (8%)
Query: 63 NSKELDKATDYFNMNRILGQGGQGTVYKGM-LADGRIIAVK---KSKVVDESKLEEFINE 118
N+ +LD+ F+ + LG G G V G A+K K KVV ++E +NE
Sbjct: 36 NTAQLDQ----FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 119 VVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIAT 178
IL +N +VKL + +V E++ G +F +L + A
Sbjct: 92 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAA 148
Query: 179 EVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGT 238
++ YLHS L + +RD+K N+L+D++ ++ DFG ++ + + GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWTLCGT 201
Query: 239 FGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
L PE S + D ++ GV++ E+ G P
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 5e-39
Identities = 61/297 (20%), Positives = 110/297 (37%), Gaps = 36/297 (12%)
Query: 74 FNMNRILGQGGQGTVYKGM-LADGRIIAVKK--SKVVDESKLEEFINEVVILSQINHRNV 130
+ +GQG G V+K G+ +A+KK + E + E+ IL + H NV
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 131 VKLLGCCLEVEVP--------LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAE 182
V L+ C P LV++F + + + T R+ +
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLN 128
Query: 183 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT---HVSTKVQGTF 239
L Y+H + I HRD+K+ N+L+ K+ADFG +R+ ++ + + T T
Sbjct: 129 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185
Query: 240 GYLDPEYFRSSQ-FTDKSDVYSFGVVLVELLTGQKP---------ISSIWANEGRNLTTY 289
Y PE + + D++ G ++ E+ T ++ I G
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245
Query: 290 F--VECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAK----RCLNSYGRNRPTMKEV 340
+ V+ E +++ Q RK + + A + L R +
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 8e-38
Identities = 55/301 (18%), Positives = 106/301 (35%), Gaps = 28/301 (9%)
Query: 62 FNSKELDKAT----DYFNMNRILGQGGQGTVYKGM-LADGRIIAVK--KSKVVDESKLEE 114
F +E+ K + + +G G G V + G +A+K E +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 115 FINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPY-EELSLTWEMR 173
E+ +L + H NV+ LL E +F + L +
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 174 LRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVST 233
+ ++ + L Y+H+ I HRD+K N+ ++E KI DFG +R + ++
Sbjct: 124 QFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTG 177
Query: 234 KVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP--------ISSIWANEGRN 285
V + ++T D++S G ++ E++TG+
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237
Query: 286 LTTYFVECIEENCLFDIIDD--QVRKSGEAEEIMAVSDVAK----RCLNSYGRNRPTMKE 339
FV+ ++ + + + ++ K A + S +A + L R T E
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 297
Query: 340 V 340
Sbjct: 298 A 298
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 130 bits (327), Expect = 1e-35
Identities = 59/298 (19%), Positives = 116/298 (38%), Gaps = 45/298 (15%)
Query: 72 DYFNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQIN-HRN 129
D + + R LG+G V++ + + + + VK ++ K ++ E+ IL + N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVK---ILKPVKKKKIKREIKILENLRGGPN 91
Query: 130 VVKLLGCCLEV--EVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYL 187
++ L + P LV+E + N Q +LT E+ +AL Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYC 145
Query: 188 HSSAYLPIYHRDIKSTNILLDEK-YRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEY 246
HS + I HRD+K N+++D + + ++ D+G + Q + + + PE
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPEL 200
Query: 247 FRSSQFTD-KSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIID- 304
Q D D++S G +L ++ ++P ++ + + + L+D ID
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFF--HGHDNYDQLVRIAKVLGTEDLYDYIDK 258
Query: 305 ------------------DQVRKSGEAEEIMAVSDVAK----RCLNSYGRNRPTMKEV 340
+ + +E VS A + L ++R T +E
Sbjct: 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 129 bits (325), Expect = 2e-35
Identities = 46/297 (15%), Positives = 97/297 (32%), Gaps = 32/297 (10%)
Query: 74 FNMNRILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVK 132
+ + R +G+G G +++G L + + +A+K S + +E + +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTGIP 64
Query: 133 LLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAY 192
+ + + ++ + +L L + S + A ++ + +H
Sbjct: 65 NVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFS--VKTVAMAAKQMLARVQSIHEK-- 120
Query: 193 LPIYHRDIKSTNILLDEKYR-----AKIADFGTSRSIAIDQTHV------STKVQGTFGY 241
+ +RDIK N L+ + DFG + T + GT Y
Sbjct: 121 -SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179
Query: 242 LDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFD 301
+ + + + D+ + G V + L G P + A + E I E
Sbjct: 180 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK----YERIGEKKQST 235
Query: 302 IIDDQVRK-SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI--RANSRDDE 355
+ + E + M N P + ++ R N+ +DE
Sbjct: 236 PLRELCAGFPEEFYKYM------HYARNLAFDATPDYDYLQGLFSKVLERLNTTEDE 286
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 3e-35
Identities = 62/214 (28%), Positives = 92/214 (42%), Gaps = 17/214 (7%)
Query: 72 DYFNMNRILGQGGQGTVYKGMLA----DGRIIAVK---KSKVVDESK-LEEFINEVVILS 123
+ F + ++LG G G V+ G++ A+K K+ +V ++K E E +L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 124 QINHR-NVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAE 182
I +V L L+ ++I G LF +L T E+
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVL 140
Query: 183 ALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYL 242
AL +LH L I +RDIK NILLD + DFG S+ D+T + GT Y+
Sbjct: 141 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197
Query: 243 DPEYFRSSQ--FTDKSDVYSFGVVLVELLTGQKP 274
P+ R D +S GV++ ELLTG P
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 3e-33
Identities = 58/305 (19%), Positives = 104/305 (34%), Gaps = 36/305 (11%)
Query: 62 FNSKELDKA----TDYFNMNRILGQGGQGTVYKGM-LADGRIIAVK--KSKVVDESKLEE 114
F +EL+K + + +G G G+V G +AVK +
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 115 FINEVVILSQINHRNVVKLLGCCLEVE-----VPLLVYEFIPNGTLFQYLHDPYEELSLT 169
E+ +L + H NV+ LL + + + L + LT
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----LT 119
Query: 170 WEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229
+ + ++ L Y+HS+ HRD+K +N+ ++E KI DFG +R
Sbjct: 120 DDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHT---DD 173
Query: 230 HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP---------ISSIWA 280
++ V + + D++S G ++ ELLTG+ + I
Sbjct: 174 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 233
Query: 281 NEGRNLTTYFVECIEENCLFDIID-DQVRKSGEAEEIMAVSDVAK----RCLNSYGRNRP 335
G + E+ I Q+ K A + + +A + L R
Sbjct: 234 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 293
Query: 336 TMKEV 340
T +
Sbjct: 294 TAAQA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 5e-33
Identities = 45/206 (21%), Positives = 86/206 (41%), Gaps = 20/206 (9%)
Query: 78 RILGQGGQGTVYKGM-LADGRIIAVKK--SKVVDESKLEEFINEVVILSQINHRNVVKLL 134
+ +G G QG V R +A+KK +++ + E+V++ +NH+N++ LL
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 135 GCCL------EVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLH 188
E + LV E + + E + ++ + +LH
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLCGIKHLH 136
Query: 189 SSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFR 248
S+ HRD+K +NI++ KI DFG +R+ + + T T Y PE
Sbjct: 137 SAGI---IHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVIL 191
Query: 249 SSQFTDKSDVYSFGVVLVELLTGQKP 274
+ + D++S G ++ E++ +
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 113 bits (284), Expect = 4e-29
Identities = 48/217 (22%), Positives = 83/217 (38%), Gaps = 27/217 (12%)
Query: 78 RILGQGGQGTVYKGM-LADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGC 136
R LG G TV+ + + +A+K + D+ E +E+ +L ++N + K
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 137 CLEVEVPLLVY-------------EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEA 183
+ LL + F G L YE + +I+ ++
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 184 LAYLHSSAYLPIYHRDIKSTNILLDEK------YRAKIADFGTSRSIAIDQTHVSTKVQG 237
L Y+H I H DIK N+L++ + KIAD G + T+
Sbjct: 138 LDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS----IQ 191
Query: 238 TFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKP 274
T Y PE + + +D++S ++ EL+TG
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 82.9 bits (204), Expect = 2e-19
Identities = 27/157 (17%), Positives = 50/157 (31%), Gaps = 20/157 (12%)
Query: 78 RILGQGGQGTVYKGMLADGRIIAVK----------KSKVVDESKLEEFINEVVILSQINH 127
+++G+G + V+ VK K K + F + ++
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 128 RNVVKLLGCCLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYL 187
R + KL G + Y + N L + + + + E +A
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKF 119
Query: 188 HSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 224
+ I H D+ N+L+ E I DF S +
Sbjct: 120 YHR---GIVHGDLSQYNVLVSE-EGIWIIDFPQSVEV 152
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 374 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.57 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.16 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.74 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.92 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.72 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.68 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-58 Score=401.86 Aligned_cols=257 Identities=27% Similarity=0.434 Sum_probs=204.7
Q ss_pred cCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeec
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIP 151 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 151 (374)
++|++.+.||+|+||+||+|.+.+++.||||++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC-cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 57889999999999999999998889999999876433 34679999999999999999999999999999999999999
Q ss_pred CCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCcee
Q 017262 152 NGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV 231 (374)
Q Consensus 152 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 231 (374)
+|+|.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++.........
T Consensus 84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 9999999875 3457899999999999999999999999 9999999999999999999999999998765544444
Q ss_pred eecccccccccCccccccCCCCccchhhhHHHHHHHHHhC-CCCCCccccccCCChHHHHHHHHHhccccccccccccCC
Q 017262 232 STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTG-QKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKS 310 (374)
Q Consensus 232 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (374)
.....||+.|+|||.+.+..++.++|||||||++|||+|+ ..||... +........ .. ..+..
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~------~~~~~~~~i-~~---------~~~~~ 222 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR------SNSEVVEDI-ST---------GFRLY 222 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC------CHHHHHHHH-HH---------TCCCC
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC------CHHHHHHHH-Hh---------cCCCC
Confidence 4456789999999999999999999999999999999995 5555432 222222221 11 11122
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 017262 311 GEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350 (374)
Q Consensus 311 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~ 350 (374)
.+...++.+.+|+.+||+.||++|||++++++.|+++..+
T Consensus 223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 2333456789999999999999999999999999999764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-57 Score=398.64 Aligned_cols=260 Identities=25% Similarity=0.410 Sum_probs=214.3
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
..++|++.+.||+|+||+||+|.+++++.||||++.... ...+.+.+|+.++++++||||+++++++.+ +..++||||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 356788999999999999999999888999999987643 334679999999999999999999998754 567999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+++|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 89 ~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 89 MENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp CTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcc
Confidence 9999999988643 3346899999999999999999999999 99999999999999999999999999988765544
Q ss_pred eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccC
Q 017262 230 HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (374)
.......||+.|+|||.+.+..++.++|||||||++|||+||..|+.... ...+.. ..+.. ..+.
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~-----~~~~~~-~~i~~---------~~~~ 229 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-----TNPEVI-QNLER---------GYRM 229 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHHHHH-HHHHT---------TCCC
T ss_pred ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC-----CHHHHH-HHHHh---------cCCC
Confidence 44555678999999999999999999999999999999999655543211 111211 11111 1222
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 017262 310 SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350 (374)
Q Consensus 310 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~ 350 (374)
..+...+..+.+|+.+||+.||++|||++++++.|+.+...
T Consensus 230 ~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 23344556899999999999999999999999999987643
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-56 Score=392.89 Aligned_cols=263 Identities=29% Similarity=0.439 Sum_probs=209.5
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 148 (374)
.++|++.+.||+|+||+||+|+.++ .||||+++.. +....+.+.+|+.++++++||||+++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 5679999999999999999998653 5999987643 45567789999999999999999999998754 56899999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
|+++|+|.+++.. ....+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 84 y~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999975 3456999999999999999999999998 9999999999999999999999999998765332
Q ss_pred -ceeeecccccccccCcccccc---CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccc
Q 017262 229 -THVSTKVQGTFGYLDPEYFRS---SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIID 304 (374)
Q Consensus 229 -~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (374)
........||+.|+|||++.+ ..++.++|||||||++|||+||+.||...... ..+......+.....
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~------~~~~~~~~~~~~~p~-- 230 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR------DQIIFMVGRGYLSPD-- 230 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHHTSCCCC--
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH------HHHHHHHhcCCCCCc--
Confidence 223345679999999999864 35789999999999999999999999753321 112222222211111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCC
Q 017262 305 DQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSR 352 (374)
Q Consensus 305 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~ 352 (374)
....+...++.+.+|+.+||+.||++|||+.++++.|+.++.+.|
T Consensus 231 ---~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 231 ---LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp ---GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ---chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 111233445689999999999999999999999999999988655
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-57 Score=394.81 Aligned_cols=251 Identities=26% Similarity=0.396 Sum_probs=204.4
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
++|++.+.||+|+||+||+|..+ +|+.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..|+||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57899999999999999999975 68999999886543 23345688999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+++|+|.+++. ....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 85 ~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 99999999997 4567999999999999999999999999 99999999999999999999999999987654332
Q ss_pred -eeeecccccccccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccc
Q 017262 230 -HVSTKVQGTFGYLDPEYFRSSQF-TDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307 (374)
Q Consensus 230 -~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (374)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....... ..+....... .
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~-----~~~~~~~~~~---------~ 224 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-----QEYSDWKEKK---------T 224 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS-----HHHHHHHTTC---------T
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH-----HHHHHHhcCC---------C
Confidence 23345679999999999988776 568999999999999999999997543221 1111111111 1
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
........+..+.+|+.+||+.||++|||++|+++
T Consensus 225 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 225 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11112233567889999999999999999999864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.9e-57 Score=400.77 Aligned_cols=258 Identities=25% Similarity=0.441 Sum_probs=204.7
Q ss_pred cCCCcCceEeeeCeEEEEEEEecC-C---cEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLAD-G---RIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
++|++.+.||+|+||+||+|.++. + ..||+|.+... .....+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 567888999999999999999753 2 36888887653 455567899999999999999999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
||||++|+|.+++.. ....+++.+++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++....
T Consensus 106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999998875 3457999999999999999999999999 99999999999999999999999999987653
Q ss_pred CCcee----eecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccc
Q 017262 227 DQTHV----STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFD 301 (374)
Q Consensus 227 ~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (374)
..... .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... +... .+.
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~------~~~~-~i~------ 247 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ------DVIN-AIE------ 247 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHH-HHH------
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH------HHHH-HHH------
Confidence 32221 122457899999999999999999999999999999998 89999754322 1111 111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 017262 302 IIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350 (374)
Q Consensus 302 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~ 350 (374)
...+...+...+..+.+|+.+||+.||++|||+.++++.|+++.++
T Consensus 248 ---~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 248 ---QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp ---TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 1222334445667899999999999999999999999999998774
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-56 Score=391.50 Aligned_cols=254 Identities=26% Similarity=0.422 Sum_probs=216.6
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEee
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFI 150 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 150 (374)
.++|++.+.||+|+||+||+|++++++.||||.++.... ..+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 367899999999999999999998888999999876543 3468999999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 230 (374)
++|+|..++.. ....+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++........
T Consensus 82 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 82 ANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp TTEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 99999999765 3557899999999999999999999999 999999999999999999999999999876655444
Q ss_pred eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccccccC
Q 017262 231 VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309 (374)
Q Consensus 231 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (374)
......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......+ .. ..+.. ..+.
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~------~~-~~i~~---------~~~~ 220 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TA-EHIAQ---------GLRL 220 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH------HH-HHHHT---------TCCC
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH------HH-HHHHh---------CCCC
Confidence 4455678999999999999999999999999999999998 899997544322 11 12221 1222
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 017262 310 SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELER 346 (374)
Q Consensus 310 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~ 346 (374)
..+...+..+.+||.+||+.||++|||++++++.|..
T Consensus 221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 3334455689999999999999999999999998854
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-57 Score=402.36 Aligned_cols=261 Identities=28% Similarity=0.431 Sum_probs=218.7
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEE
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 148 (374)
..++|++.+.||+|+||+||+|.+. +++.||||+++... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 3567889999999999999999975 58899999987543 345679999999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
|+++|+|.+++... ....+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 94 ~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 94 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred cccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 99999999998643 3467999999999999999999999999 9999999999999999999999999998776555
Q ss_pred ceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccccc
Q 017262 229 THVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVR 308 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (374)
........|++.|+|||.+.+..++.++|||||||++|||++|..||.... +... ..+.. ....+
T Consensus 170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~-----~~~~-~~~~i---------~~~~~ 234 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQ-VYELL---------EKDYR 234 (287)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC-----CHHH-HHHHH---------HTTCC
T ss_pred ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc-----hHHH-HHHHH---------hcCCC
Confidence 555555668999999999999999999999999999999999777654221 1111 11111 22223
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 017262 309 KSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350 (374)
Q Consensus 309 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~ 350 (374)
...+...+..+.+|+.+||+.||++|||+.++++.|+.+.++
T Consensus 235 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 334445567899999999999999999999999999988654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-55 Score=391.72 Aligned_cols=249 Identities=26% Similarity=0.408 Sum_probs=209.8
Q ss_pred cCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEee
Q 017262 72 DYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFI 150 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 150 (374)
++|++.+.||+|+||+||+|.. .+|+.||+|++........+.+.+|+.++++++||||+++++++.+.+..|+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 5799999999999999999996 468999999987655555678999999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 230 (374)
++|+|.+++. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 100 ~gg~L~~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~ 171 (293)
T d1yhwa1 100 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-S 171 (293)
T ss_dssp TTCBHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-C
T ss_pred CCCcHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc-c
Confidence 9999999875 346999999999999999999999999 9999999999999999999999999998765332 2
Q ss_pred eeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCC
Q 017262 231 VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKS 310 (374)
Q Consensus 231 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (374)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ............. ...
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~~~~~~~~--------~~~ 237 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNGTP--------ELQ 237 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHHCSC--------CCS
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH------HHHHHHHHhCCCC--------CCC
Confidence 33455799999999999999999999999999999999999999964322 1222222222111 112
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 311 GEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 311 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.+...+..+.+||.+||+.||++|||+.|+++
T Consensus 238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22344568899999999999999999999874
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-56 Score=392.33 Aligned_cols=261 Identities=26% Similarity=0.409 Sum_probs=214.3
Q ss_pred cCCCcCce-EeeeCeEEEEEEEec---CCcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEE
Q 017262 72 DYFNMNRI-LGQGGQGTVYKGMLA---DGRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 72 ~~~~~~~~-lg~G~~g~v~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 146 (374)
++|.+.+. ||+|+||+||+|.++ ++..||||.++.. .....+.+.+|+++|++++||||+++++++.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45666664 999999999999864 3457999998654 45556789999999999999999999999864 568999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
|||+++|+|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999999864 3457999999999999999999999999 99999999999999999999999999987654
Q ss_pred CCcee--eecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccc
Q 017262 227 DQTHV--STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDII 303 (374)
Q Consensus 227 ~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (374)
..... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||...... +.. ..+..
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~------~~~-~~i~~------- 227 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP------EVM-AFIEQ------- 227 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH------HHH-HHHHT-------
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH------HHH-HHHHc-------
Confidence 43322 233458899999999999999999999999999999998 99999754322 111 12222
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCCC
Q 017262 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDD 354 (374)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~~ 354 (374)
..+...+...+..+.+|+.+||+.||++|||+.++.+.|+.+..+..+.
T Consensus 228 --~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~ 276 (285)
T d1u59a_ 228 --GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276 (285)
T ss_dssp --TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred --CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhc
Confidence 2222344456678999999999999999999999999999887655443
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-56 Score=390.01 Aligned_cols=245 Identities=29% Similarity=0.400 Sum_probs=206.5
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
++|++.+.||+|+||+||+|..+ +++.||+|.+... +......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46899999999999999999975 5889999987642 2233567889999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
|||++|+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 86 Ey~~~g~L~~~l~---~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999999997 4557999999999999999999999999 999999999999999999999999999765432
Q ss_pred CceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (374)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ....+... ....
T Consensus 160 ---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~------~~~~~~~i-~~~~--------- 220 (263)
T d2j4za1 160 ---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT------YQETYKRI-SRVE--------- 220 (263)
T ss_dssp ---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHH-HTTC---------
T ss_pred ---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC------HHHHHHHH-HcCC---------
Confidence 2344579999999999999999999999999999999999999996432 22222211 1111
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
...+...++.+.+|+.+||+.||++|||++|+++
T Consensus 221 -~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 221 -FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1123334568899999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-56 Score=393.63 Aligned_cols=251 Identities=26% Similarity=0.362 Sum_probs=208.6
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEee
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFI 150 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 150 (374)
+.|++.+.||+|+||+||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 56899999999999999999975 58899999988766677788999999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 230 (374)
++|+|.+++.+ ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|....... .
T Consensus 92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~ 165 (288)
T d2jfla1 92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q 165 (288)
T ss_dssp TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-H
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc-c
Confidence 99999998764 3457999999999999999999999999 9999999999999999999999999997653221 1
Q ss_pred eeecccccccccCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccc
Q 017262 231 VSTKVQGTFGYLDPEYFR-----SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDD 305 (374)
Q Consensus 231 ~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (374)
......||+.|+|||++. +..|+.++|||||||++|+|++|+.||......+ .+....... .
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~------~~~~i~~~~-~------ 232 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR------VLLKIAKSE-P------ 232 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG------HHHHHHHSC-C------
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH------HHHHHHcCC-C------
Confidence 223456999999999984 4568899999999999999999999997543222 122211111 1
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 306 QVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.....+...+..+.+||.+||+.||++|||++|+++
T Consensus 233 -~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 233 -PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111223345568999999999999999999999875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-56 Score=391.45 Aligned_cols=254 Identities=25% Similarity=0.377 Sum_probs=196.7
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeee--cccceEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLE--VEVPLLV 146 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv 146 (374)
++|++.+.||+|+||+||+|+.+ +|+.||+|.+... +....+.+.+|+.++++++||||+++++++.+ .+..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999964 6899999987654 34556778999999999999999999999865 3467899
Q ss_pred EEeecCCcccccccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCC--CCEEEeccCCCceEECCCCcEEEeecccccc
Q 017262 147 YEFIPNGTLFQYLHDPY-EELSLTWEMRLRIATEVAEALAYLHSSAY--LPIYHRDIKSTNILLDEKYRAKIADFGTSRS 223 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 223 (374)
||||++|+|.+++.... ....+++..++.++.|++.||.|||+.+. .+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999986421 34579999999999999999999998651 2499999999999999999999999999987
Q ss_pred cccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccc
Q 017262 224 IAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDII 303 (374)
Q Consensus 224 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (374)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.... +......
T Consensus 164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~------~~~~~~-i~~~~~~--- 232 (269)
T d2java1 164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ------KELAGK-IREGKFR--- 232 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHH-HHHTCCC---
T ss_pred cccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH------HHHHHH-HHcCCCC---
Confidence 65322 223456799999999999999999999999999999999999999964322 222222 2222111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..+...++.+.+|+.+||+.||++|||+.|+++
T Consensus 233 ------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 233 ------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 122334567899999999999999999999874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-55 Score=385.96 Aligned_cols=249 Identities=29% Similarity=0.436 Sum_probs=203.9
Q ss_pred ceEeeeCeEEEEEEEecC---CcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEeecC
Q 017262 78 RILGQGGQGTVYKGMLAD---GRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFIPN 152 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~---~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 152 (374)
+.||+|+||+||+|.+++ ++.||+|+++.. +....+.+.+|+.++++++||||++++++|.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 479999999999998643 468999988643 34445789999999999999999999999864 567899999999
Q ss_pred CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCcee-
Q 017262 153 GTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTHV- 231 (374)
Q Consensus 153 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~- 231 (374)
|+|.+++. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.........
T Consensus 92 g~L~~~l~---~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHh---hccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 99999987 4567999999999999999999999999 9999999999999999999999999998765443332
Q ss_pred -eecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccccccC
Q 017262 232 -STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309 (374)
Q Consensus 232 -~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (374)
.....||+.|+|||.+.+..++.++|||||||++|||++ |+.||...... + +...+.. ..+.
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~------~-~~~~i~~---------~~~~ 229 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------E-VTAMLEK---------GERM 229 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------H-HHHHHHT---------TCCC
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH------H-HHHHHHc---------CCCC
Confidence 233568999999999999999999999999999999998 89999754322 1 1112221 2223
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 017262 310 SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRA 349 (374)
Q Consensus 310 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~ 349 (374)
..+...+..+.+|+.+||+.||++|||+.++.+.|+....
T Consensus 230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 3344556789999999999999999999999999988754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-55 Score=386.10 Aligned_cols=259 Identities=24% Similarity=0.407 Sum_probs=205.8
Q ss_pred cCCCcCceEeeeCeEEEEEEEecCC-----cEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLADG-----RIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLL 145 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 145 (374)
+.|+..++||+|+||+||+|.++++ ..||||++... .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4678889999999999999996542 37999988653 34455678999999999999999999999999999999
Q ss_pred EEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccc
Q 017262 146 VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 225 (374)
||||+.++++.+++.. ....+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 87 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999999988764 3457999999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCc--eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccc
Q 017262 226 IDQT--HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDII 303 (374)
Q Consensus 226 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (374)
.... .......||+.|+|||.+.+..++.++|||||||++|||++|..|+.... ...+.+. . +
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~-----~~~~~~~-~---------i 226 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-----SNHEVMK-A---------I 226 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHH-H---------H
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC-----CHHHHHH-H---------H
Confidence 3322 22234568999999999999999999999999999999999666654211 1111111 1 2
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 017262 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350 (374)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~ 350 (374)
....+...+...+..+.+|+.+||+.||++|||+.++++.|+.+.+.
T Consensus 227 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp HTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred hccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 22233344445667899999999999999999999999999998763
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-55 Score=394.39 Aligned_cols=259 Identities=27% Similarity=0.440 Sum_probs=209.6
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEecC-C-----cEEEEEEeccC-ChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecc
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLAD-G-----RIIAVKKSKVV-DESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVE 141 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 141 (374)
..++|++.+.||+|+||+||+|+... + ..||+|.+... .......+.+|+.++.++ +||||+++++++.+.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 34678999999999999999998643 2 36889987543 344456788999999998 8999999999999999
Q ss_pred cceEEEEeecCCcccccccCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccC
Q 017262 142 VPLLVYEFIPNGTLFQYLHDPYE--------------------ELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIK 201 (374)
Q Consensus 142 ~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk 201 (374)
..++|||||++|+|.+++..... ...+++..++.++.|++.||+|||+++ |+|||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCc
Confidence 99999999999999999975321 235899999999999999999999999 9999999
Q ss_pred CCceEECCCCcEEEeecccccccccCCce-eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccc
Q 017262 202 STNILLDEKYRAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIW 279 (374)
Q Consensus 202 ~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~ 279 (374)
|+|||++.++.+||+|||+|+........ ......||+.|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999876543332 3345668999999999999999999999999999999998 899997543
Q ss_pred cccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 017262 280 ANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELER 346 (374)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~ 346 (374)
... .+..... ...+.+.+...++.+.+||.+||+.||++|||+++|++.|..
T Consensus 272 ~~~------~~~~~~~---------~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 272 VDA------NFYKLIQ---------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CSH------HHHHHHH---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHH------HHHHHHh---------cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 221 1112222 222333444556789999999999999999999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-54 Score=377.38 Aligned_cols=247 Identities=24% Similarity=0.398 Sum_probs=198.4
Q ss_pred CCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeee----cccceEE
Q 017262 74 FNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLE----VEVPLLV 146 (374)
Q Consensus 74 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv 146 (374)
|+..+.||+|+||+||+|.+. ++..||+|.+... .....+.+.+|++++++++||||+++++++.+ ....++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 466778999999999999975 5789999987643 45556788999999999999999999999875 3457899
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEEC-CCCcEEEeecccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD-EKYRAKIADFGTSRSIA 225 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~~~~~~ 225 (374)
|||+++|+|.+++. ....+++..+..++.||+.||+|||+++ .+|+||||||+|||++ +++.+||+|||+++...
T Consensus 91 mE~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHh---ccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 99999999999997 4567999999999999999999999987 4599999999999996 57899999999997643
Q ss_pred cCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccc
Q 017262 226 IDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDD 305 (374)
Q Consensus 226 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (374)
.. ......||+.|+|||++.+ .++.++|||||||++|||++|+.||.... +...... ....+....
T Consensus 167 ~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~-----~~~~~~~-~i~~~~~~~---- 232 (270)
T d1t4ha_ 167 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-----NAAQIYR-RVTSGVKPA---- 232 (270)
T ss_dssp TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-----SHHHHHH-HHTTTCCCG----
T ss_pred CC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc-----cHHHHHH-HHHcCCCCc----
Confidence 22 2345579999999999875 59999999999999999999999996432 2222111 111111111
Q ss_pred cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 306 QVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 306 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..+...++.+.+|+.+||+.||++|||++|+++
T Consensus 233 ----~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 ----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 111122346889999999999999999999975
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-55 Score=388.68 Aligned_cols=261 Identities=26% Similarity=0.374 Sum_probs=208.5
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEee
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFI 150 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 150 (374)
.++|++.+.||+|+||+||+|.+++++.||||+++.... ..+.+.+|+.++++++||||+++++++.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 357899999999999999999998888999999875433 34679999999999999999999999854 5689999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 230 (374)
++|+|..++... ....+++.+++.++.||+.||+|||+++ |+||||||+|||+++++++||+|||+++........
T Consensus 94 ~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 94 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 999999888643 2446999999999999999999999999 999999999999999999999999999876544444
Q ss_pred eeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccccCC
Q 017262 231 VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRKS 310 (374)
Q Consensus 231 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (374)
......||+.|+|||.+.+..++.++||||||+++|||++|..|+.... ...+.... +. ...+..
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~-----~~~~~~~~-i~---------~~~~~~ 234 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-----VNREVLDQ-VE---------RGYRMP 234 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHHHHHHH-HH---------TTCCCC
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC-----CHHHHHHH-HH---------hcCCCC
Confidence 4455679999999999999999999999999999999999766654221 22222221 11 112223
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCC
Q 017262 311 GEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSR 352 (374)
Q Consensus 311 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~ 352 (374)
.+...+..+.+||.+||+.||++|||+++|++.|+....+..
T Consensus 235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 344556789999999999999999999999999998776554
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-55 Score=385.41 Aligned_cols=249 Identities=25% Similarity=0.337 Sum_probs=205.5
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
++|++.+.||+|+||+||+|... +|+.||+|.+... .......+.+|++++++++||||+++++++.+.+..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56999999999999999999974 6899999987642 2334567899999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
||+++|+|.+++. ..+.+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 88 Ey~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999887 4568999999999999999999999999 999999999999999999999999999876533
Q ss_pred C-ceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 228 Q-THVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 228 ~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
. ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ....+.... ...
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~~~~~~~i~-~~~-------- 226 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN------EYLIFQKII-KLE-------- 226 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHH-TTC--------
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC------HHHHHHHHH-cCC--------
Confidence 2 223345679999999999999999999999999999999999999997432 222222111 111
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017262 307 VRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAME 343 (374)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~ 343 (374)
...+...++.+.+||.+||+.||++|||++|++..
T Consensus 227 --~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 227 --YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp --CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred --CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 11223345678999999999999999999997653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.1e-54 Score=391.71 Aligned_cols=251 Identities=22% Similarity=0.298 Sum_probs=210.4
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEee
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFI 150 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 150 (374)
++|++.+.||+|+||.||+|... +|+.||+|++........+.+.+|+.+|++++||||+++++++.+.+..|+|||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999964 68999999998777777788999999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEEC--CCCcEEEeecccccccccCC
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD--EKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~--~~~~~kl~Dfg~~~~~~~~~ 228 (374)
++|+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++.......
T Consensus 106 ~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 106 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999999864 3457999999999999999999999999 99999999999996 46789999999998765332
Q ss_pred ceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccccc
Q 017262 229 THVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVR 308 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (374)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ..+.+....... . ...
T Consensus 181 --~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~------~~~~~~~i~~~~-~------~~~ 245 (350)
T d1koaa2 181 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN------DDETLRNVKSCD-W------NMD 245 (350)
T ss_dssp --CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTC-C------CSC
T ss_pred --ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC------HHHHHHHHHhCC-C------CCC
Confidence 2344579999999999999999999999999999999999999996432 222222222111 0 001
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 309 KSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 309 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.......+..+.+||.+||+.||++|||++|+++
T Consensus 246 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 246 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111234457899999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-54 Score=382.22 Aligned_cols=258 Identities=27% Similarity=0.422 Sum_probs=202.3
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecC----CcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLAD----GRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLL 145 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 145 (374)
.++|++.+.||+|+||.||+|.+.. +..||+|.+... .......+.+|+.++++++||||+++++++. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 4678999999999999999998643 346888887653 3445677999999999999999999999986 467899
Q ss_pred EEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccc
Q 017262 146 VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 225 (374)
||||+++|+|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||++++++.+||+|||+++...
T Consensus 85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999998764 3557899999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhcccccccc
Q 017262 226 IDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIID 304 (374)
Q Consensus 226 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (374)
...........||+.|+|||.+.+..++.++|||||||++|||++ |..||......+ ... .+..+
T Consensus 160 ~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~------~~~-~i~~~------- 225 (273)
T d1mp8a_ 160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIG-RIENG------- 225 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG------HHH-HHHTT-------
T ss_pred CCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH------HHH-HHHcC-------
Confidence 544444455668999999999999999999999999999999998 899997544322 111 11111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 017262 305 DQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350 (374)
Q Consensus 305 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~ 350 (374)
.+...+...+..+.+||.+||+.||++|||+.++++.|+++...
T Consensus 226 --~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 226 --ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 12233445567899999999999999999999999999998764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.5e-55 Score=389.74 Aligned_cols=245 Identities=26% Similarity=0.382 Sum_probs=202.6
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC---hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
+.|+..+.||+|+||+||+|... +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45899999999999999999964 68899999886543 334567889999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
|||++|+|..++. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 95 E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp ECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred EecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 9999999987665 4567999999999999999999999999 999999999999999999999999999865432
Q ss_pred CceeeecccccccccCcccccc---CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRS---SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIID 304 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (374)
....||+.|+|||++.+ ..|+.++|||||||++|||++|..||..... ...+....... ..
T Consensus 169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~------~~~~~~i~~~~-~~---- 232 (309)
T d1u5ra_ 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNE-SP---- 232 (309)
T ss_dssp -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSC-CC----
T ss_pred -----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCC-CC----
Confidence 33469999999999864 4589999999999999999999999964322 11122211111 11
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 305 DQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 305 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
...+...++.+.+||.+||+.||++|||+.++++
T Consensus 233 ----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 233 ----ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ----CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1112234567899999999999999999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-55 Score=393.78 Aligned_cols=269 Identities=24% Similarity=0.379 Sum_probs=207.8
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 148 (374)
.++|++.+.||+|+||+||+|... +|+.||+|+++.. .......+.+|+.+|++++||||++++++|.+.+..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 567999999999999999999964 6899999988654 34445788999999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSS-AYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
|+++|+|.+++. ....+++..+..++.|++.||.|||++ + |+||||||+|||+++++.+||+|||+|......
T Consensus 85 y~~gg~L~~~l~---~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp CCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 999999999997 345799999999999999999999974 7 999999999999999999999999999865432
Q ss_pred CceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCC---------hHHHHHH------
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRN---------LTTYFVE------ 292 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~---------~~~~~~~------ 292 (374)
......||+.|+|||++.+..|+.++||||+||++|||++|+.||.......... .......
T Consensus 159 ---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 159 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp ---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred ---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 2234579999999999999999999999999999999999999997543221000 0000000
Q ss_pred -----HHHhcc---ccccc----cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHHHH
Q 017262 293 -----CIEENC---LFDII----DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM--ELERIR 348 (374)
Q Consensus 293 -----~~~~~~---~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~--~L~~~~ 348 (374)
...... ..... ............+..+.+|+.+||..||++|||++|+++ -+++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence 000000 00000 000000011123457889999999999999999999987 455443
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.6e-53 Score=387.33 Aligned_cols=252 Identities=22% Similarity=0.313 Sum_probs=211.4
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
.++|++.+.||+|+||.||+|... +|+.||+|.+..........+.+|+.+|++++||||+++++++.+.+..|+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 357999999999999999999964 6899999998877666677888999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEEC--CCCcEEEeecccccccccC
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD--EKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~--~~~~~kl~Dfg~~~~~~~~ 227 (374)
|++|+|.+++.. ....+++.+++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 108 ~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999888764 3457999999999999999999999999 99999999999998 6789999999999876543
Q ss_pred CceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (374)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ...+....... ...
T Consensus 183 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~-------~~~ 247 (352)
T d1koba_ 183 E--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD------LETLQNVKRCD-------WEF 247 (352)
T ss_dssp S--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHHCC-------CCC
T ss_pred C--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC-------CCC
Confidence 2 23445689999999999999999999999999999999999999974332 22222211111 111
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
........+..+.+||.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12222345568899999999999999999999976
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.4e-55 Score=388.61 Aligned_cols=252 Identities=24% Similarity=0.336 Sum_probs=192.8
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
..+.|++.+.||+|+||+||+|..+ +++.||+|.+.... ......+.+|+.++++++||||+++++++.+++..|+||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3567999999999999999999975 58899999886533 233456789999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEEC---CCCcEEEeeccccccc
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLD---EKYRAKIADFGTSRSI 224 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfg~~~~~ 224 (374)
|||++|+|.+++. ....+++..+..++.|++.||+|||+++ |+||||||+|||+. +++.+||+|||+++..
T Consensus 87 E~~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHH---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred eccCCCcHHHhhh---cccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 9999999999997 4567999999999999999999999999 99999999999995 5789999999999865
Q ss_pred ccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccc
Q 017262 225 AIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIID 304 (374)
Q Consensus 225 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (374)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ........... .
T Consensus 161 ~~~--~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~~~i~~~~-~----- 226 (307)
T d1a06a_ 161 DPG--SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND------AKLFEQILKAE-Y----- 226 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHTTC-C-----
T ss_pred cCC--CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHhccC-C-----
Confidence 432 223445799999999999999999999999999999999999999974322 11121111111 1
Q ss_pred ccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 305 DQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 305 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..........++.+.+|+.+||+.||++|||++|+++
T Consensus 227 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 227 -EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp -CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1111222345568899999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-54 Score=374.99 Aligned_cols=251 Identities=28% Similarity=0.467 Sum_probs=201.8
Q ss_pred cCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeee-cccceEEEEee
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLE-VEVPLLVYEFI 150 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~ 150 (374)
++|++.+.||+|+||.||+|..+ |..||||+++.. ...+.+.+|++++++++||||+++++++.+ .+..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 46788899999999999999985 778999998653 344678999999999999999999999865 45689999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 230 (374)
++|+|.+++... ....+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 84 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence 999999999642 2335899999999999999999999998 999999999999999999999999999764322
Q ss_pred eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccccccccC
Q 017262 231 VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQVRK 309 (374)
Q Consensus 231 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (374)
.....+++.|+|||.+.+..++.++||||||+++|||+| |+.||......+ ... . +....+.
T Consensus 157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~------~~~-~---------i~~~~~~ 219 (262)
T d1byga_ 157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVP-R---------VEKGYKM 219 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG------HHH-H---------HTTTCCC
T ss_pred -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH------HHH-H---------HHcCCCC
Confidence 223457889999999999999999999999999999998 788876543222 111 1 1122233
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 017262 310 SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRA 349 (374)
Q Consensus 310 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~ 349 (374)
+.+...++.+.+|+.+||+.||++|||+.++++.|++++.
T Consensus 220 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 220 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 4444556789999999999999999999999999999865
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-53 Score=377.65 Aligned_cols=251 Identities=27% Similarity=0.340 Sum_probs=205.8
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC------hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD------ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVP 143 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 143 (374)
.++|++.+.||+|+||+||+|..+ +|+.||+|++.... ....+.+.+|+.+|++++||||+++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 468999999999999999999974 68999999875421 22357889999999999999999999999999999
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCC----cEEEeecc
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY----RAKIADFG 219 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~----~~kl~Dfg 219 (374)
++|||||++|+|.+++. ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++ .+|++|||
T Consensus 89 ~iv~E~~~gg~L~~~i~---~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhc---cccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 99999999999999997 3457999999999999999999999999 99999999999998776 49999999
Q ss_pred cccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccc
Q 017262 220 TSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCL 299 (374)
Q Consensus 220 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (374)
++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .+....... ...
T Consensus 163 ~a~~~~~~--~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~~~i~~-~~~ 233 (293)
T d1jksa_ 163 LAHKIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANVSA-VNY 233 (293)
T ss_dssp TCEECTTS--CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHT-TCC
T ss_pred hhhhcCCC--ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH------HHHHHHHHh-cCC
Confidence 99876432 223445689999999999999999999999999999999999999974332 121211111 100
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 300 FDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
. .....+...+..+.+||.+||+.||++|||++++++
T Consensus 234 ~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 E------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp C------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000001123457889999999999999999999975
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-53 Score=382.22 Aligned_cols=256 Identities=25% Similarity=0.484 Sum_probs=206.3
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCc----EEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGR----IIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLL 145 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 145 (374)
.+|++.+.||+|+||+||+|.+. +|+ +||+|++... +....+.+.+|+.++++++||||++++++|.+. ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 35899999999999999999864 343 6888887643 344567899999999999999999999999764 5678
Q ss_pred EEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccc
Q 017262 146 VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIA 225 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 225 (374)
+++++.+|+|.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999988765 4567999999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCcee-eecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccccc
Q 017262 226 IDQTHV-STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFDII 303 (374)
Q Consensus 226 ~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (374)
...... .....||+.|+|||.+.++.++.++|||||||++|||+| |..||......+ +...+
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~-------~~~~i--------- 226 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSIL--------- 226 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG-------HHHHH---------
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH-------HHHHH---------
Confidence 433332 234468999999999999999999999999999999998 889987544322 11111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 017262 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRA 349 (374)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~ 349 (374)
....+...+...+..+.+|+.+||+.||++|||+.++++.|+.+..
T Consensus 227 ~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 227 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp HHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 1222233444556789999999999999999999999999998865
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-53 Score=379.98 Aligned_cols=263 Identities=25% Similarity=0.403 Sum_probs=212.9
Q ss_pred HHHhhcCCCcCceEeeeCeEEEEEEEec------CCcEEEEEEeccCC-hhHHHHHHHHHHHHhhCCCCceeeeeeeeee
Q 017262 67 LDKATDYFNMNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVVD-ESKLEEFINEVVILSQINHRNVVKLLGCCLE 139 (374)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 139 (374)
++...++|++.+.||+|+||+||+|+.+ +++.||||++.... ......+.+|+.++++++||||+++++++.+
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 4445678999999999999999999864 35789999987543 3345679999999999999999999999999
Q ss_pred cccceEEEEeecCCcccccccCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEe
Q 017262 140 VEVPLLVYEFIPNGTLFQYLHDPY---------------------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHR 198 (374)
Q Consensus 140 ~~~~~lv~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~ 198 (374)
.+..+++|||+++|+|.+++.... ....+++..++.++.|++.||+|||+++ ++||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHr 164 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 164 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEee
Confidence 999999999999999999885311 1235889999999999999999999999 9999
Q ss_pred ccCCCceEECCCCcEEEeecccccccccCCce-eeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCC-CCCC
Q 017262 199 DIKSTNILLDEKYRAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQ-KPIS 276 (374)
Q Consensus 199 dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~-~p~~ 276 (374)
||||+|||++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++|. .||.
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 99999999999999999999999865433322 234456889999999999999999999999999999999986 5675
Q ss_pred ccccccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 017262 277 SIWANEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIR 348 (374)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~ 348 (374)
..... +.. ..+..+.. ...+...++.+.+|+.+||+.+|++|||+.+|+++|++|.
T Consensus 245 ~~~~~------e~~-~~v~~~~~---------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 245 GMAHE------EVI-YYVRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TSCHH------HHH-HHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCHH------HHH-HHHHcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 43322 222 22222211 2233345568899999999999999999999999999874
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-53 Score=381.61 Aligned_cols=247 Identities=26% Similarity=0.303 Sum_probs=207.9
Q ss_pred cCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
++|++.+.||+|+||.||+|+. .+|+.||+|++... .......+.+|+.+|++++||||+++++++.+.+..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5689999999999999999996 46899999988642 2334567889999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
|||++|+|.+++. ....+++..++.++.|++.||+|||+++ |+||||||+|||++.+|.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhh---cccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 9999999999987 4567999999999999999999999999 999999999999999999999999999865432
Q ss_pred CceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (374)
........||+.|+|||++.+..|+.++|||||||++|||++|+.||..... ...+.... ...
T Consensus 159 -~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~------~~~~~~i~-~~~--------- 221 (337)
T d1o6la_ 159 -GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELIL-MEE--------- 221 (337)
T ss_dssp -TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-HCC---------
T ss_pred -CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH------HHHHHHHh-cCC---------
Confidence 2234456799999999999999999999999999999999999999975332 22222211 111
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 017262 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPT-----MKEVAM 342 (374)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~vl~ 342 (374)
...+...++.+.+||.+||+.||++||+ ++++++
T Consensus 222 -~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 222 -IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1223344567899999999999999995 777765
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.8e-52 Score=369.80 Aligned_cols=259 Identities=28% Similarity=0.392 Sum_probs=206.6
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc----c
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVE----V 142 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~ 142 (374)
.++|++.+.||+|+||+||+|.. .+|+.||+|.++.. +......+.+|+.+++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999996 46899999998643 3445567899999999999999999999998654 3
Q ss_pred ceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccc
Q 017262 143 PLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 222 (374)
Q Consensus 143 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 222 (374)
.|+||||+++++|.+++. ....+++.+++.++.|++.||+|||+++ |+||||||+|||++.++..+++|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhc---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 789999999999999887 4567999999999999999999999999 9999999999999999999999999987
Q ss_pred ccccCCc--eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccc
Q 017262 223 SIAIDQT--HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLF 300 (374)
Q Consensus 223 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (374)
....... .......||+.|+|||++.+..++.++|||||||++|+|+||+.||.... ..+............
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~------~~~~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS------PVSVAYQHVREDPIP 233 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHCCCCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC------HHHHHHHHHhcCCCC
Confidence 6543222 23345679999999999999999999999999999999999999996432 222333333322211
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHHH
Q 017262 301 DIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRP-TMKEVAMELERIR 348 (374)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-s~~~vl~~L~~~~ 348 (374)
. .......++.+.++|.+||+.||++|| |++++++.|.+++
T Consensus 234 ~-------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 P-------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp G-------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred C-------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 1 111223456788999999999999998 8999999999875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=375.06 Aligned_cols=255 Identities=27% Similarity=0.433 Sum_probs=200.0
Q ss_pred cCCCcCceEeeeCeEEEEEEEecC--C--cEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccce
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLAD--G--RIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPL 144 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 144 (374)
++|++.+.||+|+||.||+|+... + ..||+|++... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 568999999999999999998532 2 36899987643 34445789999999999999999999999965 5678
Q ss_pred EEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccc
Q 017262 145 LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 224 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 224 (374)
+||||+++|+|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 87 lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 99999999999988764 3456999999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCcee--eecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCChHHHHHHHHHhccccc
Q 017262 225 AIDQTHV--STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRNLTTYFVECIEENCLFD 301 (374)
Q Consensus 225 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (374)
....... .....++..|+|||.+.+..++.++||||||+++|||+| |..||...... +.......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~------~~~~~i~~------ 229 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDK------ 229 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHT------
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH------HHHHHHHh------
Confidence 5433322 234457889999999999999999999999999999998 89999744322 22221111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 017262 302 IIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERI 347 (374)
Q Consensus 302 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~ 347 (374)
...+.+.+...+..+.+|+.+||+.||++|||+.++.+.|++.
T Consensus 230 ---~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 230 ---EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ---SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1222233444556899999999999999999999999999875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-53 Score=378.08 Aligned_cols=261 Identities=26% Similarity=0.457 Sum_probs=209.3
Q ss_pred cCCCcCceEeeeCeEEEEEEEecC-Cc--EEEEEEeccC-ChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeecccceEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLAD-GR--IIAVKKSKVV-DESKLEEFINEVVILSQI-NHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 146 (374)
++|++.+.||+|+||+||+|.+++ +. .||||++... .....+.+.+|+++|+++ +||||+++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 578889999999999999999754 43 4678876543 344556799999999999 799999999999999999999
Q ss_pred EEeecCCcccccccCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcE
Q 017262 147 YEFIPNGTLFQYLHDP-------------YEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRA 213 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~ 213 (374)
|||+++|+|.+++... .....+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999643 13467999999999999999999999999 9999999999999999999
Q ss_pred EEeecccccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCC-CCCCccccccCCChHHHHHH
Q 017262 214 KIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQ-KPISSIWANEGRNLTTYFVE 292 (374)
Q Consensus 214 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~-~p~~~~~~~~~~~~~~~~~~ 292 (374)
||+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|. .||..... .+...
T Consensus 167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~------~~~~~- 237 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELYE- 237 (309)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHH-
T ss_pred EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH------HHHHH-
Confidence 999999997644221 223345899999999999999999999999999999999965 56654322 22111
Q ss_pred HHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCC
Q 017262 293 CIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRD 353 (374)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~ 353 (374)
.+ ....+...+...++.+.+||.+||+.||++|||++++++.|+++....+.
T Consensus 238 ~i---------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~ 289 (309)
T d1fvra_ 238 KL---------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 289 (309)
T ss_dssp HG---------GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred HH---------HhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcC
Confidence 11 11223334445667899999999999999999999999999999875543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-53 Score=376.81 Aligned_cols=268 Identities=28% Similarity=0.398 Sum_probs=205.1
Q ss_pred HHHHHhhcCCCcCceEeeeCeEEEEEEEec------CCcEEEEEEeccC-ChhHHHHHHHHHHHHhhC-CCCceeeeeee
Q 017262 65 KELDKATDYFNMNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVV-DESKLEEFINEVVILSQI-NHRNVVKLLGC 136 (374)
Q Consensus 65 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~ 136 (374)
.+.+...++|++.+.||+|+||.||+|... +++.||+|+++.. .......+.+|...+.++ +|+||+.++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 344444578999999999999999999853 2468999998653 344556788888888777 68999999999
Q ss_pred eeecc-cceEEEEeecCCcccccccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCC
Q 017262 137 CLEVE-VPLLVYEFIPNGTLFQYLHDPY-------------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKS 202 (374)
Q Consensus 137 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~ 202 (374)
+...+ ..++|||||++|+|.+++.... ....+++..++.++.|++.||+|||+++ |+||||||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCc
Confidence 87654 6899999999999999986421 1345899999999999999999999999 99999999
Q ss_pred CceEECCCCcEEEeecccccccccCCce-eeecccccccccCccccccCCCCccchhhhHHHHHHHHHhC-CCCCCcccc
Q 017262 203 TNILLDEKYRAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTG-QKPISSIWA 280 (374)
Q Consensus 203 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g-~~p~~~~~~ 280 (374)
+|||+++++.+||+|||+|+........ ......||+.|+|||.+.+..++.++|||||||++|||++| ..||.....
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876533322 33445799999999999999999999999999999999986 457764322
Q ss_pred ccCCChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 017262 281 NEGRNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350 (374)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~ 350 (374)
. ..+......+ .+...+...++.+.+|+.+||+.||++|||+.++++.|+++.+.
T Consensus 243 ~------~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 243 D------EEFCRRLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp S------HHHHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H------HHHHHHHhcC---------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1 1122222222 12223334456789999999999999999999999999998764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-52 Score=370.16 Aligned_cols=257 Identities=29% Similarity=0.463 Sum_probs=207.4
Q ss_pred CceEeeeCeEEEEEEEecCC----cEEEEEEecc-CChhHHHHHHHHHHHHhhCCCCceeeeeeeeeec-ccceEEEEee
Q 017262 77 NRILGQGGQGTVYKGMLADG----RIIAVKKSKV-VDESKLEEFINEVVILSQINHRNVVKLLGCCLEV-EVPLLVYEFI 150 (374)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~~~----~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~ 150 (374)
.++||+|+||+||+|.+.++ ..||||++.. .+......+.+|++++++++||||+++++++.+. ...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 47899999999999996542 2589998864 4566678899999999999999999999998764 5789999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 230 (374)
++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999999875 3456788899999999999999999999 999999999999999999999999999876533222
Q ss_pred ---eeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccc
Q 017262 231 ---VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307 (374)
Q Consensus 231 ---~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (374)
......||+.|+|||.+.+..++.++||||||+++|||++|..||....... ..... . ..+ .
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~---i-~~g---------~ 251 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVY---L-LQG---------R 251 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHH---H-HTT---------C
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHH---H-HcC---------C
Confidence 2233568999999999999999999999999999999999888876422111 11111 1 111 1
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCC
Q 017262 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRD 353 (374)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~ 353 (374)
+...+...+..+.+||.+||+.||++|||+.||++.|+++......
T Consensus 252 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 252 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence 1222334456899999999999999999999999999999875443
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.1e-52 Score=371.40 Aligned_cols=244 Identities=26% Similarity=0.368 Sum_probs=205.9
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
++|++.+.||+|+||+||+|+.+ +|+.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46899999999999999999974 5899999988642 2334567889999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
||++||+|..++. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999999887 5667899999999999999999999999 999999999999999999999999999876432
Q ss_pred CceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (374)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ............
T Consensus 158 ----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~i~~~~---------- 217 (316)
T d1fota_ 158 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN------TMKTYEKILNAE---------- 217 (316)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHCC----------
T ss_pred ----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC------HHHHHHHHHcCC----------
Confidence 234579999999999999999999999999999999999999997432 222222222111
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 017262 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRP-----TMKEVAM 342 (374)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~vl~ 342 (374)
...+...++.+.+++.+||..||.+|| |++++++
T Consensus 218 -~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 218 -LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 122333456788999999999999996 8999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-52 Score=373.49 Aligned_cols=262 Identities=29% Similarity=0.437 Sum_probs=210.6
Q ss_pred hcCCCcCceEeeeCeEEEEEEEecC--------CcEEEEEEeccCC-hhHHHHHHHHHHHHhhC-CCCceeeeeeeeeec
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLAD--------GRIIAVKKSKVVD-ESKLEEFINEVVILSQI-NHRNVVKLLGCCLEV 140 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 140 (374)
.++|++.+.||+|+||.||+|+... +..||+|+++... ......+.+|...+.++ +||||++++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4678899999999999999998532 2479999886643 44557888999999888 799999999999999
Q ss_pred ccceEEEEeecCCcccccccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEE
Q 017262 141 EVPLLVYEFIPNGTLFQYLHDPY-------------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILL 207 (374)
Q Consensus 141 ~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill 207 (374)
+..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 99999999999999999996432 1346899999999999999999999999 9999999999999
Q ss_pred CCCCcEEEeecccccccccCCce-eeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccCCC
Q 017262 208 DEKYRAKIADFGTSRSIAIDQTH-VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEGRN 285 (374)
Q Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~ 285 (374)
+.++.+||+|||+++........ ......+++.|+|||.+.++.++.++||||||+++|||++ |..||......
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---- 244 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---- 244 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH----
Confidence 99999999999999876543322 2344568999999999999999999999999999999998 78888643322
Q ss_pred hHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhC
Q 017262 286 LTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANS 351 (374)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~ 351 (374)
. +...+.. ..+...+...++.+.+||.+||+.||++|||+.|+++.|+++.+-+
T Consensus 245 --~-~~~~i~~---------~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~~ 298 (299)
T d1fgka_ 245 --E-LFKLLKE---------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 298 (299)
T ss_dssp --H-HHHHHHT---------TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred --H-HHHHHHc---------CCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhcC
Confidence 1 1122222 2222333345568999999999999999999999999999997654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-52 Score=374.62 Aligned_cols=264 Identities=29% Similarity=0.451 Sum_probs=215.4
Q ss_pred HhhcCCCcCceEeeeCeEEEEEEEec------CCcEEEEEEeccC-ChhHHHHHHHHHHHHhhC-CCCceeeeeeeeeec
Q 017262 69 KATDYFNMNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVV-DESKLEEFINEVVILSQI-NHRNVVKLLGCCLEV 140 (374)
Q Consensus 69 ~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 140 (374)
...++|++.+.||+|+||.||+|++. +++.||||+++.. .......+.+|+.+++.+ +||||+++++++.+.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 34568899999999999999999852 3568999998754 345566789999999999 699999999999999
Q ss_pred ccceEEEEeecCCcccccccCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCce
Q 017262 141 EVPLLVYEFIPNGTLFQYLHDPY---------------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNI 205 (374)
Q Consensus 141 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Ni 205 (374)
+..+++||||++|+|.+++.... ....+++..+..++.||+.||+|||+++ ++||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccc
Confidence 99999999999999999986421 2336899999999999999999999999 99999999999
Q ss_pred EECCCCcEEEeecccccccccCCc-eeeecccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCccccccC
Q 017262 206 LLDEKYRAKIADFGTSRSIAIDQT-HVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLT-GQKPISSIWANEG 283 (374)
Q Consensus 206 ll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~ 283 (374)
+++.++.+|++|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||+| |..||......
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-- 254 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-- 254 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH--
Confidence 999999999999999987654333 33345678999999999999999999999999999999999 55555432221
Q ss_pred CChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 017262 284 RNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350 (374)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~ 350 (374)
..+.... ....+...+...+..+.+||.+||+.||++|||+.+++++|+++..+
T Consensus 255 ----~~~~~~i---------~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 255 ----SKFYKMI---------KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp ----HHHHHHH---------HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHHHHHH---------hcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 1122222 22223333444567899999999999999999999999999987665
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=9e-52 Score=363.85 Aligned_cols=250 Identities=27% Similarity=0.387 Sum_probs=204.9
Q ss_pred cCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCCh---------hHHHHHHHHHHHHhhCC-CCceeeeeeeeeec
Q 017262 72 DYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDE---------SKLEEFINEVVILSQIN-HRNVVKLLGCCLEV 140 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~ 140 (374)
++|++.+.||+|+||+||+|+. .+|+.+|+|++..... ...+.+.+|+.++++++ ||||+++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6799999999999999999996 4689999998765321 12346789999999997 99999999999999
Q ss_pred ccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccc
Q 017262 141 EVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGT 220 (374)
Q Consensus 141 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 220 (374)
+..|+||||+++|+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 99999999999999999997 4557999999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCceeeecccccccccCcccccc------CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHH
Q 017262 221 SRSIAIDQTHVSTKVQGTFGYLDPEYFRS------SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECI 294 (374)
Q Consensus 221 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 294 (374)
++...... ......||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||..... ........
T Consensus 157 a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~------~~~~~~i~ 228 (277)
T d1phka_ 157 SCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------MLMLRMIM 228 (277)
T ss_dssp CEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH
T ss_pred eeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH------HHHHHHHH
Confidence 98765322 2344679999999999863 3468899999999999999999999975332 11111111
Q ss_pred HhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 295 EENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
... .. .........++.+.+|+.+||+.||++|||++|+++
T Consensus 229 ~~~-~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 229 SGN-YQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HTC-CC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hCC-CC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111 11 111122345568999999999999999999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-52 Score=372.21 Aligned_cols=251 Identities=23% Similarity=0.325 Sum_probs=206.2
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
.++|++.+.||+|+||+||+|... +++.||+|.++.... ....+.+|+.+|++++||||+++++++.+.+..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 467999999999999999999975 588999999876543 345688999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCC--CcEEEeecccccccccC
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEK--YRAKIADFGTSRSIAID 227 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~--~~~kl~Dfg~~~~~~~~ 227 (374)
|++|+|.+++.. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.+ ..+||+|||++......
T Consensus 83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999999974 2346999999999999999999999999 9999999999999854 58999999999876432
Q ss_pred CceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (374)
.......+++.|+|||.+.+..++.++|||||||++|+|++|..||..... .+.+....... .. .....
T Consensus 158 --~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~------~~~~~~i~~~~-~~--~~~~~ 226 (321)
T d1tkia_ 158 --DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN------QQIIENIMNAE-YT--FDEEA 226 (321)
T ss_dssp --CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTC-CC--CCHHH
T ss_pred --CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC-CC--CChhh
Confidence 223445689999999999999999999999999999999999999975332 22222222111 00 00000
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
. ...+..+.+||.+||..||++|||++|+++
T Consensus 227 ~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 227 F----KEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp H----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred c----cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 123457889999999999999999999986
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.1e-51 Score=375.19 Aligned_cols=248 Identities=21% Similarity=0.263 Sum_probs=199.1
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCC---hhHHHHH---HHHHHHHhhCCCCceeeeeeeeeecccce
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVD---ESKLEEF---INEVVILSQINHRNVVKLLGCCLEVEVPL 144 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~---~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 144 (374)
++|++.+.||+|+||.||+|+.. +|+.||+|++.... ......+ ..++.+++.++||||+++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57999999999999999999975 58999999875321 1112223 34577788889999999999999999999
Q ss_pred EEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccc
Q 017262 145 LVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSI 224 (374)
Q Consensus 145 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 224 (374)
+||||+++|+|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 84 ivmE~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHH---hcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 9999999999999997 4567899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccc
Q 017262 225 AIDQTHVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDII 303 (374)
Q Consensus 225 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (374)
.... .....||+.|+|||++.. ..++.++|||||||++|+|++|+.||....... ..... ...
T Consensus 158 ~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~~----~~~------ 221 (364)
T d1omwa3 158 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHEID----RMT------ 221 (364)
T ss_dssp SSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC---HHHHH----HHS------
T ss_pred CCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH---HHHHH----Hhc------
Confidence 4322 334569999999999875 568999999999999999999999997543222 11111 100
Q ss_pred cccccCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 017262 304 DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPT-----MKEVAM 342 (374)
Q Consensus 304 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~vl~ 342 (374)
.......+...++.+.+||.+||+.||++||| ++++++
T Consensus 222 -~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 222 -LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -SSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -ccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 00111222334567899999999999999999 677765
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4e-51 Score=371.40 Aligned_cols=244 Identities=22% Similarity=0.272 Sum_probs=205.7
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 147 (374)
++|++.+.||+|+||.||+|..+ +|+.||+|++... .......+.+|+.+|+.++||||+++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999974 6899999987542 2234567889999999999999999999999999999999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccC
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAID 227 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 227 (374)
||+.+|+|..++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~~g~l~~~l~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 9999999999987 4457999999999999999999999999 999999999999999999999999999876432
Q ss_pred CceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccccccccccc
Q 017262 228 QTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQV 307 (374)
Q Consensus 228 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (374)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ........... .
T Consensus 195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~i~~~-~--------- 254 (350)
T d1rdqe_ 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ------PIQIYEKIVSG-K--------- 254 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHC-C---------
T ss_pred ----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC------HHHHHHHHhcC-C---------
Confidence 234569999999999999999999999999999999999999996432 22222222211 1
Q ss_pred cCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 017262 308 RKSGEAEEIMAVSDVAKRCLNSYGRNRP-----TMKEVAM 342 (374)
Q Consensus 308 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~vl~ 342 (374)
...+...++.+.+||.+||..||++|+ |++++++
T Consensus 255 -~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 255 -VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 112234456789999999999999994 8999885
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-51 Score=368.97 Aligned_cols=250 Identities=24% Similarity=0.287 Sum_probs=198.4
Q ss_pred hcCCCcC-ceEeeeCeEEEEEEEe-cCCcEEEEEEeccCChhHHHHHHHHHHHHhh-CCCCceeeeeeeeee----cccc
Q 017262 71 TDYFNMN-RILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQ-INHRNVVKLLGCCLE----VEVP 143 (374)
Q Consensus 71 ~~~~~~~-~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~----~~~~ 143 (374)
.++|.+. +.||+|+||+||+|.. .+++.||+|+++.. ..+.+|+.++.+ .+||||+++++++.+ +...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 3578876 4699999999999996 56899999998642 356689988655 489999999999875 4568
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECC---CCcEEEeeccc
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE---KYRAKIADFGT 220 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfg~ 220 (374)
|+|||||+||+|.+++... ....+++.++..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 9999999999999999753 2357999999999999999999999999 999999999999985 56799999999
Q ss_pred ccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccc
Q 017262 221 SRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLF 300 (374)
Q Consensus 221 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (374)
++...... ......||+.|+|||++.+..|+.++|||||||++|+|++|+.||......... ... ..
T Consensus 161 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~---~~~--------~~ 227 (335)
T d2ozaa1 161 AKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGM--------KT 227 (335)
T ss_dssp CEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------------
T ss_pred eeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH---HHH--------HH
Confidence 98765332 234457999999999999999999999999999999999999999754322210 000 00
Q ss_pred ccccccccCC--CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 301 DIIDDQVRKS--GEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 301 ~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.......... .....++.+.+||.+||+.||++|||+.++++
T Consensus 228 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 228 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1111111111 11245678999999999999999999999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-52 Score=372.17 Aligned_cols=247 Identities=24% Similarity=0.334 Sum_probs=203.4
Q ss_pred cCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC---ChhHHHHHHHHHHHHh-hCCCCceeeeeeeeeecccceEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV---DESKLEEFINEVVILS-QINHRNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lv 146 (374)
++|++.+.||+|+||+||+|+.. +++.||+|++... .......+..|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999975 6899999998642 1233455666777665 68999999999999999999999
Q ss_pred EEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccccccc
Q 017262 147 YEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAI 226 (374)
Q Consensus 147 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 226 (374)
|||+++|+|.+++. ....+++.++..++.||+.||+|||+++ ++||||||+|||+++++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~---~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999997 4567899999999999999999999999 99999999999999999999999999986543
Q ss_pred CCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccccccccc
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLFDIIDDQ 306 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (374)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ........ ...
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~-~~~-------- 219 (320)
T d1xjda_ 156 GD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE------EELFHSIR-MDN-------- 219 (320)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-HCC--------
T ss_pred cc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHH-cCC--------
Confidence 32 333445799999999999999999999999999999999999999974332 22222211 111
Q ss_pred ccCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 017262 307 VRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMK-EVAM 342 (374)
Q Consensus 307 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~-~vl~ 342 (374)
...+...++.+.+||.+||+.||++|||+. ++++
T Consensus 220 --~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 220 --PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 122233456789999999999999999996 6753
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=367.79 Aligned_cols=264 Identities=26% Similarity=0.402 Sum_probs=213.9
Q ss_pred HHHhhcCCCcCceEeeeCeEEEEEEEec------CCcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeee
Q 017262 67 LDKATDYFNMNRILGQGGQGTVYKGMLA------DGRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLE 139 (374)
Q Consensus 67 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 139 (374)
.+...++|++.+.||+|+||+||+|.+. ++..||||+++.. .......+.+|+.++++++||||+++++++..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 3444578899999999999999999863 2578999998653 44455678999999999999999999999999
Q ss_pred cccceEEEEeecCCcccccccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCc
Q 017262 140 VEVPLLVYEFIPNGTLFQYLHDPY-------EELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYR 212 (374)
Q Consensus 140 ~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~ 212 (374)
.+..++||||+++|+|.+++.... ....+++..+..++.|+++||.|||+++ |+||||||+|||++++++
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCC
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCce
Confidence 999999999999999999886321 2235789999999999999999999998 999999999999999999
Q ss_pred EEEeecccccccccCCcee-eecccccccccCccccccCCCCccchhhhHHHHHHHHHhC-CCCCCccccccCCChHHHH
Q 017262 213 AKIADFGTSRSIAIDQTHV-STKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTG-QKPISSIWANEGRNLTTYF 290 (374)
Q Consensus 213 ~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g-~~p~~~~~~~~~~~~~~~~ 290 (374)
+||+|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|||+|| ..||..... .+..
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~------~~~~ 245 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQVL 245 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------HHHH
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH------HHHH
Confidence 9999999998765433322 2334689999999999999999999999999999999998 467754322 2222
Q ss_pred HHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 017262 291 VECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRA 349 (374)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~ 349 (374)
.... .+ .+.+.+...+..+.+|+.+||+.||++|||++++++.|++..+
T Consensus 246 ~~i~-~~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 246 RFVM-EG---------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHHH-TT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHH-hC---------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 2221 11 1222333455689999999999999999999999999877633
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=360.66 Aligned_cols=269 Identities=22% Similarity=0.311 Sum_probs=202.0
Q ss_pred cCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHH--HHHHHhhCCCCceeeeeeeeeecc----cceE
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFIN--EVVILSQINHRNVVKLLGCCLEVE----VPLL 145 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~--e~~~l~~l~h~niv~~~~~~~~~~----~~~l 145 (374)
+.|.+.+.||+|+||+||+|+. +|+.||||++.... ...+.. |+..+.+++||||+++++++.+.+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4577888999999999999987 57899999886432 233444 444556789999999999998654 5689
Q ss_pred EEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCEEEeccCCCceEECCCCcEEEeeccc
Q 017262 146 VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSA-----YLPIYHRDIKSTNILLDEKYRAKIADFGT 220 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~-----~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 220 (374)
||||+++|+|.+++.+ ..+++..++.++.|++.||+|+|+.. ..+|+||||||+|||++.++.+||+|||+
T Consensus 79 v~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 9999999999999963 36999999999999999999999741 12399999999999999999999999999
Q ss_pred ccccccCCce---eeecccccccccCccccccCC------CCccchhhhHHHHHHHHHhCCCCCCccccccC--------
Q 017262 221 SRSIAIDQTH---VSTKVQGTFGYLDPEYFRSSQ------FTDKSDVYSFGVVLVELLTGQKPISSIWANEG-------- 283 (374)
Q Consensus 221 ~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~------~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~-------- 283 (374)
+......... ......||+.|+|||++.+.. ++.++|||||||++|||+||..||........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 9876543322 234467999999999987543 56789999999999999999988754332211
Q ss_pred CChHHHHHHHHHhccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhC
Q 017262 284 RNLTTYFVECIEENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANS 351 (374)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~ 351 (374)
...................+.. ...+.+.+..+.+|+.+||+.||++|||+.|+++.|+++.+..
T Consensus 235 ~~~~~~~~~~~~~~~~~p~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCG---GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHhccccCCCCCc---ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 1111112222111111111100 1113345667999999999999999999999999999998754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=361.40 Aligned_cols=253 Identities=24% Similarity=0.259 Sum_probs=195.0
Q ss_pred CceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhH-----HHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEee
Q 017262 77 NRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESK-----LEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEFI 150 (374)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 150 (374)
+++||+|+||+||+|... +|+.||||++....... ...+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 478999999999999964 58999999886543221 246789999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCce
Q 017262 151 PNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQTH 230 (374)
Q Consensus 151 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 230 (374)
.++++..... ....+++..+..++.||+.||+|||+++ ++||||||+|||++.++.+||+|||++........
T Consensus 83 ~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 83 ETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp SEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred cchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence 9888877665 4567899999999999999999999999 99999999999999999999999999976543322
Q ss_pred eeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHh---cc---cccc-
Q 017262 231 VSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEE---NC---LFDI- 302 (374)
Q Consensus 231 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~---~~~~- 302 (374)
......||+.|+|||++.. ..++.++|||||||++|||++|..||......+ ......+. .. ....
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~------~l~~i~~~~~~~~~~~~~~~~ 229 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD------QLTRIFETLGTPTEEQWPDMC 229 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHHHCCCCTTTSSSTT
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH------HHHHHHHhcCCCChhhccchh
Confidence 2334569999999999865 467999999999999999999999997543221 11111110 00 0000
Q ss_pred -----ccccccCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 303 -----IDDQVRKSGE-----AEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 303 -----~~~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.........+ ...++.+.+|+.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0000000111 123467899999999999999999999975
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.7e-50 Score=355.53 Aligned_cols=258 Identities=23% Similarity=0.290 Sum_probs=201.6
Q ss_pred cCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCC--hhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEEe
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVD--ESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYEF 149 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 149 (374)
++|++.+.||+|+||+||+|.+++|+.||+|++.... ......+.+|+.+|++++||||+++++++.+.+..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5799999999999999999999999999999986543 23356888999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCCc
Q 017262 150 IPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQT 229 (374)
Q Consensus 150 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 229 (374)
+.++++..+.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++|||.+.......
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~- 154 (286)
T d1ob3a_ 82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (286)
T ss_dssp CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc-
Confidence 98877777665 4568999999999999999999999999 9999999999999999999999999998754322
Q ss_pred eeeecccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHh-c----------
Q 017262 230 HVSTKVQGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEE-N---------- 297 (374)
Q Consensus 230 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~---------- 297 (374)
.......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...... +........ .
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~------~~~~~i~~~~~~~~~~~~~~~ 228 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA------DQLMRIFRILGTPNSKNWPNV 228 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHHHCCCCTTTSTTG
T ss_pred cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH------HHHHHHHHhhCCCChhhccch
Confidence 223444689999999998754 5689999999999999999999999753321 111111110 0
Q ss_pred -cccc------cccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 298 -CLFD------IIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 298 -~~~~------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.... ..............+..+.+|+.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 00000001112234567899999999999999999999974
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-50 Score=358.18 Aligned_cols=259 Identities=21% Similarity=0.291 Sum_probs=198.9
Q ss_pred cCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCCh--hHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDE--SKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 148 (374)
++|++.+.||+|+||+||+|.. .+|+.||+|+++.... .....+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5799999999999999999996 5689999999865432 234678899999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
|+.++++...... ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....+.
T Consensus 82 ~~~~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 9976544443332 3557999999999999999999999999 9999999999999999999999999998654322
Q ss_pred ceeeecccccccccCccccccCC-CCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHH-hcccccccccc
Q 017262 229 THVSTKVQGTFGYLDPEYFRSSQ-FTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIE-ENCLFDIIDDQ 306 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 306 (374)
.......||+.|+|||.+.... ++.++|||||||++|+|++|+.||...... +....... .+.........
T Consensus 157 -~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~------~~~~~i~~~~~~~~~~~~~~ 229 (298)
T d1gz8a_ 157 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI------DQLFRIFRTLGTPDEVVWPG 229 (298)
T ss_dssp -BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHHHCCCCTTTSTT
T ss_pred -ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH------HHHHHHHHhcCCCchhhccc
Confidence 2334457999999999877655 578999999999999999999999743221 11111111 00000000000
Q ss_pred ----------c--cCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 307 ----------V--RKSG-----EAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 307 ----------~--~~~~-----~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
. .... ....+..+.+|+.+||..||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp GGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0 0000 1123467899999999999999999999986
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-51 Score=359.59 Aligned_cols=240 Identities=26% Similarity=0.398 Sum_probs=195.6
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCCh------hHHHHHHHHHHHHhhCC--CCceeeeeeeeeecc
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDE------SKLEEFINEVVILSQIN--HRNVVKLLGCCLEVE 141 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~ 141 (374)
.++|++.+.||+|+||+||+|... +|+.||+|++..... .....+.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 467999999999999999999964 689999998764211 11234568999999986 899999999999999
Q ss_pred cceEEEEeecC-CcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECC-CCcEEEeecc
Q 017262 142 VPLLVYEFIPN-GTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE-KYRAKIADFG 219 (374)
Q Consensus 142 ~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg 219 (374)
..++||||+.+ +++.+++. ....+++..+..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 99999999976 57777776 4567999999999999999999999999 999999999999985 5799999999
Q ss_pred cccccccCCceeeecccccccccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcc
Q 017262 220 TSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQF-TDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENC 298 (374)
Q Consensus 220 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 298 (374)
++..... .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... ... ..
T Consensus 157 ~a~~~~~---~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------------i~~-~~ 220 (273)
T d1xwsa_ 157 SGALLKD---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIR-GQ 220 (273)
T ss_dssp TCEECCS---SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------HHH-CC
T ss_pred cceeccc---ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------------Hhh-cc
Confidence 9976532 22345679999999999987765 5678999999999999999999964211 011 00
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 299 LFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
...+...+..+.+||.+||+.||++|||++|+++
T Consensus 221 ----------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 221 ----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1112223467899999999999999999999875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-49 Score=353.88 Aligned_cols=259 Identities=23% Similarity=0.294 Sum_probs=196.7
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-C-CcEEEEEEeccC--ChhHHHHHHHHHHHHhhC---CCCceeeeeeeeee----
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-D-GRIIAVKKSKVV--DESKLEEFINEVVILSQI---NHRNVVKLLGCCLE---- 139 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~---- 139 (374)
.++|++.+.||+|+||+||+|... + ++.||+|++... .......+.+|+.+++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999963 4 567999987542 222233455677776665 79999999999863
Q ss_pred -cccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeec
Q 017262 140 -VEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADF 218 (374)
Q Consensus 140 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 218 (374)
....++++||++++++...... ....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 3467899999998877654443 4567899999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcc
Q 017262 219 GTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENC 298 (374)
Q Consensus 219 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 298 (374)
|++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.+........
T Consensus 161 g~~~~~~~--~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~------~~~~~i~~~~~ 232 (305)
T d1blxa_ 161 GLARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV------DQLGKILDVIG 232 (305)
T ss_dssp CSCCCCCG--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHHHC
T ss_pred hhhhhhcc--cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH------HHHHHHHHhhC
Confidence 99876432 22334567999999999999999999999999999999999999999754321 11111111000
Q ss_pred ------cc------cc----ccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 299 ------LF------DI----IDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 299 ------~~------~~----~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.. .. .............++.+.+|+.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 00 0000001112234567889999999999999999999875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-47 Score=341.48 Aligned_cols=263 Identities=19% Similarity=0.237 Sum_probs=199.8
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCcee-eeeeeeeecccceEEEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVV-KLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e 148 (374)
.++|++.+.||+|+||+||+|.+ .+|+.||||.+..... ...+..|+++++.++|+|++ .+..++.+.+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 46799999999999999999996 4588999998765432 24577899999999877655 45555667778899999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECC---CCcEEEeecccccccc
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE---KYRAKIADFGTSRSIA 225 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfg~~~~~~ 225 (374)
|+. ++|...+.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++. +..+||+|||+++...
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 84 LLG-PSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp CCC-CBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EcC-Cchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 994 555555543 3567999999999999999999999999 999999999999864 5579999999998765
Q ss_pred cCCce------eeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccc
Q 017262 226 IDQTH------VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCL 299 (374)
Q Consensus 226 ~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (374)
..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........................
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence 43322 223457999999999999999999999999999999999999999865443322111111111000000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 017262 300 FDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRAN 350 (374)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~ 350 (374)
. .. ....++.+.+++.+|++.+|++||++.++.+.|+.+...
T Consensus 238 ~-----~~----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 238 E-----VL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp H-----HH----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred h-----Hh----ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 0 00 112345788999999999999999999999999987654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.4e-47 Score=339.10 Aligned_cols=267 Identities=15% Similarity=0.164 Sum_probs=210.4
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCC-CceeeeeeeeeecccceEEEE
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINH-RNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e 148 (374)
.++|++.+.||+|+||+||+|++. +|+.||+|.+..... ...+.+|++.++.++| +|++.+++++.+....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999965 688999998755322 2356789999999975 899999999999999999999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECC-----CCcEEEeecccccc
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDE-----KYRAKIADFGTSRS 223 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~-----~~~~kl~Dfg~~~~ 223 (374)
|+ +++|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+++.
T Consensus 82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99 7899888864 3457999999999999999999999999 999999999999974 57899999999987
Q ss_pred cccCCce------eeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhc
Q 017262 224 IAIDQTH------VSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEEN 297 (374)
Q Consensus 224 ~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 297 (374)
....... ......||+.|+|||++.+..++.++||||||+++|||++|..||..............+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 6533221 2234569999999999999999999999999999999999999997544322111111111111111
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhCCCC
Q 017262 298 CLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAMELERIRANSRDD 354 (374)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~~L~~~~~~~~~~ 354 (374)
.... +. ...++.+.+++..|+..+|++||+++.+.+.|+++.......
T Consensus 236 ~~~~-----l~----~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~ 283 (293)
T d1csna_ 236 PLRE-----LC----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 283 (293)
T ss_dssp CHHH-----HT----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred ChHH-----hc----CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCC
Confidence 1111 11 122357889999999999999999999999999987655433
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-48 Score=348.86 Aligned_cols=260 Identities=20% Similarity=0.261 Sum_probs=195.7
Q ss_pred hcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeee--------
Q 017262 71 TDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLE-------- 139 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-------- 139 (374)
.++|++.+.||+|+||+||+|+. .+|+.||||++... .......+.+|+.+|++++|||++++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 36899999999999999999996 47899999987543 33345678899999999999999999999854
Q ss_pred cccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecc
Q 017262 140 VEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFG 219 (374)
Q Consensus 140 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 219 (374)
.+..+++|||+.++++..+.. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 345789999998887766554 4567899999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCce---eeecccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHH
Q 017262 220 TSRSIAIDQTH---VSTKVQGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIE 295 (374)
Q Consensus 220 ~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 295 (374)
++......... ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...... ........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~------~~~~~i~~ 236 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ------HQLALISQ 236 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHH
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH------HHHHHHHH
Confidence 99765532222 22335699999999998754 6899999999999999999999999643221 11111111
Q ss_pred h-cccccc-------------ccccccCCCCH-------HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 296 E-NCLFDI-------------IDDQVRKSGEA-------EEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 296 ~-~~~~~~-------------~~~~~~~~~~~-------~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
. ...... ........... ...+.+.+|+.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp HHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 0 000000 00000000111 11346789999999999999999999984
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=353.78 Aligned_cols=268 Identities=24% Similarity=0.286 Sum_probs=196.8
Q ss_pred CCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCceeeeeeeeeec------ccceE
Q 017262 73 YFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNVVKLLGCCLEV------EVPLL 145 (374)
Q Consensus 73 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~l 145 (374)
+|+..++||+|+||+||+|+.. +|+.||||++..... ...+|+.+|++++||||++++++|... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5888899999999999999975 589999998865432 224799999999999999999998643 24689
Q ss_pred EEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCC-cEEEeeccccccc
Q 017262 146 VYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY-RAKIADFGTSRSI 224 (374)
Q Consensus 146 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~~~~~ 224 (374)
||||++++++............+++..+..++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||++...
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987654443322224567999999999999999999999999 99999999999999775 8999999999876
Q ss_pred ccCCceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccC---------CChHHHHHHHH
Q 017262 225 AIDQTHVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEG---------RNLTTYFVECI 294 (374)
Q Consensus 225 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~---------~~~~~~~~~~~ 294 (374)
.... ......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+. ...........
T Consensus 174 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 174 VRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp CTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 4332 2334569999999998765 5789999999999999999999999975432210 00000000000
Q ss_pred H---hccccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHHHHh
Q 017262 295 E---ENCLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM--ELERIRA 349 (374)
Q Consensus 295 ~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~--~L~~~~~ 349 (374)
. ....................++.+.+|+.+||..||++|||+.|+++ .++.+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 0 00000000011111122234567899999999999999999999986 3444433
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-48 Score=350.70 Aligned_cols=260 Identities=19% Similarity=0.271 Sum_probs=197.1
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccC-ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc----cc
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV-DESKLEEFINEVVILSQINHRNVVKLLGCCLEVE----VP 143 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~ 143 (374)
.+++|++.+.||+|+||+||+|.. .+|+.||||++... .......+.+|+.+|++++||||+++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 356799999999999999999986 57899999998654 3455678899999999999999999999997654 23
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccc
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRS 223 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 223 (374)
+++++++.+|+|.+++. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 86 ~~l~~~~~~g~L~~~l~----~~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEEECCCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEeecCCchhhhhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceee
Confidence 55666777999999996 346999999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCce--eeecccccccccCccccc-cCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccc
Q 017262 224 IAIDQTH--VSTKVQGTFGYLDPEYFR-SSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLF 300 (374)
Q Consensus 224 ~~~~~~~--~~~~~~g~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (374)
....... ......||+.|+|||.+. +..++.++||||+||++|+|++|+.||......+ ............
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~------~~~~~~~~~~~~ 232 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD------QLNHILGILGSP 232 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHHHCSC
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH------HHHHHhhhccCC
Confidence 5433222 234466999999999985 4567899999999999999999999997543211 011000000000
Q ss_pred c---------------cccccccCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 301 D---------------IIDDQVRKSG-----EAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 301 ~---------------~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
. .......... .+..+..+.+|+.+||+.||++|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0000000000 1122357889999999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-47 Score=347.01 Aligned_cols=254 Identities=22% Similarity=0.281 Sum_probs=194.3
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecc-----
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVE----- 141 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 141 (374)
..++|++.+.||+|+||+||+|... +|+.||+|++... +....+.+.+|+.+|++++||||++++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 3578999999999999999999964 5899999998643 4455678899999999999999999999997654
Q ss_pred -cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccc
Q 017262 142 -VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGT 220 (374)
Q Consensus 142 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 220 (374)
..++||||+ +.+|..++. ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+|++|||+
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence 469999999 667777664 457999999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCceeeecccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHh-c-
Q 017262 221 SRSIAIDQTHVSTKVQGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEE-N- 297 (374)
Q Consensus 221 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~- 297 (374)
+...... .+...||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||....... ........ .
T Consensus 168 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~------~~~~~~~~~~~ 237 (346)
T d1cm8a_ 168 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD------QLKEIMKVTGT 237 (346)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHHHCC
T ss_pred eeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH------HHHHHHhccCC
Confidence 9865432 244569999999999876 456899999999999999999999997543211 01000000 0
Q ss_pred -------------------cccccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 298 -------------------CLFDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 298 -------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
..... ............++.+.+||.+||..||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 238 PPAEFVQRLQSDEAKNYMKGLPEL-EKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp CCHHHHHTCSCHHHHHHHHHSCCC-CCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CcHHHHhhhcchhhhhhhccCCcc-cccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000 000001112233457889999999999999999999987
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-47 Score=337.05 Aligned_cols=259 Identities=20% Similarity=0.267 Sum_probs=205.2
Q ss_pred cCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeecccceEEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 148 (374)
++|++.+.||+|+||+||+|++ .+++.||+|+++.. .......+.+|+.+++.++||||+++++++.+.+..+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999996 46889999987543 34556788999999999999999999999999999999999
Q ss_pred eecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccccccccCC
Q 017262 149 FIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSRSIAIDQ 228 (374)
Q Consensus 149 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 228 (374)
++.+++|..++. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.+.......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999988876 4567899999999999999999999999 9999999999999999999999999998765332
Q ss_pred ceeeecccccccccCccccccCC-CCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhccc--------
Q 017262 229 THVSTKVQGTFGYLDPEYFRSSQ-FTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCL-------- 299 (374)
Q Consensus 229 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 299 (374)
. ......+++.|+|||.+.... ++.++|||||||++|||++|..||.... +..+...........
T Consensus 156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 229 (292)
T d1unla_ 156 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-----DVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp S-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS-----SHHHHHHHHHHHHCCCCTTTCTT
T ss_pred c-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC-----CHHHHHHHHHhhcCCCChhhhhh
Confidence 2 233345788999999987655 6899999999999999999999975322 222222221110000
Q ss_pred ----------cccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 300 ----------FDIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 300 ----------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
................++.+.+|+.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000001111122344567899999999999999999999874
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.1e-46 Score=338.94 Aligned_cols=257 Identities=21% Similarity=0.291 Sum_probs=196.4
Q ss_pred cCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCChhHHHHHHHHHHHHhhCC-CCceeeeeeeeeec--ccceEEE
Q 017262 72 DYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQIN-HRNVVKLLGCCLEV--EVPLLVY 147 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~ 147 (374)
++|++.+.||+|+||+||+|+. .+|+.||+|+++... .+.+.+|+.+|+.++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999997 468999999987543 456789999999995 99999999999744 4688999
Q ss_pred EeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCC-cEEEeeccccccccc
Q 017262 148 EFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKY-RAKIADFGTSRSIAI 226 (374)
Q Consensus 148 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~ 226 (374)
||+++++|..+.. .+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||++.....
T Consensus 112 e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 9999999977642 5899999999999999999999999 99999999999998654 699999999987653
Q ss_pred CCceeeecccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChH--H-----HHHHHHHhcc
Q 017262 227 DQTHVSTKVQGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLT--T-----YFVECIEENC 298 (374)
Q Consensus 227 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~--~-----~~~~~~~~~~ 298 (374)
.. ......+|+.|+|||.+.+. .++.++||||+||++|+|++|..||............ . ..........
T Consensus 183 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 183 GQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp TC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred CC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 32 23445689999999998765 4799999999999999999999999753321100000 0 0000000000
Q ss_pred ccc------cc--------cccccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 299 LFD------II--------DDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 299 ~~~------~~--------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
... .. ............++.+.+||++||..||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 00 000111112234567899999999999999999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=348.89 Aligned_cols=252 Identities=26% Similarity=0.333 Sum_probs=203.9
Q ss_pred cCCCcCceEeeeCeEEEEEEEec----CCcEEEEEEeccC----ChhHHHHHHHHHHHHhhCCC-Cceeeeeeeeeeccc
Q 017262 72 DYFNMNRILGQGGQGTVYKGMLA----DGRIIAVKKSKVV----DESKLEEFINEVVILSQINH-RNVVKLLGCCLEVEV 142 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~ 142 (374)
++|++.+.||+|+||+||+|... +|+.||+|.++.. +....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56999999999999999999852 4789999987542 12234567889999999976 899999999999999
Q ss_pred ceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeeccccc
Q 017262 143 PLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTSR 222 (374)
Q Consensus 143 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 222 (374)
.++++||+.+|+|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 104 ~~~v~e~~~~~~L~~~i~---~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHH---hcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999997 4557889999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCceeeecccccccccCccccccC--CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccc
Q 017262 223 SIAIDQTHVSTKVQGTFGYLDPEYFRSS--QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLF 300 (374)
Q Consensus 223 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (374)
..............|++.|+|||.+.+. .++.++|||||||++|+|++|+.||......+ ............
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~--~~~~i~~~~~~~---- 251 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--SQAEISRRILKS---- 251 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--CHHHHHHHHHHC----
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcccC----
Confidence 7655444445566799999999998754 46889999999999999999999997554322 222211111111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 017262 301 DIIDDQVRKSGEAEEIMAVSDVAKRCLNSYGRNRPT-----MKEVAM 342 (374)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~vl~ 342 (374)
....+...+..+.+|+.+||++||++||| ++|+++
T Consensus 252 -------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 -------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 11223345668999999999999999995 777764
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-46 Score=339.70 Aligned_cols=261 Identities=20% Similarity=0.275 Sum_probs=191.0
Q ss_pred hcCCCcCceEeeeCeEEEEEEEec-CCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeec------c
Q 017262 71 TDYFNMNRILGQGGQGTVYKGMLA-DGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEV------E 141 (374)
Q Consensus 71 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~ 141 (374)
.++|++.+.||+|+||+||+|.+. +|+.||||++... +......+.+|+.++++++||||++++++|... .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 367999999999999999999975 5899999998643 445566788999999999999999999999643 5
Q ss_pred cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccc
Q 017262 142 VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 221 (374)
Q Consensus 142 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 221 (374)
..|+||||+.++++.. +. ..+++..++.++.|++.||.|||++| |+||||||+|||++.++.+|++|||++
T Consensus 96 ~~~iv~Ey~~~~l~~~-~~-----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 96 DVYLVMELMDANLCQV-IQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEEECCSEEHHHH-HT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eeEEEEeccchHHHHh-hh-----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence 7799999997665554 32 35899999999999999999999999 999999999999999999999999998
Q ss_pred cccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccC----------------CC
Q 017262 222 RSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEG----------------RN 285 (374)
Q Consensus 222 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~----------------~~ 285 (374)
+.... ........+|+.|+|||++.+..++.++||||+||++++|++|+.||........ ..
T Consensus 167 ~~~~~--~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 167 RTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred hcccc--ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 76542 2333455689999999999999999999999999999999999999974332110 00
Q ss_pred hHHHHHHHHHhccc------cccccccccC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 286 LTTYFVECIEENCL------FDIIDDQVRK---SGEAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 286 ~~~~~~~~~~~~~~------~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
.............. .......... ......+..+.+|+.+||..||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000000111000 0000001111 112345678999999999999999999999984
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=336.35 Aligned_cols=256 Identities=21% Similarity=0.233 Sum_probs=195.3
Q ss_pred hhcCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccC--ChhHHHHHHHHHHHHhhCCCCceeeeeeeeeec-----c
Q 017262 70 ATDYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVV--DESKLEEFINEVVILSQINHRNVVKLLGCCLEV-----E 141 (374)
Q Consensus 70 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~ 141 (374)
..++|++.+.||+|+||+||+|.. .+|+.||||++... +......+.+|+.+|++++|||++++++++... .
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 367899999999999999999996 46899999998653 344556788999999999999999999998643 3
Q ss_pred cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEeecccc
Q 017262 142 VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIADFGTS 221 (374)
Q Consensus 142 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 221 (374)
..+++++++.+|+|.+++. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+|++|||++
T Consensus 96 ~~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred ceEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchh
Confidence 4567788888999999985 346999999999999999999999999 999999999999999999999999998
Q ss_pred cccccCCceeeecccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHHHHHHHhcccc
Q 017262 222 RSIAIDQTHVSTKVQGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYFVECIEENCLF 300 (374)
Q Consensus 222 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (374)
..... ......|++.|+|||...+. .++.++|||||||++|+|++|+.||....... ............
T Consensus 169 ~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~------~~~~i~~~~~~~ 238 (348)
T d2gfsa1 169 RHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID------QLKLILRLVGTP 238 (348)
T ss_dssp -CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHHHCCC
T ss_pred cccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH------HHHHHHHhcCCC
Confidence 75432 22345689999999987665 46889999999999999999999997433211 111111100000
Q ss_pred -c-------------cccccc-cCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017262 301 -D-------------IIDDQV-RKSG-----EAEEIMAVSDVAKRCLNSYGRNRPTMKEVAM 342 (374)
Q Consensus 301 -~-------------~~~~~~-~~~~-----~~~~~~~l~~li~~cl~~~p~~Rps~~~vl~ 342 (374)
. ...... .... ....++.+.+||.+||..||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0 000000 0000 0123457889999999999999999999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.3e-41 Score=310.19 Aligned_cols=263 Identities=22% Similarity=0.228 Sum_probs=192.1
Q ss_pred cCCCcCceEeeeCeEEEEEEEe-cCCcEEEEEEeccCChhHHHHHHHHHHHHhhCC-----------CCceeeeeeeeee
Q 017262 72 DYFNMNRILGQGGQGTVYKGML-ADGRIIAVKKSKVVDESKLEEFINEVVILSQIN-----------HRNVVKLLGCCLE 139 (374)
Q Consensus 72 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~~ 139 (374)
++|++.+.||+|+||+||+|+. .+|+.||||+++.. ....+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 4599999999999999999996 46899999998754 333467788999888875 5789999998865
Q ss_pred cc--cceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCEEEeccCCCceEECCCC-----
Q 017262 140 VE--VPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHS-SAYLPIYHRDIKSTNILLDEKY----- 211 (374)
Q Consensus 140 ~~--~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~~i~H~dlk~~Nill~~~~----- 211 (374)
.. ..++++.++..+..............+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 43 456667766554433333222255678999999999999999999998 77 99999999999998655
Q ss_pred -cEEEeecccccccccCCceeeecccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCccccccCCChHHHH
Q 017262 212 -RAKIADFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVVLVELLTGQKPISSIWANEGRNLTTYF 290 (374)
Q Consensus 212 -~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 290 (374)
.++++|||.+..... ......||+.|+|||++.+..++.++||||+||++++|++|+.||...............
T Consensus 169 ~~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred ceeeEeeccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 399999999875432 224456999999999999999999999999999999999999999754432222222211
Q ss_pred HHHHHh-----------c----------cccccccc----------cccCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 017262 291 VECIEE-----------N----------CLFDIIDD----------QVRKSGEAEEIMAVSDVAKRCLNSYGRNRPTMKE 339 (374)
Q Consensus 291 ~~~~~~-----------~----------~~~~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 339 (374)
...... . .....+.. ..........+..+.+|+.+||..||.+|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 111110 0 00000000 0122345677889999999999999999999999
Q ss_pred HHH
Q 017262 340 VAM 342 (374)
Q Consensus 340 vl~ 342 (374)
+++
T Consensus 325 ~L~ 327 (362)
T d1q8ya_ 325 LVN 327 (362)
T ss_dssp HHT
T ss_pred Hhc
Confidence 975
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=2.3e-25 Score=184.19 Aligned_cols=168 Identities=18% Similarity=0.175 Sum_probs=120.1
Q ss_pred CcCceEeeeCeEEEEEEEecCCcEEEEEEeccCCh------------------hHHHHHHHHHHHHhhCCCCceeeeeee
Q 017262 75 NMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDE------------------SKLEEFINEVVILSQINHRNVVKLLGC 136 (374)
Q Consensus 75 ~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~niv~~~~~ 136 (374)
.+.+.||+|+||+||+|...+|+.||+|.++.... ........|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 46789999999999999988999999997653211 112334568889999999999888765
Q ss_pred eeecccceEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEEeccCCCceEECCCCcEEEe
Q 017262 137 CLEVEVPLLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSAYLPIYHRDIKSTNILLDEKYRAKIA 216 (374)
Q Consensus 137 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i~H~dlk~~Nill~~~~~~kl~ 216 (374)
. ..+++|||+++..+..+ +......++.|++.+++|||+++ ++||||||+|||++++ .++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~l----------~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYRV----------RVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGGC----------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred c----CCEEEEEeeccccccch----------hhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence 3 34799999988665432 23345678999999999999999 9999999999999865 58999
Q ss_pred ecccccccccCCceeeecccccccccCccccccCCCCccchhhhHHHH
Q 017262 217 DFGTSRSIAIDQTHVSTKVQGTFGYLDPEYFRSSQFTDKSDVYSFGVV 264 (374)
Q Consensus 217 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~ 264 (374)
|||++.....+.....-. .+.. .-.+ +....|+.++|+||+.--
T Consensus 145 DFG~a~~~~~~~~~~~l~--rd~~-~~~~-~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 145 DFPQSVEVGEEGWREILE--RDVR-NIIT-YFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp CCTTCEETTSTTHHHHHH--HHHH-HHHH-HHHHHHCCCCCHHHHHHH
T ss_pred ECCCcccCCCCCcHHHHH--HHHH-HHHH-HHcCCCCCcccHHHHHHH
Confidence 999997654322211000 0000 0011 123567889999996543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.57 E-value=6.5e-08 Score=82.01 Aligned_cols=149 Identities=18% Similarity=0.124 Sum_probs=100.9
Q ss_pred HHHHHhhcCCCcCceEeeeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCC-CCceeeeeeeeeecccc
Q 017262 65 KELDKATDYFNMNRILGQGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQIN-HRNVVKLLGCCLEVEVP 143 (374)
Q Consensus 65 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~ 143 (374)
.++...-..|++.+..+-++.+.||+... +++.+++|+...........+.+|...++.+. +--+++++.+..+++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 34555556677666544445578998765 45567788765443333345667888887774 33467788888888889
Q ss_pred eEEEEeecCCcccccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--------------------------------
Q 017262 144 LLVYEFIPNGTLFQYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSA-------------------------------- 191 (374)
Q Consensus 144 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~-------------------------------- 191 (374)
++||++++|.++.+.... . . ....++.+++..++.||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~---~--~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYED---E--Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEEECCSSEEHHHHTTT---C--S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred EEEEEecccccccccccc---c--c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence 999999999887654431 1 1 12335666777777777532
Q ss_pred ------------------------CCCEEEeccCCCceEECCCCcEEEeeccccc
Q 017262 192 ------------------------YLPIYHRDIKSTNILLDEKYRAKIADFGTSR 222 (374)
Q Consensus 192 ------------------------~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 222 (374)
...++|+|+.|.||++++++.+-|+||+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 0127999999999999987666799998774
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.16 E-value=6.7e-06 Score=68.76 Aligned_cols=129 Identities=19% Similarity=0.181 Sum_probs=87.3
Q ss_pred EeeeCe-EEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCC--CceeeeeeeeeecccceEEEEeecCCccc
Q 017262 80 LGQGGQ-GTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINH--RNVVKLLGCCLEVEVPLLVYEFIPNGTLF 156 (374)
Q Consensus 80 lg~G~~-g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g~L~ 156 (374)
+..|.. +.||+....++..+++|....... ..+..|...++.+.. -.+++++.+..+.+..+++|++++|.++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 344443 678998888888888897654432 345667777777642 33567788888888889999999887764
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC---------------------------------------------
Q 017262 157 QYLHDPYEELSLTWEMRLRIATEVAEALAYLHSSA--------------------------------------------- 191 (374)
Q Consensus 157 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--------------------------------------------- 191 (374)
+.. ... ...+.++...|+-||+..
T Consensus 95 ~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 95 SSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp TSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred ccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence 422 111 122344555555555321
Q ss_pred ----------CCCEEEeccCCCceEECCCCcEEEeeccccc
Q 017262 192 ----------YLPIYHRDIKSTNILLDEKYRAKIADFGTSR 222 (374)
Q Consensus 192 ----------~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 222 (374)
.+.++|+|+.|.||+++++..+-|+||+.+.
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1127999999999999987667899998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.74 E-value=4.1e-05 Score=68.25 Aligned_cols=76 Identities=16% Similarity=0.208 Sum_probs=47.7
Q ss_pred ceEeeeCeEEEEEEEecC-CcEEEEEEeccC----C---hhHHHHHHHHHHHHhhCC-C--CceeeeeeeeeecccceEE
Q 017262 78 RILGQGGQGTVYKGMLAD-GRIIAVKKSKVV----D---ESKLEEFINEVVILSQIN-H--RNVVKLLGCCLEVEVPLLV 146 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~----~---~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~~~lv 146 (374)
+.||.|....||+....+ ++.+++|.-... . +........|.+.|+.+. + ..+++++.+ +.+..+++
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 457999999999998654 678889864321 1 112234456888887663 2 345556544 45677899
Q ss_pred EEeecCCcc
Q 017262 147 YEFIPNGTL 155 (374)
Q Consensus 147 ~e~~~~g~L 155 (374)
||++++..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999976543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.92 E-value=0.002 Score=55.27 Aligned_cols=69 Identities=14% Similarity=0.084 Sum_probs=45.1
Q ss_pred EEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCce--eeee-----eeeeecccceEEEEeecCCcc
Q 017262 86 GTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNV--VKLL-----GCCLEVEVPLLVYEFIPNGTL 155 (374)
Q Consensus 86 g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~~~-----~~~~~~~~~~lv~e~~~~g~L 155 (374)
-.||++...+|+.+++|...... ....++..|...+..|...++ +... ..+...+..+.++++++|..+
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 58999999999999999876432 234567778888877742222 1111 122345567889999877554
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.72 E-value=0.0019 Score=57.20 Aligned_cols=73 Identities=19% Similarity=0.234 Sum_probs=47.8
Q ss_pred ceEeeeCeEEEEEEEecC--------CcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCc-eeeeeeeeeecccceEEEE
Q 017262 78 RILGQGGQGTVYKGMLAD--------GRIIAVKKSKVVDESKLEEFINEVVILSQINHRN-VVKLLGCCLEVEVPLLVYE 148 (374)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e 148 (374)
+.|+-|-.-.+|+....+ .+.+.++.... ... .....+|..+++.+.-.+ .+++++++.+ ..|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 467778888999988654 24566666542 222 234567888888885333 4577777643 58899
Q ss_pred eecCCccc
Q 017262 149 FIPNGTLF 156 (374)
Q Consensus 149 ~~~~g~L~ 156 (374)
|++|.+|.
T Consensus 122 fi~g~~l~ 129 (395)
T d1nw1a_ 122 YIPSRPLS 129 (395)
T ss_dssp CCCEEECC
T ss_pred EeccccCC
Confidence 99876553
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.68 E-value=0.0045 Score=52.66 Aligned_cols=158 Identities=9% Similarity=0.037 Sum_probs=80.2
Q ss_pred cChHHHHHhhcCCCcCceEe-----eeCeEEEEEEEecCCcEEEEEEeccCChhHHHHHHHHHHHHhhCCCCce--eeee
Q 017262 62 FNSKELDKATDYFNMNRILG-----QGGQGTVYKGMLADGRIIAVKKSKVVDESKLEEFINEVVILSQINHRNV--VKLL 134 (374)
Q Consensus 62 ~~~~~~~~~~~~~~~~~~lg-----~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~~~ 134 (374)
.+.+++...-..|.+++... .|---+.|+....+|+ +++|+..... ....+..|+.++..+...++ +...
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 34667777777888765543 4555778998877665 7888765421 12334446666666632222 1111
Q ss_pred ee------eeecccceEEEEeecCCccccccc-----------------CCC---CCCCCC------------------H
Q 017262 135 GC------CLEVEVPLLVYEFIPNGTLFQYLH-----------------DPY---EELSLT------------------W 170 (374)
Q Consensus 135 ~~------~~~~~~~~lv~e~~~~g~L~~~l~-----------------~~~---~~~~l~------------------~ 170 (374)
.. .........++.+..+......-. ... ...... .
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 11 112334556666665543321100 000 000000 0
Q ss_pred HHHHHHHHHHHHHHHHHhhcC-CCCEEEeccCCCceEECCCCcEEEeeccccc
Q 017262 171 EMRLRIATEVAEALAYLHSSA-YLPIYHRDIKSTNILLDEKYRAKIADFGTSR 222 (374)
Q Consensus 171 ~~~~~i~~~i~~~l~~lH~~~-~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 222 (374)
......+......+.-.+..+ ..+++|+|+.++|++++.+...-+.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 011122222222222222211 2249999999999999988777899999874
|